From: <Saved by Blink>
Snapshot-Content-Location: https://www.medicijnkosten.nl/zoeken?searchTerm=632%20Medicijnkosten%20Drugs4&type=medicine&searchTermHandover=632%20Medicijnkosten%20Drugs4&vorm=VLOEISTOF&sterkte=Alle%20sterktes
Subject: Zoeken | Medicijnkosten.nl
Date: Mon, 9 Feb 2026 13:04:13 +0530
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----"


------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/html
Content-ID: <frame-10DF4E9865BD56C151D37B20BC303921@mhtml.blink>
Content-Transfer-Encoding: quoted-printable
Content-Location: https://www.medicijnkosten.nl/zoeken?searchTerm=632%20Medicijnkosten%20Drugs4&type=medicine&searchTermHandover=632%20Medicijnkosten%20Drugs4&vorm=VLOEISTOF&sterkte=Alle%20sterktes

<!DOCTYPE html><html lang=3D"nl" class=3D"js" data-kantu=3D"1"><head><meta =
http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8"><link re=
l=3D"stylesheet" type=3D"text/css" href=3D"cid:css-06842c42-6ff6-42d3-ad3a-=
feac74438445@mhtml.blink" /><link rel=3D"stylesheet" type=3D"text/css" href=
=3D"cid:css-e30718dc-8993-479a-9861-d8463642433f@mhtml.blink" /><link rel=
=3D"stylesheet" type=3D"text/css" href=3D"cid:css-6cc66aba-3c49-4ab9-aa19-1=
4b345540fa3@mhtml.blink" />
  <meta content=3D"medicijnkosten.nl" name=3D"DCTERMS.identifier">
<meta content=3D"webcontent" name=3D"DCTERMS.type" title=3D"medicijnkosten.=
nl">
<meta content=3D"nl-NL" name=3D"DCTERMS.language" title=3D"XSD.language">
<meta content=3D"Zorginstituut Nederland" name=3D"DCTERMS.creator" title=3D=
"ZORGINSTITUUT.Organisatie">
<meta content=3D"Zorginstituut Nederland" name=3D"DCTERMS.publisher" title=
=3D"ZORGINSTITUUT.Organisatie">
<meta content=3D"Nederland" name=3D"DCTERMS.spatial" title=3D"OVERHEID.Koni=
nkrijksdeel">

<link rel=3D"apple-touch-icon" sizes=3D"180x180" href=3D"https://www.medici=
jnkosten.nl/assets/favicon/touch-icon.png">
<link rel=3D"icon" type=3D"image/png" sizes=3D"32x32" href=3D"https://www.m=
edicijnkosten.nl/assets/favicon/touch-icon.png">
<link rel=3D"icon" type=3D"image/png" sizes=3D"16x16" href=3D"https://www.m=
edicijnkosten.nl/assets/favicon/touch-icon.png">

<link rel=3D"manifest" href=3D"https://www.medicijnkosten.nl/assets/favicon=
/site.webmanifest">
<meta name=3D"msapplication-TileColor" content=3D"#39870c">
<meta name=3D"msapplication-config" content=3D"/assets/favicon/browserconfi=
g.xml">
<meta name=3D"theme-color" content=3D"#39870c">

<meta name=3D"viewport" content=3D"width =3D device-width, initial-scale =
=3D 1.0, minimum-scale =3D 1, maximum-scale =3D 1, user-scalable =3D no">
<meta name=3D"apple-mobile-web-app-capable" content=3D"yes">
<meta name=3D"mobile-web-app-capable" content=3D"yes">
<meta name=3D"apple-mobile-web-app-title" content=3D"medicijnkosten.nl">
<meta name=3D"mobile-web-app-title" content=3D"medicijnkosten.nl">
<meta name=3D"apple-mobile-web-app-status-bar-style" content=3D"default">

<meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge">




<title>Zoeken | Medicijnkosten.nl</title>
<meta property=3D"og:title" content=3D"Zoeken">
<meta name=3D"DCTERMS.title" content=3D"Zoeken">
<meta property=3D"og:title" content=3D"Medicijnkosten.nl">
<meta name=3D"DCTERMS.title" content=3D"Medicijnkosten.nl">

  <link href=3D"https://www.medicijnkosten.nl/assets/style/style.css?v=3D4.=
0.5_" type=3D"text/css" rel=3D"stylesheet" media=3D"all">
</head>

<body class=3D"product-med anonymous pat-scroll-box patterns-loaded scroll-=
up scroll-position-top">
  <div class=3D"cookiewarning clearfix" style=3D"display: none;">
    Deze website gebruikt cookies om het gebruik van de website te analyser=
en en het gebruiksgemak te verbeteren. Lees meer over <a href=3D"https://ww=
w.medicijnkosten.nl/algemeen/cookies">cookies</a>.<button class=3D"cookiewa=
rning_yes close-button">Sluit</button>
</div>
<div id=3D"global-nav" class=3D"pat-sticky anonymous" role=3D"menubar">
    <div class=3D"container">
        <nav id=3D"tabs">
    <div id=3D"dashboard-breadcrumbs" class=3D"breadcrumbs">
        <a class=3D"pat-inject homepage pat-switch" href=3D"https://www.med=
icijnkosten.nl/" data-pat-inject=3D"
                 source: #product-space; target: #product-space;
                 &amp;&amp;
                 source: #dashboard-breadcrumbs, #global-nav #breadcrumbs; =
target: #dashboard-breadcrumbs, #global-nav #breadcrumbs;
                 &amp;&amp;
                 history: record;" data-pat-switch=3D"
                 #app-space state-* state-paused &amp;&amp;
                 selector: #app-space .app-frame#app-dashboard; remove: sta=
te-*; add: state-inactive">
                                Medicijnkosten.nl</a>
                    </div>

    <div class=3D"tabs pat-tabs tabs-ready" id=3D"app-tabs">
    </div>

</nav><nav id=3D"breadcrumbs">
    <p class=3D"assistive">U bevindt zich hier:</p>

    <a class=3D"pat-inject homepage" href=3D"https://www.medicijnkosten.nl/=
" data-pat-inject=3D"history: record">Medicijnkosten.nl</a>
                    </nav><form title=3D"Search" accept-charset=3D"UTF-8" a=
ction=3D"https://www.medicijnkosten.nl/zoeken" id=3D"quick-search-form" met=
hod=3D"get" name=3D"quick-search-form" class=3D"pat-form pat-inject" data-p=
at-inject=3D"history: record; scroll: top">
    <label for=3D"global-search-lemma" data-placeholder=3D"Zoek een medicij=
n op naam of code=E2=80=A6" class=3D"focus">Zoek een medicijn op naam of co=
de=E2=80=A6</label>
    <input name=3D"searchTerm" id=3D"global-search-lemma" placeholder=3D"Zo=
ek een medicijn op naam of code=E2=80=A6" type=3D"text" value=3D"" data-pla=
ceholder=3D"Zoek een medicijn op naam of code=E2=80=A6">
    <button type=3D"submit">Zoek</button>
</form></div>
</div><div class=3D"main" role=3D"main" id=3D"main">
    <div id=3D"app-space" class=3D"state-paused">
    </div>
<div id=3D"product-space">
    <div id=3D"content" class=3D" spotlight-off">
    <div class=3D"container">
        <div id=3D"main-content">
            <div class=3D"pat-rich">
                <div class=3D"summary discrete-injection" id=3D"summary">
                    <h2>
                            <strong>1949</strong>
                            zoekresultaten,
                            gefilterd op</h2>
                    </div>
            </div>

            <form id=3D"search-form" class=3D"pat-collapsible search-box pa=
t-inject pat-form closed executed" action=3D"https://www.medicijnkosten.nl/=
zoeken" data-pat-collapsible=3D"open-trigger: .filter-open-trigger; close-t=
rigger: .filter-close-trigger" data-pat-inject=3D"history: record; source: =
#sorting; target: #sorting &amp;&amp; source: #summary; target: #summary &a=
mp;&amp; source: #result-list; target: #result-list; &amp;&amp; source: #fi=
lter-tags; target: #filter-tags; &amp;&amp; source: #standard-search-filter=
s; target: #standard-search-filters; &amp;&amp; source: #extra-search-filte=
rs; target: #extra-search-filters; &amp;&amp; source: #lemma; target: #lemm=
a">
                <h2 class=3D"main-filter-toggle collapsible-closed">
                    Filters</h2>

                <div class=3D"filter-header">
    <div class=3D"filter-tags discrete-injection" id=3D"filter-tags">
        <button type=3D"submit" id=3D"tag-searchTerm" class=3D"filter-open-=
trigger tag remove-tag pat-switch" data-pat-switch=3D"selector: #tag-search=
Term; add: collapsed" value=3D"searchTerm" name=3D"remove-filter">Trefwoord=
: 632 Medicijnkosten Drugs4</button>
        <button type=3D"submit" id=3D"tag-type" class=3D"tag remove-tag pat=
-switch" data-pat-switch=3D"selector: #tag-type; add: collapsed" value=3D"t=
ype" name=3D"remove-filter">Type:
                    Geneesmiddelen</button>
            <button type=3D"submit" id=3D"tag-vorm" class=3D"tag remove-tag=
 pat-switch" data-pat-switch=3D"selector: #tag-vorm; add: collapsed" value=
=3D"vorm" name=3D"remove-filter">
                        Vorm:
                        VLOEISTOF</button>
                </div>
    <div class=3D"buttons">
        <a class=3D"filter-open-trigger filter-toggle" type=3D"button" id=
=3D"open-trigger">Toon filters</a>
        <a class=3D"filter-close-trigger filter-toggle" type=3D"button" id=
=3D"close-trigger">Verberg filters</a>
    </div>
</div><fieldset class=3D"filters panel-content" id=3D"panel-content" style=
=3D"display: none;">
    <fieldset class=3D"form-panel section horizontal has-value" data-placeh=
older=3D"Zoek een medicijn op naam of code=E2=80=A6" data-value=3D"632 Medi=
cijnkosten Drugs4">
        <label class=3D"pat-inject pat-autosubmit pat-subform lemma has-val=
ue" id=3D"lemma" data-pat-inject=3D"source: #standard-search-filters; targe=
t: #standard-search-filters; &amp;&amp; source: #extra-search-filters; targ=
et: #extra-search-filters;" data-placeholder=3D"Zoek een medicijn op naam o=
f code=E2=80=A6" data-value=3D"632 Medicijnkosten Drugs4">
            Trefwoord<input type=3D"text" class=3D"pat-autofocus" name=3D"s=
earchTerm" placeholder=3D"Zoek een medicijn op naam of code=E2=80=A6" value=
=3D"632 Medicijnkosten Drugs4">
        </label>
        <fieldset id=3D"standard-search-filters" class=3D"pat-inject pat-au=
tosubmit pat-subform horizontal has-value" data-pat-inject=3D"source: #extr=
a-search-filters; target: #extra-search-filters;" data-value=3D"medicine">
    <label class=3D"has-value" data-value=3D"medicine">
            Type<select name=3D"type" class=3D"has-value" data-value=3D"med=
icine">
                <option value=3D"">
                            Alle documenttypen</option>
                <option value=3D"algemeen">
                            Algemeen</option>
                <option value=3D"begrippen">
                            Begrippen</option>
                <option value=3D"nieuws">
                            Nieuws</option>
                <option value=3D"tags">
                            Tags</option>
                <option value=3D"medicine" selected=3D"">
                            Geneesmiddelen</option>
                </select>
            <dfn class=3D"help-icon pat-tooltip tooltip-inactive" data-pat-=
tooltip=3D"class: info; trigger: click; source: content; position-list: tl"=
 aria-expanded=3D"false">
                U kunt hier een specifiek type document kiezen, zoals broch=
ures of jaarverslagen.</dfn>
        </label>
   =20
</fieldset><fieldset id=3D"extra-search-filters" class=3D"horizontal has-va=
lue" data-value=3D"Alle sterktes">
    <label class=3D"has-value" data-value=3D"VLOEISTOF">
        Vorm<select name=3D"vorm" class=3D"has-value" data-value=3D"VLOEIST=
OF">
            <option>
                Alle vormen</option>
            <option selected=3D"">
                                    VLOEISTOF</option>
                        </select>
    </label>
<label class=3D"has-value" data-value=3D"Alle sterktes">
        Sterkte<select name=3D"sterkte" class=3D"has-value" data-value=3D"A=
lle sterktes">
            <option>
                Alle sterktes</option>
            <option>
                                    41,67MG/ML</option>
                        <option>
                                    12,5MG/ML</option>
                        <option>
                                    8,7MG/ML</option>
                        <option>
                                    17,39MG/ML</option>
                        <option>
                                    10MG/ML</option>
                        <option>
                                    35MG/ML</option>
                        <option>
                                    22,5MG/ML</option>
                        <option>
                                    30MG/ML</option>
                        <option>
                                    50/6,25MG/ML</option>
                        <option>
                                    4,167MG/ML</option>
                        <option>
                                    1MG/1UG/ML</option>
                        <option>
                                    1,25/0,02MG/ML</option>
                        <option>
                                    60/7,5MG/ML</option>
                        <option>
                                    33333IE/ML</option>
                        <option>
                                    1/0,1MG/ML</option>
                        <option>
                                    1MG/ML</option>
                        <option>
                                    250UG/ML</option>
                        <option>
                                    2,5/0,25MG/ML</option>
                        <option>
                                    5MG/ML</option>
                        <option>
                                    2MG/ML</option>
                        <option>
                                    1/0,2MG/ML</option>
                        <option>
                                    1,25MG/0,5UG/ML</option>
                        <option>
                                    0,1MG/ML</option>
                        <option>
                                    1,25MG/1UG/ML</option>
                        <option>
                                    500IE/ML</option>
                        <option>
                                    125UG/ML</option>
                        <option>
                                    200IE/ML</option>
                        <option>
                                    0,25MG/ML</option>
                        <option>
                                    3,2/0,64MG/ML</option>
                        <option>
                                    0,125MG/ML</option>
                        <option>
                                    2,5UG/DO</option>
                        <option>
                                    9MG/ML</option>
                        <option>
                                    50MG/ML</option>
                        <option>
                                    25/4,5MG/ML</option>
                        <option>
                                    0,5MG/ML</option>
                        <option>
                                    2,5/2,5UG/DO</option>
                        <option>
                                    14MG/ML</option>
                        <option>
                                    200MG/ML</option>
                        <option>
                                    40MG/ML</option>
                        <option>
                                    0,33/0,3/8,6MG/ML</option>
                        <option>
                                    42MG/ML</option>
                        <option>
                                    100MG/ML</option>
                        <option>
                                    84MG/ML</option>
                        <option>
                                    6,5MG/ML</option>
                        <option>
                                    0,2MG/ML</option>
                        <option>
                                    33/3MG/ML</option>
                        <option>
                                    57/7,1MG/ML</option>
                        <option>
                                    50IE/ML</option>
                        <option>
                                    20MG/ML</option>
                        <option>
                                    700MG/ML</option>
                        <option>
                                    24MG/ML</option>
                        <option>
                                    15MG/ML</option>
                        <option>
                                    4MG/ML</option>
                        <option>
                                    28,6MG/ML</option>
                        <option>
                                    12MG/ML</option>
                        <option>
                                    3MG/ML</option>
                        <option>
                                    45MG/ML</option>
                        <option>
                                    75MG/ML</option>
                        <option>
                                    16MG/ML</option>
                        <option>
                                    7,5MG/ML</option>
                        <option>
                                    4,17MG/ML</option>
                        <option>
                                    0,04MG/ML</option>
                        <option>
                                    2,8MG/ML</option>
                        <option>
                                    2,4MG/ML</option>
                        <option>
                                    8,33MG/ML</option>
                        <option>
                                    6MG/ML</option>
                        <option>
                                    1,04MG/ML</option>
                        <option>
                                    1,6MG/ML</option>
                        <option>
                                    3,2MG/ML</option>
                        <option>
                                    3,6MG/ML</option>
                        <option>
                                    80/10MG/ML</option>
                        <option>
                                    1,2MG/ML</option>
                        <option>
                                    3,12MG/ML</option>
                        <option>
                                    7MG/ML</option>
                        <option>
                                    16,7MG/ML</option>
                        <option>
                                    2,08MG/ML</option>
                        <option>
                                    4,5MG/ML</option>
                        <option>
                                    8,2MG/ML</option>
                        <option>
                                    4,8MG/ML</option>
                        <option>
                                    2,5MG/ML</option>
                        <option>
                                    5,7MG/ML</option>
                        <option>
                                    2,6MG/ML</option>
                        <option>
                                    16/2MG/ML</option>
                        <option>
                                    60MG/ML</option>
                        <option>
                                    33,3MG/ML</option>
                        <option>
                                    5,2MG/ML</option>
                        <option>
                                    11,72MG/ML</option>
                        <option>
                                    5,5MG/ML</option>
                        <option>
                                    33,333MG/ML</option>
                        <option>
                                    6,25MG/ML</option>
                        <option>
                                    3,5MG/ML</option>
                        <option>
                                    32/4MG/ML</option>
                        <option>
                                    3,436MG/ML</option>
                        <option>
                                    25MG/ML</option>
                        <option>
                                    60000IE/ML</option>
                        <option>
                                    17MG/ML</option>
                        <option>
                                    15,15MG/ML</option>
                        <option>
                                    8MG/ML</option>
                        <option>
                                    3,4MG/ML</option>
                        <option>
                                    7,3MG/ML</option>
                        <option>
                                    16,67MG/ML</option>
                        <option>
                                    18MG/ML</option>
                        <option>
                                    17,5MG/ML</option>
                        <option>
                                    17,857MG/ML</option>
                        <option>
                                    8,333MG/ML</option>
                        <option>
                                    10,4MG/ML</option>
                        <option>
                                    2,679MG/ML</option>
                        <option>
                                    83,33MG/ML</option>
                        <option>
                                    20,83MG/ML</option>
                        <option>
                                    9,4MG/ML</option>
                        <option>
                                    31,25MG/ML</option>
                        <option>
                                    18,75MG/ML</option>
                        <option>
                                    28/3,5MG/ML</option>
                        <option>
                                    40000IE/ML</option>
                        <option>
                                    48/6MG/ML</option>
                        <option>
                                    96,154MG/ML</option>
                        <option>
                                    32MG/ML</option>
                        <option>
                                    26,08MG/ML</option>
                        <option>
                                    1,25MG/ML</option>
                        <option>
                                    37,5MG/ML</option>
                        <option>
                                    16,667MG/ML</option>
                        <option>
                                    16,7/2,1MG/ML</option>
                        <option>
                                    6,4MG/ML</option>
                        <option>
                                    50000IE/ML</option>
                        <option>
                                    72000IE/ML</option>
                        <option>
                                    3,75MG/ML</option>
                        <option>
                                    55000IE/ML</option>
                        <option>
                                    3,333MG/ML</option>
                        <option>
                                    40/5MG/ML</option>
                        <option>
                                    80000IE/ML</option>
                        <option>
                                    70000IE/ML</option>
                        <option>
                                    41,7MG/ML</option>
                        <option>
                                    24000IE/ML</option>
                        <option>
                                    4,31MG/ML</option>
                        <option>
                                    90000IE/ML</option>
                        <option>
                                    86956,522IE/ML</option>
                        <option>
                                    15,625MG/ML</option>
                        <option>
                                    66667IE/ML</option>
                        <option>
                                    52083IE/ML</option>
                        <option>
                                    48MG/ML</option>
                        <option>
                                    64/8MG/ML</option>
                        <option>
                                    33,3/4,2MG/ML</option>
                        <option>
                                    7,083MG/ML</option>
                        <option>
                                    5,21MG/ML</option>
                        <option>
                                    2,604MG/ML</option>
                        <option>
                                    6,875MG/ML</option>
                        <option>
                                    100000IE/ML</option>
                        <option>
                                    45000IE/ML</option>
                        <option>
                                    83333IE/ML</option>
                        <option>
                                    1,333MG/ML</option>
                        <option>
                                    20,833MG/ML</option>
                        <option>
                                    1,46MG/ML</option>
                        <option>
                                    110000IE/ML</option>
                        <option>
                                    2,71MG/ML</option>
                        <option>
                                    22,917MG/ML</option>
                        <option>
                                    3,438MG/ML</option>
                        <option>
                                    36MG/ML</option>
                        <option>
                                    6,521MG/ML</option>
                        <option>
                                    0,05MG/ML</option>
                        <option>
                                    11MG/ML</option>
                        <option>
                                    80MG/ML</option>
                        <option>
                                    120000IE/ML</option>
                        <option>
                                    1,67MG/ML</option>
                        <option>
                                    25/3,125MG/ML</option>
                        <option>
                                    116667IE/ML</option>
                        <option>
                                    180000IE/ML</option>
                        <option>
                                    4,35MG/ML</option>
                        <option>
                                    19,565MG/ML</option>
                        <option>
                                    5/0,07MG/ML</option>
                        <option>
                                    21,25MG/ML</option>
                        <option>
                                    66,7/8,3MG/ML</option>
                        <option>
                                    56000IE/ML</option>
                        <option>
                                    4,16MG/ML</option>
                        <option>
                                    29,167MG/ML</option>
                        <option>
                                    3,549MG/ML</option>
                        <option>
                                    8,696MG/ML</option>
                        <option>
                                    13MG/ML</option>
                        <option>
                                    64000IE/ML</option>
                        <option>
                                    69,6/8,7MG/ML</option>
                        <option>
                                    1,25/0,2MG/ML</option>
                        <option>
                                    7,81MG/ML</option>
                        <option>
                                    3,958MG/ML</option>
                        <option>
                                    8,8MG/ML</option>
                        <option>
                                    0,625MG/O,5UG/ML</option>
                        <option>
                                    140000IE/ML</option>
                        <option>
                                    34,8/4,3MG/ML</option>
                        <option>
                                    75/9,38MG/ML</option>
                        <option>
                                    1MG/0,2UG/ML</option>
                        <option>
                                    160000IE/ML</option>
                        <option>
                                    3,7MG/ML</option>
                        <option>
                                    48000IE/ML</option>
                        <option>
                                    50,4MG/ML</option>
                        <option>
                                    75000IE/ML</option>
                        <option>
                                    22,222MG/ML</option>
                        <option>
                                    96000IE/ML</option>
                        <option>
                                    35,71MG/ML</option>
                        <option>
                                    13,043MG/ML</option>
                        <option>
                                    6,9MG/ML</option>
                        <option>
                                    26,09MG/ML</option>
                        <option>
                                    13,04MG/ML</option>
                        <option>
                                    34,78MG/ML</option>
                        <option>
                                    52,2/6,5MG/ML</option>
                        <option>
                                    62,5MG/ML</option>
                        <option>
                                    66,667MG/ML</option>
                        <option>
                                    240000IE/ML</option>
                        <option>
                                    120MG/ML</option>
                        <option>
                                    5,417MG/ML</option>
                        <option>
                                    52,17MG/ML</option>
                        <option>
                                    5,4MG/ML</option>
                        <option>
                                    9,677MG/ML</option>
                        <option>
                                    6,14MG/ML</option>
                        <option>
                                    10,417MG/ML</option>
                        <option>
                                    18,333MG/ML</option>
                        <option>
                                    12,121MG/ML</option>
                        <option>
                                    20/0,09MG/ML</option>
                        <option>
                                    44,4MG/ML</option>
                        <option>
                                    2,5MG/1UG/ML</option>
                        <option>
                                    58333IE/ML</option>
                        <option>
                                    107,14MG/ML</option>
                        <option>
                                    23,333MG/ML</option>
                        <option>
                                    14,6MG/ML</option>
                        <option>
                                    10/0,04MG/ML</option>
                        <option>
                                    5/0,04MG/ML</option>
                        <option>
                                    76000IE/ML</option>
                        <option>
                                    500MG/ML</option>
                        <option>
                                    78261IE/ML</option>
                        <option>
                                    150000IE/ML</option>
                        <option>
                                    20/0,08MG/ML</option>
                        <option>
                                    33,33MG/ML</option>
                        <option>
                                    20/0,01MG/ML</option>
                        <option>
                                    10/0,05MG/ML</option>
                        <option>
                                    104348IE/ML</option>
                        <option>
                                    58,333MG/ML</option>
                        <option>
                                    10/0,08MG/ML</option>
                        <option>
                                    20/0,04MG/ML</option>
                        <option>
                                    520,8IE/ML</option>
                        <option>
                                    100UG/ML</option>
                        <option>
                                    400IE/ML</option>
                        <option>
                                    240/12MG/ML</option>
                        <option>
                                    10UG/ML</option>
                        <option>
                                    54MG/ML</option>
                        <option>
                                    370MQ/ML</option>
                        <option>
                                    20TV/ML</option>
                        <option>
                                    0,56TV/ML</option>
                        <option>
                                    30/40MG/ML</option>
                        <option>
                                    0,46GQ/ML</option>
                        <option>
                                    417IE/ML</option>
                        <option>
                                    125MG/ML</option>
                        <option>
                                    0,012MG/ML</option>
                        <option>
                                    149MG/ML</option>
                        <option>
                                    2MG/0,5UG/ML</option>
                        <option>
                                    2/2MG/ML</option>
                        <option>
                                    4/2/2,4MG/ML</option>
                        <option>
                                    9/1,85/1,49/MG/ML</option>
                        <option>
                                    400MG/ML</option>
                        <option>
                                    0,54MMOL/0,24MMOL</option>
                        <option>
                                    0,15MMOL/ML</option>
                        <option>
                                    0,02MG/ML</option>
                        <option>
                                    2MG/1UG/ML</option>
                        <option>
                                    8,05/99MG/ML</option>
                        <option>
                                    14,9/50MG/ML</option>
                        <option>
                                    0,1MMOL/ML</option>
                        <option>
                                    1MMOL/ML</option>
                        <option>
                                    10/4,8MG/ML</option>
                        <option>
                                    100/1,5/1MG/ML</option>
                        <option>
                                    1MG/0,5UG/ML</option>
                        <option>
                                    20/40MG/ML</option>
                        <option>
                                    0,01MG/ML</option>
                        <option>
                                    40/80MG/ML</option>
                        <option>
                                    100IE/ML</option>
                        <option>
                                    3,75MG/0,5UG/ML</option>
                        <option>
                                    5UG/ML</option>
                        <option>
                                    150MG/ML</option>
                        <option>
                                    200/25MG/ML</option>
                        <option>
                                    300MG/ML</option>
                        <option>
                                    50/9MG/ML</option>
                        <option>
                                    50/4,5MG/ML</option>
                        <option>
                                    9/1,5/1,49MG/ML</option>
                        <option>
                                    1IE/4,5MG/ML</option>
                        <option>
                                    25/4,5/1,5MG/ML</option>
                        <option>
                                    0,18MG/ML</option>
                        <option>
                                    65MG/ML</option>
                        <option>
                                    36,3MG/ML</option>
                        <option>
                                    1,5/2,5MG/ML</option>
                        <option>
                                    10/3MG/ML</option>
                        <option>
                                    1,25MG/2,5UG/ML</option>
                        <option>
                                    1E/ML</option>
                        <option>
                                    0,1IE/ML</option>
                        <option>
                                    3/9MG/ML</option>
                        <option>
                                    0,2IE/ML</option>
                        <option>
                                    0,75MG/ML</option>
                        <option>
                                    9/2/1,49MG/ML</option>
                        <option>
                                    1,5/9MG/ML</option>
                        <option>
                                    1,5/50MG/ML</option>
                        <option>
                                    87UG/ML</option>
                        <option>
                                    0,667MG/ML</option>
                        <option>
                                    0,13MG/ML</option>
                        <option>
                                    0,06MG/ML</option>
                        <option>
                                    25/25MG/ML</option>
                        <option>
                                    0,8MG/ML</option>
                        <option>
                                    4UG/ML</option>
                        <option>
                                    0,03MG/ML</option>
                        <option>
                                    1,5MG/ML</option>
                        <option>
                                    1,75MG/ML</option>
                        <option>
                                    0,08MG/ML</option>
                        <option>
                                    3,3MG/ML</option>
                        <option>
                                    9,09MG/ML</option>
                        <option>
                                    100E/ML</option>
                        <option>
                                    0,625MG/0,5UG/ML</option>
                        <option>
                                    3,84MG/ML</option>
                        <option>
                                    20/10MG/ML</option>
                        <option>
                                    14,7MG/ML</option>
                        <option>
                                    20000IE/ML</option>
                        <option>
                                    30000IE/ML</option>
                        <option>
                                    0,75/1,5MG/ML</option>
                        <option>
                                    91,5/1,5MG/ML</option>
                        <option>
                                    64MG/ML</option>
                        <option>
                                    8,3MG/ML</option>
                        </select>
    </label>
</fieldset><div class=3D"group button-bar">
            <button name=3D"search-button" value=3D"submit" class=3D"pat-bu=
tton default filter-close-trigger" type=3D"submit">Zoek</button>
        </div>
    </fieldset>
</fieldset><div class=3D"sorting" id=3D"sorting">
    <p>
        Sorteren op:&nbsp;
        <button type=3D"submit" name=3D"sorting" value=3D"by_date" class=3D=
"pat-button link">
                    Datum</button>
                /
                <strong>Relevantie</strong>
            </p>
</div></form>

            <h2 class=3D"assistive">Zoekresultaten</h2>
            <div id=3D"result-list" class=3D"search-results">
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DCEFUROXIM+INFVLST+41%2C67MG%2FML+POMP+120ML+AHZ&amp;id=3D0999864e764466d=
eaddf2eee2989ada1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 41,67MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12%2C5MG%2FML+CASSETTE+100ML+AHZ&amp;id=3D643b3f23d9288620d80fadf884=
cf536f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12,5MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+8%2C7MG%2FML+POMP+115ML+AHZ&amp;id=3D7435456a9abe2da41048fa8838d5ed=
13" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 8,7MG/ML POMP 115ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+17%2C39MG%2FML+POMP+115ML+AHZ&amp;id=3Daba07ae09ace889aa5d3b77d11e1=
5fc8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 17,39MG/ML POMP 115ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+POMP+100ML+AHZ&amp;id=3Db9b9674bb1ae51d5db278c8684824b88"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML POMP 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+35MG%2FML+POMP+100ML+AHZ&amp;id=3Dd50a8bdc635e3eb80ffc15ea0b68522f"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 35MG/ML POMP 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+22%2C5MG%2FML+CASSETTE+100ML+AHZ&amp;id=3Deb0a975fa9ccf7c90079de5286=
3a30a7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 22,5MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+POMP+100ML+AHZ&amp;id=3Df8ad2906059e84e214046cf675f87639"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML POMP 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+50%2F6%2C25MG%2FML+POMP+120ML+AHZ&amp;id=3D037576a1a0cd64413a=
c1893d2299d763" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 50/6,25MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+4%2C17MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3D0bf50427b3eae310=
97860f161b93d7ee" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 4,17MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1MG%2F1MCG%2FML+ZAK+100ML+A%2B&amp;id=3D45c20f6d2a827b9195154=
c20596316e8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1MG/1MCG/ML ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
%2FMORFIN+INF+1%2C25MG%2F20MCG%2FML+FL+50ML+A%2B&amp;id=3D4b219a8a340934591=
5250d89c8af623f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE/MORFIN INF 1,25MG/20MCG/ML FL 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/MORFINE<=
/span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILLI=
N%2FTAZOBAC+INF+60%2F7%2C5MG%2FML+CAS+100ML+AHZ&amp;id=3D53f5850fe5ceec9c3b=
2f5dd36d9901e9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILLIN/TAZOBAC INF 60/7,5MG/ML CAS 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+50%2F6%2C25MG%2FML+POMP+240ML+AHZ&amp;id=3D90db2b1b427e644a79=
4909fd42b65f24" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 50/6,25MG/ML POMP 240ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+4M+IE%2F120ML+POMP+%285ML%2FU%29+AHZ&amp;id=3Dc970296f792a3791c6f=
c900f5a263064" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 4M IE/120ML POMP (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+10MG%2FML+CASSETTE+100ML+SAH&amp;id=3Dcb93693bf54b24082d05ce3640b8=
861e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 10MG/ML CASSETTE 100ML SAH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Service Apotheek Hoeven<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATROPIUM=
%2FSALBUTAMOL+VERNOPL+0%2C1%2F1MG%2FML+FNA+MR&amp;id=3D561b35a0b1d969a10865=
449920d295a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATROPIUM/SALBUTAMOL VERNOPL 0,1/1MG/ML FNA MR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1,90&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTOLIN+++=
2%2C5+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3D809a54fb58ac9189deb6072f53d9=
0952" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTOLIN   2,5 INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">GLAXOSMITHKLINE B.V.</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3,74&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRAXA+STER=
I-NEB+INHALATIEVLST+250MCG%2FML+FL+1ML&amp;id=3D6903a8281a772835b313bc00444=
8dde9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRAXA STERI-NEB INHALATIEVLST 250MCG/ML FL 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3,89&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATROPIUM=
%2FSALBUTAMOL+VERNOPL+0%2C25%2F2%2C5MG%2FML+FNAMR&amp;id=3D674e36312d6137d1=
5e04f474465efb8c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATROPIUM/SALBUTAMOL VERNOPL 0,25/2,5MG/ML FNAMR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4,19&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTOLIN+OP=
LOSSING+INHALATIEVLOEISTOF+5MG%2FML&amp;id=3Deba55f52e0551216e5106b9403281c=
a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTOLIN OPLOSSING INHALATIEVLOEISTOF 5MG/ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">GLAXOSMITHKLINE B.V.</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4,97&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTOLIN+++=
5%2C0+INHVLST+2MG%2FML+NEBULE+2%2C5ML&amp;id=3D267086d25b8b78f9fdd55fd639b6=
ba72" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTOLIN   5,0 INHVLST 2MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">GLAXOSMITHKLINE B.V.</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6,23&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSALAMOL+STE=
RI-NEB+VERNOPL+2MG%2FML+AMPUL+2%2C5ML&amp;id=3D315c211da4db105448b6e02a717d=
1c66" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SALAMOL STERI-NEB VERNOPL 2MG/ML AMPUL 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6,23&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSALBUTAMOL+=
TEVA+INHALATIEVLOEISTOF+5MG%2FML&amp;id=3Df1e72eb8fbe7db3ef71ff7309d5d83ff"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SALBUTAMOL TEVA INHALATIEVLOEISTOF 5MG/ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6,57&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+1MG%2FML+FLACON+50ML+A%2B&amp;id=3De7f760fa2c983692e7340cff511e00f=
5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 1MG/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,55&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRAXA+STER=
I-NEB+INHALATIEVLST+250MCG%2FML+FL+2ML&amp;id=3D605b5d455308014b97af3bda467=
f6f16" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRAXA STERI-NEB INHALATIEVLST 250MCG/ML FL 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,78&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRAMOL+STE=
RI-NEB+VERNEVELOPL+0%2C2%2F1MG%2FML+FL2%2C5ML&amp;id=3D5eaf28db5aa7582bff3e=
bc5fa17af223" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRAMOL STERI-NEB VERNEVELOPL 0,2/1MG/ML FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,98&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATRO+BR%=
2FSALBUT+SDZ+UD+VERNOPL+0%2C5%2F2%2C5MG+FL2%2C5ML&amp;id=3D0ac7987dd4b222e3=
0e90deabb7341871" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATRO BR/SALBUT SDZ UD VERNOPL 0,5/2,5MG FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 8,14&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+FLACON+50ML+A%2B&amp;id=3D0b0285d6e9e28696a3e68db9b8ab98b=
7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,47&nbsp;per ver=
pakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1%2C25MG%2F0%2C5MCG%2FML+FL+50ML+A%2B&amp;id=3D2a5586b1a10b11=
d7ad922c2a4953b2a4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1,25MG/0,5MCG/ML FL 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,43&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+FLACON+50ML+MZG&amp;id=3D7b2b9de895a0ad6c73d478653a54b640"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML FLACON 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,44&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+0%2C1MG%2FML+FLAC+50ML+A15&amp;id=3Ddba3e0b0a7e7b19240617c4=
80d441deb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 0,1MG/ML FLAC 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 11,38&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1%2C25MG%2F1MCG%2FML+FL+50ML+MZG&amp;id=3Dbf029e5b2e37c301545=
1b099a8a6072a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1,25MG/1MCG/ML FL 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 11,48&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSULTANOL+FO=
RTE+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3Df32a694ce23b22362ba8b823bd28dc=
f3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SULTANOL FORTE INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Geneesmiddelentekort.nl<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,17&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSENDOLOR+IN=
FVLST+1MG%2FML+ZAK+100ML&amp;id=3D8d35a8f2ad853dfc5eac13ca2fbd74b6" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SENDOLOR INFVLST 1MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">EUROCEPT INTERNATIONAL B=
V</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,22&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSULTANOL+FO=
RTE+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3Db4d5ab358c0a28271127d96e8cd047=
73" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SULTANOL FORTE INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Pharme B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,71&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+ZAK+100ML+ZIK&amp;id=3D62a26e9c09f6df93d37be69b00705376" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+FLACON+50ML+A%2B&amp;id=3D412e1e4d2693b8b7927c69fc047b4b0e=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,76&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITRO+POHL+=
INFUSIEVLOEISTOF+1MG%2FML+AMPUL++5ML&amp;id=3Df013a917f948b7285e997d35b34b9=
e7d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITRO POHL INFUSIEVLOEISTOF 1MG/ML AMPUL  5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 17,58&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+FLACON+50ML+AHZ&amp;id=3De08def5a5fe07e014581c5b611b50ddf"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 17,89&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+FLACON+50ML+A15&amp;id=3D102d9f21f98b5957861948a070ef44a1"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML FLACON 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 17,94&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITRO+POHL+=
INFUSIEVLOEISTOF+1MG%2FML+AMPUL+10ML&amp;id=3Db1884ff11978d5c50ec88edf6be60=
81d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITRO POHL INFUSIEVLOEISTOF 1MG/ML AMPUL 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">TRAMEDICO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,53&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DATROVENT+UN=
IT+DOSE+VERNEVELOPL+125MCG%2FML+FL+2ML&amp;id=3D18f042d51913858403a8c43347c=
28a6e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATROVENT UNIT DOSE VERNEVELOPL 125MCG/ML FL 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,75&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+FLACON+50ML+CZE&amp;id=3D200d308354e97f84960fd867b95d2a30"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML FLACON 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+200IE%2FML+FLACON+50ML+SF&amp;id=3D55c190d00763bdde6c00c48bc3a7328e" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 200IE/ML FLACON 50ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,06&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLIXOTIDE++=
500+INHVLST+0%2C25MG%2FML+NEBULE+2ML&amp;id=3D52e21437c2a4f973e6f3774fdaffd=
552" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLIXOTIDE  500 INHVLST 0,25MG/ML NEBULE 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUTICASON</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLIXOTIDE++=
500+INHVLST+0%2C25MG%2FML+NEBULE+2ML&amp;id=3Dbe5a1caee881cf80b252bb2628b3b=
051" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLIXOTIDE  500 INHVLST 0,25MG/ML NEBULE 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUTICASON</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+X=
IROMED+OPL+OROMUCOSAAL+5MG%2FML+WWS+0%2C5ML&amp;id=3D11b2a4679173a91df4b04f=
f031327d17" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM XIROMED OPL OROMUCOSAAL 5MG/ML WWS 0,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">XIROMED</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 21,59&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATROPIUM=
%2FSALBUT+VERNOPL+0%2C25%2F2%2C5MG%2FML+F30ML+CZE&amp;id=3D24a41ce3bb3eea23=
4054b51bc2576e11" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATROPIUM/SALBUT VERNOPL 0,25/2,5MG/ML F30ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,19&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+FLACON+50ML+SF&amp;id=3Dc1ecbc4c277aa8627a72f2e4571163fa" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML FLACON 50ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,43&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROKIPRIM+IN=
FUSIEVLOEISTOF+FLACON+250ML&amp;id=3D1295a4b92041204ef888cafaa595610d" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROKIPRIM INFUSIEVLOEISTOF FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SULFAMETROL/TRIMETHO=
PRIM</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,08&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROKIPRIM+IN=
FUSIEVLOEISTOF+FLACON+250ML&amp;id=3D3686bd53e382bf4fd2f98abc6df89f09" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROKIPRIM INFUSIEVLOEISTOF FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SULFAMETROL/TRIMETHO=
PRIM</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,08&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATRO+BR%=
2FSALBUT+NEUTEC+VERNOPL+0%2C5%2F2%2C5MG+FL2%2C5ML&amp;id=3D415307b45af5e805=
db2c2491975d3cc7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATRO BR/SALBUT NEUTEC VERNOPL 0,5/2,5MG FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">PROLEPHA RESEARCH BV</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,96&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRAMOL+STE=
RI-NEB+VERNEVELOPL+0%2C2%2F1MG%2FML+FL2%2C5ML&amp;id=3Dbb5e8fd1b1eb548b371b=
0a8c67c59c4a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRAMOL STERI-NEB VERNEVELOPL 0,2/1MG/ML FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,96&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATRO+BR%=
2FSALBUT+CIP+UD+VERNOPL+0%2C5%2F2%2C5MG+FL2%2C5ML&amp;id=3Da1c2919e2242cb60=
73d2c1ce1f4a4f79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATRO BR/SALBUT CIP UD VERNOPL 0,5/2,5MG FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">FOCUS CARE PHARMACEUTICA=
LS</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,96&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCOMBIVENT+U=
NIT+DOSE+VERNEVELOPLOSSING+FLACON+2%2C5ML&amp;id=3D0707ed909589753d4f601448=
dde98450" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    COMBIVENT UNIT DOSE VERNEVELOPLOSSING FLACON 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 24,43&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIPRATRO+BR%=
2FSALBUT+SDZ+UD+VERNOPL+0%2C5%2F2%2C5MG+FL2%2C5ML&amp;id=3D915cee0dcaa750fe=
b0d24f16050ae309" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IPRATRO BR/SALBUT SDZ UD VERNOPL 0,5/2,5MG FL2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 24,43&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUDESONIDE+=
TEVA+STERI-NEB+VERNS+0%2C25MG%2FML+AMP+2ML&amp;id=3D1204e54cdc431ef4df79258=
0ffa3bac3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUDESONIDE TEVA STERI-NEB VERNS 0,25MG/ML AMP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUDESONIDE</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 24,51&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DATROVENT+UN=
IT+DOSE+VERNEVELOPL+250MCG%2FML+FL+2ML&amp;id=3D58f4e11da7bd93f590ae13da7d5=
d50d2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATROVENT UNIT DOSE VERNEVELOPL 250MCG/ML FL 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 24,59&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUDESONIDE+=
SANDOZ+VERNEVELSUSP+0%2C25MG%2FML+AMP+2ML&amp;id=3D07c607a5325b87da01475e64=
34fa38e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUDESONIDE SANDOZ VERNEVELSUSP 0,25MG/ML AMP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUDESONIDE</span>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,11&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUDESONIDE+=
TEVA+STERI-NEB+VERNS+0%2C125MG%2FML+AMP+2ML&amp;id=3D3e0e28aae98e88f2a27b46=
5924d493f8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUDESONIDE TEVA STERI-NEB VERNS 0,125MG/ML AMP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUDESONIDE</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,18&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIRIVA+RES=
PIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D7548e4effd38d0291cd8d8a=
c34135171" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIRIVA RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Frankrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,25&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIRIVA+RES=
PIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D866b02b452e2346e683d07c=
e8f9351f2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIRIVA RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Frankrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,25&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIRIVA+RES=
PIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D236686de53327396e0be6a6=
a6d5a2c25" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIRIVA RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,26&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+KABIPAC+FLACON+500ML&amp;id=3D72e5d51b1895356240ba77d50784d1f4" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML KABIPAC FLACON 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,23&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPMS-SALBUTA=
MOL+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3D17bfa1ff880d5fead3fec94903fe57=
36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PMS-SALBUTAMOL INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Specific Pharma A/S</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,54&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+KABIPAC+FLACON+500ML&amp;id=3Db2ee0a263f00cf211437026073bb=
447a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML KABIPAC FLACON 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,78&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPMS-SALBUTA=
MOL+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3D1718379500ee34c574fd28ec5db413=
57" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PMS-SALBUTAMOL INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Pharme B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,89&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+FREEFLEX+ZK+1000ML&amp;id=3D9f085166d67df74afb0=
7e4ec11f9eb6a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML FREEFLEX ZK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,07&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
ACCORD+INFVLST+10MG%2FML+FLACON+25ML&amp;id=3D177c309338297daa6af65e8876094=
5b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE ACCORD INFVLST 10MG/ML FLACON 25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">ACCORD HEALTHCARE B.V.</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,11&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSALBUAIR+2%=
2C5+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3D52c471e88f39edd71c9afb55bd60f8=
e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SALBUAIR 2,5 INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,24&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FLACON+100ML+GLAS%2B+AFSK&amp;id=3Dc68463b0df67351b1fe5749=
c2e7bc592" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FLACON 100ML GLAS+ AFSK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,28&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+KABIPAC+FLACON+1000ML&amp;id=3D6bdd0f09b494b8a4ed681e8415aa4735"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML KABIPAC FLACON 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,48&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSTRIVERDI+R=
ESPIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D79ed9f617fadf9881aa59=
67179452f84" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    STRIVERDI RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OLODATEROL</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Griekenland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,51&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSTRIVERDI+R=
ESPIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D37466e25ca9b026ae4d7e=
6a7f6650d96" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    STRIVERDI RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OLODATEROL</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,53&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPMS-SALBUTA=
MOL+INHVLST+2MG%2FML+NEBULE+2%2C5ML&amp;id=3D87acf4a344bc14668024c67f756ba6=
e0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PMS-SALBUTAMOL INHVLST 2MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Pharme B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,59&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+KABIPAC+FLACON+500ML&amp;id=3Dfc88c1bb043c286bc912611af5ca9abe" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT KABIPAC FLACON 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 33,68&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX+ZAK+1000ML&amp;id=3D3dd9101d1004770d21ca14902179f0af" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,34&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX%2B+ZAK+1000ML+%2B+LL&amp;id=3D5c08b8727b9658661c3cadd56=
d6d586e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX+ ZAK 1000ML + LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,34&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+FLACON+50ML+CZE&amp;id=3Dea3a73c8de8028bc677ad19839a5f9e7=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML FLACON 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,37&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+CLEAR-FLEX+EM+ZAK++1000ML&amp;id=3Ddb38bbccecbff3a0bb66dbc413274=
461" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML CLEAR-FLEX EM ZAK  1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Vantive B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,40&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++250ML+KUNSTSTOF+ECO&amp;id=3D420f4bc16eeb9058dfce75836e=
5e5b1c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   250ML KUNSTSTOF ECO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,64&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FREEFLEX+ZAK+1000ML&amp;id=3De12d66558d368ba2d2e4c71a7a942=
e0e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FREEFLEX ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,99&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPMS-SALBUTA=
MOL+INHVLST+2MG%2FML+NEBULE+2%2C5ML&amp;id=3De45cd57fa9ba4e0b6f55749f5e031c=
89" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PMS-SALBUTAMOL INHVLST 2MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Specific Pharma A/S</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 35,85&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUDESONIDE+=
TEVA+STERI-NEB+VERNS+0%2C5MG%2FML+AMP+2ML&amp;id=3D20e0c5e3377e38b00de27af7=
4a2358be" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUDESONIDE TEVA STERI-NEB VERNS 0,5MG/ML AMP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUDESONIDE</span>
                <span class=3D"facet manufacturer">PHARMACHEMIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 35,87&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUDESONIDE+=
SANDOZ+VERNEVELSUSP+0%2C5MG%2FML+AMP+2ML&amp;id=3D575535807ca6adf4064bf9e97=
16e1b19" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUDESONIDE SANDOZ VERNEVELSUSP 0,5MG/ML AMP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUDESONIDE</span>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 35,87&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++500ML+KUNSTSTOF&amp;id=3De0a52491bf9a9898675b7ea82d2eb0=
fc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   500ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 35,95&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+FREEFLEX+ZAK+1000ML&amp;id=3D311e2b989ea2e97cd9ff096a097b57a9" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT FREEFLEX ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 37,39&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++500ML+GLAS+%2B+AFSKAP&amp;id=3Db2a09be2012178b1fbf2d980=
d65ef504" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   500ML GLAS + AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 39,89&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FLACON++500ML+KUNSTSTOF&amp;id=3Dd8fd9d97ff39dd9d228e5752e=
81e2a70" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FLACON  500ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 41,83&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIOLTO+RES=
PIMAT+INHOP+2%2C5%2F2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D070c92757a8b367b=
cae2838285165ddb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIOLTO RESPIMAT INHOP 2,5/2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM/OLODATERO=
L</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,12&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIOLTO+RES=
PIMAT+INHOP+2%2C5%2F2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3Db621444dafdf67d1=
e3e7d085a0e279a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIOLTO RESPIMAT INHOP 2,5/2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM/OLODATERO=
L</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,12&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+NEW+VIAFLO+ZAK+1000ML&amp;id=3D19fc1d35f218e3b4447bbe25851=
d8515" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML NEW VIAFLO ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+NEW+VIAFLO+ZAK+1000ML&amp;id=3Dac63d40a919cbefc900283d2bc239cb7"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML NEW VIAFLO ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIOLTO+RES=
PIMAT+INHOP+2%2C5%2F2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D31a44cb2daec0f0e=
98c6ce89cf807dd7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIOLTO RESPIMAT INHOP 2,5/2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM/OLODATERO=
L</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+NEW+VIAFLO+Z+1000ML&amp;id=3D67c13f735388efc94b=
3318be52a12abd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML NEW VIAFLO Z 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+DAC+VIAFLO+ZAK+1000ML&amp;id=3Dfa66eed335481136a2c3126d476e3a76"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML DAC VIAFLO ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,63&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSALBUTAMOL+=
ARROW+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3D9bc6f98e0395cc51c6fb1da84ae6=
1f9c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SALBUTAMOL ARROW INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">Specific Pharma A/S</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 43,16&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+X=
IROMED+OPL+OROMUCOSAAL+5MG%2FML+WWSP+1ML&amp;id=3Df04c777f531fea7cbeddddd4b=
b15bc0e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM XIROMED OPL OROMUCOSAAL 5MG/ML WWSP 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">XIROMED</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 43,20&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+FLACON++500ML+KUNST&amp;id=3Ddb6568d3a700aa62e2=
349e4a6060c915" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML FLACON  500ML KUNST</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 43,99&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DSALBUAIR+5%2C0+INHVLST+2MG%2FML+NEBULE+2%2C5ML&amp;id=3D040e0ce80d6d5a9c=
ca42899ba1e5ef5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SALBUAIR 5,0 INHVLST 2MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 44,72&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+1MG%2FML+FLAC+50ML+MMC&amp;id=3D84c82a3f4aff6b1831e8cdb7b07=
13b3d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 1MG/ML FLAC 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 46,71&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FLACON++250ML+KUNSTS+ECO&amp;id=3D9e3fd06b747847685beee7b0=
95decf3f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FLACON  250ML KUNSTS ECO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 47,30&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAT=
RIUMBICARBONAAT+14MG%2FML+FL100ML+GL%2BAFSK&amp;id=3D3e2df41561e756fa13284e=
b6b6c8efd3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NATRIUMBICARBONAAT 14MG/ML FL100ML GL+AFSK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 52,10&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON++1000ML+KUNSTSTOF&amp;id=3De19ef5223673181aed81339005567a=
cb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON  1000ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 53,21&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+CLEAR-FLEX+EM+ZAK+++500ML&amp;id=3Dfaabbf92ce986c2f2a11c2de0cb8c=
dd9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML CLEAR-FLEX EM ZAK   500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Vantive B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 53,41&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+0%2C5MG%2FML+AMP+10ML+ASG&amp;id=3D858609c6f2d53c3cad9dda33=
8c110ad9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 0,5MG/ML AMP 10ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 54,83&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITRO+POHL+=
INFUSIEVLOEISTOF+1MG%2FML+AMPUL+25ML&amp;id=3D4bd3e545350b4f55a31935016b52f=
128" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITRO POHL INFUSIEVLOEISTOF 1MG/ML AMPUL 25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 55,02&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+KABIPAC+FLACON+250ML&amp;id=3D5959005bfbcef8af0ca2545042ee8466" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML KABIPAC FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 55,15&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUMAN+INF=
VLST+200MG%2FML+FLACON++50ML&amp;id=3D0af38bceebb449db5f37a033ee035773" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUMAN INFVLST 200MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 56,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUMAN+INF=
VLST++40MG%2FML+FLACON+250ML&amp;id=3D380259e7384cfeb2089dfedcd0005710" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUMAN INFVLST  40MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 56,13&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+NEW+VIAFLO+ZAK+1000ML&amp;id=3D601e2af74033a28c40fe187c3a4a6383"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT NEW VIAFLO ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GER+NEW+VIAFLO+ZAK+1000ML&amp;id=3D738dcf0c28da60c0cb3c031f08548235" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGER NEW VIAFLO ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FLACON+100ML+KUNSTSTOF&amp;id=3Dc4a2bad612685d0a68303fb487=
d04fcb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FLACON 100ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,14&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX+ZAK++500ML&amp;id=3D7d1b5c93eabd39a25817c45b51cfb252" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,86&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX%2B+ZAK++500ML+%2B+LL&amp;id=3Dd2545d09b2595fd69b405049f=
86e4b52" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX+ ZAK  500ML + LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,86&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FREEFLEX+ZAK++500ML&amp;id=3D2407469d2d530c261004af2bf4ab3=
933" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FREEFLEX ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 60,17&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+FREEFLEX+ZK++500ML&amp;id=3D84999f880431ce276f9=
25874e4a2a55d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML FREEFLEX ZK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 60,17&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINEHYDR=
OCHLORIDE+1ML&amp;id=3D658bb132cd4e9bce2cafd76bd8ff608a" class=3D"result-it=
em medicine">
            <h3 class=3D"result-title">
                    MORFINEHYDROCHLORIDE 1ML=3D 5MG EPI CAS 50ML FNA MR</h3=
>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 61,47&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAT=
RIUMBICARBONAAT+42MG%2FML+FL100ML+GL%2BAFSK&amp;id=3Df4328192a99926e04a4a75=
8a4966bcc5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NATRIUMBICARBONAAT 42MG/ML FL100ML GL+AFSK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 61,91&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++100ML+GLAS+%2B+AFSKAP&amp;id=3D5026132612766a5d7345f3c8=
119973ac" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   100ML GLAS + AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 62,57&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+ZAK++500ML&amp;id=3D3dc4cda9e81d697eafdb8276b3bc632c" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 63,87&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON++++50ML+KUNSTSTOF&amp;id=3D5fb7ba7770d66e976d5ea058aa6521=
e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON    50ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 64,10&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+X=
IROMED+OPL+OROMUCOSAAL+5MG%2FML+WWS+1%2C5ML&amp;id=3D4e1b868214dbad99c19008=
059d4d0ceb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM XIROMED OPL OROMUCOSAAL 5MG/ML WWS 1,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">XIROMED</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 64,79&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+FLACON+1000ML+KUNST&amp;id=3D41945c8a70f0771d20=
7935906c8249cc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML FLACON 1000ML KUNST</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 66,03&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAT=
RIUMBICARBONAAT+84MG%2FML+FL100ML+GL%2BAFSK&amp;id=3D71135a8650f9f1ff35356f=
ef1c1b8fbc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NATRIUMBICARBONAAT 84MG/ML FL100ML GL+AFSK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 66,27&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++100ML+KUNSTSTOF&amp;id=3D3cdf4c012387194891cb06be9b692d=
a5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   100ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 67,01&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+6%2C5MG%2FML+ZAK++500ML+FREEFLEX&amp;id=3Dd0907d3b76eeab7f6cff891387545ad=
b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 6,5MG/ML ZAK  500ML FREEFLEX</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 67,36&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+FREEFLEX+ZAK++500ML&amp;id=3D0fb53c2b7f06752e096765edcf874785" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT FREEFLEX ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 69,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+NEW+VIAFLO+ZAK++500ML&amp;id=3D5e35faabd050dc0cae45e39ef0e07cd1"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML NEW VIAFLO ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 72,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+NEW+VIAFLO+ZAK++500ML&amp;id=3Dff805a7432590cf4d0f1c643009=
238d1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML NEW VIAFLO ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 72,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+NEW+VIAFLO+Z++500ML&amp;id=3Dabf08d601de2543049=
c5b75b88bcb899" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML NEW VIAFLO Z  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 72,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+DAC+VIAFLO+ZAK+500ML&amp;id=3D84b41bfcf7c32099d1b1b4bbc29b5d0e" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML DAC VIAFLO ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 73,98&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+FREEFLEX+ZAK++250ML&amp;id=3Dda6e3420ad56cb429c4a2cebf071bffb" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT FREEFLEX ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 77,17&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIRIVA+RES=
PIMAT+INHOPL+2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3D93abe51d74fd141aeae0b19=
81bb5efdd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIRIVA RESPIMAT INHOPL 2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 78,79&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIRIVA+RES=
PIMAT+INHOPL+NAVUL+2%2C5MCG%2FDO+PATR+60DO&amp;id=3Dddddf675973cb602216909e=
244e8371b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIRIVA RESPIMAT INHOPL NAVUL 2,5MCG/DO PATR 60DO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 78,79&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+FLACON+500ML+KUNSTST+ECO&amp;id=3Dabb2b6998b1577288e78c70b=
6dec6347" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML FLACON 500ML KUNSTST ECO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 79,20&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+6%2C5MG%2FML+NEW+VIAFLO+ZAK++500ML&amp;id=3Dd93d8b83aa7c4eba4d9fd69778922=
8c0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 6,5MG/ML NEW VIAFLO ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 81,75&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNIMOTOP+INF=
VLST+0%2C2MG%2FML+FLACON+50ML+%2B+INFSLANG&amp;id=3Dc1d8bbced960ef828be40bf=
6183f94bd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NIMOTOP INFVLST 0,2MG/ML FLACON 50ML + INFSLANG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NIMODIPINE</span>
                <span class=3D"facet manufacturer">Laboratoire X.O</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 82,26&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+6%2C5MG%2FML+DAC+VIAFLO+ZAK+500ML&amp;id=3D5f385c1fbf0cdf95dd39de13db3544=
f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 6,5MG/ML DAC VIAFLO ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 82,74&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETRONIDAZO=
L+NORIDEM+INFVLST+5MG%2FML+FLES+100ML&amp;id=3D2e1af7e76e13d995247d8c1663ea=
c758" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METRONIDAZOL NORIDEM INFVLST 5MG/ML FLES 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METRONIDAZOL</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 84,58&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FLACON+1000ML+KUNSTSTOF&amp;id=3D6e1bbece34c0b626a227ea6c4=
073e658" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FLACON 1000ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 85,48&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX+ZAK++250ML&amp;id=3D25834a75fca5b9b1266be3866db9960b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 86,33&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX%2B+ZAK++250ML+%2B+LL&amp;id=3De1ec648c9da312b263eece6df=
275cb39" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX+ ZAK  250ML + LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 86,33&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETRONIDAZO=
L+B.BRAUN+INFVLST+5MG%2FML+FL+KUNST+100ML&amp;id=3Df7404afd7c56b390a2fce6a2=
6e8e3a4c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METRONIDAZOL B.BRAUN INFVLST 5MG/ML FL KUNST 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METRONIDAZOL</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 86,33&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+X=
IROMED+OPL+OROMUCOSAAL+5MG%2FML+WWSP+2ML&amp;id=3Ddc0248c6692b2aa18adf371be=
fe53007" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM XIROMED OPL OROMUCOSAAL 5MG/ML WWSP 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">XIROMED</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 86,39&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+2MG%2FML+CASS+100ML+A15&amp;id=3Df3071399d6eb2816fee4ea6337=
630c62" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 2MG/ML CASS 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 86,70&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FREEFLEX+ZAK++250ML&amp;id=3D2bf9854808f9bd478cdb98217753c=
03b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FREEFLEX ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 88,29&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF++50G%2F1L+FLAC++20ML&amp;id=3Dd9043b6fef82676d300d9435bde2b=
5d5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF  50G/1L FLAC  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 89,92&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++10ML&amp;id=3Dc9b3886c746df461d49bc2e05141=
49f0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON  10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 89,92&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAPO-GO+INFV=
LST+5MG%2FML+WWSP+10ML&amp;id=3D44cb9d0236cf19a293f2da0a40f63e56" class=3D"=
result-item medicine">
            <h3 class=3D"result-title">
                    APO-GO INFVLST 5MG/ML WWSP 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">APOMORFINE</span>
                <span class=3D"facet manufacturer">CENTRAFARM BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 90,07&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+200MG%2FML+FLACON+500ML+KUNSTST+ECO&amp;id=3D2b1247832d412f8f5ba0f538=
fb8981b1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 200MG/ML FLACON 500ML KUNSTST ECO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 93,43&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON++10ML&amp;id=3Dcf62a6cb6b55b5c50d5e1c57901a0=
cb5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON  10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 94,83&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+NEW+VIAFLO+ZAK++500ML&amp;id=3D410f18ee3ececcabd8d3e98e90442715"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT NEW VIAFLO ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 97,54&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINEHYDR=
OCHLORIDE+1ML&amp;id=3D86ffe84083997665303af9a902bd1b60" class=3D"result-it=
em medicine">
            <h3 class=3D"result-title">
                    MORFINEHYDROCHLORIDE 1ML=3D 5MG EPI CAS 100ML FNA MR</h=
3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 97,64&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GER+NEW+VIAFLO+ZAK++500ML&amp;id=3D3ddca06e62abda9623f1fb16aec29d5c" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGER NEW VIAFLO ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++33%2F3%2C0MG%2FML+NEW+VIAFLO+ZK+500ML&amp;id=3Dcbb56eda23f2804e17=
1429660d6ac9d6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  33/3,0MG/ML NEW VIAFLO ZK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,05&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+57%2F7%2C1MG%2FML+ZAK+70ML+PA&amp;id=3D5f4453e049884a274d6b96=
4d6d7e72aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 57/7,1MG/ML ZAK 70ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,07&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAT=
RIUMBICARBONAAT+14MG%2FML+FL500ML+GL%2BAFSK&amp;id=3Da0d564a5c214d170251e69=
12f24b6229" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NATRIUMBICARBONAAT 14MG/ML FL500ML GL+AFSK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,10&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPATECT+CP=
+INFUSIEVLOEISTOF+50IE%2FML+FLAC+2ML&amp;id=3Dbf7f3061cdf8dc6933b3f032e1e7a=
b57" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPATECT CP INFUSIEVLOEISTOF 50IE/ML FLAC 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPATITIS-B-IMMUNOGL=
OBULINE</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,10&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+DAC+VIAFLO+ZAK+500ML&amp;id=3Db4c0f3d05b08d88f3ac8a59ed8ab7495" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT DAC VIAFLO ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 98,56&nbsp;per ve=
rpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCIPROFLOXAC=
INE+KABI+INFVLST+2MG%2FML+FLACON+100ML&amp;id=3Ddab42d42421307d6e36811879a5=
29d5a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CIPROFLOXACINE KABI INFVLST 2MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CIPROFLOXACINE</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 100,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINEHYDR=
OCHLORIDE+1ML&amp;id=3D7b7559dd9ff107515882d518708f2f27" class=3D"result-it=
em medicine">
            <h3 class=3D"result-title">
                    MORFINEHYDROCHLORIDE 1ML=3D20MG EPI CAS 50ML FNA MR</h3=
>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 102,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+KABIPAC+FLACON+50ML&amp;id=3Dd33ce41f0ed3ba18de2390571a48ee53" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML KABIPAC FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 102,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUMAN+INF=
VLST+200MG%2FML+FLACON+100ML&amp;id=3D91632acb5adbced42c472ccab8fcbe9c" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUMAN INFVLST 200MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 104,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+NEW+VIAFLO+ZAK++250ML&amp;id=3D480336a5b51a1e6669a2cac3c4b=
3d448" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML NEW VIAFLO ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 106,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+NEW+VIAFLO+ZAK++250ML&amp;id=3D9598c8c318af49fac54a754d6612403d"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML NEW VIAFLO ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 106,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++33%2F3%2C0MG%2FML+NEW+VIAFLO+ZK+250ML&amp;id=3Dacdae1982d285e55ae=
fb676a16179cb5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  33/3,0MG/ML NEW VIAFLO ZK 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 106,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
C%2FNACL++25%2F4%2C5MG%2FML+NEW+VIAFLO+Z++250ML&amp;id=3Dc84b00b3cb7eaa9308=
b16257f225444b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUC/NACL  25/4,5MG/ML NEW VIAFLO Z  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 106,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+KABIPAC+FLACON+100ML&amp;id=3Dcb94dcb00837ab734903a5f1e5545151" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML KABIPAC FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+DAC+VIAFLO+ZAK+250ML&amp;id=3D9cc13d2ec617d9848e5a8f74959b6fde" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML DAC VIAFLO ZAK 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+1MG%2FML+ZAK+1000ML+SF&amp;id=3D48df309e79a33695640c96ccec18eb34" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 1MG/ML ZAK 1000ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+700MG%2FML+FLACON+500ML+GLAS%2BAFSKAP&amp;id=3D654613160798fd41609011=
b85b186618" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 700MG/ML FLACON 500ML GLAS+AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 113,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+FLACON+1000ML+ECOFLAC&amp;id=3D9bb2e577708bd3b302c78b4af4a7c4c6"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT FLACON 1000ML ECOFLAC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 118,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+250ML+APP&amp;id=3D52969c572f1f6ec76ad990fce32f7=
fcc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 119,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+POMP+60ML+%285ML%2FU%29+CZA&amp;id=3D07f9edf39382c774f5ae8=
f1b50ba4217" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML POMP 60ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+ZAK+100ML+APP&amp;id=3D36a9eea1639180f7e1ba2a5c72ad9=
283" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+250ML+APP&amp;id=3Dd2ef7e81a73d3c842bcf3a7f6e1c3c57" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLS+28%2C6MG%2FML+IN+GLUC+5%25+ZAK+70ML+PA&amp;id=3D991cbf5b0d554db863a6=
ff193782bf84" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLS 28,6MG/ML IN GLUC 5% ZAK 70ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,56&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+100ML+IP&amp;id=3De32d28db20a1cbfa9164466aafc1a9a6" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 121,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+12MG%2FML+ZAK+250ML+CZA&amp;id=3D746dca15ea896d53a9d591544c156=
ff3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 12MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 121,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+ZAK+100ML+PA&amp;id=3D7991acc08263bbdfa97a4bc5fc88d6=
c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML ZAK 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 122,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+FLACON++500ML+KUNSTSTOF&amp;id=3D6cc073a2cf2b705706710510d166bc6=
3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT FLACON  500ML KUNSTSTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 123,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+100ML+CZA&amp;id=3Df4435599918df9590e82239691b67051" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 123,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCONAZOL+=
FRES+KABI+INFVLST+2MG%2FML+FLACON++50ML&amp;id=3D60771ac0158199c7b79a9371eb=
f44858" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCONAZOL FRES KABI INFVLST 2MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCONAZOL</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 124,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+100ML+CZA&amp;id=3D619af36790c56fa39e57db18f542b836" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 125,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIOLTO+RES=
PIMAT+INH+NAVUL+2%2C5%2F2%2C5MCG%2FDO+PATR+60DO&amp;id=3D64753fdb20a81ebc01=
967f2290d51ffa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIOLTO RESPIMAT INH NAVUL 2,5/2,5MCG/DO PATR 60DO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM/OLODATERO=
L</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 126,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSPIOLTO+RES=
PIMAT+INHOP+2%2C5%2F2%2C5MCG%2FDO+PATR+60DO%2BINH&amp;id=3Df14bd7b279a5be49=
106d7cd647d4823c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SPIOLTO RESPIMAT INHOP 2,5/2,5MCG/DO PATR 60DO+INH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIOTROPIUM/OLODATERO=
L</span>
                <span class=3D"facet manufacturer">BOEHRINGER INGELHEIM BV<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 126,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+ZAK+250ML+APP&amp;id=3D8a9f516ce8f5f1427f9e3e4aafd110d9" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 126,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+1MG%2FML+FLAC+50ML+ASG&amp;id=3D58c18d4ba6eba153dcff8c1a86f=
b0fa2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 1MG/ML FLAC 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 127,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPULMOZYME+V=
ERNEVELOPLOSSING+1000E%2FML+AMPUL+2%2C5ML&amp;id=3D35797c3c34ce8e779b047e69=
c9469618" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PULMOZYME VERNEVELOPLOSSING 1000E/ML AMPUL 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DORNASE</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Romania</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 128,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPULMOZYME+V=
ERNEVELOPLOSSING+1000E%2FML+AMPUL+2%2C5ML&amp;id=3D57af0c609146ead73d3abf96=
f4d0aaaa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PULMOZYME VERNEVELOPLOSSING 1000E/ML AMPUL 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DORNASE</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Bulgarije</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 128,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+ZAK++100ML&amp;id=3D03cc4d5e86d3912c04f905be4089fb30" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML ZAK  100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 128,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12MG%2FML+ZAK+250ML+PA&amp;id=3D4b93c0b2e54841f5dbaa6061ad9b242c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 130,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+ZAK+100ML+CZA&amp;id=3D4d942e21287d975121fecdab2b410=
8e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 130,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+20ML+%282%2C5ML%2FU%29+AHZ&amp;id=3D1c75800aaf16bdbc=
4adefcf1823afe73" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 20ML (2,5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 131,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+ZAK+100ML+APP&amp;id=3D9533aecc40ae024b375608f2f04e2836" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 133,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+250ML+APP&amp;id=3Dfa4dc4d63d89112921fcfc5d164d962f" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 133,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+10MG%2FML+ZAK+100ML+CZA&amp;id=3D5e3b8d15f5af04b9d22ea98406862b08" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 10MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 133,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+ZAK+250ML+PA&amp;id=3Dcb4a8177ad35a5a232b8dbd8ac9725f7" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 135,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DCEFUROXIM+INFVLST+45MG%2FML+ZAK+100ML+APP&amp;id=3Dc086a170144fcb43c923c=
96fb9871626" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 136,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+75MG%2FML+POMP+20ML+%282%2C5ML%2FU%29+AHZ&amp;id=3D4cedc0f7d1029f7c=
ae713f7f311e2ac5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 75MG/ML POMP 20ML (2,5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 136,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+250ML+IP&amp;id=3Dd9afaf39f7ee96ca0e55ea80070f1f4b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 136,86&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ECOBAG+1000ML&amp;id=3De4ae197e8b25b3fcbe769de99a420487" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ECOBAG 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 137,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+16MG%2FML+ZAK+250ML+CZA&amp;id=3D0ae2a776a2d5915b666fdb04a47ca=
5c6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 16MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 137,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7%2C5MG%2FML+ZAK+100ML+CZA&amp;id=3Db680245fda87b2fb241fd0a9577232=
39" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7,5MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 137,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+15MG%2FML+ZAK+100ML+CZA&amp;id=3De0d1a4edbb6e819256c8aff6e275677d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 15MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 138,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+4%2C17MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D11bb15e8dd748390=
52c95ab0e014aaf0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 4,17MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 138,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+250ML+APP&amp;id=3D2171f71035b6e7839f43f73ee03e26a5" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+CASSETTE+250ML+APP&amp;id=3D2a5e97b79c072a76141d610bf8752=
770" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+500ML+APP&amp;id=3D3262e3f7d3969abdf58dd38ea93e3e91" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOMETA+INFV=
LST+0%2C04MG%2FML+FLACON+100ML&amp;id=3Dbdd0d9d736ff849e30b895601686d810" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOMETA INFVLST 0,04MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Ierland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOMETA+INFV=
LST+0%2C04MG%2FML+FLACON+100ML&amp;id=3De42e60075e09441509247820b439d32b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOMETA INFVLST 0,04MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">PHOENIX LABS</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C8MG%2FML+CASSETTE+250ML+IP&amp;id=3Dcb245d39a50dedd4586b9ecd49=
25c62f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,8MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C4MG%2FML+ZAK+250ML+CZA&amp;id=3D6bfe01a419cdb031bf4ec60ead68bc=
cb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,4MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 140,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C4MG%2FML+ZAK+250ML+PA&amp;id=3D90fd94601ff35deb023ed865314b2a6=
b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,4MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 140,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX%2B+ZAK++100ML+%2B+LL&amp;id=3D6e01fe34a034c3a24dc4e8af5=
7370801" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX+ ZAK  100ML + LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX+ZAK++100ML&amp;id=3Db491c0f9a914d334a64c5aad910a06ee" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX ZAK  100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+ZAK+100ML+IP&amp;id=3Deb4b72ee0ec203692ae8eac6a231848a" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+10MG%2FML+POMP+100ML+%28200ML%2FU%29+LUMC&amp;id=3D9e440f5535fcde3e74=
60a19c02d101f8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 10MG/ML POMP 100ML (200ML/U) LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+ZAK+100ML+APP&amp;id=3Db90754dd36ba655d7edc30ff62b70729" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+10MG%2FML+POMP+100ML+%28200ML%2FUUR%29+APP&amp;id=3Db7eca3ebb907136d26=
1fc7d01fd4082e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 10MG/ML POMP 100ML (200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INF+8%2C33MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3Dc7b5412014de3fa7a9=
b789e45ce78d46" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INF 8,33MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+5MG%2FML+POMP+100ML+%28200ML%2FUUR%29+APP&amp;id=3Dd36cbf53a149d58416d=
bc0b472db6a4d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 5MG/ML POMP 100ML (200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYCODON+HC=
L+INFVLST+10MG%2FML+CASSETTE+100ML+FSBA&amp;id=3D71388d9312fafbfd97376f4322=
781bb9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYCODON HCL INFVLST 10MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYCODON</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 141,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+250ML+APP&amp;id=3D28d147c62cb9ecf0a4ef23d2ec101c9c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,07&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+ZAK+100ML+APP&amp;id=3De2d973e93b79af76eb2c1b3f848d5499" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,07&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+FLACON+50ML+ASG&amp;id=3Deadc93fc9e98327c0f0bb0cf92ae6129=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML FLACON 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSENDOLOR+IN=
FVLST+1MG%2FML+ZAK+100ML&amp;id=3D63a1cce51c97edea4bd0169d334144aa" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SENDOLOR INFVLST 1MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">EUROCEPT INTERNATIONAL B=
V</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSENDOLOR+IN=
FVLST+10MG%2FML+ZAK+100ML&amp;id=3D956b1e39804de9157571ea4ce5c42b00" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SENDOLOR INFVLST 10MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">EUROCEPT INTERNATIONAL B=
V</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+10MG%2FML+ZAK+100ML+TA&amp;id=3D6858f7edcd70afea86fe928e3e2efcb1" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 10MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+5MG%2FML+CASSETTE+100ML+TA&amp;id=3D855d267d3f55f30fd89b0d7a9212ca=
c5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 5MG/ML CASSETTE 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+10MG%2FML+CASSETTE+100ML+TA&amp;id=3Db3df219052790f303e2023c2744bf=
3b5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 10MG/ML CASSETTE 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+5MG%2FML+ZAK+100ML+TA&amp;id=3Ddc17355f80231bb384c5e11e4ea5ee2d" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 5MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C04MG%2FML+POMP+120ML+%285ML%2FU%29AHZ&amp;id=3D9211bf0753c7a715=
420010eeaed3d450" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,04MG/ML POMP 120ML (5ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAPO-GO+POD+=
INFVLST+5MG%2FML+PATROON+20ML&amp;id=3Da2b10ac19e371e6f7ed1a176c14da179" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    APO-GO POD INFVLST 5MG/ML PATROON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">APOMORFINE</span>
                <span class=3D"facet manufacturer">CENTRAFARM BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+250ML+CZA&amp;id=3Dca8d010956f25574724679b9b8969=
a5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 143,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+1%2C6MG%2FML+CASSETTE+250ML+IP&amp;id=3D71d939faca82d516bc95d8ef60=
2591f1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 1,6MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 143,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FREEFLEX+ZAK++100ML&amp;id=3D206c2c9d3cc9bd2b5de262fa7fc9c=
84f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FREEFLEX ZAK  100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 143,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+10MG%2FML+CASSETTE+100ML+ASG&amp;id=3D56635e12a49be73562504f98cf73b=
7e3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 10MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+250ML+CZA&amp;id=3Dfbcb634d38f6557279a3dbe96a4d72b2" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C2MG%2FML+ZAK+250ML+CZA&amp;id=3D81ac5537ab1799b23a8e4fa54e1f05=
59" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,2MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C6MG%2FML+ZAK+250ML+CZA&amp;id=3Dda9acd2c4f0c520f4e20632ac8cb23=
06" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,6MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+80%2F10MG%2FML+ZAK+50ML+CZA&amp;id=3Dd3ce65f753bce74617efa564=
ca85e71e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 80/10MG/ML ZAK 50ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,58&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C2MG%2FML+CASSETTE+100ML+ASG&amp;id=3De7c271944f52d61ce9eb6dae88=
1d74aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,2MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+ZAK+100ML+CZA&amp;id=3D199470ef6dbda6be1cb59579de886ea8"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+3%2C125MG%2FML+POMP+240ML+%2810ML%2FU%29+CZA&amp;id=3D44292fd234d2a98b=
19ee353f15afb05e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 3,125MG/ML POMP 240ML (10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+12MG%2FML+ZAK+500ML+CZA&amp;id=3D649f2cefcfefb91aa6cb00ef7dc5d=
5c4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 12MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+CASSETTE+100ML+APP&amp;id=3D162bdcc017c02c4119018777dc7b5=
e82" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+250ML+APP&amp;id=3D23e08b31ba32200df81ea32a944293fa" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+CASSETTE+250ML+APP&amp;id=3Dc22478b905acd8998cac4e42d614e=
7f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+250ML+CZA&amp;id=3Dd196bdb5a1b3519786bb46a6d5c6961b" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+ZAK+100ML+CZA&amp;id=3De87c6de145a0eccf3a0aa42bdc42154d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 145,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+ZAK+500ML+CZA&amp;id=3Da4aa0348ed46cf5cf7794f145acd0cda" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 146,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+250ML+IP&amp;id=3D08d21460db4e224f73e2e6c351f003fd" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 146,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+250ML+PA&amp;id=3D8a3b70fe81aa991026dcb85a8a9c828b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 146,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+ZAK+100ML+IP&amp;id=3Ded3bcdd19ca7ad02b7bb2f8cdc3eba03" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 146,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+250ML+AAA&amp;id=3D72f4812f6e3442859477e1a191b547a6" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 250ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 147,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+1%2C6MG%2FML+ZAK+500ML+PA&amp;id=3D9c00901f9d831144da79dcd6391d92a=
3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 1,6MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 147,36&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML%28200ML%2FU%29+LUMC&amp;id=3Dd1af1ddac3fa27d8219=
59af0b7246298" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML(200ML/U) LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INF+16%2C67MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D00e2291a8e927cb5d=
9696aa8e3b0b4b5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INF 16,67MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML%28200ML%2FU%29+UMCU&amp;id=3Dbfa21a571c0c81c7391=
6256c3cc77f8d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML(200ML/U) UMCU</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek UMC U=
trecht</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+CASSETTE+250ML+IP&amp;id=3Dd81b828ec03524bb508d218e481841=
90" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+16MG%2FML+ZAK+500ML+APP&amp;id=3D7892ff335bc5f5eb18c8c31c40dfc=
16e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 16MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C08MG%2FML+POMP+120ML+%285ML%2FU%29AHZ&amp;id=3D9d2a098a6eab408e=
c1a835dbe4200f72" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,08MG/ML POMP 120ML (5ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 148,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+ZAK+100ML+APP&amp;id=3D29bf3c9c65a6a4de1b69136b8e6dba74" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 149,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+15MG%2FML+ZAK+100ML+CZA&amp;id=3D98a65c2d139ac07419c2aa2ae4d2f811" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 15MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 150,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+CASSETTE+250ML+ASG&amp;id=3D38c5971b6d0643d89d8d0d74cafb6=
cc8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 150,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+10MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D0b5fa7b78ed180d62835=
14fa3cb2cfe3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 10MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 150,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+CASSETTE+100ML+ASG&amp;id=3D05fff58015c2084427be2e21ce611=
4cc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+4%2C5MG%2FML+ZAK+500ML+PA&amp;id=3D1475ade732ffa91b98982ab4516e349c"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 4,5MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+ZAK+100ML+CZA&amp;id=3D8601bf7231aee833c7801abf4fbfeafb" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+CASSETTE+250ML+ASG&amp;id=3Db5d6cb54045dcf83c5c5736a52b5b=
3a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+MAN=
NITOLUM+100MG%2FML+NEW+VIAFLO+ZAK+500ML&amp;id=3D4b62aa69b66d6b57569624ab4c=
90f416" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST MANNITOLUM 100MG/ML NEW VIAFLO ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MANNITOL</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+250ML+IP&amp;id=3D93748cabec92ad46b61a26ea7d071ccd" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+250ML+PA&amp;id=3Dbb0eb4ac7ae1283f6abe99a84a302beb" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+CASSETTE+100ML+APP&amp;id=3Dd82e21fb9b44baa743f1809aed46b=
52f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+CASSETTE+100ML+APP&amp;id=3Dadaf33ee3f782769cc084a3f3ddae=
285" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+CASSETTE+250ML+APP&amp;id=3Dc7a4207738492a7a16f2853c1e10b=
cd8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+10MG%2FML+POMP+100ML+%28200ML%2FU%29+APP&amp;id=3Ddc6d1479a62551a8fd2=
47691706527ba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 10MG/ML POMP 100ML (200ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+16MG%2FML+ZAK+500ML+IP&amp;id=3D0c87f327c8e42b21ba01a009d3a249=
e7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 16MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+ECOBAG+1000ML&amp;id=3D1bcdb762ae362101e6f0b2ef308cff2e" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT ECOBAG 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+ZAK+100ML+APP&amp;id=3D7f32a92baa1cd91d4170d556a9730558" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3D028266ec8d8f720fd923f8c5f94a6=
7b8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+CZF&amp;id=3D0875db7f15d4081309249bd0d5906536" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML CZF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">CEBAN ZIEKENHUISFARMACIE=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+ZAK+100ML+APP&amp;id=3Deb633e9156141a8f32038b5a73f96af0" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOMETA+INFV=
LST+0%2C04MG%2FML+FLACON+100ML&amp;id=3Ddb33197b3c1d31cd9efce602e8f6cb74" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOMETA INFVLST 0,04MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Ierland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,36&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLEDRONINE=
ZUUR+SANDOZ+INFVLST+0%2C04MG%2FML+FL+100ML&amp;id=3D78bc65081eca05a3292f82d=
2b44f4474" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLEDRONINEZUUR SANDOZ INFVLST 0,04MG/ML FL 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLEDRONINE=
ZUUR+ACCORD+INFVLST+0%2C04MG%2FML+ZAK+100ML&amp;id=3Db1fdeaba5d0b4595a8a25a=
b9218e3436" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLEDRONINEZUUR ACCORD INFVLST 0,04MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">ACCORD HEALTHCARE B.V.</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+20MG%2FML+ZAK+100ML+APP&amp;id=3D17addef645c9a504ec4977e6db74808e" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 20MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INF+12%2C5MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3Dd9cb38accd912dfbf4=
508b6de7bfed88" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INF 12,5MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 153,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+CASSETTE+250ML+ASG&amp;id=3Daf460845cb6ead7ff4f3b44704ae9=
2aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+CASSETTE+250ML+APP&amp;id=3Dc171f7ed39fb94b4fcd26d5fed421=
22d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C4MG%2FML+ZAK+500ML+PA&amp;id=3D350bc51382deca9cd10f0d1d31a7de0=
2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,4MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2MG%2FML+CASSETTE+250ML+IP&amp;id=3Df8953069d80dd76b216983d9238670=
14" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+ZAK+100ML+IP&amp;id=3D8d7c4aab87ae968db35668b8618cff48" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+CASSETTE+100ML+IP&amp;id=3De7b0efb02bcbcca3792a19aebef908=
df" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 155,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1%2C25MG%2F1MCG%2FML+FL+50ML+ASG&amp;id=3D97489e3d0f0379d9479=
c1bf3f4686da3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1,25MG/1MCG/ML FL 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 155,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+8%2C2MG%2FML+ZAK+122ML+MSZ&amp;id=3Ddf799c5131cb315d4866eb7463ca88b=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 8,2MG/ML ZAK 122ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 155,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C8MG%2FML+ZAK+250ML+CZA&amp;id=3D40dd865e9856d64888bf23efd4d6c9=
0e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,8MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 155,99&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DVANCOMYCINE+INFVLST+2%2C5MG%2FML+ZAK+500ML+CZA&amp;id=3D4fa7722404ecfa0b=
c66b720705b375d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 156,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+ZAK+100ML+MSZ&amp;id=3Df46c0e3985faf0d1986bf05dd262c0a9" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 156,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+250ML+CZA&amp;id=3D9d60a3db9f9cdae2520afd210dbb8e3c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 156,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+15MG%2FML+CASSETTE+100ML+CZA&amp;id=3Dacbe68807d01aad0e0fef85a3cf2b=
3b1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 15MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 156,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+4%2C17MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D61e4fe33e1d82a3b=
cfa1cd20aa57290b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 4,17MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 157,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+14MG%2FML+ZAK+100ML++CZA&amp;id=3Deab504522b717c3913fe24a094676f5d=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 14MG/ML ZAK 100ML  CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 157,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+APP&amp;id=3D774a721de8812a6d3f83ffd28be178ff" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 157,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+5%2C7MG%2FML+POMP+175ML+%28175ML%2FU%29+IP&amp;id=3D82efd05fedfd8bea=
600a0388b8fda543" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 5,7MG/ML POMP 175ML (175ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 157,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C6MG%2FML+ZAK+500ML+CZA&amp;id=3Df9773e47ed1295bd448c327099cede=
79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,6MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+16%2F2MG%2FML+ZAK+250ML+APP&amp;id=3D1c8e8dc8783085e1b831943d=
fbcc2492" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 16/2MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+CASSETTE+100ML+ASG&amp;id=3D743e5b0e3ee6e0ed06bc26a41a8f4=
e16" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+250ML+CZA&amp;id=3D4ad64b4f70797e9ef8acec98bcfeedc1" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C5MG%2FML+ZAK+500ML+APP&amp;id=3D0d2e1a11897d3f5710b1fabcb56525=
b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,5MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+ZAK+100ML+APP&amp;id=3D379310bc932996ab4e94b6e989e9c4ff" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+500ML+APP&amp;id=3D48d80f9f30f78069a342bcc5d6d43965" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+CASSETTE+250ML+APP&amp;id=3D737579d283f0e2a78673c5d1f8ab1=
504" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+ZAK+250ML+APP&amp;id=3D8e885685cca95b9e6ec69a84338a17d6"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+10MG%2FML+ZAK+100ML+APP&amp;id=3Db1ddd51891866499fc08bd50b1981122" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 10MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+CASSETTE+250ML+APP&amp;id=3Dc497c1958a7f7e96f2c6679d01d51=
008" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+500ML+IP&amp;id=3D10b9fd77ec8450a22bb8abe9f1ad3ae0" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+500ML+PA&amp;id=3Dd1ea54fe5324606f26aaf6434d3a26f8" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 158,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INF+33%2C33MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D8581f071b80a48b75=
279a85600df31e8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INF 33,33MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 159,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+POMP+100ML+AHZ&amp;id=3D9db97fcb73ce53b1a042784adae27695"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML POMP 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 159,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+CASSETTE+100ML+APP&amp;id=3D61ceb8f795a820f4906d566e29bbe=
b37" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 159,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+4%2C17MG%2FML+POMP+240ML%2810ML%2FUUR%29+IP&amp;id=3D88ad175d52d85237=
d0b698f2cb79bcb3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 4,17MG/ML POMP 240ML(10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+4%2C17MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3D8dca8bf40e92e552=
2bcd59aeecf05d21" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 4,17MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3MG%2FML+ZAK+500ML+CZA&amp;id=3D474ee7fd9c4f6132e979b5db8014f43a" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+CASSETTE+100ML+CZA&amp;id=3D863a388e6dc76bb5115dfccb8f2bf=
e60" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+30MG%2FML+ZAK+100ML+MSZ&amp;id=3Db413f6a27226890f54397e650df89507" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 30MG/ML ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+30MG%2FML+CASSETTE+100ML+APP&amp;id=3Ddec17e43e40a23942210f15b2a7a17=
0f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 30MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 160,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+5%2C21MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D67459852184c0ccc=
883b8b2b9c567dc6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 5,21MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 161,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+FLACON+100ML+KUNSTST+ECO&amp;id=3D09939ba8c27b166e7169ea20=
505cb532" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML FLACON 100ML KUNSTST ECO</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 161,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+16%2C7MG%2FML+POMP+120ML+%285ML%2FUUR%29+IP&amp;id=3D8f73513da4f5381d=
b8b6ea490cee8086" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 16,7MG/ML POMP 120ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 161,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+15MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3Dbaf05ddf2b347cf635=
b0d58ade6b2ad7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 15MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 162,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+ZAK+100ML+CZA&amp;id=3D8b8ca845350a1044cd98c87ef1c91e9f" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 162,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C2MG%2FML+ZAK+500ML+CZA&amp;id=3Da9a6a6fe0749b036efdf90977a14ba=
36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,2MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 162,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+ZAK+100ML+APP&amp;id=3D2a12f7aaf30ee9f1a99b4a25ed0f4694" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 162,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+14MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D6fea89e2525aa049b0=
f062a169e4d8aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 14MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 162,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+12MG%2FML+POMP+100ML+%28200ML%2FUUR%29+IP&amp;id=3Dfb63a6b4039cee7f4f=
d944ce1bc4eb1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 12MG/ML POMP 100ML (200ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+11%2C72MG%2FML+ZAK+128ML+MSZ&amp;id=3D0c00dd4866fe33389007b433777bb=
382" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 11,72MG/ML ZAK 128ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5%2C5MG%2FML+ZAK+500ML+IP&amp;id=3D4adb86f8257da5309a72f55f5729343=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5,5MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+12%2C5MG%2FML+POMP+40ML+%285ML%2FU%29+CZA&amp;id=3D5fb97a148c3688d5=
95d8fc38b305eb58" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 12,5MG/ML POMP 40ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+33%2C33MG%2FML+POMP120ML%285ML%2FU%29LUMC&amp;id=3D98559b3ce99a1b92=
24438327a03ab68d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 33,33MG/ML POMP120ML(5ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+100ML+APP&amp;id=3Dfd7aa316248656c25027098830e7677e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+6%2C25MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3Dde7bc5f33185e05c=
af2d6cd902a51f69" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 6,25MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+5MG%2FML+CASSETTE+100ML+ASG&amp;id=3Deb3e0bebe33949f33518a16cb2d4fdd=
4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 5MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C5MG%2FML+ZAK+500ML+PA&amp;id=3D343235cf36a0ff0b278ea91f4387fda=
0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,5MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C5MG%2FML+ZAK+500ML+IP&amp;id=3D5b084a9ad58dd5cfbe6584c99ebaa68=
c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,5MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+16MG%2FML+ZAK+250ML+CZA&amp;id=3D0e4194c2b7222db49239773ec079fbbc" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 16MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+16%2C7MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3D13f9833c110202aae=
2964f6131b41d31" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 16,7MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9MG%2FML+CASSETTE+250ML+APP&amp;id=3D10a56ab31d9e9831236f1cb6f088a=
ef2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+500ML+APP&amp;id=3D1dde76a61ff2af2af796441081875b3b" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+40MG%2FML+POMP+100ML+%28200ML%2FU%29+APP&amp;id=3D29a4932ff42d9e4231c=
6056554306599" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 40MG/ML POMP 100ML (200ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+32%2F4MG%2FML+ZAK+250ML+APP&amp;id=3D5e055397f407b947bd166df1=
ab0295ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 32/4MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+POMP+100ML+%2850ML%2FU%29+IP&amp;id=3D134e8bfe8ebde95d6ed=
9fe83ead32e17" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML POMP 100ML (50ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3Da38aa6319f2f76c082407f6298c1=
394d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 164,99&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+CASSETTE+100ML+ASG&amp;id=3D5644bd6da4956537875a9f8211f7d=
577" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+ZAK+100ML+MSZ&amp;id=3D6c91fd6f9a83de186209461eeffdd359" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+ZAK+100ML+CZA&amp;id=3Db05fabbfefa4a4c92101edbedc8e0575" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX+ZAK+++50ML&amp;id=3Dd2a78d17b3068f68f7a33e84c056f390" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX ZAK   50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FREEFLEX%2B+ZAK+++50ML+%2B+LL&amp;id=3Df3e782631d5e8c1fd0edf99d0=
fabc053" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FREEFLEX+ ZAK   50ML + LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C44MG%2FML+ZAK+291ML+MSZ&amp;id=3Dff11b11e6fcfaecf60ee03074d1a8=
480" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,44MG/ML ZAK 291ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INF+25MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D104efeea143683370dc563=
930707bb00" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INF 25MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C8MG%2FML+ZAK+500ML+CZA&amp;id=3Ddd46614c123361ee51fd756914f1e3=
b1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,8MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+12%2C5MG%2FML+POMP+40ML+%285ML%2FUUR%29+IP&amp;id=3De7b1d45c9f0290f41=
95be29c36745f91" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 12,5MG/ML POMP 40ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+500ML+IP&amp;id=3D69b309df3b4c2c0868fc3816c216182d" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+10MG%2FML+POMP+100ML%28200ML%2FU%29+ASG&amp;id=3De96257e30504be482e96=
22d2badb2c29" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 10MG/ML POMP 100ML(200ML/U) ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML%28200ML%2FU%29+ASG&amp;id=3D9023ee3cc833f25ecafa=
84985edb9fb0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML(200ML/U) ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+60000IE%2FML+CAS+100ML+APP&amp;id=3D610bc2f0596c3f87dcb67ad9=
7a163f4c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 60000IE/ML CAS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+17MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3Da525b2aa08f18966cf=
8a05403e8eec9d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 17MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+15%2C15MG%2FML+ZAK+132ML+MSZ&amp;id=3Dc8683cf7771104b2a80eabeba4b5f=
9f7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 15,15MG/ML ZAK 132ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+CASSETTE+100ML+APP&amp;id=3D431b2a7f7c4ea0a6ac96f7f620=
6c7590" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+16%2C7MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D1b35fb7253c0053e=
fe4008458bafe7c4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 16,7MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+120ML+%285ML%2FUUR%29+APP&amp;id=3Dfa7ccf72f3704ca531=
7e7921625e8e1b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 120ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+33%2C3MG%2FML+POMP+120ML+10ML%2FUUR%29+IP&amp;id=3D6363ca271b2377b499=
3f7d6b3436369a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 33,3MG/ML POMP 120ML 10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+ZAK+100ML+MSZ&amp;id=3D97eb787e5c847c01780882c421829841" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 166,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+60000IE%2FML+ZAK+100ML+APP&amp;id=3D66637e54c69d5fa83b7cd813=
3d6bcc8e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 60000IE/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C8MG%2FML+CASSETTE+250ML+CZA&amp;id=3Dab0206e7fc77f416bf2762b45=
4cb3f4a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,8MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+5MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D8d389215e37954a64ea8=
8d000c184652" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 5MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8MG%2FML+POMP+250ML+%28175ML%2FU%29+IP&amp;id=3D5d34cede9f645c7e8c01=
f0c052e03818" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8MG/ML POMP 250ML (175ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+ZAK+100ML+IP&amp;id=3D0df31d9ac755884c0f187a9a0e6ce3e1" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+CASSETTE+100ML+CZA&amp;id=3D2779c02fb20b6a94e6f21eb18d6d6=
21a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+250ML+CZA&amp;id=3D78a429be96388c90f3dec7018bf26e4e" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C4MG%2FML+ZAK+500ML+CZA&amp;id=3D80b183109dcc3eb4e80c7b88d9ab96=
90" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,4MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+7%2C29MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D6208ecd0198e0324=
402dd5effff33385" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 7,29MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+60MG%2FML+ZAK+100ML+APP&amp;id=3De5ebe77332a1154d393724adac38a=
3b8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 60MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C5MG%2FML+ZAK+500ML+APP&amp;id=3Da2f3a0e360dbbad3714e2b7ee15b01=
2f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,5MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+16%2C6MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3Dd390d1930a9c6ed8=
2c30bd8e5373bc5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 16,6MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3De7dcb1b442f6ff40c155b053e74bea=
9a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+18MG%2FML+ZAK+100ML+CZA&amp;id=3D8492cd062c12432382f1df7e95d18a4b"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 18MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+20MG%2FML+ZAK+100ML+CZA&amp;id=3D3cf9e66b54fa228f74f19abf12ffbad3"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 20MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+ZAK+100ML+IP&amp;id=3D0d1821ab236ccf401da891ac02d86c20" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C5MG%2FML+ZAK+500ML+CZA&amp;id=3Df62aa753ea2d12e0be76b94cd22f2e=
43" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+CASSETTE+100ML+APP&amp;id=3Dcfcbc42a97caba851908446a43082c=
62" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+40MG%2FML+ZAK+100ML+APP&amp;id=3Df35b5b112a3d9f8bedd6799499703b73" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 40MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C6MG%2FML+ZAK+500ML+CZA&amp;id=3D7f7ccb01db3e715a1b49802e06a4bc=
3d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,6MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+120ML%285ML%2FU%29LUMC&amp;id=3D1a5c471b85854a0652c=
819f735ccbb1d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 120ML(5ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+APP&amp;id=3D1ff28b1163854069234b0c9cf5a240=
25" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+CASSETTE+100ML+APP&amp;id=3Db345c4d2e42436c8e759291d16212=
667" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+15MG%2FML+CASSETTE+100ML+CZA&amp;id=3D1392ac86b92c91c35742a2d53474c=
700" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 15MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DVANCOMYCINE+INFVLST+8MG%2FML+ZAK+250ML+CZA&amp;id=3D7cb9574fa6d71db842b8=
47a68441cba5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+FREEFLEX+ZAK+++50ML&amp;id=3Daab4e249787e0848b598fca9f651f=
83a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML FREEFLEX ZAK   50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+POMP+100ML+AHZ&amp;id=3D95a51c7eec55c505bfd23fb4e388d16f"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML POMP 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFV+17%2C5MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3Dc2a4ad6abd04cbe75=
dc01dd35531816f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFV 17,5MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+1%2C2MG%2FML+CASSETTE+250ML+IP&amp;id=3D5ab179aff05eb2f218e4dea804=
8f409f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 1,2MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1MG%2F1MCG%2FML+FL+50ML+AHZ&amp;id=3D36b468d2591b20bb449895b5=
bffdc032" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1MG/1MCG/ML FL 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+17%2C86MG%2FML+ZAK+336ML+MSZ&amp;id=3D65737b05dd8aa7d8b80897e0=
7625007b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 17,86MG/ML ZAK 336ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 169,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+8%2C33MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D876c7c397d9215c29=
ef235faa2caf1bc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 8,33MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3D2baad719315863325aa6e12679f511=
52" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+500ML+IP&amp;id=3Dc36d1bf2afc575b39240b12766f9e3=
83" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C5MG%2FML+ZAK+1000ML+IP&amp;id=3Dcb33747897f7dfd6183bca79269ca5=
0c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,5MG/ML ZAK 1000ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12%2C5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D9a0cb6189030d7413d675536=
209c4665" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12,5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+ZAK+250ML+APP&amp;id=3Dfa41403f01da450ef54843fd3a0c1d2a" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+ZAK+50ML+CZA&amp;id=3D7f0d5885edd992e06540771cf11fea8e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML ZAK 50ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+CASSETTE+250ML+CZA&amp;id=3Db6c0bcd31da9b1ef0984c676b9283=
2f7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML%28200ML%2FUUR%29+APP&amp;id=3D61ed2edc40597d355e=
eddeb4554e5b17" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML(200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+40ML+%285ML%2FUUR%29+AAA&amp;id=3D67d12e0a6ffd949770=
374855249a2190" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 40ML (5ML/UUR) AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+8%2C33MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3De74817ca6e34adbf=
13114a4dc3fdb40d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 8,33MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3D7123fe16b01ee624=
a889990eb14b31ac" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 8,33MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+30MG%2FML+ZAK+100ML+CZA&amp;id=3D9ab1328062a60bdc1207dfd507467e16" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 30MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+500ML+CZA&amp;id=3Dd05670e3130156a0af1236d7b5d8219f" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 170,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8%2C33MG%2FML+POMP+120ML+%2810ML%2FU%29CZA&amp;id=3D0d2a1d11bb7daaf8=
7a69295b32849c1d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8,33MG/ML POMP 120ML (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+16%2C7MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D352eff641ae1521f02=
99490b055f77a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 16,7MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+500ML+APP&amp;id=3D5fefd7516cdabf641e35c538d706ce71" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+8%2C33MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D768153ba4edaba42=
1ae6fb4e1e034d71" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 8,33MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+ZAK+100ML+APP&amp;id=3D89347e218ad64a174b35ee4d843649c1" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+250ML+APP&amp;id=3Df7a8dbf8c87db5c86908aec64840=
a768" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+CASSETTE+250ML+CZA&amp;id=3D3898909c39da19c26eb8d3c898477=
fa5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+CASSETTE+250ML+CZA&amp;id=3D55dd907045b9505a99b28f7b80acf=
564" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+40MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D05e17422be6fac76debe=
bd1ea92ec617" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 40MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDACEPTON+IN=
FVLST+5MG%2FML+FLACON+20ML&amp;id=3Dc53f1f1e3868bd56f375dff2c7d62ca4" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DACEPTON INFVLST 5MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">APOMORFINE</span>
                <span class=3D"facet manufacturer">EUROCEPT INTERNATIONAL B=
V</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+12MG%2FML+ZAK+500ML+IP&amp;id=3D9e5d95b1a3b4584052694c3b3f887fbf" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 12MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 171,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+500ML+IP&amp;id=3D8b6fff2d5841477a530bd239e8c18a9c" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+500ML+PA&amp;id=3Dc6481583f2a692b180209fcf0d230887" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3Dbd0c3903bc1deeaed21dfcbba1dec=
75f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+CASSETTE+100ML+ASG&amp;id=3D3f60e53489522d845fea87235d=
1c7413" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+ASG&amp;id=3D775743f798c379646ca27297b2142=
936" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+10%2C42MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3Dbfa379b983889394=
c81639b277c1802a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 10,42MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+500ML+AAA&amp;id=3D59a6de1f0038130e13882aa92432302d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 500ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+500ML+APP&amp;id=3D88a087455f0de33d984280bde5bae=
20b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+16%2C67MG%2FML+POMP+60ML%285ML%2FU%29+APP&amp;id=3D03399e1d2c4283ab6=
2c4bcab9713e6b1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 16,67MG/ML POMP 60ML(5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETRONIDAZO=
L+FRES+INFVLST+5MG%2FML+KABIPAC+FL+100ML&amp;id=3Dd036b374a7ca5a8be9e10f471=
c71c4c3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METRONIDAZOL FRES INFVLST 5MG/ML KABIPAC FL 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METRONIDAZOL</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C68MG%2FML+ZAK+560ML+MSZ&amp;id=3D9dba7b0a6c546c05b85db79d2ab03=
83f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,68MG/ML ZAK 560ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+POMP+100ML+%2850ML%2FU%29+IP&amp;id=3D486284cf21f9c0f0cdc2=
4256eac68b40" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML POMP 100ML (50ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+83%2C33MG%2FML+POMP+48ML%282ML%2FU%29CZA&amp;id=3D9a788601bc65e3bd07=
b87bc19fdede54" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 83,33MG/ML POMP 48ML(2ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 172,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCIPROFLOXAC=
INE+HIKMA+INFVLST+2MG%2FML+ZAK+200ML&amp;id=3D594fc2d9f7639de0e92835fb9d1cf=
e08" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CIPROFLOXACINE HIKMA INFVLST 2MG/ML ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CIPROFLOXACINE</span=
>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 173,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9MG%2FML+ZAK+250ML+CZA&amp;id=3D2ac318fcaa0bac82fbd517dee1fba4d7" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 173,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+20%2C83MG%2FML+POMP+120ML%285ML%2FUUR%29+IP&amp;id=3D567cd0eaeb9c155a=
e3e174f00db3eb6d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 20,83MG/ML POMP 120ML(5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 173,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+20MG%2FML+ZAK+100ML+CZA&amp;id=3D8566573e3ebc176f1bc4e7718ca95f5c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 20MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 173,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+30MG%2FML+POMP+50ML+%285ML%2FUUR%29+IP&amp;id=3D58e89fe88ab892ca043ed=
b7068d32553" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 30MG/ML POMP 50ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+CASSETTE+250ML+IP&amp;id=3D145f5be96b4a59dea96b60b8f2a9d4=
70" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C5MG%2FML+ZAK+500ML+CZA&amp;id=3D4e4191a506c24c5a634f29cb81d121=
b9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+ZAK+100ML+CZA&amp;id=3Dd127dc187a080e61c25477c3b2a58aeb" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+33%2C3MG%2FML+POMP+60ML+%285ML%2FUUR%29+AAA&amp;id=3D2af41d63da094d17=
103406eba73ae391" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 33,3MG/ML POMP 60ML (5ML/UUR) AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+500ML+PA&amp;id=3Ddeaa6d9d9aebadb5abfa008c973b9415" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+6MG%2FML+ZAK+250ML+APP&amp;id=3Dfd1c64535ed27c427fed9abe42cc17e5" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 6MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+12%2C5MG%2FML+POMP+120ML+%285ML%2FUUR%29LUMC&amp;id=3D3b6c0926c0b293ef=
0844861230ebb9bf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 12,5MG/ML POMP 120ML (5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+9%2C38MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D0a5af9f83e30dc9b=
a34e7758ef0f9121" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 9,38MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+CZA&amp;id=3Dd966369319202d14ad4b720ecbd87b01" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 174,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+30MG%2FML+ZAK+100ML+APP&amp;id=3Decac5c16adf9620648dabd704e3c9=
2d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 30MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+31%2C25MG%2FML+POMP+60ML+%285ML%2FUUR%29APP&amp;id=3D55892fdf7ae9f648=
1b5c313b13f8fc3d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 31,25MG/ML POMP 60ML (5ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+16%2C7MG%2FML+POMP+120ML+%285ML%2FUUR%29APP&amp;id=3Def7c6e9c9dd8ff45=
a9d4e644d7a4dd55" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 16,7MG/ML POMP 120ML (5ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+CASSETTE+100ML+APP&amp;id=3D1beed51f834edc39ca8eedd9bcb82=
959" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+CASSETTE+250ML+PA&amp;id=3D9e428c5012efe67ebc36aae5c89e62=
ca" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+CASSETTE+250ML+IP&amp;id=3Dd8aca33a621cdab4aec8ac23a286e3=
7d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+12%2C5MG%2FML+POMP+40ML+%285ML%2FUUR%29+APP&amp;id=3D8a8047b9fb8bb8ad=
97f375218b4a8276" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 12,5MG/ML POMP 40ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INF+18%2C75MG%2FML+POMP+240ML%2810ML%2FUUR%29LUMC&amp;id=3D584cc8baa540415f=
2b6207dbf9b21986" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INF 18,75MG/ML POMP 240ML(10ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3D4e8769effca10afa=
5895cb7c7937ae4d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 8,33MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+17%2C5MG%2FML+POMP+40ML+%285ML%2FU%29+APP&amp;id=3Dcd514d41f8b784f6=
b95ac852686894b4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 17,5MG/ML POMP 40ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+250ML+PA&amp;id=3D3c7afe27400d73a7b40ce8afc8d26d=
d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+250ML+IP&amp;id=3D8f2354b495ea8b0022329070a6ed26=
e7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+6%2C25MG%2FML+POMP+120ML+%2810ML%2FUUR%29+IP&amp;id=3Debbe7698306db6f0=
cfbe8dfb836950d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 6,25MG/ML POMP 120ML (10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+100ML+%28100ML%2FU%29+CZA&amp;id=3Dea202ff2f6139b74c9=
ee26577b8543f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 100ML (100ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+PA&amp;id=3D3712b512747ed8c608f600db5751d61a" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+IP&amp;id=3Deb1921d2827342d9eeafcaa0bf09cee4" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 175,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+250ML+AAA&amp;id=3D5fdcc2ead5feaa59fb2b5fdd4b22=
a3dd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+4MG%2FML+ZAK+500ML+CZA&amp;id=3Dbdaf152eda8c99f685d839c8a348b2da"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 4MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+33%2C3MG%2FML+POMP+120ML%2810ML%2FUUR%29APP&amp;id=3D0114968eb8531537=
fab9fd115276a538" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 33,3MG/ML POMP 120ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+33%2C3MG%2FML+POMP+60ML+%285ML%2FUUR%29+APP&amp;id=3D75433cbe7fff2397=
812bfba1375b68f1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 33,3MG/ML POMP 60ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+28%2F3%2C5MG%2FML+ZAK+285ML+ZIK&amp;id=3Dbd849e415ea0aeb02fb4=
2b50309e4b3e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 28/3,5MG/ML ZAK 285ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+31%2C25MG%2FML+POMP+60ML+%285ML%2FUUR%29+IP&amp;id=3D7842dca928d6a64f=
791995e6c52fb262" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 31,25MG/ML POMP 60ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+25MG%2FML+POMP+120ML+%285ML%2FUUR%29+APP&amp;id=3Da53c6484130eddea565=
dead4fc1b68ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 25MG/ML POMP 120ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+POMP+100ML+%28200ML%2FU%29APP&amp;id=3Ddfb0b01181ebfb8a87=
a71b5d6156c4c8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML POMP 100ML (200ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+40000IE%2FML+CAS+100ML+APP&amp;id=3D50f46eec680f26b4fbee7ee0=
c5f637a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 40000IE/ML CAS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8%2C33MG%2FML+POMP+120ML+%2810ML%2FU%29+IP&amp;id=3D5f140f3120377742=
5ef49013062dfde4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8,33MG/ML POMP 120ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8%2C33MG%2FML+POMP+120ML+%2810ML%2FU%29+PA&amp;id=3D9daa48e44539ea81=
cf901cd54cea8e87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8,33MG/ML POMP 120ML (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 176,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+50ML+%285ML%2FUUR%29+IP&amp;id=3D23c26cd9331b55f5954=
91b4cbc71dbd0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 50ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+ZAK+100ML+IP&amp;id=3Dc5e7185e384903fd20dc3f2b6991003b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+41%2C67MG%2FML+POMP+60ML%285ML%2FUUR%29+IP&amp;id=3D5743ad8182bbe6e4=
1c51a76552a7996a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 41,67MG/ML POMP 60ML(5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+CASSETTE+250ML+IP&amp;id=3Db94395cce7c4db825f37b9549=
1769d96" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+20MG%2FML+CASSETTE+100ML+APP&amp;id=3D2966f17b50c638edeaf1d8c7ae06f=
f0c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 20MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+ZAK+100ML+APP&amp;id=3Db020769d02e43467fb156ad84876fec2" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+ZAK+250ML+APP&amp;id=3D017073f0671eda3fdd9d8e7b=
b0e78609" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+60ML+%285ML%2FUUR%29+APP&amp;id=3D66722112cd0dd9d90e=
d1644b0d43b3fe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 60ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+12%2C5MG%2FML+POMP+120ML+%285ML%2FU%29APP&amp;id=3D7b4db0779c1f7f73=
5716e2945ddd8b2b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 12,5MG/ML POMP 120ML (5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+50ML+CZA&amp;id=3D61cce923218ab9f1b7bccc84e70fa3b9" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 50ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+96%2C15MG%2FML+POMP+26ML%282ML%2FUUR%29IP&amp;id=3Dfb882d46561e98a1=
a59fb69661e69239" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 96,15MG/ML POMP 26ML(2ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+15MG%2FML+CASSETTE+100ML+CZA&amp;id=3D7ae957bbdb936b7456dc587f5e49=
de1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 15MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+100ML+%28200ML%2FU%29+CZA&amp;id=3De708aea84e9d15a590=
bf5076bb472c1f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 100ML (200ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+ASG&amp;id=3D6ccaae95552274de1fb0545975f33c=
f0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DCEFTAZIDIM+INFVLST+40MG%2FML+ZAK+100ML+CZA&amp;id=3Da320da40e0597be9a2a3=
de9009976748" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+600ML+IP&amp;id=3Dcabba6b6df10266e3a195fe1bb24724b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 600ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8MG%2FML+ZAK+250ML+APP&amp;id=3D2f298cdfdadcef62abd7290561603c7e" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3D3a6abee9c44e0488d90c=
65809344fd34" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 50MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+4MG%2FML+ZAK+250ML+APP&amp;id=3D5452debb1bfe72eab359bb4004f7597a" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 4MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+ZAK+250ML+APP&amp;id=3D56275f07bd2962ec08588bef62f1c=
6e9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5%2C5MG%2FML+ZAK+500ML+APP&amp;id=3D8404bbfdfeec9171cdf342ffcf8724=
d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5,5MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12MG%2FML+ZAK+250ML+APP&amp;id=3Dbbbb5be784d2456b7f3a497047515cfb"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+ZAK+500ML+APP&amp;id=3Dfaefc3ff7e1931c1b7046de9beb0cc8c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+60ML+%285ML%2FUUR%29+IP&amp;id=3Dbc89bf2f4e6c88429ba=
1269628201cd6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 60ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVL+26%2C08MG%2FML+POMP+230ML+%2810ML%2FU%29+IP&amp;id=3Df8f4cbfc6fd852c0=
ab2846a3c01e4e7b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVL 26,08MG/ML POMP 230ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+CASSETTE+250ML+CZA&amp;id=3Da71dd775c8732917c5eccd2c9a9f9=
49d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C2MG%2FML+CASSETTE+250ML+PA&amp;id=3D70d908088a8ff2420228ccf7f6=
d7d384" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,2MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+CASSETTE+100ML+APP&amp;id=3D7ccd7abddb160afc1dce845c=
d31990f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+120ML+%285ML%2FUUR%29+IP&amp;id=3Ddb5cb79e0a5db215b0=
e67195baf8fa1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 120ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 178,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+ZAK+50ML+CZA&amp;id=3D937ff6a76cef7e78c631a6aa293760c9" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML ZAK 50ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+CASSETTE+100ML+CZA&amp;id=3Dda800d5737ff6bbf4c8d8587a17bb=
ab1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+ZAK+100ML+CZA&amp;id=3Df1a32f2e5787804af60c5faabaa20e93" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+2%2C5MG%2FML+CASSETTE+100ML+FSBA&amp;id=3Dece2d899bbbd3838e666cada=
a519add5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 2,5MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C51MG%2FML+ZAK+570ML+MSZ&amp;id=3Daa0eade39e2f7d21693da92d238e0=
828" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,51MG/ML ZAK 570ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINEHYDR=
OCHLORIDE+1ML&amp;id=3D409b75657b66df4f03b61bba4725e125" class=3D"result-it=
em medicine">
            <h3 class=3D"result-title">
                    MORFINEHYDROCHLORIDE 1ML=3D20MG EPI CAS 100ML FNA MR</h=
3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+2%2C08MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3D39b4a540129132ad=
4c75c1a2e9e879d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 2,08MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+2%2C08MG%2FML+POMP+240ML+%2810ML%2FUUR%29PA&amp;id=3D4bb2d0f88eff289e=
119d887975eba6c0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 2,08MG/ML POMP 240ML (10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+700ML+IP&amp;id=3D6e5055152c8b3a525866a75effc4ca87" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 700ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C25MG%2FML+CASSETTE+100ML+IP&amp;id=3De49e74dc9a1caf0ff781491825=
af4c44" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,25MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+CASSETTE+100ML+IP&amp;id=3Da174ff3e47961010241261202a651f=
26" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+30MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3Dd0d8fdc0bf07d1afed579f79bf5=
f58ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 30MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+ZAK+100ML+CZA&amp;id=3D05393541e30bf78ce9178c870fb9c05b" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+60MG%2FML+CASSETTE+100ML+APP&amp;id=3Dcf07f84a3df803f55661bbb1=
912819de" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 60MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++20ML&amp;id=3Dabae2a0911a1f2f3a9d2e7160013=
9c3c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF 100MG/ML FLACON  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+APP&amp;id=3D35557a642e5a10c700e4729d3d133e=
47" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
L+INF+33%2C33MG%2FML+POMP+240ML%2810ML%2FU%29LUMC&amp;id=3D53b7b5dc0b4100a0=
cee12319468b3481" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILL INF 33,33MG/ML POMP 240ML(10ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+37%2C5MG%2FML+POMP+40ML+%285ML%2FU%29+APP&amp;id=3D53fc2943b89ab564=
d5c38ec60f7e05a5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 37,5MG/ML POMP 40ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+16%2C67MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D6414e44306852280=
51faa299ee6229d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 16,67MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+20MG%2FML+POMP+100ML+%28200ML%2FUUR%29+APP&amp;id=3D885583dfd470d49c8e=
647f66dbff7230" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 20MG/ML POMP 100ML (200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+ZAK+250ML+APP&amp;id=3D8aef9e1123ce592645da5ae5009099c9" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+16%2C7%2F2%2C1MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3Db8ad86b2c3=
9d703ad155a9500aa0bb68" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 16,7/2,1MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 179,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+30MG%2FML+ZAK+100ML+IP&amp;id=3Df6398194ce63e16522ce902aa7fdf7=
00" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 30MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+20%2C83MG%2FML+POMP+120ML%285ML%2FUUR%29APP&amp;id=3D6e2221ca6db18e61=
def5b5899e015a6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 20,83MG/ML POMP 120ML(5ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+60MG%2FML+CASSETTE+100ML+APP&amp;id=3De9b8135f398e690df82b2a2cb11b8e=
8b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 60MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+40MG%2FML+POMP+100ML%28200ML%2FU%29+ASG&amp;id=3D300dc9c913aca2fe7b95=
281ede43b9b5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 40MG/ML POMP 100ML(200ML/U) ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+40ML+%285ML%2FUUR%29+CZA&amp;id=3D1f2349ec8e28265e1c=
2144f17d409c1c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 40ML (5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+40000IE%2FML+CASS+100ML+CZA&amp;id=3D7b9fc53266958c2013afde7c8=
b52d5c8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 40000IE/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+80%2F10MG%2FML+ZAK+100ML+CZA&amp;id=3De704f85bd7e114858f1cd41=
e67e3d3b5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 80/10MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 181,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C4MG%2FML+CASSETTE+250ML+CZA&amp;id=3D34b7220a5edf773efa78a6d78=
281bacc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,4MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 181,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+1000ML+APP&amp;id=3Dde73ab09a42e6d2b736b662fa767014d"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 1000ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 181,56&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+30MG%2FML+CASSETTE+100ML+PA&amp;id=3Dfa8f76f353b470deb126b8659=
3782a5a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 30MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 181,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+60000IE%2FML+ZAK+100ML+CZA&amp;id=3D9f4ed08ecef8bc2417b8025f=
0d0d610c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 60000IE/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 181,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INF+25MG%2FML+POMP+240ML%2810ML%2FUUR%29LUMC&amp;id=3D340d8d6216778622ea55a=
a5ea8a0c17b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INF 25MG/ML POMP 240ML(10ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+LUMC&amp;id=3D4ad65811e2f6c2941a=
addc3ce4f6b60d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+100ML+MSZ&amp;id=3Df184209edb31ce102250a884a8c6e8f3" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+25MG%2FML+POMP+240ML+%2810ML%2FU%29+AHZ&amp;id=3D5b771ea1fd9a26c9d8=
7574044a554159" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 25MG/ML POMP 240ML (10ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+60000IE%2FML+ZAK+100ML+PHL&amp;id=3D8fa9cc8de62da21dc2033d702f=
091dbb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 60000IE/ML ZAK 100ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+60000IE%2FML+ZAK+100ML+PA&amp;id=3Daafc9bbe2342b63d786559735=
51be79a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 60000IE/ML ZAK 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+4M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3D057c08c943188acecf7=
1b087bf636dbe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 4M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+ZAK+500ML+PA&amp;id=3De4a4d8666a1063ef8c9da85aa3ea8a36" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+ZAK+100ML+CZA&amp;id=3Df390beef21552dbb2d757c7709f42057" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+72000IE%2FML+ZAK+250ML+APP&amp;id=3D03c92fbca002443fb8cdfdc5=
2870a3aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 72000IE/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12%2C5MG%2FML+POMP+120ML+%2810ML%2FU%29CZA&amp;id=3Dcb017d0877299a3e=
d4c9efbf361ee5df" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12,5MG/ML POMP 120ML (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+24MG%2FML+ZAK+250ML+IP&amp;id=3D5343dd268b00b375066397b961a4a630" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 24MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+CASSETTE+100ML+APP&amp;id=3Dbef364649c8578ae829d32f19b79c=
486" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 182,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+3%2C75MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3D956481c975e602083=
4d11cf2e63c6ec8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 3,75MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9MG%2FML+ZAK+500ML+APP&amp;id=3De3e97fc83fee3d12676b3bbf9a045458" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+500ML+CZA&amp;id=3De4ae390c03f810317cff63fdc9441bab"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+18MG%2FML+ZAK+250ML+CZA&amp;id=3Decffc863cfe96493eaa9f50808d59048" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 18MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+50ML+IP&amp;id=3D9f3b166da439fe1bb3d7c0769301580f=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 50ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+12%2C5MG%2FML+POMP+120ML%285ML%2FU%29+CZA&amp;id=3Dfa2a9009ebef71f7=
3ee3919d08954eaf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 12,5MG/ML POMP 120ML(5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+ASG&amp;id=3D10ed7159dcb675ad5d2ca01affdcbc=
88" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+30MG%2FML+CASSETTE+100ML+ASG&amp;id=3Db1f6525ead8178440aa2b4217a14c2=
5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 30MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+CASSETTE+100ML+ASG&amp;id=3Dc07f157d233586250613b7792003ec=
36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+22%2C5MG%2FML+CASSETTE+100ML+ASG&amp;id=3Dcec62e3739ca7c08b6d792ce44=
8da2c5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 22,5MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+2%2C64M+IE%2F48ML+POMP+%282ML%2FU%29+IP&amp;id=3D96c5f8801b462804=
85f69e05d8717a85" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 2,64M IE/48ML POMP (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+2%2C64M+IE%2F48ML+POMP%28120ML%2FU%29IP&amp;id=3Dddf326d739c55414=
bd1cbad2f3ec1dc3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 2,64M IE/48ML POMP(120ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+500ML+PA&amp;id=3D7c21b3ccfc28f2f72679d3eb07ac2305" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+3%2C33MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3Df8533f1fe16e619b4=
26126596f82c251" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 3,33MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29APP&amp;id=3D6f90c82f83490367=
5483a8ef4105d785" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 8,33MG/ML POMP 120ML (5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+40ML+%285ML%2FUUR%29+APP&amp;id=3D709d689d5dde525492=
12349d215f72f7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 40ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+30MG%2FML+POMP+50ML+%285ML%2FUUR%29+APP&amp;id=3D75e86fe557536f2c8a72=
b632687144f5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 30MG/ML POMP 50ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+33%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3Ddfff2e10add897a5d=
147fef3d52732e8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 33,3MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 183,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+ZAK+100ML+ZIK&amp;id=3Dc0dce6024d77afdfe39856ebc36b3cad" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSCAVIR+IN=
FUSIEVLOEISTOF+24MG%2FML+FLACON+250ML&amp;id=3Dd2afe060dc2b3121403401c3f302=
6794" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSCAVIR INFUSIEVLOEISTOF 24MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSCARNET</span>
                <span class=3D"facet manufacturer">Clinigen Healthcare B.V.=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+IP&amp;id=3D46608a7502093458197df48d61c329c=
4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+40%2F5MG%2FML+CASS+100ML+PA&amp;id=3D494b41c157c7d8e0958ee165=
800f5b2c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 40/5MG/ML CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+PA&amp;id=3Df45565d3007aaa43bf6d4c6c5a7719c=
c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+120ML%285ML%2FUUR%29+APP&amp;id=3Da2625b739a052f482b=
8fbcbb32de1c66" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 120ML(5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+50ML+%285ML%2FUUR%29+APP&amp;id=3Dd6c58dd8ad3e1de7ef=
d6f54acc69a1fe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 50ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIQYMUNE+INF=
VLST+100MG%2FML+FLACON+20ML&amp;id=3Dd4f03d56ed4b5adbcdb6229b35590484" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IQYMUNE INFVLST 100MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CAF-DCF bv-srl</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+17%2C5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D9790457de96aec0572be3cdd=
3bbd35b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 17,5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+32%2F4MG%2FML+ZAK+250ML+PA&amp;id=3Def82ba0f33ad8e765c4582c25=
5d7821a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 32/4MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 184,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+80000IE%2FML+CAS+100ML+APP&amp;id=3D827ab2e361f6d2c300340fbf=
ab40f4e3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 80000IE/ML CAS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+70000IE%2FML+CAS+100ML+APP&amp;id=3Df4477a1389d06805db37a126=
f28444b8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 70000IE/ML CAS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+4%2C16MG%2FML+POMP+120ML+%2810ML%2FU%29+IP&amp;id=3D2e63f948c887f91d=
fd45debe508674f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 4,16MG/ML POMP 120ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
L+INF+41%2C67MG%2FML+POMP+240ML%2810ML%2FU%29LUMC&amp;id=3D23a0fcc34e0017ed=
d047b73671f87ddc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILL INF 41,67MG/ML POMP 240ML(10ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16MG%2FML+ZAK+250ML+APP&amp;id=3D5ca341d1b8ac1cad03df4e8624f1d3ac" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+24000IE%2FML+ZAK+25OML+CZA&amp;id=3Da1b49293b170563e365ac63a=
bf067ff1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 24000IE/ML ZAK 25OML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7%2C5MG%2FML+ZAK+500ML+IP&amp;id=3Df09a7bb8a5691620ebb17936ad8e603=
2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7,5MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+CASSETTE+250ML+PA&amp;id=3Dcab8e85460e96f824ce9cc4d28526c=
03" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+CASSETTE+250ML+IP&amp;id=3Dd40b359f94dc7b28e4d85722180dcb=
ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+9MG%2FML+ZAK+500ML+CZA&amp;id=3Da032981b8d1528c939cf7fd4beffc197" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 9MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+ZAK+250ML+CZA&amp;id=3Dd15d1e1a4ede1772cc8888c3af1ca3f3"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DVANCOMYCINE+INFVLST+10MG%2FML+CASSETTE+250ML+ASG&amp;id=3De26951564d5587=
8f76b471a75899ce61" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+100ML+ASG&amp;id=3Df407082985eba53edfec484c2e5b3b=
b9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+9MG%2FML+ZAK+500ML+PA&amp;id=3De501c52cd5597fe39aded6fd844dad03" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 9MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+ZAK+100ML+PA&amp;id=3D9166b6e09cf521f128feebfa4e8ba80f" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML ZAK 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+CASSETTE+100ML+ASG&amp;id=3Df4e13b055fd46229bb40f69541e2d=
d0b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C31MG%2FML+ZAK+580ML+MSZ&amp;id=3D8cbe90aac2ae81bff5b36f325da9a=
2c5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,31MG/ML ZAK 580ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+CASSETTE+100ML+IP&amp;id=3D061f8182b7985b0531f6048965df52=
36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+40MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3Da93e3a858c3b19a71fa1672f68e=
8f242" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 40MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+LUMC&amp;id=3Da54f510b5f9e55d45cc8a934a779e=
d7e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D5d77128b4d9a6bf5=
d2f21f2d51b64b35" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 8,33MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+90000IE%2FML+CAS+100ML+APP&amp;id=3Db71198b64b466f8235495792=
027e03da" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 90000IE/ML CAS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+40ML+%285ML%2FUUR%29+IP&amp;id=3D69a58af5df9fe24b2ef=
e700c31c6b0c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 40ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+POMP+100ML+%2850ML%2FU%29+IP&amp;id=3Dbb80fa1dce0169375c73=
25726c5db1e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML POMP 100ML (50ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+10MG%2FML+POMP+100ML+%28200ML%2FUUR%29+IP&amp;id=3D5411166939f254a5fa7=
e60cbc9e8a4c1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 10MG/ML POMP 100ML (200ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+10MG%2FML+POMP+100ML+%28100ML%2F30MIN%29PA&amp;id=3Dafba4296b7c20cb501=
9e52c2db62b755" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 10MG/ML POMP 100ML (100ML/30MIN)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+37%2C5MG%2FML+POMP240ML%2810ML%2FU%29APP&amp;id=3D39871e9ba7c9026a=
bf664a384c39fb87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 37,5MG/ML POMP240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 186,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+86956IE%2FML+ZAK+69ML+MSZ&amp;id=3D8de35b690eb4cd6b5330a63f5=
a1bad8e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 86956IE/ML ZAK 69ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3D6f4e4a7f2d9c4da2bc1=
3c97799b63723" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+CASSETTE+100ML+APP&amp;id=3Dfe1a2f8cffd225e8a77f6a49e25fd=
600" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+CASSETTE+100ML+CZA&amp;id=3D13d9379f94bae761694f8e0c94113=
d7f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+500ML+CZA&amp;id=3D969fe4a23e15cac01434c002048b5783" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+CZA&amp;id=3Daab9da406bab91f501e5015224e7e0=
97" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+ZAK+100ML+CZA&amp;id=3Ddd5ceff322e6e43b65614ad74bba464a" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+ZAK+250ML+IP&amp;id=3De17e2560fa8c3e3b8ddb8113e115ee94" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15%2C63MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D053368901a81a046=
35ed5f9e92c306dc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15,63MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+4M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3D0e4db6a260873297fdb=
f647f31d2e052" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 4M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+5MG%2FML+POMP+100ML+%28200ML%2FUUR%29+CZA&amp;id=3D1fc88e231d39fbb5a25=
f0e240b170585" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 5MG/ML POMP 100ML (200ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+LUMC&amp;id=3D461b713e7ef684d0a6=
17ba9acd6e7985" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+29%2C93MG%2FML+ZAK+401ML+MSZ&amp;id=3D06a389416328b397adf996c4=
26c4b16f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 29,93MG/ML ZAK 401ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+40ML+%285ML%2FUUR%29+APP&amp;id=3D109a453aea74973eba=
d514187341c1fe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 40ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+200MG%2FML+ZAK++500ML&amp;id=3Db77508edff857e4658f6e7b18705a39e" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 200MG/ML ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+2%2C5M+IE%2F48ML+POMP%282ML%2FU%29IP&amp;id=3Dbd6a68be577190dd=
d492ff987c8ac580" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 2,5M IE/48ML POMP(2ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INF+20MG%2FML+EASYP+POMP+100ML%28200ML%2FU%29PA&amp;id=3D2284755b5479804a27=
60161ca7145bae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INF 20MG/ML EASYP POMP 100ML(200ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML+%28200ML%2FUUR%29+IP&amp;id=3D3084994fd6667fa352=
8f8b200310f9f3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML (200ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML+%28100ML%2FU%29+CZA&amp;id=3D178d9c6bd05e6794a8e=
b6eac5bdbe913" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML (100ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 187,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C5MG%2FML+CASSETTE+250ML+IP&amp;id=3D4c9be430af3416fccda36b7ad2=
b5c447" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,5MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+POMP+100ML+%28200ML%2FU%29APP&amp;id=3D1f29df6b4b24708df1=
48b9ea849b2d79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML POMP 100ML (200ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+CASSETTE+250ML+IP&amp;id=3Dc1270409e92ed167dce5056720f324=
82" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6MG%2FML+CASSETTE+250ML+PA&amp;id=3Dc789fdd3b34218ebfbfe004990d511=
74" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+20MG%2FML+POMP+100ML%28200ML%2FUUR%29+CZA&amp;id=3D14ae057e84d8f240b3=
ea3727032fafe2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 20MG/ML POMP 100ML(200ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+24MG%2FML+CASSETTE+250ML+CZA&amp;id=3D13fa32ba0d05eb869c63103066482=
6cf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 24MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+60MG%2FML+ZAK+100ML+CZA&amp;id=3D83edffd97a62d8588bd68e1bbd948f37" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 60MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+12%2C5MG%2FML+POMP+120ML%285ML%2FU%29+IP&amp;id=3D5a65860cbeb907e95=
c7835ed59da86ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 12,5MG/ML POMP 120ML(5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3D059f3196ed2a1e9e478=
9985979a4e636" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 188,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+APP&amp;id=3D7d7bfea9991bef70c5d67a9ab8734=
2b7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+ZAK+250ML+APP&amp;id=3D959fef4cec1e116f4c575ff9d7ec0=
3d5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+CASSETTE+100ML+IP&amp;id=3D0191906338a9041232c32f5f766951=
f1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+20MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3D90b5dc06ccbc13ede1649b9fb7e=
3a331" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 20MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+ZAK+500ML+IP&amp;id=3De268833743937f52acd9da58dc49f0e0" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+20MG%2FML+CASSETTE+100ML+CZA&amp;id=3D1444b3b33c659e4ff5d0ebfdfd5d=
3344" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 20MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 189,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+8%2C33MG%2FML+POMP+240ML+%2810MLU%29+IP&amp;id=3Dfb99494376dd1f8161=
27c09cc6d15d73" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 8,33MG/ML POMP 240ML (10MLU) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+CASSETTE+100ML+IP&amp;id=3D421385d8687b808d5cb86ae95710a1=
d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+ZAK+100ML+IP&amp;id=3Da12b35c2a5f1281af5f3200dc0256ca3" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+60000IE%2FML+CASS+100ML+CZA&amp;id=3D574e8685e4446f1d37ba43817=
5482113" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 60000IE/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+600ML+CZA&amp;id=3D709bcd429c57a73dccc3bed65033dd23"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 600ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+40MG%2FML+ZAK+100ML+CZA&amp;id=3D82c3665f27cc98d54c7de967ad8aa55c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 40MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+ZAK+250ML+CZA&amp;id=3Df56160456b9d9416d52f938140644=
e0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+12%2C5MG%2FML+POMP+120ML%285ML%2FU%29+AHZ&amp;id=3D61ebbc996cf5ce42=
404a8ff98e599398" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 12,5MG/ML POMP 120ML(5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+60000IE%2FML+DELTEC+100ML+PA&amp;id=3D1862b241c88704c1c9c1f36b=
e1536cc1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 60000IE/ML DELTEC 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+60000IE%2FML+CASS+100ML+PHL&amp;id=3Dac78113b34f336a61e5bc5e0e=
feff188" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 60000IE/ML CASS 100ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+4MG%2FML+CASSETTE+250ML+APP&amp;id=3D568b7179bbf55852cb6c960e8592ea4=
a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 4MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+ZAK+500ML+APP&amp;id=3D80004b193307f22b651bac741936e572"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML ZAK 500ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+40MG%2FML+CASSETTE+100ML+APP&amp;id=3De198ceb3d0cb78c3d6653a2df5082=
61f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 40MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+ZAK+250ML+APP&amp;id=3D1fb6a7956e8475b89b25ee42=
6b44c19a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+16%2C66MG%2FML+POMP+120ML%285ML%2FU%29APP&amp;id=3D7e82e8942fda98d2=
140e468fa131545a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 16,66MG/ML POMP 120ML(5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3Db8769fdeb0e2218772e=
cc174b5494ab7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+33%2C3%2F4%2C2MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3Dd6f4fc7d9e=
5bfefcfbf5f6eebb6194eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 33,3/4,2MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+7%2C08MG%2FML+POMP+240ML+%2810ML%2FUUR%29+IP&amp;id=3D3874baec8e9e1df6=
f81863d029dafcc1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 7,08MG/ML POMP 240ML (10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFOTAXIM+I=
NFVLST+60MG%2FML+ZAK+100ML+CZA&amp;id=3D1e1436be5e7be4521ee868e68e24a1d1" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFOTAXIM INFVLST 60MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFOTAXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+600ML+PA&amp;id=3Dad0fbf30bda165716dab7e242b40eada" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 600ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+60ML+%285ML%2FUUR%29+APP&amp;id=3D8e2ceb1400a51f774f=
4894f6e58e50e1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 60ML (5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+0%2C5MG%2FML+CASSETTE+100ML+IP&amp;id=3D694bd9a345eb2f291e18edfd87=
1a9f1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 0,5MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+100ML+IP&amp;id=3D46800262f484ce4a930bce3b7f3898ae" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+AHZ&amp;id=3D706a34102db7906de4b=
2c41cddaaa5e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+24MG%2FML+ZAK+250ML+CZA&amp;id=3D79b08b6cf756707fdb61a822ac8c3a08" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 24MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5%2C5MG%2FML+ZAK+500ML+CZA&amp;id=3De9e8016107cd5a38eca8092441ebbb=
df" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5,5MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+16%2C67MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3Df21b290293d08d35=
dfd517b89e7bf726" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 16,67MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+18MG%2FML+ZAK+250ML+APP&amp;id=3D3c42191b86eb22a26ab616690824dcdb" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 18MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+APP&amp;id=3D69e5b266ecb550ab6d8e9b0ccafc6b=
46" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+240ML%2810ML%2FU%29LUMC&amp;id=3Dca2d7fed328909b409=
083aabe71fdef9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 240ML(10ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+CZA&amp;id=3Dda1ab3dba05d3f47d6e95e943a818=
fd7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5%2C21MG%2FML+POMP+48ML+%282ML%2FU%29+PA&amp;id=3Daabebc2858a402cef=
be63b74a3d1dc97" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5,21MG/ML POMP 48ML (2ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5%2C21MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3Dfc78e289b740c3606=
c29493717cee373" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5,21MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+POMP+48ML+%28120ML%2FU%29+IP&amp;id=3D6855ae6faf8c3f72=
da6a71249db8dd48" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML POMP 48ML (120ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C6MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3D30d5f950c9164518da=
a0f1b6e455e160" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,6MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+6%2C9MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3Df48dac71542a617d=
7609a79ae18bd1ff" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 6,9MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+25MG%2FML+POMP+60ML+%285ML%2FUUR%29+CZA&amp;id=3D4991f2e3aa81a34cd4=
247f5fb6b1f465" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 25MG/ML POMP 60ML (5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C8MG%2FML+CASSETTE+250ML+PA&amp;id=3D5326a1a9ec9c33228d9ee172fb=
1c1ec3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,8MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4%2C8MG%2FML+CASSETTE+250ML+IP&amp;id=3D65c6fecd8974909f433f0b31ba=
ba34ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4,8MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+100000IE%2FML+CAS+100MLAPP&amp;id=3Deb82f529b035440c0381f42e=
69a91313" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 100000IE/ML CAS 100MLAPP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFV+5%2C4M+IE%2F120ML+POMP+%2810ML%2FU%29+IP&amp;id=3D256106e16a5a4d7f=
10ed324c7ae4fb53" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFV 5,4M IE/120ML POMP (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3Db54e510e98a9f22afc=
e452fb4d663f53" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 191,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3D87e6285063779193aa2=
cc4e780c66884" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+50MG%2FML+POMP+120ML%285ML%2FUUR%29+APP&amp;id=3D54748cf251e92cf60d=
849c0a4cbdd5a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 50MG/ML POMP 120ML(5ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+ASG&amp;id=3D3eac3bb320d547709b9b0f8326caca=
d0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C33MG%2FML+POMP+120ML+%285ML%2FU%29APP&amp;id=3Dc6093e16b60cea49=
b4df3e5a536c86de" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,33MG/ML POMP 120ML (5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFV+5MG%2FML+RYTHMIC+FULL+SET+100ML+AAA&amp;id=3D988e0873d09f5caedbf117e5=
41edbe2f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFV 5MG/ML RYTHMIC FULL SET 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,36&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+15MG%2FML+POMP+100ML+%28100ML%2F30MIN%29PA&amp;id=3D1f1346a15d70b8509c=
146b4ec9c87b0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 15MG/ML POMP 100ML (100ML/30MIN)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+120ML+%285ML%2FU%29+AHZ&amp;id=3Dc1d098c2b12918e3e43=
832a965e1b5b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 120ML (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1000ML+IP&amp;id=3D173a76cda4116a30a59f3f30053bb6ae"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1000ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DVANCOMYCINE+INF+20%2C83MG%2FML+POMP+120ML%285ML%2FUUR%29+CZA&amp;id=3D44=
22793294481c28ee5cfc161ec722ea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 20,83MG/ML POMP 120ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFOTAXIM+I=
NFVLST+24MG%2FML+ZAK+250ML+CZA&amp;id=3D5b48118688d51496bd26b29dbc397da0" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFOTAXIM INFVLST 24MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFOTAXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+100ML+AAA&amp;id=3D3d3a3e71702294f1a39526327fd16b=
c9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+1%2C46MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D7d063c84c8523e24=
84b0012a4d46499d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 1,46MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+ZAK+100ML+CZA&amp;id=3D87c55fdbc6f1144b751e2921c112979d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+CASSETTE+100ML+APP&amp;id=3D41543a8c947bbf13da8fbf09d3d710=
bb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+100ML+%28200ML%2FU%29+APP&amp;id=3D7121e9ac3c3b4f0151=
d3dec4d52023dd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 100ML (200ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+110000IE%2FML+CAS+100MLAPP&amp;id=3D8852ddf385fab6c9675a77f0=
7f2f2387" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 110000IE/ML CAS 100MLAPP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+POMP+50ML+%28100ML%2FU%29+CZA&amp;id=3D3cb88f1c383794f7ed2=
9be357aade870" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML POMP 50ML (100ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 192,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+2%2C71MG%2FML+ZAK+1107ML+MSZ&amp;id=3De77c7eae1eb647e676bf5ed00a2b=
f0b0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 2,71MG/ML ZAK 1107ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+33%2C33MG%2FML+POMP+120ML%285ML%2FU%29APP&amp;id=3Db3a9d461aaf5c340=
37c3807a574ff8b7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 33,33MG/ML POMP 120ML(5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+3%2C12MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3D495c61a37773e6f3=
11b896f724af5783" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 3,12MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFV+5%2C4M+IE%2F120ML+POMP+%285ML%2FU%29+IP&amp;id=3Dd6e7c14923cc90e9b=
44abea773e476d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFV 5,4M IE/120ML POMP (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+60MG%2FML+DELTEC+100ML+PA&amp;id=3De4516767bc25a81e498a335ab65=
4cd87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 60MG/ML DELTEC 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+ZAK+100ML+PA&amp;id=3D2d1b9795a727c3348d110c2aa98a538b" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML ZAK 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+ZAK+100ML+IP&amp;id=3D47fa2f61f0cb4a3aa8f1bace8dc1cfde" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+AHZ&amp;id=3Dd15d1d5cacc7b1bf5eb0a45314634b=
a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C083MG%2FML+POMP+120ML+%285ML%2FU%29IP&amp;id=3D52478e28595e9361=
9d4ccf3fcad5f7ee" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,083MG/ML POMP 120ML (5ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 193,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29LUMC&amp;id=3D5bf770990a77770a7a=
15aef43cd72dbc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C25MG%2FML+CASSETTE+100ML+APP&amp;id=3D8bff565c2de370c37916815f9=
1d99ec9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,25MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+22%2C5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D0be62661dba441a1bd05a2bac5=
188fc4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 22,5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+10MG%2FML+POMP+100ML+%28200ML%2FUUR%29+CZA&amp;id=3Dbe540e268a865d7a60=
c6344eb22fd837" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 10MG/ML POMP 100ML (200ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+AAA&amp;id=3Ddeb583b5c4ab578a72e92c7348f95=
79c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+15MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D717095eab932568f89=
54c7be87575a2e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 15MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+22%2C92MG%2FML+POMP+120ML%285ML%2FUUR%29+CZA&amp;id=3D5f5ea7b9fae03ca3=
3d26a7d49ac01b8c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 22,92MG/ML POMP 120ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+3%2C44MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3D4868ded0ca97a8c65=
f2de670cecf7c99" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 3,44MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,76&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+16%2C7MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D929b1928fe6b9adb=
6d3f9bd26f6ffdfd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 16,7MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+36MG%2FML+ZAK+250ML+CZA&amp;id=3D216c95433f32e2199fb4e98273f9b=
b6c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 36MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,86&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+240ML+%285ML%2FU%29+AHZ&amp;id=3Db777afc550492d1b912=
b65cf2789d357" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 240ML (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+ZAK+100ML+ZIK&amp;id=3Dfcdba17ea4ce2d85f82f028f52e3bc6d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 194,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3D250091ab09a5a4a88bbd06fc=
392e5e76" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+CASSETTE+100ML+IP&amp;id=3Dcc8f2349a5853a01dc0c5adce0a=
1bbe0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+20%2C83MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D143eb19290c6ac99=
87154f274d76e7a4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 20,83MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+33%2C33MG%2FML+POMP+120ML%285ML%2FU%29+IP&amp;id=3D7da65f1500f95492=
204d3d67d09a8b94" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 33,33MG/ML POMP 120ML(5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D3d306cbe00678a172dd1abe648=
158a52" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+60MG%2FML+CASSETTE+100ML+CZA&amp;id=3D409867cc8d7259bea9a984d0a133dc=
6b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 60MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+ZAK+100ML+CZA&amp;id=3Dc788fb65a8f9d755d0917d6debf1d16f" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+100ML+CZA&amp;id=3Dedce9bddbc82c5a85177f2ecf0fa5da5" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+33%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+PA&amp;id=3D6dacaefb1877c678e0=
b4ae4cc6676d36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 33,3MG/ML POMP 120ML (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+33%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3Dc1577a8fcf9b5074b7=
f9774de3a56dea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 33,3MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+24MG%2FML+ZAK+250ML+PA&amp;id=3D36104d29fb2ac849bf171aca176937d8" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 24MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,76&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+33%2C3MG%2FML+POMP+120ML+%285ML%2FU%29IP&amp;id=3D9d4aacfdb9b3cac6=
503df1956a4966d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 33,3MG/ML POMP 120ML (5ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+6%2C52MG%2FML+POMP+230ML%2810ML%2FU%29+IP&amp;id=3D98d7cb838413e91b=
fa9afe47d668a8be" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 6,52MG/ML POMP 230ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,86&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+24MG%2FML+ZAK+250ML+APP&amp;id=3D1b1445db7c644861e73a989f2bdf1d31" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 24MG/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+24MG%2FML+ZAK+250ML+CZA&amp;id=3D0b92b65fee63f635fe48477a973bcce1" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 24MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+CASSETTE+250ML+APP&amp;id=3D132f47ca24e28a2feeaa3b58=
563f22c7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+POMP+100ML+%28200ML%2FU%29CZA&amp;id=3D8be71d4d20f9fdd789=
925147ec329e45" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML POMP 100ML (200ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4%2C8MG%2FML+ZAK+100ML+APP&amp;id=3D2b0490b4bcb141fcd0076a5eacc6868=
0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4,8MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1%2C6MG%2FML+CASSETTE+100ML+APP&amp;id=3D33a0efcb04b4cf162e29691ee4=
4cc08b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1,6MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+100ML+APP&amp;id=3D8284529288232bbd9c7ba4c436a694=
fa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+11MG%2FML+CASSETTE+250ML+APP&amp;id=3Da07fa289c30b5be4cadb28e8a392=
4a65" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 11MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+4MG%2FML+ZAK+1000ML+APP&amp;id=3Dbbb2cc8c47d5a87959365f1c3767dc2d=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 4MG/ML ZAK 1000ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+80MG%2FML+CASSETTE+100ML+IP&amp;id=3D6444902074ac5e61d348cffc4ce336=
a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 80MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+CASSETTE+100ML+APP&amp;id=3D6813d7206debc01d27639402bc8c5=
aae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+6MG%2FML+CASSETTE+250ML+APP&amp;id=3Ddbf484553e2479ddbe385948c8f4f68=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 6MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+100ML+APP&amp;id=3Df4602e5dea6fd2d8ff0fe5fafd95b5=
0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+2%2C08MG%2FML+POMP+120ML+%285M%2FU%29+APP&amp;id=3D383d1bf2cb60b52f=
38f981001e2d8bc0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 2,08MG/ML POMP 120ML (5M/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+CASS+250ML+APP&amp;id=3D97a595767c5979f4086d307=
47ae7e440" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML CASS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+2%2C08MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3Dcb23e701c3d41036=
c4c2b9770832f257" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 2,08MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+4%2C17MG%2FML+POMP+240ML%2810ML%2FU%29+PA&amp;id=3D82df97f1993ae18b=
ad4de90bd27b95b8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 4,17MG/ML POMP 240ML(10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+4%2C17MG%2FML+POMP+240ML%2810ML%2FU%29+IP&amp;id=3Dca40024edfa451be=
be6a01123ba337c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 4,17MG/ML POMP 240ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+120000IE%2FML+CAS+100MLAPP&amp;id=3Df43e710204ec397bd6b8e751=
e63d1c1c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 120000IE/ML CAS 100MLAPP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+CASSETTE+100ML+CZA&amp;id=3D302dbfca192766d504840bf28cb6c=
035" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+700ML+CZA&amp;id=3Dfd5ad7d44ae88ae6ad972c3678985c1f"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 700ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+1%2C67MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3Df0ffb6764907f4bf=
6994232dad81c6fc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 1,67MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+6MG%2FML+ZAK+250ML+CZA&amp;id=3D57f66320e48d0c35a03a14613e9ae03d" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 6MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILLI=
N%2FTAZOBAC+INF+80%2F10MG%2FML+CAS+100ML+PA&amp;id=3Dc77cf146bf4301a064adc6=
fa068d04dc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILLIN/TAZOBAC INF 80/10MG/ML CAS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12MG%2FML+ZAK+250ML+CZA&amp;id=3Dac879f46b6221ea7ba9aba895f23fee7"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+8%2C33MG%2FML+POMP+240ML%2810ML%2FU%29+IP&amp;id=3Dc9287bbef67ed498=
322fd8f0bd7ebab5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 8,33MG/ML POMP 240ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+AHZ&amp;id=3Dec5d89614afa233d997=
4b176a99b2bd9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+25%2F3%2C1MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3D3b1242f1b94e=
6e270b7abf0f5b713233" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 25/3,1MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+ZAK+250ML+MSZ&amp;id=3D8caf0b3d0f704a125554da4e6629b7bc" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML ZAK 250ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+CASSETTE+100ML+PA&amp;id=3D3f81fbaf458c7c52c74b6d977780ed7=
1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+CASSETTE+100ML+IP&amp;id=3Db4e625f4e1cef1361c3dde92907eb10=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVL+16%2C67MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3D8c011ef0d2774ac9=
36639afdd6611697" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVL 16,67MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+72000IE%2FML+ZAK+250ML+PA&amp;id=3D4e47df645a4b0d4432368518e=
c1ee408" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 72000IE/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+PA&amp;id=3D12ea1231d7170fa12cac177d1d30e2=
1f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8MG%2FML+CASSETTE+250ML+IP&amp;id=3D7c7ec888fd3b1da8605ef41e2cf9c0=
e6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+14M+IE%2F120ML+POMP+%285ML%2FU%29+IP&amp;id=3Da1f2a40905b66b97bd0=
4e15ae686139f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 14M IE/120ML POMP (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+600ML+CZA&amp;id=3D0baa47a0acfd9910f46f60b5a90a9b00" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 600ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+50ML+CZA&amp;id=3D73835f2be6ef19f368f189e52e5f084=
5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 50ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+45MG%2FML+CASSETTE+100ML+CZA&amp;id=3Db2de146f97389d7a0e547fdeae9fef=
ac" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 45MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5MG%2FML+ZAK+800ML+IP&amp;id=3Da5620bf850c6750e975476543a7332a9" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5MG/ML ZAK 800ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON++20ML&amp;id=3D03357a72ed02884a25ccb317648f039e" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON++20ML&amp;id=3D26e64d36216da2a20774a8147501bec0" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON++20ML&amp;id=3Dd3f606d1ea98a6d6749a1153ed01141e" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON++20ML&amp;id=3Dde03a5d479fe235caac8fb890bfe1feb" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON  20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">MERCK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+180000IE%2FML+CAS+100MLAAA&amp;id=3D6969294c9fa08ffbf8c4dadd=
eeee9cae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 180000IE/ML CAS 100MLAAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3D3c1b3ac93041977dc990b48968b3c6e=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+PA&amp;id=3Dfb412f15fa66e80e9a9865c86f987f4=
2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+4%2C35MG%2FML+POMP+230ML%2810ML%2FU%29+IP&amp;id=3Dec86d9e2c0264374=
a0bfdcf63cdd0169" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 4,35MG/ML POMP 230ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+10MG%2FML+CASSETTE+100ML+ASG&amp;id=3D0f4dd60b3015496af683a99f77c3=
e6d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 10MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9MG%2FML+CASSETTE+250ML+CZA&amp;id=3D6fdb70aa07ba4d356d07821a29b23=
f6c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+ASG&amp;id=3D66b3831a428a27e9a230f2449347b1=
43" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+24MG%2FML+CASSETTE+250ML+ASG&amp;id=3D8395b512c9f2b8278f1fe5512604c9=
b4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 24MG/ML CASSETTE 250ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+AHZ&amp;id=3D8e2973a59231428d0bad6db2bc68eb=
8b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+5%2C2MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D20b0cdfc4823e96f=
0b4b709b2196ecdc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 5,2MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+6%2C25MG%2FML+POMP+48ML+%282ML%2FU%29+CZA&amp;id=3D777c89386ca0df73=
aa1895b980bee858" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 6,25MG/ML POMP 48ML (2ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+16%2C67MG%2FML+POMP+60ML%285ML%2FUUR%29+IP&amp;id=3Ddf94f9fe9a508865=
a73b6577646b9fa5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 16,67MG/ML POMP 60ML(5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+ZAK+250ML+CZA&amp;id=3D3c21632b0810a4843e24b3b36f12f=
0f2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DBENZYLPENICILLINE+INFVLST+80000IE%2FML+ZAK+100ML+CZA&amp;id=3D4e2eb32082=
af9d8d23e505f89a7b097c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 80000IE/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+CASSETTE+100ML+CZA&amp;id=3D52acde4fbd3771efb6bdead3=
c4e87250" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 199,68&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+FLACON+++100ML+GLAS+%2B+AFSKAP&amp;id=3D3f56e3a9baa93c3e25402583=
3198c24a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML FLACON   100ML GLAS + AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+32%2F4MG%2FML+CASS+250ML+PHL&amp;id=3D9a92e388d6cf36ab6c07123=
353cd6fa4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 32/4MG/ML CASS 250ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+25MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3Df7d2aa3089223593bf=
bbf947de8a7458" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 25MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9MG%2FML+CASSETTE+250ML+IP&amp;id=3D0219e78886296fed35c01cc9ff66f7=
ca" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+80MG%2FML+CASSETTE+100ML+ASG&amp;id=3D50049a895ae398d7bdb4d913918ed=
a1d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 80MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C13MG%2FML+ZAK+1117ML+MSZ&amp;id=3D6cd9972e5fde4b6de4b9bb2f37ed=
a072" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,13MG/ML ZAK 1117ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+8%2C33MG%2FML+POMP+120ML%285ML%2FUUR%29+IP&amp;id=3Dd1b9e61a282d0d2e=
ef5d8a6adb3ac80d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 8,33MG/ML POMP 120ML(5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+5%2C21MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3D675b4892709da0d9=
eb2ea95c84ec6310" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 5,21MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+5%2C2MG%2FML+POMP+240ML%2810ML%2FUUR%29+IP&amp;id=3D9d8a84bc52da7523=
ab974f3e105677d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 5,2MG/ML POMP 240ML(10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5%2C21MG%2FML+POMP+96ML+%282ML%2FU%29+IP&amp;id=3D907b87afb05746bb1=
aef4f528b3dd112" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5,21MG/ML POMP 96ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+24MG%2FML+ZAK+250ML+CZA&amp;id=3D0322d199dc0339f3615dfe0355f76fe0" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 24MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3Dabefceff765dacd62f438b64adb1dd=
54" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+7MG%2FML+ZAK+500ML+CZA&amp;id=3Ddf3164cbee48724b4c0d092474cd4f2f" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 7MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+120000IE%2FML+DELT+100ML+PA&amp;id=3D35fd4921ba5ea634e869d1c2f=
7073c25" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 120000IE/ML DELT 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+120000IE%2FML+CASS+100ML+PHL&amp;id=3Dec8633eda8b948aed138680b=
34e91593" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 120000IE/ML CASS 100ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLS+7%2C5MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3D1b2613e596fbb78a=
1b8acc02344c08ee" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLS 7,5MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+60000IE%2FML+CAS+100ML+ASG&amp;id=3D38650d8a90583be6ddd8e5d8=
f69e439f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 60000IE/ML CAS 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+25MG%2FML+CASSETTE+100ML+CZA&amp;id=3D1d1e581596295f1b1930d50cc256=
9fea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 25MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+6%2C25MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3Db1a1c1657dd1c583=
30c6a16fcdb106d0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 6,25MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+6%2C25MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3Dfedcca32933d66e2=
a4b051a14a0e2f2c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 6,25MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCIPROFLOXAC=
INE+KABI+INFVLST+2MG%2FML+FLACON+200ML&amp;id=3D5f3991f81735681230e0aa8cf15=
0f1a8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CIPROFLOXACINE KABI INFVLST 2MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CIPROFLOXACINE</span=
>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29LUMC&amp;id=3D02ede25f4415096bdf=
63a47fc26698fe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCIPROFLOXAC=
INE+INF+2MG%2FML+POMP+200ML+%28167ML%2FU%29+IP&amp;id=3Da3e18426869c195b586=
0b78038aa4f81" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CIPROFLOXACINE INF 2MG/ML POMP 200ML (167ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CIPROFLOXACINE</span=
>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+19%2C57MG%2FML+POMP+230ML%2810ML%2FU%29IP&amp;id=3D76bae846412eeba2=
eb2f528b53c94b9e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 19,57MG/ML POMP 230ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+5%2F0%2C07MG%2FML+CASS+100ML+IP&amp;id=3D48723735a56a226b2891=
5adf46b3234c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 5/0,07MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+21%2C25MG%2FML+POMP+240ML%2810ML%2FU%29IP&amp;id=3Dbf45023554c0e087=
b7bd9ef32529d31e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 21,25MG/ML POMP 240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29APP&amp;id=3D8245ffa1d6f85c60=
8e199a5c04929db5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 8,33MG/ML POMP 120ML (5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+AHZ&amp;id=3D87aee3563c31583c0d194bf66f274f=
38" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+7%2C5MG%2FML+POMP+240ML%2810ML%2FUUR%29+IP&amp;id=3Dc407c4784f99b44b=
15a7ac4613ba6ba3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 7,5MG/ML POMP 240ML(10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+66%2C7%2F8%2C3MG%2FML+POMP+120ML%285ML%2FU%29+CZA&amp;id=3Dcdb8870406=
cc2669aaa21fddb95fa801" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 66,7/8,3MG/ML POMP 120ML(5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12MG%2FML+CASSETTE+250ML+APP&amp;id=3D16e6611504a625f9ae5d704a4e7b=
d147" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+56000IE%2FML+CAS+250ML+APP&amp;id=3Da8b6b1fd65ed45516c63075e=
01ed189d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 56000IE/ML CAS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1000ML+APP&amp;id=3Dba7066ea23794278cdcc1880ee7d1cb9=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1000ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+100000IE%2FML+ZAK+100ML+CZA&amp;id=3Da2b6c5eca8828295e5e3dc36a=
ebb5bd8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 100000IE/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,42&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+33%2C3MG%2FML+POMP+120ML%285ML%2FU%29CZA&amp;id=3Dafa69c6c25cc3134=
0ca46645a03063ad" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 33,3MG/ML POMP 120ML(5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,42&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+ZAK+100ML+APP&amp;id=3D8c4a4dd970a73ff6ff012dc0e325f0ac" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4MG%2FML+CASSETTE+50ML+APP&amp;id=3Dab65cfd3738e982bbd3d54959d19423=
5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4MG/ML CASSETTE 50ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+3%2C12MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D0bf8054074819bf5=
f031d39903df4e98" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 3,12MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+50%2F6%2C25MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3D3e4ab26922ca=
b3007afdfd9c9679ee54" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 50/6,25MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+CASS+250ML+APP&amp;id=3D44446481c1593e03a8a1c72=
10e4f65e5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML CASS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+16%2C7MG%2FML+POMP+120ML+%285ML%2FU%29APP&amp;id=3D803a866ba4ab1789=
82544607499f0987" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 16,7MG/ML POMP 120ML (5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+33%2C33MG%2FML+POMP+120ML%285ML%2FU%29APP&amp;id=3D8143c838bcbb446a=
3731d8cbb40d9fd6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 33,33MG/ML POMP 120ML(5ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3D3dbbc508a15fab32ac7c9f135=
a85da8d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3D4084cad7ffcfeb665b66e27d4=
f366f9a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3Dd7d86136178aca7eea43cfe6f=
d5df628" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3Df9fb81f6e0cfcdd23a1c1b7a2=
540fe59" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3D31dfa5ef0686ef6dce5d49785=
b8f52b1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">ORIGINALIS B.V.</span>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3D5d01c508c3628278261c12ec4=
1909468" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Slovenie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACLASTA+INF=
USIEVLOEISTOF+0%2C05MG%2FML+FLACON+100ML&amp;id=3D66bc3e80b75bad194881f087d=
b6ff301" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACLASTA INFUSIEVLOEISTOF 0,05MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">SANDOZ BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLEDRONINE=
ZUUR+SEACROSS+INFVLS+0%2C05MG%2FML+FL+100ML&amp;id=3D862e63b324172aebe1e9e1=
d604c3aba6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLEDRONINEZUUR SEACROSS INFVLS 0,05MG/ML FL 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZOLEDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">Seacross Pharma Europe B=
.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+CASSETTE+100ML+IP&amp;id=3D0d87ad6d7abfba95c5a0e1b029bbb5=
66" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+30MG%2FML+CASSETTE+100ML+PA&amp;id=3D95796d865e64aeed6152f8c46d71f7=
a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 30MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+12MG%2FML+ZAK+500ML+CZA&amp;id=3D1343ed7956d9cd1fd08a8b8b803c728d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 12MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+2%2C08MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D9c3d7f16337af429=
ed7eb64e73f2fd3b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 2,08MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+25MG%2FML+POMP+120ML%285ML%2FUUR%29+CZA&amp;id=3D901402edbe9d20b987ef8=
84cbfe7600a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 25MG/ML POMP 120ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+40MG%2FML+ZAK+100ML+CZA&amp;id=3Dd3f18ee2c91b49d4e318641ac94cef0e"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 40MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+80000IE%2FML+CASS+100ML+IP&amp;id=3Dbe23c87a568938e30dd9ec28aa=
435a78" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 80000IE/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+80000IE%2FML+DELTEC+100ML+PA&amp;id=3Df6e935012e962d469fccff63=
02431751" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 80000IE/ML DELTEC 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+5MG%2FML+POMP+120ML+%285ML%2FUUR%29+CZA&amp;id=3Dc49be19c10906965a92=
0f401b6f8fa8c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 5MG/ML POMP 120ML (5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+6MG%2FML+ZAK+500ML+IP&amp;id=3D1f7b014bcf4d78e1bf4e4728ed94d881" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 6MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,58&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+4MG%2FML+ZAK+1000ML+CZA&amp;id=3D193c08f342147b5e85393292c241eb31"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 4MG/ML ZAK 1000ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+30MG%2FML+CASSETTE+100ML+CZA&amp;id=3D3611c02b37dbedf7f7f48b400acf3=
d09" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 30MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3D36353e20504d38f08dc=
03472a77bef25" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+CASSETTE+100ML+CZA&amp;id=3D3994954727fec1c911c3fc25b3c0f=
3a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+ZAK+100ML+CZA&amp;id=3Dbc08bdd79f09591412ec54ea27b065b3" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+ZAK+100ML+CZA&amp;id=3Dc3ff2465ba2f9ca7be5662a67492a8e7" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+250ML+CZA&amp;id=3Dcd3e8aa722c90d9102fa0e137ef1=
33eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+25MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D636f7137ce8182f612f93=
58cbc6aa23c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 25MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29+AHZ&amp;id=3Dc2089f0553f6821730=
812115e7c23ff8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+33%2C3%2F4%2C2MG%2FML+POMP+240ML%2810ML%2FU%29AHZ&amp;id=3Da94f9d35ca=
c409c9e2cf5a806aee1120" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 33,3/4,2MG/ML POMP 240ML(10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVLST+60MG%2FML+CASSETTE+50ML+APP&amp;id=3D6066a4287b27f8b9c22e65d81ca9=
2379" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVLST 60MG/ML CASSETTE 50ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 204,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D402a84ac6b35b4ea98f=
235b3b9049fd8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 204,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4%2C16MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3De01c1f6b4d90cf417=
2a4071e83c01fd9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4,16MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 204,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+CASSETTE+100ML+IP&amp;id=3D783e090c720b7f70c05dd55a9=
be678d6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+CASSETTE+100ML+PA&amp;id=3D9ee676fdff0fe143770b36d0b=
19ab09a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15%2C63MG%2FML+POMP+120ML+%2810ML%2FU%29IP&amp;id=3D2c00999a149f7e61=
1b1327b2ca6aa36f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15,63MG/ML POMP 120ML (10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+100ML+CZA&amp;id=3Dbff64b61922602acc7cdc4a20df46e=
a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3Deff13ad12b224e447ef=
b6e8637861cd2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 50MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+72000IE%2FML+ZAK+250ML+MSZ&amp;id=3D48906ab1add9c99b2761229b=
79447532" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 72000IE/ML ZAK 250ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+86956IE%2FML+ZAK+138ML+MSZ&amp;id=3D89e265cbc9a5a8cf9aa9c58f=
0d1b275c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 86956IE/ML ZAK 138ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3D3595f5371fb88f798fd=
23f724e5f4fe7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+6%2C25MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3Daaebf1fa30cbd212=
69f0d6c04bbbc497" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 6,25MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+40MG%2FML+ZAK+100ML+ZIK&amp;id=3D63798d804fb8721fd10a58b11cd27c95" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 40MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+12MG%2FML+ZAK+250ML+ZIK&amp;id=3De844d1fef6630302c55adb586d9c6847" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 12MG/ML ZAK 250ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+24MG%2FML+CASSETTE+250ML+PA&amp;id=3D26d4f43e5a80dfeb51f0f06b99ad21=
22" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 24MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+90000IE%2FML+CASS+100ML+PHL&amp;id=3D2434214594c53a9b54923b3da=
6af07ce" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 90000IE/ML CASS 100ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+2%2C5MG%2FML+POMP+240ML%2810ML%2FUUR%29CZA&amp;id=3D2d4852b6bd68f1a02=
3c8ab75908a93c7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 2,5MG/ML POMP 240ML(10ML/UUR)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+25MG%2FML+POMP+120ML+%285ML%2FUUR%29+AAA&amp;id=3D04105070543ad3559d=
7dde0abdced0dd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 25MG/ML POMP 120ML (5ML/UUR) AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+29%2C17MG%2FML+POMP+120ML%285ML%2FUUR%29+CZA&amp;id=3Dbd93752ed2d4b0f3=
30de9eec87a7a2e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 29,17MG/ML POMP 120ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+75MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D179fec522887e3294da=
c4bfb355fe437" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 75MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+CASSETTE+100ML+IP&amp;id=3Da2a6e249dc484a38347881946c7b78=
ce" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C55MG%2FML+ZAK+1127ML+MSZ&amp;id=3De1d74af437c90d45a68932f5833a=
d1ba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,55MG/ML ZAK 1127ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C5MG%2FML+ZAK+100ML+APP&amp;id=3D3169845682d8811a63f011b84ad2787=
5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,5MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+APP&amp;id=3D66675f84ae699461563c4ed1c706dc=
87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+CASSETTE+250ML+APP&amp;id=3D77404c7178d1a76c9b35a2c7=
857e31c6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+8%2C33MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3D1d93d1412e4b97a1=
79bb391427f4e9e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 8,33MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+8%2C33MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3D9c7181ef1f1128bc=
539960c41bb4a6f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 8,33MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+CASSETTE+100ML+IP&amp;id=3D34a7e69806d15a1a330b7c55cf31c8=
9b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DCEFTAZIDIM+INFVLST+60MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3De4338b493e221=
a90ebe8837084a8f6ea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK++250ML+ECOBAG&amp;id=3D92c33da4a5ecec403b24edc53e2614c6" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK  250ML ECOBAG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK++500ML+ECOBAG&amp;id=3Dd79d388fbb6e1390e88f91ecb295ec79" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK  500ML ECOBAG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+15MG%2FML+CASSETTE+100ML+FSBA&amp;id=3D336528dd545854a119bc64fbff0=
5f5e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 15MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+56000IE%2FML+ZAK+250ML+CZA&amp;id=3D450d8b6a573589ffa74b09db=
68a25283" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 56000IE/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+60MG%2FML+CASSETTE+100ML+CZA&amp;id=3Dceba44e9932abcc9b4eb52ee60d49=
8a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 60MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+16MG%2FML+ZAK+250ML+CZA&amp;id=3Df33bcbb0a0842674920ae4c1369c7226" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 16MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+16MG%2FML+ZAK+250ML+PA&amp;id=3D8724ca587edd7338f0854c126f41ed6e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 16MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+40MG%2FML+CASSETTE+100ML+CZA&amp;id=3D020e28ec8918716e8771a4e8f279e=
9bb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 40MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+33%2C3MG%2FML+POMP+120ML%285ML%2FUUR%29+CZA&amp;id=3D9dea8721dc3a65722=
4d4a60ed2fd92ba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 33,3MG/ML POMP 120ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 207,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+20MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D7d44892cfd5db431cf=
3207508a135061" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 20MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+LUMC&amp;id=3D9512199a25465357cd7035299f94b=
421" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+8%2C7MG%2FML+POMP+230ML%2810ML%2FU%29+IP&amp;id=3D5c91b057f978ab3e4=
29da8daee89b382" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 8,7MG/ML POMP 230ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+13MG%2FML+CASSETTE+250ML+APP&amp;id=3D0954ef9aa09f7f45229956120057=
17c7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 13MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1200ML+APP&amp;id=3D1c0503dd88b867492289d940009f943c=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1200ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+12%2C5MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3D47f328fa92783b6c=
23cba155cbc93ddd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 12,5MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+64000IE%2FML+CAS+250ML+APP&amp;id=3D50bef3e24a1f0a544b9b80ec=
208f29f9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 64000IE/ML CAS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+12%2C5MG%2FML+POMP+120ML%285ML%2FU%29+APP&amp;id=3Daf1409c86b2176ad=
32a579d07019f573" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 12,5MG/ML POMP 120ML(5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+NEW+VIAFLO+ZAK++100ML&amp;id=3D918bb4dbf9f21b00d43e4e1c306=
fb20f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML NEW VIAFLO ZAK  100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+NEW+VIAFLO+ZAK++100ML&amp;id=3Dc79ea91ac71482d4a54df25efab09bef"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML NEW VIAFLO ZAK  100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+100ML+%28200ML%2FU%29+PA&amp;id=3D47a172ec9a03ec54c6f=
af36a6b06ac5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 100ML (200ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+1MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3Dea25ef22e1ab7db7d9a=
499d8c5f732e1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 1MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOB+INF+16%2F2G%2F230ML+POMP+%2810ML%2FU%29+PHL&amp;id=3D1c6b149993ae7f=
a3f84135436e512f98" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOB INF 16/2G/230ML POMP (10ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,58&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+CASSETTE+250ML+IP&amp;id=3D24a43cf9569f17e1696f6bb51=
accfbb7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,76&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+CASSETTE+250ML+PA&amp;id=3D757d448a79a9305fbd8e4b80d=
b1c9bce" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,76&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+16%2C66MG%2FML+POMP+120ML%285ML%2FU%29+PA&amp;id=3D6145b03e1b89025f=
ce0fff8ec8f9af4d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 16,66MG/ML POMP 120ML(5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+16%2C66MG%2FML+POMP+120ML%285ML%2FU%29+IP&amp;id=3D7860c55af7b20fa3=
e9b5b8b6bdb3ac73" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 16,66MG/ML POMP 120ML(5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+ZAK+250ML+PA&amp;id=3De1adb2ef24b26cc80c6e55690=
de82a1b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+29%2C17MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D796be213d92d0e30=
684cc3767e511af3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 29,17MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C5MG%2FML+CASSETTE+100ML+APP&amp;id=3D7bfe402f9ba4dc2e9aa524e345=
58202d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,5MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+33%2C33MG%2FML+PMP+240ML%2810ML%2FU%29APP&amp;id=3D9989b9b7fa6756ae=
61df631676662bcb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 33,33MG/ML PMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+ZAK+100ML+APP&amp;id=3Dac6f8489f96b1a078831c11f2e8e0984" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+14M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3De5a133d55aa7fef076=
6391c9a04721c4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 14M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+CASSETTE+50ML+APP&amp;id=3De9c34191dd03f9191b404828f53ee7=
e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML CASSETTE 50ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3De9cbff08883aed63a81=
52684c22f0367" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 50MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D4f72db8f57d92a6b2a0020c368b18c=
82" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+CASSETTE+250ML+CZA&amp;id=3D873f25e4d0253df833ff917b=
ab21bedc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+72000IE%2FML+ZAK+250ML+CZA&amp;id=3Dcb11514815ea115c4ac407b6=
2456bae4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 72000IE/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+ZAK+100ML+IP&amp;id=3D02b5d2504b8afa8011ab577efbd8577d" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+ZAK+250ML+IP&amp;id=3D4430afbe0736cc46e196d7421669cf=
cf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+ZAK+250ML+PA&amp;id=3Dc993770b41b9a3b452965e2bfc335a=
38" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
%2FMORFIN+INF+1%2C25%2F0%2C2MG%2FML+CASS+100ML+IP&amp;id=3De7c0c5b67b4a787c=
d539e1d8f88d4d61" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE/MORFIN INF 1,25/0,2MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/MORFINE<=
/span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 209,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16%2C67MG%2FML+POMP+120ML+%2810ML%2FU%29PA&amp;id=3Da9a58e330d9a6587=
b5509c82f16fa545" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16,67MG/ML POMP 120ML (10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+CASSETTE+100ML+IP&amp;id=3D299e64ca41f0adbe3f67b439007018=
43" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3De20ad94326b3db514ad188211dc=
9a008" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFVLST+4MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D46589a1de8d4b037b3=
e419c944e4dc23" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFVLST 4MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+16%2C66MG%2FML+POMP+240ML%2810ML%2FU%29IP&amp;id=3D927e23040fae7956=
5df9fe47892a0ce5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 16,66MG/ML POMP 240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+33%2C33MG%2FML+POMP+120ML%285ML%2FU%29CZA&amp;id=3D557b675eda8a2f39=
4f5164131708831a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 33,33MG/ML POMP 120ML(5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3De3c1654d9bd3664297c=
97be95a9776dd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C81MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3Db42f4b1c624cbe61b=
014f3e9e92244fd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,81MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+7%2C3MG%2FML+POMP+240ML%2810ML%2FUUR%29+IP&amp;id=3D5b5caf6ae630d0c2=
5dafbd97e8828579" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 7,3MG/ML POMP 240ML(10ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+7%2C29MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3Dbf5996335734e86f=
9801df9a5820f3b9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 7,29MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 210,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYQVIA+INFV=
LST+IG+100MG%2FML+FL++25ML%2BHY+FL++1%2C25ML&amp;id=3D1a9db43ee96b19b4088f3=
5ef49d300fb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYQVIA INFVLST IG 100MG/ML FL  25ML+HY FL  1,25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE, NOR=
MAAL/HYALURONIDASE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,24&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29+APP&amp;id=3Db8eccbbe1386960cf0=
01d151a422d0e6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+25MG%2FML+CASSETTE+100ML+AHZ&amp;id=3Dd710c7a69a0239e66748dbb7c27ad2=
62" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 25MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,36&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+DAC+VIAFLO+ZAK+100ML&amp;id=3D7d647a5ebb005d4066b4302f989e8e23" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML DAC VIAFLO ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+PHL&amp;id=3D09b54af279c44ccade8=
b0c7deee5526c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+6M+IE%2F120ML+POMP+%285ML%2FU%29+PA&amp;id=3De58d3f52ea7ab180350a=
57e7102fb0d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 6M IE/120ML POMP (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+80000IE%2FML+ZAK+250ML+IP&amp;id=3Dfe2ffe52f54be623af78dceb9=
7e4ad56" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 80000IE/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+25MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3D205e4f825acc705419=
58de216e8e35d0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 25MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+25MG%2FML+POMP+240ML%2810ML%2FUUR%29+PA&amp;id=3D3fa676254cd318445e=
cca9e957d81cdd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 25MG/ML POMP 240ML(10ML/UUR) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
L+INF+41%2C67MG%2FML+POMP+240ML+%2810ML%2FU%29APP&amp;id=3D9ac403fa417df851=
f9bacff4798c91ec" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILL INF 41,67MG/ML POMP 240ML (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVLST+40MG%2FML+CASSETTE+100ML+CZA&amp;id=3D768aa9de79d951758b9730f3f305b=
024" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVLST 40MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+40MG%2FML+CASSETTE+250ML+IP&amp;id=3D982285adaa0cd069f98a09e9b=
12de5e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 40MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,91&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4%2C16MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3Df7d30f2bdf098ca1=
2417cb2f586a6293" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4,16MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,07&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+POMP+100ML+%28200ML%2FU%29+CZA&amp;id=3D6aa82101a3124d02de=
81fb67ceffe675" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML POMP 100ML (200ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4%2C16MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D3adc92b3b9014bad=
5ee239910b697c8b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4,16MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+4%2C16MG%2FML+POMP+120ML+%285ML%2FU%29+PA&amp;id=3D9d7c4c86c74bbe44=
75c9ed2b69f2cf15" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 4,16MG/ML POMP 120ML (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INF+33%2C33MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D855714ec15546877=
d80595cc56b9808b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INF 33,33MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+33%2C3%2F4%2C2MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3D2600198e6d=
e3a48e9e52869629943b89" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 33,3/4,2MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+PA&amp;id=3D86fc423d053b10538ac27c08f98f676=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+IP&amp;id=3De6281bf4d63503382d32de7ff068ce3=
0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 212,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+11MG%2FML+CASSETTE+250ML+CZA&amp;id=3D3ebf81de016d5192e50dcf325806=
d4c9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 11MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,36&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+32MG%2FML+CASSETTE+250ML+CZA&amp;id=3D7dbe528e75ddd0f7976dd924=
9e7c223e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 32MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+800ML+CZA&amp;id=3Dd83fc5a1bcce67d1f89eaf697965c735"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 800ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,44&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFV+16%2C66MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3D4aa7de9bedd6f9a21=
2868e8f6a8a469d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFV 16,66MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+POMP+48ML+%282ML%2FU%29+PA&amp;id=3D743f45a8235aa73326376a=
cd47969df8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML POMP 48ML (2ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,86&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+POMP+250ML+%28500ML%2FU%29+PA&amp;id=3Dfb18b3200fc0133e94d=
1eeede10c51b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML POMP 250ML (500ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+50MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D6b6d94eb9f469036ca=
97a2770ff1002b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 50MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,99&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C96MG%2FML+ZAK+1137ML+MSZ&amp;id=3D2a276514c4af14a1997adaed8e62=
5d39" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,96MG/ML ZAK 1137ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+72000IE%2FML+CAS+250ML+APP&amp;id=3D857757f97ed1ef1bf77f41f7=
d541137e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 72000IE/ML CAS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+15MG%2FML+POMP+100ML+%28200ML%2FU%29+APP&amp;id=3Dfd5e4b4a7fad98b74c=
47247d5cea0ae3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 15MG/ML POMP 100ML (200ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFV+16%2C67MG%2FML+POMP+240ML+%2810ML%2FU%29+CZA&amp;id=3D222cb94827069818=
8ae583f5de771e87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFV 16,67MG/ML POMP 240ML (10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFVLST+6MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3Dd864870f8edc81e730=
5ae9a7c670b073" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFVLST 6MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+100MG%2FML+CASSETTE+100ML+ASG&amp;id=3D4150aab87543143f3951aee7e1cd=
a4d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 100MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F240ML+POMP+%2810ML%2FU%29APP&amp;id=3D012ed5a249d176bb55=
7e8523d0ecf3c9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/240ML POMP (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+20MG%2FML+POMP+100ML+%28200ML%2FUUR%29+IP&amp;id=3De87069f201fe1d06b8d=
41d9855925486" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 20MG/ML POMP 100ML (200ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+20MG%2FML+POMP+100ML+%28100ML%2F30MIN%29PA&amp;id=3Df9fd325731c73f4947=
84d570298aaa8f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 20MG/ML POMP 100ML (100ML/30MIN)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1200ML+PA&amp;id=3D5ada013d6073a914d17542ac47526377"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1200ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1200ML+IP&amp;id=3D6144cb1dfd1b49bf87209908bff6be48"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1200ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+ZAK+250ML+CZA&amp;id=3D167f149152c07b63a47811b6=
db2b9ded" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+56000IE%2FML+CASS+250ML+CZA&amp;id=3D31d6da20f23c616320b88e576=
9315e79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 56000IE/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+50%2F6%2C25MG%2FML+POMP+240ML+%2810ML%2FU%29IP&amp;id=3De139767769c5=
466197f61353e1aefb1b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 50/6,25MG/ML POMP 240ML (10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+50%2F6%2C25MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3Deda1bb29aa43b=
38a26a038532b91e06f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 50/6,25MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 214,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3Dc134ea707eb5b4149bf6df8887eb=
265f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8%2C8MG%2FML+CASSETTE+250ML+CZA&amp;id=3Da9a6d128b0eb1e7bddb244deef9=
990aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8,8MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+17%2C39MG%2FML+POMP+230ML%2810ML%2FU%29IP&amp;id=3D8529d53f34e6ba0b=
bbadbca3cef7634f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 17,39MG/ML POMP 230ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVL+16%2C67MG%2FML+POMP+240ML%2810ML%2FU%29+CZA&amp;id=3D7c858d3799fc6470=
3743af8df613ab2e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVL 16,67MG/ML POMP 240ML(10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+30MG%2FML+CASSETTE+100ML+AHZ&amp;id=3D2fadbd4be3d026f6b5ad8e8c6d9a62=
3f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 30MG/ML CASSETTE 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,42&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+PA&amp;id=3D10f01c5d7e42f1faaaac5d65e39c522=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DMEROPENEM+INFVLST+15MG%2FML+CASSETTE+100ML+IP&amp;id=3D409b89e19f68a0c3c=
563d2982fd517a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+40MG%2FML+POMP+100ML+%28200ML%2FU%29+CZA&amp;id=3D1bb48c0010768058c40=
767ad716f8a84" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 40MG/ML POMP 100ML (200ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFEN+INF+0%2C625MG%2F0%2C5MCG%2FML+CAS+250ML+FSBA&amp;id=3De3621ce323faf81a=
d3888572a27cb942" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFEN INF 0,625MG/0,5MCG/ML CAS 250ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,58&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+CASSETTE+100ML+APP&amp;id=3D4d0b77fa7faf39af5c3e827c0327f=
3b2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+66%2C7%2F8%2C3MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3Df6c9006d9b=
81e17aca37111ed1dfd9ef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 66,7/8,3MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+37%2C5MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3D1455d8abbb0b51c7=
163fbf1ec510dfb3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 37,5MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+15MG%2FML+CASSETTE+100ML+CZA&amp;id=3D13c1ee30dad074d46c68e2c7b9eb10=
8e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 15MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+9%2C38MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3D24d02cc84c953489=
978923ab939816de" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 9,38MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+9%2C38MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3D95a37efd86559afc=
86af7bd20bd6db62" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 9,38MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+16MG%2FML+ZAK+250ML+ZIK&amp;id=3D97971c5d07fbc7f4fc150718e869a590" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 16MG/ML ZAK 250ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+16%2C67MG%2FML+POMP+240ML%2810ML%2FU%29IP&amp;id=3D5a60b4132c4262b2=
e5de5a7dc6703dc8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 16,67MG/ML POMP 240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INF+16%2C667MG%2FML+POMP+240ML%2810ML%2FU%29+PA&amp;id=3Dc0a56ab6bb5256c8d2=
c232ff4dc72449" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INF 16,667MG/ML POMP 240ML(10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+30MG%2FML+CASSETTE+100ML+CZA&amp;id=3D16529d6a618ae59df9a48003dda7=
1187" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 30MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+140000IE%2FML+CASS+100ML+IP&amp;id=3D44cb5490f025d0e1b01255ae2=
9e7be60" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 140000IE/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+80000IE%2FML+CASS+100ML+CZA&amp;id=3D411d5d076d82e1b1aef39f177=
8bc9e92" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 80000IE/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3D85f6ff0444b1cd4030=
da1cbc779d0dc7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3Dee184b5b018f1add496=
27fbf17deed1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29+PHL&amp;id=3D92aeac19b85ce27f13=
cfbf1f94b51468" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+12%2C5MG%2FML+POMP+240ML%2810ML%2FU%29+PA&amp;id=3D9dfeb94899b49445=
3890455aa3da9e82" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 12,5MG/ML POMP 240ML(10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+10M+IE%2F120ML+POMP+%285ML%2FU%29+PA&amp;id=3Dd8be5c55b943185410e=
a27b8883a66a1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 10M IE/120ML POMP (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+33%2C3MG%2FML+POMP+240ML%2810ML%2FU%29IP&amp;id=3D0aa52cda7300cbc3=
6cd40c4c95032cd9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 33,3MG/ML POMP 240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+33%2C3MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3D6bb654bf95ec2361=
d4f7dea6afaf737f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 33,3MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+20MG%2FML+POMP+100ML+%2850ML%2FU%29+IP&amp;id=3D369b966175b54abc173f8c=
daa8934203" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 20MG/ML POMP 100ML (50ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+50%2F6%2C25MG%2FML+POMP+240ML%2810ML%2FU%29AHZ&amp;id=3Dcde1965f44e8=
7a913545ef4ec19a02df" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 50/6,25MG/ML POMP 240ML(10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOB+INF+8%2F1G%2F230ML+POMP+%2810ML%2FU%29+PHL&amp;id=3Dd816422a5bf9e8e=
d7929c595d1be8ddb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOB INF 8/1G/230ML POMP (10ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D06f1177518bf3c7587a123449f8ce=
5e7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+ZAK+250ML+CZA&amp;id=3Dab51aa77c1b6b3b84bb5907404b51=
458" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTRIAXON+=
INFVL+33%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3De337d7518c06162fd=
8ce5ca88702e1e8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTRIAXON INFVL 33,3MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTRIAXON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C5MG%2FML+POMP+48ML+%282ML%2FU%29+PA&amp;id=3D97f2b5622f9bafc7ff=
fac913c35ecc24" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,5MG/ML POMP 48ML (2ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERAC%2FT=
AZO+INF+75%2F9%2C38MG%2FML+POMP+240ML%2810ML%2FU%29IP&amp;id=3D68fd34be524e=
057cc13d9d4902dce32d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERAC/TAZO INF 75/9,38MG/ML POMP 240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 217,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8MG%2FML+CASSETTE+250ML+APP&amp;id=3D63484a87c12002458eb2b2bf2b25108=
9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16MG%2FML+CASSETTE+250ML+APP&amp;id=3Da54e6dbc273a0ea66b7443a8dfb0c1=
6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+POMP+100ML%28200ML%2FU%29+CZA&amp;id=3D61b579f840ad542f6f0=
4811040c4349e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML POMP 100ML(200ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+50%2F6%2C25MG%2FML+POMP+240ML+CZA&amp;id=3D923c346bdf21bd1929=
450ce3a8cc0e1a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 50/6,25MG/ML POMP 240ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+33%2C3MG%2FML+PMP+240ML%2810M%2FU%29CZA&amp;id=3Dc36d40fd924f851c8=
200be78326ddf57" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 33,3MG/ML PMP 240ML(10M/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+37%2C5MG%2FML+POMP240ML%2810ML%2FU%29CZA&amp;id=3Da885ae3354d65b5f=
bfb53cc9ea683d45" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 37,5MG/ML POMP240ML(10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29+AHZ&amp;id=3D3f7e29c08c179a1450=
927f5a5dc358e0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,88&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1MG%2F0%2C2MCG%2FML+CAS+100ML+CZA&amp;id=3D139314f6d46d608cba=
245e0d194cd59f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1MG/0,2MCG/ML CAS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+90000IE%2FML+CASS+100ML+CZA&amp;id=3D0356939d0692ec71f3a486dc5=
daacca7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 90000IE/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1100ML+CZA&amp;id=3Dfdeda182d47f6c47d351c7460df2cd6d=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 218,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3D145e9e94b73ecf04ef9=
5646d8b462803" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 219,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+160000IE%2FML+CASS+100ML+IP&amp;id=3Ddc411c9528741c30d0ea60218=
e6d29ec" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 160000IE/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 219,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12MG%2FML+CASSETTE+250ML+CZA&amp;id=3D23fe0fce3d497622e99eb008fbc8=
5316" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 219,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1MG%2F0%2C2MCG%2FML+CAS+100ML+CEA&amp;id=3D83bcd81c7ab1b59ea0=
7c9ac4edf6e708" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1MG/0,2MCG/ML CAS 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 219,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C7MG%2FML+ZAK+270ML+ZIK&amp;id=3Da311daaec3beafd065e232c9341eae=
c5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,7MG/ML ZAK 270ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 219,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C5MG%2FML+CASSETTE+100ML+PA&amp;id=3D2c495520a56cb7edd839dab8831=
10280" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,5MG/ML CASSETTE 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+24MG%2FML+ZAK+500ML+CZA&amp;id=3D376ec1c85071597266460cee49fbb=
916" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 24MG/ML ZAK 500ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+48000IE%2FML+ZAK+250ML+CZA&amp;id=3Db1cd63e065f6874fe7447cc7=
8ab64db1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 48000IE/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+CASS+250ML+PHL&amp;id=3D4d07003bc439214ee63fe91=
f88e3b69f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML CASS 250ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+DELT+CAS+250ML+PA&amp;id=3Dca824cf65b42cb8a9e6f=
a7d1487270cd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML DELT CAS 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+50%2C4MG%2FML+ZAK+119ML+ZIK&amp;id=3D7579237dd066d3cc30845a43673ce7=
20" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 50,4MG/ML ZAK 119ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+60MG%2FML+ZAK+100ML+ZIK&amp;id=3Dcd08886e6a09777e02da978188abd759" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 60MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,87&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+42MG%2FML+CASSETTE+250ML+IP&amp;id=3D5b7cd637eb592886884bd59fbc318a=
af" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 42MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFV+41%2C67MG%2FML+POMP+24ML%282ML%2FUUR%29+IP&amp;id=3Dd4205f72e0de8503=
ba05b4ed51dc1926" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFV 41,67MG/ML POMP 24ML(2ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8%2C4M+IE%2F120ML+POMP+%285ML%2FU%29+IP&amp;id=3D78598229f13a3ddd=
fedd27dd4931734a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8,4M IE/120ML POMP (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+6%2C25MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D1b21ba06cb195956=
d3575e02fa97039a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 6,25MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+6%2C25MG%2FML+POMP+120ML+%285ML%2FU%29+PA&amp;id=3D9881feca19922b8b=
a07d366491e75fb8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 6,25MG/ML POMP 120ML (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+1200ML+CZA&amp;id=3Df16b7aef21036f4a74cedca4027d9458=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 1200ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+35MG%2FML+CASSETTE+100ML+CZA&amp;id=3D42ae590c8586c9c9e00662766906=
ac7e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 35MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+7%2C81MG%2FML+POMP+96ML+%282ML%2FU%29+IP&amp;id=3D4dd66449293c7b97a=
d9c99b3cac31cc8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 7,81MG/ML POMP 96ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+25MG%2FML+POMP+240ML+%2810ML%2FU%29CZA&amp;id=3D889c09353730b23ef9=
30e37c408f3b86" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 25MG/ML POMP 240ML (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+CASS+250ML+CZA&amp;id=3Dfee04514fd0c512da282cce=
3b85b2e25" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+9M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3De8d98f4cb8c26d7d61e=
a8d785808e6d9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 9M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFV+4MG%2FML+POMP+100ML+%28200ML%2FUUR%29+APP&amp;id=3D903986763a0632a56e=
757d51f5d6a4b2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFV 4MG/ML POMP 100ML (200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+7%2C3MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3Da50dc6bcad2ac1d2=
ac3b3096763603be" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 7,3MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+75%2F9%2C38MG%2FML+POMP+240ML+%2810ML%2FU%29APP&amp;id=3Dfca63b5d9f59=
c62b7b36885deb76ecca" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 75/9,38MG/ML POMP 240ML (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+CASSETTE+100ML+AAA&amp;id=3D07ac14c0852d4bbab5cd9fbe2ab4d=
c98" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+DELT+CAS+250ML+PA&amp;id=3D3dc62f1196db78ba56eb=
7efe30903d3f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML DELT CAS 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+CASS+250ML+PHL&amp;id=3Dd28c6ba8c0625e14e199e94=
2b0987525" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML CASS 250ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+33%2C33MG%2FML+POMP+120ML+AHZ&amp;id=3D03b45a25cae1f06017cad03=
87e171fef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 33,33MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,80&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+PHL&amp;id=3Db2221f3b3cf0950ce14=
5d09197adb377" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+8M+IE%2F120ML+POMP+%285ML%2FU%29+PA&amp;id=3Df7cb004cec7912cbfd35=
0517921f26a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 8M IE/120ML POMP (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+100000IE%2FML+CASS+100ML+CZA&amp;id=3Da63d950b6ad8427a021b5273=
fee8f621" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 100000IE/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+48%2F6MG%2FML+CASS+250ML+CZA&amp;id=3Db15cfb93e954cf2a301e46e=
69ff843b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 48/6MG/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+22%2C2MG%2FML+ZAK+270ML+ZIK&amp;id=3D59a404a42e4236d800bac71c7=
62939cf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 22,2MG/ML ZAK 270ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3Db9ae6915710e0caae237=
fb0fbf5a6003" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 50MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,41&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+96000IE%2FML+ZAK+250ML+MSZ&amp;id=3Ddc0bc406137ac46a71b2b958=
0b389d03" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 96000IE/ML ZAK 250ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+66%2C7%2F8%2C3MG%2FML+POMP+240ML%2810ML%2FU%29AHZ&amp;id=3D53b5cc850a=
efd56385ec066e351ae70b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 66,7/8,3MG/ML POMP 240ML(10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+40MG%2FML+CASSETTE+100ML+CZA&amp;id=3Ddeb4a4d0ec42b940d7fc84b73994=
ae09" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 40MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+35%2C71MG%2FML+POMP+28ML+%282ML%2FU%29+IP&amp;id=3D3103bb05e129efb9=
620d0baeb6ffb49b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 35,71MG/ML POMP 28ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,95&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+100000IE%2FML+DELT+100ML+PA&amp;id=3D229c8272225f57b4ee8cfcaf7=
049b7be" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 100000IE/ML DELT 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+100000IE%2FML+CASS+100ML+IP&amp;id=3D9179f2f39d53e053b82ed5a30=
0be2218" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 100000IE/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+5MG%2FML+CASSETTE+100ML+FSBA&amp;id=3D84d1aa7791d8dab06d2f736495ff=
5323" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 5MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+40ML+%285ML%2FUUR%29+CZA&amp;id=3D4c882f0b2b0b556e6d=
bd3f1fa3d0771b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 40ML (5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+CASSETTE+100ML+CZA&amp;id=3D81c90342fc05cd7cdcb505611ba3cf=
87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVL+13%2C04MG%2FML+POMP+230ML+%2810ML%2FU%29+IP&amp;id=3D890276b365a49fea=
4dac96aa6717405e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVL 13,04MG/ML POMP 230ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+3%2C7MG%2FML+ZAK+540ML+ZIK&amp;id=3De8be28c7391dac40ffa9a7343bf2da=
59" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 3,7MG/ML ZAK 540ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C9MG%2FML+ZAK+290ML+ZIK&amp;id=3Deb42f87762a7f53feaae249865e987=
99" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,9MG/ML ZAK 290ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF++50MG%2FML+FLACON++50ML&amp;id=3D4bcd07c0af627c287d4584a3c657=
1e0d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF  50MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++25ML&amp;id=3D470dbb4ecd3d96ce9ab35dbcdf7e=
2ba3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON  25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+ZAK+250ML+PA&amp;id=3D2d9978294652c377e8e0f7e1b=
aa79fb9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+ZAK+250ML+IP&amp;id=3Db5b611371bba50968f43d65f4=
2962928" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,94&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+80000IE%2FML+ZAK+250ML+CZA&amp;id=3D93fd3c8c2490b05ea8c4588d=
fbef258c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 80000IE/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF++50G%2F1L+FLAC++50ML&amp;id=3D6a55576f38db089af2dba6e4a7259=
3d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF  50G/1L FLAC  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+26%2C09MG%2FML+POMP+115ML+AHZ&amp;id=3Dab8cd7144ebd794a186045302cf2=
0041" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 26,09MG/ML POMP 115ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+13%2C04MG%2FML+POMP+230ML%2810ML%2FU%29IP&amp;id=3D366c91e5825c0a36=
bbe33e4ebcce7c18" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 13,04MG/ML POMP 230ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+64%2F8MG%2FML+ZAK+250ML+CZA&amp;id=3D3001b268273ad7a06a211cb9=
2a773feb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 64/8MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+RIN=
GERLACTAAT+ECOBAG++500ML&amp;id=3Df5994cd05ee6c308ba11f1441b51b17a" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST RINGERLACTAAT ECOBAG  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">RINGER/LACTAAT</span=
>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+16MG%2FML+CASSETTE+250ML+APP&amp;id=3D9fd6363c5625b903ebc33d105e8b=
578c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 16MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 226,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NF+37%2C5MG%2FML+POMP+120ML%285ML%2FUUR%29LUMC&amp;id=3D80923eafccbbb502838=
ac994e870173e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INF 37,5MG/ML POMP 120ML(5ML/UUR)LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 226,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DVANCOMYCINE+INFVL+10%2C4MG%2FML+POMP+240ML%2810ML%2FU%29+AAA&amp;id=3D03=
b3c2cbcddf73ba59aa280732c63462" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 10,4MG/ML POMP 240ML(10ML/U) AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 226,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+34%2C78MG%2FML+POMP+115ML+AHZ&amp;id=3D650497f332e6ede325f28fc825d5=
f684" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 34,78MG/ML POMP 115ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+72000IE%2FML+CASS+250ML+CZA&amp;id=3D3df04866a878177f158643915=
80cfaa7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 72000IE/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+48000IE%2FML+CASS+250ML+CZA&amp;id=3Df03caa5af8d790602dab5bbb4=
7e257ff" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 48000IE/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAH=
CO3+42MG%2FML+FLACON+250ML+GLAS&amp;id=3Ddc5e1a61398b7796bfa1f7b0150fadff" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NAHCO3 42MG/ML FLACON 250ML GLAS</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOB+INF+12%2F1%2C5G%2F230ML+POMP%2810ML%2FU%29PHL&amp;id=3D86a25f88ba25=
265f32c565487c3508a8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOB INF 12/1,5G/230ML POMP(10ML/U)PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+62%2C5MG%2FML+POMP+48ML%282ML%2FUUR%29AAA&amp;id=3D918a76a182ddda4a=
ec186c28627ca021" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 62,5MG/ML POMP 48ML(2ML/UUR)AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+ZAK+100ML+IP&amp;id=3D0a1cee6ad398bfb8e483519a42fb90e2" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML ZAK 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 227,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+66%2C7MG%2FML+POMP+60ML+%285ML%2FU%29+APP&amp;id=3D19781dce81b2ef6d=
cfe186822b665f72" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 66,7MG/ML POMP 60ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+33%2C3MG%2FML+POMP+120ML%285ML%2FU%29+APP&amp;id=3D1f826f6fe3fb3431=
6fca4f064e43cf87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 33,3MG/ML POMP 120ML(5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+9%2C38MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D1fb9075a24819b3f=
cd4655ed3469c7ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 9,38MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFV+6MG%2FML+POMP+100ML+%28200ML%2FUUR%29+APP&amp;id=3D561dd03beefc2a832c=
711dc3bddd9b00" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFV 6MG/ML POMP 100ML (200ML/UUR) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+16M+IE%2F240ML+POMP+%2810ML%2FU%29+IP&amp;id=3Dbe53af401ad052897c=
8a3ee53ccc36eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 16M IE/240ML POMP (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+64000IE%2FML+CASS+250ML+CZA&amp;id=3Dad3783ea87844bfd2f030384a=
1e2052a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 64000IE/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,45&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+120000IE%2FML+ZAK+100ML+APP&amp;id=3D1ca3f858f177dc3bc216b4d45=
1053a61" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 120000IE/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+240000IE%2FML+CAS+100MLAAA&amp;id=3D74e9c233572b0628c733a3d9=
a2a4a48e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 240000IE/ML CAS 100MLAAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK++100ML+ECOBAG&amp;id=3Debeaba8f52bdf02c319392d6c9555da8" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK  100ML ECOBAG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+120MG%2FML+CASSETTE+100ML+ASG&amp;id=3D0c6090b92f114efb2e1ab7154c43=
b919" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 120MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+18MG%2FML+CASSETTE+250ML+APP&amp;id=3D583384a6408b4f6a10fd9ff6323fa4=
b2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 18MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+37%2C5MG%2FML+POMP+120ML%285ML%2FU%29+APP&amp;id=3Da5271f23cf1112aa=
50bb92334ba97412" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 37,5MG/ML POMP 120ML(5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,90&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3Dc6e3e3cf3ee71faed41=
98f670ede2ac4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 50MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,28&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGANCICLOVIR=
+INFVL+5%2C42MG%2FML+POMP+120ML+%285ML%2FUUR%29IP&amp;id=3Db986d5a9538b5bc8=
ec32837cba45b86c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GANCICLOVIR INFVL 5,42MG/ML POMP 120ML (5ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GANCICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29+PA&amp;id=3D83ff5a00f14ae17967a=
e2c81fbbfad81" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29+PHL&amp;id=3Db3626cf673e6dc461b=
ad9672e92e6c06" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+3MG%2FML+ZAK+500ML+ZIK&amp;id=3D2098fb27145cda4c48ec2a4fa970cb14" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 3MG/ML ZAK 500ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12%2C5MG%2FML+POMP+120ML+%2810ML%2FU%29+IP&amp;id=3Dc6fac34f5d94031d=
8fcdacd3e7129005" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12,5MG/ML POMP 120ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVL+12%2C5MG%2FML+POMP+120ML+%2810ML%2FU%29+PA&amp;id=3De3e26a8c7fbcd0a586=
c99bb46d2a5e2f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVL 12,5MG/ML POMP 120ML (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+100ML+AAA&amp;id=3D7011ac9fae683c8d4c1ca3c32aeca9=
06" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3D12d270136b23e89919bc0f3bf44d82=
2c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+DELTEC+CASS+100ML+PA&amp;id=3Dc7f9627df19df7ed4e258ecf29b=
6c3a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML DELTEC CASS 100ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+52%2C17MG%2FML+POMP+115ML+AHZ&amp;id=3D1801199831bb4757fcc3c1b5d7a2=
71a7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 52,17MG/ML POMP 115ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+37%2C5MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3Dd19386101021aa10=
5d849adb1ea72fb2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 37,5MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+2400ML+PA&amp;id=3Dc27922021bda097675e6d80ae9388c14"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 2400ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3Dc6cbae55f5f3985b4a6=
e0ec4ea256074" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 50MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12%2C5MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3Dee7c1ed89f2a9655=
71ec5f0d31b400c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12,5MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 230,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMOXICILLIN=
E+INFVLST+5MG%2FML+ZAK+2400ML+CZA&amp;id=3D6016dbecccff526d68c50d2927c9e70e=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMOXICILLINE INFVLST 5MG/ML ZAK 2400ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMOXICILLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3Db0914e6ec627bb995498f575d38a6=
f34" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+250ML+IP&amp;id=3Dba009ea5441ff8365138ae95991d6=
20e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+10MG%2FML+CASSETTE+250ML+PA&amp;id=3Df1b169adb76457d82e26b75b6dd53=
268" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 10MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+5%2C4MG%2FML+ZAK+560ML+ZIK&amp;id=3D35e52496ff25a1c145bf0e329ed811=
56" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 5,4MG/ML ZAK 560ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+9%2C7MG%2FML+ZAK+310ML+ZIK&amp;id=3D5f59e5be4a6c68a7be290f07ca3092=
4c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 9,7MG/ML ZAK 310ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F240ML+POMP+%2810ML%2FU%29AHZ&amp;id=3D71b1aa99eb57a9dc84=
a7743a5a527c97" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/240ML POMP (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8%2C33MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3D6444c5102b0dca08=
5cbc25a5e3b30ec7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8,33MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 231,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+0%2C05MG%2FML+CASSETTE+100ML+FSBA&amp;id=3D2356b8032cb8c040bd23b30275=
b372b8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 0,05MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 232,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
L+INF+41%2C67MG%2FML+POMP+240ML%2810ML%2FU%29+CZA&amp;id=3D65d012a55d1f4d0a=
711b61965bb83006" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILL INF 41,67MG/ML POMP 240ML(10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 232,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+10%2C4MG%2FML+POMP+240ML%2810ML%2FUUR%29PA&amp;id=3Dc863bfc6a050d061=
9ed2e6fea4a97f65" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 10,4MG/ML POMP 240ML(10ML/UUR)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 232,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+10%2C4MG%2FML+POMP+240ML%2810ML%2FUUR%29IP&amp;id=3Dea045973dd90116c=
711bdec5ac8bdb66" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 10,4MG/ML POMP 240ML(10ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 232,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFVLST+6MG%2FML+CASSETTE+100ML+IP&amp;id=3D9f5ccab22787044d9bd1dd8488a832=
07" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFVLST 6MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+34%2C78MG%2FML+POMP+230ML%2810ML%2FU%29IP&amp;id=3D11cb380433c9a158=
3604f1465b54b91a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 34,78MG/ML POMP 230ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C1MG%2FML+ZAK+570ML+ZIK&amp;id=3Dec02dfeefdc40abcf74afce2236545=
ac" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,1MG/ML ZAK 570ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+8%2C33MG%2FML+POMP+120ML+%285ML%2FU%29+PA&amp;id=3D525cc333aece440c=
b84ea4464d8fd248" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 8,33MG/ML POMP 120ML (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,79&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+CASSETTE+250ML+IP&amp;id=3D502197f5a7ce526547d3b116a=
13f46aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+CASSETTE+250ML+PA&amp;id=3D76d9ab992c8a91ea28bbc803c=
05c2881" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 233,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F120ML+POMP+%285ML%2FU%29+CZA&amp;id=3Db7cecd5ae4155b0c2f=
feb204cbbc17a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/120ML POMP (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 234,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+240ML%2810ML%2FU%29+APP&amp;id=3Dc3f4f381e08d1015d6b=
26965e59f7995" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 240ML(10ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 234,35&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+10%2C4MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D112aa7c392f5b9d8=
c22a5bb09dfbb653" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 10,4MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 234,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+36MG%2FML+ZAK+250ML+CZA&amp;id=3D7ac1a7a15bfa35f39d40e9d427f2f0d5" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 36MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 234,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLS+10%2C41MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3Dca5701f0ab64d796=
a25b4e54796346c3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLS 10,41MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 234,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+18%2C33MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D3488fc78a8b0aac7=
07063d8d53cb6b37" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 18,33MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+240ML+%2810ML%2FU%29+PA&amp;id=3Daa6461b733d491be1f3=
a300c3a7efda4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 240ML (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVL+12%2C5MG%2FML+POMP+240ML%2810ML%2FU%29+CZA&amp;id=3Dbca8366c12063d94=
794706680cdad699" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVL 12,5MG/ML POMP 240ML(10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFAZOLINE+=
INFVLST+25MG%2FML+POMP+240ML+%2810ML%2FU%29+CZA&amp;id=3D6deb349213023406ba=
3715811b52d3e8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFAZOLINE INFVLST 25MG/ML POMP 240ML (10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFAZOLINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F240ML+POMP+%2810ML%2FU%29APP&amp;id=3Dc0b17ead55c08b0a6b=
f2de06350874b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/240ML POMP (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFVLST+6MG%2FML+POMP+100ML+%28100ML%2FU%29CZA&amp;id=3D6c0ca387a3a71e5455=
e219421e29e6a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFVLST 6MG/ML POMP 100ML (100ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+8%2C33MG%2FML+POMP+120ML+AHZ&amp;id=3Dd97bb88966d2b73dfc8ee6f57e21=
bc69" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 8,33MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,99&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+ZAK+250ML+IP&amp;id=3D40ce2c646deeaddfaf0688bf8128144d" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+ZAK+250ML+PA&amp;id=3D7b6abfc3c88fb555552dc9b1c9a9cde9" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+6%2C9MG%2FML+ZAK+580ML+ZIK&amp;id=3D57aeb6bb7ffd8d07612e71039f5823=
7d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 6,9MG/ML ZAK 580ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12%2C12MG%2FML+ZAK+330ML+ZIK&amp;id=3D6e052d6cc4830ff12cbe401a847b=
8a54" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12,12MG/ML ZAK 330ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON++25ML&amp;id=3D57484e0a1515e9134fe98194edd80=
197" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON  25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 237,07&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F240ML+POMP+%2810ML%2FU%29CZA&amp;id=3D1c00a5130c2b7174ff=
ba8aff4454ed09" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/240ML POMP (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 237,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
OB+INF+66%2C7%2F8%2C3MG%2FML+POMP+240ML%2810ML%2FU%29PA&amp;id=3D45f7b2a846=
46167115f752ba29ed3ae9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZOB INF 66,7/8,3MG/ML POMP 240ML(10ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 237,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+66%2C66%2F8%2C33MG%2FML+POMP240ML%2810ML%2FU%29IP&amp;id=3D7ee29a72ef=
3408aad7565e6a993978f3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 66,66/8,33MG/ML POMP240ML(10ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 237,67&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+12%2C5MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D8d68a23202c510a9=
4d6a54fdc1017602" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 12,5MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+80000IE%2FML+CAS+250ML+APP&amp;id=3Dccac7c54240f9fa74f99c0c1=
8a693052" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 80000IE/ML CAS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+10MG%2FML+FLACON+50ML+ZGT&amp;id=3Dfbc5bb1ad44c29b19cf8d8b106e80de3=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 10MG/ML FLACON 50ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+48MG%2FML+CASSETTE+250ML+CZA&amp;id=3D564cdcd87e305ba9b320d5f9=
714bb7cc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 48MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12%2C5MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3D98e4c0ffef1e9f97=
9a511491c277ceab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12,5MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C09MG%2FML+CASS+100ML+IP&amp;id=3D1d5d39da07a161d2397=
85ae9844c4dba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,09MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+44%2C4MG%2FML+ZAK+270ML+ZIK&amp;id=3D14cd000273e99ae521aa19706=
cbcea33" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 44,4MG/ML ZAK 270ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,74&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTAN+INF+2%2C5MG%2F1MCG%2FML+CAS+250ML+FSBA&amp;id=3D03d4d8e71843a22db93=
1d2cbc1506ff0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTAN INF 2,5MG/1MCG/ML CAS 250ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 238,82&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+14M+IE%2F240ML+POMP+%2810ML%2FU%29CZA&amp;id=3D31878d0d61f90543d4=
529b67337f9ff7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 14M IE/240ML POMP (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 239,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+8MG%2FML+CASSETTE+250ML+CZA&amp;id=3Dc4f9cfa915ac7ded25ef842d74fd2ca=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 8MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 239,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+100000IE%2FML+ZAK+120ML+ZIK&amp;id=3D4d46b20ceecdf4e832687621d=
f0f9321" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 100000IE/ML ZAK 120ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 240,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+16M+IE%2F240ML+POMP+%2810ML%2FU%29APP&amp;id=3D69e95f3461ebd39bb8=
885ab881125791" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 16M IE/240ML POMP (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGANCICLOVIR=
+INFVL+6%2C25MG%2FML+POMP+120ML+%285ML%2FUUR%29IP&amp;id=3D00a2ffb976b49e9c=
9bc08bc7511de238" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GANCICLOVIR INFVL 6,25MG/ML POMP 120ML (5ML/UUR)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GANCICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+24MG%2FML+ZAK+250ML+ZIK&amp;id=3D327cd903b745881e78840a7621343db5" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 24MG/ML ZAK 250ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INF+107%2C14MG%2FML+POMP+28ML+%282ML%2FU%29+IP&amp;id=3Dbb6ff164c00175763=
792a018ce5277ae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INF 107,14MG/ML POMP 28ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INF+50MG%2FML+POMP+240ML%2810ML%2FUUR%29+PA&amp;id=3D73a566bc910e31b32e=
64efe1d4040f5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INF 50MG/ML POMP 240ML(10ML/UUR) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3D986a857801f9506a1c=
b48ca5b157f5d8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,52&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+23%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3Dc58b2cf7f7a12328b=
cc9467e98f7d932" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 23,3MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,84&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPER%2FTAZ=
O+INF+66%2C7%2F8%2C3MG%2FML+POMP+240ML%2810ML%2FU%29CZA&amp;id=3D81a5e01364=
aabee486fa2b31adcbc190" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPER/TAZO INF 66,7/8,3MG/ML POMP 240ML(10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+240ML+%2810ML%2FU%29CZA&amp;id=3De5ad1cb63e61b17fb0=
bbf61cc075da33" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 240ML (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+50MG%2FML+FLACON++50ML&amp;id=3D57657b887631764ea8fad251f66fe=
d40" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 50MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+96000IE%2FML+ZAK+250ML+APP&amp;id=3D39ce7183718319e0e84e49bf=
d6d1a779" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 96000IE/ML ZAK 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON++25ML&amp;id=3Da9280c2633f15e33c96b870c91c58c33" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON  25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+25ML&amp;id=3D7a3bbacedae2a2bfbb8c3d8350ef2=
419" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 100MG/ML FLACON 25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+IP&amp;id=3D7bb5c5fe41e1d514588c46412645c4d=
4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+PA&amp;id=3Da1e043665af5ccbb9b044e9e77b9592=
3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 242,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+62%2C5MG%2FML+POMP+24ML%282ML%2FUUR%29+IP&amp;id=3D9ad530642bcb4730=
6ff4d4453a5d87bc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 62,5MG/ML POMP 24ML(2ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DBENZYLPENICILL+INFVL+24M+IE%2F240ML+POMP+%2810ML%2FU%29APP&amp;id=3D64b6=
aef68cec44413e031e9397f0aa77" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 24M IE/240ML POMP (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F240ML+POMP+%2810ML%2FU%29+PA&amp;id=3D4fee1ff1a131d8d122=
9be6f241d4390f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/240ML POMP (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+24MG%2FML+ZAK+250ML+MSZ&amp;id=3D042feb9be8a398f7f7b90dea5997e4e7" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 24MG/ML ZAK 250ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+240ML%2810ML%2FU%29+CZA&amp;id=3D88836ca1edd501dc67b=
daecd9b3d3ec2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 240ML(10ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F240ML+POMP+%2810ML%2FU%29CZA&amp;id=3D8b8d2740af7b4ac0e5=
e7b6eced19b32d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/240ML POMP (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+14%2C6MG%2FML+POMP+240ML%2810ML%2FUUR%29APP&amp;id=3D2c1a229208cdfb83=
4babf000acdface8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 14,6MG/ML POMP 240ML(10ML/UUR)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 244,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINENATR+INF+96000IE%2FML+CAS+250ML+APP&amp;id=3D97ebc589dc7db017a3d6aeb5=
756243a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINENATR INF 96000IE/ML CAS 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 244,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+20M+IE%2F240ML+POMP+%2810ML%2FU%29CZA&amp;id=3Dd1aafae83f04c7c5fa=
c2a5d6270f53ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 20M IE/240ML POMP (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 244,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+12M+IE%2F240ML+POMP+%2810ML%2FU%29+IP&amp;id=3Dad73e53723b3a3e2f0=
7fb3f62187f2d0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 12M IE/240ML POMP (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 244,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16%2C66MG%2FML+POMP+240ML%2810ML%2FU%29AHZ&amp;id=3D1b733aa04f00cc51=
6ad09364779f1986" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16,66MG/ML POMP 240ML(10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 244,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+ZAK+250ML+CZA&amp;id=3Dd8f481d6f51c862bce91d8d9485af56a" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+24MG%2FML+CASSETTE+250ML+APP&amp;id=3D8e32fa1ae7a1101b7fb54e98d56a8d=
84" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 24MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C04MG%2FML+ZAK+100ML+APP&amp;id=3D95a22abd599713d5163=
edd222c774e60" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,04MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+5%2F0%2C04MG%2FML+ZAK+100ML+TA&amp;id=3D9974591894ce9924ee59d=
16e74aee174" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 5/0,04MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+250ML+APP&amp;id=3Dda04ededa0819a576c05e0b3b3d8f4=
0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5%2C21MG%2FML+POMP+240ML%2810ML%2FU%29APP&amp;id=3Df4ac01ec64f1fdeb=
5e69707055540d65" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5,21MG/ML POMP 240ML(10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1%2C25MG%2F1MCG%2FML+CAS+250ML+PA&amp;id=3D6dbb58becd1a767745=
c6b23363bb108e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1,25MG/1MCG/ML CAS 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+33%2C33MG%2FML+POMP+240ML+AHZ&amp;id=3D5c02e332f1864a2376be99f=
aceb46bef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 33,33MG/ML POMP 240ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 246,43&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+80000IE%2FML+DELTEC+250ML+PA&amp;id=3D29f28b7ee8ce9c5a1ae92905=
a488f427" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 80000IE/ML DELTEC 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 247,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+80000IE%2FML+CASS+250ML+IP&amp;id=3Da602776763e1e33e04a0b28285=
754df5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 80000IE/ML CASS 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 247,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+12%2C5MG%2FML+POMP+120ML+AHZ&amp;id=3D0d5f93ee12b7cc8448580e91df16=
325e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 12,5MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 248,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFV+16%2C67MG%2FML+POMP+240ML%2810ML%2FU%29+APP&amp;id=3D50fed607363f07f9=
a28d4c9bff9bca69" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFV 16,67MG/ML POMP 240ML(10ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 249,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+76000IE%2FML+CASS+250ML+IP&amp;id=3Dd86960c1ded36ca31270205825=
c99af7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 76000IE/ML CASS 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+120000IE%2FML+ZAK+100ML+PHL&amp;id=3D884a3d21ac7f58d605e1a4820=
7441d96" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 120000IE/ML ZAK 100ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,08&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+500MG%2FML+FLACON+100ML+GLAS&amp;id=3D072114193aeda3199fbcf502b428e10=
f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 500MG/ML FLACON 100ML GLAS</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F230ML+POMP+%2810ML%2FU%29+IP&amp;id=3Df94dbd1b79a5cb6cc4=
e2c0995597cf79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/230ML POMP (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,56&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+96000IE%2FML+ZAK+250ML+CZA&amp;id=3D8a9307d94f1c24e32db7eb4e=
57db8f8d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 96000IE/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+20M+IE%2F240ML+POMP+%2810ML%2FU%29+PA&amp;id=3D881de1914e69ca39a1=
06578f855dd217" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 20M IE/240ML POMP (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+20M+IE%2F240ML+POMP+%2810ML%2FU%29+IP&amp;id=3Dfd141d74adac222bc5=
335a91dcdce16f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 20M IE/240ML POMP (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 250,70&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INF+50MG%2FML+POMP+240ML+%2810ML%2FU%29AHZ&amp;id=3Df63862a4158b5282e7=
854854f43ec3a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INF 50MG/ML POMP 240ML (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 251,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+16%2C67MG%2FML+POMP+120ML+AHZ&amp;id=3Dd2f8819b6ea9dfe5e43c595eb19=
19866" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 16,67MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 251,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20%2C83MG%2FML+POMP+240ML%2810ML%2FU%29AHZ&amp;id=3D8de5d3b1a5b50007=
2b69ed4341cba799" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20,83MG/ML POMP 240ML(10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 251,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+72000IE%2FML+DELT+250ML+PA&amp;id=3D359a0a9dfc3751e95f1bda36ee=
080810" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 72000IE/ML DELT 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+72000IE%2FML+CASS+250ML+PHL&amp;id=3D35d3e03e9e8e5b07f383abe10=
40efff6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 72000IE/ML CASS 250ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,47&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+18%2C75MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3D5fb2e53c4030ee0d=
d9147a436f35b7af" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 18,75MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INFVLS+60MG%2FML+CASSETTE+100ML+ASG&amp;id=3D48fd881989a9c26a342700a69a=
e6ba04" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INFVLS 60MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+37%2C5MG%2FML+POMP+240ML%2810ML%2FU%29+IP&amp;id=3D207eb817df5efd41=
55aa87737b1d0d5e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 37,5MG/ML POMP 240ML(10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+37%2C5MG%2FML+POMP+240ML%2810ML%2FU%29+PA&amp;id=3D74ea542a3d5bcbe3=
4281534df7e8b923" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 37,5MG/ML POMP 240ML(10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 252,61&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+18M+IE%2F120ML+POMP+%285ML%2FU%29+PHL&amp;id=3Dd1a9dc0f42212ee334=
7e9c7d37418750" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 18M IE/120ML POMP (5ML/U) PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+20%2C83MG%2FML+POMP+120ML+AHZ&amp;id=3Dd309d08b43303676d6733594e46=
a1dfb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 20,83MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3D33a032caa43373316b5=
f91bd91501c67" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+25MG%2FML+POMP+240ML%2810ML%2FU%29+PA&amp;id=3Df4e0b2c5cefb04dffdc7=
559896dbf70c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 25MG/ML POMP 240ML(10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,63&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+20M+IE%2F240ML+POMP+%2810ML%2FU%29APP&amp;id=3D6680349a5537140b73=
5cd789257d7356" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 20M IE/240ML POMP (10ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,71&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+2MG%2FML+CASSETTE+100ML+AAA&amp;id=3D65c8e983b1b865de0980330f241b602=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 2MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 254,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK++100ML+IN+250ML+ECOBAG&amp;id=3D74b7b4a68ba8187e10aa00e9d42d=
d2d7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK  100ML IN 250ML ECOBAG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 254,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16MG%2FML+ZAK+250ML+CZA&amp;id=3Dc0fcc9e0f02b7a5bde8b7db6b6fd7813" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16MG/ML ZAK 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 254,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+5%2F0%2C04MG%2FML+CASS+100ML+IP&amp;id=3Dbedb03e9d261a21c7dc9=
3b6b5ee3a922" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 5/0,04MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+36MG%2FML+CASSETTE+250ML+IP&amp;id=3D73488b1bba42cf0ec1aa419664f7dc=
db" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 36MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFTAZIDIM+=
INFVLST+36MG%2FML+DELTEC+CASS+250ML+PA&amp;id=3De9232ac0415e3e8534c4a19300c=
9834a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFTAZIDIM INFVLST 36MG/ML DELTEC CASS 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFTAZIDIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+1MG%2FML+CASSETTE+100ML+IP&amp;id=3D35f2fb4abb4ea66fb02c70558d520b13=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 1MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LINE+INFVLST+36MG%2FML+ZAK+500ML+PA&amp;id=3D6a9f746d7645ad4a1d78665e617f4d=
7b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLINE INFVLST 36MG/ML ZAK 500ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM++50MG%2FML+VIAFLO+ZAK+++50ML&amp;id=3D90db52ddf035c9c0802a95e2b80f2d2=
5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM  50MG/ML VIAFLO ZAK   50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+VIAFLO+ZAK++50ML&amp;id=3Da7e9a413165cecb6e8eca72d0aaa0cd4" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML VIAFLO ZAK  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANCOMYCINE=
+INFVLST+25MG%2FML+POMP+120ML+AHZ&amp;id=3Defa8084b7cdbd1339a84c554bb49581a=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANCOMYCINE INFVLST 25MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">VANCOMYCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,86&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C04MG%2FML+ZAK+100ML+TA&amp;id=3Dab9a021fed035a7426d5=
19bfbf2f364e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,04MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 256,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+37%2C5MG%2FML+POMP+120ML+%285ML%2FU%29+APP&amp;id=3D01cb715b491872a9=
1f12bf603188d69f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 37,5MG/ML POMP 120ML (5ML/U) APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 257,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+12MG%2FML+CASSETTE+250ML+CZA&amp;id=3D4aaefae1541b7689e52abdd297c850=
f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 12MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 257,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+96000IE%2FML+CASS+250ML+CZA&amp;id=3D519435ab766439d23dcc0872f=
d1b5257" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 96000IE/ML CASS 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 257,51&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+25MG%2FML+POMP+240ML+%2810ML%2FU%29+AHZ&amp;id=3D8fc2d704cc1810e1226=
e9b1c6deaaef1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 25MG/ML POMP 240ML (10ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 257,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+24M+IE%2F240ML+POMP+%2810ML%2FU%29AHZ&amp;id=3De3621c5285d2b4b0a2=
948836dee6c625" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 24M IE/240ML POMP (10ML/U)AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 258,17&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C08MG%2FML+CASS+100ML+AAA&amp;id=3Da237ae5cd1a2a5babb=
4b7ccd3f25af6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,08MG/ML CASS 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 258,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+20%2C83MG%2FML+POMP+48ML+%282ML%2FU%29+IP&amp;id=3Df93db1aa623c2918=
87c5a11c8553f3bc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 20,83MG/ML POMP 48ML (2ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 258,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+MET=
RONIDAZOLUM+5MG%2FML+VIAFLO+ZAK+100ML&amp;id=3D8baf90eacb8a869717e86f9b329b=
cb93" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST METRONIDAZOLUM 5MG/ML VIAFLO ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METRONIDAZOL</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 259,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+DAC+VIAFLO+ZAK+50ML&amp;id=3D95973f34c2e470013bc757fd6c13c2a4" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML DAC VIAFLO ZAK 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 259,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+CASSETTE+250ML+CZA&amp;id=3Dadef088f837a570ee14dabfa0257d8=
98" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 260,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+2MG%2FML+CASSETTE+100ML+IP&amp;id=3D9d4b901204c708ae714facd87bfcaff8=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 2MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 260,26&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+33%2C33MG%2FML+POMP+120ML+%285ML%2FU%29CZA&amp;id=3D492b4d5df8ef5c63=
c61ffc2418640728" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 33,33MG/ML POMP 120ML (5ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 260,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+12%2C5MG%2FML+POMP+120ML+%285ML%2FU%29+AHZ&amp;id=3De325167e1a00889b=
4946e7cd2bd1d568" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 12,5MG/ML POMP 120ML (5ML/U) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 260,46&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+62%2C5MG%2FML+POMP+40ML+%285ML%2FU%29+CZA&amp;id=3D4ca991e70707cdeb=
708e3709489d49fb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 62,5MG/ML POMP 40ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 261,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+18%2C75MG%2FML+POMP+120ML+AHZ&amp;id=3D8e8c10739adc1495713097902c0c3=
938" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 18,75MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 262,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C08MG%2FML+CASS+100ML+CZA&amp;id=3De1cf1bbffafc474499=
1c817b5db1728c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,08MG/ML CASS 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 263,02&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+48000IE%2FML+ZAK+250ML+IP&amp;id=3D042f196991263186b70e0529d=
321d19b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 48000IE/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 265,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+48000IE%2FML+ZAK+250ML+PA&amp;id=3D3dc55f97578a76f3369df38e9=
f3a53b5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 48000IE/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 265,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK+++50ML+ECOBAG&amp;id=3D6a21bbf9eac36196d82def0c9f452d5d" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK   50ML ECOBAG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 266,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF++20%2F0%2C01MG%2FML+CASS+100ML+IP&amp;id=3Dd51564855021669120=
1494c62a5abc1a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF  20/0,01MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 267,32&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+25MG%2FML+POMP+120ML+AHZ&amp;id=3D23c212c3b3c9605481beca55de296990" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 25MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 267,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C05MG%2FML+CASS+100ML+AAA&amp;id=3Dd5fb0989f6150b3c19=
abc06fa8e97ddb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,05MG/ML CASS 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 267,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+20MG%2FML+ZAK+300ML+CZA&amp;id=3D6351a65044af9151bef8d78db49a6e18" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 20MG/ML ZAK 300ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 267,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+40000IE%2FML+ZAK+250ML+IP&amp;id=3Dd04731b6f6970f89ba5ec88e1=
dd355c1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 40000IE/ML ZAK 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 268,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+40000IE%2FML+ZAK+250ML+PA&amp;id=3De7679c54dffef3671475fd2e6=
c4c7099" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 40000IE/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 268,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+31%2C25MG%2FML+POMP+120ML+AHZ&amp;id=3D88fdd3eaad7aa2121142ab96077a7=
1c3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 31,25MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 269,18&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCLOXACIL=
LIN+INFVLS+120MG%2FML+CASSETTE+100ML+ASG&amp;id=3Df68e95f3de5cb28a08b65a215=
f9e0434" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCLOXACILLIN INFVLS 120MG/ML CASSETTE 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCLOXACILLINE</spa=
n>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 270,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEFEROXAMIN=
E+INFVL+50MG%2FML+POMP+40ML+%285ML%2FUUR%29+IP&amp;id=3D07716df05964a3b4f07=
a00bf47b7a736" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEFEROXAMINE INFVL 50MG/ML POMP 40ML (5ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEFEROXAMINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 270,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+37%2C5MG%2FML+POMP+120ML+AHZ&amp;id=3D252bbcb133ea8dc765dd439df0d6f5=
23" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 37,5MG/ML POMP 120ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 272,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C04MG%2FML+CASS+100ML+IP&amp;id=3D89c5299e176358db744=
f396f16e2f9ee" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,04MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 272,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C04MG%2FML+CASS+100ML+APP&amp;id=3Db376532f62ca880c73=
f1d067266051e0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,04MG/ML CASS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 272,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C04MG%2FML+CASS+100ML+AAA&amp;id=3D989f0dce8782d8081b=
c4daa8c86b0090" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,04MG/ML CASS 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 273,13&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+24M+IE%2F240ML+POMP+%2810ML%2FU%29CZA&amp;id=3D651167d8529a47cec5=
d98b8e2f56f68b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 24M IE/240ML POMP (10ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 274,04&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPENICILLINE=
+G+INFVL+120000IE%2FML+CASS+100ML+ASG&amp;id=3D3e23fdb9b6a3665d26b9a4e0fb65=
1820" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PENICILLINE G INFVL 120000IE/ML CASS 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 274,77&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+24M+IE%2F230ML+POMP+%2810ML%2FU%29PHL&amp;id=3D7e3b226473cb687233=
1d6453409cfcce" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 24M IE/230ML POMP (10ML/U)PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 276,59&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEROPENEM+I=
NFVLST+16MG%2FML+CASSETTE+250ML+CZA&amp;id=3D9c03be33ca0ff35326629b74073540=
93" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEROPENEM INFVLST 16MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MEROPENEM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 278,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C05MG%2FML+CASS+100ML+IP&amp;id=3Df8d101b3edfb7a5d5f2=
623f91f933ac5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,05MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 281,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILL+INFVL+24M+IE%2F240ML+POMP+%2810ML%2FU%29+PA&amp;id=3D00956583bf408a4332=
a918ef5320a352" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILL INFVL 24M IE/240ML POMP (10ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 281,85&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+58%2C3MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3Db530874d445e2190c=
dcadb6dc76c67c4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 58,3MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 282,76&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVLST+96000IE%2FML+ZAK+250ML+PA&amp;id=3D2eea91d30fa86d4c86f1d79c1=
ec4b36b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVLST 96000IE/ML ZAK 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 283,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+96000IE%2FML+ZAK+250ML+PHL&amp;id=3Da17b3888db011b492c4d5f8d5b=
2b5f91" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 96000IE/ML ZAK 250ML PHL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 283,06&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+20MG%2FML+ZAK+100ML+TA&amp;id=3Def53b93ac495725c53d29013640cf80b" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 20MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 283,40&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+20MG%2FML+CASSETTE+100ML+TA&amp;id=3D39c67653bf401c20835c20ea1b876=
919" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 20MG/ML CASSETTE 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 283,64&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+10%2F0%2C08MG%2FML+CASS+100ML+APP&amp;id=3D93befcc3afee876e88=
e5e35616e7d5aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 10/0,08MG/ML CASS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 284,20&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSENDOLOR+IN=
FVLST+20MG%2FML+ZAK+100ML&amp;id=3De836782139387f733572518cf0bbe4ae" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SENDOLOR INFVLST 20MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">EUROCEPT INTERNATIONAL B=
V</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 284,49&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DCEFUROXIM+INFVLST+37%2C5MG%2FML+POMP+120ML+%285ML%2FU%29+PA&amp;id=3D5f3=
a53b6bb92575159679a29f9e9614a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 37,5MG/ML POMP 120ML (5ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 285,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+37%2C5MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3Deb40a87bdcf4c2d19=
9d3253e32b6bca5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 37,5MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 285,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+20MG%2FML+CASSETTE+100ML+AAA&amp;id=3D30cd4b39ffa991ecf683fc8c3e93=
9e32" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 20MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 286,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+37%2C5MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3Dc4e45fb9759cab31=
e4baa740daa3e2a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 37,5MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 286,42&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+96000IE%2FML+CASS+250ML+IP&amp;id=3D0fecd9d792c5fffb01173b3b8d=
17bce4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 96000IE/ML CASS 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 292,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENZYLPENIC=
ILLINE+INFVL+96000IE%2FML+DELTEC+250ML+PA&amp;id=3D18219d14167bf92d9bf904ac=
42d1dd34" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENZYLPENICILLINE INFVL 96000IE/ML DELTEC 250ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENZYLPENICILLINE</s=
pan>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 292,92&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOMEPROMA=
ZINE+INFVLST+5MG%2FML+CASSETTE+100ML+IP&amp;id=3De2b37b24d6140bd9cfbd314ef8=
5e8376" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOMEPROMAZINE INFVLST 5MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOMEPROMAZINE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 299,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C04MG%2FML+ZAK+100ML+APP&amp;id=3D92f8663bea3e7fcd332=
312e2f53bcd66" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,04MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 299,75&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C04MG%2FML+CASS+100ML+AAA&amp;id=3D3371e8f9b3a8b54971=
58be40534136ba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,04MG/ML CASS 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 301,37&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+50MG%2FML+POMP+120ML+%285ML%2FU%29+CZA&amp;id=3Dcf4accdd9daffb0ec08e=
8dcba5989398" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 50MG/ML POMP 120ML (5ML/U) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 301,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCEFUROXIM+I=
NFVLST+33%2C3MG%2FML+POMP+240ML+%2810ML%2FU%29+IP&amp;id=3Dab02df009a23db32=
48017c92f3638f2b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CEFUROXIM INFVLST 33,3MG/ML POMP 240ML (10ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CEFUROXIM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 303,66&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C04MG%2FML+CASS+100ML+IP&amp;id=3D1e1ab17d926c3a5f25c=
1870e93340e4d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,04MG/ML CASS 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 307,39&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C04MG%2FML+CASS+100ML+APP&amp;id=3Da49d87ffe8c6080450=
eeffccde117501" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,04MG/ML CASS 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 309,01&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+250ML+AAA&amp;id=3D33604d98734ecad39e2825546fdbb8=
4e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 250ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 315,09&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYCODON+HC=
L+INFVLST+5MG%2FML+CASSETTE+100ML+AAA&amp;id=3D3a474d55bf8bf66dc83955a9b4c3=
5af9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYCODON HCL INFVLST 5MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYCODON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 317,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+250ML+APP&amp;id=3De3f11c4d4b29b53220ce40f4880eef=
2b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 250ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 321,38&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+50MCG%2FML+CASSETTE+250ML+IP&amp;id=3D39cff0c81314b79a86a79a0376451e9=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 50MCG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 321,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+20MG%2FML+CASSETTE+250ML+CZA&amp;id=3Db46322f7a91d79720d20b5aa7ae1=
93eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 20MG/ML CASSETTE 250ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 321,54&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C08MG%2FML+ZAK+100ML+APP&amp;id=3Dc3ed1863c09f7773bf6=
5093104e01e52" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,08MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 327,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+520%2C8IE%2FML+FLACON+48ML+ASG&amp;id=3D5d18883b933c4a553b7e58fefb3e2=
022" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 520,8IE/ML FLACON 48ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 337,21&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAH=
CO3+84MG%2FML+FLACON+100ML+GLAS+%2B+AFSKAP&amp;id=3D4cd9093fd5172b1b00ea055=
8ad3fe372" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NAHCO3 84MG/ML FLACON 100ML GLAS + AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 364,11&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTANIL+INF+1%2C25MG%2F1MCG%2FML+ZK+250ML+MZG&amp;id=3D6a41d57ef0d340a525=
ac601d3162550f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTANIL INF 1,25MG/1MCG/ML ZK 250ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 367,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIALT+INFV=
LST+100MCG%2FML+FLACON+1ML&amp;id=3D9449c755e504533107adea7dcfc73e93" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIALT INFVLST 100MCG/ML FLACON 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZICONOTIDE</span>
                <span class=3D"facet manufacturer">Esteve Pharmaceuticals G=
mbH</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 376,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYCODON+HC=
L+INFVLST+10MG%2FML+CASSETTE+100ML+AAA&amp;id=3D5c7bac2d2accc605d1dc0b7ba60=
cf932" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYCODON HCL INFVLST 10MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYCODON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 379,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGELOPLASMA+=
INFUSIEVLST+30MG%2FML+FREEFLEX+ZAK+500ML&amp;id=3D0a7a4aeb7485f3dddeece22a5=
c8cb9ca" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GELOPLASMA INFUSIEVLST 30MG/ML FREEFLEX ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GELATINE, GEMODIFICE=
ERD</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 380,19&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE%2FD=
EXAMETHAS+INF+20%2F0%2C04MG%2FML+ZAK+100ML+TA&amp;id=3D17418cefb69bae92c39e=
4956b3c00412" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE/DEXAMETHAS INF 20/0,04MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE/DEXAMETHASON=
</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 381,50&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIALT+INFV=
LST+100MCG%2FML+FLACON+1ML&amp;id=3D265b6f1eab40296697738767726dabe3" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIALT INFVLST 100MCG/ML FLACON 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZICONOTIDE</span>
                <span class=3D"facet manufacturer">Abacus Medicine BV</span=
>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 392,78&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+1MG%2FML+CASSETTE+100ML+AAA&amp;id=3D68372ebee5815a326c22a8ac9=
a38f413" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 1MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 399,83&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+1MG%2FML+CASSETTE+100ML+APP&amp;id=3D0218e0766fb2646ea239696a4=
e82d80d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 1MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 405,93&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+2MG%2FML+CASSETTE+100ML+APP&amp;id=3Df78c58eb7a952716f9fb1ea52=
0d8491e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 2MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 412,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYQVIA+INFV=
LST+IG+100MG%2FML+FL++50ML%2BHY+FL++2%2C5ML&amp;id=3D65f9c453baee69cefa6274=
37464749c5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYQVIA INFVLST IG 100MG/ML FL  50ML+HY FL  2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE, NOR=
MAAL/HYALURONIDASE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 422,48&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+1MG%2FML+CASSETTE+100ML+IP&amp;id=3Db7e79df4834e3ab6b825bbd5e9=
e3e8d2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 1MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 430,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPATECT+CP=
+INFUSIEVLOEISTOF+50IE%2FML+FLAC++10ML&amp;id=3D13e53d3089725da3daebba768aa=
9c776" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPATECT CP INFUSIEVLOEISTOF 50IE/ML FLAC  10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPATITIS-B-IMMUNOGL=
OBULINE</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 436,00&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF++50MG%2FML+FLACON+100ML&amp;id=3D82cbca76100a8a01af3dc0c4894f=
7d5d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF  50MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 449,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF++50G%2F1L+FLAC+100ML&amp;id=3D9716948e8818c2ac0e6794ca0c9d1=
a2e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF  50G/1L FLAC 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 449,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++50ML&amp;id=3Df0fae8a219f19a074ad05b7efecf=
ff26" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 449,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF+100G%2F1L+FLAC++50ML&amp;id=3D70e6092397eadab68b778e7f11679=
f83" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF 100G/1L FLAC  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 449,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++50ML&amp;id=3Dacc9c5dde8eb40d255c67bf5e7cd=
c101" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 449,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+2MG%2FML+CASSETTE+100ML+AAA&amp;id=3D67992e38cff60937b57fff89e=
83f7c75" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 2MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 451,81&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIQYMUNE+INF=
VLST+100MG%2FML+FLACON+50ML&amp;id=3Db2e2840c35cd1517f93913df5bdacd0b" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IQYMUNE INFVLST 100MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CAF-DCF bv-srl</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 461,62&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON++50ML&amp;id=3D952eede1eb3f76ad8e8dfc7ba1efb=
068" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+100ML&amp;id=3Da2ebf5295ae80d624906eb1cd50c63f=
b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Spanje</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+100ML&amp;id=3D34d6a791272c70439a8b82ae500f533=
b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON++50ML&amp;id=3D5d240942ab5531f911d51ef144ee9=
500" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON++50ML&amp;id=3Df92ca1d7d996c6dc1165b3503f35624f" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,14&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGAMUNEX+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++50ML&amp;id=3D59d2e1dbe0730efeb1ba7162e80c=
0619" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GAMUNEX INFUSIEVLOEISTOF 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 474,15&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+INFVLST+2MG%2FML+CASSETTE+100ML+FSBA&amp;id=3D193fc67d2c073dfd0886921d9402=
97be" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON INFVLST 2MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 476,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+2MG%2FML+CASSETTE+100ML+IP&amp;id=3D9fe1c28f8ae0666432a8621e88=
d1701e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 2MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 476,33&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAH=
CO3+42MG%2FML+FLACON+100ML+GLAS+%2B+AFSKAP&amp;id=3Db4c541787e0b4a7714f96c3=
d91ca6770" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NAHCO3 42MG/ML FLACON 100ML GLAS + AFSKAP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMWATERSTOFCARB=
ONAAT</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 480,65&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+50MG%2FML+FLACON+100ML&amp;id=3D9d6192a9395418187136bc0f40620=
981" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 50MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 485,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+50ML&amp;id=3Df3de7a73d8cc058d2c1c3e547c4be=
694" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 100MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 485,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON++50ML&amp;id=3D671314e39afca5f6e333bf6fb05f5ae0" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 485,05&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+2MG%2FML+CASSETTE+100ML+CZA&amp;id=3D3c5cf6a7d93450d227faec623=
cdf7259" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 2MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 485,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+INFVLST+2MG%2FML+CASSETTE+100ML+CEA&amp;id=3D96975addf8c9c4b583763cddae88c=
ccc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON INFVLST 2MG/ML CASSETTE 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 485,98&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCONAZOL+=
FRES+KABI+INFVLST+2MG%2FML+FLACON+200ML&amp;id=3D95a8860478517e1308a21f2337=
c412ff" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCONAZOL FRES KABI INFVLST 2MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCONAZOL</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 498,89&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCIPROFLOXAC=
INE+ALTAN+INFVLST+2MG%2FML+ZAK+100ML&amp;id=3D50c00808da1f477e6c756fd826838=
db8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CIPROFLOXACINE ALTAN INFVLST 2MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CIPROFLOXACINE</span=
>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 504,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYCODON+HC=
L+INFVLST+20MG%2FML+CASSETTE+100ML+AAA&amp;id=3Db14858b56698e6400a2876eec82=
4282a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYCODON HCL INFVLST 20MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYCODON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 520,73&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+10MG%2FML+FLACON+100ML+ASG&amp;id=3D68fb10bd272a828ed6dfdae255ee4a=
0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 10MG/ML FLACON 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 526,16&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON++60ML&amp;id=3Dfcc5cb358064d8c6ce3fab8c09a1=
9b91" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON  60ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 539,55&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINSUMAN+IMP=
LANTABLE+INFVLST+400IE%2FML+FLACON+10ML&amp;id=3Dd665bbe8faaab6bb8f93d09985=
9415ea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INSUMAN IMPLANTABLE INFVLST 400IE/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">INSULINE GEWOON</spa=
n>
                <span class=3D"facet manufacturer">MEDTRONIC TRADING NL B.V=
. HEERLEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 558,57&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDUODOPA+INF=
USIEVLOEISTOF+240%2F12MG%2FML+FLACON+10ML&amp;id=3D9a3e0e2f67dd0b49e7296fd4=
03b38670" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DUODOPA INFUSIEVLOEISTOF 240/12MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSLEVODOPA/FOSCARBI=
DOPA</span>
                <span class=3D"facet manufacturer">ABBVIE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 599,60&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+3MG%2FML+CASSETTE+100ML+APP&amp;id=3Da91b71438e541e91254a535dd=
4937161" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 3MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 618,03&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPULMOZYME+V=
ERNEVELOPLOSSING+1000E%2FML+AMPUL+2%2C5ML&amp;id=3D03d25af7d94fdb0490d5c40d=
e222311f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PULMOZYME VERNEVELOPLOSSING 1000E/ML AMPUL 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DORNASE</span>
                <span class=3D"facet manufacturer">ROCHE NEDERLAND BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 640,27&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPULMOZYME+I=
NHALATIEVLOEISTOF+1MG%2FML+AMPUL+2%2C5ML&amp;id=3D3feaad474a22c0d6cb4da78e3=
c3424fc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PULMOZYME INHALATIEVLOEISTOF 1MG/ML AMPUL 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DORNASE</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                <span class=3D"facet country">Belgie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 645,12&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+4MG%2FML+CASSETTE+100ML+APP&amp;id=3D9d6f2cb9f29fcfc0d6a7d0e82=
cfc0848" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 4MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 715,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+4MG%2FML+CASSETTE+100ML+AAA&amp;id=3D28b928b4e577c00e1bcc32676=
b93336a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 4MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 721,96&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+4MG%2FML+CASSETTE+100ML+IP&amp;id=3D63f43c8c698df4180dfcf0a2fa=
9a4311" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 4MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 728,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+5MG%2FML+CASSETTE+100ML+AAA&amp;id=3D55c04bd95c5f7b9861637d41a=
50e229b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 5MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 764,72&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D415a2ec30e4c696712a67da50=
7f7a739" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 786,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+INFVLST+5MG%2FML+CASSETTE+100ML+CEA&amp;id=3D7253d30b9ee2bcfbf4333258ead08=
097" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON INFVLST 5MG/ML CASSETTE 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 786,34&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+5MG%2FML+CASSETTE+100ML+APP&amp;id=3D3c0c18006222fd8fbcdf493b2=
1b079e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 5MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 818,22&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+5MG%2FML+CASSETTE+100ML+IP&amp;id=3D6f3a578479bd1e711d6aab0123=
11d940" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 5MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 821,58&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYQVIA+INFV=
LST+IG+100MG%2FML+FL+100ML%2BHY+FL++5ML&amp;id=3D4e5bae565f235619021ec77d88=
96c55c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYQVIA INFVLST IG 100MG/ML FL 100ML+HY FL  5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE, NOR=
MAAL/HYALURONIDASE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 844,97&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPOSUVI+I=
NFVLST+1MG%2FML+FLACON+10ML&amp;id=3Dd24fe58f33db7f7451de2a287a059686" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPOSUVI INFVLST 1MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">AOP Orphan Pharmaceutica=
ls Netherlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 870,69&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF++50MG%2FML+FLACON+200ML&amp;id=3D03e6f1279cae34eb2bf4d6c5faeb=
b0a6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF  50MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 899,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D3aa2878503a81736207496223edf=
9475" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 899,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF++50G%2F1L+FLAC+200ML&amp;id=3Ddace0cec4e6e25a00f61ed657b842=
a35" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF  50G/1L FLAC 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 899,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF+100G%2F1L+FLAC+100ML&amp;id=3D3ed2cae4069c0f26495b0b374075f=
c3a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF 100G/1L FLAC 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 899,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D8288a0042dffe903ab8c35d79095=
1810" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 899,25&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIQYMUNE+INF=
VLST+100MG%2FML+FLACON+100ML&amp;id=3Dde192b014a6c64df26dbe81436e19577" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IQYMUNE INFVLST 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CAF-DCF bv-srl</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 923,23&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D31ff6ac04b5ef2a8622efdeb42872=
136" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D38f2cda4bac845f5c240e1f17f4e4=
145" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D5139db3023fb6e4acdcb27713535f=
fc2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+200ML&amp;id=3D5b2f5f673e0ab8ab8efef8d6cf8c8ce=
f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Spanje</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D9b7f387a4cda422f7294a8fd4af1f=
9c7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D9e50bf486016abebb56320be2f857=
a42" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+200ML&amp;id=3D234ca5eaec9a41ce001d23a5e259ff2=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3Da86f69b00ab74809b525fbc7cf770=
cf4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON+100ML&amp;id=3D519aa78f70bfdd3d6457793597111ee1" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,29&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGAMUNEX+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D548ccabc6559d8c0998f360e896f=
4b16" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GAMUNEX INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 948,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+50MG%2FML+FLACON+200ML&amp;id=3D584d11049a101407c7d0c7f32a32e=
5bd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 50MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 970,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D27c49a93700fddd5c990979b70b8=
3f3d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 970,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON+100ML&amp;id=3D3030a42ea05f42a9de4304a9fafeed55" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 970,10&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON+100ML&amp;id=3D4b62d1cd20de8fb8c54191e8ea79cca0" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 993,30&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERBITUX+INF=
VLST+5MG%2FML+FLACON+100ML&amp;id=3De1cc66aaa63376a6db350d16da840c98" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERBITUX INFVLST 5MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CETUXIMAB</span>
                <span class=3D"facet manufacturer">MERCK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 993,31&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DENJAYMO+INF=
VLST+50MG%2FML+FLACON+22ML&amp;id=3D2fc2b846d71e6cebcdc7d6adfb2df7e1" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ENJAYMO INFVLST 50MG/ML FLACON 22ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SUTIMLIMAB</span>
                <span class=3D"facet manufacturer">RECORDATI</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 999,53&nbsp;per v=
erpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DRYBREVANT+I=
NFVLST+CONC+50MG%2FML+FLACON+7ML&amp;id=3D71795d8b3bc3c4eb3384ae3987596e77"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    RYBREVANT INFVLST CONC 50MG/ML FLACON 7ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMIVANTAMAB</span>
                <span class=3D"facet manufacturer">JANSSEN-CILAG BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.188,21&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+2MG%2FML+CASSETTE+250ML+AAA&amp;id=3Da0407ece1a97ad39fe853b306=
fdd3b99" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 2MG/ML CASSETTE 250ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.208,18&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVL+10MG%2FML+CASSETTE+100ML+FSBA&amp;id=3Dae54869ab47a44b969177569d=
b66be48" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVL 10MG/ML CASSETTE 100ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.471,12&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+10MG%2FML+CASSETTE+100ML+APP&amp;id=3Debb9d2ca15e8d63bb3fa7c00=
ca88c4c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.471,50&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DHYDROMORFON+HCL+INFVLST+10MG%2FML+CASSETTE+100ML+AAA&amp;id=3D994ca24a9d=
6e9e443440a207f0cfece4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 10MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.484,91&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3Dfe06b524e0e6620a7427144bb=
bcd04a5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.499,20&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+STERI-NEB+VERNEVELOPL+60MG%2FML+AMP+5ML&amp;id=3D3301a38bc96322e7e756a9f9d=
c2585a5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE STERI-NEB VERNEVELOPL 60MG/ML AMP 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.521,42&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+SUN+VERNEVELOPLOSSING+60MG%2FML+AMP+5ML&amp;id=3D81cc8830968e9ac342f9304a6=
e1639fc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE SUN VERNEVELOPLOSSING 60MG/ML AMP 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">SUN PHARMACEUTICAL INDUS=
TRIES EUROPE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.521,42&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+STERI-NEB+VERNEVELOPL+60MG%2FML+AMP+5ML&amp;id=3D84730c0271060cb5fc32ff591=
f4a30eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE STERI-NEB VERNEVELOPL 60MG/ML AMP 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.521,42&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+10MG%2FML+CASSETTE+100ML+CZA&amp;id=3D7fc118d66d57e002d172e33b=
0a2a7e3f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 10MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.534,28&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+INFVLST+10MG%2FML+CASSETTE+100ML+CEA&amp;id=3Db7a95ef1a80139635bdb9eb702ef=
1457" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON INFVLST 10MG/ML CASSETTE 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.534,28&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBI+INHVLS=
T+60MG%2FML+AMPUL+5ML&amp;id=3D144185eb0be7078dc63a2b3bdaa78cee" class=3D"r=
esult-item medicine">
            <h3 class=3D"result-title">
                    TOBI INHVLST 60MG/ML AMPUL 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">MYLAN B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.536,99&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYQVIA+INFV=
LST+IG+100MG%2FML+FL+200ML%2BHY+FL+10ML&amp;id=3Ded5276cec0add1647c92e4a630=
52177f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYQVIA INFVLST IG 100MG/ML FL 200ML+HY FL 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE, NOR=
MAAL/HYALURONIDASE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.689,94&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMODULIN+I=
NFVLST++1MG%2FML+FLACON+20ML&amp;id=3D29d311ecd20adae789f9aa1c2548657a" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMODULIN INFVLST  1MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Ferrer Benelux B.V.</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.719,69&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPROSTINI=
L+TILLOMED+INFVLST+1MG%2FML+FLACON+20ML&amp;id=3Dd094835e5556959f6ff00a6cba=
dcf6c0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPROSTINIL TILLOMED INFVLST 1MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.719,80&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D7c2d3c3f084549e1d26142f12005=
ff91" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAGAM INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">EUROCEPT PHARMACEUTICALS=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.798,50&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D2895700525e6ce227389809b6cea=
d216" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.798,50&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINTRATECT+I=
NFUSIEVLOEISTOF+100G%2F1L+FLAC+200ML&amp;id=3D9ed4458a3f8fba05429064fd720f2=
7aa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INTRATECT INFUSIEVLOEISTOF 100G/1L FLAC 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.798,50&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIQYMUNE+INF=
VLST+100MG%2FML+FLACON+200ML&amp;id=3Deb774623e31c9248e9112d2e123fbaf3" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IQYMUNE INFVLST 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CAF-DCF bv-srl</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.846,46&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D18df7f77b1f738a5596464410ebcc=
1e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">STEPHAR BV</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D27ef5f748452fd0b5b05289efefdd=
433" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D434687512659274ba59410c444752=
29e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+400ML&amp;id=3Da7b1f60afa595446eee7f9fa2b1471c=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 400ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Spanje</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3Dc124767d22eafc9f367d0b7f9b032=
035" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">BROCACEF EXTRAMURAAL</sp=
an>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D01388fe43ccc95e4bff12dcffa891=
d87" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,60&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEBOGAMMA+=
DIF+INFVLST+50MG%2FML+FLACON+400ML&amp;id=3Dfef0f70ad1253cc4d47d22ddfe8c1af=
f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEBOGAMMA DIF INFVLST 50MG/ML FLACON 400ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,60&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBRAMITOB+VE=
RNEVELOPLOSSING+75MG%2FML+AMPUL+4ML&amp;id=3Dd59307c43db5a4e5d51806d4346c4c=
b7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BRAMITOB VERNEVELOPLOSSING 75MG/ML AMPUL 4ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">CHIESI PHARMACEUTICALS B=
.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,63&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON+200ML&amp;id=3D5632c117516bfe8498b14aa7f68e22d6" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Duitsland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,59&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGAMUNEX+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D7c2b6be05565af612f6251ed1859=
226f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GAMUNEX INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Pharmanovia Benelux BV</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.896,60&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+50MG%2FML+FLACON+400ML&amp;id=3Ddea2047d780a6cd60ef342509e194=
06c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 50MG/ML FLACON 400ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.940,20&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3D4e01da410b8d5331a83b9ed9286a=
0e1c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.940,20&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON+200ML&amp;id=3D49d92692c27f70ad12fb0bb434285015" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.940,20&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPOSUVI+I=
NFVLST+2%2C5MG%2FML+FLACON+10ML&amp;id=3Db04dbd7990c006435558cc1bf17ada88" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPOSUVI INFVLST 2,5MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">AOP Orphan Pharmaceutica=
ls Netherlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.037,46&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DATRIANCE+IN=
FVLST+5MG%2FML+FLACON+50ML&amp;id=3D4a685da0cf477523fb7cf67cf3f8ad73" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATRIANCE INFVLST 5MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NELARABINE</span>
                <span class=3D"facet manufacturer">ORIGINALIS B.V.</span>
                <span class=3D"facet country">Ierland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.038,19&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVANTOBRA+VE=
RNOPL+100MG%2FML+AMP+1%2C7ML%2BTOLERO+VERNEV&amp;id=3Dec5bc1ca582b6c7bf3fe8=
eaa6a13c355" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VANTOBRA VERNOPL 100MG/ML AMP 1,7ML+TOLERO VERNEV</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">CRESCO PHARMA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.147,30&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYQVIA+INFV=
LST+IG+100MG%2FML+FL+300ML%2BHY+FL+15ML&amp;id=3D10cedfb1ecf4affb84b6ec3abc=
82505c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYQVIA INFVLST IG 100MG/ML FL 300ML+HY FL 15ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE, NOR=
MAAL/HYALURONIDASE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.534,90&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDROMORFON=
+HCL+INFVLST+20MG%2FML+CASSETTE+100ML+IP&amp;id=3Def8e3ed2222cd223d02bcbee1=
e10c591" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDROMORFON HCL INFVLST 20MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HYDROMORFON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.552,09&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+100ML&amp;id=3D897064047d97e0d495a3e72944bb=
f1eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.697,75&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3Df2c5df1c13231e048f80cbcae6e2=
4d63" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.697,75&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DQUINSAIR+VE=
RNOPL+100MG%2FML+AMP+2%2C4ML%2BZIRELA+VERNEV&amp;id=3D9804a638a8fcb65573740=
e103eec9ca1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    QUINSAIR VERNOPL 100MG/ML AMP 2,4ML+ZIRELA VERNEV</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOFLOXACINE</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Italie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.752,54&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DQUINSAIR+VE=
RNOPL+100MG%2FML+AMP+2%2C4ML%2BZIRELA+VERNEV&amp;id=3D86c46c5d35ea9c0fc8584=
a924c8f65cf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    QUINSAIR VERNOPL 100MG/ML AMP 2,4ML+ZIRELA VERNEV</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOFLOXACINE</span>
                <span class=3D"facet manufacturer">CHIESI PHARMACEUTICALS B=
.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.752,56&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3D060c51541ae4181ef4708e67e0ec4=
b34" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">ORIFARM B.V.</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.844,89&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3D34816341b889f7e27a91d822fb1c9=
85a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.844,89&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3De9fd8e022f7433f4f08f0d78ac92d=
712" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Oostenrijk</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.844,89&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKIOVIG+INFU=
SIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3D21007fb2bdbac1bf2343a12ed9fee=
f9d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KIOVIG INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.844,90&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTAVIS+VE=
RNEVELOPLOSSING+10MCG%2FML+AMPUL+1ML&amp;id=3Da5db4a71c8fc3005004dbce10f112=
20f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTAVIS VERNEVELOPLOSSING 10MCG/ML AMPUL 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ILOPROST</span>
                <span class=3D"facet manufacturer">BAYER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.873,35&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNANOGAM+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+300ML&amp;id=3D499435564493596c7bc3879100a6=
dce5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NANOGAM INFUSIEVLOEISTOF 100MG/ML FLACON 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">Prothya Biosolutions Net=
herlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.910,30&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DASPAVELI+10=
80+INFVLST+54MG%2FML+FLACON+20ML&amp;id=3Db6f3cca48806cab11618ddd7319fef58"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ASPAVELI 1080 INFVLST 54MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PEGCETACOPLAN</span>
                <span class=3D"facet manufacturer">Swedish Orphan Biovitrum=
 (The Netherlands) B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.280,90&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPATECT+CP=
+INFUSIEVLOEISTOF+50IE%2FML+FLAC+100ML&amp;id=3De426120f9a3430f50025686c055=
86d9c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPATECT CP INFUSIEVLOEISTOF 50IE/ML FLAC 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPATITIS-B-IMMUNOGL=
OBULINE</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.486,91&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPOSUVI+I=
NFVLST+5MG%2FML+FLACON+10ML&amp;id=3Dbfd665a63f9a957bf995656f59d9dd3f" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPOSUVI INFVLST 5MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">AOP Orphan Pharmaceutica=
ls Netherlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.629,18&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIVIGEN+IN=
FVLST+100MG%2FML+FLACON+400ML&amp;id=3Db0139798bdebac77ea7ef11b7f6e0dba" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIVIGEN INFVLST 100MG/ML FLACON 400ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.880,40&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMODULIN+I=
NFVLST++2%2C5MG%2FML+FLACON+20ML&amp;id=3D9e38ccc03f0dba425ad32590660c4e00"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMODULIN INFVLST  2,5MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Ferrer Benelux B.V.</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4.014,91&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPROSTINI=
L+TILLOMED+INFVLST+2%2C5MG%2FML+FLACON+20ML&amp;id=3D540baff94f49c6faeedf67=
58db91084c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPROSTINIL TILLOMED INFVLST 2,5MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4.015,01&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGRAFALON+IN=
FVLST+CONC+20MG%2FML+FLACON+5ML&amp;id=3Dcff63154085fec838498727e2c782751" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GRAFALON INFVLST CONC 20MG/ML FLACON 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">THYMOCYTENIMMUNOGLOB=
ULINE</span>
                <span class=3D"facet manufacturer">Movianto Nederland BV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4.832,33&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANZYGA+INF=
USIEVLOEISTOF+100MG%2FML+FLACON+200ML&amp;id=3Dd8d857a1c6b13af22595eb729936=
f5f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANZYGA INFUSIEVLOEISTOF 100MG/ML FLACON 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IMMUNOGLOBULINE NORM=
AAL</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5.395,50&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPOSUVI+I=
NFVLST+10MG%2FML+FLACON+10ML&amp;id=3D010811910d883c59d6de3d7c12a59204" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPOSUVI INFVLST 10MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">AOP Orphan Pharmaceutica=
ls Netherlands B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6.714,56&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMODULIN+I=
NFVLST++5MG%2FML+FLACON+20ML&amp;id=3Da65dbd2ab559514fd0ce9aeab9cbd78b" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMODULIN INFVLST  5MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Ferrer Benelux B.V.</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7.140,81&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPROSTINI=
L+TILLOMED+INFVLST+5MG%2FML+FLACON+20ML&amp;id=3Dd34f5c3cd371fe4f7fb3328542=
61f343" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPROSTINIL TILLOMED INFVLST 5MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7.140,92&nbsp;per=
 verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMODULIN+I=
NFVLST+10MG%2FML+FLACON+20ML&amp;id=3Da712a348114daa27603b91ed010509d0" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMODULIN INFVLST 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Ferrer Benelux B.V.</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13.215,36&nbsp;pe=
r verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTREPROSTINI=
L+TILLOMED+INFVLST+10MG%2FML+FLACON+20ML&amp;id=3D692e4142993c35e3fcc221658=
4b7671b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TREPROSTINIL TILLOMED INFVLST 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TREPROSTINIL</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13.215,47&nbsp;pe=
r verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLUTATHERA+I=
NFVLST+370MBQ%2FML+FLACON+20%2C5-25ML&amp;id=3D4eb500655b4b46c9460a2a71dc68=
5284" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LUTATHERA INFVLST 370MBQ/ML FLACON 20,5-25ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LUTETIUM LU-177 OXOD=
OTREOTIDE</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 21.329,97&nbsp;pe=
r verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DASPAVELI+10=
80+INFVLST+54MG%2FML+FLACON+20ML&amp;id=3De7bf0128bb5804fbfe2cd2c25d7cffc3"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ASPAVELI 1080 INFVLST 54MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PEGCETACOPLAN</span>
                <span class=3D"facet manufacturer">Swedish Orphan Biovitrum=
 (The Netherlands) B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26.247,20&nbsp;pe=
r verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBRINEURA+IN=
FVLST%282+FL+150MG%2F5ML%2B1+FL+SPOELOPL+5ML%29&amp;id=3D898c6feeb07ac31691=
d3ed2aa206e03a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BRINEURA INFVLST(2 FL 150MG/5ML+1 FL SPOELOPL 5ML)</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CERLIPONASE ALFA</sp=
an>
                <span class=3D"facet manufacturer">BIOMARIN EUROPE LTD</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27.047,15&nbsp;pe=
r verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D559453bc6c2fa91e72b22c59cd01=
c20d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL5%2C5ML%2B10XFL+8%2C3ML&amp;id=3D7725dc34d1499f9176=
5fdc8225b80437" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL5,5ML+10XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL5%2C5ML%2B11XFL+8%2C3ML&amp;id=3De16980f44c4c45c841=
3e6be246d6437d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL5,5ML+11XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D293946e5e6916c8ea000d84164ee=
ea5b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B2XFL+8%2C3ML&amp;id=3D43642bd14e57f95ddf=
484b2b3d079778" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+2XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D763f64f2bcdbdc3a378a300793b8=
d163" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B7XFL+8%2C3ML&amp;id=3D96cb27b23a47988755=
54ee28d0991028" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+7XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B1XFL+8%2C3ML&amp;id=3Db7ff20163e19778039=
e9f27fe3436868" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+1XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B8XFL+8%2C3ML&amp;id=3Dbe1576c33059768f66=
1b7a9d9e10b4df" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+8XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D0bb7759fde7a6196d43c727dc38e=
b212" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B9XFL+8%2C3ML&amp;id=3D12903fe068639c0553=
2725152d81b2e9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+9XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B2XFL+8%2C3ML&amp;id=3D18d2727e2bed0f442f=
e3375cbffba79d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+2XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D3107f79b68b6342de2c29985f56a=
6439" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B8XFL+8%2C3ML&amp;id=3D344d47cab245348ec6=
d764a40f97851c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+8XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B3XFL+8%2C3ML&amp;id=3D63e391beeddd5cde00=
facf2e276c38a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+3XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B4XFL+8%2C3ML&amp;id=3D76df250e5a5beb45e3=
624c45d379cb79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+4XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B6XFL+8%2C3ML&amp;id=3D7ac04f861de53c46d1=
00c430cb47bf5c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+6XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D7cef97fadbbd01b96a6e0f53c6c2=
a9cb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D888a7a6ec4426679f8b924da169e=
7e21" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B3XFL+8%2C3ML&amp;id=3D8b34b9097cd838ece5=
da9854b380c3d3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+3XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3Dc782ddc0b7b2c6d00d0bea498e0b=
6821" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B7XFL+8%2C3ML&amp;id=3Dedc280b888b232bacf=
15977f6dbffe47" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+7XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B4XFL+8%2C3ML&amp;id=3D12a57ed219a26de94e=
dfef47b9fdf622" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+4XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B6XFL+8%2C3ML&amp;id=3D4df23c80df58726935=
3b84dd0c0532ba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+6XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D62cc0c0534521327c8eae1e721b5=
1cab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL5%2C5ML%2B12XFL+8%2C3ML&amp;id=3D6b1a7841b89303477e=
d344eefb9744f7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL5,5ML+12XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL+5%2C5ML%2B5XFL+8%2C3ML&amp;id=3D6b92cf27592ab9dafa=
52aea6d0c4fbf1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL 5,5ML+5XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B9XFL+8%2C3ML&amp;id=3D757ab8f469884b512f=
3ef5d10f77cb39" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+9XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D796dfb3210bad35f7fcfaded196e=
b517" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL5%2C5ML%2B10XFL+8%2C3ML&amp;id=3D85760665a324546cab=
8b5726ee80e4ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL5,5ML+10XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D87b2cc4c91f0cd515d3eb2448652=
5f43" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL5%2C5ML%2B13XFL+8%2C3ML&amp;id=3Db189849df447e63408=
6dda4c2abc93c9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL5,5ML+13XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL+5%2C5ML%2B5XFL+8%2C3ML&amp;id=3Db6eca63b841702758a=
5789d97d358e5b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL 5,5ML+5XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3Dd61f7bbb5366bb6749d4866468c3=
d705" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+2XFL5%2C5ML%2B11XFL+8%2C3ML&amp;id=3D24eed830cada2414fc=
9706e170b7fc4c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 2XFL5,5ML+11XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFV+20XTERA+VG%2FML+1XFL5%2C5ML%2B12XFL+8%2C3ML&amp;id=3D7d214e214655b0fd65=
bb69ab6597c99f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFV 20XTERA VG/ML 1XFL5,5ML+12XFL 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZOLGENSMA+I=
NFVLST+20XTERA+VG%2FML+FLACON+8%2C3ML&amp;id=3D89a1c13d72a56debecac77a2c54b=
db65" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZOLGENSMA INFVLST 20XTERA VG/ML FLACON 8,3ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONASEMNOGEEN ABEPARV=
OVEC</span>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.120.050,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DUPSTAZA+INF=
VLST+5%2C6X10%5E11+VG%2FML+FLACON+0%2C5ML&amp;id=3Dd9045c12698b9d8a82b9d907=
bd4f56db" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    UPSTAZA INFVLST 5,6X10^11 VG/ML FLACON 0,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ELADOCAGEEN EXUPARVO=
VEC</span>
                <span class=3D"facet manufacturer">PTC THERAPEUTICS Interna=
tional LTD</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.815.000,00&nbsp=
;per verpakking</span>
                <span class=3D"reimbursed reimbursement byline-item">Vergoe=
d</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTOLIN+++=
2%2C5+INHVLST+1MG%2FML+NEBULE+2%2C5ML&amp;id=3De9bf43098427e49460d3c1201a75=
591a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTOLIN   2,5 INHVLST 1MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"partially-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,76&nbsp;per ver=
pakking</span>
                <span class=3D"partially-reimbursed reimbursement byline-it=
em">Deels vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVENTOLIN+++=
5%2C0+INHVLST+2MG%2FML+NEBULE+2%2C5ML&amp;id=3D303475f40c3f2ac4a5d909906c09=
a9dc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VENTOLIN   5,0 INHVLST 2MG/ML NEBULE 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL</span>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"partially-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,85&nbsp;per ve=
rpakking</span>
                <span class=3D"partially-reimbursed reimbursement byline-it=
em">Deels vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DATROVENT+UN=
IT+DOSE+VERNEVELOPL+125MCG%2FML+FL+2ML&amp;id=3D782fc5edb7989bbee245072e72c=
2c44f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATROVENT UNIT DOSE VERNEVELOPL 125MCG/ML FL 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"partially-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 40,55&nbsp;per ve=
rpakking</span>
                <span class=3D"partially-reimbursed reimbursement byline-it=
em">Deels vergoed</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DATROVENT+UNIT+DOSE+VERNEVELOPL+250MCG%2FML+FL+2ML&amp;id=3Dcdd6b0f02fa57=
e182758ed943f85b892" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATROVENT UNIT DOSE VERNEVELOPL 250MCG/ML FL 2ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IPRATROPIUM</span>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"partially-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 40,88&nbsp;per ve=
rpakking</span>
                <span class=3D"partially-reimbursed reimbursement byline-it=
em">Deels vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCOMBIVENT+U=
NIT+DOSE+VERNEVELOPLOSSING+FLACON+2%2C5ML&amp;id=3Df1f8e9a80fce7103317b9842=
55a56e08" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    COMBIVENT UNIT DOSE VERNEVELOPLOSSING FLACON 2,5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALBUTAMOL/IPRATROPI=
UM</span>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"partially-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 47,41&nbsp;per ve=
rpakking</span>
                <span class=3D"partially-reimbursed reimbursement byline-it=
em">Deels vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DJODIUM+AANS=
TIPVLOEISTOF+3%25+MSZ&amp;id=3D89250f173080ada7d56fdd8ac03280f8" class=3D"r=
esult-item medicine">
            <h3 class=3D"result-title">
                    JODIUM AANSTIPVLOEISTOF 3% MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JODIUM/KALIUMJODIDE<=
/span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C05MG%2FML+AMPUL+10ML+AHZ&amp;id=3D4f45130be2e070b75989e268ae=
dcd9c6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,05MG/ML AMPUL 10ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3D131I+MIBG+T=
HERAP+AMER+INF+0%2C185-0%2C74GBQ%2FML+FL+1ML&amp;id=3D5802024d69fc46d67bb66=
4e8f885ca65" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    131I MIBG THERAP AMER INF 0,185-0,74GBQ/ML FL 1ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JOBENGUAAN I-131</sp=
an>
                <span class=3D"facet manufacturer">GE HEALTHCARE BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INHVLST+4%2C5%25+FLACON+50ML+A%2B&amp;id=3Dd0d66981c83359c18530d080d3d=
e28de" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INHVLST 4,5% FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+417IE%2FML+FLACON+48ML+MSZ&amp;id=3D0051cfac0229bd7dba386bf927ece13d"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 417IE/ML FLACON 48ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+0%2C5MMOL%2FML+ZAK+1000ML+A%2B&amp;id=3D13f85d8017ad9b28af278ed=
ff36ae452" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 0,5MMOL/ML ZAK 1000ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+125MG%2FML+WWSP+48ML+MSZ&amp;id=3D36f34f1cddb32a6d380843633a9=
8f132" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 125MG/ML WWSP 48ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+PFSS+50ML+A%2B&amp;id=3D4f3b5fb3e3f5c600e685d1d2eb54=
31e6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML PFSS 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+WWSP+50ML+A%2B&amp;id=3D56031f843fe2381e3ac714a72d63=
5fd6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML WWSP 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLONIDINE+H=
CL+INFVLST+0%2C012MG%2FML+FLACON+50ML+MSZ&amp;id=3D56e46f4f0c4805b007a167fb=
8b6c244d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLONIDINE HCL INFVLST 0,012MG/ML FLACON 50ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLONIDINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+2MG%2FML+WWSP+50ML+MSZ&amp;id=3D598678ea8cca722f7a6d6c38cdb3fdd2" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 2MG/ML WWSP 50ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST++0%2C5MG%2FML+AMPUL+3ML+MSZ&amp;id=3D5bfb90582565461987181cd7=
1c07b670" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST  0,5MG/ML AMPUL 3ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+125MG%2FML+FLACON+48ML+MSZ&amp;id=3D5c6d2831274b45ecb449b1994=
16ae255" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 125MG/ML FLACON 48ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLONIDINE+H=
CL+INFVLST+0%2C012MG%2FML+WWSP+50ML+MSZ&amp;id=3D5d025a839b6121107a39e69396=
276b49" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLONIDINE HCL INFVLST 0,012MG/ML WWSP 50ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLONIDINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+2MMOL%2FML+WWSP+50ML+MSZ&amp;id=3D64f128ef90c354e901ef291a3f40e=
065" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 2MMOL/ML WWSP 50ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+ZAK+1000ML+A%2B&amp;id=3D6a569f6dd8b603828abd20b73c7=
039f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML ZAK 1000ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST++1MG%2FML+AMPUL+3ML+MSZ&amp;id=3D7123324204f82741c2e31e9b6541=
ded6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST  1MG/ML AMPUL 3ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INHVLST+3%25+AMPUL+4ML+MSZ&amp;id=3D71d9812f63b8cba5cba3465fe492b257" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INHVLST 3% AMPUL 4ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTHIOPENTAL+=
INFVL+100MG%2FML+POMP+20ML+%28200ML%2FUUR%29+IP&amp;id=3D7c7e0babe75421a64c=
608cc1e6d2c250" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    THIOPENTAL INFVL 100MG/ML POMP 20ML (200ML/UUR) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">THIOPENTAL</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST++8MG%2FML+AMPUL+3ML+MSZ&amp;id=3D82d201fa21b7bcdbc19226805b56=
4431" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST  8MG/ML AMPUL 3ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+32MG%2FML+AMPUL+3ML+MSZ&amp;id=3Db269ee49decc46fb1c484606a557=
cbc0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 32MG/ML AMPUL 3ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNEG+CONTROL=
E+V+HISTAMINE+INHALVLST+AMPUL+3ML+MSZ&amp;id=3Db84e837090b44240aba5d0196ed6=
41c1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NEG CONTROLE V HISTAMINE INHALVLST AMPUL 3ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+5MG%2FML+FLACON+100ML+MSZ&amp;id=3Dbd7915f129acd2ec3f09a174662096f5"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 5MG/ML FLACON 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+100ML+MSZ&amp;id=3Dd9bf24d95e4c2245a3a0d80a146da2e4" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 100ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+CASSETTE+100ML+SAH&amp;id=3De3df7866a329bc7a3947107f9045d6f=
7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML CASSETTE 100ML SAH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Service Apotheek Hoeven<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+ZAK+100ML+A%2B&amp;id=3Df88aa1ed93f866c4a9958238=
9d58f6e0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+2MG%2F0%2C5MCG%2FML+FL+50ML+MSZ&amp;id=3D86a0987eb359e3911f=
4136ebfdb9cafa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 2MG/0,5MCG/ML FL 50ML MSZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Maasstad Ziekenhuis Apot=
heek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHL%2=
FMAGN+SULF+INFVLS+2%2F2MG%2FML+ZAK+1000ML+AHZ&amp;id=3Da0015b8425abcc410119=
5469ad4edd41" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHL/MAGN SULF INFVLS 2/2MG/ML ZAK 1000ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/MAGNE=
SIUMSULFAAT</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSEDATIECASS=
ETTE+INFVL+4%2F2%2F2%2C4MG%2FML+CASS+100ML+SAH&amp;id=3D03e57d9077d7e314316=
3ef5620c13781" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SEDATIECASSETTE INFVL 4/2/2,4MG/ML CASS 100ML SAH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM/LEVOMEPROM=
AZINE/SCOPOLAMINEBUTYL</span>
                <span class=3D"facet manufacturer">Service Apotheek Hoeven<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNACL%2FKCL%=
2FMAGN+INF+9MG%2F0%2C02%2F0%2C0075MMOL%2FML+ZAK+1L+A%2B&amp;id=3Ddd56dc5755=
99e4099c20abbcde842e1f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NACL/KCL/MAGN INF 9MG/0,02/0,0075MMOL/ML ZAK 1L A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE/MAGN=
ESIUMSULFAAT/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,01&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+VERNEVELOPLOSSING+0%2C9%25+FNA+MR&amp;id=3D0cc5c885dd2d916bd2dc079c015=
8a782" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE VERNEVELOPLOSSING 0,9% FNA MR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 0,38&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOMENTHOL=
+STOOMDRUPPELS+5%25+FNA+MR&amp;id=3D15ecc2064fda1cbf68876c4d58627ca9" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOMENTHOL STOOMDRUPPELS 5% FNA MR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOMENTHOL</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1,32&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++250ML%2B2LL&amp;id=3Da131dde496f2e737f74e9cf105=
247a02" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  250ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2,75&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++500ML%2B2LL&amp;id=3Df03e85e9c4f97a35be6eaf96c6=
ab68e0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  500ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2,89&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK+1000ML+NXSTAGE&amp;id=3D8d31ab9928f854e6e60a886a71=
ef72c0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK 1000ML NXSTAGE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3,67&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+1000ML%2B2LL&amp;id=3D37051a56df09e436985588d06a=
0d9413" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 1000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3,68&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK++500ML+%2B+SL+%2B+2+LL+%2B+SPIKE&amp;id=3Dcf23b6b92b088bd827=
383bd5349eec30" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK  500ML + SL + 2 LL + SPIKE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4,15&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+NAC=
L+9MG%2FML+ZAK+1000ML+%2B+SL+%2B+2+LL+%2B+SPIKE&amp;id=3D553fdc4aaf5c812287=
7c8d53e22a7acf" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST NACL 9MG/ML ZAK 1000ML + SL + 2 LL + SPIKE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5,00&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+FLACON+50ML+MMC&amp;id=3Dcf379df1c1a8150987cdaea4cd1=
acce9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML FLACON 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5,09&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DUREUM+OPLOS=
SING+40%25+FNA+MR&amp;id=3Df6edd6daa631f3e6464a10946452b5a4" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    UREUM OPLOSSING 40% FNA MR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">UREUM</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5,14&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+0%2C9%25+WWSP+50ML+MMC&amp;id=3D30c650451653cd4e9eba38e60c001b=
bb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 0,9% WWSP 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5,53&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+FLACON+50ML+MMC&amp;id=3D73f5c5c32ebc6afb764b154=
a14e4d1fb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML FLACON 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 5,64&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+0%2C05MG%2FML+WWSP+2ML+A15&amp;id=3D0d65cb43d2fe5e35d9c874440cf78818"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 0,05MG/ML WWSP 2ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6,17&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+FLACON+50ML+CZE&amp;id=3D03aa4bf00e5e2d3eb94e07e0cd1=
72f6c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML FLACON 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 6,18&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+FLACON+50ML+MZG&amp;id=3Da3a44ad91ec7c111311b5077839=
39c8c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML FLACON 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,19&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+2000ML%2B2LL&amp;id=3D9786d0ccaaace854f2bb6eb35d=
34c6b3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 2000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,30&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+FLACON+50ML+A%2B&amp;id=3Db1ef8975e6efc461359a55=
e22eb6c1e2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 7,35&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCALCIUM%2FM=
AGNESI+INF+0%2C54%2F0%2C24MMOL%2FML+FL+50ML+A%2B&amp;id=3D32c2678a245b9897d=
06c30eaf27f88fd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CALCIUM/MAGNESI INF 0,54/0,24MMOL/ML FL 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CALCIUMCHLORIDE/MAGN=
ESIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 8,11&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+FLACON+50ML+CZE&amp;id=3D1abd75953f80697d990d9f2=
6e7a4334d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML FLACON 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 8,31&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+0%2C8MMOL%2FML+FLAC+50ML+MMC&amp;id=3D7feaff1cf71f610064e96d4=
5a933ba8c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 0,8MMOL/ML FLAC 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 8,59&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+400IE%2FML+FLACON+50ML+LUMC&amp;id=3D3eb6ab7c02d2617eb64d51e606aa9a1f=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 400IE/ML FLACON 50ML LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 8,74&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+10%25+FLACON+100ML+CZE&amp;id=3D48dac8dfd856861bd05804a0578127=
ae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 10% FLACON 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,25&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+100ML+CZE&amp;id=3Dd70d4ed0e1a5e167a577be0eb2bfc859" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,46&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAAT+INF=
VLST+0%2C15MMOL%2FML+ZAK+100ML+A%2B&amp;id=3Dfef1f3a0622844efb1356648d55235=
2a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAAT INFVLST 0,15MMOL/ML ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSFATEN</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,68&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+100ML+A%2B&amp;id=3De800f79f016e5ce89bf3107f4c7c6ae9"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 9,70&nbsp;per ver=
pakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C02MG%2FML+FLACON+50ML+A15&amp;id=3D858daf70c316b359e3860f85a=
b05310a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,02MG/ML FLACON 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,40&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+1MG%2FML+PFSS+5ML+A15&amp;id=3Ded570055ed0b165de4303997dfa1=
4874" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 1MG/ML PFSS 5ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,47&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+2MG%2F1MCG%2FML+FL+50ML+A15&amp;id=3D08ed38eb76726076fc0885=
8d9c8797e1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 2MG/1MCG/ML FL 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,77&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNEO+CALCIUM=
GL%2FGLUC+INFV+8%2C05%2F99MG%2FML+FLAC+50ML+A15&amp;id=3D291f5c3254a8ba4313=
47c046f8b41808" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NEO CALCIUMGL/GLUC INFV 8,05/99MG/ML FLAC 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CALCIUMGLUCONAAT/GLU=
COSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10,80&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+FLACON+50ML+A15&amp;id=3D914d0cad0aa1f64c202a4b6f2d8a5d7b=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% FLACON 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 11,16&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSINORA+INFV=
LST+0%2C1MG%2FML+FLACON+50ML&amp;id=3D3976926809848e87cddf5324f25d6ab9" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SINORA INFVLST 0,1MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 11,39&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+2MG%2F1MCG%2FML+FL+50ML+MZG&amp;id=3D2f5ac87649b1a57e6b536e=
57022a5702" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 2MG/1MCG/ML FL 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 11,45&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+WWSP+50ML+ZIK&amp;id=3D9f8202eed6176ddb568e23d620cb7=
ece" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFUROSEMIDE+=
INFVLST+5MG%2FML+WWSP+50ML+ZIK&amp;id=3Db6647852cb1ae61efbc8492506df6cdd" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FUROSEMIDE INFVLST 5MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FUROSEMIDE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+0%2C9%25+WWSP+50ML+ZIK&amp;id=3Dbf4e09dd043867b8b981586062b5be=
27" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 0,9% WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+1MG%2FML+WWSP+50ML+ZIK&amp;id=3D7ab12c60f2f5c99051f78ded0381599d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 1MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHL%2=
FGLUC+INFVL+0%2C2MMOL%2F5%25%2FML+ZAK+100ML+A15&amp;id=3D3061b5ebc1a0334467=
5d9483d4feedec" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHL/GLUC INFVL 0,2MMOL/5%/ML ZAK 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/GLUCO=
SE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,23&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+500ML+CZE&amp;id=3Dbc3071c3367bd11975be59aaf822c1d5" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 500ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,32&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FS=
UFENTAN+INF+1%2C25MG%2F0%2C5MCG%2FML+WW+50ML+ZIK&amp;id=3D3ba030b773655cebc=
5a5cee0953fde78" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/SUFENTAN INF 1,25MG/0,5MCG/ML WW 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,46&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUP%2FS=
UFENTAN+INF+1%2C25MG%2F1MCG%2FML+WWSP+50ML+ZIK&amp;id=3Dca4fed2894ebf510413=
b3a83e0cd8b7c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUP/SUFENTAN INF 1,25MG/1MCG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE/SUFE=
NTANIL</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,48&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAAT+INF=
VLST+0%2C1MMOL%2FML+FLACON+100ML+AHZ&amp;id=3D24b69627ca319bf135d8831bfeb3f=
060" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAAT INFVLST 0,1MMOL/ML FLACON 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSFATEN</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,55&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAAT+INF=
VLST+1MMOL%2FML+WWSP+50ML+ZIK&amp;id=3D08669193788ce413421dc5a27cfc2b17" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAAT INFVLST 1MMOL/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSFATEN</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,73&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPYRALVEX+OR=
OMUCOSALE+APPLICATIEVLOEISTOF&amp;id=3D9de835335333edab7c0420a58e61ca21" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PYRALVEX OROMUCOSALE APPLICATIEVLOEISTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALICYLZUUR/RHEUM</s=
pan>
                <span class=3D"facet manufacturer">Cooper Consumer Health N=
L BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 12,99&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C1MG%2FML+WWSP+50ML+ZIK&amp;id=3Dafc0dbb3feb1f9bce42b725a87a5=
4423" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,1MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,06&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSUFENTANIL%=
2FBUPIVAC+INFV+1MCG%2F1%2C25MG%2FML+WW+50ML+ZIK&amp;id=3D0a14e92baae205b6e6=
c3f966d5cc389f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SUFENTANIL/BUPIVAC INFV 1MCG/1,25MG/ML WW 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,06&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUIMUCIL+I=
NHVLST+100MG%2FML+AMPUL+4ML&amp;id=3D27310893ae630327cbfda96b82b18bde" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACETYLCYSTEINE</span=
>
                <span class=3D"facet manufacturer">ZAMBON NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,12&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUC%2FNACL=
%2FKCL+INFVLST+100%2F1%2C5%2F1MG%2FML+ZK+100ML+CZE&amp;id=3Dd6934c834299b2d=
b89b4f4791098bfc7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUC/NACL/KCL INFVLST 100/1,5/1MG/ML ZK 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,18&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C2MG%2FML+PFSS+50ML+A15&amp;id=3D5fa24f51f80a6610d9e71b5d4342=
451a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,2MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,23&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+1MG%2F1MCG%2FML+ZAK+100ML+A%2B&amp;id=3D733541fbe580a2ca3c5=
0f139ef41485a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 1MG/1MCG/ML ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,33&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+200MG%2FML+WWSP+50ML+ZIK&amp;id=3D0682d9b8864dcd457b3e84d2917=
da76d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 200MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,41&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C02MG%2FML+WWSP+50ML+A%2B&amp;id=3D6c2d6cd5d7af0ce4670789d58a=
012774" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,02MG/ML WWSP 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,43&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSINORA+INFV=
LST+0%2C2MG%2FML+FLACON+50ML&amp;id=3D1da8b0916827714b5411f4c73613d790" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SINORA INFVLST 0,2MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,49&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENT+INF+1MG%2F0%2C5MCG%2FML+ZAK+100ML+A%2B&amp;id=3Dc5fd8a9f84bf74819=
619f3017e1f0fbe" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENT INF 1MG/0,5MCG/ML ZAK 100ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,51&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DJODIUM+IN+W=
ATER+2%25+APPLICATIEVLOEISTOF+MZG&amp;id=3D8a5be4e1a443a158ba5fe2df4c22a76a=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    JODIUM IN WATER 2% APPLICATIEVLOEISTOF MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JODIUM/KALIUMJODIDE<=
/span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,57&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+100MG%2FML+PFSS+50ML+A15&amp;id=3Df163058fa720aca20ed948967a5=
12e3b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 100MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 13,69&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIMENE+INF=
VLST+10%25+WWSP+40ML+A15&amp;id=3D5f71879c37850ee8fc242e88013215b0" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PRIMENE INFVLST 10% WWSP 40ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,08&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOZUUR+I=
NFVLST+10%25+WWSP+40ML+A15&amp;id=3Da6809e3563f203f3697c8afa5c1e9c11" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOZUUR INFVLST 10% WWSP 40ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,08&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPYRALVEX+OR=
OMUCOSALE+APPLICATIEVLOEISTOF&amp;id=3D8a9a91abe29d8a8e8fb4dbb0836af515" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PYRALVEX OROMUCOSALE APPLICATIEVLOEISTOF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SALICYLZUUR/RHEUM</s=
pan>
                <span class=3D"facet manufacturer">MEDCOR PHARMACEUTICALS B=
V</span>
                <span class=3D"facet country">Belgie</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,16&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETOPROLOLT=
ARTRAAT+INFVLST+1MG%2FML+FLACON+50ML+A15&amp;id=3Dec30c01849c2548175acfb451=
cc399c8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METOPROLOLTARTRAAT INFVLST 1MG/ML FLACON 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METOPROLOL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,36&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+1MG%2FML+PFSS+50ML+A15&amp;id=3D3d30e44a1109967abaa0322cc300ceab" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 1MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,41&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTETRACAINE+=
HCL+INHVLST+10MG%2FML+FLACON+50ML+A%2B&amp;id=3D212ba449431a0dbfaf3eec30961=
2500a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TETRACAINE HCL INHVLST 10MG/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TETRACAINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,55&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTETRACAINE+=
HCL+INHVLST+5MG%2FML+FLACON+50ML+A%2B&amp;id=3D6f10a11c34e56e7712919dfea416=
f57e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TETRACAINE HCL INHVLST 5MG/ML FLACON 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TETRACAINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,55&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+2MG%2F0%2C5MCG%2FML+FL+50ML+A15&amp;id=3Dd63161b98c0b250d1e=
9a4cfed3b3d091" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 2MG/0,5MCG/ML FL 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 14,85&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DWATER+VOOR+=
INHALATIE+ZAK+1000ML+CZE&amp;id=3D0f4c6387f4c8484df474fbf928a87e6a" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    WATER VOOR INHALATIE ZAK 1000ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">WATER</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAZIJNZUUR+O=
PLOSSING+5%25+MZG&amp;id=3D7db00c987be169f39a3cb235d13716bb" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    AZIJNZUUR OPLOSSING 5% MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AZIJNZUUR</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,04&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+10%25+PFSS+50ML+A15&amp;id=3D18d5c36d00adfa93f3e3e8ef80b76309" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 10% PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,05&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+2%2C5%25+HYPERT+FL+100ML+AHZ&amp;id=3D777d112c3283f4f6b65f7c95=
8ccf3488" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 2,5% HYPERT FL 100ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,07&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITROGLYCER=
INE+HAMELN+INFVLST+1MG%2FML+FLACON+50ML&amp;id=3D664f68e2b8785da6adf96d8a0e=
e7f785" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITROGLYCERINE HAMELN INFVLST 1MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">Hameln Pharma GmbH</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,17&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DUREUM+OPLOSSING+40%25+FNA+MR&amp;id=3D99cfb9c45cb2c0017167b275841cd1a7" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    UREUM OPLOSSING 40% FNA MR</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">UREUM</span>
                <span class=3D"facet manufacturer">FNA-voorschriften p/o kn=
mp</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,38&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C2MG%2FML+WWSP+50ML+A15&amp;id=3D4f09bfec93bbc018ea6935b273f5=
4abc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,2MG/ML WWSP 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,55&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+0%2C9%25+PFSS+50ML+A15&amp;id=3Ddac53252afb980e5dab2b9600afa29=
10" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 0,9% PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,65&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+1MG%2FML+WWSP+50ML+ZIK&amp;id=3Dcc78c2c14cebb530576445e0a4d97408" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 1MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,67&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+2MG%2FML+WWSP+50ML+ZIK&amp;id=3Dd32923f51e60e7cbe577c225e25816a0" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 2MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,67&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+5%25+PFSS+50ML+A15&amp;id=3Dde5fa8adab860e566621131e077f27c7" class=3D=
"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 5% PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,75&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+PFSS+50ML+A15&amp;id=3Dc0272a7330f8818a300a2b9614e6d=
e67" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,75&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLONIDINE+H=
CL+INFVLST+0%2C01MG%2FML+PFSS+50ML+A15&amp;id=3Dea1a70b0c0d911b648f26505f6b=
c176e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLONIDINE HCL INFVLST 0,01MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLONIDINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,75&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+3WATER+INFVLST+1MG%2FML+PFSS+50ML+A15&amp;id=3Dfeb879eb2395a6b08f66ad9c01f=
d0fd8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL 3WATER INFVLST 1MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,75&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+50MG%2FML+FLES+100ML+A15&amp;id=3D5e420f58327c77494e8420abd6fa=
c503" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 50MG/ML FLES 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 15,76&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPARACETAMOL=
+B.BRAUN+INFVLST+10MG%2FML+FLACON+100ML&amp;id=3D2781f769f3411ecfe66bb0c703=
751be8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PARACETAMOL B.BRAUN INFVLST 10MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARACETAMOL</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPARACETAMOL=
+NORIDEM+INFVLST+10MG%2FML+FLES+100ML&amp;id=3D724d396b04324e2fb97235fe5c30=
1d5f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PARACETAMOL NORIDEM INFVLST 10MG/ML FLES 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARACETAMOL</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,08&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITROGLYCER=
INE+MACURE+INFVLST+1MG%2FML+FLACON+50ML&amp;id=3D36604a0e39d90124a9a4d20150=
348922" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITROGLYCERINE MACURE INFVLST 1MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,16&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+1MG%2F1MCG%2FML+FL+50ML+A15&amp;id=3Dbd5b96bec3256bb414a7ec=
d280bdae11" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 1MG/1MCG/ML FL 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,51&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCARBOPLATIN=
E+HIKMA+INFVLST10MG%2FML+FLACON+5ML&amp;id=3Dcb89e2eff81696052d947a8e8a0523=
8f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CARBOPLATINE HIKMA INFVLST10MG/ML FLACON 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CARBOPLATINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,62&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPARENTERALE=
+VOEDING+INFVL+NEON+BASIS+A+WW+55ML+RAD&amp;id=3D310e34fd61fc0d371312948ad9=
d3c7f5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PARENTERALE VOEDING INFVL NEON BASIS A WW 55ML RAD</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARENTERALE VOEDING<=
/span>
                <span class=3D"facet manufacturer">RADBOUD UMC APOTHEEK</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,72&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+250ML+A15&amp;id=3Da20402cef1c14c5e90ce6797e1098986" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,72&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+FLACON+35ML+MZG&amp;id=3D48cc4294c0b057773ae601be7758a57e" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML FLACON 35ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,73&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C2MG%2FML+WWSP+50ML+A%2B&amp;id=3D4d87bc65db3a9b55043370c74b5=
84387" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,2MG/ML WWSP 50ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,88&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPARACETAMOL=
+FRES+KABI+INFVLST+10MG%2FML+FLACON++50ML&amp;id=3D834182959a91dcd21f82778c=
cfdbf1c8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PARACETAMOL FRES KABI INFVLST 10MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARACETAMOL</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 16,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUC%2FNACL=
%2FKCL+INFVLST+100%2F1%2C5%2F1MG%2FML+ZAK+500ML+A%2B&amp;id=3Db3801bce6faaa=
8c23b6fe4a054539120" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUC/NACL/KCL INFVLST 100/1,5/1MG/ML ZAK 500ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 17,31&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAZIJNZUUR+O=
PLOSSING+3%25+CZE&amp;id=3D020f967ff3c0a8c224db0186f68888a6" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    AZIJNZUUR OPLOSSING 3% CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AZIJNZUUR</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 17,42&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAZIJNZUUR+O=
PLOSSING+5%25+ZGT&amp;id=3D1b8e24193bbbac667a41e688812a206a" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    AZIJNZUUR OPLOSSING 5% ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AZIJNZUUR</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,00&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAZIJNZUUR+O=
PLOSSING+5%25+CZE&amp;id=3D9124a10dd778a5a967f948369848eaf4" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    AZIJNZUUR OPLOSSING 5% CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AZIJNZUUR</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,01&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+0%2C08MMOL%2FML+ZAK+500ML+SF&amp;id=3Deb98484f4664672bccac5d35b=
be637e5" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 0,08MMOL/ML ZAK 500ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,02&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+WWSP+50ML+ZIK&amp;id=3De25b27e4bd34d9948606a0c76bbc9309" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,31&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNITROGLYCER=
INE+HAMELN+INFVLST+1MG%2FML+AMPUL+10ML&amp;id=3D57c73a240732bac710e47dd6b73=
4085b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NITROGLYCERINE HAMELN INFVLST 1MG/ML AMPUL 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NITROGLYCERINE</span=
>
                <span class=3D"facet manufacturer">Hameln Pharma GmbH</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,52&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLUGOL+FORTE=
+OPLOSSING+MMC&amp;id=3D6bac0587f995a20313d481d93710f25e" class=3D"result-i=
tem medicine">
            <h3 class=3D"result-title">
                    LUGOL FORTE OPLOSSING MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JODIUM/KALIUMJODIDE<=
/span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 18,56&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+100IE%2FML+FLACON+50ML+SF&amp;id=3D9890d2a1ab7e7c8ba6f2e07589abdb30" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 100IE/ML FLACON 50ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 19,04&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+FLACON+50ML+AHZ&amp;id=3D17e9d6b61dbb8469369328b4f61e16e2" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 19,34&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFEN+INF+3%2C75MG%2F0%2C5MCG%2FML+FL+50ML+A15&amp;id=3D2db9ad0a27913b67=
d14f9f4962099ee0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFEN INF 3,75MG/0,5MCG/ML FL 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 19,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAATGEBU=
FFERDE+NACL+INFVL+PH7%2C4+ZAK+500ML+CZE&amp;id=3Dab229115e6e91c099cbea2c1ef=
6642f9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAATGEBUFFERDE NACL INFVL PH7,4 ZAK 500ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 19,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+WWSP+50ML+ZIK&amp;id=3De6d373127c3aea4bfb592da1dd67575b" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML WWSP 50ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 19,97&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+20%25+ZAK+250ML+A15&amp;id=3Daf2bec0ad1b52e893043de68f7d9ce9b" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 20% ZAK 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,33&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+400MG%2FML+ZAK+500ML+A%2B&amp;id=3Dbba7503f319158525349e6db8739b90e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 400MG/ML ZAK 500ML A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,66&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUIMUCIL+I=
NHVLST+100MG%2FML+AMPUL+4ML&amp;id=3D86c4d8b146cd9b88eb5b278fa70ba858" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUIMUCIL INHVLST 100MG/ML AMPUL 4ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACETYLCYSTEINE</span=
>
                <span class=3D"facet manufacturer">UNIT DOSE PACK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 20,76&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPARACETAMOL=
+FRES+KABI+INFVLST+10MG%2FML+FLACON+100ML&amp;id=3D1590fde83958126b59c00901=
26a0c8f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PARACETAMOL FRES KABI INFVLST 10MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARACETAMOL</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 21,69&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
+ALTAN+INFVLST+2MG%2FML+ZAK+100ML&amp;id=3Da2ef36ffef189ff3ff93a1a2401b43cf=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE ALTAN INFVLST 2MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE</span>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 21,80&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+PFSS+50ML+A15&amp;id=3D001f1a2d663efaf8a24952a2903b8f73" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,25&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSUFENTANIL+=
INFVLST+5MCG%2FML+WWSP+50ML+A15&amp;id=3D7643a3aebf13ee2874527a64e715ed92" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SUFENTANIL INFVLST 5MCG/ML WWSP 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SUFENTANIL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,42&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+2MG%2FML+ZAK+100ML+MMC&amp;id=3D02f54e260d03ed2fae66c36becc6d7c3" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 2MG/ML ZAK 100ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,48&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+500IE%2FML+PFSS+50ML+A15&amp;id=3Dcd7cca297d60b4a63d8e6a2130be6ce4" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 500IE/ML PFSS 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,53&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLU%2FNACL%=
2FKCL%2FMG+INF+2%2C5%2F0%2C45%25%2F20MMOL%2F2G%2FL+Z+1L+A%2B&amp;id=3D4071d=
37cf25413b79a93104e4e4b852c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLU/NACL/KCL/MG INF 2,5/0,45%/20MMOL/2G/L Z 1L A+</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE/MAGNESIUMSU</span>
                <span class=3D"facet manufacturer">A+ APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,70&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOFLOXACI=
NE+HIKMA+INFVLST+5MG%2FML+ZAK+100ML&amp;id=3D75861c4c453856fa33cf5c9dd8bf1a=
35" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOFLOXACINE HIKMA INFVLST 5MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOFLOXACINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,84&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOFLOXACI=
NE+HIKMA+INFVLST+5MG%2FML+FLACON+100ML&amp;id=3Dd165d45372409b5cf83a1ef2e31=
a06b4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOFLOXACINE HIKMA INFVLST 5MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOFLOXACINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 22,84&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLUGOL+FORTE=
+OPLOSSING+ASG&amp;id=3D07c094f28901daa2461c3451e98d3624" class=3D"result-i=
tem medicine">
            <h3 class=3D"result-title">
                    LUGOL FORTE OPLOSSING ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JODIUM/KALIUMJODIDE<=
/span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 23,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+10%25+WWSP+50ML+PA&amp;id=3D690a7d28e4d20c4a0c47a3aa1b10ea0a" class=3D=
"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 10% WWSP 50ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,31&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+2MG%2FML+ZAK+100ML+CZE&amp;id=3D972d4a95a33716320c4a060549f43cf7" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 2MG/ML ZAK 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,43&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+15%25+ZAK+250ML+A15&amp;id=3Dcd3a7e447039f33a662bf0004bc8811a" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 15% ZAK 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,51&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIPERACILL%=
2FTAZOBAC+INF+200%2F25MG%2FML+WWSP+20ML+CZF&amp;id=3D7bd8884cc50532bc4d1c9e=
49f22a66f3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIPERACILL/TAZOBAC INF 200/25MG/ML WWSP 20ML CZF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIPERACILLINE/TAZOBA=
CTAM</span>
                <span class=3D"facet manufacturer">CEBAN ZIEKENHUISFARMACIE=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,66&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DUROGRAFIN+I=
NFUSIEVLOEISTOF+300MG%2FML+FLACON+250ML&amp;id=3Dbdc97f0597d5c22c203f5533e0=
a88980" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    UROGRAFIN INFUSIEVLOEISTOF 300MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMIDOTRIZOINEZUUR</s=
pan>
                <span class=3D"facet manufacturer">BAYER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,68&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE%2FN=
ACL+INFVLST+5%2F0%2C9%25+ZAK+500ML+A15&amp;id=3D966955ed5c0f4aa46694957f07b=
fef8f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE/NACL INFVLST 5/0,9% ZAK 500ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE%2FN=
ACL+INFVLST+5%2F0%2C45%25+ZAK+500ML+A15&amp;id=3Dac1278243c2ca0da35795c0253=
71676b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE/NACL INFVLST 5/0,45% ZAK 500ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 25,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+1MG%2FML+FLACON+50ML+AHZ&amp;id=3D284dae0e6226ade9b3e9c8314e2db8=
73" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 1MG/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,66&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHYDRATATIEV=
LOEISTOF+V+CISPLATINE+INF+ZK+1000ML+MZG&amp;id=3D7145ff496209d009670be56161=
f50e71" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HYDRATATIEVLOEISTOF V CISPLATINE INF ZK 1000ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE/MAGN=
ESIUMSULFAAT/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,68&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+FLACON+100ML+A15&amp;id=3Dc883009de120c34263f2a1d4b6020b18"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML FLACON 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 26,84&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUNORM+IN=
FVLST+50MG%2FML+FLACON+100ML&amp;id=3Df6c515cad0f5421bec1df07cb795f893" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUNORM INFVLST 50MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,47&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DARGININE+HC=
L+INFVLST+100MG%2FML+ZAK+100ML+A15&amp;id=3Dd77d839c3bb3b2ec19cf7e2dba4465d=
9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ARGININE HCL INFVLST 100MG/ML ZAK 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,70&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+100IE%2FML+WWSP+5ML+APP&amp;id=3D26753305d62abe683dee5ce3aa230b4c" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 100IE/ML WWSP 5ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAAT+INF=
VLST+0%2C1MMOL%2FML+ZAK+500ML+CZE&amp;id=3D2faa587a7b83b9b9c4662b657b1b7019=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAAT INFVLST 0,1MMOL/ML ZAK 500ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSFATEN</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+100IE%2FML+WWSP+10ML+APP&amp;id=3D7c443a1df4c3dce30da9e4163722db20" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 100IE/ML WWSP 10ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+100IE%2FML+WWSP+2%2C5ML+APP&amp;id=3Dc158de8cde3f78a4ec6de0db3862e24c=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 100IE/ML WWSP 2,5ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHEPARINE+IN=
FVLST+100IE%2FML+WWSP+3ML+APP&amp;id=3Dfb402163728e1380b7b1ca5719e54735" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HEPARINE INFVLST 100IE/ML WWSP 3ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 27,91&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+ZAK+100ML+CZE&amp;id=3Dd244db6112cdf26a87770206e46ba0bb" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML ZAK 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,01&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNACL%2FHEPA=
RINE+INFVLST+0%2C45%25%2F1IE%2FML+ZK+500ML+CZE&amp;id=3D71fcd9d7afbcacc8be5=
ed1a4a3793b6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NACL/HEPARINE INFVLST 0,45%/1IE/ML ZK 500ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HEPARINE/NATRIUMCHLO=
RIDE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,18&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUC%2FNACL=
%2FKCL+INFV+2%2C5%2F0%2C45%25%2F20MMOL%2FL+ZAK+1L+A15&amp;id=3D7be9b75a75ef=
a27c823acbc4ea7dcea2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUC/NACL/KCL INFV 2,5/0,45%/20MMOL/L ZAK 1L A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 28,44&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DARGININE+HC=
L+INFVLST+100MG%2FML+FLACON+100ML+CZE&amp;id=3Da3ca0a68f90f5ebb7067a2e7638b=
8faa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ARGININE HCL INFVLST 100MG/ML FLACON 100ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 29,50&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+2%2C5%25+HYPERT+ZAK+500ML+AHZ&amp;id=3D40e528d96459a9d70f8b998=
d1a1d088f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 2,5% HYPERT ZAK 500ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 30,69&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+0%2C9%25+WWSP+50ML+AHZ&amp;id=3D93f55b3de944b3df6519ddf6294ccd=
f3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 0,9% WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,77&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLU%2FNACL%=
2FKCL%2FMG+INF+2%2C5%2F0%2C45%25%2F20MMOL%2F2G%2FL+Z+1L+A15&amp;id=3D47ba07=
5e174fa1358c659ced4d40ca81" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLU/NACL/KCL/MG INF 2,5/0,45%/20MMOL/2G/L Z 1L A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE/MAGNESIUMSU</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 31,90&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPAMIDRONINE=
ZUUR+DI-NA+INFVL+0%2C18MG%2FML+ZK+500ML+CZE&amp;id=3D47f7d303d42ed33db832e5=
610b13f517" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PAMIDRONINEZUUR DI-NA INFVL 0,18MG/ML ZK 500ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PAMIDRONINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,42&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLACOSAMIDE+=
VIVANTA+INFVLS+10MG%2FML+FLACON+20ML&amp;id=3Daf5f52f0e7fa345fc181bf675daba=
c36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LACOSAMIDE VIVANTA INFVLS 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LACOSAMIDE</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 32,60&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INHVLST+6%2C5%25+FLACON+8ML+SAH&amp;id=3Ddde4b57ec850a7619e86656a30527=
c6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INHVLST 6,5% FLACON 8ML SAH</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Service Apotheek Hoeven<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 33,00&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTROMETAMOL+=
INFVLST+36%2C3MG%2FML+FLACON+100ML+A15&amp;id=3D63e3611de3cd82a1e8d9260cdd8=
3e3a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TROMETAMOL INFVLST 36,3MG/ML FLACON 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TROMETAMOL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 33,17&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DESKETAMINE+=
INFVLST+2%2C5MG%2FML+ZAK+100ML+ZIK&amp;id=3Dd58787e5060bd5961a1916cd2af3428=
c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ESKETAMINE INFVLST 2,5MG/ML ZAK 100ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ESKETAMINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 33,63&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSFAAT+INF=
VLST+0%2C1MMOL%2FML+ZAK+500ML+A15&amp;id=3Da6ad1535a710c7a4995a54b21ff3808e=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSFAAT INFVLST 0,1MMOL/ML ZAK 500ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSFATEN</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 34,30&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+5%25+WWSP+50ML+AHZ&amp;id=3D41675eeba96bddc6dd14f8c2e1146c71" class=3D=
"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 5% WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 35,70&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+2000ML%2B2LL&amp;id=3D726486c5cc51e8f57f4f8d8a2d=
7ae283" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 2000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 36,53&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGENTAMICINE=
+INFVLST+1MG%2FML+WWSP+20ML+A15&amp;id=3Db4cc1edc466d7b220ec3350629067fd6" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GENTAMICINE INFVLST 1MG/ML WWSP 20ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GENTAMICINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 36,75&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK+1000ML+NXSTAGE&amp;id=3Df28859a5a4c806407044359136=
c429da" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK 1000ML NXSTAGE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 36,81&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+1000ML%2B2LL&amp;id=3Df1e972d9fe6df89f4dfbec3637=
a5cf55" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 1000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 36,93&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDECTOVA+INF=
VLST+10MG%2FML+FLACON+20ML&amp;id=3D40233740934b7d5e78cb7610ea786362" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DECTOVA INFVLST 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ZANAMIVIR</span>
                <span class=3D"facet manufacturer">GLAXOSMITHKLINE B.V.</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 38,14&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADRENALINE+=
INHVLST+1MG%2FML+AMPUL+5ML+MMC&amp;id=3D04a60ddd864cf56f87eb4aae7ffae640" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADRENALINE INHVLST 1MG/ML AMPUL 5ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADRENALINE</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 41,38&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+30%25+ZAK+250ML+A15&amp;id=3Dd7841f1444df7a1b9436c23aa0b83823" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 30% ZAK 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,38&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INHVLST+3%25+AMPUL+5ML+ZGT&amp;id=3Daa11eb29715046faa917c3d8b22521c9" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INHVLST 3% AMPUL 5ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,53&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVAMIN++18+Z=
ONDER+ELECTROLYTEN+INFVLST+FLAC++500ML&amp;id=3D7ed8ba793a70be8ac6e1da671e9=
e3f06" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VAMIN  18 ZONDER ELECTROLYTEN INFVLST FLAC  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 42,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHL%2=
FMAGN+SULF+INFV+1%2C5%2F2%2C5MG%2FML+ZK+1000ML+SF&amp;id=3D41c888e1ce1d1345=
b652ce3c5fa459f9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHL/MAGN SULF INFV 1,5/2,5MG/ML ZK 1000ML SF</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/MAGNE=
SIUMSULFAAT</span>
                <span class=3D"facet manufacturer">SCHELDEZOOM FARMACIE</sp=
an>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 43,55&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
+ALTAN+INFVLST+2MG%2FML+ZAK+200ML&amp;id=3D5c0a79ae02afdb3aeae0e3a1b4c3f45b=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE ALTAN INFVLST 2MG/ML ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE</span>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 43,60&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIBUPROFEN+B=
.BRAUN+INFVLST+6MG%2FML+FLACON+100ML&amp;id=3Dd156cfa2634750923cbdb0506e85e=
58c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IBUPROFEN B.BRAUN INFVLST 6MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IBUPROFEN</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 44,47&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+9MG%2FML+PATROON+1%2C6ML+CZA&amp;id=3Df1fd2079edbfc9834557e9f8=
97315aad" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 9MG/ML PATROON 1,6ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 45,10&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIONOLYTE+IN=
FVLST+FREEFLEX+ZAK+1000ML&amp;id=3Dc539b359c4048fd523ce11e43c2f6ff2" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IONOLYTE INFVLST FREEFLEX ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IONOLYTE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 45,34&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DATROPINESUL=
FAAT+INFVLST+0%2C5MG%2FML+FLACON+50ML+A15&amp;id=3D89130e6d981816901e748466=
b37ead37" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ATROPINESULFAAT INFVLST 0,5MG/ML FLACON 50ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ATROPINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 45,98&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCOMBOVAL+IN=
FUSIEVLOEISTOF+10%2F3MG%2FML+FLACON+100ML&amp;id=3Ddde33dcb7e3d74db7aa0116e=
ba33f969" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    COMBOVAL INFUSIEVLOEISTOF 10/3MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PARACETAMOL/IBUPROFE=
N</span>
                <span class=3D"facet manufacturer">Aguettant BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 49,05&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK+1000ML%2BSL%2B2LL%2BSP&amp;id=3D2d9855938676819273=
dd7d12d34c7ee4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK 1000ML+SL+2LL+SP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 50,14&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCARBOPLATIN=
E+HIKMA+INFVLST+10MG%2FML+FLACON+15ML&amp;id=3D34767609e50cb9a3df42af04b594=
8c6f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CARBOPLATINE HIKMA INFVLST 10MG/ML FLACON 15ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CARBOPLATINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 51,23&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIBUPROFEN+B=
.BRAUN+INFVLST+4MG%2FML+FLACON+100ML&amp;id=3D36fb3f7f1c5b45d07e7e67ebdc9ce=
d60" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IBUPROFEN B.BRAUN INFVLST 4MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IBUPROFEN</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 51,61&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVAC%2FF=
ENTANYL+INFV+1%2C25MG%2F2%2C5MCG%2FML+FL+50ML+MMC&amp;id=3Da92d0833ec5a515a=
8e207ff34757a4ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVAC/FENTANYL INFV 1,25MG/2,5MCG/ML FL 50ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE/FENTANYL=
</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 54,87&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUNORM+IN=
FVLST+200MG%2FML+FLACON++50ML&amp;id=3Db16e6e25251a4782c01ec32f7df86ffa" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUNORM INFVLST 200MG/ML FLACON  50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 54,94&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCALCIUMGLUC=
ONAAT+INFVLST+20MG%2FML+ZAK+50ML+ACE&amp;id=3D77dea8cb0c3ac21ca4bf870d04b20=
73a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CALCIUMGLUCONAAT INFVLST 20MG/ML ZAK 50ML ACE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CALCIUMGLUCONAAT</sp=
an>
                <span class=3D"facet manufacturer">ACE Apotheek</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 55,18&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINSULINE+AS=
PART+INFVLST+1E%2FML+WWSP+50ML+MZG&amp;id=3D1c0b642c5668b041663f837d3931492=
b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INSULINE ASPART INFVLST 1E/ML WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">INSULINE ASPART</spa=
n>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 55,32&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DKALIUMCHLORIDE+INF+1MMOL%2FML+SMARTINJ+WWSP+50ML+MZG&amp;id=3Dc65488cd52=
0404f507e83f60f93f3dc9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INF 1MMOL/ML SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 55,32&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++500ML%2B2LL&amp;id=3D5f0eed4565831d9eecdc732da9=
1daccc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  500ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 57,94&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+5%25+SMARTINJ+WWSP+50ML+MZG&amp;id=3D11fa55ce13d60a109220a2b292c9c0e0"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 5% SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 58,31&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYTOCINE+I=
NFVLST+0%2C1IE%2FML+WWSP+50ML+AHZ&amp;id=3D2397924179902a405994e48deb414de8=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYTOCINE INFVLST 0,1IE/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYTOCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 59,45&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+1MG%2FML+SMARTINJ+WWSP+50ML+MZG&amp;id=3D4c52df2e6644a704850779421=
c4ca9fd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 1MG/ML SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 60,00&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C02MG%2FML+WWSP+50ML+AHZ&amp;id=3Db0469ea63b91768dbd20d79740f=
c9ee4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,02MG/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 61,13&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK++500ML%2BSL%2B2LL%2BSP&amp;id=3D11d780fedc9df6515e=
ac6dd07abe608b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK  500ML+SL+2LL+SP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 62,38&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPLASMA-LYTE=
+148+INFUSIEVLOEISTOF+ZAK+1000ML&amp;id=3D86cb17349ac83b5a3b85823e352541c0"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PLASMA-LYTE 148 INFUSIEVLOEISTOF ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA-LYTE 148</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 62,82&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INF+0%2C1MG%2FML+SMARTINJ+WWSP+50ML+MZG&amp;id=3D1351f2090f14afbcaadbe3e=
c7f8a0ee1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INF 0,1MG/ML SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 63,27&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINSULINE+AS=
PART+INFVLST+1IE%2FML+WWSP+50ML+AHZ&amp;id=3D0ea7f044968104e133c3d87fc8cbf5=
b2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INSULINE ASPART INFVLST 1IE/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">INSULINE ASPART</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 63,65&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+1MG%2FML+SMARTINJ+WWSP+50ML+MZG&amp;id=3D540e2877ac0538bfd3d57bec746=
c9117" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 1MG/ML SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 64,47&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C02MG%2FML+WWSP+10ML+AHZ&amp;id=3Dc43bba69527c0452ddb8bc1a43f=
ea16a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,02MG/ML WWSP 10ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 64,70&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DJODIUM+OPLO=
SSING+IN+WATER+A15&amp;id=3D86299557527efee3fb593c91327f755a" class=3D"resu=
lt-item medicine">
            <h3 class=3D"result-title">
                    JODIUM OPLOSSING IN WATER A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">JODIUM/KALIUMJODIDE<=
/span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 66,59&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSTEROFUNDIN=
+ISO+INFUSIEVLOEISTOF+ECOFLAC++500ML&amp;id=3Ddd6137025a6ef5ad9d83d306a7df1=
2dd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    STEROFUNDIN ISO INFUSIEVLOEISTOF ECOFLAC  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">STEROFUNDIN ISO</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 68,09&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+KCL=
%2FNACL+3%2F9MG%2FML+ECOFLAC++500ML&amp;id=3Dd90ec45b53188242b5ee35a7c649d6=
36" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST KCL/NACL 3/9MG/ML ECOFLAC  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/NATRI=
UMCHLORIDE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 68,09&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAINTELYTE+=
INFUSIEVLOEISTOF+ZAK+1L&amp;id=3D52704e2342d3648fd9a377fedd9d96d2" class=3D=
"result-item medicine">
            <h3 class=3D"result-title">
                    MAINTELYTE INFUSIEVLOEISTOF ZAK 1L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAINTELYTE INFVLST</=
span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 68,34&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUNORM+IN=
FVLST++50MG%2FML+FLACON+250ML&amp;id=3Dccbf57efaea26e513c7e74c368e46a1b" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUNORM INFVLST  50MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 68,67&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+12%2C5%25+ZAK+500ML+A15&amp;id=3D45d9265df0d604df57e60516583645df" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 12,5% ZAK 500ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 69,32&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOXYTOCINE+I=
NFVLST+0%2C2IE%2FML+WWSP+50ML+AHZ&amp;id=3D4413328d44d3c51e5eed4ae6f5679442=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OXYTOCINE INFVLST 0,2IE/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">OXYTOCINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 69,74&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKALIUMCHLOR=
IDE+INFVLST+1MMOL%2FML+FLACON+50ML+AHZ&amp;id=3D69e655d68d5edd21b63dd690725=
b53ed" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KALIUMCHLORIDE INFVLST 1MMOL/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE</span=
>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 70,09&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUREX+INF=
VLST++50MG%2FML+FLACON+250ML&amp;id=3D10cce9a8aabb2b95894d38c7b7687689" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUREX INFVLST  50MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 70,17&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C1MG%2FML+WWSP+50ML+AHZ&amp;id=3D9276770724f23ed36bb67c39e7aa=
809a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,1MG/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 72,17&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFENTANYL+IN=
FVLST+0%2C05MG%2FML+SMARTINJ+WWSP+50ML+MZG&amp;id=3Da5b5868c23e75246c9c7d94=
ffe6f4e1d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FENTANYL INFVLST 0,05MG/ML SMARTINJ WWSP 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FENTANYL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 74,12&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C02MG%2FML+VGS+WW+50ML+AHZ&amp;id=3Dbb7ebc3a0767f9198b98d7fbe=
4fdb09f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,02MG/ML VGS WW 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 74,24&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+BLANCO+INHVLST+AMPUL+3ML+A15&amp;id=3D644de4fc75e06ca9d269aa838f683ed=
c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT BLANCO INHVLST AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 74,99&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+KCL=
%2FNACL+3%2F9MG%2FML+ECOFLAC+1000ML&amp;id=3D0c5f36952f0dc0586cfc2771644847=
10" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST KCL/NACL 3/9MG/ML ECOFLAC 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/NATRI=
UMCHLORIDE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 76,37&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBACLOFEN+SI=
NTETICA+INFVLST+0%2C5MG%2FML+AMPUL+20ML&amp;id=3Da129c4ddd2fd0432351cd92009=
1d2a03" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BACLOFEN SINTETICA INFVLST 0,5MG/ML AMPUL 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BACLOFEN</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 77,44&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DIONOLYTE+IN=
FVLST+FREEFLEX+ZAK++500ML&amp;id=3D30f841a06c67d4d1f755ddda59f62d98" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    IONOLYTE INFVLST FREEFLEX ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IONOLYTE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 78,48&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DEPTIFIBATID=
E+AFTPHARM+INFVLST+0%2C75MG%2FML+FLAC+100ML&amp;id=3Dd699faa51f5095dd6ef2ca=
7ebb368605" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    EPTIFIBATIDE AFTPHARM INFVLST 0,75MG/ML FLAC 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">EPTIFIBATIDE</span>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 80,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DEPTIFIBATID=
E+ACCORD+INFVLST+0%2C75MG%2FML+FLACON+100ML&amp;id=3Dacfca0c618039b649a731d=
13b83d323b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    EPTIFIBATIDE ACCORD INFVLST 0,75MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">EPTIFIBATIDE</span>
                <span class=3D"facet manufacturer">ACCORD HEALTHCARE B.V.</=
span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 80,90&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+BLANCO+INHVLST+AMPUL+3ML+CZE&amp;id=3Df7f039ba273b574ba2bc9e24a695cbd=
7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT BLANCO INHVLST AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 80,97&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNACL%2FKCL%=
2FMAGN+INF+9MG%2F0%2C02%2F0%2C0081MMOL%2FML+Z2%2C5L+A15&amp;id=3Da95b697f7b=
97812e686d65d7e7da9fef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NACL/KCL/MAGN INF 9MG/0,02/0,0081MMOL/ML Z2,5L A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE/MAGN=
ESIUMSULFAAT/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 81,06&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUMINE+HU=
MAAN+BAXALTA+INFVLST+200MG%2FML+FL+100ML&amp;id=3Dcd3e3abc85fb46761e527789c=
86273f7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUMINE HUMAAN BAXALTA INFVLST 200MG/ML FL 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 81,89&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+ZAK++500ML&amp;id=3D605c880105ad7c6eb4f233a50241421b" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 82,00&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMMONIUMCHL=
ORIDE+INFVLST+100MG%2FML+FLACON+100ML+A15&amp;id=3D41f2e22e35c0de45fe576475=
7f2b5879" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMMONIUMCHLORIDE INFVLST 100MG/ML FLACON 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMMONIUMCHLORIDE</sp=
an>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 82,30&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++250ML%2B2LL&amp;id=3D57a4f1c0e4df0fe8453f10f359=
30a598" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  250ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 82,49&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C2MG%2FML+VGS+WW+50ML+AHZ&amp;id=3Da8b21ccdb7a6e17391062fa69e=
c09ba8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,2MG/ML VGS WW 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 83,59&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C2MG%2FML+WWSP+50ML+AHZ&amp;id=3Dbd560866ede269533569cc0e02b4=
4d9d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,2MG/ML WWSP 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 84,27&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DARGININE+HC=
L+INFVLST+100MG%2FML+FLACON+500ML+AHZ&amp;id=3Dbfb4d30fd18e820762ea50a61689=
8a9b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ARGININE HCL INFVLST 100MG/ML FLACON 500ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 84,42&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+400MG%2FML+ZAK+100ML+LUMC&amp;id=3D79143f10232e0c22bedbb62cf6530b0e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 400MG/ML ZAK 100ML LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 85,13&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+KCL=
%2FNACL+1%2C5%2F9MG%2FML+ECOFLAC+1000ML&amp;id=3Df06e3f8069d45e8097bac43195=
f2e2f6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST KCL/NACL 1,5/9MG/ML ECOFLAC 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/NATRI=
UMCHLORIDE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 87,46&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE%2FK=
CL+INFVLST+5%25%2F20MMOL%2FL+ZAK+2%2C5L+A15&amp;id=3D73ff72da60825530c57c87=
1f948e90a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE/KCL INFVLST 5%/20MMOL/L ZAK 2,5L A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/GLUCO=
SE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 92,76&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+1MG%2FML+AMPUL+3ML+A15&amp;id=3D2b56fa7c5a85cd0a2a399e1f83872=
ed9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 1MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 94,72&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+2MG%2FML+AMPUL+3ML+A15&amp;id=3D8b8a8a928c3dbae2d6379b70a6b53=
22e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 2MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 94,94&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+4MG%2FML+AMPUL+3ML+A15&amp;id=3Df6389c4afb588f2ed443673f1b822=
426" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 4MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 95,16&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+FLACON+50ML+ASG&amp;id=3D37cbdfef9cec0fa1d32cb2a=
e1e6aef2e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML FLACON 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 95,66&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+CASSETTE+100ML+TA&amp;id=3D0b1fd2a8747faf8278c1153054628fd8=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML CASSETTE 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 95,92&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+ZAK+100ML+TA&amp;id=3Dcc3e227294e59b6a5e2e77b98b1cecc5" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML ZAK 100ML TA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">TRANSVAAL APOTHEEK</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 95,92&nbsp;per ve=
rpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUPIVAC=
AINE+FRES+KABI+INFV+1%2C25MG%2FML+ZAK+100ML&amp;id=3Dc2cac8e1d2dc888e767960=
988f00d4c4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUPIVACAINE FRES KABI INFV 1,25MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 102,46&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+0%2C9%25+WWSP+50ML+CZE&amp;id=3D825bc69a0e36a7cbbf8ad34df7f74a=
16" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 0,9% WWSP 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 104,38&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUREX+INF=
VLST+200MG%2FML+FLACON+100ML&amp;id=3D65de9a9c76d1af2c4edfa6d5b332e547" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUREX INFVLST 200MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">CSL BEHRING BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 104,64&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C25MG%2FML+AMPUL+3ML+A15&amp;id=3De38ffe6dcbe601548fd2e4c0=
98b07b1b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,25MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 104,97&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C5MG%2FML+AMPUL+3ML+A15&amp;id=3D886bb745c439fc078a18d6ca4=
979ccea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,5MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 105,08&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCORVERT+INF=
USIEVLOEISTOF+87MCG%2FML+FLACON+10ML&amp;id=3Db404b4b7fac4e2daa6aac84ac35ec=
c5f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CORVERT INFUSIEVLOEISTOF 87MCG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">IBUTILIDE</span>
                <span class=3D"facet manufacturer">PFIZER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 105,63&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANTOPRAZOL=
+INFVLST+0%2C67MG%2FML++ZAK+60ML+PA&amp;id=3De05bd9cbe5233956e9f17319f5e720=
ae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANTOPRAZOL INFVLST 0,67MG/ML  ZAK 60ML PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PANTOPRAZOL</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 106,72&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+GLU=
COSUM+100MG%2FML+ZAK++250ML&amp;id=3D94d19e342bea85dbbef8c202366324f5" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST GLUCOSUM 100MG/ML ZAK  250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 107,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPLASMA-LYTE=
+148+INFUSIEVLOEISTOF+ZAK++500ML&amp;id=3D4ae5418486723d8c77a0715d9af6faf6"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PLASMA-LYTE 148 INFUSIEVLOEISTOF ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA-LYTE 148</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 107,32&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+2%2C5MG%2FML+FLACON+40ML+ASG&amp;id=3D5f4fff405e9f4f724130274d=
ac4a4f78" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 2,5MG/ML FLACON 40ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,22&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPLASMA-LYTE=
+148+INFUSIEVLOEISTOF+DAC+ZAK++500ML&amp;id=3D232ecb4eb58a6b8bffb305ba2092b=
015" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PLASMA-LYTE 148 INFUSIEVLOEISTOF DAC ZAK  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA-LYTE 148</spa=
n>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,34&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLINDAMYCIN=
E+ADDEDPHARMA+INFVLST+12MG%2FML+ZAK+50ML&amp;id=3D471eb572488e7317b75dc6a20=
9359776" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLINDAMYCINE ADDEDPHARMA INFVLST 12MG/ML ZAK 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLINDAMYCINE</span>
                <span class=3D"facet manufacturer">ADDED PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 108,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+2MG%2F1MCG%2FML+CAS+250ML+A15&amp;id=3D0ac2daedbde4f8fb6e19=
4638cc9da205" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 2MG/1MCG/ML CAS 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 109,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
+INFVLST+2MG%2FML+CASSETTE+250ML+A15&amp;id=3D3c85cded3f5411791983b06e97ff6=
6e6" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE INFVLST 2MG/ML CASSETTE 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 109,61&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUNORM+IN=
FVLST+200MG%2FML+FLACON+100ML&amp;id=3Dd3ca11eb4d59e0bf9d32a0ca7d0c0c05" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUNORM INFVLST 200MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 109,87&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDOPAMINE+HC=
L+INFVLST+4MG%2FML+FLACON+50ML+ASG&amp;id=3D0e1c3fa454ba1ea8887c500fee3fdb8=
1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DOPAMINE HCL INFVLST 4MG/ML FLACON 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DOPAMINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 112,14&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPLASMA-LYTE=
+148+%2B+GLUCOSE+5%25+INFVL+ZAK+500ML&amp;id=3Da89057abc3708c1ef35b74d98132=
f36c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PLASMA-LYTE 148 + GLUCOSE 5% INFVL ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA-LYTE 148 + GL=
UCOSE</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 113,17&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C13MG%2FML+AMPUL+3ML+A15&amp;id=3D2468b65cae337ffa30cefef3=
11880290" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,13MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 116,52&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C06MG%2FML+AMPUL+3ML+A15&amp;id=3D5deeb9f0c28ec59834cee527=
dd4e5845" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,06MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 116,63&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+16MG%2FML+AMPUL+3ML+A15&amp;id=3D08b62c8fb318b7d28bc5c8175921=
601e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 16MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 117,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMIFENTANI=
L+INFVLST+0%2C1MG%2FML+WWSP+20ML+ASG&amp;id=3Dc54288a15bd963e797abc888f2788=
594" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMIFENTANIL INFVLST 0,1MG/ML WWSP 20ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">REMIFENTANIL</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 118,11&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKCL%2FGLUCO=
SE+B.BRAUN+INFVL+1%2C5%2F50MG%2FML+ECOFL+500ML&amp;id=3D5c6aeed44e3116446e0=
0c5fcee59d53d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KCL/GLUCOSE B.BRAUN INFVL 1,5/50MG/ML ECOFL 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/GLUCO=
SE</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,36&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C25MG%2FML+AMPUL+3ML+CZE&amp;id=3D5f5db15616d004bd761dc254=
5eb31d10" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,25MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+1MG%2FML+AMPUL+3ML+CZE&amp;id=3D7f809ad3edd56d0cf7ddd9771c28f=
275" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 1MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+0%2C5MG%2FML+AMPUL+3ML+CZE&amp;id=3D946aba24dd3ed2d89ad56aeec=
d1e8795" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 0,5MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 120,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVETIRACET=
AM+STRAGEN+INFVLST+5MG%2FML+ZAK+100ML&amp;id=3D1fc815c9667e7f76b2bbef477746=
bf48" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVETIRACETAM STRAGEN INFVLST 5MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVETIRACETAM</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 122,62&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVETIRACET=
AM+EURECO-PH+INFVLST+5MG%2FML+ZAK+100ML&amp;id=3D92ef6e33e2f0c71a1b03ffcb57=
c94f72" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVETIRACETAM EURECO-PH INFVLST 5MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVETIRACETAM</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                <span class=3D"facet country">Spanje</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 122,62&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDOBUTAMINE+=
INFVLST+2MG%2FML+POMP+120ML+%285ML%2FUUR%29+AHZ&amp;id=3D69bdc65cdaab28399d=
de5f1a930c398b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DOBUTAMINE INFVLST 2MG/ML POMP 120ML (5ML/UUR) AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DOBUTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 124,73&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+4MG%2FML+AMPUL+3ML+CZE&amp;id=3D70d906dad63357dfd384fd1c46bce=
d99" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 4MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 125,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+2MG%2FML+AMPUL+3ML+CZE&amp;id=3De09d2623baf8a89f218de6d5a7361=
e8a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 2MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 125,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+8MG%2FML+AMPUL+3ML+A15&amp;id=3Dce3eda08dd5f09e282b0237b0e08c=
dba" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 8MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 128,29&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+400MG%2FML+FLACON+50ML+AHZ&amp;id=3D66a8b6a874d4c9643959b2f1a2598ebd" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 400MG/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 130,16&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+2MG%2FML+CASSETTE+100ML+A15&amp;id=3Db42fd6c1de50e0aacf244f2dfcf22=
34e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 2MG/ML CASSETTE 100ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 131,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDOBUTAMINE+=
HAMELN+INFVLST+5MG%2FML+FLACON+50ML&amp;id=3Daa2aa439dc71838568e6f8f84985ff=
58" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DOBUTAMINE HAMELN INFVLST 5MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DOBUTAMINE</span>
                <span class=3D"facet manufacturer">Hameln Pharma GmbH</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 136,25&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DARGININE%2F=
LYSINE+HCL+INFVL+25%2F25MG%2FML+ZK+1000ML+A15&amp;id=3D4c43dc135153f407e86a=
e363284ded7d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ARGININE/LYSINE HCL INFVL 25/25MG/ML ZK 1000ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE/LYSINE</spa=
n>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 137,17&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DALBUNORM+IN=
FVLST+50MG%2FML+FLACON+500ML&amp;id=3Dc6d24ab10f84891fd3f6f46b2ffbac90" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ALBUNORM INFVLST 50MG/ML FLACON 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 137,34&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLINDAMYCIN=
E+INFVLST+4%2C5MG%2FML+ZAK+100ML+CZA&amp;id=3Decb2345ad27c04a43783994aab741=
c0a" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLINDAMYCINE INFVLST 4,5MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLINDAMYCINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 138,82&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+FLACON+50ML+ZGT&amp;id=3D4f7625c7dd077da79a32d43=
d2995dea0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML FLACON 50ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 139,57&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSTEROFUNDIN=
+ISO+INFUSIEVLOEISTOF+ECOBAG+1000ML&amp;id=3Dd565f6f8bb7c0211866c02f600f5be=
67" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    STEROFUNDIN ISO INFUSIEVLOEISTOF ECOBAG 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">STEROFUNDIN ISO</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 142,18&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+0%2C1MG%2FML+FLACON+50ML+ASG&amp;id=3D30fce50a780998237c158dfa24=
ca8457" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 0,1MG/ML FLACON 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 144,70&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUPIVAC=
AINE+FRES+KABI+INFV+1%2C25MG%2FML+ZAK+200ML&amp;id=3D74742d92f6759ca87d360d=
100873f7f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUPIVACAINE FRES KABI INFV 1,25MG/ML ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 149,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+200MG%2FML+FLACON+30ML+ASG&amp;id=3D35f6707ce2700f8063041aee7=
06078a9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 200MG/ML FLACON 30ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 151,99&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+0%2C1MG%2FML+CASSETTE+100ML+IP&amp;id=3D8d9486070d4a806a64b9c3ed66=
8fb31c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 0,1MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,35&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+5MG%2FML+POMP+100ML+%2850ML%2FU%29+IP&amp;id=3D69e4c173103328275ea57=
ca2670f12e4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 5MG/ML POMP 100ML (50ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,85&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+8MG%2FML+AMPUL+3ML+CZE&amp;id=3D3c4437369e5e83b3b0923ca2abe39=
af4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 8MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 152,91&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTRANEXAMINE=
ZUUR+KABI+INFVLST+10MG%2FML+FLACON+50ML&amp;id=3D7e37dd16c1b440ced9f857f07d=
d81436" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TRANEXAMINEZUUR KABI INFVLST 10MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TRANEXAMINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPANTOPRAZOL=
+INFVL+0%2C8MG%2FML+POMP+100ML+%28200ML%2FU%29APP&amp;id=3D90a605bc11a8a74b=
0ff8da984cea293e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PANTOPRAZOL INFVL 0,8MG/ML POMP 100ML (200ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PANTOPRAZOL</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,74&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCARBOPLATIN=
E+HIKMA+INFVLST+10MG%2FML+FLACON+45ML&amp;id=3Dab5148d38f43af79a55ea8f60816=
064e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CARBOPLATINE HIKMA INFVLST 10MG/ML FLACON 45ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CARBOPLATINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 154,78&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTOBRAMYCINE=
+INFVLST+0%2C8MG%2FML+CASSETTE+100ML+IP&amp;id=3D893397ce241fba1c392ab32bb5=
91ea94" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TOBRAMYCINE INFVLST 0,8MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TOBRAMYCINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 156,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+400MG%2FML+ZAK+1000ML+LUMC&amp;id=3D05346d0eb88b931656cbddac684bf20c" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 400MG/ML ZAK 1000ML LUMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">APOTHEEK LUMC</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 157,18&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPEMETREXED+=
ZENTIVA+INFVLST+10MG%2FML+FLACON+10ML&amp;id=3Dc4dc83b69530b25f91e3d4ee8dd0=
5ba3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PEMETREXED ZENTIVA INFVLST 10MG/ML FLACON 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PEMETREXED</span>
                <span class=3D"facet manufacturer">Zentiva k.s.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+2%2C5MG%2FML+ZAK+250ML+ZIK&amp;id=3Dc1d63d93ea54e6e9494b6e58ee=
e58dd0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 2,5MG/ML ZAK 250ML ZIK</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">Ziekenhuisapotheek Isala=
 Klinieken</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 163,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DNATRIUMCHLORIDE+9MG%2FML+POMP+120ML+%285ML%2FU%29+IP&amp;id=3D6cbf49c597=
0c443364fd7610a0984a86" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE 9MG/ML POMP 120ML (5ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 165,90&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LFAAT+INFVLST+100MG%2FML+FLACON+50ML+ASG&amp;id=3De9f332763e0151c4b08144a19=
098d09d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULFAAT INFVLST 100MG/ML FLACON 50ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 167,26&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+16MG%2FML+AMPUL+3ML+CZE&amp;id=3Dfc5eb76f06e25d6c410cb9f1865d=
5623" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 16MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,21&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+32MG%2FML+AMPUL+3ML+A15&amp;id=3D6bd23b9f2028ad5a0b1da13d24bf=
267e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 32MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 168,40&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEXMEDETOMI=
DINE+ALTAN+INFVLST+4MCG%2FML+ZAK+100ML&amp;id=3D7132a44cf5e75711cb298261825=
89ac8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEXMEDETOMIDINE ALTAN INFVLST 4MCG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEXMEDETOMIDINE</spa=
n>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 177,67&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+0%2C03MG%2FML+CASSETTE+100ML+IP&amp;id=3D5789d354f40e6fb41acf0a1a6=
20aabbd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 0,03MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 180,04&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+1%2C5MG%2FML+POMP+100ML%28200ML%2FU%29+IP&amp;id=3D9960ff04eb8bb8fb=
42c58e6910dd90cc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 1,5MG/ML POMP 100ML(200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,08&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAZIJNZUUR+O=
PLOSSING+3%25+ASG&amp;id=3De3965dae811f624d57f656684f10969e" class=3D"resul=
t-item medicine">
            <h3 class=3D"result-title">
                    AZIJNZUUR OPLOSSING 3% ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AZIJNZUUR</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 185,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+10MG%2FML+POMP+100ML+%28100ML%2FU%29+IP&amp;id=3Dafc22f970ea033051af=
b0a9c320230bb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 10MG/ML POMP 100ML (100ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 190,41&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+20%25+FLACON+100ML+ASG&amp;id=3Dce9aef12c696199af25ca0dcc78076dd" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 20% FLACON 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,09&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+1%2C75MG%2FML+POMP+100ML%28200ML%2FU%29IP&amp;id=3D023551630be9c8c3=
9840decdc46cf9ae" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 1,75MG/ML POMP 100ML(200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVAMINOLACT+=
INFUSIEVLOEISTOF+FLACON+100ML&amp;id=3D9667d5d8c011c9bd7b36f55addd14252" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VAMINOLACT INFUSIEVLOEISTOF FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 195,98&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOL+INF+0%2C08MG%2FML+PMP+50ML%28200ML%2FU%29APP&amp;id=3D84dcd1aac45d1fe1=
a26f0cba276ec316" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOL INF 0,08MG/ML PMP 50ML(200ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE+INF=
VLST+15%25+FLACON+100ML+ASG&amp;id=3D73848285336199d266417cf79ec8e8f3" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE INFVLST 15% FLACON 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,31&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFOSCARNET+T=
ILLOMED+INFVLST+24MG%2FML+FLACON+250ML&amp;id=3Dff116de216c51a348f950253aa8=
3409c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FOSCARNET TILLOMED INFVLST 24MG/ML FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FOSCARNET</span>
                <span class=3D"facet manufacturer">Devrimed B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 196,34&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTIROFIBAN+A=
DDIMED+INFVLST+0%2C05MG%2FML+ZAK+250ML&amp;id=3Df2e58eac1e684c24024cd1ea245=
5ae2f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TIROFIBAN ADDIMED INFVLST 0,05MG/ML ZAK 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIROFIBAN</span>
                <span class=3D"facet manufacturer">Addimed Pharma B.V.</spa=
n>
                <span class=3D"facet country">Spanje</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,66&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAGGRASTAT+I=
NFVLST+0%2C05MG%2FML+ZAK+250ML&amp;id=3Daf9b8ac9619c31297de6814d35cb9319" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AGGRASTAT INFVLST 0,05MG/ML ZAK 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TIROFIBAN</span>
                <span class=3D"facet manufacturer">Advanz Pharma GmbH</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 197,82&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+3%2C3MG%2FML+ZAK+500ML+IP&amp;id=3D6cdf9bc341ff12431fc6982e9aa70e65"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 3,3MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 198,73&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLIDOCAINE+H=
CL+INFVLST+9%2C09MG%2FML+ZAK+110ML+APP&amp;id=3D67caba1969f9d65edb8ffc5ba10=
d931c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LIDOCAINE HCL INFVLST 9,09MG/ML ZAK 110ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LIDOCAINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 200,29&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMORFINE+HCL=
+INFVLST+1MG%2FML+WWSP+10ML+ASG&amp;id=3Df48e4dce6f0d159206c5fda4d02c97e2" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MORFINE HCL INFVLST 1MG/ML WWSP 10ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MORFINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 201,64&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+2%2C5MG%2FML+POMP+100ML+%28200ML%2FU%29IP&amp;id=3D3e4292803c94e259=
642965f42ae5fc42" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 2,5MG/ML POMP 100ML (200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 202,14&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+2MG%2FML+POMP+100ML%28200ML%2FU%29+IP&amp;id=3D281e189b98f6e27257=
289defff4f49a1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 2MG/ML POMP 100ML(200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,02&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVIMPAT+INFV=
LST+10MG%2FML+FLACON+20ML&amp;id=3Db2cd9a310b078cbbab28a52df59cd19b" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VIMPAT INFVLST 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LACOSAMIDE</span>
                <span class=3D"facet manufacturer">UCB PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLACOSAMIDE+=
HAMELN+INFVLST+10MG%2FML+FLACON+20ML&amp;id=3D56bf326bb70d573a6c5e8d4b7dfbd=
dd9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LACOSAMIDE HAMELN INFVLST 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LACOSAMIDE</span>
                <span class=3D"facet manufacturer">Hameln Pharma GmbH</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLACOSAMIDE+=
VIVANTA+INFVLS+10MG%2FML+FLACON+20ML&amp;id=3D733b3f5fd9e2c0fba6d1099c0b63d=
024" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LACOSAMIDE VIVANTA INFVLS 10MG/ML FLACON 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LACOSAMIDE</span>
                <span class=3D"facet manufacturer">Vivanta Generics s.r.o.<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUMETANIDE+=
INFVLST+0%2C1MG%2FML+CASSETTE+100ML+IP&amp;id=3D11d031a22a93c26ca8ea2978384=
7ab12" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUMETANIDE INFVLST 0,1MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUMETANIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,59&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEGALOTECT+=
INFUSIEVLOEISTOF+100E%2FML+FLAC+10ML&amp;id=3D2950ef16e4d87c077b1d499cad0b3=
6ca" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEGALOTECT INFUSIEVLOEISTOF 100E/ML FLAC 10ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CYTOMEGALIE-IMMUNOGL=
OBULINE</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 203,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETOCLOPRAM=
IDE+HCL+INFVLST+5MG%2FML+CASS+100ML+AAA&amp;id=3De4ceb3292e8ec60568e5c7f8c9=
a8c362" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METOCLOPRAMIDE HCL INFVLST 5MG/ML CASS 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METOCLOPRAMIDE</span=
>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 204,49&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFVLST+5MG%2FML+ZAK+100ML+AAA&amp;id=3Dd200b36dd90f136daf473ea8542d74c4" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFVLST 5MG/ML ZAK 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,28&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+4MG%2FML+POMP+250ML%28500ML%2FU%29+PA&amp;id=3Daa107251c182db87a6=
00955675fa1196" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 4MG/ML POMP 250ML(500ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 205,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCARBOPLATIN=
E+HIKMA+INFVLST+10MG%2FML+FLACON+60ML&amp;id=3D45a974280010b6fe778eed61e913=
12ad" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CARBOPLATINE HIKMA INFVLST 10MG/ML FLACON 60ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CARBOPLATINE</span>
                <span class=3D"facet manufacturer">HIKMA PHARMA BENELUX B.V=
.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 206,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DREMIFENTANI=
L+INFVLST+20MCG%2FML+CASSETTE+100ML+CEA&amp;id=3D2221b4df7decbcb7ee723bdf6e=
5d76ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    REMIFENTANIL INFVLST 20MCG/ML CASSETTE 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">REMIFENTANIL</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 208,15&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+3%2C2MG%2FML+ZAK+500ML+IP&amp;id=3De61731ec13a9d7a2f062a57edb003e56"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 3,2MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,08&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAPLASLG+=
INFVLST+BLOEDGROEP+O+ZAK+200ML&amp;id=3D5f042d4f9a5d8a1111f7799ee46756e0" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAPLASLG INFVLST BLOEDGROEP O ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA VERSBEVROREN<=
/span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,69&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAPLASLG+=
INFVLST+BLOEDGROEP+A+ZAK+200ML&amp;id=3D809c420239a4999e54996dccea39fe08" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAPLASLG INFVLST BLOEDGROEP A ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA VERSBEVROREN<=
/span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,69&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAPLASLG+=
INFVLST+BLOEDGROEP+AB+ZAK+200ML&amp;id=3D972069532b38f421addb33725f0ac89d" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAPLASLG INFVLST BLOEDGROEP AB ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA VERSBEVROREN<=
/span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,69&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DOCTAPLASLG+=
INFVLST+BLOEDGROEP+B+ZAK+200ML&amp;id=3Dd6f29273e8a1095e205aee64a815160c" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    OCTAPLASLG INFVLST BLOEDGROEP B ZAK 200ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PLASMA VERSBEVROREN<=
/span>
                <span class=3D"facet manufacturer">OCTAPHARMA BENELUX NV</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 211,69&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOMIX+1+=
NOVUM+INFVLST+ZAK+1500ML&amp;id=3D292367b2dde816808aff0fdd43bdbca1" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOMIX 1 NOVUM INFVLST ZAK 1500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOMIX 1 NOVUM</sp=
an>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 213,64&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMAGNESIUMSU=
LF+INF+29%2C17MG%2FML+POMP+120ML%2810ML%2FU%29CEA&amp;id=3D91be2b691129826d=
1d5d201dc0c92c62" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MAGNESIUMSULF INF 29,17MG/ML POMP 120ML(10ML/U)CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MAGNESIUMSULFAAT</sp=
an>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,09&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+MAN=
NITOLUM+150MG%2FML+ZAK+500ML&amp;id=3Daeb37dc44806003a4db87dfc0dcf6f70" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST MANNITOLUM 150MG/ML ZAK 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MANNITOL</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 215,41&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUC%2FNACL=
%2FKCL+INFVLST+100%2F1%2C5%2F1MG%2FML+FL+100ML+ASG&amp;id=3D420184177a537cc=
ad468c448db88af86" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUC/NACL/KCL INFVLST 100/1,5/1MG/ML FL 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE/KALIUMCHLORIDE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 216,30&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+4MG%2FML+POMP+100ML%28200ML%2FU%29+PA&amp;id=3D119525be11540af47c=
a8346718e4af7b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 4MG/ML POMP 100ML(200ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+4MG%2FML+POMP+100ML%28200ML%2FU%29+IP&amp;id=3D1305ee52bddbe333ac=
1e2c7ef6e8e4cc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 4MG/ML POMP 100ML(200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 220,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSUFENTANIL+=
INFVLST+5MCG%2FML+FLACON+50ML+AHZ&amp;id=3D84bc824990194ee8c34469ac549793a0=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    SUFENTANIL INFVLST 5MCG/ML FLACON 50ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">SUFENTANIL</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 221,00&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLIDOCAINE+H=
CL+INFVLST+20MG%2FML+CASSETTE+250ML+IP&amp;id=3D1d4274aa444cd9556a5cc3c2065=
591bd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LIDOCAINE HCL INFVLST 20MG/ML CASSETTE 250ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LIDOCAINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 222,00&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROCURONIUM+=
INFVLST+1%2C5MG%2FML+ZAK+100ML+ASG&amp;id=3D597891f43c0d41a37c12bac6671d6a5=
d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROCURONIUM INFVLST 1,5MG/ML ZAK 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROCURONIUM</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,06&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+2MG%2FML+CASSETTE+100ML+AAA&amp;id=3Dea32ace9c63025ab519fbd8316928=
16b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 2MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 223,70&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DSTEROFUNDIN=
+ISO+INFUSIEVLOEISTOF+ECOBAG++500ML&amp;id=3D1ecdc84b256be3245d98b51454a1e9=
88" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    STEROFUNDIN ISO INFUSIEVLOEISTOF ECOBAG  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">STEROFUNDIN ISO</spa=
n>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 224,66&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUP%2FS=
UFEN+INF+0%2C625MG%2F0%2C5MCG%2FML+CAS+250ML+FSBA&amp;id=3D494d69a5593d307a=
c517f6a4a32611a2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUP/SUFEN INF 0,625MG/0,5MCG/ML CAS 250ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE/SUFE=
NTANIL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 225,61&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+3%2C84MG%2FML+ZAK+500ML+IP&amp;id=3D8c301a3becab9374a6485d0d782ed6b8=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 3,84MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 228,10&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENTAN+INF+1MG%2F0%2C5MCG%2FML+FL+50ML+MZG&amp;id=3Db5d10ddb891501ee70=
033cc10c054e9b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENTAN INF 1MG/0,5MCG/ML FL 50ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 229,99&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+5MG%2FML+ZAK+600ML+CZA&amp;id=3D4f5afecac4d39bfdab921f5ab1b779dc" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 5MG/ML ZAK 600ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 235,47&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFEN+INF+1MG%2F0%2C5MCG%2FML+CAS+250ML+FSBA&amp;id=3D430301621d26793876=
048e12ad8729ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFEN INF 1MG/0,5MCG/ML CAS 250ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,26&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOMIX+1+=
NOVUM+INFVLST+ZAK+2000ML&amp;id=3Da92723e8f62f740f72465638873378a7" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOMIX 1 NOVUM INFVLST ZAK 2000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOMIX 1 NOVUM</sp=
an>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 236,36&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+1MG%2FML+CASSETTE+100ML+APP&amp;id=3D17dec7724a3c608e9f72defafaf34=
f26" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 1MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,02&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOLON+INFVLST+10MG%2FML+ZAK+100ML+APP&amp;id=3Da168ea49f94eee53553735518d2=
547cd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOLON INFVLST 10MG/ML ZAK 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 241,02&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOLON+INF+5MG%2FML+POMP+100ML%28100ML%2FU%29IP&amp;id=3Dc8b0d79e07aec27650=
0014208009d505" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOLON INF 5MG/ML POMP 100ML(100ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 243,10&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMIDAZOLAM+I=
NFV+5MG%2FML+RYTHMIC+FULL+SET+100ML+AAA&amp;id=3D13f3b9118d24ee2cec41ff2879=
388d5c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MIDAZOLAM INFV 5MG/ML RYTHMIC FULL SET 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MIDAZOLAM</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 245,40&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
+INFVLST+2MG%2FML+POMP+400ML%285ML%2FUUR%29+CZA&amp;id=3D3cab16358812319bc6=
5fac2eac377b09" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE INFVLST 2MG/ML POMP 400ML(5ML/UUR) CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 247,34&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOLON+INF+10MG%2FML+PMP100ML%28200ML%2FU%29APP&amp;id=3De45e74fba0564284fd=
56b80d5b48570c" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOLON INF 10MG/ML PMP100ML(200ML/U)APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 247,38&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUP%2FS=
UFENTAN+INF+2%2C5MG%2F1MCG%2FML+CASS+250ML+FSBA&amp;id=3Db223708221fb7baab2=
123098f5cb8a43" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUP/SUFENTAN INF 2,5MG/1MCG/ML CASS 250ML FSBA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE/SUFE=
NTANIL</span>
                <span class=3D"facet manufacturer">FAGRON STERIELE BEREIDIN=
GSAPOTHEEK BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 251,80&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDOBUTAMINE+=
INFVLST+7%2C5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D48e30a2f613944d247de33ea55=
92e741" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DOBUTAMINE INFVLST 7,5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DOBUTAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,37&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTHIOPE+INF+=
20MG%2FML+Z100ML%2BLIDO+INJ+10MG%2FML+WWS+ASG&amp;id=3Ddf1f4bbf24ab6d7908d1=
ec50530ce740" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    THIOPE INF 20MG/ML Z100ML+LIDO INJ 10MG/ML WWS ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">THIOPENTAL/LIDOCAINE=
</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,68&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOLON+INFVL+10MG%2FML+CASSETTE+100ML+APP&amp;id=3D1e8ed3533c8ad2d95fa3e84b=
53b70956" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOLON INFVL 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,71&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+2MG%2FML+CASSETTE+100ML+APP&amp;id=3Dfbbc8818d9f5caff2574387a6c690=
3c2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 2MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 253,71&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+ADDEDPHARMA+INFVLST+0%2C5MG%2FML+FL+50ML&amp;id=3D34e7a69376226756382272=
7a5eb83404" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE ADDEDPHARMA INFVLST 0,5MG/ML FL 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">ADDED PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 255,06&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DACICLOVIR+I=
NFVLST+5%2C4MG%2FML+ZAK+500ML+IP&amp;id=3Df0d076eab6b80479ccf0fecb8f89bd88"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ACICLOVIR INFVLST 5,4MG/ML ZAK 500ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ACICLOVIR</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 259,06&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCADDERA+INF=
VLST+100MMOL%2FL+ZAK+1500ML&amp;id=3Df899dda7a8473a514c5601b1dacf7682" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CADDERA INFVLST 100MMOL/L ZAK 1500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CALCIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS MEDICAL CARE N=
EDERLAND BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 261,16&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLUCYTOSINE=
+INFVLST+10MG%2FML+FLACON+250ML+A15&amp;id=3Dd062d97aa510820ae8638134621382=
00" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLUCYTOSINE INFVLST 10MG/ML FLACON 250ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">FLUCYTOSINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 261,25&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCOLISTINE+I=
NFVL+20000IE%2FML+POMP+100ML+%28200ML%2FU%29CZA&amp;id=3D8c67dcfa74aff055c3=
cf65aa2e6dc641" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    COLISTINE INFVL 20000IE/ML POMP 100ML (200ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">COLISTINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 261,64&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHYLPREDN=
ISOLON+INF+10MG%2FML+PMP+100ML%28100ML%2FU%29IP&amp;id=3D378596a1a31dd866af=
a4e01002bce25d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHYLPREDNISOLON INF 10MG/ML PMP 100ML(100ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHYLPREDNISOLON</s=
pan>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 262,62&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERTAPENEM+I=
NFVLST+5MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D454d52eb597d76d136e1=
2618e6aafb3e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERTAPENEM INFVLST 5MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ERTAPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 268,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERTAPENEM+I=
NFVLST+5MG%2FML+POMP+100ML+%28200ML%2FU%29+PA&amp;id=3D968bdf39a729381c3261=
bec214ded7ce" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERTAPENEM INFVLST 5MG/ML POMP 100ML (200ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ERTAPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 268,45&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOFLOXACI=
NE+FRES+KABI+INFVLST+5MG%2FML+FLAC+100ML&amp;id=3Dcf66a8779d67389812566bfa8=
6085693" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOFLOXACINE FRES KABI INFVLST 5MG/ML FLAC 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOFLOXACINE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 269,12&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+32MG%2FML+AMPUL+3ML+CZE&amp;id=3D4623a6e397749bc6de09413bb20b=
0ad7" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 32MG/ML AMPUL 3ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 269,71&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGELOFUSINE+=
INFUSIEVLOEISTOF+40MG%2FML+FLAC+0%2C5L&amp;id=3D2da9ac0b5b8636d04c9a293dd58=
41509" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GELOFUSINE INFUSIEVLOEISTOF 40MG/ML FLAC 0,5L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GELATINE, GEMODIFICE=
ERD</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 277,36&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+6MG%2FML+POMP+100ML+%28200ML%2FU%29IP&amp;id=3Dd8a6b40431f5bf7d90=
9328453a6b726b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 6MG/ML POMP 100ML (200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 278,78&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOMIX+1+=
NOVUM+INFVLST+ZAK+1000ML&amp;id=3D041dbef61fefe66cd5192040517c2cbe" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOMIX 1 NOVUM INFVLST ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOMIX 1 NOVUM</sp=
an>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 286,39&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOMIX+2+=
NOVUM+INFVLST+ZAK+1000ML&amp;id=3D168e74cb30faa68f2c2955db9bb65d8e" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOMIX 2 NOVUM INFVLST ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOMIX 2 NOVUM</sp=
an>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 286,39&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCOLISTINE+I=
NFVL+30000IE%2FML+POMP+100ML+%28200ML%2FU%29CZA&amp;id=3Dd2955d06f7f1665b82=
3efbd27c7ebc0f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    COLISTINE INFVL 30000IE/ML POMP 100ML (200ML/U)CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">COLISTINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 289,19&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBACLOFEN+SI=
NTETICA+INFVLST+2MG%2FML+AMPUL+20ML&amp;id=3D72827ffc9916ffd390692c44797c04=
cd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BACLOFEN SINTETICA INFVLST 2MG/ML AMPUL 20ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BACLOFEN</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 291,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+2%2C4MG%2FML+POMP+250ML+%28500ML%2FU%29PA&amp;id=3D413d5233afd04f23=
686a898d1180ac8d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 2,4MG/ML POMP 250ML (500ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 291,63&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+2%2C4MG%2FML+POMP+250ML+%28500ML%2FU%29IP&amp;id=3D56f43953a2c9a3c3=
d9d0561e017e78bc" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 2,4MG/ML POMP 250ML (500ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 291,63&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCALC=
IUMEDETAAT+INFVLS+200MG%2FML+AMP+10ML+ZGT&amp;id=3Df0e656de8e92d61b9c51b144=
8821e7f4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCALCIUMEDETAAT INFVLS 200MG/ML AMP 10ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCALCIUMEDETAA=
T</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 294,79&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DKCL%2FMAGN+=
INF+10MMOL%2F1%2C5G%2FL+IN+NACL+0%2C9%25+ZAK+1L+AHZ&amp;id=3D008f23d9af9945=
01d9b19d0d05866946" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    KCL/MAGN INF 10MMOL/1,5G/L IN NACL 0,9% ZAK 1L AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">KALIUMCHLORIDE/MAGNE=
SIUMSULFAAT</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 296,97&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+FLACON+30ML+ASG&amp;id=3D308654a839f8124566dc3081e600c0de" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML FLACON 30ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 297,23&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERTAPENEM+I=
NFVLST+10MG%2FML+POMP+100ML+%28200ML%2FU+%29APP&amp;id=3D2e09c9721beed1508b=
dafbc3c7a71097" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERTAPENEM INFVLST 10MG/ML POMP 100ML (200ML/U )APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ERTAPENEM</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 297,57&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLUCOSE%2FN=
ACL+INFVLST+8%2C3%2F0%2C15%25+ZAK+500ML+AHZ&amp;id=3D911032a42c95d4469b7e98=
240b79b4b4" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLUCOSE/NACL INFVLST 8,3/0,15% ZAK 500ML AHZ</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GLUCOSE/NATRIUMCHLOR=
IDE</span>
                <span class=3D"facet manufacturer">APOTHEEK HAAGSE ZIEKENHU=
IZEN</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 302,40&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBUPIVACAINE=
+HCL+INFVLST+1%2C25MG%2FML+ZAK+250ML+MZG&amp;id=3D695dab96405f18edbe1921439=
94732bb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BUPIVACAINE HCL INFVLST 1,25MG/ML ZAK 250ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BUPIVACAINE</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 305,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLEVOBUP%2FS=
UFENTA+INF+1%2C25MG%2F0%2C5MCG%2FML+ZAK+250ML+MZG&amp;id=3Df6cb91dc34d9d52b=
fbe9380d49b1c256" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LEVOBUP/SUFENTA INF 1,25MG/0,5MCG/ML ZAK 250ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LEVOBUPIVACAINE/SUFE=
NTANIL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 308,47&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERTAPENEM+I=
NFVLST+10MG%2FML+POMP+100ML+%28200ML%2FU%29+IP&amp;id=3D0263aae883fa7f96144=
727e4c39c0fbb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERTAPENEM INFVLST 10MG/ML POMP 100ML (200ML/U) IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ERTAPENEM</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 308,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DERTAPENEM+I=
NFVLST+10MG%2FML+POMP+100ML+%28200ML%2FU%29+PA&amp;id=3Da93bfb577f470d6db77=
8c6682401762d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ERTAPENEM INFVLST 10MG/ML POMP 100ML (200ML/U) PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ERTAPENEM</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 308,83&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTRANEXAMINE=
ZUUR+KABI+INFVLST+10MG%2FML+FLACON+100ML&amp;id=3Dc7631162f11bf7ecf2fa73e1d=
b9d0388" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TRANEXAMINEZUUR KABI INFVLST 10MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TRANEXAMINEZUUR</spa=
n>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 309,01&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+8MG%2FML+POMP+100ML+%28200ML%2FU%29IP&amp;id=3D2beff7a11c5ce8c8b5=
9064e2c4805e1f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 8MG/ML POMP 100ML (200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 316,49&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+10MG%2FML+POMP+100ML%28200ML%2FU%29IP&amp;id=3Dd5a25623cdb31874c3=
c17ea77d059cc3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 10MG/ML POMP 100ML(200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 322,61&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVLST+12MG%2FML+POMP+100ML%28200ML%2FU%29IP&amp;id=3D4f61f3c153c59d88b0=
81b91ca316b43e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVLST 12MG/ML POMP 100ML(200ML/U)IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 325,53&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTEICOPLANIN=
E+INFVL+3%2C2MG%2FML+POMP+250ML+%28500ML%2FU%29PA&amp;id=3Db749e8390339d408=
a565c86cd13b21d0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    TEICOPLANINE INFVL 3,2MG/ML POMP 250ML (500ML/U)PA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">TEICOPLANINE</span>
                <span class=3D"facet manufacturer">PHARMA ASSIST BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 325,99&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FADRENAL+INF+2MG%2F1MCG%2FML+ZAK+100ML+CEA&amp;id=3D3d209f44b22db9a38bb0e=
1a973f7ce79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/ADRENAL INF 2MG/1MCG/ML ZAK 100ML CEA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/ADRENALI=
NE</span>
                <span class=3D"facet manufacturer">Ceban Compounding Ad Hoc=
</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 327,39&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DAMINOPLASMA=
L+B.BRAUN+INFVLS+100MG%2FML+E-VR+FL+500ML&amp;id=3D0da67a127dece41d4a6253ab=
8eac0e34" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    AMINOPLASMAL B.BRAUN INFVLS 100MG/ML E-VR FL 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOPLASMAL E VRIJ<=
/span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 329,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+FLACON+100ML+ZGT&amp;id=3D7dfd6b47ea16d4e5c43d93ffe6e7dde=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% FLACON 100ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 341,67&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
   =20
                <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=
=3DINFVLST+MANNITOLUM+150MG%2FML+ZAK+100ML&amp;id=3Dbdc7262bd1bbcdaad8b5afb=
ca3212881" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST MANNITOLUM 150MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MANNITOL</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 363,60&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+5MG%2FML+CASSETTE+100ML+IP&amp;id=3D895c8dedebb0980dbc65dc5438b86e=
1e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 5MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 365,52&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMOXIFLOXACI=
NE+FRES+KABI+INFVLST+1%2C6MG%2FML+FL+250ML&amp;id=3D5190704a3bcc2511468d697=
97912a1f0" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MOXIFLOXACINE FRES KABI INFVLST 1,6MG/ML FL 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MOXIFLOXACINE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 374,63&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DARGININE+HC=
L+INFVLST+100MG%2FML+FLACON+100ML+ASG&amp;id=3D1fc690c1aa750873f64aa7c74be0=
43eb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ARGININE HCL INFVLST 100MG/ML FLACON 100ML ASG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE</span>
                <span class=3D"facet manufacturer">Apotheek Spaarne Gasthui=
s</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 396,93&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DESKETAMINE+=
INFVLST+5MG%2FML+ZAK+100ML+CZA&amp;id=3D584929bf58e49fb8e269407c2a4e4a1e" c=
lass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ESKETAMINE INFVLST 5MG/ML ZAK 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ESKETAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 398,66&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHLO=
RIDE+INFVLST+3%25+ZAK+100ML+MMC&amp;id=3De4274fc62ef01beb917f7d1ab688e20f" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHLORIDE INFVLST 3% ZAK 100ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 408,80&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DESKETAMINE+=
INFVLST+5MG%2FML+CASSETTE+100ML+CZA&amp;id=3D5b3482caeb622368c6468004cd0dc1=
ab" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ESKETAMINE INFVLST 5MG/ML CASSETTE 100ML CZA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ESKETAMINE</span>
                <span class=3D"facet manufacturer">Ceban Ziekenhuisfarmacie=
 Ad-hoc</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 413,12&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGELOFUSINE+=
INFUSIEVLOEISTOF+40MG%2FML+ZAK+0%2C5L&amp;id=3D8a008cc326fc4c660cd99821ef79=
50e9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GELOFUSINE INFUSIEVLOEISTOF 40MG/ML ZAK 0,5L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">GELATINE, GEMODIFICE=
ERD</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 421,01&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+32MG%2FML+AMPUL+5ML+MMC&amp;id=3D1c6499dbc44dff87910c16cf0a95=
2be9" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 32MG/ML AMPUL 5ML MMC</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">MEANDER MC ZIEKENHUIS</s=
pan>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 421,35&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVAMIN++18+Z=
ONDER+ELECTROLYTEN+INFVLST+FLAC++500ML&amp;id=3Dbc0998ae4ab367627bfc7176fe2=
f193f" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VAMIN  18 ZONDER ELECTROLYTEN INFVLST FLAC  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 428,92&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DESKETAMINE+=
INFVLST+5MG%2FML+CASSETTE+100ML+APP&amp;id=3D78245ae84d82f08eab9baa1f6aeb71=
4d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ESKETAMINE INFVLST 5MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ESKETAMINE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 435,18&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DINFVLST+MAN=
NITOLUM+150MG%2FML+ZAK+100ML&amp;id=3Dc410afe8bed55d3b67b99c1c141d46ff" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    INFVLST MANNITOLUM 150MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">MANNITOL</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 436,33&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DADENOSINE+I=
NFVLST+3MG%2FML+FLACON+50ML+ZGT&amp;id=3Dce567373a8ddfc85735a969aaa766692" =
class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ADENOSINE INFVLST 3MG/ML FLACON 50ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ADENOSINE</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 443,56&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+10MG%2FML+CASSETTE+100ML+APP&amp;id=3D9eb70efe4f672ee6a7f330ca52d0=
1eef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 10MG/ML CASSETTE 100ML APP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">APPO Meppel B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 443,99&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DHISTAMINEFO=
SFAAT+INHVLST+64MG%2FML+AMPUL+3ML+A15&amp;id=3Dae07b9fb6a40034b9a3f06cfbd45=
1fcb" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    HISTAMINEFOSFAAT INHVLST 64MG/ML AMPUL 3ML A15</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">HISTAMINE</span>
                <span class=3D"facet manufacturer">APOTHEEK A15</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 447,55&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPIRITRAMIDE=
+INFVLST+10MG%2FML+CASSETTE+100ML+AAA&amp;id=3D4e72027a15dacebdaf9bae77e001=
f24d" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PIRITRAMIDE INFVLST 10MG/ML CASSETTE 100ML AAA</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PIRITRAMIDE</span>
                <span class=3D"facet manufacturer">Ace Adhoc Apotheek</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 448,39&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DZYVOXID+INF=
USIEVLOEISTOF+2MG%2FML+ZAK+300ML&amp;id=3Df54cb1de92d3f8dda2b672250975b0d7"=
 class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ZYVOXID INFUSIEVLOEISTOF 2MG/ML ZAK 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LINEZOLID</span>
                <span class=3D"facet manufacturer">PFIZER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 450,87&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLINEZOLID+E=
URECO-PHARMA+INFVLST+2MG%2FML+ZAK+300ML&amp;id=3D5eea0973998c65fd4f4d364f85=
8b2916" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    LINEZOLID EURECO-PHARMA INFVLST 2MG/ML ZAK 300ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">LINEZOLID</span>
                <span class=3D"facet manufacturer">EURECO PHARMA</span>
                <span class=3D"facet country">Griekenland</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 450,87&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DTHEOFYLLINE=
+INFVLST+8%2C3MG%2FML+FLACON+50ML+ZGT&amp;id=3Df315c6b858326bf87176b07f8566=
38a3" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    THEOFYLLINE INFVLST 8,3MG/ML FLACON 50ML ZGT</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">THEOFYLLINE</span>
                <span class=3D"facet manufacturer">ZGT APOTHEEK</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 462,98&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBENELYTE+IN=
FVLST+KABIPAC+FLACON+250ML&amp;id=3D3eeedc06d1741a3751f1f8ee294b73be" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BENELYTE INFVLST KABIPAC FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BENELYTE</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 478,29&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DGLAMIN+INFU=
SIEVLOEISTOF+FLACON++500ML&amp;id=3D78f9873b02954dd19ee7f0bc096c4fa7" class=
=3D"result-item medicine">
            <h3 class=3D"result-title">
                    GLAMIN INFUSIEVLOEISTOF FLACON  500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 511,32&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPRIMENE+INF=
VLST+10%25+FLACON+250ML&amp;id=3D465272d0ac6508863b6f332e8b8ef177" class=3D=
"result-item medicine">
            <h3 class=3D"result-title">
                    PRIMENE INFVLST 10% FLACON 250ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 514,94&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNORADRENALI=
NE+INFVLST+1MG%2FML+FLACON+50ML+CZE&amp;id=3Dc0063279607ed0f8eb877c6e218f78=
20" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NORADRENALINE INFVLST 1MG/ML FLACON 50ML CZE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NORADRENALINE</span>
                <span class=3D"facet manufacturer">ZIEKENHUISAPOTHEEK CATHA=
RINA</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 516,66&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DROPIVACAINE=
%2FSUFENT+INF+1MG%2F0%2C5MCG%2FML+ZAK+250ML+MZG&amp;id=3D534e67379600a728d7=
db4d5d992619fd" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ROPIVACAINE/SUFENT INF 1MG/0,5MCG/ML ZAK 250ML MZG</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ROPIVACAINE/SUFENTAN=
IL</span>
                <span class=3D"facet manufacturer">MARTINI ZIEKENHUIS</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 521,57&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DVAMINOLACT+=
INFUSIEVLOEISTOF+FLACON+500ML&amp;id=3D1e01a76ca026619fd3c5ca307fa69dc2" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    VAMINOLACT INFUSIEVLOEISTOF FLACON 500ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">AMINOZUREN</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 545,44&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNUTRIFLEX+S=
PECIAL+70%2F240+INFVLST+TWIN+FLEX+ZK+1%2C5L&amp;id=3D37cb9197758bc9cec84e9b=
03af7a5891" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NUTRIFLEX SPECIAL 70/240 INFVLST TWIN FLEX ZK 1,5L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NUTRIFLEX 70/240 INF=
VLST</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 570,46&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPEMETREXED+=
ZENTIVA+INFVLST+10MG%2FML+FLACON+50ML&amp;id=3Da64d144a313c7a4d4d13192afa79=
ddfa" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PEMETREXED ZENTIVA INFVLST 10MG/ML FLACON 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PEMETREXED</span>
                <span class=3D"facet manufacturer">Zentiva k.s.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 599,50&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCUSTODIOL+K=
OHLER+INFUSIEVLOEISTOF+ZAK+1000ML&amp;id=3D526559fdd652f562da9f9c70e8d1ca45=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CUSTODIOL KOHLER INFUSIEVLOEISTOF ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CUSTODIOL</span>
                <span class=3D"facet manufacturer">Truvion Healthcare B.V.<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 621,30&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNUTRIFLEX+P=
LUS+48%2F150+INFVLST+TWIN+FLEX+V90+ZAK+2L&amp;id=3D88a876529d43db091ba3084a=
678a9ee8" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NUTRIFLEX PLUS 48/150 INFVLST TWIN FLEX V90 ZAK 2L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NUTRIFLEX 48/150 INF=
VLST</span>
                <span class=3D"facet manufacturer">B.BRAUN MEDICAL BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 624,08&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMETHADON+HC=
L+INFVLST+10MG%2FML+CASSETTE+100ML+IP&amp;id=3D446af6f67608cd306a87bd436153=
9dec" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    METHADON HCL INFVLST 10MG/ML CASSETTE 100ML IP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">METHADON</span>
                <span class=3D"facet manufacturer">Infinity Pharma Oldenzaa=
l</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 700,71&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DDEXMEDETOMI=
DINE+ALTAN+INFVLST+4MCG%2FML+ZAK+100ML&amp;id=3Ddeed52a07114483c00997624603=
95cc1" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    DEXMEDETOMIDINE ALTAN INFVLST 4MCG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">DEXMEDETOMIDINE</spa=
n>
                <span class=3D"facet manufacturer">BMODESTO B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 710,67&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DBACLOFEN+SI=
NTETICA+INFVLST+2MG%2FML+AMPUL+5ML&amp;id=3D2a1b7fc6df25b054d447972fdeef893=
e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    BACLOFEN SINTETICA INFVLST 2MG/ML AMPUL 5ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">BACLOFEN</span>
                <span class=3D"facet manufacturer">EU-PHARMA BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 733,42&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCUSTODIOL+K=
OHLER+INFUSIEVLOEISTOF+ZAK+2000ML&amp;id=3D483c1e1046665e92984c4354bac5c3d7=
" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CUSTODIOL KOHLER INFUSIEVLOEISTOF ZAK 2000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CUSTODIOL</span>
                <span class=3D"facet manufacturer">Truvion Healthcare B.V.<=
/span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 828,40&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DONDANSETRON=
+FRES+KABI+INFVLST+0%2C08MG%2FML+FL+50ML&amp;id=3Da905208b60f5c56e9141a74b4=
af7b368" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    ONDANSETRON FRES KABI INFVLST 0,08MG/ML FL 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ONDANSETRON</span>
                <span class=3D"facet manufacturer">FRESENIUS KABI NEDERLAND=
 BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 850,20&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DLYSAKARE+IN=
FVLST+ZAK+1000ML&amp;id=3D353f74b1666f3a68e61dfe9fd5dfb60c" class=3D"result=
-item medicine">
            <h3 class=3D"result-title">
                    LYSAKARE INFVLST ZAK 1000ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ARGININE/LYSINE</spa=
n>
                <span class=3D"facet manufacturer">NOVARTIS PHARMA BV</span=
>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 872,00&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLINIMIX+IN=
FUSIEVLOEISTOF+N14G30E+ZAK+2L&amp;id=3De611911327c6d790026e552ae102978d" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLINIMIX INFUSIEVLOEISTOF N14G30E ZAK 2L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLINIMIX INFVLST N14=
G30E</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 946,52&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLINIMIX+IN=
FUSIEVLOEISTOF+N14G30+ZAK+2L&amp;id=3Deb5fc48f8e543e0ed30197fa0a0ee022" cla=
ss=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLINIMIX INFUSIEVLOEISTOF N14G30 ZAK 2L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLINIMIX INFVLST N14=
G30</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 946,52&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DMEGALOTECT+=
INFUSIEVLOEISTOF+100E%2FML+FLAC+50ML&amp;id=3Da2ea67366d0dba51718f55eba1004=
340" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    MEGALOTECT INFUSIEVLOEISTOF 100E/ML FLAC 50ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CYTOMEGALIE-IMMUNOGL=
OBULINE</span>
                <span class=3D"facet manufacturer">Twinpharma B.V.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 975,55&nbsp;per v=
erpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DCLINIMIX+IN=
FUSIEVLOEISTOF+N17G35E+ZAK+2L&amp;id=3Dd794990ed45298ec6657bcd2092a96f6" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    CLINIMIX INFUSIEVLOEISTOF N17G35E ZAK 2L</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">CLINIMIX INFVLST N17=
G35E</span>
                <span class=3D"facet manufacturer">BAXTER BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.009,56&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DFLEXBUMIN+I=
NFVLST+200MG%2FML+ZAK+100ML&amp;id=3D4a61a58db8a8d276ae9ff703fd75b25e" clas=
s=3D"result-item medicine">
            <h3 class=3D"result-title">
                    FLEXBUMIN INFVLST 200MG/ML ZAK 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">ALBUMINE</span>
                <span class=3D"facet manufacturer">TAKEDA NEDERLAND BV</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.091,95&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPEMETREXED+=
ZENTIVA+INFVLST+10MG%2FML+FLACON+100ML&amp;id=3D7af584029e7ac20483350025c46=
d8c4b" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PEMETREXED ZENTIVA INFVLST 10MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">PEMETREXED</span>
                <span class=3D"facet manufacturer">Zentiva k.s.</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.144,50&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+1000ML%2B2LL&amp;id=3Ddf7db788c8ddd38063ecd76b85=
da3dea" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 1000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 1.846,53&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK+2000ML%2B2LL&amp;id=3D1956b8458b1df3e57323f424ae=
11f48e" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK 2000ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.191,99&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK+1000ML+NXSTAGE&amp;id=3D04f79509afdcddc7a038e54931=
abda79" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK 1000ML NXSTAGE</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.209,02&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++500ML%2B2LL&amp;id=3D1c84a260f0e4369ba2c1202f7c=
35efb2" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  500ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 2.897,62&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK+1000ML%2BSL%2B2LL%2BSP&amp;id=3D871c1b57fb5ff411ef=
3147792da35539" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK 1000ML+SL+2LL+SP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.008,54&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INF+9MG%2FML+ZAK++500ML%2BSL%2B2LL%2BSP&amp;id=3Dc37b05b3f8f9242516=
760be5932c9590" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INF 9MG/ML ZAK  500ML+SL+2LL+SP</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 3.743,10&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DNATRIUMCHL+=
DIRINCO+INFVL+9MG%2FML+ZAK++250ML%2B2LL&amp;id=3D706e798690b0295c93fe4288e5=
6ba9ef" class=3D"result-item medicine">
            <h3 class=3D"result-title">
                    NATRIUMCHL DIRINCO INFVL 9MG/ML ZAK  250ML+2LL</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMCHLORIDE</spa=
n>
                <span class=3D"facet manufacturer">DIRINCO BV</span>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 4.124,86&nbsp;per=
 verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
    <a href=3D"https://www.medicijnkosten.nl/medicijn?artikel=3DPEDMARQSI+I=
NFVLST+80MG%2FML+FLACON+100ML&amp;id=3D87729112a9bd3fdf664467b0ece04fdd" cl=
ass=3D"result-item medicine">
            <h3 class=3D"result-title">
                    PEDMARQSI INFVLST 80MG/ML FLACON 100ML</h3>
            <p class=3D"result-description">
                <span class=3D"facet active-substance">NATRIUMTHIOSULFAAT</=
span>
                <span class=3D"facet manufacturer">NORGINE PHARMA B.V.</spa=
n>
                </p>
            <p class=3D"meta">
                                            <span class=3D"document-type by=
line-item">Geneesmiddel</span>
                <span class=3D"not-reimbursed price byline-item">
                                               =20
                                                =E2=82=AC 10.625,32&nbsp;pe=
r verpakking</span>
                <span class=3D"not-reimbursed reimbursement byline-item">Ni=
et vergoed</span>
                </p>
        </a>
   =20


















</div>
        </div>
    </div>
</div></div>

      </div>

  <div role=3D"header" id=3D"site-header">
    <a class=3D"homepage" href=3D"https://www.medicijnkosten.nl/" title=3D"=
Terug naar homepage">
    <span class=3D"ro-serif dept">Zorginstituut Nederland</span>
</a>
<p class=3D"date-modified">
    Bijgewerkt tot
    <time>1 februari 2026</time>
</p>
<div id=3D"global-functions">
        <a class=3D"pat-inject" id=3D"login" href=3D"https://www.medicijnko=
sten.nl/inloggen">Inloggen</a>
            </div>
</div>
<div class=3D"do-not-print" id=3D"footer">
    <div class=3D"container">
        <blockquote class=3D"seven columns payoff">
    Informatie over prijzen<br> en vergoeding van medicijnen</blockquote>
<div class=3D"column">
    <h2>
        Service</h2>

    <ul class=3D"links">
            <li>
                                <a class=3D"pat-inject" data-pat-inject=3D"=
history: record; scroll: top" href=3D"https://www.medicijnkosten.nl/contact=
">Contact</a>
                            </li>
                        <li>
                                    <a class=3D"pat-inject" data-pat-inject=
=3D"history: record; scroll: top" href=3D"https://www.medicijnkosten.nl/beg=
rippen">Begrippenlijst</a>
                                </li>
                            <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/ma=
p/veelgestelde-vragen">
                                Veelgestelde vragen</a>
                        </li>
                    </ul>
    </div><div class=3D"column">
    <h2>
        Over deze site</h2>

    <ul class=3D"links">
            <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/co=
pyright">
                                Copyright</a>
                        </li>
                    <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/pr=
ivacy">
                                Privacy</a>
                        </li>
                    <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/co=
okies">
                                Cookies</a>
                        </li>
                    <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/to=
egankelijkheid">
                                Toegankelijkheid</a>
                        </li>
                    <li>
                            <a class=3D"pat-inject" data-pat-inject=3D"hist=
ory: record; scroll: top" href=3D"https://www.medicijnkosten.nl/algemeen/kw=
etsbaarheid-melden">
                                Kwetsbaarheid melden</a>
                        </li>
                    </ul>
    </div></div>
</div>


 =20
 =20

<div id=3D"give-freely-root-kkkbiiikppgjdiebcabomlbidfodipjg" class=3D"give=
-freely-root" data-extension-id=3D"kkkbiiikppgjdiebcabomlbidfodipjg" data-e=
xtension-name=3D"Substital: Add subtitles to videos and movies" style=3D"di=
splay: block;"><template shadowmode=3D"open"><div><div class=3D"gf-app"></d=
iv></div></template></div><div id=3D"automa-palette"><template shadowmode=
=3D"open"><div id=3D"app" data-v-app=3D""><!----></div></template></div><ve=
epn-lock-screen><template shadowmode=3D"open"></template></veepn-lock-scree=
n></body><chatgpt-sidebar data-rendered=3D"true" data-gpts-theme=3D"light">=
<template shadowmode=3D"open"><div class=3D"chat-gpt-quick-query-container"=
><div class=3D"css-1d6rho5 ant-app"><div dir=3D"ltr" class=3D"quick-action-=
container absolute top-0 left-0 text-text-primary-1 z-max"></div><div dir=
=3D"ltr" class=3D"disable-translator-fab"><div class=3D"chatgpt-quick-query=
-float"><div class=3D"relative" style=3D"transform: translate3d(0px, 0px, 0=
px);"><div class=3D"pointer-events-auto"><div class=3D"absolute right-0 bot=
tom-full py-2 text-text-primary-1 px-1 transition-[padding,opacity] duratio=
n-300 opacity-100"><div class=3D"flex flex-col items-center gap-[3px] p-[3p=
x] bg-grey-layer2-normal rounded-full transition-all" style=3D"box-shadow: =
0px 0px 1px 0px var(--sds-color-grey-line2-hover), 0px 6px 24px 0px rgba(12=
, 13, 25, 0.06), 0px 12px 48px 0px rgba(12, 13, 25, 0.06), 0px 24px 96px 0p=
x rgba(12, 13, 25, 0.06);"><div class=3D"w-full"><div class=3D"w-full relat=
ive overflow-hidden transition-[height] duration-300 h-[26px]"><div class=
=3D"absolute w-full bottom-0 flex flex-col items-center gap-[3px]"><button =
class=3D"border-none outline-none font-family-base inline-flex justify-cent=
er items-center select-none transition-colors cursor-pointer click-scale bg=
-transparent hover:bg-grey-fill1-hover hover:text-text-primary-1 active:bg-=
grey-fill1-click active:text-text-primary-1 data-[popup-open]:text-text-pri=
mary-1 data-[popup-open]:bg-grey-fill1-hover size-[26px] p-0 rounded-full t=
ext-text-primary-1"><svg xmlns=3D"http://www.w3.org/2000/svg" width=3D"16" =
height=3D"16" fill=3D"none" viewBox=3D"0 0 60 60"><path fill=3D"currentColo=
r" fill-rule=3D"evenodd" d=3D"M24.455 4.367h11.089c2.682 0 4.536-.002 6.236=
.55a11.25 11.25 0 0 1 4.051 2.34c1.329 1.196 2.255 2.802 3.595 5.125l.18.31=
 5.185 8.983.18.31c1.342 2.322 2.269 3.927 2.64 5.676a11.25 11.25 0 0 1 0 4=
.678c-.371 1.749-1.298 3.354-2.64 5.676l-.18.31-5.186 8.983-.179.31c-1.34 2=
.323-2.266 3.929-3.595 5.125a11.25 11.25 0 0 1-4.05 2.34c-1.701.552-3.555.5=
5-6.236.55h-11.09c-2.682 0-4.535.002-6.235-.55a11.25 11.25 0 0 1-4.052-2.34=
c-1.328-1.196-2.254-2.802-3.594-5.125l-.18-.31-5.186-8.983-.18-.31c-1.341-2=
.322-2.268-3.927-2.64-5.676a11.25 11.25 0 0 1 0-4.678c.372-1.749 1.299-3.35=
4 2.64-5.676l.18-.31 5.186-8.983.18-.31c1.34-2.323 2.266-3.929 3.594-5.125a=
11.25 11.25 0 0 1 4.052-2.34c1.7-.552 3.553-.55 6.235-.55m.359 4.5c-3.18 0-=
4.268.026-5.204.33a6.75 6.75 0 0 0-2.43 1.404c-.732.659-1.298 1.587-2.889 4=
.341l-5.186 8.983c-1.59 2.754-2.11 3.709-2.315 4.672a6.75 6.75 0 0 0 0 2.80=
6c.204.963.725 1.918 2.315 4.672l5.186 8.983c1.59 2.754 2.157 3.682 2.888 4=
.34a6.75 6.75 0 0 0 2.431 1.404c.936.304 2.023.33 5.204.33h10.372c3.18 0 4.=
267-.026 5.203-.33A6.75 6.75 0 0 0 42.82 49.4c.732-.659 1.298-1.587 2.888-4=
.341l5.186-8.983c1.59-2.754 2.111-3.709 2.316-4.672a6.75 6.75 0 0 0 0-2.806=
c-.205-.963-.725-1.918-2.316-4.672l-5.186-8.983c-1.59-2.754-2.156-3.682-2.8=
88-4.34a6.75 6.75 0 0 0-2.43-1.404c-.937-.305-2.023-.33-5.204-.33zM30 21.75=
a8.25 8.25 0 1 0 0 16.5 8.25 8.25 0 0 0 0-16.5M17.25 30c0-7.042 5.708-12.75=
 12.75-12.75S42.75 22.958 42.75 30 37.04 42.75 30 42.75 17.25 37.042 17.25 =
30" clip-rule=3D"evenodd"></path></svg></button><button class=3D"border-non=
e outline-none font-family-base inline-flex justify-center items-center sel=
ect-none transition-colors cursor-pointer click-scale bg-transparent hover:=
bg-grey-fill1-hover hover:text-text-primary-1 active:bg-grey-fill1-click ac=
tive:text-text-primary-1 data-[popup-open]:text-text-primary-1 data-[popup-=
open]:bg-grey-fill1-hover size-[26px] p-0 rounded-full text-text-primary-1"=
><div class=3D"relative flex"><svg xmlns=3D"http://www.w3.org/2000/svg" wid=
th=3D"16" height=3D"16" fill=3D"none" viewBox=3D"0 0 16 16"><path fill=3D"c=
urrentColor" fill-rule=3D"evenodd" d=3D"M5.146 2.659a.47.47 0 0 0-.425 0c-.=
006.004-.083.061-.233.35-.153.294-.326.716-.578 1.33L3.638 5h2.59l-.27-.662=
c-.253-.613-.427-1.035-.579-1.329-.15-.289-.227-.346-.233-.35M6.72 6.198l.7=
24 1.763a.6.6 0 0 0 1.11-.456l-1.5-3.65c-.237-.579-.43-1.05-.61-1.398-.174-=
.334-.396-.684-.753-.867a1.67 1.67 0 0 0-1.517 0c-.357.183-.58.533-.753.867=
-.18.347-.373.82-.61 1.398l-1.5 3.65a.6.6 0 1 0 1.11.456L3.145 6.2h3.522l.0=
54-.002zm4.551-2.904c-.325-.027-.745-.027-1.352-.027h-.053a.6.6 0 0 1 0-1.2=
h.078c.576 0 1.045 0 1.425.03.393.033.744.101 1.071.268.514.262.932.68 1.19=
4 1.194.167.327.235.678.267 1.071.031.38.031.849.031 1.425v.078a.6.6 0 1 1-=
1.2 0V6.08c0-.607 0-1.027-.027-1.352-.026-.319-.074-.495-.14-.624a1.53 1.53=
 0 0 0-.67-.67c-.13-.066-.305-.114-.624-.14M2.667 9.267a.6.6 0 0 1 .6.6v.05=
3c0 .607 0 1.027.027 1.352.026.319.074.495.14.624.147.289.381.523.67.67.13.=
066.305.114.624.14.325.027.745.027 1.352.027h.053a.6.6 0 0 1 0 1.2h-.078c-.=
576 0-1.045 0-1.425-.03-.393-.033-.744-.101-1.07-.268a2.73 2.73 0 0 1-1.195=
-1.194c-.167-.327-.235-.678-.267-1.071-.031-.38-.031-.849-.031-1.425v-.078a=
.6.6 0 0 1 .6-.6" clip-rule=3D"evenodd"></path><path fill=3D"currentColor" =
d=3D"M14.172 8.715a.6.6 0 0 0-1.144-.363c-.29.914-.815 2.075-1.704 2.99l-.0=
91.094c-.392-.432-.753-.89-1.012-1.252a.6.6 0 0 0-.975.7c.278.386.664.88 1.=
092 1.352-.527.402-1.155.761-2.007 1.066a.6.6 0 1 0 .404 1.13c1.052-.376 1.=
825-.835 2.473-1.354.477.363 1.094.673 1.587.895a16 16 0 0 0 1.115.451l.019=
.007.005.002h.002a.6.6 0 1 0 .394-1.133l-.004-.002-.014-.005-.06-.021c-.052=
-.02-.13-.048-.225-.085-.19-.073-.453-.18-.74-.308a8.4 8.4 0 0 1-1.173-.628=
l.071-.073c1.066-1.098 1.666-2.45 1.987-3.463"></path></svg></div></button>=
</div></div></div><div class=3D"h-px w-[14px] bg-grey-line2-normal"></div><=
button class=3D"border-none outline-none font-family-base inline-flex justi=
fy-center items-center select-none transition-colors cursor-pointer click-s=
cale bg-transparent hover:bg-grey-fill1-hover hover:text-text-primary-1 act=
ive:bg-grey-fill1-click active:text-text-primary-1 data-[popup-open]:text-t=
ext-primary-1 data-[popup-open]:bg-grey-fill1-hover size-[26px] p-0 rounded=
-full text-text-primary-1"><svg xmlns=3D"http://www.w3.org/2000/svg" width=
=3D"16" height=3D"16" fill=3D"none" viewBox=3D"0 0 16 16"><path fill=3D"cur=
rentColor" fill-rule=3D"evenodd" d=3D"m7.699 2.491-2.44-.69c-.53-.149-.966-=
.272-1.324-.34-.367-.07-.723-.095-1.073.005a2.2 2.2 0 0 0-1.266.958c-.192.3=
1-.264.66-.297 1.032-.032.362-.032.816-.032 1.366v5.393c0 .577-.001 1.028.1=
5 1.416q.203.519.628.88c.182.153.386.258.608.351.213.089.479.18.796.289l.01=
8.006c1.129.387 2.613.926 3.943 1.505l.028.012c.1.044.235.103.377.127q.185.=
03.37 0a1.6 1.6 0 0 0 .377-.127l.028-.012c1.33-.579 2.815-1.118 3.943-1.505=
l.018-.006c.317-.109.583-.2.796-.289.222-.093.426-.198.608-.352a2.16 2.16 0=
 0 0 .628-.879c.151-.388.15-.839.15-1.416V4.822c0-.55 0-1.004-.032-1.366-.0=
33-.372-.105-.722-.297-1.032a2.2 2.2 0 0 0-1.266-.958c-.35-.1-.706-.074-1.0=
73-.005-.358.068-.794.191-1.324.34l-2.44.69a2 2 0 0 1-.25.064.5.5 0 0 1-.10=
2 0 2 2 0 0 1-.25-.064m-4.507.129c.087-.025.226-.035.52.02.3.057.684.165 1.=
248.324l2.44.69v9.7a60 60 0 0 0-3.543-1.332c-.34-.117-.569-.195-.742-.268a1=
.1 1.1 0 0 1-.294-.16.96.96 0 0 1-.286-.4c-.058-.149-.068-.35-.068-1.085V4.=
85c0-.585 0-.985.027-1.288.027-.298.075-.43.122-.507a1 1 0 0 1 .576-.435M8.=
6 13.353a60 60 0 0 1 3.543-1.33c.34-.118.569-.196.742-.268.169-.07.246-.12.=
295-.16a.96.96 0 0 0 .285-.4c.058-.15.068-.35.068-1.086V4.85c0-.585 0-.985-=
.027-1.288-.027-.298-.075-.43-.122-.507a1 1 0 0 0-.576-.435c-.087-.025-.226=
-.035-.52.02-.3.057-.684.165-1.248.324l-2.44.69z" clip-rule=3D"evenodd"></p=
ath></svg></button><button class=3D"border-none outline-none font-family-ba=
se inline-flex justify-center items-center select-none transition-colors cu=
rsor-pointer click-scale bg-transparent hover:bg-grey-fill1-hover hover:tex=
t-text-primary-1 active:bg-grey-fill1-click active:text-text-primary-1 data=
-[popup-open]:text-text-primary-1 data-[popup-open]:bg-grey-fill1-hover siz=
e-[26px] p-0 relative rounded-full text-text-primary-1"><svg xmlns=3D"http:=
//www.w3.org/2000/svg" width=3D"16" height=3D"16" fill=3D"none" viewBox=3D"=
0 0 60 60"><path fill=3D"currentColor" d=3D"M23.88 19.792c1.205-.359 2.456-=
.192 3.601.07 1.252.287 2.818.8 4.708 1.418l13.669 4.467c3.067 1.002 5.508 =
1.798 7.277 2.544 1.543.65 3.122 1.468 4.007 2.817l.167.278a6.75 6.75 0 0 1=
 .241 6.074l-.19.384c-.816 1.53-2.49 2.44-4.124 3.16-1.757.775-4.184 1.61-7=
.234 2.661l-1.301.448c-.138.048-.246.084-.337.117q-.058.02-.1.037l-.035.097=
-.117.338-.448 1.3c-1.052 3.051-1.886 5.478-2.66 7.235-.676 1.532-1.519 3.0=
98-2.881 3.961l-.28.163a6.75 6.75 0 0 1-6.077.144l-.38-.195c-1.517-.842-2.4=
-2.529-3.095-4.174-.746-1.77-1.542-4.211-2.544-7.279L21.28 32.19c-.618-1.89=
1-1.131-3.457-1.417-4.71-.28-1.22-.452-2.561.008-3.84l.127-.326a6.25 6.25 0=
 0 1 3.641-3.444l.24-.078Zm1.345 4.3-.064.014c-.43.154-.78.469-.98.874l-.07=
6.18c-.004.012-.093.283.143 1.317.23 1.004.663 2.34 1.31 4.315l4.467 13.669=
c1.029 3.149 1.757 5.371 2.412 6.925.325.769.594 1.282.821 1.618.227.335.34=
.387.31.371l.128.065a2.25 2.25 0 0 0 2.025-.047l.062-.054c.054-.052.14-.147=
.256-.313.232-.332.51-.84.846-1.604.68-1.543 1.445-3.754 2.525-6.886l.447-1=
.3.12-.35c.133-.378.312-.829.59-1.233l.114-.157a4.3 4.3 0 0 1 .816-.814l.15=
5-.114.206-.13c.485-.288 1.007-.454 1.376-.58l1.302-.448 2.18-.754c2.015-.7=
02 3.547-1.26 4.704-1.77.764-.336 1.274-.614 1.606-.846.33-.231.381-.345.36=
6-.317l.063-.128a2.25 2.25 0 0 0-.08-2.026l-.054-.06a2 2 0 0 0-.318-.25c-.3=
36-.227-.849-.497-1.618-.822-1.553-.655-3.776-1.384-6.925-2.413l-13.669-4.4=
66c-1.975-.646-3.31-1.08-4.313-1.309-.777-.178-1.124-.172-1.253-.156ZM14.30=
6 34.19a2.25 2.25 0 0 1 3.183 3.182l-5.137 5.136a2.25 2.25 0 1 1-3.182-3.18=
2zM11.75 23.515a2.25 2.25 0 0 1 0 4.5H4.484a2.25 2.25 0 0 1 0-4.5h7.263ZM9.=
17 9.02a2.25 2.25 0 0 1 3.182 0l5.137 5.136a2.25 2.25 0 0 1-3.183 3.182L9.1=
7 12.202a2.25 2.25 0 0 1 0-3.182m30.306 0a2.25 2.25 0 0 1 3.182 3.182l-5.13=
6 5.136a2.25 2.25 0 0 1-3.183-3.182zM25.914 2.085a2.25 2.25 0 0 1 2.25 2.25=
v7.264a2.25 2.25 0 0 1-4.5 0V4.335a2.25 2.25 0 0 1 2.25-2.25"></path></svg>=
</button><button class=3D"border-none outline-none font-family-base inline-=
flex justify-center items-center select-none transition-colors cursor-point=
er click-scale bg-transparent hover:bg-grey-fill1-hover hover:text-text-pri=
mary-1 active:bg-grey-fill1-click active:text-text-primary-1 data-[popup-op=
en]:text-text-primary-1 data-[popup-open]:bg-grey-fill1-hover size-[26px] p=
-0 rounded-full relative text-text-primary-1"><svg xmlns=3D"http://www.w3.o=
rg/2000/svg" width=3D"16" height=3D"16" fill=3D"none" viewBox=3D"0 0 60 60"=
><path fill=3D"currentColor" d=3D"M27.75 33a2.25 2.25 0 0 0 4.5 0V19a2.25 2=
.25 0 0 0-4.5 0zM42 35.25A2.25 2.25 0 0 1 39.75 33v-8a2.25 2.25 0 0 1 4.5 0=
v8A2.25 2.25 0 0 1 42 35.25M15.75 33a2.25 2.25 0 0 0 4.5 0V23a2.25 2.25 0 0=
 0-4.5 0z"></path><path fill=3D"currentColor" fill-rule=3D"evenodd" d=3D"M2=
.75 16C2.75 9.787 7.787 4.75 14 4.75h32c6.213 0 11.25 5.037 11.25 11.25v24.=
764A2.25 2.25 0 0 1 57 45.25H32.25v7.5H39a2.25 2.25 0 0 1 0 4.5H21a2.25 2.2=
5 0 0 1 0-4.5h6.75v-7.5H3a2.25 2.25 0 0 1-.25-4.486zm4.5 0v24.75h45.5V16A6.=
75 6.75 0 0 0 46 9.25H14A6.75 6.75 0 0 0 7.25 16" clip-rule=3D"evenodd"></p=
ath></svg><div class=3D"pointer-events-none size-[5px] bg-error-normal abso=
lute top-1 right-1 rounded-full"></div></button><button class=3D"border-non=
e outline-none font-family-base inline-flex justify-center items-center sel=
ect-none transition-colors cursor-pointer click-scale bg-transparent hover:=
bg-grey-fill1-hover hover:text-text-primary-1 active:bg-grey-fill1-click ac=
tive:text-text-primary-1 data-[popup-open]:text-text-primary-1 data-[popup-=
open]:bg-grey-fill1-hover size-[26px] p-0 rounded-full text-text-primary-1"=
><svg xmlns=3D"http://www.w3.org/2000/svg" width=3D"16" height=3D"16" fill=
=3D"none" viewBox=3D"0 0 16 16"><path fill=3D"currentColor" fill-rule=3D"ev=
enodd" d=3D"M6.481 1H8a.6.6 0 0 1 0 1.2H6.507c-.682 0-1.158 0-1.528.03-.363=
.03-.572.086-.73.166a1.8 1.8 0 0 0-.786.787c-.08.158-.136.366-.166.73-.03.3=
7-.03.845-.03 1.527v6.465c0 .47 0 .78.021 1.009.021.23.057.286.063.294a.47.=
47 0 0 0 .314.194c.01.002.076.009.292-.075.214-.084.492-.222.911-.432l2.1-1=
.05.05-.025c.23-.115.443-.222.675-.265.203-.039.411-.039.614 0 .232.043.445=
.15.674.265l.05.025 2.1 1.05c.42.21.698.348.912.432.216.084.282.077.292.075=
a.47.47 0 0 0 .314-.194c.006-.008.042-.064.063-.294s.021-.54.021-1.009V8.26=
7a.6.6 0 1 1 1.2 0v3.666c0 .434 0 .8-.026 1.09-.027.296-.088.606-.275.873a1=
.67 1.67 0 0 1-1.122.693c-.322.048-.626-.036-.903-.145-.272-.106-.6-.27-.98=
7-.463l-2.125-1.063c-.311-.155-.364-.176-.409-.184a.5.5 0 0 0-.172 0c-.045.=
008-.098.029-.409.184L5.38 13.981a13 13 0 0 1-.987.463c-.277.109-.58.193-.9=
03.145a1.67 1.67 0 0 1-1.122-.693c-.187-.267-.248-.577-.275-.873-.026-.29-.=
026-.656-.026-1.09V5.414c0-.65 0-1.174.034-1.6.036-.436.112-.82.293-1.176a3=
 3 0 0 1 1.31-1.311c.356-.181.74-.257 1.177-.292C5.306 1 5.831 1 6.481 1" c=
lip-rule=3D"evenodd"></path><path fill=3D"currentColor" d=3D"M11.667 6.4a.6=
.6 0 1 0 1.2 0V4.333h2.066a.6.6 0 1 0 0-1.2h-2.066V1.067a.6.6 0 0 0-1.2 0v2=
.066H9.6a.6.6 0 0 0 0 1.2h2.067z"></path></svg></button></div></div><div ro=
le=3D"button" class=3D"float-btn relative flex-center bg-grey-layer2-normal=
 select-none" style=3D"touch-action: none;"><img class=3D"size-5 pointer-ev=
ents-none" src=3D"chrome-extension://difoiogjjojoaoomphldepapgpbgkhkb/asset=
s/logo-O35E636P.png" alt=3D"logo icon"><div tabindex=3D"0" class=3D"relativ=
e inline-flex outline-none close-btn size-4 rounded-full text-text-white-1 =
bg-glass-fill1-normal backdrop-blur-md cursor-pointer hover:bg-glass-fill1-=
hover"><svg xmlns=3D"http://www.w3.org/2000/svg" width=3D"10" height=3D"10"=
 fill=3D"none" viewBox=3D"0 0 16 16"><path fill=3D"currentColor" d=3D"M3.62=
4 2.776a.6.6 0 0 0-.848.848L7.152 8l-4.376 4.376a.6.6 0 0 0 .848.848L8 8.85=
l4.376 4.375a.6.6 0 0 0 .848-.848L8.85 8l4.375-4.376a.6.6 0 0 0-.848-.848L8=
 7.152z"></path></svg></div></div></div></div></div><div class=3D"chat-gpt-=
query-model-wrapper outline-none active:outline-none focus:outline-none " t=
abindex=3D"1"><div class=3D"chat-gpt-query-model text-base min-w-[440px] ma=
x-sm:min-w-[90vw]"><div class=3D"flip-y"><div></div></div><div class=3D"abs=
olute -left-1 z-[1001] h-full w-2" style=3D"touch-action: none;"><div class=
=3D"h-full w-1/4 m-auto cursor-ew-resize"></div></div><button class=3D"size=
-10 absolute z-[-1] bottom-[10px] flex-center p-0 outline-none border-none =
text-title bg-bg2 cursor-pointer hover:text-primary transition-colors -left=
-[38px] rounded-tl-full rounded-bl-full" style=3D"transform: translate3d(0p=
x, 0px, 0px); box-shadow: rgba(0, 0, 0, 0.04) -12px 0px 32px, rgba(0, 0, 0,=
 0.08) -8px 0px 16px, rgba(0, 0, 0, 0.12) -4px 0px 8px; touch-action: none;=
"><svg aria-hidden=3D"true" focusable=3D"false" class=3D"octicon octicon-x =
ml-1" viewBox=3D"0 0 16 16" width=3D"20" height=3D"20" fill=3D"currentColor=
" display=3D"inline-block" overflow=3D"visible" style=3D"vertical-align: te=
xt-bottom;"><path d=3D"M3.72 3.72a.75.75 0 0 1 1.06 0L8 6.94l3.22-3.22a.749=
.749 0 0 1 1.275.326.749.749 0 0 1-.215.734L9.06 8l3.22 3.22a.749.749 0 0 1=
-.326 1.275.749.749 0 0 1-.734-.215L8 9.06l-3.22 3.22a.751.751 0 0 1-1.042-=
.018.751.751 0 0 1-.018-1.042L6.94 8 3.72 4.78a.75.75 0 0 1 0-1.06Z"></path=
></svg></button></div></div></div><div></div><div class=3D"fixed inset-0 po=
inter-events-none z-max overflow-hidden"><div class=3D"pointer-events-auto"=
></div><div class=3D"grid auto-cols-max auto-rows-max p-[16px]" style=3D"wi=
dth: 0px; height: 0px; place-content: start; transform: none;"><div class=
=3D"grid cursor-pointer group grid-rows-[1fr] relative hover:grid-cols-[1fr=
] max-w-max max-h-max hover:delay-0 grid-cols-[0fr] delay-150" style=3D"tra=
nsition-property: grid-template-columns; transition-timing-function: ease-i=
n-out; transition-duration: 150ms; opacity: 0; visibility: hidden; pointer-=
events: none;"><div class=3D"min-w-[32px] min-h-[32px] rounded-[8px] px-[9p=
x] gap-[9px] max-w-max backdrop-blur-[15px] overflow-hidden flex items-cent=
er text-white bg-text-black-2" style=3D"grid-area: 1 / 1;"><img src=3D"chro=
me-extension://difoiogjjojoaoomphldepapgpbgkhkb/assets/logo-O35E636P.png" a=
lt=3D"Logo" class=3D"size-[14px] grayscale brightness-[10]"><div class=3D"f=
lex items-center gap-[4px]"><div class=3D"whitespace-nowrap shrink-0">AI To=
ols</div></div></div><div tabindex=3D"0" class=3D"inline-flex outline-none =
absolute top-0 right-0"><span class=3D"absolute -top-[7px] -right-[7px] opa=
city-0 size-[14px] flex-center bg-[#8B8F91] text-white rounded-full transit=
ion-opacity group-hover:opacity-100 group-hover:delay-150 opacity-0 delay-0=
"><svg aria-hidden=3D"true" focusable=3D"false" class=3D"octicon octicon-x"=
 viewBox=3D"0 0 12 12" width=3D"10" height=3D"10" fill=3D"currentColor" dis=
play=3D"inline-block" overflow=3D"visible" style=3D"vertical-align: text-bo=
ttom;"><path d=3D"M2.22 2.22a.749.749 0 0 1 1.06 0L6 4.939 8.72 2.22a.749.7=
49 0 1 1 1.06 1.06L7.061 6 9.78 8.72a.749.749 0 1 1-1.06 1.06L6 7.061 3.28 =
9.78a.749.749 0 1 1-1.06-1.06L4.939 6 2.22 3.28a.749.749 0 0 1 0-1.06Z"></p=
ath></svg></span></div></div></div></div><div dir=3D"ltr" class=3D"absolute=
 top-0 left-0 z-max"><div class=3D"gpt-dark"><div class=3D"fixed top-0 left=
-0"></div></div></div><div class=3D"fixed top-0 left-0 right-0 z-max pointe=
r-events-none"></div><div class=3D"sider-popup-container absolute z-max3 to=
p-0 start-0 end-0"></div><span></span><div></div><span class=3D"ant-dropdow=
n-trigger"></span></div></div><meta name=3D"sider-selection-tags" content=
=3D"disable-translator-fab"></template></chatgpt-sidebar></html>
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: image/png
Content-Transfer-Encoding: base64
Content-Location: chrome-extension://difoiogjjojoaoomphldepapgpbgkhkb/assets/logo-O35E636P.png
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------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: https://www.medicijnkosten.nl/assets/style/fontello-020/css/fontello.css

@charset "utf-8";

@font-face { font-family: fontello; src: url("../font/fontello.woff2?373148=
2") format("woff2"), url("../font/fontello.woff?3731482") format("woff"), u=
rl("../font/fontello.ttf?3731482") format("truetype"); font-weight: normal;=
 font-style: normal; }

[class^=3D"icon-"]::before, [class*=3D" icon-"]::before { font-family: font=
ello; font-style: normal; font-weight: normal; display: inline-block; text-=
decoration: inherit; width: 1em; margin-right: 0.2em; text-align: center; f=
ont-variant: normal; text-transform: none; line-height: 1em; margin-left: 0=
.2em; -webkit-font-smoothing: antialiased; }

.icon-heart::before { content: "=EE=9E=92"; }

.icon-fork::before { content: "=EE=A0=80"; }

.icon-flow-tree::before { content: "=EE=A0=81"; }

.icon-heart-empty::before { content: "=EE=A0=82"; }

.icon-star::before { content: "=EE=A0=83"; }

.icon-star-empty::before { content: "=EE=A0=84"; }

.icon-cancel-circle::before { content: "=EE=A0=85"; }

.icon-cancel-circle-open::before { content: "=EE=A0=86"; }

.icon-plus-circle::before { content: "=EE=A0=87"; }

.icon-minus-circle::before { content: "=EE=A0=88"; }

.icon-help-circle::before { content: "=EE=A0=89"; }

.icon-info-circle::before { content: "=EE=A0=8A"; }

.icon-pin::before { content: "=EE=A0=8B"; }

.icon-tag::before { content: "=EE=A0=8C"; }

.icon-tags::before { content: "=EE=A0=8D"; }

.icon-flag::before { content: "=EE=A0=8E"; }

.icon-download::before { content: "=EE=A0=8F"; }

.icon-upload::before { content: "=EE=A0=90"; }

.icon-export::before { content: "=EE=A0=91"; }

.icon-edit::before { content: "=EE=A0=92"; }

.icon-comment::before { content: "=EE=A0=93"; }

.icon-chat::before { content: "=EE=A0=94"; }

.icon-attention::before { content: "=EE=A0=95"; }

.icon-trash::before { content: "=EE=A0=96"; }

.icon-document::before { content: "=EE=A0=97"; }

.icon-cog::before { content: "=EE=A0=98"; }

.icon-cog-many::before { content: "=EE=A0=99"; }

.icon-wrench::before { content: "=EE=A0=9A"; }

.icon-resize-full::before { content: "=EE=A0=9B"; }

.icon-resize-small::before { content: "=EE=A0=9C"; }

.icon-up-circle::before { content: "=EE=A0=9D"; }

.icon-down-circle::before { content: "=EE=A0=9E"; }

.icon-cut::before { content: "=EE=A0=9F"; }

.icon-paste::before { content: "=EE=A0=A0"; }

.icon-check-on::before { content: "=EE=A0=A1"; }

.icon-check-off::before { content: "=EE=A0=A2"; }

.icon-radio-off::before { content: "=EE=A0=A3"; }

.icon-search::before { content: "=EE=A0=A4"; }

.icon-mail::before { content: "=EE=A0=A5"; }

.icon-user::before { content: "=EE=A0=A6"; }

.icon-users::before { content: "=EE=A0=A7"; }

.icon-user-add::before { content: "=EE=A0=A8"; }

.icon-tiles::before { content: "=EE=A0=A9"; }

.icon-list::before { content: "=EE=A0=AA"; }

.icon-home::before { content: "=EE=A0=AB"; }

.icon-3945-link::before { content: "=EE=A0=AC"; }

.icon-attach::before { content: "=EE=A0=AD"; }

.icon-lock::before { content: "=EE=A0=AE"; }

.icon-lock-open::before { content: "=EE=A0=AF"; }

.icon-eye::before { content: "=EE=A0=B0"; }

.icon-thumbs-up::before { content: "=EE=A0=B1"; }

.icon-upload-cloud::before { content: "=EE=A0=B2"; }

.icon-pencil::before { content: "=EE=A0=B3"; }

.icon-print::before { content: "=EE=A0=B4"; }

.icon-vcard::before { content: "=EE=A0=B5"; }

.icon-folder::before { content: "=EE=A0=B6"; }

.icon-archive::before { content: "=EE=A0=B7"; }

.icon-rss::before { content: "=EE=A0=B8"; }

.icon-phone::before { content: "=EE=A0=B9"; }

.icon-down-dir::before { content: "=EE=A0=BA"; }

.icon-right-dir::before { content: "=EE=A0=BB"; }

.icon-network::before { content: "=EE=A0=BC"; }

.icon-grid-large::before { content: "=EE=A0=BD"; }

.icon-list-large::before { content: "=EE=A0=BE"; }

.icon-cancel-circle-open-light::before { content: "=EE=A0=BF"; }

.icon-brush::before { content: "=EE=A1=80"; }

.icon-calendar::before { content: "=EE=A1=81"; }

.icon-picture::before { content: "=EE=A1=82"; }

.icon-ok-1::before { content: "=EE=A1=83"; }

.icon-left-open::before { content: "=EE=A1=84"; }

.icon-right-open-2::before { content: "=EE=A1=85"; }

.icon-left-circle::before { content: "=EE=A1=86"; }

.icon-right-circle::before { content: "=EE=A1=87"; }

.icon-dot-circled::before { content: "=EE=A1=88"; }

.icon-medicine-group::before { content: "=EE=A1=89"; }

.icon-medicine-group-old-1::before { content: "=EE=A1=8A"; }

.icon-medicine::before { content: "=EE=A1=8B"; }

.icon-search-1::before { content: "=EE=A1=8C"; }

.icon-angle-double-right::before { content: "=EE=A1=8D"; }

.icon-paragraph::before { content: "=EE=A1=8E"; }

.icon-brandmark::before { content: "=EE=A1=8F"; }

.icon-close-thin::before { content: "=EE=A1=90"; }

.icon-icon-down-thin::before { content: "=EE=A1=91"; }

.icon-bookmark::before { content: "=EE=A1=92"; }

.icon-bookmark-empty::before { content: "=EE=A1=93"; }

.icon-plus-circled::before { content: "=EE=A1=94"; }

.icon-biceps::before { content: "=EE=A1=95"; }

.icon-2-pills::before { content: "=EE=A1=96"; }

.icon-packaging::before { content: "=EE=A1=97"; }

.icon-mini-scale::before { content: "=EE=A1=98"; }

.icon-speedometer::before { content: "=EE=A1=99"; }

.icon-link-internal::before { content: "=EE=A1=9A"; }

.icon-measuring-cup::before { content: "=EE=A1=9B"; }

.icon-switch::before { content: "=EE=A1=9C"; }

.icon-brandmark-squared::before { content: "=EE=A1=9D"; }

.icon-icon-otc::before { content: "=EE=A1=9E"; }

.icon-icon-mnt::before { content: "=EE=A1=9F"; }

.icon-icon-xgvs::before { content: "=EE=A1=A0"; }

.icon-icon-b2::before { content: "=EE=A1=A1"; }

.icon-arrow-curved::before { content: "=EE=A1=A2"; }

.icon-briefcase::before { content: "=EE=A1=A3"; }

.icon-users-1::before { content: "=EE=A1=A4"; }

.icon-0016-groep-mensen-torso::before { content: "=EE=A1=A5"; }

.icon-0015-groep-mensen::before { content: "=EE=A1=A6"; }

.icon-2014-nieuws_diap::before { content: "=EE=A1=A7"; }

.icon-2019-formulier-1::before { content: "=EE=A1=A8"; }

.icon-2019-formulier_diap::before { content: "=EE=A1=A9"; }

.icon-4142-geneesmiddelen-verbeteren::before { content: "=EE=A1=AA"; }

.icon-4085-geneesmiddelen::before { content: "=EE=A1=AB"; }

.icon-2002-info::before { content: "=EE=A1=AC"; }

.icon-2023-informatiemanagement::before { content: "=EE=A1=AD"; }

.icon-8000-binnenlandse-zaken-en-koninkrijksrelaties::before { content: "=
=EE=A1=AE"; }

.icon-4187-medicatieveiligheid::before { content: "=EE=A1=AF"; }

.icon-4180-jodiumtablet::before { content: "=EE=A1=B0"; }

.icon-4087-zwangerschap::before { content: "=EE=A1=B1"; }

.icon-4178-ehbo-doos::before { content: "=EE=A1=B3"; }

.icon-4073-reageerbuis::before { content: "=EE=A1=B4"; }

.icon-4179-pillendoosje::before { content: "=EE=A1=B5"; }

.icon-right-open-big::before { content: "=EE=A1=B6"; }

.icon-1003-pijl-rechts::before { content: "=EE=A1=B7"; }

.icon-lungs::before { content: "=EE=A1=B8"; }

.icon-virus::before { content: "=EE=A1=B9"; }

.icon-cancer::before { content: "=EE=A1=BA"; }

.icon-stomach::before { content: "=EE=A1=BB"; }

.icon-4000-psychisch::before { content: "=EE=A1=BC"; }

.icon-1020-hart::before { content: "=EE=A1=BD"; }

.icon-013-neuron::before { content: "=EE=A1=BE"; }

.icon-bacteriophage::before { content: "=EE=A1=BF"; }

.icon-lymphocyte::before { content: "=EE=A2=80"; }

.icon-3916-vraagteken-cirkel::before { content: "=EE=A2=81"; }

.icon-vraagteken::before { content: "=EE=A2=82"; }

.icon-3909-kruis::before { content: "=EE=A2=83"; }

.icon-angle-right::before { content: "=EE=A2=84"; }

.icon-right-open-mini::before { content: "=EE=A2=85"; }

.icon-key::before { content: "=EE=A2=86"; }

.icon-plus::before { content: "=EE=A2=87"; }

.icon-ok-circle::before { content: "=EE=A2=88"; }

.icon-arrow-stop-full::before { content: "=EE=A2=89"; }

.icon-arrow-stop-open::before { content: "=EE=A2=8A"; }

.icon-arrow-stop-small::before { content: "=EE=A2=8B"; }

.icon-arrow-curved-down::before { content: "=EE=A2=8C"; }

.icon-arrow-curved-up::before { content: "=EE=A2=8D"; }

.icon-arrow-stop::before { content: "=EE=A2=8E"; }

.icon-arrow::before { content: "=EE=A2=8F"; }

.icon-exit::before { content: "=EE=A2=90"; }

.icon-file-pdf::before { content: "=EE=A2=91"; }

.icon-file-word::before { content: "=EE=A2=92"; }

.icon-file-excel::before { content: "=EE=A2=93"; }

.icon-file-powerpoint::before { content: "=EE=A2=94"; }

.icon-file-image::before { content: "=EE=A2=95"; }

.icon-file-archive::before { content: "=EE=A2=96"; }

.icon-file-audio::before { content: "=EE=A2=97"; }

.icon-file-video::before { content: "=EE=A2=98"; }

.icon-file-code::before { content: "=EE=A2=99"; }

.icon-doc-text::before { content: "=EE=A2=9A"; }

.icon-docs::before { content: "=EE=A2=9B"; }

.icon-arrows-cw::before { content: "=EE=A2=9C"; }

.icon-update::before { content: "=EE=A2=9D"; }

.icon-ellipsis-hor::before { content: "=EE=A2=9E"; }

.icon-wallet::before { content: "=EE=A2=9F"; }

.icon-eye-1::before { content: "=EE=A2=A0"; }

.icon-eye-off::before { content: "=EE=A2=A1"; }

.icon-indication-old::before { content: "=EE=A2=A2"; }

.icon-medicine-group-old::before { content: "=EE=A2=A3"; }

.icon-medicine-old::before { content: "=EE=A2=A4"; }

.icon-4158-boek::before { content: "=EE=A2=A5"; }

.icon-left-open-big::before { content: "=EE=A2=A6"; }

.icon-left-open-mini::before { content: "=EE=A2=A7"; }

.icon-left::before { content: "=EE=A2=A8"; }

.icon-apple-share::before { content: "=EE=A2=A9"; }

.icon-award::before { content: "=EE=A2=AA"; }

.icon-award-1::before { content: "=EE=A2=AB"; }

.icon-gauge::before { content: "=EE=A2=AC"; }

.icon-indication-1::before { content: "=EE=A2=AD"; }

.icon-globe::before { content: "=EE=A2=AE"; }

.icon-type-is::before { content: "=EE=A2=AF"; }

.icon-is::before { content: "=EE=A2=B0"; }

.icon-database-on-square::before { content: "=EE=A2=B1"; }

.icon-3902-klaarzetten::before { content: "=EE=A2=B2"; }

.icon-information-standard::before { content: "=EE=A2=B3"; }

.icon-3907-zoek::before { content: "=EE=A2=B4"; }

.icon-history::before { content: "=EE=A2=B5"; }

.icon-share::before { content: "=EE=A2=B6"; }

.icon-megaphone-1::before { content: "=EE=A2=B7"; }

.icon-building::before { content: "=EE=A2=B8"; }

.icon-industrial-building::before { content: "=EE=A2=B9"; }

.icon-zoom-in::before { content: "=EE=A2=BA"; }

.icon-zoom-out::before { content: "=EE=A2=BB"; }

.icon-level-down-1::before { content: "=EE=A2=BC"; }

.icon-level-up-1::before { content: "=EE=A2=BD"; }

.icon-firefox-1::before { content: "=EE=A2=BE"; }

.icon-chrome-1::before { content: "=EE=A2=BF"; }

.icon-ie::before { content: "=EE=A3=80"; }

.icon-opera-1::before { content: "=EE=A3=81"; }

.icon-dialogue::before { content: "=EE=A3=82"; }

.icon-left-open-1::before { content: "=EE=A3=83"; }

.icon-theatre::before { content: "=EE=A3=84"; }

.icon-arrows-apart::before { content: "=EE=A3=85"; }

.icon-3915-waarschuwing::before { content: "=EE=A3=86"; }

.icon-down-open::before { content: "=EE=A3=87"; }

.icon-up-open::before { content: "=EE=A3=88"; }

.icon-droplet::before { content: "=EE=A3=89"; }

.icon-analytics::before { content: "=EE=A3=8A"; }

.icon-data::before { content: "=EE=A3=8B"; }

.icon-swiss-army-knife::before { content: "=EE=A3=8C"; }

.icon-bold::before { content: "=EE=A3=8D"; }

.icon-2013-externe-link::before { content: "=EE=A3=8E"; }

.icon-3938-diagonale-pijl::before { content: "=EE=A3=8F"; }

.icon-italic::before { content: "=EE=A3=90"; }

.icon-link::before { content: "=EE=A3=91"; }

.icon-minus::before { content: "=EE=A3=92"; }

.icon-picture-1::before { content: "=EE=A3=93"; }

.icon-video::before { content: "=EE=A3=94"; }

.icon-arrow-combo::before { content: "=EE=A3=95"; }

.icon-language::before { content: "=EE=A3=96"; }

.icon-1008-oog::before { content: "=EE=A3=97"; }

.icon-1037-proces::before { content: "=EE=A3=98"; }

.icon-3927-pijl-omlaag-24px::before { content: "=EE=A3=99"; }

.icon-quality-thumb::before { content: "=EE=A3=9A"; }

.icon-quality-tick::before { content: "=EE=A3=9B"; }

.icon-quality-thumb-circle::before { content: "=EE=A3=9C"; }

.icon-form-pencil::before { content: "=EE=A3=9D"; }

.icon-3926-pijl-omhoog-24px::before { content: "=EE=A3=9E"; }

.icon-form-pencil-portrait::before { content: "=EE=A3=9F"; }

.icon-data-protection::before { content: "=EE=A3=A0"; }

.icon-personal-data::before { content: "=EE=A3=A1"; }

.icon-privacy-ok::before { content: "=EE=A3=A2"; }

.icon-2038-instellingen::before { content: "=EE=A3=A3"; }

.icon-3937-plus::before { content: "=EE=A3=A4"; }

.icon-dashboard::before { content: "=EE=A3=A5"; }

.icon-calendar-1::before { content: "=EE=A3=A6"; }

.icon-18-favoriet::before { content: "=EE=A3=A7"; }

.icon-01-activiteit::before { content: "=EE=A3=A8"; }

.icon-64-waarschuwing::before { content: "=EE=A3=A9"; }

.icon-language-2::before { content: "=EE=A3=AA"; }

.icon-27-kalender::before { content: "=EE=A3=AB"; }

.icon-36-nieuws::before { content: "=EE=A3=AC"; }

.icon-info::before { content: "=EE=A3=AD"; }

.icon-plus-squared::before { content: "=EE=A3=AE"; }

.icon-ccw::before { content: "=EE=A3=AF"; }

.icon-megaphone::before { content: "=EE=A3=B0"; }

.icon-cw::before { content: "=EE=A3=B1"; }

.icon-lock-1::before { content: "=EE=A3=B2"; }

.icon-lock-open-1::before { content: "=EE=A3=B3"; }

.icon-footer::before { content: "=EE=A3=B4"; }

.icon-picture-2::before { content: "=EE=A3=B5"; }

.icon-6027-planten-en-bloemen::before { content: "=EE=A3=B6"; }

.icon-5213-gedrag-en-gebruikersconcepten::before { content: "=EE=A3=B7"; }

.icon-5170-gebouwenbeheer::before { content: "=EE=A3=B8"; }

.icon-2047-samenhang-van-documenten::before { content: "=EE=A3=B9"; }

.icon-3905-user::before { content: "=EE=A3=BA"; }

.icon-9003-stapeltje-euros::before { content: "=EE=A3=BB"; }

.icon-headset::before { content: "=EE=A3=BC"; }

.icon-financiering::before { content: "=EE=A3=BD"; }

.icon-over-ons::before { content: "=EE=A3=BE"; }

.icon-publicaties::before { content: "=EE=A3=BF"; }

.icon-werkagenda::before { content: "=EE=A4=80"; }

.icon-37.-diagonale-pijl::before { content: "=EE=A4=81"; }

.icon-glass::before { content: "=EE=A4=82"; }

.icon-music::before { content: "=EE=A4=83"; }

.icon-mail-1::before { content: "=EE=A4=84"; }

.icon-star-half::before { content: "=EE=A4=85"; }

.icon-user-1::before { content: "=EE=A4=86"; }

.icon-videocam::before { content: "=EE=A4=87"; }

.icon-camera::before { content: "=EE=A4=88"; }

.icon-camera-alt::before { content: "=EE=A4=89"; }

.icon-home-1::before { content: "=EE=A4=8A"; }

.icon-plus-1::before { content: "=EE=A4=8B"; }

.icon-cancel::before { content: "=EE=A4=8C"; }

.icon-ok-circled2::before { content: "=EE=A4=8D"; }

.icon-ok::before { content: "=EE=A4=8E"; }

.icon-th-list::before { content: "=EE=A4=8F"; }

.icon-th::before { content: "=EE=A4=90"; }

.icon-checkboxes-checked::before { content: "=EE=A4=91"; }

.icon-checkboxes-double-checked::before { content: "=EE=A4=92"; }

.icon-checkboxes-double-unchecked::before { content: "=EE=A4=93"; }

.icon-checkboxes-unchecked.svg::before { content: "=EE=A4=94"; }

.icon-th-large::before { content: "=EE=A4=95"; }

.icon-attach-1::before { content: "=EE=A4=96"; }

.icon-forward::before { content: "=EE=A4=97"; }

.icon-pencil-1::before { content: "=EE=A4=98"; }

.icon-print-1::before { content: "=EE=A4=99"; }

.icon-retweet::before { content: "=EE=A4=9A"; }

.icon-thumbs-up-1::before { content: "=EE=A4=9B"; }

.icon-thumbs-down::before { content: "=EE=A4=9C"; }

.icon-bell::before { content: "=EE=A4=9D"; }

.icon-attention-circled::before { content: "=EE=A4=9E"; }

.icon-location::before { content: "=EE=A4=9F"; }

.icon-folder-1::before { content: "=EE=A4=A0"; }

.icon-folder-open::before { content: "=EE=A4=A1"; }

.icon-clock::before { content: "=EE=A4=A2"; }

.icon-volume-down::before { content: "=EE=A4=A3"; }

.icon-volume-up::before { content: "=EE=A4=A4"; }

.icon-headphones::before { content: "=EE=A4=A5"; }

.icon-volume-off::before { content: "=EE=A4=A6"; }

.icon-login::before { content: "=EE=A4=A7"; }

.icon-basket::before { content: "=EE=A4=A8"; }

.icon-phone-1::before { content: "=EE=A4=A9"; }

.icon-block::before { content: "=EE=A4=AA"; }

.icon-resize-vertical::before { content: "=EE=A4=AB"; }

.icon-resize-horizontal::before { content: "=EE=A4=AC"; }

.icon-down-circled2::before { content: "=EE=A4=AD"; }

.icon-up-circled2::before { content: "=EE=A4=AE"; }

.icon-down-dir-1::before { content: "=EE=A4=AF"; }

.icon-up-dir::before { content: "=EE=A4=B0"; }

.icon-left-dir::before { content: "=EE=A4=B1"; }

.icon-right-dir-1::before { content: "=EE=A4=B2"; }

.icon-down-open-1::before { content: "=EE=A4=B3"; }

.icon-right-open::before { content: "=EE=A4=B4"; }

.icon-up-open-1::before { content: "=EE=A4=B5"; }

.icon-down-big::before { content: "=EE=A4=B6"; }

.icon-left-big::before { content: "=EE=A4=B7"; }

.icon-right-big::before { content: "=EE=A4=B8"; }

.icon-up-big::before { content: "=EE=A4=B9"; }

.icon-right-hand::before { content: "=EE=A4=BA"; }

.icon-left-hand::before { content: "=EE=A4=BB"; }

.icon-up-hand::before { content: "=EE=A4=BC"; }

.icon-down-hand::before { content: "=EE=A4=BD"; }

.icon-target::before { content: "=EE=A4=BE"; }

.icon-eject::before { content: "=EE=A4=BF"; }

.icon-fast-bw::before { content: "=EE=A5=80"; }

.icon-to-start-alt::before { content: "=EE=A5=81"; }

.icon-fast-fw::before { content: "=EE=A5=82"; }

.icon-to-start::before { content: "=EE=A5=83"; }

.icon-to-end::before { content: "=EE=A5=84"; }

.icon-to-end-alt::before { content: "=EE=A5=85"; }

.icon-pause::before { content: "=EE=A5=86"; }

.icon-stop::before { content: "=EE=A5=87"; }

.icon-play-circled2::before { content: "=EE=A5=88"; }

.icon-play::before { content: "=EE=A5=89"; }

.icon-shuffle::before { content: "=EE=A5=8A"; }

.icon-signal::before { content: "=EE=A5=8B"; }

.icon-inbox::before { content: "=EE=A5=8C"; }

.icon-cloud::before { content: "=EE=A5=8D"; }

.icon-flash::before { content: "=EE=A5=8E"; }

.icon-umbrella::before { content: "=EE=A5=8F"; }

.icon-flight::before { content: "=EE=A5=90"; }

.icon-leaf::before { content: "=EE=A5=91"; }

.icon-font::before { content: "=EE=A5=92"; }

.icon-indent-right::before { content: "=EE=A5=93"; }

.icon-list-1::before { content: "=EE=A5=94"; }

.icon-align-justify::before { content: "=EE=A5=95"; }

.icon-indent-left::before { content: "=EE=A5=96"; }

.icon-align-right::before { content: "=EE=A5=97"; }

.icon-align-center::before { content: "=EE=A5=98"; }

.icon-align-left::before { content: "=EE=A5=99"; }

.icon-text-width::before { content: "=EE=A5=9A"; }

.icon-text-height::before { content: "=EE=A5=9B"; }

.icon-off::before { content: "=EE=A5=9C"; }

.icon-road::before { content: "=EE=A5=9D"; }

.icon-list-alt::before { content: "=EE=A5=9E"; }

.icon-qrcode::before { content: "=EE=A5=9F"; }

.icon-barcode::before { content: "=EE=A5=A0"; }

.icon-book::before { content: "=EE=A5=A1"; }

.icon-adjust::before { content: "=EE=A5=A2"; }

.icon-tint::before { content: "=EE=A5=A3"; }

.icon-asterisk::before { content: "=EE=A5=A4"; }

.icon-gift::before { content: "=EE=A5=A5"; }

.icon-fire::before { content: "=EE=A5=A6"; }

.icon-magnet::before { content: "=EE=A5=A7"; }

.icon-chart-bar::before { content: "=EE=A5=A8"; }

.icon-credit-card::before { content: "=EE=A5=A9"; }

.icon-floppy::before { content: "=EE=A5=AA"; }

.icon-key-1::before { content: "=EE=A5=AB"; }

.icon-beaker::before { content: "=EE=A5=AC"; }

.icon-truck::before { content: "=EE=A5=AD"; }

.icon-hammer::before { content: "=EE=A5=AE"; }

.icon-lemon::before { content: "=EE=A5=AF"; }

.icon-publish::before { content: "=EE=A6=96"; }

.icon-zorgprofessionals::before { content: "=EE=A6=AF"; }

.icon-x-squared::before { content: "=EE=A6=B8"; }

.icon-book-page-turning::before { content: "=EE=A7=89"; }

.icon-app::before { content: "=EE=A7=8F"; }

.icon-angle-right-larger::before { content: "=EF=80=86"; }

.icon-ruler::before { content: "=EF=81=84"; }

.icon-move::before { content: "=EF=81=87"; }

.icon-doc-1::before { content: "=EF=81=8A"; }

.icon-link-ext::before { content: "=EF=82=8E"; }

.icon-phone-squared::before { content: "=EF=82=98"; }

.icon-twitter::before { content: "=EF=82=99"; }

.icon-facebook::before { content: "=EF=82=9A"; }

.icon-github-circled::before { content: "=EF=82=9B"; }

.icon-rss-1::before { content: "=EF=82=9E"; }

.icon-hdd::before { content: "=EF=82=A0"; }

.icon-certificate::before { content: "=EF=82=A3"; }

.icon-left-circled::before { content: "=EF=82=A8"; }

.icon-right-circled::before { content: "=EF=82=A9"; }

.icon-up-circled::before { content: "=EF=82=AA"; }

.icon-down-circled::before { content: "=EF=82=AB"; }

.icon-tasks::before { content: "=EF=82=AE"; }

.icon-filter::before { content: "=EF=82=B0"; }

.icon-resize-full-alt::before { content: "=EF=82=B2"; }

.icon-6012-chemische-producten::before { content: "=EF=83=83"; }

.icon-blank::before { content: "=EF=83=88"; }

.icon-menu::before { content: "=EF=83=89"; }

.icon-list-bullet::before { content: "=EF=83=8A"; }

.icon-list-numbered::before { content: "=EF=83=8B"; }

.icon-strike::before { content: "=EF=83=8C"; }

.icon-underline::before { content: "=EF=83=8D"; }

.icon-table::before { content: "=EF=83=8E"; }

.icon-magic::before { content: "=EF=83=90"; }

.icon-pinterest-circled::before { content: "=EF=83=92"; }

.icon-pinterest-squared::before { content: "=EF=83=93"; }

.icon-gplus-squared::before { content: "=EF=83=94"; }

.icon-gplus::before { content: "=EF=83=95"; }

.icon-money::before { content: "=EF=83=96"; }

.icon-columns::before { content: "=EF=83=9B"; }

.icon-sort::before { content: "=EF=83=9C"; }

.icon-sort-down::before { content: "=EF=83=9D"; }

.icon-sort-up::before { content: "=EF=83=9E"; }

.icon-mail-alt::before { content: "=EF=83=A0"; }

.icon-linkedin::before { content: "=EF=83=A1"; }

.icon-gauge-1::before { content: "=EF=83=A4"; }

.icon-comment-empty::before { content: "=EF=83=A5"; }

.icon-chat-empty::before { content: "=EF=83=A6"; }

.icon-sitemap::before { content: "=EF=83=A8"; }

.icon-lightbulb::before { content: "=EF=83=AB"; }

.icon-exchange::before { content: "=EF=83=AC"; }

.icon-download-cloud::before { content: "=EF=83=AD"; }

.icon-upload-cloud-1::before { content: "=EF=83=AE"; }

.icon-indication::before { content: "=EF=83=B0"; }

.icon-stethoscope::before { content: "=EF=83=B1"; }

.icon-suitcase::before { content: "=EF=83=B2"; }

.icon-bell-alt::before { content: "=EF=83=B3"; }

.icon-coffee::before { content: "=EF=83=B4"; }

.icon-food::before { content: "=EF=83=B5"; }

.icon-hospital::before { content: "=EF=83=B8"; }

.icon-ambulance::before { content: "=EF=83=B9"; }

.icon-medkit::before { content: "=EF=83=BA"; }

.icon-fighter-jet::before { content: "=EF=83=BB"; }

.icon-beer::before { content: "=EF=83=BC"; }

.icon-h-sigh::before { content: "=EF=83=BD"; }

.icon-plus-squared-1::before { content: "=EF=83=BE"; }

.icon-angle-double-left::before { content: "=EF=84=80"; }

.icon-angle-double-up::before { content: "=EF=84=82"; }

.icon-angle-double-down::before { content: "=EF=84=83"; }

.icon-angle-left::before { content: "=EF=84=84"; }

.icon-angle-right-thinner::before { content: "=EF=84=85"; }

.icon-angle-up::before { content: "=EF=84=86"; }

.icon-angle-down::before { content: "=EF=84=87"; }

.icon-desktop::before { content: "=EF=84=88"; }

.icon-laptop::before { content: "=EF=84=89"; }

.icon-tablet::before { content: "=EF=84=8A"; }

.icon-mobile::before { content: "=EF=84=8B"; }

.icon-quote-left::before { content: "=EF=84=8D"; }

.icon-quote-right::before { content: "=EF=84=8E"; }

.icon-spinner::before { content: "=EF=84=90"; }

.icon-circle::before { content: "=EF=84=91"; }

.icon-reply::before { content: "=EF=84=92"; }

.icon-github::before { content: "=EF=84=93"; }

.icon-folder-empty::before { content: "=EF=84=94"; }

.icon-folder-open-empty::before { content: "=EF=84=95"; }

.icon-smile::before { content: "=EF=84=98"; }

.icon-frown::before { content: "=EF=84=99"; }

.icon-meh::before { content: "=EF=84=9A"; }

.icon-gamepad::before { content: "=EF=84=9B"; }

.icon-keyboard::before { content: "=EF=84=9C"; }

.icon-flag-empty::before { content: "=EF=84=9D"; }

.icon-flag-checkered::before { content: "=EF=84=9E"; }

.icon-terminal::before { content: "=EF=84=A0"; }

.icon-code::before { content: "=EF=84=A1"; }

.icon-reply-all::before { content: "=EF=84=A2"; }

.icon-star-half-alt::before { content: "=EF=84=A3"; }

.icon-direction::before { content: "=EF=84=A4"; }

.icon-crop::before { content: "=EF=84=A5"; }

.icon-spin::before { content: "=EF=84=A6"; }

.icon-unlink::before { content: "=EF=84=A7"; }

.icon-help::before { content: "=EF=84=A8"; }

.icon-info-1::before { content: "=EF=84=A9"; }

.icon-attention-alt::before { content: "=EF=84=AA"; }

.icon-superscript::before { content: "=EF=84=AB"; }

.icon-subscript::before { content: "=EF=84=AC"; }

.icon-eraser::before { content: "=EF=84=AD"; }

.icon-puzzle::before { content: "=EF=84=AE"; }

.icon-mic::before { content: "=EF=84=B0"; }

.icon-mute::before { content: "=EF=84=B1"; }

.icon-shield::before { content: "=EF=84=B2"; }

.icon-calendar-empty::before { content: "=EF=84=B3"; }

.icon-extinguisher::before { content: "=EF=84=B4"; }

.icon-rocket::before { content: "=EF=84=B5"; }

.icon-maxcdn::before { content: "=EF=84=B6"; }

.icon-angle-circled-left::before { content: "=EF=84=B7"; }

.icon-angle-circled-right::before { content: "=EF=84=B8"; }

.icon-html5::before { content: "=EF=84=BB"; }

.icon-css3::before { content: "=EF=84=BC"; }

.icon-anchor::before { content: "=EF=84=BD"; }

.icon-lock-open-alt::before { content: "=EF=84=BE"; }

.icon-bullseye::before { content: "=EF=85=80"; }

.icon-ellipsis-vert::before { content: "=EF=85=82"; }

.icon-rss-squared::before { content: "=EF=85=83"; }

.icon-play-circled::before { content: "=EF=85=84"; }

.icon-ticket::before { content: "=EF=85=85"; }

.icon-minus-squared::before { content: "=EF=85=86"; }

.icon-minus-squared-alt::before { content: "=EF=85=87"; }

.icon-level-up::before { content: "=EF=85=88"; }

.icon-level-down::before { content: "=EF=85=89"; }

.icon-ok-squared::before { content: "=EF=85=8A"; }

.icon-pencil-squared::before { content: "=EF=85=8B"; }

.icon-link-ext-alt::before { content: "=EF=85=8C"; }

.icon-export-alt::before { content: "=EF=85=8D"; }

.icon-compass::before { content: "=EF=85=8E"; }

.icon-expand::before { content: "=EF=85=90"; }

.icon-collapse::before { content: "=EF=85=91"; }

.icon-expand-right::before { content: "=EF=85=92"; }

.icon-euro::before { content: "=EF=85=93"; }

.icon-pound::before { content: "=EF=85=94"; }

.icon-dollar::before { content: "=EF=85=95"; }

.icon-rupee::before { content: "=EF=85=96"; }

.icon-yen::before { content: "=EF=85=97"; }

.icon-rouble::before { content: "=EF=85=98"; }

.icon-won::before { content: "=EF=85=99"; }

.icon-bitcoin::before { content: "=EF=85=9A"; }

.icon-doc-inv::before { content: "=EF=85=9B"; }

.icon-doc-text-inv::before { content: "=EF=85=9C"; }

.icon-sort-name-up::before { content: "=EF=85=9D"; }

.icon-sort-name-down::before { content: "=EF=85=9E"; }

.icon-sort-alt-up::before { content: "=EF=85=A0"; }

.icon-sort-alt-down::before { content: "=EF=85=A1"; }

.icon-sort-number-up::before { content: "=EF=85=A2"; }

.icon-sort-number-down::before { content: "=EF=85=A3"; }

.icon-thumbs-up-alt::before { content: "=EF=85=A4"; }

.icon-thumbs-down-alt::before { content: "=EF=85=A5"; }

.icon-youtube-squared::before { content: "=EF=85=A6"; }

.icon-youtube::before { content: "=EF=85=A7"; }

.icon-xing::before { content: "=EF=85=A8"; }

.icon-xing-squared::before { content: "=EF=85=A9"; }

.icon-youtube-play::before { content: "=EF=85=AA"; }

.icon-dropbox::before { content: "=EF=85=AB"; }

.icon-stackoverflow::before { content: "=EF=85=AC"; }

.icon-instagram::before { content: "=EF=85=AD"; }

.icon-flickr::before { content: "=EF=85=AE"; }

.icon-adn::before { content: "=EF=85=B0"; }

.icon-bitbucket::before { content: "=EF=85=B1"; }

.icon-bitbucket-squared::before { content: "=EF=85=B2"; }

.icon-tumblr::before { content: "=EF=85=B3"; }

.icon-tumblr-squared::before { content: "=EF=85=B4"; }

.icon-down::before { content: "=EF=85=B5"; }

.icon-up::before { content: "=EF=85=B6"; }

.icon-left-1::before { content: "=EF=85=B7"; }

.icon-right::before { content: "=EF=85=B8"; }

.icon-apple::before { content: "=EF=85=B9"; }

.icon-windows::before { content: "=EF=85=BA"; }

.icon-android::before { content: "=EF=85=BB"; }

.icon-linux::before { content: "=EF=85=BC"; }

.icon-dribbble::before { content: "=EF=85=BD"; }

.icon-skype::before { content: "=EF=85=BE"; }

.icon-foursquare::before { content: "=EF=86=80"; }

.icon-trello::before { content: "=EF=86=81"; }

.icon-female::before { content: "=EF=86=82"; }

.icon-male::before { content: "=EF=86=83"; }

.icon-gittip::before { content: "=EF=86=84"; }

.icon-sun::before { content: "=EF=86=85"; }

.icon-moon::before { content: "=EF=86=86"; }

.icon-box::before { content: "=EF=86=87"; }

.icon-bug::before { content: "=EF=86=88"; }

.icon-vkontakte::before { content: "=EF=86=89"; }

.icon-weibo::before { content: "=EF=86=8A"; }

.icon-renren::before { content: "=EF=86=8B"; }

.icon-pagelines::before { content: "=EF=86=8C"; }

.icon-stackexchange::before { content: "=EF=86=8D"; }

.icon-right-circled2::before { content: "=EF=86=8E"; }

.icon-left-circled2::before { content: "=EF=86=90"; }

.icon-collapse-left::before { content: "=EF=86=91"; }

.icon-wheelchair::before { content: "=EF=86=93"; }

.icon-vimeo-squared::before { content: "=EF=86=94"; }

.icon-try::before { content: "=EF=86=95"; }

.icon-plus-squared-alt::before { content: "=EF=86=96"; }

.icon-space-shuttle::before { content: "=EF=86=97"; }

.icon-slack::before { content: "=EF=86=98"; }

.icon-mail-squared::before { content: "=EF=86=99"; }

.icon-wordpress::before { content: "=EF=86=9A"; }

.icon-openid::before { content: "=EF=86=9B"; }

.icon-bank::before { content: "=EF=86=9C"; }

.icon-graduation-cap::before { content: "=EF=86=9D"; }

.icon-yahoo::before { content: "=EF=86=9E"; }

.icon-google::before { content: "=EF=86=A0"; }

.icon-reddit::before { content: "=EF=86=A1"; }

.icon-reddit-squared::before { content: "=EF=86=A2"; }

.icon-stumbleupon-circled::before { content: "=EF=86=A3"; }

.icon-stumbleupon::before { content: "=EF=86=A4"; }

.icon-delicious::before { content: "=EF=86=A5"; }

.icon-digg::before { content: "=EF=86=A6"; }

.icon-pied-piper-squared::before { content: "=EF=86=A7"; }

.icon-pied-piper-alt::before { content: "=EF=86=A8"; }

.icon-drupal::before { content: "=EF=86=A9"; }

.icon-joomla::before { content: "=EF=86=AA"; }

.icon-language-1::before { content: "=EF=86=AB"; }

.icon-fax::before { content: "=EF=86=AC"; }

.icon-building-filled::before { content: "=EF=86=AD"; }

.icon-child::before { content: "=EF=86=AE"; }

.icon-paw::before { content: "=EF=86=B0"; }

.icon-spoon::before { content: "=EF=86=B1"; }

.icon-cube::before { content: "=EF=86=B2"; }

.icon-cubes::before { content: "=EF=86=B3"; }

.icon-behance::before { content: "=EF=86=B4"; }

.icon-behance-squared::before { content: "=EF=86=B5"; }

.icon-steam::before { content: "=EF=86=B6"; }

.icon-steam-squared::before { content: "=EF=86=B7"; }

.icon-recycle::before { content: "=EF=86=B8"; }

.icon-cab::before { content: "=EF=86=B9"; }

.icon-taxi::before { content: "=EF=86=BA"; }

.icon-tree::before { content: "=EF=86=BB"; }

.icon-spotify::before { content: "=EF=86=BC"; }

.icon-deviantart::before { content: "=EF=86=BD"; }

.icon-soundcloud::before { content: "=EF=86=BE"; }

.icon-database::before { content: "=EF=87=80"; }

.icon-vine::before { content: "=EF=87=8A"; }

.icon-codeopen::before { content: "=EF=87=8B"; }

.icon-jsfiddle::before { content: "=EF=87=8C"; }

.icon-lifebuoy::before { content: "=EF=87=8D"; }

.icon-circle-notch::before { content: "=EF=87=8E"; }

.icon-rebel::before { content: "=EF=87=90"; }

.icon-empire::before { content: "=EF=87=91"; }

.icon-git-squared::before { content: "=EF=87=92"; }

.icon-git::before { content: "=EF=87=93"; }

.icon-hacker-news::before { content: "=EF=87=94"; }

.icon-tencent-weibo::before { content: "=EF=87=95"; }

.icon-qq::before { content: "=EF=87=96"; }

.icon-wechat::before { content: "=EF=87=97"; }

.icon-paper-plane::before { content: "=EF=87=98"; }

.icon-paper-plane-empty::before { content: "=EF=87=99"; }

.icon-circle-thin::before { content: "=EF=87=9B"; }

.icon-header::before { content: "=EF=87=9C"; }

.icon-sliders::before { content: "=EF=87=9E"; }

.icon-share-squared::before { content: "=EF=87=A1"; }

.icon-bomb::before { content: "=EF=87=A2"; }

.icon-soccer-ball::before { content: "=EF=87=A3"; }

.icon-tty::before { content: "=EF=87=A4"; }

.icon-binoculars::before { content: "=EF=87=A5"; }

.icon-plug::before { content: "=EF=87=A6"; }

.icon-slideshare::before { content: "=EF=87=A7"; }

.icon-twitch::before { content: "=EF=87=A8"; }

.icon-yelp::before { content: "=EF=87=A9"; }

.icon-newspaper::before { content: "=EF=87=AA"; }

.icon-wifi::before { content: "=EF=87=AB"; }

.icon-calc::before { content: "=EF=87=AC"; }

.icon-paypal::before { content: "=EF=87=AD"; }

.icon-gwallet::before { content: "=EF=87=AE"; }

.icon-cc-visa::before { content: "=EF=87=B0"; }

.icon-cc-mastercard::before { content: "=EF=87=B1"; }

.icon-cc-discover::before { content: "=EF=87=B2"; }

.icon-cc-amex::before { content: "=EF=87=B3"; }

.icon-cc-paypal::before { content: "=EF=87=B4"; }

.icon-cc-stripe::before { content: "=EF=87=B5"; }

.icon-bell-off::before { content: "=EF=87=B6"; }

.icon-bell-off-empty::before { content: "=EF=87=B7"; }

.icon-trash-1::before { content: "=EF=87=B8"; }

.icon-copyright::before { content: "=EF=87=B9"; }

.icon-at::before { content: "=EF=87=BA"; }

.icon-eyedropper::before { content: "=EF=87=BB"; }

.icon-brush-1::before { content: "=EF=87=BC"; }

.icon-birthday::before { content: "=EF=87=BD"; }

.icon-chart-area::before { content: "=EF=87=BE"; }

.icon-chart-pie::before { content: "=EF=88=80"; }

.icon-chart-line::before { content: "=EF=88=81"; }

.icon-lastfm::before { content: "=EF=88=82"; }

.icon-lastfm-squared::before { content: "=EF=88=83"; }

.icon-toggle-off::before { content: "=EF=88=84"; }

.icon-toggle-on::before { content: "=EF=88=85"; }

.icon-bicycle::before { content: "=EF=88=86"; }

.icon-bus::before { content: "=EF=88=87"; }

.icon-ioxhost::before { content: "=EF=88=88"; }

.icon-angellist::before { content: "=EF=88=89"; }

.icon-cc::before { content: "=EF=88=8A"; }

.icon-shekel::before { content: "=EF=88=8B"; }

.icon-meanpath::before { content: "=EF=88=8C"; }

.icon-buysellads::before { content: "=EF=88=8D"; }

.icon-connectdevelop::before { content: "=EF=88=8E"; }

.icon-dashcube::before { content: "=EF=88=90"; }

.icon-forumbee::before { content: "=EF=88=91"; }

.icon-leanpub::before { content: "=EF=88=92"; }

.icon-sellsy::before { content: "=EF=88=93"; }

.icon-shirtsinbulk::before { content: "=EF=88=94"; }

.icon-simplybuilt::before { content: "=EF=88=95"; }

.icon-skyatlas::before { content: "=EF=88=96"; }

.icon-cart-plus::before { content: "=EF=88=97"; }

.icon-cart-arrow-down::before { content: "=EF=88=98"; }

.icon-diamond::before { content: "=EF=88=99"; }

.icon-ship::before { content: "=EF=88=9A"; }

.icon-user-secret::before { content: "=EF=88=9B"; }

.icon-motorcycle::before { content: "=EF=88=9C"; }

.icon-street-view::before { content: "=EF=88=9D"; }

.icon-heartbeat::before { content: "=EF=88=9E"; }

.icon-venus::before { content: "=EF=88=A1"; }

.icon-mars::before { content: "=EF=88=A2"; }

.icon-mercury::before { content: "=EF=88=A3"; }

.icon-transgender::before { content: "=EF=88=A4"; }

.icon-transgender-alt::before { content: "=EF=88=A5"; }

.icon-venus-double::before { content: "=EF=88=A6"; }

.icon-mars-double::before { content: "=EF=88=A7"; }

.icon-venus-mars::before { content: "=EF=88=A8"; }

.icon-mars-stroke::before { content: "=EF=88=A9"; }

.icon-mars-stroke-v::before { content: "=EF=88=AA"; }

.icon-mars-stroke-h::before { content: "=EF=88=AB"; }

.icon-neuter::before { content: "=EF=88=AC"; }

.icon-genderless::before { content: "=EF=88=AD"; }

.icon-facebook-official::before { content: "=EF=88=B0"; }

.icon-pinterest::before { content: "=EF=88=B1"; }

.icon-whatsapp::before { content: "=EF=88=B2"; }

.icon-server::before { content: "=EF=88=B3"; }

.icon-user-plus::before { content: "=EF=88=B4"; }

.icon-user-times::before { content: "=EF=88=B5"; }

.icon-bed::before { content: "=EF=88=B6"; }

.icon-viacoin::before { content: "=EF=88=B7"; }

.icon-train::before { content: "=EF=88=B8"; }

.icon-subway::before { content: "=EF=88=B9"; }

.icon-medium::before { content: "=EF=88=BA"; }

.icon-y-combinator::before { content: "=EF=88=BB"; }

.icon-optin-monster::before { content: "=EF=88=BC"; }

.icon-opencart::before { content: "=EF=88=BD"; }

.icon-expeditedssl::before { content: "=EF=88=BE"; }

.icon-battery-4::before { content: "=EF=89=80"; }

.icon-battery-3::before { content: "=EF=89=81"; }

.icon-battery-2::before { content: "=EF=89=82"; }

.icon-battery-1::before { content: "=EF=89=83"; }

.icon-battery-0::before { content: "=EF=89=84"; }

.icon-mouse-pointer::before { content: "=EF=89=85"; }

.icon-i-cursor::before { content: "=EF=89=86"; }

.icon-object-group::before { content: "=EF=89=87"; }

.icon-object-ungroup::before { content: "=EF=89=88"; }

.icon-sticky-note::before { content: "=EF=89=89"; }

.icon-sticky-note-o::before { content: "=EF=89=8A"; }

.icon-cc-jcb::before { content: "=EF=89=8B"; }

.icon-cc-diners-club::before { content: "=EF=89=8C"; }

.icon-clone::before { content: "=EF=89=8D"; }

.icon-balance-scale::before { content: "=EF=89=8E"; }

.icon-hourglass-o::before { content: "=EF=89=90"; }

.icon-hourglass-1::before { content: "=EF=89=91"; }

.icon-hourglass-2::before { content: "=EF=89=92"; }

.icon-hourglass-3::before { content: "=EF=89=93"; }

.icon-hourglass::before { content: "=EF=89=94"; }

.icon-hand-grab-o::before { content: "=EF=89=95"; }

.icon-hand-paper-o::before { content: "=EF=89=96"; }

.icon-hand-scissors-o::before { content: "=EF=89=97"; }

.icon-hand-lizard-o::before { content: "=EF=89=98"; }

.icon-hand-spock-o::before { content: "=EF=89=99"; }

.icon-hand-pointer-o::before { content: "=EF=89=9A"; }

.icon-hand-peace-o::before { content: "=EF=89=9B"; }

.icon-trademark::before { content: "=EF=89=9C"; }

.icon-registered::before { content: "=EF=89=9D"; }

.icon-creative-commons::before { content: "=EF=89=9E"; }

.icon-gg::before { content: "=EF=89=A0"; }

.icon-gg-circle::before { content: "=EF=89=A1"; }

.icon-tripadvisor::before { content: "=EF=89=A2"; }

.icon-odnoklassniki::before { content: "=EF=89=A3"; }

.icon-odnoklassniki-square::before { content: "=EF=89=A4"; }

.icon-get-pocket::before { content: "=EF=89=A5"; }

.icon-wikipedia-w::before { content: "=EF=89=A6"; }

.icon-safari::before { content: "=EF=89=A7"; }

.icon-chrome::before { content: "=EF=89=A8"; }

.icon-firefox::before { content: "=EF=89=A9"; }

.icon-opera::before { content: "=EF=89=AA"; }

.icon-internet-explorer::before { content: "=EF=89=AB"; }

.icon-television::before { content: "=EF=89=AC"; }

.icon-contao::before { content: "=EF=89=AD"; }

.icon-500px::before { content: "=EF=89=AE"; }

.icon-amazon::before { content: "=EF=89=B0"; }

.icon-calendar-plus-o::before { content: "=EF=89=B1"; }

.icon-calendar-minus-o::before { content: "=EF=89=B2"; }

.icon-calendar-times-o::before { content: "=EF=89=B3"; }

.icon-calendar-check-o::before { content: "=EF=89=B4"; }

.icon-industry::before { content: "=EF=89=B5"; }

.icon-map-pin::before { content: "=EF=89=B6"; }

.icon-map-signs::before { content: "=EF=89=B7"; }

.icon-map-o::before { content: "=EF=89=B8"; }

.icon-map::before { content: "=EF=89=B9"; }

.icon-commenting::before { content: "=EF=89=BA"; }

.icon-commenting-o::before { content: "=EF=89=BB"; }

.icon-houzz::before { content: "=EF=89=BC"; }

.icon-vimeo::before { content: "=EF=89=BD"; }

.icon-black-tie::before { content: "=EF=89=BE"; }

.icon-fonticons::before { content: "=EF=8A=80"; }

.icon-reddit-alien::before { content: "=EF=8A=81"; }

.icon-edge::before { content: "=EF=8A=82"; }

.icon-credit-card-alt::before { content: "=EF=8A=83"; }

.icon-codiepie::before { content: "=EF=8A=84"; }

.icon-modx::before { content: "=EF=8A=85"; }

.icon-fort-awesome::before { content: "=EF=8A=86"; }

.icon-usb::before { content: "=EF=8A=87"; }

.icon-product-hunt::before { content: "=EF=8A=88"; }

.icon-mixcloud::before { content: "=EF=8A=89"; }

.icon-scribd::before { content: "=EF=8A=8A"; }

.icon-pause-circle::before { content: "=EF=8A=8B"; }

.icon-pause-circle-o::before { content: "=EF=8A=8C"; }

.icon-stop-circle::before { content: "=EF=8A=8D"; }

.icon-stop-circle-o::before { content: "=EF=8A=8E"; }

.icon-shopping-bag::before { content: "=EF=8A=90"; }

.icon-shopping-basket::before { content: "=EF=8A=91"; }

.icon-hashtag::before { content: "=EF=8A=92"; }

.icon-bluetooth::before { content: "=EF=8A=93"; }

.icon-bluetooth-b::before { content: "=EF=8A=94"; }

.icon-percent::before { content: "=EF=8A=95"; }

.icon-gitlab::before { content: "=EF=8A=96"; }

.icon-wpbeginner::before { content: "=EF=8A=97"; }

.icon-wpforms::before { content: "=EF=8A=98"; }

.icon-envira::before { content: "=EF=8A=99"; }

.icon-universal-access::before { content: "=EF=8A=9A"; }

.icon-wheelchair-alt::before { content: "=EF=8A=9B"; }

.icon-question-circle-o::before { content: "=EF=8A=9C"; }

.icon-blind::before { content: "=EF=8A=9D"; }

.icon-audio-description::before { content: "=EF=8A=9E"; }

.icon-volume-control-phone::before { content: "=EF=8A=A0"; }

.icon-braille::before { content: "=EF=8A=A1"; }

.icon-assistive-listening-systems::before { content: "=EF=8A=A2"; }

.icon-american-sign-language-interpreting::before { content: "=EF=8A=A3"; }

.icon-asl-interpreting::before { content: "=EF=8A=A4"; }

.icon-glide::before { content: "=EF=8A=A5"; }

.icon-glide-g::before { content: "=EF=8A=A6"; }

.icon-sign-language::before { content: "=EF=8A=A7"; }

.icon-low-vision::before { content: "=EF=8A=A8"; }

.icon-viadeo::before { content: "=EF=8A=A9"; }

.icon-viadeo-square::before { content: "=EF=8A=AA"; }

.icon-snapchat::before { content: "=EF=8A=AB"; }

.icon-snapchat-ghost::before { content: "=EF=8A=AC"; }

.icon-snapchat-square::before { content: "=EF=8A=AD"; }

.icon-pied-piper::before { content: "=EF=8A=AE"; }

.icon-first-order::before { content: "=EF=8A=B0"; }

.icon-yoast::before { content: "=EF=8A=B1"; }

.icon-themeisle::before { content: "=EF=8A=B2"; }

.icon-google-plus-circle::before { content: "=EF=8A=B3"; }

.icon-font-awesome::before { content: "=EF=8A=B4"; }

.icon-handshake-o::before { content: "=EF=8A=B5"; }

.icon-envelope-open::before { content: "=EF=8A=B6"; }

.icon-envelope-open-o::before { content: "=EF=8A=B7"; }

.icon-linode::before { content: "=EF=8A=B8"; }

.icon-address-book::before { content: "=EF=8A=B9"; }

.icon-address-book-o::before { content: "=EF=8A=BA"; }

.icon-address-card::before { content: "=EF=8A=BB"; }

.icon-address-card-o::before { content: "=EF=8A=BC"; }

.icon-user-circle::before { content: "=EF=8A=BD"; }

.icon-user-circle-o::before { content: "=EF=8A=BE"; }

.icon-user-o::before { content: "=EF=8B=80"; }

.icon-id-badge::before { content: "=EF=8B=81"; }

.icon-id-card::before { content: "=EF=8B=82"; }

.icon-id-card-o::before { content: "=EF=8B=83"; }

.icon-quora::before { content: "=EF=8B=84"; }

.icon-free-code-camp::before { content: "=EF=8B=85"; }

.icon-telegram::before { content: "=EF=8B=86"; }

.icon-thermometer::before { content: "=EF=8B=87"; }

.icon-thermometer-3::before { content: "=EF=8B=88"; }

.icon-thermometer-2::before { content: "=EF=8B=89"; }

.icon-thermometer-quarter::before { content: "=EF=8B=8A"; }

.icon-thermometer-0::before { content: "=EF=8B=8B"; }

.icon-shower::before { content: "=EF=8B=8C"; }

.icon-bath::before { content: "=EF=8B=8D"; }

.icon-podcast::before { content: "=EF=8B=8E"; }

.icon-window-maximize::before { content: "=EF=8B=90"; }

.icon-window-minimize::before { content: "=EF=8B=91"; }

.icon-window-restore::before { content: "=EF=8B=92"; }

.icon-window-close::before { content: "=EF=8B=93"; }

.icon-window-close-o::before { content: "=EF=8B=94"; }

.icon-bandcamp::before { content: "=EF=8B=95"; }

.icon-grav::before { content: "=EF=8B=96"; }

.icon-etsy::before { content: "=EF=8B=97"; }

.icon-imdb::before { content: "=EF=8B=98"; }

.icon-ravelry::before { content: "=EF=8B=99"; }

.icon-eercast::before { content: "=EF=8B=9A"; }

.icon-microchip::before { content: "=EF=8B=9B"; }

.icon-snowflake-o::before { content: "=EF=8B=9C"; }

.icon-superpowers::before { content: "=EF=8B=9D"; }

.icon-wpexplorer::before { content: "=EF=8B=9E"; }

.icon-meetup::before { content: "=EF=8B=A0"; }

.icon-github-squared::before { content: "=EF=8C=80"; }

.icon-twitter-squared::before { content: "=EF=8C=84"; }

.icon-facebook-squared::before { content: "=EF=8C=88"; }

.icon-linkedin-squared::before { content: "=EF=8C=8C"; }

.icon-spread::before { content: "=EF=94=A7"; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: https://www.medicijnkosten.nl/assets/style/fontello/css/fontello.css

@charset "utf-8";

@font-face { font-family: fontello; src: url("../font/fontello.woff2?350960=
32") format("woff2"), url("../font/fontello.woff?35096032") format("woff"),=
 url("../font/fontello.ttf?35096032") format("truetype"); font-weight: norm=
al; font-style: normal; }

[class^=3D"icon-"]::before, [class*=3D" icon-"]::before { font-family: font=
ello; font-style: normal; font-weight: normal; display: inline-block; text-=
decoration: inherit; width: 1em; margin-right: 0.2em; text-align: center; f=
ont-variant: normal; text-transform: none; line-height: 1em; margin-left: 0=
.2em; -webkit-font-smoothing: antialiased; }

.icon-heart::before { content: "=EE=9E=92"; }

.icon-fork::before { content: "=EE=A0=80"; }

.icon-flow-tree::before { content: "=EE=A0=81"; }

.icon-heart-empty::before { content: "=EE=A0=82"; }

.icon-star::before { content: "=EE=A0=83"; }

.icon-star-empty::before { content: "=EE=A0=84"; }

.icon-cancel-circle::before { content: "=EE=A0=85"; }

.icon-cancel-circle-open::before { content: "=EE=A0=86"; }

.icon-plus-circle::before { content: "=EE=A0=87"; }

.icon-minus-circle::before { content: "=EE=A0=88"; }

.icon-help-circle::before { content: "=EE=A0=89"; }

.icon-info-circle::before { content: "=EE=A0=8A"; }

.icon-pin::before { content: "=EE=A0=8B"; }

.icon-tag::before { content: "=EE=A0=8C"; }

.icon-tags::before { content: "=EE=A0=8D"; }

.icon-flag::before { content: "=EE=A0=8E"; }

.icon-download::before { content: "=EE=A0=8F"; }

.icon-upload::before { content: "=EE=A0=90"; }

.icon-export::before { content: "=EE=A0=91"; }

.icon-edit::before { content: "=EE=A0=92"; }

.icon-comment::before { content: "=EE=A0=93"; }

.icon-chat::before { content: "=EE=A0=94"; }

.icon-attention::before { content: "=EE=A0=95"; }

.icon-trash::before { content: "=EE=A0=96"; }

.icon-document::before { content: "=EE=A0=97"; }

.icon-cog::before { content: "=EE=A0=98"; }

.icon-cog-many::before { content: "=EE=A0=99"; }

.icon-wrench::before { content: "=EE=A0=9A"; }

.icon-resize-full::before { content: "=EE=A0=9B"; }

.icon-resize-small::before { content: "=EE=A0=9C"; }

.icon-up-circle::before { content: "=EE=A0=9D"; }

.icon-down-circle::before { content: "=EE=A0=9E"; }

.icon-cut::before { content: "=EE=A0=9F"; }

.icon-paste::before { content: "=EE=A0=A0"; }

.icon-check-on::before { content: "=EE=A0=A1"; }

.icon-check-off::before { content: "=EE=A0=A2"; }

.icon-radio-off::before { content: "=EE=A0=A3"; }

.icon-search::before { content: "=EE=A0=A4"; }

.icon-mail::before { content: "=EE=A0=A5"; }

.icon-user::before { content: "=EE=A0=A6"; }

.icon-users::before { content: "=EE=A0=A7"; }

.icon-user-add::before { content: "=EE=A0=A8"; }

.icon-tiles::before { content: "=EE=A0=A9"; }

.icon-list::before { content: "=EE=A0=AA"; }

.icon-home::before { content: "=EE=A0=AB"; }

.icon-3945-link::before { content: "=EE=A0=AC"; }

.icon-attach::before { content: "=EE=A0=AD"; }

.icon-lock::before { content: "=EE=A0=AE"; }

.icon-lock-open::before { content: "=EE=A0=AF"; }

.icon-eye::before { content: "=EE=A0=B0"; }

.icon-thumbs-up::before { content: "=EE=A0=B1"; }

.icon-upload-cloud::before { content: "=EE=A0=B2"; }

.icon-pencil::before { content: "=EE=A0=B3"; }

.icon-print::before { content: "=EE=A0=B4"; }

.icon-vcard::before { content: "=EE=A0=B5"; }

.icon-folder::before { content: "=EE=A0=B6"; }

.icon-archive::before { content: "=EE=A0=B7"; }

.icon-rss::before { content: "=EE=A0=B8"; }

.icon-phone::before { content: "=EE=A0=B9"; }

.icon-down-dir::before { content: "=EE=A0=BA"; }

.icon-right-dir::before { content: "=EE=A0=BB"; }

.icon-network::before { content: "=EE=A0=BC"; }

.icon-grid-large::before { content: "=EE=A0=BD"; }

.icon-list-large::before { content: "=EE=A0=BE"; }

.icon-cancel-circle-open-light::before { content: "=EE=A0=BF"; }

.icon-brush::before { content: "=EE=A1=80"; }

.icon-calendar::before { content: "=EE=A1=81"; }

.icon-picture::before { content: "=EE=A1=82"; }

.icon-ok-1::before { content: "=EE=A1=83"; }

.icon-left-open::before { content: "=EE=A1=84"; }

.icon-right-open-2::before { content: "=EE=A1=85"; }

.icon-left-circle::before { content: "=EE=A1=86"; }

.icon-right-circle::before { content: "=EE=A1=87"; }

.icon-dot-circled::before { content: "=EE=A1=88"; }

.icon-medicine-group::before { content: "=EE=A1=89"; }

.icon-medicine-group-old-1::before { content: "=EE=A1=8A"; }

.icon-medicine::before { content: "=EE=A1=8B"; }

.icon-search-1::before { content: "=EE=A1=8C"; }

.icon-angle-double-right::before { content: "=EE=A1=8D"; }

.icon-paragraph::before { content: "=EE=A1=8E"; }

.icon-brandmark::before { content: "=EE=A1=8F"; }

.icon-close-thin::before { content: "=EE=A1=90"; }

.icon-icon-down-thin::before { content: "=EE=A1=91"; }

.icon-bookmark::before { content: "=EE=A1=92"; }

.icon-bookmark-empty::before { content: "=EE=A1=93"; }

.icon-plus-circled::before { content: "=EE=A1=94"; }

.icon-biceps::before { content: "=EE=A1=95"; }

.icon-2-pills::before { content: "=EE=A1=96"; }

.icon-packaging::before { content: "=EE=A1=97"; }

.icon-mini-scale::before { content: "=EE=A1=98"; }

.icon-speedometer::before { content: "=EE=A1=99"; }

.icon-link-internal::before { content: "=EE=A1=9A"; }

.icon-measuring-cup::before { content: "=EE=A1=9B"; }

.icon-switch::before { content: "=EE=A1=9C"; }

.icon-brandmark-squared::before { content: "=EE=A1=9D"; }

.icon-icon-otc::before { content: "=EE=A1=9E"; }

.icon-icon-mnt::before { content: "=EE=A1=9F"; }

.icon-icon-xgvs::before { content: "=EE=A1=A0"; }

.icon-icon-b2::before { content: "=EE=A1=A1"; }

.icon-arrow-curved::before { content: "=EE=A1=A2"; }

.icon-briefcase::before { content: "=EE=A1=A3"; }

.icon-users-1::before { content: "=EE=A1=A4"; }

.icon-0016-groep-mensen-torso::before { content: "=EE=A1=A5"; }

.icon-0015-groep-mensen::before { content: "=EE=A1=A6"; }

.icon-2014-nieuws_diap::before { content: "=EE=A1=A7"; }

.icon-2019-formulier::before { content: "=EE=A1=A8"; }

.icon-2019-formulier_diap::before { content: "=EE=A1=A9"; }

.icon-4142-geneesmiddelen-verbeteren::before { content: "=EE=A1=AA"; }

.icon-4085-geneesmiddelen::before { content: "=EE=A1=AB"; }

.icon-2002-info::before { content: "=EE=A1=AC"; }

.icon-2023-informatiemanagement::before { content: "=EE=A1=AD"; }

.icon-8000-binnenlandse-zaken-en-koninkrijksrelaties::before { content: "=
=EE=A1=AE"; }

.icon-4187-medicatieveiligheid::before { content: "=EE=A1=AF"; }

.icon-4180-jodiumtablet::before { content: "=EE=A1=B0"; }

.icon-4087-zwangerschap::before { content: "=EE=A1=B1"; }

.icon-4178-ehbo-doos::before { content: "=EE=A1=B3"; }

.icon-4073-reageerbuis::before { content: "=EE=A1=B4"; }

.icon-4179-pillendoosje::before { content: "=EE=A1=B5"; }

.icon-right-open-big::before { content: "=EE=A1=B6"; }

.icon-1003-pijl-rechts::before { content: "=EE=A1=B7"; }

.icon-lungs::before { content: "=EE=A1=B8"; }

.icon-virus::before { content: "=EE=A1=B9"; }

.icon-cancer::before { content: "=EE=A1=BA"; }

.icon-stomach::before { content: "=EE=A1=BB"; }

.icon-4000-psychisch::before { content: "=EE=A1=BC"; }

.icon-1020-hart::before { content: "=EE=A1=BD"; }

.icon-013-neuron::before { content: "=EE=A1=BE"; }

.icon-bacteriophage::before { content: "=EE=A1=BF"; }

.icon-lymphocyte::before { content: "=EE=A2=80"; }

.icon-3916-vraagteken-cirkel::before { content: "=EE=A2=81"; }

.icon-vraagteken::before { content: "=EE=A2=82"; }

.icon-3909-kruis::before { content: "=EE=A2=83"; }

.icon-angle-right::before { content: "=EE=A2=84"; }

.icon-right-open-mini::before { content: "=EE=A2=85"; }

.icon-key::before { content: "=EE=A2=86"; }

.icon-plus::before { content: "=EE=A2=87"; }

.icon-ok-circle::before { content: "=EE=A2=88"; }

.icon-arrow-stop-full::before { content: "=EE=A2=89"; }

.icon-arrow-stop-open::before { content: "=EE=A2=8A"; }

.icon-arrow-stop-small::before { content: "=EE=A2=8B"; }

.icon-arrow-curved-down::before { content: "=EE=A2=8C"; }

.icon-arrow-curved-up::before { content: "=EE=A2=8D"; }

.icon-arrow-stop::before { content: "=EE=A2=8E"; }

.icon-arrow::before { content: "=EE=A2=8F"; }

.icon-exit::before { content: "=EE=A2=90"; }

.icon-file-pdf::before { content: "=EE=A2=91"; }

.icon-file-word::before { content: "=EE=A2=92"; }

.icon-file-excel::before { content: "=EE=A2=93"; }

.icon-file-powerpoint::before { content: "=EE=A2=94"; }

.icon-file-image::before { content: "=EE=A2=95"; }

.icon-file-archive::before { content: "=EE=A2=96"; }

.icon-file-audio::before { content: "=EE=A2=97"; }

.icon-file-video::before { content: "=EE=A2=98"; }

.icon-file-code::before { content: "=EE=A2=99"; }

.icon-doc-text::before { content: "=EE=A2=9A"; }

.icon-docs::before { content: "=EE=A2=9B"; }

.icon-arrows-cw::before { content: "=EE=A2=9C"; }

.icon-update::before { content: "=EE=A2=9D"; }

.icon-ellipsis-hor::before { content: "=EE=A2=9E"; }

.icon-wallet::before { content: "=EE=A2=9F"; }

.icon-eye-1::before { content: "=EE=A2=A0"; }

.icon-eye-off::before { content: "=EE=A2=A1"; }

.icon-indication-old::before { content: "=EE=A2=A2"; }

.icon-medicine-group-old::before { content: "=EE=A2=A3"; }

.icon-medicine-old::before { content: "=EE=A2=A4"; }

.icon-4158-boek::before { content: "=EE=A2=A5"; }

.icon-left-open-big::before { content: "=EE=A2=A6"; }

.icon-left-open-mini::before { content: "=EE=A2=A7"; }

.icon-left::before { content: "=EE=A2=A8"; }

.icon-apple-share::before { content: "=EE=A2=A9"; }

.icon-award::before { content: "=EE=A2=AA"; }

.icon-award-1::before { content: "=EE=A2=AB"; }

.icon-gauge::before { content: "=EE=A2=AC"; }

.icon-indication-1::before { content: "=EE=A2=AD"; }

.icon-globe::before { content: "=EE=A2=AE"; }

.icon-type-is::before { content: "=EE=A2=AF"; }

.icon-is::before { content: "=EE=A2=B0"; }

.icon-database-on-square::before { content: "=EE=A2=B1"; }

.icon-3902-klaarzetten::before { content: "=EE=A2=B2"; }

.icon-information-standard::before { content: "=EE=A2=B3"; }

.icon-3907-zoek::before { content: "=EE=A2=B4"; }

.icon-history::before { content: "=EE=A2=B5"; }

.icon-share::before { content: "=EE=A2=B6"; }

.icon-megaphone-up::before { content: "=EE=A2=B7"; }

.icon-building::before { content: "=EE=A2=B8"; }

.icon-industrial-building::before { content: "=EE=A2=B9"; }

.icon-zoom-in::before { content: "=EE=A2=BA"; }

.icon-zoom-out::before { content: "=EE=A2=BB"; }

.icon-level-down-1::before { content: "=EE=A2=BC"; }

.icon-level-up-1::before { content: "=EE=A2=BD"; }

.icon-firefox::before { content: "=EE=A2=BE"; }

.icon-chrome::before { content: "=EE=A2=BF"; }

.icon-ie::before { content: "=EE=A3=80"; }

.icon-opera::before { content: "=EE=A3=81"; }

.icon-dialogue::before { content: "=EE=A3=82"; }

.icon-left-open-1::before { content: "=EE=A3=83"; }

.icon-theatre::before { content: "=EE=A3=84"; }

.icon-arrows-apart::before { content: "=EE=A3=85"; }

.icon-3915-waarschuwing::before { content: "=EE=A3=86"; }

.icon-down-open::before { content: "=EE=A3=87"; }

.icon-up-open::before { content: "=EE=A3=88"; }

.icon-analytics::before { content: "=EE=A3=8A"; }

.icon-data::before { content: "=EE=A3=8B"; }

.icon-swiss-army-knife::before { content: "=EE=A3=8C"; }

.icon-2013-externe-link::before { content: "=EE=A3=8E"; }

.icon-3938-diagonale-pijl::before { content: "=EE=A3=8F"; }

.icon-megaphone::before { content: "=EE=A3=B0"; }

.icon-book-page-turning::before { content: "=EE=A7=89"; }

.icon-angle-right-larger::before { content: "=EF=80=86"; }

.icon-ruler::before { content: "=EF=81=84"; }

.icon-doc::before { content: "=EF=81=8A"; }

.icon-filter::before { content: "=EF=82=B0"; }

.icon-6012-chemische-producten::before { content: "=EF=83=83"; }

.icon-gauge-1::before { content: "=EF=83=A4"; }

.icon-exchange::before { content: "=EF=83=AC"; }

.icon-indication::before { content: "=EF=83=B0"; }

.icon-angle-left::before { content: "=EF=84=84"; }

.icon-angle-right-thinner::before { content: "=EF=84=85"; }

.icon-spin::before { content: "=EF=84=A6"; }

.icon-puzzle::before { content: "=EF=84=AE"; }

.icon-ellipsis-vert::before { content: "=EF=85=82"; }

.icon-level-up::before { content: "=EF=85=88"; }

.icon-level-down::before { content: "=EF=85=89"; }

.icon-euro::before { content: "=EF=85=93"; }

.icon-doc-inv::before { content: "=EF=85=9B"; }

.icon-dropbox::before { content: "=EF=85=AB"; }

.icon-building-filled::before { content: "=EF=86=AD"; }

.icon-spoon::before { content: "=EF=86=B1"; }

.icon-newspaper::before { content: "=EF=87=AA"; }

.icon-eyedropper::before { content: "=EF=87=BB"; }

.icon-edge::before { content: "=EF=8A=82"; }

.icon-envelope-open::before { content: "=EF=8A=B6"; }

.icon-envelope-open-o::before { content: "=EF=8A=B7"; }

.icon-thermometer::before { content: "=EF=8B=87"; }

.icon-spread::before { content: "=EF=94=A7"; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: https://www.medicijnkosten.nl/assets/style/style.css?v=4.0.5_

@charset "utf-8";

@import url("fontello/css/fontello.css");

@import url("fontello-020/css/fontello.css");

@font-face { font-family: "RO Sans"; src: url("fonts/ROsanswebtextregular.w=
off") format("opentype"); font-style: normal; font-weight: normal; }

@font-face { font-family: "RO Sans"; src: url("fonts/ROsanswebtextitalic.wo=
ff") format("opentype"); font-style: italic; font-weight: normal; }

@font-face { font-family: "RO Sans"; src: url("fonts/ROsanswebtextbold.woff=
") format("opentype"); font-weight: bold; font-style: normal; }

@font-face { font-family: "RO Serif"; src: url("fonts/ROserifwebregular.wof=
f") format("opentype"); font-style: normal; font-weight: normal; }

@font-face { font-family: "RO Serif"; src: url("fonts/ROserifwebitalic.woff=
") format("opentype"); font-style: italic; font-weight: normal; }

.ro-sans { display: inline-block; font-family: "RO Sans"; text-rendering: a=
uto; -webkit-font-smoothing: antialiased; }

.ro-serif { display: inline-block; font-family: "RO Serif"; text-rendering:=
 auto; -webkit-font-smoothing: antialiased; }

:root { --select-box-height: 44px; }

body, h1, h2, h3, h4, h5, h6, p, blockquote, ul, ol, li, table, tr, th, td,=
 form, fieldset, legend, button, div, object, figure, table img { margin: 0=
px; border: 0px; padding: 0px; list-style: none; text-align: left; }

input, select, textarea, button { padding: 0px; background-color: rgb(255, =
255, 255); }

.animated { animation-duration: 1s; animation-fill-mode: both; }

.animated.infinite { animation-iteration-count: infinite; }

.animated.hinge { animation-duration: 2s; }

@-webkit-keyframes bounce {=20
  0%, 20%, 53%, 80%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); transform: translate3d(0px, 0px, 0px); }
  40%, 43% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0=
.06); transform: translate3d(0px, -30px, 0px); }
  70% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0.06);=
 transform: translate3d(0px, -15px, 0px); }
  90% { transform: translate3d(0px, -4px, 0px); }
}

@keyframes bounce {=20
  0%, 20%, 53%, 80%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); transform: translate3d(0px, 0px, 0px); }
  40%, 43% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0=
.06); transform: translate3d(0px, -30px, 0px); }
  70% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0.06);=
 transform: translate3d(0px, -15px, 0px); }
  90% { transform: translate3d(0px, -4px, 0px); }
}

.bounce { animation-name: bounce; transform-origin: center bottom; }

@-webkit-keyframes flash {=20
  0%, 50%, 100% { opacity: 1; }
  25%, 75% { opacity: 0; }
}

@keyframes flash {=20
  0%, 50%, 100% { opacity: 1; }
  25%, 75% { opacity: 0; }
}

.flash { animation-name: flash; }

@-webkit-keyframes pulse {=20
  0% { transform: scale3d(1, 1, 1); }
  50% { transform: scale3d(1.05, 1.05, 1.05); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes pulse {=20
  0% { transform: scale3d(1, 1, 1); }
  50% { transform: scale3d(1.05, 1.05, 1.05); }
  100% { transform: scale3d(1, 1, 1); }
}

.pulse { animation-name: pulse; }

@-webkit-keyframes rubberBand {=20
  0% { transform: scale3d(1, 1, 1); }
  30% { transform: scale3d(1.25, 0.75, 1); }
  40% { transform: scale3d(0.75, 1.25, 1); }
  50% { transform: scale3d(1.15, 0.85, 1); }
  65% { transform: scale3d(0.95, 1.05, 1); }
  75% { transform: scale3d(1.05, 0.95, 1); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes rubberBand {=20
  0% { transform: scale3d(1, 1, 1); }
  30% { transform: scale3d(1.25, 0.75, 1); }
  40% { transform: scale3d(0.75, 1.25, 1); }
  50% { transform: scale3d(1.15, 0.85, 1); }
  65% { transform: scale3d(0.95, 1.05, 1); }
  75% { transform: scale3d(1.05, 0.95, 1); }
  100% { transform: scale3d(1, 1, 1); }
}

.rubberBand { animation-name: rubberBand; }

@-webkit-keyframes shake {=20
  0%, 100% { transform: translate3d(0px, 0px, 0px); }
  10%, 30%, 50%, 70%, 90% { transform: translate3d(-10px, 0px, 0px); }
  20%, 40%, 60%, 80% { transform: translate3d(10px, 0px, 0px); }
}

@keyframes shake {=20
  0%, 100% { transform: translate3d(0px, 0px, 0px); }
  10%, 30%, 50%, 70%, 90% { transform: translate3d(-10px, 0px, 0px); }
  20%, 40%, 60%, 80% { transform: translate3d(10px, 0px, 0px); }
}

.shake { animation-name: shake; }

@-webkit-keyframes swing {=20
  20% { transform: rotate3d(0, 0, 1, 15deg); }
  40% { transform: rotate3d(0, 0, 1, -10deg); }
  60% { transform: rotate3d(0, 0, 1, 5deg); }
  80% { transform: rotate3d(0, 0, 1, -5deg); }
  100% { transform: rotate3d(0, 0, 1, 0deg); }
}

@keyframes swing {=20
  20% { transform: rotate3d(0, 0, 1, 15deg); }
  40% { transform: rotate3d(0, 0, 1, -10deg); }
  60% { transform: rotate3d(0, 0, 1, 5deg); }
  80% { transform: rotate3d(0, 0, 1, -5deg); }
  100% { transform: rotate3d(0, 0, 1, 0deg); }
}

.swing { transform-origin: center top; animation-name: swing; }

@-webkit-keyframes tada {=20
  0% { transform: scale3d(1, 1, 1); }
  10%, 20% { transform: scale3d(0.9, 0.9, 0.9) rotate3d(0, 0, 1, -3deg); }
  30%, 50%, 70%, 90% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, =
3deg); }
  40%, 60%, 80% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg=
); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes tada {=20
  0% { transform: scale3d(1, 1, 1); }
  10%, 20% { transform: scale3d(0.9, 0.9, 0.9) rotate3d(0, 0, 1, -3deg); }
  30%, 50%, 70%, 90% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, =
3deg); }
  40%, 60%, 80% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg=
); }
  100% { transform: scale3d(1, 1, 1); }
}

.tada { animation-name: tada; }

@-webkit-keyframes wobble {=20
  0% { transform: none; }
  15% { transform: translate3d(-25%, 0px, 0px) rotate3d(0, 0, 1, -5deg); }
  30% { transform: translate3d(20%, 0px, 0px) rotate3d(0, 0, 1, 3deg); }
  45% { transform: translate3d(-15%, 0px, 0px) rotate3d(0, 0, 1, -3deg); }
  60% { transform: translate3d(10%, 0px, 0px) rotate3d(0, 0, 1, 2deg); }
  75% { transform: translate3d(-5%, 0px, 0px) rotate3d(0, 0, 1, -1deg); }
  100% { transform: none; }
}

@keyframes wobble {=20
  0% { transform: none; }
  15% { transform: translate3d(-25%, 0px, 0px) rotate3d(0, 0, 1, -5deg); }
  30% { transform: translate3d(20%, 0px, 0px) rotate3d(0, 0, 1, 3deg); }
  45% { transform: translate3d(-15%, 0px, 0px) rotate3d(0, 0, 1, -3deg); }
  60% { transform: translate3d(10%, 0px, 0px) rotate3d(0, 0, 1, 2deg); }
  75% { transform: translate3d(-5%, 0px, 0px) rotate3d(0, 0, 1, -1deg); }
  100% { transform: none; }
}

.wobble { animation-name: wobble; }

@-webkit-keyframes bounceIn {=20
  0%, 20%, 40%, 60%, 80%, 100% { transition-timing-function: cubic-bezier(0=
.215, 0.61, 0.355, 1); }
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  20% { transform: scale3d(1.1, 1.1, 1.1); }
  40% { transform: scale3d(0.9, 0.9, 0.9); }
  60% { opacity: 1; transform: scale3d(1.03, 1.03, 1.03); }
  80% { transform: scale3d(0.97, 0.97, 0.97); }
  100% { opacity: 1; transform: scale3d(1, 1, 1); }
}

@keyframes bounceIn {=20
  0%, 20%, 40%, 60%, 80%, 100% { transition-timing-function: cubic-bezier(0=
.215, 0.61, 0.355, 1); }
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  20% { transform: scale3d(1.1, 1.1, 1.1); }
  40% { transform: scale3d(0.9, 0.9, 0.9); }
  60% { opacity: 1; transform: scale3d(1.03, 1.03, 1.03); }
  80% { transform: scale3d(0.97, 0.97, 0.97); }
  100% { opacity: 1; transform: scale3d(1, 1, 1); }
}

.bounceIn { animation-name: bounceIn; animation-duration: 0.75s; }

@-webkit-keyframes bounceInDown {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, -3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, 25px, 0px); }
  75% { transform: translate3d(0px, -10px, 0px); }
  90% { transform: translate3d(0px, 5px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInDown {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, -3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, 25px, 0px); }
  75% { transform: translate3d(0px, -10px, 0px); }
  90% { transform: translate3d(0px, 5px, 0px); }
  100% { transform: none; }
}

.bounceInDown { animation-name: bounceInDown; }

@-webkit-keyframes bounceInLeft {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(-3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(25px, 0px, 0px); }
  75% { transform: translate3d(-10px, 0px, 0px); }
  90% { transform: translate3d(5px, 0px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInLeft {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(-3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(25px, 0px, 0px); }
  75% { transform: translate3d(-10px, 0px, 0px); }
  90% { transform: translate3d(5px, 0px, 0px); }
  100% { transform: none; }
}

.bounceInLeft { animation-name: bounceInLeft; }

@-webkit-keyframes bounceInRight {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(-25px, 0px, 0px); }
  75% { transform: translate3d(10px, 0px, 0px); }
  90% { transform: translate3d(-5px, 0px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInRight {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(-25px, 0px, 0px); }
  75% { transform: translate3d(10px, 0px, 0px); }
  90% { transform: translate3d(-5px, 0px, 0px); }
  100% { transform: none; }
}

.bounceInRight { animation-name: bounceInRight; }

@-webkit-keyframes bounceInUp {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, 3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  75% { transform: translate3d(0px, 10px, 0px); }
  90% { transform: translate3d(0px, -5px, 0px); }
  100% { transform: translate3d(0px, 0px, 0px); }
}

@keyframes bounceInUp {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, 3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  75% { transform: translate3d(0px, 10px, 0px); }
  90% { transform: translate3d(0px, -5px, 0px); }
  100% { transform: translate3d(0px, 0px, 0px); }
}

.bounceInUp { animation-name: bounceInUp; }

@-webkit-keyframes bounceOut {=20
  20% { transform: scale3d(0.9, 0.9, 0.9); }
  50%, 55% { opacity: 1; transform: scale3d(1.1, 1.1, 1.1); }
  100% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
}

@keyframes bounceOut {=20
  20% { transform: scale3d(0.9, 0.9, 0.9); }
  50%, 55% { opacity: 1; transform: scale3d(1.1, 1.1, 1.1); }
  100% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
}

.bounceOut { animation-name: bounceOut; animation-duration: 0.75s; }

@-webkit-keyframes bounceOutDown {=20
  20% { transform: translate3d(0px, 10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

@keyframes bounceOutDown {=20
  20% { transform: translate3d(0px, 10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

.bounceOutDown { animation-name: bounceOutDown; }

@-webkit-keyframes bounceOutLeft {=20
  20% { opacity: 1; transform: translate3d(20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

@keyframes bounceOutLeft {=20
  20% { opacity: 1; transform: translate3d(20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

.bounceOutLeft { animation-name: bounceOutLeft; }

@-webkit-keyframes bounceOutRight {=20
  20% { opacity: 1; transform: translate3d(-20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

@keyframes bounceOutRight {=20
  20% { opacity: 1; transform: translate3d(-20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

.bounceOutRight { animation-name: bounceOutRight; }

@-webkit-keyframes bounceOutUp {=20
  20% { transform: translate3d(0px, -10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, 20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

@keyframes bounceOutUp {=20
  20% { transform: translate3d(0px, -10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, 20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

.bounceOutUp { animation-name: bounceOutUp; }

@-webkit-keyframes fadeIn {=20
  0% { opacity: 0; }
  100% { opacity: 1; }
}

@keyframes fadeIn {=20
  0% { opacity: 0; }
  100% { opacity: 1; }
}

.fadeIn { animation-name: fadeIn; }

@-webkit-keyframes fadeInDown {=20
  0% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInDown {=20
  0% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInDown { animation-name: fadeInDown; }

@-webkit-keyframes fadeInDownBig {=20
  0% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInDownBig {=20
  0% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInDownBig { animation-name: fadeInDownBig; }

@-webkit-keyframes fadeInLeft {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInLeft {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInLeft { animation-name: fadeInLeft; }

@-webkit-keyframes fadeInLeftBig {=20
  0% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInLeftBig {=20
  0% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInLeftBig { animation-name: fadeInLeftBig; }

@-webkit-keyframes fadeInRight {=20
  0% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInRight {=20
  0% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInRight { animation-name: fadeInRight; }

@-webkit-keyframes fadeInRightBig {=20
  0% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInRightBig {=20
  0% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInRightBig { animation-name: fadeInRightBig; }

@-webkit-keyframes fadeInUp {=20
  0% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInUp {=20
  0% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInUp { animation-name: fadeInUp; }

@-webkit-keyframes fadeInUpBig {=20
  0% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInUpBig {=20
  0% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInUpBig { animation-name: fadeInUpBig; }

@-webkit-keyframes fadeOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; }
}

@keyframes fadeOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; }
}

.fadeOut { animation-name: fadeOut; }

@-webkit-keyframes fadeOutDown {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
}

@keyframes fadeOutDown {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
}

.fadeOutDown { animation-name: fadeOutDown; }

@-webkit-keyframes fadeOutDownBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

@keyframes fadeOutDownBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

.fadeOutDownBig { animation-name: fadeOutDownBig; }

@-webkit-keyframes fadeOutLeft {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
}

@keyframes fadeOutLeft {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
}

.fadeOutLeft { animation-name: fadeOutLeft; }

@-webkit-keyframes fadeOutLeftBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

@keyframes fadeOutLeftBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

.fadeOutLeftBig { animation-name: fadeOutLeftBig; }

@-webkit-keyframes fadeOutRight {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
}

@keyframes fadeOutRight {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
}

.fadeOutRight { animation-name: fadeOutRight; }

@-webkit-keyframes fadeOutRightBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

@keyframes fadeOutRightBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

.fadeOutRightBig { animation-name: fadeOutRightBig; }

@-webkit-keyframes fadeOutUp {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
}

@keyframes fadeOutUp {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
}

.fadeOutUp { animation-name: fadeOutUp; }

@-webkit-keyframes fadeOutUpBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

@keyframes fadeOutUpBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

.fadeOutUpBig { animation-name: fadeOutUpBig; }

@-webkit-keyframes flip {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, -360deg); animation-=
timing-function: ease-out; }
  40% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -190deg); animation-timing-function: ease-out; }
  50% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -170deg); animation-timing-function: ease-in; }
  80% { transform: perspective(400px) scale3d(0.95, 0.95, 0.95); animation-=
timing-function: ease-in; }
  100% { transform: perspective(400px); animation-timing-function: ease-in;=
 }
}

@keyframes flip {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, -360deg); animation-=
timing-function: ease-out; }
  40% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -190deg); animation-timing-function: ease-out; }
  50% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -170deg); animation-timing-function: ease-in; }
  80% { transform: perspective(400px) scale3d(0.95, 0.95, 0.95); animation-=
timing-function: ease-in; }
  100% { transform: perspective(400px); animation-timing-function: ease-in;=
 }
}

.animated.flip { backface-visibility: visible; animation-name: flip; }

@-webkit-keyframes flipInX {=20
  0% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(1, 0, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(1, 0, 0, -5deg); }
  100% { transform: perspective(400px); }
}

@keyframes flipInX {=20
  0% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(1, 0, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(1, 0, 0, -5deg); }
  100% { transform: perspective(400px); }
}

.flipInX { animation-name: flipInX; backface-visibility: visible !important=
; }

@-webkit-keyframes flipInY {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(0, 1, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(0, 1, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(0, 1, 0, -5deg); }
  100% { transform: perspective(400px); }
}

@keyframes flipInY {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(0, 1, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(0, 1, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(0, 1, 0, -5deg); }
  100% { transform: perspective(400px); }
}

.flipInY { animation-name: flipInY; backface-visibility: visible !important=
; }

@-webkit-keyframes flipOutX {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); opacity: 0=
; }
}

@keyframes flipOutX {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); opacity: 0=
; }
}

.flipOutX { animation-name: flipOutX; animation-duration: 0.75s; backface-v=
isibility: visible !important; }

@-webkit-keyframes flipOutY {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(0, 1, 0, -15deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); opacity: 0=
; }
}

@keyframes flipOutY {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(0, 1, 0, -15deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); opacity: 0=
; }
}

.flipOutY { animation-name: flipOutY; animation-duration: 0.75s; backface-v=
isibility: visible !important; }

@-webkit-keyframes lightSpeedIn {=20
  0% { transform: translate3d(100%, 0px, 0px) skewX(-30deg); opacity: 0; }
  60% { transform: skewX(20deg); opacity: 1; }
  80% { transform: skewX(-5deg); opacity: 1; }
  100% { transform: none; opacity: 1; }
}

@keyframes lightSpeedIn {=20
  0% { transform: translate3d(100%, 0px, 0px) skewX(-30deg); opacity: 0; }
  60% { transform: skewX(20deg); opacity: 1; }
  80% { transform: skewX(-5deg); opacity: 1; }
  100% { transform: none; opacity: 1; }
}

.lightSpeedIn { animation-name: lightSpeedIn; animation-timing-function: ea=
se-out; }

@-webkit-keyframes lightSpeedOut {=20
  0% { opacity: 1; }
  100% { transform: translate3d(100%, 0px, 0px) skewX(30deg); opacity: 0; }
}

@keyframes lightSpeedOut {=20
  0% { opacity: 1; }
  100% { transform: translate3d(100%, 0px, 0px) skewX(30deg); opacity: 0; }
}

.lightSpeedOut { animation-name: lightSpeedOut; animation-timing-function: =
ease-in; }

@-webkit-keyframes rotateIn {=20
  0% { transform-origin: center center; transform: rotate3d(0, 0, 1, -200de=
g); opacity: 0; }
  100% { transform-origin: center center; transform: none; opacity: 1; }
}

@keyframes rotateIn {=20
  0% { transform-origin: center center; transform: rotate3d(0, 0, 1, -200de=
g); opacity: 0; }
  100% { transform-origin: center center; transform: none; opacity: 1; }
}

.rotateIn { animation-name: rotateIn; }

@-webkit-keyframes rotateInDownLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg);=
 opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

@keyframes rotateInDownLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg);=
 opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

.rotateInDownLeft { animation-name: rotateInDownLeft; }

@-webkit-keyframes rotateInDownRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 45deg);=
 opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

@keyframes rotateInDownRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 45deg);=
 opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

.rotateInDownRight { animation-name: rotateInDownRight; }

@-webkit-keyframes rotateInUpLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg); =
opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

@keyframes rotateInUpLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg); =
opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

.rotateInUpLeft { animation-name: rotateInUpLeft; }

@-webkit-keyframes rotateInUpRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -90deg)=
; opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

@keyframes rotateInUpRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -90deg)=
; opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

.rotateInUpRight { animation-name: rotateInUpRight; }

@-webkit-keyframes rotateOut {=20
  0% { transform-origin: center center; opacity: 1; }
  100% { transform-origin: center center; transform: rotate3d(0, 0, 1, 200d=
eg); opacity: 0; }
}

@keyframes rotateOut {=20
  0% { transform-origin: center center; opacity: 1; }
  100% { transform-origin: center center; transform: rotate3d(0, 0, 1, 200d=
eg); opacity: 0; }
}

.rotateOut { animation-name: rotateOut; }

@-webkit-keyframes rotateOutDownLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg)=
; opacity: 0; }
}

@keyframes rotateOutDownLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg)=
; opacity: 0; }
}

.rotateOutDownLeft { animation-name: rotateOutDownLeft; }

@-webkit-keyframes rotateOutDownRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -45de=
g); opacity: 0; }
}

@keyframes rotateOutDownRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -45de=
g); opacity: 0; }
}

.rotateOutDownRight { animation-name: rotateOutDownRight; }

@-webkit-keyframes rotateOutUpLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg=
); opacity: 0; }
}

@keyframes rotateOutUpLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg=
); opacity: 0; }
}

.rotateOutUpLeft { animation-name: rotateOutUpLeft; }

@-webkit-keyframes rotateOutUpRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 90deg=
); opacity: 0; }
}

@keyframes rotateOutUpRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 90deg=
); opacity: 0; }
}

.rotateOutUpRight { animation-name: rotateOutUpRight; }

@-webkit-keyframes hinge {=20
  0% { transform-origin: left top; animation-timing-function: ease-in-out; =
}
  20%, 60% { transform: rotate3d(0, 0, 1, 80deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; }
  40%, 80% { transform: rotate3d(0, 0, 1, 60deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; opacity: 1; }
  100% { transform: translate3d(0px, 700px, 0px); opacity: 0; }
}

@keyframes hinge {=20
  0% { transform-origin: left top; animation-timing-function: ease-in-out; =
}
  20%, 60% { transform: rotate3d(0, 0, 1, 80deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; }
  40%, 80% { transform: rotate3d(0, 0, 1, 60deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; opacity: 1; }
  100% { transform: translate3d(0px, 700px, 0px); opacity: 0; }
}

.hinge { animation-name: hinge; }

@-webkit-keyframes rollIn {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px) rotate3d(0, 0, 1=
, -120deg); }
  100% { opacity: 1; transform: none; }
}

@keyframes rollIn {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px) rotate3d(0, 0, 1=
, -120deg); }
  100% { opacity: 1; transform: none; }
}

.rollIn { animation-name: rollIn; }

@-webkit-keyframes rollOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px) rotate3d(0, 0, =
1, 120deg); }
}

@keyframes rollOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px) rotate3d(0, 0, =
1, 120deg); }
}

.rollOut { animation-name: rollOut; }

@-webkit-keyframes zoomIn {=20
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  50% { opacity: 1; }
}

@keyframes zoomIn {=20
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  50% { opacity: 1; }
}

.zoomIn { animation-name: zoomIn; }

@-webkit-keyframes zoomInDown {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -1000=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

@keyframes zoomInDown {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -1000=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

.zoomInDown { animation-name: zoomInDown; }

@-webkit-keyframes zoomInLeft {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(-1000px, 0=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(10p=
x, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

@keyframes zoomInLeft {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(-1000px, 0=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(10p=
x, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

.zoomInLeft { animation-name: zoomInLeft; }

@-webkit-keyframes zoomInRight {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(1000px, 0p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-10=
px, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

@keyframes zoomInRight {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(1000px, 0p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-10=
px, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

.zoomInRight { animation-name: zoomInRight; }

@-webkit-keyframes zoomInUp {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 1000p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

@keyframes zoomInUp {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 1000p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

.zoomInUp { animation-name: zoomInUp; }

@-webkit-keyframes zoomOut {=20
  0% { opacity: 1; }
  50% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  100% { opacity: 0; }
}

@keyframes zoomOut {=20
  0% { opacity: 1; }
  50% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  100% { opacity: 0; }
}

.zoomOut { animation-name: zoomOut; }

@-webkit-keyframes zoomOutDown {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, =
0.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 200=
0px, 0px); transform-origin: center bottom; animation-timing-function: cubi=
c-bezier(0.175, 0.885, 0.32, 1); }
}

@keyframes zoomOutDown {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, =
0.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 200=
0px, 0px); transform-origin: center bottom; animation-timing-function: cubi=
c-bezier(0.175, 0.885, 0.32, 1); }
}

.zoomOutDown { animation-name: zoomOutDown; }

@-webkit-keyframes zoomOutLeft {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(42p=
x, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(-2000px, 0px, 0px); =
transform-origin: left center; }
}

@keyframes zoomOutLeft {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(42p=
x, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(-2000px, 0px, 0px); =
transform-origin: left center; }
}

.zoomOutLeft { animation-name: zoomOutLeft; }

@-webkit-keyframes zoomOutRight {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-42=
px, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(2000px, 0px, 0px); t=
ransform-origin: right center; }
}

@keyframes zoomOutRight {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-42=
px, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(2000px, 0px, 0px); t=
ransform-origin: right center; }
}

.zoomOutRight { animation-name: zoomOutRight; }

@-webkit-keyframes zoomOutUp {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0=
.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -20=
00px, 0px); transform-origin: center bottom; animation-timing-function: cub=
ic-bezier(0.175, 0.885, 0.32, 1); }
}

@keyframes zoomOutUp {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0=
.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -20=
00px, 0px); transform-origin: center bottom; animation-timing-function: cub=
ic-bezier(0.175, 0.885, 0.32, 1); }
}

.zoomOutUp { animation-name: zoomOutUp; }

:root { --border-radii: 0; --pat-toggle-height: 26px; --pat-toggle-switch-b=
order-radius: 14px; --pat-toggle-background-colour-off: silver; --pat-toggl=
e-background-colour-on: #e1eddb; --pat-toggle-toggle-distance: 2px; --pat-t=
oggle-toggle-border-radius: 50%; --pat-toggle-toggle-background-colour: whi=
te; --pat-toggle-toggle-background-colour-on: white; --pat-toggle-padding-s=
tart-end: 10px; --pat-toggle-box-shadow: none; --pat-toggle-box-shadow-on: =
none; --pat-toggle-text-colour: white; --pat-toggle-text-shadow-on: none; -=
-pat-auto-suggest-cancel-button-edge-distance: 12px; --pat-portlet-backgrou=
nd-colour: rgba(255, 255, 255, 0.5); --pat-form-horizontal-label-width: 27%=
; --pat-form-horizontal-extra-width: 26px; --pat-form-horizontal-column-gap=
: 25px; --pat-form-proportion-gutter: 15px; --pat-form-input-field-line-hei=
ght: 28px; --pat-form-input-field-padding-top-bottom-disabled: 0; --pat-for=
m-input-field-padding-left-right-disabled: 0; --pat-form-input-field-font-s=
ize: 1.265625rem; --pat-form-input-field-font-weight: normal; --pat-form-in=
put-field-background-colour: var(--colour-form-fields-background); --pat-fo=
rm-input-field-background-colour-disabled: transparent; --pat-form-input-fi=
eld-text-colour: black; --pat-form-fields-border-radius: var(--border-radii=
); --pat-form-placeholder-colour: rgba(0, 0, 0, 0.35); --pat-form-input-fie=
ld-text: inherit; --pat-form-input-field-text-disabled: rgba(0, 0, 0, 0.5);=
 --pat-form-panel-background-colour: #f2f2f2; --pat-form-panel-collapsible-=
button-height: $collapsible-button-height; --pat-form-input-field-outline: =
none; --pat-form-input-field-outline-offset: 2px; --pat-form-input-field-ou=
tline-focus: dodgerblue 2px solid; --pat-form-input-field-border-focus: non=
e; --pat-form-input-field-box-shadow-disabled: none; --pat-form-input-field=
-box-shadow-focus: none; --pat-form-help-button-height: 37px; --pat-form-he=
lp-button-width: 26px; --pat-form-help-button-icon-height: 37px; --pat-form=
-help-button-icon-glyph: $glyph-question-mark; --pat-form-help-button-icon-=
border-radius: 0; --pat-form-panel-box-shadow-hover: 0 0 1px 1px rgba(0, 0,=
 0, 0.5); --pat-form-panel-padding: 40px; --pat-form-panel-padding-large: 4=
0px; --pat-form-panel-padding-medium: 30px; --pat-form-panel-padding-small:=
 20px; --pat-form-input-field-padding-top-bottom: 4px; --pat-form-input-fie=
ld-padding-start-end: 10px; --pat-form-input-field-border: none; --pat-form=
-input-field-box-shadow: none; --pat-form-input-field-border-radius: 0; --p=
at-form-proportion-ceiling: 260%; --pat-form-proportion-name: 30%; --pat-fo=
rm-proportion-value: 80%; --pat-form-proportion-value-small: 100%; --pat-fo=
rm-input-field-tail-white: 26px; --pat-select-box-arrow-width: 35px; --pat-=
select-box-arrow-size: 18px; --pat-select-arrow-space: 29px; --pat-select-b=
ox-padding-top-bottom: var(--pat-form-input-field-padding-top-bottom); --pa=
t-select-box-padding-start: var(--pat-form-input-field-padding-start-end); =
--pat-select-box-box-shadow: var(--pat-form-input-field-box-shadow); --pat-=
select-box-background-colour: var(--pat-form-input-field-background-colour)=
; --pat-select-box-background-colour-hover: var(--pat-form-input-field-back=
ground-colour); --pat-select-box-arrow-background-colour: rgba(0, 0, 0, 0.1=
); --pat-select-box-arrow-text-colour: inherit; --pat-select-box-font-size:=
 var(--pat-form-input-field-font-size); --pat-select-arrow-edge-distance: 1=
2px; --pat-select-box-height: var(--pat-form-input-field-line-height); --pa=
t-checklist-label-padding-start: 1.5em; --pat-checklist-label-padding-end: =
0; --pat-checklist-item-separation: 0.2em; --pat-menu-list-item-padding-sta=
rt: 34px; --pat-button-height: 35px; --pat-button-line-height: 35px; --pat-=
button-font-size: 1.265625rem; --pat-button-font-weight: bold; --pat-button=
-paddings: 0 1.265625rem; --pat-sortable-blocks-padding-start: 44px; --pat-=
sortable-blocks-button-width: 36px; --pat-sortable-blocks-gap: 6px; --pat-s=
ortable-blocks-handle-colour: #e17000; --pat-sortable-blocks-remove-button-=
width: 20px; --pat-sortable-blocks-remove-button-height: 34px; --pat-sortab=
le-blocks-remove-button-icon-height: 20px; --pat-sortable-blocks-remove-but=
ton-icon-border-radius: 50%; --pat-sortable-blocks-item-info-box-shadow: no=
ne; --pat-context-menu-panel-distance: 1.7em; --pat-context-menu-panel-widt=
h: 250px; }

@keyframes bounceInCentred {=20
  0%, 20%, 40%, 60%, 80%, 100% { transition-timing-function: cubic-bezier(0=
.215, 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate(-50%, -50%) scale3d(0.3, 0.3, 0.3);=
 }
  20% { transform: translate(-50%, -50%) scale3d(1.1, 1.1, 1.1); }
  40% { transform: translate(-50%, -50%) scale3d(0.9, 0.9, 0.9); }
  60% { opacity: 1; transform: translate(-50%, -50%) scale3d(1.03, 1.03, 1.=
03); }
  80% { transform: translate(-50%, -50%) scale3d(0.97, 0.97, 0.97); }
  100% { opacity: 1; transform: translate(-50%, -50%) scale3d(1, 1, 1); }
}

.animate-spin { animation: 2s linear 0s infinite normal none running spin; =
display: inline-block; }

@-webkit-keyframes spin {=20
  0% { transform: rotate(0deg); }
  100% { transform: rotate(359deg); }
}

@keyframes spin {=20
  0% { transform: rotate(0deg); }
  100% { transform: rotate(359deg); }
}

:root { --colour-link: #01689b; --colour-form-fields-background: rgba(0, 0,=
 0, 0.1); --colour-accent: #e17000; }

@media only screen and (max-width: 769px) {
  body { --pat-form-panel-padding: 20px; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  body { --pat-form-panel-padding: 30px; }
}

@media only screen and (min-width: 1280px) {
  body { --pat-form-panel-padding: 40px; }
}

body, h1, h2, h3, h4, h5, h6, p, blockquote, ul, ol, li, table, tr, th, td,=
 form, fieldset, legend, button, div, object, figure, table, img, abbr { ma=
rgin: 0px; border: 0px; padding: 0px; list-style: none; text-align: left; t=
ext-decoration: none; }

body[dir=3D"rtl"] body, body[dir=3D"rtl"] h1, body[dir=3D"rtl"] h2, body[di=
r=3D"rtl"] h3, body[dir=3D"rtl"] h4, body[dir=3D"rtl"] h5, body[dir=3D"rtl"=
] h6, body[dir=3D"rtl"] p, body[dir=3D"rtl"] blockquote, body[dir=3D"rtl"] =
ul, body[dir=3D"rtl"] ol, body[dir=3D"rtl"] li, body[dir=3D"rtl"] table, bo=
dy[dir=3D"rtl"] tr, body[dir=3D"rtl"] th, body[dir=3D"rtl"] td, body[dir=3D=
"rtl"] form, body[dir=3D"rtl"] fieldset, body[dir=3D"rtl"] legend, body[dir=
=3D"rtl"] button, body[dir=3D"rtl"] div, body[dir=3D"rtl"] object, body[dir=
=3D"rtl"] figure, body[dir=3D"rtl"] table, body[dir=3D"rtl"] img, body[dir=
=3D"rtl"] abbr { text-align: right; }

input, select, textarea, button { padding: 0px; background-color: rgb(255, =
255, 255); font-size: 1em; }

.animated { animation-duration: 1s; animation-fill-mode: both; }

.animated.infinite { animation-iteration-count: infinite; }

.animated.hinge { animation-duration: 2s; }

@-webkit-keyframes bounce {=20
  0%, 20%, 53%, 80%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); transform: translate3d(0px, 0px, 0px); }
  40%, 43% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0=
.06); transform: translate3d(0px, -30px, 0px); }
  70% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0.06);=
 transform: translate3d(0px, -15px, 0px); }
  90% { transform: translate3d(0px, -4px, 0px); }
}

@keyframes bounce {=20
  0%, 20%, 53%, 80%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); transform: translate3d(0px, 0px, 0px); }
  40%, 43% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0=
.06); transform: translate3d(0px, -30px, 0px); }
  70% { transition-timing-function: cubic-bezier(0.755, 0.05, 0.855, 0.06);=
 transform: translate3d(0px, -15px, 0px); }
  90% { transform: translate3d(0px, -4px, 0px); }
}

.bounce { animation-name: bounce; transform-origin: center bottom; }

@-webkit-keyframes flash {=20
  0%, 50%, 100% { opacity: 1; }
  25%, 75% { opacity: 0; }
}

@keyframes flash {=20
  0%, 50%, 100% { opacity: 1; }
  25%, 75% { opacity: 0; }
}

.flash { animation-name: flash; }

@-webkit-keyframes pulse {=20
  0% { transform: scale3d(1, 1, 1); }
  50% { transform: scale3d(1.05, 1.05, 1.05); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes pulse {=20
  0% { transform: scale3d(1, 1, 1); }
  50% { transform: scale3d(1.05, 1.05, 1.05); }
  100% { transform: scale3d(1, 1, 1); }
}

.pulse { animation-name: pulse; }

@-webkit-keyframes rubberBand {=20
  0% { transform: scale3d(1, 1, 1); }
  30% { transform: scale3d(1.25, 0.75, 1); }
  40% { transform: scale3d(0.75, 1.25, 1); }
  50% { transform: scale3d(1.15, 0.85, 1); }
  65% { transform: scale3d(0.95, 1.05, 1); }
  75% { transform: scale3d(1.05, 0.95, 1); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes rubberBand {=20
  0% { transform: scale3d(1, 1, 1); }
  30% { transform: scale3d(1.25, 0.75, 1); }
  40% { transform: scale3d(0.75, 1.25, 1); }
  50% { transform: scale3d(1.15, 0.85, 1); }
  65% { transform: scale3d(0.95, 1.05, 1); }
  75% { transform: scale3d(1.05, 0.95, 1); }
  100% { transform: scale3d(1, 1, 1); }
}

.rubberBand { animation-name: rubberBand; }

@-webkit-keyframes shake {=20
  0%, 100% { transform: translate3d(0px, 0px, 0px); }
  10%, 30%, 50%, 70%, 90% { transform: translate3d(-10px, 0px, 0px); }
  20%, 40%, 60%, 80% { transform: translate3d(10px, 0px, 0px); }
}

@keyframes shake {=20
  0%, 100% { transform: translate3d(0px, 0px, 0px); }
  10%, 30%, 50%, 70%, 90% { transform: translate3d(-10px, 0px, 0px); }
  20%, 40%, 60%, 80% { transform: translate3d(10px, 0px, 0px); }
}

.shake { animation-name: shake; }

@-webkit-keyframes swing {=20
  20% { transform: rotate3d(0, 0, 1, 15deg); }
  40% { transform: rotate3d(0, 0, 1, -10deg); }
  60% { transform: rotate3d(0, 0, 1, 5deg); }
  80% { transform: rotate3d(0, 0, 1, -5deg); }
  100% { transform: rotate3d(0, 0, 1, 0deg); }
}

@keyframes swing {=20
  20% { transform: rotate3d(0, 0, 1, 15deg); }
  40% { transform: rotate3d(0, 0, 1, -10deg); }
  60% { transform: rotate3d(0, 0, 1, 5deg); }
  80% { transform: rotate3d(0, 0, 1, -5deg); }
  100% { transform: rotate3d(0, 0, 1, 0deg); }
}

.swing { transform-origin: center top; animation-name: swing; }

@-webkit-keyframes tada {=20
  0% { transform: scale3d(1, 1, 1); }
  10%, 20% { transform: scale3d(0.9, 0.9, 0.9) rotate3d(0, 0, 1, -3deg); }
  30%, 50%, 70%, 90% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, =
3deg); }
  40%, 60%, 80% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg=
); }
  100% { transform: scale3d(1, 1, 1); }
}

@keyframes tada {=20
  0% { transform: scale3d(1, 1, 1); }
  10%, 20% { transform: scale3d(0.9, 0.9, 0.9) rotate3d(0, 0, 1, -3deg); }
  30%, 50%, 70%, 90% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, =
3deg); }
  40%, 60%, 80% { transform: scale3d(1.1, 1.1, 1.1) rotate3d(0, 0, 1, -3deg=
); }
  100% { transform: scale3d(1, 1, 1); }
}

.tada { animation-name: tada; }

@-webkit-keyframes wobble {=20
  0% { transform: none; }
  15% { transform: translate3d(-25%, 0px, 0px) rotate3d(0, 0, 1, -5deg); }
  30% { transform: translate3d(20%, 0px, 0px) rotate3d(0, 0, 1, 3deg); }
  45% { transform: translate3d(-15%, 0px, 0px) rotate3d(0, 0, 1, -3deg); }
  60% { transform: translate3d(10%, 0px, 0px) rotate3d(0, 0, 1, 2deg); }
  75% { transform: translate3d(-5%, 0px, 0px) rotate3d(0, 0, 1, -1deg); }
  100% { transform: none; }
}

@keyframes wobble {=20
  0% { transform: none; }
  15% { transform: translate3d(-25%, 0px, 0px) rotate3d(0, 0, 1, -5deg); }
  30% { transform: translate3d(20%, 0px, 0px) rotate3d(0, 0, 1, 3deg); }
  45% { transform: translate3d(-15%, 0px, 0px) rotate3d(0, 0, 1, -3deg); }
  60% { transform: translate3d(10%, 0px, 0px) rotate3d(0, 0, 1, 2deg); }
  75% { transform: translate3d(-5%, 0px, 0px) rotate3d(0, 0, 1, -1deg); }
  100% { transform: none; }
}

.wobble { animation-name: wobble; }

@-webkit-keyframes bounceIn {=20
  0%, 20%, 40%, 60%, 80%, 100% { transition-timing-function: cubic-bezier(0=
.215, 0.61, 0.355, 1); }
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  20% { transform: scale3d(1.1, 1.1, 1.1); }
  40% { transform: scale3d(0.9, 0.9, 0.9); }
  60% { opacity: 1; transform: scale3d(1.03, 1.03, 1.03); }
  80% { transform: scale3d(0.97, 0.97, 0.97); }
  100% { opacity: 1; transform: scale3d(1, 1, 1); }
}

@keyframes bounceIn {=20
  0%, 20%, 40%, 60%, 80%, 100% { transition-timing-function: cubic-bezier(0=
.215, 0.61, 0.355, 1); }
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  20% { transform: scale3d(1.1, 1.1, 1.1); }
  40% { transform: scale3d(0.9, 0.9, 0.9); }
  60% { opacity: 1; transform: scale3d(1.03, 1.03, 1.03); }
  80% { transform: scale3d(0.97, 0.97, 0.97); }
  100% { opacity: 1; transform: scale3d(1, 1, 1); }
}

.bounceIn { animation-name: bounceIn; animation-duration: 0.75s; }

@-webkit-keyframes bounceInDown {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, -3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, 25px, 0px); }
  75% { transform: translate3d(0px, -10px, 0px); }
  90% { transform: translate3d(0px, 5px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInDown {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, -3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, 25px, 0px); }
  75% { transform: translate3d(0px, -10px, 0px); }
  90% { transform: translate3d(0px, 5px, 0px); }
  100% { transform: none; }
}

.bounceInDown { animation-name: bounceInDown; }

@-webkit-keyframes bounceInLeft {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(-3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(25px, 0px, 0px); }
  75% { transform: translate3d(-10px, 0px, 0px); }
  90% { transform: translate3d(5px, 0px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInLeft {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(-3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(25px, 0px, 0px); }
  75% { transform: translate3d(-10px, 0px, 0px); }
  90% { transform: translate3d(5px, 0px, 0px); }
  100% { transform: none; }
}

.bounceInLeft { animation-name: bounceInLeft; }

@-webkit-keyframes bounceInRight {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(-25px, 0px, 0px); }
  75% { transform: translate3d(10px, 0px, 0px); }
  90% { transform: translate3d(-5px, 0px, 0px); }
  100% { transform: none; }
}

@keyframes bounceInRight {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(3000px, 0px, 0px); }
  60% { opacity: 1; transform: translate3d(-25px, 0px, 0px); }
  75% { transform: translate3d(10px, 0px, 0px); }
  90% { transform: translate3d(-5px, 0px, 0px); }
  100% { transform: none; }
}

.bounceInRight { animation-name: bounceInRight; }

@-webkit-keyframes bounceInUp {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, 3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  75% { transform: translate3d(0px, 10px, 0px); }
  90% { transform: translate3d(0px, -5px, 0px); }
  100% { transform: translate3d(0px, 0px, 0px); }
}

@keyframes bounceInUp {=20
  0%, 60%, 75%, 90%, 100% { transition-timing-function: cubic-bezier(0.215,=
 0.61, 0.355, 1); }
  0% { opacity: 0; transform: translate3d(0px, 3000px, 0px); }
  60% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  75% { transform: translate3d(0px, 10px, 0px); }
  90% { transform: translate3d(0px, -5px, 0px); }
  100% { transform: translate3d(0px, 0px, 0px); }
}

.bounceInUp { animation-name: bounceInUp; }

@-webkit-keyframes bounceOut {=20
  20% { transform: scale3d(0.9, 0.9, 0.9); }
  50%, 55% { opacity: 1; transform: scale3d(1.1, 1.1, 1.1); }
  100% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
}

@keyframes bounceOut {=20
  20% { transform: scale3d(0.9, 0.9, 0.9); }
  50%, 55% { opacity: 1; transform: scale3d(1.1, 1.1, 1.1); }
  100% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
}

.bounceOut { animation-name: bounceOut; animation-duration: 0.75s; }

@-webkit-keyframes bounceOutDown {=20
  20% { transform: translate3d(0px, 10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

@keyframes bounceOutDown {=20
  20% { transform: translate3d(0px, 10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, -20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

.bounceOutDown { animation-name: bounceOutDown; }

@-webkit-keyframes bounceOutLeft {=20
  20% { opacity: 1; transform: translate3d(20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

@keyframes bounceOutLeft {=20
  20% { opacity: 1; transform: translate3d(20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

.bounceOutLeft { animation-name: bounceOutLeft; }

@-webkit-keyframes bounceOutRight {=20
  20% { opacity: 1; transform: translate3d(-20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

@keyframes bounceOutRight {=20
  20% { opacity: 1; transform: translate3d(-20px, 0px, 0px); }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

.bounceOutRight { animation-name: bounceOutRight; }

@-webkit-keyframes bounceOutUp {=20
  20% { transform: translate3d(0px, -10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, 20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

@keyframes bounceOutUp {=20
  20% { transform: translate3d(0px, -10px, 0px); }
  40%, 45% { opacity: 1; transform: translate3d(0px, 20px, 0px); }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

.bounceOutUp { animation-name: bounceOutUp; }

@-webkit-keyframes fadeIn {=20
  0% { opacity: 0; }
  100% { opacity: 1; }
}

@keyframes fadeIn {=20
  0% { opacity: 0; }
  100% { opacity: 1; }
}

.fadeIn { animation-name: fadeIn; }

@-webkit-keyframes fadeInDown {=20
  0% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInDown {=20
  0% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInDown { animation-name: fadeInDown; }

@-webkit-keyframes fadeInDownBig {=20
  0% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInDownBig {=20
  0% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInDownBig { animation-name: fadeInDownBig; }

@-webkit-keyframes fadeInLeft {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInLeft {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInLeft { animation-name: fadeInLeft; }

@-webkit-keyframes fadeInLeftBig {=20
  0% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInLeftBig {=20
  0% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInLeftBig { animation-name: fadeInLeftBig; }

@-webkit-keyframes fadeInRight {=20
  0% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInRight {=20
  0% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInRight { animation-name: fadeInRight; }

@-webkit-keyframes fadeInRightBig {=20
  0% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInRightBig {=20
  0% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInRightBig { animation-name: fadeInRightBig; }

@-webkit-keyframes fadeInUp {=20
  0% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInUp {=20
  0% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInUp { animation-name: fadeInUp; }

@-webkit-keyframes fadeInUpBig {=20
  0% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

@keyframes fadeInUpBig {=20
  0% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
  100% { opacity: 1; transform: none; }
}

.fadeInUpBig { animation-name: fadeInUpBig; }

@-webkit-keyframes fadeOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; }
}

@keyframes fadeOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; }
}

.fadeOut { animation-name: fadeOut; }

@-webkit-keyframes fadeOutDown {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
}

@keyframes fadeOutDown {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 100%, 0px); }
}

.fadeOutDown { animation-name: fadeOutDown; }

@-webkit-keyframes fadeOutDownBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

@keyframes fadeOutDownBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, 2000px, 0px); }
}

.fadeOutDownBig { animation-name: fadeOutDownBig; }

@-webkit-keyframes fadeOutLeft {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
}

@keyframes fadeOutLeft {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-100%, 0px, 0px); }
}

.fadeOutLeft { animation-name: fadeOutLeft; }

@-webkit-keyframes fadeOutLeftBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

@keyframes fadeOutLeftBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(-2000px, 0px, 0px); }
}

.fadeOutLeftBig { animation-name: fadeOutLeftBig; }

@-webkit-keyframes fadeOutRight {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
}

@keyframes fadeOutRight {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px); }
}

.fadeOutRight { animation-name: fadeOutRight; }

@-webkit-keyframes fadeOutRightBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

@keyframes fadeOutRightBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(2000px, 0px, 0px); }
}

.fadeOutRightBig { animation-name: fadeOutRightBig; }

@-webkit-keyframes fadeOutUp {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
}

@keyframes fadeOutUp {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -100%, 0px); }
}

.fadeOutUp { animation-name: fadeOutUp; }

@-webkit-keyframes fadeOutUpBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

@keyframes fadeOutUpBig {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(0px, -2000px, 0px); }
}

.fadeOutUpBig { animation-name: fadeOutUpBig; }

@-webkit-keyframes flip {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, -360deg); animation-=
timing-function: ease-out; }
  40% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -190deg); animation-timing-function: ease-out; }
  50% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -170deg); animation-timing-function: ease-in; }
  80% { transform: perspective(400px) scale3d(0.95, 0.95, 0.95); animation-=
timing-function: ease-in; }
  100% { transform: perspective(400px); animation-timing-function: ease-in;=
 }
}

@keyframes flip {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, -360deg); animation-=
timing-function: ease-out; }
  40% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -190deg); animation-timing-function: ease-out; }
  50% { transform: perspective(400px) translate3d(0px, 0px, 150px) rotate3d=
(0, 1, 0, -170deg); animation-timing-function: ease-in; }
  80% { transform: perspective(400px) scale3d(0.95, 0.95, 0.95); animation-=
timing-function: ease-in; }
  100% { transform: perspective(400px); animation-timing-function: ease-in;=
 }
}

.animated.flip { backface-visibility: visible; animation-name: flip; }

@-webkit-keyframes flipInX {=20
  0% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(1, 0, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(1, 0, 0, -5deg); }
  100% { transform: perspective(400px); }
}

@keyframes flipInX {=20
  0% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(1, 0, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(1, 0, 0, -5deg); }
  100% { transform: perspective(400px); }
}

.flipInX { animation-name: flipInX; backface-visibility: visible !important=
; }

@-webkit-keyframes flipInY {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(0, 1, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(0, 1, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(0, 1, 0, -5deg); }
  100% { transform: perspective(400px); }
}

@keyframes flipInY {=20
  0% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); transition-t=
iming-function: ease-in; opacity: 0; }
  40% { transform: perspective(400px) rotate3d(0, 1, 0, -20deg); transition=
-timing-function: ease-in; }
  60% { transform: perspective(400px) rotate3d(0, 1, 0, 10deg); opacity: 1;=
 }
  80% { transform: perspective(400px) rotate3d(0, 1, 0, -5deg); }
  100% { transform: perspective(400px); }
}

.flipInY { animation-name: flipInY; backface-visibility: visible !important=
; }

@-webkit-keyframes flipOutX {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); opacity: 0=
; }
}

@keyframes flipOutX {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(1, 0, 0, -20deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(1, 0, 0, 90deg); opacity: 0=
; }
}

.flipOutX { animation-name: flipOutX; animation-duration: 0.75s; backface-v=
isibility: visible !important; }

@-webkit-keyframes flipOutY {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(0, 1, 0, -15deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); opacity: 0=
; }
}

@keyframes flipOutY {=20
  0% { transform: perspective(400px); }
  30% { transform: perspective(400px) rotate3d(0, 1, 0, -15deg); opacity: 1=
; }
  100% { transform: perspective(400px) rotate3d(0, 1, 0, 90deg); opacity: 0=
; }
}

.flipOutY { animation-name: flipOutY; animation-duration: 0.75s; backface-v=
isibility: visible !important; }

@-webkit-keyframes lightSpeedIn {=20
  0% { transform: translate3d(100%, 0px, 0px) skewX(-30deg); opacity: 0; }
  60% { transform: skewX(20deg); opacity: 1; }
  80% { transform: skewX(-5deg); opacity: 1; }
  100% { transform: none; opacity: 1; }
}

@keyframes lightSpeedIn {=20
  0% { transform: translate3d(100%, 0px, 0px) skewX(-30deg); opacity: 0; }
  60% { transform: skewX(20deg); opacity: 1; }
  80% { transform: skewX(-5deg); opacity: 1; }
  100% { transform: none; opacity: 1; }
}

.lightSpeedIn { animation-name: lightSpeedIn; animation-timing-function: ea=
se-out; }

@-webkit-keyframes lightSpeedOut {=20
  0% { opacity: 1; }
  100% { transform: translate3d(100%, 0px, 0px) skewX(30deg); opacity: 0; }
}

@keyframes lightSpeedOut {=20
  0% { opacity: 1; }
  100% { transform: translate3d(100%, 0px, 0px) skewX(30deg); opacity: 0; }
}

.lightSpeedOut { animation-name: lightSpeedOut; animation-timing-function: =
ease-in; }

@-webkit-keyframes rotateIn {=20
  0% { transform-origin: center center; transform: rotate3d(0, 0, 1, -200de=
g); opacity: 0; }
  100% { transform-origin: center center; transform: none; opacity: 1; }
}

@keyframes rotateIn {=20
  0% { transform-origin: center center; transform: rotate3d(0, 0, 1, -200de=
g); opacity: 0; }
  100% { transform-origin: center center; transform: none; opacity: 1; }
}

.rotateIn { animation-name: rotateIn; }

@-webkit-keyframes rotateInDownLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg);=
 opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

@keyframes rotateInDownLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg);=
 opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

.rotateInDownLeft { animation-name: rotateInDownLeft; }

@-webkit-keyframes rotateInDownRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 45deg);=
 opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

@keyframes rotateInDownRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 45deg);=
 opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

.rotateInDownRight { animation-name: rotateInDownRight; }

@-webkit-keyframes rotateInUpLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg); =
opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

@keyframes rotateInUpLeft {=20
  0% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg); =
opacity: 0; }
  100% { transform-origin: left bottom; transform: none; opacity: 1; }
}

.rotateInUpLeft { animation-name: rotateInUpLeft; }

@-webkit-keyframes rotateInUpRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -90deg)=
; opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

@keyframes rotateInUpRight {=20
  0% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -90deg)=
; opacity: 0; }
  100% { transform-origin: right bottom; transform: none; opacity: 1; }
}

.rotateInUpRight { animation-name: rotateInUpRight; }

@-webkit-keyframes rotateOut {=20
  0% { transform-origin: center center; opacity: 1; }
  100% { transform-origin: center center; transform: rotate3d(0, 0, 1, 200d=
eg); opacity: 0; }
}

@keyframes rotateOut {=20
  0% { transform-origin: center center; opacity: 1; }
  100% { transform-origin: center center; transform: rotate3d(0, 0, 1, 200d=
eg); opacity: 0; }
}

.rotateOut { animation-name: rotateOut; }

@-webkit-keyframes rotateOutDownLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg)=
; opacity: 0; }
}

@keyframes rotateOutDownLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, 45deg)=
; opacity: 0; }
}

.rotateOutDownLeft { animation-name: rotateOutDownLeft; }

@-webkit-keyframes rotateOutDownRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -45de=
g); opacity: 0; }
}

@keyframes rotateOutDownRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, -45de=
g); opacity: 0; }
}

.rotateOutDownRight { animation-name: rotateOutDownRight; }

@-webkit-keyframes rotateOutUpLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg=
); opacity: 0; }
}

@keyframes rotateOutUpLeft {=20
  0% { transform-origin: left bottom; opacity: 1; }
  100% { transform-origin: left bottom; transform: rotate3d(0, 0, 1, -45deg=
); opacity: 0; }
}

.rotateOutUpLeft { animation-name: rotateOutUpLeft; }

@-webkit-keyframes rotateOutUpRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 90deg=
); opacity: 0; }
}

@keyframes rotateOutUpRight {=20
  0% { transform-origin: right bottom; opacity: 1; }
  100% { transform-origin: right bottom; transform: rotate3d(0, 0, 1, 90deg=
); opacity: 0; }
}

.rotateOutUpRight { animation-name: rotateOutUpRight; }

@-webkit-keyframes hinge {=20
  0% { transform-origin: left top; animation-timing-function: ease-in-out; =
}
  20%, 60% { transform: rotate3d(0, 0, 1, 80deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; }
  40%, 80% { transform: rotate3d(0, 0, 1, 60deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; opacity: 1; }
  100% { transform: translate3d(0px, 700px, 0px); opacity: 0; }
}

@keyframes hinge {=20
  0% { transform-origin: left top; animation-timing-function: ease-in-out; =
}
  20%, 60% { transform: rotate3d(0, 0, 1, 80deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; }
  40%, 80% { transform: rotate3d(0, 0, 1, 60deg); transform-origin: left to=
p; animation-timing-function: ease-in-out; opacity: 1; }
  100% { transform: translate3d(0px, 700px, 0px); opacity: 0; }
}

.hinge { animation-name: hinge; }

@-webkit-keyframes rollIn {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px) rotate3d(0, 0, 1=
, -120deg); }
  100% { opacity: 1; transform: none; }
}

@keyframes rollIn {=20
  0% { opacity: 0; transform: translate3d(-100%, 0px, 0px) rotate3d(0, 0, 1=
, -120deg); }
  100% { opacity: 1; transform: none; }
}

.rollIn { animation-name: rollIn; }

@-webkit-keyframes rollOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px) rotate3d(0, 0, =
1, 120deg); }
}

@keyframes rollOut {=20
  0% { opacity: 1; }
  100% { opacity: 0; transform: translate3d(100%, 0px, 0px) rotate3d(0, 0, =
1, 120deg); }
}

.rollOut { animation-name: rollOut; }

@-webkit-keyframes zoomIn {=20
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  50% { opacity: 1; }
}

@keyframes zoomIn {=20
  0% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  50% { opacity: 1; }
}

.zoomIn { animation-name: zoomIn; }

@-webkit-keyframes zoomInDown {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -1000=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

@keyframes zoomInDown {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -1000=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

.zoomInDown { animation-name: zoomInDown; }

@-webkit-keyframes zoomInLeft {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(-1000px, 0=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(10p=
x, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

@keyframes zoomInLeft {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(-1000px, 0=
px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19)=
; }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(10p=
x, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, 1=
); }
}

.zoomInLeft { animation-name: zoomInLeft; }

@-webkit-keyframes zoomInRight {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(1000px, 0p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-10=
px, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

@keyframes zoomInRight {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(1000px, 0p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-10=
px, 0px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

.zoomInRight { animation-name: zoomInRight; }

@-webkit-keyframes zoomInUp {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 1000p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

@keyframes zoomInUp {=20
  0% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 1000p=
x, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0.19);=
 }
  60% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.175, 0.885, 0.32, =
1); }
}

.zoomInUp { animation-name: zoomInUp; }

@-webkit-keyframes zoomOut {=20
  0% { opacity: 1; }
  50% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  100% { opacity: 0; }
}

@keyframes zoomOut {=20
  0% { opacity: 1; }
  50% { opacity: 0; transform: scale3d(0.3, 0.3, 0.3); }
  100% { opacity: 0; }
}

.zoomOut { animation-name: zoomOut; }

@-webkit-keyframes zoomOutDown {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, =
0.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 200=
0px, 0px); transform-origin: center bottom; animation-timing-function: cubi=
c-bezier(0.175, 0.885, 0.32, 1); }
}

@keyframes zoomOutDown {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, -60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, =
0.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, 200=
0px, 0px); transform-origin: center bottom; animation-timing-function: cubi=
c-bezier(0.175, 0.885, 0.32, 1); }
}

.zoomOutDown { animation-name: zoomOutDown; }

@-webkit-keyframes zoomOutLeft {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(42p=
x, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(-2000px, 0px, 0px); =
transform-origin: left center; }
}

@keyframes zoomOutLeft {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(42p=
x, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(-2000px, 0px, 0px); =
transform-origin: left center; }
}

.zoomOutLeft { animation-name: zoomOutLeft; }

@-webkit-keyframes zoomOutRight {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-42=
px, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(2000px, 0px, 0px); t=
ransform-origin: right center; }
}

@keyframes zoomOutRight {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(-42=
px, 0px, 0px); }
  100% { opacity: 0; transform: scale(0.1) translate3d(2000px, 0px, 0px); t=
ransform-origin: right center; }
}

.zoomOutRight { animation-name: zoomOutRight; }

@-webkit-keyframes zoomOutUp {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0=
.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -20=
00px, 0px); transform-origin: center bottom; animation-timing-function: cub=
ic-bezier(0.175, 0.885, 0.32, 1); }
}

@keyframes zoomOutUp {=20
  40% { opacity: 1; transform: scale3d(0.475, 0.475, 0.475) translate3d(0px=
, 60px, 0px); animation-timing-function: cubic-bezier(0.55, 0.055, 0.675, 0=
.19); }
  100% { opacity: 0; transform: scale3d(0.1, 0.1, 0.1) translate3d(0px, -20=
00px, 0px); transform-origin: center bottom; animation-timing-function: cub=
ic-bezier(0.175, 0.885, 0.32, 1); }
}

.zoomOutUp { animation-name: zoomOutUp; }

.attachment-list { display: block; }

.attachment-list .meta { top: 0.3em; }

.attachment-list::before { display: none; }

.attachment-list .attached-file { width: 100%; margin-bottom: 0px; position=
: relative; display: grid; grid-template-columns: auto 90px; grid-template-=
areas: "title functions" "description description"; }

.attachment-list .attached-file .preview-link { position: absolute; inset: =
0px; opacity: 0; z-index: 0; display: block; }

.attachment-list .attached-file.mode-edit .preview-link { display: none; }

.attachment-list .attached-file.mode-edit .icon.icon-rename::before, .attac=
hment-list .attached-file.mode-edit .icon.icon-rename:hover::before { color=
: rgb(225, 112, 0); }

.attachment-list .attached-file.mode-edit .flex-field::before { color: rgba=
(0, 0, 0, 0); }

.attachment-list .attached-file.mode-view .title-group .name::before { colo=
r: rgb(1, 104, 155); }

.attachment-list .attached-file.mode-view .title-group:hover .name::before =
{ text-decoration: underline; }

.attachment-list .attached-file.mode-view .flex-field::before, .attachment-=
list .attached-file.mode-view .flex-field textarea { background-color: rgba=
(0, 0, 0, 0); padding: 0px; white-space: normal; }

.attachment-list .attached-file.mode-view .flex-field textarea { display: n=
one; }

.attachment-list .attached-file.mode-view .flex-field::before { color: inhe=
rit; }

.attachment-list .attached-file .title-group { color: rgb(0, 0, 0); grid-ar=
ea: title; position: relative; margin-bottom: 15px; }

.attachment-list .attached-file .title-group .title { margin: 0px; }

.attachment-list .attached-file .title-group .title .name { display: block;=
 }

.attachment-list .attached-file .title-group .title .time-stamp { color: rg=
ba(0, 0, 0, 0.4); font-size: 0.8em; clear: both; display: block; line-heigh=
t: 1.3; margin-bottom: 7px; }

.attachment-list .attached-file .description { display: block; color: rgb(0=
, 0, 0); font-weight: normal; font-size: 0.9em; line-height: 1.25; grid-are=
a: description; user-select: all; margin-bottom: 15px; margin-top: -15px; }

.attachment-list .attached-file .flex-field { position: relative; }

.attachment-list .attached-file .flex-field .field-name { position: absolut=
e; opacity: 0; }

.attachment-list .attached-file .flex-field::before { content: attr(data-va=
lue); padding-bottom: 5px; display: block; min-height: calc(1em + 10px); }

.attachment-list .attached-file .flex-field::before, .attachment-list .atta=
ched-file .flex-field textarea { white-space: pre-wrap; }

.attachment-list .attached-file .flex-field textarea { position: absolute; =
inset: 0px; color: rgb(0, 0, 0); margin: 0px; resize: none; overflow: hidde=
n; }

.attachment-list .attached-file .functions { grid-area: functions; z-index:=
 1; font-size: 0px; text-align: right; }

.attachment-list .attached-file .functions[data-value=3D"on"] { display: no=
ne; }

.attachment-list .attached-file .functions[data-value=3D"on"] + .title-grou=
p, .attachment-list .attached-file .functions[data-value=3D"on"] ~ .descrip=
tion { display: none; }

.attachment-list .attached-file .functions .icon { width: 30px; height: 30p=
x; line-height: 30px; cursor: default; overflow: hidden; display: inline-bl=
ock; color: rgba(0, 0, 0, 0); background-color: rgba(0, 0, 0, 0); padding: =
0px; vertical-align: middle; }

.attachment-list .attached-file .functions .icon input { position: absolute=
; opacity: 0; }

.attachment-list .attached-file .functions .icon::before { color: rgba(0, 0=
, 0, 0.5); text-align: center; display: block; width: 30px; line-height: 30=
px; margin: 0px; font-size: 1.26562rem; }

.attachment-list .attached-file .functions .icon:hover::before { color: rgb=
(0, 0, 0); text-decoration: none; }

.attachment-list .upload-area { padding: 0.2em; display: block; }

.attachment-list .upload-area fieldset { margin: 0px; }

.attachment-list .upload-area .upload-area .upload-queue .previews, .attach=
ment-list .upload-area .upload-area .dz-message p { margin-bottom: 0px !imp=
ortant; }

.pat-avatar { display: inline-block; overflow: hidden; border-radius: 50%; =
border: 0.055556em solid rgba(0, 0, 0, 0.2); aspect-ratio: 1 / 1; width: 2e=
m; height: 2em; }

.pat-avatar.inactive { background-color: rgb(255, 255, 255) !important; box=
-shadow: rgba(0, 0, 0, 0.2) 0px 0px 8px 2px inset; }

.pat-avatar.inactive img { filter: grayscale(100%) brightness(250%) contras=
t(50%); }

.pat-avatar.inactive::before { color: gray !important; }

.pat-avatar img { width: 100%; height: 100%; object-fit: cover; clip-path: =
circle(50%); display: block; }

.pat-auto-scale { transform-origin: left top; opacity: 0; transition: opaci=
ty 0.2s; }

.pat-auto-scale.scaled { opacity: 1; }

:root { --pat-auto-suggest-search-field-colour: var(--pat-form-input-field-=
background-colour); --pat-glyph-remove-tag: =EE=A0=88; --pat-auto-suggest-p=
ills-colour: var(--colour-accent); --pat-auto-suggest-cancel-button-edge-di=
stance: 12px; --pat-auto-suggest-pill-height: 1.6rem; --pat-auto-suggest-pa=
dding-top-bottom: 0.2rem; --pat-auto-suggest-padding-start-end: 10px; --pat=
-auto-suggest-drop-sheet-box-shadow: -1px 1px 0 0 dimgray, 1px 1px 0 0 dimg=
ray, -1px 0 0 0 dimgray; }

.select2-hidden-accessible { opacity: 0; position: absolute; pointer-events=
: none; bottom: 0px; }

.select2-container { margin: 0px; position: relative; display: inline-block=
; zoom: 1; vertical-align: middle; width: 100%; font-weight: normal; paddin=
g: 0px; }

@media print {
  .select2-container { display: inline; }
}

.lt-ie10 .select2-container { width: 100% !important; height: auto !importa=
nt; }

.select2-container, .select2-drop { box-sizing: border-box; }

.select2-search { border-radius: var(--pat-form-fields-border-radius); box-=
sizing: border-box; }

.select2-search input { box-sizing: border-box; }

.select2-container.select2-allowclear .select2-choice .select2-chosen { mar=
gin-right: 42px; }

.select2-container .select2-choice { text-decoration: none; cursor: default=
; }

.select2-container .select2-choice abbr.select2-search-choice-close { width=
: 16px; height: 16px; background: none; cursor: default; right: 34px; displ=
ay: none; position: absolute; top: 50%; transform: translateY(-50%); font-s=
ize: 1px; text-decoration: none; border: 0px; outline: 0px; }

.select2-container .select2-choice abbr.select2-search-choice-close::before=
 { display: inline-block; width: 16px; height: 16px; line-height: 16px; con=
tent: "=EE=A2=83"; font-family: fontello; position: absolute; top: 0px; lef=
t: 0px; color: rgb(102, 102, 102); font-size: 16px; cursor: default; }

.select2-container .select2-choice abbr.select2-search-choice-close:hover::=
before { color: rgb(0, 0, 0); }

.select2-container .select2-choice > .select2-chosen { margin-right: 26px; =
display: block; overflow: hidden; white-space: nowrap; text-overflow: ellip=
sis; }

.select2-container.select2-allowclear .select2-choice abbr { display: inlin=
e-block; }

.select2-drop-mask { border: 0px; margin: 0px; padding: 0px; position: fixe=
d; left: 0px; top: 0px; min-height: 100%; min-width: 100%; height: auto; wi=
dth: auto; opacity: 0; z-index: 9998; background-color: rgb(255, 255, 255);=
 }

.select2-drop { width: 100%; margin-top: -1px; position: absolute; z-index:=
 9999; top: 100%; background: rgb(255, 255, 255); color: rgb(0, 0, 0); box-=
shadow: var(--pat-auto-suggest-drop-sheet-box-shadow); border-bottom-left-r=
adius: var(--pat-form-input-field-border-radius); border-bottom-right-radiu=
s: var(--pat-form-input-field-border-radius); }

.select2-drop .select2-search input { padding: var(--pat-form-input-field-p=
adding-top-bottom) var(--pat-form-input-field-padding-start-end); border: v=
ar(--pat-form-input-field-border); box-shadow: var(--pat-form-input-field-b=
ox-shadow); outline: var(--pat-form-input-field-outline); outline-offset: v=
ar(--pat-form-input-field-outline-offset); color: var(--pat-form-input-fiel=
d-text-colour); }

.select2-drop-auto-width { width: auto; }

.select2-drop-auto-width .select2-search { padding-top: 4px; }

.select2-drop.select2-drop-above { margin-top: 1px; border-bottom: 0px; box=
-shadow: rgba(0, 0, 0, 0.15) 0px -4px 5px; border-top-right-radius: var(--p=
at-form-field-border-radius); border-bottom-left-radius: 0px; border-bottom=
-right-radius: 0px; }

.select2-drop-active { border-top: none; }

.select2-container .select2-choice .select2-arrow { display: inline-block; =
width: 18px; height: 100%; position: absolute; right: var(--pat-auto-sugges=
t-cancel-button-edge-distance); top: 0px; background-image: url("data:image=
/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KPHN2ZyB=
2ZXJzaW9uPSIxLjEiIGlkPSJMYWFnXzEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3=
N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiIHg9IjBweCIge=
T0iMHB4IgoJIHZpZXdCb3g9IjAgMCAxNC42IDguOCIgc3R5bGU9ImVuYWJsZS1iYWNrZ3JvdW5k=
Om5ldyAwIDAgMTQuNiA4Ljg7IiB4bWw6c3BhY2U9InByZXNlcnZlIj4KPHN0eWxlIHR5cGU9InR=
leHQvY3NzIj4KCS5zdDB7ZmlsbDpub25lO3N0cm9rZTojMDM2ODlCO3N0cm9rZS13aWR0aDozO3=
N0cm9rZS1saW5lY2FwOnJvdW5kO3N0cm9rZS1saW5lam9pbjpyb3VuZDtzdHJva2UtbWl0ZXJsa=
W1pdDoxMDt9Cjwvc3R5bGU+Cjxwb2x5bGluZSBjbGFzcz0ic3QwIiBwb2ludHM9IjEuNSwxLjUg=
Ny4zLDcuMyAxMy4xLDEuNSAiLz4KPC9zdmc+"); background-size: auto 10px; backgro=
und-position: right center; background-repeat: no-repeat; }

.select2-container .select2-choice .select2-arrow b { display: block; width=
: 100%; height: 100%; }

.select2-search { display: inline-block; width: 100%; min-height: 26px; mar=
gin: 0px; padding-left: 9px; padding-right: 9px; padding-top: 9px; position=
: relative; z-index: 10000; white-space: nowrap; }

.select2-search input { width: 100%; min-height: 26px; padding: 4px 20px 4p=
x 5px; margin: 0px; outline: 0px; font-family: sans-serif; font-size: 1em; =
border: none; background: var(--pat-auto-suggest-search-field-colour); bord=
er-radius: var(--pat-form-fields-border-radius); box-shadow: none; height: =
auto !important; }

.select2-search input:focus { border: none; }

.select2-drop.select2-drop-above .select2-search input { margin-top: 0.5em;=
 }

.select2-container-active .select2-choice, .select2-container-active .selec=
t2-choices { background-color: rgba(0, 0, 0, 0.09); box-sizing: border-box;=
 }

.select2-dropdown-open .select2-choice, .select2-dropdown-open .select2-cho=
ices { border-bottom-color: rgba(0, 0, 0, 0); box-shadow: rgb(255, 255, 255=
) 0px 1px 0px inset; background-color: rgb(238, 238, 238); border-bottom-le=
ft-radius: 0px !important; border-bottom-right-radius: 0px !important; }

.select2-dropdown-open.select2-drop-above .select2-choice, .select2-dropdow=
n-open.select2-drop-above .select2-choices { border-top-color: rgba(0, 0, 0=
, 0); box-sizing: border-box; border-bottom-left-radius: var(--pat-form-fie=
lds-border-radius) !important; border-bottom-right-radius: var(--pat-form-f=
ields-border-radius) !important; border-top-left-radius: 0px !important; bo=
rder-top-right-radius: 0px !important; }

.select2-results { max-height: 20em; padding: 0px 0px 0px 0.5em; margin: 0.=
5em 0.5em 0.5em 0px; position: relative; overflow: hidden auto; -webkit-tap=
-highlight-color: rgba(0, 0, 0, 0); }

.select2-results ul.select2-result-sub { margin: 0px; padding-left: 0px; }

.select2-results ul.select2-result-sub > li .select2-result-label { padding=
-left: 20px; }

.select2-results ul.select2-result-sub ul.select2-result-sub > li .select2-=
result-label { padding-left: 40px; }

.select2-results ul.select2-result-sub ul.select2-result-sub ul.select2-res=
ult-sub > li .select2-result-label { padding-left: 60px; }

.select2-results ul.select2-result-sub ul.select2-result-sub ul.select2-res=
ult-sub ul.select2-result-sub > li .select2-result-label { padding-left: 80=
px; }

.select2-results ul.select2-result-sub ul.select2-result-sub ul.select2-res=
ult-sub ul.select2-result-sub ul.select2-result-sub > li .select2-result-la=
bel { padding-left: 100px; }

.select2-results ul.select2-result-sub ul.select2-result-sub ul.select2-res=
ult-sub ul.select2-result-sub ul.select2-result-sub ul.select2-result-sub >=
 li .select2-result-label { padding-left: 110px; }

.select2-results ul.select2-result-sub ul.select2-result-sub ul.select2-res=
ult-sub ul.select2-result-sub ul.select2-result-sub ul.select2-result-sub u=
l.select2-result-sub > li .select2-result-label { padding-left: 120px; }

.select2-results li { list-style: none; display: list-item; background-imag=
e: none; }

.select2-results li.select2-result-with-children > .select2-result-label { =
font-weight: bold; }

.select2-results .select2-result-label { padding: 3px 7px 4px; margin: 0px;=
 cursor: pointer; min-height: 1em; user-select: none; }

.select2-results .select2-highlighted { background: rgb(225, 112, 0); color=
: rgb(255, 255, 255); border-radius: var(--pat-form-fields-border-radius); =
}

.select2-results li em { background: rgb(254, 255, 222); font-style: normal=
; }

.select2-results .select2-highlighted em { background: rgba(0, 0, 0, 0); }

.select2-results .select2-highlighted ul { background: rgb(255, 255, 255); =
color: rgb(0, 0, 0); }

.select2-results .select2-no-results, .select2-results .select2-searching, =
.select2-results .select2-selection-limit { color: gray; }

.select2-results .select2-disabled { background: rgb(244, 244, 244); displa=
y: list-item; cursor: default; }

.select2-results .select2-disabled.select2-highlighted { color: rgb(102, 10=
2, 102); background: rgb(244, 244, 244); display: list-item; cursor: defaul=
t; }

.select2-results .select2-selected { display: none; }

.select2-more-results { background: rgb(244, 244, 244); display: list-item;=
 }

.select2-container.select2-container-disabled .select2-choice { background-=
image: none; cursor: default; }

.select2-container.select2-container-disabled .select2-choice abbr { displa=
y: none; }

.select2-container .select2-choices, .select2-container .select2-choice { m=
argin: 0px; padding: 0.05em; position: relative; overflow: hidden; width: 1=
00%; min-height: calc(var(--pat-auto-suggest-pill-height) + 2*var(--pat-aut=
o-suggest-padding-top-bottom)); height: auto !important; }

.select2-locked { padding: 3px 5px !important; }

.select2-container-multi .select2-choices { padding: var(--pat-auto-suggest=
-padding-top-bottom) var(--pat-auto-suggest-padding-start-end) 0 var(--pat-=
auto-suggest-padding-top-bottom); }

.select2-container-multi.select2-container-disabled .select2-choices { over=
flow: visible; }

.select2-container-multi.select2-container-disabled .select2-choices::after=
 { content: " "; display: table; clear: both; }

.select2-container-multi.select2-container-active .select2-choices { outlin=
e: var(--pat-form-input-field-outline-focus); }

.select2-container-multi .select2-choices { outline-offset: var(--pat-form-=
input-field-outline-offset); cursor: text; }

.select2-container-multi .select2-choices li { float: left; list-style: non=
e; }

.select2-container-multi .select2-choices .select2-search-field { margin: 0=
px; padding: 0px 0.5em 0px 0px; white-space: nowrap; height: 1.6em; }

.select2-container-multi .select2-choices .select2-search-field input { pad=
ding: 0px; margin: 0px; font-size: 100%; outline: 0px; border: 0px; box-sha=
dow: none; clear: none; display: inline; width: 20px; background-color: rgb=
a(0, 0, 0, 0); color: var(--pat-form-placeholder-colour); }

.select2-container-multi .select2-choices .select2-search-field input.has-v=
alue { color: var(--pat-form-input-field-text-colour); }

.select2-default { color: gray; }

.select2-container-multi .select2-choices .select2-search-choice { padding:=
 0px 0.6em 0px 1.5em; margin: 0 .5em var(--pat-auto-suggest-padding-top-bot=
tom) 0; position: relative; line-height: var(--pat-auto-suggest-pill-height=
); height: var(--pat-auto-suggest-pill-height); color: rgb(255, 255, 255); =
cursor: default; border-radius: 0px; background-clip: padding-box; user-sel=
ect: none; background-color: var(--pat-auto-suggest-pills-colour); font-siz=
e: 0.9em; max-width: calc(95% - 1em); }

.select2-container-multi .select2-choices .select2-search-choice div { over=
flow: hidden; text-overflow: ellipsis; white-space: nowrap; }

.select2-container-multi .select2-choices .select2-search-choice.confirmed =
{ background-color: rgb(91, 183, 91); }

.select2-container-multi .select2-choices .select2-search-choice.declined {=
 background-color: red; }

.select2-container-multi .select2-choices .select2-search-choice.tentative =
{ background-color: rgb(255, 147, 0); }

.select2-container-multi .select2-choices .select2-search-choice.group { ba=
ckground-color: gray; }

.select2-container-multi .select2-choices .select2-search-choice.disabled {=
 background-color: silver; color: rgb(0, 0, 0); opacity: 0.7; pointer-event=
s: none; padding: 0px 0.6em; }

.select2-container-multi .select2-choices .select2-search-choice.disabled .=
select2-search-choice-close { display: none; }

.select2-container-multi .select2-choices .select2-search-choice .select2-c=
hosen { cursor: default; }

.select2-container-multi .select2-choices .select2-search-choice-focus { bo=
x-shadow: rgb(255, 255, 255) 0px 0px 0px 1px, rgb(225, 112, 0) 0px 0px 0px =
3px; }

.select2-choices .select2-search-choice-close { display: block; width: 1em;=
 height: 1em; position: absolute; right: 0.3em; top: 0em; font-size: 1em; t=
ext-decoration: none; opacity: 0.8; outline: none; cursor: default; }

.select2-choices .select2-search-choice-close:hover { text-decoration: none=
; opacity: 1; }

.select2-choices .select2-search-choice-close::before { content: "=EE=A0=88=
"; color: rgb(255, 255, 255); font: 1em fontello; }

.select2-container-multi .select2-search-choice-close { left: 0.4em; top: 0=
em; }

.select2-container-multi .select2-choices .select2-search-choice .select2-s=
earch-choice-close:hover, .select2-container-multi .select2-choices .select=
2-search-choice-focus .select2-search-choice-close { background-position: r=
ight -11px; }

.select2-container-multi.select2-container-disabled .select2-choices { back=
ground-color: rgba(0, 0, 0, 0); box-shadow: none; background-image: none; b=
order: none; cursor: default; padding: 0px; }

.select2-container-multi.select2-container-disabled .select2-choices .selec=
t2-search-choice { margin-left: 0px; margin-right: 5px; margin-bottom: 5px;=
 padding-left: 5px; }

.select2-container-multi .select2-choices .select2-search-choice.state-arch=
ived { opacity: 0.5; background-color: gray; }

.select2-container-multi .select2-choices .select2-search-choice.state-arch=
ived div { text-decoration: line-through; }

.select2-container-multi .select2-choices .select2-search-choice.state-draf=
t { background-color: rgb(225, 112, 0); color: rgb(255, 255, 255); }

.select2-container.users .select2-choices .select2-search-choice div::befor=
e, .select2-container.user-groups .select2-choices .select2-search-choice.u=
ser div::before, .select2-container .select2-choices .select2-search-choice=
.user div::before { content: "=EE=A0=A6"; display: inline-block; margin-rig=
ht: 3px; font: 0.8em / 2.1em fontello; margin-left: 5px; float: left; }

.select2-container.user-groups .select2-choices .select2-search-choice div:=
:before, .select2-container.users .select2-choices .select2-search-choice.u=
ser-group div::before, .select2-container .select2-choices .select2-search-=
choice.user-group div::before { content: "=EE=A0=A7"; display: inline-block=
; margin-right: 3px; font: 0.8em / 2.1em fontello; margin-left: 5px; float:=
 left; }

.select2-container.documents .select2-choices .select2-search-choice div::b=
efore { content: "=EE=A0=91"; display: inline-block; margin-right: 4px; mar=
gin-left: 7px; font-family: fontello; margin-bottom: -1px; }

.select2-container.tags .select2-choices .select2-search-choice div::before=
 { content: "=EE=9C=8C"; display: inline-block; margin-right: 4px; margin-l=
eft: 7px; font-family: fontello; margin-bottom: -2px; }

.select2-container.skills .select2-choices .select2-search-choice div::befo=
re { content: "=F0=9F=91=8D"; display: inline-block; margin-right: 4px; mar=
gin-left: 7px; top: -1px; position: relative; font-family: fontello; }

.select2-container.users .select2-choices .select2-search-choice.group div:=
:before { content: "=EE=A0=A7"; display: inline-block; margin-right: 3px; f=
ont: 0.8em / 2.1em fontello; margin-left: 5px; float: left; }

.select2-container-multi.select2-container-disabled .select2-choices .selec=
t2-search-choice .select2-search-choice-close { display: none; background: =
none; }

.select2-result-selectable .select2-match, .select2-result-unselectable .se=
lect2-match { text-decoration: underline; }

.select2-offscreen { clip: rect(0px, 0px, 0px, 0px) !important; width: 1px =
!important; height: 1px !important; border: 0px !important; margin: 0px !im=
portant; padding: 0px !important; overflow: hidden !important; position: ab=
solute !important; outline: 0px !important; left: 0px !important; top: 0px =
!important; min-width: 0px !important; }

.select2-offscreen:focus { clip: rect(0px, 0px, 0px, 0px) !important; width=
: 1px !important; height: 1px !important; border: 0px !important; margin: 0=
px !important; padding: 0px !important; overflow: hidden !important; positi=
on: absolute !important; outline: 0px !important; left: 0px !important; top=
: 0px !important; }

.select2-display-none { display: none; }

.select2-measure-scrollbar { position: absolute; top: -10000px; left: -1000=
0px; width: 100px; height: 100px; overflow: scroll; }

@media only screen and (-webkit-min-device-pixel-ratio: 1.5), only screen a=
nd (min-resolution: 144dpi) {
  .select2-search input, .select2-search-choice-close { background-repeat: =
no-repeat !important; background-size: 60px 40px !important; }
  .select2-search input { background-position: 100% -21px !important; }
}

.pat-back-button { display: inline-block; line-height: 35px; height: 44px; =
color: rgb(1, 104, 154); font-size: 18px; padding: 0px 1.5em 0px 2em; posit=
ion: relative; margin-left: 0px; font-weight: normal; max-width: 100%; over=
flow: hidden; text-overflow: ellipsis; box-sizing: border-box; cursor: defa=
ult; white-space: nowrap !important; text-decoration: none !important; }

.pat-toolbar .pat-back-button { line-height: 44px; }

.pat-back-button .overflow-protector { width: 100%; overflow: hidden; text-=
overflow: ellipsis; display: block; }

@media only screen and (max-width: 769px) {
  #app-space .pat-back-button { display: none; }
}

.pat-back-button::before { content: " "; width: 0px; height: 0px; border-st=
yle: solid; border-width: 19.92px 15px 19.92px 0px; border-color: rgba(0, 0=
, 0, 0) rgb(242, 242, 242) rgba(0, 0, 0, 0) rgba(0, 0, 0, 0); position: abs=
olute; left: 0px; top: 2.4px; }

.pat-back-button::after { content: " "; background: rgb(242, 242, 242); pos=
ition: absolute; inset: 0px 0px 0px 13px; clip-path: inset(0px 0px 0px 2px)=
; display: block; border-radius: 8px 0px 0px 8px; z-index: -1; }

.pat-back-button.dp::before { border-color: rgba(0, 0, 0, 0) rgba(255, 255,=
 255, 0.5) rgba(0, 0, 0, 0) rgba(0, 0, 0, 0); }

.pat-back-button.dp::after { background: rgba(255, 255, 255, 0.5); }

.pat-back-button:hover { color: rgb(1, 104, 154); text-decoration: none; }

.pat-back-button:hover::before { border-color: rgba(0, 0, 0, 0) rgb(237, 23=
7, 237) rgba(0, 0, 0, 0) rgba(0, 0, 0, 0); }

.pat-back-button:hover::after { background: rgb(237, 237, 237); }

@media only screen and (max-width: 769px) {
  .pat-breadcrumbs .button.shift { display: none; }
  .pat-breadcrumbs .pat-breadcrumbs-content { width: auto !important; margi=
n: 0px !important; }
  .pat-breadcrumbs a { color: rgb(0, 0, 0); font-weight: normal; }
  .pat-breadcrumbs a[href] { color: rgb(1, 104, 155); }
  .pat-breadcrumbs a[href]::after { content: " > "; color: gray; }
}

@media only screen and (min-width: 770px) {
  .pat-breadcrumbs { position: relative; overflow: hidden; }
  .pat-breadcrumbs::after { position: absolute; right: 0px; top: 0px; displ=
ay: block; width: 2em; height: 2em; content: " "; background-image: linear-=
gradient(to left, rgb(232, 232, 232) 0%, rgba(240, 240, 240, 0) 100%); }
  .pat-breadcrumbs .button.shift { display: none; position: absolute; left:=
 0px; width: 1em; height: 1.2em; background-color: rgb(232, 232, 232); bord=
er-right: 1px solid silver; overflow: hidden; line-height: 1em; user-select=
: none; }
  .pat-breadcrumbs .button.shift::before { font-family: fontello; content: =
"=EE=92=A1"; font-size: 0.5em; width: 2em; height: 2em; display: inline-blo=
ck; color: gray; font-weight: normal; }
  .pat-breadcrumbs .button.shift.shift-left::before { content: "=EE=92=A2";=
 font-weight: normal; }
  .pat-breadcrumbs .button.shift.shift-right, .pat-breadcrumbs .button.shif=
t.shift-left { display: inline-block; }
  .pat-breadcrumbs.shifting .pat-breadcrumbs-content { padding: 0px 1.5em; =
}
  .pat-breadcrumbs a { color: rgb(0, 0, 0); text-decoration: none; }
  .pat-breadcrumbs a:hover { text-decoration: none; }
  .pat-breadcrumbs a::before { display: inline-block; content: "=EE=A2=84";=
 padding: 0px 0.5em; font-family: fontello; font-weight: normal; }
  .pat-breadcrumbs a[href] { color: rgb(1, 104, 155); font-weight: normal; =
}
  .pat-breadcrumbs a[href]:hover { }
  .pat-breadcrumbs a:first-child::before { display: none; }
}

:root { --pat-button-bar-margin-top-bottom: 15px; }

.pat-button-bar { display: flex; justify-content: start; gap: 1rem; margin:=
 var(--pat-button-bar-margin-top-bottom) 0; }

.pat-button-bar .pat-button { margin: 0px; }

.pat-button-bar .pat-button.float-after { margin-left: auto; }

.pat-button { font-family: "RO Sans"; margin: 0px; border: none; cursor: de=
fault; border-radius: 0px; background-image: none; text-decoration: none; l=
ine-height: var(--pat-button-height); display: inline-block; padding: var(-=
-pat-button-paddings); font-size: 1.26562rem; vertical-align: text-bottom; =
font-weight: var(--pat-button-font-weight); box-shadow: none; color: rgb(1,=
 104, 154); background-color: rgb(242, 242, 242); max-width: 100%; overflow=
: hidden; text-overflow: ellipsis; white-space: nowrap; }

.pat-button::before { line-height: inherit; }

.pat-button:focus { outline: var(--pat-form-input-field-outline-focus); out=
line-offset: var(--pat-form-input-field-outline-offset); }

.pat-button:hover { background-color: rgb(237, 237, 237); text-decoration: =
none; color: rgb(1, 104, 154); }

.pat-button.default { color: white; background-color: rgb(1, 104, 155); box=
-shadow: none; }

.pat-button.default:hover { background-color: rgb(1, 70, 104); color: white=
; }

.pat-button[disabled], .pat-button.disabled, .pat-button:is(a):not([href]),=
 .pat-button.default[disabled], .pat-button.default.disabled, .pat-button:i=
s(a).default:not([href]) { color: rgba(0, 0, 0, 0.3); background-color: rgb=
(242, 242, 242); }

.pat-button[disabled]:hover, .pat-button.disabled:hover, .pat-button:is(a):=
not([href]):hover, .pat-button.default[disabled]:hover, .pat-button.default=
.disabled:hover, .pat-button:is(a).default:not([href]):hover { color: rgba(=
0, 0, 0, 0.3); background-color: rgb(242, 242, 242); }

@media print {
  .pat-button { display: none; }
}

.pat-button.small { font-size: 18px; padding: 0px 0.8rem; height: 29px; lin=
e-height: 29px; vertical-align: baseline; box-shadow: none; font-weight: no=
rmal; }

.pat-button.small::before { font-size: 15px; }

.pat-button.iconified { width: 30px; padding: 0px; }

.pat-button.iconified::before { width: 100%; text-align: center; line-heigh=
t: 44px; }

.pat-button.link { padding: 0px; display: inline; background: none; color: =
rgb(1, 104, 155); line-height: inherit; text-decoration: underline; vertica=
l-align: baseline; cursor: pointer; }

.pat-button.link:hover { background: none; color: rgb(0, 2, 3); text-decora=
tion: underline !important; }

.pat-button.no-label { padding: 0px; aspect-ratio: 1 / 1; text-overflow: cl=
ip; height: var(--pat-button-height); min-width: var(--pat-button-height); =
}

.pat-button.no-label::before { width: 100%; text-align: center; margin: 0px=
 1em 0px 0px; line-height: var(--pat-button-height); }

.pat-button::before { font-weight: normal; margin-right: 5px; }

.pat-button.add::before { font-family: fontello; content: "=EE=A3=A4"; }

.button-bar .pat-button { margin-bottom: 5px; }

.pat-button-cluster { --pat-toolbar-icon-background-colour: transparent; di=
splay: inline-flex; border-radius: 0px; background: rgb(242, 242, 242); box=
-shadow: rgba(0, 0, 0, 0.15) 0px 1px 6px inset; }

.pat-button-cluster.pat-tabs { position: relative; height: 44px; line-heigh=
t: 44px; overflow: visible; float: none; white-space: nowrap; max-width: 10=
0%; font-size: 0px; vertical-align: top; border-radius: 0px; background: rg=
ba(0, 0, 0, 0.05); box-shadow: rgba(0, 0, 0, 0.12) 0px 1px 6px inset; paddi=
ng: 0px calc(6px); display: inline-block; }

@media only screen and (max-width: 769px) {
  .pat-button-cluster.pat-tabs { display: block; }
}

.pat-button-cluster.pat-tabs button, .pat-button-cluster.pat-tabs a.button,=
 .pat-button-cluster.pat-tabs .pat-button, .pat-button-cluster.pat-tabs lab=
el, .pat-button-cluster.pat-tabs > a { margin: 0px; border-radius: 0px; flo=
at: left; border: none; background: rgba(0, 0, 0, 0); padding: 0px 10px; co=
lor: rgb(1, 104, 155); cursor: default; line-height: 44px; height: 44px; bo=
x-shadow: none; font-size: 18px; font-weight: normal; position: relative; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs button, body[dir=3D"rtl"] .p=
at-button-cluster.pat-tabs a.button, body[dir=3D"rtl"] .pat-button-cluster.=
pat-tabs .pat-button, body[dir=3D"rtl"] .pat-button-cluster.pat-tabs label,=
 body[dir=3D"rtl"] .pat-button-cluster.pat-tabs > a { float: right; }

.pat-button-cluster.pat-tabs button.icon, .pat-button-cluster.pat-tabs a.bu=
tton.icon, .pat-button-cluster.pat-tabs .pat-button.icon, .pat-button-clust=
er.pat-tabs label.icon, .pat-button-cluster.pat-tabs > a.icon { padding: 0p=
x 5px; }

.pat-button-cluster.pat-tabs button input, .pat-button-cluster.pat-tabs a.b=
utton input, .pat-button-cluster.pat-tabs .pat-button input, .pat-button-cl=
uster.pat-tabs label input, .pat-button-cluster.pat-tabs > a input { positi=
on: absolute; opacity: 0; }

.pat-button-cluster.pat-tabs button:not(:has(:checked)):not(.active):not(.c=
urrent):hover, .pat-button-cluster.pat-tabs a.button:not(:has(:checked)):no=
t(.active):not(.current):hover, .pat-button-cluster.pat-tabs .pat-button:no=
t(:has(:checked)):not(.active):not(.current):hover, .pat-button-cluster.pat=
-tabs label:not(:has(:checked)):not(.active):not(.current):hover, .pat-butt=
on-cluster.pat-tabs > a:not(:has(:checked)):not(.active):not(.current):hove=
r { text-decoration: underline; text-underline-offset: 4px; color: rgb(0, 0=
, 0); cursor: pointer; background-color: rgba(0, 0, 0, 0) !important; }

.pat-button-cluster.pat-tabs button::before, .pat-button-cluster.pat-tabs a=
.button::before, .pat-button-cluster.pat-tabs .pat-button::before, .pat-but=
ton-cluster.pat-tabs label::before, .pat-button-cluster.pat-tabs > a::befor=
e { margin-right: 5px; margin-left: 0px; color: rgb(1, 104, 155); }

.pat-button-cluster.pat-tabs button::after, .pat-button-cluster.pat-tabs a.=
button::after, .pat-button-cluster.pat-tabs .pat-button::after, .pat-button=
-cluster.pat-tabs label::after, .pat-button-cluster.pat-tabs > a::after { b=
ackground: rgb(39, 89, 55); position: absolute; inset: 3px calc(-3px); z-in=
dex: -1; display: block; content: " "; border-radius: 0px; opacity: 0; }

.pat-button-cluster.pat-tabs button:has(input:checked), .pat-button-cluster=
.pat-tabs button.active, .pat-button-cluster.pat-tabs button.current, .pat-=
button-cluster.pat-tabs a.button:has(input:checked), .pat-button-cluster.pa=
t-tabs a.button.active, .pat-button-cluster.pat-tabs a.button.current, .pat=
-button-cluster.pat-tabs .pat-button:has(input:checked), .pat-button-cluste=
r.pat-tabs .pat-button.active, .pat-button-cluster.pat-tabs .pat-button.cur=
rent, .pat-button-cluster.pat-tabs label:has(input:checked), .pat-button-cl=
uster.pat-tabs label.active, .pat-button-cluster.pat-tabs label.current, .p=
at-button-cluster.pat-tabs > a:has(input:checked), .pat-button-cluster.pat-=
tabs > a.active, .pat-button-cluster.pat-tabs > a.current { background-colo=
r: rgba(0, 0, 0, 0); box-shadow: none; color: rgb(255, 255, 255) !important=
; text-decoration: none !important; cursor: default !important; }

.pat-button-cluster.pat-tabs button:has(input:checked)::after, .pat-button-=
cluster.pat-tabs button.active::after, .pat-button-cluster.pat-tabs button.=
current::after, .pat-button-cluster.pat-tabs a.button:has(input:checked)::a=
fter, .pat-button-cluster.pat-tabs a.button.active::after, .pat-button-clus=
ter.pat-tabs a.button.current::after, .pat-button-cluster.pat-tabs .pat-but=
ton:has(input:checked)::after, .pat-button-cluster.pat-tabs .pat-button.act=
ive::after, .pat-button-cluster.pat-tabs .pat-button.current::after, .pat-b=
utton-cluster.pat-tabs label:has(input:checked)::after, .pat-button-cluster=
.pat-tabs label.active::after, .pat-button-cluster.pat-tabs label.current::=
after, .pat-button-cluster.pat-tabs > a:has(input:checked)::after, .pat-but=
ton-cluster.pat-tabs > a.active::after, .pat-button-cluster.pat-tabs > a.cu=
rrent::after { opacity: 1; }

.pat-button-cluster.pat-tabs button:has(input:checked)::before, .pat-button=
-cluster.pat-tabs button.active::before, .pat-button-cluster.pat-tabs butto=
n.current::before, .pat-button-cluster.pat-tabs a.button:has(input:checked)=
::before, .pat-button-cluster.pat-tabs a.button.active::before, .pat-button=
-cluster.pat-tabs a.button.current::before, .pat-button-cluster.pat-tabs .p=
at-button:has(input:checked)::before, .pat-button-cluster.pat-tabs .pat-but=
ton.active::before, .pat-button-cluster.pat-tabs .pat-button.current::befor=
e, .pat-button-cluster.pat-tabs label:has(input:checked)::before, .pat-butt=
on-cluster.pat-tabs label.active::before, .pat-button-cluster.pat-tabs labe=
l.current::before, .pat-button-cluster.pat-tabs > a:has(input:checked)::bef=
ore, .pat-button-cluster.pat-tabs > a.active::before, .pat-button-cluster.p=
at-tabs > a.current::before { color: rgb(255, 255, 255); }

.pat-button-cluster.pat-tabs button:has(input:checked) .counter, .pat-butto=
n-cluster.pat-tabs button.active .counter, .pat-button-cluster.pat-tabs but=
ton.current .counter, .pat-button-cluster.pat-tabs a.button:has(input:check=
ed) .counter, .pat-button-cluster.pat-tabs a.button.active .counter, .pat-b=
utton-cluster.pat-tabs a.button.current .counter, .pat-button-cluster.pat-t=
abs .pat-button:has(input:checked) .counter, .pat-button-cluster.pat-tabs .=
pat-button.active .counter, .pat-button-cluster.pat-tabs .pat-button.curren=
t .counter, .pat-button-cluster.pat-tabs label:has(input:checked) .counter,=
 .pat-button-cluster.pat-tabs label.active .counter, .pat-button-cluster.pa=
t-tabs label.current .counter, .pat-button-cluster.pat-tabs > a:has(input:c=
hecked) .counter, .pat-button-cluster.pat-tabs > a.active .counter, .pat-bu=
tton-cluster.pat-tabs > a.current .counter { background: red; }

.pat-button-cluster.pat-tabs button:first-child, .pat-button-cluster.pat-ta=
bs a.button:first-child, .pat-button-cluster.pat-tabs .pat-button:first-chi=
ld, .pat-button-cluster.pat-tabs label:first-child, .pat-button-cluster.pat=
-tabs > a:first-child { border-top-left-radius: 0px; border-bottom-left-rad=
ius: 0px; }

.pat-button-cluster.pat-tabs button:last-child, .pat-button-cluster.pat-tab=
s a.button:last-child, .pat-button-cluster.pat-tabs .pat-button:last-child,=
 .pat-button-cluster.pat-tabs label:last-child, .pat-button-cluster.pat-tab=
s > a:last-child { border-top-right-radius: 0px; border-bottom-right-radius=
: 0px; }

.pat-button-cluster.pat-tabs button .counter, .pat-button-cluster.pat-tabs =
a.button .counter, .pat-button-cluster.pat-tabs .pat-button .counter, .pat-=
button-cluster.pat-tabs label .counter, .pat-button-cluster.pat-tabs > a .c=
ounter { display: inline-block; margin: -0.9em 0em 0px 0.5em; background-co=
lor: red; color: rgb(255, 255, 255); border-radius: 1em; border: 1px solid =
rgb(255, 255, 255); height: 1.8em; min-width: 1.8em; box-sizing: border-box=
; padding: 0px 0.5em; transition: opacity 0.5s; animation: 0.6s ease 0s 1 n=
ormal none running zoomIn; float: right; vertical-align: baseline; line-hei=
ght: 1.7em; font-size: 0.6em; text-align: center; font-weight: normal; posi=
tion: relative; top: 50%; }

.pat-button-cluster.pat-tabs button .counter.disabled, .pat-button-cluster.=
pat-tabs a.button .counter.disabled, .pat-button-cluster.pat-tabs .pat-butt=
on .counter.disabled, .pat-button-cluster.pat-tabs label .counter.disabled,=
 .pat-button-cluster.pat-tabs > a .counter.disabled { opacity: 0.2; animati=
on: auto ease 0s 1 normal none running none; background-color: gray; }

.pat-button-cluster.pat-tabs button .counter.injecting, .pat-button-cluster=
.pat-tabs a.button .counter.injecting, .pat-button-cluster.pat-tabs .pat-bu=
tton .counter.injecting, .pat-button-cluster.pat-tabs label .counter.inject=
ing, .pat-button-cluster.pat-tabs > a .counter.injecting { opacity: 0; }

.pat-button-cluster.pat-tabs button .counter.injecting::before, .pat-button=
-cluster.pat-tabs a.button .counter.injecting::before, .pat-button-cluster.=
pat-tabs .pat-button .counter.injecting::before, .pat-button-cluster.pat-ta=
bs label .counter.injecting::before, .pat-button-cluster.pat-tabs > a .coun=
ter.injecting::before { display: none; }

.pat-button-cluster.pat-tabs.align-centre { position: absolute; }

.js .pat-button-cluster.pat-tabs { opacity: 0; transition: opacity 1s; }

.js .pat-button-cluster.pat-tabs.tabs-ready { opacity: 1; }

.pat-button-cluster.pat-tabs.tabs-wrapped { padding-right: 60px; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs.tabs-wrapped { padding-left:=
 60px; padding-right: 0px; }

.pat-button-cluster.pat-tabs a { float: none; display: inline-block; font-s=
ize: 18px; vertical-align: top; }

.pat-button-cluster.pat-tabs a.icon { width: 14px; padding: 0px 20px; color=
: rgba(0, 0, 0, 0); }

.pat-button-cluster.pat-tabs a.icon::before { margin-right: 20px; }

.pat-button-cluster.pat-tabs.open span.extra-tabs { overflow: visible; heig=
ht: auto; width: 300px; padding-bottom: 15px; padding-top: 69px; }

.pat-button-cluster.pat-tabs.open span.extra-tabs::before { color: rgb(0, 0=
, 0); background-color: rgba(255, 255, 255, 0.4); }

.pat-button-cluster.pat-tabs.open span.extra-tabs::after { border-color: si=
lver; }

.pat-button-cluster.pat-tabs.open span.extra-tabs a, .pat-button-cluster.pa=
t-tabs.open span.extra-tabs label { animation: 0.5s ease 0.2s 1 normal forw=
ards running fadeIn; }

.pat-button-cluster.pat-tabs span.extra-tabs { font-size: 1.26562rem; paddi=
ng-top: 54px; display: inline-block; float: right; height: 0px; width: 64px=
; overflow: hidden; position: absolute; top: 0px; right: 0px; z-index: 1; b=
ox-sizing: border-box; transition: 0.1s; background: rgba(0, 0, 0, 0) !impo=
rtant; box-shadow: none !important; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs span.extra-tabs { right: aut=
o; left: 0px; float: left; }

.pat-button-cluster.pat-tabs span.extra-tabs::before { font-family: fontell=
o; content: "=EE=A1=8D"; display: block; height: 44px; width: 64px; text-al=
ign: center; position: absolute; top: 0px; right: 0px; border-top-right-rad=
ius: 0px; border-bottom-right-radius: 0px; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs span.extra-tabs::before { co=
ntent: ""; right: auto; left: 0px; }

.pat-button-cluster.pat-tabs span.extra-tabs::after { content: " "; display=
: block; position: absolute; inset: 54px 0px 0px; border: 1px solid rgba(0,=
 0, 0, 0); box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 15px; border-radius: 0px;=
 background: rgb(255, 255, 255); transition: border 0.2s; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs span.extra-tabs::after { rig=
ht: auto; left: 0px; }

.pat-button-cluster.pat-tabs span.extra-tabs:hover::before { color: rgb(0, =
0, 0); }

.pat-button-cluster.pat-tabs span.extra-tabs a, .pat-button-cluster.pat-tab=
s span.extra-tabs label { display: block; float: none; padding: 0.4em 0.7em=
; line-height: 1.5; text-align: left; color: rgb(0, 0, 0); position: relati=
ve; z-index: 1; opacity: 0; height: auto; border: none !important; border-r=
adius: 0px !important; }

body[dir=3D"rtl"] .pat-button-cluster.pat-tabs span.extra-tabs a, body[dir=
=3D"rtl"] .pat-button-cluster.pat-tabs span.extra-tabs label { text-align: =
right; }

.pat-button-cluster.pat-tabs span.extra-tabs a::after, .pat-button-cluster.=
pat-tabs span.extra-tabs label::after { left: 0px; right: 0px; }

.pat-button-cluster.pat-tabs span.extra-tabs a:hover, .pat-button-cluster.p=
at-tabs span.extra-tabs label:hover { background-color: rgba(0, 0, 0, 0.05)=
; text-decoration: none; }

.pat-button-cluster.pat-tabs span.extra-tabs a.current, .pat-button-cluster=
.pat-tabs span.extra-tabs label.current { background: var(--colour-accent);=
 color: rgb(255, 255, 255); }

.pat-button-cluster.abecedary { box-shadow: none; background-color: rgba(0,=
 0, 0, 0); z-index: 1; }

.pat-button-cluster.abecedary::after { content: " "; position: absolute; z-=
index: -2; inset: 0px; background-color: rgb(242, 242, 242); }

.pat-button-cluster.abecedary > a { width: 32px; box-sizing: border-box; te=
xt-align: center; padding: 0px; }

.pat-button-cluster.abecedary > a::after { box-shadow: none; }

.pat-button-cluster button, .pat-button-cluster a.button, .pat-button-clust=
er .pat-button, .pat-button-cluster label, .pat-button-cluster > a { margin=
: 0px; border-radius: 0px; float: left; border: none; background: rgba(0, 0=
, 0, 0); padding: 0px 1.2em; color: rgba(0, 0, 0, 0.7); cursor: default; li=
ne-height: 44px; height: 44px; box-shadow: none; font-size: 1.26562rem; fon=
t-weight: normal; }

body[dir=3D"rtl"] .pat-button-cluster button, body[dir=3D"rtl"] .pat-button=
-cluster a.button, body[dir=3D"rtl"] .pat-button-cluster .pat-button, body[=
dir=3D"rtl"] .pat-button-cluster label, body[dir=3D"rtl"] .pat-button-clust=
er > a { float: right; }

.pat-button-cluster button.select-all[disabled], .pat-button-cluster button=
.deselect-all[disabled], .pat-button-cluster a.button.select-all[disabled],=
 .pat-button-cluster a.button.deselect-all[disabled], .pat-button-cluster .=
pat-button.select-all[disabled], .pat-button-cluster .pat-button.deselect-a=
ll[disabled], .pat-button-cluster label.select-all[disabled], .pat-button-c=
luster label.deselect-all[disabled], .pat-button-cluster > a.select-all[dis=
abled], .pat-button-cluster > a.deselect-all[disabled] { background-color: =
var(--colour-accent); color: rgb(255, 255, 255); opacity: 1; }

.pat-button-cluster button.select-all[disabled]:hover, .pat-button-cluster =
button.deselect-all[disabled]:hover, .pat-button-cluster a.button.select-al=
l[disabled]:hover, .pat-button-cluster a.button.deselect-all[disabled]:hove=
r, .pat-button-cluster .pat-button.select-all[disabled]:hover, .pat-button-=
cluster .pat-button.deselect-all[disabled]:hover, .pat-button-cluster label=
.select-all[disabled]:hover, .pat-button-cluster label.deselect-all[disable=
d]:hover, .pat-button-cluster > a.select-all[disabled]:hover, .pat-button-c=
luster > a.deselect-all[disabled]:hover { background-color: var(--colour-ac=
cent); color: rgb(255, 255, 255); }

.pat-button-cluster button.icon, .pat-button-cluster a.button.icon, .pat-bu=
tton-cluster .pat-button.icon, .pat-button-cluster label.icon, .pat-button-=
cluster > a.icon { padding: 0px; font-size: 0px; }

.pat-button-cluster button.icon:active, .pat-button-cluster a.button.icon:a=
ctive, .pat-button-cluster .pat-button.icon:active, .pat-button-cluster lab=
el.icon:active, .pat-button-cluster > a.icon:active { box-shadow: none; }

.pat-button-cluster button.icon::before, .pat-button-cluster a.button.icon:=
:before, .pat-button-cluster .pat-button.icon::before, .pat-button-cluster =
label.icon::before, .pat-button-cluster > a.icon::before { font-size: 18px;=
 line-height: inherit; display: block; text-align: center; margin: 0px; wid=
th: 2em; }

.pat-button-cluster button input, .pat-button-cluster a.button input, .pat-=
button-cluster .pat-button input, .pat-button-cluster label input, .pat-but=
ton-cluster > a input { position: absolute; opacity: 0; }

.pat-button-cluster button[href]:not(.current):not(.active):not(.current):h=
over, .pat-button-cluster a.button[href]:not(.current):not(.active):not(.cu=
rrent):hover, .pat-button-cluster .pat-button[href]:not(.current):not(.acti=
ve):not(.current):hover, .pat-button-cluster label[href]:not(.current):not(=
.active):not(.current):hover, .pat-button-cluster > a[href]:not(.current):n=
ot(.active):not(.current):hover { color: rgb(0, 0, 0); }

.pat-button-cluster button::before, .pat-button-cluster a.button::before, .=
pat-button-cluster .pat-button::before, .pat-button-cluster label::before, =
.pat-button-cluster > a::before { margin-right: 0px; margin-left: 0px; colo=
r: rgba(0, 0, 0, 0.7); }

.pat-button-cluster button:has(input:checked), .pat-button-cluster button.a=
ctive, .pat-button-cluster button.current, .pat-button-cluster a.button:has=
(input:checked), .pat-button-cluster a.button.active, .pat-button-cluster a=
.button.current, .pat-button-cluster .pat-button:has(input:checked), .pat-b=
utton-cluster .pat-button.active, .pat-button-cluster .pat-button.current, =
.pat-button-cluster label:has(input:checked), .pat-button-cluster label.act=
ive, .pat-button-cluster label.current, .pat-button-cluster > a:has(input:c=
hecked), .pat-button-cluster > a.active, .pat-button-cluster > a.current { =
background: var(--colour-accent); color: rgb(255, 255, 255); text-decoratio=
n: none; box-shadow: none; }

.pat-button-cluster button:has(input:checked)::before, .pat-button-cluster =
button.active::before, .pat-button-cluster button.current::before, .pat-but=
ton-cluster a.button:has(input:checked)::before, .pat-button-cluster a.butt=
on.active::before, .pat-button-cluster a.button.current::before, .pat-butto=
n-cluster .pat-button:has(input:checked)::before, .pat-button-cluster .pat-=
button.active::before, .pat-button-cluster .pat-button.current::before, .pa=
t-button-cluster label:has(input:checked)::before, .pat-button-cluster labe=
l.active::before, .pat-button-cluster label.current::before, .pat-button-cl=
uster > a:has(input:checked)::before, .pat-button-cluster > a.active::befor=
e, .pat-button-cluster > a.current::before { color: rgb(255, 255, 255); }

.pat-button-cluster button:has(input:checked) .counter, .pat-button-cluster=
 button.active .counter, .pat-button-cluster button.current .counter, .pat-=
button-cluster a.button:has(input:checked) .counter, .pat-button-cluster a.=
button.active .counter, .pat-button-cluster a.button.current .counter, .pat=
-button-cluster .pat-button:has(input:checked) .counter, .pat-button-cluste=
r .pat-button.active .counter, .pat-button-cluster .pat-button.current .cou=
nter, .pat-button-cluster label:has(input:checked) .counter, .pat-button-cl=
uster label.active .counter, .pat-button-cluster label.current .counter, .p=
at-button-cluster > a:has(input:checked) .counter, .pat-button-cluster > a.=
active .counter, .pat-button-cluster > a.current .counter { background: red=
; }

.pat-button-cluster button:first-child, .pat-button-cluster a.button:first-=
child, .pat-button-cluster .pat-button:first-child, .pat-button-cluster lab=
el:first-child, .pat-button-cluster > a:first-child { border-top-left-radiu=
s: 0px; border-bottom-left-radius: 0px; }

.pat-button-cluster button:last-child, .pat-button-cluster a.button:last-ch=
ild, .pat-button-cluster .pat-button:last-child, .pat-button-cluster label:=
last-child, .pat-button-cluster > a:last-child { border-top-right-radius: 0=
px; border-bottom-right-radius: 0px; }

.pat-button-cluster button .counter, .pat-button-cluster a.button .counter,=
 .pat-button-cluster .pat-button .counter, .pat-button-cluster label .count=
er, .pat-button-cluster > a .counter { display: inline-block; margin: 0.8em=
 0em 0.5em 0.5em; background-color: red; color: rgb(255, 255, 255); border-=
radius: 1em; border: 1px solid rgb(255, 255, 255); height: 1.8em; min-width=
: 1.8em; box-sizing: border-box; padding: 0px 0.5em; transition: opacity 0.=
5s; animation: 0.6s ease 0s 1 normal none running zoomIn; float: right; ver=
tical-align: baseline; line-height: 1.7em; font-size: 0.6em; text-align: ce=
nter; font-weight: normal; }

body[dir=3D"rtl"] .pat-button-cluster button .counter, body[dir=3D"rtl"] .p=
at-button-cluster a.button .counter, body[dir=3D"rtl"] .pat-button-cluster =
.pat-button .counter, body[dir=3D"rtl"] .pat-button-cluster label .counter,=
 body[dir=3D"rtl"] .pat-button-cluster > a .counter { float: left; }

.pat-button-cluster button .counter.disabled, .pat-button-cluster a.button =
.counter.disabled, .pat-button-cluster .pat-button .counter.disabled, .pat-=
button-cluster label .counter.disabled, .pat-button-cluster > a .counter.di=
sabled { opacity: 0.2; animation: auto ease 0s 1 normal none running none; =
background-color: gray; }

.pat-button-cluster button .counter.injecting, .pat-button-cluster a.button=
 .counter.injecting, .pat-button-cluster .pat-button .counter.injecting, .p=
at-button-cluster label .counter.injecting, .pat-button-cluster > a .counte=
r.injecting { opacity: 0; }

.pat-button-cluster button .counter.injecting::before, .pat-button-cluster =
a.button .counter.injecting::before, .pat-button-cluster .pat-button .count=
er.injecting::before, .pat-button-cluster label .counter.injecting::before,=
 .pat-button-cluster > a .counter.injecting::before { display: none; }

.pat-comma-separated > .segment::after { content: ", "; color: rgb(0, 0, 0)=
; text-decoration: none; display: inline-block; }

.pat-comma-separated > .segment:last-child::after { content: "."; color: rg=
b(0, 0, 0); text-decoration: none; display: inline-block; }

:root { --pat-tooltip-box-shadow: 0 4px 14px -2px $transparent-light; }

.pat-context-menu { position: relative; }

.pat-context-menu .close-menu { color: rgba(0, 0, 0, 0); text-align: right;=
 cursor: default; height: 0px; margin: 0px; opacity: 0; }

.pat-context-menu .close-menu::after { font-family: fontello; content: "=EE=
=A2=83"; color: gray; font-size: 1.2em; }

.pat-context-menu .close-menu:hover::after { color: rgb(0, 0, 0); }

.pat-context-menu .context-menu-label { user-select: none; font-weight: nor=
mal; cursor: default; display: inline-block; }

.pat-context-menu .context-menu-label.collapsible-closed, .pat-context-menu=
 .context-menu-label.collapsible-open { padding: 0px 30px 0px 0px; text-dec=
oration: none; color: rgba(0, 0, 0, 0.6); cursor: default; }

.pat-context-menu .context-menu-label.collapsible-closed:hover, .pat-contex=
t-menu .context-menu-label.collapsible-closed:active, .pat-context-menu .co=
ntext-menu-label.collapsible-open:hover, .pat-context-menu .context-menu-la=
bel.collapsible-open:active { color: rgb(0, 0, 0); }

.pat-context-menu .context-menu-label.collapsible-closed { text-decoration:=
 none; }

.canvas-subnav .pat-context-menu .context-menu-label.collapsible-closed { c=
ursor: pointer; }

.pat-context-menu .context-menu-label.collapsible-open::before { display: b=
lock; position: fixed; inset: 0px; z-index: 1; content: " "; }

.pat-context-menu .context-menu-label:not(.iconified)::after, .pat-context-=
menu .context-menu-label.iconified.pat-button::after { content: " "; paddin=
g-right: 1em; overflow: hidden; white-space: nowrap; text-overflow: ellipsi=
s; position: absolute; top: 2%; right: 12px; bottom: 0px; background-repeat=
: no-repeat; background-position: right center; background-image: url("data=
:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KP=
HN2ZyB2ZXJzaW9uPSIxLjEiIGlkPSJMYWFnXzEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8y=
MDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiIHg9IjB=
weCIgeT0iMHB4IgoJIHZpZXdCb3g9IjAgMCAxNC42IDguOCIgc3R5bGU9ImVuYWJsZS1iYWNrZ3=
JvdW5kOm5ldyAwIDAgMTQuNiA4Ljg7IiB4bWw6c3BhY2U9InByZXNlcnZlIj4KPHN0eWxlIHR5c=
GU9InRleHQvY3NzIj4KCS5zdDB7ZmlsbDpub25lO3N0cm9rZTojMDM2ODlCO3N0cm9rZS13aWR0=
aDozO3N0cm9rZS1saW5lY2FwOnJvdW5kO3N0cm9rZS1saW5lam9pbjpyb3VuZDtzdHJva2UtbWl=
0ZXJsaW1pdDoxMDt9Cjwvc3R5bGU+Cjxwb2x5bGluZSBjbGFzcz0ic3QwIiBwb2ludHM9IjEuNS=
wxLjUgNy4zLDcuMyAxMy4xLDEuNSAiLz4KPC9zdmc+"); background-size: auto 10px; b=
ox-shadow: none !important; }

.pat-context-menu .context-menu-label.iconified { text-indent: -1000px; ove=
rflow: hidden; width: 2.2em; }

.pat-context-menu .context-menu-label.iconified.pat-button { width: 2.4em; =
position: relative; }

.pat-context-menu .context-menu-label.iconified.pat-button::after { positio=
n: absolute; right: 0.3em; width: 100%; height: 1em; top: 0.2em; }

.pat-context-menu .context-menu-label.iconified.pat-button::before { width:=
 1.7em; line-height: 1.75em; display: block; }

.pat-context-menu .context-menu-label.iconified.pat-button.collapsible-open=
::after, .pat-context-menu .context-menu-label.iconified.pat-button.collaps=
ible-open::before { color: rgb(225, 112, 0); }

.pat-context-menu .context-menu-label.iconified::before { font-family: font=
ello; content: "=EE=A2=9E"; padding: 0px; position: absolute; top: 0px; lef=
t: 0px; width: 100%; height: 100%; text-indent: 0px; text-align: center; }

.pat-context-menu.no-label::before { width: 100%; height: 100%; line-height=
: 44px; position: absolute; margin: 0px; }

.pat-context-menu.no-label:hover::before { color: rgb(0, 0, 0); }

.pat-context-menu.no-label.open::before, .pat-context-menu.no-label.in-prog=
ress.closed::before { background: rgb(225, 112, 0); color: rgb(255, 255, 25=
5); border-radius: 0px; }

.pat-context-menu.no-label .context-menu-label { opacity: 0; width: 44px; p=
adding: 0px; }

.pat-context-menu.no-label .panel-content { top: var(--pat-context-menu-pan=
el-distance, 1.7em); }

.pat-context-menu.open .label { color: rgb(0, 0, 0); }

.pat-context-menu.open .label.pat-button { box-shadow: rgba(0, 0, 0, 0.3) 0=
px 0px 0.3em inset; }

.pat-context-menu.open.iconified .label { color: rgb(225, 112, 0); }

.pat-context-menu.open .panel-content { display: block; }

.pat-context-menu .panel-content { position: absolute; top: var(--pat-conte=
xt-menu-panel-distance, 1.7em); left: 0px; display: none; background-color:=
 rgb(255, 255, 255); width: var(--pat-context-menu-panel-width, 250px); z-i=
ndex: 10; border-radius: 0px; font-size: 1.26562rem; border: 1px solid silv=
er; box-shadow: var(--pat-tooltip-box-shadow); max-height: calc(-170px + 10=
0vh); overflow: auto; padding: 15px !important; height: auto !important; }

.pat-context-menu .panel-content :last-child { margin-bottom: 0px; }

.batch-functions .pat-context-menu .panel-content { width: 85%; right: 0px;=
 left: inherit; }

@media only screen and (min-width: 770px) {
  .pat-context-menu.align-right .panel-content { right: 0px; left: inherit;=
 }
}

:root { --pat-checklist-label-padding-start: 1.5em; --pat-checklist-label-p=
adding-end: 0; --pat-checklist-item-separation: 0.2em; --pat-checklist-chec=
kbox-size: 18px; --pat-checklist-checkbox-background-colour: white; --pat-c=
hecklist-checkbox-box-shadow: inset 0 0 0 2px black; --pat-checklist-checkb=
ox-box-shadow-checked: none; --pat-checklist-checkbox-box-shadow-radio-chec=
ked: inset 0 0 0 2px var(--colour-accent), inset 0 0 0 5px white; --pat-che=
cklist-checkbox-background-colour-checked: var(--colour-accent); --pat-chec=
klist-checkbox-border-radius: calc(0.25 * var(--pat-checklist-checkbox-size=
)); --pat-checklist-line-height: 24px; --pat-checklist-checkbox-vertical-po=
sition: 12px; --pat-checklist-margin-bottom: 1rem; }

label.pat-checklist { display: grid; grid-template-columns: var(--pat-check=
list-label-padding-start) auto; grid-template-areas: "icon label" ". descri=
ption"; align-items: start; user-select: none; line-height: var(--pat-check=
list-line-height); padding-left: 1.1em; padding-right: 0.5em; }

body[dir=3D"rtl"] label.pat-checklist { padding-left: var(--pat-checklist-l=
abel-padding-end); }

label.pat-checklist > * { grid-area: label; }

label.pat-checklist:has(:focus)::before { outline: var(--pat-form-input-fie=
ld-outline-focus); outline-offset: var(--pat-form-input-field-outline-offse=
t); }

label.pat-checklist:has(input[type=3D"checkbox"])::before, label.pat-checkl=
ist:has(input[type=3D"radio"])::before { box-shadow: var(--pat-checklist-ch=
eckbox-box-shadow); content: ""; font-weight: normal; background-color: var=
(--pat-checklist-checkbox-background-colour); font-size: 0px; text-align: c=
enter; height: var(--pat-checklist-checkbox-size); width: var(--pat-checkli=
st-checkbox-size); line-height: var(--pat-checklist-checkbox-size); border-=
radius: var(--pat-checklist-checkbox-border-radius); justify-self: start; g=
rid-area: icon; position: relative; top: var(--pat-checklist-checkbox-verti=
cal-position); transform: translateY(-50%); transition: 0.2s ease-out; }

label.pat-checklist:has(input[type=3D"radio"])::before { border-radius: 50%=
; }

label.pat-checklist:has(input:checked)::before { background-color: var(--pa=
t-checklist-checkbox-background-colour-checked); box-shadow: var(--pat-chec=
klist-checkbox-box-shadow-checked); color: rgb(255, 255, 255); font-family:=
 fontello; content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-che=
ckbox-size)); }

label.pat-checklist:has([disabled]):has(input[type=3D"checkbox"])::before, =
label.pat-checklist:has([disabled]):has(input[type=3D"radio"])::before, lab=
el.pat-checklist:has([disabled]) .label-fragment-description:has(input[type=
=3D"checkbox"])::before, label.pat-checklist:has([disabled]) .label-fragmen=
t-description:has(input[type=3D"radio"])::before { background-color: rgba(0=
, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

label.pat-checklist .label-fragment-title { margin: 0px 0px 0px -30px; padd=
ing-left: 30px; }

label.pat-checklist .label-fragment-description { margin: 5px 0px 12px; col=
or: rgba(0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: desc=
ription; }

label.pat-checklist .label-fragment-description > * { color: rgb(0, 0, 0); =
}

label.pat-checklist input[type=3D"checkbox"], label.pat-checklist input[typ=
e=3D"radio"] { opacity: 0; position: absolute; left: 0px; width: 0px; margi=
n-top: 0.6px; }

.pat-checklist:not(.free-form) { line-height: 1.2em; min-height: 0.7em; mar=
gin-bottom: var(--pat-checklist-margin-bottom); }

form.vertical .pat-checklist:not(.free-form) > legend, form fieldset.vertic=
al .pat-checklist:not(.free-form) > legend, form.vertical .pat-checklist:no=
t(.free-form) > .legend, form fieldset.vertical .pat-checklist:not(.free-fo=
rm) > .legend { margin-bottom: calc(2*var(--pat-checklist-item-separation))=
; }

.pat-checklist:not(.free-form) .pat-checklist-sub { padding-left: 1em; padd=
ing-bottom: 1em; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label, .pat-checklist:n=
ot(.free-form) .pat-checklist-sub .label, .pat-checklist:not(.free-form) .p=
at-checklist-sub > li > label { position: relative; display: grid; grid-tem=
plate-columns: var(--pat-checklist-label-padding-start) auto; grid-template=
-areas: "icon label" ". description"; align-items: start; padding-right: va=
r(--pat-checklist-label-padding-end); user-select: none; line-height: var(-=
-pat-checklist-line-height); margin-top: var(--pat-checklist-item-separatio=
n); margin-bottom: var(--pat-checklist-item-separation); white-space: norma=
l; }

body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub > label=
, body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub .labe=
l, body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub > li=
 > label { padding-left: var(--pat-checklist-label-padding-end); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label > *, .pat-checkli=
st:not(.free-form) .pat-checklist-sub .label > *, .pat-checklist:not(.free-=
form) .pat-checklist-sub > li > label > * { grid-area: label; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(:focus)::befo=
re, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(:focus)::b=
efore, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label:has(:=
focus)::before { outline: var(--pat-form-input-field-outline-focus); outlin=
e-offset: var(--pat-form-input-field-outline-offset); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input[type=3D=
"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub > l=
abel:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pa=
t-checklist-sub .label:has(input[type=3D"checkbox"])::before, .pat-checklis=
t:not(.free-form) .pat-checklist-sub .label:has(input[type=3D"radio"])::bef=
ore, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label:has(inp=
ut[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checkli=
st-sub > li > label:has(input[type=3D"radio"])::before { box-shadow: var(--=
pat-checklist-checkbox-box-shadow); content: ""; font-weight: normal; backg=
round-color: var(--pat-checklist-checkbox-background-colour); font-size: 0p=
x; text-align: center; height: var(--pat-checklist-checkbox-size); width: v=
ar(--pat-checklist-checkbox-size); line-height: var(--pat-checklist-checkbo=
x-size); border-radius: var(--pat-checklist-checkbox-border-radius); justif=
y-self: start; grid-area: icon; position: relative; top: var(--pat-checklis=
t-checkbox-vertical-position); transform: translateY(-50%); transition: 0.2=
s ease-out; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input[type=3D=
"radio"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label=
:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-ch=
ecklist-sub > li > label:has(input[type=3D"radio"])::before { border-radius=
: 50%; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input:checked=
)::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(inp=
ut:checked)::before, .pat-checklist:not(.free-form) .pat-checklist-sub > li=
 > label:has(input:checked)::before { background-color: var(--pat-checklist=
-checkbox-background-colour-checked); box-shadow: var(--pat-checklist-check=
box-box-shadow-checked); color: rgb(255, 255, 255); font-family: fontello; =
content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-size)=
); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has([disabled]):h=
as(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-c=
hecklist-sub > label:has([disabled]):has(input[type=3D"radio"])::before, .p=
at-checklist:not(.free-form) .pat-checklist-sub > label:has([disabled]) .la=
bel-fragment-description:has(input[type=3D"checkbox"])::before, .pat-checkl=
ist:not(.free-form) .pat-checklist-sub > label:has([disabled]) .label-fragm=
ent-description:has(input[type=3D"radio"])::before, .pat-checklist:not(.fre=
e-form) .pat-checklist-sub .label:has([disabled]):has(input[type=3D"checkbo=
x"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(=
[disabled]):has(input[type=3D"radio"])::before, .pat-checklist:not(.free-fo=
rm) .pat-checklist-sub .label:has([disabled]) .label-fragment-description:h=
as(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-c=
hecklist-sub .label:has([disabled]) .label-fragment-description:has(input[t=
ype=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub =
> li > label:has([disabled]):has(input[type=3D"checkbox"])::before, .pat-ch=
ecklist:not(.free-form) .pat-checklist-sub > li > label:has([disabled]):has=
(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-checkl=
ist-sub > li > label:has([disabled]) .label-fragment-description:has(input[=
type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checklist-=
sub > li > label:has([disabled]) .label-fragment-description:has(input[type=
=3D"radio"])::before { background-color: rgba(0, 0, 0, 0.2); color: rgba(0,=
 0, 0, 0.3); box-shadow: none; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-t=
itle, .pat-checklist:not(.free-form) .pat-checklist-sub .label .label-fragm=
ent-title, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label .=
label-fragment-title { margin: 0px 0px 0px -30px; padding-left: 30px; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-d=
escription, .pat-checklist:not(.free-form) .pat-checklist-sub .label .label=
-fragment-description, .pat-checklist:not(.free-form) .pat-checklist-sub > =
li > label .label-fragment-description { margin: 5px 0px 12px; color: rgba(=
0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: description; =
}

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-d=
escription > *, .pat-checklist:not(.free-form) .pat-checklist-sub .label .l=
abel-fragment-description > *, .pat-checklist:not(.free-form) .pat-checklis=
t-sub > li > label .label-fragment-description > * { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label input[type=3D"che=
ckbox"], .pat-checklist:not(.free-form) .pat-checklist-sub > label input[ty=
pe=3D"radio"], .pat-checklist:not(.free-form) .pat-checklist-sub .label inp=
ut[type=3D"checkbox"], .pat-checklist:not(.free-form) .pat-checklist-sub .l=
abel input[type=3D"radio"], .pat-checklist:not(.free-form) .pat-checklist-s=
ub > li > label input[type=3D"checkbox"], .pat-checklist:not(.free-form) .p=
at-checklist-sub > li > label input[type=3D"radio"] { opacity: 0; position:=
 absolute; left: 0px; width: 0px; margin-top: 0.6px; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label::after, .pat-chec=
klist:not(.free-form) .pat-checklist-sub .label::after, .pat-checklist:not(=
.free-form) .pat-checklist-sub > li > label::after { content: " "; display:=
 table; clear: both; }

.pat-checklist:not(.free-form) > br { display: none; }

.pat-checklist:not(.free-form):not(.free-form) > label, .pat-checklist:not(=
.free-form):not(.free-form) .label, .pat-checklist:not(.free-form):not(.fre=
e-form) li > label { position: relative; display: grid; grid-template-colum=
ns: var(--pat-checklist-label-padding-start) auto; grid-template-areas: "ic=
on label" ". description"; align-items: start; padding-right: var(--pat-che=
cklist-label-padding-end); user-select: none; line-height: var(--pat-checkl=
ist-line-height); margin-top: var(--pat-checklist-item-separation); margin-=
bottom: var(--pat-checklist-item-separation); white-space: normal; font-wei=
ght: normal; }

body[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) > label, b=
ody[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) .label, bod=
y[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) li > label { =
padding-left: var(--pat-checklist-label-padding-end); }

.pat-checklist:not(.free-form):not(.free-form) > label > *, .pat-checklist:=
not(.free-form):not(.free-form) .label > *, .pat-checklist:not(.free-form):=
not(.free-form) li > label > * { grid-area: label; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(:focus)::before,=
 .pat-checklist:not(.free-form):not(.free-form) .label:has(:focus)::before,=
 .pat-checklist:not(.free-form):not(.free-form) li > label:has(:focus)::bef=
ore { outline: var(--pat-form-input-field-outline-focus); outline-offset: v=
ar(--pat-form-input-field-outline-offset); }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input[type=3D"ch=
eckbox"])::before, .pat-checklist:not(.free-form):not(.free-form) > label:h=
as(input[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free=
-form) .label:has(input[type=3D"checkbox"])::before, .pat-checklist:not(.fr=
ee-form):not(.free-form) .label:has(input[type=3D"radio"])::before, .pat-ch=
ecklist:not(.free-form):not(.free-form) li > label:has(input[type=3D"checkb=
ox"])::before, .pat-checklist:not(.free-form):not(.free-form) li > label:ha=
s(input[type=3D"radio"])::before { box-shadow: var(--pat-checklist-checkbox=
-box-shadow); content: ""; font-weight: normal; background-color: var(--pat=
-checklist-checkbox-background-colour); font-size: 0px; text-align: center;=
 height: var(--pat-checklist-checkbox-size); width: var(--pat-checklist-che=
ckbox-size); line-height: var(--pat-checklist-checkbox-size); border-radius=
: var(--pat-checklist-checkbox-border-radius); justify-self: start; grid-ar=
ea: icon; position: relative; top: var(--pat-checklist-checkbox-vertical-po=
sition); transform: translateY(-50%); transition: 0.2s ease-out; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input[type=3D"ra=
dio"])::before, .pat-checklist:not(.free-form):not(.free-form) .label:has(i=
nput[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free-for=
m) li > label:has(input[type=3D"radio"])::before { border-radius: 50%; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input:checked)::=
before, .pat-checklist:not(.free-form):not(.free-form) .label:has(input:che=
cked)::before, .pat-checklist:not(.free-form):not(.free-form) li > label:ha=
s(input:checked)::before { background-color: var(--pat-checklist-checkbox-b=
ackground-colour-checked); box-shadow: var(--pat-checklist-checkbox-box-sha=
dow-checked); color: rgb(255, 255, 255); font-family: fontello; content: "=
=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-size)); }

.pat-checklist:not(.free-form):not(.free-form) > label:has([disabled]):has(=
input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form):not(.free=
-form) > label:has([disabled]):has(input[type=3D"radio"])::before, .pat-che=
cklist:not(.free-form):not(.free-form) > label:has([disabled]) .label-fragm=
ent-description:has(input[type=3D"checkbox"])::before, .pat-checklist:not(.=
free-form):not(.free-form) > label:has([disabled]) .label-fragment-descript=
ion:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(=
.free-form) .label:has([disabled]):has(input[type=3D"checkbox"])::before, .=
pat-checklist:not(.free-form):not(.free-form) .label:has([disabled]):has(in=
put[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free-form=
) .label:has([disabled]) .label-fragment-description:has(input[type=3D"chec=
kbox"])::before, .pat-checklist:not(.free-form):not(.free-form) .label:has(=
[disabled]) .label-fragment-description:has(input[type=3D"radio"])::before,=
 .pat-checklist:not(.free-form):not(.free-form) li > label:has([disabled]):=
has(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form):not(.=
free-form) li > label:has([disabled]):has(input[type=3D"radio"])::before, .=
pat-checklist:not(.free-form):not(.free-form) li > label:has([disabled]) .l=
abel-fragment-description:has(input[type=3D"checkbox"])::before, .pat-check=
list:not(.free-form):not(.free-form) li > label:has([disabled]) .label-frag=
ment-description:has(input[type=3D"radio"])::before { background-color: rgb=
a(0, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-titl=
e, .pat-checklist:not(.free-form):not(.free-form) .label .label-fragment-ti=
tle, .pat-checklist:not(.free-form):not(.free-form) li > label .label-fragm=
ent-title { margin: 0px 0px 0px -30px; padding-left: 30px; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-desc=
ription, .pat-checklist:not(.free-form):not(.free-form) .label .label-fragm=
ent-description, .pat-checklist:not(.free-form):not(.free-form) li > label =
.label-fragment-description { margin: 5px 0px 12px; color: rgba(0, 0, 0, 0.=
7); font-size: 0.9em; line-height: 1.4; grid-area: description; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-desc=
ription > *, .pat-checklist:not(.free-form):not(.free-form) .label .label-f=
ragment-description > *, .pat-checklist:not(.free-form):not(.free-form) li =
> label .label-fragment-description > * { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form):not(.free-form) > label input[type=3D"checkb=
ox"], .pat-checklist:not(.free-form):not(.free-form) > label input[type=3D"=
radio"], .pat-checklist:not(.free-form):not(.free-form) .label input[type=
=3D"checkbox"], .pat-checklist:not(.free-form):not(.free-form) .label input=
[type=3D"radio"], .pat-checklist:not(.free-form):not(.free-form) li > label=
 input[type=3D"checkbox"], .pat-checklist:not(.free-form):not(.free-form) l=
i > label input[type=3D"radio"] { opacity: 0; position: absolute; left: 0px=
; width: 0px; margin-top: 0.6px; }

.pat-checklist:not(.free-form):not(.free-form) > label:first-of-type, .pat-=
checklist:not(.free-form):not(.free-form) .label:first-of-type, .pat-checkl=
ist:not(.free-form):not(.free-form) li > label:first-of-type { margin-top: =
0px; }

.pat-checklist:not(.free-form).cloud label { display: inline-grid; margin-r=
ight: 1em; }

.pat-checklist:not(.free-form):has(input[type=3D"radio"]) label:has(input:c=
hecked)::before, .pat-checklist:not(.free-form).radio-bars label:has(input:=
checked)::before { content: ""; box-shadow: var(--pat-checklist-checkbox-bo=
x-shadow-radio-checked); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form), .pat-checklist:n=
ot(.free-form).bars:not(.free-form) { --pat-checklist-label-padding-start: =
50px; border-radius: 0px; box-shadow: rgba(0, 0, 0, 0.15) 0px 1px 6px inset=
; padding: 5px 5px 0px; background: rgb(242, 242, 242); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label, .pat-che=
cklist:not(.free-form).bars:not(.free-form) > label { border-radius: 0px; p=
adding: 0.6em 0.6em 0.6em 0px; margin-bottom: 5px; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label .label-fr=
agment-description, .pat-checklist:not(.free-form).bars:not(.free-form) > l=
abel .label-fragment-description { margin-bottom: 0px; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label::before, =
.pat-checklist:not(.free-form).bars:not(.free-form) > label::before { align=
-self: center; justify-self: center !important; grid-row: 1 / last !importa=
nt; top: auto !important; transform: none !important; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:hover, .p=
at-checklist:not(.free-form).bars:not(.free-form) > label:hover { backgroun=
d: rgba(0, 0, 0, 0.05); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked), .pat-checklist:not(.free-form).bars:not(.free-form) > label:has(=
input:checked) { background: rgb(225, 112, 0); color: rgb(255, 255, 255); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked) > *, .pat-checklist:not(.free-form).bars:not(.free-form) > label:=
has(input:checked) > * { color: rgb(255, 255, 255); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked)::before, .pat-checklist:not(.free-form).bars:not(.free-form) > la=
bel:has(input:checked)::before { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form) fieldset.composed { padding-left: 0px; margi=
n-bottom: 0px; position: relative; }

.pat-checklist:not(.free-form) .additional-meta-data { position: relative; =
float: right; width: 70%; right: -100%; top: 0px; opacity: 0; transition: 1=
s; height: 0px; }

.sidebar-large .pat-checklist:not(.free-form) .additional-meta-data { right=
: 0%; opacity: 1; height: auto; }

.pat-checklist:not(.free-form) .meta-column { width: 0%; overflow: hidden; =
transition: width 1s; float: right; padding: 0px 0.5em; margin: 0px; box-si=
zing: border-box; }

.item-selector .pat-checklist:not(.free-form) .meta-column { padding: 1.2em=
 0.5em 1em; }

.pat-checklist:not(.free-form) .meta-column.tag-cloud { width: 40%; }

.sidebar-large .pat-checklist:not(.free-form) .meta-column { width: 30%; }

.sidebar-large .pat-checklist:not(.free-form) .meta-column.tag-cloud { widt=
h: 40%; }

.slick-slider { position: relative; display: block; box-sizing: border-box;=
 user-select: none; touch-action: pan-y; -webkit-tap-highlight-color: rgba(=
0, 0, 0, 0); }

.slick-list { position: relative; overflow: hidden; display: block; margin:=
 0px; padding: 0px; }

.slick-list:focus { outline: none; }

.slick-list.dragging { cursor: pointer; }

.slick-slider .slick-track, .slick-slider .slick-list { transform: translat=
e3d(0px, 0px, 0px); }

.slick-track { position: relative; left: 0px; top: 0px; display: block; mar=
gin-left: auto; margin-right: auto; }

.slick-track::before, .slick-track::after { content: ""; display: table; }

.slick-track::after { clear: both; }

.slick-loading .slick-track { visibility: hidden; }

.slick-slide { float: left; height: 100%; min-height: 1px; display: none; }

[dir=3D"rtl"] .slick-slide { float: right; }

.slick-slide img { display: block; }

.slick-slide.slick-loading img { display: none; }

.slick-slide.dragging img { pointer-events: none; }

.slick-initialized .slick-slide { display: block; }

.slick-loading .slick-slide { visibility: hidden; }

.slick-vertical .slick-slide { display: block; height: auto; border: 1px so=
lid rgba(0, 0, 0, 0); }

.slick-arrow.slick-hidden { display: none; }

.pat-carousel { margin-top: 2em; margin-bottom: 2em; }

.pat-carousel:hover .slick-dots { opacity: 1; }

.pat-carousel[data-pat-carousel*=3D"height: fixed"] .slick-slide img { heig=
ht: 500px; object-fit: cover; }

@media only screen and (max-width: 769px) {
  .pat-carousel[data-pat-carousel*=3D"height: fixed"] .slick-slide img { he=
ight: 200px; }
}

.pat-carousel .slick-slide { position: relative; }

.pat-carousel .slick-slide div li { display: block !important; }

.pat-carousel .slick-slide img { width: 100%; background-color: rgb(242, 24=
2, 242); }

.pat-carousel .slick-slide .icon-zoom-in { opacity: 0; transition: opacity =
0.4s 0.5s; right: 110px; }

@media only screen and (max-width: 769px) {
  .pat-carousel .slick-slide .icon-zoom-in { display: none; }
}

.pat-carousel .slick-slide.slick-current figcaption { opacity: 1; }

.pat-carousel .slick-slide.slick-current .icon-zoom-in { opacity: 0.5; }

.pat-carousel .slick-slide figcaption { color: rgba(0, 0, 0, 0.5); font-siz=
e: 0.8em; padding-top: 0.5em; line-height: 1.5; opacity: 0; transition: opa=
city 0.5s 0.5s; }

.pat-carousel .icon, .pat-carousel .slick-prev, .pat-carousel .slick-next {=
 position: absolute; opacity: 0.5; top: 10px; right: 10px; background: rgba=
(0, 0, 0, 0.6); color: rgba(0, 0, 0, 0); height: 40px; width: 40px; border-=
radius: 0px; transition: opacity 0.4s; overflow: hidden; z-index: 1; cursor=
: default; box-sizing: border-box; box-shadow: rgba(255, 255, 255, 0.7) 0px=
 0px 0px 2px; }

.pat-carousel .icon:hover, .pat-carousel .slick-prev:hover, .pat-carousel .=
slick-next:hover { background: rgba(0, 0, 0, 0.8); text-decoration: none; }

.pat-carousel .icon::before, .pat-carousel .slick-prev::before, .pat-carous=
el .slick-next::before { width: 100%; height: 100%; text-align: center; col=
or: rgb(255, 255, 255); display: block; line-height: 40px; margin: 0px; fon=
t-family: fontello; }

.pat-carousel .slick-prev.slick-disabled, .pat-carousel .slick-next.slick-d=
isabled { opacity: 0.2; pointer-events: none; }

.pat-carousel .slick-prev { right: 60px; }

.pat-carousel [dir=3D"rtl"] .slick-prev { left: 60px; right: auto; }

.pat-carousel .slick-prev::before { content: "=EE=A3=86"; font-size: 15px; =
}

.pat-carousel [dir=3D"rtl"] .slick-prev::before { content: "=EE=A3=86"; }

.pat-carousel .slick-next { right: 10px; }

.pat-carousel [dir=3D"rtl"] .slick-next { right: auto; left: 10px; }

.pat-carousel .slick-next::before { content: "=EE=A2=88"; font-size: 15px; =
}

.pat-carousel [dir=3D"rtl"] .slick-next::before { content: "=EE=A3=86"; }

.pat-carousel .slick-dotted.slick-slider { margin-bottom: 30px; }

.slick-dots { list-style: none; text-align: left; position: absolute; line-=
height: 15px; left: 14px; top: 10px; right: 160px; opacity: 0; transition: =
opacity 0.5s; }

@media only screen and (max-width: 769px) {
  .slick-dots { display: none !important; }
}

.slick-dots li { padding: 10px 8px; position: relative; width: 20px; height=
: 15px; margin: 0px 5px; display: inline-block; }

.slick-dots li:hover button { background-color: rgba(0, 0, 0, 0.8); }

.slick-dots li button { border-radius: 50%; border: 2px solid rgb(255, 255,=
 255); background-color: rgba(0, 0, 0, 0.4); width: 15px; height: 15px; col=
or: rgba(0, 0, 0, 0); }

.slick-dots li button::before { display: none; }

.slick-dots li.slick-active button { background-color: rgb(247, 53, 88); bo=
rder: 2px solid rgb(255, 255, 255); }

.pat-collapsible .js { display: none; }

.patterns-loaded .pat-collapsible .js { display: inherit; }

#product-space:not(.spotlight-on) .pat-collapsible:not(.pat-modal-pop-over)=
 { animation: 1s ease 0s 1 normal none running fadeIn; }

.pat-container { display: block; margin: 0px auto; max-width: 1280px; paddi=
ng: 0px 40px; box-sizing: border-box; }

@media only screen and (max-width: 769px) {
  .pat-container { padding: 0px 15px; }
}

.tooltip-container .pat-container { padding: 0px; }

.pika-single { z-index: 9999; display: block; position: relative; color: gr=
ay; background: rgb(255, 255, 255); border: 1px solid silver; border-radius=
: 0px; }

.pika-single.is-hidden { display: none; }

.pika-single.is-bound { position: absolute; box-shadow: rgba(0, 0, 0, 0.5) =
0px 5px 15px -5px; }

.pika-single { }

.pika-single::before, .pika-single::after { content: " "; display: table; }

.pika-single::after { clear: both; }

.pika-lendar { float: left; width: 18em; margin: 0.6em; }

.pika-title { position: relative; text-align: center; color: rgb(0, 0, 0); =
}

.pika-title select { cursor: pointer; position: absolute; z-index: 9998; ma=
rgin: 0px; left: 0px; top: 5px; opacity: 0; }

.pika-label { display: inline-block; position: relative; z-index: 9999; ove=
rflow: hidden; margin: 0px; padding: 0.3em 0.2em; font-size: 1.2em; line-he=
ight: 150%; font-weight: bold; background-color: rgb(255, 255, 255); }

.pika-prev, .pika-next { display: block; cursor: pointer; position: relativ=
e; outline: none; border: 0px; padding: 0px; width: 1.6em; height: 2.7em; t=
ext-indent: 2em; white-space: nowrap; overflow: hidden; background-color: r=
gba(0, 0, 0, 0); background-position: center center; background-repeat: no-=
repeat; background-size: 75% 75%; opacity: 0.5; }

.pika-prev:hover, .pika-next:hover { opacity: 1; }

.pika-prev.is-disabled, .pika-next.is-disabled { cursor: default; opacity: =
0.2; }

.pika-prev, .is-rtl .pika-next { float: left; background-image: url("data:i=
mage/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAeCAYAAAAsEj5rAAAAUklEQVR42u3=
VMQoAIBADQf8Pgj+OD9hG2CtONJB2ymQkKe0HbwAP0xucDiQWARITIDEBEnMgMQ8S8+AqBIl6kK=
gHiXqQqAeJepBo/z38J/U0uAHlaBkBl9I4GwAAAABJRU5ErkJggg=3D=3D"); }

.pika-next, .is-rtl .pika-prev { float: right; background-image: url("data:=
image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAeCAYAAAAsEj5rAAAAU0lEQVR42u=
3VOwoAMAgE0dwfAnNjU26bYkBCFGwfiL9VVWoO+BJ4Gf3gtsEKKoFBNTCoCAYVwaAiGNQGMUHMk=
jGbgjk2mIONuXo0nC8XnCf1JXgArVIZAQh5TKYAAAAASUVORK5CYII=3D"); }

.pika-select { display: inline-block; }

.pika-table { width: 100%; border-collapse: collapse; border-spacing: 0px; =
border: 0px; }

.pika-table th, .pika-table td { width: 14.2857%; padding: 0.2em; }

.pika-table th { color: rgb(153, 153, 153); font-size: 1em; line-height: 15=
0%; font-weight: bold; text-align: center; }

.pika-table abbr { border-bottom: none; cursor: help; }

.pika-button { cursor: pointer; display: block; box-sizing: border-box; out=
line: none; border: 0px; margin: 0px; width: 100%; padding: 5px; color: rgb=
(102, 102, 102); font-size: 1em; line-height: 15px; text-align: right; back=
ground: rgb(245, 245, 245); }

.is-today .pika-button { color: rgb(225, 112, 0); font-weight: bold; }

.is-selected .pika-button { color: rgb(255, 255, 255); font-weight: bold; b=
ackground: rgb(225, 112, 0); box-shadow: rgb(23, 143, 229) 0px 1px 3px inse=
t; border-radius: 0px; }

.is-disabled .pika-button { pointer-events: none; cursor: default; color: r=
gb(153, 153, 153); opacity: 0.3; }

.pika-button:hover { color: rgb(255, 255, 255); background: rgb(255, 128, 0=
); box-shadow: none; border-radius: 0px; }

.pika-week { font-size: 0.9em; color: rgb(153, 153, 153); }

@media print {
  #editor-toolbar, .editor-toolbar, .canvas-toolbar.editor-toolbar { displa=
y: none; }
}

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external, .edit=
or-toolbar.redactor .redactor-toolbar.redactor-toolbar-external, .canvas-to=
olbar.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external {=
 border: none; overflow: hidden; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton, .editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external =
.re-button, .canvas-toolbar.editor-toolbar.redactor .redactor-toolbar.redac=
tor-toolbar-external .re-button { text-align: center; outline: none; box-sh=
adow: none; border: none; text-decoration: none; cursor: default; zoom: 1; =
box-sizing: content-box; height: 44px; width: 44px; line-height: 44px; padd=
ing: 0px; color: rgba(0, 0, 0, 0); float: left; margin: 0px; background: rg=
ba(0, 0, 0, 0); border-radius: 0px; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton:hover, .editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-ext=
ernal .re-button:hover, .canvas-toolbar.editor-toolbar.redactor .redactor-t=
oolbar.redactor-toolbar-external .re-button:hover { outline: none; backgrou=
nd-color: rgba(0, 0, 0, 0); cursor: default; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton:hover::before, .editor-toolbar.redactor .redactor-toolbar.redactor-too=
lbar-external .re-button:hover::before, .canvas-toolbar.editor-toolbar.reda=
ctor .redactor-toolbar.redactor-toolbar-external .re-button:hover::before {=
 color: rgb(0, 0, 0); }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.redactor-button-active, .editor-toolbar.redactor .redactor-toolbar.red=
actor-toolbar-external .re-button.redactor-button-active, .canvas-toolbar.e=
ditor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-butt=
on.redactor-button-active { background-color: rgb(225, 112, 0) !important; =
}

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.redactor-button-active::before, .editor-toolbar.redactor .redactor-too=
lbar.redactor-toolbar-external .re-button.redactor-button-active::before, .=
canvas-toolbar.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-e=
xternal .re-button.redactor-button-active::before { color: rgb(255, 255, 25=
5); }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton::before, .editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-e=
xternal .re-button::before, .canvas-toolbar.editor-toolbar.redactor .redact=
or-toolbar.redactor-toolbar-external .re-button::before { font-family: font=
ello; color: rgba(0, 0, 0, 0.6); position: absolute; font-weight: normal; f=
ont-style: normal; width: 100%; display: block; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-video::before, .editor-toolbar.redactor .redactor-toolbar.redactor-=
toolbar-external .re-button.re-video::before, .canvas-toolbar.editor-toolba=
r.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-video:=
:before { content: "=EE=A1=81"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-unorderedlist::before, #editor-toolbar.redactor .redactor-toolbar.r=
edactor-toolbar-external .re-button.re-lists::before, .editor-toolbar.redac=
tor .redactor-toolbar.redactor-toolbar-external .re-button.re-unorderedlist=
::before, .editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-exter=
nal .re-button.re-lists::before, .canvas-toolbar.editor-toolbar.redactor .r=
edactor-toolbar.redactor-toolbar-external .re-button.re-unorderedlist::befo=
re, .canvas-toolbar.editor-toolbar.redactor .redactor-toolbar.redactor-tool=
bar-external .re-button.re-lists::before { content: "=EE=A1=9B"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-undo::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-undo::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-undo::be=
fore { content: "=EE=98=82"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-underline::before, .editor-toolbar.redactor .redactor-toolbar.redac=
tor-toolbar-external .re-button.re-underline::before, .canvas-toolbar.edito=
r-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.r=
e-underline::before { content: "=EE=98=83"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-textdirection::before, .editor-toolbar.redactor .redactor-toolbar.r=
edactor-toolbar-external .re-button.re-textdirection::before, .canvas-toolb=
ar.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-=
button.re-textdirection::before { content: "=EE=98=84"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-fontcolor::before, .editor-toolbar.redactor .redactor-toolbar.redac=
tor-toolbar-external .re-button.re-fontcolor::before, .canvas-toolbar.edito=
r-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.r=
e-fontcolor::before { content: "=EE=98=85"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-table::before, .editor-toolbar.redactor .redactor-toolbar.redactor-=
toolbar-external .re-button.re-table::before, .canvas-toolbar.editor-toolba=
r.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-table:=
:before { content: "=EE=A1=A4"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-redo::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-redo::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-redo::be=
fore { content: "=EE=98=87"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-quote::before, .editor-toolbar.redactor .redactor-toolbar.redactor-=
toolbar-external .re-button.re-quote::before, .canvas-toolbar.editor-toolba=
r.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-quote:=
:before { content: "=EE=98=88"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-outdent::before, .editor-toolbar.redactor .redactor-toolbar.redacto=
r-toolbar-external .re-button.re-outdent::before, .canvas-toolbar.editor-to=
olbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-ou=
tdent::before { content: "=EE=98=89"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-orderedlist::before, .editor-toolbar.redactor .redactor-toolbar.red=
actor-toolbar-external .re-button.re-orderedlist::before, .canvas-toolbar.e=
ditor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-butt=
on.re-orderedlist::before { content: "=EE=98=8A"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-link::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-link::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-link::be=
fore { content: "=EE=A0=BB"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-line::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-line::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-line::be=
fore { content: "=E2=80=94"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-italic::before, .editor-toolbar.redactor .redactor-toolbar.redactor=
-toolbar-external .re-button.re-italic::before, .canvas-toolbar.editor-tool=
bar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-ital=
ic::before { content: "=EE=A1=A3"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-indent::before, .editor-toolbar.redactor .redactor-toolbar.redactor=
-toolbar-external .re-button.re-indent::before, .canvas-toolbar.editor-tool=
bar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-inde=
nt::before { content: "=EE=98=8E"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-image::before, .editor-toolbar.redactor .redactor-toolbar.redactor-=
toolbar-external .re-button.re-image::before, .canvas-toolbar.editor-toolba=
r.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-image:=
:before { content: ""; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-fullscreen::before, .editor-toolbar.redactor .redactor-toolbar.reda=
ctor-toolbar-external .re-button.re-fullscreen::before, .canvas-toolbar.edi=
tor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button=
.re-fullscreen::before { content: "=EE=9D=84"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-normalscreen::before, .editor-toolbar.redactor .redactor-toolbar.re=
dactor-toolbar-external .re-button.re-normalscreen::before, .canvas-toolbar=
.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-normalscreen::before { content: "=EE=98=91"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-format::before, .editor-toolbar.redactor .redactor-toolbar.redactor=
-toolbar-external .re-button.re-format::before, .canvas-toolbar.editor-tool=
bar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-form=
at::before { content: "=EE=A1=A1"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-fontsize::before, .editor-toolbar.redactor .redactor-toolbar.redact=
or-toolbar-external .re-button.re-fontsize::before, .canvas-toolbar.editor-=
toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-=
fontsize::before { content: "=EE=98=93"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-fontfamily::before, .editor-toolbar.redactor .redactor-toolbar.reda=
ctor-toolbar-external .re-button.re-fontfamily::before, .canvas-toolbar.edi=
tor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button=
.re-fontfamily::before { content: "=EE=98=94"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-deleted::before, .editor-toolbar.redactor .redactor-toolbar.redacto=
r-toolbar-external .re-button.re-deleted::before, .canvas-toolbar.editor-to=
olbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-de=
leted::before { content: "=EE=A1=9D"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-html::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-html::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-html::be=
fore { content: "<>"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-clips::before, .editor-toolbar.redactor .redactor-toolbar.redactor-=
toolbar-external .re-button.re-clips::before, .canvas-toolbar.editor-toolba=
r.redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-clips:=
:before { content: "=EE=98=97"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-bold::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-bold::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-bold::be=
fore { content: "=EE=A1=A2"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-backcolor::before, .editor-toolbar.redactor .redactor-toolbar.redac=
tor-toolbar-external .re-button.re-backcolor::before, .canvas-toolbar.edito=
r-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button.r=
e-backcolor::before { content: "=EE=98=99"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-file::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-file::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-file::be=
fore { content: "=EE=98=9A"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-alignright::before, .editor-toolbar.redactor .redactor-toolbar.reda=
ctor-toolbar-external .re-button.re-alignright::before, .canvas-toolbar.edi=
tor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-button=
.re-alignright::before { content: "=EE=A1=99"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-alignment::before, #editor-toolbar.redactor .redactor-toolbar.redac=
tor-toolbar-external .re-button.re-alignleft::before, .editor-toolbar.redac=
tor .redactor-toolbar.redactor-toolbar-external .re-button.re-alignment::be=
fore, .editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external =
.re-button.re-alignleft::before, .canvas-toolbar.editor-toolbar.redactor .r=
edactor-toolbar.redactor-toolbar-external .re-button.re-alignment::before, =
.canvas-toolbar.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-=
external .re-button.re-alignleft::before { content: "=EE=A1=97"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-alignjustify::before, .editor-toolbar.redactor .redactor-toolbar.re=
dactor-toolbar-external .re-button.re-alignjustify::before, .canvas-toolbar=
.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-alignjustify::before { content: "=EE=A1=9A"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-aligncenter::before, .editor-toolbar.redactor .redactor-toolbar.red=
actor-toolbar-external .re-button.re-aligncenter::before, .canvas-toolbar.e=
ditor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-butt=
on.re-aligncenter::before { content: "=EE=A1=98"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-undo::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-undo::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-undo::be=
fore { content: "=EE=A1=A7"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-redo::before, .editor-toolbar.redactor .redactor-toolbar.redactor-t=
oolbar-external .re-button.re-redo::before, .canvas-toolbar.editor-toolbar.=
redactor .redactor-toolbar.redactor-toolbar-external .re-button.re-redo::be=
fore { content: "=EE=A1=A6"; }

#editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-romanlisting::before, .editor-toolbar.redactor .redactor-toolbar.re=
dactor-toolbar-external .re-button.re-romanlisting::before, .canvas-toolbar=
.editor-toolbar.redactor .redactor-toolbar.redactor-toolbar-external .re-bu=
tton.re-romanlisting::before { content: "I./II."; }

#editor-toolbar .icon, .editor-toolbar .icon, .canvas-toolbar.editor-toolba=
r .icon { margin: 0px; }

@media only screen and (max-width: 769px) {
  #editor-toolbar, .editor-toolbar, .canvas-toolbar.editor-toolbar { displa=
y: none; }
}

.pat-expandable.twisties { list-style-type: none; }

.pat-expandable.twisties .current { font-weight: bold; display: inline-bloc=
k; color: red; }

.pat-expandable.twisties li li { display: block; padding-left: 30px; }

.pat-expandable.twisties li span.toggle { width: 1.2em; height: 1.2em; floa=
t: left; font-size: 1em; line-height: 1.2em; }

.pat-expandable.twisties li ul { margin-bottom: 0px; margin-left: 0px; marg=
in-top: 0px; padding: 0px; display: none; }

.pat-expandable.twisties li.open > ul, .pat-expandable.twisties li a { disp=
lay: block; }

.pat-expandable.twisties span.toggle::before { content: "=E2=96=B6"; }

.pat-expandable.twisties .open > span.toggle::before { content: "=E2=96=BC"=
; display: inline-block; }

.flag-list { display: grid; gap: 30px; grid-auto-rows: 1fr; }

@media only screen and (min-width: 1280px) {
  .flag-list { grid-template-columns: 1fr 1fr 1fr 1fr 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .flag-list { grid-template-columns: 1fr 1fr 1fr 1fr; }
}

@media only screen and (max-width: 769px) {
  .flag-list { grid-template-columns: 1fr 1fr; }
}

.flag-list .flag { text-align: center; }

.flag-list .flag a { display: block; font-size: 16px; line-height: 1.3; }

.flag-list .flag a::before { width: 100%; aspect-ratio: 5 / 3; display: blo=
ck; content: ""; margin-bottom: 10px; background-size: cover; background-po=
sition: center center; box-shadow: none; background-repeat: no-repeat; box-=
sizing: border-box; border-radius: 0px; transition: 0.15s ease-out; }

.flag-list .flag a:hover::before { transform: scale(1.08); box-shadow: rgba=
(0, 0, 0, 0.2) 0px 0px 15px; }

.flag-list .de a::before { background-image: linear-gradient(rgb(0, 0, 0) 3=
3.3333%, rgb(221, 0, 0) 33.3333%, rgb(221, 0, 0) 66.6667%, rgb(255, 204, 0)=
 66.6667%); }

.flag-list .at a::before { background-image: linear-gradient(rgb(237, 41, 5=
7) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.6667%, rgb(=
237, 41, 57) 66.6667%); }

.flag-list .be a::before { background-image: linear-gradient(to right, rgb(=
0, 0, 0) 33.3333%, rgb(253, 218, 36) 33.3333%, rgb(253, 218, 36) 66.6667%, =
rgb(239, 51, 64) 66.6667%); }

.flag-list .bg a::before { background-image: linear-gradient(rgb(255, 255, =
255) 33.3333%, rgb(0, 150, 110) 33.3333%, rgb(0, 150, 110) 66.6667%, rgb(21=
4, 38, 18) 66.6667%); }

.flag-list .cz a { position: relative; }

.flag-list .cz a::before { background-image: linear-gradient(rgb(255, 255, =
255) 50%, rgb(215, 20, 26) 50%); background-size: 100% 100%; background-pos=
ition: 0px 0px, 0px 0px, 0px 0px; background-repeat: no-repeat, no-repeat, =
repeat; }

.flag-list .cz a::after { content: ""; width: 50%; aspect-ratio: 2.5 / 3; p=
osition: absolute; top: 0px; left: 0px; background: rgb(17, 69, 126); clip-=
path: polygon(100% 50%, 0px 0px, 0px 100%); }

.flag-list .ee a::before { background-image: linear-gradient(rgb(0, 114, 20=
6) 33.3333%, rgb(0, 0, 0) 33.3333%, rgb(0, 0, 0) 66.6667%, rgb(255, 255, 25=
5) 66.6667%); }

.flag-list .fr a::before { background-image: linear-gradient(to right, rgb(=
0, 85, 164) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.66=
67%, rgb(239, 65, 53) 66.6667%); }

.flag-list .hu a::before { background-image: linear-gradient(rgb(206, 41, 5=
7) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.6667%, rgb(=
71, 112, 80) 66.6667%); }

.flag-list .ie a::before { background-image: linear-gradient(to right, rgb(=
22, 155, 98) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.6=
667%, rgb(255, 136, 62) 66.6667%); }

.flag-list .it a::before { background-image: linear-gradient(to right, rgb(=
0, 140, 69) 33.3333%, rgb(244, 245, 240) 33.3333%, rgb(244, 245, 240) 66.66=
67%, rgb(205, 33, 42) 66.6667%); }

.flag-list .lv a::before { background-image: linear-gradient(rgb(157, 34, 5=
3) 40%, rgb(255, 255, 255) 40%, rgb(255, 255, 255) 60%, rgb(157, 34, 53) 60=
%); }

.flag-list .lt a::before { background-image: linear-gradient(rgb(253, 185, =
19) 33.3333%, rgb(0, 106, 68) 33.3333%, rgb(0, 106, 68) 66.6667%, rgb(193, =
39, 45) 66.6667%); }

.flag-list .lu a::before { background-image: linear-gradient(rgb(239, 51, 6=
4) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.6667%, rgb(=
0, 163, 224) 66.6667%); }

.flag-list .nl a::before { background-image: linear-gradient(rgb(173, 29, 3=
7) 33.3333%, rgb(255, 255, 255) 33.3333%, rgb(255, 255, 255) 66.6667%, rgb(=
30, 71, 133) 66.6667%); }

.flag-list .pl a::before { background-image: linear-gradient(rgb(255, 255, =
255) 0px, rgb(255, 255, 255) 50%, rgb(220, 20, 60) 50%, rgb(220, 20, 60) 10=
0%); }

.flag-list .ro a::before { background-image: linear-gradient(to right, rgb(=
0, 43, 127) 33.3333%, rgb(252, 209, 22) 33.3333%, rgb(252, 209, 22) 66.6667=
%, rgb(206, 17, 38) 66.6667%); }

.flag-list .xk a::before, .flag-list .cs a::before { background-color: rgb(=
36, 74, 165); background-size: 70%; background-image: url("data:image/svg+x=
ml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiIHN0YW5kYWxvbmU9I=
m5vIj8+CjxzdmcKICAgeG1sbnM6ZGM9Imh0dHA6Ly9wdXJsLm9yZy9kYy9lbGVtZW50cy8xLjEv=
IgogICB4bWxuczpjYz0iaHR0cDovL2NyZWF0aXZlY29tbW9ucy5vcmcvbnMjIgogICB4bWxuczp=
yZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiCiAgIHhtbG=
5zOnN2Zz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciCiAgIHhtbG5zPSJodHRwOi8vd3d3L=
nczLm9yZy8yMDAwL3N2ZyIKICAgeG1sbnM6c29kaXBvZGk9Imh0dHA6Ly9zb2RpcG9kaS5zb3Vy=
Y2Vmb3JnZS5uZXQvRFREL3NvZGlwb2RpLTAuZHRkIgogICB4bWxuczppbmtzY2FwZT0iaHR0cDo=
vL3d3dy5pbmtzY2FwZS5vcmcvbmFtZXNwYWNlcy9pbmtzY2FwZSIKICAgaGVpZ2h0PSI2MDAiCi=
AgIHdpZHRoPSI4NDAiCiAgIHZlcnNpb249IjEuMSIKICAgaWQ9InN2ZzE4IgogICBzb2RpcG9ka=
Tpkb2NuYW1lPSJGbGFnX29mX0tvc292by5zdmciCiAgIGlua3NjYXBlOnZlcnNpb249IjAuOTIu=
MiAoNWMzZTgwZCwgMjAxNy0wOC0wNikiPgogIDxtZXRhZGF0YQogICAgIGlkPSJtZXRhZGF0YTI=
yIj4KICAgIDxyZGY6UkRGPgogICAgICA8Y2M6V29yawogICAgICAgICByZGY6YWJvdXQ9IiI+Ci=
AgICAgICAgPGRjOmZvcm1hdD5pbWFnZS9zdmcreG1sPC9kYzpmb3JtYXQ+CiAgICAgICAgPGRjO=
nR5cGUKICAgICAgICAgICByZGY6cmVzb3VyY2U9Imh0dHA6Ly9wdXJsLm9yZy9kYy9kY21pdHlw=
ZS9TdGlsbEltYWdlIiAvPgogICAgICA8L2NjOldvcms+CiAgICA8L3JkZjpSREY+CiAgPC9tZXR=
hZGF0YT4KICA8c29kaXBvZGk6bmFtZWR2aWV3CiAgICAgcGFnZWNvbG9yPSIjZmZmZmZmIgogIC=
AgIGJvcmRlcmNvbG9yPSIjNjY2NjY2IgogICAgIGJvcmRlcm9wYWNpdHk9IjEiCiAgICAgb2JqZ=
WN0dG9sZXJhbmNlPSIxMCIKICAgICBncmlkdG9sZXJhbmNlPSIxMCIKICAgICBndWlkZXRvbGVy=
YW5jZT0iMTAiCiAgICAgaW5rc2NhcGU6cGFnZW9wYWNpdHk9IjAiCiAgICAgaW5rc2NhcGU6cGF=
nZXNoYWRvdz0iMiIKICAgICBpbmtzY2FwZTp3aW5kb3ctd2lkdGg9IjEzNjYiCiAgICAgaW5rc2=
NhcGU6d2luZG93LWhlaWdodD0iNzA1IgogICAgIGlkPSJuYW1lZHZpZXcyMCIKICAgICBzaG93Z=
3JpZD0iZmFsc2UiCiAgICAgaW5rc2NhcGU6c25hcC1iYm94PSJ0cnVlIgogICAgIGlua3NjYXBl=
Onpvb209IjEiCiAgICAgaW5rc2NhcGU6Y3g9IjQ0My43NDU0NSIKICAgICBpbmtzY2FwZTpjeT0=
iMzIxLjMyOTQ2IgogICAgIGlua3NjYXBlOndpbmRvdy14PSItOCIKICAgICBpbmtzY2FwZTp3aW=
5kb3cteT0iLTgiCiAgICAgaW5rc2NhcGU6d2luZG93LW1heGltaXplZD0iMSIKICAgICBpbmtzY=
2FwZTpjdXJyZW50LWxheWVyPSJzdmcxOCIgLz4KICA8ZGVmcwogICAgIGlkPSJkZWZzMyIgLz4K=
ICA8ZwogICAgIGlkPSJnMTMyIj4KICAgIDxwYXRoCiAgICAgICBpZD0icGF0aDUiCiAgICAgICB=
maWxsPSIjMjQ0YWE1IgogICAgICAgZD0ibTAgMGg4NDB2NjAwaC04NDB6IiAvPgogICAgPHBhdG=
gKICAgICAgIGlkPSJwYXRoMjYiCiAgICAgICBkPSJtIDQyNC41NDExNCwxOTAuMTM0NzYgYyAzL=
jUxNDQ0LDQuMTAxNiA1Ljg2NzM4LDguMiA1Ljg2NzM4LDEzLjE4NTAyIC0yLjk1MDgsMS40NTg4=
MyAtNy4wMjc4LDIuMDU0NTUgLTkuMzgwNzQsNC42OTA5MSAxNC42NTEzMywtMi4wNTU2MSAxNy4=
1NzAwNSwxNC45MzM2OSAzMy45Nzg2LDguNDg2NjMgMC41OTU3MywyLjM1Mjk0IDIuOTQ4NjcsNC=
40MDY0MiA1Ljg2NjMxLDMuNTE4NzIgbCAxLjc1NzIyLC00LjY3OTE0IGMgNi40MzIwOSwtMS43N=
TcyMiA0LjY3NDg3LDguNzgzOTUgMTEuNzMxNTUsNi43Mjk0MSAzLjUxNjU4LDIuOTMzNjkgMS4x=
NjM2NCw3LjkwNjk1IDMuNTE2NTgsMTEuNDM2MzYgMCw0LjA5NDEyIDEuNzU4MjksNy42MDg1NiA=
zLjUxMzM3LDExLjEyMTkzIDEuNzU4MjksLTIuMDM5NTggMi45MTg3MiwtNC45NzMyNyA3LjAyNz=
gxLC00LjA5NDEyIDIuOTE4NzEsMy4yMTYwNCA1LjI3MTY2LDYuMTQ5NzMgNS44NjUyNCw5LjY2M=
zEgLTEuMTkwMzgsNi43NDU0NSAtMi45NDc1OSwxMi41OTY3OSA0LjA4MDIxLDE2LjExMDE2IHYg=
Mi4wNTQ1NCBjIDQuNzA1ODgsMi4wNTQ1NSAxNS4yNDgxMywtMi4wNTQ1NCAxNS4yNDgxMyw2LjE=
0OTc0IC0wLjU5Nzg2LDIuOTMzNjkgMi45MTc2NSwwLjI5ODM5IDQuMTA5MDksMi4wNTQ1NCAyLj=
kxODcyLC0xLjE3NjQ3IDcuMDI3ODEsLTAuNTc5NjggMTAuNTQxMTgsLTAuNTc5NjggMi45MTg3M=
Sw2LjE0OTc0IC0zLjUxMzM3LDEwLjU0MTE4IC01LjI3MDU5LDE2LjExMDE2IDIuOTE3NjUsMi45=
MTg3MiAxLjc1NzIyLDguMjA0MjggMS4xNjE1LDExLjcwMTYxIGwgLTEuNzU4MjksMC44NzkxNCB=
jIDQuNjc0ODYsMC44NzgwOCAxMC41NDExNywtMC41NjQ3IDE0LjY1MjQsMi4wNzA1OSBsIDcuNj=
IzNTMsMi45MTc2NSBjIDMuNTEzMzcsLTIuMDM4NTEgNy41OTM1OSwtMi4zNTE4NyAxMi4yOTg0L=
C0yLjAzODUxIDMuNTE0NDQsMi42MzYzNyAtMS4xOTE0NCw3LjAyNzgxIDEuNzU4MjksOS4wNjcz=
OCA0LjExMDE2LDAgNy42MjM1MywwLjU5NjggOC4xODgyMyw0LjExMTIzIGwgMC41OTU3MywxLjE=
2MDQzIGMgMi45MTg3MSwtNS4yNzE2NiAxMS4xMzc5NiwtMS43NTgyOSAxNC42NTI0LC01LjU1Mj=
k0IDUuODY2MzEsMCA3LjAyNjc0LDYuNDMyMDkgOS45NDQzOSw5Ljk0NjUyIDEuMTkyNTEsOS4wO=
TczMyAtOS45NDQzOSwxMy4yMDg1NiAtNi40MzEwMiwyMi4yNzQ4NyAtMi4zNTI5NCw0LjM5MTQ0=
IC03LjAyNzgxLDcuOTA2OTUgLTEwLjU0MTE4LDEyLjAxNjA0IDEuMTYwNDMsMC41OTU3MyAwLjU=
2MzY0LDIuMDM5NTggMC41NjM2NCwyLjkxNzY1IC0zLjUxMzM3LDIuMDcxNjYgLTAuNTYzNjQsOC=
4yMjAzMiAtNS4yNzA1OSw4Ljc4NzE3IC0wLjU2NDcsMy44MjU2NiAtNy41OTI1MSwyLjM1MTg3I=
C01LjI3MDU5LDYuNDYwOTYgNC43MDQ4Miw2LjE0OTczIC0yLjMyMTkyLDkuOTQ2NTIgLTIuMzIx=
OTIsMTUuNTMwNDggLTIuOTQ5NzMsMy4yMzEwMiAtOC44MTYwNCwtMi45NDk3MyAtOC44MTYwNCw=
zLjIzMTAyIC0zLjUxNDQ0LDAuODc4MDcgLTcuMDI3ODEsLTMuMjMxMDIgLTkuMzQ5NzQsMC4yOD=
M0MiAtMS4xOTE0NCw0LjExMDE2IDIuMzIxOTMsNS41NTI5NCAxLjc1NzIyLDkuNjYzMSA1LjgzN=
jM3LC0wLjU5Njc5IDcuNTkzNTksNS4yNzA1OSA5Ljk0NjUzLDguNzg1MDMgbCA1Ljg2NjMxLDUu=
ODY2MzEgYyAtNS44NjYzMSw0LjY3NDg2IC0xMy40OTA5MSwtMC41OTY4IC0yMC41MTk3OSwyLjA=
zODUgLTEuNzU3MjIsLTAuODc4MDggMCwtMy4yIC0xLjc1NzIyLC00LjA3ODA4IC0xLjc1NzIyLC=
0yLjA3MTY1IC01LjI3MDU5LC0yLjA3MTY1IC04LjE4ODIzLC0yLjYzNzQzIDAuNTY0NywyLjYzN=
zQzIC00LjcwNTg5LDMuNTE0NDQgLTIuMzUyOTQsNi43MTQ0NCAwLDAuODc4MDcgMS4xNjA0Miwz=
LjUxNDQ0IC0xLjE2MTUsMy41MTQ0NCAtNC43MDU4OCwxLjQ3NDg2IC00LjEwOTA5LC00LjA3ODA=
4IC04LjIyMDMyLC0yLjAzOTU3IC01LjI3MDU5LDIuMDM5NTcgLTEuMTYwNDMsOS45NDY1MiAtOC=
43ODM5Niw5LjA2NzM3IDEuMTYwNDMsNy4wNTk5IC0xMS43MDI2NywxMS43MzQ3NiAtMi45MTg3M=
iwxNy44ODQ1IDEuMTYwNDMsMS4xNjE0OSAwLjU2NDcxLDMuNTEzMzcgMC41NjQ3MSw1LjI3MDU4=
IC01LjI3MTY2LDQuNzA1ODkgLTE0LjYyMjQ2LDIuOTQ5NzQgLTIwLjQ4NzcsMS4xOTE0NSAtNC4=
3MDU4OCwtMS4xOTE0NSAtMS43NTcyMiwtNy4wNTg4MiAtMy41MTMzNywtMTAuMjU4ODIgLTEuNz=
U3MjIsLTIuOTQ4NjcgLTcuMDI3ODEsLTQuOTg4MjQgLTcuMDI3ODEsLTkuMDk4NCAtMy41MTY1N=
ywtMS40NDQ5MiAtNi40NjMxLC0yLjM1MDggLTguODE2MDQsLTUuMjcxNjYgLTguMTg4MjMsNy45=
MDY5NSAtMTguMTYyNTcsMTUuNTMwNDggLTI5Ljg2ODQ1LDE1LjgxMjg0IC01LjI3MDU5LDIuNjM=
1MjkgLTguMjE5MjUsMTMuMjA5NjIgLTE2LjQwODU1LDguODE0OTcgLTMuMjE2MDUsNS4yNzI3My=
AtMTIuODk1MTksMCAtMTMuNDc1OTQsNy41OTQ2NSAtMy44MTE3NiwxLjQ3MzggLTIuMDU0NTUsN=
i40NjIwMyAtNC4zOTE0NCw4Ljc4Mzk2IC0wLjg3OTE1LDUuODY2MzEgMCwxMC44NTQ1NCA0Ljk3=
MjE5LDE0LjM3MDA1IDIuMDU0NTQsNC4zOTE0NSAtNC4zOTI1MSw0LjM5MTQ1IC0xLjc1NzIyLDg=
uNTAyNjggMC41OTY3OSwxLjQ0Mzg1IDAsMy41MTMzNiAtMC44NzgwOCw0LjEwOTA5IC0xLjc1Nz=
IxLDAuODc4MDcgLTIuMzM2ODksMS43NTgyOCAtMS43NTcyMSwzLjUxNDQzIC0xLjQ1ODgzLDAgL=
TIuMDUzNDgsMC44NzgwOCAtMy4yMTYwNSwyLjAzODUxIC0xLjQ3NDg2LDIuOTE4NzEgLTYuMTQ5=
NzMsNC4zOTI1MSAtOS4zODA3NSw2LjQzMjA4IC0zLjIxNjA0LDAuODc4MDggLTUuNTY4OTgsLTE=
uNDQzODUgLTcuNjA4NTUsLTMuNTEzMzcgLTAuNTk2NzksMy4yMzEwMiAtMy4yMzEwMiw0Ljk4OD=
I0IC02LjQ0NzA2LDQuOTg4MjQgLTQuNjkwOTEsMCAtMy44MTE3NiwtNC4xMTAxNiAtNy4zMjYyL=
C01Ljg2NjMxIDEuNDU4ODIsLTUuMjcxNjYgLTMuMjMxMDIsLTcuNTkzNTggLTEuNzU3MjIsLTEy=
LjI5OTQ3IDMuODEwNjksLTIuOTE3NjQgMTAuMjQzODUsLTQuOTg4MjMgOC40ODY2MywtMTEuMTM=
2ODkgLTQuMDk0MTIsLTQuOTU4MjkgLTIuNjM1MywtMTIuMjk5NDcgLTYuNzI5NDEsLTE4LjE2NT=
c4IC0yLjYzNTMsLTIuMzIxOTIgLTcuMDI3ODEsLTUuODM1MjkgLTUuNTY4OTksLTExLjQyMDMyI=
DMuODExNzcsLTQuMzkxNDQgMCwtOS42NjMxIC0yLjA1NDU0LC0xNC4zMzc5NyAtMC44NzgwOCwt=
My44MjY3NCAtMy4yMTYwNSwtNy4zNDAxIC0zLjIxNjA1LC0xMS43MzM2OSAtNi40NDcwNSwtMy4=
3OTU3MiAtNi43NDU0NSwtMTMuNzczMjYgLTE1LjgyNzgsLTE0LjY1MTMzIC02LjQ0NzA2LDAgLT=
cuNjA4NTYsLTguMTg5MzEgLTE0LjA1NTYyLC03LjYyNDYgLTAuNTk1NzIsLTEuMTYwNDMgLTIuM=
DU0NTQsLTIuMDM4NTEgLTMuMjMxMDEsLTMuMiAtNC42NzQ4NywzLjIgLTEwLjU0MTE4LC0wLjg3=
ODA4IC0xNi4zOTM1OSwwLjU2NDcgLTMuODExNzYsLTYuNDMyMDggMy4yMTYwNSwtMTUuMjE3MTE=
gLTcuMDQyNzgsLTE5LjA0NDkyIHYgLTQuMDc4MDcgYyAxLjE3NjQ3LDAuNTYzNjQgMS43NTcyMi=
wtMC41OTc4NiAyLjA1NDU1LC0xLjE5MjUxIDAuNTgwNzUsLTQuMzkyNTIgLTcuMzI2MiwtNC45N=
TcyMiAtNC4wOTQxMiwtOS45NDY1MyAtMS43NTcyMiwtMS40NzM4IC0zLjgxMTc2LC0yLjA3MDU5=
IC0yLjYzNTI5LC00Ljk4ODIzIC00LjQwNzQ5LC05LjA2NzM4IC0xNy41ODUwMywtOC4xODgyNCA=
tMjAuNTE4NzIsLTE3LjI4NjYzIDIuMzUyOTQsLTIuMDM4NTEgMi4zNTI5NCwtNC4xMTAxNiAzLj=
IzMjA5LC01Ljg2NjMxIC0yLjA1NTYyLC0zLjUxNDQ0IC0yLjYzNTMsLTcuMzExMjMgLTIuMDU1N=
jIsLTExLjEwNjk2IDIuMDU1NjIsLTAuNTk2NzkgMy4yMTYwNCwtMy4yMzEwMSA0LjM5MjUxLC01=
LjMwMjY3IC0yLjYzNTI5LC0xLjc1NjE1IC01Ljg1MjQsLTQuMzkxNDQgLTguNzg1MDIsLTMuNTE=
zMzcgLTUuMjcwNTksLTAuODc4MDcgLTkuMDgzNDIsLTQuOTU3MjIgLTEzLjc3MzI2LC03LjMxMD=
E2IC0xLjE3NjQ3LC0xLjE2MTUgLTAuNTc5NjgsLTMuMjMxMDIgLTAuNTc5NjgsLTQuNjc0ODcgN=
i40NDU5OSwtMi4wNzE2NSAtMC44NzgwOCwtMTEuMTU0MDEgNy4wMjc4LC05Ljk3NjQ3IDIuMDU1=
NjIsLTIuNjM1MjkgNi40NDcwNiwtMy41MTQ0MyA5LjY2NDE4LC01LjU2ODk4IDMuMjMxMDEsLTA=
uNTc5NjggNS44NjYzMSwwLjU5NTcyIDkuMDgyMzUsMS40NzQ4NyAyLjYzNTI5LDMuNDk4MzkgNy=
4zMjYyLDIuMDM5NTcgOS45NjA0Myw0Ljk3MjE5IDIuNjM1MjksLTAuNTk1NzIgNS44NjczOCwtM=
i4wNTU2MiA5LjA4MzQyLC0wLjU5NTcyIDAsLTQuOTczMjYgMi4zMzc5NywtNy45MDY5NSA1Ljg2=
NjMxLC0xMS40MjEzOSAwLjU4MDc1LC0yLjAzOTU4IDMuNzk2NzksLTMuNTEzMzcgNi40MzIwOCw=
tNC42NzQ4NyA0Ljk4OTMxLDEuMTYxNSAxMC44NDA2NSwxLjE2MTUgMTQuMzcwMDYsLTIuMzUyOT=
QgMi4zMzc5NiwxLjQ3MzggNC4zOTI1MSwtMS40NTg4MiA3LjAyNzgsLTEuNDU4ODIgMy4yMTQ5O=
CwtMC41OTU3MyA1Ljg1MTM0LDAuMjgyMzUgOC4yMDQyOCwxLjc1NzIyIDAuMjgyMzYsLTUuODY3=
MzggMTAuNTQxMTgsLTAuODc5MTUgMTIuNTk2NzksLTcuOTA2OTYgMi4zMzc5NywtNC42OTA5MSA=
tNi40NDcwNiwtNi40NDcwNiAtNS44NjczOCwtMTAuNTU3MjIgLTEuNDU4ODIsLTQuNjkwOSAyLj=
A1NTYyLC03LjAyNzggMy44MTE3NywtMTAuMjQzODUgMi4wNTQ1NCwtMC44NzkxNCA0LjM5MjUxL=
C0yLjA1NDU0IDcuMDI3ODEsLTEuNDc0ODYgNi43NDU0NSwtMi4zMzc5NyAxLjQ3Mzc5LC0xNi4x=
MTAxNiAxMi4zMTQ0MywtMTEuMTIxOTMgMCwxLjQ1OTkgLTAuNTk1NzIsMy4yMTYwNSAwLjI4MjM=
2LDMuNTE0NDQgMy44MTE3NiwwIDQuMzk2NzksLTQuMzk2NzkgNy4wNDM4NSwtNS44NjYzMSAxLj=
E2MDQzLC00LjA5NDEyIC0xLjQ3MzgsLTkuMDgyMzUgMi4wMzk1NywtMTIuMjk5NDYgMS43NTcyM=
iwtMC4yOTczMyAzLjIzMTAyLC0wLjg3ODA4IDQuMzkyNTEsLTIuMzUyOTQgMCwtMy4yMTYwNSAt=
MS43NTcyMiwtNC45NzIyIC00LjM5MjUxLC03LjAyNzgxIC0wLjg3ODA4LDEuNDY0MTcgLTMuMjE=
2MDQsMC4yOTgzOSAtNC42ODY2MywwLjg3OTE0IDAsLTMuNTE0NDQgLTIuMDQzODUsLTUuODUxMz=
MgLTIuNjM5NTcsLTkuMDgzNDIgLTEuNzU3MjIsLTAuODc4MDggLTIuNjM1MywtMi4zMzY5IC0yL=
jAzOTU4LC00LjM5MjUxIDIuNjM1MywtMi42MzUzIDAsLTkuMDgyMzYgNi4xNDk3NCwtNy42MjAz=
MiAyLjMzNzk2LC0yLjA0Mjc4IDYuNDQ3MDYsLTAuNTgzOTYgOC43ODUwMiwtNC4wOTg0IDYuMTQ=
5NzQsLTMuNTEzMzcgMTQuMzUyOTQsLTMuNTEzMzcgMTkuMDQzODUsLTkuOTYwNDMgMi4wNTQ1NS=
wwLjI5NzMzIDQuMzkyNTIsLTEuNzU3MjIgNi40NDcwNiwwIDAuNTgxODIsMy44MTA3IDYuMTUwO=
CwyLjMzNTgzIDYuMTUwOCw1Ljg1Nzc2IgogICAgICAgaW5rc2NhcGU6Y29ubmVjdG9yLWN1cnZh=
dHVyZT0iMCIKICAgICAgIHN0eWxlPSJmaWxsOiNkMGE2NTAiIC8+CiAgICA8cGF0aAogICAgICA=
gc3R5bGU9ImZpbGw6I2ZmZmZmZiIKICAgICAgIGQ9Im0gNDY5LjksMTEwLjcgLTguMSwtMjQuOS=
AtOCwyNC45IGggLTI2LjIgbCAyMS4yLDE1LjQgLTguMSwyNC45IDIxLjEsLTE1LjQgMjEuMiwxN=
S40IC04LjEsLTI0LjkgMjEuMiwtMTUuNCB6IgogICAgICAgaWQ9InBvbHlnb24zNyIKICAgICAg=
IGlua3NjYXBlOmNvbm5lY3Rvci1jdXJ2YXR1cmU9IjAiIC8+CiAgICA8cGF0aAogICAgICAgc3R=
5bGU9ImZpbGw6I2ZmZmZmZiIKICAgICAgIGQ9Im0gNTUyLjMsMTI1LjIgLTguMSwtMjQuOCAtOC=
wyNC44IEggNTEwIGwgMjEuMiwxNS40IC04LjEsMjQuOSAyMS4xLC0xNS40IDIxLjIsMTUuNCAtO=
C4xLC0yNC45IDIxLjIsLTE1LjQgeiIKICAgICAgIGlkPSJwb2x5Z29uMzkiCiAgICAgICBpbmtz=
Y2FwZTpjb25uZWN0b3ItY3VydmF0dXJlPSIwIiAvPgogICAgPHBhdGgKICAgICAgIHN0eWxlPSJ=
maWxsOiNmZmZmZmYiCiAgICAgICBkPSJtIDYzMC45LDE1My44IC04LC0yNC44IC04LjEsMjQuOC=
BoIC0yNi4yIGwgMjEuMiwxNS40IC04LjEsMjQuOSAyMS4yLC0xNS40IDIxLjEsMTUuNCAtOC4xL=
C0yNC45IDIxLjIsLTE1LjQgeiIKICAgICAgIGlkPSJwb2x5Z29uNDEiCiAgICAgICBpbmtzY2Fw=
ZTpjb25uZWN0b3ItY3VydmF0dXJlPSIwIiAvPgogICAgPHBhdGgKICAgICAgIHN0eWxlPSJmaWx=
sOiNmZmZmZmYiCiAgICAgICBkPSJtIDM4Ni4yLDExMC43IC04LC0yNC45IC04LjEsMjQuOSBoIC=
0yNi4yIGwgMjEuMiwxNS40IC04LjEsMjQuOSAyMS4yLC0xNS40IDIxLjEsMTUuNCAtOC4xLC0yN=
C45IDIxLjIsLTE1LjQgeiIKICAgICAgIGlkPSJwb2x5Z29uNDMiCiAgICAgICBpbmtzY2FwZTpj=
b25uZWN0b3ItY3VydmF0dXJlPSIwIiAvPgogICAgPHBhdGgKICAgICAgIHN0eWxlPSJmaWxsOiN=
mZmZmZmYiCiAgICAgICBkPSJtIDMwMy44LDEyNS4yIC04LC0yNC44IC04LjEsMjQuOCBoIC0yNi=
4yIGwgMjEuMiwxNS40IC04LjEsMjQuOSAyMS4yLC0xNS40IDIxLjEsMTUuNCAtOC4xLC0yNC45I=
DIxLjIsLTE1LjQgeiIKICAgICAgIGlkPSJwb2x5Z29uNDUiCiAgICAgICBpbmtzY2FwZTpjb25u=
ZWN0b3ItY3VydmF0dXJlPSIwIiAvPgogICAgPHBhdGgKICAgICAgIHN0eWxlPSJmaWxsOiNmZmZ=
mZmYiCiAgICAgICBkPSJtIDIyNS4yLDE1My44IC04LjEsLTI0LjggLTgsMjQuOCBoIC0yNi4yIG=
wgMjEuMiwxNS40IC04LjEsMjQuOSAyMS4xLC0xNS40IDIxLjIsMTUuNCAtOC4xLC0yNC45IDIxL=
jIsLTE1LjQgeiIKICAgICAgIGlkPSJwb2x5Z29uNDciCiAgICAgICBpbmtzY2FwZTpjb25uZWN0=
b3ItY3VydmF0dXJlPSIwIiAvPgogIDwvZz4KPC9zdmc+Cg=3D=3D"); }

.flag-list .me a::before { border: 5px solid rgb(233, 181, 40); background-=
color: rgb(227, 6, 19); background-image: url("data:image/svg+xml;base64,PD=
94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KPCEtLSBHZW5lcmF0b3I6IEFkb=
2JlIElsbHVzdHJhdG9yIDI4LjAuMCwgU1ZHIEV4cG9ydCBQbHVnLUluIC4gU1ZHIFZlcnNpb246=
IDYuMDAgQnVpbGQgMCkgIC0tPgo8c3ZnIHZlcnNpb249IjEuMSIgaWQ9IkxhYWdfMSIgeG1sbnM=
9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My=
5vcmcvMTk5OS94bGluayIgeD0iMHB4IiB5PSIwcHgiCgkgdmlld0JveD0iMCAwIDEyMDAgNjAwI=
iBzdHlsZT0iZW5hYmxlLWJhY2tncm91bmQ6bmV3IDAgMCAxMjAwIDYwMDsiIHhtbDpzcGFjZT0i=
cHJlc2VydmUiPgo8c3R5bGUgdHlwZT0idGV4dC9jc3MiPgoJLnN0MHtmaWxsOiNERTZGMTA7fQo=
JLnN0MXtmaWxsOiNFMzA2MTM7fQoJLnN0MntmaWxsOiNFOUI1Mjg7fQoJLnN0M3tmaWxsOiMwMD=
VEOTU7fQoJLnN0NHtmaWxsOiM2MThEMzM7fQo8L3N0eWxlPgo8ZyB0cmFuc2Zvcm09Im1hdHJpe=
CgwLjY0Mzk0MzkxLCAwLCAwLCAwLjY0Mzk0MzkxLCA0MjYuNDU3MjE0MzYsIDk5LjczMzMzNzQp=
Ij4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0zMTQuOSwxNTguMWMtNi41LDMuNi0xMC4yLDIuOC0=
xMCw1LjVjMC4zLDIuNyw2LjEsNC43LDYuMSw0LjdzLTYsNi40LTEwLjYsOS4zYy00LjYsMi45LT=
EwLjEsNC44LTEwLjEsNC44CgkJcy0xLjksMC4zLTAuOCwzLjJjMS4xLDIuOSwyLjksNC45LDQuN=
Cw1LjdjMS41LDAuOCwyLjMsMS4xLDIuMywxLjFzLTguMSw4LjctMTEuNywxMS40Yy0zLjYsMi44=
LTUuNiwzLjctOC41LDQuOQoJCWMtMi45LDEuMi0xLjUsNi0wLjgsOC4xYzAuNywyLjEsMy4yLDU=
uMSw0LjYsNS41YzEuNSwwLjQsMiwxLjUsMC4xLDQuNGMtMS40LDIuMi02LDgtOC4yLDExLjJsLT=
AuMSwwLjFjLTIuMi0zLjItNi45LTkuMS04LjMtMTEuMwoJCWMtMS45LTIuOS0xLjMtNCwwLjEtN=
C40YzEuNS0wLjQsNC0zLjMsNC42LTUuNWMwLjctMi4xLDIuMS02LjktMC44LTguMWMtMi45LTEu=
Mi00LjktMi4xLTguNS00LjljLTMuNi0yLjgtMTEuNy0xMS40LTExLjctMTEuNAoJCXMwLjgtMC4=
zLDIuMy0xLjFjMS41LTAuOCwzLjMtMi44LDQuNC01LjdjMS4xLTIuOS0wLjgtMy4yLTAuOC0zLj=
JzLTUuNC0xLjktMTAuMS00LjhjLTQuNi0yLjktMTAuNi05LjMtMTAuNi05LjNzNS44LTIsNi4xL=
TQuNwoJCWMwLjMtMi43LTMuNS0xLjktMTAtNS41Yy02LjUtMy42LTguNi04LjEtOC42LTguMXM3=
LjYtMi41LDExLjMtMTAuMWMxLjMtMi43LDEuNi01LjEsMS41LTcuMmwwLjMsMC4xYzEyLjEsMy4=
5LDI2LjIsNS41LDM4LjgsNS41CgkJYzEyLjYsMCwyNi43LTEuNiwzOC44LTUuNWwwLjMtMC4xYy=
0wLjEsMi4xLDAuMiw0LjUsMS41LDcuMmMzLjcsNy42LDExLjMsMTAuMSwxMS4zLDEwLjFTMzIxL=
jQsMTU0LjUsMzE0LjksMTU4LjEgTTIyNi45LDk0LjcKCQljLTEuOSwxLjYtNS4zLDAuNi03Ljkt=
MC40Yy0yLjYtMS01LjQtMS43LTUuNC0xLjdzMC42LTAuNiwxLjMtMS45YzAuNy0xLjMsMC43LTM=
uNCwwLjItN2MtMC42LTMuNi0xLjEtNy4zLTAuNi05LjQKCQljMC42LTIuMSwwLjUtNC4zLDQuMi=
04LjVjMy43LTQuMiw5LjktNy4xLDkuOS03LjFzLTAuOCwxLjMtMi4zLDQuMmMtMS41LDIuOC01L=
DEwLjYtNC41LDE4LjJjMC42LDcuNiw1LDguOCw2LjEsOS45CgkJQzIyOS4zLDkyLDIyOC44LDkz=
LjEsMjI2LjksOTQuNyBNMjUwLjcsNThjNi42LTYsMTEuMi03LDExLjItN2MtMC4zLDYuNy0xLjU=
sMTItMi40LDE4LjJjLTEuMSw3LjQtMC41LDEwLjgsMC45LDE0LjQKCQljMS40LDMuNiw1LjMsNS=
44LDUuMyw1LjhzLTEuMywwLjItMy4yLDEuMmMtMS45LDEtMy45LDIuNS03LjMsMi43Yy0zLjMsM=
C4yLTQuOC0wLjgtNy0yLjNjLTIuMi0xLjUtNC42LTIuNS00LjYtMi41CgkJczEuMS0yLjYsMC44=
LTUuNWMtMC4yLTIuOS0xLjgtNi42LTEuOC05LjZDMjQyLjYsNzAuMiwyNDQuMSw2NCwyNTAuNyw=
1OCBNMjgyLjksODMuNmMxLjQtMy42LDItNywwLjktMTQuNAoJCWMtMC45LTYuMi0yLjEtMTEuNS=
0yLjQtMTguMmMwLDAsNC42LDEsMTEuMiw3YzYuNiw2LDguMSwxMi4yLDguMSwxNS4zYzAsMy0xL=
jYsNi43LTEuOCw5LjZjLTAuMiwyLjksMC44LDUuNSwwLjgsNS41CgkJcy0yLjQsMS00LjYsMi41=
Yy0yLjIsMS41LTMuNywyLjQtNywyLjNjLTMuMy0wLjItNS40LTEuNy03LjMtMi43Yy0xLjktMS0=
zLjItMS4yLTMuMi0xLjJTMjgxLjUsODcuMiwyODIuOSw4My42IE0zMTYuOSw2Mi45CgkJYy0xLj=
UtMi44LTIuMy00LjItMi4zLTQuMnM2LjIsMi45LDkuOSw3LjFjMy43LDQuMiwzLjYsNi40LDQuM=
iw4LjVjMC42LDIuMSwwLDUuOC0wLjUsOS40Yy0wLjYsMy42LTAuNiw1LjcsMC4yLDcKCQljMC43=
LDEuMywxLjMsMS45LDEuMywxLjlzLTIuOCwwLjctNS40LDEuN2MtMi42LDEtNiwyLTcuOSwwLjR=
jLTEuOS0xLjYtMi40LTIuNy0xLjItMy43YzEuMi0xLDUuNi0yLjMsNi4xLTkuOQoJCUMzMjEuOS=
w3My41LDMxOC40LDY1LjgsMzE2LjksNjIuOSBNMTgzLjYsNDIwLjNjLTMuMSw1LjctMTEuNCwxM=
S43LTE3LjUsMTQuNGMtNi4xLDIuNy0xMi44LDMuNS0xNS42LDMuOQoJCWMtMi44LDAuNC0wLjQs=
My44LTAuNCwzLjhsMi45LDQuMmMwLDAtMC40LDEuMy00LjksMi41Yy00LjQsMS4zLTkuOSwyLjI=
tMTQuNSwzLjVjLTQuNiwxLjMsMS4zLDUsMy45LDYuNGMyLjYsMS40LDEuOSwyLjksMC42LDQuMw=
oJCWMtMS40LDEuNC02LjUsNC4zLTkuMiw1LjJjLTIuNiwwLjgtMi4yLDIuMiwwLjQsMy40YzIuN=
iwxLjEsOS45LDIuNSw5LjksMi41cy0wLjEsMC4zLTQuNiwzLjZjLTQuNCwzLjMtMTIuMiw1LjYt=
MTcuNCw1LjkKCQljLTUuMSwwLjMtMTMuMywwLjYtMjMuNiwwLjFjLTEwLjMtMC41LTExLjUtMC4=
3LTExLjUtMC43cy0wLjQtMy40LTEuMS04LjVjLTAuNy01LjEtMy44LTEyLjMtNi4yLTE1LjZjLT=
IuNC0zLjMtNy4zLTEwLTcuMy0xMAoJCXMwLjEtMS40LDAuNS0zLjFjMC40LTEuNywwLjEtMy40L=
TEuMS02LjZjLTEuMi0zLjEtNy4yLTcuNy03LjItNy43cy0wLjItMy40LTAuMi02LjVjMC0zLjEt=
Mi4yLTE1LjQtNC4xLTIxLjIKCQljLTEuOS01LjgtMTEuMy0yMS0xNS43LTI4LjJjLTQuMy03LjI=
tNi45LTE3LjktOC4yLTI2LjNjLTEuMy04LjMtMC44LTExLTAuNC0xMy4yYzAuMi0xLDAuNi0xLj=
gsMS0yLjZjMS44LDIuMyw0LjEsNC41LDcsNi4zCgkJYzEyLjYsNy43LDM3LjcsOC40LDM3LjcsO=
C40cy0yLjgsMC44LTExLjgsMC45Yy05LDAuMS0yMS0yLjktMjEtMi45cy0wLjMsMC42LTAuMywy=
LjhjMCwyLjEsMC42LDExLjMsMTMuNywxOAoJCWMxMy4yLDYuNywyNy43LDIuMSwyNy43LDIuMXM=
tMS4yLDEtNC45LDIuNGMtMy43LDEuNC0xMy45LDMuNS0xMy45LDMuNWMwLDguMSw3LjEsMTIuNS=
wxMi41LDE0LjRjOS40LDMuMiwyMCwxLDI1LjUtMC4yCgkJYzUuNS0xLjEsMi40LDAuNy0yLjgsM=
i45Yy01LjIsMi4yLTEyLjUsMi42LTEyLjUsMi42YzEuMSw1LjksMTIuOCwxMSwxNy4yLDExLjlj=
MTEuMSwyLjQsMTkuMywwLjksMjIuNi0wLjQKCQljMy4zLTEuMywyLjcsMC4yLDEuNywxLjNjLTI=
sMi01LjMsMi41LTUuMyw1LjdjMCwwLjktMC4xLDQuMSwxNi40LDUuMmMxNi41LDEuMSwyMi04Lj=
EsMjQuOS0xMC44YzIuOS0yLjcsMi43LTEuMywyLTAuMgoJCWMtMC43LDEuMS0zLjYsNC4zLTYuM=
Sw3LjljLTIuNSwzLjYtMS4zLDcsOS43LDYuN2M4LjEtMC4zLDEzLjQtOC44LDE1LjctMTMuM2ww=
LjIsMC4yYzAuMSwwLjIsMC4zLDAuNCwwLjQsMC42CgkJQzE4Ny40LDQxMi4zLDE4NS42LDQxNi4=
2LDE4My42LDQyMC4zIE0yOS42LDMzMC4xYy0xLjIsMC43LTUuMSwyLjktNS4xLDIuOXMtMi00Lj=
EtMi41LTUuM2MtMC41LTEuMi0wLjMtMS44LDAuNC0xLjgKCQljMC43LDAsMi44LTAuNiw0LjUtM=
C44YzAuMiwwLDAuNS0wLjEsMC42LTAuMWMwLjYsMS42LDEuMywzLjMsMi4yLDVDMjkuNywzMzAu=
MSwyOS43LDMzMC4xLDI5LjYsMzMwLjEgTTQ4MS4zLDMwMS4zCgkJYzUuNi0xLjYsMjUuMi03LjM=
sMzkuMS0xOC41YzEzLjgtMTEuMiwxNi41LTIwLjIsMTcuNi0yNWMxLjEtNC45LDEuNi04LjctMi=
01LjljLTMuNiwyLjgtMTQuMywxMS4yLTIxLjYsMTUuMwoJCWMtNy4zLDQuMS0xNC4xLDYtMTgsN=
y4xYy00LDEuMS03LjEsMS44LTMuMywwLjNjMy44LTEuNSwxNi4zLTUuOSwyNS45LTE1LjVjOS42=
LTkuNiwxNy4yLTI0LDE3LjQtMzIuOWMwLjItOC45LTAuNS04LjItMy4zLTYKCQljLTIuOCwyLjI=
tMTMsMTQuNy0xOC43LDE5LjRjLTUuNyw0LjctMTQuOSwxMS4xLTE5LjQsMTMuOGMtNC42LDIuNy=
0xMS4xLDUuNy0yLjEtMC41YzktNi4yLDI2LjEtMjAuNywzMy0zOS41CgkJYzctMTguOCw1LjctM=
jkuOSw1LjUtMzEuOGMtMC4yLTEuOS0xLjctNS43LTMuMy0yLjJjLTEuNiwzLjUtMTMsMjYuMi0y=
Mi4xLDM2Yy05LjIsOS44LTcsNy45LTksOS41Yy0yLjEsMS42LTUuNSw0LjQtMS4xLTEuMQoJCWM=
0LjQtNS41LDEzLjYtMTguMywxOC4zLTMxYzQuNy0xMi42LDYtMjUuMyw2LjItMzIuNmMwLjItNy=
4zLTMtMTcuNC00LjQtMjAuNGMtMS40LTMtMi44LTUuMi0zLjMtMS43Yy0wLjUsMy41LTcuNywyN=
S45LTExLjcsMzYuOAoJCWMtNCwxMC45LTExLjksMjMuMi0xMy40LDI1LjZjLTEuNiwyLjQtNS43=
LDcuMy0xLjMtMC45YzQuNC04LjIsMTMtMzIuNCwxNC4xLTU1LjNjMS4xLTIyLjktMi4xLTM1LjY=
tNS4yLTQxLjkKCQljLTMuMi02LjMtNS45LTguNi01LjktOC42czAuNSwxNS42LTQuMSwzOC4xYy=
00LjcsMjIuNS0xMS41LDM0LjMtMTEuNSwzNC4zcy0yLjksMy4yLTAuOS0yLjJjMS4zLTMuNiw0L=
jEtMTEuNiw1LjMtMjUuMgoJCWMxLjMtMTQuMiwxLjUtMzAuNC0yLjctNDQuMWMtNC41LTE1LTEy=
LjMtMjIuNi0xMi4zLTIyLjZjLTIuMiwyMS41LTEuOCw0OS4yLTkuNiw3MS42Yy0xLjUtMS4zLTM=
uNC0zLjgtNC4yLDEuMgoJCWMtMS40LDcuNC00LjMsMjEuMi0xNCwzOC44Yy05LjcsMTcuNi0xMy=
42LDIwLTEzLjYsMjBzLTEuOC00LjMtMy4xLTYuN2MtMS4zLTIuMy0yLTMuNi0zLjYtMC40Yy0xL=
jYsMy4yLTcsMTUuNi0xOC45LDI5LjMKCQljLTExLjksMTMuNy0xOC41LDIwLjMtMTguMSwzMC42=
YzAuNCwxMC4zLDUuNywxNS41LDEyLjksMjAuMWM3LjIsNC43LDguNCw3LjIsNy40LDEyLjhjLTE=
uMSw1LjYtNy41LDcuNi0xMy4xLDcuNwoJCWMtNS42LDAuMi0xMi42LTAuNC0xNS4xLDEuMWMtMi=
41LDEuNC0yLjcsNS01LjIsNy41Yy0yLjUsMi41LTMuNiw0LTUuOSw0LjNjLTAuOCwwLjEtMS41L=
DAuMi0yLDAuM2MtMC41LTI3LDEwLTM5LjEsMTAtMzkuMQoJCUwzMzcuNCwyMzdjLTEuNSwwLjct=
MywxLjQtNC41LDIuMWMtMC4yLTAuNC0wLjUtMC44LTAuOS0xLjNjLTMuOS01LTUuMi05LjItNS4=
yLTE1LjZjMS41LDAuMSw0LjQsMS4yLDcsMC43CgkJYzIuNy0wLjUsMC43LTMuMi0wLjEtNS43Yy=
0wLjgtMi41LTEuNi0xMS4zLTEuMS0xNC42YzAuNS0zLjMsMC44LTQuNywwLjgtNC43czQuMyw0L=
jcsNi45LDQuN2MyLjcsMCwyLjQtMi43LDIuOC01LjYKCQljMC42LTQuNCwyLjctMTAsNi4xLTEz=
YzAsMCw0LjYsMy4yLDEwLDMuMmM1LjMsMCwxMi41LTEuNSwxOC4yLTYuOWM1LjctNS41LDUuNi0=
2LjgsNS42LTYuOHMxMC42LDMuNywxOC43LDQuMQoJCWM4LjEsMC40LDE2LjctMC45LDIwLjgtOS=
41YzQuMS04LjUtMS4yLTE2LjQtMi4xLTE3LjdjLTAuOS0xLjMtMy42LTIuNC0zLjYsMGMwLDIuN=
CwwLjEsOC44LTQuOCwxMmMtNC45LDMuMi04LjgsMy4xLTEzLjQsMS42CgkJYy00LjYtMS41LTEx=
LjEtMy4zLTE4LjYtMi4zYy02LjcsMS03LjYsMS41LTcuNywxLjZjMC4zLTAuNCw2LjQtNi42LDE=
yLjMtOC40YzYuMS0xLjksOS43LDAuNywxMS43LDMuMWMyLDIuNCwzLjcsNi4zLDUuMywwLjcKCQ=
ljMS42LTUuNiwwLjctMTItMi0xNi4xYy0yLjctNC4xLTguNC02LjgtMTQuMy02LjFjLTYsMC43L=
TguMSwxLjYtOC4xLDEuNnMtMy4xLTguNi0xMC44LTEwLjJjLTkuNC0yLTE5LjcsMS42LTI3Ljks=
Ni4xCgkJYzAsMC02LjQsMS41LTEyLjktMC40Yy00LjMtMS4yLTguNS0zLjgtMTAuOS01LjRjMC4=
3LTIuNSwyLjItNy4xLDIuMi03LjFzMS45LTAuNiwzLjgtMS4zYzEuOS0wLjcsMS41LTEuNCwxLj=
gtMwoJCWMwLjItMS42LTMuNy00LjQtMy43LTQuNHMtMC42LTQuOSw1LjgtOC4yYzYuNC0zLjMsN=
S43LTIuOCw1LjctMi44czMuOCwwLjcsNS4zLTAuNGMxLjUtMS4xLDEuNS0xLjgsMS41LTEuOHMy=
LjgtMC45LDMuOS0yLjYKCQljMS0xLjcsMS4yLTQuMiwwLjUtNi4yYy0wLjgtMi0xLjctMi40LTA=
uNy0zLjNjMS0wLjksMi0zLjIsMi4xLTQuOGMwLjEtMS42LDAuMS0yLDAuMS0yczIuMi0wLjgsMi=
4xLTQuMWMtMC4xLTMuMy0xLjktNC43LTIuOS00LjkKCQljLTEtMC4zLTEuNy0wLjMtMS43LTAuM=
3MtMC4yLTItMS45LTQuNmMtMS43LTIuNy0yLjgtMy44LTIuOC0zLjhzMS4yLTAuOSwwLjYtMy4x=
Yy0wLjctMi4yLTIuMi0zLjUtMy43LTRjLTEuNS0wLjUtMy4xLDAtMy4xLDAKCQlzLTUtMy03LjQ=
tNC4zYy0yLjQtMS4yLTIuOS0xLjUtMi45LTEuNXMtMC4xLTIuMS0wLjktMy4yYy0wLjktMS4xLT=
IuOC0xLjYtMy45LTEuNnMtMi4yLDAuNi0yLjIsMC42cy04LjUtMi4yLTEyLTIuOAoJCWMtMy41L=
TAuNi0zLjctMC45LTMuNy0wLjlzLTcuNi0zLjYtMTAuNS00LjJjLTIuOS0wLjYtMy44LTAuOS0z=
LjgtMC45czMuMS0zLjcsMy4yLThjMC4yLTQuMy0yLjYtOC4zLTUuNy0xMC4xCgkJYy0xLjctMS0=
yLjYtMS4yLTMuMi0xLjVsLTAuMS0yLjlsNS43LDAuNmwwLjUtOS4ybC01LjUsMC43bDAuOS01Lj=
VsLTExLjYtMC4xbDAuOSw1LjVsLTUuNi0wLjRsMC41LDlsNS45LTAuOGwtMC42LDMuNAoJCWMwL=
DAtMi4xLDAuNC00LDEuN2MtMywxLjgtNS42LDUuMy01LjQsOS42YzAuMiw0LjMsMi43LDguMSwy=
LjcsOC4xcy0wLjgsMC4yLTMuNywwLjhjLTIuOSwwLjYtMTAuNSw0LjItMTAuNSw0LjJzLTAuMiw=
wLjMtMy43LDAuOQoJCWMtMy41LDAuNi0xMiwyLjgtMTIsMi44cy0xLjEtMC42LTIuMi0wLjZjLT=
EsMC0zLDAuNS0zLjksMS42Yy0wLjksMS4xLTAuOSwzLjItMC45LDMuMnMtMC42LDAuMy0yLjksM=
S41Yy0yLjQsMS4yLTcuNCw0LjMtNy40LDQuMwoJCXMtMS42LTAuNS0zLjEsMGMtMS41LDAuNS0z=
LDEuOC0zLjcsNGMtMC43LDIuMiwwLjYsMy4xLDAuNiwzLjFzLTEuMSwxLjEtMi44LDMuOGMtMS4=
3LDIuNy0xLjksNC42LTEuOSw0LjZzLTAuNywwLTEuNywwLjMKCQljLTEsMC4zLTIuOCwxLjYtMi=
45LDQuOWMtMC4xLDMuMywyLjEsNC4xLDIuMSw0LjFzMCwwLjQsMC4xLDJjMC4xLDEuNiwxLDMuO=
SwyLjEsNC44YzEsMSwwLjEsMS4zLTAuNywzLjNjLTAuOCwyLTAuNiw0LjUsMC41LDYuMgoJCWMx=
LDEuNywzLjksMi42LDMuOSwyLjZzMCwwLjcsMS41LDEuOGMxLjUsMS4xLDUuMywwLjQsNS4zLDA=
uNHMtMC43LTAuNiw1LjcsMi44YzYuNCwzLjMsNS44LDguMiw1LjgsOC4ycy0zLjksMi44LTMuNy=
w0LjQKCQljMC4yLDEuNi0wLjIsMi4zLDEuOCwzYzEuOSwwLjcsMy44LDEuMywzLjgsMS4zczEuN=
Sw0LjYsMi4yLDcuMWMtMi40LDEuNi02LjcsNC4yLTEwLjksNS40Yy02LjUsMS45LTEyLjksMC40=
LTEyLjksMC40CgkJYy04LjEtNC41LTE4LjUtOC4xLTI3LjktNi4xYy03LjcsMS42LTEwLjgsMTA=
uMi0xMC44LDEwLjJzLTIuMS0wLjktOC4xLTEuNmMtNi0wLjctMTEuNywyLTE0LjMsNi4xYy0yLj=
csNC4xLTMuNiwxMC41LTIsMTYuMQoJCWMxLjYsNS42LDMuMywxLjcsNS4zLTAuN2MyLTIuNCw1L=
jYtNC45LDExLjctMy4xYzUuOSwxLjgsMTIsOCwxMi4zLDguNGMtMC4xLTAuMS0xLTAuNi03Ljct=
MS42Yy03LjQtMS4xLTEzLjksMC44LTE4LjYsMi4zCgkJYy00LjYsMS41LTguNSwxLjYtMTMuNC0=
xLjZjLTQuOS0zLjItNC44LTkuNi00LjgtMTJjMC0yLjQtMi43LTEuMy0zLjYsMGMtMC45LDEuMy=
02LjIsOS4yLTIuMSwxNy43YzQuMSw4LjUsMTIuNyw5LjgsMjAuOCw5LjUKCQljOC4xLTAuNCwxO=
C43LTQuMSwxOC43LTQuMXMtMC4xLDEuMyw1LjYsNi44YzUuNyw1LjUsMTIuOSw2LjksMTguMiw2=
LjlzOS45LTMuMiw5LjktMy4yYzMuNCwzLjEsNS41LDguNiw2LjEsMTMKCQljMC40LDIuOSwwLjE=
sNS42LDIuOCw1LjZjMi43LDAsNi45LTQuNyw2LjktNC43czAuMywxLjMsMC44LDQuN2MwLjUsMy=
4zLTAuMywxMi4xLTEuMSwxNC42Yy0wLjgsMi41LTIuOCw1LjItMC4xLDUuNwoJCWMyLjcsMC41L=
DUuNi0wLjUsNy0wLjdjMCw2LjQtMS4zLDEwLjYtNS4yLDE1LjZjLTAuMywwLjQtMC42LDAuOC0w=
LjgsMS4yYy0xLjUtMC42LTIuOS0xLjMtNC40LTJsLTI5LjMsMzQuNAoJCWMwLDAsMTAuNSwxMi4=
xLDEwLDM5LjNsMC0wLjJjLTAuNSwwLTEuMi0wLjEtMi4xLTAuM2MtMi4zLTAuNC0zLjQtMS44LT=
UuOS00LjNjLTIuNS0yLjUtMi43LTYuMS01LjItNy41CgkJYy0yLjUtMS40LTkuNS0wLjktMTUuM=
S0xLjFjLTUuNi0wLjItMTItMi4yLTEzLjEtNy43Yy0xLjEtNS42LDAuMi04LjEsNy40LTEyLjhj=
Ny4yLTQuNywxMi42LTkuOSwxMi45LTIwLjEKCQljMC40LTEwLjItNi4zLTE2LjktMTguMS0zMC4=
2Yy0xMS45LTEzLjctMTcuMi0yNi4xLTE4LjktMjkuM2MtMS42LTMuMi0yLjMtMi0zLjYsMC40Yy=
0xLjMsMi4zLTMuMSw2LjctMy4xLDYuN3MtNC0yLjMtMTMuNi0yMAoJCWMtOS43LTE3LjYtMTIuN=
i0zMS41LTE0LTM4LjhjLTAuOC01LTIuNy0yLjUtNC4yLTEuMmMtNy45LTIyLjQtNy40LTUwLjEt=
OS42LTcxLjZjMCwwLTcuOCw3LjctMTIuMywyMi42CgkJYy00LjEsMTMuOC00LDI5LjktMi43LDQ=
0LjFjMS4zLDEzLjUsNCwyMS41LDUuMywyNS4yYzIsNS40LTAuOSwyLjItMC45LDIuMnMtNi44LT=
ExLjktMTEuNS0zNC4zYy00LjctMjIuNS00LjEtMzguMS00LjEtMzguMQoJCXMtMi43LDIuMi01L=
jksOC42Yy0zLjIsNi4zLTYuMywxOS01LjIsNDEuOWMxLjEsMjIuOSw5LjYsNDcuMSwxNC4xLDU1=
LjNjNC40LDguMiwwLjMsMy4zLTEuMywwLjljLTEuNi0yLjQtOS41LTE0LjctMTMuNC0yNS42Cgk=
JYy00LTEwLjktMTEuMi0zMy40LTExLjctMzYuOGMtMC41LTMuNS0xLjktMS4zLTMuMywxLjdjLT=
EuNCwzLTQuNiwxMy4xLTQuNCwyMC40YzAuMiw3LjMsMS40LDE5LjksNi4yLDMyLjYKCQljNC43L=
DEyLjYsMTMuOSwyNS40LDE4LjMsMzFjNC40LDUuNSwwLjksMi43LTEuMSwxLjFjLTIuMS0xLjYs=
MC4yLDAuMy05LTkuNWMtOS4yLTkuOC0yMC41LTMyLjYtMjIuMS0zNmMtMS42LTMuNS0zLjIsMC4=
zLTMuMywyLjIKCQljLTAuMiwxLjktMS40LDEzLDUuNSwzMS44YzcsMTguOCwyNCwzMy40LDMzLD=
M5LjVjOSw2LjIsMi41LDMuMi0yLjEsMC41Yy00LjYtMi43LTEzLjgtOS0xOS40LTEzLjhjLTUuN=
y00LjctMTUuOC0xNy4yLTE4LjctMTkuNAoJCWMtMi44LTIuMi0zLjUtMi44LTMuMyw2YzAuMiw4=
LjksNy43LDIzLjMsMTcuNCwzMi45YzkuNiw5LjYsMjIuMSwxNCwyNS45LDE1LjVjMy44LDEuNSw=
wLjYsMC44LTMuMy0wLjNjLTQtMS4xLTEwLjctMy0xOC03LjEKCQljLTcuMy00LjEtMTgtMTIuNS=
0yMS42LTE1LjNjLTMuNi0yLjgtMy4xLDEtMiw1LjljMS4xLDQuOSwzLjgsMTMuOCwxNy42LDI1Y=
zEzLjgsMTEuMiwzMy40LDE2LjksMzkuMSwxOC41CgkJYzUuNiwxLjYsMS43LDEuNiwxLjcsMS42=
cy0yLjItMC4zLTEzLjctMi45Yy0xMS40LTIuNS0yOC43LTExLjYtMzMuNC0xNC41Yy00LjctMi4=
5LTUuNC00LjEtNC44LDIuMWMwLjYsNi4yLDcuMiwxOS41LDE3LjgsMjUuNwoJCWMxMC42LDYuMi=
wyOS42LDkuNCwzNC41LDkuNmM0LjksMC4yLDMuNywxLDEuNCwxLjFjLTIuMiwwLjItNy43LDAuM=
i0xNi43LTAuOWMtNy40LTAuOS0xOC4zLTQuNC0yMi01LjdjLTAuNC0xLjYtMC44LTMuMS0xLTQu=
MQoJCWMtMC40LTIuNC0xLjctMi0yLjQtMS41Yy0wLjgsMC41LTEuMiwxLTMuOCwyLjNjLTIuNiw=
xLjMtMi43LTAuMy0yLjgtMWMtMC4xLTAuOC0wLjYtNC4yLTAuNy02Yy0wLjEtMS44LTEtMS44LT=
IuMy0xLjMKCQljLTEuMiwwLjUtNy4xLDMtOS4zLDMuOWMtMi4yLDEtMC4yLDIuNywxLDQuOGMxL=
jEsMi4xLDIuOSw1LjIsMi45LDUuMnMtNS41LDEuNS03LjMsMS45Yy0xLjcsMC40LTEuMiwxLjct=
MC44LDIuOQoJCWMwLjQsMS4yLDMuMSw3LjQsMy44LDkuMWMwLjcsMS44LDIuMywwLjcsMi4zLDA=
uN2w1LjUtMy4ybDEuOSw3LjRjLTAuMSwwLjEtMi41LDAuNi01LjMsMi41Yy0yLjgsMi0yLjEsNC=
41LDEuMyw1LjQKCQljMy4zLDEsNy4yLDIuNiwxMS41LDEwLjVjNC4zLDcuOCw1LjQsMjEuOSw4L=
jEsNDQuMWMyLjYsMjIuMiwxNi44LDMzLjUsMTguOCwzNC45YzEuOSwxLjQsMC44LDIuNSwwLjgs=
Mi41cy0xLjksMi44LTEuMSw3LjEKCQljMC44LDQuMyw0LjYsNi44LDYuNSw3LjVjMS45LDAuNyw=
xLjQsMi42LDEuNCwyLjZzLTEsNC43LDAsMTMuNGMxLDguNiw4LjEsMTguNCwxMCwyMC4xYzEuOS=
wxLjcsMi4xLDIuNSwxLjgsMy4yCgkJYy0wLjMsMC43LTEuNSwwLjEtMy45LDJjLTIuNCwxLjgtN=
Sw0LjMtNi43LDcuNGMtMS43LDMuMS0xLjEsNC45LTAuNiw5LjFjMC42LDQuMiw2LjcsNy45LDYu=
Nyw3LjlzLTEuMSwwLjMtMS40LDMuMwoJCWMtMC4zLDMuMSwxLjksNi42LDQuNyw4LjhjMi44LDI=
uMiw4LjEsMy4zLDguMSwzLjNzMC40LDIuNiwwLjcsNC41YzAuMywxLjgsMy44LDMuNiw2LDQuOW=
MyLjIsMS4zLDYuNSwwLjYsOC4zLTAuMwoJCWMxLjgtMC44LDMuMSwwLjEsNC4yLDJjMS4xLDEuO=
CwwLjcsOC44LDAuNywxMS42YzAsMi44LTEuNyw1LjctMC43LDcuMWMxLDEuNCwzLjYsMC40LDYu=
My0xLjFjMi42LTEuNSwzLjMtMC40LDUuNywxLjEKCQljMi40LDEuNSw2LjEsMi45LDcuMSwyLjh=
jMS0wLjEsMC42LTIuNywwLjYtNC43YzAtMi4xLDAuNC02LjgsMS4zLTcuNWMwLjUtMC4zLDQuNi=
0wLjYsNy43LTJjMS41LTAuNiwzLjMtMS4zLDMuNS0yLjYKCQljMC4xLTEuNC0xLjktMS40LTYuN=
S0zLjhjLTQuNi0yLjQtNS40LTMuOC04LjMtNS43Yy0yLjktMi0xLjUtMi42LTEuNS0zLjVjMC0w=
LjgsMS40LTEuOCwxLjktMi45YzAuNi0xLjEsMC4zLTMuNiwwLjMtMy42CgkJczIuNC0yLjQsMy4=
1LTMuNmMxLjEtMS4zLDIuNS0zLjIsNC00LjVjMS41LTEuMywzLjktNy4yLDUuNC05LjJjMS41LT=
IsNS00LDcuMS02LjdjMi4xLTIuNyw3LjYtNywxMC44LTkuMQoJCWMzLjItMi4xLDExLjgtNi4xL=
DExLjgtNi4xcy0wLjEsNS4yLDIuMSw3LjdjMi4yLDIuNSw1LjEtMS45LDE1LTguOWM5LjktNywx=
Ny40LTkuNSwxNy40LTkuNXMyLjEsMy4yLDQuNyw2LjYKCQljMi42LDMuNCw1LTAuMSwxNy4xLTE=
2LjljOS41LTEzLjIsMjIuMS0yNS4zLDI3LTI5LjhjMC45LDAuNCwxLjgsMC44LDIuNywxLjJjLT=
AuMiwwLjYtMC41LDEuNC0wLjcsMi4yYy0xLjEsMy41LTIuOSw1LjctNS4zLDEwLjUKCQljLTIuN=
Cw0LjgtNiw2LTEwLjEsMTIuNWMtNC4yLDYuNS00LjcsMTAuOS01LjEsMTcuNmMtMC40LDYuNywz=
LjMsOCwzLjMsOHMtNi4xLDYtNy45LDEwLjRjLTEuOCw0LjQtMi44LDEzLjQtMi44LDEzLjQKCQl=
zLTEsMC40LTMuMiw1Yy0yLjIsNC42LTYuMiw1LjMtMTIuMSwxMS4xYy01LjgsNS44LTEyLjMsOC=
4zLTE1LjQsMTAuMWMtMywxLjgtMi4yLDMuNi0xLjQsNmMwLjgsMi40LDUsNC43LDkuOCw2LjUKC=
QljNC44LDEuOCw2LjUsMS4xLDkuOCwxYzMuMy0wLjEsMC43LDIuNS0wLjcsMy45Yy0xLjQsMS40=
LTMuMiw2LjItMi45LDExLjZjMC4zLDUuNCw0LjMsNC4yLDkuMywzLjNjNS0wLjgsMTAuOC0zLjM=
sMTAuOC0zLjMKCQlsLTAuNiwxLjVjLTAuNiwxLjUtMC44LDIuNi0wLjgsNi45YzAsNC4zLDAuNy=
w2LjQsMS45LDcuNWMxLjIsMS4xLDMuNy0xLjIsNS41LTEuOGMxLjgtMC42LDQuOS0yLjQsOS4zL=
TMuM2M0LjQtMSw2LjEtMi45LDYuMS0yLjkKCQlzLTEuMSwxLjQtMS40LDQuNGMtMC4zLDMuMS0w=
LjEsNy42LDAuNiwxMC4zYzAuNywyLjYsMi42LDUuOCw1LjcsOC42YzMsMi44LDMuNywxLjUsNi0=
xLjljMi4yLTMuNSw2LjgtNy45LDYuOC03LjkKCQlzMC4zLDEuMSwzLjMsMTAuOWMzLDkuOCwxMy=
wxOCwxMywxOHMxMC04LjIsMTMtMThjMy05LjgsMy4zLTEwLjksMy4zLTEwLjlzNC42LDQuNCw2L=
jgsNy45YzIuMiwzLjUsMi45LDQuNyw2LDEuOQoJCWMzLTIuOCw1LTYsNS43LTguNmMwLjctMi42=
LDAuOC03LjIsMC42LTEwLjNjLTAuMy0zLTEuNC00LjQtMS40LTQuNHMxLjcsMS45LDYuMSwyLjl=
jNC40LDEsNy41LDIuOCw5LjMsMy4zCgkJYzEuOCwwLjYsNC4zLDIuOSw1LjUsMS44YzEuMi0xLj=
EsMS45LTMuMiwxLjktNy41YzAtNC4zLTAuMy01LjQtMC44LTYuOWwtMC42LTEuNWMwLDAsNS44L=
DIuNSwxMC44LDMuM2M1LDAuOCw5LDIuMSw5LjMtMy4zCgkJYzAuMy01LjQtMS41LTEwLjItMi45=
LTExLjZjLTEuNC0xLjQtNC00LTAuNy0zLjljMy4zLDAuMSw1LDAuOCw5LjgtMWM0LjgtMS44LDk=
tNC4yLDkuOC02LjVjMC44LTIuNCwxLjctNC4yLTEuNC02CgkJYy0zLTEuOC05LjYtNC4zLTE1Lj=
QtMTAuMWMtNS44LTUuOC05LjgtNi41LTEyLjEtMTEuMWMtMi4yLTQuNi0zLjItNS0zLjItNXMtM=
S05LTIuOC0xMy40Yy0xLjgtNC40LTcuOS0xMC40LTcuOS0xMC40CgkJczMuNy0xLjQsMy4zLThj=
LTAuNC02LjctMS0xMS4xLTUuMS0xNy42Yy00LjItNi41LTcuOC03LjYtMTAuMS0xMi41Yy0yLjQ=
tNC44LTQuMi03LjEtNS4zLTEwLjVjLTAuMi0wLjctMC41LTEuNC0wLjctMi4xCgkJYzEuMi0wLj=
UsMi40LTEuMSwzLjYtMS42YzQuOCw0LjUsMTcuNSwxNi42LDI3LDI5LjhjMTIuMSwxNi43LDE0L=
jUsMjAuMiwxNy4xLDE2LjljMi42LTMuMyw0LjctNi41LDQuNy02LjVzNy41LDIuNSwxNy40LDku=
NQoJCWM5LjksNywxMi44LDExLjQsMTUsOC45YzEuMi0xLjMsMS40LTMuNSwxLjYtNS4yYzAsMCw=
1LjcsMS43LDEyLjIsMy45YzMuOSwxLjQsOC4yLDMuMSwxMS40LDQuNGM4LjYsMy42LDkuNSw1Lj=
UsMTYuMywxMC45CgkJYzYuOCw1LjQsMTYuNSw0LjksMjUuNywyLjFjOS4yLTIuOCwzMy42LTEwL=
jgsNDMuNC0xNS4xYzkuOC00LjIsMTYuOC04LDE3LjgtOS45YzEtMiwyLjItNy40LDIuMi05LjRj=
MC0yLTIuMi00LjktMi45LTUuNAoJCWMtMC43LTAuNS0wLjQtMi4xLTAuMi0zLjNjMC4yLTEuMi0=
wLjQtNS0yLTYuNmMtMS41LTEuNy0xLjMtMi4zLTEuMS03YzAuNC0xMC4xLTYuOC0yMi44LTE3LT=
I2LjhjMCwwLTAuMy0xLjItMS4xLTEuOQoJCWMtMC44LTAuNy0yLjItMS4zLTIuMi0xLjNzMC4yL=
TUuOCwwLjEtN2MtMC4xLTEuMiwwLjUtMS4xLDEuMi0wLjhjMC43LDAuMywxLjgsMS43LDMuNCwy=
LjFjMS43LDAuNCwyLjctMC44LDMtMi42CgkJYzAuMy0xLjksMS43LTUuNiwyLjMtNy41YzAuNi0=
xLjktMC4xLTIuMS0wLjktMi4zYy0wLjgtMC4yLTMuMi0wLjUtNC40LTAuOGMtMS4yLTAuMy0xLj=
ItMC4zLTAuOS0xYzAuMy0wLjYsMC43LTEuNiwyLjItMy45CgkJYzEuNS0yLjMsMC4xLTIuNC0xL=
jMtMi45Yy0xLjQtMC41LTgtMi41LTkuOC0yLjhjLTEuOC0wLjMtMi4yLDEuMi0yLjIsMmMwLDAu=
OCwwLjEsNC4xLDAuMSw1LjNjMC4xLDEuMi0xLjEsMC45LTEuOCwwLjYKCQljLTAuNy0wLjMtMi4=
zLTEuMy0zLjUtMi4zYy0xLjItMS0yLjEtMC4xLTIuNiwxLjNjLTAuNSwxLjQtMiw3LTIuNSw4Lj=
djLTAuNSwxLjctMC4zLDMsMC4zLDMuMmMwLjcsMC4zLDMuOSwwLDUuOSwwCgkJYzEuOSwwLDAuO=
CwxLjEsMC44LDEuMXMtMi4xLDMuNC0yLjgsNC43Yy0wLjcsMS4zLTEuOSwxLjUtMy40LDEuNWMt=
MS42LDAtNC4yLDAtNC4yLDBzLTEwLjYsMC40LTE4LjQsNi4yCgkJYy03LjgsNS44LTEwLDEwLjY=
tMTEuMiwxMy40Yy0xLjIsMi44LTIuNiwyLjItMy44LDMuMmMtMS4yLDEtNC42LDQuNi00LjYsNi=
44YzAsMi4yLDAuOCwzLjQtMi42LDUuNmMtMy40LDIuMi02LjIsMTEuOC0xLjYsMTYuOAoJCWM0L=
jYsNSw2LjQsMTAsNy44LDEyLjRjMS40LDIuNCwwLDMuNC0xLjIsMy40Yy0xLjIsMC0zLjctMi01=
LjgtMy42Yy0yLjEtMS42LTEyLjYtOS44LTE3LjItMTMuMmMtNC41LTMuNC0xLjItMy0xLjItMwo=
JCXMxLjIsMC4xLDMuOC0xYzIuNi0xLjEsMy4xLTIuNSwwLjQtMy4zYy0yLjYtMC44LTcuOC0zLj=
gtOS4yLTUuMmMtMS40LTEuNC0yLjEtMi45LDAuNi00LjNjMi42LTEuNCw4LjUtNS4yLDMuOS02L=
jQKCQljLTQuNi0xLjMtMTAtMi4yLTE0LjUtMy41Yy00LjQtMS4zLTQuOS0yLjUtNC45LTIuNWwy=
LjktNC4yYzAsMCwyLjQtMy4zLTAuNC0zLjhjLTIuOC0wLjQtOS41LTEuMy0xNS42LTMuOQoJCWM=
tMTIuMi01LjMtMTkuOS0xNC4zLTIyLjctMjUuMmwwLjItMC4zYzIuMyw0LjUsNy42LDEzLDE1Lj=
YsMTMuMmMxMSwwLjQsMTIuMi0zLjEsOS43LTYuN2MtMi41LTMuNi01LjQtNi44LTYuMS03LjkKC=
QljLTAuNy0xLjEtMC45LTIuNSwyLDAuMnM4LjMsMTEuOSwyNC45LDEwLjhjMTYuNS0xLjEsMTYu=
NC00LjMsMTYuNC01LjJjMC0zLjItMy40LTMuNy01LjMtNS43Yy0xLTEtMS43LTIuNSwxLjctMS4=
zCgkJYzMuMywxLjMsMTEuNSwyLjgsMjIuNiwwLjRjNC40LTAuOSwxNi02LDE3LjEtMTEuOWMwLD=
AtNy40LTAuNC0xMi41LTIuNmMtNS4yLTIuMi04LjMtNC4xLTIuOC0yLjljNS41LDEuMSwxNi4xL=
DMuMywyNS41LDAuMgoJCWM1LjUtMS45LDEyLjUtNi4zLDEyLjUtMTQuNGMwLDAtMTAuMi0yLjEt=
MTMuOS0zLjVjLTMuNy0xLjQtNC45LTIuNC00LjktMi40czE0LjUsNC42LDI3LjctMi4xYzEzLjI=
tNi43LDEzLjctMTUuOCwxMy43LTE4CgkJYzAtMi4xLTAuMy0yLjgtMC4zLTIuOHMtMTIsMi45LT=
IxLDIuOWMtOS0wLjEtMTEuOC0wLjktMTEuOC0wLjlzMjUuMS0wLjcsMzcuNy04LjRjMTIuNi03L=
jcsMTMuMy0yMi45LDEzLjMtMjIuOQoJCXMtMTQuMyw1LjEtMjMuMyw2LjFjLTksMS0xNC41LDEt=
MTYuNywwLjljLTIuMi0wLjItMy41LTAuOSwxLjQtMS4xYzQuOS0wLjIsMjQtMy40LDM0LjUtOS4=
2YzEwLjYtNi4yLDE3LjItMTkuNSwxNy44LTI1LjcKCQljMC42LTYuMi0wLjEtNS4xLTQuOC0yLj=
FjLTQuNywyLjktMjIsMTItMzMuNCwxNC41Yy0xMS40LDIuNS0xMy43LDIuOS0xMy43LDIuOVM0N=
zUuNiwzMDIuOSw0ODEuMywzMDEuMyIvPgoJPHBhdGggY2xhc3M9InN0MSIgZD0iTTE4MS40LDE2=
OC41Yy0yLjYtMS41LTkuNC00LjQtMTYuNy01LjFjLTcuMy0wLjYtMTIuOSwwLjUtMTksMi4xYy0=
0LjMsMS4yLTcuOSwxLjQtMTEuMywwLjQKCQljLTUuMi0xLjQtOS4zLTYuMS0xMC43LTExLjljMC=
wwLTQuOCw2LjIsMC4xLDEyLjljMi40LDMuMiw1LjUsNS4yLDguNiw1LjljMTAuMiwyLjEsMjAuM=
y00LjIsMjguOC00LjdjOC4yLTAuNSwxNC42LDQuNywxNC42LDQuNwoJCXMxLjksMS42LDQuNyww=
QzE4My4yLDE3MS4yLDE4NCwxNzAsMTgxLjQsMTY4LjUiLz4KCTxwYXRoIGNsYXNzPSJzdDEiIGQ=
9Ik00MTkuNywxNTQuMWMtMS40LDUuOC01LjQsMTAuNS0xMC43LDExLjljLTMuNSwwLjktNywwLj=
gtMTEuMy0wLjRjLTYuMS0xLjYtMTEuNy0yLjctMTktMi4xCgkJYy03LjMsMC42LTE0LjIsMy42L=
TE2LjcsNS4xYy0yLjUsMS41LTEuOCwyLjcsMSw0LjNjMi43LDEuNiw0LjcsMCw0LjcsMHM2LjQt=
NS4yLDE0LjYtNC43YzguNSwwLjUsMTguNSw2LjgsMjguOCw0LjcKCQljMy4xLTAuNiw2LjItMi4=
3LDguNi01LjlDNDI0LjUsMTYwLjMsNDE5LjcsMTU0LjEsNDE5LjcsMTU0LjEiLz4KCTxwYXRoIG=
NsYXNzPSJzdDIiIGQ9Ik0zNTQuNCwzMDQuNmMwLTIwLjQsOS40LTMzLjMsOS40LTMzLjNMMzM4L=
jIsMjQyYy0yNC4zLDkuNC00Ni42LDEwLTY2LjUtMC4xYy0xOS45LDEwLjEtNDIuMiw5LjUtNjYu=
NSwwLjEKCQlsLTI1LjYsMjkuM2MwLDAsOS40LDEyLjksOS40LDMzLjNjMCwyMC40LTMuOSwzNS4=
2LTYuMyw0NS40Yy0yLjMsOS45LTQuMywyOC4zLDEsNDEuNWM1LjMsMTMuMiwxMC45LDI0LjcsMz=
MuNiwzNC4yCgkJYzIyLjcsOS41LDM0LjYsMTQuNSw0Mi41LDIxLjFjNy45LDYuNiwxMS45LDExL=
jksMTEuOSwxMS45czQtNS4zLDExLjktMTEuOWM3LjktNi42LDE5LjgtMTEuNSw0Mi41LTIxLjEK=
CQljMjIuNy05LjUsMjguMy0yMS4xLDMzLjYtMzQuMmM1LjMtMTMuMiwzLjMtMzEuNiwxLTQxLjV=
DMzU4LjQsMzQwLjIsMzU0LjQsMzI1LDM1NC40LDMwNC42Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIi=
BkPSJNMTU4LjQsNDY3LjZjMCwwLTguMiwzLjktMTAuOSw0LjZjLTIuNiwwLjctMy4yLDAuNy0zL=
jIsMC43cy01LjYsNS4xLTkuOCw3LjZjLTQuMywyLjYtOS4zLDQuNC0xNC4zLDUKCQljLTYuNCww=
LjctMjQuMSwwLjUtMzIuMSwwLjJjLTcuOS0wLjMtMTIuOSwxLjYtMTYuMyw1LjRjLTMuNCwzLjg=
tNC4yLDkuNCwwLjEsMTMuNmM0LjMsNC4yLDkuMiwyLjEsMTAuOC0wLjUKCQljMS42LTIuNiwwLj=
gtNiwwLjEtNy41Yy0wLjctMS41LDEuNC0yLDMuNi0yLjFjMi4yLTAuMSw1LjksMC4yLDkuNCwwL=
jdjMy40LDAuNSw5LjUsMi41LDEyLjEsMy45YzIuNiwxLjQsMS4xLDEuNi0wLjcsMS4zCgkJYy0x=
LjgtMC4zLTMuOC0xLTctMi4yYy0zLjItMS4yLTUuOS0xLjgtNy45LTEuOWMtMi0wLjEtMS4zLDE=
tMC45LDEuN2MwLjQsMC43LDEuNSwyLjQsMS44LDMuMmMwLjMsMC44LTAuNiwzLjgtMC42LDMuOG=
wxLDEuOQoJCWMwLDAsMS4yLTEuOSwxLjYtMi45YzAuNC0xLTAuMS0yLjksMC4zLTMuOGMwLjQtM=
C45LDIuMS0wLjksMy40LDAuNmMxLjMsMS41LDIuOCwzLjMsMy41LDcuMmMwLjcsMy44LTAuNiw2=
LjYtMC42LDYuNgoJCXMxLjYsMS4zLDEuOSwyLjJjMC4zLDAuOS0wLjQsNC41LTAuNCw0LjVzMS4=
xLDAuNywyLjEtMS40YzEtMi4xLDIuMi01LjgsMi41LTcuMmMwLjMtMS4zLDEuMi0zLjcsMi44LT=
EuOWMxLjYsMS44LDIuNyw0LDMsNS4xCgkJYzAuMywxLjEsMC4zLDIsMC4zLDJzMy42LTMuNSw0L=
jgtNS42YzEuMi0yLDMuNy01LDcuMS03LjljMy40LTIuOCw5LjQtOC41LDEyLjMtMTAuNGMyLjkt=
MS45LDEwLjQtNiwxMi43LTcuNHMyLjctMS41LDMuMS01LjUKCQljMC40LTMuOSwyLjMtNy41LDM=
uMi0xMC4yQzE1OC4yLDQ2OC42LDE1OC40LDQ2Ny42LDE1OC40LDQ2Ny42Ii8+Cgk8cGF0aCBjbG=
Fzcz0ic3QyIiBkPSJNMTUyLDQ2NC42YzAsMC0xLTAuMS0yLjQtMC4zYy0xLjQtMC4yLTQuNC0xL=
jItNS4zLTEuNmMtMC45LTAuNC0yLjMtMC41LTMuMiwwLjVjLTAuOSwxLTguMiw1LjMtOC4yLDUu=
M2gxMi4yCgkJQzE0OS4yLDQ2OC41LDE1Miw0NjQuNiwxNTIsNDY0LjYiLz4KCTxwYXRoIGNsYXN=
zPSJzdDIiIGQ9Ik0xODYuMyw0NjIuNXYtMS4ybC0xLjYtMy41YzAsMC0xLjksMS4yLTMuNywzLj=
FjLTIuNCwyLjUtNC45LDUuOS02LjEsNy40Yy0yLDIuNi00LjksNS0yLjQsMC45CgkJYzIuNC00L=
jEsMy4yLTUuOSw1LjItOC43YzEuOS0yLjgsMy40LTQsMy4yLTQuMWMtMC4yLTAuMi0xLjgtMC40=
LTYuOS0xLjFjLTUuMS0wLjctOC4zLTIuNi0xMC42LTRjLTIuNC0xLjQtNi42LTMuNy02LjYtMy4=
3CgkJcy04LjcsMy43LTExLjksNC41Yy0zLjIsMC44LTUuMiwxLjMtMiwyLjhjMy4yLDEuNSw1Lj=
gsMiw3LjQsM2MxLjUsMSw2LjMsMi41LDkuMiwyLjVjMi45LDAsNy45LDAuMSw1LjksMi4xCgkJY=
y0xLjksMi00LjEsNS45LTYuMiwxMS45Yy0yLjEsNS45LTIuMiwxMS4yLTIuMiwxMy44YzAsMi42=
LDAuMyw1LjIsMC4zLDUuMnMzLjYtNCwxMy4xLTEwYzkuNi02LDEzLjEtOCwxNC45LTguOQoJCWM=
xLjgtMC44LDIuNy0wLjgsMi40LTMuMUMxODcuMiw0NjkuMiwxODYuMyw0NjMuNiwxODYuMyw0Nj=
IuNSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIyMi44LDQzMy40Yy0wLjYtMC4zLTEuMi0wL=
jUtMS44LTAuOGMtMC4yLDAtMC4zLDAuMS0wLjQsMC4yYy0xLjEsMC42LTcsNC41LTkuMyw4LjNj=
LTIuNCwzLjgtNC43LDQuMi0yLjEsMAoJCWMyLjYtNC4yLDQuNS02LjUsNi41LTguM2MwLjgtMC4=
3LDEuNS0xLjMsMi0xLjdjLTQuNy0yLjMtOS44LTUtMTQuNy04LjRjLTAuNiwxLjMtMS45LDMuNS=
0zLjIsNWMtMiwyLjEtNi41LDMuOS02LjUsMy45CgkJczMuNi0zLjcsNC44LTYuNWMwLjgtMS44L=
DEuMy0zLjcsMS42LTQuOWMtMy40LTIuNy02LjctNS43LTkuNy05LjJjLTAuNiwyLjQtMi41LDgu=
My04LjMsMTQuOGMtNy41LDguNC0yMi42LDEyLjctMjIuNiwxMi43CgkJcy01LjMsMC42LTEsMS4=
3YzQuMywxLjEsNy4zLDMsMTUuNiwxLjZjOC4zLTEuNSw4LjktMS44LDEwLTIuMWMxLjEtMC4zLD=
QuMi0wLjEsMCwxLjVjLTQuMSwxLjYtMTMuOCwzLTE3LjUsMi43CgkJYy0zLjctMC4zLTguOC0xL=
jEtMy41LDEuN2M1LjMsMi44LDcuNSwzLjksMTAuOCwzLjljMy4zLDAsNC42LDEsNy43LDFjMy4x=
LDAsNC0wLjYsNi4zLTFjMi4yLTAuNCwzLjcsMC4zLDMuNywxLjIKCQljMCwwLjktMywzLjQtMi4=
5LDkuNWMwLjEsNi4yLDAuNiwxMC4yLDEuMSwxMmMwLjYsMS44LDEuOSw0LjcsMi44LDYuNGMwLj=
ksMS43LDEuMiwzLjQsMi4xLTAuMmMwLjktMy42LDIuOS04LjgsMy43LTEyLjIKCQljMC44LTMuN=
SwxLjItMy42LDEuNi01LjRjMC4zLTEuOCwyLjItMy4xLDEuMywwLjFjLTAuOSwzLjMtMS45LDcu=
NC0yLjYsMTAuM2MtMC43LDIuOS0yLjIsOC4zLDAuNCw0YzIuNy00LjMsMTIuOC0xNS42LDE0LjU=
tMTcuNgoJCWMxLjctMiwzLTMuOSw0LjMtNS42YzEuMi0xLjcsNC43LTMuOSw2LjQtNi40YzEuNS=
0yLjIsNi02LjYsNy45LTguMUMyMjksNDM2LjEsMjI2LDQzNC45LDIyMi44LDQzMy40Ii8+Cgk8c=
GF0aCBjbGFzcz0ic3QyIiBkPSJNMjYuNSwzMTkuN2MtMC4xLTAuNy0xLjQtMy0xLjctNC4yYy0w=
LjMtMS4yLTEuNS0wLjUtMS41LTAuNXMtMi42LDEuNS00LjYsMmMtMS45LDAuNS0yLjItMC4yLTI=
uNC0xLjIKCQljLTAuMi0xLTAuNy00LjItMS02LjRjLTAuMy0yLjItMC44LTIuMS0xLjYtMS44Yy=
0wLjgsMC4zLTMuMiwxLjItNC45LDJjLTEuNywwLjctMS4xLDEuNS0wLjYsMi41YzAuNSwwLjksM=
i41LDQuOSwzLjQsNi4zCgkJYzAuOSwxLjQsMC4xLDItMC45LDIuNWMtMSwwLjUtMi41LDAuNy00=
LjUsMS4zYy0yLDAuNy0xLjksMS4xLTEuNywxLjhjMC4yLDAuNywxLjUsMy40LDIuMyw0LjdjMC4=
3LDEuMywxLjQsMC40LDEuNCwwLjQKCQlzMi4xLTEuOSw0LTIuOGMxLjgtMC45LDEuOS0wLjYsMi=
40LDAuN2MwLjUsMS4zLDIuNSw4LjQsMyw5LjhjMC40LDEuMywxLjEsMS4yLDIsMC44YzAuOS0wL=
jQsMi4yLTAuNiwzLjMtMC45CgkJYzEuMS0wLjMsMS41LTIuNSwxLjUtMi41cy00LTcuMS01LTgu=
OWMtMS4xLTEuOCwwLTIuMiwwLjgtMi40YzAuOC0wLjEsMy4yLTAuNSw1LjItMC45QzI3LjEsMzI=
xLjUsMjYuNSwzMjAuNCwyNi41LDMxOS43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNzEuMi=
w1MTMuNGMtMC4zLTEuNywwLTMuNC0xLjMtNC43Yy0xLjMtMS4zLTIuOS0zLjktMy41LTYuMWMtM=
C42LTIuMSwwLjUtMy4xLDAuMy00LjMKCQljLTAuMi0xLjItMS44LTEuMi0zLjQsMC4xYy0xLjYs=
MS4zLTMuNywyLjUtMy43LDYuNGMwLDMuOCwxLjQsOC40LDYuNywxMEM3MS42LDUxNi40LDcxLjU=
sNTE1LjEsNzEuMiw1MTMuNCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTc2LjYsNTExLjZjMC=
wwLTEuMS0wLjctMS42LDAuM2MtMC41LDEtMC40LDEuNSwxLDMuN3MyLjMsMi43LDMuOSwzLjdjM=
S42LDEsMC41LTEsMC4zLTEuNgoJCWMtMC4yLTAuNiwwLTEuNC0wLjQtMS45Yy0wLjQtMC41LTAu=
Ni0xLjEtMC42LTIuN0M3OS4yLDUxMS41LDc2LjYsNTExLjYsNzYuNiw1MTEuNiIvPgoJPHBhdGg=
gY2xhc3M9InN0MiIgZD0iTTgzLjEsNTI5LjhjMS0xLjUsMS45LTEuOSw0LjMtM2MyLjQtMS4xLD=
YuOC0xLjcsOC4zLTEuOGMxLjUtMC4xLDQuOS0zLDQuNC02LjFjLTAuNS0zLTIuNy00LjItNC42L=
TQuNgoJCWMtMS45LTAuNC0zLjYtMC40LTQuMiwwLjVjLTAuNiwwLjktMS43LDIuMS0zLjgsMi44=
Yy0yLjEsMC43LTIuNCwxLjQtMy43LDEuOGMtMS4zLDAuNC0wLjMsMS4yLTEuNCwyLjFjLTEuMSw=
wLjktMi42LDAtNC4zLTAuNQoJCWMtMS43LTAuNS0xLjgtMC44LTMuNy0wLjljLTEuOS0wLjEtNi=
45LTAuNC02LjktMC40cy0wLjItMC4xLTEuMy0wLjFjLTEuMSwwLTEuMiwwLjItMS43LDEuNGMtM=
C41LDEuMiwwLjEsNC4yLDEuMyw1LjgKCQljMS4yLDEuNSw1LjEsMi4yLDcuNywzYzIuNiwwLjgs=
My45LDEuMSw2LjEsMS41QzgxLjgsNTMxLjcsODIuMSw1MzEuMyw4My4xLDUyOS44Ii8+Cgk8cGF=
0aCBjbGFzcz0ic3QyIiBkPSJNMTA3LjYsNTMyLjJjMi4xLTEuNCwwLjktMy44LDAuNC01LjNjLT=
AuNS0xLjUtMy40LTEuOC00LjktMS44Yy0xLjUsMC0yLjMsMC0zLjEsMC43CgkJYy0wLjgsMC43L=
TEuOSwxLjctNC4xLDIuNGMtMi4yLDAuNy0zLjksMS41LTYuOSwyLjdjLTMsMS4yLTMuOSwzLjIt=
NS4yLDRjLTEuMywwLjgtMy44LDAtMy44LDBzLTEuOC0wLjUtMi40LDAKCQljLTAuNiwwLjUsMCw=
xLjUsMS4yLDIuOGMxLjIsMS4zLDMuNSwxLjIsNi4xLDJjMi42LDAuOCwzLjEsMC4yLDQuMS0wLj=
VjMS0wLjcsMS44LTIuMiwzLjYtMy4zYzEuOC0xLjEsNS43LTEuMyw3LjYtMS41CgkJQzEwMi4xL=
DUzNC4yLDEwNS41LDUzMy42LDEwNy42LDUzMi4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJN=
MTA3LjYsNTIzYzAuOSwwLjgsMS45LDEuOSwyLjcsMC42YzAuOC0xLjMsMi4xLTQsMS4yLTUuNmM=
tMC45LTEuNi0yLTMtMi0zcy0xLjUsNC42LTIuMiw1LjkKCQlDMTA2LjYsNTIyLDEwNi43LDUyMi=
4yLDEwNy42LDUyMyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTk5LjQsNTA5LjFjMC0yLjYtM=
S44LTUuOS0xLjgtNS45cy0wLjYsMi40LTEuNyw0LjVjLTEuMSwyLjEtMi4yLDMuMi0yLjIsMy4y=
czIuNiwwLjcsMy42LDAuNwoJCVM5OS40LDUxMS43LDk5LjQsNTA5LjEiLz4KCTxwYXRoIGNsYXN=
zPSJzdDIiIGQ9Ik04NC40LDUxNC42YzIuOC0wLjYsNC4zLTEuNyw1LjUtMi43YzEuMi0xLDEuOS=
0zLjcsMS4xLTUuMWMtMC44LTEuNC0yLjgtMi45LTMuNi0yLjloLTEuNQoJCWMwLDAtMC44LDIuN=
i0xLjksMy45Yy0xLjEsMS4zLTIuNCwyLjItMi4zLDMuOUM4MS43LDUxMy40LDgxLjUsNTE1LjIs=
ODQuNCw1MTQuNiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTkwLjEsNTAxLjhjMC4xLTEuMy0=
wLjQtMi43LTEuMy0zLjZjLTAuOS0wLjktMS41LTEuNS0xLjUtMS41cy0wLjIsMi0wLjQsMy4xYy=
0wLjIsMS4xLTAuMywxLjMtMC4zLDEuMwoJCXMwLjgsMC44LDEuNSwxLjFDODguOCw1MDIuNSw5M=
Cw1MDMuMSw5MC4xLDUwMS44Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNTUuMyw0MzAuMmMw=
LDAsMy4zLDAsMS45LTExLjljLTEuNC0xMS45LTcuNi0yMy4xLTEyLjUtMzAuOWMtNC45LTcuOC0=
xMC0yMC0xMi4yLTI2LjUKCQljLTIuMi02LjUtMy43LTE1LjQtMy43LTIwLjFjMC00LjcsMi03Lj=
EsMi03LjFzMC45LTEuMywwLjEtMi4xYy0wLjgtMC44LTIuMS0wLjEtMy4zLDEuMmMtMS4zLDEuM=
y0yLjYsMy42LTMuMSw1LjMKCQljLTAuNSwxLjctMC41LDIuMy0wLjUsMi4zcy0yLjUtMC42LTYu=
Ni0wLjNjLTQsMC4zLTYsMC43LTYuMSwxLjVjLTAuMSwwLjksMC41LDEuNSwzLjUsMi44YzIuOSw=
xLjMsNC44LDEuOCw2LjIsMy41CgkJYzEuNSwxLjcsNS4yLDEwLjQsNi4zLDE0LjZjMS4xLDQuMi=
wzLjYsMTUuNiw0LjYsMjQuNWMxLDguOSw0LDE5LjgsOC4yLDI4LjhDNDEuNCw0MTksNDguOSw0M=
zMsNTUuMyw0MzAuMiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTYyLjcsNDUxLjJjLTIuOCwx=
LjUtMi43LDEyLjgtMS40LDE4LjZjMS4yLDUuOCw2LjksMTMuMSw4LjcsMTVjMS43LDEuOSwyLjE=
sMS45LDMuMSwxLjQKCQljMC45LTAuNSwxLjMtMC41LDEuMy0wLjVzMi40LTAuOCw0LjMtMi4zYz=
EuOC0xLjQsMS4xLTUsMC44LTguMmMtMC4zLTMuMi0yLjgtOS41LTcuMi0xNi45QzY3LjcsNDUxL=
jEsNjUuNCw0NDkuNiw2Mi43LDQ1MS4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNjUuNyw0=
NDIuMWMwLTMuNy0zLjItNi40LTYuOC02LjRjLTEuNywwLTMuMywwLjQtNC4yLDEuM2MtMy43LDM=
uMy0xLjUsMTEuNywzLjksMTEuN2MxLjksMCw0LjItMC4zLDUuNi0xLjcKCQlDNjUuNCw0NDUuOC=
w2NS43LDQ0My44LDY1LjcsNDQyLjEiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0xMTguOSw1N=
DcuOGMtMS41LTAuMy0yLjMtMC45LTQuNS0yLjNjLTIuMi0xLjUtNS42LTQuNS02LjItNmMtMC42=
LTEuNS0wLjYtMS42LTIuNy0wLjkKCQljLTIuMSwwLjctNSwwLjYtNy4zLDAuN2MtMi4yLDAuMSw=
wLjMsMi42LDEuOCw0LjljMS42LDIuMywxLDEwLjIsMSwxMC4yczAsMC43LTAuMywxLjhjLTAuMy=
wxLjEtMC4xLDEuOSwwLjUsMi4yCgkJYzAuNiwwLjMsMC45LTAuMywyLjUtMi4xYzEuNi0xLjgsN=
C40LTYuNiw0LjQtNi42czAuNCwwLjEsMi44LDAuN2MyLjQsMC42LDYuMywwLjMsOC4zLTAuM0Mx=
MjEuMyw1NDkuNSwxMjAuNCw1NDguMSwxMTguOSw1NDcuOCIKCQkvPgoJPHBhdGggY2xhc3M9InN=
0MiIgZD0iTTEwOS43LDU1My45Yy0xLTAuMi0xLjUtMC4zLTIsMC40Yy0wLjUsMC43LTAuOSwyLT=
EuMiwyLjdjLTAuMywwLjctMC4yLDEuMywwLjQsMS44YzAuNiwwLjUsMS41LDEuMSwxLjUsMS4xC=
gkJczAuOSwxLDEuNywxLjRjMC45LDAuNCwxLTAuOSwxLTEuOGMwLTAuOSwwLjUtMi43LDAuNS0z=
LjhDMTExLjcsNTU0LjYsMTEwLjcsNTU0LDEwOS43LDU1My45Ii8+Cgk8cGF0aCBjbGFzcz0ic3Q=
yIiBkPSJNODMuMywxNzQuNGMwLjMsNi4yLDcuMSwxOCwxMSwyNC4zYzMuOSw2LjMsNSw4LjksNC=
4zLDkuM2MtMC43LDAuNC0yLjMtMi44LTQuNC01LjYKCQljLTIuMS0yLjgtNi4zLTkuNC05LjgtM=
TQuNGMtMy41LTUtOC42LTE2LjgtOS4zLTE3LjljLTAuNy0xLjEtMC45LTEuNy0yLjctMC40Yy0x=
LjcsMS4zLTUuMSwxNC40LTEuMSwyMy4zCgkJYzQsOC45LDEwLjEsMTUuMywxMi42LDE4LjRjMi4=
2LDMuMSw1LjksNy45LDUuNCw4LjNjLTAuNSwwLjQtMS41LTAuOC00LjYtNGMtMy4xLTMuMi04Lj=
ItOC43LTExLjUtMTIuOGMtMi43LTMuMy02LjQtOS45LTcuNy0xMi4zCgkJYy0wLjUtMC45LTEuM=
S0wLjctMS42LTAuMmMtMS4xLDEuMS0yLjksMy43LTIuMSwxMC43YzEuMSw5LjgsNi4yLDE1LjUs=
MTAuNywyMC40YzQuNiw1LDkuMSw5LjEsOC41LDkuOGMtMC43LDAuNy01LjQtMy41LTguNi02LjY=
KCQljLTMuMi0zLjEtMTEuMS0xMC44LTEyLjktMTIuOWMtMS43LTIuMS00LjMtMS4xLTQuMiw3Lj=
RjMC4xLDguNSw5LjUsMTcuMSwxMy40LDIxLjhjMy45LDQuNyw4LjcsNy41LDguMyw4LjUKCQljL=
TAuNCwwLjktNC4zLTEuNS02LjgtMy4yYy0yLjUtMS43LTEyLjEtNy45LTE0LTkuM2MtMS45LTEu=
My0yLjgsMS4yLTAuNCw5LjNjMi40LDguMSw5LjQsMTQuNSwxMy42LDE3LjVjNC4yLDMsMTAuOSw=
2LjYsMTAuNSw3LjUKCQljLTAuNCwwLjktMy4yLTAuMy03LjEtMi4yYy0zLjktMS45LTguNi0zLj=
YtMTEuOS00LjZjLTMuNC0wLjktMy40LDEuNS0zLjQsMS41cy0wLjcsNi45LDQuMywxMi40YzUsN=
S41LDEwLjYsNy43LDE2LDguNgoJCWM1LjQsMC45LDYuMiwxLjIsNiwyYy0wLjEsMC44LTAuNyww=
LjktMS45LDAuOWMtMS4yLDAtNi4yLDAuNS0xMC43LDAuNWMtNC42LDAtNywxLjEtNywzLjFzLTA=
uMSw0LjcsNi43LDkuMwoJCWM2LjgsNC42LDE0LjUsNS4yLDE3LjcsNS45YzMuMiwwLjcsMy40LD=
AuOSwyLjcsMS45Yy0wLjcsMC45LTIuMSwwLjgtNy4yLDEuM2MtNS4xLDAuNS04LjIsMi42LTguO=
SwzLjljLTAuNywxLjMsMC40LDUuNCw0LjYsOC4yCgkJYzQuMiwyLjgsOS41LDMuOCwxNy42LDMu=
MmM4LjEtMC41LDEwLjEtMC43LDEwLjMsMC43YzAuMywxLjMtMi40LDEuNy02LjQsMi40Yy00LDA=
uNy03LjEsMC43LTkuNCwyLjVjLTIuMywxLjktMC41LDUuOCwzLjQsOC42CgkJYzMuOSwyLjgsMT=
MuNiwyLjgsMTcuNiwyLjZjNC0wLjMsMTAuMi0xLjcsMTAuNi0wLjdjMC40LDEuMS0zLDIuNy03L=
jEsNC4yYy00LjIsMS41LTUuNCwyLjQtNi4yLDQuMmMtMC44LDEuNy0wLjEsMy40LDQuOCw1LjIK=
CQljNSwxLjksMTIuMiwxLjksMTYsMC4xYzMuOC0xLjcsNS44LTIuNCw2LjQtMS43YzAuNywwLjc=
sMCwxLjMtMC44LDIuM2MtMC44LDAuOS00LDMuNS04LjIsNC42Yy00LjIsMS4xLTQuNiwxLjEtNi=
w0LjQKCQljLTEuNSwzLjQsMi4zLDYuMSw5LjgsNi4zYzcuNSwwLjMsMTcuNi0yLjcsMjAuOC00L=
jZjMy4yLTEuOSw0LjQtMi4zLDUtMS42YzAuNSwwLjcsMC40LDEuMS0xLjIsMi4zYy0xLjYsMS4y=
LTYuNyw0LjgtOS4zLDUuNQoJCWMtMi42LDAuNy0yLjgsMi42LTIuOCw0LjNjMCwxLjctMC43LDU=
uMiw2LDYuOWM2LjcsMS42LDE0LjYsMC40LDIxLjktNC43YzIuMy0xLjYsMy43LTMsNC41LTQuMm=
MtMC42LTYuOS0wLjMtMTEuNiwwLjUtMTUuOQoJCWMtMS40LTAuMS00LjEtMC42LTYuOS0xLjdjL=
TQtMS42LTUuNi01LjQtNi42LTcuNGMtMC45LTItMi4zLTItMy45LTEuNWMtMS42LDAuNS0zLjIs=
MS4yLTUuNSwxLjFjLTIuMy0wLjEtNy4xLTEuMy0xMC42LTUuNQoJCWMtMy41LTQuMi0yLjgtOC4=
yLTMtMTAuMmMtMC4xLTItMy40LTAuNS01LTAuNWMtMS42LDAtNi4zLTAuNy0xMC42LTMuNmMtNC=
4zLTMtNC4zLTctNC43LTguNmMtMC40LTEuNi0yLjEtMi43LTMuNS0zLjIKCQljLTEuMy0wLjUtM=
y41LTEuMS02LjQtMy41Yy0zLTIuNC00LTcuMS00LjItOC43Yy0wLjEtMS42LTEuOS0xLjctNy45=
LTQuOGMtNi0zLjEtNS41LTkuNS01LjItMTIuMWMwLjMtMi42LDMuMS00LjcsMy4xLTUuNwoJCWM=
wLTAuOS0yLTEuMi00LTIuNGMtMi0xLjItNy4xLTMuMi03LjItMTAuOGMtMC4xLTcuNSw0LjgtOC=
4zLDQuOC04LjNzLTAuOS0wLjQtMy0xLjZjLTItMS4yLTcuNS01LTcuNS05LjRjMC00LjQsMi02L=
jUsMy41LTcuNQoJCWMxLjUtMS4xLDUuNS0yLjEsNS41LTIuMXMtMi42LTEuNi0zLjYtNS4xcy0x=
LjUtNy44LDEuMS0xMC45YzIuNi0zLjEsNi44LTMuMSw5LjEtMy4xYzIuMywwLDQuMywxLjIsNS4=
xLDAuNQoJCWMwLjgtMC43LDAuOS0xLjIsMC4xLTNjLTAuOC0xLjctMC45LTYuMS0wLjMtNy41Yz=
AuNy0xLjUsMC44LTQuNCw2LjYtNi4zYzUuOC0xLjksMTEuOCwyLDEzLjcsMy4xYzEuOSwxLjEsM=
S4xLTEuNSwxLjEtMy40CgkJcy0zLjktNi42LTguMy0xMy4zYy00LjQtNi43LTYuNC0xMC4yLTEx=
LjQtMjAuNGMtNS0xMC4yLTguMi0yMy40LTguOS0yNi44Yy0wLjctMy40LTItMS44LTItMS44cy0=
xLjMsMC41LTQuNCw4LjMKCQlDODMuNSwxNjEuMSw4MywxNjguMiw4My4zLDE3NC40Ii8+Cgk8cG=
F0aCBjbGFzcz0ic3QyIiBkPSJNMTg0LjUsMzExLjljLTMuNS0wLjItOC0yLjEtMTEuNC03LjFjL=
TMuNS01LTguNi02LjItMTcuNi02LjFjLTksMC4yLTEzLjEtNC4yLTE1LjQtMTAuNAoJCWMtMi4y=
LTYuMiwwLjMtMTMuMyw5LjUtMTcuOGM5LjItNC41LDEzLjMtOS41LDEzLjctMTcuM2MwLjMtNy4=
4LTkuMi0xNy41LTE4LjctMjguNGMtOS41LTEwLjktMTYuOS0yNi4zLTE2LjktMjYuMwoJCXMtMi=
44LDMuNi0yLjgsNy4zYzAsMy42LDEuNCw3LjQsMCw4LjVjLTEuNCwxLTEuOS0xLjYtNy40LTRjL=
TUuNS0yLjQtMTAtMi44LTEzLjUsMS4yYy0zLjUsNCwwLDEwLjksMy4xLDE0LjIKCQljMy4xLDMu=
Myw1LjcsNS43LDQuOCw2LjljLTAuOSwxLjItNS41LTEuOS03LjEtMi45Yy0xLjYtMS01LjItNS0=
xMC41LTQuNWMtNS40LDAuNS03LjMsMi4xLTcuOCw2LjZjLTAuNSw0LjUsNC44LDguNSw4LjMsMT=
AuMgoJCWMzLjUsMS43LDQuOCwzLjMsNCw0Yy0wLjksMC43LTEuNywwLTMuMy0wLjVjLTEuNi0wL=
jUtNS45LTEtOC42LDBjLTIuOCwxLTcuMyw0LjgtMy4xLDkuNWM0LjIsNC43LDEyLjgsNi40LDE0=
LjUsNi43CgkJYzEuNywwLjMsMi42LTAuMiwyLjgsMS4yYzAuMiwxLjQtMy42LDEuNC04LjMsMS4=
2Yy00LjcsMC4yLTYuMSw0LjctNS40LDguMWMwLjcsMy41LDguNSw3LjMsMTIuOCw4YzQuMywwLj=
csNS45LDAsNi4yLDEuMgoJCWMwLjMsMS4yLTAuNSwxLjctMi45LDIuNGMtMi40LDAuNy03LjEsM=
S4yLTgsNWMtMC45LDMuOC0xLDUuNSwyLjYsOC44YzMuNiwzLjMsOS41LDIuOCwxMS4yLDIuNGMx=
LjctMC4zLDMuOC0yLjMsNS41LTAuNQoJCWMxLjcsMS43LTEuNiwzLjEtNC41LDUuMmMtMi45LDI=
uMS0yLjgsNi4xLDIuMiw4LjhjNSwyLjgsMTAsMS43LDEyLjEsMWMyLjEtMC43LDQuOC00LDYuMi=
0xLjljMS40LDIuMS00LjMsMi44LTYuNyw1LjcKCQljLTIuNCwyLjktMS42LDcuOCwzLjMsMTAuN=
2M0LjgsMi45LDEyLjgsMC45LDE0LjItMC4zYzEuNC0xLjIsMy4xLTEuNyw0LjEtMC43YzEsMS0w=
LjUsMy44LTEuNiw2LjJjLTEsMi40LTIuOSw5LjUsNC4zLDEyLjMKCQljNy4zLDIuOCwxMy44LTM=
uNSwxNS00LjdjMS4yLTEuMiwyLjQtMS40LDMuNS0wLjljMSwwLjUsMC41LDEuNi0wLjMsMi44Yy=
0wLjksMS4yLTIuOCw2LjQsMi40LDEwYzMuNSwyLjUsNy40LDIuMyw5LjUsMS45CgkJYzEuMS00L=
jEsMi41LTguNCwzLjktMTQuNWMwLDAtMywyLjYtMy45LDMuMmMtMC45LDAuNi0xLjcsMS40LTIu=
MiwxYy0wLjUtMC4zLDEuOS0xLjYsMi41LTIuNGMwLjYtMC44LDEuOS0xLjksMS45LTIuOAoJCWM=
wLjEtMC44LDAuNS0xLjMsMS43LTIuNGMwLjQtMC4zLDAuNy0wLjcsMC45LTEuMWMwLjgtNCwxLj=
YtOC44LDIuNC0xNC41YzAuNS0zLjksMC44LTcuNSwwLjktMTFMMTg0LjUsMzExLjl6Ii8+Cgk8c=
GF0aCBjbGFzcz0ic3QyIiBkPSJNMzYuOCwyMDMuOWM3LjcsMTUuNiwxOC42LDI0LjQsMTguNiwy=
NC40cy0xLjQtMy45LTIuMS02LjZjLTAuNi0yLjctMC4xLTUuNy0wLjEtNS43cy0yLjctMy41LTc=
uOC0xMS4zCgkJYy01LjEtNy44LTcuNy0xOS4zLTcuNy0xOS4zczQuNywxMS41LDguNCwxNy42Yz=
MuNyw2LjEsNy45LDExLjEsNy45LDExLjFzMS41LTUuNCwyLjUtNS43YzEuMS0wLjMsMS44LDAuN=
iwyLjcsMS44CgkJYzAuOSwxLjIsMS43LDEuMSwxLjcsMS4xcy0xLjItMi42LTMuMi01LjdjLTAu=
OS0xLjQtMi4xLTIuOS0zLTQuM2MtMi45LTQuNS05LjEtMTMuMi0xMi4zLTIxLjhjLTMuMi04LjY=
tMTAuMS0zMC4zLTExLjQtMzYuNwoJCWMtMS4yLTYuNC0yLjQtMi45LTMuNiwxLjhjLTEuMiw0Lj=
ctMi45LDExLjQtMS44LDIxLjRDMjYuNiwxNzYsMjksMTg4LjMsMzYuOCwyMDMuOSIvPgoJPHBhd=
GggY2xhc3M9InN0MiIgZD0iTTQ2LjgsMjQ2LjFjMi45LDIuMSw3LjEsNSw3LjEsNXMtMC43LTEu=
Ni0xLjEtMy40Yy0wLjQtMS45LTAuNi01LjgtMC42LTUuOHMtMy40LTMtNS43LTUKCQljLTIuNC0=
yLjEtNS4zLTQuNy0xMS4yLTEyYy01LjktNy4zLTEuMS0yLjksMy42LDIuM2M0LjgsNS4yLDEzLj=
ksMTIuOCwxMy45LDEyLjhzMC0wLjEsMC4xLTEuN2MwLjEtMS42LDAuNS0yLjcsMS40LTMuOAoJC=
WMwLjgtMS4xLDAuNC0xLjItNC44LTUuMmMtNS4xLTMuOS0xOC41LTE5LTIzLjktMjcuOWMtNS41=
LTktMTEuNC0yMS4xLTExLjQtMjEuMXMtMi45LDE3LjksOCwzNy42QzMzLjEsMjM3LjYsNDMuOSw=
yNDQsNDYuOCwyNDYuMQoJCSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTEwNCwzNTkuMWM2LT=
IuMyw0LjMtOC4yLDQuMy04LjNjMC0wLjEtMy43LDEuMi03LDIuNGMtMy40LDEuMy0xMS43LDMuN=
y0xNC45LDMuOGMtMy4zLDAuMS0zLjMtMC40LTMuNC0wLjkKCQljLTAuMS0wLjUsMi41LDAsNy4y=
LTAuOWM0LjctMC45LDEzLTUuMiwxNC41LTYuMmMxLjQtMSwxLjMtMS4yLTAuOS0xLjRjLTIuMS0=
wLjItNC0xLjItNC43LTEuOGMtMC44LTAuNy0zLDAuMy04LjQsMS41CgkJYy01LjQsMS4zLTE2Lj=
YsMy4yLTI1LjIsMy4yYy04LjYsMC0xNi42LTEuNC0xNy45LTEuN2MtMS4zLTAuMy0yLjgsMC41L=
DEuMyw3LjRjNC4xLDYuOSwxOC43LDEwLjcsMjguOCwxMC42CgkJQzg3LjksMzY2LjgsOTgsMzYx=
LjQsMTA0LDM1OS4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNzcuMSwzNDQuN2MxMC40LDA=
uMSwxNC4zLTMsMTQuMy0zczAtMC41LTEuNC0yLjdjLTEuNC0yLjEtMS4xLTUuOC0xLjEtNS44cy=
0yLjUsMC40LTYuOCwxLjEKCQljLTQuMywwLjYtOS40LDEuMi0xNSwwLjNjLTUuNi0xLTMuMi0xL=
jYsMS4yLTEuMWM0LjQsMC41LDEyLjktMS4xLDE1LjctMmMyLjctMSwxLjYtMS45LTAuMy0yLjVj=
LTEuOS0wLjYtNi45LTMuOC02LjktMy44CgkJcy0xMi43LDEuNi0yNC40LDAuM2MtMTEuOC0xLjM=
tMTkuMi00LjMtMjEuNi00LjdjLTIuNC0wLjQtMi4zLDAuNi0yLjMsMC42cy0wLjYsMS4xLDMuNS=
w3LjRjNC4xLDYuNCwxMiwxMC42LDE4LjgsMTIuNQoJCUM1Ny40LDM0My4zLDY2LjYsMzQ0LjYsN=
zcuMSwzNDQuNyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTc0LjQsMzIwLjNjMCwwLTAuNC0w=
LjYtMS4xLTIuOGMtMC42LTIuMSwxLjItMy43LDEuMi0zLjdzLTIuNC0wLjctMTAuMi0xLjdjLTc=
uOC0xLTguMi0xLjYtMTMtMi43CgkJYy00LjgtMS4xLTgtMi41LTcuOS0zYzAuMS0wLjUsMS42LD=
AuMyw0LjQsMS4zYzIuOCwxLjEsMTQuOCwyLjMsMTkuOCwzYzUsMC43LDcuOSwxLjIsOC44LDAuN=
2MwLjktMC41LDQtMS4zLDQtMS4zCgkJcy0yLjEtMC42LTQuOC0xLjFjLTIuNy0wLjQtNS0xLjYt=
Ni41LTIuNmMtMS40LTEtMS45LTEuMi04LjItMS45Yy02LjQtMC43LTExLjUtMi44LTIyLjktNi4=
5Yy0xMS40LTQuMi0yMC05LjEtMjIuMy0xMQoJCWMtMi4zLTEuOS0yLjEtMC41LTEuNSwxLjljMC=
42LDIuNCwwLjUsNS40LDYuMywxMi4xYzUuNyw2LjcsOC42LDkuNywyMy4xLDE1QzU4LjEsMzIxL=
Dc0LjQsMzIwLjMsNzQuNCwzMjAuMyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTMxLjUsMjg0=
LjljMTIuOCw5LDI3LjksMTIuNCwzMS4xLDEyLjhjMC43LTAuOC0wLjgtMy44LTAuMS01LjdjMC4=
4LTIuMiwyLjItMi4yLDUuMy0yLjQKCQljMy4xLTAuMiwxLjEtMC44LDAuNC0wLjhzLTAuOS0wLj=
EtNi0xLjRjLTUuMS0xLjMtMTAuNC0yLjEtMTcuNC00LjhjLTcuMS0yLjctOS4yLTQuNi05LTUuM=
WMwLjItMC41LDMuMywxLjcsOS44LDQuMgoJCWM2LjUsMi41LDE0LjIsMy41LDE4LjMsNC4zYzQu=
MiwwLjksMC41LTAuOS0xLjQtMmMtMS45LTEuMi00LjctNS40LTQuNy01LjRzLTQuNi0wLjgtMTI=
uMS0zLjFjLTcuNS0yLjMtMTMuOC00LjktMjAuMS04LjQKCQljLTIuMi0xLjItNC4yLTIuOC02Lj=
UtNC40Yy00LjMtMy4xLTguNi02LjItMTAuMy03LjVjLTIuNi0xLjktMS44LTAuNC0xLjUsMC44Y=
zAuMywxLjIsMiw2LjUsNi4xLDEyLjMKCQlDMTcuMywyNzQuMSwxOC43LDI3NS45LDMxLjUsMjg0=
LjkiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yOS40LDI1OS41YzEyLjcsMTAsMjMuNSwxMy4=
xLDI1LjQsMTMuOWMxLjksMC44LDEuNy0wLjMsMS4zLTEuM2MtMC40LTEuMS0wLjYtNC41LTAuNi=
00LjVTNTEsMjY1LDQ1LjksMjYyCgkJYy01LTIuOS0xMC42LTYuOS0xNC4zLTkuNWMtMy43LTIuN=
i0xLjUtMi40LTAuNC0xLjRjMS4xLDEsNi4zLDQsMTEuNCw3LjJjNS4xLDMuMiwxMi45LDcuOCwx=
Mi45LDcuOHMwLjItMS43LDEuMi0yLjcKCQljMS4xLTEuMSwzLjctMC44LDMuNy0wLjhzLTEuMy0=
xLjMtMi4xLTIuNmMtMC44LTEuMi01LTIuNi05LjYtNC44Yy00LjctMi4yLTEzLjEtOC40LTE5Lj=
MtMTMuNmMtNi4yLTUuMi0xOC4yLTE4LjMtMTktMTkuNAoJCWMtMC44LTEuMS0xLjMtMC45LTEuN=
CwwLjRjLTAuMSwxLjMtMC41LDIuMiwwLjgsOC4yQzExLjEsMjM2LjksMTYuNywyNDkuNCwyOS40=
LDI1OS41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNzQuMiwxNjQuOGMxLjQsMywzLDUuMiw=
0LjEsNy4yYzEuNywyLjksMi43LDQuOCwyLjcsNC44czAuMy0xLDAuMS0yLjhjLTAuMy0xLjgtMC=
41LTQuMi0wLjEtNy4xCgkJYzAuMy0xLjYsMC42LTMuMSwwLjUtNC41Yy0wLjEtMS42LTAuNi0yL=
jktMC44LTMuOGMtMC40LTEuNy0yLjItOS4xLTMuMS0xNC4zYy0wLjktNS4yLTEuOC0xMi43LTEu=
OC0xOS4yYzAuMS02LjYsMS0zLjMsMS0wLjEKCQljMCwzLjIsMC4zLDguMSwxLjQsMTUuNmMxLDc=
uNSw0LjIsMTksNC4yLDE5czAuMi0xLjgsMS4yLTQuM2MwLjktMi41LDIuNS01LjMsMy43LTguNW=
MxLjItMy4xLDAuOC0zLjYsMC44LTMuNnMtNC40LTIxLjMtNS42LTMxLjMKCQljLTEuMi0xMC0zL=
TM2LjUtMy0zNi41Yy02LjUsNi41LTExLjMsMjMuNy0xMi4yLDQwYy0wLjYsMTIuMywxLjMsMjMu=
NiwxLjksMjguMkM3MC4yLDE1Mi43LDcxLjgsMTU5LjgsNzQuMiwxNjQuOCIvPgoJPHBhdGggY2x=
hc3M9InN0MiIgZD0iTTU5LjcsMTk4LjNjMC4yLTQuOCwxLjMtOC41LDQuNC05LjVjMCwwLTIuNy=
00LjgtNS4xLTExLjdjLTEuNi00LjctMy0xMC43LTMuNy0xNS40CgkJYy0xLjctMTEuNC0zLjEtM=
jMuMSwwLjMtMy45YzMuNCwxOS4yLDcuNSwyNiw3LjUsMjZsNC45LDhjLTAuNy0zLjUtMC44LTYt=
MC43LTkuOGMwLjItMy44LDAuNy05LDEuOC0xMy4xYzAsMC01LjktMTEuOS05LjctMjYuMgoJCWM=
tMy43LTE0LjMtNS45LTI3LjMtNS45LTM1Yy0wLjMtNy41LTAuNS0xMC40LTAuNS0xMC40cy02Lj=
EsNC42LTguMSwyNy45Yy0yLDIzLjMsNC4xLDQ1LjYsNy4xLDU0LjEKCQlDNTUuMiwxODcuOCw1O=
S43LDE5OC4zLDU5LjcsMTk4LjMiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0xMjYuNCwzNzZj=
MCwwLTEtMC43LTMuOS0yLjVjLTIuOS0xLjgtMi03LjMtMi03LjNzLTAuOCwwLjYtMi45LDJjLTI=
uMSwxLjQtNC41LDMuMS03LjQsNC4yCgkJYy0yLjksMS4yLTQuMywxLjktNi4yLDIuNWMtMS44LD=
AuNi0xLjMtMC4yLDAuMi0xLjFjMS41LTAuOSwyLTEuNCw1LjktMi45YzMuOS0xLjUsMTEuNi04L=
jMsMTEuNi04LjNzLTEuOC0wLjItNS0wLjMKCQljLTMuMi0wLjEtNy4yLTEuNy03LjItMS43cy0z=
LjIsMi45LTE2LDguNGMtMTIuOCw1LjUtMjMuNyw2LjktMjMuNyw2LjlzMS4zLDYuNiw3LjUsOC4=
4YzUuMSwyLjIsMTIuMSwzLjYsMjUuOSwwLjMKCQlDMTE3LDM4MS44LDEyNi40LDM3NiwxMjYuNC=
wzNzYiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0xNDMuMywzODkuMmMxLjEtNS40LTItOS4yL=
TItOS4ycy0wLjcsMC40LTIuNiwyLjFjLTEuOSwxLjctNC43LDUtMTAuMSw3LjdzLTcuMywyLjUt=
Mi4xLTAuMwoJCWM1LjItMi44LDEyLjgtMTAuNywxMi44LTEwLjdsLTItMC44Yy0yLTAuOC01LjU=
sMC42LTIwLDkuM2MtMTQuNSw4LjctMjIuOSw5LTIyLjksOXM2LjUsNy44LDI0LDcuMgoJCUMxMz=
UuOSw0MDMsMTQyLjMsMzk0LjYsMTQzLjMsMzg5LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9I=
k0xNzYuNSwzODIuOWMwLDAtMS45LDIuNy00LjUsNC40Yy0yLjYsMS43LTkuNSwyLjgtOS41LDIu=
OHMtMC4zLDAuOC0xLjYsMi41Yy0xLjMsMS43LTQuMyw1LjktNy40LDguMQoJCWMtMy4xLDIuMi0=
3LjksMy43LTguMiwzLjFzMi44LTEuNyw1LjgtMy42YzMtMS44LDUuNy01LjIsNy43LTcuNWMyLT=
IuMy0wLjktMS45LTAuOS0xLjlzLTMuNywwLjEtNy0wLjJjLTMuNC0wLjMtMi43LDAtMy43LDEuN=
goJCWMtMSwxLjYtMi4zLDMuMS00LjgsNmMtMy4xLDMuNS02LDYuNy04LjksMTAuMmMtMS45LDIu=
My0wLjUsMy0wLjUsM3MwLjksMS41LDguNywyLjNjNC44LDAuNSwxMC0wLjEsMTUuNS0zLjIKCQl=
jMy40LTIsNi45LTUuMSwxMC41LTlDMTc3LDM5MS4zLDE3Ni41LDM4Mi45LDE3Ni41LDM4Mi45Ii=
8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMTgwLjYsNDA0Yy0xLjksMi41LTMsMy42LTMsMy42c=
zEuNC00LjIsMi41LTYuMWMwLjYtMSwxLjMtMiwxLjgtMi43Yy0xLjMtMi45LTIuNC02LTMuMS05=
LjQKCQljLTAuOSwyLjgtMy41LDEwLjktNi44LDE2LjJjLTQsNi41LTcuNiw4LjgtNS4zLDEwLjV=
jMi4zLDEuNyw2LjgsMi4xLDEyLTAuNGM0LjktMi40LDYuNC02LjcsNy4xLTEwLjFjLTAuOS0xLj=
MtMS43LTIuNy0yLjQtNC4yCgkJQzE4Mi42LDQwMS45LDE4MS43LDQwMi43LDE4MC42LDQwNCIvP=
goJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ3NCwyNjMuOGM0LjItMywxMS4xLTkuNCwxMy42LTE3=
LjVjMi40LTguMSwxLjUtMTAuNi0wLjQtOS4zYy0xLjksMS4zLTExLjQsNy41LTE0LDkuMwoJCWM=
tMi41LDEuOC02LjQsNC4yLTYuOCwzLjJjLTAuNC0wLjksNC40LTMuOCw4LjMtOC41YzMuOS00Lj=
csMTMuMy0xMy4zLDEzLjQtMjEuOGMwLjEtOC41LTIuNC05LjUtNC4yLTcuNAoJCWMtMS43LDIuM=
i05LjcsOS44LTEyLjksMTIuOWMtMy4yLDMuMS03LjksNy4zLTguNiw2LjZjLTAuNy0wLjcsMy45=
LTQuOCw4LjUtOS44YzQuNi01LDkuNy0xMC42LDEwLjctMjAuNGMwLjgtNy0xLTkuNi0yLjEtMTA=
uNwoJCWMtMC41LTAuNS0xLjEtMC43LTEuNiwwLjJjLTEuMywyLjQtNSw5LTcuNywxMi4zYy0zLj=
QsNC04LjUsOS41LTExLjUsMTIuOGMtMy4xLDMuMi00LDQuNC00LjYsNGMtMC41LTAuNCwyLjgtN=
S4yLDUuNC04LjMKCQljMi42LTMuMSw4LjYtOS41LDEyLjYtMTguNGM0LTguOSwwLjctMjEuOS0x=
LjEtMjMuM2MtMS43LTEuMy0yLTAuNy0yLjcsMC40Yy0wLjcsMS4xLTUuOCwxMi45LTkuMywxNy4=
5Yy0zLjUsNS03LjcsMTEuNi05LjgsMTQuNAoJCWMtMi4xLDIuOC0zLjgsNi00LjQsNS42Yy0wLj=
ctMC40LDAuNC0zLDQuMy05LjNjMy45LTYuMywxMC43LTE4LjEsMTEtMjQuM2MwLjMtNi4yLTAuM=
y0xMy4zLTMuNC0yMS4xYy0zLjEtNy44LTQuNC04LjMtNC40LTguMwoJCXMtMS4zLTEuNi0yLDEu=
OGMtMC43LDMuNC0zLjksMTYuNS04LjksMjYuOGMtNSwxMC4yLTcsMTMuNy0xMS40LDIwLjRjLTQ=
uNCw2LjctOC4zLDExLjQtOC4zLDEzLjNjMCwxLjktMC44LDQuNCwxLjEsMy40CgkJYzEuOS0xLj=
EsNy45LTUsMTMuNy0zLjFjNS44LDEuOSw1LjksNC44LDYuNiw2LjNjMC43LDEuNSwwLjUsNS44L=
TAuMyw3LjVjLTAuOCwxLjgtMC43LDIuMywwLjEsM2MwLjgsMC43LDIuOC0wLjUsNS4xLTAuNQoJ=
CWMyLjMsMCw2LjYsMCw5LjEsMy4xYzIuNiwzLjEsMi4yLDcuNCwxLjEsMTAuOWMtMS4xLDMuNS0=
zLjYsNS4xLTMuNiw1LjFzNCwxLjEsNS41LDIuMWMxLjUsMS4xLDMuNSwzLjEsMy41LDcuNQoJCW=
MwLDQuNC01LjUsOC4yLTcuNSw5LjRjLTIsMS4yLTMsMS42LTMsMS42czUsMC44LDQuOCw4LjNjL=
TAuMSw3LjUtNS4yLDkuNS03LjIsMTAuOGMtMiwxLjItNCwxLjUtNCwyLjRjMCwwLjksMi44LDMu=
MSwzLjEsNS43CgkJYzAuMywyLjUsMC44LDktNS4yLDEyLjFjLTYsMy4xLTcuOCwzLjItNy45LDQ=
uOGMtMC4xLDEuNi0xLjIsNi4zLTQuMiw4LjdjLTMsMi40LTUuMSwzLTYuNCwzLjVjLTEuMywwLj=
UtMy4xLDEuNi0zLjUsMy4yCgkJYy0wLjQsMS42LTAuNCw1LjYtNC43LDguNmMtNC4zLDMtOSwzL=
jYtMTAuNiwzLjZjLTEuNiwwLTQuOC0xLjUtNSwwLjVjLTAuMSwyLDAuNSw2LjEtMi45LDEwLjJj=
LTMuNSw0LjItOC4zLDUuNC0xMC42LDUuNQoJCWMtMi4zLDAuMS0zLjktMC41LTUuNS0xLjFjLTE=
uNi0wLjUtMy0wLjUtMy45LDEuNWMtMC45LDItMi41LDUuOC02LjYsNy40Yy0yLjgsMS4xLTUuNS=
wxLjUtNi45LDEuN2MwLjgsNC40LDEuMSw5LjEsMC41LDE1LjkKCQljMC44LDEuMiwyLjEsMi41L=
DQuNSw0LjJjNy4yLDUuMSwxNS4yLDYuMywyMS45LDQuN2M2LjctMS42LDYtNS4xLDYtNi45YzAt=
MS43LTAuMy0zLjYtMi44LTQuM2MtMi42LTAuNy03LjctNC4zLTkuMy01LjUKCQljLTEuNi0xLjI=
tMS43LTEuNi0xLjItMi4zYzAuNS0wLjcsMS43LTAuMyw1LDEuNmMzLjIsMS45LDEzLjMsNC44LD=
IwLjgsNC42YzcuNS0wLjMsMTEuMy0zLDkuOC02LjNjLTEuNS0zLjQtMS45LTMuNC02LTQuNAoJC=
WMtNC4yLTEuMS03LjQtMy42LTguMi00LjZjLTAuOC0wLjktMS41LTEuNi0wLjgtMi4zYzAuNy0w=
LjcsMi43LDAsNi40LDEuN2MzLjgsMS43LDExLDEuNywxNi0wLjFjNS0xLjksNS42LTMuNSw0Ljg=
tNS4yCgkJYy0wLjgtMS44LTItMi43LTYuMi00LjJjLTQuMi0xLjUtNy41LTMuMS03LjEtNC4yYz=
AuNC0xLjEsNi42LDAuNCwxMC42LDAuN2M0LDAuMywxMy43LDAuMywxNy42LTIuNmMzLjktMi44L=
DUuNi02LjcsMy40LTguNgoJCWMtMi4zLTEuOS01LjQtMS45LTkuNC0yLjZjLTQtMC43LTYuNy0x=
LjEtNi40LTIuNGMwLjMtMS4zLDIuMy0xLjIsMTAuMy0wLjdjOC4xLDAuNSwxMy40LTAuNCwxNy4=
2LTMuMmM0LjItMi44LDUuMi02LjksNC42LTguMgoJCWMtMC43LTEuMy0zLjgtMy40LTguOS0zLj=
ljLTUuMS0wLjUtNi42LTAuNC03LjItMS4zYy0wLjctMC45LTAuNS0xLjIsMi43LTEuOWMzLjItM=
C43LDEwLjktMS4zLDE3LjctNS45YzYuOC00LjYsNi43LTcuMyw2LjctOS4zCgkJYzAtMi0yLjQt=
My4xLTctMy4xYy00LjYsMC05LjUtMC41LTEwLjctMC41Yy0xLjIsMC0xLjctMC4xLTEuOS0wLjl=
jLTAuMS0wLjgsMC43LTEuMSw2LTJjNS40LTAuOSwxMS0zLjEsMTYtOC42CgkJYzUtNS41LDQuMy=
0xMi40LDQuMy0xMi40czAtMi40LTMuNC0xLjVjLTMuNCwwLjktOCwyLjctMTEuOSw0LjZjLTMuO=
SwxLjktNi43LDMuMS03LjEsMi4yQzQ2My4yLDI3MC40LDQ2OS45LDI2Ni44LDQ3NCwyNjMuOCIv=
PgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ1Ni42LDI0NS40Yy0yLjgtMS03LjEtMC41LTguNiw=
wYy0xLjYsMC41LTIuNCwxLjItMy4zLDAuNWMtMC45LTAuNywwLjUtMi4zLDQtNGMzLjUtMS43LD=
guOC01LjcsOC4zLTEwLjIKCQljLTAuNS00LjUtMi40LTYuMS03LjgtNi42Yy01LjQtMC41LTksM=
y41LTEwLjUsNC41Yy0xLjYsMS02LjIsNC4yLTcuMSwyLjljLTAuOS0xLjIsMS43LTMuNiw0Ljgt=
Ni45YzMuMS0zLjMsNi42LTEwLjIsMy4xLTE0LjIKCQljLTMuNS00LTgtMy42LTEzLjUtMS4yYy0=
1LjUsMi40LTYsNS03LjQsNGMtMS40LTEsMC00LjgsMC04LjVjMC0zLjYtMi44LTcuMy0yLjgtNy=
4zcy03LjQsMTUuNC0xNi45LDI2LjMKCQljLTkuNSwxMC45LTE5LDIwLjYtMTguNywyOC40YzAuM=
yw3LjgsNC41LDEyLjgsMTMuNywxNy4zYzkuMiw0LjUsMTEuOCwxMS42LDkuNSwxNy44Yy0yLjIs=
Ni4yLTYuNCwxMC42LTE1LjQsMTAuNAoJCWMtOS0wLjItMTQuMiwxLTE3LjYsNi4xYy0zLjUsNS0=
4LDYuOS0xMS40LDcuMWwtMi4zLDAuMWMwLjEsMy40LDAuNCw3LjEsMC45LDExYzAuNyw1LjcsMS=
42LDEwLjUsMi40LDE0LjUKCQljMC4yLDAuNCwwLjUsMC44LDAuOSwxLjFjMS4yLDEsMS43LDEuN=
SwxLjcsMi40YzAuMSwwLjgsMS4zLDIsMS45LDIuOGMwLjYsMC44LDMsMiwyLjUsMi40Yy0wLjUs=
MC4zLTEuMy0wLjQtMi4yLTEKCQljLTAuOS0wLjYtMi4xLTEuNy0yLjktMi40bC0xLTAuOGMxLjQ=
sNi4xLDIuOCwxMC40LDMuOSwxNC41YzIuMSwwLjQsNiwwLjUsOS41LTEuOWM1LjItMy42LDMuMy=
04LjgsMi40LTEwCgkJYy0wLjktMS4yLTEuNC0yLjItMC4zLTIuOGMxLTAuNSwyLjMtMC4zLDMuN=
SwwLjljMS4yLDEuMiw3LjgsNy40LDE1LDQuN2M3LjMtMi44LDUuNC05LjksNC4zLTEyLjNjLTEt=
Mi40LTIuNi01LjItMS42LTYuMgoJCWMxLTEsMi44LTAuNSw0LjIsMC43YzEuNCwxLjIsOS4zLDM=
uMywxNC4yLDAuM2M0LjgtMi45LDUuNy03LjgsMy4zLTEwLjdjLTIuNC0yLjktOC4xLTMuNi02Lj=
ctNS43YzEuNC0yLjEsNC4xLDEuMiw2LjIsMS45CgkJYzIuMSwwLjcsNy4xLDEuNywxMi4xLTFjN=
S0yLjgsNS4yLTYuOCwyLjItOC44Yy0yLjktMi4xLTYuMi0zLjUtNC41LTUuMmMxLjctMS43LDMu=
OCwwLjIsNS41LDAuNWMxLjcsMC4zLDcuNiwwLjksMTEuMi0yLjQKCQljMy42LTMuMywzLjUtNSw=
yLjYtOC44Yy0wLjktMy44LTUuNS00LjMtOC01Yy0yLjQtMC43LTMuMy0xLjItMi45LTIuNGMwLj=
MtMS4yLDEuOS0wLjUsNi4yLTEuMmM0LjMtMC43LDEyLjEtNC41LDEyLjgtOAoJCWMwLjctMy41L=
TAuNy04LTUuNC04LjFjLTQuNy0wLjItOC41LTAuMi04LjMtMS42YzAuMi0xLjQsMS0wLjksMi44=
LTEuMmMxLjctMC4zLDEwLjQtMi4xLDE0LjUtNi43CgkJQzQ2My45LDI1MC4yLDQ1OS40LDI0Ni4=
0LDQ1Ni42LDI0NS40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNDg4LjEsMjI4LjRjMCwwLD=
EwLjktOC44LDE4LjYtMjQuNGM3LjctMTUuNiwxMC4xLTI3LjksMTEuMi0zNy45YzEuMS0xMC0wL=
jYtMTYuNy0xLjgtMjEuNAoJCWMtMS4yLTQuNy0yLjQtOC4yLTMuNi0xLjhjLTEuMiw2LjQtOC4y=
LDI4LjEtMTEuNCwzNi43Yy0zLjIsOC42LTkuNCwxNy4zLTEyLjMsMjEuOGMtMC45LDEuNC0yLjI=
sMi45LTMsNC4zCgkJYy0xLjksMy4xLTMuMiw1LjctMy4yLDUuN3MwLjgsMC4xLDEuNy0xLjFjMC=
45LTEuMiwxLjctMiwyLjctMS44YzEuMSwwLjMsMi41LDUuNywyLjUsNS43czQuMi01LDcuOS0xM=
S4xCgkJYzMuNy02LjEsOC40LTE3LjYsOC40LTE3LjZzLTIuNywxMS41LTcuNywxOS4zYy01LjEs=
Ny44LTcuOCwxMS4zLTcuOCwxMS4zczAuNSwzLTAuMSw1LjdDNDg5LjUsMjI0LjUsNDg4LjEsMjI=
4LjQsNDg4LjEsMjI4LjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik01MjkuMywxODAuM2MwLD=
AtNS45LDEyLjEtMTEuNCwyMS4xYy01LjQsOS0xOC44LDI0LTIzLjksMjcuOWMtNS4xLDMuOS01L=
jYsNC4xLTQuNyw1LjIKCQljMC44LDEuMSwxLjMsMi4yLDEuNCwzLjhjMC4xLDEuNiwwLjEsMS43=
LDAuMSwxLjdzOS4xLTcuNiwxMy45LTEyLjhjNC44LTUuMiw5LjUtOS42LDMuNi0yLjNjLTUuOSw=
3LjMtOC44LDkuOS0xMS4yLDEyCgkJYy0yLjQsMi4xLTUuNyw1LTUuNyw1cy0wLjIsMy45LTAuNi=
w1LjhjLTAuNCwxLjktMS4xLDMuNC0xLjEsMy40czQuMi0yLjksNy4xLTVjMi45LTIuMSwxMy42L=
TguNSwyNC41LTI4LjIKCQlDNTMyLjIsMTk4LjIsNTI5LjMsMTgwLjMsNTI5LjMsMTgwLjMiLz4K=
CTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik00NzYuMywxMTUuNGMtMC45LTE2LjMtNS43LTMzLjUtMTI=
uMi00MGMwLDAtMS45LDI2LjQtMywzNi41Yy0xLjIsMTAtNS42LDMxLjMtNS42LDMxLjNzLTAuNC=
wwLjUsMC44LDMuNgoJCWMxLjIsMy4xLDIuOCw2LDMuNyw4LjVjMC45LDIuNSwxLjEsNC4zLDEuM=
Sw0LjNzMy4yLTExLjQsNC4yLTE5YzEtNy41LDEuMy0xMi40LDEuMy0xNS42YzAtMy4yLDEtNi41=
LDEsMC4xCgkJYzAuMSw2LjYtMC45LDE0LTEuOCwxOS4yYy0wLjksNS4yLTIuNywxMi42LTMuMSw=
xNC4zYy0wLjIsMC45LTAuNywyLjMtMC44LDMuOGMtMC4xLDEuNCwwLjMsMi45LDAuNSw0LjVjMC=
41LDIuOSwwLjIsNS4zLTAuMSw3LjEKCQljLTAuMywxLjgsMC4xLDIuOCwwLjEsMi44czEtMS45L=
DIuNy00LjhjMS4xLTEuOSwyLjctNC4yLDQuMS03LjJjMi40LTUsNC0xMi4xLDUuMS0yMS4yQzQ3=
NSwxMzksNDc3LDEyNy42LDQ3Ni4zLDExNS40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNDk=
xLjQsMTc5LjNjMy4xLTguNSw5LjItMzAuOCw3LjEtNTQuMWMtMi0yMy4zLTguMS0yNy45LTguMS=
0yNy45cy0wLjIsMi45LTAuNSwxMC40CgkJYy0wLjEsNy43LTIuMiwyMC43LTUuOSwzNWMtMy43L=
DE0LjMtOS43LDI2LjItOS43LDI2LjJjMS4yLDQuMSwxLjcsOS4zLDEuOCwxMy4xYzAuMiwzLjgs=
MC4xLDYuMy0wLjcsOS44bDQuOS04CgkJYzAsMCw0LjEtNi44LDcuNS0yNmMzLjQtMTkuMiwyLTc=
uNSwwLjMsMy45Yy0wLjcsNC42LTIsMTAuNy0zLjcsMTUuNGMtMi40LDYuOS01LjEsMTEuNy01Lj=
EsMTEuN2MzLjEsMS4xLDQuMiw0LjcsNC40LDkuNQoJCUM0ODMuNywxOTguMyw0ODguMywxODcuO=
Cw0OTEuNCwxNzkuMyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ5NS45LDM0OC44Yy0xLjQs=
MC4zLTkuNCwxLjctMTcuOSwxLjdjLTguNiwwLTE5LjgtMS45LTI1LjItMy4yYy01LjQtMS4zLTc=
uNi0yLjItOC40LTEuNQoJCWMtMC44LDAuNy0yLjYsMS42LTQuNywxLjhjLTIuMSwwLjItMi4zLD=
AuNC0wLjksMS40YzEuNCwxLDkuNyw1LjMsMTQuNSw2LjJjNC43LDAuOSw3LjMsMC40LDcuMiwwL=
jljLTAuMSwwLjUtMC4xLDEtMy40LDAuOQoJCWMtMy4zLTAuMS0xMS42LTIuNS0xNC45LTMuOGMt=
My40LTEuMy03LTIuNS03LTIuNGMwLDAuMS0xLjYsNiw0LjMsOC4zYzYsMi4zLDE2LjEsNy43LDI=
2LjIsNy44YzEwLjEsMC4xLDI0LjctMy43LDI4LjgtMTAuNgoJCUM0OTguNywzNDkuMyw0OTcuMi=
wzNDguNSw0OTUuOSwzNDguOCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTUxMi43LDMyMC44Y=
y0yLjQsMC40LTkuOCwzLjQtMjEuNiw0LjdjLTExLjgsMS4zLTI0LjQtMC4zLTI0LjQtMC4zcy01=
LDMuMi02LjksMy44Yy0xLjksMC42LTMsMS41LTAuMywyLjUKCQljMi43LDEsMTEuMiwyLjYsMTU=
uNywyYzQuNC0wLjUsNi44LDAuMSwxLjIsMS4xYy01LjYsMS0xMC42LDAuNC0xNS0wLjNjLTQuMy=
0wLjYtNi44LTEuMS02LjgtMS4xczAuMywzLjYtMS4xLDUuOAoJCWMtMS40LDIuMS0xLjQsMi43L=
TEuNCwyLjdzMy45LDMuMSwxNC4zLDNjMTAuNC0wLjEsMTkuNi0xLjQsMjYuNC0zLjRjNi43LTEu=
OSwxNC43LTYuMSwxOC44LTEyLjVjNC4xLTYuNCwzLjQtNy40LDMuNC03LjQKCQlTNTE1LjEsMzI=
wLjQsNTEyLjcsMzIwLjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik01MjcuNywyODYuN2MtMi=
4zLDEuOS0xMC45LDYuOC0yMi4zLDExYy0xMS40LDQuMi0xNi41LDYuMi0yMi45LDYuOWMtNi40L=
DAuNy02LjgsMS04LjIsMS45CgkJYy0xLjQsMS0zLjgsMi4xLTYuNSwyLjZjLTIuNywwLjQtNC44=
LDEuMS00LjgsMS4xczMuMSwwLjgsNCwxLjNjMC45LDAuNSwzLjcsMCw4LjgtMC43YzUtMC43LDE=
3LTIsMTkuOC0zYzIuOC0xLjEsNC4zLTEuOSw0LjQtMS4zCgkJYzAuMSwwLjUtMy4xLDItNy45LD=
NjLTQuOCwxLjEtNS4yLDEuNy0xMywyLjdjLTcuOCwxLTEwLjIsMS43LTEwLjIsMS43czEuOCwxL=
jYsMS4yLDMuN2MtMC42LDIuMS0xLjEsMi44LTEuMSwyLjgKCQlzMTYuMywwLjcsMzAuOC00LjZj=
MTQuNS01LjMsMTcuMy04LjIsMjMuMS0xNWM1LjgtNi43LDUuNy05LjcsNi4zLTEyLjFDNTI5Ljk=
sMjg2LjEsNTMwLDI4NC44LDUyNy43LDI4Ni43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNT=
M0LjgsMjU1LjFjLTEuNywxLjItNiw0LjQtMTAuMyw3LjVjLTIuMywxLjYtNC4zLDMuMi02LjUsN=
C40Yy02LjMsMy41LTEyLjYsNi4xLTIwLjEsOC40CgkJYy03LjUsMi4zLTEyLjEsMy4xLTEyLjEs=
My4xcy0yLjcsNC4zLTQuNyw1LjRjLTEuOSwxLjItNS42LDIuOS0xLjQsMmM0LjItMC45LDExLjg=
tMS45LDE4LjMtNC4zYzYuNS0yLjUsOS43LTQuNyw5LjgtNC4yCgkJYzAuMiwwLjUtMS45LDIuNS=
05LDUuMWMtNy4xLDIuNy0xMi4zLDMuNS0xNy40LDQuOGMtNS4xLDEuMy01LjMsMS40LTYsMS40Y=
y0wLjcsMC0yLjcsMC42LDAuNCwwLjhjMy4xLDAuMiw0LjUsMC4yLDUuMywyLjQKCQljMC43LDEu=
OC0wLjgsNC44LTAuMSw1LjdjMy4yLTAuNCwxOC4yLTMuNywzMS4xLTEyLjhjMTIuOC05LDE0LjI=
tMTAuOCwxOC4yLTE2LjdjNC4xLTUuOCw1LjgtMTEuMiw2LjEtMTIuMwoJCUM1MzYuNiwyNTQuOC=
w1MzcuNCwyNTMuMyw1MzQuOCwyNTUuMSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ4Ni43L=
DI2My40YzEuMSwxLjEsMS4yLDIuNywxLjIsMi43czcuOC00LjYsMTIuOS03LjhjNS4xLTMuMiwx=
MC4zLTYuMiwxMS40LTcuMmMxLjItMSwzLjQtMS4xLTAuNCwxLjQKCQljLTMuNywyLjYtOS4zLDY=
uNi0xNC4zLDkuNWMtNSwyLjktOS42LDUuNS05LjYsNS41cy0wLjMsMy41LTAuNiw0LjVjLTAuNC=
wxLjEtMC41LDIuMSwxLjMsMS4zYzEuOS0wLjgsMTIuNy0zLjksMjUuNC0xMy45CgkJYzEyLjctM=
TAsMTguMi0yMi42LDE5LjYtMjguNmMxLjMtNiwwLjktNi45LDAuOC04LjJjLTAuMS0xLjMtMC42=
LTEuNS0xLjQtMC40Yy0wLjgsMS4xLTEyLjgsMTQuMi0xOSwxOS40CgkJYy02LjIsNS4yLTE0LjY=
sMTEuNC0xOS4zLDEzLjZjLTQuNywyLjItOC44LDMuNS05LjYsNC44Yy0wLjgsMS4yLTIuMSwyLj=
YtMi4xLDIuNlM0ODUuNiwyNjIuMyw0ODYuNywyNjMuNCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZ=
D0iTTQzNCwzNjAuN2MwLDAtNCwxLjYtNy4yLDEuN2MtMy4yLDAuMS01LDAuMy01LDAuM3M3Ljcs=
Ni44LDExLjYsOC4zYzMuOSwxLjUsNC4zLDIsNS45LDIuOQoJCWMxLjUsMC45LDIsMS42LDAuMiw=
xLjFjLTEuOC0wLjYtMy4zLTEuMy02LjItMi41Yy0yLjktMS4yLTUuMy0yLjgtNy40LTQuMmMtMi=
4xLTEuNC0yLjktMi0yLjktMnMwLjksNS41LTIsNy4zCgkJYy0yLjksMS44LTMuOSwyLjUtMy45L=
DIuNXM5LjUsNS44LDIzLjIsOS4xYzEzLjgsMy4zLDIwLjgsMS45LDI1LjktMC4zYzYuMi0yLjIs=
Ny41LTguOCw3LjUtOC44cy0xMC45LTEuNC0yMy43LTcKCQlDNDM3LjIsMzYzLjYsNDM0LDM2MC4=
3LDQzNCwzNjAuNyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQwNi4yLDM3OC4xbC0yLDAuOG=
MwLDAsNy42LDcuOSwxMi44LDEwLjdjNS4yLDIuOCwzLjMsMy0yLjEsMC4zYy01LjQtMi43LTguM=
i02LTEwLjEtNy43CgkJYy0xLjktMS43LTIuNi0yLjEtMi42LTIuMXMtMy4xLDMuOC0yLDkuMmMx=
LjEsNS40LDcuNCwxMy44LDI1LDE0LjRjMTcuNSwwLjYsMjQtNy4yLDI0LTcuMnMtOC41LTAuMy0=
yMi45LTkKCQlDNDExLjcsMzc4LjYsNDA4LjMsMzc3LjMsNDA2LjIsMzc4LjEiLz4KCTxwYXRoIG=
NsYXNzPSJzdDIiIGQ9Ik00MDEuMiwzOTguM2MtMi41LTIuOS0zLjktNC4zLTQuOC02Yy0xLTEuN=
i0wLjMtMS45LTMuNy0xLjZjLTMuNCwwLjMtNywwLjItNywwLjJzLTIuOS0wLjQtMC45LDEuOQoJ=
CWMyLDIuMyw0LjcsNS43LDcuNyw3LjVjMywxLjgsNi4xLDMsNS44LDMuNmMtMC4zLDAuNi01LjE=
tMC45LTguMi0zLjFjLTMuMS0yLjItNi4xLTYuNC03LjQtOC4xYy0xLjQtMS43LTEuNi0yLjUtMS=
42LTIuNQoJCXMtNi45LTEuMS05LjUtMi44Yy0yLjYtMS43LTQuNS00LjQtNC41LTQuNHMtMC41L=
DguNCw4LjksMTguNmMzLjYsMy45LDcuMSw3LDEwLjUsOWM1LjUsMy4yLDEwLjcsMy44LDE1LjUs=
My4yCgkJYzcuOC0wLjksOC43LTIuMyw4LjctMi4zczEuNC0wLjctMC41LTNDNDA3LjIsNDA1LDQ=
wNC4zLDQwMS44LDQwMS4yLDM5OC4zIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzY0LjcsMz=
g5LjVjLTAuOCwzLjQtMS44LDYuNS0zLjEsOS40YzAuNSwwLjcsMS4yLDEuNywxLjgsMi43YzEuM=
iwxLjksMi41LDYuMSwyLjUsNi4xcy0xLjEtMS4xLTMtMy42CgkJYy0xLTEuNC0yLTIuMS0yLjYt=
Mi41Yy0wLjgsMS41LTEuNiwyLjktMi40LDQuMmMwLjcsMy40LDIuMSw3LjYsNy4xLDEwLjFjNS4=
xLDIuNSw5LjYsMi4xLDEyLDAuNGMyLjMtMS43LTEuMy00LjEtNS4zLTEwLjUKCQlDMzY4LjIsND=
AwLjQsMzY1LjYsMzkyLjIsMzY0LjcsMzg5LjUiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zN=
jAuMywxNDUuOWMwLDEuOCwxLjYsMy4zLDMuNiwzLjNjMiwwLDMuNi0xLjUsMy42LTMuM2MwLTEu=
OC0xLjYtMy4zLTMuNi0zLjMKCQlDMzYxLjksMTQyLjYsMzYwLjMsMTQ0LjEsMzYwLjMsMTQ1Ljk=
iLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zMjAuMywxNDQuMWMxLjksMS4xLDMuOCwyLjEsNS=
44LDIuN2M3LDIsMTQuMiwwLjgsMTkuNy0xLjdjNy0zLjcsMTIuOC02LjIsMTcuMS02LjZjMy42L=
TAuMyw1LjQsMS4yLDguNiwxLjMKCQljMS4xLDAsMi0wLjIsMi40LTFjMC43LTEuNCwwLjMtNC44=
LTQuNy03LjZjLTUtMi44LTEyLjQtMi42LTE5LTAuN2MtNi42LDEuOS0xMC41LDQuNS0xMy4xLDY=
uNWMtMi42LDEuOS01LjcsNC45LTYuNSw0LjMKCQljLTAuOC0wLjYsMS41LTIuMSwyLjgtMy4zYz=
EuMi0xLjIsMS44LTEuNywxLjgtMS43Yy03LjMsMC41LTE1LTEuOS0yMS4zLTYuNUMzMTMuOCwxM=
jkuNywzMTEuOCwxMzkuMiwzMjAuMywxNDQuMSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTM5=
My44LDEzOS43Yy00LjgtMi4yLTkuNi0xLjktMTUuNSwwLjNjLTUuOSwyLjItOC44LDQtOC44LDR=
zMC44LDUuMS0yLjcsNy40Yy0zLjYsMi40LTcuMiwxLTguMS0xLjQKCQljLTEtMi4zLTEuMi0zLj=
YtMS4yLTMuNnMtNS42LDMuMi0xMy40LDQuNmMtNC40LDAuOC0xMi41LDEuNy0xNy42LTAuNGMwL=
DAtNC43LDQuNi04LjEsNy4zYy0zLjQsMi44LTcuMiw1LjEtNy4yLDUuMQoJCXMwLjQsMS4xLDIu=
MSwxLjdjMS43LDAuNiwyLjIsMC44LDEuMSwyLjZjLTEuMSwxLjgtOS4xLDktMTIuNSwxMS41Yy0=
zLjQsMi41LTguNSw0LjQtOC41LDQuNHMxLjYsMyw0LDRjMi4zLDEsMi44LDIuNSwxLjgsNC4xCg=
kJYy0xLDEuNy05LjIsMTAuOC0xMi43LDEzLjljLTMuNCwzLjItNi4xLDMuNi03LjYsNGMtMS41L=
DAuNC00LjMsMS45LTEuMiw1LjRjMywzLjUsMTAuMiw0LjcsMTcuMywyLjZjNy4yLTIuMSwxNC0x=
MC41LDE0LTEwLjUKCQlzLTEuNSwxMi4xLTEuNSwxNy44YzAsNS43LDAuNywxMi4xLDEuNywxNS4=
1YzEsMy4zLDEuOSw1LDEuOSw1czQuOC0yLjgsOC4xLTExLjJjMy4zLTguNCw0LjEtMTMuMSw0Lj=
EtMTUuNmMwLTIuNSwwLjEtMy45LDIuMy0yLjYKCQljMi4yLDEuMiwzLjksMi4yLDQuNywyLjNjM=
C44LDAuMSwxLjQsMC4xLDEuNCwwLjFzLTEuNC02LjEtMS40LTEwLjZjMC00LjYsMS41LTE0LjUs=
My40LTE2LjNjMS45LTEuOCwyLjMsMC43LDIuNSwxLjgKCQljMC40LDIuMywyLjQsNS4yLDUuMiw=
2LjFjMC45LTYuNywyLjQtMTIuMiw4LTE4LjFjMS0xLjEsMS43LTIuNSw1LjEtMS4xYzUuMSwyLD=
ExLjYsMy4zLDE2LjcsMS4zYzUuMS0yLDguOC03LjIsNy43LTcuOAoJCWMtMC4zLTAuMS03LjgsM=
y43LTEzLjgsMS44Yy01LjktMS45LTguNy0zLjktNS4yLTcuNWMzLjQtMy42LDQuOS00LDExLjgt=
OS43YzYuOS01LjcsMTIuNC04LjYsMTguNC03LjZjNi4xLDEsNy4yLDQuNiw3LjcsNS4yCgkJYzA=
uNSwwLjcsMy4yLDIuOCwzLjItMi4yQzQwMC45LDE0OC41LDM5OC42LDE0MS45LDM5My44LDEzOS=
43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzI5LjEsMjM3LjVjLTEuMi0xLjctMy40LTYuN=
S0zLjQtNi41cy0wLjIsMS4yLTEuNCw0LjZjLTEuMywzLjQtNC44LDguMy00LjgsOC4zczIuOC0w=
LjYsNi0xLjYKCQljMy4yLTEsNS4zLTIuOCw1LjMtMi44UzMzMC4zLDIzOS4yLDMyOS4xLDIzNy4=
1Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzA0LjcsMjE4LjljMCwwLTIsNS02LjQsOS40Yy=
00LjQsNC4zLTcuNywzLjgtNy43LDMuOHMwLjUtMC4xLDMuOC0yLjRjMy4zLTIuMyw2LjYtOSw2L=
jYtOQoJCWMtMy42LDIuMi0xMS45LDQuMi0xNi4zLDMuNGMwLDAtMC43LDEuNS0xLjcsNC4yYy0x=
LjEsMi43LTQuMSw3LjctNS44LDkuOWMtMS43LDIuMi0wLjQsMi41LTAuNCwyLjVzMC44LDAuOSw=
xMS4yLDMuOAoJCWMxMC40LDIuOSwxOS44LDEuMywxOS44LDEuM3MtMC40LTAuOS0yLjItOEMzMD=
MuNywyMzAuNSwzMDQuNywyMTguOSwzMDQuNywyMTguOSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZ=
D0iTTE3NS45LDE0NS45YzAsMS44LDEuNiwzLjMsMy42LDMuM2MyLDAsMy42LTEuNSwzLjYtMy4z=
YzAtMS44LTEuNi0zLjMtMy42LTMuMwoJCUMxNzcuNSwxNDIuNiwxNzUuOSwxNDQuMSwxNzUuOSw=
xNDUuOSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTE3MS45LDEzOS43YzMuMy0wLjEsNS0xLj=
YsOC42LTEuM2M0LjMsMC40LDEwLDIuOSwxNy4xLDYuNmM1LjUsMi41LDEyLjcsMy43LDE5LjcsM=
S43YzItMC42LDMuOS0xLjYsNS44LTIuNwoJCWM4LjUtNC44LDYuNS0xNC40LDYuNS0xNC40Yy02=
LjMsNC41LTE0LjEsNy0yMS4zLDYuNWMwLDAsMC42LDAuNCwxLjgsMS43YzEuMiwxLjIsMy41LDI=
uNywyLjgsMy4zYy0wLjgsMC42LTMuOS0yLjQtNi41LTQuMwoJCWMtMi42LTEuOS02LjUtNC42LT=
EzLjEtNi41Yy02LjYtMS45LTE0LTIuMS0xOSwwLjdjLTUsMi44LTUuNCw2LjItNC43LDcuNkMxN=
jkuOSwxMzkuNSwxNzAuOSwxMzkuNywxNzEuOSwxMzkuNyIvPgoJPHBhdGggY2xhc3M9InN0MiIg=
ZD0iTTI2NC42LDIwOS4yYy0xLjUtMC40LTQuMS0wLjgtNy42LTRjLTMuNC0zLjItMTEuNy0xMi4=
zLTEyLjctMTMuOWMtMS0xLjctMC42LTMuMiwxLjgtNC4xYzIuMy0xLDQtNCw0LTQKCQlzLTUuMS=
0xLjktOC41LTQuNGMtMy40LTIuNS0xMS40LTkuNy0xMi41LTExLjVjLTEuMS0xLjgtMC41LTIuM=
SwxLjEtMi42YzEuNy0wLjYsMi4xLTEuNywyLjEtMS43cy0zLjctMi4zLTcuMi01LjEKCQljLTMu=
NC0yLjgtOC4xLTcuMy04LjEtNy4zYy01LjIsMi4xLTEzLjIsMS4yLTE3LjYsMC40Yy03LjctMS4=
0LTEzLjMtNC42LTEzLjMtNC42cy0wLjMsMS4yLTEuMiwzLjZjLTEsMi4zLTQuNSwzLjctOC4xLD=
EuNAoJCWMtMy42LTIuMy0yLjgtNy40LTIuOC03LjRzLTIuOS0xLjgtOC44LTRjLTUuOS0yLjItM=
TAuNy0yLjUtMTUuNS0wLjNjLTQuOCwyLjItNy4yLDguOC03LjIsMTMuOGMwLDUsMi42LDIuOSwz=
LjIsMi4yCgkJYzAuNi0wLjcsMS43LTQuMyw3LjctNS4yYzYuMS0xLDExLjYsMS45LDE4LjQsNy4=
2YzYuOSw1LjcsOC40LDYuMSwxMS44LDkuN2MzLjQsMy42LDAuNyw1LjUtNS4yLDcuNWMtNS45LD=
EuOS0xMy41LTEuOS0xMy44LTEuOAoJCWMtMS4xLDAuNiwyLjYsNS44LDcuNyw3LjhjNS4xLDIsM=
TEuNiwwLjcsMTYuNy0xLjNjMy40LTEuNCw0LjEsMCw1LjEsMS4xYzUuNiw1LjksNywxMS40LDgs=
MTguMWMyLjktMC45LDQuOC0zLjcsNS4yLTYuMQoJCWMwLjItMS4xLDAuNi0zLjYsMi41LTEuOGM=
xLjksMS44LDMuNCwxMS43LDMuNCwxNi4zYzAsNC42LTEuNCwxMC42LTEuNCwxMC42czAuNiwwLD=
EuNC0wLjFjMC44LTAuMSwyLjUtMS4xLDQuNy0yLjMKCQljMi4yLTEuMiwyLjMsMC4xLDIuMywyL=
jZzMC44LDcuMiw0LjEsMTUuNmMzLjMsOC40LDguMSwxMS4yLDguMSwxMS4yczEtMS43LDEuOS01=
YzEtMy4zLDEuNy05LjgsMS43LTE1LjVjMC01LjctMS41LTE3LjgtMS41LTE3LjgKCQlzNi45LDg=
uNCwxNCwxMC41YzcuMiwyLjEsMTQuMywwLjgsMTcuMy0yLjZDMjY4LjksMjExLjEsMjY2LjIsMj=
A5LjYsMjY0LjYsMjA5LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yMTcuNiwyMzFjMCwwL=
TIuMiw0LjgtMy40LDYuNWMtMS4yLDEuNy0xLjcsMi0xLjcsMnMyLjIsMS44LDUuMywyLjhjMy4y=
LDEsNiwxLjYsNiwxLjZzLTMuNi00LjktNC44LTguMwoJCUMyMTcuOCwyMzIuMiwyMTcuNiwyMzE=
sMjE3LjYsMjMxIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjYwLjUsMjI4LjJjLTEuMS0yLj=
ctMS43LTQuMi0xLjctNC4yYy00LjQsMC45LTEyLjctMS4yLTE2LjMtMy40YzAsMCwzLjMsNi43L=
DYuNiw5YzMuMywyLjMsMy44LDIuNCwzLjgsMi40CgkJcy0zLjMsMC41LTcuNy0zLjhjLTQuNC00=
LjMtNi40LTkuNC02LjQtOS40czEsMTEuNi0wLjgsMTguN2MtMS44LDcuMS0yLjIsOC0yLjIsOHM=
5LjQsMS42LDE5LjgtMS4zYzEwLjQtMi45LDExLjItMy44LDExLjItMy44CgkJczEuMi0wLjMtMC=
40LTIuNUMyNjQuNywyMzUuOSwyNjEuNiwyMzAuOSwyNjAuNSwyMjguMiIvPgoJPHBhdGggY2xhc=
3M9InN0MiIgZD0iTTIyNCw0ODljMi4yLDAuNyw2LjMtMC45LDguMy0zLjRjMi0yLjUsMi44LTYu=
Myw0LjItOC41YzEuNS0yLjIsMi41LTMuOCwyLjUtMy44cy0wLjMsMy42LTIuMyw4LjUKCQljLTE=
uOSw0LjYtMi4yLDEwLjktMS43LDEzLjdjMC45LDUuNCw0LjQsNi4zLDYuNCw1LjZjMS42LTAuNi=
wzLjktMyw2LjEtNi41YzAuNy0xLjEsMS4yLTIuNywxLjgtNGMxLjQtMi42LDIuNi02LjksMy4yL=
TYuOAoJCWMxLjQsMC4zLDAuNSwzLjMsMCw1LjRjLTEsNC4xLTMuMSwxMC4xLTMuMiwxMy44Yy0w=
LjEsMy43LDAuMywxMC4yLDQsMTAuNWMzLjcsMC4zLDUuNi0yLjksNy42LTEwLjRjMi03LjUsMi4=
1LTkuOCwzLjQtOS44CgkJYzAuOSwwLDAuOSw1LjEsMC45LDcuM2MwLDAuOCwwLDIuOCwwLjMsNC=
45YzAuNiw0LDEuNyw4LjgsMi45LDkuOWMxLjgsMS42LDMuMiwxLjMsMy4yLDEuM3MxLjUsMC4zL=
DMuMi0xLjMKCQljMS44LTEuNiwzLjItMTIuNiwzLjItMTQuOHMwLTcuMywwLjktNy4zYzAuOSww=
LDEuMywyLjMsMy40LDkuOGMyLjEsNy41LDQsMTAuNyw3LjYsMTAuNGMzLjctMC4zLDQuMS02Ljk=
sNC0xMC41CgkJcy0yLjItOS43LTMuMi0xMy44Yy0xLTQuMSwwLjQtMy44LDMuMiwxLjVjMC45LD=
EuNiwxLjgsMy43LDIuNiw1LjFjMiwzLjEsMy44LDUsNS4zLDUuNWMyLDAuNyw1LjYtMC4xLDYuN=
C01LjYKCQljMC45LTUuNC0zLjItMjAuOS0zLjItMjAuOXMwLjMsMC40LDEuOCwyLjZjMS41LDIu=
MiwyLjIsNiw0LjIsOC41YzIsMi41LDYuMSw0LjEsOC4zLDMuNGMyLjItMC43LDIuNS00LjgsMC4=
5LTEyLjEKCQljLTEuNi03LjMtOC4yLTExLjQtMTIuOS0xNy4zYy00LjMtNS40LTcuNi0xNC45LT=
guMS0xNi4zYy01LjksMi45LTExLjEsNi4yLTE1LjcsMTEuMWMtOS43LDEwLjEtMTEuOCwxMi42L=
TExLjgsMTIuNgoJCXMtMi4xLTIuNS0xMS44LTEyLjZjLTQuNy00LjktOS45LTguMi0xNS44LTEx=
LjJjLTAuNSwxLjItNC42LDEwLjMtOC45LDE1LjdjLTIuMiwyLjctNS4xLDQuNy03LjMsNy4zYy0=
yLjUsMy00LDYuNi00LjgsMTAuNgoJCUMyMjEuNSw0ODQuMSwyMjEuOCw0ODguMiwyMjQsNDg5Ii=
8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjIzLjgsNTEzLjhjMi44LTIuNSw0LjMtMy45LDQuM=
y0zLjlzMi4xLTEuNywxLjUsMS41Yy0wLjUsMy4zLTEuNiwxMC0wLjksMTIuOWMwLjcsMi45LDEs=
NS40LDQuNiwzLjMKCQljMy42LTIuMSw0LjUtMy40LDYuMi01LjJjMS43LTEuOCwzLjUtMi42LDM=
uMSwwLjNjLTAuNCwyLjgtMS43LDcuMS0xLjEsMTIuOWMwLjYsNS44LDMuNCw2LjYsNy4xLDEuN2=
MzLjctNC45LDUuOS05LjQsNy0xMS44CgkJYzEuMS0yLjQsMy40LTQuNSwzLjQsMGMwLDkuNiwyL=
jIsMjMuNiwxMi44LDI3LjNjMTAuNi0zLjcsMTIuOC0xNy43LDEyLjgtMjcuM2MwLTQuNSwyLjIt=
Mi40LDMuMywwYzEuMSwyLjQsMy40LDYuOSw3LDExLjgKCQljMy43LDQuOSw2LjUsNCw3LjEtMS4=
3YzAuNi01LjgtMC43LTEwLTEuMS0xMi45Yy0wLjQtMi44LDEuNC0yLjEsMy4xLTAuM2MxLjcsMS=
44LDIuNiwzLjEsNi4yLDUuMmMzLjYsMi4xLDQtMC4zLDQuNi0zLjMKCQljMC43LTIuOS0wLjQtO=
S42LTAuOS0xMi45Yy0wLjUtMy4zLDEuNS0xLjUsMS41LTEuNXMxLjUsMS40LDQuMywzLjljMi44=
LDIuNSw2LjcsMi42LDYuNywyLjZzMS44LTEwLjEtMi40LTE2LjEKCQljLTQuMi02LTUuNy04LTU=
uNy04cy0yLjQtMC4xLTQuMi0wLjhjLTEuOC0wLjctMy42LTItMy42LTJ2NS42YzAsMCw1LjEsNC=
45LDYuNCw2LjRjMS4yLDEuNSwzLjYsMy45LDAuMSwxLjUKCQljLTMuNS0yLjQtNi40LTQuOC02L=
jQtNC44cy0wLjcsNS4xLTIuMSw2LjRjLTEuNSwxLjMtMy41LDEuNS00LjQsMS4xbC0wLjktMC4z=
bC0wLjMsMmMwLDAsMy4yLDUuOSwzLjYsOC4zCgkJYzAuNCwyLjQtMC4zLDIuMS0xLjctMC45Yy0=
xLjUtMy4xLTQuMy03LTUuNi05LjJjLTEuMy0yLjEtMy4yLTMuNi0zLTAuOWMwLjIsMi43LTAuOS=
w3LjctMS45LDkuNWMtMC45LDEuOC0xLjUsMi40LTEuNSwyLjQKCQlzMiw3LDIuMiw4LjJjMC4zL=
DEuMywwLjEsMi43LTEsMS4xYy0xLjEtMS42LTQuMy04LjUtNC4zLTguNXMtNC4yLTAuMi01LjQt=
MS40Yy0xLjItMS4yLTMuMS01LjgtMy4xLTUuOHMtMS43LDUuOS0zLjEsNy44CgkJYy0xLjQsMS4=
5LTQuNywzLjgtNC43LDMuOHMtMC4yLDEwLjMtMC41LDEyLjFjLTAuMiwxLjgtMC4zLDIuNi0xLj=
EsMi42Yy0wLjgsMC0wLjktMC44LTEuMS0yLjZjLTAuMi0xLjgtMC41LTEyLjEtMC41LTEyLjEKC=
QlzLTMuMy0xLjktNC43LTMuOGMtMS40LTEuOS0zLjEtNy44LTMuMS03LjhzLTEuOSw0LjYtMy4x=
LDUuOGMtMS4yLDEuMi01LjQsMS40LTUuNCwxLjRzLTMuMiw2LjktNC4zLDguNWMtMS4xLDEuNi0=
xLjMsMC4yLTEtMS4xCgkJYzAuMy0xLjMsMi4yLTguMiwyLjItOC4ycy0wLjYtMC42LTEuNS0yLj=
RjLTAuOS0xLjgtMi4xLTYuOC0xLjktOS41YzAuMi0yLjgtMS43LTEuMy0zLDAuOWMtMS4zLDIuM=
S00LjEsNi4xLTUuNiw5LjIKCQljLTEuNSwzLjEtMi4xLDMuNC0xLjcsMC45YzAuNC0yLjQsMy42=
LTguMywzLjYtOC4zbC0wLjMtMmwtMC45LDAuM2MtMC45LDAuMy0yLjksMC4yLTQuNC0xLjFjLTE=
uNS0xLjMtMi4xLTYuNC0yLjEtNi40CgkJcy0yLjksMi40LTYuNCw0LjhjLTMuNSwyLjQtMS4xLT=
AuMSwwLjEtMS41YzEuMi0xLjUsNi40LTYuNCw2LjQtNi40di01LjZjMCwwLTEuOCwxLjMtMy42L=
DJjLTEuOCwwLjctNC4yLDAuOC00LjIsMC44CgkJcy0xLjUsMi01LjcsOGMtNC4yLDYtMi40LDE2=
LjEtMi40LDE2LjFTMjIwLjksNTE2LjIsMjIzLjgsNTEzLjgiLz4KCTxwYXRoIGNsYXNzPSJzdDI=
iIGQ9Ik0yMTIuNCw1NDguMWMyLjUtMS42LDQuNy0zLjQsMTAuNS03LjJjNS43LTMuOCw3LjgtOC=
w3LjgtOGgtMmMtMS4xLDAtMi0xLjUtMi4xLTNjLTAuMS0xLjUsMC00LjcsMC40LTguMwoJCWMwL=
jQtMy42LTAuNi02LjYtMC42LTYuNnMtMi40LDIuMy02LjIsNC4yYy0zLjcsMS45LTUuMiwxLTUu=
MiwxbC0wLjktMy43YzAsMC0xLjYsMy40LTMuOSw3LjRjLTIuMyw0LTguNCw4LjQtMTIuOCwxMS4=
3CgkJYy00LjQsMy4zLTkuMiw2LjgtMTIuOCw4Yy0zLjYsMS4zLTEuNSwzLTEuNSwzczMuNiwzLj=
YsMTMsNS4zQzIwNS40LDU1My41LDIwOS45LDU0OS43LDIxMi40LDU0OC4xIi8+Cgk8cGF0aCBjb=
GFzcz0ic3QyIiBkPSJNMjQ1LjIsNTQ0LjRjLTMuMy0wLjQtNS4zLTEuNi02LTUuM2MtMC40LTIu=
NCwwLjItMTEuNCwwLjItMTEuNHMtMS4xLDAuOS0yLjQsMi41Yy0xLjMsMS41LTQuMSwxLjktNC4=
xLDEuOQoJCXMtMC40LDEuMy0xLjcsMy4zYy0xLjMsMi0yLjksNC41LTYuMSw2LjVjLTMuMiwyLT=
YuOSw0LjQtOS40LDYuNGMtMi40LDItNS4zLDQuNC04LjUsNi4yYy0zLjIsMS44LTYuMSw0LjctN=
y4yLDkuNAoJCWMtMS4xLDQuNy0wLjIsNi4zLDMuNSw2YzMuNy0wLjMsNC4xLDAuMSwxMC4xLTEu=
NGM2LTEuNSwxNC41LTguMiwyMC44LTEyLjJDMjQwLjYsNTUyLjMsMjQ1LjIsNTQ0LjQsMjQ1LjI=
sNTQ0LjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNjEuOCw1NDkuOWMwLDAtMi41LTMuMi=
0zLjUtNi45Yy0wLjktMy42LTIuNy0xMC44LTIuNy0xMC44cy0wLjgsMi4zLTIuOSw2LjZjLTIsN=
C4zLTUuNSw1LjMtNS41LDUuMwoJCXMtMC4yLDEuOS0zLDUuNWMtMi45LDMuNi03LjEsNy0xMS40=
LDkuNmMtNC4zLDIuNS05LjksNi0xMi45LDEwLjNjLTMsNC4zLTMuMyw4LjgtMS45LDEwLjhjMS4=
0LDEuOSwzLjUtMC4zLDYuMy0xLjcKCQljMi45LTEuNCwxMS4xLTIuNywyMi40LTguOEMyNTguMS=
w1NjMuNywyNjEuOCw1NDkuOSwyNjEuOCw1NDkuOSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iT=
TI2Ni43LDU3NS4yYzMuMS00LjcsMy42LTE2LDMuNi0xNnMtMS4xLTAuOC0yLjYtMmMtMS41LTEu=
My00LjUtNS44LTQuNS01LjhzLTEuOSwzLjktMy45LDcuNQoJCWMtMiwzLjYtMyw0LjktNy4zLDg=
uOGMtNC4yLDMuOS0xMCw3LjctMTIuNCwxMS45Yy0yLjQsNC4xLTEuMSwxMi40LDAuNSwxNS4yYz=
EuNiwyLjgsMy45LDEuOSw2LjItMC40YzIuNC0yLjMsMy4xLTIuOSw3LjMtNi40CgkJQzI1Ny44L=
DU4NC41LDI2My42LDU3OS45LDI2Ni43LDU3NS4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJN=
MzU5LDU0My41Yy0zLjYtMS4zLTguNC00LjctMTIuOC04Yy00LjQtMy4zLTEwLjUtNy43LTEyLjg=
tMTEuN2MtMi4zLTQtMy45LTcuNC0zLjktNy40bC0wLjksMy43CgkJYzAsMC0xLjUsMC45LTUuMi=
0xYy0zLjctMi02LjItNC4yLTYuMi00LjJzLTEsMy0wLjYsNi42YzAuNCwzLjYsMC41LDYuOCwwL=
jQsOC4zYy0wLjEsMS41LTEsMy0yLjEsM2gtMmMwLDAsMi4xLDQuMiw3LjgsOAoJCWM1LjcsMy44=
LDcuOSw1LjYsMTAuNSw3LjJjMi41LDEuNiw3LDUuNCwxNi40LDMuN2M5LjQtMS43LDEzLTUuMyw=
xMy01LjNTMzYyLjYsNTQ0LjgsMzU5LDU0My41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMz=
M2LjQsNTU0LjVjLTMuMi0xLjgtNi4xLTQuMS04LjUtNi4yYy0yLjQtMi02LjItNC40LTkuNC02L=
jRjLTMuMi0yLTQuOC00LjUtNi4xLTYuNWMtMS4zLTItMS43LTMuMy0xLjctMy4zCgkJcy0yLjkt=
MC4zLTQuMS0xLjljLTEuMy0xLjUtMi40LTIuNS0yLjQtMi41czAuNiw5LjEsMC4yLDExLjRjLTA=
uNiwzLjYtMi42LDQuOS02LDUuM2MwLDAsNC42LDcuOSwxMC44LDExLjgKCQljNi4yLDQsMTQuOC=
wxMC43LDIwLjgsMTIuMmM2LDEuNSw2LjQsMS4yLDEwLjEsMS40YzMuNywwLjMsNC42LTEuMywzL=
jUtNkMzNDIuNSw1NTkuMiwzMzkuNiw1NTYuMywzMzYuNCw1NTQuNSIvPgoJPHBhdGggY2xhc3M9=
InN0MiIgZD0iTTMxMC43LDU1OS4yYy00LjMtMi41LTguNS01LjktMTEuNC05LjZjLTIuOS0zLjY=
tMy01LjUtMy01LjVzLTMuNS0xLTUuNS01LjNjLTItNC4zLTIuOS02LjYtMi45LTYuNgoJCXMtMS=
44LDcuMi0yLjcsMTAuOGMtMC45LDMuNi0zLjUsNi45LTMuNSw2LjlzMy43LDEzLjgsMTUsMTkuO=
WMxMS4zLDYuMSwxOS41LDcuNCwyMi40LDguOGMyLjksMS40LDQuOSwzLjYsNi4zLDEuNwoJCWMx=
LjQtMS45LDEuMi02LjQtMS45LTEwLjhDMzIwLjYsNTY1LjIsMzE1LDU2MS44LDMxMC43LDU1OS4=
yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjkxLjUsNTY3LjhjLTQuMi0zLjktNS4yLTUuMi=
03LjMtOC44Yy0yLTMuNi0zLjktNy41LTMuOS03LjVzLTMsNC41LTQuNSw1LjhjLTEuNSwxLjMtM=
i42LDItMi42LDIKCQlzMC41LDExLjMsMy42LDE2YzMuMSw0LjcsOC45LDkuMiwxMywxMi44YzQu=
MSwzLjYsNC45LDQuMiw3LjMsNi40YzIuNCwyLjMsNC42LDMuMiw2LjIsMC40YzEuNi0yLjgsMy0=
xMS4xLDAuNS0xNS4yCgkJQzMwMS40LDU3NS41LDI5NS43LDU3MS43LDI5MS41LDU2Ny44Ii8+Cg=
k8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjc1LjQsNTgwLjljLTIuNy0zLjItMy42LTQuOC0zLjYtN=
C44cy0wLjksMS42LTMuNiw0LjhjLTIuNywzLjItOS4xLDguMS05LjEsOC4xczAuNiw4LjQsMy42=
LDEyLjkKCQljMi42LDMuOCw1LDcuMyw5LjEsMTBjNC0yLjcsNi41LTYuMSw5LjEtMTBjMy4xLTQ=
uNSwzLjYtMTIuOSwzLjYtMTIuOVMyNzguMiw1ODQuMSwyNzUuNCw1ODAuOSIvPgoJPHBhdGggY2=
xhc3M9InN0MyIgZD0iTTUwMi4zLDQ3OGMtMi41LTAuNi0zLjYtMS42LTMuNi0xLjZzLTEuMS0wL=
jEtMS45LDEuNGMtMC44LDEuNi00LjEsMy42LTQuMSwzLjZzLTQuNiwxLjItNS4yLDQuMwoJCWMt=
MC42LDMuMSwxLjYsNC4yLDMuNywzLjhjMi4yLTAuNCw3LjQtMS40LDkuNy00LjJjMi4zLTIuOCw=
yLjYtNC4zLDMuMS01LjRDNTA0LjYsNDc4LjksNTA0LjgsNDc4LjYsNTAyLjMsNDc4Ii8+Cgk8cG=
F0aCBjbGFzcz0ic3QzIiBkPSJNNTA5LjQsNDUzLjFjLTEuNi02LjktNi4xLTE1LjUtMTQuOC0xO=
S44YzAsMC0zLjIsMTEuNC00LjIsMTVjLTEsMy42LTEsMy41LDEuOCw0LjIKCQljMi44LDAuNywx=
MS42LDIuNiwxMy40LDMuMUM1MDcuNCw0NTYuMSw1MTAuNCw0NTcuNyw1MDkuNCw0NTMuMSIvPgo=
JPHBhdGggY2xhc3M9InN0MyIgZD0iTTQ2OC4yLDQ0Ni42YzIsMC40LDEuOC0wLjUsMi41LTMuMm=
MwLjctMi44LDQuMy0xNi40LDQuMy0xNi40cy05LjEtMC40LTE3LDMuNWMtNy45LDMuOC0xMS40L=
DEwLjktMTEuNCwxMC45CgkJczIsMC44LDcuNCwyQzQ1OS40LDQ0NC42LDQ2Ni4yLDQ0Ni4zLDQ2=
OC4yLDQ0Ni42Ii8+Cgk8cGF0aCBjbGFzcz0ic3QzIiBkPSJNNDQ3LjEsNDY1LjVjLTMuMi0wLjY=
tNC40LTEtNC40LTFzMiw3LjgsNS40LDEyLjFjMy40LDQuMyw3LjEsNi41LDE0LDYuNmM3LDAuMS=
wxMi4yLTMuNywxMy4xLTYuNwoJCWMwLjgtMywyLjMtNS4zLDIuMy01LjNzLTEyLjYtMS43LTE3L=
jgtMi45QzQ1NC41LDQ2Ny4yLDQ1MC4zLDQ2Ni4xLDQ0Ny4xLDQ2NS41Ii8+Cgk8cGF0aCBjbGFz=
cz0ic3QwIiBkPSJNMzQ2LjQsMzEzYy0zLjItMTkuNSw4LTM2LjcsOC0zNi43bC0yMS45LTI1LjZ=
jLTE2LjksOS41LTQwLjMsOC4yLTYwLjctMS4yYy0yMC40LDkuNC00My45LDEwLjctNjAuNywxLj=
IKCQlsLTIxLjksMjUuNmMwLDAsMTEuMiwxNy4yLDgsMzYuN2MtMy4yLDE5LjUtMTAuMSw1MC40L=
TguNCw2Mi45YzEuNywxMi42LDEwLjYsMjcuMiwxOS44LDM0LjhjOS4xLDcuNywyMi43LDE0LjEs=
MzIuMywxNy41CgkJYzkuNiwzLjUsMTksMTAuMSwyMy41LDEzLjZjNC40LDMuNSw3LjQsNi40LDc=
uNCw2LjRzMy0zLDcuNC02LjRzMTMuOC0xMC4xLDIzLjQtMTMuNmM5LjYtMy41LDIzLjItOS45LD=
MyLjMtMTcuNQoJCWM5LjEtNy43LDE4LTIyLjIsMTkuOC0zNC44QzM1Ni41LDM2My40LDM0OS42L=
DMzMi41LDM0Ni40LDMxMyIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTMwMS43LDIwMi43Yy0z=
LjIsMy43LTExLDcuMi0xMSw3LjJsLTAuMiwwLjZjMCwwLDMuMS0wLjYsNi4yLTIuM2MzLjEtMS4=
4LDcuNy01LjgsOC42LTcuNAoJCWMxLTEuNi0wLjItMi43LTAuMi0yLjdTMzA0LjksMTk5LDMwMS=
43LDIwMi43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMzE1LjIsMjEwLjJjMCwyLjItMC44L=
DE2LjctMC44LDE2LjdjMCwwLjctMC4zLDUuMS0xLjQsNS43YzAuNiwwLjEsMS43LDAuMywyLTJj=
MC40LTIuNywzLjEtMjEuMywzLjEtMjEuMwoJCWwtMS42LTAuN0MzMTYuNiwyMDguNiwzMTUuMiw=
yMDgsMzE1LjIsMjEwLjIiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0zMzkuNywxNzMuMmMtMS=
40LDAuNC00LjgsMi45LTYuNSw0LjRjLTEuOCwxLjUtMywxLjUtNC43LDIuM2MtMS43LDAuOC0xL=
jEtMi45LTAuMS01LjhjMS0zLDQuNC02LjUsNi45LTkuNAoJCWMyLjYtMi45LTAuMS0yLTEuMy0w=
LjhjLTEuMiwxLjItNCw0LjItNy4yLDkuNGMtMy4zLDUuMi01LjEsMTcuMS01LjEsMTcuMXMyLTE=
uMiw0LTIuNmMyLTEuNCw0LjItMi42LDcuOS01LjMKCQljMy44LTIuOCw1LjktNC45LDcuOS03Qz=
M0My42LDE3My4yLDM0MS4xLDE3Mi44LDMzOS43LDE3My4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QwI=
iBkPSJNMjQxLjcsMjAyLjdjLTMuMi0zLjctMy41LTQuNi0zLjUtNC42cy0xLjEsMS4xLTAuMiwy=
LjdjMSwxLjYsNS41LDUuNiw4LjYsNy40YzMuMSwxLjgsNi4yLDIuMyw2LjIsMi4zCgkJbC0wLjI=
tMC42QzI1Mi43LDIwOS45LDI0NC45LDIwNi40LDI0MS43LDIwMi43Ii8+Cgk8cGF0aCBjbGFzcz=
0ic3QwIiBkPSJNMjI4LjksMjI2LjljMCwwLTAuOC0xNC42LTAuOC0xNi43YzAtMi4yLTEuNC0xL=
jYtMS40LTEuNmwtMS42LDAuN2MwLDAsMi43LDE4LjYsMy4xLDIxLjMKCQljMC4zLDIuMywxLjUs=
Mi4xLDIsMkMyMjkuMiwyMzIsMjI5LDIyNy42LDIyOC45LDIyNi45Ii8+Cgk8cGF0aCBjbGFzcz0=
ic3QwIiBkPSJNMjA5LjMsMTYzLjhjLTEuMi0xLjItMy45LTIuMS0xLjMsMC44YzIuNiwyLjksNS=
45LDYuNCw2LjksOS40YzEsMywxLjYsNi42LTAuMSw1LjhjLTEuNy0wLjgtMi45LTAuOC00LjctM=
i4zCgkJYy0xLjgtMS41LTUuMS00LTYuNS00LjRjLTEuNC0wLjQtMy45LDAtMS45LDIuMmMyLDIu=
Miw0LjIsNC4zLDcuOSw3YzMuOCwyLjgsNS45LDQsNy45LDUuM2MyLDEuNCw0LDIuNiw0LDIuNnM=
tMS44LTExLjktNS4xLTE3LjEKCQlDMjEzLjMsMTY4LDIxMC41LDE2NSwyMDkuMywxNjMuOCIvPg=
oJPHBhdGggY2xhc3M9InN0MCIgZD0iTTI3MS41LDUwMS44YzAuNCwwLjEsMC40LTAuOCwwLjUtM=
i41YzAuMS0xLjcsMC4zLTUuNywwLjctOC4xYzAuNC0yLjQtMC42LTIuMi0xLjMtMi4xYy0wLjYs=
MC4xLTEsMi0xLDMKCQljMCwxLDAuMyw3LDAuMyw4LjNDMjcwLjgsNTAxLjcsMjcxLjIsNTAxLjg=
sMjcxLjUsNTAxLjgiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0zMTMuOSw0ODAuM2MxLjcsMy=
40LDIsMywxLjMsMC4xYy0wLjctMi44LTEuNy01LjMtMy4zLTcuOWMtMS42LTIuNi01LjYtNi4zL=
TUuNi02LjNzMS4xLDIuNCwyLjYsNC41CgkJQzMxMC40LDQ3Mi44LDMxMi4zLDQ3Ni45LDMxMy45=
LDQ4MC4zIi8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMjk3LjksNDgzLjJjMC42LDIuMiw0LDg=
uNCw0LjQsOC4yYzAuNC0wLjItMS40LTUuNi0yLjUtOS4yYy0xLjItMy43LTMtNi41LTMuMy02Lj=
RjLTAuNCwwLjEsMC4zLDIuMywwLjMsMi4zCgkJUzI5Ny4zLDQ4MSwyOTcuOSw0ODMuMiIvPgoJP=
HBhdGggY2xhc3M9InN0MCIgZD0iTTI4NS4zLDQ5My40YzAuNywxLjYsMS42LDMuNSwxLjksMy4z=
YzAuNC0wLjMtMC45LTMuNS0xLjEtNC41Yy0wLjItMC45LTAuMy0zLTEuNC01LjIKCQljLTEuMS0=
yLjItMS41LTEuMi0xLjUtMC4zYzAsMC45LDEuMyw1LjEsMS4zLDUuMVMyODQuNSw0OTEuOCwyOD=
UuMyw0OTMuNCIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTIyOS42LDQ4MC4zYzEuNy0zLjQsM=
y41LTcuNSw1LjEtOS42YzEuNS0yLjEsMi42LTQuNSwyLjYtNC41cy00LDMuNy01LjYsNi4zYy0x=
LjYsMi42LTIuNiw1LjEtMy4zLDcuOQoJCUMyMjcuNSw0ODMuMywyMjcuOSw0ODMuNywyMjkuNiw=
0ODAuMyIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTI0NS42LDQ4My4yYzAuNi0yLjIsMS0zLj=
csMS0zLjdzMC43LTIuMiwwLjMtMi4zYy0wLjQtMC4xLTIsMS4zLTMuMiw1Yy0xLjIsMy43LTIuO=
Sw5LTIuNSw5LjIKCQlDMjQxLjYsNDkxLjYsMjQ0LjksNDg1LjQsMjQ1LjYsNDgzLjIiLz4KCTxw=
YXRoIGNsYXNzPSJzdDAiIGQ9Ik0yNTguMiw0OTMuNGMwLjctMS42LDAuNy0xLjcsMC43LTEuN3M=
xLjMtNC4yLDEuMy01LjFjMC0wLjktMC40LTEuOS0xLjUsMC4zYy0xLjEsMi4yLTEuMiw0LjMtMS=
40LDUuMgoJCWMtMC4yLDAuOS0xLjQsNC4yLTEuMSw0LjVDMjU2LjYsNDk2LjksMjU3LjUsNDk1L=
DI1OC4yLDQ5My40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMjE5LDUzMS45bC0xLjctMWMw=
LDAtMSwxLjQtMi40LDIuOWMtMS40LDEuNS0zLDIuMS00LjEsMy42Yy0xLjEsMS40LTIuOCwzLjI=
tNS40LDQuNgoJCWMtMi42LDEuNC0zLjYsMS44LTMuMSwyLjJjMC41LDAuNCwyLjMtMC42LDIuMy=
0wLjZzMC44LTAuMSwzLjktMS45YzMuMS0xLjksMy45LTIuOSw1LjktNC43QzIxNi4zLDUzNS4xL=
DIxOSw1MzEuOSwyMTksNTMxLjkiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0yMzIuNyw1NDgu=
MWMxLjItMS4zLDIuNC0yLjEsMS44LTIuOGMtMC43LTAuNy0xLjUtMC42LTIuNiwwLjNjLTEuMSw=
wLjktNC4yLDMuOS01LjcsNS4yCgkJYy0xLjQsMS4zLTIuNiwyLTQsMy4xYy0xLjQsMS4xLTQuNi=
wyLjgtNi4xLDMuNmMtMS41LDAuOC0wLjEsMC45LTAuMSwwLjlzMS4yLTAuNiwyLjQtMWMxLjMtM=
C40LDQuOS0yLDQuOS0yczEuNC0wLjcsMy40LTIKCQlDMjI4LjYsNTUyLDIzMS41LDU0OS4zLDIz=
Mi43LDU0OC4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMjQ4LjUsNTU5YzEtMi0wLjEtMS4=
0LTEuOC0wLjhjLTEuNywwLjctNS41LDQuOC03LjcsNi4zYy0yLjIsMS41LTQuMSwyLjEtNS45LD=
MuMWMtMS45LDAuOS0xLjksMS40LTEuOCwxLjkKCQljMC4xLDAuNCwwLjgsMC40LDEuNiwwLjFjM=
C44LTAuMywzLjQtMS45LDMuNC0xLjlzMS4xLTAuMywyLjEtMC40YzEtMC4xLDIuNC0xLjIsNC43=
LTMuMUMyNDUuNCw1NjIuMiwyNDcuNCw1NjEsMjQ4LjUsNTU5Ii8+Cgk8cGF0aCBjbGFzcz0ic3Q=
wIiBkPSJNMjU1LjgsNTczLjVjLTIuOCwxLjctNy42LDUuNS04LjksOGMtMS4zLDIuNS0yLjEsNC=
4zLTEuNyw0LjdjMC40LDAuNCwxLjgtMC40LDIuNC0xLjRjMC42LTEsMS45LTIuNSwxLjktMi41C=
gkJczQuOC00LjcsNi42LTUuOGMxLjgtMS4xLDQuNi00LjIsNS4zLTYuMWMwLjctMS45LDAuMi0y=
LjksMC4yLTIuOVMyNTguNiw1NzEuOCwyNTUuOCw1NzMuNSIvPgoJPHBhdGggY2xhc3M9InN0MCI=
gZD0iTTMzOC4yLDU0MS45Yy0yLjYtMS40LTQuMy0zLjEtNS40LTQuNmMtMS4xLTEuNC0yLjctMi=
00LjEtMy42Yy0xLjQtMS41LTIuNC0yLjktMi40LTIuOWwtMS43LDEKCQljMCwwLDIuNywzLjIsN=
C43LDVjMiwxLjgsMi44LDIuOCw1LjksNC43YzMuMSwxLjksMy45LDEuOSwzLjksMS45czEuOCwx=
LDIuMywwLjZDMzQxLjksNTQzLjcsMzQwLjgsNTQzLjIsMzM4LjIsNTQxLjkiLz4KCTxwYXRoIGN=
sYXNzPSJzdDAiIGQ9Ik0zMjcuNSw1NTcuNWMtMS41LTAuOC00LjYtMi41LTYuMS0zLjZjLTEuNC=
0xLjEtMi42LTEuOS00LTMuMWMtMS40LTEuMy00LjYtNC4yLTUuNy01LjIKCQljLTEuMS0wLjktM=
S45LTEtMi42LTAuM2MtMC43LDAuNywwLjYsMS41LDEuOCwyLjhjMS4yLDEuMyw0LjEsNCw2LDUu=
M2MxLjksMS40LDMuNCwyLDMuNCwyczMuNiwxLjYsNC45LDJjMS4zLDAuNCwyLjQsMSwyLjQsMQo=
JCVMzMjksNTU4LjQsMzI3LjUsNTU3LjUiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0zMTAuNS=
w1NjcuNmMtMS45LTAuOS0zLjctMS41LTUuOS0zLjFjLTIuMi0xLjUtNi01LjctNy43LTYuM2MtM=
S43LTAuNy0yLjgtMS4zLTEuOCwwLjhjMSwyLDMsMy4yLDUuMyw1LjIKCQljMi4zLDEuOSwzLjcs=
Myw0LjcsMy4xYzEsMC4xLDIuMSwwLjQsMi4xLDAuNHMyLjYsMS41LDMuNCwxLjljMC44LDAuMyw=
xLjUsMC4zLDEuNi0wLjFDMzEyLjMsNTY5LjEsMzEyLjMsNTY4LjUsMzEwLjUsNTY3LjYiLz4KCT=
xwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0yODcuOCw1NzMuNWMtMi44LTEuNy01LjctNi01LjctNnMtM=
C41LDEsMC4yLDIuOWMwLjcsMS45LDMuNSw1LDUuMyw2LjFjMS44LDEuMSw2LjYsNS44LDYuNiw1=
LjgKCQlzMS4zLDEuNSwxLjksMi41YzAuNiwxLDEuOSwxLjksMi40LDEuNGMwLjQtMC40LTAuNC0=
yLjItMS43LTQuN0MyOTUuNCw1NzksMjkwLjUsNTc1LjIsMjg3LjgsNTczLjUiLz4KCTxwYXRoIG=
NsYXNzPSJzdDAiIGQ9Ik0yNzAuNSw1OTEuMmMwLjIsMS45LDAuMSw2LjksMS4zLDYuOWMxLjIsM=
CwxLTQuOSwxLjMtNi45YzAuMi0xLjksMC4zLTYuNiwwLjMtNi42aC0zLjIKCQlDMjcwLjEsNTg0=
LjUsMjcwLjIsNTg5LjIsMjcwLjUsNTkxLjIiLz4KCTxwYXRoIGNsYXNzPSJzdDMiIGQ9Ik0zNDQ=
uMywzMTUuM2MtMy4yLTIxLjEsNi4zLTM4LDYuMy0zOGwtMTkuOC0yMmMtMTYuNyw4LjYtMzcsNi=
40LTU5LjEtMS4zYy0yMi4xLDcuNy00Mi40LDkuOS01OS4xLDEuMwoJCWwtMTkuOCwyMmMwLDAsO=
S41LDE3LDYuMywzOGMtMy4yLDIxLjEtOCw0NC45LTcuMSw1OC45YzAuMSwxLDAuMiwxLjksMC4z=
LDIuOWgxOGMwLDAsMS0xLjIsMy0yLjFjMi0wLjksMi42LTEuNCwyLjYtMS40CgkJczAuNC0zLjY=
sMi42LTQuNGMyLjItMC44LDMuMS0wLjgsNC0wLjhjMC45LDAsMS41LTAuMiwyLjYtMS4yYzEuMS=
0xLDMuOS0zLjYsNS4xLTcuM2MxLjItMy42LDItNS4xLDItNy41YzAtMi40LDAuOS02LjIsMC45L=
TYuMgoJCXMtMC41LTEuMS0yLjMtMC41Yy0xLjgsMC43LTIuMS0xLjEtMi4zLTNjLTAuMi0xLjgt=
MC4xLTUuNSwxLTcuM2MxLTEuNywxLjQtMi4zLDEuNC0yLjNsLTAuOC0yLjljMCwwLTExLjQsMi4=
zLTEzLjQtNi42CgkJYy0yLTguOS0yLjQtMTMuMi0yLjctMTQuMWMtMC4zLTEtMC42LTEuNC0yLj=
EtMS4zYy0xLjUsMC4xLTQuOC0xLTcuMS01LjVjLTIuMy00LjYtMi41LTYuNS0xLjgtOC4zYzAuN=
y0xLjgsMS45LTEuMSwyLjMtMC42CgkJYzAuNCwwLjYsMy40LDUsNC43LDMuN2MxLjItMS4yLDAu=
Ni0xLjItMS4xLTQuN2MtMS43LTMuNC0xLjEtNC42LTEtNi4zYzAuMi0xLjctMC42LTQtMC42LTV=
jMC0xLDEtMS43LDIuMS0xLjIKCQljMSwwLjUsMiwxLjIsMi41LDEuOGMwLjUsMC42LDAuNywxLj=
QsMS42LDAuOWMxLTAuNiwwLjQtMy43LDAuNC00LjhjMC0xLjEsMS4yLTEuOCwyLjgtMWMxLjUsM=
C45LDIuMywyLjUsMi4zLDMuNgoJCWMwLDEuMSwwLjEsMi4yLDAuNywyLjJjMC42LDAsMS4yLTEu=
NywxLjMtMi45YzAuMS0xLjEsMC44LTIuOSwxLjgtMS40YzEuMSwxLjQsMS40LDMuNSwxLjEsNS4=
3Yy0wLjQsMi4yLDAuNCwxLjEtMC40LDQuOQoJCWMtMC44LDMuOC0xLjEsNS41LTEsOC40YzAuMS=
wyLjksMC4yLDQuNSwxLjYsOGMxLjQsMy41LDIuNiw3LjYsNS4yLDcuN2MyLjcsMC4xLDMuNCwwL=
jEsMy40LDAuMXMzLTUuNyw1LjItNy4xCgkJYzIuMy0xLjMsNS41LTEuNSw3LjgtMS44YzIuMy0w=
LjMsMy4yLTEsMy4yLTEuNXMtMC44LTAuOC0zLjUtMS4xYy0yLjgtMC40LTUtMS4xLTUuMS0zLjJ=
jLTAuMS0yLjEsMC41LTMuOS0xLjMtNAoJCWMtMS44LTAuMS02LjMtMS41LTcuOS00LjVjLTEuNi=
0zLTEuMi0zLjYtMS01LjNjMC4yLTEuNiwyLjMtNC45LDMuNi0xLjhjMS4zLDMuMSwyLjIsMy40L=
DMuMyw0LjFjMS4xLDAuNywyLjcsMC45LDEuOS0xLjIKCQljLTAuOC0yLjEtMS4yLTMuNC0xLjEt=
NWMwLjItMS41LDEuMi0yLjIsMi41LTIuNWMxLjItMC4zLDUtMS40LDYuOS0xLjhjMS45LTAuNCw=
yLTAuNiwyLTAuNnMwLjItMS4zLDIuNy0yLjEKCQljMi41LTAuOCw0LjEtMC45LDUuOS0wLjljMS=
44LDAsMy4xLDAuMyw1LjUtMC45YzIuNC0xLjEsNC4zLTEuMyw1LjgtMS4yYzEuNSwwLjEsMi43L=
DAuNywzLjgsMS40YzEuMSwwLjgsMC44LDEuOCwwLjgsMi45CgkJYzAsMS4xLDAuMiwxLjYsMS44=
LDEuNmMxLjYsMCwzLjEsMCw0LjYsMC42YzEuNSwwLjYsMy42LDEuNCwyLjMsMy4xYy0xLjMsMS4=
2LTEuNCwzLjQtMi4zLDMuM2MtMC45LTAuMS0wLjgsMC45LTEuMSwxLjQKCQljLTAuNCwwLjYtMC=
43LDEsMC4zLDEuNmMwLjksMC42LDEsMS4xLDIuNCwyLjRjMS4zLDEuMiwzLjMsMi42LDEuMyw0L=
jZjLTIsMi01LjUsMy42LTUuNSwzLjZzLTIsMSwwLjMsMi4zCgkJYzIuMywxLjMsMy4zLDQuMSw0=
LjIsNC42YzAuOSwwLjUsMS43LDEuMiwyLjMsMS41YzAuNiwwLjMsMC41LDIuMiwwLjUsMi4ycy0=
xLjIsMC45LTMsMS41Yy0xLjcsMC43LTMuNSwxLjQtNS4xLDEuNAoJCWMtMS42LDAtMi41LDAtMS=
44LDEuNWMwLjcsMS41LDEuOCwzLjIsMi4xLDRjMC4zLDAuOSwwLjcsMi40LDAuNywyLjRzMi43L=
DAuNiw1LDAuNmMyLjQsMCwzLjQsMC4xLDguNy0wLjUKCQljNS4yLTAuNiw2LjgtMC44LDExLjgt=
MC4yYzUuMSwwLjYsNS44LDAuNCw3LjEsMC45YzEuMywwLjUsMi43LDEuMiwyLjcsMS4yczcuMS0=
wLjEsMTEuMS0xYzMuOS0wLjksNC45LTMuNCw0LjMtNC43CgkJYy0wLjYtMS4zLTAuNS0zLjMtNy=
4zLTQuM2MtNi45LTEtOS42LTAuNi0xNS4xLTEuNmMtNS40LTEtMTMuOS0zLjgtMTUuNC0xMC42Y=
y0xLjUtNi44LDQtOS42LDYuOC0xMWMyLjgtMS4zLDguOC0zLjQsMTEuNS00LjYKCQljMi44LTEu=
MSw3LjgtMi4zLDEzLjEtMS41YzUuMywwLjgsOC40LDIuMiwxMC41LDFjMi4xLTEuMiwzLjgtMC4=
zLDMuNCwxLjZjLTAuNCwxLjktMi41LDUuOC04LjUsNy42Yy02LDEuOC0xMy4yLDItMTcuMSwxCg=
kJYy0zLjktMS4xLTYuOS0yLjYtOS4yLTEuN2MtMi40LDAuOS01LDMuOC0yLjUsNy40YzIuNiwzL=
jUsMTUuNyw0LjYsMTkuMiw1YzMuNSwwLjQsMTYuNi0wLjYsMjAuMyw1LjljMy43LDYuNSwwLjgs=
MTMuOC0zLjYsMTUuNAoJCWMtNC40LDEuNi04LjEsMi43LTExLjQsMy4ybC0zLjMsMC41YzAsMCw=
xLjUsMy40LDEuNSw0LjljMCwxLjQtMC4yLDQuMSwxLjQsNS4yYzEuNiwxLjEsMy45LDEuOCw2Lj=
csMS41YzIuOC0wLjMsNi4xLDEuNiw2LjMsNC4xCgkJYzAuMiwyLjUsMSw1LjksMS4yLDEwLjljM=
C4zLDUsMCw5LjEsMCw5LjFzLTAuMiwxLjktMC45LDMuN2MtMC43LDEuOC00LjEsOC45LTQuMSw4=
LjlIMzUxYzAuMS0xLDAuMi0yLDAuMy0yLjkKCQlDMzUyLjMsMzYwLjIsMzQ3LjQsMzM2LjQsMzQ=
0LjMsMzE1LjMiLz4KCTxwYXRoIGNsYXNzPSJzdDQiIGQ9Ik0xOTQuOCwzODYuNWMzLjgsMTAuNy=
wxMS41LDIxLjYsMjMuMywyOC43YzE2LjQsOS45LDIzLjUsOC42LDM5LDE4LjZjMTUuNSwxMC4xL=
DE0LjUsMTEuNywxNC43LDExLjcKCQljMC4yLDAtMC43LTEuNywxNC43LTExLjdjMTUuNS0xMC4x=
LDIyLjUtOC44LDM4LjktMTguNmMxMS44LTcuMSwxOS42LTE4LDIzLjMtMjguN0gxOTQuOHoiLz4=
KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yMDguMiwzMDMuNWMxLjgsMS45LDMuMSwyLjQsNS43LD=
IuMWMyLjctMC4zLDMuMywxLjcsMy44LDMuOGMwLjUsMi4xLDAuNSw3LjEsMi40LDExLjgKCQljM=
S45LDQuNiw4LjQsNC45LDguNCw0LjljMC4yLTIuMiwxLTUuMiwxLjktNy43YzAuMi0wLjQsMS0y=
LjUtMS4zLTIuNWMtMi4zLDAtMi4yLTAuOS0zLjYtMy4yYy0xLjQtMi4yLTQuMS04LjItNC43LTE=
yCgkJYy0wLjYtMy44LDAuNi05LjUsMS4yLTExLjVjMC42LTIsMC43LTMuNCwwLTMuOGMtMC43LT=
AuNC0yLjIsMC0yLjIsMHMwLjYsMS44LTAuMSwyYy0wLjYsMC4zLTEuMi0wLjktMS43LTIuMgoJC=
WMtMC41LTEuMy0xLTEuMS0xLjktMWMtMC45LDAuMS0wLjksMC45LTAuMywxLjljMC42LDAuOSww=
LjMsMi42LDAuMywyLjZzLTItMS41LTIuOS0xLjljLTAuOC0wLjQtMi44LDAuNC0zLDEuNQoJCWM=
tMC4yLDEuMSwwLjcsNCwyLjUsNS41YzEuOCwxLjUsMS44LDQuNSwxLjIsNS45Yy0wLjYsMS40LT=
MuMiwxLjItMy43LDAuNmMtMC42LTAuNi0xLjctMC44LTIuNCwwCgkJQzIwNy4yLDMwMS4yLDIwN=
i40LDMwMS42LDIwOC4yLDMwMy41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjA3LjIsMjk4=
LjZjMCwwLTEtMC44LTEuNC0xLjNjLTAuNC0wLjUtMS4xLTEuNS0xLjEtMS41cy0wLjIsMC41LTA=
uMiwxLjZjMCwxLjEsMS4yLDIuMywxLjIsMi4zTDIwNy4yLDI5OC42CgkJeiIvPgoJPHBhdGggY2=
xhc3M9InN0MiIgZD0iTTIxMS4xLDI4NS43YzAuOC0wLjQsMS41LTAuNiwwLjgtMS41Yy0wLjYtM=
C45LTEuMi0xLjktMS45LTIuMWMtMC42LTAuMi0xLjItMC4xLTEuMi0wLjFzMC43LDEuNywwLjks=
Mi43CgkJQzIwOS45LDI4NS43LDIxMC4yLDI4Ni4xLDIxMS4xLDI4NS43Ii8+Cgk8cGF0aCBjbGF=
zcz0ic3QyIiBkPSJNMjE1LjksMjgxLjhjLTAuMSwwLjgsMC4xLDEuMiwwLjgsMC44YzAuNy0wLj=
QsMS0xLjQsMC42LTIuMWMtMC40LTAuNy0xLjItMS4zLTEuMi0xLjNsLTAuNi0wLjQKCQlDMjE1L=
jYsMjc4LjgsMjE2LDI4MSwyMTUuOSwyODEuOCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIy=
Mi44LDI4Mi45YzAuMS0wLjktMC4zLTEuOS0wLjMtMS45czAsMS4xLTAuNSwxLjhjLTAuNSwwLjY=
tMC40LDAuNSwwLjEsMQoJCUMyMjIuNiwyODQuMywyMjIuNywyODMuOCwyMjIuOCwyODIuOSIvPg=
oJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIzMy43LDMzMGMxLjQsMy4yLDQuOC0xLjgsOC01LjhjM=
y4xLTQsMy0wLjksMi42LDIuM2MtMC40LDMuMywwLjgsNi43LDIuMSw5YzEuMywyLjIsMi4zLDAu=
OSwyLjgtMC42CgkJYzAuNS0xLjYsMC45LTQuOCwyLTYuNGMxLTEuNiwyLjEtMC4yLDIuMiwxLjJ=
jMC4xLDEuNCwxLjgsNC40LDMuNCw2LjJjMS42LDEuOCwyLjMtMC42LDIuOC0yLjhjMC41LTIuMi=
wxLjItNS42LDEuNi03CgkJYzAuNC0xLjQsMS45LTAuMiwxLjktMC4yczEuMSwxLjEsMy4xLDMuM=
WMyLjEsMiwyLjMtMS4yLDIuNS0yLjdjMC4yLTEuNi0wLjMtNS4xLDAuMy01LjZjMC42LTAuNSwy=
LjQsMC43LDUuMSwyLjEKCQljMi43LDEuNCwyLjYtMS4zLDIuMy0yLjdjLTAuMy0xLjUtMS45LTQ=
uOC00LjEtNi43Yy0yLjItMS45LTIuNS00LjEtMS44LTUuMWMwLjctMC45LDMuNC0wLjEsNS0wLj=
NjMS43LTAuMiwyLjUtMC40LDMuOC0wLjYKCQljMS4zLTAuMiwxLjMtMS41LDEuMy0xLjVzLTAuO=
S0xLjYtMi43LTMuMmMtMS44LTEuNi0yLjgtMi44LTUtMy40Yy0yLjItMC41LTUuMiwwLTUuMiww=
bC0wLjMtMC42Yy0wLjMtMC42LTAuOS0wLjYtMS40LDAKCQljLTAuNCwwLjYtMS41LDEuNS0yLjM=
sMi4yYy0wLjgsMC43LTEuNCwxLjItMS45LDAuOGMtMC41LTAuMywwLjQtMS4xLDAuNC0xLjFzMS=
4yLTAuOCwyLjItMi45YzEtMi4xLDEuNC00LjEsMC41LTUuMQoJCWMtMC44LTEtMy4xLDAtNC40L=
DBjLTEuMywwLTIsMC4yLTIuMS0wLjRjLTAuMS0wLjYsMS4zLTAuMywyLjgtMC41YzEuNi0wLjIs=
Mi41LTIuMSwzLTMuN2MwLjUtMS42LDAuOS0xLjQsMS45LTAuNAoJCWMwLjksMC45LDEuOCwwLjc=
sMiwwLjFjMC4yLTAuNiwxLTIuMiwyLjEtMy44YzEtMS42LDEuNy0zLjgsMC41LTUuM2MtMS4yLT=
EuNS00LTEuMy01LjEtMC4zYy0xLjIsMC45LTEuOSwxLjktMi4yLDQuMgoJCWMtMC4zLDIuMy0wL=
jksMS0wLjksMC4zYzAtMC43LTAuOS0xLjktMC41LTIuOGMwLjQtMC45LDAtMiwwLTJzLTAuMi0y=
LTIuNC0yLjRjLTIuMi0wLjQtNC43LDAuMS02LjksMC42Yy0yLjIsMC41LTEuOCwyLjQtMS44LDI=
uNAoJCXMtMS43LDAuMS0zLjUsMC4zYy0xLjgsMC4yLTMuOSwwLjktNS42LDEuNGMtMS43LDAuNC=
0yLjMsMC42LTIuMywxLjVjMCwwLjgsMC4zLDIuMiwwLjMsMi4yczEuNCwwLDIuMSwwLjQKCQljM=
C43LDAuNCwwLjMsMS4yLTAuNSwxLjVjLTAuOCwwLjMtMS4yLDAuNC0xLjIsMS41YzAsMS4xLDAu=
NCwxLjMsMS4zLDEuM2MwLjgsMCwyLjYsMCw0LjcsMC45YzIuMSwwLjksMi42LDIuOCwyLjQsMy4=
5CgkJYy0wLjIsMS4xLTMuMiwyLjQtNC42LDIuNHMtMS45LDAuMy0xLjksMS4zYzAsMC45LDEuOC=
wwLjgsMS44LDAuOHMxLjgsMC4xLDUuMiwwLjVjMy41LDAuNCw0LDEuMiw1LjYsMi41YzEuNiwxL=
jQsMC40LDEuNy0wLjMsMi4xCgkJYy0wLjcsMC40LTEuOSwxLjQtMywxLjhjLTEuMiwwLjQtMS45=
LDEuMy0yLjksMS41Yy0xLDAuMi0zLjcsMC4xLTguNSwyYy00LjgsMS45LTYuNSw4LjItNi41LDg=
uMnMwLjYtMC4yLDIuOC0xLjQKCQljMi4yLTEuMiw0LjktMi40LDcuNC00YzIuNS0xLjYsMi41LD=
AuNywxLjMsMi45Yy0xLjMsMi4yLDEuMiwxLjgsMS45LDEuMmMwLjctMC42LDEuNy0xLjMsNC4xL=
TIuNWMyLjQtMS4zLDEuNiwwLjcsMS42LDAuNwoJCXMtMC43LDEuNS0wLjksNC45Yy0wLjIsMy41=
LDMuNSwwLjIsNS4xLTJjMS43LTIuMiwyLjQsMCwxLjIsMi41Yy0xLjMsMi41LTMuNyw0LjUtNSw=
0LjVjLTEuNCwwLTIuNC0xLjUtMi41LTIuMwoJCWMtMC4xLTAuOCwwLjQtMy40LTAuNC00Yy0wLj=
gtMC42LTMuMywwLjEtNSwxLjJjLTEuOCwxLjEtMi4yLDAuMi0yLjYtMC43Yy0wLjQtMC45LDAuN=
i0xLjMsMC4yLTEuOWMtMC40LTAuNi0xLjQsMC0yLjEsMC4zCgkJYy0wLjcsMC4zLTIuNCwxLjMt=
NS43LDIuOWMtMy4zLDEuNy0zLDIuNi0zLDVDMjMxLjcsMzI2LjUsMjMyLjQsMzI2LjksMjMzLjc=
sMzMwIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjY1LjIsMjc3LjRjMC43LTAuNCwxLjktMC=
45LDEuOS0wLjlzMS41LTAuNCwzLTAuNmMxLjQtMC4yLDEuMi0xLDAuOS0xLjdjLTAuMy0wLjctM=
C45LTAuOS0yLjctMC45CgkJYy0xLjksMC0zLDAuOS00LjEsMS40Yy0xLjEsMC40LTIuMywwLjct=
Mi4zLDAuN3MwLjIsMC4zLDAuOSwxLjNDMjYzLjUsMjc3LjcsMjY0LjUsMjc3LjgsMjY1LjIsMjc=
3LjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNzIuOCwyODQuOWMwLjcsMCwxLjUtMC40LD=
EuNS0wLjRzMS40LTAuNywyLjYtMS4xYzEuMi0wLjQsMS43LTAuNiwyLjUtMi4xYzAuNy0xLjUtM=
C44LTEuNS0zLTIKCQljLTIuMi0wLjYtMy4yLDAuMi0zLjUsMWMtMC4zLDAuOC0wLjIsMS43LTEu=
MSwzLjNDMjcxLDI4NSwyNzIsMjg0LjksMjcyLjgsMjg0LjkiLz4KCTxwYXRoIGNsYXNzPSJzdDI=
iIGQ9Ik0yNzIuMSwyODYuOGMtMi4xLDAtNC41LDMuMi01LjMsMy43Yy0wLjksMC42LTAuNCwxLj=
EtMC40LDEuMXMwLjYsMS4zLDAuOSwyLjVjMC4zLDEuMiwwLjMsMy40LDAuMywzLjQKCQlzMC4zL=
DAuMSwxLjUsMC4xYzEuMiwwLDItMC42LDMuMi0xLjVjMS4yLTAuOSwyLjEtMS4yLDMuOC0xLjVj=
MS43LTAuMywyLjUtMC42LDQuMy0xLjZjMS45LTEtMS0yLjctMy00LjMKCQlDMjc1LjQsMjg3LjE=
sMjc0LjIsMjg2LjgsMjcyLjEsMjg2LjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNDQuMS=
wyOTRjMS43LTAuMiwyLjQtMSwyLjQtMS45cy0wLjgtMS45LTMtMS44Yy01LjIsMC41LTEwLjMtM=
S40LTExLjItNi42YzAsMC0xLjgsMy4yLDEuNSw2LjkKCQlDMjM3LDI5NC4yLDI0Mi40LDI5NC4y=
LDI0NC4xLDI5NCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIyNi4zLDM3Ni4yYzAuMywwLjU=
sMC42LDAuNywwLjksMC45aDhjMS40LTAuNCwxLjQtMS42LDEuNC0yLjVjMC4xLTEsMC45LTQsMi=
05LjNjMS4xLTUuMywzLTkuMSwzLjgtMTEuMwoJCXMtMC44LTIuOS0xLjMtNC4yYy0wLjYtMS4zL=
TEuNC0zLjctMS43LTQuOWMtMC4yLTEuMi0yLjEtMS0zLjItMWMtMSwwLjEtMS4yLDEuNy0xLjMs=
My4zYy0wLjIsMS42LTAuOSw2LjMtMS43LDEwLjMKCQljLTAuOCw0LTUuNCw5LjQtNi42LDEwLjZ=
jLTEuMywxLjItMi4zLDEuNy0zLjIsMS43Yy0wLjksMC0yLjgsMC0zLjcsMC42Yy0wLjksMC42LT=
EuOSwyLjEtMiwzLjJjLTAuMSwxLjIsMS44LDEuOCwxLjgsMS44CgkJczEuNS0wLjksMi4xLTEuN=
mMwLjYtMC43LDEuOC0wLjksMy4xLTEuMWMxLjMtMC4yLDEuNCwwLjIsMC45LDAuOUMyMjUuMiwz=
NzQuNCwyMjUuMywzNzQuNiwyMjYuMywzNzYuMiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTI=
xNCwzNzUuOGMtMC42LDAuMi0xLDAuOC0xLjMsMS4zaDUuMmMtMC4xLTAuNC0wLjItMC45LTAuNS=
0xLjNDMjE2LjgsMzc1LDIxNS4xLDM3NS40LDIxNCwzNzUuOCIvPgoJPHBhdGggY2xhc3M9InN0M=
iIgZD0iTTIyMS4xLDM3NS43Yy0wLjYsMC4zLTEuNCwwLjktMS44LDEuNWg1LjZjMC4yLTAuNSww=
LjMtMS4yLTAuNC0xLjhDMjIzLjMsMzc0LjMsMjIyLDM3NS4yLDIyMS4xLDM3NS43Ii8+Cgk8cGF=
0aCBjbGFzcz0ic3QyIiBkPSJNMjY5LjksMzczLjRjLTAuNiwwLTEuMiwwLjUtMiwxLjJjLTAuOS=
wwLjYtMS4yLDEuNi0xLjMsMi4zYzAsMC4xLDAsMC4yLDAsMC4zaDIuNGMwLjEtMC4xLDAuMi0wL=
jIsMC4yLTAuMwoJCWMwLTAuNywwLjMtMS4zLDEuMy0yLjJDMjcxLjUsMzczLjgsMjcwLjYsMzcz=
LjQsMjY5LjksMzczLjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNzQuNiwzNzUuOWMwLTA=
uNy0wLjMtMS40LTAuOC0xLjRjLTAuNSwwLjEtMS40LDEtMi4yLDEuNmMtMC40LDAuMy0wLjcsMC=
43LTEsMWgzLjUKCQlDMjc0LjQsMzc2LjgsMjc0LjYsMzc2LjMsMjc0LjYsMzc1LjkiLz4KCTxwY=
XRoIGNsYXNzPSJzdDIiIGQ9Ik0yOTYuNCwzNTBjMS43LTEuMiwxLjQtMS42LDEuNS0yLjljMC4x=
LTEuMywwLjEtMS43LTAuNi0yLjJjLTAuNy0wLjUtMy4yLTEuNi01LjYtMS42cy02LjksMC41LTg=
uNiwxLjcKCQljLTEuNywxLjItMi41LDUuMy0yLjUsNy41czAuMywyLjUsMSwyLjVzMS42LTEuNi=
wxLjYtMS42czIuMiwyLjksMy42LDVjMS40LDIsMC43LDIuOSwwLjEsNC40Yy0wLjYsMS42LTIuO=
Sw1LjctNC42LDYuNgoJCWMtMS44LDAuOS0zLjEsMC4xLTUuMi0wLjNjLTIuMS0wLjMtMy4zLDAu=
My00LjUsMS41Yy0xLjIsMS4yLTAuMSwyLjIsMC43LDIuMmMwLjcsMCwxLjgtMC4xLDIuNiwxYzA=
uNiwwLjcsMC4yLDIuMy0wLjEsMy4zaDEwLjQKCQljMS44LTAuOCwzLTMuMiwzLjUtNC42YzAuNS=
0xLjUsMi44LTMuNSwzLjktNC41YzEuMS0xLDEuMi0xLjcsMS4yLTRjMC0yLjItMC42LTMuNS0xL=
jQtNS4xYy0wLjgtMS42LTEuNC0zLjgtMS4yLTUuMQoJCUMyOTIuNCwzNTIuNiwyOTQuNywzNTEu=
MiwyOTYuNCwzNTAiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNzkuMiwzMjRjMSwxLjcsMC4=
1LDItMSwyLjNjLTEuNSwwLjMtMy4xLDAuNi01LjQsMC40Yy0yLjMtMC4yLTIuMywwLjEtMi4zLD=
EuM2MtMC4xLDEuMi0wLjMsMy42LTEuNiw1LjQKCQljLTEuNCwxLjgtMy4xLDEuMS00LjEsMC40Y=
y0xLTAuNy0xLjYtMC41LTIsMC44cy0xLjEsMi4yLTIuMiw0LjJjLTEuMSwxLjktMS44LDItMi42=
LDEuOGMtMC44LTAuMi0xLjUtMS40LTIuMy0xLjQKCQljLTAuOC0wLjEtMi0xLjYtMy4yLTMuNWM=
tMS4yLTEuOS0xLjgsMC4yLTIuNSwxLjhjLTAuOCwxLjYtMS42LDIuOC0zLjEsMi42Yy0xLjUtMC=
4yLTMuMi0zLTQtNC43Yy0wLjgtMS43LTEuNC0zLjMtMi43LTMuMgoJCWMtMS4zLDAuMS0zLjQsM=
i44LTQuOSwzLjVjLTEuNCwwLjctMS44LDAuNS0yLjUtMC41Yy0wLjYtMC45LTEuNSwwLjMtMi4z=
LDIuNWMtMC44LDIuMSwwLjEsNCwxLjIsNC41YzEuMiwwLjYsMy41LTEuMSw1LjEtMi4xCgkJYzE=
uNi0xLDIuMy0wLjgsMy45LTAuOGMxLjYsMCwxLjUsMi43LDIuMiw2LjVjMC43LDMuOSwzLDQuNC=
wzLDQuNHMwLjgsMC42LDIuNS0yLjNjMS44LTMsMS45LTUuOSwzLjYtNS45YzEuNywwLDEuOCwwL=
jQsMy41LDIuNwoJCWMxLjcsMi4zLDMuMSw0LjEsNC4xLDIuM2MxLTEuOCwxLjgtNC40LDIuOS01=
LjNjMS4xLTAuOSwyLjEtMS4yLDEsMC41Yy0xLjIsMS43LTEuNywzLjUsMC43LDIuOGMyLjQtMC4=
3LDExLjUtNC40LDE1LjItNS4xCgkJYzAsMCw0LjMtMC43LDkuMy0xYzUtMC4zLDYuMi0wLjYsOC=
4yLTAuNmMxLjksMCwyLTAuMiwyLjEtMS41YzAuMS0xLjMtMC45LTEtNC41LTFjLTMuNiwwLTYuM=
iwwLjUtOC43LDAuOAoJCWMtMi41LDAuNC0zLjcsMC4zLTMuMi0wLjNjMC41LTAuNiwxLjItMS4x=
LDQuMS0xLjZjMi45LTAuNSw4LjktMC44LDEyLTAuOGMzLjEtMC4xLDIuMSwwLjksMS45LDNjLTA=
uMywyLjEsMC4zLDUuMSwwLjUsNy4xCgkJYzAuMiwxLjksMC4zLDIuNSwxLjksNS4zYzEuNywyLj=
csNy41LDQuNCw5LjIsNS4zYzEuNywwLjksMS40LDAsMS40LTEuNmMtMC4xLTEuNiwxLjMtMS42L=
DIuOC0wLjdjMS41LDAuOSw0LDEuNiw1LjcsMgoJCWMxLjgsMC40LDIsMC44LDIsMS43YzAsMC45=
LDAuMiwyLjksMC40LDQuOGMwLjIsMS45LDAuMSwyLjUtMC43LDMuNmMtMC44LDEuMi00LjEsNC4=
1LTQuMSw0LjVzLTEuNSwwLTQuNywwLjgKCQljLTMuMiwwLjgtNC4yLDIuMy00LjUsMy42Yy0wLj=
MsMS4zLDAuNiwxLjcsMC43LDIuMmMwLjEsMC4zLDAsMSwwLDEuNmgwLjdjMC4zLTAuNSwwLjYtM=
SwxLjEtMS43YzEuMS0xLjQsMy45LTEuOCw1LjctMC45CgkJYzEuMiwwLjYsMS4yLDEuOCwxLjEs=
Mi42aDcuM2MxLTEuOSwzLjMtNi40LDMuOS03LjhjMC44LTEuNywxLjItMi45LDEuMy01LjNjMC4=
xLTIuNCwwLjMtMTEuNy0wLjEtMTIuMmMtMC41LTAuNSwwLjEtMi4xLDAtNC43CgkJYy0wLjEtMi=
42LDAtNC41LTQuOC01Yy00LjgtMC41LTYuMy0yLjUtNy45LTQuMWMtMS42LTEuNi0xLjItNS40L=
TIuNS05LjljLTEuMy00LjUtNC41LTUuMy0xMC4xLTYuNGMtNS42LTEuMS05LjgtMS4yLTE0LTAu=
OAoJCWMtNC4yLDAuNC05LjUsMS0xMi40LDAuN0MyNzcuNywzMjEuNSwyNzguMiwzMjIuMywyNzk=
uMiwzMjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zMDYuNSwzNzYuMWMtMC41LDAuMy0wLj=
gsMC43LTEsMWg0LjljMC0wLjQsMC0wLjktMC41LTEuNEMzMDkuMSwzNzQuOCwzMDcuNywzNzUuM=
ywzMDYuNSwzNzYuMSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTMxNS4zLDM3NS44Yy0wLjgs=
MC40LTEuMywwLjktMS42LDEuNGg1YzAtMC4yLDAtMC40LDAtMC42QzMxOC41LDM3NS44LDMxNyw=
zNzUsMzE1LjMsMzc1LjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0xOTIuOCwzNzguOWMwLj=
MsMS41LDAuNiwzLjEsMS4xLDQuN2gxNTUuOGMwLjQtMS42LDAuOC0zLjEsMS4xLTQuN0gxOTIuO=
HoiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yOTcuOCwzMDQuNWM0LjksMy4zLDIwLjYsMy41=
LDI3LjksNC45YzcuMywxLjUsNi44LDcuMSw0LjYsMTBjLTIuMiwyLjktMTIuNiwzLjMtMTQuNCw=
zLjUKCQljMSwwLjcsMi41LDIuOSwyLjUsMi45czEuMS0wLjEsNC4yLTAuM2MzLjEtMC4zLDguNS=
0xLDEyLjMtNC4xYzMuNy0zLjEsMy41LTguMSwwLjItMTEuNWMtMy4zLTMuNC04LjctMy43LTE0L=
jMtNC4zCgkJYy01LjUtMC42LTkuOC0xLTE2LjEtMi4xYy02LjItMS05LjItMy41LTkuMi03LjJj=
MC0zLjYsMy40LTUuNSw1LjgtNi4yYzIuNC0wLjcsNi4zLTEuNyw5LjgtMC40YzMuNSwxLjMsNy4=
1LDEuNSwxNC4zLDAuNgoJCWM2LjgtMC45LDguNC01LjYsOC40LTUuNnMtMC45LDAuNC00LjMsMC=
41Yy0zLjUsMC4xLTYtMS41LTEyLjMtMS42Yy02LjMtMC4xLTguNiwyLjItMTEuNSwzLjJjLTIuO=
SwxLTEwLjgsMS44LTEzLjEsNi45CgkJQzI5MC4yLDI5OC44LDI5Mi44LDMwMS4yLDI5Ny44LDMw=
NC41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMjU2LjgsMjc4Yy0xLjYsMC0yLjksMS4zLTI=
uOSwyLjljMCwxLjYsMS4zLDIuOSwyLjksMi45YzEuNiwwLDIuOS0xLjMsMi45LTIuOQoJCUMyNT=
kuNywyNzkuMywyNTguNCwyNzgsMjU2LjgsMjc4Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNM=
zIwLDI4NS45Yy0zLjktMC4zLTksMC43LTksMC43czAuOSwwLjgsMi4yLDAuN2MxLjMtMC4xLDMu=
Ni0wLjIsNy40LDAuNWMzLjgsMC43LDYuNi0xLjEsNi42LTEuMQoJCVMzMjMuOCwyODYuMiwzMjA=
sMjg1LjkiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik00NDQuOSw0NjAuNmMzLjEsMC43LDI4Lj=
gsNS42LDMxLDYuMWMyLjIsMC41LDQsMSw0LjYsMC40YzAuNi0wLjYsMS0xLDMuMi0xLjhjMi4zL=
TAuOCwyLjItMy4xLDIuMi0zLjEKCQlzMC42LTIuMiwwLjgtNC4zYzAuMi0yLjIsMS40LTIuOSw0=
LTAuMmMyLjUsMi42LDMsNi41LDMuNSwxMC4yYzAuNSwzLjcsNi40LDQuNyw4LjYsNWMyLjMsMC4=
0LDMuNC0wLjQsNC43LTIuNQoJCWMxLjMtMi4yLDItNi41LDIuNC05LjJjMC40LTIuOCwwLjEtMi=
41LTIuOC0zLjJjLTIuOS0wLjctMTYuMi0zLjctMTguNi00LjNjLTIuNC0wLjYtMS45LTIuMi0xL=
jYtMy44YzAuNC0xLjcsNS42LTE4LjYsNS42LTE4LjYKCQljLTMuOC0yLjMtOS0zLjctMTUuNC00=
LjRjMCwwLTMuOCwxNy4zLTQuNiwxOS45Yy0wLjcsMi42LTIuNCwyLjYtNS4yLDIuMmMtMi44LTA=
uNS0yMi43LTUuMi0yMi43LTUuMmwtMS42LDMuNwoJCWMtMS42LDMuNy0yLjMsOC4yLTIuMywxMC=
40UzQ0MS44LDQ1OS44LDQ0NC45LDQ2MC42Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNTEzL=
jEsNDc2LjJjLTIuNi0xLjctNC42LTIuMi02LDFjLTEuNCwzLjItMS41LDcuOS00LjksMTEuM2Mt=
My40LDMuMy04LjMsNi44LTEzLjEsNi40CgkJYy00LjgtMC4zLTcuNi0xLjUtNi40LTdjMS4yLTU=
uNSw4LjUtNy4yLDEwLjItMTAuMWMxLjctMi45LDEuMy02LjItMS4zLTguNGMtMi41LTIuMi02Lj=
ItMi42LTcuMi0yYy0xLDAuNy00LDMuMi01LjUsNy40CgkJYy0xLjUsNC4xLTIuNCw3LjUtNS42L=
DEwLjFjLTMuMiwyLjYtMTEuNSw1LjMtMTcuOSwzLjhjLTYuNC0xLjUtOC43LTMuNS0xMS4xLTku=
OGMtMi40LTYuMy01LjMtMTYuOC02LjUtMTcuOQoJCWMtMS4zLTEuMS0yLjktMi4xLTUuNi0wLjF=
jLTIuOCwyLTMsNC44LTMuMyw3LjFjLTAuMywyLjMsMCw1LDIuOCw4LjNjMi44LDMuMyw1LjYsNi=
43LDYuNywxMC4xYzEsMy41LDQuMSw4LjctMC4yLDkKCQljLTQuNCwwLjItNi4zLDAuMy05LjYtM=
i45Yy0zLjMtMy4yLTE2LjMtMTIuMS0xOS45LTE1Yy0zLjYtMi45LTUuMS0zLjgtNS4xLTMuOGMt=
Ni0wLjEtMTItMi42LTE4LTYuN2MwLDAsMy40LDguOSw0LjEsMTIuMgoJCWMwLjcsMy4zLDAuNiw=
1LjIsMC42LDUuMnMxMy4xLDYuNywxOC4zLDkuMmM1LjIsMi41LDE1LjYsOC41LDIwLjcsMTEuNm=
M1LjEsMy4xLDkuMyw3LjksMTguMyw2LjFjOS0xLjgsMjcuMS03LjQsMzMtOS4xCgkJYzUuOS0xL=
jcsMjIuMS01LjgsMjgtOS45YzYtNC4xLDYuNS0zLjksNy42LTguMUM1MTYuOCw0ODAuMiw1MTUu=
Nyw0NzcuOSw1MTMuMSw0NzYuMiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ3OC41LDQxNC4=
yYzEtMC4xLDEuNC0wLjMsNC41LTAuN2MzLjEtMC40LDEuOSwyLjUsMS40LDMuN2MtMC41LDEuMS=
0xLjUsMy40LTIuNyw1LjUKCQljLTEuMywyLjEsMC40LDIuNSwxLjMsMi44YzAuOSwwLjMsMi4xL=
DAuNSw0LjYsMS4xYzIuNSwwLjcsMi0xLjEsMi4xLTIuMWMwLjEtMC45LDAuMi01LjgsMC41LTcu=
NWMwLjMtMS43LDEuOS0xLjMsMi41LTAuOQoJCWMwLjYsMC4zLDIuMSwxLjIsMy40LDEuOWMxLjM=
sMC43LDEuOS0wLjEsMi4xLTAuOGMwLjMtMC43LDAuOS0yLjEsMS40LTRjMC41LTEuOS0wLjctMS=
41LTEuOS0xLjVjLTEuMiwwLTIuOSwwLTQuOS0wLjEKCQljLTItMC4xLTAuNy0yLTAuNy0yczEuN=
S0yLjQsMi42LTQuMmMxLjEtMS44LDAuNy0yLjEtMC40LTIuNGMtMS4xLTAuMy00LjYtMS4xLTUu=
Ni0xLjRjLTEtMC4zLTEuNS0wLjEtMS41LDAuNXMtMC4xLDQuMS0wLjEsNS41CgkJYzAsMS4zLTA=
uMSwyLjEtMS45LDIuMmMtMS43LDAuMS0yLjgtMC45LTQuMi0yLjVjLTEuNC0xLjUtMi0wLjktMi=
4xLTAuM2MtMC4xLDAuNi0xLjMsNS0xLjUsNi4yCgkJQzQ3Ni44LDQxNC40LDQ3Ny41LDQxNC4zL=
DQ3OC41LDQxNC4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzc4LjcsNDYyLjljLTEuOS0y=
LDMtMi4xLDUuOS0yLjFjMi45LDAsNy43LTEuNSw5LjItMi41YzEuNS0xLDQuMi0xLjUsNy40LTN=
jMy4yLTEuNSwxLjItMi0yLTIuOAoJCWMtMy4yLTAuOC0xMS45LTQuNS0xMS45LTQuNXMtNC4yLD=
IuMy02LjYsMy43Yy0yLjQsMS40LTUuNSwzLjMtMTAuNiw0Yy01LjEsMC42LTYuNiwwLjktNi45L=
DEuMWMtMC4yLDAuMiwxLjIsMS40LDMuMiw0LjEKCQljMS45LDIuOCwyLjgsNC42LDUuMiw4Ljdj=
Mi40LDQuMS0wLjQsMS43LTIuNC0wLjljLTEuMS0xLjUtMy43LTQuOS02LjEtNy40Yy0xLjgtMS4=
5LTMuNy0zLjEtMy43LTMuMWwtMS42LDMuNXYxLjIKCQljMCwxLjEtMSw2LjgtMS4zLDljLTAuMy=
wyLjMsMC42LDIuMywyLjMsMy4xYzEuOCwwLjgsNS4zLDIuOCwxNC45LDguOWM5LjYsNiwxMy4xL=
DEwLDEzLjEsMTBzMC4zLTIuNiwwLjMtNS4yCgkJYzAtMi42LTAuMS03LjktMi4yLTEzLjhDMzgy=
LjksNDY4LjgsMzgwLjcsNDY0LjksMzc4LjcsNDYyLjkiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ=
9Ik0zNTYuNSw0NDkuNmMyLjIsMC41LDMuMSwxLDYuMywxYzMuMSwwLDQuNS0xLDcuNy0xYzMuMy=
wwLDUuNS0xLjEsMTAuOC0zLjljNS4zLTIuOCwwLjItMi0zLjUtMS43CgkJYy0zLjcsMC4zLTEzL=
jQtMS4xLTE3LjUtMi43Yy00LjEtMS42LTEuMS0xLjgsMC0xLjVjMS4xLDAuMywxLjcsMC43LDEw=
LDIuMWM4LjMsMS41LDExLjMtMC40LDE1LjYtMS42YzQuMy0xLjEtMS0xLjctMS0xLjcKCQlzLTE=
1LTQuMy0yMi42LTEyLjdjLTUuNy02LjQtNy43LTEyLjQtOC4zLTE0LjhjLTIuOSwzLjUtNi4yLD=
YuNS05LjcsOS4yYzAuMywxLjIsMC44LDMuMSwxLjYsNC45YzEuMiwyLjgsNC44LDYuNSw0LjgsN=
i41CgkJcy00LjUtMS44LTYuNS0zLjljLTEuNC0xLjUtMi42LTMuNy0zLjItNWMtNC45LDMuNC0x=
MCw2LjItMTQuNyw4LjRjMC42LDAuNCwxLjMsMSwyLDEuN2MyLDEuOCwzLjksNC4yLDYuNSw4LjM=
KCQljMi42LDQuMiwwLjIsMy44LTIuMSwwYy0yLjQtMy44LTguMi03LjctOS4zLTguM2MtMC4xLT=
AuMS0wLjMtMC4xLTAuNC0wLjJjLTAuNiwwLjMtMS4yLDAuNS0xLjgsMC44Yy0zLjIsMS40LTYuM=
iwyLjctOS4xLDMuOQoJCWMxLjksMS42LDYuNCw1LjksNy45LDguMWMxLjcsMi41LDUuMiw0Ljcs=
Ni40LDYuNGMxLjIsMS43LDIuNiwzLjYsNC4zLDUuNmMxLjcsMiwxMS44LDEzLjQsMTQuNSwxNy4=
2YzIuNyw0LjMsMS4xLTEuMSwwLjQtNAoJCWMtMC43LTIuOS0xLjctNy4xLTIuNi0xMC4zYy0wLj=
ktMy4zLDEtMS45LDEuMy0wLjFjMC4zLDEuOCwwLjgsMS45LDEuNiw1LjRjMC44LDMuNSwyLjgsO=
C42LDMuNywxMi4yYzAuOSwzLjYsMS4yLDEuOSwyLjEsMC4yCgkJYzAuOS0xLjcsMi4yLTQuNiwy=
LjgtNi40YzAuNi0xLjgsMS01LjgsMS4xLTEyYzAuMS02LjItMi45LTguNi0yLjktOS41QzM1Mi4=
4LDQ1MCwzNTQuMyw0NDkuMiwzNTYuNSw0NDkuNiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTT=
M5OS44LDQ2M2MtMC45LDAuNC0zLjksMS40LTUuMywxLjZjLTEuNCwwLjItMi40LDAuMy0yLjQsM=
C4zczIuOCwzLjksNywzLjloMTIuMmMwLDAtNy4zLTQuMy04LjMtNS4zCgkJQzQwMi4xLDQ2Mi41=
LDQwMC43LDQ2Mi42LDM5OS44LDQ2MyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ4OC4xLDQ=
1Ny44YzAsMC0wLjEsMy41LTAuNSw0LjdjLTAuNCwxLjItMS4yLDMsMC4yLDMuNWMxLjQsMC41LD=
IuOCwxLjEsMy42LDAuOGMwLjgtMC4yLDAuNS0xLjksMC0zLjQKCQljLTAuNS0xLjQtMS4yLTMuM=
i0yLjMtNC40TDQ4OC4xLDQ1Ny44eiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTUwOS4yLDQ3=
MS43YzAuNSwxLjEsMS40LDEuMywyLjIsMS42YzAuNywwLjIsMS43LDAuMiwxLjctMS4xYzAtMS4=
zLDAuMi0zLTAuOC00LjRjLTEuMS0xLjQtMS43LTIuNS0yLjMtMC40CgkJQzUwOS4zLDQ2OS41LD=
UwOC44LDQ3MC42LDUwOS4yLDQ3MS43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNNDM1LjcsN=
DU3LjdjMC42LDAuMSwyLjksMC44LDIuOSwwLjhzMC0zLjQsMC41LTUuNmMwLjUtMi4zLDEuNC0z=
LjgsMC42LTMuOGMtMC44LDAtMS4zLDAuNy0xLjksMS43CgkJYy0wLjYsMS0yLjMsMS4yLTIuOSw=
0QzQzNC4yLDQ1Ny40LDQzNS4xLDQ1Ny42LDQzNS43LDQ1Ny43Ii8+Cgk8cGF0aCBjbGFzcz0ic3=
QwIiBkPSJNMTQ1LjEsMzYyLjljLTIuNCwxLjgtNS42LDIuNi01LjYsMi42cy0xLjUtMC4xLTEuN=
SwwLjVjMCwwLjYsMS43LDAsMy42LTAuM2MxLjgtMC4zLDQuMy0yLjIsNS4yLTIuOAoJCWMwLjkt=
MC43LDIuMi0xLjUsMS44LTIuN0MxNDguMiwzNTksMTQ3LjUsMzYxLjEsMTQ1LjEsMzYyLjkiLz4=
KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0xNjUuOCwzNzRjLTAuNSwwLjYtNC41LDMuNi00LjUsMy=
42cy0xLjIsMC44LTIuNiwxLjNjLTEuMywwLjUtMS43LDEuMy0xLjcsMS4zczAuMiwwLjMsMS43L=
TAuMQoJCWMxLjQtMC40LDUuNi0zLjMsNi45LTQuNWMxLjMtMS4yLDEuOS0xLjUsMS40LTJDMTY2=
LjYsMzczLjEsMTY2LjMsMzczLjQsMTY1LjgsMzc0Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJ=
NODEuOCwyMjQuNmMwLjcsMC45LDEuNywyLjIsMi4xLDEuN2MwLjQtMC40LTAuMS0wLjgtMS4xLT=
JjLTEtMS4yLTEuNi0xLjctMS42LTEuN3MtMS40LTIuMi0yLjItMy4xCgkJYy0wLjgtMC44LTIuM=
S0xLjItMC41LDAuN0M4MCwyMjIuMiw4MSwyMjMuNyw4MS44LDIyNC42Ii8+Cgk8cGF0aCBjbGFz=
cz0ic3QwIiBkPSJNNzUuNCwyMzguNmMwLjksMC44LDEuNywxLjYsMi43LDIuN3MxLjcsMi4yLDI=
uMywxLjdjMC42LTAuNi0xLjUtMS44LTIuNC0zYy0wLjktMS4yLTEuNy0xLjktMi44LTIuOAoJCW=
MtMS4yLTAuOS0yLjYtMS43LTIuNi0xLjdTNzQuNSwyMzcuOCw3NS40LDIzOC42Ii8+Cgk8cGF0a=
CBjbGFzcz0ic3QwIiBkPSJNNzcuOCwyNjEuMmMxLjYsMS43LDMuOSwyLjIsNC4yLDEuNWMwLjMt=
MC43LTAuMi0xLjItMS41LTEuOWMtMS4zLTAuNy0zLjUtMi4xLTQuNi0yLjgKCQljLTEuMS0wLjc=
tMi4yLTEuNi0yLjktMi4zYy0wLjctMC43LTEuNi0xLjQtMS45LTEuMmMtMC4zLDAuMywyLjIsMi=
45LDIuOSwzLjNDNzQuOSwyNTguMyw3Ni4yLDI1OS42LDc3LjgsMjYxLjIiLz4KCTxwYXRoIGNsY=
XNzPSJzdDAiIGQ9Ik04Mi4zLDI3OS4zYzAtMC43LDAuMi0xLTEuMi0xLjFjLTEuMy0wLjEtMy4y=
LTAuMy0zLjItMC4zcy0yLjYtMS0yLjctMC41Yy0wLjIsMC41LDIuMiwxLjUsMy4yLDEuNwoJCWM=
xLDAuMiwyLjIsMC41LDIuOCwwLjhDODEuOCwyODAuMiw4Mi4zLDI4MCw4Mi4zLDI3OS4zIi8+Cg=
k8cGF0aCBjbGFzcz0ic3QwIiBkPSJNODQuMywyOTljLTIuOCwwLTUuMi0wLjctNS40LTAuM2MtM=
C4yLDAuNCwxLjMsMS4xLDIuNywxLjZjMS40LDAuNSw0LjEsMC43LDUuOSwwLjdjMS44LDAuMSwy=
LjItMC4zLDIuMS0xLjIKCQlDODkuNiwyOTguOSw4Ny4yLDI5OSw4NC4zLDI5OSIvPgoJPHBhdGg=
gY2xhc3M9InN0MCIgZD0iTTEwNi41LDMyMC41Yy0wLjQtMC40LTEuNC0wLjEtMywwLjJjLTEuNi=
wwLjMtNC4yLDAuOC01LjcsMC44Yy0xLjUtMC4xLTQuNy0wLjItNC43LTAuMnMtMS44LDAtMS44L=
DAuNAoJCWMwLDAuNCwyLjQsMC4zLDUuOSwwLjdjMy41LDAuNCw1LjgtMC4zLDcuNS0wLjZDMTA2=
LjMsMzIxLjYsMTA2LjksMzIwLjksMTA2LjUsMzIwLjUiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ=
9Ik0xMTUuNiwzMzUuOGMtMS43LDAuNy0zLDAuOC00LjMsMC44Yy0xLjMsMC00LjUsMC42LTQuNS=
wwLjZzLTEuNSwwLjItMS4yLDAuOGMwLjIsMC42LDAuNywwLDIuMS0wLjIKCQljMS4zLTAuMiwyL=
jMsMCw0LjctMC4xYzIuMy0wLjEsMy43LTAuNyw1LjEtMC45YzEuNC0wLjMsMy0xLDIuMi0xLjlD=
MTE4LjksMzM0LDExNy40LDMzNS4xLDExNS42LDMzNS44Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiB=
kPSJNMTMzLjQsMzQ3LjRjLTEsMS00LjgsMy42LTQuOCwzLjZzLTAuNywwLjYtMi4yLDEuM2MtMS=
41LDAuNy0xLjQsMS4xLTEuMiwxLjVjMC4yLDAuNCwxLjItMC42LDItMC45CgkJYzAuOC0wLjMsM=
y42LTIuMiw1LTMuM2MxLjQtMS4yLDMuMi0yLjEsMi45LTIuOUMxMzQuOCwzNDUuOCwxMzQuNCwz=
NDYuNCwxMzMuNCwzNDcuNCIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTEwMy44LDE5Ny40YzA=
sMCwwLjMsMC44LDMuNCw0LjZjMy4xLDMuOCwxLjQsMC4yLDAuNy0wLjhjLTAuOC0xLTUuMy03Lj=
QtNi44LTkuMWMtMS41LTEuOC0xLjgtMC45LTEsMC4yCgkJQzEwMC44LDE5My40LDEwMy44LDE5N=
y40LDEwMy44LDE5Ny40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNOTcuMywyMTcuMWMwLjQt=
MC40LTAuNi0wLjktMi4zLTMuMWMtMS44LTIuMi01LjMtNi43LTUuMy02LjdzLTEtMi4xLTEuMy0=
xLjljLTAuMywwLjIsMS4yLDMuNSwyLjYsNC45CgkJYzEuNCwxLjQsMy4zLDQuMiw0LjMsNS40Qz=
k2LjMsMjE3LDk2LjksMjE3LjYsOTcuMywyMTcuMSIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iT=
TEwNS45LDI1NC4yYzAtMS4xLTMuNS0wLjktNS0xLjJjLTEuNi0wLjMtNC40LTAuOS00LjQtMC45=
cy0zLjMtMC42LTMuNC0wLjJjLTAuMSwwLjQsMC43LDAuOCwyLjUsMS4yCgkJYzEuOCwwLjMsNC4=
2LDEuMiw2LjYsMS41UzEwNS45LDI1NS4yLDEwNS45LDI1NC4yIi8+Cgk8cGF0aCBjbGFzcz0ic3=
QwIiBkPSJNOTcuMywyMzQuMmMyLjMsMS45LDMuOCwyLjcsNSwzLjRzMi4yLDEuNiwyLjksMC45Y=
zAuNy0wLjgtMC42LTEuMy0yLjUtMi4yYy0yLTAuOS0zLTEuNi0zLTEuNgoJCXMtMS4xLTAuNS0y=
LjEtMS4xQzk2LjcsMjMyLjksOTUsMjMyLjMsOTcuMywyMzQuMiIvPgoJPHBhdGggY2xhc3M9InN=
0MCIgZD0iTTExNy4yLDIyMWMtMS40LTEuMi0yLjYtMS45LTIuNi0xLjlzLTEuOC0xLjYtMi4xLT=
EuMWMtMC4zLDAuNiwyLDIuMiwzLjEsMy4yYzEuMSwxLDMuMSwzLjgsNC4xLDMuMwoJCUMxMjAuN=
iwyMjMuOSwxMTguNiwyMjIuMiwxMTcuMiwyMjEiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0x=
MDQuMiwyNzIuNmMwLDAtMS45LDAuNS0zLjIsMC44Yy0xLjIsMC4zLTEuMywwLjksMC45LDAuOXM=
zLjItMC42LDUuNC0xYzIuMi0wLjQsMy0wLjcsMi43LTEuNAoJCWMtMC4zLTAuOC0xLjUtMC41LT=
IuNC0wLjJDMTA2LjcsMjcxLjksMTA0LjIsMjcyLjYsMTA0LjIsMjcyLjYiLz4KCTxwYXRoIGNsY=
XNzPSJzdDAiIGQ9Ik0xMDcuNywyOTEuMmMtMC4yLDAuNCwxLjYsMCwyLjctMC40YzEuMi0wLjQs=
My42LTEuNyw1LTIuMWMxLjQtMC40LDEuNC0wLjcsMS40LTEuNWMwLTAuOC0xLjUtMC4yLTMuMyw=
wLjQKCQljLTEuOCwwLjYtNC4yLDIuNC00LjIsMi40UzEwNy45LDI5MC44LDEwNy43LDI5MS4yIi=
8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMTMxLjgsMzAyLjZjMS43LTEsMi0xLjgsMS40LTIuM=
2MtMC42LTAuNS0xLjEtMC40LTIuNCwwLjdjLTEuMywxLjEtMy45LDIuOS0zLjksMi45cy0xLjMs=
MC41LTIuMywxCgkJYy0xLDAuNS0yLjIsMS4zLTEuOSwxLjhjMC4zLDAuNSwyLjQsMCwzLjUtMC4=
5QzEyNy4yLDMwNC45LDEzMC4xLDMwMy42LDEzMS44LDMwMi42Ii8+Cgk8cGF0aCBjbGFzcz0ic3=
QwIiBkPSJNMTQzLjEsMzE3LjZjMC43LTAuNiwyLjctMS4yLDMuNi0xLjljMC45LTAuNywxLjUtM=
i43LDAuNy0yLjljLTAuNy0wLjItMS4yLDAuOC0yLjcsMmMtMS42LDEuMi03LDQuOC03LDQuOAoJ=
CXMwLjEsMC0xLjQsMC42Yy0xLjUsMC42LTAuOCwxLDAuNCwwLjhjMS4yLTAuMiwyLjEtMC4yLDM=
uNi0xLjNDMTQxLjgsMzE4LjQsMTQyLjQsMzE4LjEsMTQzLjEsMzE3LjYiLz4KCTxwYXRoIGNsYX=
NzPSJzdDAiIGQ9Ik0xNTkuOSwzMzEuOGMxLjQtMC42LDMuNS0yLjQsNC41LTMuM2MxLTAuOSwyL=
jItMi4xLDEuNS0yLjdjLTAuOC0wLjYtMS42LDAuMi0yLjcsMS4yCgkJYy0xLjIsMS4xLTQuMiw0=
LjMtNC4yLDQuM3MtMC40LDAuMS0yLjEsMS40Yy0xLjcsMS4zLDAuMSwxLjEsMC43LDAuNUMxNTg=
uMSwzMzIuNywxNTguNSwzMzIuNCwxNTkuOSwzMzEuOCIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD=
0iTTQwNCwzNjUuNWMwLDAtMy4yLTAuNy01LjYtMi42Yy0yLjQtMS44LTMuMi0zLjktMy42LTIuO=
GMtMC40LDEuMiwwLjksMiwxLjgsMi43YzAuOSwwLjcsMy40LDIuNSw1LjIsMi44CgkJYzEuOCww=
LjMsMy42LDAuOSwzLjYsMC4zQzQwNS41LDM2NS40LDQwNCwzNjUuNSw0MDQsMzY1LjUiLz4KCTx=
wYXRoIGNsYXNzPSJzdDAiIGQ9Ik0zODQuNywzNzguOWMtMS4zLTAuNS0yLjYtMS4zLTIuNi0xLj=
NzLTQtMy00LjUtMy42Yy0wLjUtMC42LTAuNy0wLjktMS4zLTAuNGMtMC41LDAuNSwwLjEsMC44L=
DEuNCwyCgkJYzEuMywxLjIsNS41LDQuMSw2LjksNC41YzEuNCwwLjQsMS43LDAuMSwxLjcsMC4x=
UzM4Ni4xLDM3OS40LDM4NC43LDM3OC45Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNNDYxLjc=
sMjI0LjZjMC43LTAuOSwxLjctMi41LDMuMy00LjRjMS42LTEuOSwwLjMtMS41LTAuNS0wLjdjLT=
AuOCwwLjgtMi4yLDMuMS0yLjIsMy4xcy0wLjYsMC42LTEuNiwxLjcKCQljLTEsMS4yLTEuNSwxL=
jYtMS4xLDJDNDYwLjEsMjI2LjgsNDYxLDIyNS42LDQ2MS43LDIyNC42Ii8+Cgk8cGF0aCBjbGFz=
cz0ic3QwIiBkPSJNNDYzLDI0M2MwLjYsMC42LDEuMy0wLjYsMi4zLTEuN2MxLTEuMSwxLjgtMS4=
4LDIuNy0yLjdjMC45LTAuOCwyLjctMy4xLDIuNy0zLjFzLTEuNCwwLjctMi42LDEuNwoJCWMtMS=
4yLDAuOS0xLjksMS43LTIuOCwyLjhDNDY0LjUsMjQxLjEsNDYyLjUsMjQyLjQsNDYzLDI0MyIvP=
goJPHBhdGggY2xhc3M9InN0MCIgZD0iTTQ3Mi4zLDI1NC42Yy0wLjMtMC4zLTEuMiwwLjQtMS45=
LDEuMmMtMC43LDAuNy0xLjgsMS42LTIuOSwyLjNjLTEuMSwwLjctMy4yLDIuMi00LjYsMi44Cgk=
JYy0xLjMsMC43LTEuOCwxLjItMS41LDEuOWMwLjMsMC43LDIuNywwLjIsNC4yLTEuNWMxLjYtMS=
43LDIuOS0yLjksMy43LTMuM0M0NzAuMSwyNTcuNSw0NzIuNiwyNTQuOCw0NzIuMywyNTQuNiIvP=
goJPHBhdGggY2xhc3M9InN0MCIgZD0iTTQ2NS41LDI3Ny45YzAsMC0xLjgsMC4yLTMuMiwwLjNj=
LTEuMywwLjEtMS4yLDAuNC0xLjIsMS4xczAuNSwwLjksMS4xLDAuNmMwLjYtMC4zLDEuOC0wLjc=
sMi44LTAuOAoJCWMxLTAuMiwzLjMtMS4yLDMuMi0xLjdDNDY4LDI3Ni45LDQ2NS41LDI3Ny45LD=
Q2NS41LDI3Ny45Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNNDU5LjEsMjk5Yy0yLjgsMC01L=
jItMC4xLTUuMywwLjhjLTAuMSwwLjksMC4yLDEuMywyLjEsMS4yYzEuOC0wLjEsNC41LTAuMiw1=
LjktMC43YzEuNC0wLjUsMi45LTEuMiwyLjgtMS42CgkJQzQ2NC40LDI5OC4zLDQ2MiwyOTksNDU=
5LjEsMjk5Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNNDUwLjQsMzIxLjNjMCwwLTMuMiwwLj=
EtNC43LDAuMmMtMS41LDAuMS00LjEtMC40LTUuNy0wLjhjLTEuNi0wLjMtMi42LTAuNy0zLTAuM=
mMtMC40LDAuNCwwLjIsMS4yLDEuOCwxLjQKCQljMS43LDAuMyw0LDEsNy41LDAuNmMzLjUtMC40=
LDUuOS0wLjMsNS45LTAuN0M0NTIuMiwzMjEuMyw0NTAuNCwzMjEuMyw0NTAuNCwzMjEuMyIvPgo=
JPHBhdGggY2xhc3M9InN0MCIgZD0iTTQzNi43LDMzNy4yYzAsMC0zLjItMC42LTQuNS0wLjZjLT=
EuMywwLTIuNi0wLjItNC4zLTAuOHMtMy4yLTEuOC00LTAuOWMtMC43LDAuOSwwLjgsMS43LDIuM=
iwxLjkKCQljMS40LDAuMiwyLjcsMC44LDUuMSwwLjljMi4zLDAuMSwzLjMtMC4xLDQuNywwLjFj=
MS4zLDAuMiwxLjgsMC44LDIuMSwwLjJDNDM4LjIsMzM3LjQsNDM2LjcsMzM3LjIsNDM2LjcsMzM=
3LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik00MTcuMSwzNTIuM2MtMS41LTAuNy0yLjItMS=
4zLTIuMi0xLjNzLTMuOC0yLjYtNC44LTMuNmMtMS0xLTEuMy0xLjYtMS43LTAuN2MtMC4zLDAuO=
CwxLjUsMS43LDIuOSwyLjkKCQljMS40LDEuMiw0LjIsMyw1LDMuM2MwLjgsMC4zLDEuNywxLjMs=
MiwwLjlDNDE4LjUsMzUzLjQsNDE4LjYsMzUzLjEsNDE3LjEsMzUyLjMiLz4KCTxwYXRoIGNsYXN=
zPSJzdDAiIGQ9Ik00MzYuMywyMDJjMy4xLTMuOCwzLjQtNC42LDMuNC00LjZzMy00LDMuNy01Lj=
FjMC44LTEuMSwwLjUtMi0xLTAuMmMtMS41LDEuOC02LDguMS02LjgsOS4xCgkJQzQzNC45LDIwM=
i4yLDQzMy4yLDIwNS44LDQzNi4zLDIwMiIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTQ1NSwy=
MDUuNWMtMC4zLTAuMi0xLjMsMS45LTEuMywxLjlzLTMuNSw0LjUtNS4zLDYuN2MtMS44LDIuMi0=
yLjcsMi42LTIuMywzLjFjMC40LDAuNCwxLTAuMSwyLTEuMwoJCWMxLTEuMiwyLjktMy45LDQuMy=
01LjRDNDUzLjgsMjA5LDQ1NS40LDIwNS43LDQ1NSwyMDUuNSIvPgoJPHBhdGggY2xhc3M9InN0M=
CIgZD0iTTQzNy42LDI1NC4yYzAsMS4xLDEuNywwLjcsMy43LDAuM2MyLjEtMC4zLDQuOC0xLjIs=
Ni42LTEuNWMxLjgtMC4zLDIuNi0wLjgsMi41LTEuMgoJCWMtMC4xLTAuNC0zLjQsMC4yLTMuNCw=
wLjJzLTIuOCwwLjYtNC40LDAuOVM0MzcuNiwyNTMuMSw0MzcuNiwyNTQuMiIvPgoJPHBhdGggY2=
xhc3M9InN0MCIgZD0iTTQ0NS44LDIzMy41Yy0xLDAuNS0yLjEsMS4xLTIuMSwxLjFzLTEsMC44L=
TMsMS42Yy0yLDAuOS0zLjIsMS40LTIuNSwyLjJjMC43LDAuOCwxLjYtMC4yLDIuOS0wLjkKCQlj=
MS4yLTAuNywyLjctMS41LDUtMy40QzQ0OC41LDIzMi4zLDQ0Ni44LDIzMi45LDQ0NS44LDIzMy4=
1Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNNDIzLjksMjI0LjVjMSwwLjYsMy0yLjMsNC4xLT=
MuM2MxLjEtMSwzLjQtMi42LDMuMS0zLjJjLTAuMy0wLjUtMi4xLDEuMS0yLjEsMS4xcy0xLjIsM=
C43LTIuNiwxLjkKCQlDNDI0LjksMjIyLjIsNDIyLjksMjIzLjksNDIzLjksMjI0LjUiLz4KCTxw=
YXRoIGNsYXNzPSJzdDAiIGQ9Ik00MzYuMSwyNzMuM2MyLjIsMC40LDMuMiwxLDUuNCwxYzIuMiw=
wLDIuMi0wLjYsMC45LTAuOWMtMS4yLTAuMy0zLjItMC44LTMuMi0wLjhzLTIuNS0wLjctMy40LT=
AuOQoJCWMtMC45LTAuMi0yLjEtMC41LTIuNCwwLjJDNDMzLjEsMjcyLjYsNDMzLjgsMjcyLjksN=
DM2LjEsMjczLjMiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik00MzQuMSwyOTAuMWMwLDAtMi4z=
LTEuOC00LjItMi40Yy0xLjgtMC42LTMuMy0xLjItMy4zLTAuNGMwLDAuOCwwLDEuMSwxLjQsMS4=
1YzEuNCwwLjQsMy44LDEuNyw1LDIuMQoJCWMxLjIsMC40LDIuOSwwLjgsMi44LDAuNEM0MzUuNi=
wyOTAuOCw0MzQuMSwyOTAuMSw0MzQuMSwyOTAuMSIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iT=
TQxOC45LDMwNC45Yy0xLTAuNS0yLjMtMS0yLjMtMXMtMi42LTEuOC0zLjktMi45Yy0xLjMtMS4x=
LTEuOC0xLjItMi40LTAuN2MtMC42LDAuNS0wLjIsMS4yLDEuNCwyLjMKCQljMS43LDEsNC42LDI=
uMyw1LjcsMy4yYzEuMSwwLjksMy4yLDEuNCwzLjUsMC45QzQyMS4yLDMwNi4yLDQxOS45LDMwNS=
40LDQxOC45LDMwNC45Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNNDA3LjIsMzIwLjFjLTEuN=
S0wLjYtMS40LTAuNi0xLjQtMC42cy01LjQtMy42LTctNC44Yy0xLjYtMS4yLTItMi4yLTIuNy0y=
Yy0wLjgsMC4yLTAuMiwyLjIsMC43LDIuOQoJCWMwLjksMC43LDIuOSwxLjMsMy42LDEuOWMwLjc=
sMC42LDEuMywwLjgsMi44LDJjMS41LDEuMiwyLjMsMS4yLDMuNiwxLjNDNDA4LDMyMS4xLDQwOC=
43LDMyMC42LDQwNy4yLDMyMC4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMzg2LjcsMzMyL=
jhjLTEuNy0xLjMtMi4xLTEuNC0yLjEtMS40cy0zLjEtMy4yLTQuMi00LjNjLTEuMi0xLjEtMi0x=
LjgtMi43LTEuMmMtMC43LDAuNiwwLjUsMS43LDEuNSwyLjcKCQljMSwwLjksMy4xLDIuNyw0LjU=
sMy4zYzEuNCwwLjYsMS44LDAuOSwyLjQsMS41QzM4Ni42LDMzMy45LDM4OC4zLDMzNC4xLDM4Ni=
43LDMzMi44Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjcxLjcsMTMxLjJjLTExLjMsMC4yL=
TI0LjYtMS40LTMxLjktNC4xYy0yLjYsMC42LTUuMiwxLjEtNy44LDEuN2MxMi4xLDQuNSwyMi4x=
LDYuMywzOS43LDYuNQoJCWMxNy42LTAuMiwyNy43LTEuOSwzOS43LTYuNWMtMi42LTAuNi01LjI=
tMS4xLTcuOC0xLjdDMjk2LjMsMTI5LjgsMjgzLDEzMS40LDI3MS43LDEzMS4yIi8+Cgk8cGF0aC=
BjbGFzcz0ic3QyIiBkPSJNMzEyLjksMTIxLjdjLTAuOS0wLjctNi4xLTQuNC03LjQtNS4xYy0xL=
jMtMC43LTAuMy0yLjUtMC4xLTMuMmMwLjItMC44LDYuMS0yLjQsOS4zLTMuMgoJCWMzLjItMC44=
LDIuNy0xLjUsMi43LTEuNXMtMS45LTIuMi0xMy41LTMuNGMtMTEuNy0xLjMtMzIuMS0xLTMyLjE=
tMXMtMjAuNS0wLjMtMzIuMSwxYy0xMS43LDEuMy0xMy41LDMuNC0xMy41LDMuNAoJCXMtMC41LD=
AuNywyLjcsMS41YzMuMiwwLjgsOSwyLjUsOS4zLDMuMmMwLjIsMC43LDEuMywyLjUtMC4xLDMuM=
mMtMS4zLDAuNy02LjUsNC4zLTcuNCw1LjFjLTAuOSwwLjgtMSwxLjksMC40LDIKCQljMS40LDAu=
MSwxLjQsMC4xLDUuNS0wLjhjMTItMi40LDIzLjMtMy4xLDM1LjMtMy4yYzEyLDAuMiwyMy4zLDA=
uOCwzNS4zLDMuMmM0LDAuOCw0LDAuOCw1LjUsMC44CgkJQzMxMy45LDEyMy43LDMxMy44LDEyMi=
41LDMxMi45LDEyMS43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjI3LjIsMTExLjVsLTUuM=
Sw0LjFsNi4zLDIuOGw2LjgtNC44TDIyNy4yLDExMS41eiIvPgoJPHBhdGggY2xhc3M9InN0MiIg=
ZD0iTTMxNi4yLDExMS41bC04LDJsNi44LDQuOGw2LjMtMi44TDMxNi4yLDExMS41eiIvPgoJPHB=
hdGggY2xhc3M9InN0MiIgZD0iTTI5OS42LDEyNi43Yy04LTAuOS0xMy4xLTItMjcuOS0xLjljLT=
E0LjgsMC4xLTE5LjksMC45LTI3LjksMS45YzUsMiwxMy4yLDMsMjcuOSwzCgkJQzI4Ni41LDEyO=
S43LDI5NC42LDEyOC43LDI5OS42LDEyNi43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QzIiBkPSJNMjgz=
LDM1OC40Yy0xLTEuNS0xLjItMS40LTIuMy0wLjRjLTEuMSwxLTIuMi0yLjMtMi4zLTQuNGMtMC4=
xLTIsMC44LTguMywwLjgtOC4zcy01LjMsMS4xLTguMiwyCgkJYy0yLjksMS01LjYsMS4yLTcuOS=
wxLjhjLTIuMywwLjUtMy41LDEuMS00LjgsMC44Yy0xLjItMC4zLTMuOC0wLjQtNS45LTAuNGMtM=
iwwLTEuOSwwLjQtMy45LDIuNWMtMiwyLTIuNiwzLjEtNC4yLDYuOQoJCWMtMS42LDMuOC0yLjIs=
Ny4zLTIuNywxMmMtMC40LDMtMC45LDUuMS0xLjMsNi4yaDI0LjRjMC4zLTAuOCwwLjctMS44LDE=
tMi41YzAuNi0xLjQsMi0yLjMsMi45LTIuOGMxLTAuNCwxLjgtMC40LDIuMi0xLjUKCQljMC40LT=
EuMSwxLjctMiwyLjktMi42YzEuMy0wLjYsMy41LTAuMyw1LjYsMC4zYzIsMC42LDIuNy0wLjgsM=
y4zLTEuNmMwLjYtMC44LDAuOC0xLjksMS45LTMuM2MxLjEtMS40LDAuMy0yLjcsMC4zLTIuNwoJ=
CVMyODQsMzU5LjksMjgzLDM1OC40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QzIiBkPSJNMzIyLjEsMzU=
5LjFjLTAuMy0xLjQtMC4yLTEuNi0xLTEuOGMtMC44LTAuMi0yLjItMC40LTMuNS0xYy0xLjItMC=
41LTEuMSwyLjctMS4xLDIuN3MtMi45LDAuMy02LjEtMC4xCgkJYy0zLjMtMC40LTcuMS0zLjMtO=
C40LTQuM2MtMS4zLTEtMi44LTMuMS0yLjgtMy4xcy0xLDEtMiwxLjVzLTEuNiwyLjYtMS44LDQu=
N2MtMC4yLDIsMi40LDQuNSwyLjYsNi42YzAuMiwyLTIuMiw2LjEtMy41LDcuOAoJCWMtMC44LDE=
uMS0xLjksMy42LTIuNSw1aDExLjhjMC4yLTAuNiwwLjYtMS40LDEuMy0yYzEuMi0xLjIsMy4zLT=
EuNSwzLjMtMS41czAtMC41LDAuNC0xLjZjMC40LTEuMSwxLjctMi40LDQuNi0zLjUKCQljMi45L=
TEuMSw2LjUtMS4zLDYuNS0xLjNzMS40LTEuMSwyLjQtMi43QzMyMy4yLDM2Mi45LDMyMi41LDM2=
MC41LDMyMi4xLDM1OS4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjY5LjMsMTYuOWw2LjE=
tMC41bC0wLjYtNS4zbDYuNSwwLjlsMC4zLTUuM2wtNi45LDAuNmwxLjItNS43bC03LjYtMC4xbD=
EuMyw1LjhMMjYzLDYuN1YxMmw2LjYtMC44CgkJTDI2OS4zLDE2Ljl6Ii8+Cgk8cGF0aCBjbGFzc=
z0ic3QyIiBkPSJNMjgyLjYsMjUuNWgtOC4ydi03Yy0wLjgtMC4yLTEuNi0wLjItMi40LTAuMmMt=
MC43LDAtMS40LDAuMS0yLjEsMC4ydjdoLTguNWMtMC4zLDAuOS0wLjQsMS44LTAuNCwyLjgKCQl=
jMCwwLjQsMCwwLjgsMC4xLDEuMmgyMmMwLjEtMC40LDAuMS0wLjgsMC4xLTEuMkMyODMsMjcuNC=
wyODIuOSwyNi40LDI4Mi42LDI1LjUiLz4KCTxwYXRoIGNsYXNzPSJzdDMiIGQ9Ik0yNzIsMzguN=
GM0LjksMCw5LTIuOSwxMC41LTYuOWgtMjFDMjYzLDM1LjUsMjY3LjEsMzguNCwyNzIsMzguNCIv=
PgoJPHBhdGggY2xhc3M9InN0MyIgZD0iTTI3Ni41LDE5LjJWMjRoNS40QzI4MC44LDIxLjksMjc=
4LjksMjAuMiwyNzYuNSwxOS4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QzIiBkPSJNMjY3LjQsMTkuMm=
MtMi40LDEtNC4zLDIuNy01LjQsNC44aDUuNFYxOS4yeiIvPgoJPHBhdGggY2xhc3M9InN0MCIgZ=
D0iTTI3OC4zLDEwOC40Yy0yLjEtMS02LjYtMi45LTYuNi0yLjlzLTQuMywyLjEtNi42LDMuM2Mt=
Mi4zLDEuMi0yLDAuOC0yLjcsMi41Yy0wLjcsMS43LDAuMSwyLjMsMS4xLDIuOAoJCWMxLDAuNSw=
4LjQsNC4yLDguNCw0LjJzNy4zLTMuNCw5LjEtNC4yYzEuOC0wLjgsMS40LTEuNywwLjktMi45Qz=
I4MS4zLDEwOS45LDI4MC4zLDEwOS40LDI3OC4zLDEwOC40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwI=
iBkPSJNMjkzLjMsMTA2LjRjMy42LDAsNi41LDIuOCw2LjUsNi4ycy0yLjksNi4yLTYuNSw2LjJz=
LTYuNS0yLjgtNi41LTYuMlMyODkuOCwxMDYuNCwyOTMuMywxMDYuNCIvPgoJPHBhdGggY2xhc3M=
9InN0MCIgZD0iTTI1MCwxMDYuNGMzLjYsMCw2LjUsMi44LDYuNSw2LjJzLTIuOSw2LjItNi41LD=
YuMmMtMy42LDAtNi41LTIuOC02LjUtNi4yUzI0Ni41LDEwNi40LDI1MCwxMDYuNCIvPgoJPHBhd=
GggY2xhc3M9InN0MiIgZD0iTTI2NC42LDExMC42bDcuMiwzLjdsNy4xLTMuN2wtNy4zLTMuNEwy=
NjQuNiwxMTAuNnoiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yOTMuMywxMDcuNmMtMi4yLDA=
tMy45LDEuNy0zLjksMy43YzAsMi4xLDEuNywzLjcsMy45LDMuN2MyLjIsMCwzLjktMS43LDMuOS=
0zLjcKCQlDMjk3LjIsMTA5LjMsMjk1LjUsMTA3LjYsMjkzLjMsMTA3LjYiLz4KCTxwYXRoIGNsY=
XNzPSJzdDIiIGQ9Ik0yNTAsMTA3LjZjLTIuMiwwLTMuOSwxLjctMy45LDMuN2MwLDIuMSwxLjcs=
My43LDMuOSwzLjdjMi4yLDAsMy45LTEuNywzLjktMy43CgkJQzI1My45LDEwOS4zLDI1Mi4yLDE=
wNy42LDI1MCwxMDcuNiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIzNi41LDkxLjNjMS43LD=
AuNiwzLjgsMC4zLDMuOCwwLjNzMC43LTIuOS0wLjktNC4zYy0xLjYtMS40LTMtMi40LTMuOS0zL=
jNjLTAuOS0wLjktMS4yLTEuMi0xLjItMS4yCgkJczAsMi41LTAuMSw0QzIzNC4xLDg4LjQsMjM0=
LjksOTAuNywyMzYuNSw5MS4zIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjQwLDkzLjNjLTA=
uNywwLTEuMiwwLjUtMS4yLDEuMWMwLDAuNiwwLjUsMS4xLDEuMiwxLjFjMC43LDAsMS4yLTAuNS=
wxLjItMS4xCgkJQzI0MS4xLDkzLjgsMjQwLjYsOTMuMywyNDAsOTMuMyIvPgoJPHBhdGggY2xhc=
3M9InN0MiIgZD0iTTIzMS4xLDkzLjJjLTAuNSwwLjctMS42LDEuOC0xLjYsMS44czEuMywwLDIu=
NCwwLjhjMS4xLDAuOCwyLjUsMS40LDMuNywxLjNjMS4zLTAuMiwxLjgtMS40LDEuNS0yLjIKCQl=
jLTAuMy0wLjgtMC45LTEuNy0zLTIuNUMyMzIuMiw5MS42LDIzMS42LDkyLjUsMjMxLjEsOTMuMi=
IvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIzNS43LDEwMC44Yy00LjEsMC40LTkuNC00LjEtO=
S40LTQuMWMtMC41LDMuNi0yLjcsNS41LTYuMSw2LjJsMC4zLDAuMmMwLDAsMy4yLDEuNiw2Ljks=
Mi4yCgkJYzEuNywwLjMsMy4yLDAsNS0wLjRjMi4yLTAuNCw0LjctMS4xLDYtMS45YzIuNC0xLjU=
sMS43LTUuNCwxLjctNS40UzIzOS43LDEwMC40LDIzNS43LDEwMC44Ii8+Cgk8cGF0aCBjbGFzcz=
0ic3QyIiBkPSJNMjE5LjksOTYuN2MtMS43LTAuNi00LjItMS44LTUuMi0xLjljLTEtMC4xLTIuN=
i0wLjMtMi4zLDEuNmMwLjMsMS45LDIuMiwyLjksNC4yLDIuOQoJCWMxLjksMC4xLDIuOS0wLjcs=
NC4xLTEuM0MyMjEuNyw5Ny41LDIyMS41LDk3LjMsMjE5LjksOTYuNyIvPgoJPHBhdGggY2xhc3M=
9InN0MiIgZD0iTTIwNy4yLDg5LjhjLTEuOC0xLjMtMy40LTEuNy0zLjQtMS43cy0xLjIsMy4xLT=
AuNSw1LjFjMC43LDEuOSwyLjEsMi40LDMuOCwyLjRjMS43LDAsNC4zLTAuOSwzLjUtMi4yCgkJQ=
zIwOS44LDkyLDIwOSw5MS4xLDIwNy4yLDg5LjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0y=
MDguOCw5Ny42YzAuOCwwLDEuNCwwLjUsMS40LDFzLTAuNiwxLTEuNCwxcy0xLjQtMC41LTEuNC0=
xUzIwOC4xLDk3LjYsMjA4LjgsOTcuNiIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTIxMi43LD=
gzYy0xLjEtNS4zLTAuOS0xMS4xLDQuMS0xOC41YzUuMS03LjQsMTMuOS0xMC40LDEzLjktMTAuN=
HMwLjMtMC42LDMuMS0zLjZjMi44LTMsOC41LTYuNyw4LjUtNi43CgkJcy02LjYsMS42LTEwLjQs=
Mi44YzAsMC4xLDAsMC4xLDAsMC4yYzAsMi42LTIsNC42LTQuNSw0LjZjLTEsMC0xLjktMC4zLTI=
uNi0wLjhjLTIsMC40LTguOSw0LjUtMTAuNiw1LjljMC40LDAuNywwLjcsMS41LDAuNywyLjQKCQ=
ljMCwyLjYtMiw0LjYtNC41LDQuNmMtMC44LDAtMS41LTAuMi0yLjEtMC41Yy0wLjIsMC4zLTAuN=
CwwLjctMC42LDFjLTEuNCwyLjYtMi41LDUuMS0zLjMsNy41YzEuMiwwLjgsMS45LDIuMywxLjks=
NAoJCWMwLDIuNS0xLjcsNC42LTMuOSw0LjZjLTAuMSwxLjUtMC4xLDIuNS0wLjEsM2MwLjIsMS4=
1LDAuNywyLjQsMy40LDMuMmMyLjYsMC44LDYuMiw1LjMsNi4yLDUuM0MyMTIuMiw5MS43LDIxNC=
4xLDg4LjQsMjEyLjcsODMiCgkJLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yMjguOCw0OC44Y=
zEtMC44LDEuMS0yLDAuNC0yLjZjLTAuOC0wLjctMi4xLTAuNi0zLjEsMC4yYy0xLDAuOC0xLjEs=
Mi0wLjQsMi43CgkJQzIyNi41LDQ5LjcsMjI3LjksNDkuNiwyMjguOCw0OC44Ii8+Cgk8cGF0aCB=
jbGFzcz0ic3QyIiBkPSJNMjExLjksNjAuM2MxLjEtMSwxLjMtMi41LDAuNC0zLjNjLTAuOS0wLj=
ktMi40LTAuOC0zLjUsMC4yYy0xLjEsMS0xLjMsMi41LTAuNCwzLjMKCQlDMjA5LjIsNjEuNCwyM=
TAuOCw2MS4zLDIxMS45LDYwLjMiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yMDQuNCw3NC43=
YzAtMS40LTEuMi0yLjYtMi42LTIuNmMtMS40LDAtMi42LDEuMi0yLjYsMi42YzAsMS40LDEuMiw=
yLjYsMi42LDIuNgoJCUMyMDMuMiw3Ny4zLDIwNC40LDc2LjIsMjA0LjQsNzQuNyIvPgoJPHBhdG=
ggY2xhc3M9InN0MiIgZD0iTTI1OC4zLDM4LjNjLTEuNCwwLjMtMy45LDEuMS03LjYsMy4xaDAuM=
WMyLjYsMCw0LjcsMS43LDQuNywzLjhjMCwyLjItMi40LDQuNS01LDQuNWMtMi42LDAtNC40LTIu=
My00LjQtNC40CgkJYzAtMC41LDAuMS0xLDAuMy0xLjVjLTEuMSwwLjctMi4zLDEuNS0zLjYsMi4=
zYy04LjMsNS42LTEwLjMsOC4zLTE0LjQsMTZjLTQuMSw3LjctNS42LDE2LjEtMy44LDIxLjFjMS=
44LDUsOC4zLDYsOC40LDYKCQljMC4xLDAtMC43LTAuNy0wLjgtMS43Yy0wLjEtMC45LDAuMi0xL=
jQsMC41LTMuM2MwLjMtMS45LDAuMS00LjEsMC4xLTQuMXMxLjUtMC4yLDIuMywwLjhjMC44LDEs=
Mi4xLDIuMiwyLjksMy4zCgkJYzAuOCwxLDMuMSwzLDMuMSwzczEuMy0xLjksMS4zLTQuMWMwLTI=
uMi0xLjUtNC43LTEuOC04LjZjLTAuMy0zLjksMS44LTExLDUuNi0xNi4xYzMuOC01LjIsMTEuMS=
05LjgsMTMuMi0xMC45CgkJYzIuMi0xLDIuNS0yLjYsMi42LTMuNmMwLjEtMC45LDAuMy0xLjYsM=
C41LTMuOUMyNjIuNiwzNy44LDI2MC41LDM3LjksMjU4LjMsMzguMyIvPgoJPHBhdGggY2xhc3M9=
InN0MiIgZD0iTTI1MCw0Ny4yYzEuNSwwLDIuOC0xLjMsMi44LTIuNWMwLTEuMi0xLjEtMi4yLTI=
uNi0yLjJzLTIuNywxLTIuNywyLjJDMjQ3LjYsNDYsMjQ4LjYsNDcuMiwyNTAsNDcuMiIvPgoJPH=
BhdGggY2xhc3M9InN0MiIgZD0iTTI2Mi40LDk2LjJjMiwwLjgsNC4zLDAuNCw1LjMtMC40YzEuM=
S0wLjcsMS40LTIuNSwwLjItMy42Yy0xLjMtMS0zLjEtMS00LjMtMC40Yy0xLjIsMC43LTMuOCwy=
LjUtMy44LDIuNQoJCVMyNjAuNCw5NS40LDI2Mi40LDk2LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDI=
iIGQ9Ik0yNjguOSw5OC41Yy0wLjcsMS4xLTEuMywxLjgtMy41LDEuOWMtMi4yLDAuMS00LjcsMC=
02LjEtMS41Yy0xLjUtMS41LTIuNS0zLjUtMi41LTMuNWwtMi41LDAKCQljMCwwLTAuOCwzLjUtM=
S45LDQuNWMtMS4xLDEtNSwxLjEtNi43LTAuMWMtMS43LTEuMy0zLjItMi44LTMuNS0yLjZjLTAu=
MywwLjIsMCwxLjUsMS43LDNjMS43LDEuNSwzLDIuNCw1LjgsMi40aDE2CgkJYzAsMCwzLjIsMC4=
yLDQuMi0xLjhjMC45LTEuOSwxLTMuMiwwLjUtMy42QzI2OS45LDk2LjUsMjY5LjYsOTcuNCwyNj=
guOSw5OC41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjQ0LjYsOTUuOGMyLjQsMS4zLDMuN=
ywwLjUsNC42LTAuNmMwLjktMS4xLDEtMS42LDEtMS42cy0yLjMtMC44LTMuNC0xLjVjLTEuMS0w=
LjYtMS44LTEuMy0yLjktMS4xCgkJYy0xLjEsMC4xLTEuMywwLjMtMS4zLDAuM1MyNDIuMiw5NC4=
0LDI0NC42LDk1LjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNzUuNCw5Mi4zYy0xLjMsMS=
0wLjksMi45LDAuMiwzLjZjMS4xLDAuNywzLjMsMS4yLDUuNCwwLjRjMi0wLjgsMi42LTEuOCwyL=
jYtMS44cy0yLjYtMS44LTMuOC0yLjUKCQlDMjc4LjYsOTEuMywyNzYuNyw5MS4yLDI3NS40LDky=
LjMiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yOTcuNyw5OS42Yy0xLjcsMS4zLTUuNiwxLjE=
tNi43LDAuMWMtMS4xLTEtMS45LTQuNS0xLjktNC41bC0yLjUsMGMwLDAtMSwyLTIuNSwzLjUKCQ=
ljLTEuNSwxLjUtMy45LDEuNi02LjEsMS41Yy0yLjItMC4xLTIuOC0wLjgtMy41LTEuOWMtMC43L=
TEuMS0xLTEuOS0xLjUtMS41Yy0wLjQsMC41LTAuNCwxLjcsMC41LDMuNmMwLjksMS45LDQuMiwx=
LjgsNC4yLDEuOGgxNgoJCWMyLjgsMCw0LTAuOSw1LjgtMi40YzEuNy0xLjUsMi0yLjgsMS43LTN=
DMzAxLDk2LjgsMjk5LjQsOTguNCwyOTcuNyw5OS42Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPS=
JNMjk2LjYsOTIuMmMtMS4xLDAuNi0zLjQsMS41LTMuNCwxLjVzMC4yLDAuNSwxLDEuNmMwLjksM=
S4xLDIuMiwxLjksNC42LDAuNmMyLjQtMS4zLDEuOS00LjQsMS45LTQuNAoJCXMtMC4yLTAuMi0x=
LjMtMC4zQzI5OC40LDkwLjksMjk3LjcsOTEuNSwyOTYuNiw5Mi4yIi8+Cgk8cGF0aCBjbGFzcz0=
ic3QyIiBkPSJNMzA5LjIsODYuOGMtMC4xLTEuNi0wLjEtNC0wLjEtNHMtMC4yLDAuMy0xLjIsMS=
4yYy0wLjksMC45LTIuNCwxLjktMy45LDMuM2MtMS42LDEuNC0wLjksNC4zLTAuOSw0LjMKCQlzM=
i4yLDAuMywzLjgtMC4zQzMwOC41LDkwLjcsMzA5LjMsODguNCwzMDkuMiw4Ni44Ii8+Cgk8cGF0=
aCBjbGFzcz0ic3QyIiBkPSJNMzA0LjYsOTQuNGMwLTAuNi0wLjUtMS4xLTEuMi0xLjFjLTAuNyw=
wLTEuMiwwLjUtMS4yLDEuMWMwLDAuNiwwLjUsMS4xLDEuMiwxLjEKCQlDMzA0LjEsOTUuNSwzMD=
QuNiw5NSwzMDQuNiw5NC40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzA3LjcsOTcuMWMxL=
jMsMC4yLDIuNy0wLjUsMy43LTEuM2MxLjEtMC44LDIuNC0wLjgsMi40LTAuOHMtMS4xLTEuMS0x=
LjYtMS44Yy0wLjUtMC43LTEtMS42LTMuMS0wLjgKCQljLTIuMSwwLjgtMi43LDEuNy0zLDIuNUM=
zMDUuOSw5NS44LDMwNi40LDk3LDMwNy43LDk3LjEiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik=
0zMTcuMSw5Ni42YzAsMC01LjQsNC41LTkuNCw0LjFjLTQuMS0wLjQtNC40LTMuMy00LjQtMy4zc=
y0wLjcsMy45LDEuNyw1LjRjMS4zLDAuOCwzLjgsMS40LDYsMS45CgkJYzEuOCwwLjQsMy4zLDAu=
Nyw1LDAuNGMzLjctMC42LDYuOS0yLjIsNi45LTIuMmwwLjMtMC4yQzMxOS45LDEwMi4xLDMxNy4=
2LDEwMC4yLDMxNy4xLDk2LjYiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zMjguNyw5NC44Yy=
0xLDAuMS0zLjUsMS4zLTUuMiwxLjljLTEuNywwLjYtMS45LDAuOC0wLjcsMS40YzEuMSwwLjYsM=
i4xLDEuMyw0LjEsMS4zYzEuOS0wLjEsMy45LTEsNC4yLTIuOQoJCUMzMzEuMyw5NC41LDMyOS44=
LDk0LjgsMzI4LjcsOTQuOCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTMzNi4yLDg5LjhjLTE=
uOCwxLjMtMi43LDIuMi0zLjQsMy42Yy0wLjcsMS4zLDEuOCwyLjIsMy41LDIuMmMxLjcsMC4xLD=
MuMS0wLjUsMy44LTIuNAoJCWMwLjctMS45LTAuNS01LjEtMC41LTUuMVMzMzgsODguNSwzMzYuM=
iw4OS44Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzM0LjUsOTcuNmMtMC44LDAtMS40LDAu=
NS0xLjQsMWMwLDAuNiwwLjYsMSwxLjQsMWMwLjgsMCwxLjQtMC41LDEuNC0xQzMzNiw5OCwzMzU=
uMyw5Ny42LDMzNC41LDk3LjYiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zMzcsNzUuNmMwLT=
EuNywwLjgtMy4yLDEuOS00Yy0wLjgtMi4zLTEuOC00LjgtMy4zLTcuNWMtMC4yLTAuMy0wLjQtM=
C43LTAuNi0xYy0wLjYsMC4zLTEuMywwLjUtMi4xLDAuNQoJCWMtMi41LDAtNC41LTIuMS00LjUt=
NC42YzAtMC45LDAuMi0xLjcsMC43LTIuNGMtMS43LTEuNS04LjYtNS41LTEwLjYtNS45Yy0wLjc=
sMC41LTEuNiwwLjgtMi42LDAuOGMtMi41LDAtNC41LTIuMS00LjUtNC42CgkJYzAtMC4xLDAtMC=
4xLDAtMC4yYy0zLjgtMS4yLTEwLjQtMi44LTEwLjQtMi44czUuNywzLjcsOC41LDYuN2MyLjgsM=
ywzLjEsMy42LDMuMSwzLjZzOC44LDMsMTMuOSwxMC40YzUuMSw3LjQsNS4yLDEzLjIsNC4xLDE4=
LjUKCQljLTEuNCw1LjMsMC41LDguNywwLjcsOC43YzAsMCwzLjYtNC42LDYuMi01LjNjMi42LTA=
uOCwzLjItMS43LDMuNC0zLjJjMC4xLTAuNCwwLjEtMS41LTAuMS0zQzMzOC44LDgwLjIsMzM3LD=
c4LjEsMzM3LDc1LjYiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0zMTQuNiw0OC44YzEsMC44L=
DIuMywwLjksMy4xLDAuMmMwLjgtMC43LDAuNi0xLjktMC40LTIuN2MtMS0wLjgtMi4zLTAuOS0z=
LjEtMC4yCgkJQzMxMy40LDQ2LjksMzEzLjYsNDguMSwzMTQuNiw0OC44Ii8+Cgk8cGF0aCBjbGF=
zcz0ic3QyIiBkPSJNMzMxLjUsNjAuM2MxLjEsMSwyLjYsMS4xLDMuNSwwLjJjMC45LTAuOSwwLj=
ctMi4zLTAuNC0zLjNjLTEuMS0xLTIuNi0xLjEtMy41LTAuMgoJCUMzMzAuMyw1Ny45LDMzMC40L=
DU5LjMsMzMxLjUsNjAuMyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTM0MS42LDcyLjJjLTEu=
NCwwLTIuNiwxLjItMi42LDIuNmMwLDEuNCwxLjIsMi42LDIuNiwyLjZjMS40LDAsMi42LTEuMiw=
yLjYtMi42CgkJQzM0NC4zLDczLjMsMzQzLjEsNzIuMiwzNDEuNiw3Mi4yIi8+Cgk8cGF0aCBjbG=
Fzcz0ic3QyIiBkPSJNMjgxLjQsNDQuMWMwLjEsMC45LDAuNSwyLjUsMi42LDMuNmMyLjIsMSw5L=
jQsNS43LDEzLjIsMTAuOWMzLjgsNS4yLDUuOSwxMi4yLDUuNiwxNi4xCgkJYy0wLjMsMy45LTEu=
OCw2LjQtMS44LDguNmMwLDIuMiwxLjMsNC4xLDEuMyw0LjFzMi4yLTIsMy4xLTNjMC44LTEsMi4=
xLTIuMiwyLjktMy4zYzAuOC0xLDIuMy0wLjgsMi4zLTAuOHMtMC4yLDIuMiwwLjEsNC4xCgkJYz=
AuMywxLjksMC42LDIuMywwLjUsMy4zYy0wLjEsMC45LTAuOSwxLjctMC44LDEuN2MwLjEsMCw2L=
jYtMSw4LjQtNmMxLjgtNSwwLjMtMTMuNC0zLjgtMjEuMWMtNC4xLTcuNy02LjEtMTAuNC0xNC40=
LTE2CgkJYy0xLjMtMC45LTIuNS0xLjYtMy42LTIuM2MwLjIsMC41LDAuMywwLjksMC4zLDEuNWM=
wLDIuMi0xLjgsNC40LTQuNCw0LjRzLTUtMi40LTUtNC41YzAtMi4yLDItMy44LDQuNy0zLjhoMC=
4xCgkJYy0zLjgtMi02LjMtMi44LTcuNi0zLjFjLTIuMi0wLjUtNC4zLTAuNi00LjEsMS44QzI4M=
S4xLDQyLjUsMjgxLjMsNDMuMSwyODEuNCw0NC4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJN=
MjcxLjcsODIuNGMwLDAtMC42LDIuNS0xLjQsMy42Yy0wLjgsMS4xLTEuNCwyLTEuMiwzLjRjMC4=
yLDEuMywxLjcsMi4yLDIuNiwyLjJjMC45LDAsMi40LTAuOSwyLjYtMi4yCgkJYzAuMi0xLjMtMC=
40LTIuMy0xLjItMy40QzI3Mi4zLDg0LjksMjcxLjcsODIuNCwyNzEuNyw4Mi40Ii8+Cgk8cGF0a=
CBjbGFzcz0ic3QyIiBkPSJNMjcxLjcsOTIuOGMtMC43LDAtMS40LDAuNi0xLjQsMS40YzAsMC43=
LDAuNiwxLjQsMS40LDEuNGMwLjgsMCwxLjQtMC42LDEuNC0xLjQKCQlDMjczLjEsOTMuNCwyNzI=
uNSw5Mi44LDI3MS43LDkyLjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNjYuOSw4Ny4yYz=
AsMCwyLjMtMi42LDMuMi00LjNjMC45LTEuNiwxLjYtMy4xLDEuNi0zLjFzMC43LDEuNSwxLjYsM=
y4xYzAuOSwxLjYsMy4yLDQuMywzLjIsNC4zCgkJczMuMy0xLjcsNS4yLTguMWMxLjktNi4zLTAu=
NC0xMy0xLjMtMjAuMmMtMC45LTcuMi0xLjYtMTkuNi0xLjYtMTkuNmMtMi41LDEuNC00LjksMi0=
3LjEsMi4xYy0yLjMsMC00LjYtMC42LTcuMS0yLjEKCQljMCwwLTAuNywxMi40LTEuNiwxOS42Yy=
0wLjksNy4yLTMuMiwxMy45LTEuMywyMC4yQzI2My42LDg1LjQsMjY2LjksODcuMiwyNjYuOSw4N=
y4yIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjkwLjUsNDQuN2MwLDEuMiwxLjMsMi41LDIu=
OCwyLjVjMS41LDAsMi41LTEuMywyLjUtMi41YzAtMS4yLTEuMi0yLjItMi43LTIuMgoJCUMyOTE=
uNyw0Mi41LDI5MC41LDQzLjUsMjkwLjUsNDQuNyIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTT=
IzMi45LDY2LjhjMi45LDAsNS4zLDIuNCw1LjMsNS4zcy0yLjQsNS4zLTUuMyw1LjNzLTUuMy0yL=
jQtNS4zLTUuM1MyMzAsNjYuOCwyMzIuOSw2Ni44Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJN=
MjQyLjIsNTMuOGMtMi4xLTEuNC01LjMtMC45LTcsMS4zYy0xLjcsMi4yLTEuNCw1LjEsMC43LDY=
uNWMyLjEsMS40LDUuMywwLjksNy0xLjMKCQlDMjQ0LjcsNTguMSwyNDQuNCw1NS4yLDI0Mi4yLD=
UzLjgiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yMzIuNyw2OC41Yy0xLjcsMC0zLjEsMS4zL=
TMuMSwzYzAsMS42LDEuNCwzLDMuMSwzYzEuNywwLDMuMS0xLjMsMy4xLTNDMjM1LjgsNjkuOCwy=
MzQuNCw2OC41LDIzMi43LDY4LjUiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik0yNDAsNTQuNGM=
tMS40LTAuNC0zLjEsMC4zLTMuOCwxLjVjLTAuNywxLjIsMCwyLjUsMS45LDIuOUMyNDEuNCw1OS=
40LDI0My4xLDU1LjIsMjQwLDU0LjQiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik0yNzEuNyw2N=
y40Yy0zLjEsMC01LjcsMi41LTUuNyw1LjVjMCwzLDIuNSw1LjUsNS43LDUuNXM1LjctMi41LDUu=
Ny01LjVDMjc3LjQsNjkuOSwyNzQuOCw2Ny40LDI3MS43LDY3LjQiLz4KCTxwYXRoIGNsYXNzPSJ=
zdDAiIGQ9Ik0yNzEuNyw1NC43YzMsMCw1LjUsMi40LDUuNSw1LjNjMCwyLjktMi41LDUuMy01Lj=
UsNS4zYy0zLDAtNS41LTIuNC01LjUtNS4zCgkJQzI2Ni4yLDU3LjEsMjY4LjYsNTQuNywyNzEuN=
yw1NC43Ii8+Cgk8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMjcxLjcsNDIuNmMyLjksMCw1LjIsMi4z=
LDUuMiw1YzAsMi44LTIuMyw1LTUuMiw1cy01LjItMi4zLTUuMi01UzI2OC44LDQyLjYsMjcxLjc=
sNDIuNiIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0iTTMxMC40LDY2LjhjLTMsMC01LjMsMi40LT=
UuMyw1LjNjMCwyLjksMi40LDUuMyw1LjMsNS4zYzIuOSwwLDUuMy0yLjQsNS4zLTUuMwoJCUMzM=
TUuOCw2OS4yLDMxMy40LDY2LjgsMzEwLjQsNjYuOCIvPgoJPHBhdGggY2xhc3M9InN0MCIgZD0i=
TTMwOC4yLDU1LjFjLTEuNy0yLjEtNC45LTIuNy03LTEuM2MtMi4xLDEuNC0yLjUsNC40LTAuNyw=
2LjVjMS43LDIuMSw0LjksMi43LDcsMS4zCgkJQzMwOS42LDYwLjEsMzA5LjksNTcuMiwzMDguMi=
w1NS4xIi8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzEwLjcsNjguNWMtMS43LDAtMy4xLDEuM=
y0zLjEsM2MwLDEuNiwxLjQsMywzLjEsM2MxLjcsMCwzLjEtMS4zLDMuMS0zQzMxMy44LDY5Ljgs=
MzEyLjQsNjguNSwzMTAuNyw2OC41Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMzAzLjQsNTQ=
uNGMtMy4xLDAuOC0xLjUsNS4xLDEuOSw0LjRjMS44LTAuNCwyLjYtMS43LDEuOS0yLjlDMzA2Lj=
UsNTQuNywzMDQuOCw1NCwzMDMuNCw1NC40Ii8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjcxL=
jcsNjljLTEuNywwLTMsMS4zLTMsMi45YzAsMS42LDEuNCwyLjksMywyLjlzMy0xLjMsMy0yLjlD=
Mjc0LjcsNzAuMywyNzMuMyw2OSwyNzEuNyw2OSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTI=
3MS43LDYxLjljMS42LDAsMi45LTEuMywyLjktMi44YzAtMS41LTEuMy0yLjgtMi45LTIuOGMtMS=
42LDAtMi45LDEuMy0yLjksMi44CgkJQzI2OC44LDYwLjYsMjcwLjEsNjEuOSwyNzEuNyw2MS45I=
i8+Cgk8cGF0aCBjbGFzcz0ic3QyIiBkPSJNMjcxLjcsNDkuMmMxLjQsMCwyLjUtMS4xLDIuNS0y=
LjVjMC0xLjQtMS4xLTIuNS0yLjUtMi41Yy0xLjQsMC0yLjUsMS4xLTIuNSwyLjUKCQlDMjY5LjE=
sNDguMSwyNzAuMyw0OS4yLDI3MS43LDQ5LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik00NT=
AuMSw0NDcuMmMtMi42LDAtNC43LDIuMS00LjcsNC43YzAsMi42LDIuMSw0LjcsNC43LDQuN2MyL=
jYsMCw0LjctMi4xLDQuNy00LjcKCQlDNDU0LjgsNDQ5LjMsNDUyLjcsNDQ3LjIsNDUwLjEsNDQ3=
LjIiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik00NjMuMyw0NTAuM2MtMi42LDAtNC44LDIuMi0=
0LjgsNC44YzAsMi42LDIuMiw0LjgsNC44LDQuOGMyLjcsMCw0LjgtMi4xLDQuOC00LjhTNDY1Lj=
ksNDUwLjMsNDYzLjMsNDUwLjMiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik01MDEuNyw0NTguN=
WMtMi43LDAtNC44LDIuMi00LjgsNC44YzAsMi43LDIuMiw0LjgsNC44LDQuOGMyLjYsMCw0Ljgt=
Mi4yLDQuOC00LjgKCQlDNTA2LjUsNDYwLjcsNTA0LjMsNDU4LjUsNTAxLjcsNDU4LjUiLz4KCTx=
wYXRoIGNsYXNzPSJzdDAiIGQ9Ik00NzYuNSw0NTMuNWMtMi43LDAtNC44LDIuMi00LjgsNC44Yz=
AsMi42LDIuMSw0LjgsNC44LDQuOGMyLjYsMCw0LjgtMi4yLDQuOC00LjgKCQlDNDgxLjMsNDU1L=
jYsNDc5LjEsNDUzLjUsNDc2LjUsNDUzLjUiLz4KCTxwYXRoIGNsYXNzPSJzdDAiIGQ9Ik00ODAs=
NDQxLjljLTIuNywwLTQuOCwyLjEtNC44LDQuOGMwLDIuNiwyLjIsNC44LDQuOCw0LjhjMi42LDA=
sNC44LTIuMiw0LjgtNC44CgkJQzQ4NC44LDQ0NC4xLDQ4Mi42LDQ0MS45LDQ4MCw0NDEuOSIvPg=
oJPHBhdGggY2xhc3M9InN0MCIgZD0iTTQ4My4zLDQzMC40Yy0yLjYsMC00LjgsMi4yLTQuOCw0L=
jhjMCwyLjcsMi4yLDQuOCw0LjgsNC44YzIuNywwLDQuOC0yLjIsNC44LTQuOAoJCUM0ODguMSw0=
MzIuNiw0ODYsNDMwLjQsNDgzLjMsNDMwLjQiLz4KCTxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik00NTA=
uNCw0NDkuMWMxLjMsMCwyLjMsMSwyLjMsMi4zYzAsMS4zLTEsMi4zLTIuMywyLjNjLTEuMywwLT=
IuMy0xLTIuMy0yLjMKCQlDNDQ4LjEsNDUwLjEsNDQ5LjEsNDQ5LjEsNDUwLjQsNDQ5LjEiLz4KC=
TxwYXRoIGNsYXNzPSJzdDIiIGQ9Ik00NjMuNiw0NTIuM2MtMS4zLDAtMi40LDEuMS0yLjQsMi40=
YzAsMS4zLDEuMSwyLjQsMi40LDIuNGMxLjMsMCwyLjQtMS4xLDIuNC0yLjQKCQlDNDY2LDQ1My4=
zLDQ2NSw0NTIuMyw0NjMuNiw0NTIuMyIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTUwMi4xLD=
Q2MC40Yy0xLjMsMC0yLjQsMS4xLTIuNCwyLjRjMCwxLjMsMS4xLDIuNCwyLjQsMi40YzEuMywwL=
DIuNC0xLjEsMi40LTIuNAoJCUM1MDQuNCw0NjEuNSw1MDMuNCw0NjAuNCw1MDIuMSw0NjAuNCIv=
PgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ3Ni44LDQ1NS40Yy0xLjMsMC0yLjQsMS4xLTIuNCw=
yLjRjMCwxLjMsMS4xLDIuNCwyLjQsMi40YzEuMywwLDIuNC0xLjEsMi40LTIuNAoJCUM0NzkuMy=
w0NTYuNSw0NzguMiw0NTUuNCw0NzYuOCw0NTUuNCIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iT=
TQ4MC4zLDQ0My45Yy0xLjMsMC0yLjQsMS4xLTIuNCwyLjRjMCwxLjMsMS4xLDIuNCwyLjQsMi40=
YzEuMywwLDIuNC0xLjEsMi40LTIuNAoJCUM0ODIuNyw0NDQuOSw0ODEuNyw0NDMuOSw0ODAuMyw=
0NDMuOSIvPgoJPHBhdGggY2xhc3M9InN0MiIgZD0iTTQ4My43LDQzMi4zYy0xLjMsMC0yLjQsMS=
4xLTIuNCwyLjRjMCwxLjMsMS4xLDIuNCwyLjQsMi40YzEuMywwLDIuNC0xLjEsMi40LTIuNAoJC=
UM0ODYuMSw0MzMuNCw0ODUsNDMyLjMsNDgzLjcsNDMyLjMiLz4KPC9nPgo8L3N2Zz4K"); }

.flag-list .no a::before { background-image: url("data:image/svg+xml;base64=
,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB4bWxucz0iaHR0cD=
ovL3d3dy53My5vcmcvMjAwMC9zdmciIHZlcnNpb249IjEuMSIgdmlld0JveD0iMCAwIDIyIDE2I=
j4KCTx0aXRsZT5GbGFnIG9mIE5vcndheTwvdGl0bGU+Cgk8cmVjdCB3aWR0aD0iMjIiIGhlaWdo=
dD0iMTYiIGZpbGw9IiNiYTBjMmYiLz4KCTxwYXRoIGQ9Ik0wLDhoMjJNOCwwdjE2IiBzdHJva2U=
9IiNmZmYiIHN0cm9rZS13aWR0aD0iNCIvPgoJPHBhdGggZD0iTTAsOGgyMk04LDB2MTYiIHN0cm=
9rZT0iIzAwMjA1YiIgc3Ryb2tlLXdpZHRoPSIyIi8+Cjwvc3ZnPg=3D=3D"); }

.flag-list .si a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB3aWR0aD0iMTIwMCIgaGVpZ2h0PSI2MDAiIHZpZXdCb3g9IjAgMCAyNDAgMTIwIiBmaW=
xsPSIjMDBmIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayIgeG1sb=
nM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4NCiAgPHBhdGggZD0iTTAgMGgyNDB2MTIw=
SDBaIiBmaWxsPSJyZWQiLz4NCiAgPHBhdGggZD0iTTAgMGgyNDB2ODBIMFoiLz4NCiAgPHBhdGg=
gZD0iTTAgMGgyNDB2NDBIMFoiIGZpbGw9IiNmZmYiLz4NCiAgPGcgdHJhbnNmb3JtPSJtYXRyaX=
goLjM5MTQwNjg4IDAgMCAuMzkxNDA2ODggNjAgNjApIj4NCiAgICA8cGF0aCBkPSJNLTM3LjE3N=
TM0Mi05NC4zNjgyMDVhOTIuMTk1NDQ1IDkyLjE5NTQ0NSAwIDAgMSA3NC4zNTA2ODQgMFE0My0x=
MiAwLTFxLTQzLTExLTM3LjE3NTM0Mi05My4zNjgyMDVaIi8+DQogICAgPHBhdGggaWQ9ImEiIGQ=
9Im0wLTg0LjUgMS4xMjUgMi41NTE0NDNMMy44OTcxMTQtODIuMjUgMi4yNS04MGwxLjY0NzExNC=
AyLjI1TDEuMTI1LTc4LjA1MTQ0MyAwLTc1LjVsLTEuMTI1LTIuNTUxNDQzLTIuNzcyMTE0LjMwM=
TQ0M0wtMi4yNS04MGwtMS42NDcxMTQtMi4yNSAyLjc3MjExNC4zMDE0NDMiIGZpbGw9IiNmZjAi=
Lz4NCiAgICA8dXNlIHhsaW5rOmhyZWY9IiNhIiB4PSItMTAuNSIgeT0iLTE0Ii8+DQogICAgPHV=
zZSB4bGluazpocmVmPSIjYSIgeD0iMTAuNSIgeT0iLTE0Ii8+DQogICAgPHBhdGggZD0ibTAtNz=
AgOSAxOCA2LTggMTUgMjBhMTAgMTAgMCAwIDEtLjM4NDc2MSAyLjc0NzIxMUE0Ni40MDA1NDkgN=
DYuNDAwNTQ5IDAgMCAxIDAtNi4wOTA4NzhhNDYuNDAwNTQ5IDQ2LjQwMDU0OSAwIDAgMS0yOS42=
MTUyMzktMzEuMTYxOTExQTEwIDEwIDAgMCAxLTMwLTQwbDE1LTIwIDYgOHoiIGZpbGw9IiNmZmY=
iLz4NCiAgICA8cGF0aCBpZD0iYiIgZD0iTS0yOS42MTUyMzktMzcuMjUyNzg5QTEwIDEwIDAgMC=
AwLTE1LTMxLjMzOTc0NmExMCAxMCAwIDAgMSAxMCAwIDEwIDEwIDAgMCAwIDEwIDAgMTAgMTAgM=
CAwIDEgMTAgMCAxMCAxMCAwIDAgMCAxNC42MTUyMzktNS45MTMwNDNMMzAtMzcuMTEzMjQ5djcu=
MzIwNTA4YTEwIDEwIDAgMCAwLTUgMS4zMzk3NDYgMTAgMTAgMCAwIDEtMTAgMCAxMCAxMCAwIDA=
gMC0xMCAwIDEwIDEwIDAgMCAxLTEwIDAgMTAgMTAgMCAwIDAtMTAgMCAxMCAxMCAwIDAgMS0xMC=
AwIDEwIDEwIDAgMCAwLTUtMS4zMzk3NDZ2LTcuMzIwNTA4Ii8+DQogICAgPHVzZSB4bGluazpoc=
mVmPSIjYiIgeT0iNS43NzM1MDI4Ii8+DQogICAgPHBhdGggZD0iTS00MC05My4wNjYyMzlhOTIu=
MTk1NDQ1IDkyLjE5NTQ0NSAwIDAgMSAyLjgyNDY1OC0xLjMwMTk2NmwyLjk3MDY0IDQ3LjQ0ODc=
3OEE0OS4zMDEwNDEgNDkuMzAxMDQxIDAgMCAwIDAtMy4wMzYyNjJhNDkuMzAxMDQxIDQ5LjMwMT=
A0MSAwIDAgMCAzNC4yMDQ3MDItNDMuODgzMTY0bDIuOTcwNjQtNDcuNDQ4Nzc4QTkyLjE5NTQ0N=
SA5Mi4xOTU0NDUgMCAwIDEgNDAtOTMuMDY2MjM5TDM3LjA5OTUyNi00Ni43MzgxOUE1Mi4yMDE1=
MzMgNTIuMjAxNTMzIDAgMCAxIDAgMGE1Mi4yMDE1MzMgNTIuMjAxNTMzIDAgMCAxLTM3LjA5OTU=
yNi00Ni43MzgxODlaIiBmaWxsPSJyZWQiLz4NCiAgPC9nPg0KPC9zdmc+"); }

.flag-list .tr a::before { background-color: rgb(227, 10, 23); background-i=
mage: url("data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcm=
cvMjAwMC9zdmciIHdpZHRoPSIxMjAwIiBoZWlnaHQ9IjgwMCIgdmlld0JveD0iMCAtMzAwMDAgO=
TAwMDAgNjAwMDAiPgoJPHRpdGxlPkZsYWcgb2YgVHVya2V5PC90aXRsZT4KCTxwYXRoIGZpbGw9=
IiNlMzBhMTciIGQ9Im0wLTMwMDAwaDkwMDAwdjYwMDAwSDB6Ii8+Cgk8cGF0aCBmaWxsPSIjZmZ=
mIiBkPSJtNDE3NTAgMCAxMzU2OC00NDA4LTgzODYgMTE1NDFWLTcxMzNsODM4NiAxMTU0MXptOT=
I1IDgwMjFhMTUwMDAgMTUwMDAgMCAxIDEgMC0xNjA0MiAxMjAwMCAxMjAwMCAwIDEgMCAwIDE2M=
DQyeiIvPgo8L3N2Zz4K"); }

.flag-list .gr a::before { background-size: auto 100%; background-position:=
 left top; background-image: url("data:image/svg+xml;base64,PD94bWwgdmVyc2l=
vbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KPCEtLSBHZW5lcmF0b3I6IEFkb2JlIElsbHVzdH=
JhdG9yIDI4LjAuMCwgU1ZHIEV4cG9ydCBQbHVnLUluIC4gU1ZHIFZlcnNpb246IDYuMDAgQnVpb=
GQgMCkgIC0tPgo8c3ZnIHZlcnNpb249IjEuMSIgaWQ9IkxhYWdfMSIgeG1sbnM9Imh0dHA6Ly93=
d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS9=
4bGluayIgeD0iMHB4IiB5PSIwcHgiCgkgdmlld0JveD0iMCAwIDgxMCA0MDAiIHN0eWxlPSJlbm=
FibGUtYmFja2dyb3VuZDpuZXcgMCAwIDgxMCA0MDA7IiB4bWw6c3BhY2U9InByZXNlcnZlIj4KP=
HN0eWxlIHR5cGU9InRleHQvY3NzIj4KCS5zdDB7ZmlsbDojMEQ1RUFGO30KCS5zdDF7ZmlsbDpu=
b25lO3N0cm9rZTojRkZGRkZGO3N0cm9rZS13aWR0aDo0NC40NDQ0O3N0cm9rZS1taXRlcmxpbWl=
0Ojg4Ljg4ODk7fQo8L3N0eWxlPgo8cmVjdCBjbGFzcz0ic3QwIiB3aWR0aD0iODEwIiBoZWlnaH=
Q9IjQwMCIvPgo8cGF0aCBjbGFzcz0ic3QxIiBkPSJNMTExLjEsMHYyNDQuNCBNMCwxMTEuMWgyM=
jIuMiBNMjIyLjIsNjYuN0g4MTAgTTIyMi4yLDE1NS42SDgxMCBNMCwyNDQuNGg4MTAgTTAsMzMz=
LjNoODEwIi8+Cjwvc3ZnPgo=3D"); }

.flag-list .il a::before { background-color: rgb(255, 255, 255); background=
-size: cover; background-image: url("data:image/svg+xml;base64,PD94bWwgdmVy=
c2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KPCEtLSBHZW5lcmF0b3I6IEFkb2JlIElsbHV=
zdHJhdG9yIDI4LjAuMCwgU1ZHIEV4cG9ydCBQbHVnLUluIC4gU1ZHIFZlcnNpb246IDYuMDAgQn=
VpbGQgMCkgIC0tPgo8c3ZnIHZlcnNpb249IjEuMCIgaWQ9IkxhYWdfMSIgeG1sbnM9Imh0dHA6L=
y93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5=
OS94bGluayIgeD0iMHB4IiB5PSIwcHgiCgkgdmlld0JveD0iMCAwIDE0MDAgODAwIiBzdHlsZT0=
iZW5hYmxlLWJhY2tncm91bmQ6bmV3IDAgMCAxNDAwIDgwMDsiIHhtbDpzcGFjZT0icHJlc2Vydm=
UiPgo8c3R5bGUgdHlwZT0idGV4dC9jc3MiPgoJLnN0MHtmaWxsOiNGRkZGRkY7fQoJLnN0MXtma=
WxsOiMwMDM4Qjg7fQo8L3N0eWxlPgo8cGF0aCBjbGFzcz0ic3QwIiBkPSJNMCwwaDE0MDB2ODAw=
SDBWMHoiLz4KPHBhdGggY2xhc3M9InN0MSIgZD0iTTAsNzVoMTQwMHYxMjVIMFY3NXoiLz4KPHB=
hdGggY2xhc3M9InN0MSIgZD0iTTAsNjAwaDE0MDB2MTI1SDBWNjAweiIvPgo8cGF0aCBjbGFzcz=
0ic3QxIiBkPSJNNzAwLDU3My4ybC01MC04Ni42SDU1MGw1MC04Ni42bC01MC04Ni42aDEwMGw1M=
C04Ni42bDUwLDg2LjZoMTAwTDgwMCw0MDBsNTAsODYuNkg3NTBMNzAwLDU3My4yegoJIE02ODEu=
OCw0ODYuNmwxOC4yLDMxLjZsMTguMi0zMS42SDY4MS44eiBNNzY1LjksNDU5LjFoMzYuNWwtMTg=
uMi0zMS42TDc2NS45LDQ1OS4xeiBNNjY1LjksNDU5LjFoNjguMmwzNC4xLTU5LjFsLTM0LjEtNT=
kuMWgtNjguMgoJTDYzMS44LDQwMEw2NjUuOSw0NTkuMXogTTU5Ny42LDQ1OS4xaDM2LjVsLTE4L=
jItMzEuNkw1OTcuNiw0NTkuMXogTTc2NS45LDM0MC45bDE4LjIsMzEuNmwxOC4yLTMxLjZINzY1=
Ljl6IE01OTcuNiwzNDAuOQoJbDE4LjIsMzEuNmwxOC4yLTMxLjZINTk3LjZ6IE02ODEuOCwzMTM=
uNGgzNi41TDcwMCwyODEuOEw2ODEuOCwzMTMuNHoiLz4KPC9zdmc+Cg=3D=3D"); }

.flag-list .ad a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMD=
AwIDcwMCIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiPg0KPHBhd=
GggZmlsbD0iIzAwMThhOCIgZD0ibTAsMCAwLDcwMCAzMjAsMCAwLTcwMC0zMjAsMHoiLz4NCjxw=
YXRoIGZpbGw9IiNkMDEwM2EiIGQ9Im02ODAsMCAwLDcwMCAzMjAsMCAwLTcwMC0zMjAsMHoiLz4=
NCjxwYXRoIGZpbGw9IiNmZWRmMDAiIGQ9Im0zMjAsMGgzNjB2NzAwaC0zNjB6Ii8+DQo8ZyBmaW=
xsPSJub25lIiBzdHJva2UtbGluZWNhcD0icm91bmQiIHN0cm9rZS13aWR0aD0iLjk4NyIgc3Ryb=
2tlLW1pdGVybGltaXQ9IjMuODY0Ij4NCjxwYXRoIHN0cm9rZT0iIzIzMWYyMCIgZD0ibTUxNy44=
MDI3LDIyOS44MjI3Yy0uNjktLjM4NjQtMS4zNTA0LS43NTU4LTEuOTgwNS0xLjEwMTktMS42NDg=
xLS45MDU2LTMuNDA3OC0uNzIwNy00LjI2MDQsLjMxMDktLjk2MjksMS4xNjQ0LTEuMzAzNCwzLj=
E0ODkgLjAzMjcsNC4zODE5Ii8+DQo8cGF0aCBzdHJva2U9IiNjN2IzN2YiIGQ9Im0zOTkuMDYyN=
SwzNzkuOTgyMWMtLjM4MSwuODk0LS42MDMsMS4xOS0xLjAwMjksMS45NDM2LS40MjEsLjc5MzUt=
LjY1MDYsMS4yNDYzLTEuMTA0MiwyLjAyMTYtLjQ0MjEsLjc1NTgtLjcwMjksMS4xNzY1LTEuMTg=
5NSwxLjkwNDUtLjY1NjgsLjk4MzUtMS4wOTA3LDEuNDk0LTEuNzg4LDIuNDQ5Ii8+DQo8L2c+DQ=
o8cGF0aCBmaWxsPSIjYzdiMzdmIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGQ9Im00NjkuMzczMywxO=
DguNDc3MmMxMi4wNTA3LDAgMTYuOTc4OCwxMC4zMzc4IDI5LjAyOTUsMTAuMzM3OCA3LjQzOTEs=
MCAxMS43NzY2LTIuNDI5MyAxOC4yNjExLTYuMDg3IDQuNTIzNS0yLjU2MTggNy40MDk4LTMuOTI=
3MiAxMi42MDQ3LTMuOTI3MiA1LjMxODgsMCA4LjU3OTksMS42MDggMTEuMzAxLDYuMTY2OSAxLj=
UzNzMsMi41Nzk2IDIuODE0LDcuNjI4MiAyLjEzNzgsMTAuNTI0OS0xLjI4MTUsNS40OTM1LTIuM=
DcxMSw3Ljg4MTQtNC4yNjIxLDEyLjk1MjYtMS4wNDI2LDIuNDM4My0yLjAyNzgsMy44OTc5LTIu=
MDI3OCw2LjU2NjEgMCw2LjM5NjMgOC43MDQsOC41OTM3IDE0LjYyMjEsOC42ODUyIDEuMjg5OSw=
uMDIgMTIuMTM4NywuMTk4MSAxOC44MTQ5LTYuNTYwOS0zLjYyMjItLjE1OTQtNy42NzU0LTIuOT=
Y0Mi03LjY3NTQtNi41ODY3IDAtNC4wOTkyIDIuODgwNC02Ljg3MzUgNi43ODU0LTguMDU3MyAuN=
zQyLS4yMTE5IDIuMDA1OCwuNDQzMiAyLjY3NzUsLjA5IC45NTM5LS40OTQ3IC41MDc3LTEuNTY4=
NSAxLjM1NTgtMi4yNCAxLjk0MzYtMS41NTQ3IDMuMjA3MS0yLjUyNTMgNS42OTg2LTIuNTI1MyA=
xLjYyNTQsMCAyLjU3NzksLjIyOTEgMy44ODUzLDEuMTY1NiAuNjg5MSwuNDk0NyAuOTQyNywxLj=
EwNyAxLjc5MDgsMS4xMDcgMS43ODQ2LDAgMi42NjgyLTEuMTMwOSA0LjQ1MjktMS4xMzA5IDEuN=
DQ4OSwwIDIuMzMyNSwuMTk0NSAzLjYwNDQsLjg0ODEgMS4wNjAzLC41NDc5IDEuMDM2NywyLjM0=
ODkgMi4yMzgyLDIuMzQ4OSAuNjAwOCwwIDMuNzc4Ni0xLjI5NTMgNS40Mzk1LTEuMjk1MyAzLjQ=
0NTcsMCA1LjI4NTMsMS4yNDc0IDcuNTExNywzLjg2MjUgLjYwMTEsLjcwNjggLjk4NTIsMi4xMz=
Y5IDEuNTk2MSwyLjEzNjkgMS4yMzAzLDAgNC4wNjUxLC43OTI0IDUuODMyLDIuNTU5NCAuNzU5O=
CwuNzU5NyAxLjA5NjYsMS4xMTk0IDEuNjc5NywyLjAzODEgLjQwNjYsLjY1NCAxLjAyOTksMi4y=
NDkzIDEuNzQ4MywyLjUyNTYgLjg0MTksLjMyMzkgMS41NDgsLjI2MTcgMi42NTUsLjk3MTQgMi4=
1MjU2LDEuNjE4OSA0LjQ2ODQsNC42NjIyIDQuMzc3NCw3LjYxMS0uMDMwNCwuOTg4OC0uNDgxOC=
wyLjM2NzctLjc1MSwzLjMwOTYtMi45NDA5LDEwLjI4NDMtOS45Mzk5LDEzLjU0NzctMTcuMDA3O=
CwyMi4zODI1LTMuMDA0LDMuNzYzNy01LjM3NDcsNi43NjczLTUuMzc0NywxMS41OTExIDAsMS4x=
NjY0IDEuNDM2LDMuMzAxOSAyLjA3MjIsNC4yNzM5LS4zODg2LTIuMjY2NCAuNjQ3NS01LjA1MDg=
gMy4wNDMzLTUuMTgwMyAzLjI4Mi0uMTc3NiA1LjgxNjgsMi4zMTc2IDYuMjU4Niw1LjU2ODkgLj=
A4ODIsLjc1OTgtLjE5NDUsMi4wNzIzLS41MTgxLDIuODQ5MiAxLjc2NjktMS4xNjYxIDQuMDk2M=
S0xLjk1NDMgNi4yMTY0LTIuMjAxNyAxLjE0ODctLjEyMzggMS44MTMtLjE1ODUgMi45Nzg5LS4x=
Mjk0IDUuMjQ1MywuMTI5NCAxMS4wMzQzLDMuMDgwMiAxNC41NDcyLDYuMDYzOSAxMC43NDk1LDk=
uMTMwNSAxMi4wNDg3LDIyLjQ5MjUgMTEuNDYxNywyNi4yMDMtMS4zMDQzLDguMjQ2Mi0uNDgzNy=
wyMy4xNjgyLTIxLjU2LDI5LjExNyAzLjg5NzcsMS42NDEyIDYuNTQ5Myw0LjU3MzEgNi41NDkzL=
DguMTc3OCAwLDMuOTIyNy0zLjAwMzcsNy4yNzk4LTYuOTI2NCw3LjI3OTgtMi4yNDQyLDAtMy43=
OTkyLS41NDc5LTUuMzcxNy0yLjEyMDMtNC4zODIyLDQuMzgxOS01LjIzMDQsOC44NTI1LTUuMjM=
wNCwxNS4wNTQzIDAsMy43MTA4IC43MDY5LDUuOTAxOCAyLjI2MTksOS4yNTg5IDEuNjQzMSwzLj=
U1MTggMi44MjY5LDUuNjM2NyA1Ljc5NTcsOC4xOTg4IDEuNTcyNS0yLjM2NzcgMy4yMzM2LTQuM=
Dk5NCA2LjA3ODItNC4wOTk0IDIuNzU2NiwwIDUuMDg5MSwuODgzNiA2LjIxOTgsMy4zOTI2IC4z=
MzU3LC43NTk4IC4wMzUzLDEuMzc4MyAuNDI0MSwyLjEyMDMgLjQ5NDcsLjk1NDIgMS4zMjU0LDE=
uMTY2NCAxLjgzNzgsMi4xMjA2IC43OTUsMS40NjY0IC4wMTgsMi43MjA5IC43MDY2LDQuMjQwNS=
AuNDQxOCwuOTg5NiAxLjQxMzgsMS4xMzA5IDEuODM3OCwyLjEyMDMgLjY3MTQsMS41MTk4IC44N=
DgyLDIuNTYyMSAuODQ4Miw0LjI0MDcgMCw0LjcwMDItNC4yNzYyLDguMDU3Ni04Ljk3NjQsOC4w=
NTc2LTEuNDEzNSwwLTIuMTkxLS41NjU2LTMuNjA0Ny0uNDI0MSAyLjY4NiwyLjY4NTcgNC43MzU=
3LDMuODUxOCA2Ljc4NTQsNy4wNjc3IDIuOTY4NSw0LjY0NzMgMy43MTA1LDcuOTUxNSA0LjM4Mi=
wxMy40Mjg5IC4xMjM4LDEuMDI0OSAuMTQxNiwxLjY0MzQgLjE0MTYsMi42ODYgMCw3LjAzMjQtM=
S4wOTU1LDExLjIzNzctNC4yNDA3LDE3LjUyODEtMy4wMDQsNi4wMjUzLTUuNTY2MSw5LjM2NS0x=
MS4wMjYxLDEzLjI4NzQtOC41MTY4LDYuMTMxNC0xNC43MTg5LDcuODk4Ni0yNS4wMjA0LDkuODk=
1MS02LjYwODcsMS4yNzIyLTEwLjM5MDEsMS44Mzc4LTE3LjEwNDYsMi4yNjE2LTguNTg3NSwuNT=
Q3OS0xMy40ODE5LC41NjU3LTIyLjA1MTksMS4xMzEtMTEuMjM4LC43NTk4LTE5LjAzMDUsMi4zN=
Dk5LTI2Ljk5OTUsMTAuMzE5MiAzLjc2MzcsMi43NTYzIDYuMzYxLDUuNDU5NyA2LjM2MSwxMC4x=
MDcgMCw0Ljc3MDYtMi45NTA4LDguMTgwOS03LjQ5Miw5LjY4My0xLjA2MDEsLjM1MzEtMS44Mzc=
1LC4wMzUtMi44MjcyLC41NjUzLTEuMTgzOCwuNjE4NS0xLjEzMDksMS45Nzg4LTIuMjYxNiwyLj=
Y4NTctMS45OTY4LDEuMjcyMi0zLjU1MTYsMS41NTUtNS45MzcsMS41NTUtNC4yMDU1LDAtNy4wN=
jgyLS45ODk0LTEwLjAzNjctMy45NTgyLTMuNDQ1NSwyLjg2MjctNC42MTE5LDUuNDQyNi04LjQ4=
MTQsNy42MzM2LTEuMjcyNSwuNzA2Ni0xLjkyNjIsMS42OTYyLTMuMzkyNiwxLjY5NjItMi4zMTQ=
4LDAtMy4zNzUxLTEuNDY2Ni01LjIzMDQtMi44MjcyLTIuOTUwOC0yLjE1NTgtNC41MjM1LTMuNT=
g3LTYuOTI2Ny02LjM2MS0zLjUxNjEsMi4xMDI2LTUuNjcxOSwzLjgxNjYtOS43NTM2LDMuODE2N=
i0yLjUwOTMsMC00LjA5OTQtLjM1MzQtNi4yMTk4LTEuNjk2My0xLjExMzItLjY4OTEtMS4yODk5=
LTEuNzE0LTIuNDAzMS0yLjQwMzEtMS4xNjYxLS43MjQzLTIuMTM4MS0uNDU5My0zLjM5MjYtLjk=
4OTQtNC43MTc5LTIuMDMyLTcuNzc0OC01LjUzMDctNy43NzQ4LTEwLjY3MjQgMC00LjUwNTggMi=
44NDQ5LTcuMzY4NCA2LjkyNjYtOS4yNTkyLTcuODI4LTcuODI3NC0xNS41MzE4LTkuMTg4LTI2L=
jU3NTYtOS44OTQ4LTguNTM0My0uNTQ3Ni0xMy4zOTM1LS41NjUzLTIxLjkxMDYtMS4xMzEtNi43=
Njc0LS40NTkyLTEwLjUzMTEtMS4xNDg0LTE3LjI0NTYtMi4yNjE2LTUuMDcxNC0uODMwNC04LjA=
3NS0xLjA5NTUtMTIuNzIyNC0zLjI1MTMtMTUuOTkxMS03LjQ1NjUtMjYuMTg2OC0xNy42ODcxLT=
I4LjI3MTctMzUuMTk3Ny0uMTc2Ny0xLjUwMTktLjE0MTEtMi4zNjc3LS4xNDExLTMuODg3MyAwL=
TkuMTE3NiAzLjU4NjctMTQuNjgzNCAxMC4wMzY0LTIxLjEzMjgtMS42NjExLS4zODg5LTIuNzc0=
LC4xNTg5LTQuMzgyMi0uNDI0MS00LjAyODgtMS40NjY2LTYuOTI2NC00LjI1ODQtNi45MjY0LTg=
uNTUyMyAwLTEuNTkwMiAuMDcwNy0yLjY1MDUgLjg0ODEtNC4wMjg1IC41NDc2LS45NzE5IDEuNT=
kwMi0xLjE2NjQgMS44Mzc1LTIuMjYxOSAuMzE4LTEuNDQ4Ny0uMTA2LTIuNDczNSAuNTY1Ni0zL=
jgxNjYgLjQ0MTUtLjkwMTEgMS4yNzIyLTEuMDc3OCAxLjY5NjMtMS45NzkxIDEuMzk1Ny0yLjg5=
NzYgMy4xNDUyLTUuMjMwMSA2LjM2MS01LjIzMDEgMi43NTYzLDAgNC41MjM1LDEuNDQ4OSA1Ljk=
zNywzLjgxNjYgMi42ODYtMS4yMzY3IDMuNDI4LTMuMjUxMyA0Ljk0NzYtNS43OTU0IDIuNTI2Ny=
00LjIyMzIgMy42NzU0LTcuMTc0IDMuNjc1NC0xMi4wODYxIDAtMy40MjgtLjMzNTctNS40NDIzL=
TEuNDEzNS04LjY5MzYtLjc3NzUtMi4zMzIyLTEuMDk1OC0zLjkyMjQtMi44MjcyLTUuNjU0MS0x=
LjU3MjcsMS41NzI0LTMuMTI3OCwyLjEyMDMtNS4zNzE3LDIuMTIwMy00LjQ4ODMsMC03LjkxNi0=
zLjg1MjEtNy45MTYtOC4zNDAxIDAtMy4zMzk3IDEuNjQzMS01LjgxMzIgNC42NjQ4LTcuMjA5Mi=
0yLjQyMDktMi4wODQ5LTQuNTIzNS0yLjI2MTktNy4yMDkyLTMuOTU3OS00LjA4Mi0yLjU3OTktN=
S41MTI5LTUuMzAxLTguMTk4OS05LjMyOTgtMS43NDk1LTIuNjMyOC0yLjIwODctNC40NzAzLTMu=
MTEtNy40OTE3LTEuMDc3OC0zLjYzOTktMS42OTYzLTUuODEzNC0xLjY5NjMtOS42MTIzIDAtLjk=
4OTQgLjAxOC0xLjU3MjUgLjE0MTEtMi41NDQ0IDEuMDA3NC03LjY2ODcgMi4zODU3LTEyLjQ3ND=
ggNy4yMDk1LTE4LjUxNzggMi44NjI0LTMuNTg3IDQuODA2My01Ljc5NTcgOS4wNDctNy42MzMzI=
DMuNjA0NC0xLjU1NSA1Ljc2MDItMi42ODYgOS42ODMtMi42ODYgMS4xODM4LDAgMS44NzMsMCAz=
LjAzOTQsLjE0MTYgMS44MDIxLC4yMjk3IDIuOTUwOCwuMzg4NyA0LjUyMzIsMS4yNzIzIC42MDA=
4LC4zMzU3IDEuNjk2MywxLjM0MjggMS42OTYzLC42MzU5IDAtLjgxMjYtLjQyNDEtMS4yMzY3LS=
40MjQxLTIuMDQ5NyAwLTMuMjUxIDIuMzMyNS02LjIxOTUgNS41ODM4LTYuMjE5NSAyLjM1LDAgM=
y4zMDQyLDIuMDY3MiA0LjQ1MjksNC4wOTk1IC43NDIxLTEuMjM3MSAxLjEzMDctMi4wODUyIDEu=
MTMwNy0zLjUzNDIgMC01LjM3MTYtMi44ODAxLTguMTEwMi02LjIxOTUtMTIuMjk4LTcuMjgwMS0=
5LjA5OTktMTYuMzk3Ny0xMy4zNTgzLTE2LjM5NzctMjUuMDIwMSAwLTMuNDgwOSAxLjY3ODUtNS=
44NDg4IDQuNjY0OC03LjYzMzIgLjg2NTktLjUxMjcgMi4wMjk3LDAgMi44Nzc5LS41NDI1IC43M=
jQzLS40NTk2IC42NDEzLTEuMzk1IDEuMTAwOC0yLjEzNyAuNzI0My0xLjE0ODQgMS4zNjU3LTEu=
NjQxOSAyLjM3MzEtMi41MjU2IDEuNjYwOC0xLjQ0ODYgMy4xMTkzLTEuMDE0NyA0Ljk1NjgtMi4=
yODY5IC45MTg4LS42MzYyIDEuMTM1Ny0xLjQ2MjQgMS44NDI2LTIuMzEwNiAyLjA0OTctMi40Nz=
M3IDMuODg5NS0zLjY2OCA3LjEyMzEtMy42NjggMS42MjU2LDAgMi41Mzc3LC4wMSA0LjAzOTUsL=
jYwNyAuNTEyNCwuMTk0NSAxLjQ2OTgsLjk2NjkgMS41OTQyLC44MTc0IC4zMjM5LS4zODgzIDEu=
MjAxMy0xLjMxODMgMi4yNDM2LTEuODEzIDEuMzYwNi0uNjUzNyAxLjkxMjQtLjkwNjcgMy40MzI=
yLS45MDY3IDEuNzMxNCwwIDIuODY2LC45NzE0IDQuNTk3NSwuOTcxNCAuNjM2MiwwIC43ODI5LS=
42MzU0IDEuMjk1My0uOTcxNCAxLjUzNzMtMS4wNDIzIDIuNDIyLTEuNjMxNSA0LjI5NS0xLjYzM=
TUgMS44MDIzLDAgMi43OTc5LC41OTUxIDQuMzE3NSwxLjU2NjggMS40MzEyLC45MDEzIDEuNjM3=
MiwyLjEwODIgMy4xMDM4LDIuOTU2NCAuODEyNywuNDc3MiAxLjUwMTgsLjI2NTEgMi40MDMyLC4=
1NjU2IDQuMDI4NSwxLjM0MjggNy4wNjc5LDQuMDI4NSA3LjA2NzksOC4yNjkyIDAsMi4yOTcxLS=
41NDc5LDMuOTQwNC0yLjI2MTksNS40NDIzLTEuMzYwNiwxLjIwMTUtMi42NTA1LC45ODk2LTQuM=
zgyLDEuNTU1IDUuNjE5LDQuNDg4IDEwLjUwOCw1LjYwMTIgMTcuNjgyLDUuNjAxMiA2LjU3MzIs=
MCAxNC42MTItMi42ODY4IDE0LjYxMi05LjI1OTcgMC0zLjA1NzEtMS42ODk4LTQuNjk5NC0yLjg=
5MTQtNy41MDg5LTIuMTU1OC01LjAwMDQtMy4zMjUzLTcuOTQyMi0zLjMyNTMtMTMuMzg0MiAwLT=
QuMzExNiAuNDY5Ni02LjkyNzIgMi45Nzg5LTEwLjQyNTggMi41Nzk2LTMuNjA0NSA1LjczMTYtN=
C40NDUgMTAuMTY2Ny00LjQ0NXoiLz4NCjxnIHN0cm9rZT0iIzcwM2QyOSIgc3Ryb2tlLW1pdGVy=
bGltaXQ9IjMuODY0Ij4NCjxnPg0KPHBhdGggZmlsbD0iI2ZlZGYwMCIgc3Ryb2tlLXdpZHRoPSI=
uNzk3IiBkPSJtNTAzLjYwMDIsMjQ5LjI0NTggODIuMTc5NCwwIDAsODIuMDIyOS04Mi4xNzk0LD=
AgMC04Mi4wMjI5eiIvPg0KPC9nPg0KPGcgZmlsbD0ibm9uZSI+DQo8ZyBzdHJva2Utd2lkdGg9I=
i45ODciPg0KPGcgc3Ryb2tlLWxpbmVjYXA9InJvdW5kIj4NCjxwYXRoIGQ9Im0zODAuOTQ3MSwy=
OTEuMTk1MWMyLjM5MjIsMS4yNTI2IDQuODE5NS0uNTgzNiA0LjMyMTctMy42OTU5LS4yMzMzLTE=
uNDU3Ni0xLjgwNTItMy4yOTg4LTMuOTMyOC0zLjQzMzMiLz4NCjxwYXRoIGQ9Im0zODAuODY1NS=
wyOTEuMTQ0MmMyLjI1NDgsMS42MzI0IDUuMTUwMi0xLjEyMzkgNC4wMjk3LTQuMDQ5My0uNzU2M=
S0xLjk3NTItMy41NjMxLTQuMTA3MS03LjQ1MDQtMS40NjM2LTQuMjkzMywyLjkxOTItMy4xMSwx=
Mi4xMjg2IDUuMTMxMywxMi4yODM5IDcuMzQ5OSwuMTM4NyAxMS44MTc3LTEwLjU3MzYgNS4yODY=
5LTE4LjA5MzEtNi4yODI4LTcuMjM0Mi0xNy43MjY4LTUuNTQxOS0yNS4xOTAzLC4zOTU5LTMuMT=
c2MiwyLjUyNjQtOS4xNzQ1LDkuMTQ1Mi0xMS4wNDAxLDE4LjE2MzgtLjU4MTEsMi44MDgxLS45N=
TYyLDUuMTEyMi0uOTEyLDcuOTMwMSAuMDI5MiwxLjg1NjcgLjIwMDYsMy45MzY1IC43NTY0LDYu=
NTMwNyAxLjEyMzEsNS4yNDAzIDIuOTY3OSw5LjA3OTcgNC44MDU1LDExLjc0NTEgLjcwNDEsMS4=
wMjE4IDEuMzQ3MSwxLjg3MSAyLjAzNjUsMi41NjA1IDEuMjc5LDEuMjc4OSAxLjY2MTksMS45NT=
Y1IDIuOTU0MSwzLjAzMiA0LjIyMzUsMy41MTQ3IDkuNjY0OSw2LjI2OTkgMTYuMzI3MSw1Ljk4N=
jUgNy4zMDgyLS4zMTEyIDExLjUwNjctNS40NDIyIDEwLjcyOTItMTEuNTA2Ny0uNzUzNi01Ljg3=
OS02LjY5MDMtOC44MDUyLTEwLjU3MzYtNi4wNjQxLTIuNjQzNSwxLjg2NTktMy41ODM5LDcuNjQ=
0NSAxLjA4ODUsOS4wMTg1IDIuNjQzNSwuNzc3NiA0Ljk3NTctMi41NjU1IDMuMTA5OC00LjUwOT=
EiLz4NCjwvZz4NCjxnPg0KPHBhdGggZD0ibTUzMS43ODMyLDQ4Ny40MjU4Yy43MSwuNDg0MyAxL=
jE2NjEsMS40OTI2IDEuMTY2MSwxLjQ5MjYgLjE5NjcsLjQ2ODUgLjQ1MDUsLjkxMTQgLjUyMDks=
MS4zMjY4IC40MDM1LDIuMzc4NC0xLjE1NiwzLjg2MDUtMy4wODI4LDQuMDg0OC0yLjY0NzcsLjM=
wNzgtNC42MzUyLTEuMjY1Mi01LjQ4MjUtMy4xNyIvPg0KPHBhdGggZD0ibTM5MC44Njc4LDQyMi=
44NTk1Yy41MTU1LC40ODUyIC42MjU4LDEuMTE0OSAxLjMyMTgsMS4yNDM4IDEuMDQ5NiwuMTk0N=
SAxLjg2NTksLjU4MzEgMi45MTU2LS44MTYzIDEuMjkzOS0xLjcyNSAuNTk4NS00LjQwODItLjc0=
NzQtNi4wOTc0LTEuNDQwNS0xLjgwOC01LjYxMzQtMy40MDU1LTkuMTEyLTEuNDYxNi0xLjE3MDY=
sLjY1MDMtMi42MzgxLDEuNTA2My0zLjk2NTIsMy4yNjU0LS41MDE3LC42NjQ5LTEuMzUwNCwxLj=
czOS0xLjc4OCwyLjQ4NzgtMS4wNTg5LDEuODEwOC0xLjQ5MzksMy4yOTI0LTEuNzAzMywzLjg4N=
zMtMy4yMDEyLDkuMDk3OSAuNTk5OSwxOC42NjM4IDYuNDg4NSwyNC40OTI3Ii8+DQo8L2c+DQo8=
ZyBzdHJva2UtbGluZWNhcD0icm91bmQiPg0KPHBhdGggZD0ibTUzMS41OTEzLDQ4Ny4yMzM2Yy4=
2Mzc5LC42NjQ3IDEuMDEwNSwxLjI0NDEgMS4wMTA1LDEuMjQ0MSAuMTk2NywuNDY4MiAuMzU3MS=
wuOTExMiAuNDI3NywxLjMyNjggLjQwMzIsMi4zNzg0LTEuMTU2LDMuODYwNS0zLjA4Myw0LjA4N=
DUtMi42NDc3LC4zMDgyLTQuNDE5Ny0xLjI1MTktNS4yNjcyLTMuMTU2NyIvPg0KPHBhdGggZD0i=
bTQ3OS4xNjg1LDIzMC43MzkyYzEuMzAxOC0uNzIwOSAyLjUxMDEtMS40MDY0IDMuNjI0NC0yLjA=
xODQgMS42NDgxLS45MDU2IDMuNjI5Mi0uNzE1NyA0LjQ4MjEsLjMxNiAuOTYyNywxLjE2NDQgMS=
4xMTA0LDMuMTgyNi0uMjI1NCw0LjQxNiIvPg0KPC9nPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva=
2UtbGluZWpvaW49InJvdW5kIiBzdHJva2Utd2lkdGg9IjEuMDQxIiBkPSJtNDI1LjU4NjcsMjIz=
LjQ2MzFjLjQzMjIsMS42MzE1IDEuNzUxNywzLjE2MDQgMy44MTk3LDMuODA2OCAxLjI0NDEsLjM=
4ODYgNC4xMjA4LC4yMzMgNS45ODY4LTIuMTc3IDEuNTEyNS0xLjk1MzcgMS4zOTY5LTQuMzczNS=
AuODMyMS02LjI5NjgtLjM2NTgtMS4yNDQ3LTEuMzcwNy0yLjQ0NTctMi42OTgxLTMuNDY4M2wtN=
y45Mzc0LDguMDU2OC0uMDAyLC4wNzl6Ii8+DQo8L2c+DQo8L2c+DQo8L2c+DQo8cGF0aCBmaWxs=
PSIjYzdiMzdmIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGQ9Im00MzIuNDAzMywyMTQuNDkyOSAxLjA=
4ODUsLjc3NzUgMS4xNjYxLDEuMjQ0MSAuNzc3NSwxLjU1NSAuMzg4NiwxLjMyMTcgLjA3NzksMS=
43MTA0LS4wNzc5LDEuMTY2MS0uMzg4NiwxLjMyMTctLjc3NzUsLjkzMjgtLjkzMzEsMS4wMTA5L=
TEuMzIxNSwuNjk5OC0xLjcxMDYsLjM4ODYtMS40NzcxLC4yMzMzLTEuNTU1LS42OTk5LTEuMzk5=
NC0xLjAxMDUtLjg1NTItMS4yNDQtLjYyMjItMS41NTUgMC0uNjIxOSA3LjYxOTUtNy4yMzA2eiI=
vPg0KPGcgc3Ryb2tlPSIjNzAzZDI5IiBzdHJva2UtbWl0ZXJsaW1pdD0iMy44NjQiPg0KPGcgZm=
lsbD0ibm9uZSI+DQo8ZyBzdHJva2Utd2lkdGg9Ii45ODciPg0KPGc+DQo8cGF0aCBkPSJtNDYwL=
jQ4NDQsMjM5LjQ4NzljOC41ODc1LTEuNzkyMiAxNS41ODUzLTUuNjM4MSAyMC44NzUxLTguNTk2=
NyIvPg0KPHBhdGggZD0ibTQ2MC4wNDM1LDIzOS4wNDczYzguNTg3NS0xLjc5MjUgMTUuNTg1My0=
1LjYzODQgMjAuODc1MS04LjU5NjgiLz4NCjxwYXRoIGQ9Im01MTEuMTcwNyw1MDAuNzU2NmMtMi=
4wMjEzLDMuMTA5Ny02Ljg0MTcsNy43NzQ4LTExLjg5NTMsOS42NDA0LTUuMDUzNy0xLjg2NTYtO=
S44NzQtNi41MzA3LTExLjg5NTMtOS42NDA0Ii8+DQo8L2c+DQo8ZyBzdHJva2UtbGluZWNhcD0i=
cm91bmQiPg0KPHBhdGggZD0ibTU4NC4zOTU3LDIxMC42ODMzYzQuMjE3OS0yLjI5MDkgNy40Njk=
yLTEuODY2OCA5Ljg3NCwxLjQ3IDIuNjEzNCwzLjYyNjIgMi45ODYyLDguNDUyNSAyLjQxMDIsMT=
EuMjgwNS0uODU1Miw0LjE5ODUtMi4wNjg2LDUuOTQyLTUuNDA3NCw4Ljk4NzYiLz4NCjxwYXRoI=
GQ9Im01OTQuNTgwNywyMTIuNTQ5M2M0LjgyMDQtMy4xODc0IDEwLjA0MTUtMS44MzM2IDEyLjkw=
NjEsMi40MTAyIDIuMDk5MiwzLjEwOTcgMi42MzU5LDUuNzEyMSAyLjQ4NzgsOS41NjI3LS4yNTM=
1LDYuNjAwMy00LjM4MzksMTEuODMxNS04Ljk0MDksMTQuMzgzMiIvPg0KPC9nPg0KPGc+DQo8cG=
F0aCBkPSJtNjA4LjQ5NzYsMjE2LjgxMDhjNS4yMjc4LC42Mzc2IDkuNzgzNyw1LjYyNzcgOS43O=
DM3LDEwLjk5MTcgMCw2LjkxOTQtMi4zMzExLDkuNDk2MS01Ljk3NDEsMTQuNDQ2LTMuODk4NSw1=
LjI5NzMtMTYuNjM4LDE1LjAwNTMtMTYuNjM4LDI2LjA0NTIgMCw2LjY4NjQgMS44NjU5LDEwLjk=
2MjIgNi42ODYzLDEzLjEzOTEgMy4xMDgxLDEuNDAzNiA2Ljc0MjMtLjExNTcgOC4zOTY3LTEuNj=
EwNyA0LjA0MjktMy42NTQzIDIuNDI2NS0xMC4wNjIzLTEuNzg4LTEwLjgyODUtNS4xMzE2LS45M=
zMyLTYuMDk2LDcuMTQ1LTEuMDg4NSw2LjYwODMiLz4NCjxwYXRoIGQ9Im02MTcuMjgzMiwyMjMu=
NjY3MWMzLjk2NDksLjMxMDkgNy4xNTI2LDMuOTAwNyA3LjE1MjYsOC4wODU3IDAsNS45ODY1LTE=
uNjcwNyw4LjU4MzYtNi40NTMxLDE0LjUzODYtNC4xMjA1LDUuMTMxMy0xNi40ODI0LDE0LjE0OT=
ktMTYuMTcxNSwyMi43Nzk4IC4xMTc3LDMuMjYzNCAyLjg2ODYsNi4zMzgzIDUuMjQxOSw2LjUwO=
TQiLz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgZD0ibTYxNy43NDk1LDI5MS4xNDQy=
Yy0yLjI1NDYsMS42MzI0LTUuMTMxMy0xLjAwMzUtMy44ODczLTMuODAyNiAuODU4OC0xLjkzMjY=
gMy40MjEtNC4zNTM4IDcuMzA4Mi0xLjcxMDMgNC4yOTMzLDIuOTE5MiAzLjExLDEyLjEyODYtNS=
4xMzEzLDEyLjI4MzktNy4zNTAyLC4xMzg3LTEyLjMxNjktMTAuMjk3Mi01LjI4NjktMTguMDkzM=
SA2LjQxNjUtNy4xMTU4IDE4LjMxNDktNS43MjM0IDI1Ljc3ODUsLjIxNDEgMy4xNzYxLDIuNTI2=
NyA5LjU2NTksOS40NjYgMTAuOTM2MywxOC41NzI2IDEuNjU4LDExLjAxOTYgMS40NDU1LDI0LjU=
3NDctOS45MzY1LDMyLjkyMTUtNC41NzY3LDMuMzU2LTEwLjkxNzcsNC44ODE3LTE2LjUxNTYsNC=
42MzY0LTcuMzA4LS4zMjA1LTExLjUwNjQtNS40NDIzLTEwLjcyOTItMTEuNTA2NyAuNzUzOS01L=
jg3OTEgNi40MTUzLTguMzY3NSAxMC41NzM5LTYuMDY0MiA0LjMxOTIsMi4zOTI0IDMuNTY1LDgu=
NDY1OS0xLjA4ODQsOS4wMTg2LTIuNzM2MSwuMzI1LTQuOTc2LTIuNTY1NS0zLjExLTQuNTA5MiI=
vPg0KPHBhdGggZD0ibTYxMy44NjIyLDI4Ny4zNDE2YzEuMjEyLTUuNDU0MyA1Ljg4NDYtNS45Nj=
IzIDkuNjU3Ni01LjkwNjggMTAuMjk2MSwuMTUwOCAxNy40MTU4LDEyLjM2MzYgMTcuNTM1MSwyN=
C4xNzg0IC4xNTA4LDE0LjkyMjYtNi4zMzQsMjMuNzEwOC0xNy4yNDExLDI0LjE3ODItMi44MjIx=
LC4xMjExLTcuNjgzOS0xLjIyMTMtNy43Njc1LTQuNjY0OCIvPg0KPHBhdGggc3Ryb2tlLWxpbmV=
jYXA9InNxdWFyZSIgZD0ibTYyMC4yMDE4LDI4NC45MDMzYzEwLjg1ODQsMi40MTMgMTQuNjY5OS=
wxMi4xOTY0IDE0LjY2OTksMjEuNTMxOSAwLDcuNjE1OC0uNzU0MiwxOC4wMjE3LTE1LjU3NDksM=
jEuNjgyNCIvPg0KPC9nPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva2UtbGluZWNhcD0icm91bmQi=
IHN0cm9rZS13aWR0aD0iMS4wMzciIGQ9Im02MjYuNjEyNywzNDMuOTQxM2MtMS44NjU5LTQuNTA=
5Mi02LjY4NjMtMi40ODc5LTYuOTgyNywwLS42ODMyLDUuNzMyMSA0LjMzOTUsNy40NjM4IDcuOT=
E1OCw2LjUzMDcgMS43NzE0LS40NjIxIDMuMDY3My0xLjU3NzggMy44OTU3LTMuMDMxMyAuOTM0N=
S0xLjY0IDEuMjE3MS0zLjc3OTcgLjYxMDEtNS44MjM1LS4yNzQ5LS45MjY5LS42NjI0LTEuNzA3=
My0xLjMyNTQtMi41ODEtLjY2NTgtLjg3OC0xLjM1NDQtMS40NzkxLTEuOTk5My0xLjg5MDUtMS4=
zNzU1LS44Nzc5LTIuODczOS0uOTY0Ni01LjIyMzktLjk2NDYtOC43MDc5LDAtMTYuMzI2NSwxMC=
4yODk0LTE4Ljg4NTYsMjAuOTc3Mi0uODQyOCwzLjUyLTIuMDAxMywxMS4zNzE0LS4zOTU5LDE4L=
jgxNDcgMS43MTAzLDcuOTMwMSA1LjEzODEsMTMuNDIwMiA5LjE1OTgsMTcuNTg1MiAyLjE3Njks=
Mi4yNTQ2IDUuMTQ1Nyw0LjI2MTggOC45ODk2LDYuNDM1MSAxLjE4NTYsLjY3MDUgNC4zMTk4LDI=
uMDYwOSA2LjQ5NjcsMi42ODMxIDIuMjM1NywuNjM4OCA0LjMwMDEsLjU0NTQgNi4xNTgxLC4xND=
E4IDUuMTU5OC0xLjEyMDUgNy41NTktNS45MTg5IDQuOTU5Ny0xMC44MjkzLTIuMTI3OS00LjAyM=
DEtOC4zOTY3LTYuMjE5OC0xMS4zNTExLTEuMDg4NS0uMjUwNywuNDM1My0uNjQxLDEuMzgzNi0u=
NjI4MywyLjQxMDcgLjAxNTgsMS4zNjgyIC41ODQyLDMuMDE3MiAxLjU2MTIsMy42MzkxIDIuMjQ=
1OCwxLjQyOTIgNS44MzgyLDEuMDI1MSA1LjY3MTMtMi45NDAxIi8+DQo8L2c+DQo8ZyBzdHJva2=
Utd2lkdGg9Ii45ODciPg0KPHBhdGggZD0ibTYzMy4zNzY3LDM5Ny40OTQ0Yy0xLjYzMjcsLjYyO=
TItMi41MjU4LC41NDQtNC41NTctLjM1NzktLjgzMzgtLjM3MDMtMS43ODgzLS45NDM1LTIuOTA2=
Ni0xLjU3ODQtMy45ODA3LTIuMjYwNy04LjcwNzktNS44MjM4LTEzLjEzOTQtMTQuMTQyOS0xLjM=
xMDUtMi40NjAyLTIuMTI0Ni00Ljc0MzItMi42NzI3LTYuOTkyMi0uNDIyNy0xLjczNTQtLjcxNT=
ktMy40NTA1LS43NzkyLTUuMjExMi0uMTA3OC0zIC4yMTUtNi4xMzIzIC45NjM4LTkuNzIxIDEuM=
jM2NS01LjkyNTQgMi43MjUxLTkuMTQzMiA2LjM3NTQtMTQuMTUwMiAxLjc5NTMtMi40NjIyIDMu=
MzQzMy0zLjk2NDkgNi42ODYzLTQuMDQyNSIvPg0KPHBhdGggZD0ibTYzOC4xMDgyLDM4OS41NzY=
0Yy4wNjc3LS4zNjQ3IC4xMDM2LS43NDA2IC4xMDM2LTEuMTI1IDAtMy4zNzA2LTIuNzMyNy02Lj=
EwMy02LjEwMzMtNi4xMDMtMy4zNzA5LDAtNi4xMDMzLDIuNzMyNC02LjEwMzMsNi4xMDMgMCwxL=
jkzOTQgLjkwNDcsMy42Njc1IDIuMzE1MSw0Ljc4NTQiLz4NCjxwYXRoIGQ9Im02MzUuNzM0OCwz=
ODMuNTEwM2MtLjQ1OTUtMi43NzAxLTIuODEzMi00Ljg3OTUtNS42NDgtNC44Nzk1LTMuMTYzOCw=
wLTUuNzI4NywyLjYyOC01LjcyODcsNS44NyAwLDEuNTg3NyAuNjE1MSwzLjAyODEgMS42MTQ3LD=
QuMDg0OCIvPg0KPHBhdGggZD0ibTYyNC41OTE0LDM4My4xOTYyYy01LjIwOS0zLjczMTktOS42N=
zItMTAuODU1OC05LjcxODQtMTkuMjczOS0uMDM2LTYuNDczOSAyLjU2NTUtMTMuMDYxNCA1LjU5=
NzYtMTUuNjI2OSIvPg0KPHBhdGggc3Ryb2tlLWxpbmVjYXA9InJvdW5kIiBkPSJtNjE2LjMyODQ=
sMzgwLjMyNjhjMi4wNDMyLDMuMDMyMSA0LjUxNjUsNi40MDM1IDkuNzQwMSw5LjIzNzUiLz4NCj=
wvZz4NCjxnPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIxLjI3NiIgZD0ibTU5OS42OTQzLDQwMy4wN=
jg5YzEuNzQ3OC0yLjA1NjEgNS43NTY5LTUuMTQwMyAxMC4zNDMxLTUuNzAzNCA0LjY1NDEtLjU3=
MTggOC42OTg2LC43ODM3IDEyLjgyODQsMy4wMDQ4IDguMDU5NSw0LjMzNDcgMTIuNTUzNSw4Ljk=
5NDcgMTUuNTQ5MywxNy42NDEzIC43NjA2LDIuMTk1MiAxLjM5MTUsNS41MDU1IDEuMzAzNyw5Lj=
AyMTEtLjE0MDMsNS42MDQtMS41NjI5LDExLjcyOTUtMy4wOTE3LDE0LjY5MTktMS4zMzM1LDIuN=
TgzNS00LjgyMDQsMTMuOTk0Mi0yMy45NDYzLDIxLjg2ODQtMTEuMTYxMiw0LjU5NDktMjguMzAw=
MSw1LjY1MzgtNDAuMTE4LDYuMTIwNC0xNi4yNTU5LC42NDE2LTMxLjI1NDUsMS4yNDM4LTM5Ljk=
2MjEsMTEuOTczIi8+DQo8cGF0aCBzdHJva2UtbGluZWNhcD0icm91bmQiIHN0cm9rZS13aWR0aD=
0iLjk4NyIgZD0ibTYyNC4xMTMsNDA2LjA0NzhjLTUuMTE5NS0zLjM1ODctMTQuODM3OS03Ljc2M=
TUtMjMuNjIzNS0zLjQyNzctMy4yNTg5LDEuNjA3Ny01LjQ0MjMsMy41OTYzLTYuNjc1MSw2Ljgz=
OTctMi4yMTk3LDUuODM5MyAuMjYxNCwxMi4yNzQ3IDIuNzg3OCwxNC45NDk0IDEuMzIxNywxLjM=
5OTQgNC4yMDA1LDQuMDczNSA3Ljc3NDgsNC4xMjA4IDUuOTA4NiwuMDc4IDcuMzEzMy00LjA1Nz=
IgNy40NjM2LTQuOTc2IC42OTk4LTQuMjc1OS0xLjc4OC01Ljk4NjUtMy4xMDk4LTYuNDUzLTEuM=
DEzOS0uMzU3Ny00LjMxMjItLjI2NjItNS4wMTIsMi4wNjU0LS4yMzMsLjc3NzMtLjI3NDksMi4x=
MzMgLjM0NzMsMy4xNDM4Ii8+DQo8cGF0aCBzdHJva2Utd2lkdGg9IjEuMTIxIiBkPSJtNjAzLjc=
1NDksNDIxLjQ1NDhjLS40NjYzLTEuNzEwNC0uMDM0OS0zLjM1MDEgMS4zMjE3LTUuMjA5IDEuOD=
EzOS0yLjQ4NTYgNS42NzU2LTMuMzQzMSA5LjE3NDUtMS4zOTk0IDEuMTcwMywuNjUwMyAyLjYzN=
zgsMS41MDY2IDMuOTY0OSwzLjI2NTMgLjUwMiwuNjY1MyAxLjM1MDQsMS43MzkxIDEuNzg4Mywy=
LjQ4NzkgMS4wNTg2LDEuODEwOCAxLjQ5NCwzLjI5MjcgMS43MDMsMy44ODc1IDMuODQ1MywxMC4=
5Mjc5LTIuMjY1NSwyMi43NzA5LTEwLjI1NTMsMjcuNTIyMy02LjIwNjIsMy42OTA2LTEzLjYwOD=
IsNS4zMzU3LTIyLjQ2OTIsNi4zNzUxLTMuOTgyNiwuNDY3NC02LjI1NjksLjQzNjgtMTAuMjYyN=
ywuNjIyMi0zLjIyMzcsLjE0OTMtNi4wMDgyLC4wOTYtOC42MywuMDY0LTIuMTU3NS0uMDI3LTQu=
MjA0OS0uMDE2LTYuMjk2OS0uMDY0LTMuNDE1Ni0uMDc5LTYuOTQ5Ny0uMTU4OS0xMS4yNzQsLjE=
1NTYtNC41NDk3LC4zMzA5LTcuOTcyOSwuNDQ3Ny0xMS44MTc3LDEuMDg4NC0yLjUxMTgsLjQxOD=
ctNS40NTU4LC44MjI2LTguNTQyMiwxLjUxNTEtLjkyNjEsLjIwNzUtMS44NjUxLC4zNzczLTIuO=
DA5MiwuNjYxOC0uNjM0LC4xOTEyLTEuMjYwNCwuMzg1My0xLjg4MTEsLjU3NDYtNS41NzE3LDEu=
Njk5NC0xMC45ODUzLDMuNzY5Ny0xNS4yNTcyLDYuNTIwOS0xLjMxOTgsLjg1MDEtMi44MTA2LDE=
uNzAxMS0zLjg3NzEsMi43MDc5LS42NjQ3LC42MjctMS40NzIsMS4yNTY1LTIuMTIzNywxLjg5Nz=
gtMi45ODk5LDIuOTQxNS02LjA0NzMsNi4xMjYxLTYuNzYyMywxMC40Mzc3LS4xMzE5LC43OTU1L=
S4xMzE3LDEuNjI5My0uMTMxNywyLjUwNyAwLDIuNzk4OCAyLjI3NzQsNi42MDg0IDguNDE5NSw3=
Ljg1MjQiLz4NCjwvZz4NCjxnIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8ZyBzdHJva2UtbGluZWN=
hcD0icm91bmQiPg0KPHBhdGggZD0ibTUzMS45OTM3LDQ4OC4xNjE3YzEuNjMyNywzLjM0My0uMj=
I0Miw1LjAyMzUtMi40ODc4LDUuMjg2Ni0zLjM0MywuMzg4Ny01LjEzMTMtMi4yNTQ1LTUuMzY0N=
i00LjY2NDctLjM3ODItMy45MDgxIDIuOTE1OS03LjQ0OTIgNi44NDE5LTcuMzg1OSAzLjUzNTIs=
LjA1NyA2LjQxNDUsMi4zMzc2IDcuNzY0NCw1LjQ3NjYgLjQ5MDUsMS4xNDExIC43MTc4LDIuMzk=
1MiAuNzg3NiwzLjY5NzYgLjEzMjYsMi40Njc4LS43MzQ3LDQuNzQxMy0yLjIyMjgsNi40NzM2LT=
EuOTk3NCwyLjMyNi01LjExMjgsMy43MzM2LTguNDI4NSwzLjg2NjQtNi42MDAyLC4yNjQ4LTExL=
jc0LTUuOTA4NS0xMS43NC0xMi4yMDYgMC0xMi4wNTA5IDE3Ljg3MjMtMTguNjIzMyAyNC45NTct=
MjAuMzEzNyA4LjcwNzYtMi4wNzc1IDE0LjAwNTYtMi44NTUzIDI3Ljk4OTEtMy42MzIzIDUuNTk=
3OS0uMzEwOSA5LjY5NzMtLjE1MzEgMTUuODYwNS0uNzkyMSA1LjUxNTEtLjU3MTUgOC4zOTY3LS=
44NDA1IDE0LjA3MjItMi4xNjIzIDcuMDgyOC0xLjY0OTMgMTMuNjgzNi00LjU4NzEgMTkuNTkyN=
C05Ljk1MTcgNC41NTAyLTQuMTMwOSA3LjE1MjktNy4wNzQ5IDkuMjU5Mi0xMi43NTA1IDEuODE3=
OS00Ljg5NzUgMi42NTMtMTQuNTk1Ni0xLjk1MDktMjEuNzY5MS00LjA2ODgtNi4zMzk5LTkuNzE=
4NC05LjYzMzEtMTYuMTcxNS0xMC41NjYyLTUuODI5Mi0uODQyOC0xMC45NDE3LDEuNjcyNi0xMy=
45OTQ2LDcuNDU2NS0xLjQ3NzEsMi43OTg4LTEuMDIyLDcuNDc5OSAuMTQ4NCw5LjY0MDQgMS4wM=
TA4LDEuODY2IDMuODk2OCw0LjYxNzggNy40NzEyLDQuNjY1MSA1LjkwODYsLjA3OCA3LjMxMzMt=
NC4wNTcyIDcuNDYzNi00Ljk3NiAuNjk5OC00LjI3NTktMS43ODgtNS45ODY1LTMuMTA5OC02LjQ=
1My0xLjAxMzktLjM1NzctNC4zMTIyLS4yNjYyLTUuMDEyLDIuMDY1NC0uMjMzLC43NzczLS4yNz=
Q5LDIuMTMzIC4zNDczLDMuMTQzOCIvPg0KPHBhdGggZD0ibTUyNi44OTczLDQ2OS4wMjAzYy03L=
jU3NjQsMy4zNTg4LTEzLjEyOTgsNS44NzQ1LTE3LjgzOSwxMy4zMTAyLTEuNDc3NCwyLjMzMjUt=
MS44NjYsNS42NzU2LTEuODY2LDcuNjE5MiAwLDQuMTk4MiAxLjcxMDMsOC45NDA5IDUuMjA5Myw=
xMS44OTUzIDMuMjQ2MiwyLjc0MTQgNi40NTI4LDMuNTc2MyAxMC40MTgsMy4xODc3IDMuMDA3LS=
4yOTQ5IDUuODMxMi0yLjQ4NzggNi4yOTc3LTQuMDQyOCIvPg0KPC9nPg0KPGc+DQo8cGF0aCBkP=
SJtNTk5Ljc5LDI3OS44NzgxYy0yLjc3OTQsMi4zNjIzLTQuMTIwOCw1LjI4NjYtNC4xMjA4LDgu=
OTQwOSAwLDQuODQwOSA0LjA1MDIsMTIuNzUwNSAxNC4wMDE5LDE1LjU0OTMgMy44MTM1LDEuMDc=
yNCA3LjQ1NzQsLjk3MTQgOS43Mzk4LS40MTY4Ii8+DQo8cGF0aCBkPSJtNjAxLjczMzYsMzI1Lj=
IwNDVjLTMuNTQ0OCwxLjE4MjUtNi4wNjQ0LDYuNTg2Mi02LjA2NDQsMTEuNzM5OCAwLDUuOTA4N=
SAyLjg3NjcsOS41NjI3IDYuMjE5OCwxMS42NjIiLz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJy=
b3VuZCIgZD0ibTYwNS42MjA4LDM0NC40MDc4Yy02LjM3NTQsNy45MzAxLTkuNzU3OCwxMi42Mzc=
xLTkuOTUxNywyMi4wOC0uMTgxOSw4Ljg2MjcgMi42NDM1LDE0LjkyNzQgNy45MzA0LDIxLjMwMj=
giLz4NCjxwYXRoIGQ9Im01NzEuNjQyMSwyMTIuNTgxNGMuMTY0MS0uMjQ0MyAuMzQ1Ni0uNTEzI=
C41NDczLS44MDk2IDIuNjQzNS0zLjg4NzMgNy4zMTE2LTQuOTExNiAxMC43MjkyLTIuMzMyMyA0=
LjEyMDUsMy4xMDk4IDUuMTYxMiw4LjQwMjMgNC4wNDI5LDEzLjk5NDMtLjY5OTgsMy40OTg3LTM=
uMDczMiw2LjQxMjgtNi4zMjUsOC41MjExIi8+DQo8L2c+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm=
9rZS1saW5lY2FwPSJyb3VuZCIgc3Ryb2tlLXdpZHRoPSIxLjA0MSIgZD0ibTQzMC4wMTM5LDIyM=
C41NzI4Yy0uNDc4NC0yLjU4MTMtMy40OTU4LTMuMTEwOS00LjY2NDgtMS41ODYtMS44MDAxLDIu=
MzQ3OC0uNDg1MSw2LjI1NzIgMy4xNzU5LDcuNDAxNCAxLjI0MzgsLjM4ODkgNC4xMjA1LC4yMzM=
zIDUuOTg2NS0yLjE3NjkgMS41MTI1LTEuOTUzNyAxLjM5NjktNC4zNzM1IC44MzIxLTYuMjk2OS=
0uMzY1NS0xLjI0NDYtMS4zNjQyLTIuMzI5NC0yLjY5ODEtMy4zNDM1LTQuMjUxMS0zLjIzMzMtM=
TEuMTE3OC0yLjQ4NzktMTMuMzcyNywyLjk1NDEtMi45MDg2LDcuMDIwMyAzLjQyMSwxMi4yODQy=
IDkuMjUyMiwxNi4yNDkxIDcuMzQwOSw0Ljk5MTggMTUuNzA0Niw1Ljg5OTYgMjIuMDAyNiw1Ljg=
zMTIgMTQuMzA1NS0uMTU1NiAyNS4xOS02Ljk5NzMgMzIuMjY1My0xMC44ODQ1IDEuNjQ4MS0uOT=
A1NiAzLjM0NTMtLjcyMDcgNC4xOTgyLC4zMTA5IC45NjI5LDEuMTY0NCAuOTQ3NSwzLjA0MjgtL=
jM4ODYsNC4yNzU5Ii8+DQo8L2c+DQo8ZyBzdHJva2Utd2lkdGg9Ii45ODciPg0KPGc+DQo8cGF0=
aCBzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im00MTQuMjE5NSwyMTAuNjgzM2MtNC4wNDMyLTE=
uODY1Ny03LjM3MS0xLjUwNjYtOS44NzQsMS40Ny0yLjg3NjgsMy40MjEtMi45ODY1LDguNDUyNS=
0yLjQxMDIsMTEuMjgwNSAuODU1Miw0LjE5ODUgMi4wNjgzLDUuOTQyIDUuNDA3NCw4Ljk4NzYiL=
z4NCjxwYXRoIGQ9Im00MDQuMDM0MywyMTIuNTQ5M2MtNC44MjAxLTMuMTg3NC0xMC4wNDEyLTEu=
ODMzNi0xMi45MDU4LDIuNDEwMi0yLjA5OTIsMy4xMDk3LTIuNjM1OSw1LjcxMjEtMi40ODgxLDk=
uNTYyNyAuMjUzOCw2LjYwMDMgNC4zODQyLDExLjgzMTUgOC45NDEyLDE0LjM4MzIiLz4NCjxwYX=
RoIGQ9Im0zOTAuMTE3NiwyMTYuODEwOGMtNS4yMjc4LC42Mzc2LTkuNDAwNCw1LjA2ODgtOS40M=
DA0LDEwLjQzMjYgMCw2LjkxOTYgMS43MDMzLDkuNzE4NCA1LjU5MDYsMTUuMDA1MSAzLjg5NjUs=
NS4yOTkgMTYuNjM4MywxNS4wMDUzIDE2LjYzODMsMjYuMDQ1MiAwLDYuNjg2NC0xLjg2NTksMTA=
uOTYyMi02LjY4NjMsMTMuMTM5MS0zLjEwODMsMS40MDM2LTYuNzQyMy0uMTE1Ny04LjM5NjctMS=
42MTA3LTQuMDQzMi0zLjY1NDMtMi40MjY1LTEwLjA2MjMgMS43ODgtMTAuODI4NSA1LjEzMTMtL=
jkzMzIgNi4wOTU3LDcuMTQ1IDEuMDg4NSw2LjYwODMiLz4NCjxwYXRoIGQ9Im0zODEuMzMyMSwy=
MjMuNjY3MWMtMy45NjUyLC4zMTA5LTcuODY2NSwzLjcyMjktNy44NjY1LDcuOTA3OSAwLDUuOTg=
2NSAyLjM4NDYsOC43NjE0IDcuMTY2NywxNC43MTY0IDQuMTIwOCw1LjEzMTMgMTUuNzYxOCwxMy=
45NzE3IDE1LjQ1MDUsMjIuNjAxNy0uMTE3MywzLjI2MzQtMi4zMTExLDcuMjUzMS00LjQ4OCw2L=
jc4NjUiLz4NCjxwYXRoIGQ9Im0zNzUuNjEzMiwyODcuODAzN2MtMi4zNzg0LC43OTM4LTUuMzQ4=
NSwyLjI3NzQtNy41NDk3LDUuMzk1My0xLjg1NjEsMi42Mjk3LTIuOTM4NCw2LjI4NTYtMy42MDg=
3LDkuNDg0Ni0uMjkzMiwxLjM5OTktLjY0Myw1LjgzMiAuMjUyNCwxMC40MDk1IC42NjEzLDMuMz=
gwNSAyLjA1NzMsNi41MjcxIDMuNjAxNyw4LjgwNjQgLjU1MzUsLjgxNjkgMS4wNTU4LDEuMzY3M=
SAxLjYyMDYsMS45MzE4IC41MTc4LC41MTc4IDEuMjUyOCwuOTc1MSAxLjc3MzcsMS4zNzI3Ii8+=
DQo8cGF0aCBzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im0zNzIuMDAyMywzNDMuOTQxM2MxLjg=
2Ni00LjUwOTIgNi42ODY0LTIuNDg3OSA2Ljk4MjksMCAuNjgzMiw1LjczMjEtNC4zMzk1LDcuND=
YzOC03LjkxNTgsNi41MzA3LTEuNzcxNC0uNDYyMS0zLjA2NzUtMS41Nzc4LTMuODk1Ny0zLjAzM=
TMtLjkzNDUtMS42NC0xLjIxNzEtMy43Nzk3LS42MTA0LTUuODIzNSAuMjc1Mi0uOTI2OSAuNjYy=
Ny0xLjcwNzMgMS4zMjU3LTIuNTgxIC42NjU4LS44NzggMS4zNTQxLTEuNDc5MSAxLjk5OTEtMS4=
4OTA1IDEuMzc1NS0uODc3OSAyLjg3NDItLjk2NDYgNS4yMjQyLS45NjQ2IDguNzA3NiwwIDE2Lj=
MyNjUsMTAuMjg5NCAxOC44ODU2LDIwLjk3NzIgLjg0MjgsMy41MiAyLjAwMTMsMTEuMzcxNCAuM=
zk1OSwxOC44MTQ3LTEuNzEwNiw3LjkzMDEtNS4xMzg0LDEzLjQyMDItOS4xNTk4LDE3LjU4NTIt=
Mi4xNzY5LDIuMjU0Ni01LjE0Niw0LjI2MTgtOC45ODk2LDYuNDM1MS0xLjE4NTUsLjY3MDUtNC4=
zMTk4LDIuMDYwOS02LjQ5NjcsMi42ODMxLTIuMjM2LC42Mzg4LTQuMzM2OSwuNjg4LTYuMTU4Mi=
wuMTQxOC00LjQyMjUtMS4zMjY4LTcuMjYxMi01LjQ1OTEtNC45NTk3LTEwLjgyOTMgMS43OTE3L=
TQuMTgwOCA4LjM5NjctNi4yMTk4IDExLjM1MTEtMS4wODg1IC4yNTA3LC40MzUzIC42NDA3LDEu=
MzgzNiAuNjI4NCwyLjQxMDctLjAxNTgsMS4zNjgyLS41ODQyLDMuMDE3Mi0xLjU2MTUsMy42Mzk=
xLTIuMjQ1OSwxLjQyOTItNS44MzgyLDEuMDI1MS01LjY3MTEtMi45NDAxIi8+DQo8cGF0aCBkPS=
JtMzY1LjIzODMsMzk3LjQ5NDRjMS42MzI3LC42MjkyIDIuNTI1OCwuNTQ0IDQuNTU3My0uMzU3O=
SAuODMzNS0uMzcwMyAxLjc4ODMtLjk0MzUgMi45MDY2LTEuNTc4NCAzLjk4MDQtMi4yNjA3IDgu=
NzA3Ni01LjgyMzggMTMuMTM5NC0xNC4xNDI5IDEuMzEwNS0yLjQ2MDIgMi4xMjQ2LTQuNzQzMiA=
yLjY3MjUtNi45OTIyIC40MjI5LTEuNzM1NCAuNzE1OS0zLjQ1MDUgLjc3OTItNS4yMTEyIC4xMD=
gtMy0uMjE1LTYuMTMyMy0uOTYzOC05LjcyMS0xLjIzNjItNS45MjU0LTIuNzI1MS05LjE0MzItN=
i4zNzU0LTE0LjE1MDItMS43OTUxLTIuNDYyMi0zLjM0My0zLjk2NDktNi42ODY0LTQuMDQyNSIv=
Pg0KPHBhdGggZD0ibTM2MC41MDY4LDM4OS41NzY0Yy0uMDY3OC0uMzY0Ny0uMTAzMy0uNzQwNi0=
uMTAzMy0xLjEyNSAwLTMuMzcwNiAyLjczMjQtNi4xMDMgNi4xMDMzLTYuMTAzIDMuMzcwNiwwID=
YuMTAzLDIuNzMyNCA2LjEwMyw2LjEwMyAwLDEuOTM5NC0uOTA0NCwzLjY2NzUtMi4zMTQ4LDQuN=
zg1NCIvPg0KPHBhdGggZD0ibTM2Mi44ODA0LDM4My41MTAzYy40NTk1LTIuNzcwMSAyLjgxMzIt=
NC44Nzk1IDUuNjQ3Ny00Ljg3OTUgMy4xNjQxLDAgNS43MjksMi42MjggNS43MjksNS44NyAwLDE=
uNTg3Ny0uNjE1MSwzLjAyODEtMS42MTQ3LDQuMDg0OCIvPg0KPHBhdGggZD0ibTM3NC4wMjM4LD=
M4My4xOTYyYzUuMjA5LTMuNzMxOSA5LjY3Mi0xMC44NTU4IDkuNzE4NC0xOS4yNzM5IC4wMzU4L=
TYuNDczOS0yLjU2NTgtMTMuMDYxNC01LjU5NzYtMTUuNjI2OSIvPg0KPHBhdGggc3Ryb2tlLWxp=
bmVjYXA9InJvdW5kIiBkPSJtMzgyLjI4NjksMzgwLjMyNjhjLTIuMDQzMiwzLjAzMjEtNC41MTY=
1LDYuNDAzNS05Ljc0MDQsOS4yMzc1Ii8+DQo8cGF0aCBkPSJtMzk3LjgxNDgsNDAyLjYzMzFjLT=
EuNDQ4OS0zLjQwODktNC4zMjg4LTQuOTg1My05LjAxODktNS40ODU2LTQuNjYyNS0uNDk3OC04L=
jY5ODYsLjc4MzctMTIuODI4NSwzLjAwNDgtOC4wNTk4LDQuMzM0Ni0xMi41NTM4LDguOTk0Ni0x=
NS41NDk2LDE3LjY0MTItLjc2MDMsMi4xOTUyLTEuMzkxMiw1LjUwNTYtMS4zMDM0LDkuMDIxMSA=
uMTQwMiw1LjYwNDEgMS41NjI5LDExLjcyOTYgMy4wOTE3LDE0LjY5MTkgMS4zMzM2LDIuNTgzNS=
A0LjgyMDQsMTMuOTk0MyAyMy45NDYzLDIxLjg2ODQgMTEuMTYxMSw0LjU5NDkgMjguMzAwMSw1L=
jY1MzkgNDAuMTE3Nyw2LjEyMDEgMTYuMjU2MiwuNjQxOSAzMS4yNTQ4LDEuMjQ0MSAzOS45NjI0=
LDExLjk3MyIvPg0KPHBhdGggc3Ryb2tlLWxpbmVjYXA9InJvdW5kIiBkPSJtMzc0LjUwMTksNDA=
2LjA0NzhjNS4xMTk4LTMuMzU4NyAxNC44MzgyLTcuNzYxNSAyMy42MjM4LTMuNDI3NyAzLjI1OD=
ksMS42MDc3IDUuNDQyMywzLjU5NjMgNi42NzUxLDYuODM5NyAyLjIxOTcsNS44MzkzLS4yNjE3L=
DEyLjI3NDctMi43ODc4LDE0Ljk0OTQtMS4zMjE3LDEuMzk5NC00LjIwMDQsNC4wNzM1LTcuNzc0=
OCw0LjEyMDgtNS45MDg4LC4wNzgtNy4zMTMzLTQuMDU3Mi03LjQ2MzYtNC45NzYtLjY5OTgtNC4=
yNzU5IDEuNzg4LTUuOTg2NSAzLjEwOTgtNi40NTMgMS4wMTM5LS4zNTc3IDQuMzEyMi0uMjY2Mi=
A1LjAxMTcsMi4wNjU0IC4yMzMzLC43NzczIC4yNzQ5LDIuMTMzLS4zNDcsMy4xNDM4Ii8+DQo8c=
GF0aCBkPSJtMzk0Ljg2MDEsNDIxLjQ1NDhjLjQ2NjYtMS43MTA0IC4yMjY1LTMuNTA2My0xLjMy=
MTUtNS4yMDktMS41NTUtMS43MTA0LTUuNjc1NS0zLjM0MzEtOS4xNzQ1LTEuMzk5NC0xLjE3MDM=
sLjY1MDMtMi42MzgxLDEuNTA2Ni0zLjk2NDksMy4yNjUzLS41MDIsLjY2NTMtMS4zNTA0LDEuNz=
M5MS0xLjc4ODMsMi40ODc5LTEuMDU4OSwxLjgxMDgtMS40OTM5LDMuMjkyNy0xLjcwMzMsMy44O=
Dc1LTMuODQ1MSwxMC45Mjc5IDIuNDEzLDIyLjUzMTcgMTAuMjU1NiwyNy41MjIzIDYuODQxNyw0=
LjM1MzggMTMuODM4OSw1LjU5NzkgMjIuNDY5Miw2LjM3NTEgMy45OTM2LC4zNTk5IDYuMjU2Niw=
uNDM2OCAxMC4yNjI2LC42MjIyIDMuMjIzNywuMTQ5MyA2LjAwODIsLjA5NiA4LjYzLC4wNjQgMi=
4xNTc1LS4wMjcgNC4yMDQ5LS4wMTYgNi4yOTY5LS4wNjQgMy40MTU2LS4wNzkgNi45NDk1LS4xN=
Tg5IDExLjI3NCwuMTU1NiA0LjU0OTcsLjMzMDkgNy45NzI5LC40NDc3IDExLjgxNzcsMS4wODg0=
IDIuNTExNSwuNDE4NyA1LjQ1NTgsLjgyMjYgOC41NDIyLDEuNTE1MSAuOTI2MSwuMjA3NSAxLjg=
2NTEsLjM3NzMgMi44MDg5LC42NjE4IC42MzQzLC4xOTEyIDEuMjYwNCwuMzg1MyAxLjg4MTQsLj=
U3NDYgNS41NzE1LDEuNjk5NCAxMC45ODUsMy43Njk3IDE1LjI1NzIsNi41MjA5IDEuMzE5OCwuO=
DUwMSAyLjg0MDEsMS42NzA3IDMuODc3MSwyLjcwNzkgLjc5NTgsLjc5NTYgMS40NzIsMS4yNTY1=
IDIuMTIzNCwxLjg5NzggMi45OTAxLDIuOTQxNSA2LjA0NzYsNi4xMjYxIDYuNzYyNiwxMC40Mzc=
3IC4xMzE5LC43OTU1IC4xMzE3LDEuNjI5MyAuMTMxNywyLjUwNyAwLDIuNzk4OC0yLjI3NzQsNi=
42MDg0LTguNDE5NSw3Ljg1MjQiLz4NCjxwYXRoIGQ9Im00NjYuNjIxNSw0ODguMTYxN2MtMS42M=
zI3LDMuMzQzIC4yMjQyLDUuMDIzNSAyLjQ4NzgsNS4yODY2IDMuMzQzLC4zODg3IDUuMTMxMy0y=
LjI1NDUgNS4zNjQ2LTQuNjY0NyAuMzc4Mi0zLjkwODEtMi45MTU5LTcuNDQ5Mi02Ljg0MTktNy4=
zODU5LTMuNTM1MiwuMDU3LTYuNDE0NSwyLjMzNzYtNy43NjQ0LDUuNDc2Ni0uNDkwNywxLjE0MT=
EtLjcxNzgsMi4zOTUyLS43ODc5LDMuNjk3Ni0uMTMyNCwyLjQ2NzggLjczNSw0Ljc0MTMgMi4yM=
jI4LDYuNDczNiAxLjk5NzQsMi4zMjYgNS4xMTMsMy43MzM2IDguNDI4OCwzLjg2NjQgNi42MDAy=
LC4yNjQ4IDExLjc0LTUuOTA4NSAxMS43NC0xMi4yMDYgMC0xMi4wNTA5LTE3Ljg3MjUtMTguNjI=
zMy0yNC45NTctMjAuMzEzNy04LjcwNzktMi4wNzc1LTE0LjAwNTUtMi44NTUzLTI3Ljk4OTEtMy=
42MzIzLTUuNTk3OS0uMzEwOS05LjY5NzMtLjE1MzEtMTUuODYwNS0uNzkyMS01LjUxNTItLjU3M=
TUtOC4zOTY3LS44NDA1LTE0LjA3MjUtMi4xNjIzLTcuMDgyNi0xLjY0OTMtMTMuNjgzNi00LjU4=
NzEtMTkuNTkyNS05Ljk1MTctNC41NS00LjEzMDktNy4xNTI2LTcuMDc0OS05LjI1OTItMTIuNzU=
wNS0xLjgxNzUtNC44OTc1LTIuNjUyNy0xNC41OTU2IDEuOTUxLTIxLjc2OTEgNC4wNjktNi4zMz=
k5IDkuNzE4NC05LjYzMzEgMTYuMTcxNy0xMC41NjYyIDUuODI5Mi0uODQyOCAxMC45NDE3LDEuN=
jcyNiAxMy45OTQ2LDcuNDU2NSAxLjQ3NzEsMi43OTg4IDEuMDIxOCw3LjQ3OTktLjE0ODMsOS42=
NDA0LTEuMDEwOCwxLjg2Ni0zLjg5NjgsNC42MTc4LTcuNDcxMiw0LjY2NTEtNS45MDg4LC4wNzg=
tNy4zMTMzLTQuMDU3Mi03LjQ2MzYtNC45NzYtLjY5OTgtNC4yNzU5IDEuNzg4LTUuOTg2NSAzLj=
EwOTgtNi40NTMgMS4wMTM5LS4zNTc3IDQuMzEyMi0uMjY2MiA1LjAxMTcsMi4wNjU0IC4yMzMzL=
C43NzczIC4yNzQ5LDIuMTMzLS4zNDcsMy4xNDM4Ii8+DQo8cGF0aCBkPSJtNDcxLjcxNzYsNDY5=
LjAyMDNjNy41NzY0LDMuMzU4OCAxMy4xMzAxLDUuODc0NSAxNy44MzkzLDEzLjMxMDIgMS40Nzc=
xLDIuMzMyNSAxLjg2Niw1LjY3NTYgMS44NjYsNy42MTkyIDAsNC4xOTgyLTEuNzEwNiw4Ljk0MD=
ktNS4yMDkzLDExLjg5NTMtMy4yNDYyLDIuNzQxNC02LjQ1MzEsMy41NzYzLTEwLjQxODMsMy4xO=
Dc3LTMuMDA3LS4yOTQ5LTUuODMwOS0yLjQ4NzgtNi4yOTc0LTQuMDQyOCIvPg0KPHBhdGggZD0i=
bTM5OC44MjUzLDI3OS44NzgxYzIuNzc5NCwyLjM2MjMgNC4xMjA4LDUuMjg2NiA0LjEyMDgsOC4=
5NDA5IDAsNC44NDA5LTQuMDUwMiwxMi43NTA1LTE0LjAwMTksMTUuNTQ5My0zLjgxMzgsMS4wNz=
I0LTcuNTg4MiwuMjA3My05Ljg3MDYtMS4xODA3Ii8+DQo8cGF0aCBkPSJtNDAwLjQ1NzksMjk2L=
jI4MjZjMS43ODgzLDEuMjQzOCAyLjQ4ODEsMi42NDA2IDIuNDg4MSw1LjA2OTcgMCwxLjY2NDct=
MS4wNzYzLDMuODIyOC0yLjkwNzQsNS44NjY2LTIuOTk3NywzLjM0NjEtOC4wODIxLDYuMTg5Ny0=
xMy43MTYzLDYuMjYwMy0zLjA1NjMsLjAzOC02LjIyOTQtLjYwMDgtOS40MjE4LTIuNzM1OC0zLj=
QxMzEtMi4yODIxLTUuMjA5My01LjM2NDMtNS45ODY4LTguMzk2NyIvPg0KPHBhdGggZD0ibTQwM=
C4yOTgxLDMwNi43MTE1YzIuMDI1OCwxLjg2MjMgMi42NDgsNC4xOTMyIDIuNjQ4LDcuMTI5IDAs=
NC4yODkxLTEuNzQyNCw3LjU5OTgtNS43NDkzLDExLjEwNzQtLjg5NiwuNzg0LTEuOTA0OCwxLjU=
xODctMy4wMzI5LDIuMTc4MyIvPg0KPHBhdGggZD0ibTM5Ni44ODE2LDMyNS4yMDQ1YzQuMjc2MS=
wzLjM0MzEgNi4wNjQ0LDYuNTg2MiA2LjA2NDQsMTEuNzM5OCAwLDUuOTA4NS0yLjg3NjcsOS41N=
jI3LTYuMjIwMSwxMS42NjIiLz4NCjwvZz4NCjxnIHN0cm9rZS1saW5lY2FwPSJyb3VuZCI+DQo8=
cGF0aCBkPSJtMzkyLjk5NDQsMzQ0LjQwNzhjNi4zNzUxLDcuOTMwMSA5Ljc1NzgsMTIuNjM3MSA=
5Ljk1MTcsMjIuMDggLjE4MTUsOC44NjI3LTIuNjQzNSwxNC45Mjc0LTcuOTMwNCwyMS4zMDI4Ii=
8+DQo8cGF0aCBkPSJtNDI2Ljk3MzEsMjEyLjU4MTRjLS4xNjQxLS4yNDQzLS4zNDU4LS41MTMtL=
jU0NzMtLjgwOTYtMi42NDM1LTMuODg3My03LjMxMTYtNC45MTE2LTEwLjcyOTItMi4zMzIzLTQu=
MTIwNSwzLjEwOTgtNS4xNjEyLDguNDAyMy00LjA0MjksMTMuOTk0MyAuNjk5NSwzLjQ5ODcgMy4=
wNzMyLDYuNDEyOCA2LjMyNDcsOC41MjExIi8+DQo8L2c+DQo8Zz4NCjxwYXRoIGQ9Im01NzMuMD=
QyNCwyMjQuMzY2OWMtNi4yOTc1LDYuODQxNy0xMi41OTU1LDkuMDI2Mi0yMi4wMDI2LDkuMzI5N=
i0yLjkzNzUsLjA5NS04LjU1MjMtLjkzMjktMTEuODE3Ny0zLjI1ODEtMi4wOTc1LTEuNDkzNi00=
LjQzMTUtNC4wNTAyLTIuOTU0NC04LjQ4MTcgLjk4NzUtMi45NjIyIDUuNzQ2Mi0xMS4yNzM0IDU=
uOTc5NS0xNy4wMjY2IC4zNTYzLTguNzg5Mi0zLjAyNS0xMy42MDU3LTguMzEyLTE1LjQ3MTYtOS=
43NzM5LTMuNDQ5Ny0yMC4yNjY3LDYuMjExMy0yNi41ODk1LDguMzE5LTMuMzA1MywxLjEwMTctN=
C45OTAzLDEuMjMxOS04LjAwODEsMS4yNDI5LTMuMDE3Ny0uMDExLTQuNzYyNy0uMTQxMS04LjA2=
OC0xLjI0MjktNi4zMjI4LTIuMTA3Ny0xNi44MTU2LTExLjc2ODctMjYuNTg5Ny04LjMxOS01LjI=
4NjcsMS44NjU5LTguNjY4LDYuNjgyNC04LjMxMTcsMTUuNDcxNiAuMjMzMyw1Ljc1MzIgNC45OT=
E4LDE0LjA2NDQgNS45NzkyLDE3LjAyNjYgMS40Nzc0LDQuNDMxNS0uODU2Niw2Ljk4ODEtMi45N=
TQxLDguNDgxNy0zLjI2NTYsMi4zMjUyLTguODgwMSwzLjM1MjktMTEuODE3NywzLjI1ODEtOS40=
MDcyLS4zMDM0LTE1LjcwNTItMi40ODc5LTIyLjAwMjctOS4zMjk2Ii8+DQo8L2c+DQo8L2c+DQo=
8Zz4NCjxwYXRoIHN0cm9rZS13aWR0aD0iMS4xMjEiIGQ9Im01MTYuMzY2NSwyMjkuMTA5NGMxLj=
I4NTIsMi4zMjQxIDEuOTkyLDMuNzM3OCAxLjI0NDEsNi4xNDIxLS44NDczLDIuNzIzMS0yLjc3O=
DMsNC4zNTM4LTUuNTIwMiw0LjM1MzgtNi4yMTk4LDAtOS44NzgyLTcuMzY0Mi03LjA3NS0xMi4w=
NTEgNC45NzYtOC4zMTg3IDE0LjUzODgtMy42NDY2IDIzLjQwMjEsLjQ3MzktLjQyNzUtMi4xMzM=
4LTEuMTczNC0yLjgyNzgtMS4wOTU4LTUuNDcxMiAuMTkzMS02LjU2NDIgNS4wNjEtOS41NDEyID=
cuMDA0Ni0xNS42MDUzIDEuMTU3Ny0zLjYxMjQgMS42MTgzLTYuNzQ5Ny0xLjAyNTEtOS4zMTU1L=
TIuMzA3OC0yLjIzOTYtNC45ODE5LTIuMjA1Ni03Ljk5MzctMS4wMjQ4LTYuMDE3NCwyLjM1ODct=
MTMuMjQ1OCw5LjEzNzMtMjUuOTY5OCw5LjMyNTYtMTIuNzIzOC0uMTg4My0yMC4wMTIzLTYuOTY=
2OS0yNi4wMy05LjMyNTYtMy4wMTE1LTEuMTgwOC01LjY4Ni0xLjIxNDgtNy45OTM0LDEuMDI0OC=
0yLjY0MzUsMi41NjU4LTIuMTgzMSw1LjcwMzEtMS4wMjUxLDkuMzE1NSAxLjk0MzYsNi4wNjQxI=
DYuODExNiw5LjA0MTEgNy4wMDQzLDE1LjYwNTMgLjA3NzksMi42NDM0LS42NjgzLDMuMzM3NC0x=
LjA5NTUsNS40NzEyIDguODYzMy00LjEyMDUgMTguNzk3OC05LjIxMTkgMjMuNDAyMS0uNDczOSA=
yLjU2NTIsNC44Njg4LS44NTUyLDEyLjA1MS03LjA3NTIsMTIuMDUxLTIuNzQxNywwLTQuNjY3My=
0xLjc0ODEtNS41MTk5LTQuMzUzOC0uNzYtMi4zMjI3IDAtNC4zNTM4IDEuMjQ0MS02LjE0MjEiL=
z4NCjwvZz4NCjxnIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8cGF0aCBkPSJtNDcxLjQ2NDksMjI3=
LjQ1M2MuMzc5My0xLjE4MjEgLjc2NzEtMi4wNzE5IC43MS00LjAxNDQtLjE5MzItNi41NjQyLTU=
uMDYwNy05LjU0MTItNy4wMDQ2LTE1LjYwNTYtMS4xNTc3LTMuNjEyLTEuNjE4LTYuNzQ5NCAxLj=
AyNTQtOS4zMTUyIDIuMzA3NS0yLjIzOTYgNC45ODE2LTIuMjA1OCA3Ljk5MzQtMS4wMjUxIDYuM=
DE3NCwyLjM1OSAxMy4zMDgyLDkuMTM3NiAyNi4wMzIzLDkuMzI1OS0xMi43MjQtLjE4ODItMjAu=
MDE0OC02Ljk2NjktMjYuMDMyMy05LjMyNTktMy4wMTE4LTEuMTgwNy01LjkzNDctMS41MjU1LTg=
uMjQyNSwuNzE0Mi0yLjY0MzIsMi41NjU4LTEuOTM0MSw2LjAxNDEtLjc3NjQsOS42MjYxIDEuOT=
QzOSw2LjA2NDQgNi41NjI4LDkuMDQxNCA2Ljc1NTgsMTUuNjA1NiAuMDU3MiwxLjk0MjUtLjQ1N=
SwyLjgzMjMtLjgzNDEsNC4wMTQ0Ii8+DQo8cGF0aCBkPSJtNTAwLjE4MTIsMjA2LjM3MzdjMTIu=
NTE3Mi0uNjYxIDIzLjI0NTMtOS4wNzEyIDI2LjcwNjItOS43NTczIDMuMDg1Ni0uNjEyIDQuODA=
4Ni0uMzM1NCA3LjA3MjEsMS43MjEzLTIuMjYzNi0yLjA1NjctNC44NDE4LTEuOTkzMS03Ljc3MD=
YtLjg0NS02LjAxNzUsMi4zNTktMTMuMjQ2LDkuMTM3Ni0yNS45Njk4LDkuMzI1OSIvPg0KPHBhd=
GggZD0ibTUxNS4yMjU0LDIzOS41NzE1YzEuMTU5MS0uNzYwOSAyLjAwOTgtMS45NzkxIDIuNDk3=
NC0zLjQ4NDggLjc1My0yLjMyNTIgLjc2OTEtNC4zMDc3LS40NzQ3LTYuMDk1NyAxLjUzNDUsMi4=
wMDgxIDEuNjc1NywzLjcwNDMgMS4yNDM4LDYuMTQxOC0uMjc0NiwxLjU1MjItMS4yNjQ0LDIuMz=
Y4NS0yLjQ5NzQsMy40ODQ5Ii8+DQo8cGF0aCBkPSJtNTk2LjM5OCwzNzQuMjM3NiAwLDI1LjI0M=
TMgLjA2NjgsMGMwLC4wMTgtLjAwOSwyLjM4ODgtLjIxMTgsMy44ODcyLS4xMzMxLC45ODI0LS4y=
NzE2LDEuODcwNS0uNDI4NiwyLjcwMjMiLz4NCjxwYXRoIGQ9Im01OTUuOTU3LDM3MS44MTQ1IDA=
sMjcuMjIzNCAuMDY3MywuMDAwM2MwLC4wMTgtLjAwOSwyLjM4ODUtLjIxMTgsMy44ODcyLS4yMT=
E4LDEuNTYyNC0uNDM3LDIuODg2OS0uNzI5NCw0LjEyNDUiLz4NCjxwYXRoIGQ9Im01OTUuOTU3L=
DMzOS45NDM0IDAsMjIuNzAxNiIvPg0KPHBhdGggZD0ibTU5Ni4zOTgsMzQxLjczNDIgMCwxOC40=
NjMyIi8+DQo8cGF0aCBkPSJtNTk2LjM5OCwzMTguMjUxMSAwLDEzLjg0MTMiLz4NCjxwYXRoIGQ=
9Im01OTUuOTU3LDMxNi42MTc2IDAsMTcuMDYzNSIvPg0KPHBhdGggZD0ibTU5Ni4zOTgsMzA0Lj=
EwMTMgMCw1LjM2OTMiLz4NCjxwYXRoIGQ9Im01OTUuOTU3LDMwMy4wMTMxIDAsNy43NzYyIi8+D=
Qo8cGF0aCBkPSJtNTk2LjM5OCwyOTIuNjMzMSAwLDUuNTE4OCIvPg0KPHBhdGggZD0ibTU5NS45=
NTcsMjkxLjI3NDIgMCw3Ljc3NCIvPg0KPHBhdGggZD0ibTU5Ni4zOTgsMjc0LjQ0MDYgMCwxMC4=
xODUiLz4NCjxwYXRoIGQ9Im01OTUuOTU3LDI3Mi4xODY2IDAsMTMuOTE3NSIvPg0KPHBhdGggZD=
0ibTU5Mi45ODc3LDQxNC4xNzNjLTEuOTMwNCwzLjgzNTItMy40NzI3LDUuODQ5Mi02LjUzMDcsO=
C44NjMyLTMuMDg1NSwzLjA0MDgtNS4yMjM5LDQuNDM0My05LjA5NjUsNi4zNzUxLTMuNzcxOSwx=
Ljg5MDUtNi4xNDc3LDIuNDkxNi0xMC4yNjI3LDMuNDIxLTQuMTEyNCwuOTI4Ni02LjUxNzUsMS4=
xMzEtMTAuNzI5MiwxLjMyMTUtMy44NjE5LC4xNzUxLTYuMDUyOSwuMDE0LTkuOTA5NS0uMjU0NC=
00LjEyNzYtLjI4NTYtNi40MTY4LS44NjA4LTEwLjUzODEtMS4yMjI3LTMuNDAzOC0uMjk4OC01L=
jMyNjMtLjU3NDEtOC43NDM0LS41NjU2LTMuNTEyMiwuMDEtNS41MjQ3LC4wMzEtOC45ODMxLC42=
NDMzLTMuMjIzNCwuNTcwOS01LjA1MiwxLjAyNTctOC4wODU3LDIuMjU0OC00LjE5NzYsMS43MDA=
1LTguOTQxMiw0LjY2NDgtOS45NTE3LDUuOTg2NS0xLjAxMDgtMS4zMjE3LTUuNzU0MS00LjI4Ni=
05Ljk1Mi01Ljk4NjUtMy4wMzM4LTEuMjI5MS00Ljg2MjMtMS42ODM5LTguMDg1NS0yLjI1NDgtM=
y40NTktLjYxMjQtNS40NzEtLjYzNDYtOC45ODM0LS42NDMzLTMuNDE3LS4wMS01LjMzOTUsLjI2=
NjgtOC43NDM0LC41NjU2LTQuMTIxMSwuMzYxOS02LjQxMDYsLjkzNzEtMTAuNTM4MSwxLjIyMjc=
tMy44NTY2LC4yNjY4LTYuMDQ3MywuNDI5NC05LjkwOTIsLjI1NDQtNC4yMTItLjE5MDUtNi42MT=
c0LS4zOTAzLTEwLjcyOTItMS4zMjE1LTQuMTE0OS0uOTMxNy02LjQ4ODgtMS41MzQ3LTEwLjI2M=
jktMy40MjEtMy44NzUyLTEuOTM2OC02LjAxMS0zLjMzNDMtOS4wOTY1LTYuMzc1MS0uMzMzMi0u=
MzI4Ni0uNjQ4Ni0uNjQ1Mi0uOTQ4My0uOTUzNiIvPg0KPHBhdGggZD0ibTU5My4wNzY2LDQxMi4=
2NDgxYy0uMTY1NSwuMzUwMy0uMzQxOSwuNzEwOC0uNTI5NiwxLjA4NDItMS45MzA0LDMuODM1Mi=
0zLjQ3Myw1Ljg0OTItNi41MzEsOC44NjMtMy4wODUzLDMuMDQxMS01LjIyMzYsNC40MzQzLTkuM=
Dk2NSw2LjM3NTQtMy43NzE2LDEuODkwMS02LjE0NzUsMi40OTE1LTEwLjI2MjcsMy40MjEtNC4x=
MTIxLC45Mjg2LTYuNTE3NSwxLjEzMDktMTAuNzI5MiwxLjMyMTQtMy44NjE3LC4xNzQ3LTYuMDU=
yOSwuMDExLTkuOTA5Mi0uMjU0Ny00LjEyNzYtLjI4NTMtNi40MTY4LS44NjA1LTEwLjUzODQtMS=
4yMjI0LTMuNDAzOC0uMjk5MS01LjMyNjMtLjU3NDMtOC43NDMxLS41NjU2LTMuNTEyNCwuMDEtN=
S41MjQ0LC4wMzEtOC45ODMxLC42NDMzLTMuMjIzNCwuNTcwNy01LjA1MiwxLjAyNTQtOC4wODYs=
Mi4yNTQ2LTQuMTk3NywxLjcwMDctOC45NDA5LDQuNjY0Ny05Ljk1MTcsNS45ODY1LTEuMDEwOC0=
xLjMyMTgtNS43NTM4LTQuMjg1OC05Ljk1MTctNS45ODY1LTMuMDMzOC0xLjIyOTItNC44NjIzLT=
EuNjgzOS04LjA4NTctMi4yNTQ2LTMuNDU4Ny0uNjEyMy01LjQ3MS0uNjM0NS04Ljk4MzQtLjY0M=
zMtMy40MTY4LS4wMS01LjMzOTMsLjI2NjUtOC43NDMxLC41NjU2LTQuMTIxNCwuMzYxOS02LjQx=
MDgsLjkzNzEtMTAuNTM4MSwxLjIyMjQtMy44NTY2LC4yNjY4LTYuMDQ3MywuNDI5NC05LjkwOTU=
sLjI1NDctNC4yMTItLjE5MDQtNi42MTcxLS4zOS0xMC43MjkyLTEuMzIxNC00LjExNDYtLjkzMj=
MtNi40ODkxLTEuNTM0LTEwLjI2MjctMy40MjEtMy44NzQ5LTEuOTM3OC02LjAxMTMtMy4zMzQzL=
TkuMDk2NS02LjM3NTQtMS42MTU1LTEuNTkyMi0yLjgwODEtMi45MDU1LTMuODU4My00LjM1NTUi=
Lz4NCjwvZz4NCjwvZz4NCjxnPg0KPHBhdGggZmlsbD0iI2ZlZGYwMCIgZmlsbC1ydWxlPSJldmV=
ub2RkIiBzdHJva2Utd2lkdGg9Ii43OTciIGQ9Im01ODUuNDc1NCw0MDIuMzkwMmMtLjIzMzMsMS=
40NzcxLS43NTkyLDQuMDExNi0yLjE2MjYsNi42MDg0LTEuNDc3MSwyLjMzMjUtLjkzMjksMi4yN=
jkyLTQuMjc1OSw2LjAwMDktMS42NDU2LDEuODM2OS00LjIxNCwzLjQxMDgtNi4yMjcxLDQuNDk1=
LTIuMDIxNiwxLjA4ODUtMy41MTY5LDEuNjIyNi02Ljg0MTcsMi40OTUyLTYuNTE3OCwxLjcxMDM=
tMTEuMDkxMSwxLjgxNy0xNi41NzQ0LDEuNTk4MS00LjI3NzgtLjE3MDctNy41NDQtLjY5NzMtMT=
AuMjQ4Ni0xLjA2MTItMy44NTc0LS41MTg5LTYuNzMwNS0uODI3OS0xMS4xMTgxLTEuMDEwOC0yL=
jEzMy0uMDg5LTQuMTQ5LS4xMDk2LTYuMTQyMSwwLTIuNDA1NywuMTMyNi00Ljc4MTUsLjUwNTQt=
Ny4zMDgyLDEuMDEwOC01LjQ0MjMsMS4wODg1LTExLjAzMjgsMy4xODc3LTExLjAzMjgsMy4xODc=
3bC4wNTY1LTg1LjY1NTIgODIuMTkzMi0uMDIzdjU4LjU0MzJjMCwwLS4xNjgxLDIuODU5Ni0uMz=
E4MywzLjgwOTZ6Ii8+DQo8L2c+DQo8L2c+DQo8dXNlIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjcwM=
CIgeGxpbms6aHJlZj0iI3BhdGgzMDE4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwIDM2LjU5NDkp=
Ii8+DQo8ZyBzdHJva2UtbWl0ZXJsaW1pdD0iMy44NjQiPg0KPGc+DQo8cGF0aCBmaWxsPSIjYzd=
iMzdmIiBzdHJva2U9IiNjN2IzN2YiIHN0cm9rZS13aWR0aD0iLjUxMyIgZD0ibTM4Ny40MDgxLD=
QyMS4zMjM5YzAtMi4xNTc1IDEuNzQ5Mi0zLjkwNjcgMy45MDctMy45MDY3IDIuMTU3NSwwIDMuO=
TA2NywxLjc0OTIgMy45MDY3LDMuOTA2NyAwLDIuMTU3OC0xLjc0OTIsMy45MDY3LTMuOTA2Nywz=
LjkwNjctMi4xNTc4LDAtMy45MDctMS43NDg5LTMuOTA3LTMuOTA2N3oiLz4NCjwvZz4NCjxnIGZ=
pbGw9Im5vbmUiPg0KPGcgc3Ryb2tlPSIjNzAzZDI5Ij4NCjxnPg0KPHBhdGggc3Ryb2tlLXdpZH=
RoPSIxLjA1NyIgZD0ibTM4Ny42MDI1LDQxNC4zNDYxLTMuMTg3NywxLjE2NjMtMy4yNjU0LDIuN=
Dg3OS0xLjM5OTQsMS45NDM2LTEuNzg4MywzLjEwOTgtLjc3NzUsMi4zMzI1LS42MjE5LDIuODc2=
OC0uMzExLDIuMTc2NiIvPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIuOTg3IiBkPSJtNDA2LjQxNzQ=
sNDEzLjI1NzNjLjY2NTUsNC45NDIyLTEuNDEyOSw5Ljc5OTUtMy41MjI4LDEyLjAzMzUtMS4zMj=
E3LDEuMzk5NC00LjIwMDUsNC4wNzM2LTcuNzc0OCw0LjEyMDUtNS45MDg4LC4wNzgtNy42NzI2L=
TMuOTg2My04LjAzMDYtNC45NzU3Ii8+DQo8cGF0aCBzdHJva2Utd2lkdGg9IjEuMDU3IiBkPSJt=
NDA1Ljk1MDksNDE0LjY1Ny0uMjMzMywyLjc5OTEtLjQ2NjMsMS45NDM2LTEuMzk5NywzLjM0My0=
yLjE3NjksMi44NzY4LTIuMzMyNSwxLjg2NTktMS43MTA0LC44NTUyLTIuNDEwMiwuNTQ0MyIvPg=
0KPC9nPg0KPGcgc3Ryb2tlLXdpZHRoPSIuOTg3Ij4NCjxwYXRoIGQ9Im0zOTkuNDA0OSw0MTAuN=
zAwMmMxLjA5NjYsMS4wODI5IDIuMDcsMi40MDQ5IDIuODkzMywzLjk2NSAxLjQ3NzEsMi43OTg4=
IDEuMDIyLDcuNDgwMS0uMTQ4Myw5LjY0MDctLjEyODYsLjIzNzUtLjI4NzksLjQ4OTQtLjQ3NDc=
sLjc0ODIiLz4NCjxwYXRoIGQ9Im0zNzAuMDQ0Myw0NTMuMjA0YzMuNTEzNiwzLjY4NzQgOC44Mj=
c1LDcuNjkyIDE2Ljk4OTgsMTEuMDUyMiAxMS4xNjA5LDQuNTk1MyAyOC4zMDAxLDUuNjUzOSA0M=
C4xMTc4LDYuMTIwNSAxNS43MTUzLC42MjA0IDMwLjE5MzEsMS4yNjYgMzkuMDEwNCwxMC45OTc2=
Ii8+DQo8cGF0aCBkPSJtNDkzLjI4NTUsNDc1LjAwOTljMi41OTgyLDIuNTU2IDUuMjQ3LDUuMjk=
1NCA2LjM2NTgsOC43OTgiLz4NCjwvZz4NCjxnPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIxLjE5Ny=
IgZD0ibTQ5OS41OTg0LDQ4OS4yMzQ5Yy0uNTc5NywyLjU4NzgtMy4wMDM5LDUuNTQ4NC04LjI3O=
Sw2LjYxNjkgMCwwLS42MjU2LC4xMjkyLTEuMDI1NCwuMjExOCIvPg0KPC9nPg0KPGcgc3Ryb2tl=
LXdpZHRoPSIuOTg3Ij4NCjxnIHN0cm9rZS1saW5lY2FwPSJyb3VuZCI+DQo8cGF0aCBkPSJtNDk=
xLjI3OTQsNDk0LjcyNTNjLS42MzM3LDIuMzQ4OS0xLjc4NTIsNC42MjYtMy40Njc3LDYuNDUxMS=
IvPg0KPHBhdGggZD0ibTQ2NC41ODA1LDQ2Ni4yNzMzYzEuMjQ2LC40ODY4IC4zMDM0LS4yOTUyI=
DguMTk0NywzLjIwMzIgNy41NzY0LDMuMzU4NSAxMi45NTQsNi4yOTk5IDE3LjY2MzIsMTMuNzM1=
NiAxLjQ3NzQsMi4zMzIzIDEuODY2LDUuNjc1NiAxLjg2Niw3LjYxOTIgMCwxLjI1MjgtLjE1MjI=
sMi41NTQtLjQ1ODcsMy44NDE3Ii8+DQo8L2c+DQo8Zz4NCjxwYXRoIGQ9Im00ODguMTc4NCw1MD=
EuNjk3Yy0uMzM5NywuMzYyNS0uNzAwNywuNzA2Ni0xLjA4MzEsMS4wMjk3LTMuMjQ2MiwyLjc0M=
TEtNi40NTMxLDMuNTc2My0xMC40MTgzLDMuMTg3NC0zLjAwNy0uMjk0Ny01LjkwNzctMi41NDc4=
LTYuNjg1Mi00LjAyNTIiLz4NCjxwYXRoIGQ9Im00OTEuNzg0NSw0OTEuNDcxLS42OTk4LDMuNDI=
wNiIvPg0KPHBhdGggZD0ibTQ4Ny40MzA0LDUwMS40MjI0LTEuNDc3MSwxLjQ3NzMtMi42NDM1LD=
EuNDc3MS0zLjAzMjEsLjkzMzEiLz4NCjxwYXRoIGQ9Im01MTEuNjExNyw1MDEuMTk3M2MtMi4wM=
jE2LDMuMTEtNi44NDE5LDcuNzc0Ny0xMS44OTU2LDkuNjQwNy01LjA1MzYtMS44NjYtOS44NzM4=
LTYuNTMwNy0xMS44OTUzLTkuNjQwNyIvPg0KPC9nPg0KPC9nPg0KPC9nPg0KPGc+DQo8cGF0aCB=
zdHJva2U9IiMyMzFmMjAiIHN0cm9rZS13aWR0aD0iLjk4NyIgZD0ibTUxMi4wNTI0LDUwMS42Mz=
gyYy0yLjAyMTYsMy4xMDk4LTYuODQxOSw3Ljc3NDUtMTEuODk1Myw5LjY0MDUtNS4wNTM3LTEuO=
DY2LTkuODc0MS02LjUzMDctMTEuODk1Ni05LjY0MDUtLjE2MzQtLjI1MTgtLjMyMDgtLjQ5Mzgt=
LjQ3MTktLjcyNjYiLz4NCjwvZz4NCjxnIHN0cm9rZT0iIzcwM2QyOSI+DQo8ZyBzdHJva2Utd2l=
kdGg9Ii45ODciPg0KPHBhdGggZD0ibTQ3OC44MDA1LDUwNS40NjUyIDIuNzk4OC0uMzQ5NyIvPg=
0KPHBhdGggZD0ibTQ2MS42MzM0LDQ5Ny4zNTA1Yy4xNDUsLjE5ODEgLjI5NzQsLjM5MDYgLjQ1N=
zMsLjU3NjYgMS44ODc2LDIuMTk4MyA0Ljg2NzQsMy41NzYgNy45Nzc3LDMuODMzMiIvPg0KPHBh=
dGggZD0ibTQ2NS4wOTEsNTAwLjA2MzhjMS41MzYyLC43NjgyIDMuMjc5MiwxLjIxNjcgNS4wODE=
sMS4yODkxIDYuNjAwMiwuMjY0OCAxMS43NC01LjkwODkgMTEuNzQtMTIuMjA2MyAwLTQuMzY2Mi=
0yLjM3Ny04LjA0NDEtNS43MDYyLTExLjAwMDIiLz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJyb=
3VuZCIgZD0ibTQ2Ni41MTY1LDQ4OC4xNTFjLTEuNTkzOCwzLjU1MzIgLjY3NjgsNS40NzQ5IDIu=
OTQwMSw1LjczOCAzLjM0MzMsLjM4ODkgNS4yMjQ4LTIuMjU0NiA1LjQ1OC00LjY2NDcgLjI1MzY=
tMi42MjEzLTEuMTQ1LTUuMTcxLTMuMjc4LTYuNDg1MiIvPg0KPHBhdGggZD0ibTUxMi4wNTI0LD=
UwMS42MzgyYy0yLjAyMTYsMy4xMDk4LTYuODQxOSw3Ljc3NDUtMTEuODk1Myw5LjY0MDUtNS4wN=
TM3LTEuODY2LTkuODc0MS02LjUzMDctMTEuODk1Ni05LjY0MDUtLjE2MzQtLjI1MTgtLjMyMDgt=
LjQ5MzgtLjQ3MTktLjcyNjYiLz4NCjxwYXRoIGQ9Im01MTIuMTI2Nyw1MDEuNjE3OWMuMzYwNyw=
uMzkxNyAuNzQ2MywuNzYyNCAxLjE1NjIsMS4xMDg4IDMuMjQ2MiwyLjc0MTEgNi40NTMxLDMuNT=
c2MyAxMC40MTgzLDMuMTg3NCAzLjAwNy0uMjk0NyA1LjM5NS0yLjMwMzYgNi4zNTk2LTQuMDQyO=
SAwLDAgLjU0MTEtLjU4MTYgLjY5MjUtMS4xMzY2Ii8+DQo8cGF0aCBkPSJtNTI5Ljc1MjEsNTAw=
Ljk4Ny0xLjE2MDUsMS44NjY2LTEuNzY1NSwxLjQ2MzMtMi42NzM5LDEuMTA5OC0yLjQyMTQsLjE=
wMTEiLz4NCjxwYXRoIGQ9Im01MzYuMDMwNCw0ODMuMjIxNGMxLjQzMDYsMS4wOTY5IDIuODM1NC=
wyLjc1OTQgMy41OTg1LDQuNTM0MiAuNDkwOCwxLjE0MTEgLjcxODEsMi4zOTU2IC43ODc5LDMuN=
jk3NiAuMTMyMiwyLjQ2ODItLjczNSw0Ljc0MTMtMi4yMjI4LDYuNDczOS0xLjk5NzQsMi4zMjYt=
NS4xMTMsMy43MzM2LTguNDI4OCwzLjg2NjQtLjI0NjgsLjAxLS40OTE5LC4wMTEtLjczNDUsMCI=
vPg0KPHBhdGggZD0ibTUyOS4zMjQ3LDUwMS4zNTI5Yy0zLjE3MDYsLjEyNzEtNi4wMDM3LTEuMj=
MxMi04LjA5MjUtMy4zNzU0Ii8+DQo8cGF0aCBkPSJtNTI4Ljg5OTIsNTAxLjQ0MDkgMi44MjUtL=
jI2OSAyLjY5MDctMS4wNzYzIDEuODgzNC0xLjE0MzcgMi41NTYyLTMuMDI3IC41Mzc3LTEuMTQz=
NiAuNDAzOC0yLjYyMzUgLjEzNDYtMS4yMTA4Ii8+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm9rZS1=
3aWR0aD0iMS4zNTYiIGQ9Im02MzEuNTkwNiw0MDYuNTY1OWMzLjMzOTQsMy4xMTQgNS42ODUxLD=
YuOTA1IDcuNDg4MSwxMi4xMDkyIC43NjA2LDIuMTk1MiAxLjM5MTIsNS41MDU2IDEuMzAzNCw5L=
jAyMTEtLjEzOTgsNS42MDQxLTEuNTYyNiwxMS43Mjk2LTMuMDkxNywxNC42OTE2LTEuMzMzMywy=
LjU4MzgtNC44MjAxLDEzLjk5NDMtMjMuOTQ2MywyMS44Njg0LTExLjE2MDksNC41OTUzLTI4LjM=
wMDEsNS42NTM5LTQwLjExNzcsNi4xMjA1LTE2LjAyMjEsLjYzMjYtMzAuODIyMywxLjIyNjYtMz=
kuNTgyMiwxMS41MTU3Ii8+DQo8cGF0aCBzdHJva2Utd2lkdGg9Ii45ODciIGQ9Im01MzMuMDY4N=
Cw0ODEuNDQxNiAyLjc5ODgtMi41NjU4IDEuOTQzOS0xLjQ3NzEgMy42NTQtMi4yNTQ2IDMuNDIx=
LTEuNjMyNiAyLjQxMDItLjYyMjIgNC44MjA0LTEuMDg4MiA1LjU5NzktLjg1NTQiLz4NCjxwYXR=
oIHN0cm9rZS13aWR0aD0iLjkyOSIgZD0ibTYwNS40NTEyLDQxNi45NDUzYzEuMTg4MS0xLjYyMT=
EgNS41MTc0LTMuNjczNCA5LjAxNjMtMS43Mjk1IDEuMTUxNSwuNjM5NyAyLjUxNjMsMS40NDg3I=
DMuNzEzNiwzLjI0MjYiLz4NCjwvZz4NCjwvZz4NCjwvZz4NCjwvZz4NCjxnIGZpbGw9IiM3MDNk=
MjkiIGZpbGwtcnVsZT0iZXZlbm9kZCI+DQo8cGF0aCBkPSJtNDEzLjExOTgsNDM0LjQxOTdjLjg=
xMDItLjg3MjQgMS40MjI1LS41NDM5IDEuNTcyOC0uOTQ1OCAuMTExLS4yOTcxLS4xMjktLjMyNy=
0uNDU5LS40NTA1LS40NDA0LS4xNjQ2LS45MDY5LS4yNTkyLTEuMzQ3My0uNDI0MS0uNDU2MS0uM=
TcwNC0uODcwNC0uNDA0OS0xLjMyNjUtLjU3NTQtLjE4ODktLjA3MS0uNjI1My0uMjkzNS0uNzQ5=
NiwuMDM5LS4yMjg1LC42MTE0IDEuNjAxNywuNTU4OCAuOTg3NywyLjIwMTYtLjEwNDcsLjI3OTQ=
tLjM2NDcsLjg3OTQtMS4yNzQ0LDEuODczOGwtNC4xNDExLDQuNTA3MmMtLjA5MjksLjEwNDctLj=
I0NzQsLjMyNTktLjM0MTYsLjI5MDQtLjA5NDUtLjAzNS0uMDgxNy0uMzA5Mi0uMDgzLS40NDk0b=
C4wNTkyLTYuMzkxN2MuMDA1LTEuMjEyOCAuMTA4MS0yLjExMDcgLjMwNDItMi42MzUgLjI3NDQt=
LjczMzkgMS4xMi0uMTE5MSAxLjI5NjQtLjU5MDkgLjExMTItLjI5NjkgLjAyNTktLjMwOS0uNDc=
3My0uNDk3My0uMjUxOC0uMDk0LS43MzM5LS4xOTQ3LTEuNzQwNS0uNTcwOS0uNTM0OS0uMjAwMi=
0xLjA0MzQtLjQ3LTEuNTYyNi0uNjYzOC0uMjM1OC0uMDg4LS42NzExLS40MTAzLS44Mjc5LC4wM=
S0uMDQ1OSwuMTIyNCAuMTE5MywuMzAzNiAuMTYwMSwuMzM4OCAuNTc5NCwuNDE1OSAuNzI3Nywu=
NjkwMiAuNzQwMywxLjQ3MTlsLjExMzUsMTEuNjM1NGMuMDA5LC44Mzk3IC4xMDA2LDEuMDczMiA=
uMjU4LDEuMTMyIC4xNzMxLC4wNjUgLjI5MS0uMDExIC42MzM3LS40MDA0bDguMjA1LTguOTAzNX=
oiLz4NCjxwYXRoIGQ9Im00MTcuOTQ2MSw0MzYuMjIzOGMuNTMzMi0xLjY5MDQgMS41MzIyLS42N=
zEyIDEuNzIzLTEuMjc2MiAuMDY3My0uMjEzNi0uMDAxLS4yNzQ0LS40ODItLjQyNTgtLjkxMjYt=
LjI4NzgtMS41MTE3LS4zOTg0LTIuMDg4My0uNTgwMi0uNTYwNi0uMTc2Ny0xLjE2MjUtLjQ0NDk=
tMS43ODcyLS42NDE2LS4xNDQxLS4wNDYtLjUyNzYtLjIyNTQtLjYyMywuMDc3LS4xOTY1LC42Mj=
I4IDEuNzcwMywuNjk1MSAxLjI1OTgsMi4zMTQybC0yLjY5Myw4LjU0MTFjLS41MzMsMS42OTA0L=
TEuNTQwMSwuODY0Mi0xLjczNjUsMS40ODY5LS4wMjgyLC4wODktLjAzNTUsLjIyMzggLjEwOSwu=
MjY5MyAuNDE2MiwuMTMxMyAxLjEyNzMsLjI3NzIgMS44MTU5LC40OTQxIDEuMjQ5MSwuMzk0IDE=
uODE5MiwuNjUyIDIuNDExOSwuODM4OSAuMzY4MSwuMTE2MSAuNTM0OSwuMDkgLjU5NjYtLjEwNT=
QgLjE3OTQtLjU2OTUtMS44NzIxLS4zMTY1LTEuMTgyMS0yLjUwNTNsMi42NzYxLTguNDg3NXoiL=
z4NCjxwYXRoIGQ9Im00MjMuNzM0NSw0MzcuOTI4NWMuMzE4LTEuMDczMyAuODE2OS0uOTI1NiAx=
LjQxMjYtLjc0OTEgMS42MjYyLC40ODE3IDIuMTM1NSwyLjA3MjUgMS42MTY0LDMuODI1Ni0uMzE=
yNiwxLjA1NTUtLjcwNiwyLjAyODktMy4xNTM0LDEuMzAzNy0uNDgyOS0uMTQyOS0xLjA3ODYtLj=
MxOTQtLjk0NjEtLjc2NjVsMS4wNzA0LTMuNjEzN3ptLTQuNDMzNyw3LjY5NmMtLjY2NzgsMi4yN=
TQtMS43OTcsMS4yNzc1LTEuOTY2NCwxLjg0OTktLjEwNiwuMzU3NyAuMjQ3OSwuNDA0NCAuNDI0=
OSwuNDU2NyAuODA1MSwuMjM4MyAxLjYzMTMsLjQwNTUgMi41MDA1LC42NjMgLjY3NjIsLjIwMDE=
gMS4wODk5LC40MDA3IDEuMzYzNywuNDgxNyAuMzcsLjEwOTUgLjUzMDcsLjA0IC41Nzg2LS4xMj=
A2IC4xOTA3LS42NDM5LTEuNjIwNi0uMzgyNy0xLjA1MzYtMi4yOTY4bC45MTY4LTMuMDk0OGMuM=
Tg1NS0uNjI2MSAuMTI1OC0uNzgwMSAuOTc5My0uNTI3MSAuODA1MSwuMjM4MyAxLjA0NzEsLjQ4=
NTEgMS4xODQxLDEuMzgybC41MTUyLDMuMjI3Yy4xOTE2LDEuMTg1NiAuMzczMSwyLjQ2NTEgMS4=
2NDUxLDIuODQxOSAuNjQzOCwuMTkwNyAxLjgyMzIsLjExMTkgMS45ODc1LS40NDI2IC4wNDIzLS=
4xNDMtLjAyMjUtLjI3ODktLjE2NzUtLjMyMi0uMTYxLS4wNDgtLjM1MzcsLjAxMS0uNTE0Ny0uM=
DM2LS4xMjktLjAzOC0uNDM0OC0uMTI5LS40OTUtLjQ1NzgtLjQ5MTMtMi41OTczLTEuMDkxNS01=
LjU5NjgtMS4wNTk4LTUuNzA0MyAuMDUyOS0uMTc4NyAuNTY3Ni0uMjAxNCAxLjE1NjMtLjQ3NDc=
gLjU5NC0uMjkxIDEuMjU3LS44MTQ0IDEuNTk2MS0xLjk1OTQgLjI0NC0uODIyOCAuNjY5Mi0zLj=
Q0MDYtMi44NTY4LTQuNDg0OS0xLjA3ODktLjMxOTctMi4xOTQ5LS41NzI0LTMuMjczNS0uODkyL=
TEuMDE0Mi0uMzAwMy0xLjEyMTktLjQxMDEtMS44NjI2LS42Mjk2LS4xOTI5LS4wNTctLjM4MDct=
LjAxNi0uNDMzNywuMTYzNS0uMTkwNywuNjQzOCAxLjc2MDQsLjUwMiAxLjE2NjcsMi41MDUzbC0=
yLjMzMTQsNy44NzEzeiIvPg0KPHBhdGggZD0ibTQzMi40NjQ5LDQ0OS40Nzk0Yy0uNTE4MywyLj=
E1ODktMi4xNTQxLC44NDUzLTIuMzI0MSwxLjU1MjQtLjA5NTksLjM5OTQgLjE4NTksLjQ0NzggL=
jQ4MDEsLjUxODQgLjY1MzEsLjE1NjcgMS4yMDkyLC4yMTM2IDIuMzAzMiwuNDc2NCAxLjA5Mzgs=
LjI2MjUgMS42MTUyLC40NjQ2IDIuMjY4NCwuNjIxMyAuNDczNiwuMTEzNyAuNzg3MSwuMjQ2NSA=
uODkxNS0uMTg4OCAuMTIyMi0uNTA4LTIuMDk0Mi0uNDgzOC0xLjU1ODQtMi43MTUzbDEuOTY4Ny=
04LjIwMDJjLjIwOTEtLjg3MDcgLjM5NDItLjkyMjIgMS4wNjM3LS43NjE1bDEuMzg3NiwuMzMzM=
mMxLjg5NTIsLjM3ODIgLjg4OTIsMi4yNjY3IDEuNTQyNCwyLjQyMzQgLjQyNDYsLjEwMiAuNDE0=
OC0uNjQ4NiAuNDM0NS0uODc0M2wuMjIxMy0xLjcxMjNjLjAyNy0uMTg1MSAuMDg4LS40MzkzLS4=
xNTY3LS40OTc4LTEuNTE4NC0uMzY0Ny0yLjYzLS41NTQ5LTUuMDEzNy0xLjEyNzMtMi4zODQtLj=
U3MjQtMy40NjA0LS45MDc1LTQuOTc4OC0xLjI3MTktLjI0NDgtLjA1OS0uMzA1OSwuMTk0OS0uM=
zY1OCwuMzcyNWwtLjgzNiwyLjMzMmMtLjA4OTYsLjIyNzktLjI4MzEsLjYwMzYgLjA1OTcsLjY4=
NiAuNzM0NywuMTc2MyAuODE1NS0yLjMxNzggMi42NjA2LTEuODc0OWwxLjM3MTUsLjMyOTJjLjY=
2OTIsLjE2MSAuODEwNywuMjkwNyAuNjAxNiwxLjE2MTZsLTIuMDIxLDguNDE3OHoiLz4NCjxwYX=
RoIGQ9Im00NTIuMjk1MSw0NDQuNDE3NmMuNjQ2NC0uOTk5NiAxLjMwNjItLjc4MjMgMS4zODQ4L=
TEuMjA0NCAuMDU3Ni0uMzExOC0uMTgzNy0uMjk5Ny0uNTMwNC0uMzYzOS0uNDYyMy0uMDg2LS45=
MzgyLS4wOTgtMS40MDA1LS4xODM3LS40Nzg3LS4wODktLjkyNzUtLjI0NzktMS40MDYyLS4zMzY=
2LS4xOTgxLS4wMzctLjY2NjktLjE4MDMtLjczMTQsLjE2OC0uMTE5MSwuNjQyMSAxLjY3NDMsLj=
I3MjQgMS4zNTQ3LDEuOTk2OC0uMDU0MywuMjkzOC0uMjA2NCwuOTI5Ny0uOTI5NSwyLjA2NjlsL=
TMuMjk1Nyw1LjE1NzhjLS4wNzMyLC4xMTktLjE4NjgsLjM2MzgtLjI4NTksLjM0NTItLjA5OS0u=
MDE4LS4xMzQtLjI5MDQtLjE1OTgtLjQyOGwtMS4wNTE2LTYuMzA0N2MtLjIwNTUtMS4xOTU3LS4=
yNi0yLjA5NzktLjE1OC0yLjY0OCAuMTQyOS0uNzcwNSAxLjA4MjUtLjMxMTggMS4xNzQzLS44MD=
czIC4wNTc2LS4zMTE4LS4wMjgyLS4zMDg3LS41NTYzLS40MDY3LS4yNjQyLS4wNDktLjc1NjctL=
jA2NC0xLjgxMzMtLjI2LS41NjE0LS4xMDQtMS4xMDkzLS4yODE0LTEuNjU0MS0uMzgyNC0uMjQ3=
Ni0uMDQ2LS43MzIyLS4yODc2LS44MTM4LC4xNTI0LS4wMjM5LC4xMjg1IC4xNzA0LC4yNzgzIC4=
yMTY2LC4zMDU5IC42NDI3LC4zMDkgLjgzNjYsLjU1MzUgLjk4NDYsMS4zMjA5bDIuMTMyMiwxMS=
40Mzg5Yy4xNTQ0LC44MjU2IC4yODU2LDEuMDM5NyAuNDUwOCwxLjA3MDQgLjE4MTQsLjAzNCAuM=
jg0NS0uMDYxIC41NTQ2LS41MDQ1bDYuNTM0MS0xMC4xOTMyeiIvPg0KPHBhdGggZD0ibTQ1My4y=
MjYsNDU0LjkzMTJjLjAwOSwuNDU1Ni0uMDMyNCwuNiAuMzYzLC43Nzk1IC45MjA3LC40MDAxIDE=
uNjkxNSwuOTgzMiAyLjcwMTcsMS4xNTIgMi4xNjkzLC4zNjMgMy45NjcyLTEuMDE5OCA0LjM3MD=
QtMy40MzAyIC4zOTExLTIuMzM3MS0uNTY5Ni0zLjMxMTMtMi4xOTY5LTQuNDcyNi0yLjAzNzMtM=
S40NTcxLTIuOTA4My0xLjg0ODgtMi43MDItMy4wODE2IC4yMDYyLTEuMjMyOCAxLjA2ODUtMS44=
MDc0IDIuMTYxNy0xLjYyNDUgMi44NDg2LC40NzY3IDIuNTI0MiwzLjk0MSAyLjkwNDksNC4wMDQ=
2IC4zNjQ0LC4wNjEgLjQ1MTEtLjE1MTUgLjQ4NTctLjU2MTdsLjIzMDUtMi40OTY2Yy4wMzc4LS=
40Mjg1IC4xMzM3LS42OTY0LS4xMTQ4LS43Mzc4LS4yMTUyLS4wMzYtLjY3ODcsLjE4OTEtLjg5M=
zcsLjE1MzEtLjQ5NjktLjA4My0xLjA3MjQtLjkxNzQtMi40MzA1LTEuMTQ0NS0xLjkzNzctLjMy=
NDQtMy41MjE0LC45OTk2LTMuODc1NCwzLjExNTktLjMyMzMsMS45MzIxIC41MzM4LDIuODEzMiA=
xLjg0MDksMy43NTA4IDIuNDQ3OSwxLjc1MjkgMy40NTExLDIuMTY2NSAzLjE4OTQsMy43MzA4LS=
4yNDY1LDEuNDcyLTEuMzg3OSwyLjE4OS0yLjY3OTgsMS45NzI5LTEuODM4MS0uMzA3OC0yLjU4N=
DctMi4xNTQxLTIuODE5MS00LjAwOTQtLjAyNjEtLjI1MDEtLjAzMTUtLjQyMTItLjI5NjYtLjQ2=
NTctLjQxNDItLjA2OS0uMzM3NywuNDkyMi0uMzMxMiwuNzU4MWwuMDkxOSwyLjYwNjl6Ii8+DQo=
8cGF0aCBkPSJtNDc3Ljk1NDksNDQ3Ljk1NTNjLjUzODMtMS4wNjIgMS4yMTczLS45MTQ4IDEuMj=
UxMS0xLjM0MjYgLjAyNDctLjMxNjMtLjIxMzktLjI3OTEtLjU2NTYtLjMwNjctLjQ2ODUtLjAzN=
y0uOTQzMiwuMDAwOS0xLjQxMjEtLjAzNi0uNDg1NC0uMDM4LS45NDgtLjE0OTctMS40MzM3LS4x=
ODgtLjIwMDgtLjAxNi0uNjgxOC0uMTA5Ni0uNzA5NywuMjQzNy0uMDUxMSwuNjUwOSAxLjY5Mzc=
sLjA5NiAxLjU1NjEsMS44NDQzLS4wMjM1LC4yOTc3LS4xMDgxLC45NDYxLS43MDg2LDIuMTUyN2=
wtMi43MzgzLDUuNDczOGMtLjA2MDUsLjEyNjMtLjE0NzksLjM4MTMtLjI0ODUsLjM3MzQtLjEwM=
DQtLjAxLS4xNjM0LS4yNzQ5LS4yMDM1LS40MDg4bC0xLjcwNDctNi4xNjA0Yy0uMzI5Mi0xLjE2=
NzgtLjQ3ODEtMi4wNTktLjQzNDItMi42MTcxIC4wNjEyLS43ODExIDEuMDQ0LS40MjMyIDEuMDg=
zNC0uOTI1NSAuMDI0Ny0uMzE2LS4wNjAyLS4zMDM5LS41OTYtLjM0NjEtLjI2NzktLjAyLS43NT=
ksLjAxNi0xLjgzMDUtLjA2OS0uNTY5LS4wNDUtMS4xMzIzLS4xNjQxLTEuNjg0Ny0uMjA3My0uM=
jUxLS4wMi0uNzU4NC0uMjA5Ni0uNzkzNSwuMjM2Ny0uMDExMywuMTMwMyAuMTk4OCwuMjU5MSAu=
MjQ3MywuMjgxNiAuNjcxNywuMjQwMSAuODg5OCwuNDYzMiAxLjExNzUsMS4yMTA5bDMuMzE2Myw=
xMS4xNTMzYy4yMzk4LC44MDUxIC4zOTI2LDEuMDA0IC41NiwxLjAxNzIgLjE4MzksLjAxNCAuMj=
c2Ni0uMDkxIC40OTg5LS41NTk3bDUuNDMzLTEwLjgyMDF6Ii8+DQo8cGF0aCBkPSJtNDgwLjU5O=
TQsNDU2Ljk5OTJjLS4wMTU4LDEuOTAyOC0xLjYyNTYsMS41NTMxLTEuNjMyMSwyLjI5OTMtLjAw=
MiwuMzE3MiAuMzMzNywuMjI2OCAuNTE4NiwuMjI4NSAuNDUzMywwIC45MDcyLS4wNjcgMS40NDQ=
0LS4wNjIgLjU4NzksLjAxIDEuMTU4LC4wODUgMS45ODA4LC4wOTIgLjIxODQsMCAuNjM3OSwuMD=
I0IC42NDAyLS4yMzY5IC4wMDctLjg3NjktMi4xNTI3LC4zNzI4LTIuMTIxNS0zLjIwOTFsLjA1N=
TMtNi4zNDMzYy4wMDEtLjE2NzkgLjAzNi0uMjk4MyAuMTM2OS0uMjk3NSAuMDg0MiwuMDAwOSAu=
MTgzOSwuMDk1IC4zMDAzLC4yNDU0bDcuOTkyLDkuNzcxOWMuMTE2MiwuMTUwNCAuMTk5MiwuMjY=
yOCAuNDM0MiwuMjY1MSAuMjAxNSwwIC4yMDI4LS4xNDc1IC4yMDY0LS41NThsLjA5MTItMTAuND=
Y2NGMuMDE1OC0xLjk1ODggMS40NDAyLTEuNDk4NyAxLjQ0NTMtMi4wNTg0IC4wMDA2LS4wNTYgL=
jAwMi0uMjQyNi0uMzE2OC0uMjQ1NC0uMTUxLDAtLjczOTUsLjA2OC0xLjc5NzMsLjA1OS0xLjE1=
ODgtLjAxMS0xLjY0NTEtLjA4OS0xLjkxMzgtLjA5MS0uMjE4MSwwLS4yNzAxLC4xODQzLS4yNzE=
zLC4zMTQ4LS4wMDUsLjYxNTcgMi4wNDYsLjI5NzggMi4wMzExLDEuOTk1NWwtLjA1NDEsNi4yMT=
I3Yy0uMDA1LC40NjYzLS4wMzk2LC42OS0uMTQwNSwuNjg5MS0uMTAwNi0uMDAwOC0uMzAwMi0uM=
jI2NS0uNTE2My0uNDg5NmwtNi42NzgyLTguMjg2NmMtLjI5OTEtLjM1NzEtLjA5NjYtLjQ4Ni0u=
NjMzNy0uNDkwNS0uODkwMS0uMDEtMS4zMjc0LC4wNjMtMS43NjM4LC4wNTktLjMxOTEsMC0uNjI=
wOC0uMDgtLjkzOTYtLjA4My0uMjAxNSwwLS4yODY3LC4xNDY1LS4yODgyLC4zMTQ2LS4wMDksLj=
g5NTQgMS44ODMxLS4zMDA4IDEuODUxOSwzLjI4MTRsLS4wNjE3LDcuMDg5NnoiLz4NCjxwYXRoI=
GQ9Im00OTYuODYxLDQ0OC42MDA4Yy4wMTU4LTEuNzcyNSAxLjI2OTEtMS4wODk4IDEuMjc0NS0x=
LjcyNDEgLjAwMi0uMjI0LS4wODE0LS4yNjItLjU4NTMtLjI2NjUtLjk1NzEtLjAxLTEuNTYyMyw=
uMDYxLTIuMTY2NSwuMDU2LS41ODc4LDAtMS4yNDIxLS4wODYtMS44OTY5LS4wOTEtLjE1MS0uMD=
AxLS41NzA0LS4wNjEtLjU3MzIsLjI1NjQtLjAwNSwuNjUyOCAxLjgwMjksLjE0NzIgMS43ODgsM=
S44NDQ4bC4wMTU4LDguOTU1M2MtLjAxNTgsMS43NzIyLTEuMjIwMSwxLjI3NjctMS4yMjU4LDEu=
OTI5OC0uMDAwOCwuMDkzIC4wMzE1LC4yMjQgLjE4MjYsLjIyNTQgLjQzNjcsLjAxIDEuMTU5NC0=
uMDY0IDEuODgxNC0uMDU4IDEuMzA5NiwuMDExIDEuOTMwNCwuMDkxIDIuNTUxNCwuMDk3IC4zOD=
Y0LDAgLjUzOC0uMDcgLjUzOTctLjI3NTIgLjAwNS0uNTk3MS0xLjg4MjgsLjI0NDgtMS44NjI5L=
TIuMDVsLjA3NzYtOC44OTkyeiIvPg0KPHBhdGggZD0ibTUwMy44OTgyLDQ1Ny4yNzFjLjAyMDIs=
Mi4yMjAzLTEuODg1OSwxLjM0MTItMS44Nzk1LDIuMDY4OSAuMDA1LC40MTA2IC4yODg3LC4zODk=
0IC41OTEyLC4zODY2IC42NzE0LS4wMSAxLjIyNDktLjA4NSAyLjM1LS4wOTUgMS4xMjUtLjAxID=
EuNjc5NywuMDYgMi4zNTE0LC4wNTQgLjQ4NjgsMCAuODIzNCwuMDQ5IC44MTk0LS4zOTktLjAwN=
S0uNTIyNi0yLjE0OSwuMDM3LTIuMTY5My0yLjI1NzRsLS4wNzM0LTguNDMzYy0uMDA3LS44OTU0=
IC4xNTk0LS45OTAyIC44NDc2LS45OTYxbDEuNDI3My0uMDExYzEuOTMwNC0uMDkxIDEuNDExMiw=
xLjk4NDEgMi4wODI5LDEuOTc4MiAuNDM2NCwwIC4yNDU0LS43Mjk5IC4yMDk4LS45NTM0bC0uMT=
k5Ny0xLjcxNDhjLS4wMTgxLS4xODY2LS4wMjAyLS40NDc3LS4yNzI0LS40NDU1LTEuNTYxOCwuM=
DE0LTIuNjg2LC4wOTgtNS4xMzc1LC4xMTk1LTIuNDUxNiwuMDItMy41NzcyLS4wNDQtNS4xMzg5=
LS4wMy0uMjUxOCwwLS4yNDk2LC4yNjM0LS4yNjQ4LC40NTAzbC0uMjQ3MSwyLjQ2NWMtLjAzMTU=
sLjI0MjktLjEyODUsLjY1NCAuMjI0LC42NTEyIC43NTU4LS4wMSAuMjMwOC0yLjQ0NjIgMi4xMj=
c5LTIuNDYyOGwxLjQxMDQtLjAxNGMuNjg4Ni0uMDEgLjg1NzEsLjA4NiAuODY1LC45ODEybC4wN=
zU3LDguNjU2N3oiLz4NCjxwYXRoIGQ9Im01MTMuNjc4OCw0NTMuNzM5NWMtLjMwMTQsLjAyNC0u=
NTM0NCwuMDYxLS41NDktLjEyNTItLjAyMDItLjI2MDMgLjA2MzktLjQ3MjggLjEyOTktLjcwMjd=
sMS4wMjk5LTMuMzkzM2MuMDY3NS0uMjExNCAuMTMzLS4yMzUzIC4xNjY2LS4yMzc4IC4wODM1LS=
4wMSAuMDMzNiwwIC4xNDU0LC4xMzgybDEuNjM3NywzLjI1ODZjLjEwMTMsLjIxNjUgLjIxNzcsL=
jQxMzMgLjIzODMsLjY3MzcgLjAxMzUsLjE4NTktLjIyMTMsLjE4NTctLjUyMjYsLjIwOTVsLTIu=
Mjc2NSwuMTc5em0yLjg3NDUsLjc4NDVjLjQzNTMtLjAzNCAuNTMzNSwuMTQ1MiAxLjIwMDIsMS4=
1NTI1IC4yMjM4LC40ODc3IC4zNjcyLC44MTMyIC4zOTkzLDEuMjIyNCAuMDg5NiwxLjEzNDYtMS=
4xMTUyLDEuMDIzNC0xLjA3MjcsMS41NjI5IC4wMjAyLC4yNjA2IC4yMzUyLC4yMDYyIC41MzYzL=
C4xODIzIC40ODU3LS4wMzggMS4wOTkyLS4xNjExIDEuODM1Ni0uMjE5MiAxLjEwNS0uMDg3IDEu=
NTYyNi0uMDQ4IDIuMTY1NC0uMDk2IC40NTE5LS4wMzUgLjYwNTYtLjAxMSAuNTgwOC0uMzI2NS0=
uMDQ4NC0uNjEzNy0uODk1MSwuMTgyOC0xLjUzNS0xLjA5NTRsLTUuNDE1Ni0xMS4wMjc1Yy0uMj=
YxNy0uNTQwOS0uMjk4LS41NzU1LS40NDg4LS41NjM3LS4yMTc1LC4wMTgtLjI3MzUsLjM3NzEtL=
jM2NzIsLjY4NDFsLTMuNjUwOSwxMS42MWMtLjMzNjMsMS4wNzQ0LTEuMTk4OCwxLjAyOTktMS4x=
NjUzLDEuNDU3NyAuMDIwMiwuMjQyIC4yODM5LC4xODM0IC41MTgzLC4xNjUyIC40ODU0LS4wMzg=
gLjk2NTItLjE1MDggMS40NjcyLS4xOTA1IC41MzU4LS4wNDIgMS4wNDM3LS4wMSAxLjU3OTUtLj=
A0OSAuMzUxNS0uMDI4IC44ODA4LC4wNjIgLjg1MDEtLjMyODktLjAzOTYtLjUwMi0xLjgyNDMtL=
jA2Mi0xLjkyOTYtMS40MDE0LS4wMzUxLS40NDY2IC4xNDc5LTEuMTE2IC4yMzU4LTEuNDk3IC4y=
ODg1LTEuMjU4MiAuNjM0My0xLjM2IC45MTg4LTEuMzgyNWwzLjI5NzctLjI1OTV6Ii8+DQo8cGF=
0aCBkPSJtNTI5LjUzMTgsNDQ2Ljc5MjhjLS4xNjg0LTEuMjc2NC0uMTA0Mi0xLjMwMzcgMS45MT=
A0LTEuNTY4OCAzLjIxMy0uNDIzMiAyLjE5OTQsMS45MTIxIDIuOTgyLDEuODA5MiAuMzgyNy0uM=
DUgLjIxOTMtLjY0OTggLjE3MDktLjg4ODJsLS4zMDc2LTEuODIyNmMtLjAyMjUtLjE2NjYtLjE2=
My0uMzM2LS4zNzkzLS4zMDc1LTEuNDY1LC4xOTI3LTIuNjA0MSwuNDE4MS0zLjc4NiwuNTczNy0=
yLjU0NzIsLjMzNTItMy43NTU1LC40MTktNC40MzgsLjUwODgtLjIzMzMsLjAzMS0uMzQ2OSwuMT=
k2My0uMzI1LC4zNjMgLjA5NzQsLjczOTggMS45MDA4LS4xIDIuMTIwMSwxLjU2NDlsMS4xMzk3L=
DguNjU3MmMuMjk2OSwyLjI1NjYtMS4wOTk3LDEuNDI0NS0uOTg3NywyLjI3NTEgLjAxNTgsLjEx=
MTMgLjEyNjgsLjE5MDUgLjM0MywuMTYyMSAuOTE1Ny0uMTIwNiAxLjYwNTEtLjI4NjcgMi4xMjE=
yLS4zNTQ1IC43MzI4LS4wOTcgMS4zNTgzLS4xMDM2IDEuOTkwOS0uMTg2OSAuNDE2Mi0uMDU1IC=
43NzU1LS4wMjcgLjcyNjgtLjM5Ny0uMDY1Ny0uNDk5Mi0xLjg4NTksLjIxMDctMi4xNTYzLTEuO=
DQyNGwtLjM2MDUtMi43Mzc3Yy0uMTQxMi0xLjA3My0uMjM2OS0xLjI4NiAuNTI4OC0xLjM4N2wx=
LjIzMi0uMTYyMWMxLjczMTQtLjIyNzkgMS41MjM1LDEuNzk0MiAyLjA1NjIsMS43MjQxIC4zOTk=
2LS4wNTMgLjIxMTgtLjcwNTQgLjE2MzktLjk0MzhsLS41NTAxLTMuMjc3MWMtLjA4MjQtLjQ5Nz=
MtLjI2MDYtLjQzNjItLjM3NzEtLjQyMS0uMzMzMiwuMDQ0LS4xNTg5LDEuNzUyMi0xLjU5MDgsM=
S45NDA4bC0xLjA0ODgsLjEzODJjLS43MTU5LC4wOTQtLjczMjgtLjAzNS0uODM3Ny0uODMwN2wt=
LjM0MDgtMi41ODk3eiIvPg0KPHBhdGggZD0ibTUzNS42NjY4LDQ1MS4wMzAyYy42OTAzLDMuNzI=
0IDMuMzc4Miw1Ljc4NzUgNi42OTY3LDUuMTcyNCA1LjI2NjktLjk3NTkgNS40NDA4LTUuNjU3My=
A0Ljk2NS04LjIyNTMtLjcyMS0zLjg4OTMtMy42MTk3LTUuOC02LjgzMjQtNS4xNjY1LTMuOTM5L=
C43Njc5LTUuNTc0LDQuMjAxOC00LjgyOTQsOC4yMTk0em0xLjgzNy0xLjQyMmMtLjQ5My0yLjY2=
LS4xMzY5LTUuMzQ0OSAyLjY0MzUtNS45MTcgMi4xMjI5LS40MzEzIDQuNTMxNywxLjMyMzUgNS4=
yODMsNS4zNzc2IC41NjQ1LDMuMDQ1MyAuMDk1Nyw1LjY3NS0yLjczNDEsNi4yNTY0LTIuOTQ1MS=
wuNjAyNy00LjY5Ni0zLjAzODYtNS4xOTI0LTUuNzE3eiIvPg0KPHBhdGggZD0ibTU1MC41MjU5L=
DQ0My4xMDljLS4yNjExLTEuMDg4NyAuMjQ1MS0xLjIxIC44NDktMS4zNTUyIDEuNjQ5My0uMzk1=
OSAyLjg4NiwuNzI3MiAzLjMxMjYsMi41MDUgLjI1NzIsMS4wNzA1IC40MDMsMi4xMS0yLjA3ODc=
sMi43MDU3LS40ODk5LC4xMTc3LTEuMDk0MSwuMjYyNS0xLjIwMy0uMTkwN2wtLjg3OTktMy42Nj=
Q2em0uMDA5LDguODgxOGMuNTQ4NywyLjI4NTktLjkxNzQsMi4wMDQ1LS43NzgxLDIuNTg1IC4wO=
DY5LC4zNjMgLjQxNjgsLjIyNjIgLjU5NjYsLjE4MzIgLjgxNjQtLjE5NiAxLjYxNTItLjQ2NDYg=
Mi40OTcxLS42NzYyIC42ODU1LS4xNjQ1IDEuMTQzOS0uMTk4MSAxLjQyMTQtLjI2NDUgLjM3NTc=
tLjA5IC40ODAxLS4yMzA1IC40NDA5LS4zOTM3LS4xNTY3LS42NTMxLTEuNTk0NywuNDc4Ny0yLj=
A2MDctMS40NjI0bC0uNzUzNi0zLjEzODVjLS4xNTIyLS42MzUxLS4yODA4LS43Mzg2IC41ODQ0L=
S45NDYzIC44MTY0LS4xOTU5IDEuMTQ5NS0uMTAzMyAxLjcxNjgsLjYwNDdsMi4wNTk2LDIuNTM3=
NGMuNzU5LC45MzA2IDEuNTU1OSwxLjk0ODEgMi44NDU1LDEuNjM4NiAuNjUzMS0uMTU2NyAxLjY=
zNDktLjgxNDcgMS41MDAxLTEuMzc3Mi0uMDM0OC0uMTQ0OS0uMTU4OS0uMjMwNC0uMzA2Mi0uMT=
k0OS0uMTYzMiwuMDM5LS4zMDAzLC4xODcxLS40NjM3LC4yMjY1LS4xMzA2LC4wMzEtLjQ0MDcsL=
jEwNTYtLjY1NzMtLjE0OTUtMS43MjQ0LTIuMDAzNS0zLjc0MzctNC4zMDA5LTMuNzY5OS00LjQw=
OTgtLjA0MzctLjE4MTQgLjM5MDYtLjQ1ODQgLjc2NC0uOTg5NCAuMzY5Mi0uNTQ5IC42ODE2LTE=
uMzMzOCAuNDAyNy0yLjQ5NDktLjIwMDQtLjgzNDYtMS4xNDExLTMuMzE0My00LjcxNjgtMi40NT=
U3LTEuMDk0MSwuMjYyNS0yLjE4NjcsLjYwMTYtMy4yODA4LC44NjQxLTEuMDI4NSwuMjQ3MS0xL=
jE3NjYsLjIwNTgtMS45Mjc5LC4zODYxLS4xOTU5LC4wNDctLjMzNzQsLjE3Ny0uMjkzOCwuMzU4=
NSAuMTU2NywuNjUzMiAxLjc3NTQtLjQ0NTQgMi4yNjMzLDEuNTg2NmwxLjkxNjMsNy45ODI0eiI=
vPg0KPHBhdGggZD0ibTU2NC4wMDUyLDQ0OC45ODFjLjU1NiwyLjE0OTYtMS41MDUyLDEuNzU3Ni=
0xLjMyMzIsMi40NjIgLjEwMjcsLjM5NzYgLjM3NDYsLjMwODEgLjY2NzIsLjIzMjQgLjY1MDMtL=
jE2ODIgMS4xNjgxLS4zNzkzIDIuMjU3NC0uNjYxIDEuMDg5LS4yODE3IDEuNjQ0Mi0uMzQ4MSAy=
LjI5NDUtLjUxNjQgLjQ3MTMtLjEyMTggLjgxMDQtLjE1MTcgLjY5ODQtLjU4NTMtLjEzMDgtLjU=
wNTctMi4wNzYyLC41NTYzLTIuNjUwOC0xLjY2NTZsLTIuMTExNi04LjE2NDVjLS4yMjQyLS44Nj=
ctLjA4NTEtLjk5OTMgLjU4MTQtMS4xNzE4bDEuMzgxOS0uMzU3M2MxLjg1MDgtLjU1NTggMS44N=
DkxLDEuNTgzNyAyLjQ5OTQsMS40MTU3IC40MjI3LS4xMDk0IC4wNjE3LS43Njc3LS4wMjctLjk3=
NTlsLS42MDg3LTEuNjE1NWMtLjA2MjgtLjE3NjUtLjEyODMtLjQyOTUtLjM3Mi0uMzY2NC0xLjU=
xMiwuMzkxMS0yLjU4MjQsLjc0NTEtNC45NTYsMS4zNTg5LTIuMzczMywuNjEzNy0zLjQ4MTIsLj=
gyMzEtNC45OTMyLDEuMjE0Mi0uMjQzNywuMDYzLS4xNzg1LC4zMTYtLjE0ODEsLjUwMDZsLjM1N=
jUsMi40NTE4Yy4wMjg0LC4yNDMyIC4wMzM2LC42NjU4IC4zNzQ4LC41Nzc1IC43MzE2LS4xODkx=
LS4zNjgxLTIuNDI5MyAxLjQ2ODktMi45MDQzbDEuMzY1Ni0uMzUzMmMuNjY2Ni0uMTcyNCAuODU=
yNC0uMTI0IDEuMDc2NiwuNzQyOWwyLjE2NzYsOC4zODEyeiIvPg0KPHBhdGggZD0ibTU3Mi42MD=
I1LDQzNy41MTcxYy0uNDczOS0xLjcwNzkgLjkxOTQtMS4zOTcyIC43NS0yLjAwODctLjA1OTktL=
jIxNTYtLjE1MDgtLjIyOS0uNjM2My0uMDk1LS45MjI0LC4yNTU4LTEuNDg0OSwuNDg5NC0yLjA2=
NzQsLjY1MDktLjU2NjIsLjE1NjktMS4yMTczLC4yNi0xLjg0ODIsLjQzNS0uMTQ1OSwuMDQtLjU=
2NTMsLjA5OC0uNDgwNiwuNDA0NCAuMTc0NywuNjI5MiAxLjg2MzQtLjM4MTMgMi4zMTcsMS4yNT=
Q4bDIuMzkzNiw4LjYyOTljLjQ3MzYsMS43MDc5LS44MjExLDEuNTYzNS0uNjQ2NywyLjE5MyAuM=
DI1LC4wOSAuMDkyMywuMjA2OSAuMjM4MSwuMTY2NCAuNDIwNC0uMTE2OSAxLjA5NjMtLjM4MTYg=
MS43OTIyLS41NzQ2IDEuMjYyMS0uMzUwMSAxLjg4MDYtLjQ0NDEgMi40Nzk0LS42MTAxIC4zNzI=
zLS4xMDM0IC40OTc4LS4yMTU1IC40NDI5LS40MTM0LS4xNTk2LS41NzUyLTEuNzQyNCwuNzU0NC=
0yLjM1NTYtMS40NTcxbC0yLjM3ODQtOC41NzU5eiIvPg0KPHBhdGggZD0ibTU3Ni4xODI4LDQ0M=
S42OTQ3YzEuMjAxOCwzLjU5MTggNC4xNTA5LDUuMjYxMSA3LjM1MTYsNC4xOTAxIDUuMDc5Ni0x=
LjY5OTQgNC42MDA2LTYuMzU5NCAzLjc3MTYtOC44MzY1LTEuMjU1LTMuNzUwOC00LjM5MTMtNS4=
yMzk0LTcuNDg0Ny00LjE2NTEtMy43OTM4LDEuMzA4OC00LjkzNDksNC45MzY2LTMuNjM4NSw4Lj=
gxMTV6bTEuNjIxNC0xLjY2MzljLS44NTg2LTIuNTY1Mi0uODc5NC01LjI3MzQgMS43OTM5LTYuM=
jI3MSAyLjA0MjQtLjcyMjYgNC42NzE4LC42Nzk5IDUuOTgwMyw0LjU4OTkgLjk4MjcsMi45Mzcz=
IC44ODQyLDUuNjA2NC0xLjgzNyw2LjU3NjEtMi44MzI2LDEuMDA2NS01LjA3MzEtMi4zNTU3LTU=
uOTM3Mi00LjkzODl6Ii8+DQo8cGF0aCBkPSJtNTg5LjcxNTYsNDMxLjU2MTVjLS40MTAzLTEuMD=
QxNCAuMDc0MS0xLjIzMjIgLjY1MjMtMS40NTk5IDEuNTc4MS0uNjIxNiAyLjk1ODksLjMxODMgM=
y42Mjg5LDIuMDE5MyAuNDAzNSwxLjAyNDMgLjY5MjUsMi4wMzM0LTEuNjgxOSwyLjk2ODgtLjQ2=
ODgsLjE4NDYtMS4wNDY4LC40MTIzLTEuMjE3OS0uMDIzbC0xLjM4MTQtMy41MDY1em0xLjI0NDY=
sOC43OTQzYy44NjE3LDIuMTg3MS0uNjI5OCwyLjExMjgtLjQxMDgsMi42NjgzIC4xMzY3LC4zND=
cyIC40NDQzLC4xNjYxIC42MTYzLC4wOTggLjc4MTItLjMwNzYgMS41MzUtLjY4NDcgMi4zNzg0L=
TEuMDE3IC42NTYyLS4yNTg2IDEuMTA1Ni0uMzU1MSAxLjM3MS0uNDYwMSAuMzU5Ni0uMTQxMiAu=
NDQzNS0uMjk0NiAuMzgxOC0uNDUxMS0uMjQ2Mi0uNjI1LTEuNTEyNSwuNjk2Mi0yLjI0NDEtMS4=
xNjEzbC0xLjE4My0zLjAwMzFjLS4yMzkyLS42MDc2LS4zODEtLjY5MjMgLjQ0NzEtMS4wMTg0IC=
43ODEyLS4zMDc2IDEuMTIzOS0uMjYyMyAxLjc4NDEsLjM1OTlsMi4zOTI3LDIuMjI1OWMuODgxL=
C44MTYgMS44MTE3LDEuNzEyOCAzLjA0NTksMS4yMjY2IC42MjUtLjI0NjIgMS41MDU4LTEuMDM0=
MSAxLjI5MzYtMS41NzI1LS4wNTQ1LS4xMzg3LS4xODkzLS4yMDYtLjMyOTgtLjE1MDYtLjE1NjU=
sLjA2Mi0uMjcxNSwuMjI3MS0uNDI3NywuMjg4Ny0uMTI0OSwuMDQ5LS40MjE4LC4xNjYyLS42Nz=
ItLjA1Ni0xLjk4NjQtMS43NDQxLTQuMzA2LTMuNzM4MS00LjM0NjgtMy44NDIyLS4wNjg3LS4xN=
zM2IC4zMjMtLjUwODIgLjYxODgtMS4wODU5IC4yODktLjU5NTIgLjQ4OTEtMS40MTYgLjA1MTUt=
Mi41MjctLjMxNDYtLjc5ODYtMS41OTEzLTMuMTIzLTUuMDEyOS0xLjc3NTMtMS4wNDY4LC40MTI=
1LTIuMDgxOCwuOTAwMi0zLjEyODYsMS4zMTI3LS45ODQxLC4zODc3LTEuMTM2MywuMzY3NS0xLj=
g1NTMsLjY1MDYtLjE4NzUsLjA3NC0uMzA5NSwuMjIxOS0uMjQxMSwuMzk1NiAuMjQ2MiwuNjI1I=
DEuNjk2My0uNjg4IDIuNDYyMywxLjI1NjJsMy4wMDg3LDcuNjM4eiIvPg0KPC9nPg0KPGcgc3Ry=
b2tlLW1pdGVybGltaXQ9IjMuODY0Ij4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZT0iIzcwM2QyOSI=
+DQo8ZyBzdHJva2Utd2lkdGg9Ii45ODciPg0KPHBhdGggZD0ibTYyMC43MjEzLDM5MS45MzM0Yy=
0yLjQ3MzgtMi4yNzk5LTUuMDM2Mi01LjQzOTctNy41MDY5LTEwLjA3NzItMS4zMTA1LTIuNDYwM=
y0yLjEyNDYtNC43NDMzLTIuNjcyNS02Ljk5MjUtLjQyMjktMS43MzU0LS43MTU5LTMuNDUwNS0u=
Nzc5Mi01LjIxMS0uMTA3OC0zLjAwMDIgLjIxNS02LjEzMjIgLjk2MzgtOS43MjEyIDEuMjM2Mi0=
1LjkyNTEgMy40NDI2LTEwLjUwODYgNi4zNzU0LTE0LjE0OTkgLjk5OTgtMS4yNDE4IDIuMTU0NC=
0yLjc5MTUgMy4yNTA3LTMuNDg3OSIvPg0KPHBhdGggZD0ibTYyNC41Mzg1LDM4My4xNjk4Yy0uN=
jc4Ny0uNTU0NC0xLjQwNjQtMS4wMjQ2LTIuMDQxOC0xLjY4OTUtMy44MjU5LTQuMDA0NC02Ljcw=
MzgtOS45MjQyLTYuNzQyMy0xNi42NzY2LS4wMzY5LTYuNDczNyAyLjU2NTgtMTMuMDYxNSA1LjU=
5NzktMTUuNjI3Ii8+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm9rZS13aWR0aD0iLjg4MSIgZD0ibT=
YxNS4zMzMxLDM2My4xNjQyIC4xOTYxLTIuNTAyMiAuODM0MS0zLjk3MzkgMS4xNzc0LTMuMDkwO=
SAxLjMyNDUtMi41NTEyIDEuNzE3MS0yLjA2MDYiLz4NCjxwYXRoIHN0cm9rZS13aWR0aD0iMS4z=
NTYiIGQ9Im02MjcuNTA1Myw0MDIuNzkwN2MuNzgyMywuMzAwOCAxLjU2MDQsLjU3MTggMi4yNDM=
2LC43NjcxIDIuMjM2LC42Mzg3IDQuMzM3MiwuNjg4MyA2LjE1ODQsLjE0MTggNC40MjI1LTEuMz=
I2NSA3LjI2MTMtNS40NTg5IDQuOTU5Ny0xMC44MjkxLS41MzM4LTEuMjQ1Mi0xLjU1NTYtMi40M=
zkyLTIuNzE2NC0zLjMzMzUiLz4NCjwvZz4NCjxnIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8cGF0=
aCBkPSJtNjM4Ljk4OTgsMzkwLjQ1OGMuMDY3OC0uMzY1IC4xMDMzLS43NDA5IC4xMDMzLTEuMTI=
1IDAtMS44MTA1LS43NTcyLTMuNDY4LTIuMDA5Mi00LjU4NTctLjQyNzUtLjM4MTYtLjg0MTQtLj=
k3MzYtMS4zNTk1LTEuMjMyOCIvPg0KPHBhdGggZD0ibTYzNi40NzA0LDM4NC4yNTA0Yy0uMDcyN=
y0yLjkxMjMtMi40NTYxLTQuOTk1NC01LjQwOTktNS41MTM1Ii8+DQo8cGF0aCBkPSJtNjIxLjU0=
NDQsMzQ5LjM3NzFjMS41NzI1LDIuMDU0NyA0LjUzODQsMi41ODggNi44ODI3LDEuOTc2NSAxLjc=
3MTctLjQ2MjEgMy4wNjc1LTEuNTc4MSAzLjg5NTctMy4wMzEyIC45MzQ1LTEuNjQgMS4yMTczLT=
MuNzc5OCAuNjEwNC01LjgyMzktLjI3NTItLjkyNjYtLjY2MjQtMS43MDY5LTEuMzI1NC0yLjU4M=
S0uNjY2MS0uODc3Ny0xLjQ5Mi0xLjgxMTEtMi4xMzIyLTIuMjI5OC0uMTY5Ny0uMTExLS4zMzkx=
LS4yNjE0LS41MTgzLS4zODMiLz4NCjwvZz4NCjxnPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIuODg=
xIiBkPSJtNjMyLjc0MSwzNDMuNjc0Mi0uMTk0NSwyLjQ0OS0uNjk5OCwxLjY3MTgtMS4wODg0LD=
EuNTkzOS0xLjI0MzgsLjkzMjgtMS45MDQ4LC42OTk2LTEuNjcxNSwuMTE2OC0xLjI0NDEtLjE5N=
DUiLz4NCjwvZz4NCjxnIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8cGF0aCBzdHJva2UtbGluZWNh=
cD0icm91bmQiIGQ9Im02MjkuMjQyNCwzOTcuMTY0MWMuMTMzNSwuMTQ0NyAuNTgxNCwuMjE3MiA=
uNzM4NywuMzEwOSAyLjIxNTcsMS4zMjE3IDYuNTc3NC0uMzI2NCA1LjI5NDUtMy43NDc0Ii8+DQ=
o8cGF0aCBkPSJtNjE4LjIwMjgsMjIzLjgzMDZjMy45NjUyLC4zMTA5IDcuNjM4Niw0LjU3OTIgN=
y41OTAyLDguNzYzOS0uMDcwMyw2LjA3ODItMi4xMDgyLDguNTg5NC02Ljg5MDcsMTQuNTQ0Ny00=
LjEyMDUsNS4xMzEzLTE2LjQ4MjQsMTQuMTQ5OS0xNi4xNzE1LDIyLjc3OTYgLjA1NTEsMS41MzE=
2IC44ODAyLDMuMTE1NCAxLjgwMjEsNC4zODk1Ii8+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm9rZS=
13aWR0aD0iLjg4MSIgZD0ibTYwMi4zMzQ3LDI2OC40MTU2IC41NDQyLTIuNjQzNSAxLjE2NjEtM=
i40NDkgMS41MTYyLTIuNDQ5MSAyLjYwNDYtMy4zNDMgMi4wNjAxLTIuMjkzNyAzLjM0My0zLjM4=
MTggMi44NzY3LTIuOTE1NiAxLjgyNzEtMi4wOTkzIDIuNDEwMi0yLjkxNTMgMi4xMzgxLTMuMjI=
2NSAxLjI4MjktMi42NDM1IC42OTk2LTMuNDIwNyAuMjEyNS00LjI0MTgtLjM4ODYtMS4yMzAyIi=
8+DQo8L2c+DQo8ZyBzdHJva2Utd2lkdGg9Ii45ODciPg0KPGc+DQo8cGF0aCBkPSJtNjEzLjIzM=
DQsMjc3LjM1OTNjMS4yMTMxLTQuMTI3Ni0uMjY3Ni04LjQ4MzEtNC4yNjYzLTguMzY1NyIvPg0K=
PHBhdGggZD0ibTU5OS41ODkzLDI3OS43MThjLjg3ODMsLjg2NzIgMS45NDA1LDEuNTgzOSAzLjI=
wNjgsMi4xNTU4IDIuMjYxMywxLjAyMTIgNC44MDEyLC40OTUyIDYuNjU0My0uNDQzMiIvPg0KPH=
BhdGggZD0ibTYwOS41MzQ4LDIxNi44NzM4YzUuMDE4MiwwIDkuMzk0LDUuNTg1NSA5LjM5NCwxM=
S4zMTc0IDAsNi42MDUtMy41MTI3LDEwLjY0ODEtNi4wODY5LDEzLjcwNS0yLjA3MjIsMi40NjA4=
LTQuMzE1OCw0LjY2MjUtNi45ODI0LDcuMzQ4MiIvPg0KPC9nPg0KPGcgc3Ryb2tlLWxpbmVjYXA=
9InJvdW5kIj4NCjxwYXRoIGQ9Im02MDMuNTgyMSwyMTEuNTgxM2MxLjcwNjQsLjc5MDEgMy4yMD=
M3LDIuMTI3NiA0LjM0NTYsMy44MTg4IDIuMDk5LDMuMTEwMSAyLjYzMzEsNS43MTIxIDIuNDg3O=
Sw5LjU2MzEtLjI0OTEsNi42LTQuOTk3OSwxMS4xNjk5LTkuMjQ2MiwxMy45NTk0Ii8+DQo8cGF0=
aCBkPSJtNTkzLjcxLDIxMS41Nzk4Yy4zNDY5LC4yOTYxIC42ODA0LC42MzM4IDEuMDAwNCwxLjA=
xNDIgMi44NzY4LDMuNDIxIDMuMDk5Myw4LjQ3NzUgMi40MTAyLDExLjI4MDgtMS4wMzUzLDQuMj=
EyOC0yLjQyNzYsNi4wMjg3LTUuODQ2NCw4LjU0ODMiLz4NCjxwYXRoIGQ9Im01ODMuMzU5MywyM=
DkuODQ5MmM0LjEyMDUsMy4xMDk4IDUuMzQ1OCw4LjQ4ODcgMy45ODA3LDE0LjAyNTYtLjk3NTYs=
My45NTY3LTMuNDYzNSw2LjMyODEtNi41NjU2LDguMjE3NCIvPg0KPC9nPg0KPGc+DQo8cGF0aCB=
kPSJtNTc2LjM2NzksMjEzLjkwNDVjMS4zMjc2LC45MDQ0IDIuNjgxNCwyLjI5MDkgMy40MTUxLD=
QuMDYxNCAyLjkwODIsNy4wMjA0LTMuNDIxLDEyLjI4NC05LjI1MjIsMTYuMjQ5Mi00LjE4MSwyL=
jg0MjktOC42OTQxLDQuMzYxNC0xMi45NjgzLDUuMTI4OCIvPg0KPHBhdGggZD0ibTU2OS42ODc4=
LDIyNy40MzIyYy0xLjQxMzgtLjAxNC0zLjA5NDUtLjQxNy00LjkyMDMtMi4zMzkzLS40MjA0LS4=
0NDI2LS45MTI2LTEuMDI3Ni0xLjEwNTMtMS41NTMiLz4NCjxwYXRoIGQ9Im01NDAuNDU0MywyMz=
EuMTk1NGMtLjczODQtLjM3MDMtMS41MzE0LS45MDkyLTIuMDYyNi0xLjUwMzgtMS4zODY0LTEuN=
TUwNS0yLjMxMDMtMy42NDk4LTEuMjQyNC02Ljg1MzIgLjk4NzQtMi45NjI2IDUuNzQ2Mi0xMS4y=
NzM1IDUuOTc5NS0xNy4wMjY3IC4zNTYzLTguNzg5NS0zLjAyNDItMTMuOTc2OC04LjMxMi0xNi4=
wMDAxIi8+DQo8L2c+DQo8ZyBzdHJva2UtbGluZWNhcD0icm91bmQiPg0KPHBhdGggZD0ibTU0Mi=
42ODUsMjAzLjg1MDYtLjIwNjQsMy4zMDUxLS44OTQ5LDMuMzc0LTEuNzIxMyw0LjYxMjktMS4zM=
DgyLDIuOTYwNi0xLjM3NjksMi45NjA5LS42ODg2LDIuMDY1OC0uMjc1NSwxLjUxNDggLjIwNjks=
MS40NDU4Ii8+DQo8cGF0aCBkPSJtNTk4LjE1NywyOTYuMjgyNmMuNDkzLDEuNDQ3MiAxLjMwNjU=
sMS45NDg2IDIuMzMxNywzLjAyMjUgMi4yMjksMi4zMzUgNS40OTYzLDQuMzQzNCA5LjYyMyw1Lj=
UwMzkgMy44MTM4LDEuMDcyNyA3LjI0OTQsLjI2NjIgOS44NzA2LTEuMzY3MSIvPg0KPHBhdGggZ=
D0ibTU5NS44MTEsNDIzLjQwMzhjLjI3MjEsLjY2MDcgLjkzMjgsMS4zMDU5IC45MzI4LDEuMzA1=
OSAxLjAxMDgsMS42ODczIDQuOTQwMiw0LjY1NDcgOC41MTQ2LDQuNzAxNiA1LjkwODgsLjA3OCA=
3LjMxMTktNC4wNTcyIDcuNDYzOC00Ljk3NTcgLjc0Ni00LjUwODgtLjc5NjEtNS43NDI1LTMuMT=
EtNy4wMTI3IDAsMC0xLjM2MTctLjcwNTUtMi45OTQ0LS40MzM0Ii8+DQo8L2c+DQo8L2c+DQo8Z=
z4NCjxwYXRoIHN0cm9rZS13aWR0aD0iLjg4MSIgZD0ibTYwNS40NDAyLDQyOS40Mzc4IDIuNTI3=
LS41MDU0IDEuOTA0OC0xLjAxMDggMS4wNDk2LTEuMDQ5NiAuNzM4Ny0xLjIwNSAuNTA1NC0xLjk=
0MzYgLjAzODgtMS4zNjA2Ii8+DQo8cGF0aCBzdHJva2Utd2lkdGg9Ii45ODciIGQ9Im0zNzAuMj=
I4Niw0MDMuNjY2NGMtMi4wODYsLjUzNDEtNC4wNDU0LC41NDctNS43NTc0LC4wMzMtNC40MjI4L=
TEuMzI2NS04LjAwNjctNS41NjM2LTYuMTc5NS0xMC44MjkxIi8+DQo8cGF0aCBzdHJva2Utd2lk=
dGg9Ii44ODEiIGQ9Im0zNjQuOTM4OSw0MDMuMzgzOSAxLjg2NjIsLjE1NTUgMi40MDk5LS4xOTQ=
1IDIuNDEwMi0uODU1MiIvPg0KPHBhdGggc3Ryb2tlLWxpbmVjYXA9InJvdW5kIiBzdHJva2Utd2=
lkdGg9Ii45ODciIGQ9Im0zNjUuMjg5MiwzODcuODczNGMxLjkzNzEtLjAzNSAzLjg2OSwxLjI3M=
yA1LjEzMjUsMy40Njc3IC4yNTA3LC40MzU2IC42NDEsMS4zODM2IC42Mjg0LDIuNDEwNy0uMDE1=
OCwxLjM2ODItLjYxNTQsMi44MzA5LTEuNTkyNCwzLjQ1MjUtMi4yNDU2LDEuNDI5Mi02LjIzMjc=
sLjgxNDktNi4wNjU5LTMuMTUiLz4NCjwvZz4NCjwvZz4NCjxnPg0KPHBhdGggZmlsbD0iI2M3Yj=
M3ZiIgc3Ryb2tlPSIjYzdiMzdmIiBzdHJva2Utd2lkdGg9Ii41MTMiIGQ9Im0zNjMuNDIyOSwzO=
TMuNzEyMWMwLTEuOTMyMSAxLjIzNTYtMy40OTg2IDIuNzYtMy40OTg2IDEuNTI0NCwwIDIuNzYw=
MiwxLjU2NjUgMi43NjAyLDMuNDk4NiAwLDEuOTMyNC0xLjIzNTksMy40OTg3LTIuNzYwMiwzLjQ=
5ODctMS41MjQzLDAtMi43Ni0xLjU2NjMtMi43Ni0zLjQ5ODd6Ii8+DQo8L2c+DQo8ZyBmaWxsPS=
Jub25lIj4NCjxnIHN0cm9rZT0iIzcwM2QyOSI+DQo8ZyBzdHJva2Utd2lkdGg9Ii45ODciPg0KP=
HBhdGggZD0ibTM3Ny4zMzM0LDMzNi4zOTc1YzcuNzAzMywxLjQzNzkgMTUuMTE5LDEwLjcyODYg=
MTcuNTQ1OCwyMC44NjQ5IC44NDI4LDMuNTIwMSAyLjAwMTYsMTEuMzcxNCAuMzk1OSwxOC44MTQ=
3LTEuNzEwMyw3LjkzMDEtNS4xMzgxLDEzLjQxOTktOS4xNTk4LDE3LjU4NTItLjk1MzQsLjk4Nz=
UtMi4wNTg3LDEuOTI3Ni0zLjMyMzEsMi44NTQ4bC0xLjY0MjgsMS4xMTM1Ii8+DQo8cGF0aCBkP=
SJtMzc5LjIxNCwzNDMuMTUyOGMuNDQyOSwuNDQ0NiAuNTg1NiwxLjEwNzYgLjY1MjgsMS42NzAx=
IC42ODMyLDUuNzMxOC00LjMzOTUsNy40MDE2LTcuOTE1OCw2LjQ2ODUtMS43NzE0LS40NjItMy4=
4ODI1LTIuMTA2OC00LjcxMDYtMy41Ni0uNTk3MS0xLjA0NzMtLjk1OS0yLjI5ODctLjk2MjEtMy=
41OTg4Ii8+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm9rZS13aWR0aD0iLjg4MSIgZD0ibTM3OS40M=
zkxLDM0NS4zODQ4LS4zMTA5LDIuMTc2OS0uNTA1NCwuOTcxNy0uNzM4NywuOTMzMS0xLjAxMDgs=
Ljc3NzMtMS4xMjczLC41MDU0LTEuNDc3MywuMjMzMi0xLjAxMDgsLjA3OCIvPg0KPC9nPg0KPC9=
nPg0KPGcgc3Ryb2tlLXdpZHRoPSIuOTg3Ij4NCjxnPg0KPHBhdGggc3Ryb2tlPSIjYzdiMzdmIi=
BzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im0zNzMuOTE4OSwzNDAuNTQxMWMtLjU3MzgsLjI0O=
TktLjg5MDYsLjQ1NjEtMS4zMjE4LC45MDk4LS40MTIsLjQzMzMtLjQ5NzUsLjU5MDYtLjgxNjMs=
MS4yOTgzLS4yMzMzLC41MTc4LS4yOTQ2LDEuMTE4LS4zODEsMS44NTgxIi8+DQo8L2c+DQo8ZyB=
zdHJva2U9IiM3MDNkMjkiPg0KPHBhdGggZD0ibTM2OC43NjQyLDM3OC42NjgyYzMuMTY0MSwwID=
UuOTMzNiwzLjAzMTYgNS45MzM2LDYuMjczMyAwLDEuNTg3Ni0uNjE1MiwzLjAyODEtMS42MTQ3L=
DQuMDg0OCIvPg0KPHBhdGggZD0ibTM2Ni42MTgyLDM4Mi4zNDU2YzMuMjk2NiwwIDYuNDMyNSwz=
LjE3NTggNi40MzI1LDYuNTQ2NCAwLDEuOTM5Ny0uOTA0NywzLjY2NzgtMi4zMTUxLDQuNzg1NSI=
vPg0KPC9nPg0KPGcgc3Ryb2tlPSIjYzdiMzdmIiBzdHJva2UtbGluZWNhcD0icm91bmQiPg0KPH=
BhdGggZD0ibTM3OC43NzA1LDM4Ni4zOTZjLjU0MjYtLjY1NzkgLjg3MDQtMS4wMTE5IDEuMzkxN=
S0xLjY4NyAuNDMzNi0uNTYxNiAuNjkxNy0uODcwOSAxLjA3My0xLjQ2OTQgLjM0MzYtLjUzOTIg=
LjQ5NzUtLjg2NzYgLjgwMDktMS40MzA3IC40Mjc1LS43OTM4IC42NDAyLTEuMjU2NyAxLjA0OTY=
tMi4wNjAxIi8+DQo8cGF0aCBkPSJtMzgxLjExMDYsNDAxLjUzMzRjLS45MjUsLjQyNDYtMS40Nz=
IzLC42MTIzLTIuMzcxMywxLjA4ODQtLjY4MzUsLjM2MjItMS4wNTQ3LC41OTM1LTEuNzEwNiwxL=
jAwMjktLjc3NDQsLjQ4NC0xLjIwNjksLjc2NjYtMS45NDM2LDEuMzA2My0uNzY3NCwuNTYyMi0x=
LjE2MTksLjkyOTctMS45MDQ4LDEuNTIzNyIvPg0KPHBhdGggZD0ibTM5Ni41NTkyLDM0Ny4yNTA=
1Yy0uNTAwMy0uNTE1Mi0uNzcxOS0uODE2OS0xLjI4MjktMS4zMjE0LS41MzQ0LS41Mjc0LS44Mj=
UxLS44Mzg2LTEuMzk5NC0xLjMyMTgtLjU1NzItLjQ2ODUtLjkxMDktLjY4MjktMS40OTI4LTEuM=
TE5NyIvPg0KPC9nPg0KPGcgc3Ryb2tlPSIjNzAzZDI5Ij4NCjxnIHN0cm9rZS1saW5lY2FwPSJy=
b3VuZCI+DQo8cGF0aCBkPSJtMzk2LjgzOCwzNDkuMjAwOWMzLjAyNzMsNC4wNjI5IDUuMDI1Miw=
3LjU2MTIgNS45NTQ0LDEyLjA3MDEiLz4NCjxwYXRoIGQ9Im00MDIuNjg4MSwzNzQuNTMxOWMtLj=
Q5OTUsMi4yNDU5LTEuMjU5Myw0LjMyNDYtMi4yNjM5LDYuMzIyMi0xLjI3MzEsMi41MzA0LTMuN=
DkxOSw1LjM0NzgtNS41NTIzLDcuMjUyNSIvPg0KPC9nPg0KPGc+DQo8cGF0aCBkPSJtNDAyLjc4=
NjgsMzQxLjc1MzZjLTEuMDEzNiwzLjQyODEtMy4xOTM5LDUuNzcwMi01LjYxOTgsNy4yOTM0Ii8=
+DQo8cGF0aCBkPSJtMzk3LjMyMjMsMzI1LjUyMDhjMi45MTg3LDIuMjgxNiA0LjY3OCw0LjY0MT=
IgNS41MDExLDcuNDY4NyIvPg0KPHBhdGggZD0ibTQwMC43Mzg4LDMwNy4xNTI1Yy44OTU3LC44M=
jM0IDEuNTE3LDEuNzM4MiAxLjkzMTUsMi43NTY2Ii8+DQo8cGF0aCBzdHJva2UtbGluZWNhcD0i=
cm91bmQiIGQ9Im0zOTcuMzIwOSwzMjUuMDg1MmMtMS4xMjczLDEuMDEwNS0yLjI1MDMsMS42MzA=
0LTMuMjY1NCwyLjAyODkiLz4NCjwvZz4NCjwvZz4NCjxnPg0KPHBhdGggc3Ryb2tlPSIjYzdiMz=
dmIiBkPSJtMzk3LjE3MzIsMzI2LjQ2ODljLS43NDI5LC4zMzA2LTEuMTMyNywuNTkzMi0xLjkwN=
DgsLjg0NzYtLjg4NSwuMjkxNS0xLjQ4NDksLjQ0MzEtMi4zNDAxLC40ODIiLz4NCjwvZz4NCjxn=
IHN0cm9rZT0iIzcwM2QyOSI+DQo8cGF0aCBzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im00MDI=
uODk4LDMxNy45MjM2Yy0uNzY2NSwyLjY1OTItMi41MDU5LDQuNjczOC01LjI2NjEsNy4xOTI2Ii=
8+DQo8cGF0aCBkPSJtNDAwLjg5ODksMjk2LjU5ODljLjgyOTYsLjU3NzEgMS40MjUsMS4zMTE2I=
DEuODI0OSwyLjA0MjQiLz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgZD0ibTQwMi45=
MDk4LDMwMy45NDJjLS40ODMyLDEuMTkwNi0xLjMxNzIsMi40NzUyLTIuNDMwNSwzLjcxNzgtMi4=
5OTc3LDMuMzQ1OS04LjA4MjEsNi4xODk0LTEzLjcxNjMsNi4yNi0zLjA1NjMsLjAzOC02LjIyOT=
QtLjYwMDctOS40MjE4LTIuNzM1NC0zLjQxMzEtMi4yODI1LTUuNjM4MS01LjUyODEtNi4zNzY4L=
TguNzE1OCIvPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva2U9IiNjN2IzN2YiIHN0cm9rZS1saW5l=
Y2FwPSJyb3VuZCIgZD0ibTM3MC45OTU0LDMwMC42ODAzYy4yNTQ3LC45MDY3IC4zMTA0LDEuNDQ=
3OCAuNjUzMSwyLjMyNDYgLjQzMDgsMS4xMDIgLjc5MSwxLjY4MTcgMS40NDYxLDIuNjY2OCAuNj=
gzLDEuMDI2NiAxLjEwOTYsMS41OTM5IDEuOTkwMywyLjQ1NjkgLjc3MzYsLjc1NzYgMS4yNjM4L=
DEuMTQgMi4xNjkzLDEuNzMzNyAuODU5NywuNTYzNyAxLjQxOCwuNzU4NyAyLjMyNDcsMS4yNDM4=
Ii8+DQo8L2c+DQo8ZyBzdHJva2U9IiM3MDNkMjkiPg0KPHBhdGggZD0ibTM5OS4xMTA2LDI4MC4=
xMzIyYzEuNzMwNiwxLjQ3MTEgMy4wNTk0LDMuMzQ2NyAzLjY5ODIsNS4yOTQ1Ii8+DQo8cGF0aC=
BzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im00MDIuODU3NywyOTIuNTYxYy0xLjM4NDIsNC41N=
zM5LTUuNTEwNCwxMC4yMzA2LTEzLjQ3MjgsMTIuMjQ4LTMuODAzNywuOTYzOC04LjcwMi0uMjQx=
Mi0xMC4zNzM1LTEuNjYzOSIvPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva2U9IiNjN2IzN2YiIHN=
0cm9rZS1saW5lY2FwPSJyb3VuZCIgZD0ibTM3OC4wMzk0LDMwMS45NDc3Yy43NTgxLC40MDYxID=
EuMTQ5NSwuNzExOSAxLjk0MzksMS4wNDE3IC43MTksLjI5ODYgMS4xNDU2LC40MjQ3IDEuOTA0N=
SwuNTk4NiAxLjAyNjgsLjIzNTUgMS42MjkzLC4yOTQ2IDIuNjgyNiwuMzE4OCAxLjE0MDIsLjAy=
NyAxLjQ3NzEsMCAyLjkxNTYtLjIzMzMiLz4NCjwvZz4NCjxnIHN0cm9rZT0iIzcwM2QyOSI+DQo=
8cGF0aCBkPSJtMzc1LjA1NjMsMjkxLjQ4OTJjLjQxNjcsNC4xMjA1IDMuMTc0Miw3LjIwODkgOC=
40MDEyLDcuMzA3NyA3LjM1MDIsLjEzODYgMTEuODE3Ny0xMC41NzM2IDUuMjg2OS0xOC4wOTM1I=
i8+DQo8cGF0aCBzdHJva2UtbGluZWNhcD0icm91bmQiIGQ9Im0zODMuMzMxMSwyOTguMjY5MyAz=
LjM2ODYtLjg4NjUgMS45OTQzLTEuNTA3MSAxLjI4NTQtMS44MTc2IDEuMTA4MS0yLjgzNjggLjQ=
0MzItMi4zMDQ5Ii8+DQo8cGF0aCBkPSJtMzc2LjUxMTcsMjg2LjQwODhjLTEuMDYzNCwuMjY1OC=
0yLjQxMDksLjY1OTUtMy44MjM5LDEuMzMyOC0xLjg5MjgsLjkwMTktMy45MDMzLDIuMzA1Ni01L=
jUwNiw0LjU3NTgtMS44NTYxLDIuNjI5Ni0yLjkzODQsNi4yODU5LTMuNjA4NCw5LjQ4NDgtLjI5=
MzIsMS4zOTk3LS42NDMzLDUuODMyIC4yNTIxLDEwLjQwOTYgLjY2MTMsMy4zODAxIDIuMDU3Myw=
2LjUyNyAzLjYwMTYsOC44MDYxIC41NTM4LC44MTcyIDEuMDU2MSwxLjUyMjYgMS42MjA2LDIuMD=
g3NCAyLjAyMTYsMi4wMjEzIDMuODg3NSwzLjI2NTQgNi45OTczLDIuNjQzMiIvPg0KPC9nPg0KP=
C9nPg0KPGc+DQo8cGF0aCBzdHJva2U9IiM3MDNkMjkiIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIg=
c3Ryb2tlLXdpZHRoPSIxLjA0MSIgZD0ibTM3NS40NDQ5LDI4Ny4xMjgxYy0yLjk2ODUsMS44Mzc=
4LTUuMTgyMywyLjI3MjgtNy40OTIsNC45NDc1LTIuMjk5NCw0LjU1MzEtMy4yMDM0LDYuOTk5MS=
00LjEwMDEsMTAuNjQ5OSIvPg0KPC9nPg0KPC9nPg0KPC9nPg0KPHBhdGggZmlsbD0iI2M3YjM3Z=
iIgZD0ibTM3Ny4wNDUyLDMyNC4zNjI5YzAtMS41ODcxIDEuMTkzMS0yLjg3MzQgMi42NjQ5LTIu=
ODczNCAxLjQ3MTcsMCAyLjY2NDksMS4yODYzIDIuNjY0OSwyLjg3MzQgMCwxLjU4NjgtMS4xOTM=
xLDIuODczMy0yLjY2NDksMi44NzMzLTEuNDcxNywwLTIuNjY0OS0xLjI4NjUtMi42NjQ5LTIuOD=
czM3oiLz4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZS1taXRlcmxpbWl0PSIzLjg2NCI+DQo8ZyBzd=
HJva2U9IiM3MDNkMjkiPg0KPGcgc3Ryb2tlLWxpbmVjYXA9InJvdW5kIiBzdHJva2Utd2lkdGg9=
Ii45ODciPg0KPHBhdGggZD0ibTM1OC41MjQ5LDMyNy4zOTQxYzEuMDczOCwxLjM0NzEgMi4zMzc=
zLDIuNTYxIDMuNjI5OCwzLjYzNjUgMi42MjEyLDIuMTgxNCA1LjcxMTksNC4xMDE0IDkuMjcyMS=
w1LjE1MjgiLz4NCjxwYXRoIGQ9Im0zNzkuNjcyOSwzMzYuOTUyMWM2LjU2OS0uNzg5IDEwLjI3M=
jItNS42ODM3IDkuNTM4LTExLjQxMDUtLjU1OTQtNC4zNjMzLTQuNTYyOS03LjcxODItNy4yODQ5=
LTcuOTEyMyIvPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva2Utd2lkdGg9Ii44ODEiIGQ9Im0zODg=
uNzI5OCwzMjYuNjQ3OC0uNTQ0MiwzLjM4MTktLjY2MDcsMS40Nzc0LTEuMzYwNiwxLjg2NTktMS=
44MjcxLDEuMzk5NC0xLjg2NTksLjkzMjgtMy42MTU0LC44OTQxIi8+DQo8cGF0aCBzdHJva2Utd=
2lkdGg9Ii45ODciIGQ9Im00MDIuODY0OCwyNzYuMDU0MWMtLjk5OTUsMi44ODg5LTIuODI4OSw0=
Ljk1My01LjcyMzcsNi4yNjA0LTIuODg2NiwxLjMwMzctNi4yMjc0LC4wODYtOC4wMTQtMS4yOTI=
yIi8+DQo8cGF0aCBzdHJva2Utd2lkdGg9Ii44ODEiIGQ9Im00MDIuNzYzMiwyNzQuNDc5Ny0uNj=
k5NiwyLjAyMTMtLjg1NTIsMS40Nzc0LTEuMTY2NCwxLjYzMjYtMS42MzI3LDEuNDc3MS0xLjk0M=
zYsLjkzMzEtMS42MzI3LC4zODg2LTEuMDEwOC0uMDc4Ii8+DQo8L2c+DQo8ZyBzdHJva2Utd2lk=
dGg9Ii45ODciPg0KPHBhdGggZD0ibTM5MC4zODU4LDI2OC45MjA5YzIuODQ5NC0uMTA1MyA0LjQ=
3MDMsMi40ODMxIDQuNDQ0NCw0LjY2NDUiLz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJyb3VuZC=
IgZD0ibTM5NS4zNzY0LDI3MS41Nzg4Yy0uNTQ2MiwyLjAwNjYtMS42MjQ4LDQuNDkzMy00Ljc3M=
zcsNC4yMjEzIi8+DQo8L2c+DQo8Zz4NCjxwYXRoIHN0cm9rZS13aWR0aD0iLjg4MSIgZD0ibTM5=
NC40MDUzLDI3Mi42NTI2IC4wMzkxLDEuNTU1Ii8+DQo8L2c+DQo8L2c+DQo8ZyBzdHJva2UtbGl=
uZWNhcD0icm91bmQiIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8Zz4NCjxwYXRoIHN0cm9rZT0iIz=
cwM2QyOSIgZD0ibTM4OS43MjA5LDIyOS44MDY0YzEuNTYwOSw0LjA4MzEgNC42MDM0LDcuMjc1M=
yA3Ljg2MDYsOS4wOTkiLz4NCjwvZz4NCjxnIHN0cm9rZT0iI2M3YjM3ZiI+DQo8cGF0aCBkPSJt=
Mzk4LjY4OTQsMjQwLjE1NDZjLTEuMjQ2My0uNzI3Ny0yLjAwODEtMS4wNDYtMy4xOTU2LTEuODY=
2LTEuMjA3OC0uODM0MS0xLjg3MzMtMS4zNDUzLTIuOTIzMi0yLjM3MTMtLjc1NzItLjczOTUtMS=
4xODE2LTEuMTcwNy0xLjgxMTYtMi4wMjEzLS41NjIyLS43NTk1LS43Nzc4LTEuMjU3LTEuMjc1L=
TIuMDYwNCIvPg0KPHBhdGggZD0ibTQwMS4yMDA2LDIyNC43MjE4Yy4zOTExLDEuMDQ1OSAuNTAy=
OSwxLjY4MzkgMS4wMDI5LDIuNjgyMyAuNjc4NywxLjM1NTIgMS4yMDI3LDIuMDY3MSAyLjIyMzY=
sMy4xODc3IDEuNDE0OSwxLjU1MjUgMi42MTMxLDEuOTkxNyA0LjI4MzcsMy4yNjUzIi8+DQo8cG=
F0aCBkPSJtNDEwLjk4MTIsMjI0LjYwNTNjLjM4ODEsLjkzOTggLjUwNjUsMS41MTgxIC45OTUzL=
DIuNDA5OSAuNDMxOSwuNzg4NSAuNzI5NiwxLjIwODMgMS4yOTg0LDEuOTA0OCAuNzI1MiwuODg4=
NiAxLjE5NjgsMS4zNTIxIDIuMDk5MiwyLjA2MDQgMS4wNDkxLC44MjM2IDEuNzkyNSwxLjA2NzE=
gMi45Mzg2LDEuNzQ5MiIvPg0KPC9nPg0KPC9nPg0KPC9nPg0KPHBhdGggZmlsbD0iI2M3YjM3Zi=
IgZD0ibTQyNC45MDY4LDIyMS44MDc5Yy0uMTY4Mi0xLjU5MTkgLjc4NzYtMi45OTY5IDIuMTM1L=
TMuMTM3OSAxLjM0NzMtLjE0MDkgMi41NzYyLDEuMDM1IDIuNzQ0NSwyLjYyNzEgLjE2ODQsMS41=
OTE5LS43ODc2LDIuOTk2Ny0yLjEzNTMsMy4xMzc5LTEuMzQ3MywuMTQxLTIuNTc1OS0xLjAzNDk=
tMi43NDQyLTIuNjI3MXoiLz4NCjxnIHN0cm9rZT0iIzcwM2QyOSIgc3Ryb2tlLW1pdGVybGltaX=
Q9IjMuODY0Ij4NCjxnIGZpbGw9Im5vbmUiPg0KPGcgc3Ryb2tlLXdpZHRoPSIuOTg3Ij4NCjxnP=
g0KPHBhdGggc3Ryb2tlLWxpbmVjYXA9InJvdW5kIiBkPSJtNjIyLjg1ODgsMjg3LjI4NjJjMi42=
ODYyLDMuNjc4NSAuOTI3MiwxMC45MzE4LTYuMzc5LDExLjA2OTctMi44NTQsLjA1NC01LjQyOTE=
tMS41MjgzLTYuOTM4NS0zLjkyNDQiLz4NCjxwYXRoIGQ9Im0zODMuODczNCwyODUuMTk1NGMtMy=
4wMjM2LTIuOTU1OC05LjQyOTEtMy43MjYzLTE1Ljc5ODMsLjMwMjItLjgxODYsLjUxODEtMS42M=
zcyLDEuMTgzLTIuNDQ3OSwxLjg1ODctLjg3NjMsLjcyOTktMS41NzUzLDEuNTY5My0yLjI1MDYs=
Mi40ODE5LS43MzQyLC45OTI1LTEuNjM2MSwyLjY4MDEtMi4xODExLDMuODAwOS0uNzUwMiwxLjU=
0MzgtMS4wNjA5LDIuNTU3OS0xLjQ3NDIsNC4xNDA4LTEuMTYzLDQuNDU1NC0xLjE1OCw4LjU5NT=
ktMS4wMjA5LDkuNzc2MSAuMTc2MywxLjUxMzEgLjMyMDIsMi45MDM1IC41Njc2LDQuMTgyMiAuO=
DQ1MSw0LjM3MTUgMi4xMzgxLDcuNDM5IDMuNDc1Myw5LjY1NjUgMS40MDY3LDIuMzMyNSA0Ljkw=
NTMsNy42ODk4IDEyLjA1ODMsOC4zOTY3IDIuODExMiwuMjc4IDcuNjEyMS0xLjAxMDYgNy43Njc=
1LTQuNjY0OCIvPg0KPC9nPg0KPGcgc3Ryb2tlLWxpbmVjYXA9InJvdW5kIj4NCjxwYXRoIGQ9Im=
01NjguMzgzNSwyMjAuNDE3MmMuNDc4NC0yLjU4MTMgMy41ODkyLTMuMDc5NiA0Ljc1ODItMS41N=
TUgMS44MDAxLDIuMzQ4IC42MDk1LDYuMzgxOC0zLjA1MTUsNy41MjYtMS4yNDQxLC4zODg5LTQu=
MTIwNSwuMjMzMy01Ljk4NjUtMi4xNzY5LTEuNTEyNS0xLjk1MzctMS4zOTY5LTQuMzczNS0uODM=
yMS02LjI5NjkgLjM2NTUtMS4yNDQ2IDEuMzY0Mi0yLjMyOTQgMi42OTgxLTMuMzQzNSA0LjI1MT=
EtMy4yMzMzIDExLjExNzgtMi40ODc5IDEzLjM3MjQsMi45NTQxIDIuOTA4NSw3LjAyMDMtMy40M=
jA3LDEyLjI4NDItOS4yNTE5LDE2LjI0OTEtNy4zNDA5LDQuOTkxOC0xNS43MDQ2LDUuODk5Ni0y=
Mi4wMDI2LDUuODMxMi0xNC4zMDU1LS4xNTU2LTI1LjE5MDMtNi45OTczLTMyLjI2NTMtMTAuODg=
0NS0xLjY0ODEtLjkwNTYtMy4zNDU2LS43MjA3LTQuMTk4MiwuMzEwOS0uOTYyOSwxLjE2NDQtLj=
k0NzUsMy4wNDI4IC4zODg2LDQuMjc1OSIvPg0KPHBhdGggZD0ibTU3MS4yNTgsMjE4LjAwNDVjM=
S41MTYyLC4wNyAxLjkyMiwuNjYxNiAyLjM4NjgsMS4yNjc0IDEuNzk5OCwyLjM0OCAuNDg0OSw2=
LjM4MjEtMy4xNzYxLDcuNTI2Ii8+DQo8L2c+DQo8L2c+DQo8ZyBzdHJva2UtbGluZWNhcD0icm9=
1bmQiPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIxLjEyMSIgZD0ibTQ5MS41MDAzLDIyNC43ODk2Yz=
IuNDAyOSwxLjgzNzggNC4wOTk0LDQuMDk5NCAzLjgxNjYsNy43NzQ4LS4zMDY0LDMuOTg2My0xL=
jI3MjIsNC45NDc2LTQuMzgyLDcuMDY3OSIvPg0KPC9nPg0KPGc+DQo8cGF0aCBzdHJva2Utd2lk=
dGg9Ii45ODciIGQ9Im01OTYuMzk4LDIzOS4yNDY1IDAsMjQuNjg1NSIvPg0KPHBhdGggc3Ryb2t=
lLWxpbmVjYXA9InJvdW5kIiBzdHJva2Utd2lkdGg9IjEuMTIxIiBkPSJtNDk0LjY4MDcsMjMzLj=
Y5NTNjLS4xNDExLDIuNDAyOS0xLjEzMDcsMy45NTc5LTMuNTMzOCw0Ljk0NzMiLz4NCjwvZz4NC=
jwvZz4NCjxnPg0KPHBhdGggZmlsbD0iIzcwM2QyOSIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJv=
a2Utd2lkdGg9Ii4yNzciIGQ9Im01MjAuNzgzMSwyMTEuOTExMWMtLjA4MDItMi42NDg5LTIuNjg=
5Ni0yLjkyNDMtMy42ODk0LTIuOTI0My0yLjg4NTUsMC0zLjY2NjEsMS43OTk4LTcuMjY1NywzLj=
czMjctNC41MTIsMi40MjMxLTYuNDU1MywyLjk2MTUtMTAuNDY1NSwyLjk5NzUtNC4wMTAyLS4wM=
zYtNi4wMDQ4LS41NzQ0LTEwLjUxNjgtMi45OTc1LTMuNTk5NC0xLjkzMjktNC4yMDUyLTMuNjc0=
OC03LjA5MS0zLjY3NDgtMS41NjYzLDAtMy41ODk1LDEuMzUzLTMuNTEyNywzLjgzMjcgMCwwLS4=
wMzAxLC44MDMxIC4wOTMyLDEuMzQ2NSAuMDQ2MywuMjA0NiAuMjk1MiwuMTQwNyAuMzczNCwuMz=
E5OS0uMDM3MS0xLjIwMjQgLjIwNzYtMS44MjUxIC44LTIuNjMyNyAuNzYwNi0xLjAzNzggMi4wM=
jQ0LTEuMzEzMyAyLjUzOTYtMS4zMTMzIDIuODg1NSwwIDMuOTUzNywxLjg1MTYgNy41NTMzLDMu=
Nzg0NSA0LjUxMiwyLjQyMzEgNi40NTM0LDIuOTYxNSAxMC40NjM2LDIuOTk3NSA0LjAxMDItLjA=
zNiA2LjAwNjgtLjU3NDQgMTAuNTE4Ny0yLjk5NzUgMy41OTk3LTEuOTMyOSA0LjYzNDEtMy45Mz=
c5IDcuNTE5OC0zLjkzNzkgLjk5OTgsMCAxLjcwNTMsLjY0NzIgMi4wMzI4LDEuNjY2NSAuMjAxN=
ywuNjI2OSAuMDg4LDEuMDQ1MSAuMTQwMywxLjI5MzIgLjAyNTQsLjEyMTIgLjE3MzgsLjEwODgg=
LjIwNjQsLjIzOTggLjEwMDItLjQ2NjUgLjMzMzQtLjYzMzEgLjMtMS43MzI4eiIvPg0KPC9nPg0=
KPGcgZmlsbD0ibm9uZSI+DQo8Zz4NCjxwYXRoIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgc3Ryb2=
tlLXdpZHRoPSIxLjA0MSIgZD0ibTQzNS44NzU1LDIyMS45NjI3YzAsMi42ODU2LTEuOTc5MSw0L=
jM4MTktNC42NjQ4LDQuOTQ3NSIvPg0KPC9nPg0KPGcgc3Ryb2tlLXdpZHRoPSIuOTg3Ij4NCjxw=
YXRoIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgZD0ibTU5OC4zNDQ0LDMwNy4zMzM0Yy01LjQ1MDQ=
sNS45MzI1LS40MzcsMTYuMTE1OCAzLjYzNjUsMTguNDE3NiAxLjQxMDEsMS4wOTY2IDIuMDEyNi=
wuNTE1MyAzLjE0MDQsMS4xNzQ5Ii8+DQo8cGF0aCBkPSJtNTk4LjYyODksMjk1Ljk5MWMtMS43O=
DgzLDEuMjQ0MS0yLjQxODQsMi42NDE1LTIuNDg3OSw1LjA2OTctLjA1ODMsMi4wMzIgLjI5Niw0=
LjI4ODMgMi4yMDM0LDYuMjcyNyAyLjk3MTMsMy4wOTE3IDguNzg1OSw1Ljc4MzYgMTQuNDIsNS4=
4NTQyIDMuMDU2MywuMDM4IDYuMjI5NC0uNjAwNyA5LjQyMTgtMi43MzU0IDMuNDEzMS0yLjI4Mj=
UgNS4yMDkzLTUuMzY0NiA1Ljk4NjgtOC4zOTY3Ii8+DQo8cGF0aCBkPSJtNTk1LjU4MzMsMzk4L=
jU5NzVjMCwuMDE4LS4wMDksMi4zODg1LS4yMTE4LDMuODg3My0uNTkxNSw0LjM2MzEtMS4yODU3=
LDYuODczNy0zLjI2NTQsMTAuODA2Ni0xLjkzMDQsMy44MzU0LTMuNDcyOCw1Ljg0OTEtNi41MzA=
3LDguODYzMi0zLjA4NTMsMy4wNDExLTUuMjIzNiw0LjQzNDMtOS4wOTY1LDYuMzc1NC0zLjc3MT=
YsMS44OTAyLTYuMTQ3NywyLjQ5MTItMTAuMjYyNywzLjQyMDctNC4xMTIxLC45Mjg2LTYuNTE3N=
SwxLjEzMTItMTAuNzI5MiwxLjMyMTctMy44NjE5LC4xNzQ3LTYuMDUyOSwuMDExLTkuOTA5NS0u=
MjU0Ni00LjEyNzMtLjI4NTctNi40MTY3LS44NjA2LTEwLjUzODEtMS4yMjI0LTMuNDAzOC0uMjk=
5Mi01LjMyNjMtLjU3NDQtOC43NDMxLS41NjU5LTMuNTEyNCwuMDEtNS41MjUsLjAzMS04Ljk4Mz=
QsLjY0MzUtMy4yMjMyLC41NzA3LTUuMDUxNywxLjAyNTQtOC4wODU3LDIuMjU0Ni00LjE5NzksM=
S43MDA4LTguOTQwOSw0LjY2NDgtOS45NTE3LDUuOTg2NS0xLjAxMDgtMS4zMjE3LTUuNzU0MS00=
LjI4Ni05Ljk1MTctNS45ODY1LTMuMDM0LTEuMjI5Mi00Ljg2MjYtMS42ODM5LTguMDg1Ny0yLjI=
1NDYtMy40NTg0LS42MTIzLTUuNDcxLS42MzQ1LTguOTgzNC0uNjQzNS0zLjQxNzEtLjAxLTUuMz=
M5NiwuMjY2Ny04Ljc0MzEsLjU2NTktNC4xMjE3LC4zNjE4LTYuNDEwOCwuOTM2Ny0xMC41MzgyL=
DEuMjIyNC0zLjg1NjksLjI2NjctNi4wNDc1LC40Mjk0LTkuOTA5NSwuMjU0Ni00LjIxMTctLjE5=
MDQtNi42MTcxLS4zOTMxLTEwLjcyOTItMS4zMjE3LTQuMTE0OS0uOTI5NS02LjQ5MTEtMS41MzA=
1LTEwLjI2MjctMy40MjA3LTMuODcyOS0xLjk0MTEtNi4wMTEzLTMuMzM0My05LjA5NjUtNi4zNz=
U0LTMuMDU4LTMuMDE0MS00LjYwMDYtNS4wMjc4LTYuNTMwNy04Ljg2MzItMS45Nzk2LTMuOTMyO=
S0yLjY3MzktNi40NDM1LTMuMjY1Ni0xMC44MDY2LS4yMDMzLTEuNDk4OC0uMjExNi0zLjg2ODct=
LjIxMTYtMy44ODczIDAsMCAwLS4wMDAzIDAtLjAwMDN2LTE1OS4wMjAzaDE5Mi41NDg5djE1OS4=
wMjAzbC4wNjY4LC4wMDAzeiIvPg0KPC9nPg0KPC9nPg0KPC9nPg0KPHBhdGggZmlsbD0iI2Q1Mm=
IxZSIgaWQ9InBhdGg0MDIzIiBkPSJtNTE1LjExMDUsMjQ5LjYzNDkgMTIuMjUzLDAgMCw4MS4yM=
y0xMi4yNTMsMCAwLTgxLjIzeiIvPg0KPHBhdGggZmlsbD0iI2Q1MmIxZSIgc3Ryb2tlPSIjNzAz=
ZDI5IiBzdHJva2Utd2lkdGg9Ii43OTciIGQ9Im00MTIuNjY0NSwyNDkuMjQ1OCA4Mi4xNzkxLDA=
gMCw4Mi4wMjI5LTgyLjE3OTEsMCAwLTgyLjAyMjl6IiBzdHJva2UtbWl0ZXJsaW1pdD0iMy44Nj=
QiLz4NCjx1c2Ugd2lkdGg9IjEwMDAiIGhlaWdodD0iNzAwIiB4bGluazpocmVmPSIjcGF0aDI5O=
TgiIHRyYW5zZm9ybT0ibWF0cml4KC0xIDAgMCAxIDkwNy41MjA2IDApIi8+DQo8cGF0aCBmaWxs=
PSIjZmZmIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGlkPSJwYXRoMjk5OCIgZD0ibTQ1MS4yMDA4LDM=
xMy44MjYxYzAsMC0uMDQ4LDIuOTMxNC0uODU1Miw1LjI4NjctLjkzMzEsMi43MjE0LS45NDAyLD=
IuNzIxNC0xLjc5NTYsNC4wNDI5LTEuMTUyNCwxLjc4MDktMi41NTcxLDMuMDgyNy0zLjgwOTYsM=
y44ODc1LTEuOTU4MywxLjI1ODQtMy45NDgzLDEuODg3Ni01Ljk0ODIsMS43MTAzLTUuNDkxLS40=
ODY1LTguMDM4Mi02LjQ0MDEtOS4yODMxLTExLjI3MzQtMS4zMjE3LTUuMTMxLTUuMDczMy03Ljk=
yMzEtNy40NjM4LTYuMDY0Mi0xLjM5OTQsMS4wODg1LTEuNDc4MiwyLjkxNDItLjMxMDksNC42Nj=
UxIDEuMjQ0MSwxLjg2NTcgNC4wOTkxLDIuNzk4OCA0LjA5OTEsMi43OTg4bC0yLjkzMjcsMy43M=
zE5YzAsMC02LjMwMTktLjgyMDUtNy41MzQ1LTcuMzkzMi0uNDY2My0yLjQ4ODEgLjc0MTgtNy4x=
MzM1IDQuODkxLTguNTIyMiA1LjI5NjgtMS43NzMxIDguNjg2LDIuMDA0MSAxMC4zMTg0LDUuMTk=
xNiAyLjI0NTYsNC4zODM2IDMuMjA5NywxMi40MzQyIDkuNDI5NCwxMS4xOTAxIDMuMzgzOC0uNj=
c2OCA0Ljk3Ni01LjU5NzkgNC45NzYtNy44NTI1bDIuNDY3LTIuNjQzNCAzLjY1NDIsMS4xNjY0I=
C4wOTg2LC4wNzh6Ii8+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiPg0KPHBhdGggZmlsbD0iI2Zl=
ZGYwMCIgZD0ibTQ2MS4xMTY4LDI3OC45NSAxMC43NTk5LTExLjY0MjljMCwwIDEuNjI0LTEuMzA=
5NiAxLjYwOTYtMy40MDE1bC0yLjIxODYsLjM0NTItLjQ5NjktMS4xNDE2LS4xMTA1LTEuMTQ3My=
AyLjk4MTctLjYyOTJjLjA0NzMtLjQ4NDMgLjAwNy0uODUwNyAuMDkyLTEuMzg1IC4wNzk1LS40O=
TM5IC4xOS0uNzU4NyAuMzExMi0xLjI0NDFsLTMuMjY1NiwuMjE4OGMuMTY1OS0uNTcxNSAuMTI4=
MS0uODc1NCAuMzEwOS0xLjQwNjcgLjE1NC0uNDQ2OSAuMTk2OC0uNjE3NyAuNTAyOS0xLjEwMjg=
gLjYwNjQtLjA5MSAxLjE1OC0uMjI3OSAxLjkwNzMtLjMwMzkgLjcyNzctLjA3MyAxLjE0MzMtLj=
AzOSAxLjg3MzMtLjA4NSAxLjc4MS0zLjMyMTQgOS4xODk0LTYuMzczMiAxNC40NTM4LS45MDQyI=
DMuODA5NiwzLjk1ODIgMi45ODc2LDExLjIxODktMS45NTA5LDEzLjEzOTQtMi43OTg4LDEuMDg4=
NS01LjA1MzQsLjQ0NDktNi44NjE3LTEuMTEwMWwxLjk3MDktMy44NjU2YzIuNzIxMSwxLjYyNTQ=
gNC45NzU3LS4zOTU5IDQuODIwNC0yLjQ5NTItLjE5NjgtMi42NTM1LTEuOTE4Ni00LjI5NjYtNC=
4zNTM4LTQuNTA5NC0yLjI1NDMtLjE5Ny0zLjg3MjYsMS4wOTMtNC44OTgzLDMuMTEwMS0uNjI1O=
CwxLjIzMDUtLjMzNjMsMi4xMzMyLS41NDQyLDMuNDk4Ni0uMjI1NywxLjQ4MzMtLjA5ODgsMi4z=
MTA5LS41MzY5LDMuODA5Ni0uMzE4MiwxLjA4ODItMS4xNTQ5LDIuNDM0MS0yLjM2OTcsMy41OTI=
2bC0xMS4wMjk3LDExLjkzNS00Mi45NDEzLDQ2LjQ0NS0zLjIyNjgtMi45ODMxIDQzLjIxMTItND=
YuNzM2OHoiLz4NCjxwYXRoIGZpbGw9IiNmZmYiIGQ9Im00MjkuNTEsMjgzLjAzODVjMCwwIDIuN=
jk5NSwxMy4zNzI0IDExLjg3MzYsMzMuNDMxMSA0LjY2NTEtMS43MTAzIDcuNDE5MS0yLjc5OTEg=
MTIuMzYxOS0yLjc5OTEgNC45NDMxLDAgNy42OTcxLC45MzMxIDEyLjM2MTksMi43OTkxIDkuMTc=
0Mi0yMC4wNTg3IDExLjg3MzctMzMuNDMxMSAxMS44NzM3LTMzLjQzMTFsLTI0LjIzNTYtMzEuMT=
c2Ni0yNC4yMzU1LDMxLjE3NjZ6Ii8+DQo8L2c+DQo8dXNlIHdpZHRoPSIxMDAwIiBoZWlnaHQ9I=
jcwMCIgeGxpbms6aHJlZj0iI3BhdGgzMDA2IiB0cmFuc2Zvcm09Im1hdHJpeCgtMSAwIDAgMSA5=
MDcuNTAwMyAwKSIvPg0KPHBhdGggZmlsbD0iI2ZlZGYwMCIgZmlsbC1ydWxlPSJldmVub2RkIiB=
pZD0icGF0aDMwMDYiIGQ9Im00NTEuMzgzNCwyNjIuNDEyNC0xNi44MTk4LDIxLjYzNjljMCwwID=
IuMjQzMywxMC41MTk1IDkuMDc4MywyNi4zNTM5IDIuNjQ2LS42MDI1IDQuOTE1OC0xLjEyNzYgN=
y43MzIzLTEuMzE5NWwuMDA5LTQ2LjY3MTN6Ii8+DQo8cGF0aCBmaWxsPSIjMDA2NWJkIiBmaWxs=
LXJ1bGU9ImV2ZW5vZGQiIGlkPSJwYXRoMzAxMiIgZD0ibTUyNS4xMzA5LDM2NC4xNzQyYy0uNzk=
2OS0uMjM3NS0xLjk2NTktLjgyNTktMS45NjU5LS44MjU5IC4zMjI4LS4yNTEgLjU4NjctLjI2NT=
EgLjg2MjgtLjU1NDcgLjM4OTItLjQwODMgLjM3MjktLjc4ODUgLjU5MjYtMS4zMTkyIC4yMTU3L=
S41MiAuMTg0Ni0uOTU0NSAuNjcxNC0xLjM0MjggLjI4OTYtLjIzMSAuNzYyMy0uMjY5IDEuMTE3=
Ny0uMTY1MiAuMzUyOSwuMTEyNyAuNzU5MiwuNDAxMiAuODQ4NCwuNzY2MiAuMTM3MywuNTYxMS0=
uMTU5OCwuODg1My0uMjQ1OSwxLjQ1NC0uMDg1OCwuNTY3OS0uMjkzLC44OTQtLjE5NDcsMS40NT=
k5IC4wNjUxLC4zNzQzIC4yMjYzLC41MTg2IC4zNTM0LC45MDcyIDAsMC0xLjI2NDMtLjE0ODgtM=
i4wMzk5LS4zNzk2eiIvPg0KPHBhdGggZmlsbD0iIzAwNjViZCIgZmlsbC1ydWxlPSJldmVub2Rk=
IiBpZD0icGF0aDMwMTQiIGQ9Im01MjQuMTM1NCwzNjUuMTI0MmMtLjAwNy0uMzQ3MyAuMjcwNy0=
uNjM0IC42MTc5LS42Mzk5IC4zNDc1LS4wMSAuNjM0LC4yNzA3IC42NDAyLC42MTc5IC4wMDcsLj=
M0NzUtLjI3MDcsLjYzNC0uNjE3OSwuNjM5OS0uMzQ3NSwuMDEtLjYzNC0uMjcwNC0uNjQwMi0uN=
jE3OXoiLz4NCjxwYXRoIGZpbGw9IiMwMDY1YmQiIGZpbGwtcnVsZT0iZXZlbm9kZCIgaWQ9InBh=
dGgzMDE2IiBkPSJtNTIyLjM4NDIsMzQ4LjYxYzAsMC0uMDg5OC0uMDYtLjE0MzYtLjEwMzYtLjM=
4MzMtLjMwOTgtLjQxOTgtLjY1MzEtLjYwMTYtMS4xMTEtLjE3MjItLjQzMzMtLjI1NjktLjY5MD=
gtLjMxNDYtMS4xNTM0LS4wNTA2LS40MDU4IDAtLjYzOTYgMC0xLjA0ODUgMC0uMzY4MSAuMDM5N=
i0uNTc3NyAwLS45NDM1LS4wNDA1LS4zNzUxLS4wMzA2LS42MTIxLS4yMS0uOTQzOC0uMDk3LS4x=
ODAxLS4zOTQ1LS4zMzc0LS4zMTQzLS40MTk2IC4wOTQ2LS4wOTcgLjI1NjktLjAyIC40MTkzLDA=
gLjM5OTksLjA0OCAuNjMwOSwuMTY1NyAuOTQzOCwuNDE5NiAuMzc3MSwuMzA1OCAuNTI2NSwuNT=
cwOSAuNjcxNywxLjA0ODUgLjE2NjgsLjU0ODEgLjI0ODUsLjg5ODIgLjQwNzcsMS40NjggLjA4M=
jYsLjI5NTUgLjEyODgsLjQ2ODggLjI4MzYsLjczMzkgLjE2MSwuMjc1OCAuMzE5NywuMzgzOCAu=
NTI0MywuNjI5MmwtLjAxMTMsLjAyM2MtLjI5ODMsLjMyNy0uNDQzOCwuNTM5NC0uNzc2NywuODM=
zOC0uMzA1LC4yNjk5LS41NiwuNDAzMy0uODQ2NywuNTcyOWwtLjAzMjQtLjAxeiIvPg0KPHBhdG=
ggZmlsbD0iI2Q1MmIxZSIgZmlsbC1ydWxlPSJldmVub2RkIiBpZD0icGF0aDMwMTgiIGQ9Im01M=
jQuNjI1LDM0Ni45MDYyYzAsMC0uMzY2NCwuMTc1My0uNTkzOCwuMjgxMy0uMjk4MywuMzI3My0u=
NDQ3NSwuNTE5LS43ODEyLC44MTI1LS40NDI5LC4zODkyLS43Njg4LC41MDMtMS4yNSwuODQzNy0=
uMjMwNSwuMTYzLS40MTkzLC4yMTU2LS41OTM4LC40Mzc1LS4yNTIyLC4zMjA4LS4wNzkxLC42Mj=
kyLS4yNSwxLS4xODY2LC40MDUtLjM2OSwuNTk2NS0uNjU2MiwuOTM3NS0uMzY2MSwuNDM0OC0uN=
jQ5MSwuNjA5OC0xLjA2MjUsMS0uNDE4MiwuMzk1MS0uNTg3NSwuNzI2NS0xLjA5MzgsMS0uMTMz=
OSwuMDcyLS4xOTgzLC4xNDI1LS4zNDM4LC4xODc1LS4yMTU1LC4wNjctLjM0OTMtLjAxMS0uNTY=
yNSwuMDYyLS4zODgxLC4xMzQzLS41MTAyLC41NjI2LS43ODEyLC43MTg4IC4xMTIsLjIxNzggLj=
EwNjksLjM3MjUgLjIxODgsLjU5MzcgLjE1NzksLjMyMzQgLjcwNTEsMS4yMTU0IC44MTI1LDEuN=
DM3NSAuMjA5MSwuMzA1MSAuMjcwMSwuNjk5NiAuNTMxMiwuNzgxMyAuNTM3NywuMTY4MSAuODU4=
NiwuMTUzMiAxLjMxMjUsLjEyNSAuNzkyMSwuMTgxOCAxLjI4MDUsLjE1NzggMi4wMzEyLC40Njg=
3IC42MTI5LC4yNTM5IC44NjI2LC41NzUgMS40Njg4LC44NDM4IC40NzQyLC4yMTAyIC43NzE5LC=
4zMzk0IDEuMjgxMiwuNDM3NSAuMzg2NywuMDc0IC42MDgsLjEzMiAxLC4wOTQgLjI0OTYtLjAyN=
CAuMzc2OC0uMTE5NyAuNjI1LS4xNTYyIC4wNDg4LS4wMSAuMDgwOSwwIC4xMjUsMGwtLjAzMTIs=
LjM3NWMtLjAwNSwwIC4wMDUsLjAyOCAwLC4wMzF2LjA2MmguMDYyNWwyLjA2MjUsLjkwNjNjLS4=
wNzM4LC4xMTc2LS4xNTE1LC4yNTY2LS4xODc1LC4zNzUtLjA5ODEsLjMyMDUtLjExNCwuNjg4Ni=
0uMDYyNSwuODQzNyAuNjI5MiwxLjg4NzcgMS4xNTkyLDMuMDY4NCAxLjQ2ODgsMy4xODc1IC42M=
TU0LC4yMzY0IC44MDU5LC44NjQ5IDEuMTU2MiwxLjUtLjEyMzcsLjEzMjEtLjIyNzMsLjIwMDgt=
LjM0MzgsLjMxMjUtLjYxNDksLjU5MDItMS4xNTIsMS4wMDkzLTEuNjU2MiwxLjgxMjUtLjc0NTQ=
sMS4xODc5LTEuMjQ4NywxLjIwMzgtLjMxMjUsMi43ODEzIC41NDksLjkyNDcgLjgxNDMsMS4wOT=
k0IDEuNTMxMiwyLjQwNjIgLjM2MTYsLjY1OTEgLjU2MjIsMS4xNzMzIC43ODEyLDEuOTY4OCAuM=
jA3MSwuNzUxOSAuMjc3OSwxLjE4OTUgLjMxMjUsMS45Njg3bC45Njg4LC4zNzUgLjY1NjItLjY1=
NjIgLjYyNS0xLjE4NzUgLjAzMTItLjkwNjNjLS4yMzg2LS4yMDI2LS4zMDc2LS40NzMzLS4yNS0=
uNzgxMiAuMDY5NS0uMzY4NiAuNTE0My0uMjkxMyAuNzE4OC0uNjI1IC4yODMxLS40NjE1LS4zMz=
E1LS43MzQ0LS42NTYyLTEuMDkzOC0uNjA1Ni0uNjY5Ny0xLjQzMDUtLjgzMjktMS42MjUtMS44N=
DM3LS4wNTIzLS4yNzMyIC4wNzc2LS40MjY3IC4zNzUtLjcxODggLjg1NTItLjgzOTkgMS4xMjk5=
LS45NzM2IDEuOTY4OC0xLjgxMjUgLjI0MiwuMTQyIC42MTA1LC4xOTMyIC45Njg4LC4xMjUgLjI=
3OTEtLjA1MyAuNTI5MSwuMTI1MiAxLjQwNjIsLjM3NSAuNjA5NSwuMTczNiAuODczMiwuMDg2ID=
EuMjE4OCwuMDMxbC4zNzUtLjA5NGMuMDUwNCwuMjExNCAuMTExNSwuNDE1NyAuMTI1LC42ODc1I=
C4wNTMxLDEuMDYwNC0uMTU0NywyLjk5NDcgLjE1NjIsMy41IC4xMzEyLC4yMTMxIC4xODYxLC4z=
MzE1IC4yODEyLC41NjI1IC4wOTg2LC4yNDA2IC4yMTM4LC4zOTYzIC4yMTg4LC42NTYzIC4wMTE=
yLC42OTU2IC4wNDcxLDEuMTQwNSAwLDEuODc1LS4wNDQxLC42OTExLS4xMDMsMS4wNDItLjIxOD=
gsMS43NS0uMDc0LC40NTExLS4xNjU5LC43MTM2LS40Mzc1LDEuMDYyNS0uMjgzNCwuMzYzOS0uN=
Tk1MSwuNDE3NC0uOTY4OCwuNjg3NWwtLjA5MzcsMSAxLjEyNSwuNDY4NyAxLjI4MTIsLjMxMjUg=
LjY4NzUtLjI4MTJjMC0uMjU0NCAuMDM5OS0uMzk5IC4xNTYyLS42MjUgLjEyNzUtLjI0NjUgLjI=
zMTgtLjQzODYgLjQ2ODgtLjUzMTMgLjM2MjQtLjE0MjMgLjc1OTUsLjEyOTIgLjkwNjItLjA5NC=
AuMTU5NS0uMjQyIC4wNTk0LS4zMzc1IC4wMzEyLS43NS0uMDQ1My0uNjYyMS0uMTgzNS0uOTg4O=
C0uMjgxMi0xLjY1NjMtLjE2NDItMS4xMTA3LS4yMDk4LTEuNjg2NS0uMTU2Mi0yLjc1IC4wMzEx=
LS42MTY1IC4wMzgzLS45NTYzIC4xNTYyLTEuNTYyNSAuMTcyLS44ODI0IC40ODU2LTEuMzExMiA=
uNjg3NS0yLjE4NzUgLjIyNTQtLjk3NzUgLjI2NDctMS42MDYyIC4zNzUtMi40Njg3IDMuMTY5NC=
wuNDUyOCA1LjgwNzQsLjM5NzIgOS4zNDM4LS4zNzUgLjE2OTEtLjAzNyAuNzUtLjI1IC43NS0uM=
jUgLjc5OTUsLjY4ODkgMS43MDYsMS4yNjQyIDIuNzE4OCwxLjYyNS0uMDA2LC4xMDE2LS4wMTU4=
LC44NDU2IDAsLjk2ODcgLjAzNjUsLjI4NzYtLjA0MTQsLjQ4MTMgLjEyNSwuNzE4OCAuMTA1NSw=
uMTUwNiAuMTk2LC4yMzk2IC4zNzUsLjI4MTIgLjI2MjYsLjA2MSAuNDU0OCwuMDIzIC42NTYyLS=
4xNTYyIC4yMjYzLS4yMDE1IC4xODQzLS40NTQ1IC4yNS0uNzUgLjAzMi0uMTQwNyAuMDA3LS41N=
jQ0IDAtLjY4NzUgLjM2NjcsLjA1NSAuNDkxMiwuMDYyIC44NzUsLjA2MiAuMzU3NywwIC41Mjk0=
LC4wMTQgLjg3NS0uMDMxIC4wMDUsLjA4MSAuMDE5OSwuMzY4OSAuMDMxMiwuNDY4OCAuMDI2OCw=
uMjQ0My0uMDc1NywuNDM0NyAuMDMxMiwuNjU2MiAuMTEwOSwuMjI5NiAuMjQ5NSwuMzU5MiAuNS=
wuNDA2MyAuMjA2LC4wMzkgLjM1MzYsLjAxOCAuNTMxMi0uMDk0IC4yOTU1LS4xODUxIC4yNjMyL=
S40OTg0IC4zMTI1LS44NDM3IC4wMTQ2LS4xMSAuMDExMy0uNjkxOSAwLS43ODEzIC4yMTE2LS4w=
NjcgLjgyNzMtLjI5MTcgMS4wMzEyLS4zNzUtLjAwNSwuMjQyNi0uMDM4OCwuNTE2OC0uMDkzNyw=
uODEyNS0uMDY5OSwuMzc2LS4xMTk2LC41Nzg1LS4yNSwuOTM3NS0uMjA2LC41Njc2LS40NDE2LC=
44NTYxLS43NSwxLjM3NS0uMzc2OCwuNjMzOC0uNTcyOSwuOTg1NC0xLjAzMTIsMS41NjI1LS4yM=
TExLC4yNjYtLjM1NzYsLjM4NTYtLjU2MjUsLjY1NjMtLjI1NTIsLjMzNzQtLjM0MjIsLjU2NjMt=
LjU5MzgsLjkwNjItLjMyNDIsLjQzODItLjUxMDMsLjcyNC0uOTM3NSwxLjA2MjUtLjY5MzYsLjU=
0OTktMS4xNDk5LC4xMDk5LTIuMDkzOCwuODQzOGwtLjIxODgsMS4wMzEyIDEuNDM3NSwuNTMxMy=
AxLjI4MTIsLjI1IC40Mzc1LS4yNWMtLjAxMTgtLjMwMTEgLjAzMTktLjUxMzkgLjIxODgtLjc1I=
C4yMTM2LS4yNjk4IC40NDE2LS4zNTExIC43ODEyLS40MDYzIC4zNjEzLS4wNTkgLjc0NjgsLjAz=
NCAxLjAzMTItLjIxODcgLjM1MDEtLjMxMDkgLjM0ODctLjkxNDEgLjYyNS0xLjQ2ODggLjg1ODM=
tMS43MjM1IDEuNjIwOS0yLjU2MjggMy0zLjkwNjIgLjYxMjYtLjU5NjYgMS4xMzczLS43NTc5ID=
EuNjU2Mi0xLjQzNzUgLjI0NjUtLjMyMjUgLjUxOTktLjQ2OTIgLjUzMTItLjg3NSAuMDA4LS4yO=
DI4LS4xNDQtLjQxNTEtLjIxODgtLjY4NzUtLjEwMzYtLjM3NzEtLjE4NzUtMS0uMTg3NS0xIDEu=
NTIxOCwuNzQ0NiAuOTcwOSwuNjQ2MiAxLjI1LDEuNDA2MiAuMjI1NSwuNjE0OS0uMDMyNSwxLjA=
zOTUgLjA2MjUsMS42ODc1IC4xMTExLC43NTU5IC40NjYxLDEuMTEzOSAuNTMxMiwxLjg3NSAuMD=
c3NywuOTA0OC0uMTQzLDEuNDIwNS0uMzEyNSwyLjMxMjUtLjE0ODksLjc4NDYtLjEzLDEuMjc2O=
C0uNDY4OCwyLS4zMjI1LC42ODg5LS41NzA5LDEuMDc2OS0xLjE1NjIsMS41NjI1LS4yMTExLC4x=
NzUtLjM2ODQsLjI1MDMtLjU5MzgsLjQwNjNsLS4xMjUsMS4wMzEyIDEuMTI1LC4zNzUgMS42MjU=
sLjQzNzUgLjM3NS0uMzQzN2MuMTYzNS0uNjU0NS0uMDU0Ny0xLjYxNjUgLjQwNjItMS42ODc1IC=
40MDYxLS4wNjIgLjY5MjgsLjAwMDEgLjc4MTItLjMxMjUgLjAzNjctLjEzMTQgLjA1ODktLjMyN=
TkgLjA5MzctLjYyNSAuMjIxMi0xLjg4NTkgLjQyMTUtMy42NDU0IC42MjUtNC41IC4yMzAxLS45=
Njc3IC4yMTQ1LTEuMTc4IC40MDYyLTEuOTA2MyAuMTc1My0uNjY0MS0uMDg1My0uMjgyNCAuNDA=
2Mi0xLjY4NzUgLjczNDItMi4wOTcyLS4yMDgyLTIuMzc1LTEuMDYyNS0zLjY1NjItLjQ2Mi0uNj=
kzMS0uNjIxOC0uOTQ0Mi0uNjg3NS0xLjUtLjA5Ny0uODE2OSAuMTY0Ny0xLjQ5NDcgLjEyNS0yL=
jc1LS4wNDEtMS4zMTk4LS4wMjI1LTIuMTU5MSAwLTIuODc1IC4xMTU0LS4wNTMgLjIyMTgtLjEy=
MDcgLjM0MzgtLjE4NzUgMS4xNzA2LS42NDI3IDEuNjM2My0uODM2MSAyLjM3NS0yLjQ2ODggLjI=
yMzktLjQ5NTUgLjMxOTUtLjk5MzcgLjMxMjUtMS40Njg3LS4wMDUtLjMzMjEtLjA2NDgtLjY1Mj=
ItLjA5MzctMS4wMzEzLS4wMzA0LS4zOTktLjE5MDktLjYzNzUtLjMxMjUtLjkzNzUtLjEyOTUtL=
jMxODItLjMyNDQtLjU1ODYtLjU2MjUtLjg0MzctLjc3MjQtLjkyNDctMS43Nzg5LTEuMTMxOS0y=
LjcxODgtMS40Njg4LTEuNDgzNS0uNTMxNy0yLjUwNS0uNDM0Ni00LjEyNS0uNTYyNS0xLjY3MjE=
tLjEzMjEtMi42MDY0LS4xNTc3LTQuMjgxMi0uMDYyLTIuMDA2NywuMTE0My0zLjEyNzksLjUxOS=
01LjEyNSwuNzUtMS45MTU4LC4yMjE3LTIuOTc3OCwuMzcwMS00LjkwNjIsLjQwNjMtMi4yNjAyL=
C4wNDItNC40MjA3LS40NjA2LTUuNzgxMi0uMzQzOC0yLjQ1MSwuMjEtMi40OTMsLjc2MTItNi4x=
ODc1LDEuMDYyNS0xLjkyNywuMTU3NC0zLjg0MzgsLjE4NzUtMy44NDM4LC4xODc1bC0yLjE1NjI=
tLjY4NzVjLjg1NjYtLjMwNjEgMS4wNjYxLS40ODgxIDEuNDY4OC0xLjAzMTIgLjI3MTgtLjM2Nj=
EgLjIzMzMtLjY3ODQgLjU2MjUtMS4wNjI1IC4yNjY4LS4zMTE4IC40NDMtLjYyMjQgLjc4MTItL=
jk2ODgtLjMxMDEtLjI0OTEtLjY0MjktLjM3NjMtLjkzNzUtLjQzNzUtLjM2MzktLjA3Ni0uNTcz=
NC0uMDQyLS45Mzc1LDAtLjQ5NDEsLjA1Ni0uNzcyNSwuMTI0My0xLjIxODgsLjM0MzgtLjM1OTM=
sLjE3Ny0uNjI0LC4zNTc0LS44NDM4LC41OTM3IDAsMC0xLjI4NTYtLjgyODctMi4xODc1LTEuMj=
E4Ny0xLjExODYtLjQ4NDMtMS42MDA2LS43MTE3LTMtLjkwNjN6bTEuOTY4OCwxMS45MDYzYy4wM=
jEzLDAgLjA0LDAgLjA2MjUsMC0uMDEyMywuMDEtLjAxOSwuMDIyLS4wMzEyLC4wMzFsLS4wMzEy=
LS4wMzF6Ii8+DQo8ZyBzdHJva2U9IiNmZWRmMDAiIHN0cm9rZS1taXRlcmxpbWl0PSIzLjg2NCI=
+DQo8Zz4NCjxwYXRoIGZpbGw9Im5vbmUiIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgc3Ryb2tlLX=
dpZHRoPSIuOTg3IiBkPSJtNTY4Ljc2NTQsMzU5LjUxNzMtLjc2MzEsLjI0NGMtLjg2NywuNDAyM=
S0xLjU3NzgsLjQxNzgtMi42MDAxLC40OTYxLTIuNjQzNywuMjAyMS00LjI3MTMtMS4wNTcyLTYu=
OTk3Ni0uODQ3Ni0xLjQwMzksLjEwOC0yLjAyNTIsMS4xOTA5LTMuNDU5OCwxLjU0ODMtLjY1MjY=
sLjE2MjUtMS4wMzEzLC4yMjU0LTEuNzAxNiwuMjgxOWwuNTEyNy0xLjAzMzNjMCwwLTEuMjg0LC=
4yNjE3LTIuMTE1MywuMjYzNC0uNTk2MywuMDAxLS45MzYtLjAyOC0xLjUyMzUtLjEzMDFsMS4wM=
TgxLS45NTA2YzAsMC0uODEzNS0uMTMxOS0xLjI5MzYtLjMzNTEtLjQ0MjYtLjE4NzEtLjY4MzUt=
LjMzMDEtMS4wNi0uNjI5MiAuNjYzMy0uMTEzOSAxLjAzNTgtLjE5MjEgMS42ODkzLS4zNTM1IDE=
uNTU2MS0uMzg0OSAyLjAzOTktMS4xNDcgMy44OTA5LTEuMzI1NCAxLjE0OS0uMTExMiAzLjAzMj=
EtLjA0NiA3LjY0MjgsLjcxNjggMy4wMzU3LC41MDIgNC4zODIyLC4yNjcgNS41MzU0LS4yNTcyI=
C43NjA5LS4zNDU5IDEuMDEwOC0xLjAxMDggMS4xMDMxLTEuNzg4MyAuMDkyNS0uNzc2NC0uNDA0=
MS0xLjQwNDUtLjg3MzgtMS44MS0uMTIyNy0uMTA2LS40NDQtLjMzNTEtMS4xMTI5LS4zNjMiLz4=
NCjxwYXRoIGZpbGw9IiNmY2Q5MDAiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPS=
IuNTEzIiBkPSJtNTI0Ljc5NTUsMzUwLjYwNTljLS41MzA0LS4wNjYtLjg4NDQsLjAxMS0xLjMzO=
TcsLjI5MTUtLjQ4MDQsLjI5NTgtLjU0MTcsLjY5NjUtLjg4ODEsMS4xNDIgLjQ0NTIsLjA5OSAu=
Njk4NCwuMzYwNyAxLjE0MTksLjI1MzggLjM0NjctLjA4NCAuNTI2OC0uMjM4NiAuNzYxMi0uNTA=
3NiAuMzE1NS0uMzYyNSAuNDMxNC0uNjc1NCAuNDI3NS0xLjE1NmwtLjEwMjctLjAyNHoiLz4NCj=
wvZz4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgc3Ryb2tlLXdpZHRoP=
SIuOTg3Ij4NCjxwYXRoIGQ9Im01MzYuMDQ0NSwzNjMuNzk0YzAsMCAuMjY0LC40ODAxIC40MDY2=
LC43OTkyIC4yNDc5LC41NTUyIC4zNzYyLC44Nzg1IC41MjQzLDEuNDY4IC4yMDA0LC43OTg3IC4=
xMTM3LDEuMjgzOCAuMjQwOSwyLjA5NzMgLjAyMjUsLjE0MzIgLjA0OTgsLjI2MzQgLjA3NjcsLj=
M3NjhsLS4wNTExLDEuMTI4NyIvPg0KPHBhdGggZD0ibTU0NC4wMzcxLDM2Mi43MDU1YzAsMC0uM=
jE4OCwuODEyMi0uMzU0LDEuMzMyNS0uMzUyLDEuMzUzOC0uNjc2NSwyLjA4NzEtLjk0MzgsMy40=
NjAxLS4wNDQ4LC4yMzAyLS4wNzc3LC40NDI5LS4xMDM2LC42NDQ0Ii8+DQo8L2c+DQo8L2c+DQo=
8cGF0aCBmaWxsPSIjMDA2NWJkIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGlkPSJwYXRoMzAyOCIgZD=
0ibTUyNS45ODQyLDM1OS4yNDU3IDIuMjMwOSwxLjAzMTFjMS4xNDgxLS42MzQ4IDIuNDczMi0xL=
jkyMzkgMy40OTY0LTMuOTE5MSAuODgwOC0xLjcxNzYgMS4wMjA2LTIuNjUwNSAxLjM2MzktNC4z=
MTI3bC0xLjc4OTEtLjU4MTctLjM1NzEsLjA3M2MtLjU1MjQsMS43MjMzLS42OTI1LDIuNzA0LTE=
uNjE3OCw0LjE5MjYtLjgwMjMsMS4yOTExLTEuNzE4NSwyLjMwNDktMi42NDkxLDMuMDMzOGwtLj=
Y3ODIsLjQ4MzR6Ii8+DQo8cGF0aCBmaWxsPSIjMDA2NWJkIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiI=
GlkPSJwYXRoMzAzMiIgZD0ibTUzMC45MTYzLDM3Ny4zNjgyYy4zNTk2LS40OTI4IC41MTMzLS44=
MTA3IC45MjIxLTEuMjYzNSAuNDU2Mi0uNTA1MSAuOC0uNzAyMSAxLjMxMTYtMS4xNTEgLjE1NTY=
sLjAxNiAuMzM1NC0uMDExIC40ODEyLC4wNzItLjAyODQsLjU0NDgtLjA1NjMsLjk0ODctLjE4MD=
EsMS41NDA3LS4xMDA0LC40ODA0LS4xODY0LC43NDYtLjM0NywxLjIwOTctLjEzNDYsLjM4ODEtL=
jE1ODUsLjYzOTEtLjM4OTcsLjk3OS0uMTU0MiwuMjI2Ni0uMjkwMSwuMzE1OC0uNDc1OSwuNTE3=
OC0uNTEwNS0uNzQxOC0xLjMzMDItMS4yOTY3LTEuMzIyMy0xLjkwNTN6Ii8+DQo8cGF0aCBmaWx=
sPSIjMDA2NWJkIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGlkPSJwYXRoMzAzNCIgZD0ibTU2My45Mj=
YxLDM3OS4yMTg2Yy41NzI2LC4yMTAzIC45MjA3LC4yNzAyIDEuNDY4NiwuNTM4NCAuNjExMiwuM=
jk5NCAuODk1NCwuNTc1NyAxLjQ2NzgsLjk0MzggLjAyNjgsLjE1NCAuMTAzOCwuMzE4OCAuMDYz=
LC40ODIzLS41MzE2LC4xMjI5LS45Mjc1LC4yMDc2LTEuNTMwOCwuMjUxNi0uNDg5MywuMDM2LS4=
3Njg1LC4wMjctMS4yNTg0LDAtLjQxMDMtLjAyMy0uNjU4MiwuMDI0LTEuMDQ4NS0uMTA0Ny0uMj=
YwNi0uMDg2LS4zODM4LS4xOTItLjYyODktLjMxNDYgLjU3MjQtLjY5NTQgLjg3OTktMS42MzY0I=
DEuNDY3Mi0xLjc5Njh6Ii8+DQo8cGF0aCBmaWxsPSIjMDA2NWJkIiBmaWxsLXJ1bGU9ImV2ZW5v=
ZGQiIGlkPSJwYXRoMzAzNiIgZD0ibTU1NC4xNzI1LDM3Ny4xODE2Yy41NzI2LC4yMSAuOTIwNSw=
uMjY5OSAxLjQ2ODMsLjUzOCAuNjExMiwuMjk5NCAuODk1NywuNTc1OCAxLjQ2ODEsLjk0MzggLj=
AyNjMsLjE1NCAuMTAzOCwuMzE4OSAuMDYzLC40ODI2LS41MzE2LC4xMjI3LS45Mjc1LC4yMDc0L=
TEuNTMxMSwuMjUxMy0uNDg5MywuMDM2LS43NjgyLC4wMjctMS4yNTgxLDAtLjQxMDMtLjAyMy0u=
NjU4MiwuMDI0LTEuMDQ4NS0uMTA0Ni0uMjYwNi0uMDg2LS4zODM4LS4xOTE4LS42MjkyLS4zMTQ=
2IC41NzI2LS42OTU0IC44Nzk5LTEuNjM2NCAxLjQ2NzUtMS43OTY1eiIvPg0KPHBhdGggZmlsbD=
0iIzAwNjViZCIgZmlsbC1ydWxlPSJldmVub2RkIiBpZD0icGF0aDMwMzgiIGQ9Im01MzYuODI1M=
SwzNzkuMzExNWMuNTcyOSwuMjEgLjkyMDcsLjI3MDEgMS40Njg2LC41MzgzIC42MTEyLC4yOTkx=
IC44OTU3LC41NzU4IDEuNDY4MSwuOTQzOCAuMDI2NiwuMTU0IC4xMDM4LC4zMTg5IC4wNjMsLjQ=
4MjQtLjUzMTYsLjEyMjctLjkyNzUsLjIwNzUtMS41MzExLC4yNTE1LS40ODkzLC4wMzYtLjc2OD=
IsLjAyNy0xLjI1ODEsMC0uNDEwMy0uMDIyLS42NTgyLC4wMjQtMS4wNDg1LS4xMDQ5LS4yNjA2L=
S4wODYtLjM4MzgtLjE5MTUtLjYyOTItLjMxNDMgLjU3MjQtLjY5NTMgLjg3OTktMS42MzYzIDEu=
NDY3Mi0xLjc5Njd6Ii8+DQo8cGF0aCBmaWxsPSIjMDA2NWJkIiBmaWxsLXJ1bGU9ImV2ZW5vZGQ=
iIGlkPSJwYXRoMzA0MCIgZD0ibTUyNy44NTMyLDM0OS41MDg1Yy0uNjEyNi0uMjc4MS0xLjA0OT=
MtMS4wNDQ2LS42NjA3LTEuNTkzOSAuMTU1NS0uMjE5NyAuNDEzMS0uMTczNiAuNTY2Mi0uMzk1M=
SAuMTg4Ny0uMjcyNiAuMTQxNi0uNTA3NiAuMTM2LS44Mzg4LS4wMDctLjM3NzEtLjE0MzktLjU3=
MjctLjIwOTYtLjk0MzgtLjA3Mi0uNDA1OC0uMTM5MS0uNjM2My0uMTM2LTEuMDQ4NSAuMDA1LS4=
2MjgxLS4wMzc4LTEuMDc1NiAuMzQ1Ni0xLjU3MjggLjI0NDUtLjMxNzEgLjY2MDQtLjU5MjMgLj=
gyNDItLjYxMjMgLjE0NzUsLjEzNjQtLjA1NjUsLjUwMi0uMDMyMiwuODIyIC4wMzUzLC40NjIgL=
jEzMDYsLjcxNzMgLjI4NzYsMS4xNTM0IC4yMDI0LC41NjI1IC40Nzg3LC44MDg1IC43MDI3LDEu=
MzYzMSAuMjA4NSwuNTE1NiAuMzk5OSwuODA3NCAuNDE5NiwxLjM2MzEgLjAxNTgsLjQ1NjctLjA=
yNDEsLjczNTYtLjIwOTYsMS4xNTM1LS4xNjQzLC4zNjk1LS4yOTk3LC41NzkxLS42MDk1LC44Mz=
g4LS4yNjkzLC4yMjUyLS40NTg0LC4zMjUxLS43OTY0LC40MTkzLS4yNDczLC4wMi0uNDAxNi0uM=
DEtLjYyNzgtLjEwOHoiLz4NCjxnIHN0cm9rZT0iI2ZlZGYwMCIgc3Ryb2tlLW1pdGVybGltaXQ9=
IjMuODY0Ij4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZS13aWR0aD0iLjk4NyI+DQo8Zz4NCjxwYXR=
oIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgZD0ibTUzMS43NzU3LDM2NC4xNzM5Yy43OTAyLC4xNz=
U2IC41NDQyLDMuMzYwMiAxLjc4ODksNC4wOTA0Ii8+DQo8cGF0aCBkPSJtNTYwLjEyMywzNjkuN=
zgwNSAuMzg0NC0uMjQ5YzEuMDEzOS0uNDE0NiAxLjkyNTEtMS4wMjcxIDIuNjg1Ny0xLjc4OTci=
Lz4NCjwvZz4NCjxnIHN0cm9rZS1saW5lY2FwPSJyb3VuZCI+DQo8cGF0aCBkPSJtNTUyLjM3OTU=
sMzY4LjAyMzRjLjAwMi0uMDAwNSAuMDA1LS4wMDA5IC4wMDcsMCAzLjUzMy0uODgzIDUuODg0OS=
0yLjY0NzYgNy41Nzg3LTIuODY4OCIvPg0KPHBhdGggZD0ibTU1NS45NjcsMzYzLjYwODhjLjI5O=
DktLjAxMSAuNTg0Ny0uMDMzIC44MjkzLS4wNjggMS40NjgxLS4yMDk2IDEuNzA0MiwuNjg2OSAy=
LjcyNjIsMS4yNTg0IDEuODU2NCwxLjAzODEgMi4wOTczLDIuMzA3IDQuMjk5LDMuMzU1NSAuMTE=
2NCwuMDU1IC4yMjMzLC4xMDY5IC4zMjE0LC4xNTUxbC44NDczLC40Mjg4Ii8+DQo8L2c+DQo8L2=
c+DQo8Zz4NCjxwYXRoIGZpbGw9IiNmY2Q5MDAiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlL=
XdpZHRoPSIuNTEzIiBkPSJtNTE3LjY5NTgsMzU0LjUyOTJjLjI2ODIsLjA2NyAuNDMyLC4wOCAu=
NzA3NCwuMDU0IC4zMzE1LS4wMzEgLjQ4MzctLjIzNzggLjgxNjQtLjI0ODggLjI3MS0uMDEgLjQ=
2MjYtLjAzMiAuNjg0MSwuMTI0NSAuMTQwOSwuMDk5IC4xOTk5LC4xODk0IC4yOCwuMzQxOSAuMD=
g3MSwuMTY2OCAuMTYzLC4yODIzIC4xMjQ1LC40NjY2LS4wNTk1LC4yODQyLS4zMjQyLC40MTczL=
S42MTQzLC40MTk4LS4yMzcyLDAtLjQzMzktLjA2Mi0uNTQ0Mi0uMjcyMS0uMDcwNy0uMTM0OC0u=
MDgxNS0uMjQyNS0uMDM4OC0uMzg4Ni0uMjgzOSwuMTA2Ny0uNDg5NiwuMTEwOC0uNzc3NSwuMDE=
2LS4zMDMxLS4xMDAyLS40NzQ3LS4yMzg2LS42Mzc0LS41MTN6Ii8+DQo8L2c+DQo8L2c+DQo8dX=
NlIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjcwMCIgeGxpbms6aHJlZj0iI3BhdGgzMDEyIiB0cmFuc=
2Zvcm09InRyYW5zbGF0ZSgwIDM2LjU5MDQ0KSIvPg0KPHVzZSB3aWR0aD0iMTAwMCIgaGVpZ2h0=
PSI3MDAiIHhsaW5rOmhyZWY9IiNwYXRoMzAxNCIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMCAzNi4=
1OTA1NSkiLz4NCjx1c2Ugd2lkdGg9IjEwMDAiIGhlaWdodD0iNzAwIiB4bGluazpocmVmPSIjcG=
F0aDMwMTYiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgMzYuNTkwNDUpIi8+DQo8ZyBzdHJva2Utb=
Wl0ZXJsaW1pdD0iMy44NjQiPg0KPGc+DQo8cGF0aCBmaWxsPSJub25lIiBzdHJva2U9IiNmZWRm=
MDAiIHN0cm9rZS1saW5lY2FwPSJyb3VuZCIgc3Ryb2tlLXdpZHRoPSIuOTg3IiBkPSJtNTY4Ljc=
2NTQsMzk2LjEwOC0uNzYzMSwuMjQzN2MtLjg2NywuNDAyMS0xLjU3NzgsLjQxNzgtMi42MDAxLC=
40OTYxLTIuNjQzNywuMjAxOS00LjI3MTMtMS4wNTcyLTYuOTk3Ni0uODQ3Ni0xLjQwMzksLjEwO=
C0yLjAyNTUsMS4xOTA5LTMuNDU5OCwxLjU0ODMtLjY1MjYsLjE2MjUtMS4wMzEzLC4yMjU0LTEu=
NzAxNiwuMjgxOWwuNTEyNy0xLjAzMzNjMCwwLTEuMjg0LC4yNjE3LTIuMTE1MywuMjYzNC0uNTk=
2MywuMDAxLS45MzYtLjAyOC0xLjUyMzUtLjEyOTdsMS4wMTgxLS45NTA4YzAsMC0uODEzNS0uMT=
MxOS0xLjI5MzYtLjMzNTEtLjQ0MjYtLjE4NzEtLjY4MzUtLjMzMDEtMS4wNi0uNjI5IC42NjMzL=
S4xMTQxIDEuMDM1OC0uMTkyMiAxLjY4OTMtLjM1MzcgMS41NTYxLS4zODQ5IDIuMDM5OS0xLjE0=
NjcgMy44OTA5LTEuMzI1NCAxLjE0OS0uMTExMiAzLjAzMjEtLjA0NiA3LjY0MjgsLjcxNjcgMy4=
wMzU3LC41MDIxIDQuMzgyMiwuMjY3MSA1LjUzNTQtLjI1NzIgLjc2MDktLjM0NTggMS4wMTA4LT=
EuMDEwOCAxLjEwMzEtMS43ODgyIC4wOTI1LS43NzY0LS40MDQxLTEuNDA0NS0uODczOC0xLjgxL=
S4xMjI3LS4xMDYtLjQ0NC0uMzM1Mi0xLjExMjktLjM2MjciLz4NCjxwYXRoIGZpbGw9IiNmZWRm=
MDAiIHN0cm9rZT0iI2ZjZDkwMCIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9Ii4=
1MTMiIGQ9Im01MjQuNzk1NSwzODcuMTk2NmMtLjUzMDQtLjA2Ni0uODg0NCwuMDExLTEuMzM5Ny=
wuMjkxMy0uNDgwNCwuMjk2LS41NDE3LC42OTY3LS44ODgxLDEuMTQxOSAuNDQ1MiwuMDk5IC42O=
Tg0LC4zNjA3IDEuMTQxOSwuMjUzOCAuMzQ2Ny0uMDgzIC41MjY4LS4yMzg2IC43NjEyLS41MDc3=
IC4zMTU3LS4zNjI0IC40MzE0LS42NzUzIC40Mjc1LTEuMTU1OWwtLjEwMjctLjAyNHoiLz4NCjw=
vZz4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZT0iI2ZlZGYwMCIgc3Ryb2tlLWxpbmVjYXA9InJvdW=
5kIiBzdHJva2Utd2lkdGg9Ii45ODciPg0KPHBhdGggZD0ibTUzNi4wNDQ1LDM5OC42ODgxYzAsM=
CAuMjY0LC40Nzk4IC40MDY2LC43OTkyIC4yNDc5LC41NTQ5IC4zNzYyLC44NzgzIC41MjQzLDEu=
NDY4MSAuMjAwNCwuNzk4MyAuMTEzNywxLjI4MzcgLjI0MDksMi4wOTcgLjAyMjUsLjE0MzYgLjA=
0OTgsLjI2MzYgLjA3NjcsLjM3N2wtLjA1MTEsMS4xMjg0Ii8+DQo8cGF0aCBkPSJtNTQ0LjAzNz=
EsMzk5LjI5NTljMCwwLS4yMTg4LC44MTIyLS4zNTQsMS4zMzI1LS4zNTIsMS4zNTM4LS42NzY1L=
DIuMDg3MS0uOTQzOCwzLjQ2MDEtLjA0NDgsLjIzMDItLjA3NzcsLjQ0MjktLjEwMzYsLjY0NDQi=
Lz4NCjwvZz4NCjwvZz4NCjx1c2Ugd2lkdGg9IjEwMDAiIGhlaWdodD0iNzAwIiB4bGluazpocmV=
mPSIjcGF0aDMwMjgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgMzYuNTkwNSkiLz4NCjx1c2Ugd2=
lkdGg9IjEwMDAiIGhlaWdodD0iNzAwIiB4bGluazpocmVmPSIjcGF0aDMwMzIiIHRyYW5zZm9yb=
T0idHJhbnNsYXRlKDAgMzYuNTkwNikiLz4NCjx1c2Ugd2lkdGg9IjEwMDAiIGhlaWdodD0iNzAw=
IiB4bGluazpocmVmPSIjcGF0aDMwMzQiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgMzYuNTkwNTU=
pIi8+DQo8dXNlIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjcwMCIgeGxpbms6aHJlZj0iI3BhdGgzMD=
M2IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwIDM2LjU5MDQpIi8+DQo8dXNlIHdpZHRoPSIxMDAwI=
iBoZWlnaHQ9IjcwMCIgeGxpbms6aHJlZj0iI3BhdGgzMDM4IiB0cmFuc2Zvcm09InRyYW5zbGF0=
ZSgwIDM2LjU5MDQpIi8+DQo8dXNlIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjcwMCIgeGxpbms6aHJ=
lZj0iI3BhdGgzMDQwIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwIDM2LjU5MDU1KSIvPg0KPGcgc3=
Ryb2tlLW1pdGVybGltaXQ9IjMuODY0Ij4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZT0iI2ZlZGYwM=
CIgc3Ryb2tlLXdpZHRoPSIuOTg3Ij4NCjxnPg0KPHBhdGggc3Ryb2tlLWxpbmVjYXA9InJvdW5k=
IiBkPSJtNTMxLjc3NTcsNDAwLjc2NDNjLjc5MDIsLjE3NTYgLjU0NDIsMy4zNjAyIDEuNzg4OSw=
0LjA5MDciLz4NCjxwYXRoIGQ9Im01NjAuMTIzLDQwNi4zNzA5IC4zODQ0LS4yNDljMS4wMTM5LS=
40MTQ1IDEuOTI1MS0xLjAyNzEgMi42ODU3LTEuNzg5NyIvPg0KPC9nPg0KPGcgc3Ryb2tlLWxpb=
mVjYXA9InJvdW5kIj4NCjxwYXRoIGQ9Im01NTIuMzc5NSw0MDQuNjEzOGMuMDAyLS4wMDA1IC4w=
MDUtLjAwMDggLjAwNywwIDMuNTMzLS44ODMgNS44ODQ5LTIuNjQ3NCA3LjU3ODctMi44Njg2Ii8=
+DQo8cGF0aCBkPSJtNTU1Ljk2Nyw0MDAuMTk5Yy4yOTg5LS4wMTEgLjU4NDctLjAzMyAuODI5My=
0uMDY4IDEuNDY4MS0uMjA5NiAxLjcwNDIsLjY4NjkgMi43MjYyLDEuMjU4NCAxLjg1NjQsMS4wM=
zgxIDIuMDk3MywyLjMwNjkgNC4yOTksMy4zNTU0IC4xMTY0LC4wNTUgLjIyMzMsLjEwNjkgLjMy=
MTQsLjE1NTFsLjg0NzMsLjQyODkiLz4NCjwvZz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9=
kZCI+DQo8ZyBmaWxsPSIjZmVkZjAwIj4NCjxwYXRoIHN0cm9rZT0iI2ZjZDkwMCIgc3Ryb2tlLX=
dpZHRoPSIuNTEzIiBkPSJtNTE3LjY5NTgsMzkxLjExOTZjLjI2ODIsLjA2NyAuNDMyLC4wOCAuN=
zA3NCwuMDU0IC4zMzE1LS4wMzEgLjQ4MzctLjIzNzggLjgxNjQtLjI0ODggLjI3MS0uMDEgLjQ2=
MjYtLjAzMiAuNjg0MSwuMTI0NSAuMTQwOSwuMDk5IC4xOTk5LC4xODkzIC4yOCwuMzQyMiAuMDg=
3MSwuMTY2NiAuMTYzLC4yODIyIC4xMjQ1LC40NjY1LS4wNTk1LC4yODQtLjMyNDIsLjQxNzEtLj=
YxNDMsLjQxOTYtLjIzNzIsMC0uNDMzOS0uMDYyLS41NDQyLS4yNzE4LS4wNzA3LS4xMzQ5LS4wO=
DE1LS4yNDI2LS4wMzg4LS4zODg5LS4yODM5LC4xMDY3LS40ODk2LC4xMTEtLjc3NzUsLjAxNi0u=
MzAzMS0uMTAwMi0uNDc0Ny0uMjM4NC0uNjM3NC0uNTEzeiIvPg0KPHBhdGggc3Ryb2tlPSIjNzA=
zZDI5IiBzdHJva2Utd2lkdGg9Ii43OTciIGQ9Im00MTIuOTY4Nyw0MDIuNDA2OGMuMjMzMywxLj=
Q3NzQgLjc1OTIsNC4wMTE5IDIuMTYyNSw2LjYwODcgMS40NzcxLDIuMzMyMiAuOTMyOCwyLjI2O=
DkgNC4yNzYxLDYuMDAwOCAxLjY0NTYsMS44MzcgNC4yMTM3LDMuNDEwOSA2LjIyNzEsNC40OTQ4=
IDIuMDIxMywxLjA4ODUgMy41MTY5LDEuNjIyOSA2Ljg0MTcsMi40OTUyIDYuNTE3NSwxLjcxMDQ=
gMTEuMDkwOCwxLjgxNyAxNi41NzQyLDEuNTk4NCA0LjI3ODEtLjE3MDkgNy41NDQzLS42OTczID=
EwLjI0ODktMS4wNjE1IDMuODU3NC0uNTE4OSA2LjczMDUtLjgyNzggMTEuMTE3OC0xLjAxMDUgM=
i4xMzMzLS4wODkgNC4xNDktLjExMDEgNi4xNDIxLDAgMi40MDU3LC4xMzI2IDQuNzgxOCwuNTA1=
NCA3LjMwODUsMS4wMTA1IDUuNDQyLDEuMDg4NSAxMC45NjIyLDMuMTg3NyAxMC45NjIyLDMuMTg=
3N2wuMDEzNS04NS42NTUyLTgyLjE5MzItLjAyM3Y1OC41NDMyYzAsMCAuMTY4NiwyLjg1OTkgLj=
MxODMsMy44MDk2eiIvPg0KPC9nPg0KPGcgZmlsbD0iI2Q1MmIxZSIgc3Ryb2tlPSIjZDUyYjFlI=
iBzdHJva2Utd2lkdGg9Ii41MTMiPg0KPHBhdGggZD0ibTQyMi41MDg0LDQxNi44Mzg2YzEuMzA4=
NSwuODQzOSAyLjY1MDIsMS4zODUxIDMuODUxOCwyLjAyMjUgMS45Njg0LDEuMDQ0OSAyLjg5MjU=
sMS4yOTQ2IDUuMjc4MiwyLjE0ODlsLS4wMDUtODAuNDQyN2gtOS4xMjY0djc2LjA1NDJsLjAwMS=
0uMDExIC4wMDA0LC4yMjg0eiIvPg0KPHBhdGggZD0ibTQ2OC4xNjg2LDQyMS4xNDQ0IC4wMTEzL=
TgwLjU3NzEtOS4xNDM1LDAgMCw4MS4zMDAzYzAsMCA2LjI1NzItLjUzNjkgOS4xMzExLS43MjMy=
eiIvPg0KPHBhdGggZD0ibTQ4Ni40MDczLDM0MC41NjczLTkuMTEzNCwwIDAsODAuMjQxMWMyLjk=
2OTksLjMyMTMgNi4wMjM2LC43NjM0IDkuMTMxMSwxLjU5NDFsLS4wMTgtODEuODM1MnoiLz4NCj=
wvZz4NCjwvZz4NCjxnIGZpbGw9Im5vbmUiIHN0cm9rZT0iIzcwM2QyOSI+DQo8cGF0aCBzdHJva=
2Utd2lkdGg9Ii45OTciIGQ9Im02MjAuNDg4NiwyNzUuMDMxM2M3LjM4OTgtLjE1MDkgMjguODU5=
Miw1LjYzOTIgMjkuMDEyLDMwLjg3NiAuMTUwOCwyNC45MjQ5LTE1LjM4MywyOC45OTY4LTIxLjY=
wNzMsMzAuNjU1NyIvPg0KPHBhdGggc3Ryb2tlLXdpZHRoPSIxLjAzNyIgZD0ibTYyMi40MjU3LD=
I3NS4wMjgyYzEyLjc0MjktLjU1NDEgMjUuODkyNCw4LjgyNjEgMjYuNDcxNSwzMi4yMzYzIC40N=
TI1LDE4LjI4OTMtMTIuNTE3NSwyNi41ODM4LTE4Ljc0MTgsMjguMjQyNiIvPg0KPC9nPg0KPC9n=
Pg0KPHVzZSB3aWR0aD0iMTAwMCIgaGVpZ2h0PSI3MDAiIHhsaW5rOmhyZWY9IiNwYXRoNDAyMyI=
gdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMjMuNDgwNDEpIi8+DQo8dXNlIHdpZHRoPSIxMDAwIiBoZW=
lnaHQ9IjcwMCIgeGxpbms6aHJlZj0iI3BhdGg0MDIzIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSg0N=
i45NjA5NykiLz4NCjxwYXRoIGZpbGw9IiNkNTJiMWUiIHN0cm9rZT0iI2Q1MmIxZSIgZmlsbC1y=
dWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9Ii41MTMiIGQ9Im00NDkuOTI0NiwzNDAuNTY3MyA=
wLDgyLjQxMjFjLS4wOTAzLC4wMS02LjEwMDcsLjEzODQtOS4xNzMzLS4xNzk0bC4wMDItODIuMj=
E4MyA5LjE3MDgtLjAxNHoiIHN0cm9rZS1taXRlcmxpbWl0PSIzLjg2NCIvPg0KPC9zdmc+DQo=
=3D"); }

.flag-list .al a::before { background-color: rgb(222, 33, 16); background-s=
ize: 70%; background-image: url("data:image/svg+xml;base64,PHN2ZyB4bWxucz0i=
aHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAzMTUgMjE3IiB4bWxuczp=
4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayI+DQo8cGF0aCBmaWxsPSIjZGUyMT=
EwIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgZD0ibTAtMGgzMTV2M=
jE3aC0zMTV6Ii8+DQo8cGF0aCBkPSJtMTE0Ljk0LDQyYzMuNTQtLjM0NSA0LjI1LS4yOTggNi44=
NCwuMzcyLTMuMzIsMS41MjQtNy4yNiwuNzYyLTkuNy0xLjQwMS0zLjY5LTMuMzUtMTIuNDc3LTk=
uMTQxLTkuMzQtNC4yMDYgMTYuMywxOC4wNjIgMzAuMzQsNS44NSAzOC44OCwxNi4yNSAyLjkxLD=
MuNTQzIDUuNDgsOC4yOTggMy45NSwxMi45NjktLjUzLDEuNTk4LTIuNDIsNS4zNTktNC43LDQuN=
DAzLTIuOTktMS4yNTEgLjU3LTExLjA4My0xLjYxLTE0LjI4Mi00Ljk1LTcuMjYzLTEzLjkxLTUu=
MzItMjEuMjYtNi4xMDUtMi4xMyw1Ljc4NC03LjI3LDQuOTEyLTEyLDEuOTk1LTYuMDI2LTMuNzI=
1LTUuODQtMTIuODg0LTExLjIzNC0xNS45MDktNS42MTYtMy4xNTItNC43MDEsNy40MDYtMy43OT=
YsOS45MTQgMy45MiwxMC44NyAxNS40NiwxNC45MzIgMjYuMDMsMTMtNy44MiwxMi4xMDgtMjAuM=
jE0LTcuODM4LTI2LjM1My0yLjk1My0zLjg5NiwzLjEgMi45ODUsOC43MzkgNS4zNjgsMTAuMDMz=
IDYuNTk1LDMuNTggMTQuNTE1LDEuNzgyIDIwLjk4NS0xLjA4LTMuNjksNC4wMS0xMC40OCw2LjQ=
3LTE2LDUuNjU3LTIuODQ4LS40MjEtOC41NTQtNC0xMS4xNDktMS42MTUtNC4wMDYsMy42ODMgNS=
43NzQsOC4wNTEgOC4xNDksOC41NjggOC4wMSwxLjc0MSAxMy42OC0yLjQ4MyAyMC02LjYxLTMuO=
TcsMy45NjktOC4yMSw5LjQwMy0xNCwxMC41OTEtMy42MSwuNzQxLTExLjU4LTIuOTQ0LTEzLjkx=
NCwuODgxLTIuNzksNC41NzUgNC42MDgsNy40NjkgNy45MTQsNy4xODMgNy44My0uNjc3IDE1LjE=
tNi45NzkgMjEtMTEuNjU1LTQuMDUsNS43NDgtMTAuMzEsMTEuODMtMTcsMTQuNDI4LTMuNTE0LD=
EuMzYzLTkuNTU0LS43NDctMTIuMTk5LDIuMzE0LTQuMDc1LDQuNzE2IDQuODk3LDcuNDk4IDguM=
Tk5LDYuNjk4IDkuNjQtMi4zNDcgMTQuNzgtMTIuODk0IDI0LTE2LjQ0LTYuMjUsNS43Ni0xMi44=
OCwxNC42ODItMjAuMDksMTguOTUtMy41ODQsMi4xMi05LjQyOC0uNDgtMTIuMjYzLDIuNjUtNi4=
0MDYsNy4wOCA5LjY0NSw4LjU5IDE0LjE4Myw0Ljg0IDcuNTktNi4yOCAxMS4yMy0xNS4yNzMgMj=
AuMTctMjAuNDQtNS45Niw4LjEwNy0xMy41MSwyMC4yMS0yMS4wOSwyNi43Ni0zLjYxMywzLjExL=
TExLjUzOCwuMzgtMTMuODI0LDMuODQtNC41OTIsNi45NiAxMC4yMTgsOC4xNiAxMy45MTQsNS43=
IDEyLjEyLTguMDcgMTIuNzgtMjYuNzggMjgtMzEuMy00LjMxLDkuMjQtOC42MiwyMS43NC0xOSw=
yNSAxLjU2LDQuNjkgNy4wNyw1LjEgMTAuNjEsMS42OCA2LjA3LTUuODcgNC44Mi0xOS4yMyAxNS=
4zOS0xOS42OGwtNy42MiwxMC42OWMuNCw0LjM2IDguMjItMS40OSAxMC42Mi01LjY5aDFjLTQuM=
TcsOS45NC0xMS41MiwxNS40OS0yMSwyMCAuMTksNS45Mi0zLjc4LDguOTgtOSwxMS0yLjgxLTUu=
MTctMTAuMy05LjAxLTE0LTMgMi45NCwuNCA1LjU2LC45NSA2LDQtNC42NTktMS42OC04LjMzNi0=
yLjQ4LTEwLDMgNS40NTgtLjkgNy4zMi0uNyA4LjI1LDEuNjktMy43MzEsNC4yOS0zLjEyMiwxMC=
44MyAzLjc1LDExLjQ3LTEuOTItMS4zOS0zLjIxLTIuMzEtMi4xNi00LjE2IDEuNTMtMi4wMiAzL=
jMzLC4wMiA0LjIyLTEuMTggMS42NS0yLjQxIC4xNi0xLjU3IDIuMjYtLjYgMS43MywxLjIzIDQu=
NTMtMy45MyA4LjUyLDQuNzggNC44LTMuNDUgLjE5LTguOTEtMS44NC0xM2wxNS0zIDE3LTE2IDE=
sMWMtNS41LDguNjUtMTMuNCwxNi4wNy0yNCwxNyAzLjU1LDYuNDMgMTAuNTEsMy4xMiAxNiwxLT=
IuMzksNC42Ni04LjU5LDQuNjktMTAuNjcsOC41NC00LjI3LDcuOTIgMTMuNTYtLjI0IDE0LjY3L=
S41NC0xLjQyLDUuMDItNy4wNCw2LjAzLTguNSwxMC4yOC0xLjE0LDMuMyAzLjQ5LDMuNjMgNS40=
NiwyLjY3IDMuNzktMS44NSA2LjI3LTYuODggOS4wNC05Ljk1LTEuMyw2IDEuMTYsMTAuNzUtNS4=
0NSwxNy42OWwxMC4xNCwxMi40NyAxMS41Ny0xMi40OWMtNi4zOS01LjUyLTIuNDYtMTEuOTktMy=
43LTE3Ljk4IDIuNzEsMy4xNyAzLjYzLDguMzggNy40OCwxMC4yNiAxLjc5LC44OCA1LjQ5LC45M=
SA1LjA0LTIuMDQtLjY0LTQuMTktNi43OC02LjMzLTguMDgtMTAuOTEgMS4yOCwuNDIgMTguNTcs=
OC41MyAxNC41OSwuNTQtMS44OC0zLjc4LTguMjYtNC0xMC41OS04LjU0IDUuNTYsMi4xNCAxMS4=
yNiw0Ljg0IDE2LDAtOC44MS0zLjA2LTIxLjkxLTguMjctMjMtMTlsMTcuMjgsMTQuODggMTQuNz=
IsNS4xMnYxYy0zLjU5LDMuNzQtNS42Niw2LjM0LTIuNjksMTAuOTFsMy42NiwxLjA5Yy0yLjM1L=
TIuNTgtMS41Ni0zLjkyIDAtNC45NCAyLjY1LTEuMjYgNC4yNCwxLjE5IDUuMjYtMS4zNCAuNDct=
MS4yMiAuNjMtMS44IC44Ny0uMyAuMjYsMi42NSAzLjkzLC42MSA1LjIxLC45NiAyLjAxLDEuOTc=
tLjk4LDMuOTUtMS4zMSw1LjYyIDUuNjgtMS45OSA2Ljc2LTUuNDggNS0xMSAuMzgtMi4wOSAxLj=
Y5LTMuMDkgMy0zIDEuNDksLjE4IDIuNjcsLjY3IDQsMS0xLjk1LTUuMS01LjM5LTQuOS0xMC0zI=
C40Mi0zLjA1IDEuOTMtNC41NCA1LTQtMi4zMS02LjkzLTEwLjY2LTEuMzctMTMsMy01LjQ0LTEu=
OC0xMC42NC00Ljc1LTktMTEtOS4xOS00LjM3LTE3Ljc0LTkuNzktMjEtMjBoMWMyLjQsNC4yIDE=
wLjA2LDcuMDggOS41MywzLjE5bC02LjUzLTguMTljMTQuMDYsLjYgOC40NiwyNi4xNyAyNiwyMX=
YtMmMtMTAuMDktNS42Mi0xNC4yNC0xNS44LTE5LTI2IDE0Ljk3LDQuNDUgMTUuNDYsMjMuMDEgM=
jcuMDksMzEuMTIgMy43MiwyLjU5IDE5LjM3LDEuOSAxNC43Ny01LjUyLTIuMDctMy4zMy0xMC4z=
Mi0uOTItMTMuODItMy44NC03LjYtNi4zNC0xNS4yNC0xOC42NTktMjEuMDQtMjYuNzYgOS4xOSw=
1LjgzOCAxMy41OCwxNy42IDIzLDIyLjMxIDMuOTgsMS45OSAxMy40LDEuNyAxMi4wNS01LjE3LS=
45Ni00Ljg4LTguNzktMi4xNi0xMi4wMy0zLjU1LTcuMjgtMy4xMi0xNS4xOS0xNC4wMDktMjEuM=
DItMTkuNTkgOC43MywzLjgzNSAxMy45MSwxMy42MDMgMjMsMTYuMzUgMy4zNSwxLjAxIDExLjk5=
LS41IDkuNTktNS45MTctMS43LTMuODUtOS4zMS0xLjc3NS0xMi41OS0yLjk1NS03LjItMi41OTQ=
tMTIuNzQtOS4yMi0xOC0xNC40NzggNy4wNiw0LjA1OSAxMy40NCwxMC45MjYgMjIsMTEuNjU1ID=
MuMywuMjgyIDExLjg4LTMuNjQgNy4zOC03LjgyMy0yLjkzLTIuNzIxLTguODUsLjMxNS0xMi4zO=
C0uMDg1LTUuNjgtLjY0NS0xMC40Ni01LjY1NC0xNC05Ljc0NyA4LjI2LDUuMDc0IDMzLjksNy4y=
MzYgMjkuNDEtMy4zNzUtMy4xMi0yLjU5NC02LjUzLDEuOTI0LTEyLjY2LDIuMDk1LTYuNDMsLjA=
xNC0xMi44LTEuNTEtMTguMDYtNS41NjQgNi43LDIuMjYyIDE0LjM5LDQuNjYzIDIxLjI5LDEuND=
I3IDIuNDYtMS4xNTEgMTEuMjUtOC40MzUgNS41Ny0xMC45MzYtNC40My0xLjk0OS04Ljk5LDQuM=
zI4LTEyLjU1LDUuOTE2LTQuNDEsMS45NjktOS41NSwuNTM0LTE0LS41NjN2LTFjOS4xMy0uNDg1=
IDE4LjItMS4wMDQgMjQuMjEtOS4wNCAxLjk3LTIuNjM5IDcuMTItMTMuNDQ4IDEuMzctMTUuMjA=
4LTIuMjktLjcwMy00LjA3LDEuNTg2LTUuMDIsMy4zMDctMi44MSw1LjA1OC0xNS4zMiwyNS4xND=
UtMjAuNTYsMTAuOTQxLTcuMzcsLjc4Ni0xNi4yOS0xLjE1Mi0yMS4yNiw2LjEwNS0yLjIsMy4yM=
iAxLjIsMTMuMTAzLTEuNzcsMTQuMjgyLTguNDEsMy4zMzMtMi43OS0xNS4wMzEtLjc2LTE3LjM3=
MiA5LjA2LTEwLjQxIDMzLjU1LTEuNDQ3IDM3Ljc5LTE2LjAxNSAuNDYtMy44NjMtNS4wNCwzLjA=
1LTcuNjQsNC43MjYtMi44LDEuNzMtNi4zNywxLjg0My05LjM2LDEuMjc0IDMuMTctMS42NjIgNS=
43Mi0xLjEzNiA3LjcyLTEuNDY5LTEuODgtMy4yOTgtNi4xOC0yLjg3OS03LjI4LTQuNzA2LTEuN=
DQtMi41OTMtNy4xNy0zLjM0OS0xMC40Mi0yLjgzNS02LjE5LDEuMzY3LTguNTcsMy4yMTMtMjAu=
MDIsLjAxbDUsNi03LjE3LDIuOTk0IDMuMTcsMi4wMDYtNiw0YzEsLjMzMyAzLjM4LC4zMzUgMy4=
yMiwxLjI3NmwtNC44Myw4LjIyMWMtMS4wMS0xLjcyMy00LjMxLTYuMjM1LTQuNzctNy45NjctLj=
IzLS43NzIgMS4xNi0xLjEzMyAzLjA1LTEuNDc1bC01LjY3LTQuMDU1IDMuNjYtMi4xNDEtNy42N=
i0yLjg1OSA0LTZjLTYuMzgsNC4yNTQtMTEuODUtMS42OTItMTkuMjMsLjA0Ny0zLjE1LC43MTYt=
NS42OSw0LjIyMS04LjY2LDMuNjM2LTIuNS0uNDI4LTUuNDEsMS4wNTktNy4xNyw0LjMxN3oiLz4=
NCjxnIGZpbGw9IiNkZTIxMTAiIGZpbGwtcnVsZT0iZXZlbm9kZCI+DQo8cGF0aCBkPSJtMTMyLj=
M0LDM2LjI5N2MuNjYsLjMxMiAxLjg1LC4xNTYgMi4wMywuODU5LTEuMjIsLjQ0My0yLjY4LC40O=
TUtMy45LC4zOTEgLjU3LTEuMzAyIDEuMjItLjgwOCAxLjg3LTEuMjV6Ii8+DQo8cGF0aCBkPSJt=
MTg4LjIsMzYuNTMxYy0uNjUsLjMxMi0xLjg0LC4xNTYtMi4wMywuODU5IDEuMjMsLjQ0MyAyLjY=
5LC40OTUgMy45MSwuMzkxLS41Ny0xLjMwMi0xLjIzLS44MDctMS44OC0xLjI1eiIvPg0KPC9nPg=
0KPC9zdmc+DQo=3D"); }

.flag-list .am a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB3aWR0aD0iMTAwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiBoZW=
lnaHQ9IjUwMCIgdmlld0JveD0iLTMgLTEuNSA2IDMiIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3L=
nczLm9yZy8xOTk5L3hsaW5rIj4NCjxnIGZpbGw9Im5vbmUiPg0KPHBhdGggc3Ryb2tlPSIjZjAw=
IiBkPSJtLTMtMWg2Ii8+DQo8cGF0aCBzdHJva2U9IiMwMDAwZDYiIGQ9Im0tMywwaDYiLz4NCjx=
wYXRoIHN0cm9rZT0iI2ZmYjEwMCIgZD0ibS0zLDFoNiIvPg0KPC9nPg0KPC9zdmc+DQo=3D"); =
}

.flag-list .basque a::before { background-image: url("data:image/svg+xml;ba=
se64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMC=
AxMDAwIDU2MCI+DQo8cGF0aCBmaWxsPSIjZGMyNDFmIiBkPSJtMCw1NjAgMTAwMCwwIDAtNTYwL=
TEwMDAsMCAwLDU2MHoiLz4NCjxwYXRoIGZpbGw9IiMwMDk1NDMiIGQ9Ik0gMjEsLTM4IC0yMSwz=
NyA0MTIuMTU2MjUsMjgwIC0yMSw1MjMgMjEsNTk4IDUwMCwzMjkuMjgxMjUgOTc5LDU5OCAxMDI=
xLDUyMyA1ODcuODQzNzUsMjgwIDEwMjEsMzcgOTc5LC0zOCA1MDAsMjMwLjcxODc1IDIxLC0zOC=
B6Ii8+DQo8cGF0aCBmaWxsPSIjZmZmIiBkPSJtNDU3LDAgMCwyMzctNDU3LDAgMCw4NiA0NTcsM=
CAwLDIzNyA4NiwwIDAtMjM3IDQ1NywwIDAtODYtNDU3LDAgMC0yMzctODYsMHoiLz4NCjwvc3Zn=
Pg0K"); }

.flag-list .ba a::before { background-color: rgb(22, 23, 150); background-i=
mage: url("data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTAwMCIgeG1sbnM9Imh0dH=
A6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiBoZWlnaHQ9IjUwMCIgdmlld0JveD0iMCAwIDIwMCAxM=
DAiPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIj4NCjxwYXRoIGZpbGw9IiMxNjE3OTYiIGQ9Im0w=
LDBoMjAwdjEwMGgtMjAweiIvPg0KPHBhdGggZmlsbD0iI2ZmY2QwMCIgZD0ibTUzLDBoMTAwdjE=
wMGwtMTAwLTEwMHoiLz4NCjwvZz4NCjxnIGZpbGw9IiNmZmYiPg0KPGcgZmlsbC1ydWxlPSJldm=
Vub2RkIj4NCjxwYXRoIGQ9Im04MS41MzEyLDUxLjEyNWgzLjQ2ODggMy40Njg4bDIuMTE1Miw2L=
jU2MDctNS41ODQtNC4wNjA3LTUuNTg0LDQuMDYwNyAyLjExNTItNi41NjA3eiIgdHJhbnNmb3Jt=
PSJ0cmFuc2xhdGUoLTUwIC01MS4xMjUpIi8+DQo8cGF0aCBkPSJtODEuNTMxMiw1MS4xMjVsLTU=
uNTY2My00LjA2MDcgNi45MS0uMDAxOCAyLjEyNS02LjU2MjUgMi4xMjUsNi41NjI1IDYuOTEsLj=
AwMTgtNS41NjYzLDQuMDYwN2gtMy40Njg4LTMuNDY4OHoiIHRyYW5zZm9ybT0idHJhbnNsYXRlK=
DUwIDQ4Ljg3NSkiLz4NCjwvZz4NCjxwYXRoIGQ9Im03OS40MTYsNTcuNjg1N2w1LjU4NC0xNy4x=
ODU3IDUuNTg0LDE3LjE4NTctMTQuNjE5LTEwLjYyMTMgMTguMDcwMSwwLTE0LjYxOSwxMC42MjE=
zeiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTM3LjUgLTM4LjYyNSkiLz4NCjxwYXRoIGQ9Im03OS=
40MTYsNTcuNjg1N2w1LjU4NC0xNy4xODU3IDUuNTg0LDE3LjE4NTctMTQuNjE5LTEwLjYyMTMgM=
TguMDcwMSwwLTE0LjYxOSwxMC42MjEzeiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTI1IC0yNi4x=
MjUpIi8+DQo8cGF0aCBkPSJtNzkuNDE2LDU3LjY4NTdsNS41ODQtMTcuMTg1NyA1LjU4NCwxNy4=
xODU3LTE0LjYxOS0xMC42MjEzIDE4LjA3MDEsMC0xNC42MTksMTAuNjIxM3oiIHRyYW5zZm9ybT=
0idHJhbnNsYXRlKC0xMi41IC0xMy42MjUpIi8+DQo8cGF0aCBkPSJtNzkuNDE2LDU3LjY4NTdsN=
S41ODQtMTcuMTg1NyA1LjU4NCwxNy4xODU3LTE0LjYxOS0xMC42MjEzIDE4LjA3MDEsMC0xNC42=
MTksMTAuNjIxM3oiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgLTEuMTI1KSIvPg0KPHBhdGggZD0=
ibTc5LjQxNiw1Ny42ODU3bDUuNTg0LTE3LjE4NTcgNS41ODQsMTcuMTg1Ny0xNC42MTktMTAuNj=
IxMyAxOC4wNzAxLDAtMTQuNjE5LDEwLjYyMTN6IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMi41I=
DExLjM3NSkiLz4NCjxwYXRoIGQ9Im03OS40MTYsNTcuNjg1N2w1LjU4NC0xNy4xODU3IDUuNTg0=
LDE3LjE4NTctMTQuNjE5LTEwLjYyMTMgMTguMDcwMSwwLTE0LjYxOSwxMC42MjEzeiIgdHJhbnN=
mb3JtPSJ0cmFuc2xhdGUoMjUgMjMuODc1KSIvPg0KPHBhdGggZD0ibTc5LjQxNiw1Ny42ODU3bD=
UuNTg0LTE3LjE4NTcgNS41ODQsMTcuMTg1Ny0xNC42MTktMTAuNjIxMyAxOC4wNzAxLDAtMTQuN=
jE5LDEwLjYyMTN6IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgzNy41IDM2LjM3NSkiLz4NCjwvZz4N=
Cjwvc3ZnPg0K"); }

.flag-list .catalonia a::before { background-image: url("data:image/svg+xml=
;base64,PHN2ZyB3aWR0aD0iNzUwIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmc=
iIGhlaWdodD0iNTAwIiB2aWV3Qm94PSIwIDAgNjc1IDQ1MCIgeG1sbnM6eGxpbms9Imh0dHA6Ly=
93d3cudzMub3JnLzE5OTkveGxpbmsiPg0KPHBhdGggZmlsbD0iI2ZjZGQwOSIgZD0ibTAsMGg2N=
zV2NDUwaC02NzV6Ii8+DQo8cGF0aCBzdHJva2U9IiNkYTEyMWEiIGlkPSJyZWRfc3Ryb2tlIiBz=
dHJva2Utd2lkdGg9IjUwIiBkPSJtLTAsNzcuNzc3OGg2NzUiLz4NCjx1c2Ugd2lkdGg9IjY3NSI=
gaGVpZ2h0PSI0NTAiIHN0cm9rZT0iI2RhMTIxYSIgeGxpbms6aHJlZj0iI3JlZF9zdHJva2UiIH=
RyYW5zZm9ybT0idHJhbnNsYXRlKDAgOTQuNDQ0NDQpIi8+DQo8dXNlIHdpZHRoPSI2NzUiIGhla=
WdodD0iNDUwIiBzdHJva2U9IiNkYTEyMWEiIHhsaW5rOmhyZWY9IiNyZWRfc3Ryb2tlIiB0cmFu=
c2Zvcm09InRyYW5zbGF0ZSgwIDE5NC40NDQ0NCkiLz4NCjx1c2Ugd2lkdGg9IjY3NSIgaGVpZ2h=
0PSI0NTAiIHN0cm9rZT0iI2RhMTIxYSIgeGxpbms6aHJlZj0iI3JlZF9zdHJva2UiIHRyYW5zZm=
9ybT0idHJhbnNsYXRlKDAgMjk0LjQ0NDQ0KSIvPg0KPC9zdmc+DQo=3D"); }

.flag-list .ch a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAzMj=
AgMzIwIj4NCjxwYXRoIGZpbGw9IiNkNTJiMWUiIGQ9Im0wLDBoMzIwdjMyMGgtMzIweiIvPg0KP=
GcgZmlsbD0iI2ZmZiI+DQo8cGF0aCBkPSJtNjAsMTMwaDIwMHY2MGgtMjAweiIvPg0KPHBhdGgg=
ZD0ibTEzMCw2MGg2MHYyMDBoLTYweiIvPg0KPC9nPg0KPC9zdmc+DQo=3D"); background-si=
ze: 60%; background-color: rgb(213, 43, 30); }

.flag-list .cy a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB3aWR0aD0iMTAzMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiBoZW=
lnaHQ9IjYxOCIgdmlld0JveD0iMCAwIDEwMDAgNjAwIiB4bWxuczp4bGluaz0iaHR0cDovL3d3d=
y53My5vcmcvMTk5OS94bGluayI+DQo8cGF0aCBmaWxsPSIjZmZmIiBkPSJtMCwwaDEwMDB2NjAw=
aC0xMDAweiIvPg0KPHBhdGggZmlsbD0iI2VkODAwMCIgZD0ibTQyNy42NTYsMTg1LjU4OWMwLDc=
uNjggLjk2LDguNjQgMS40NCwxMC4wOCAuNDgsMS40NCAxLjA4LDI3LjgzOS0yLjg4LDM1LjA0LT=
MuOTYsNy4yMDEtMTEuNzYsMTEuMjgtMTQuODgsMTItMy4xMiwuNzItMTIuOTYtNi4yNC0yMi4wO=
DEtOS4xMi05LjEyLTIuODgtOC42NC0yLjQtMTIuNDc5LTIuNHMtMTIuNDgsMy4yMzktMTQuODgs=
NS4yOGMtMS41Ni0uMjQtMS45Mi0uOTYtMi44OCwwLS45NTksLjk2LTQuOCw0LjgtNS43Niw3LjI=
tLjk2LDIuNC0zLjM1OSwxMS41MjEtNi4yNCwxMi40OC0yLjg4LC45Ni0xMC42OCw4Ljc1OS0xNS=
44NCw5LjEyMS01LjE1OSwuMzYtMy43Mi0uMjQtNy4yLS40OC0zLjQ3OS0uMjQtMy44NC0zLjg0L=
TcuMi01Ljc2LTMuMzU5LTEuOTItNC4zMi0zLjM2LTQuMzItMy4zNnMtLjk2LTMuODQtMi40LTMu=
ODRjLTEuNDM5LDAtMi44NzksNi43MjEtMi44NzksOC42NDFzMy44MzksOS4xMiA1Ljc2LDEwLjU=
1OWMxLjkyLDEuNDQgMS45MiwxMC4wODEgLjk2LDEyLjQ4LS45NiwyLjQgMS45Miw0LjgwMSAyLj=
M5OSw3LjIgLjQ4LDIuNC0yLjg3OSw0LjMxOS0xLjQzOSw0LjggMS40MzksLjQ3OSAzLjM2LDMuM=
zU5IDMuMzYsNi4yNCAwLDIuODggNy4yLDMuODQgOC42NCw2LjcyIDEuNDQsMi44OCAxLjkyLDcu=
NjggMi40LDEwLjU2MSAuNDgsMi44OCAyLjE2LDEuNTYgMi4zOTksOC42NCAyLjI4LDEuMDggNS4=
3NiwzLjM1OSA4LjY0LDQuOCAyLjg4LDEuNDQgMi40MDEsNC44IDYuMjQsNi4yNCAzLjg0LDEuND=
M5IDMuODQsMCA1Ljc2LC40NzkgMS45MiwuNDgtLjk2LC45NjEgMi40LDEuOTIgMy4zNjEsLjk2I=
DQuOC0uNDc5IDcuNjgxLC45NiAyLjg4LDEuNDQgNC4zMiw0LjgwMSA2LjI0LDUuNzYxczEwLjA4=
LDMuMzU5IDEwLjU2LDMuODRjLjQ4LC40NzkgNS43NiwyLjQgNi43MiwyLjQgLjk2LDAgMy44NC0=
xLjkyMSAzLjg0LTEuOTIxczMuMzYsLjk2IDYuMjQsMGMyLjg4LS45NTkgNC44LTMuODQgNi43Mi=
0zLjg0czIuNCwuOTYgNC4zMiwuOTZjMS45MiwwIDQuNzk5LS45NiA0Ljc5OS0uOTZzNC4zMi0uO=
TYgNy42OCwuOTZjMy4zNiwxLjkyMSAxMS4wNCwxMS4wNDEgMTEuMDQsMTQuODgxIDAsMy44Mzkt=
LjQ3OSw1Ljc2LS40NzksNS43NnMzLjgzOS0uNDgxIDUuMjc5LC40NzljMS40NCwuOTYxIDEuMzI=
tLjgzOSAxMiwuOTYxLS43Mi0yLjY0MS0xMS4wNC0xMC4wOC0xLjQ0LTIwLjY0MSA5LjYtMTAuNT=
YxIDEwLjItNi4yNCAxMi40OC04LjE1OSAyLjI4LTEuOTIxIDExLjA0LTcuNTYyIDI1LjkyLTIuN=
DAxIDE0LjQtMi4zOTkgMy44NC00LjMxOSAxMi00Ljc5OSAxLjQ0LS42MDEgNC4yMDEsLjExOSA3=
LjIwMSwuOTYgLjk2LTEuODAxIDMtMy40OCA2LjI0LTIuODgxIC42LTEuNjggNC41NTktMy45NiA=
4LjYzOS00LjMxOSAuNjAxLTMuMjQxIDEwLjkyMS03LjMxOSAxNi44MDEtNy42ODEgMi4zOTktMi=
4xNiA1LjE2LTExLjc2IDE4LjI0LTcuMiAuNDc5LTMuMTE5IDIuNjQtOC4xNiA2LjI0LTkuMTIgL=
jcyLTYuNDc5LTEuNjgyLTE5LjU2MSA0LjgtMjQgNi40NzktNS44OCAxMi42LTQuNTYxIDIzLjUy=
LTQuMzE5IDcuNDQsMS41NiAxMS4wNCw3LjE5OSAxMy40MzksNy42OCAyLjQsLjQ4IDMuMzYsLjQ=
4IDYuMjQtMS40MzkgMi44OC0xLjkyMS0uNDc5LTUuNzYxIDEuOTItNS43NjEgMi40LDAgMS40Mz=
ksLjQ4IDUuMjgsMCAzLjg0LS40NzkgMy4zNi0xLjggNS43Ni0yLjM5OSAzLjg0MSwxLjkyMSA4L=
jE2LC40NzkgMTAuMDgsMS45MiAxLjkyMSwxLjQzOSAyLjE2LDEuMzE5IDYuMjQsMS45MiAxLjQz=
OSwyLjM5OSA1LjI3OSwyLjM5OSA1LjI3OSwyLjM5OXMtMi44NzktLjk2LTEuOTE5LTIuMzk5Yy4=
5Ni0xLjQ0IDAtNS43NjEtMS45MjEtNy42ODEtMS45MTktMS45Mi0yLjg3OS0yLjQtNC4zMTktNC=
4zMTktMS40MzktMS45MiAuNDc5LTEuOTIxLTEuOTIxLTQuMzItMi4zOTktMi40LTcuNjc5LTQuO=
C05LjExOS03LjY4LTEuNDM5LTIuODgtLjk2LTQuOC0zLjM2LTcuMi0yLjM5OS0yLjQtMTItMTAu=
NTYtMTIuNDc5LTE5LjJzLjQ3OS0xNi45MTkgNi4yMzktMTkuNjhjLS4yNC01LjA0IC45NjEtNS4=
3NiA2LjI0LTguNjRzNS43NjItLjk2IDkuMTItLjk2YzMuMzU5LDAgNS4yODEsLjQ4IDguNjQtMS=
45MTkgMy4zNi0yLjQgLjQ4LTcuNjggOS4xMi0xNS4zNiA4LjY0MS03LjY4IDEyLTExLjUyIDE0L=
jg4MS0xMiAyLjg4LS40OCAxMy4zMTktNy44IDE3Ljc2LTcuMiAzLjEyLTMuNzE5IDYuMjQtOC4x=
NiAxMC4wOC0xMS4wNCAzLjg0LTIuODggOC4xNjEtMi44OCAxMC4wOC01LjI4IDEuOTItMi40IDE=
uNDM5LTYuNzIxIDcuMi0xMC41NjEgNS43Ni0zLjgzOSAxMC41NjEtNi4yMzkgMTIuOTYtOC4xNi=
AyLjM5OS0xLjkyIDcuNjgtLjQ4IDkuNi0yLjQgMS45Mi0xLjkyIDEuOTItOS4xMiAzLjgzOS0xM=
C41NiAxLjkyMS0xLjQ0LTYuMjM5LDMuMzYtMTAuNTU5LDUuMjgtNC4zMiwxLjkyLTEwLjU2LDUu=
MjgtMTUuODQsNC44cy0yLjQwMSwyLjg3OS01LjI4LDMuODRjLTIuODgsLjk2LTcuNjgsLjQ4LTk=
uNjAxLDIuNC0xLjkyLDEuOTItNS4yNzksNi43Mi04LjE1OSw4LjY0LTIuODgxLDEuOTE5LTQuMz=
IsMS40NC03LjIsMi44OC0yLjg4MSwxLjQ0LTUuMjgsMi44OC03LjY4LDMuODQtMi40LC45Ni05L=
jYwMSwuNDgtOS42MDEsLjQ4cy02LjI0LDguMTYtOS4xMiwxMS4wNGMtMi44OCwyLjg4LTYuMjQs=
Mi40LTkuMTIsMy44NC0yLjg4LDEuNDM5LTI3LjM2LDE3LjI4LTQ0LjE1OSwxOS42OC0xNi44MDE=
sMi4zOTktOS4xMjEtMS40NC0xNC40LDAtNS4yNzksMS40NC0xMi45NjEsMTEuNTE5LTE5LjIsMT=
ItNi4yNCwuNDgtOC4xNiwwLTkuNiwwLTEuNDQsMC05LjEyLDQuOC0xMy45MiwzLjg0LTcuMDgsM=
i4xNi0xMi4zNTksMS42OC0xNC40LDEuNDM5LTIuMDQtLjIzOS01Ljc2LDIuNC0xMS4wNCwwLTQu=
MDgtMS4zMTktNC4wOCwxLjU2LTExLjk5OS0uOTU5LTcuOTIxLTIuNTItMTMuNDQxLC45Ni0xNy4=
yODEtLjk2LTMuODQtMS45Mi0zLjM2LTMuMzYtNi4yNC0zLjM2LTIuODgsMC0yLjg4LDEuOTItNi=
4yNCwxLjkyLTMuMzYsMC0zLjg0LTEuOTItNi43Mi0xLjkyLTIuODgsMC02LjI0LDEuOTItMTAuN=
TYsMS40NC00LjMyLS40OC01Ljc2LTIuNC04LjY0LTIuNC0yLjg4MS0uMDAzLTE4LjcyMS02Ljcy=
My0xOC43MjEtNi43MjN6Ii8+DQo8ZyBmaWxsPSIjMDA2NjUxIj4NCjxwYXRoIGQ9Im00NzYuNzY=
1LDQ3OC44MDFjOC4zMzQtNiAxNS42NjYtOCAyNy0xMCAxMS4zMzQtMiAyMy4zMzQtNS4zMzIgMj=
kuNjY2LTdzLTIxLjMzMiw4LTI4LjMzMiwxMGMtNywyLTI4LjMzNCw3LTI4LjMzNCw3eiIvPg0KP=
HBhdGggZD0ibTUyMi40MzIsNDYxLjEzM2MtMi4zMzItMTQuMzMyIDMuMzMyLTI5LjMzMiAxNi4z=
MzItMzUuMzMyIDMsMTAuMzMyLTYuMzMyLDI4LTE2LjMzMiwzNS4zMzJ6Ii8+DQo8cGF0aCBkPSJ=
tNTQ0LjM4Myw0NTMuNjc0Yy02Ljk1MS0xMS44NzMgNC44MTQtMjcuMTg4IDEzLjQzMi0zNC42OT=
cgMy45NTEsNy4xNTYtMy4wNDksMjguNDktMTMuNDMyLDM0LjY5N3oiLz4NCjxwYXRoIGQ9Im01N=
jQuNzY2LDQ0NC40NjdjLTcuNDMyLTEwLjE4MiAxLjMzMi0yOCAxMC42NjYtMzUgMy42NjYsMTAg=
MCwyOC0xMC42NjYsMzV6Ii8+DQo8cGF0aCBkPSJtNTg1LjE1NCw0MzEuNzM0Yy02LjcyMy05LjY=
wMi0yLjA1NS0yNC42MDIgNy42MTEtMzQuMjY4IDcuMDAxLDguMDAxIDEuMDAxLDI1LjMzNS03Lj=
YxMSwzNC4yNjh6Ii8+DQo8cGF0aCBkPSJtNjAxLjQzMiw0MTguODAxYy01LjY2Ni05IDEuMzM0L=
TMwLjY2OCAxMC4zMzQtMzYuNjY4IDQsOCAxLDMwLjY2OC0xMC4zMzQsMzYuNjY4eiIvPg0KPHBh=
dGggZD0ibTYxNC40MzIsNDE1LjQ2N2MtMS42NjYtMTMgMjEuMDAyLTI3LjMzNCAzMC4zMzQtMjc=
tMSwxMC42NjYtMTAuNjY4LDIyLjMzNC0zMC4zMzQsMjd6Ii8+DQo8cGF0aCBkPSJtNjAxLjc2Ni=
w0MzAuMTMzYzEwLjY2Ni0xMSAzMS4zMzItMTEgMzguNjY2LTguNjY2LTIsNi4zMzQtMjYuMzMyL=
DIwLjMzMi0zOC42NjYsOC42NjZ6Ii8+DQo8cGF0aCBkPSJtNTg3LjA5OCw0NDEuMTMzYzE1LTQg=
MjQuNjY4LTcuMzM0IDMzLjY2OCwyLTYuMzM0LDgtMzAuNjY4LDUuNjY2LTMzLjY2OC0yeiIvPg0=
KPHBhdGggZD0ibTU2NS43NjYsNDUwLjgwMWMxNC4zMzItNy42NjggMzEuNjY2LDMuNjY2IDM0Lj=
MzMiwxMC4zMzItMTYsNi42NjgtMzQuNjY0LTguNjY0LTM0LjMzMi0xMC4zMzJ6Ii8+DQo8cGF0a=
CBkPSJtNTQ2LjA5OCw0NjEuODAxYzEzLTUgMjgsMS42NjggMzQsOS03LDMuMzMyLTI1LjMzNCw3=
LTM0LTl6Ii8+DQo8cGF0aCBkPSJtNTI4LjEsNDY3LjQ2N2MxNS0xLjY2NiAyOS4zOTMsOS42ODY=
gMzIuNTI5LDE2LjE3Ni0xOS4xOTcsMS44MjQtMjYuNTI5LTMuODQyLTMyLjUyOS0xNi4xNzZ6Ii=
8+DQo8cGF0aCBkPSJtNTIzLjI2OCw0NzguODAxYy04LjMzNC02LTE1LjY2Ni04LTI3LTEwLTExL=
jMzNC0yLTIzLjMzNC01LjMzMi0yOS42NjctN3MyMS4zMzMsOCAyOC4zMzMsMTBjNywyIDI4LjMz=
NCw3IDI4LjMzNCw3eiIvPg0KPHBhdGggZD0ibTQ3Ny42LDQ2MS4xMzNjMi4zMzMtMTQuMzMyLTM=
uMzMyLTI5LjMzMi0xNi4zMzMtMzUuMzMyLTMsMTAuMzMyIDYuMzMzLDI4IDE2LjMzMywzNS4zMz=
J6Ii8+DQo8cGF0aCBkPSJtNDU1LjY0OSw0NTMuNjc0YzYuOTUxLTExLjg3My00LjgxNC0yNy4xO=
DgtMTMuNDMyLTM0LjY5Ny0zLjk1MSw3LjE1NiAzLjA0OSwyOC40OSAxMy40MzIsMzQuNjk3eiIv=
Pg0KPHBhdGggZD0ibTQzNS4yNjYsNDQ0LjQ2N2M3LjQzMi0xMC4xODItMS4zMzItMjgtMTAuNjY=
2LTM1LTMuNjY2LDEwIDAsMjggMTAuNjY2LDM1eiIvPg0KPHBhdGggZD0ibTQxNC44NzcsNDMxLj=
czNGM2LjcyMy05LjYwMiAyLjA1NS0yNC42MDItNy42MTEtMzQuMjY4LTcsOC4wMDEtMSwyNS4zM=
zUgNy42MTEsMzQuMjY4eiIvPg0KPHBhdGggZD0ibTM5OC42LDQxOC44MDFjNS42NjYtOS0xLjMz=
NC0zMC42NjgtMTAuMzM0LTM2LjY2OC00LDgtMSwzMC42NjggMTAuMzM0LDM2LjY2OHoiLz4NCjx=
wYXRoIGQ9Im0zODUuNiw0MTUuNDY3YzEuNjY2LTEzLTIxLjAwMi0yNy4zMzQtMzAuMzM0LTI3ID=
EsMTAuNjY2IDEwLjY2OCwyMi4zMzQgMzAuMzM0LDI3eiIvPg0KPHBhdGggZD0ibTM5OC4yNjYsN=
DMwLjEzM2MtMTAuNjY2LTExLTMxLjMzMi0xMS0zOC42NjYtOC42NjYgMiw2LjMzNCAyNi4zMzIs=
MjAuMzMyIDM4LjY2Niw4LjY2NnoiLz4NCjxwYXRoIGQ9Im00MTIuOTM0LDQ0MS4xMzNjLTE1LTQ=
tMjQuNjY4LTcuMzM0LTMzLjY2OCwyIDYuMzM0LDggMzAuNjY4LDUuNjY2IDMzLjY2OC0yeiIvPg=
0KPHBhdGggZD0ibTQzNC4yNjYsNDUwLjgwMWMtMTQuMzMyLTcuNjY4LTMxLjY2NiwzLjY2Ni0zN=
C4zMzIsMTAuMzMyIDE2LDYuNjY4IDM0LjY2NC04LjY2NCAzNC4zMzItMTAuMzMyeiIvPg0KPHBh=
dGggZD0ibTQ1My45MzQsNDYxLjgwMWMtMTMtNS0yOCwxLjY2OC0zNCw5IDcsMy4zMzIgMjUuMzM=
0LDcgMzQtOXoiLz4NCjxwYXRoIGQ9Im00NzEuOTMzLDQ2Ny40NjdjLTE1LTEuNjY2LTI5LjM5NC=
w5LjY4Ni0zMi41MywxNi4xNzYgMTkuMTk3LDEuODI0IDI2LjUzLTMuODQyIDMyLjUzLTE2LjE3N=
noiLz4NCjwvZz4NCjwvc3ZnPg0K"); }

.flag-list .dk a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAzNz=
AgMjgwIj4NCjxwYXRoIGZpbGw9IiNkMDBjMzMiIGQ9Im0wLDBoMzcwdjI4MGgtMzcweiIvPg0KP=
Gcgc3Ryb2tlPSIjZmZmIiBzdHJva2Utd2lkdGg9IjQwIj4NCjxwYXRoIGQ9Im0xNDAsMHYyODAi=
Lz4NCjxwYXRoIGQ9Im0wLDE0MGgzNzAiLz4NCjwvZz4NCjwvc3ZnPg0K"); }

.flag-list .es a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCA3NT=
AgNTAwIj4NCjxwYXRoIGZpbGw9IiNjNjBiMWUiIGQ9Im0wLDBoNzUwdjUwMGgtNzUweiIvPg0KP=
HBhdGggZmlsbD0iI2ZmYzQwMCIgZD0ibTAsMTI1aDc1MHYyNTBoLTc1MHoiLz4NCjwvc3ZnPg0K=
"); }

.flag-list .eu a::before { background-color: rgb(0, 51, 153); background-si=
ze: 85%; background-image: url("data:image/svg+xml;base64,PHN2ZyB4bWxucz0ia=
HR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9y=
Zy8xOTk5L3hsaW5rIiB2ZXJzaW9uPSIxLjEiIHdpZHRoPSI4MTAiIGhlaWdodD0iNTQwIiB2aWV=
3Qm94PSIwIDAgODEwIDU0MCI+DQo8ZGVmcz48ZyBpZD0icyI+PGcgaWQ9ImMiPjxwYXRoIGlkPS=
J0IiBkPSJNMCwwdjFoMC41eiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMCwtMSlyb3RhdGUoMTgpI=
i8+PHVzZSB4bGluazpocmVmPSIjdCIgdHJhbnNmb3JtPSJzY2FsZSgtMSwxKSIvPjwvZz48ZyBp=
ZD0iYSI+PHVzZSB4bGluazpocmVmPSIjYyIgdHJhbnNmb3JtPSJyb3RhdGUoNzIpIi8+PHVzZSB=
4bGluazpocmVmPSIjYyIgdHJhbnNmb3JtPSJyb3RhdGUoMTQ0KSIvPjwvZz48dXNlIHhsaW5rOm=
hyZWY9IiNhIiB0cmFuc2Zvcm09InNjYWxlKC0xLDEpIi8+PC9nPjwvZGVmcz4NCjxyZWN0IGZpb=
Gw9IiMwMzkiIHdpZHRoPSI4MTAiIGhlaWdodD0iNTQwIi8+PGcgZmlsbD0iI2ZjMCIgdHJhbnNm=
b3JtPSJzY2FsZSgzMCl0cmFuc2xhdGUoMTMuNSw5KSI+PHVzZSB4bGluazpocmVmPSIjcyIgeT0=
iLTYiLz48dXNlIHhsaW5rOmhyZWY9IiNzIiB5PSI2Ii8+PGcgaWQ9ImwiPjx1c2UgeGxpbms6aH=
JlZj0iI3MiIHg9Ii02Ii8+PHVzZSB4bGluazpocmVmPSIjcyIgdHJhbnNmb3JtPSJyb3RhdGUoM=
TUwKXRyYW5zbGF0ZSgwLDYpcm90YXRlKDY2KSIvPjx1c2UgeGxpbms6aHJlZj0iI3MiIHRyYW5z=
Zm9ybT0icm90YXRlKDEyMCl0cmFuc2xhdGUoMCw2KXJvdGF0ZSgyNCkiLz48dXNlIHhsaW5rOmh=
yZWY9IiNzIiB0cmFuc2Zvcm09InJvdGF0ZSg2MCl0cmFuc2xhdGUoMCw2KXJvdGF0ZSgxMikiLz=
48dXNlIHhsaW5rOmhyZWY9IiNzIiB0cmFuc2Zvcm09InJvdGF0ZSgzMCl0cmFuc2xhdGUoMCw2K=
XJvdGF0ZSg0MikiLz48L2c+PHVzZSB4bGluazpocmVmPSIjbCIgdHJhbnNmb3JtPSJzY2FsZSgt=
MSwxKSIvPjwvZz4NCjwvc3ZnPg=3D=3D"); }

.flag-list .fi a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxOD=
AwIDExMDAiPg0KPHBhdGggZmlsbD0iI2ZmZiIgZD0ibTAsMGgxODAwdjExMDBoLTE4MDB6Ii8+D=
Qo8ZyBmaWxsPSIjMDAzNTgwIj4NCjxwYXRoIGQ9Im0wLDQwMGgxODAwdjMwMGgtMTgwMHoiLz4N=
CjxwYXRoIGQ9Im0wLTgwMGgxMTAwdjMwMGgtMTEwMHoiIHRyYW5zZm9ybT0icm90YXRlKDkwKSI=
vPg0KPC9nPg0KPC9zdmc+DQo=3D"); }

.flag-list .gb a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB3aWR0aD0iMTIwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2aW=
V3Qm94PSIwIDAgNjAgMzAiIGhlaWdodD0iNjAwIj4NCjxkZWZzPg0KPGNsaXBQYXRoIGlkPSJ0I=
j4NCjxwYXRoIGQ9Im0zMCwxNWgzMHYxNXp2MTVoLTMwemgtMzB2LTE1enYtMTVoMzB6Ii8+DQo8=
L2NsaXBQYXRoPg0KPC9kZWZzPg0KPHBhdGggZmlsbD0iIzAwMjQ3ZCIgZD0ibTAsMHYzMGg2MHY=
tMzB6Ii8+DQo8cGF0aCBzdHJva2U9IiNmZmYiIHN0cm9rZS13aWR0aD0iNiIgZD0ibTAsMGw2MC=
wzMG0wLTMwbC02MCwzMCIvPg0KPHBhdGggc3Ryb2tlPSIjY2YxNDJiIiBzdHJva2Utd2lkdGg9I=
jQiIGQ9Im0wLDBsNjAsMzBtMC0zMGwtNjAsMzAiIGNsaXAtcGF0aD0idXJsKCN0KSIvPg0KPHBh=
dGggc3Ryb2tlPSIjZmZmIiBzdHJva2Utd2lkdGg9IjEwIiBkPSJtMzAsMHYzMG0tMzAtMTVoNjA=
iLz4NCjxwYXRoIHN0cm9rZT0iI2NmMTQyYiIgc3Ryb2tlLXdpZHRoPSI2IiBkPSJtMzAsMHYzMG=
0tMzAtMTVoNjAiLz4NCjwvc3ZnPg0K"); }

.flag-list .hr a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMj=
AwIDYwMCIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiPg0KPGRlZ=
nMvPg0KPHBhdGggZmlsbD0iI2ZmZiIgZD0ibTAsMjAwaDEyMDB2MjAwaC0xMjAweiIvPg0KPHBh=
dGggZmlsbD0iIzAwMjk4YyIgZD0ibTAsNDAwaDEyMDB2MjAwaC0xMjAweiIvPg0KPHBhdGggZml=
sbD0iI2RlMTgxOCIgZD0ibTAsMGgxMjAwdjIwMGgtMTIwMHoiLz4NCjxnIGZpbGwtcnVsZT0iZX=
Zlbm9kZCI+DQo8cGF0aCBmaWxsPSIjZmZmIiBzdHJva2U9IiNkZTE4MTgiIHN0cm9rZS1saW5lY=
2FwPSJyb3VuZCIgc3Ryb2tlLXdpZHRoPSIxLjYwMSIgZD0ibTQ4MC43Nzc2LDE5Ny4xMTM5YzM2=
LjgzMi0xMy4xMDI5IDc3LjY3LTIwLjE3MjcgMTE3LjU4NC0yMC4yNzM0IDM5LjkxNC0uMTAwNyA=
4MC42MTk1LDYuMTYyMyAxMjAuODQxNywyMC41NzU4bDI5LjkzOTctNjAuNDAxNi0yMS4wNDQtMz=
YuNjU4MWMwLDAtMzcuNTQ1NSwxNS40MjE2LTM3Ljg1MzcsMTUuNDIxNi0uMzA4MywwLTI2LjQ3M=
zEtMjguNzk2Mi0yNi40NzMxLTI4Ljc5NjJsLTMzLjYwMDIsMjAuMzAxNC0zMS41NTE4LTI0LjEz=
LTI5LjY3ODcsMjMuNzU3OC0zNC42NDgxLTIwLjAyNjktMjUuMjczNiwzMC4wMzMzLTM3Ljg4MjE=
tMTYuMTk4Mi0yMC4yODA2LDM2LjMyMyAyOS45MjA2LDYwLjA3MTV6Ii8+DQo8cGF0aCBmaWxsPS=
IjMDg3YmE1IiBzdHJva2U9IiMzNDc3ZDkiIHN0cm9rZS13aWR0aD0iLjUiIGQ9Im02NzIuNzEzN=
ywxODAuMzU5MWwxNy4xNDM5LTYwLjYwNyAzNi43MTQxLTE0LjkgMTkuMzQyMiwzMi40Nzg0LTI3=
Ljc3MDgsNTYuODA1Yy0xNS45NjM4LTYuMzc4NC0yNC41MTU5LTkuMTExMS00NS40Mjk0LTEzLjc=
3NjR6Ii8+DQo8cGF0aCBzdHJva2Utb3BhY2l0eT0iLjk5NiIgZmlsbD0ibm9uZSIgc3Ryb2tlLX=
dpZHRoPSIxLjI1IiBkPSJtNTI3LjM4MSwxODAuNTE3MmwtMTYuMDI0Ny01OS41ODQgMjQuMTEwO=
C0yOS41OTMgMzQuMzA3NywxOS44MDcyIDUuNzkwMSw2Mi42MzM4Yy0xNi43NjMyLDEuMjQzOS0y=
OC44NzkzLDIuODM2LTQ4LjE4MzgsNi43MzZ6Ii8+DQo8ZyBmaWxsPSIjMDg3YmE1IiBzdHJva2U=
9IiMzNDc3ZDkiIHN0cm9rZS13aWR0aD0iLjUiPg0KPHBhdGggZD0ibTU3Ni4wNDE3LDE3My43OT=
YxbC01Ljc4OTQtNjIuNzY4MSAyOS4xNzY0LTIzLjE5MzYgMzAuNDgzNywyMy4xMzc1LTUuMzg2N=
yw2Mi44ODA2Yy0xNi43OTYzLS44ODgzLTI4Ljc5MTYtLjg2MTUtNDguNDg0LS4wNTY0eiIvPg0K=
PHBhdGggZD0ibTQ4Mi4yMjA3LDE5NC4wOTk3bC0yNy4xOTctNTcuNTI5OCAxOC4xNzU3LTMxLjc=
1ODQgMzcuNjc4LDE2LjQgMTUuOTIwMiw1OS4zNTIxYy0xNy4yMDI5LDMuNTU3NS0yNi4zMTI3LD=
YuNDY0My00NC41NzY4LDEzLjUzNjF6Ii8+DQo8L2c+DQo8cGF0aCBmaWxsPSIjZmZmIiBzdHJva=
2U9IiNmZmYiIHN0cm9rZS13aWR0aD0iLjQ1NyIgZD0ibTQ3Ni40MzA1LDE2NS4yMjU1YzguMzQ5=
NCwuODA0NiAxNC4yMDUxLC4zNjY2IDIxLjM5OTctMi4wNjY5IDguNDk1LTMuOTc3IDExLjE5Njc=
tOC41OTcxIDEzLjczNTMtMTIuMzQyNSAyLjAxOTYsNy4yODkzIDEuMjUwOSwxNC4xMTM0LTguMz=
U1NSwxOS42ODk5LTguNjcwNyw0LjQ5NC0yMS4wNTM2LDMuMTY3Ny0yNi43Nzk0LTUuMjgwNnoiL=
z4NCjxnIHN0cm9rZT0iI2NjYTMwMCI+DQo8ZyBzdHJva2Utd2lkdGg9Ii41Ij4NCjxwYXRoIGZp=
bGw9IiNmZmZhMDAiIGQ9Im02MDcuMzc1LDEyMC43NzM0bC0xLjY0MTQsLjQwMjcgLjA2MywyLjk=
3MjUtMi4wMTk5LC40MzM2LTEuNDEyNywyLjYyMTQgLjg3MjIsLjgxMDFjLjA0NDgsLjA4NzYtLj=
Y4OCwxLjkzODktLjY1NjUsMS45Mzg5IC4wMzE1LDAgLjUzNDUsLjY5ODMgLjUzNDUsLjY5ODNsL=
jUzNjUsMS42MTAzIDEuMzU3LC4xODU1IC4zNDc0LDEuODg4OSAyLjE0NiwuMzQwNSAxLjk4ODQs=
MS4zOTM1IC4xMjYsLjg2NzIgMi4yNzI0LC4wNjE4IDEuNTQ2OCwuNDk1NCA1LjM5NjgtLjYxOTU=
gLjcyNi0xLjExNDUgLjA2My0xLjUxNzIgMi45MDM4LS4wOTMxIC4yNjU0LTIuNDE5NmgxLjUzOD=
hsLS4xOTE1LTIuNzI0OCAxLjI4MzQsLjExMzMtLjMzMTMtMS4zMDU5LS43OTc5LTEuMDYzNC0uM=
TU3Ni0xLjY3MTgtMi4yNzI0LTIuMjI5NC0uNTA1LTIuOTEwN2MwLDAtMS40NTE5LS42NTA0LTEu=
NDUxOS0uNjgxMyAwLS4wMzA5LS4wOTQ1LTEuOTUwOC0uMDk0NS0xLjk1MDhsMS42NDEtMi4yNjA=
zLS4xNTc2LS44OTc3LTEuNTE0OS0uMDMxMy0xLjEzNjQsLjkyOWMwLDAtMS41MTQ5LC4xNTUtMS=
41MTQ5LC4xODU5IDAsLjAzMDkgMCwuNjgxMyAwLC42ODEzIDAsMCAuMzc4OSwxLjI2OTUgLjM3O=
DksMS4zMDA0IDAsLjAzMDktMS43MzU5LDAtMS43MzU5LDBsLS4wNjM0LTIuMDEyNi0yLjQ2MTUt=
MS4yMDc2YzAsMC0yLjMwMzksMS41NDgxLTIuMzAzOSwxLjU3OSAwLC4wMzA5LS4xMjY0LDEuNzk=
2Mi0uMTI2NCwxLjc5NjJsLTEuMTA0NSwuMzA5NS0xLjEzNjQtMS42NzIxLTEuOTg4NC0uNzQzMS=
0xLjA3My0uMDYxOC0uMDMxNSwxLjMwMDQgMi4wODI5LDIuNjkzOS0uMTg5MSwxLjU3OXoiLz4NC=
jxnIGZpbGw9Im5vbmUiPg0KPHBhdGggZD0ibTYyMi44NDYsMTMxLjY2MjNsLS40NDY0LTEuNjIw=
MiIvPg0KPHBhdGggZD0ibTYyNC4wOTU1LDEyOC45OTFsLS43NTg3LTEuMDk0NyIvPg0KPC9nPg0=
KPHBhdGggZmlsbD0iI2NjYTMwMCIgZD0ibTYwMy4yOTYsMTI3Ljc2NTFsMi4zNjU3LS4xMzE2IC=
40NDY0LDIuMTAxOCAuODAzMSwuNzAwNyAuMTM0MSwzLjg1MzYgLjc1ODcsLjMwNjQgLjIyMzQtM=
S41MzI2IDEuODMtLjEzMTIgLjM1NjcsMy4xMDg4LS40NDYsLjM5NDQgLjE3ODYsLjQ4MTUgMi4x=
ODY4LS4wNDM2YzAsMCAuNDkxMi0uODMyMyAuNTM1Ny0uODMyMyAuMDQ0OCwwIDEuMjQ5OS0uMTM=
xMiAxLjI0OTktLjA4NzYgMCwuMDQ0IC40OTA4LC45MTk5IC40OTA4LC45MTk5bC4zNTcxLTEuMT=
gyN2MwLDAgMS4xNjA2LS40ODE1IDEuMTYwNi0uNDM3NiAwLC4wNDM2IC45MzcyLDEuNDg4NiAuO=
TM3MiwxLjQ4ODZsMS42MDY3LS4yMTg4LS45ODE3LS45MTk1LS40MDItMi4wMTQ2IDIuMjMxNi0x=
LjE4MjMgLjg5MjgsMS40ODljMCwwIC44NDgsLjA0MzYgLjgwMzUsMC0uMDQ0OC0uMDQ0LS45ODI=
xLTEuNzA3OC0uOTgyMS0xLjcwNzh2LTMuNTAzMmwxLjY5NjMtMi4yNzY5IDIuMzY1My0uMjYyOH=
YtLjk2MzVsLTIuMzY1My0yLjE0NTgtLjYyNS0yLjk3NzctMS4zMzkyLS42NTY3LS4zNTcxLC4zO=
TQtMS40NzI5LC4xMzE2IDEuNDcyOSwyLjE0NTh2MS40MDFsLjY2OTgsLjM1MDQtLjEzNDEsMy44=
NTM2YzAsMC0xLjY1MTUsLjIxODgtMS42NTE1LC4yNjI4IDAsLjA0MzYtLjEzMzcsMi4xNDU0LS4=
xMzM3LDIuMTQ1NGwtMS4wMjY1LDEuMDA3NWMwLDAtLjU4MDUsMi4wMTQyLS42MjUsMi4wMTQyLS=
4wNDQ4LDAtLjk4MjEsMS4yMjU5LS45ODIxLDEuMjI1OWwtMS44MywuMDQ0YzAsMC0xLjA3MS0xL=
jAwNzEtMS4wNzEtMS4wNTExIDAtLjA0MzYtLjE3ODYtMS40ODg2LS4xNzg2LTEuNDg4NiAwLDAt=
LjcxNDItLjIxOTItLjc1OTEtLjIxOTItLjA0NDQsMC0uNDAxNi0xLjYyMDItLjQwMTYtMS42MjA=
ybC0xLjI0OTktLjcwMDMtLjA4ODktLjk2MzUtMS4yMDU1LS41MjU1YzAsMC0uMTMzNy0uODc1OS=
0uMTc4Ni0uOTE5NS0uMDQ0NC0uMDQ0LS41ODAxLS4zOTQtLjYyNDYtLjM5NC0uMDQ0OCwwLS4wN=
DQ4LTIuNDA4NS0uMDQ0OC0yLjQwODVsMS4wNzE0LS4xNzUyLS41OTk5LS43Njg5LS4yMDM2LS42=
NzYydi0uNzAwN2wuODkyOC0uODc1OWMwLDAtMS42MDctLjIxODgtMS42MDctLjE3NTIgMCwuMDQ=
0LTEuNTYxOCwuNzAwNy0xLjU2MTgsLjY1NzEgLjA0NDQsMC0uMDQ0OCwyLjg0NjEtLjA0NDgsMi=
44NDYxbC0xLjgzMDEsLjU2OTUtMS40NzI5LDIuMzIwNSAuNzU4NywuNjU3MXoiLz4NCjwvZz4NC=
jxwYXRoIGZpbGw9IiM2NjNkMTkiIHN0cm9rZS13aWR0aD0iLjIiIGQ9Im02MTIuNTM1NSwxMzEu=
NjYyM2wxLjIwNTEtLjcwMDctLjA0NDgtMS4zNTc1LTEuMTYwMi0uMjYyOC0uNDQ2OC0uNDM4IDE=
uMjk0OCwuMjE5MiAxLjYwNjYtLjEzMTYgLjUzNTctLjI2MjhjLS4yMjMsLjU2OTUtLjQwMTYsLj=
UyNTUtLjQ0NjQsLjUyNTUtLjA0NDQsMC0uODkyNCwuNDM4LS44OTI0LC40MzhsLjA0NDQsMS4zM=
TM5YzAsMCAyLjc2NzMsLjM1IDIuNzIyOCwuMzUtLjA0NDgsMCAwLC41MjU1LS4wODkzLC41MjU1=
LS4wODkzLDAtMi44NTY2LS42MTMxLTIuODU2Ni0uNjEzMWwtMS43NDA4LDEuMDUxMSAuMjY3OC0=
uNjU2N3oiLz4NCjxwYXRoIGZpbGw9IiNjY2EzMDAiIHN0cm9rZS13aWR0aD0iLjUiIGQ9Im02MT=
kuNDk4MiwxMjMuNTE3NmwtMS42MDY2LDEuMjI1OS0xLjAyNjUsMS43OTU0LS41MzU3LC4wODc2L=
TEuNTYyMi0yLjA1ODItMS43ODUyLC4wNDRjMCwwLS45ODIxLDIuNDA4MS0uOTgyMSwyLjQ1MjEg=
MCwuMDQzNi0uNzE0Mi0uMDg3Ni0uNzE0Mi0uMDg3NmwtMS44NzQ1LTIuMDE0MmMwLDAtLjU4MDU=
tMS4wMDc1LS40OTEyLTEuMDA3NSAuMDg5MywwIDQuNjg2NiwuMDQ0IDQuNjg2NiwuMDQ0bC0uMD=
Q0NC0yLjE4OTRjMCwwLS43MTQyLS4yMTkyLTEuMDcxNC0uNDM4IC4yNjc4LS4wODc2IDIuNTQ0M=
y0uMDg3NiAyLjU0NDMtLjA4NzZsLS45ODIxLC42NTY3djEuODgzbDQuMDYxNywuMDQzNiAxLjM4=
MzYtLjM1eiIvPg0KPC9nPg0KPGcgZmlsbD0iIzY2M2QxOSIgc3Ryb2tlLXdpZHRoPSIxLjI1Ij4=
NCjxwYXRoIGQ9Im02MTEuMTc3LDEyNC41NjhoLjM5NmEuMzM4LC4zMzE2IDAgMCwxIC4zMzcsLj=
MzMnYuMzg4YS4zMzgsLjMzMTYgMCAwLDEgLS4zMzcsLjMzMWgtLjM5NmEuMzM4LC4zMzE2IDAgM=
CwxIC0uMzM4LS4zMzF2LS4zODhhLjMzOCwuMzMxNiAwIDAsMSAuMzM4LS4zMzIiLz4NCjxwYXRo=
IGQ9Im02MTYuMjY2LDEyNC4zNDloLjM5NWEuMzM4LC4zMzE2IDAgMCwxIC4zMzgsLjMzMnYuMzg=
4YS4zMzgsLjMzMTYgMCAwLDEgLS4zMzgsLjMzMWgtLjM5NWEuMzM4LC4zMzE2IDAgMCwxIC0uMz=
M4LS4zMzF2LS4zODhhLjMzOCwuMzMxNiAwIDAsMSAuMzM4LS4zMzIiLz4NCjwvZz4NCjxnIHN0c=
m9rZT0iI2NjYTMwMCI+DQo8ZyBzdHJva2Utd2lkdGg9Ii41Ij4NCjxwYXRoIGZpbGw9Im5vbmUi=
IGQ9Im02MDguNDI5LDEyMS4wNjUxYzEuNjk1OS0uNjcxNCAyLjkwMS0xLjIxMTIgNC45OTg5LTE=
uNDAxIDEuOTc4Ny0uMjA0NSAzLjUxMTQsLjA3MjkgNS4yNjY3LC4zOTQiLz4NCjxnIGZpbGw9Ii=
NjY2EzMDAiPg0KPHBhdGggZD0ibTYwOS4zNjYzLDExNy41MTgzaC0xLjM4MzZsLTEuOTY0Mi0yL=
jA1ODIgMS4xMTYyLC4xMzE2IDEuMjk0NCwuNTY5MSAuOTM3MiwxLjM1NzR6Ii8+DQo8cGF0aCBk=
PSJtNjE3LjcxMywxMTYuNzNsMy4xMjQ0LTIuMzY0MS0xLjAyNjUtLjEzMTYtMS4xNjA2LDEuMDU=
wNy0xLjM4MzYsLjIxOTIgLjQ0NjQsMS4yMjU5eiIvPg0KPHBhdGggZD0ibTYxNS44NzA4LDExNy=
4xNjQ0bC00Ljg5NzUsLjE3ODcgLjA0NDQtLjUyNTUgMS43ODU2LS4xNzUyIC4yMjMtLjcwMDNjM=
CwwIC41MzU3LS4wNDM2IC41MzU3LDAgMCwuMDQ0IC40MDE2LC42NTY3IC40MDE2LC42NTY3bDEu=
NzQwOCwuMzA2NCAuMTY2NCwuMjU5MnoiLz4NCjxwYXRoIGQ9Im02MTUuNjE1MSwxMTUuMzI4OWw=
tMS42OTU5LC4wNDM2LS4xMzQxLS45MTk1IDEuODMwMSwuODc1OXoiLz4NCjxwYXRoIGQ9Im02MT=
IuNzU4NSwxMTQuNDk3bC0uMTM0MSwuOTE5MS0xLjY1MTEsLjI2MjggMS43ODUyLTEuMTgxOXoiL=
z4NCjxwYXRoIGQ9Im02MDMuMzg1MywxMzEuMjY4bC44NDgtMi4xMDE4LS43NTg3LTEuNDQ1LS43=
NTg3LDIuMTQ1OCAuNjY5NCwxLjQwMXoiLz4NCjxwYXRoIGQ9Im02MDUuMDgxNCwxMzIuNDA2OGw=
xLjAyNjUtMi40OTYxLTEuOTYzOCwyLjAxNDIgLjkzNzMsLjQ4MTl6Ii8+DQo8L2c+DQo8cGF0aC=
BmaWxsPSIjZmZmYTAwIiBkPSJtNTgwLjI4MDEsMTIxLjY0ODZsLTEuNjQxNCwuNDAyNyAuMDYzL=
DIuOTcyNS0yLjAxOTksLjQzMzYtMS40MTI3LDIuNjIxNCAuODcyMiwuODEwMWMuMDQ0OCwuMDg3=
Ni0uNjg4LDEuOTM4OS0uNjU2NSwxLjkzODkgLjAzMTUsMCAuNTM0NSwuNjk4NCAuNTM0NSwuNjk=
4NGwuNTM2NSwxLjYxMDMgMS4zNTcsLjE4NTUgLjM0NzQsMS44ODg5IDIuMTQ2LC4zNDA1IDEuOT=
g4NCwxLjM5MzUgLjEyNjEsLjg2NzIgMi4yNzI0LC4wNjE4IDEuNTQ2OSwuNDk1NCA1LjM5NjgtL=
jYxOTUgLjcyNi0xLjExNDUgLjA2My0xLjUxNzIgMi45MDM4LS4wOTMxIC4yNjU0LTIuNDE5Nmgx=
LjUzODhsLS4xOTE1LTIuNzI0OCAxLjI4MzUsLjExMzQtLjMzMTMtMS4zMDU5LS43OTc5LTEuMDY=
zNC0uMTU3Ni0xLjY3MTctMi4yNzI0LTIuMjI5NC0uNTA1LTIuOTEwN2MwLDAtMS40NTE5LS42NT=
A0LTEuNDUxOS0uNjgxMyAwLS4wMzA5LS4wOTQ1LTEuOTUwOC0uMDk0NS0xLjk1MDhsMS42NDEtM=
i4yNjAzLS4xNTc2LS44OTc3LTEuNTE0OS0uMDMxMy0xLjEzNjQsLjkyOWMwLDAtMS41MTQ5LC4x=
NTUtMS41MTQ5LC4xODU5IDAsLjAzMDkgMCwuNjgxMyAwLC42ODEzIDAsMCAuMzc4OSwxLjI2OTU=
gLjM3ODksMS4zMDA0IDAsLjAzMDktMS43MzU5LDAtMS43MzU5LDBsLS4wNjM0LTIuMDEyNi0yLj=
Q2MTUtMS4yMDc2YzAsMC0yLjMwMzksMS41NDgxLTIuMzAzOSwxLjU3OSAwLC4wMzA5LS4xMjY1L=
DEuNzk2Mi0uMTI2NSwxLjc5NjJsLTEuMTA0NSwuMzA5NS0xLjEzNjQtMS42NzIxLTEuOTg4NC0u=
NzQzMS0xLjA3My0uMDYxOC0uMDMxNSwxLjMwMDQgMi4wODI5LDIuNjkzOS0uMTg5MSwxLjU3OXo=
iLz4NCjxnIGZpbGw9Im5vbmUiPg0KPHBhdGggZD0ibTU5NS43NTExLDEzMi41Mzc1bC0uNDQ2NC=
0xLjYyMDIiLz4NCjxwYXRoIGQ9Im01OTcuMDAwNiwxMjkuODY2MmwtLjc1ODctMS4wOTQ3Ii8+D=
Qo8L2c+DQo8cGF0aCBmaWxsPSIjY2NhMzAwIiBkPSJtNTc2LjIwMTEsMTI4LjY0MDRsMi4zNjU3=
LS4xMzE2IC40NDY0LDIuMTAxOCAuODAzMSwuNzAwNyAuMTM0MSwzLjg1MzYgLjc1ODcsLjMwNjQ=
gLjIyMzQtMS41MzI2IDEuODMtLjEzMTIgLjM1NjcsMy4xMDg5LS40NDYsLjM5NDMgLjE3ODYsLj=
Q4MTUgMi4xODY4LS4wNDM2YzAsMCAuNDkxMi0uODMyMyAuNTM1Ny0uODMyMyAuMDQ0OCwwIDEuM=
jQ5OS0uMTMxMiAxLjI0OTktLjA4NzYgMCwuMDQ0IC40OTA4LC45MTk5IC40OTA4LC45MTk5bC4z=
NTcxLTEuMTgyN2MwLDAgMS4xNjA2LS40ODE1IDEuMTYwNi0uNDM3NiAwLC4wNDM2IC45MzcyLDE=
uNDg4NiAuOTM3MiwxLjQ4ODZsMS42MDY3LS4yMTg4LS45ODE3LS45MTk1LS40MDItMi4wMTQ2ID=
IuMjMxNi0xLjE4MjMgLjg5MjgsMS40ODljMCwwIC44NDgsLjA0MzYgLjgwMzUsMC0uMDQ0OC0uM=
DQ0LS45ODIxLTEuNzA3OC0uOTgyMS0xLjcwNzh2LTMuNTAzMmwxLjY5NjMtMi4yNzcgMi4zNjUz=
LS4yNjI4di0uOTYzNWwtMi4zNjUzLTIuMTQ1OC0uNjI1LTIuOTc3Ny0xLjMzOTItLjY1NjctLjM=
1NzEsLjM5NC0xLjQ3MjksLjEzMTYgMS40NzI5LDIuMTQ1OHYxLjQwMWwuNjY5OCwuMzUwNC0uMT=
M0MSwzLjg1MzZjMCwwLTEuNjUxNSwuMjE4OC0xLjY1MTUsLjI2MjggMCwuMDQzNi0uMTMzNywyL=
jE0NTQtLjEzMzcsMi4xNDU0bC0xLjAyNjUsMS4wMDc1YzAsMC0uNTgwNSwyLjAxNDItLjYyNSwy=
LjAxNDItLjA0NDgsMC0uOTgyMSwxLjIyNTktLjk4MjEsMS4yMjU5bC0xLjgzMDEsLjA0NGMwLDA=
tMS4wNzEtMS4wMDcxLTEuMDcxLTEuMDUxMSAwLS4wNDM2LS4xNzg2LTEuNDg4Ni0uMTc4Ni0xLj=
Q4ODYgMCwwLS43MTQyLS4yMTkyLS43NTkxLS4yMTkyLS4wNDQ0LDAtLjQwMTYtMS42MjAyLS40M=
DE2LTEuNjIwMmwtMS4yNDk5LS43MDAzLS4wODg5LS45NjM1LTEuMjA1NS0uNTI1NWMwLDAtLjEz=
MzctLjg3NTktLjE3ODYtLjkxOTUtLjA0NDQtLjA0NC0uNTgwMS0uMzk0LS42MjQ2LS4zOTQtLjA=
0NDgsMC0uMDQ0OC0yLjQwODUtLjA0NDgtMi40MDg1bDEuMDcxNC0uMTc1Mi0uNTk5OS0uNzY4OS=
0uMjAzNi0uNjc2MXYtLjcwMDdsLjg5MjgtLjg3NTljMCwwLTEuNjA3LS4yMTg4LTEuNjA3LS4xN=
zUyIDAsLjA0NC0xLjU2MTgsLjcwMDctMS41NjE4LC42NTcxIC4wNDQ0LDAtLjA0NDgsMi44NDYx=
LS4wNDQ4LDIuODQ2MWwtMS44MywuNTY5NS0xLjQ3MjksMi4zMjA2IC43NTg3LC42NTcxeiIvPg0=
KPC9nPg0KPHBhdGggZmlsbD0iIzY2M2QxOSIgc3Ryb2tlLXdpZHRoPSIuMiIgZD0ibTU4NS40ND=
A2LDEzMi41Mzc1bDEuMjA1MS0uNzAwNy0uMDQ0OC0xLjM1NzQtMS4xNjAyLS4yNjI4LS40NDY4L=
S40MzggMS4yOTQ4LC4yMTkyIDEuNjA2Ny0uMTMxNiAuNTM1Ny0uMjYyOGMtLjIyMywuNTY5NS0u=
NDAxNiwuNTI1NS0uNDQ2NCwuNTI1NS0uMDQ0NCwwLS44OTI0LC40MzgtLjg5MjQsLjQzOGwuMDQ=
0NCwxLjMxMzljMCwwIDIuNzY3MywuMzUgMi43MjI4LC4zNS0uMDQ0OCwwIDAsLjUyNTUtLjA4OT=
MsLjUyNTUtLjA4OTMsMC0yLjg1NjYtLjYxMzEtMi44NTY2LS42MTMxbC0xLjc0MDgsMS4wNTExI=
C4yNjc4LS42NTY3eiIvPg0KPHBhdGggZmlsbD0iI2NjYTMwMCIgc3Ryb2tlLXdpZHRoPSIuNSIg=
ZD0ibTU5Mi40MDMzLDEyNC4zOTI4bC0xLjYwNjYsMS4yMjU5LTEuMDI2NSwxLjc5NTQtLjUzNTc=
sLjA4NzYtMS41NjIyLTIuMDU4Mi0xLjc4NTIsLjA0NGMwLDAtLjk4MjEsMi40MDgxLS45ODIxLD=
IuNDUyMSAwLC4wNDM2LS43MTQyLS4wODc2LS43MTQyLS4wODc2bC0xLjg3NDUtMi4wMTQyYzAsM=
C0uNTgwNS0xLjAwNzUtLjQ5MTItMS4wMDc1IC4wODkzLDAgNC42ODY2LC4wNDQgNC42ODY2LC4w=
NDRsLS4wNDQ0LTIuMTg5NGMwLDAtLjcxNDItLjIxOTItMS4wNzE0LS40MzggLjI2NzgtLjA4NzY=
gMi41NDQzLS4wODc2IDIuNTQ0My0uMDg3NmwtLjk4MjEsLjY1Njd2MS44ODNsNC4wNjE3LC4wND=
M2IDEuMzgzNi0uMzV6Ii8+DQo8L2c+DQo8ZyBmaWxsPSIjNjYzZDE5IiBzdHJva2Utd2lkdGg9I=
jEuMjUiPg0KPHBhdGggZD0ibTU4NC4wODIsMTI1LjQ0NGguMzk2YS4zMzgsLjMzMTYgMCAwLDEg=
LjMzOCwuMzMxdi4zODhhLjMzOCwuMzMxNiAwIDAsMSAtLjMzOCwuMzMxaC0uMzk2YS4zMzgsLjM=
zMTYgMCAwLDEgLS4zMzgtLjMzMXYtLjM4OGEuMzM4LC4zMzE2IDAgMCwxIC4zMzgtLjMzMSIvPg=
0KPHBhdGggZD0ibTU4OS4xNzEsMTI1LjIyNWguMzk1YS4zMzgsLjMzMTYgMCAwLDEgLjMzOCwuM=
zMxdi4zODhhLjMzOCwuMzMxNiAwIDAsMSAtLjMzOCwuMzMyaC0uMzk1YS4zMzgsLjMzMTYgMCAw=
LDEgLS4zMzgtLjMzMnYtLjM4OGEuMzM4LC4zMzE2IDAgMCwxIC4zMzgtLjMzMSIvPg0KPC9nPg0=
KPGcgc3Ryb2tlLXdpZHRoPSIuNSI+DQo8ZyBzdHJva2U9IiNjY2EzMDAiPg0KPHBhdGggZmlsbD=
0ibm9uZSIgZD0ibTU4MS4zMzQxLDEyMS45NDAzYzEuNjk1OS0uNjcxNCAyLjkwMS0xLjIxMTIgN=
C45OTg5LTEuNDAxIDEuOTc4Ny0uMjA0NSAzLjUxMTQsLjA3MjkgNS4yNjY3LC4zOTQiLz4NCjxn=
IGZpbGw9IiNjY2EzMDAiPg0KPHBhdGggZD0ibTU4Mi4yNzEzLDExOC4zOTM1aC0xLjM4MzZsLTE=
uOTY0Mi0yLjA1ODIgMS4xMTYyLC4xMzE2IDEuMjk0NCwuNTY5MSAuOTM3MiwxLjM1NzV6Ii8+DQ=
o8cGF0aCBkPSJtNTkwLjYxODEsMTE3LjYwNTJsMy4xMjQ0LTIuMzY0MS0xLjAyNjUtLjEzMTYtM=
S4xNjA2LDEuMDUwNy0xLjM4MzYsLjIxOTIgLjQ0NjQsMS4yMjU5eiIvPg0KPHBhdGggZD0ibTU4=
OC43NzU5LDExOC4wMzk2bC00Ljg5NzUsLjE3ODggLjA0NDQtLjUyNTUgMS43ODU2LS4xNzUyIC4=
yMjMtLjcwMDNjMCwwIC41MzU3LS4wNDM2IC41MzU3LDAgMCwuMDQ0IC40MDE2LC42NTY3IC40MD=
E2LC42NTY3bDEuNzQwOCwuMzA2NCAuMTY2NCwuMjU5MnoiLz4NCjxwYXRoIGQ9Im01ODguNTIwM=
iwxMTYuMjA0MWwtMS42OTU5LC4wNDM2LS4xMzQxLS45MTk1IDEuODMwMSwuODc1OXoiLz4NCjxw=
YXRoIGQ9Im01ODUuNjYzNiwxMTUuMzcyMmwtLjEzNDEsLjkxOTEtMS42NTExLC4yNjI4IDEuNzg=
1Mi0xLjE4MTl6Ii8+DQo8cGF0aCBkPSJtNTc2LjI5MDQsMTMyLjE0MzJsLjg0OC0yLjEwMTgtLj=
c1ODctMS40NDUtLjc1ODcsMi4xNDU4IC42Njk0LDEuNDAxeiIvPg0KPHBhdGggZD0ibTU3Ny45O=
DY1LDEzMy4yODJsMS4wMjY1LTIuNDk2MS0xLjk2MzgsMi4wMTQyIC45MzcyLC40ODJ6Ii8+DQo8=
L2c+DQo8L2c+DQo8cGF0aCBmaWxsPSIjMDAyOThjIiBzdHJva2U9IiMwMDAwODIiIGQ9Im02MjQ=
uOTU4MywxNzMuNzY2OWw1LjQyNDItNjIuOTUzOSAzMy4zMzU5LTE5LjE4MDcgMjUuNzY4OCwyNy=
45My0xNy4xNzM3LDYwLjY1MTRjLTE2LjY0NjItMy4zOTk1LTI2LjE0MzktNC44NTYyLTQ3LjM1N=
TEtNi40NDY5eiIvPg0KPGcgc3Ryb2tlPSIjY2NhMzAwIj4NCjxwYXRoIGZpbGw9IiNmZmZhMDAi=
IGQ9Im01OTQuMzI5MywxNDUuMTY3OGwtMS42NDE0LC40MDI3IC4wNjMsMi45NzI1LTIuMDE5OSw=
uNDMzNi0xLjQxMjcsMi42MjE0IC44NzIyLC44MTAxYy4wNDQ4LC4wODc2LS42ODgsMS45Mzg5LS=
42NTY1LDEuOTM4OSAuMDMxNSwwIC41MzQ1LC42OTgzIC41MzQ1LC42OTgzbC41MzY1LDEuNjEwM=
yAxLjM1NywuMTg1NSAuMzQ3NCwxLjg4ODkgMi4xNDYsLjM0MDQgMS45ODg0LDEuMzkzNSAuMTI2=
LC44NjcyIDIuMjcyNCwuMDYxOCAxLjU0NjgsLjQ5NTQgNS4zOTY4LS42MTk1IC43MjYtMS4xMTQ=
1IC4wNjMtMS41MTcyIDIuOTAzOC0uMDkzMSAuMjY1NC0yLjQxOTZoMS41Mzg4bC0uMTkxNS0yLj=
cyNDggMS4yODM1LC4xMTM0LS4zMzEzLTEuMzA1OS0uNzk3OS0xLjA2MzQtLjE1NzYtMS42NzE3L=
TIuMjcyNC0yLjIyOTQtLjUwNS0yLjkxMDdjMCwwLTEuNDUxOS0uNjUwNC0xLjQ1MTktLjY4MTMg=
MC0uMDMwOS0uMDk0NS0xLjk1MDgtLjA5NDUtMS45NTA4bDEuNjQxLTIuMjYwMy0uMTU3Ni0uODk=
3Ny0xLjUxNDktLjAzMTMtMS4xMzY0LC45MjljMCwwLTEuNTE0OSwuMTU1LTEuNTE0OSwuMTg1OS=
AwLC4wMzA5IDAsLjY4MTMgMCwuNjgxMyAwLDAgLjM3ODksMS4yNjk1IC4zNzg5LDEuMzAwNCAwL=
C4wMzA5LTEuNzM1OSwwLTEuNzM1OSwwbC0uMDYzNC0yLjAxMjYtMi40NjE1LTEuMjA3NmMwLDAt=
Mi4zMDM5LDEuNTQ4MS0yLjMwMzksMS41NzkgMCwuMDMwOS0uMTI2NCwxLjc5NjItLjEyNjQsMS4=
3OTYybC0xLjEwNDUsLjMwOTUtMS4xMzY0LTEuNjcyMS0xLjk4ODQtLjc0MzEtMS4wNzMtLjA2MT=
gtLjAzMTUsMS4zMDA0IDIuMDgyOSwyLjY5MzktLjE4OTEsMS41Nzl6Ii8+DQo8ZyBmaWxsPSJub=
25lIj4NCjxwYXRoIGQ9Im02MDkuODAwMywxNTYuMDU2N2wtLjQ0NjQtMS42MjAyIi8+DQo8cGF0=
aCBkPSJtNjExLjA0OTgsMTUzLjM4NTRsLS43NTg3LTEuMDk0NyIvPg0KPC9nPg0KPHBhdGggZml=
sbD0iI2NjYTMwMCIgZD0ibTU5MC4yNTAzLDE1Mi4xNTk1bDIuMzY1Ny0uMTMxNiAuNDQ2NCwyLj=
EwMTggLjgwMzEsLjcwMDcgLjEzNDEsMy44NTM2IC43NTg3LC4zMDY0IC4yMjM0LTEuNTMyNiAxL=
jgzLS4xMzEyIC4zNTY3LDMuMTA4OC0uNDQ2LC4zOTQ0IC4xNzg2LC40ODE1IDIuMTg2OC0uMDQz=
NmMwLDAgLjQ5MTItLjgzMjMgLjUzNTctLjgzMjMgLjA0NDgsMCAxLjI0OTktLjEzMTIgMS4yNDk=
5LS4wODc2IDAsLjA0NCAuNDkwOCwuOTE5OSAuNDkwOCwuOTE5OWwuMzU3MS0xLjE4MjdjMCwwID=
EuMTYwNi0uNDgxNSAxLjE2MDYtLjQzNzUgMCwuMDQzNiAuOTM3MiwxLjQ4ODYgLjkzNzIsMS40O=
Dg2bDEuNjA2Ni0uMjE4OC0uOTgxNy0uOTE5NS0uNDAyLTIuMDE0NiAyLjIzMTYtMS4xODIzIC44=
OTI4LDEuNDg5YzAsMCAuODQ4LC4wNDM2IC44MDM1LDAtLjA0NDgtLjA0NC0uOTgyMS0xLjcwNzg=
tLjk4MjEtMS43MDc4di0zLjUwMzJsMS42OTYzLTIuMjc2OSAyLjM2NTMtLjI2Mjh2LS45NjM1bC=
0yLjM2NTMtMi4xNDU4LS42MjUtMi45Nzc3LTEuMzM5Mi0uNjU2Ny0uMzU3MSwuMzkzOS0xLjQ3M=
jksLjEzMTYgMS40NzI5LDIuMTQ1OHYxLjQwMWwuNjY5OCwuMzUwNC0uMTM0MSwzLjg1MzZjMCww=
LTEuNjUxNSwuMjE4OC0xLjY1MTUsLjI2MjggMCwuMDQzNi0uMTMzNywyLjE0NTQtLjEzMzcsMi4=
xNDU0bC0xLjAyNjUsMS4wMDc1YzAsMC0uNTgwNSwyLjAxNDItLjYyNSwyLjAxNDItLjA0NDgsMC=
0uOTgyMSwxLjIyNTktLjk4MjEsMS4yMjU5bC0xLjgzMDEsLjA0NGMwLDAtMS4wNzEtMS4wMDcxL=
TEuMDcxLTEuMDUxMSAwLS4wNDM2LS4xNzg2LTEuNDg4Ni0uMTc4Ni0xLjQ4ODYgMCwwLS43MTQy=
LS4yMTkyLS43NTkxLS4yMTkyLS4wNDQ0LDAtLjQwMTYtMS42MjAyLS40MDE2LTEuNjIwMmwtMS4=
yNDk5LS43MDAzLS4wODg5LS45NjM1LTEuMjA1NS0uNTI1NWMwLDAtLjEzMzctLjg3NTktLjE3OD=
YtLjkxOTUtLjA0NDQtLjA0NC0uNTgwMS0uMzk0LS42MjQ2LS4zOTQtLjA0NDgsMC0uMDQ0OC0yL=
jQwODUtLjA0NDgtMi40MDg1bDEuMDcxNC0uMTc1Mi0uNTk5OS0uNzY4OS0uMjAzNi0uNjc2MnYt=
LjcwMDdsLjg5MjgtLjg3NTljMCwwLTEuNjA3LS4yMTg4LTEuNjA3LS4xNzUyIDAsLjA0NC0xLjU=
2MTgsLjcwMDctMS41NjE4LC42NTcxIC4wNDQ0LDAtLjA0NDgsMi44NDYxLS4wNDQ4LDIuODQ2MW=
wtMS44MzAxLC41Njk1LTEuNDcyOSwyLjMyMDUgLjc1ODcsLjY1NzF6Ii8+DQo8L2c+DQo8L2c+D=
Qo8ZyBzdHJva2U9IiNjY2EzMDAiPg0KPHBhdGggZmlsbD0iIzY2M2QxOSIgc3Ryb2tlLXdpZHRo=
PSIuMiIgZD0ibTU5OS40ODk4LDE1Ni4wNTY3bDEuMjA1MS0uNzAwNy0uMDQ0OC0xLjM1NzUtMS4=
xNjAyLS4yNjI4LS40NDY4LS40MzggMS4yOTQ4LC4yMTkyIDEuNjA2Ni0uMTMxNiAuNTM1Ny0uMj=
YyOGMtLjIyMywuNTY5NS0uNDAxNiwuNTI1NS0uNDQ2NCwuNTI1NS0uMDQ0NCwwLS44OTI0LC40M=
zgtLjg5MjQsLjQzOGwuMDQ0NCwxLjMxMzljMCwwIDIuNzY3MywuMzUgMi43MjI5LC4zNS0uMDQ0=
OSwwIDAsLjUyNTUtLjA4OTMsLjUyNTUtLjA4OTMsMC0yLjg1NjYtLjYxMzEtMi44NTY2LS42MTM=
xbC0xLjc0MDgsMS4wNTExIC4yNjc4LS42NTY3eiIvPg0KPHBhdGggZmlsbD0iI2NjYTMwMCIgc3=
Ryb2tlLXdpZHRoPSIuNSIgZD0ibTYwNi40NTI0LDE0Ny45MTJsLTEuNjA2NiwxLjIyNTktMS4wM=
jY1LDEuNzk1NC0uNTM1NywuMDg3Ni0xLjU2MjItMi4wNTgyLTEuNzg1MiwuMDQ0YzAsMC0uOTgy=
MSwyLjQwODEtLjk4MjEsMi40NTIxIDAsLjA0MzYtLjcxNDItLjA4NzYtLjcxNDItLjA4NzZsLTE=
uODc0NS0yLjAxNDJjMCwwLS41ODA1LTEuMDA3NS0uNDkxMi0xLjAwNzUgLjA4OTMsMCA0LjY4Nj=
YsLjA0NCA0LjY4NjYsLjA0NGwtLjA0NDQtMi4xODk0YzAsMC0uNzE0Mi0uMjE5Mi0xLjA3MTQtL=
jQzNzkgLjI2NzgtLjA4NzYgMi41NDQzLS4wODc2IDIuNTQ0My0uMDg3NmwtLjk4MjEsLjY1Njd2=
MS44ODNsNC4wNjE3LC4wNDM2IDEuMzgzNi0uMzV6Ii8+DQo8L2c+DQo8ZyBmaWxsPSIjNjYzZDE=
5IiBzdHJva2Utd2lkdGg9IjEuMjUiPg0KPHBhdGggZD0ibTU5OC4xMzIsMTQ4Ljk2M2guMzk1YS=
4zMzgsLjMzMTYgMCAwLDEgLjMzOCwuMzMxdi4zODhhLjMzOCwuMzMxNiAwIDAsMSAtLjMzOCwuM=
zMyaC0uMzk1YS4zMzgsLjMzMTYgMCAwLDEgLS4zMzgtLjMzMnYtLjM4OGEuMzM4LC4zMzE2IDAg=
MCwxIC4zMzgtLjMzMSIvPg0KPHBhdGggZD0ibTYwMy4yMiwxNDguNzQ0aC4zOTVhLjMzOCwuMzM=
xNiAwIDAsMSAuMzM4LC4zMzF2LjM4OGEuMzM4LC4zMzE2IDAgMCwxIC0uMzM4LC4zMzJoLS4zOT=
VhLjMzOCwuMzMxNiAwIDAsMSAtLjMzOC0uMzMydi0uMzg4YS4zMzgsLjMzMTYgMCAwLDEgLjMzO=
C0uMzMxIi8+DQo8L2c+DQo8ZyBzdHJva2Utd2lkdGg9Ii41Ij4NCjxnIHN0cm9rZT0iI2NjYTMw=
MCI+DQo8cGF0aCBmaWxsPSJub25lIiBkPSJtNTk1LjM4MzMsMTQ1LjQ1OTVjMS42OTU5LS42NzE=
0IDIuOTAxLTEuMjExMiA0Ljk5ODktMS40MDEgMS45Nzg3LS4yMDQ1IDMuNTExNCwuMDcyOSA1Lj=
I2NjcsLjM5NCIvPg0KPGcgZmlsbD0iI2NjYTMwMCI+DQo8cGF0aCBkPSJtNTk2LjMyMDUsMTQxL=
jkxMjdoLTEuMzgzNmwtMS45NjQyLTIuMDU4MiAxLjExNjIsLjEzMTYgMS4yOTQ0LC41NjkxIC45=
MzcyLDEuMzU3NXoiLz4NCjxwYXRoIGQ9Im02MDQuNjY3MiwxNDEuMTI0NGwzLjEyNDQtMi4zNjQ=
xLTEuMDI2NS0uMTMxNi0xLjE2MDYsMS4wNTA3LTEuMzgzNywuMjE5MiAuNDQ2NCwxLjIyNTl6Ii=
8+DQo8cGF0aCBkPSJtNjAyLjgyNTEsMTQxLjU1ODhsLTQuODk3NSwuMTc4NyAuMDQ0NC0uNTI1N=
SAxLjc4NTYtLjE3NTIgLjIyMy0uNzAwM2MwLDAgLjUzNTctLjA0MzYgLjUzNTcsMCAwLC4wNDQg=
LjQwMTYsLjY1NjcgLjQwMTYsLjY1NjdsMS43NDA4LC4zMDY0IC4xNjY0LC4yNTkyeiIvPg0KPHB=
hdGggZD0ibTYwMi41Njk0LDEzOS43MjMzbC0xLjY5NTksLjA0MzYtLjEzNDEtLjkxOTUgMS44My=
wuODc1OXoiLz4NCjxwYXRoIGQ9Im01OTkuNzEyOCwxMzguODkxNGwtLjEzNDEsLjkxOTEtMS42N=
TExLC4yNjI4IDEuNzg1Mi0xLjE4MTl6Ii8+DQo8cGF0aCBkPSJtNTkwLjMzOTYsMTU1LjY2MjRs=
Ljg0OC0yLjEwMTgtLjc1ODctMS40NDUtLjc1ODcsMi4xNDU4IC42Njk0LDEuNDAxeiIvPg0KPHB=
hdGggZD0ibTU5Mi4wMzU3LDE1Ni44MDEybDEuMDI2NS0yLjQ5NjEtMS45NjM4LDIuMDE0MiAuOT=
M3MywuNDgxOXoiLz4NCjwvZz4NCjwvZz4NCjxnIGZpbGw9IiNkZTE4MTgiPg0KPGcgc3Ryb2tlP=
SIjZTYxNzE3Ij4NCjxwYXRoIGQ9Im02MzMuMjIxNywxNjIuNDkxNWwtMS42NzA4LDEuOTU0MyAu=
MTI4NCwxLjYzOTMgMy40NzAyLS4wNjNjMS4xMTM4LS4yNjI4IDEuMzkyMi0uNjUxNiAxLjYwNjY=
tMS4xMDM0IC4zNDI2LS41NTY4IC4xMDctLjg2MTYgLjE5MjgtMS42MDc1bC0zLjcyNzItLjgxOT=
Z6Ii8+DQo8cGF0aCBkPSJtNjQxLjQ2MTMsMTY3LjExODFsLTEuNTMyLDEuMTg1My0uMTQyLDEuN=
TA2NSAzLjA3NzIsLjIyNjdjMS4xMzM0LS4xNTcxIDEuMzAxLS4zNDIgMS41NTY5LS43NzEzIC4z=
OTM0LS41MjI3IC4yODYyLS41MjIgLjQ0MTUtMS4yNTY2bC0zLjQwMTctLjg5MDZ6Ii8+DQo8cGF=
0aCBkPSJtNjU1LjEzNTMsMTYzLjE4NWwtMS42MDY2LDEuNjM5MiAuMDY0MiwxLjI2MDggMy4yNz=
c1LC4xMjZjMS4xMTM4LS4yNjI4IC45NDIxLS4yMTAxIDEuMjg1MS0uNzg3OSAuMzQyNi0uNTU2O=
SAuMjM1OS0uNjcyNiAuMzIxNy0xLjQxODVsLTMuMzQxOC0uODE5NnoiLz4NCjxwYXRoIGQ9Im02=
NjQuNzEwMiwxNjYuMTQ4MmwtMS44NjM1LDEuNTc1OHYxLjU3NjJsMy40NzAxLC4zMTU1YzEuMTE=
zOC0uMjYyOCAxLjE5OTUtLjU4ODYgMS40NzgyLS45Nzc0IC4zNDI1LS41NTY4IC4xNzEzLS42MD=
k2IC4yNTY5LTEuMzU1NWwtMy4zNDE3LTEuMTM0N3oiLz4NCjwvZz4NCjxwYXRoIHN0cm9rZT0iI=
2MwMCIgZD0ibTY0MS4zODMsMTI0LjkxNmw2LjU1NDcsNC4zNTAyYzEuMjMyMi0xLjAyMjIgMy43=
OTU1LS40MDI3IDQuNzk5My0uMTE5MyAxLjgwMjYsLjQ3MDQgMy4wNzMxLDEuNTM3OCA0LjY0NzU=
sMS44MjE2IDIuODc5NSwuNzIzNyA2LjMyOTUsMS4yMjM1IDguOTQyNSwuOTM5NyAyLjYxMzUtLj=
I4MzQgNC44MDgyLTEuNjQ5MSA2LjczNzMtMi42NDJ2LS42MzAyaC0xLjI4NTFjLTIuMDg2MiwuN=
zUwNy01LjAwOTMsLjc5MTktNy4yNDc4LC40OTc4LTIuMjM4NS0uMjk0MS0yLjg0MTYtMS4yOTc2=
LTYuMTgzLTIuMjYzMWwtLjI1Ny0uNjMwNmM0LjA1NjEsLjE5MjYgNC44Nzk3LC4wODc2IDYuNTc=
3Ny0uNjUyNyAxLjY1OTktLjQ0MDcgMi40MDc4LTEuNDA0MiAzLjM0NS0yLjA2OTdsLS4wMjYzLS=
43NDUxLTEuMjIxMi0uMDYzYy0xLjU3MzEsMS4wNDc5LTIuNTc1OSwxLjIzNzQtNC45ODYxLDEuM=
DE2Ni0yLjE5MzEtLjIyMi00LjE2ODYtMS40NzA0LTUuNjQtMS40OTY2LTEuNTYwNSwuMDExOS0x=
LjQ4Ny0uNzMzNi0yLjk5NjMtLjgwNjktMi4zOTkzLS4yMTAxLTQuOTkyNCwuMTA5OC03LjI2Mjg=
sLjY1NjMtMi43MjA0LC44MTk2LTMuMTI3NywxLjUxMjgtNC40OTg0LDIuODM3eiIvPg0KPC9nPg=
0KPGcgZmlsbD0iIzhlMzczNyIgc3Ryb2tlPSIjOGYzNjM2Ij4NCjxwYXRoIGQ9Im02NDIuNjU2L=
DEyMy45NTE0Yy42Mjc0LC4xNDI3IDEuMzMxMiwuMzIzNCAxLjg0NDIsLjYxNTUgLjUxMzUsLjI5=
MjEgLjM4MDUsLjI4NjIgLjkzMTksLjY5LS4wODg1LS41MjItLjA2MzQtLjQ4NDctLjQxODItLjg=
5NDktLjM1NTEtLjQxMDYtLjkzODQtLjc4MzYtMS40MDctMS4xMTk3bC0uOTUxLC43MDkxeiIvPg=
0KPHBhdGggZD0ibTY0OC4xMzI1LDEyOC42NTIzYy4wMTI0LS41NjU2LS4yNzg5LTEuMDU3LS40O=
TQ1LTEuNTQ4MS0uMjE1NC0uNDkxMS0uMzkzMS0uOTA4LS43OTg3LTEuMzk5MSAuNTA2OSwuMTQy=
NyAuNzg2LC4zNjAzIDEuMjE3MSwuODc2MyAuNDMwNiwuNTE2NCAuNDA1NiwxLjAzMjUgLjQ5NDE=
sMS43NzJsLS40MTgxLC4yOTg4eiIvPg0KPHBhdGggZD0ibTY0OS4zODc2LDEyMS43NTAxYy4xNT=
IyLC4zOTIgLjQ1MDgsLjY2MTEgLjcwMzcsMS40OTczIC4yMTg2LC43NTk4IC4zMjI4LDEuODIzM=
iAuMzIyOCwxLjgyMzItLjA4MjQtLjU2NiAuMDYzNC0xLjIwNjQtLjAxOS0xLjc3MjQtLjA4MjQt=
LjU2NTYtLjM5MzEtMS4wNTctLjQ3NTQtMS42MjNsLS41MzIxLC4wNzQ5eiIvPg0KPHBhdGggZD0=
ibTY1NC43MTE1LDEyMi4wODU4bC4yNjYyLDMuMTM0MiAuMzA0Ni0yLjk0NzUtLjU3MDgtLjE4Nj=
d6Ii8+DQo8cGF0aCBkPSJtNjUzLjQxODYsMTI4LjU3NzdjLjEyNjktLjUwOTcgLjEwMTUtMS4wM=
Tk4IC4wMzgtMS41Mjk5LS4wNjMzLS41MDk3LS4yNDExLS45NDQ5LS40MTg1LTEuNTI5NCAuNTA3=
LC40MzUyIC43MTAyLC45ODI1IC45ODg5LDEuNTY3MSAwLC41ODQyLS4xNTE5LDEuMDkzOS0uNjA=
4NCwxLjQ5MjJ6Ii8+DQo8cGF0aCBkPSJtNjU4LjkzMywxMjcuMTk3MmMuMDE4OSwwIC4xNjIsMS=
4wNjM0LS4wODA0LDEuODI4My0uMjQyMywuNzY0OS0uNDEzNiwuODIwOC0uODcwMiwxLjIzMTQgL=
jYwODMtLjQ0NzUgMS4xNDA5LS41OTY5IDEuMzMxMS0xLjA4MiAuMTkwMy0uNzQ2My0uMzA0NS0x=
Ljg2NTUtLjM4MDUtMS45Nzc3eiIvPg0KPHBhdGggZD0ibTY1OS44ODM2LDEyNi4xOTAxYy0uMzg=
wMSwuMDYyMi0uNDU2MS0xLjUxNzYtLjY4NDMtMi4yNzYyIC4xNjQ5LS4wODcyIC4zMjk3LS4wNj=
IyIC40OTQ1LC4yOTg0IC4xNzczLC4yMTE2IC4xMjY1LDEuMzE4NiAuMTg5OCwxLjk3Nzd6Ii8+D=
Qo8cGF0aCBkPSJtNjYzLjY0ODUsMTI1LjU1NTVsLjE1MjQtMS4zMDU5IC40MTgxLS4wMzcyYzAs=
MCAwLDEuMDgyIDAsMS4xMTkzIDAsLjAzNzYtLjUzMjEsLjI2MTItLjU3MDUsLjIyMzl6Ii8+DQo=
8cGF0aCBkPSJtNjYzLjM0NDMsMTI5LjA2MjdjLjI0MTIsLjM5NzkgLjY3MTksLjg3MDcgLjcyMj=
csMS4zMDU5IC4wNTA5LC40MzUyLS4wODg4LC42NDY4LS40MTgyLDEuMzA1OWwuNjA4NCwuMDM3M=
2MuMzI5My0uNTI4MyAuNDMxMS0uOTA3NiAuMzgwNi0xLjMyNDItLjA1MS0uNDE2OS0uMjU0MS0u=
ODMzNS0uNjg0Ny0xLjE3NTVsLS42MDg4LS4xNDk0eiIvPg0KPHBhdGggZD0ibTY2Ny44NzA0LDE=
yOS4zOTg4bC4xNTE5LDEuODI3OSAuNDk0NC0uMjYxMi0uMTEzOS0xLjU2NjdoLS41MzI0eiIvPg=
0KPC9nPg0KPHBhdGggZmlsbD0iI2ZmZmEwMCIgc3Ryb2tlPSIjZWZkNjA4IiBkPSJtNjQwLjk3N=
jYsMTI1LjIzODdjLTEuNDgzMywuNDI5Mi0yLjAxOTksMS4yNDg4LTIuNzQ1OCwxLjk1NzFsLTQu=
MTc5Ny0yLjExNjhjLS42Nzc4LC41NjI0LS45Mzg5LDEuMzY1OC0uNjEyOCwyLjE4ODIgLjMyNiw=
uODIyIDEuNjM3MywyLjEwODkgMi41Njk4LDIuNzQ1LS4yMzM2LDEuMTM1NS0uNTc3NywxLjk5Mj=
QtLjk4NTQsMi45ODg0LS40NTQ1LDEuMTE5Ny0xLjQzMDEsMi41MzQyLTEuNDU4NCwyLjk4ODQtL=
jA1NTcsLjUyLS4yMjU0LDEuNjM0MSAuNTUyMiwxLjkzMDkgLjc3ODEsLjI5NjkgMy4yNzk2LS4y=
MDU3IDQuMTE0My0uMTUwNi0uMTM1OCwuNDQ2Ny0uNDYwNiwxLjIyNzktLjM0OTksMS41NjMxIC4=
xMTA3LC4zMzUzIC4zMzQ5LC40NDcxIDEuMDE0MSwuNDY2NS0uMTk1NywuNDE1LS42MTc3LC45ND=
A5LS40MTUzLDEuMTg4NiAuNTI0NCwuMzk2NyAxLjEyNTEsLjMyODEgMS42MzA1LC4yOTcyLS4yO=
TczLC4zNDQ3LS43NjA4LC44MDgzLTEuMjU4NiwxLjI5NTUtLjgzNjgsLjgxODgtMS43NzA3LDEu=
NzA0LTIuMTc1OCwyLjIwMjItLjY4MzUsLjkyNDMtLjc0MjEsMS45MjI2IC41ODI3LDEuODI0Ny0=
uNDkyOSwuNTQ2MS0uOTY2OCwxLjA3MzctLjg5MTIsMS41NDUzIC4xMTQsLjU2NDggLjM5NzksLj=
k0MzcgMS4zNDQ4LC42MTYzLS41NjAyLDEuMjY3MS0uMTkyMiwyLjQwNDIgLjAwNTMsMy43MjY3L=
S40Nzg0LDEuMDAwOC0uMjc1MiwxLjkyNzQtLjM5MzksMy4wNzY4LS45NzQ0LC41NTE3LTEuMDk1=
NiwxLjI3MDYtMS43MjksMi4zOC0uNTcxMiwxLjIwMDktMS42MzQ1LDEuNTI4Ny0yLjIyNDMsNC4=
xMDUzbDMuODIzNywuOTUzNmMuMTQwNS0uNTI5OSAuNjQwNy0uODczOSAuNzgxNC0xLjQwMzQgLj=
E0MDItLjUyOTkgLjEyOTItMS4xODk4IC4wNjA5LTEuNzc1NiAuNzU4OC0xLjA5ODYgMi4yOTM5L=
TMuMzY4MSAyLjc4NzEtNC41NzgxIC44MzUtLjQ0NTkgMS40NDIyLS43MjQ5IDIuMDY4OC0uNzI0=
OSAuNjI2NiwwIDEuMDI1MiwuMzcxOCAxLjY4OTgsLjcyNDktLjI5NCwxLjAxOTgtMS4xMTg2LDI=
uMTMxOS0xLjE2NjIsMy41NjA3djMuOTQyNGMtLjE2NjUsLjk3OTQtMS4yODAyLC45OTI0LTEuNz=
UwMSwzLjk0MmwzLjQzNTEsLjg5MDJjLjU4MzMtLjk5MiAxLjUwNzItMS4xMjg3IDEuNzQ5Ni0xL=
jUyNTlsLjI0ODEtNC4wOTU3Yy40MzcxLTEuOTMzMyAzLjE0NzctMy41MzE3IDMuMTg3LTUuNjMy=
MyAuOTcyOC0uMDEzMSAxLjM0LC4wODYgMS43MjU3LS4xMTMgLjUxODQtLjE4MDMgLjY5NjEtLjQ=
3MiAxLjEwMS0uODM4MiAuMTU1OSwuNjMyMiAuNjUzMiwuNjg3NyAxLjA3NDYsLjY4NzcgLjQyMS=
wwIDEuMjU4OC0uNTk0NSAxLjYwNDYtLjgzNjMgLjI0MzMsLjM0MjggLjM3MjEsLjY2NyAuODgwM=
iwuNzg2NyAuNTA4MywuMTE5NyAxLjk0NDQtLjA5NTEgMi41Mjg2LS4yMzU4bC0yLjgyMjcsNC42=
MTgxYy0uMTA1NCwuNDQ1MSAuMDM1NiwuNzIyOS0uMTgzMywxLjI0MjUtLjIwNTMsLjQ2NjUtLjY=
xODksLjY5MTItLjgwNTIsMS4xMjA5bDMuMiwuNzY0NSAuNTEwNy0xLjM0NzVjLjY3ODMtLjI4NT=
ggMS4yMjQ1LS40NDE1IDEuNTgwOC0uODc1OSAuMzU2Mi0uNDM0NCAuMzUzMS0xLjI1OTYgLjU1N=
zktMS43MzEyIDEuMDkzMi0uNzkzNSAyLjgxMTQtMi41MTYzIDQuMDE4LTMuOTQyIC44MTkyLC4x=
MzgzIDEuOTc5NSwuODE1NyAyLjQxOTksMS44Mjc5IC4wNjE4LDEuMDg2IC4xNDE4LDMuMDgzMS0=
uMzQ1OSw0LjQ2NjdsLTIuMDc0LDMuMjQyOC0uMjM1MSwuNTMxOSAzLjI2NSwxLjE2MzMgMi4wNz=
QtMS41ODk3IC4wODA5LTIuMjY3NGMxLjA0MTgtMS44Mzk4IDIuNTMyNS0yLjg0NTMgMy45NTM0L=
TQuMDA1NCAwLS4wNjM4IC4xNTE1LTIuNDM1MSAuMDk0NS0yLjUyNzgtLjM1MS0uMjY3MS0uNTg4=
Mi0uMTA2Ni0uNzEyMi0uNTk2OS0uMTIzNi0uNDg5OS0uMDM5Mi0xLjgzNSAuMDI2Ni0yLjM2MjI=
gLjIwNTItLjI1NDUgLjYzNzktLjU0NjUgLjYxNTctLjc2MzgtLjU2NTEtLjYyMDMtLjM5MjItMi=
4yMjU4LS4yMTktMy40Nzc4LS4wNDI0LTEuNDI1NiAxLjkwNDktMy4xMTEyIDIuMjAzNC0zLjk0M=
mwuMTIxNi0xLjQ5NjZjLS4xOTkyLS4zNjc4LS40OTI1LS41ODctLjUwMjItLjg5OTMtLjAwOTMt=
LjMxMTkgLjM3ODUtLjgyODcgLjYxNTctMS4xNTk3bC40MTI4LS43MDQzLS4wNjQ2LTMuNjg3OWM=
tLjExNTYtLjM5ODMtLjQ1ODUtMS4wMTk0LS43ODI2LTEuMDgzMi0uMzI0NC0uMDYzNC0uNzk5OC=
wuMzAwOC0xLjE2MTgsLjcwMTVsLTEuODc2NCwxLjM4NTJjLS44OTk3LC4yNzUxLTEuNjg1OSwuM=
zgzMy0zLjI2NzUtLjAxMDdsLTIuNDEyNiwuMDQ4Yy0xLjI2NjgsLjM1MzktMS45Mjc4LC40MTEt=
My4xMTkyLS4xMDg2bC0xLjQyODUsLjAyM2MtLjQ0NTIsLjI0MjYtMS4wNjEzLC42MzMtMS41NDQ=
zLC43MjY1LS40ODI4LC4wOTMxLTEuMTM2NCwuMTEyMi0xLjYxOTYtLjAzNjEtMy42ODc3LC4yND=
gxLTIuNzcxOCwuNTE0NS0zLjgyNTgsLjc0MzktLjg0NjMtLjE2MDUtLjU3NDgtLjU4MS0zLjg2N=
DQtLjYxMTlsLTEuMzA0MS0uMzgxN2MtMS42NDU0LTEuMDkwMy0yLjkxMjMtMi44MzEtNC4wMDgz=
LTQuODMyMSAzLjQyNzUtLjk4MTcgNC44NjU2LTIuMDAxMSA1LjkwNTUtNC4zMzk1bC00Ljg0NjY=
sLjE4MTEtNi44NTM3LTQuNTU0M3oiLz4NCjxwYXRoIGZpbGw9IiM2NjRjMDAiIHN0cm9rZT0iIz=
Y2NGMwMCIgZD0ibTYzOS4yNjEzLDEzMS4yMmwxLjM3MjIsLjU4MTRjLjE2NzcsLjE5OTQgLjQ5M=
jUsLjQyOTIgLjcwNzQsLjQ0MjcgLjIxNDQsLjAxMzEgLjM5NzQtLjIwNTcgLjU4MDgtLjM2Mjds=
MS4yNjM0LS42NjE1Yy0uNzQ4Ni0uMTA4Mi0uOTc2OS0uNTcyNy0xLjc3MjctLjU3MjctLjc5NTk=
sMC0xLjM1NTQsLjQxNzctMi4xNTEyLC41NzI3eiIvPg0KPGcgZmlsbD0iI2NjYTMwMCIgc3Ryb2=
tlPSIjY2NhMzAwIj4NCjxwYXRoIGQ9Im02NDEuNzgxMiwxNDcuNDA2M2MtLjAwMDUsLjExMzQtL=
jE5MDMsLjE5NjItLjI4NTcsLjA2MTgtLjExNzYtMS42MDgzLS40NzE5LTIuNzM2Ny0uOTY3OS0z=
Ljk4OTEgLjU1OTgsLjk1MjggMS4wMjQ5LDIuNDk0MSAxLjI1MzYsMy45MjczeiIvPg0KPHBhdGg=
gZD0ibTY0OS44NCwxNDcuNTgwNWMuMjgxMiwuMDc3MyAuNjczMSwuMDc3NyAuNzY0OC0uMTA4Mi=
AuMTE5MS0uMzQ0OC0uMjM1Ni0uNzIwNS0uMzY4NC0xLjE0MjYtLjQ2MjUtLjkwNjQtLjcxOTItM=
S44ODk3LS45MTI3LTIuMzE1OC0uMjAzNS0uMTI4NC0uNDIyOS0uMTE2OS0uMzc0NCwuMDk1NSAu=
MjY1NSwuODA2MiAuNzIwMywzLjE2MDQgLjg5MDgsMy40NzExeiIvPg0KPHBhdGggZD0ibTY1NC4=
yNjA0LDE0Ny4wOTI2Yy4wMzA0LC4xOTU0LS42MzM3LS4wODg4LS43NDU3LS4zMTExLS4wMDk3LS=
40MzE2LS45MDM4LTMuNTg4NC0uNzU1OC0zLjcxMDUgLjE4NzktLjA5MTkgLjc3MDQsMS4wNTUgL=
jk1ODIsMS41ODMgLjA0NDEsLjMxMjMgLjQzNTksMS40NjA1IC41NDMzLDIuNDM4NnoiLz4NCjxw=
YXRoIGQ9Im02NTMuNjMzOSwxNTMuNTk3N2MtLjAxNTcsLjIyMDcgLjUwNSwuMDM5MiAuNzEwMi0=
uMTI2OCAuNTk1LS45MzAyIDEuMzMyMy0xLjkwNjggMS41NDg5LTIuMjc5MyAuMTMwNS0uMzk4My=
AuNzgxNy0yLjkzMjkgLjU4MDgtMi45MTI3LS4wNzA5LS4wNzMzLS42Mzc0LDEuMjU3Mi0xLjM2O=
DYsMi41NzAyLS43NjA4LDEuMzM3My0xLjQ3OTUsMi42MjA2LTEuNDcxMywyLjc0ODZ6Ii8+DQo8=
cGF0aCBkPSJtNjU4LjA2NzIsMTUyLjIzNTVjLS4yMTY2LC4xMDQyIC40MzQ2LTIuMTkxMyAuNDg=
2My0yLjU5OCAuMTE5Mi0uNjQyOCAuMjg1MS0xLjc5NjYgLjU0NjItMy4yOTA4IC4zMTg3LDIuMD=
g2Ny0uMDU3NCw0LjMyODQtMS4wMzI2LDUuODg4OHoiLz4NCjxwYXRoIGQ9Im02NjAuNzI2MiwxN=
DUuMjA5N2MtLjE0MjIsLjEyNDEtMi4wNDY2LTMuMDI0MS0xLjg3MTYtMy4wMzk1IC4wNDg5LS4x=
Mzk1IDEuNTk2MSwxLjk3MDIgMS44MTcxLDIuMzQxNSAuMDkyMSwuMTc2IC4xODM0LC40NDQ3IC4=
wNTQ1LC42OTh6Ii8+DQo8cGF0aCBkPSJtNjY1LjE4MywxNDcuNTQ2OWMtLjE0MjItLjEwNzQtLj=
A4NTMtMS4xMTI1LS4zNjczLTIuMjE2My0uMjgxNS0xLjEwMzgtLjc2MDctMi4xNjc2LS42NjU3L=
TIuNDY5NiAuMDg4OS0uMTU4OSAuMzk4OC0uMDg1NiAuNjQ1NiwuMTI2OCAuMTE3NSwuNjAwNCAu=
MzkyNiwyLjkwNDMgLjcxNTUsNC40MDI5LS4wMDQ1LC4xNDUtLjE2NjEsLjI0MzctLjMyODEsLjE=
1NjJ6Ii8+DQo8cGF0aCBkPSJtNjY4LjI5NzcsMTQ0Ljc0OTljLS4xNTIzLS4xNjIxIC40MTM2LD=
EuMDgwOCAuODI1NywyLjU1NzYgLjQxMjEsMS40NzcxIC42MjMsNC4wODYyIC43MjMyLDMuOTAwN=
yAuMjgzMS0uMTg3OSAuMjM1LS40MjIxIC42NzYyLS41MTcyIC40NDA5LS4wOTQ3IDIuMDgxMywu=
MDU3OSAxLjk4Ni0uMDUyMy0xLjAxNDgtLjkwNDEtMS45NTA4LTEuNjUzNS0yLjY1MDEtMi42MzQ=
5LS42OTg5LS45ODEzLTEuMTYxNS0yLjI3MjYtMS41NjEtMy4yNTM5eiIvPg0KPC9nPg0KPC9nPg=
0KPHBhdGggc3Ryb2tlLW9wYWNpdHk9Ii45OTYiIGZpbGw9Im5vbmUiIHN0cm9rZS13aWR0aD0iM=
S4yNSIgZD0ibTY3Mi42ODU5LDE4MC4zNDJsMTcuMjgyMy02MC45MTY0IDM2LjY4MzUtMTQuNzc3=
OSAxOS40NTUsMzIuODk2Mi0yNy44NDYsNTYuNTQ5OWMtMTUuNzUwOC01Ljk1MjktMjQuNzU4OC0=
5LjEzMzEtNDUuNTc0OS0xMy43NTE4eiIvPg0KPGcgc3Ryb2tlLXdpZHRoPSIuNSI+DQo8cGF0aC=
BmaWxsPSIjZmZmIiBzdHJva2U9IiNmZmYiIGQ9Im02ODQuMTQ0MywxNDAuMDU0NWM5LjQxMDEsM=
S45ODggMTguMTIxMSw0LjI1MDMgMjYuODMyMyw3LjA2MDcgOC43MTA2LDIuODEwNCAxNy4wMDI0=
LDYuMTY5NCAyNS40MzQsOS44MDI2bC0xNC4xMTQ4LDI4LjUxNzZjLTcuODc4NS0yLjk5ODMtMTU=
uNjU3Ny01LjQxNTEtMjMuNDM3Mi03LjkyODMtNy43NzkxLTIuNTEzNi0xNS4zNjA2LTQuNzM2Ni=
0yMy4yMzg3LTcuMTUzMWw4LjUyNDQtMzAuMjk5NXoiLz4NCjxwYXRoIGZpbGw9IiNkZTE4MTgiI=
HN0cm9rZT0iI2U2MTcxNyIgZD0ibTY4Mi4yNjk5LDE0Ni43OTFjMCwwIDEzLjE0MjQsMi45MzI1=
IDI1Ljg3NzUsNy4wMjg2IDEyLjczNTMsNC4wOTU3IDI1LjE2MTQsOS4zNTQ3IDI1LjExMiw5LjM=
1NDctLjA5ODksMC04LjAwNDUsMTYuMjg3NC04LjAwNDUsMTYuMjg3NC03LjY3NDUtMy4wNTM4LT=
E1Ljc0NDktNS45MTQxLTIzLjcxNTktOC40ODMyLTcuOTcxNC0yLjU2OTEtMTUuOTQyNS01LjA0M=
S0yNC4xMTEzLTYuOTMxNWw0Ljg0MjItMTcuMjU2MXoiLz4NCjxnIHN0cm9rZT0iIzAwMCI+DQo8=
cGF0aCBmaWxsPSIjMDAwIiBkPSJtNjgzLjM2MTgsMTU0Ljc1NjJjMS4yOTI3LS43MjIxIDIuMTY=
4Mi0uOTE3MSAyLjg2NDItMi4xMDczbDQuNjUzOSwuMDAwNCAuMDYwMSwxLjY5NzFjMS4xNDM2LC=
41NDY1IDEuODA5OSwxLjE1MTggMi45NTM1LDEuNjk3OSAxLjE0MzcsLjU0NjUgMi43NjUsMS4wM=
zQxIDMuOTA4NiwxLjU4MDZsMTAuMDI0NCwuODc4M2MxLjM0MjQsLjIxNDQgMy4yODIsLjc4MDQg=
NC40NDU0LDEuNDYzMyAxLjE2MzUsLjY4MzMgMS45MDk2LDEuNTQxOCAyLjUzNjMsMi42MzQ0IDI=
uMDU4MywuNzIyMSA0LjExNzQsMS4xNTE0IDYuMjM1NCwxLjQ2MzcgMi4xMTg3LC4zMTE5IDQuNz=
czNiwuNDQ4NiA2LjgzMjIsLjUyNjcgMS4wMTQ0LC4zNTE1IDEuMDE0NCwuODc4MyAuNTM2OSwxL=
jQwNSAwLDAtMS4xMzQsMS41MzY2LTQuMjI5MywxLjU1MTMtMy4wOTUyLC4wMTQ3LTYuNjAxMS0x=
LjcyNjgtOC4xMjI1LTEuNDkyNiAuMDU5OSwuOTM2NSAxLjY3MSwyLjg2ODcgMy41MjA3LDMuNjI=
5NmwtLjA1OTQsNC40NDg1LS44MzU4LC43NjEzLS44OTQ5LS41ODU0Yy43MTYzLTEuMDUzNSAuND=
c3MS0yLjI4MzMgLjE3ODktMy4zMzY4LS42ODYzLS45OTUyLS43NzU2LTEuNDA1LTIuMDU4Mi0xL=
jQ2MzMtMS41MjE5LS4yOTMzLTIuNjI2LS43MDMxLTQuNTY1MS0yLjA0OTRsLS43MTYyLC4xMTcz=
Yy0uNDE3NywuNzQxNi0uODM1NSwxLjI0ODktMS43OSwxLjY5NzVsLTEuOTY5MS0uMTE2OWMwLDA=
tNC41MzUyLS45OTUyLTQuNTM1Mi0xLjA1MzkgMC0uMDU4My0uMDU5Ni0uNzAyMyAuMDU5OS0uNz=
YxIC4xMTkyLS4wNTg3IDEuNTUxMy0uMDU4MiAxLjY3MDQtLjA1ODIgLjk1NTEsLjI5MjUgMi45O=
DQsLjI5MjUgMi45ODQsLjI5MjVsLS4wNi0xLjY5NzkgMy4wNDMzLS4xNzU2Yy0uNjE2NS0yLjEw=
NzMtLjgxNTctMy40NTQtMy42Mzk5LTMuOTIyMWwtOC44MzE0LC4yMzQyIC4xMTk1LDEuMjI5NGM=
tMi4yMDc4LS4yOTI5LTYuMjA1Ni0uMzQ1Mi04LjI0NzYsLjMzMTMtMS4xOTM1LC4xMTczLTIuOT=
EwOCwuNzIyMS0zLjY4NjQsLjcyMjFsLS44OTUzLS4yMzM4Yy0uNTk2Ny0uMTc1Ni0uNTk2Ny0uM=
zUxMS0uMzU4LS44NzgzIDMuODE4OS0uMjkyOSA0LjQxNTktLjU4NTQgNS41NDk1LTEuMTEyMSAu=
MDU5OC0uMzUxMi0uNDE3OC0xLjExMjUtLjU5NjYtMS4xNzEyLTIuMzg2Ny0uMTE2OS00LjI5NjM=
sLjA1ODctNC45NTI0LS4wNTgzLTEuMDE0NS0uMjkyOS0yLjM4NzItLjgxOTYtMi4zODcyLS44Nz=
gzIDAtLjA1ODYtLjE3ODktLjkzNjUtLjExOTItLjkzNjUgLjA1OTMsMCAxLjU1MTcsLjQwOTggM=
S42MTA3LC40MDk4IDEuNjExNSwuMjkyNSA0LjQxNiwuMTc1NiA1LjA3MjUtLjE3NTZsLjA1OTgt=
MS4yODgxYy0uMDU5OC0uNTg1NC0uNDc3NS0xLjExMjEtLjU5NzEtMS4xNzA4LS4xMTkyLS4wNTg=
2LTIuNjI1Ni0uMzUxMS0zLjUyMDctLjM1MTEtMS40NTItLjI1MzctMS4yMzMtLjk3NTgtMS4yNT=
I4LTEuNjk3OXoiLz4NCjxwYXRoIGZpbGw9IiNmZmYiIGQ9Im03MDIuNjM1LDE2NS4xNzY3YzEuM=
zUyNiwuNDI5MiAyLjM0NzIsLjU2NTYgNC4zNTYxLC43MDIzbDMuMDQzMy0uMTc1NmMtLjYxNjUt=
Mi4xMDczLS44MTU3LTMuNDU0LTMuNjM5OS0zLjkyMjFsLTguODMxNCwuMjM0MiAuMTE5NSwxLjI=
yOTRjMi42ODU0LC45OTQ4IDMuOTk3OSwxLjU0MTQgNC45NTI0LDEuOTMxN3oiLz4NCjwvZz4NCj=
xwYXRoIGZpbGw9IiMwMDI5OGMiIHN0cm9rZT0iIzAwMDA4MiIgZD0ibTUyNy4yNTE2LDE4MC4zM=
zA2bC0xNS45NTk5LTU5LjQ4MDIgMjQuMzUzNi0yOS41MDI4IDM0LjE0OTEsMTkuNDk0OSA1Ljc4=
ODUsNjMuMDI5MWMtMTcuNDI0NywxLjI5MTQtMjguNzEzMywyLjk2ODMtNDguMzMxMyw2LjQ1OXo=
iLz4NCjxwYXRoIGZpbGw9IiNmZmZhMDAiIHN0cm9rZT0iI2ZmYzcwMCIgZD0ibTQ3MC4xMzg0LD=
EzMC43Nmw1Ljg0MzMsNC41NDM4LTEuMDk0NSw3Ljk0NjYgNy41MjQtMy4xMjg3IDUuOTY5Miw0L=
jUzNjEgLjgxNzMtNy4zMDkgNi4xNzU1LTIuNDI1OC01LjEwNjItNC44OTkgMS4xMzYxLTcuMjY2=
MmMwLDAtNy40MjQzLDIuNjg3OC03LjQyODEsMi42MjYxLS4wMDM4LS4wNjE3LTUuMzM1MS00LjU=
xMjYtNS4zOTQ2LTQuNDQ2OS0uMDU5MSwuMDY1Ni0xLjIyMTksNi44OTk0LTEuMjIxOSw2Ljg5OT=
RsLTcuMjIwMSwyLjkyMzh6Ii8+DQo8L2c+DQo8ZyBzdHJva2Utd2lkdGg9IjEuMjUiPg0KPHBhd=
GggZmlsbD0iI2ZmYzUwMCIgZD0ibTQ3MC4yNjgyLDEzMC44MTRsMjUuMDM4NSw0LjA1MTQtNi4y=
MzEzLDIuNTUyOC02LjAxNjktNC4yODQ5YzAsMCA1LjM3MzYsMTEuMzM1MSA1LjMwNjksMTEuMjc=
3My0uMDY2Ny0uMDU3OS01LjY5NDUtNC4xODA4LTUuODk0OS00LjM1NDRsLjUyNTEtNi45MTkxYz=
AsMC03Ljk4NiwxMC4wNDM5LTcuOTg5OCw5Ljk4MjItLjAwMzgtLjA2MjEgMS4xNjEzLTcuODg4O=
CAxLjE2MTMtNy44ODg4bC01Ljg5ODgtNC40MTY1eiIvPg0KPGcgZmlsbD0iI2ZmYzcwMCI+DQo8=
cGF0aCBkPSJtNDc3LjI3OTMsMTI3Ljk4MzVsNS44MDMxLDQuOTE4Ny00LjUyNTgtMTEuOTQ1NC0=
xLjI3NzMsNy4wMjY3eiIvPg0KPHBhdGggZD0ibTQ4My44OTI4LDEyNS42MzI5Yy4wNjY3LC4wNT=
g1LS44ODgyLDcuMjYwMy0uODI1Myw3LjI1NjQgLjU4NDQtLjc4OCA4LjMxMjEtOS45NzU0IDguM=
jQ5Ni05Ljk3MTUtLjA2MzMsLjAwMzktNy4yOTQ3LDIuNzY5Ny03LjQyNDMsMi43MTUxeiIvPg0K=
PC9nPg0KPC9nPg0KPHBhdGggZmlsbD0iI2ZmZmEwMCIgc3Ryb2tlPSIjZmZjNzAwIiBzdHJva2U=
td2lkdGg9Ii41IiBkPSJtNzA4LjcyNzEsMTIwLjY1ODZsMS40NzE0LDcuMTc3OC02LjA1NzQsNS=
4zODg2IDcuNzk1OCwyLjM3MDIgMS41NzI1LDcuMjUxNSA1LjQyNy01LjA3NjIgNi4zMDUyLDIuM=
DU0MS0uNjc1Ni02Ljk4MjggNS42NDE5LTQuODQxNmMwLDAtNy40MzAxLTIuNjQ0NS03LjM5MjUt=
Mi42OTQxIC4wMzc3LS4wNDk3LTEuMTA0Mi02LjgzMi0xLjE5MjgtNi44MTk2LS4wODgzLC4wMTI=
3LTUuNDY2NCw0LjUwNjUtNS40NjY0LDQuNTA2NWwtNy40MjkzLTIuMzM0NXoiLz4NCjxnIGZpbG=
w9IiNmZmM3MDAiPg0KPHBhdGggZD0ibTcwOC43OTA2LDEyMC43ODIxbDE2LjQzOCwxOC45NTY0L=
TYuNDMxMi0xLjk5MjMtMS43NzQtNy4wODk2YzAsMC0zLjM1MDIsMTIuMDc3OS0zLjM2MywxMS45=
OTE0LS4wMTI4LS4wODY1LTEuNTk2NC02LjgwNTctMS42MzUyLTcuMDY1NWw0Ljk0NzgtNC45NjI=
4YzAsMC0xMi42OTI5LDIuNjI5Ni0xMi42NTUzLDIuNTggLjAzOC0uMDQ5OSA2LjA3MDQtNS4zMD=
IxIDYuMDcwNC01LjMwMjFsLTEuNTk3NS03LjExNTV6Ii8+DQo8ZyBzdHJva2Utd2lkdGg9IjEuM=
jUiPg0KPHBhdGggZD0ibTcxNi4xMDU5LDEyMi45NTYxbDEuMTk0Miw3LjQzOTIgNC4zOTgtMTIu=
MDA4LTUuNTkyMyw0LjU2ODh6Ii8+DQo8cGF0aCBkPSJtNzIyLjcyNzQsMTI1LjMxOTRjLjAxMjk=
sLjA4NjUtNS40MDIyLDQuOTM5NS01LjM1MTYsNC45NzY0IC45NTg2LS4yMjcxIDEyLjgzMjQtMi=
4yOTU5IDEyLjc4MjItMi4zMzI1LS4wNTA5LS4wMzcxLTcuMzY3MS0yLjUyMDUtNy40MzA2LTIuN=
jQzOXoiLz4NCjwvZz4NCjwvZz4NCjxnIGZpbGw9IiNkZTE4MTgiIHN0cm9rZT0iI2U2MTcxNyIg=
c3Ryb2tlLXdpZHRoPSIuNSI+DQo8cGF0aCBkPSJtNTExLjQwODEsMTIxLjA4MWM4LjY2NzktNC4=
xNDM0IDE4LjM5NjYtNy4zNzU5IDI4LjY1NjUtOC43ODU2IDkuODYxMi0xLjQxMDMgMTkuNzMwNi=
0xLjUzMjQgMjkuODU3Ni0xLjUxMDggMCwwIDEuMzI2NywxNS41MDk4IDEuMzI2NywxNS42NDAxL=
TcuOTYwMSwuMDY1LTEzLjg5MjItLjA4MjgtMjcuOTM0MywxLjczMzYtMTMuOTYzMywxLjkzNjUt=
MTkuNzE1MiwzLjU5Ni0yOC4yMDYxLDYuODVsLTMuNzAwNS0xMy45Mjc0eiIvPg0KPHBhdGggZD0=
ibTUxOC44MzA1LDE0OC41MzczYy0uMTMyOSwwIDQuMzg1MywxNi40MDcyIDQuMzg1MywxNi40MD=
cyIDguMzM2Mi0yLjEwNDIgMTYuODA0OS0zLjY4NzkgMjUuMjczNy00Ljg4MDkgOC40Njg3LTEuM=
TkzIDE3LjQ3NTEtMS44NzI3IDI1LjY3ODQtMi40MTQ5bC0xLjQ1MjMtMTYuMDAyNWMtOC42NDU3=
LS41MjA4LTE4LjQ5OTMtLjUyMDgtMjcuNDEwMywuNjUwNC04LjkxMTEsMS4xNzE2LTE3LjU2MzY=
sMy4yNDcyLTI2LjQ3NDcsNi4yNDA3eiIvPg0KPC9nPg0KPGcgc3Ryb2tlPSIjZGUxODE4Ij4NCj=
xwYXRoIGZpbGw9IiNmZmYiIHN0cm9rZS13aWR0aD0iMS42MDEiIGQ9Im00NzkuMDQwMywxOTkuM=
jAyMmgyNDEuOTM0OHYxNTUuMTM0M2MtNi4xNDk0LDYwLjQxNjMtNjQuMjE3MiwxMDUuNTc3Mi0x=
MTcuMjc3NywxMDUuMjMyOC01Ny4yNzczLDIuNDk4OS0xMjAuNjE2My00NC4zODU3LTEyNS4xODQ=
yLTEwNS43NWwuNTI3MS0xNTQuNjE3MXoiLz4NCjxwYXRoIGZpbGw9IiNkZTE4MTgiIHN0cm9rZS=
13aWR0aD0iMS41MzQiIGQ9Im00ODQuMDcxNCwyMDQuNjMwN2gyMzEuODUwNXYxNDguNjY4NWMtN=
S44OTMyLDU3Ljg5ODItNjEuNTQwNSwxMDEuMTc2OS0xMTIuMzg5NCwxMDAuODQ2OC01NC44ODk3=
LDIuMzk0Ny0xMTUuNTg4Ny00Mi41MzU4LTExOS45NjYyLTEwMS4zNDI1bC41MDUxLTE0OC4xNzI=
4eiIvPg0KPC9nPg0KPC9nPg0KPHBhdGggZmlsbD0iI2ZmZiIgZmlsbC1ydWxlPSJldmVub2RkIi=
BpZD0icmVjdDM3MTEiIHN0cm9rZS13aWR0aD0iMS4yNSIgZD0ibTUzMC43NjQsMjA1LjQyMmg0N=
i4xMDd2NDkuNTU3aC00Ni4xMDd6Ii8+DQo8dXNlIHdpZHRoPSIxMjAwIiBoZWlnaHQ9IjYwMCIg=
eGxpbms6aHJlZj0iI3BhdGgzNzE5IiB0cmFuc2Zvcm09Im1hdHJpeCgtMSAwIDAgMSAxMTk5LjY=
4IC4wNjU5NSkiLz4NCjx1c2Ugd2lkdGg9IjEyMDAiIGhlaWdodD0iNjAwIiB4bGluazpocmVmPS=
IjcGF0aDM3MTciIHRyYW5zZm9ybT0ibWF0cml4KC0xIDAgMCAxIDEyMDAgMCkiLz4NCjxwYXRoI=
GZpbGw9IiNmZmYiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlPSIjZmZmIiBpZD0icGF0aDM3=
MTciIHN0cm9rZS13aWR0aD0iLjUwOCIgZD0ibTUzMS4wODQ1LDQwMy44NzY3bC4wOTYsMjYuMjg=
0M2MxNS43MDY2LDExLjA4NzEgMzMuNjQ0MSwxNy44MTg0IDQ1LjU5MDEsMjAuMzEzNGwtLjE1ND=
EtNDYuNTgwMy00NS41MzItLjAxNzR6Ii8+DQo8cGF0aCBmaWxsPSIjZmZmIiBmaWxsLXJ1bGU9I=
mV2ZW5vZGQiIHN0cm9rZT0iI2ZmZiIgaWQ9InBhdGgzNzE5IiBzdHJva2Utd2lkdGg9Ii41MTIi=
IGQ9Im00ODQuOTA5OSwzNTQuMzY5MmMxLjQ2NDcsMTkuMTg4MiAxMC4wOTIxLDM2LjM3ODYgMTg=
uNzA4NCw0OC40MTU4bDI2Ljg4OTIsLjU2MDIgLjAwNDktNDguOTk2OS00NS42MDI2LC4wMjA5ei=
IvPg0KPHVzZSB3aWR0aD0iMTIwMCIgaGVpZ2h0PSI2MDAiIHhsaW5rOmhyZWY9IiNyZWN0MzcxM=
SIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTQ2LjEwNjQgNDkuNTU2NykiLz4NCjx1c2Ugd2lkdGg9=
IjEyMDAiIGhlaWdodD0iNjAwIiB4bGluazpocmVmPSIjcmVjdDM3MTEiIHRyYW5zZm9ybT0idHJ=
hbnNsYXRlKDQ2LjEwNjQgNDkuNTU2NikiLz4NCjx1c2Ugd2lkdGg9IjEyMDAiIGhlaWdodD0iNj=
AwIiB4bGluazpocmVmPSIjcmVjdDM3MTEiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDkyLjIxMjgpI=
i8+DQo8dXNlIHdpZHRoPSIxMjAwIiBoZWlnaHQ9IjYwMCIgeGxpbms6aHJlZj0iI3JlY3QzNzEx=
IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMzguMzE5IDQ5LjU1NjYpIi8+DQo8dXNlIHdpZHRoPSI=
xMjAwIiBoZWlnaHQ9IjYwMCIgeGxpbms6aHJlZj0iI3JlY3QzNzExIiB0cmFuc2Zvcm09InRyYW=
5zbGF0ZSgwIDk5LjExMzMpIi8+DQo8dXNlIHdpZHRoPSIxMjAwIiBoZWlnaHQ9IjYwMCIgeGxpb=
ms6aHJlZj0iI3JlY3QzNzExIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSg5Mi4yMTI4IDk5LjExMzMp=
Ii8+DQo8dXNlIHdpZHRoPSIxMjAwIiBoZWlnaHQ9IjYwMCIgeGxpbms6aHJlZj0iI3JlY3QzNzE=
xIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSg0Ni4xMDY2IDE0OC42NykiLz4NCjxwYXRoIGZpbGw9Ii=
NjY2EzMDAiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlPSIjY2NhMzAwIiBzdHJva2Utd2lkd=
Gg9Ii41IiBkPSJtNjQ1LjU2NCwxNDYuODQ4NGMtLjE1MzYsLjE4NDktLjUxNjMtMi4xNzM2LS42=
Mzg0LTIuNTY0OS0uMTU5LS42MzQyLS40ODgtMS43NTI0LS44NzIxLTMuMjE5OCAxLjE1NzgsMS4=
3NjUgMS43NDgzLDMuOTYgMS41MTA1LDUuNzg0NnoiLz4NCjwvc3ZnPg0K"); }

.flag-list .is a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMD=
AwIDcyMCI+DQo8ZyB0cmFuc2Zvcm09InNjYWxlKDQwKSI+DQo8cGF0aCBmaWxsPSIjMDAzODk3I=
iBkPSJtMCwwaDI1djE4aC0yNXoiLz4NCjxnIGZpbGw9IiNmZmYiPg0KPHBhdGggZD0ibTAsN2gy=
NXY0aC0yNXoiLz4NCjxwYXRoIGQ9Im03LDBoNHYxOGgtNHoiLz4NCjwvZz4NCjxnIGZpbGw9IiN=
kNzI4MjgiPg0KPHBhdGggZD0ibTAsOGgyNXYyaC0yNXoiLz4NCjxwYXRoIGQ9Im04LDBoMnYxOG=
gtMnoiLz4NCjwvZz4NCjwvZz4NCjwvc3ZnPg0K"); }

.flag-list .li a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCA5MD=
AgNjAwIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayI+DQo8cGF0a=
CBmaWxsPSIjMDAyYjdmIiBkPSJtMCwwaDkwMHY2MDBoLTkwMHoiLz4NCjxwYXRoIGZpbGw9IiNj=
ZTExMjYiIGQ9Im0wLDMwMGg5MDB2MzAwaC05MDB6Ii8+DQo8ZyBmaWxsPSIjZmZkODNkIiBzdHJ=
va2U9IiMwMDAiIHN0cm9rZS1saW5lam9pbj0icm91bmQiIHN0cm9rZS1saW5lY2FwPSJyb3VuZC=
I+DQo8ZyBzdHJva2Utd2lkdGg9IjIiPg0KPGcgaWQ9ImhhbGYiPg0KPHBhdGggc3Ryb2tlPSJub=
25lIiBkPSJtMjE2LjM3NzEsMTIyLjI4ODZsLTEuODM4Miw2Mi41aC02My40MTkxYy03LjgwMjUt=
MTUuMTY4My0xNC4yNDYzLTI4LjA1MTMtMTQuMjQ2My00NS40OTYzIDAtMTQuNTk5NiAxMS40ODM=
xLTI2LjE5NDkgMjguMDMzMS0yNi4xOTQ5IDE3LjUxOTcsMCAzNi43Njg3LDUuOTAzNiA1MS40Nz=
A2LDkuMTkxMnoiLz4NCjxnIHN0cm9rZS13aWR0aD0iMS41Ij4NCjxwYXRoIGQ9Im0xNDQuNDU2M=
SwxMjUuMTYwOHYzNi4wNzU0Ii8+DQo8cGF0aCBkPSJtMTQ5LjU0OTYsMTIxLjQ3OTN2NDguMDM0=
Ii8+DQo8cGF0aCBkPSJtMTU0LjY0MywxMTguOTUxOHY1Ny4yMjUyIi8+DQo8cGF0aCBkPSJtMTU=
5LjczNjQsMTE3Ljc3MDh2NDQuODgxMiIvPg0KPHBhdGggZD0ibTE2NC44Mjk5LDExNy41NDgydj=
Q1LjMyNjUiLz4NCjxwYXRoIGQ9Im0xNjkuOTIzMywxMTUuOTY0NnY0Ni44ODUxIi8+DQo8cGF0a=
CBkPSJtMTc1LjAxNjgsMTE1Ljk2NDZ2NDYuODg1MSIvPg0KPHBhdGggZD0ibTE4MC4xMTAyLDEx=
Ni40MjQydjQ2Ljg4NTEiLz4NCjxwYXRoIGQ9Im0xODUuMjAzNywxMTYuODgzOHY0Ni44ODUxIi8=
+DQo8cGF0aCBkPSJtMTkwLjI5NzEsMTE5Ljg3MDl2NDYuODg1MSIvPg0KPHBhdGggZD0ibTE5NS=
4zOTA2LDEyMC4zMzA0djUyLjg1OTQiLz4NCjxwYXRoIGQ9Im0yMDAuNDg0LDEyMC4zMzA0djQ2L=
jg4NTEiLz4NCjxwYXRoIGQ9Im0yMDUuNTc3NSwxMjAuMzMwNHY0Ni44ODUxIi8+DQo8cGF0aCBm=
aWxsPSIjMDAwIiBkPSJtMTc2LjM5NTQsMTE3LjkyMjhjMTAuNzYzNSwxLjc3NTUgMzQuNDA2MSw=
xMi44MzcxIDMxLjcwOTYsMjcuODAzMy0zLjgyMTMsMjEuMjA5My0xNi4yMDc4LDEyLjY5NzYtMz=
IuNjI4Nyw5LjY1MDdsLTEyLjQwODEsNC4xMzZjLTQuNDM5OCw0LjUzMTgtMTAuOTc3OCw4LjY4M=
zUtMTUuMzk1MiwzLjIxNjloLTcuMzUyOXYyOC43MjI0aDgxLjM0MTl2LTY5LjM5MzR6Ii8+DQo8=
L2c+DQo8Y2lyY2xlIGN4PSIyMTIuODE1IiBjeT0iMTEyLjk4MyIgcj0iNC45NCIgZD0ibSAyMTc=
uNzU1NzUsMTEyLjk4MjU1IGMgMCwyLjcyODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuOTQwMjYsNC=
45NDAyNiAtMi43Mjg0MywwIC00Ljk0MDI2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0MDI2IDAsL=
TIuNzI4NDMgMi4yMTE4MywtNC45NDAyNiA0Ljk0MDI2LC00Ljk0MDI2IDIuNzI4NDMsMCA0Ljk0=
MDI2LDIuMjExODMgNC45NDAyNiw0Ljk0MDI2IHoiLz4NCjxjaXJjbGUgY3g9IjIwMS43MTMiIGN=
5PSIxMTAuMzExIiByPSI0Ljk0IiBkPSJtIDIwNi42NTMyNiwxMTAuMzEwNTIgYyAwLDIuNzI4ND=
MgLTIuMjExODMsNC45NDAyNiAtNC45NDAyNiw0Ljk0MDI2IC0yLjcyODQzLDAgLTQuOTQwMjYsL=
TIuMjExODMgLTQuOTQwMjYsLTQuOTQwMjYgMCwtMi43Mjg0MyAyLjIxMTgzLC00Ljk0MDI2IDQu=
OTQwMjYsLTQuOTQwMjYgMi43Mjg0MywwIDQuOTQwMjYsMi4yMTE4MyA0Ljk0MDI2LDQuOTQwMjY=
geiIvPg0KPGNpcmNsZSBjeD0iMTkwLjQ1IiBjeT0iMTA3LjQ4MiIgcj0iNC45NCIgZD0ibSAxOT=
UuMzksMTA3LjQ4MTc4IGMgMCwyLjcyODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuOTQwMjYsNC45N=
DAyNiAtMi43Mjg0MywwIC00Ljk0MDI2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0MDI2IDAsLTIu=
NzI4NDMgMi4yMTE4MywtNC45NDAyNiA0Ljk0MDI2LC00Ljk0MDI2IDIuNzI4NDMsMCA0Ljk0MDI=
2LDIuMjExODMgNC45NDAyNiw0Ljk0MDI2IHoiLz4NCjxjaXJjbGUgY3g9IjE3OS4xNDMiIGN5PS=
IxMDUuNTk2IiByPSI0Ljk0IiBkPSJtIDE4NC4wODMyLDEwNS41OTU5NiBjIDAsMi43Mjg0MyAtM=
i4yMTE4Myw0Ljk0MDI2IC00Ljk0MDI2LDQuOTQwMjYgLTIuNzI4NDMsMCAtNC45NDAyNiwtMi4y=
MTE4MyAtNC45NDAyNiwtNC45NDAyNiAwLC0yLjcyODQzIDIuMjExODMsLTQuOTQwMjYgNC45NDA=
yNiwtNC45NDAyNiAyLjcyODQzLDAgNC45NDAyNiwyLjIxMTgzIDQuOTQwMjYsNC45NDAyNiB6Ii=
8+DQo8Y2lyY2xlIGN4PSIxNjcuODM2IiBjeT0iMTA0LjQ4MSIgcj0iNC45NCIgZD0ibSAxNzIuN=
zc2NDMsMTA0LjQ4MDcxIGMgMCwyLjcyODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuOTQwMjYsNC45=
NDAyNiAtMi43Mjg0MywwIC00Ljk0MDI2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0MDI2IDAsLTI=
uNzI4NDMgMi4yMTE4MywtNC45NDAyNTcgNC45NDAyNiwtNC45NDAyNTcgMi43Mjg0MywwIDQuOT=
QwMjYsMi4yMTE4MjcgNC45NDAyNiw0Ljk0MDI1NyB6Ii8+DQo8Y2lyY2xlIGN4PSIxNTYuNzQ5I=
iBjeT0iMTA1LjExMyIgcj0iNC45NCIgZD0ibSAxNjEuNjg5NTcsMTA1LjExMjYxIGMgMCwyLjcy=
ODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuOTQwMjYsNC45NDAyNiAtMi43Mjg0MywwIC00Ljk0MDI=
2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0MDI2IDAsLTIuNzI4NDMgMi4yMTE4MywtNC45NDAyNi=
A0Ljk0MDI2LC00Ljk0MDI2IDIuNzI4NDMsMCA0Ljk0MDI2LDIuMjExODMgNC45NDAyNiw0Ljk0M=
DI2IHoiLz4NCjxjaXJjbGUgY3g9IjE0Ni4xNzkiIGN5PSIxMDguNzMyIiByPSI0Ljk0IiBkPSJt=
IDE1MS4xMTk3MiwxMDguNzMxNjMgYyAwLDIuNzI4NDMgLTIuMjExODMsNC45NDAyNiAtNC45NDA=
yNiw0Ljk0MDI2IC0yLjcyODQzLDAgLTQuOTQwMjYsLTIuMjExODMgLTQuOTQwMjYsLTQuOTQwMj=
YgMCwtMi43Mjg0MyAyLjIxMTgzLC00Ljk0MDI2IDQuOTQwMjYsLTQuOTQwMjYgMi43Mjg0MywwI=
DQuOTQwMjYsMi4yMTE4MyA0Ljk0MDI2LDQuOTQwMjYgeiIvPg0KPGNpcmNsZSBjeD0iMTM3LjI3=
NiIgY3k9IjExNS4yOCIgcj0iNC45NCIgZD0ibSAxNDIuMjE1NzcsMTE1LjI4MDM1IGMgMCwyLjc=
yODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuOTQwMjYsNC45NDAyNiAtMi43Mjg0MywwIC00Ljk0MD=
I2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0MDI2IDAsLTIuNzI4NDMgMi4yMTE4MywtNC45NDAyN=
iA0Ljk0MDI2LC00Ljk0MDI2IDIuNzI4NDMsMCA0Ljk0MDI2LDIuMjExODMgNC45NDAyNiw0Ljk0=
MDI2IHoiLz4NCjxjaXJjbGUgY3g9IjEzMC45NTciIGN5PSIxMjQuNDE0IiByPSI0Ljk0IiBkPSJ=
tIDEzNS44OTY4MywxMjQuNDE0MDggYyAwLDIuNzI4NDMgLTIuMjExODMsNC45NDAyNiAtNC45ND=
AyNiw0Ljk0MDI2IC0yLjcyODQzLDAgLTQuOTQwMjYsLTIuMjExODMgLTQuOTQwMjYsLTQuOTQwM=
jYgMCwtMi43Mjg0MyAyLjIxMTgzLC00Ljk0MDI2IDQuOTQwMjYsLTQuOTQwMjYgMi43Mjg0Myww=
IDQuOTQwMjYsMi4yMTE4MyA0Ljk0MDI2LDQuOTQwMjYgeiIvPg0KPGNpcmNsZSBjeD0iMTI3Ljk=
xMiIgY3k9IjEzNS4xNTYiIHI9IjQuOTQiIGQ9Im0gMTMyLjg1MjI2LDEzNS4xNTYyNyBjIDAsMi=
43Mjg0MyAtMi4yMTE4Myw0Ljk0MDI2IC00Ljk0MDI2LDQuOTQwMjYgLTIuNzI4NDMsMCAtNC45N=
DAyNiwtMi4yMTE4MyAtNC45NDAyNiwtNC45NDAyNiAwLC0yLjcyODQzIDIuMjExODMsLTQuOTQw=
MjYgNC45NDAyNiwtNC45NDAyNiAyLjcyODQzLDAgNC45NDAyNiwyLjIxMTgzIDQuOTQwMjYsNC4=
5NDAyNiB6Ii8+DQo8Y2lyY2xlIGN4PSIxMjguMDI3IiBjeT0iMTQ2LjMwMSIgcj0iNC45NCIgZD=
0ibSAxMzIuOTY3MTUsMTQ2LjMwMDU3IGMgMCwyLjcyODQzIC0yLjIxMTgzLDQuOTQwMjYgLTQuO=
TQwMjYsNC45NDAyNiAtMi43Mjg0MywwIC00Ljk0MDI2LC0yLjIxMTgzIC00Ljk0MDI2LC00Ljk0=
MDI2IDAsLTIuNzI4NDMgMi4yMTE4MywtNC45NDAyNiA0Ljk0MDI2LC00Ljk0MDI2IDIuNzI4NDM=
sMCA0Ljk0MDI2LDIuMjExODMgNC45NDAyNiw0Ljk0MDI2IHoiLz4NCjxjaXJjbGUgY3g9IjEzMC=
4xNTIiIGN5PSIxNTcuMjE1IiByPSI0Ljk0IiBkPSJtIDEzNS4wOTI2MiwxNTcuMjE1MDkgYyAwL=
DIuNzI4NDMgLTIuMjExODMsNC45NDAyNiAtNC45NDAyNiw0Ljk0MDI2IC0yLjcyODQzLDAgLTQu=
OTQwMjYsLTIuMjExODMgLTQuOTQwMjYsLTQuOTQwMjYgMCwtMi43Mjg0MyAyLjIxMTgzLC00Ljk=
0MDI2IDQuOTQwMjYsLTQuOTQwMjYgMi43Mjg0MywwIDQuOTQwMjYsMi4yMTE4MyA0Ljk0MDI2LD=
QuOTQwMjYgeiIvPg0KPHBhdGggZD0ibTIxNC45OTg0LDExOS41MzEybC0uNDU5Niw2LjQzMzhjL=
TEyLjI5MS0xLjg4MzEtMjkuNzE0OS04LjczMTYtNDUuOTU1OS04LjczMTYtMTUuMDA2NCwwLTI2=
LjY1NDQsNi4wMDI3LTI2LjY1NDQsMjEuMTM5NyAwLDE0LjkxODUgNi4zMTc4LDI4LjQ4NTIgMTQ=
uNzA1OSw0Mi4yNzk0bC04LjczMTYsNC4xMzZjLTcuODAyNS0xNS4xNjgzLTE0LjI0NjMtMjguMD=
UxMy0xNC4yNDYzLTQ1LjQ5NjMgMC0xNC41OTk2IDExLjQ4MzEtMjguOTUyMiAzMS4yNS0yOC45N=
TIyIDE3LjUxOTcsMCAzNS4zOSw1LjkwMzYgNTAuMDkxOSw5LjE5MTJ6Ii8+DQo8L2c+DQo8dXNl=
IHhsaW5rOmhyZWY9IiNoYWxmIiB0cmFuc2Zvcm09Im1hdHJpeCgtMSAwIDAgMSA0NDMuOTM3NSA=
wKSIvPg0KPHBhdGggZD0ibTIyMS45Njg4LDUzLjEyNWwtNS4xNTYyLDkuNjU2MiA1LjE1NjIsOS=
42MjUgNS4xNTYyLTkuNjI1LTUuMTU2Mi05LjY1NjJ6bTAsMjQuMzc1bC01LjE1NjIsOS42MjUgN=
S4xNTYyLDkuNjU2MiA1LjE1NjItOS42NTYyLTUuMTU2Mi05LjYyNXoiLz4NCjxwYXRoIGQ9Im0y=
MDMuNTg3Myw3NC45NTMxbDguMTMxNSw1LjE1NjIgOC4xMDUyLTUuMTU2Mi04LjEwNTItNS4xNTY=
yLTguMTMxNSw1LjE1NjJ6bTIwLjUyNjIsMGw4LjEwNTIsNS4xNTYyIDguMTMxNS01LjE1NjItOC=
4xMzE1LTUuMTU2Mi04LjEwNTIsNS4xNTYyeiIvPg0KPGNpcmNsZSBjeD0iMjIxLjk2OSIgY3k9I=
jc1LjA2OSIgcj0iMy45MDYiLz4NCjxjaXJjbGUgY3g9IjIyMS45NjkiIGN5PSIxMDAiIHI9IjEw=
LjQ1NSIvPg0KPHBhdGggZmlsbD0ibm9uZSIgc3Ryb2tlLXdpZHRoPSIxLjUiIGQ9Im0yMTkuMzQ=
zOCw4OS44NzVjMCwzLjExNDQtLjAyMjEsNC45MjQxLS4wMzEyLDYuNjI1LTIuNTIwNCwuMTExOS=
01LjAwNTcsLjM3NjctNy40Mzc1LC43ODEybTIwLjE4NzUsMGMtMi40MzE4LS40MDQ1LTQuOTE3M=
S0uNjY5NC03LjQzNzUtLjc4MTJ2LTYuNjI1bS0xMi43ODEyLDEyLjY4NzVjMy4yOTQ3LS41NTAz=
IDYuNjc0MS0uODQzOCAxMC4xMjUtLjg0MzhzNi44MzAzLC4yOTM0IDEwLjEyNSwuODQzOCIvPg0=
KPHBhdGggZD0ibTIxMS43NSwxMTcuNjg3NWMtLjk5MTksMTcuMDgyMi0zLjAwODYsMzQuNDc5Mi=
05LjY1NjIsNDcuMTI1bDEwLjgxMjUtNC4zNzVjMy43NzY1LTE0LjMyODggNC41Njk4LTMyLjg0M=
jYgNS43MTg4LTQxLjU5MzhsLTYuODc1LTEuMTU2MnptMjAuNDM3NSwwbC02Ljg3NSwxLjE1NjJj=
MS4xNDg5LDguNzUxMiAxLjk0MjMsMjcuMjY1IDUuNzE4OCw0MS41OTM4bDEwLjgxMjUsNC4zNzV=
jLTYuNjQ3Ny0xMi42NDU4LTguNjY0NC0zMC4wNDI4LTkuNjU2Mi00Ny4xMjV6Ii8+DQo8cGF0aC=
BkPSJtMjIxLjk1MzEsMTU0LjY4NzVjLTEyLjkxMzQsMC0yMi4zOTkxLDYuMDg2Ni0yMi45Njg4L=
DIxLjU5MzgtMy4xNTY3LTUuNTU0OS0xNi41MTAyLTIzLjAyNTctMjguOTY4OC0yMC42ODc1LTcu=
NDA5OSwxLjM5MDctMTMuOTU3MSwxMS42NjU5LTEyLjg0MzgsMjMuNDM3NS02LjEzNDktMTcuNjI=
5OS0yNC4xMDY4LTIwLjUxOS0zNy4yMTg4LTEwLjA5MzggMTEuNjQyMiw5LjU3MjUgMTYuODIxMS=
wzNy44MzQ3IDI2LjYyNSw1MC4wOTM4aDc1LjM3NSA3NS4zNzVjOS44MDM5LTEyLjI1OSAxNS4wM=
TQxLTQwLjUyMTIgMjYuNjU2Mi01MC4wOTM4LTEzLjExMi0xMC40MjUzLTMxLjA4MzktNy41MzYx=
LTM3LjIxODgsMTAuMDkzOCAxLjExMzMtMTEuNzcxNi01LjQ2NTEtMjIuMDQ2OC0xMi44NzUtMjM=
uNDM3NS0xMi40NTg2LTIuMzM4Mi0yNS43ODA4LDE1LjEzMjYtMjguOTM3NSwyMC42ODc1LS41Nj=
k2LTE1LjUwNzEtMTAuMDg2Ni0yMS41OTM4LTIzLTIxLjU5Mzh6Ii8+DQo8L2c+DQo8ZyBzdHJva=
2Utd2lkdGg9IjEuNSI+DQo8cGF0aCBmaWxsPSIjMDAwIiBkPSJtMjk3LjEwNjYsMjE5LjAyNTdj=
MCw1LjU4MDktMzMuNjYxOCwxMS43MTg3LTc1LjEzNzksMTEuNzE4Ny00MS40NzYxLDAtNzUuMTM=
3OS02LjEzNzgtNzUuMTM3OS0xMS43MTg3IDAtNS41ODA5IDMzLjY2MTgtOC41MDE4IDc1LjEzNz=
ktOC41MDE4IDQxLjQ3NjEsMCA3NS4xMzc5LDIuOTIxIDc1LjEzNzksOC41MDE4eiIvPg0KPGNpc=
mNsZSBjeD0iMjIxLjk2OSIgY3k9IjExNC40NDUiIHI9IjMuNTA0Ii8+DQo8Y2lyY2xlIGN4PSIy=
MjEuOTY5IiBjeT0iMTIyLjAyNyIgcj0iMy43MzQiLz4NCjxjaXJjbGUgY3g9IjIyMS45NjkiIGN=
5PSIxMzAuMTg0IiByPSI0LjA3OSIvPg0KPGNpcmNsZSBjeD0iMjIxLjk2OSIgY3k9IjEzOS4yNj=
EiIHI9IjQuNjUzIi8+DQo8Y2lyY2xlIGN4PSIyMjEuOTY5IiBjeT0iMTQ5LjM3MSIgcj0iNS4xM=
TMiLz4NCjxwYXRoIGZpbGw9IiMwMDAiIHN0cm9rZT0ibm9uZSIgZD0ibTIxOS45Mzc1LDE1OS4y=
MDU5Yy0uNTUzLS4wMDY5LTEuMDc1OSwuNDU5LS45Mzc1LDEuMzQzOCAuMTYzLDEuMDQzNSAuMzY=
3MSwyLjk5NTIgLjU2MjUsNC4zMTI1IC4yMjA5LDEuNDkzMiAxLjA5MTIsMS4xMzAyIDEuMzEyNS=
0uMDMxMiAuMjIxMy0xLjE2MSAuMTMyMS0xLjkwNTkgLjE4NzUtNC4wNjI1IC4wMjc3LTEuMDc4M=
S0uNTcyLTEuNTU1Ni0xLjEyNS0xLjU2MjV6bTQuMDYyNSwwYy0uNTUzLC4wMDY5LTEuMTUyNywu=
NDg0NC0xLjEyNSwxLjU2MjUgLjA1NTQsMi4xNTY2LS4wMzM4LDIuOTAxNSAuMTg3NSw0LjA2MjU=
gLjIyMTMsMS4xNjE1IDEuMDkxNiwxLjUyNDQgMS4zMTI1LC4wMzEyIC4xOTU0LTEuMzE3MyAuMz=
k5Ni0zLjI2OSAuNTYyNS00LjMxMjUgLjEzODQtLjg4NDctLjM4NDUtMS4zNTA2LS45Mzc1LTEuM=
zQzOHptLTcuNjg3NSwuNTYyNWMtLjUwNTgsLjA3MDQtMS4wMzAzLC41ODA1LTEsMS4xMjUgLjA1=
NSwuOTk1MiAuMzMwNCwyLjE4ODkgLjQzNzUsMy42ODc1IC4xMTA0LDEuNTQ4MiAxLjIwMTcsLjk=
0NjggMS4zMTI1LC4wNjI1IC4xMTA0LS44ODQ3IC4yMzU0LTIuMTkyMiAuMTI1LTMuOTA2Mi0uMD=
QxNC0uNjQyOS0uMzIyMi0uOTI1Ni0uNjU2Mi0uOTY4OC0uMDY5Ni0uMDA5LS4xNDY1LS4wMTAxL=
S4yMTg4LDB6bTExLjA5MzgsMGMtLjMzNCwuMDQzMS0uNjE0OCwuMzI1OC0uNjU2MiwuOTY4OC0u=
MTEwNCwxLjcxNCAuMDE0NiwzLjAyMTUgLjEyNSwzLjkwNjIgLjExMDgsLjg4NDMgMS4yMDIxLDE=
uNDg1NyAxLjMxMjUtLjA2MjUgLjEwNzEtMS40OTg2IC4zODI1LTIuNjkyMyAuNDM3NS0zLjY4Nz=
UgLjAzMDMtLjU0NDUtLjQ5NDEtMS4wNTQ2LTEtMS4xMjUtLjA3MjMtLjAxMDEtLjE0OTEtLjAwO=
S0uMjE4OCwwem0tMTUuNDM3NSwxLjc1Yy0uNDYzMSwuMTE5Ny0uODg4NCwuNjc2Ni0uNzUsMS4z=
MTI1IC4yNzYzLDEuMjcxOSAuNTMxMiwyLjY3ODEgLjUzMTIsMy45Njg4IDAsMS4xMDYgLjk0NDY=
sLjcxMTQgMS0uMDYyNSAuMDU1LS43NzQzIC4xNTYyLTIuNDEzNSAuMTU2Mi0zLjkwNjIgMC0xLj=
ExNDYtLjQ3NDQtMS40MzIyLS45Mzc1LTEuMzEyNXptMTkuNjg3NSwwYy0uMzI4OCwuMDkxMS0uN=
jI1LC40NzY2LS42MjUsMS4zMTI1IDAsMS40OTI4IC4xMDEyLDMuMTMyIC4xNTYyLDMuOTA2MiAu=
MDU1NCwuNzczOSAxLDEuMTY4NSAxLC4wNjI1IDAtMS4yOTA2IC4yNTUtMi42OTY5IC41MzEyLTM=
uOTY4OCAuMTM4NC0uNjM1OS0uMjg2OS0xLjE5MjgtLjc1LTEuMzEyNS0uMTE1OC0uMDI5OS0uMj=
AyOS0uMDMwNC0uMzEyNSwwem0tNTkuMDkzOCwuMTcxYy0uNTU0MS0uMDE4NC0uOTQyOCwuNzMzM=
i0uNTYyNSwxLjU2MjUgLjYwOCwxLjMyNzMgMS4yNTQxLDIuMTY0NyAxLjg3NSwzLjU5MzggLjU1=
MywxLjI3MTkgMS40MDEzLC40Nzg5IDEuMTI1LS40MDYyLS4yNzY3LS44ODQ3LS41NzY5LTEuODc=
wMS0xLjQwNjItMy43NS0uMzExMS0uNzA1MS0uNjk4OC0uOTg4OS0xLjAzMTItMXptOTguODEyNS=
wwYy0uMzMyNCwuMDExMS0uNzIwMSwuMjk0OS0xLjAzMTIsMS0uODI5MywxLjg3OTktMS4xMjk1L=
DIuODY1My0xLjQwNjIsMy43NS0uMjc2MywuODg1MSAuNTcyLDEuNjc4MSAxLjEyNSwuNDA2MiAu=
NjIwOS0xLjQyOSAxLjI2Ny0yLjI2NjQgMS44NzUtMy41OTM4IC4zODAzLS44MjkzLS4wMDg0LTE=
uNTgwOS0uNTYyNS0xLjU2MjV6bS05NC44MTI1LC4wNjI1Yy0uNDA3OCwuMTI0NS0uNjU1LC42ND=
E4LS40MDYyLDEuMjUgLjQ5OCwxLjIxNjUgMS4yMTY2LDIuNDYzNSAxLjcxODgsMy43ODEyIC40N=
DIyLDEuMTYxIDEuNDI1OSwuODMxOSAxLjA5MzgtLjIxODgtLjMzMTctMS4wNTA2LS40MzAzLTEu=
NjY1NS0xLjA5MzgtMy42NTYyLS4zMzE5LS45OTUyLS45MDQ3LTEuMjgwNy0xLjMxMjUtMS4xNTY=
yem05MC41LDBjLS4zNDg3LC4wNzQ1LS43NTExLC40MDk5LTEsMS4xNTYyLS42NjM1LDEuOTkwNy=
0uNzYyLDIuNjA1Ny0xLjA5MzgsMy42NTYyLS4zMzIxLDEuMDUwNiAuNjUxNiwxLjM3OTggMS4wO=
TM4LC4yMTg4IC41MDIyLTEuMzE3NyAxLjIyMDctMi41NjQ4IDEuNzE4OC0zLjc4MTIgLjI0ODgt=
LjYwODIgLjAwMTYtMS4xMjU1LS40MDYyLTEuMjUtLjEwMi0uMDMxMS0uMTk2My0uMDI0OC0uMzE=
yNSwwem0tODUuNSwuOTY4OGMtLjUxNDEsLjA5NzgtLjkxMjMsLjg4MjItLjU2MjUsMS44NDM4IC=
40NDI2LDEuMjE2NSAxLjA3MiwyLjM2NzcgMS42MjUsMy43NSAuNTUzLDEuMzgyMyAxLjQ3MTMsM=
S4xMDM1IDEuMjUsLjIxODgtLjIyMTMtLjg4NDctLjQ5MjQtMi4zNTA5LTEuMTU2Mi00LjU2MjUt=
LjI5MDItLjk2NzgtLjc1NjQtMS4zMjYxLTEuMTU2Mi0xLjI1em04MC44MTI1LDBjLS4zOTk5LS4=
wNzYxLS44NjYsLjI4MjItMS4xNTYyLDEuMjUtLjY2MzksMi4yMTE2LS45MzUsMy42Nzc4LTEuMT=
U2Miw0LjU2MjUtLjIyMTMsLjg4NDcgLjY5NywxLjE2MzYgMS4yNS0uMjE4OCAuNTUzLTEuMzgyM=
yAxLjE4MjQtMi41MzM1IDEuNjI1LTMuNzUgLjM0OTctLjk2MTYtLjA0ODQtMS43NDU5LS41NjI1=
LTEuODQzOHptLTkzLjE4NzUsLjY4NzVjLS41NTY5LC4wNTY5LTEuMDY0MSwuOTY1Mi0uNzE4OCw=
xLjY1NjIgLjU1MzQsMS4xMDYgLjkwMzcsMS40ODIzIDEuNDM3NSwyLjY1NjIgLjU1MywxLjIxNj=
UgMS4xNTg4LC4yNzQzIC45Mzc1LS41LS4yMjEzLS43NzQzLS41MDQ5LTEuNjc1Ny0uNzgxMi0yL=
jc4MTItLjIwMjUtLjgxLS41NDA5LTEuMDY1NC0uODc1LTEuMDMxMnptMTA1LjU2MjUsMGMtLjMz=
NDEtLjAzNDEtLjY3MjUsLjIyMTMtLjg3NSwxLjAzMTItLjI3NjMsMS4xMDU2LS41NiwyLjAwNy0=
uNzgxMiwyLjc4MTItLjIyMTMsLjc3NDMgLjM4NDUsMS43MTY1IC45Mzc1LC41IC41MzM4LTEuMT=
czOSAuODg0MS0xLjU1MDIgMS40Mzc1LTIuNjU2MiAuMzQ1NC0uNjkxLS4xNjE5LTEuNTk5NC0uN=
zE4OC0xLjY1NjJ6bS02Ny4wMzEyLDIuNzk3OGMtLjU4MzgtLjAwMDUtMS4yMDczLC43NzQ0LTEs=
MS41IC4zMzE3LDEuMTYxNSAuODQ0NSwyLjE5MSAxLjIxODgsMy42ODc1IC4zMzE3LDEuMzI2OSA=
xLjI3NDIsLjY2NiAxLjIxODgtLjIxODgtLjA1NTQtLjg4NDctLjIwNy0yLjA4ODQtLjU5MzgtMy=
45Njg4LS4xNDUyLS43MDUtLjQ5MzUtLjk5OTctLjg0MzgtMXptMjguNSwwYy0uMzUwMywuMDAwM=
y0uNjk4NiwuMjk1LS44NDM4LDEtLjM4NjgsMS44ODAzLS41MzgzLDMuMDg0LS41OTM4LDMuOTY4=
OC0uMDU1NCwuODg0NyAuODg3LDEuNTQ1NyAxLjIxODgsLjIxODggLjM3NDItMS40OTY1IC44ODc=
tMi41MjYgMS4yMTg4LTMuNjg3NSAuMjA3My0uNzI1Ni0uNDE2Mi0xLjUwMDUtMS0xLjV6bS0xNC=
4yNSwxLjE4NzVjLS43MTkyLDAtLjgxODUsLjk2NTYtLjg0MzgsMS43NS0uMDgyNywyLjU3MTMtM=
S4xNDk4LDUuMDY4NS0yLjA2MjUsNi4zMTI1LS45MTIyLDEuMjQ0NC0yLjI1NTYsLjkxMzUtMy41=
LC4yNS0xLjI0NDQtLjY2MzQtMS45ODU2LTEuMTYwNy0zLjMxMjUtMi4xNTYyLTEuMzI3My0uOTk=
1MS0yLjMzMzYtLjQxMzMtLjc1LDEuODQzOCA0LjYxNzUsNi41ODAzIDkuNjI1LDEyLjIwNDggOS=
42MjUsMjIuOTM3NSAwLDEuMzg3NyAuMjQyNSwxLjgxMjUgLjg0MzgsMS44MTI1cy44NzUtLjQyN=
DggLjg3NS0xLjgxMjVjMC0xMC43MzI3IDQuOTc2My0xNi4zNTcyIDkuNTkzOC0yMi45Mzc1IDEu=
NTgzNi0yLjI1NyAuNTc3My0yLjgzODktLjc1LTEuODQzOC0xLjMyNjksLjk5NTYtMi4wNjgxLDE=
uNDkyOC0zLjMxMjUsMi4xNTYyLTEuMjQ0NCwuNjYzNS0yLjU4NzcsLjk5NDQtMy41LS4yNS0uOT=
EyNy0xLjI0NC0xLjk3OTgtMy43NDEyLTIuMDYyNS02LjMxMjUtLjAyNTItLjc4NDQtLjEyNDUtM=
S43NS0uODQzOC0xLjc1em0tMzUuMjgxMi0xLjYxMDNjLS4wNjI5LS4wMDE3LS4xMzE1LC4wMTM2=
LS4xODc1LC4wMzEyLS4yNjg2LC4wODQ2LS40NDc1LC40MDg4LS4zNDM4LC45Njg4IC4xODU1LDE=
uMDAyMyAuODgsMi45NjY1IDEuMTU2MiwzLjkwNjIgLjI3NjcsLjk0MDIgMS40MzI1LC43NDAyID=
EuMTU2Mi0uNTMxMi0uMjc2Ny0xLjI3MTktLjI2Mi0xLjY1Ni0uNTkzOC0zLjA5MzgtLjE4MTQtL=
jc4NjMtLjc0Ny0xLjI2OTItMS4xODc1LTEuMjgxMnptNzAuNTYyNSwwYy0uNDQwNSwuMDEyMS0x=
LjAwNjEsLjQ5NS0xLjE4NzUsMS4yODEyLS4zMzE3LDEuNDM3Ny0uMzE3LDEuODIxOS0uNTkzOCw=
zLjA5MzgtLjI3NjMsMS4yNzE1IC44Nzk1LDEuNDcxNCAxLjE1NjIsLjUzMTIgLjI3NjMtLjkzOT=
cgLjk3MDgtMi45MDQgMS4xNTYyLTMuOTA2MiAuMTAzOC0uNTU5OS0uMDc1Mi0uODg0MS0uMzQzO=
C0uOTY4OC0uMDU2LS4wMTc2LS4xMjQ2LS4wMzMtLjE4NzUtLjAzMTJ6bS05MS41MzEyLC40MDYy=
Yy0uNTc4OCwuMDQ1My0uOTkzOSwuNzcyNS0uNDA2MiwxLjg0MzggLjYzMzksMS4xNTY5IDEuNzI=
xMiwyLjYwODIgMi4yMTg4LDMuNDM3NSAuNDk3NiwuODI5MyAxLjM1ODQsLjI2OTggLjc1LS43OD=
EyLS42MDgtMS4wNTA2LS44MTI0LTIuMjU3Mi0xLjUzMTItMy43NS0uMjY5Ni0uNTU5OS0uNjg0L=
S43NzcyLTEuMDMxMi0uNzV6bTExMi41LDBjLS4zNDczLS4wMjcyLS43NjE3LC4xOTAxLTEuMDMx=
MiwuNzUtLjcxODksMS40OTI4LS45MjMyLDIuNjk5NC0xLjUzMTIsMy43NS0uNjA4NCwxLjA1MSA=
uMjUyNCwxLjYxMDYgLjc1LC43ODEyIC40OTc2LS44MjkzIDEuNTg0OS0yLjI4MDYgMi4yMTg4LT=
MuNDM3NSAuNTg3Ni0xLjA3MTMgLjE3MjUtMS43OTg0LS40MDYyLTEuODQzOHptLTE0NC4xODc1L=
DMuMzI5Yy0uNjY3OC0uMDM1NS0uODc3MiwxLjE3MDMtLjI1LDEuOTY4OCAuOTEyNywxLjE2MSAx=
LjU0NzgsMS43NzY5IDIuNTkzOCwyLjcxODggLjgyOTcsLjc0NjQgMS4wNzA5LS4yMjI0IC42NTY=
yLS45Njg4LS40MTQ2LS43NDY0LTEuMDE0NC0xLjUwNTYtMS44NDM4LTIuNzUtLjQ1NDYtLjY4Mi=
0uODUyNy0uOTUyNi0xLjE1NjItLjk2ODh6bTE3NS44NzUsMGMtLjMwMzUsLjAxNjEtLjcwMTYsL=
jI4NjctMS4xNTYyLC45Njg4LS44MjkzLDEuMjQ0NC0xLjQyOTEsMi4wMDM2LTEuODQzOCwyLjc1=
LS40MTQ3LC43NDY0LS4xNzM1LDEuNzE1MSAuNjU2MiwuOTY4OCAxLjA0Ni0uOTQxOCAxLjY4MTE=
tMS41NTc3IDIuNTkzOC0yLjcxODggLjYyNzItLjc5ODUgLjQxNzgtMi4wMDQyLS4yNS0xLjk2OD=
h6bS0xNzAuODQzOCwxYy0uNTMyMiwuMDA2OS0uODgzNCwuNC0uNDY4OCwxLjMxMjUgLjU5MzksM=
S4zMDYxIDEuMzc3LDIuNzg1NyAxLjg3NSwzLjc4MTIgLjQ5NzYsLjk5NTIgMi4wMTQzLDEuMzI5=
NCAxLjQwNjItLjIxODgtLjYwODQtMS41NDgyLS43MjgyLTIuMzQzNS0xLjI4MTItMy43ODEyLS4=
yNzY1LS43MTg5LS45OTktMS4xMDA3LTEuNTMxMi0xLjA5Mzh6bTE2NS44MTI1LDBjLS41MzIyLS=
4wMDY5LTEuMjU0OCwuMzc0OS0xLjUzMTIsMS4wOTM4LS41NTMsMS40Mzc3LS42NzI4LDIuMjMzM=
S0xLjI4MTIsMy43ODEyLS42MDgsMS41NDgyIC45MDg3LDEuMjEzOSAxLjQwNjIsLjIxODggLjQ5=
OC0uOTk1NiAxLjI4MTEtMi40NzUyIDEuODc1LTMuNzgxMiAuNDE0Ni0uOTEyNSAuMDYzNS0xLjM=
wNTYtLjQ2ODgtMS4zMTI1em0tMTc1LjU2MjUsLjM0MzhjLS43NzM4LC4wMDc5LS44NDA0LC43OD=
M3LS4xNTYyLDEuMjgxMiAuOTEyNywuNjYzNSAyLjAwMDIsMS4zOTk4IDMuMDYyNSwyLjI1IDEuM=
jQ0LC45OTUyIDEuNzI1OSwuMDc5NyAxLjA2MjUtLjc1LS42NjM0LS44MjkzLTEuMzA5Ny0xLjY3=
MDMtMi45Njg4LTIuNS0uNDE0Ny0uMjA3My0uNzQyMS0uMjgzOS0xLS4yODEyem0xODUuMzEyNSw=
wYy0uMjU3OS0uMDAyNi0uNTg1MiwuMDczOS0xLC4yODEyLTEuNjU5LC44Mjk3LTIuMzA1MywxLj=
Y3MDctMi45Njg4LDIuNS0uNjYzNCwuODI5Ny0uMTgxNSwxLjc0NTIgMS4wNjI1LC43NSAxLjA2M=
jMtLjg1MDIgMi4xNDk4LTEuNTg2NSAzLjA2MjUtMi4yNSAuNjg0Mi0uNDk3NiAuNjE3NS0xLjI3=
MzMtLjE1NjItMS4yODEyem0tMTA5LjY1NjIsLjcxODhjLS40MzMsLjA2MDYtLjgwNjQsLjU1MjM=
tLjYyNSwxLjE4NzUgLjMzMTcsMS4xNjEgLjcwODMsMi4zOTE0IC45Mzc1LDMuNTkzOCAuMjIxMy=
wxLjE2MTUgMS41NjUsMS4xNzU2IDEuMzQzOCwuMTI1LS4yMjA5LTEuMDUwNi0uMzMyLTIuMzY1M=
S0uNzE4OC0zLjk2ODgtLjE0NTItLjYwMTMtLjQ0ODMtLjg5MDItLjc1LS45Mzc1LS4wNjI4LS4w=
MDk4LS4xMjU3LS4wMDg2LS4xODc1LDB6bTMzLjgxMjUsMGMtLjMwMTcsLjA0NzMtLjYwNDgsLjM=
zNjItLjc1LC45Mzc1LS4zODY3LDEuNjAzNi0uNDk3OSwyLjkxODItLjcxODgsMy45Njg4LS4yMj=
EzLDEuMDUwNiAxLjEyMjUsMS4wMzY1IDEuMzQzOC0uMTI1IC4yMjkyLTEuMjAyMyAuNjA1OC0yL=
jQzMjcgLjkzNzUtMy41OTM4IC4xODE0LS42MzUyLS4xOTItMS4xMjY5LS42MjUtMS4xODc1LS4w=
NjE4LS4wMDg2LS4xMjQ2LS4wMDk4LS4xODc1LDB6bS02My45MDYyLTEuOTg1M2MtLjM0LC4wOTQ=
tLjUzNTYsLjc0NC0uMjgxMiwxLjY1NjIgMS40MTAyLDUuMDU5NiAxLjg0MjUsNy43MjQ0IDEuNT=
kzOCw4Ljk2ODgtLjI0ODgsMS4yNDQtLjkzMTUsMS40MTQ2LTEuODQzOCwxLS45MTIyLS40MTQ2L=
TEuOTgzMi0xLjAxMzItMi44MTI1LTEuNTkzOC0uODI5My0uNTgwOS0xLjY5MTksLjExNC0uNSwx=
LjA5MzggNi4wNTQ4LDQuOTc2NyAxMC4yNTE4LDEwLjY2NDIgMTEuODc1LDE3LjU2MjUgLjMzMTc=
sMS40MDk5IDEuMjE3NSwxLjU3NTcgLjk2ODgsMC0xLjM3MjMtOC42ODk4LTEuNjM2Mi0xNS44Mz=
M0IC40Mzc1LTIwLjMxMjUgLjc3OTMtMS42ODMyLS4wMDU2LTMuMjk5Ni0xLjI1LS41NjI1LS44M=
jkzLDEuODI0OS0yLjE3MTUsMi41NDQ5LTMuMjUsLjk2ODgtMS4wNzgxLTEuNTc1Ny0zLjMwNTMt=
NS43Nzk3LTMuOTY4OC03LjY4NzUtLjI0ODktLjcxNTQtLjU1Ni0xLjA0NjQtLjgxMjUtMS4wOTM=
4LS4wNTM0LS4wMDk5LS4xMDc3LS4wMTM0LS4xNTYyLDB6bTk0LjAzMTIsMGMtLjI1NjUsLjA0Nz=
MtLjU2MzYsLjM3ODMtLjgxMjUsMS4wOTM4LS42NjM0LDEuOTA3OC0yLjg5MDYsNi4xMTE4LTMuO=
TY4OCw3LjY4NzUtMS4wNzg1LDEuNTc2MS0yLjQyMDcsLjg1NjItMy4yNS0uOTY4OC0xLjI0NDQt=
Mi43MzcxLTIuMDI5My0xLjEyMDctMS4yNSwuNTYyNSAyLjA3MzcsNC40NzkxIDEuODA5OCwxMS4=
2MjI3IC40Mzc1LDIwLjMxMjUtLjI0ODgsMS41NzU3IC42MzcsMS40MDk5IC45Njg4LDAgMS42Mj=
MyLTYuODk4MyA1LjgyMDItMTIuNTg1OCAxMS44NzUtMTcuNTYyNSAxLjE5MTktLjk3OTcgLjMyO=
TMtMS42NzQ3LS41LTEuMDkzOC0uODI5MywuNTgwNS0xLjkwMDMsMS4xNzkxLTIuODEyNSwxLjU5=
MzgtLjkxMjIsLjQxNDYtMS41OTUsLjI0NC0xLjg0MzgtMS0uMjQ4OC0xLjI0NDQgLjE4MzUtMy4=
5MDkxIDEuNTkzOC04Ljk2ODggLjI1NDMtLjkxMjMgLjA1ODctMS41NjIzLS4yODEyLTEuNjU2Mi=
0uMDQ4Ni0uMDEzNC0uMTAyOC0uMDA5OS0uMTU2Miwwem0tMTI0LjQ2ODgsMi40MjI4Yy0uNTQ2M=
SwuMDA2OS0uOTk4OCwuMzg5NC0uNzUsMS4yMTg4IC4zOTg4LDEuMzI4NiAxLjIyMzcsMi43NjQ0=
IDEuNSwzLjU5MzggLjI3NjcsLjgyOTMgMS4xNjU5LC40NDIzIDEtLjcxODgtLjE2NTgtMS4xNjE=
tLjI0NzUtMS44NTMxLS40Njg4LTMuMTI1LS4xMTA2LS42MzU3LS43MzUyLS45NzU3LTEuMjgxMi=
0uOTY4OHptMTU1LjA2MjUsMGMtLjU0NjEtLjAwNjktMS4xNzA2LC4zMzMtMS4yODEyLC45Njg4L=
S4yMjEzLDEuMjcxOS0uMzAyOSwxLjk2NC0uNDY4OCwzLjEyNS0uMTY1OSwxLjE2MSAuNzIzMywx=
LjU0ODEgMSwuNzE4OCAuMjc2My0uODI5MyAxLjEwMTItMi4yNjUyIDEuNS0zLjU5MzggLjI0ODg=
tLjgyOTMtLjIwMzktMS4yMTE4LS43NS0xLjIxODh6bS0xMzYuMjgxMi0xLjczNTNjLS42MzUtLj=
ExNC0uNzI2MywxLjUyNDItLjE4NzUsMi4xODc1IC43MTg5LC44ODUyIDEuNzE3MywxLjk1NDggM=
i43MTg4LDMuMTU2MiAuODI5MywuOTk1NiAxLjM0MTcsLjExMDYgLjg0MzgtLjcxODgtLjQ5NzYt=
LjgyOTctMS4yMzU2LTEuNzExMy0yLjU2MjUtMy44MTI1LS4zMzE4LS41MjUzLS42MDA4LS43NzQ=
1LS44MTI1LS44MTI1em0xMTcuNSwwYy0uMjExNywuMDM4LS40ODA3LC4yODcyLS44MTI1LC44MT=
I1LTEuMzI2OSwyLjEwMTItMi4wNjQ5LDIuOTgyOC0yLjU2MjUsMy44MTI1LS40OTgsLjgyOTMgL=
jAxNDQsMS43MTQzIC44NDM4LC43MTg4IDEuMDAxNC0xLjIwMTUgMS45OTk5LTIuMjcxMSAyLjcx=
ODgtMy4xNTYyIC41Mzg4LS42NjMzIC40NDc1LTIuMzAxNS0uMTg3NS0yLjE4NzV6bS0xMzIsMy4=
5NTRjLS4zOTQtLjAyNzYtLjcyODQsLjI5Mi0uNTYyNSwxLjA5MzggLjIzMTMsMS4xMTY0IC41Nj=
csMi4wNDMxIC44NDM4LDMuMDkzOCAuMjc2MywxLjA1MDYgMSwuODcwNiAxLS4xMjUgMC0uOTk1M=
i0uMTc3OS0yLjEwNTYtLjM0MzgtMy4xNTYyLS4wODI5LS41MjUzLS41NDM1LS44Nzg2LS45Mzc1=
LS45MDYyem0xNDYuNSwwYy0uMzk0LC4wMjc3LS44NTQ2LC4zODEtLjkzNzUsLjkwNjItLjE2NTk=
sMS4wNTA2LS4zNDM4LDIuMTYxMS0uMzQzOCwzLjE1NjIgMCwuOTk1NiAuNzIzNywxLjE3NTYgMS=
wuMTI1IC4yNzY3LTEuMDUwNiAuNjEyNS0xLjk3NzMgLjg0MzgtMy4wOTM4IC4xNjU5LS44MDE4L=
S4xNjg1LTEuMTIxNC0uNTYyNS0xLjA5Mzh6bS0xMzMuNDA2MiwxLjQyMWMtLjYxODksLjA5MzUt=
MS4xNjM0LC42OTE4LS40Mzc1LDEuNjI1IDEuMTYxMSwxLjQ5MjggMi40MzI0LDIuNTQwNyAyLjg=
3NSwzLjA5MzggLjQ0MjIsLjU1MyAxLjU2MjYsLjM0OSAuODQzOC0uODEyNS0uNzM0Ny0xLjE4Nj=
UtMS44NDYyLTIuNjE1My0yLjM0MzgtMy41LS4xODY2LS4zMzE4LS41NjYyLS40NjIzLS45Mzc1L=
S40MDYyem0xMjAuMDYyNSwwYy0uMjcyMiwuMDI4Ni0uNTQ3NiwuMTU3NC0uNjg3NSwuNDA2Mi0u=
NDk3NiwuODg0Ny0xLjYwOTEsMi4zMTM1LTIuMzQzOCwzLjUtLjcxODksMS4xNjE1IC40MDE2LDE=
uMzY1NSAuODQzOCwuODEyNSAuNDQyNi0uNTUzIDEuNzEzOS0xLjYwMSAyLjg3NS0zLjA5MzggLj=
cyNTktLjkzMzIgLjE4MTQtMS41MzE1LS40Mzc1LTEuNjI1LS4wOTI4LS4wMTQtLjE1OTMtLjAwO=
TUtLjI1LDB6bS0xNDAuNzE4OCw0LjE3MjhjLS40ODgzLS4wNDQzLS42NTY5LC4zNDk2IDAsMS4y=
NSAxLjQ5MjgsMi4wNDU4IDMuMTM5Niw1LjE0MTkgMy4yNSw2LjQ2ODggLjExMDksMS4zMjczLS4=
1NDUzLDEuMzEyNS0xLjE1NjIsMS4zMTI1LTEuODI0OSwwLTIuNzE2NC0xLjMzMi00LjM3NS0xLj=
cxODgtMS42NTktLjM4NzEtMS44OTk4LC40ODUzLS43MTg4LDEuMzQzOCA2LjA4MjMsNC40MjM3I=
DEyLjE3ODgsOS4zNTkyIDE0LjYyNSwxMy44NDM4IC45OTUyLDEuODI0OSAyLjM0MDYsMi40OTIg=
MS41OTM4LC43NS0yLjI4NzEtNS4zMzcyLTIuODQxMy05Ljg1NjYtMi4zNDM4LTEyLjU5MzggLjQ=
5OC0yLjczNzEgMS4xNzY3LTQuNTgwMiAxLjA5MzgtNi4xNTYyLS4wODI5LTEuNTc1Ny0uOTc2Ni=
0xLjQ2ODItMS4zNDM4LDAtLjI0ODgsLjk5NTYtLjczMDgsMi4zMTQ1LTEuMDYyNSwyLjgxMjUtL=
jMzMTcsLjQ5NzYtMS42NjU2LC43NzY1LTIuOTM3NS0uOTM3NS0xLjI3MTktMS43MTQtNC40ODA2=
LTUuMDE0NC01LjUzMTItNS44NDM4LS4zOTQtLjMxMS0uODAwOC0uNTA0Ni0xLjA5MzgtLjUzMTJ=
6bTE2MS42MjUsMGMtLjI5MywuMDI2Ni0uNjk5OCwuMjIwMy0xLjA5MzgsLjUzMTItMS4wNTA2LC=
44MjkzLTQuMjU5NCw0LjEyOTctNS41MzEyLDUuODQzOC0xLjI3MTksMS43MTQtMi42MDU4LDEuN=
DM1MS0yLjkzNzUsLjkzNzUtLjMzMTctLjQ5OC0uODEzNy0xLjgxNjktMS4wNjI1LTIuODEyNS0u=
MzY3MS0xLjQ2ODItMS4yNjA4LTEuNTc1Ny0xLjM0MzgsMC0uMDgyOSwxLjU3NjEgLjU5NTgsMy4=
0MTkxIDEuMDkzOCw2LjE1NjIgLjQ5NzYsMi43MzcxLS4wNTY3LDcuMjU2Ni0yLjM0MzgsMTIuNT=
kzOC0uNzQ2OCwxLjc0MiAuNTk4NiwxLjA3NDkgMS41OTM4LS43NSAyLjQ0NjMtNC40ODQ1IDguN=
TQyNy05LjQyMDEgMTQuNjI1LTEzLjg0MzggMS4xODEtLjg1ODUgLjk0MDMtMS43MzA5LS43MTg4=
LTEuMzQzOC0xLjY1ODYsLjM4NjctMi41NTAxLDEuNzE4OC00LjM3NSwxLjcxODgtLjYxMDksMC0=
xLjI2NzEsLjAxNDgtMS4xNTYyLTEuMzEyNSAuMTEwNC0xLjMyNjkgMS43NTcyLTQuNDIzIDMuMj=
UtNi40Njg4IC42NTY5LS45MDA0IC40ODgzLTEuMjk0MyAwLTEuMjV6Ii8+DQo8cGF0aCBkPSJtM=
TUwLjEyNjksMjEyLjY1MTEgMS45NDk3LDYuMTc0Mm0yLjA2MDgtNy4zNDQ0IDEuNzI3Niw2LjI0=
bTIuNjA0Ni02Ljk1MjQgMS4xODcsNi4zNjVtMi44MzMyLTcuMTY5MyAxLjI3MDUsNi4zNDg5bTM=
uODg1MS02Ljg1NzggMS4wMzI5LDYuMzkxOG00LjQ1MTYtNi4zODUxIDEuMTEyNCw2LjM3ODRtNC=
4yNDEzLTguMTg4OCAuODAzNSw2LjQyNDdtNC4yMzMzLTYuMDk5NyAuODAzNSw2LjQyNDdtNC4wN=
zA4LTcuMDc0NiAuODAzNSw2LjQyNDdtNC4wODkxLTYuOTI5NiAuNDQyLDYuNDU5Nm00Ljc4NjYt=
Ni40NjE1IC4zODM1LDYuNDYzM200LjM1NjgtNi43ODk5IC4zMjY2LDYuNDY2NW00LjkwMDQtNi4=
3OTI3IC4yNzEzLDYuNDY5bTUuNzQwNC02LjYzMTUgLjI3MTMsNi40NjltNzkuMDQ0MSwuMTc3NS=
0xLjk0OTcsNi4xNzQybS0yLjA2MDgtNy4zNDQ0LTEuNzI3Niw2LjI0bS0yLjYwNDYtNi45NTI0L=
TEuMTg3LDYuMzY1bS0yLjgzMzItNy4xNjkzLTEuMjcwNSw2LjM0ODltLTMuODg1MS02Ljg1Nzgt=
MS4wMzMsNi4zOTE4bS00LjQ1MTYtNi4zODUxLTEuMTEyNCw2LjM3ODRtLTQuMjQxMy04LjE4ODg=
tLjgwMzUsNi40MjQ3bS00LjIzMzMtNi4wOTk3LS44MDM1LDYuNDI0N20tNC4wNzA4LTcuMDc0Ni=
0uODAzNSw2LjQyNDdtLTQuMDg5MS02LjkyOTYtLjQ0Miw2LjQ1OTZtLTQuNzg2Ni02LjQ2MTUtL=
jM4MzUsNi40NjMzbS00LjM1NjgtNi43ODk5LS4zMjY2LDYuNDY2NW0tNC45MDA0LTYuNzkyNy0u=
MjcxMyw2LjQ2OW0tNS43NDA0LTYuNjMxNS0uMjcxMyw2LjQ2OW0tNy4yMDIyLTYuODg5OSAwLDc=
uMTIzMiIvPg0KPC9nPg0KPC9nPg0KPC9zdmc+DQo=3D"); }

.flag-list .mk a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCA4MD=
AgNDAwIj4NCjxwYXRoIGZpbGw9IiNkMjAwMDAiIGQ9Im0wLDBoODAwdjQwMGgtODAweiIvPg0KP=
GcgZmlsbD0iI2ZmZTYwMCI+DQo8cGF0aCBkPSJNMCwwIDEyMCwwIDY4MCw0MDAgODAwLDQwMCAw=
LDB6IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwIC4wMDAwMSkiLz4NCjxwYXRoIGQ9Im0zNjAsMCA=
4MCwwLTgwLDQwMCA4MCwwLTgwLTQwMHoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgLjAwMDAxKS=
IvPg0KPHBhdGggZD0iTTY4MCwwIDgwMCwwIDAsNDAwIDEyMCw0MDAgNjgwLDB6IiB0cmFuc2Zvc=
m09InRyYW5zbGF0ZSgwIC4wMDAwMSkiLz4NCjxwYXRoIGQ9Im0wLDE2MCAwLDgwIDgwMC04MCAw=
LDgwLTgwMC04MHoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAgLjAwMDAxKSIvPg0KPC9nPg0KPGN=
pcmNsZSBmaWxsPSIjZDIwMDAwIiBjeD0iNDAwIiBjeT0iMjAwIiByPSI2MCIgdHJhbnNmb3JtPS=
JtYXRyaXgoMS4xOTA0OCAwIDAgMS4xOTA0OCAtNzYuMTkwNTIgLTM4LjA5NTI0KSIvPg0KPGNpc=
mNsZSBmaWxsPSIjZmZlNjAwIiBjeD0iNDAwIiBjeT0iMjAwIiByPSI1MCIgdHJhbnNmb3JtPSJt=
YXRyaXgoMS4xNDI4NiAwIDAgMS4xNDI4NiAtNTcuMTQyODYgLTI4LjU3MTQxKSIvPg0KPC9zdmc=
+DQo=3D"); }

.flag-list .mt a::before { background-position: left top; background-image:=
 url("data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVR=
GLTgiIHN0YW5kYWxvbmU9Im5vIj8+DQo8c3ZnIHhtbG5zOnN2Zz0iaHR0cDovL3d3dy53My5vcm=
cvMjAwMC9zdmciIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iM=
S4wIiB3aWR0aD0iOTAwIiBoZWlnaHQ9IjYwMCIgdmlld0JveD0iMCAwIDkwMCA2MDAiPg0KICA8=
ZGVmcyBpZD0iZGVmczU1MCIvPg0KICA8cmVjdCB3aWR0aD0iNDUwIiBoZWlnaHQ9IjYwMCIgeD0=
iNDUwIiB5PSIwIiBpZD0icmVjdDQiIHN0eWxlPSJmaWxsOiNjZjE0MmIiLz4NCiAgPHJlY3Qgd2=
lkdGg9IjQ1MCIgaGVpZ2h0PSI2MDAiIHg9IjAiIHk9IjAiIGlkPSJyZWN0NiIgc3R5bGU9ImZpb=
Gw6I2ZmZmZmZiIvPg0KICA8cGF0aCBkPSJtIDEwMC41MTc3MSw5MS40ODcwODYgYyAwLDAuOTg5=
OTQgLTEuMTIwMzc0LDEuNzkyNDEgLTIuNTAyNDI0LDEuNzkyNDEgLTEuMzgyMDU0LDAgLTIuNTA=
yNDE3LC0wLjgwMjQ3IC0yLjUwMjQxNywtMS43OTI0MSAwLC0wLjk4OTk0MSAxLjEyMDM3LC0xLj=
c5MjQxIDIuNTAyNDE3LC0xLjc5MjQxIDEuMzgyMDUzLDAgMi41MDI0MjQsMC44MDI0NjkgMi41M=
DI0MjQsMS43OTI0MSB6IiBpZD0icGF0aDIyODkiIHN0eWxlPSJmaWxsOiNmMWVlZWU7ZmlsbC1v=
cGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOm5vbmUiLz4NCiAgPHBhdGggZD0ibSA=
yMi4yMjIyMjMsODIuODI3NzM1IDAsNDUuNDU2Nzk1IDQ1LjQ1NDc3OSwwIGMgMCw3LjU3NDA3ID=
cuNTc2MjI1LDE1LjE1MDY2IDE1LjE1MjQ0OSwxNS4xNTA2NiBsIDAsNDUuNDU0MjggNDUuNDUyM=
jA5LDAgMCwtNDUuNDU0MjggYyA3LjU3NjIyLDAgMTUuMTUyNDUsLTcuNTc2NTkgMTUuMTUyNDUs=
LTE1LjE1MDY2IGwgNDUuNDU0NzgsMCAwLC00NS40NTY3OTUgLTQ1LjQ1NDc4LDAgYyAwLC03LjU=
3NDA3NCAtNy41NzYyMywtMTUuMTUwNjYzIC0xNS4xNTI0NSwtMTUuMTUwNjYzIGwgMCwtNDUuND=
U0Mjc2IC00NS40NTIyMDksMCAwLDQ1LjQ1NDI3NiBjIC03LjU3NjIyNCwwIC0xNS4xNTI0NDksN=
y41NzY1ODkgLTE1LjE1MjQ0OSwxNS4xNTA2NjMgbCAtNDUuNDU0Nzc5LDAgeiIgaWQ9InBhdGgy=
MjkxIiBzdHlsZT0iZm9udC1zaXplOjEycHg7ZmlsbDojZTYwZDJlO2ZpbGwtb3BhY2l0eToxO2Z=
pbGwtcnVsZTpldmVub2RkO3N0cm9rZS13aWR0aDoxcHQiLz4NCiAgPHBhdGggZD0ibSAyNS4yNT=
M1MTUsODUuODU2NTQyIDAsMzkuMzk2NjU4IDQ1LjQ1MjIxNiwwIGMgMCw3LjU3Mzg1IDcuNTc2M=
jIzLDE1LjE1MDQ0IDE1LjE1MjQ0NiwxNS4xNTA0NCBsIDAsNDUuNDU0NSAzOS4zOTIyNTMsMCAw=
LC00NS40NTQ1IGMgNy41NzYyMywwIDE1LjE1MjQ1LC03LjU3NjU5IDE1LjE1MjQ1LC0xNS4xNTA=
0NCBsIDQ1LjQ1MjIyLDAgMCwtMzkuMzk2NjU4IC00NS40NTIyMiwwIGMgMCwtNy41NzQwNzUgLT=
cuNTc2MjIsLTE1LjE1MDY2NCAtMTUuMTUyNDUsLTE1LjE1MDY2NCBsIDAsLTQ1LjQ1NDI3NiAtM=
zkuMzkyMjUzLDAgMCw0NS40NTQyNzYgYyAtNy41NzYyMjMsMCAtMTUuMTUyNDQ2LDcuNTc2NTg5=
IC0xNS4xNTI0NDYsMTUuMTUwNjY0IGwgLTQ1LjQ1MjIxNiwwIHoiIGlkPSJwYXRoMjI5NSIgc3R=
5bGU9ImZvbnQtc2l6ZToxMnB4O2ZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bG=
U6ZXZlbm9kZDtzdHJva2Utd2lkdGg6MXB0Ii8+DQogIDxwYXRoIGQ9Im0gMjYuNzY5Nzg2LDg3L=
jM3Mjc3NCAwLDM2LjM2Mzk2NiA0NS40NTIyMTQsMCBjIDAsNy41NzQwOCA3LjU3NjIyOCwxNS4x=
NTMxOCAxNS4xNTI0NTEsMTUuMTUzMTggbCAwLDQ1LjQ1NDI4IDM2LjM2MjI3OSwwIDAsLTQ1LjQ=
1NDI4IGMgNy41NzYyMiwwIDE1LjE1MjQ1LC03LjU3OTEgMTUuMTUyNDUsLTE1LjE1MzE4IGwgND=
UuNDUyMjEsMCAwLC0zNi4zNjM5NjYgLTQ1LjQ1MjIxLDAgYyAwLC03LjU3Mzg0NiAtNy41NzYyM=
ywtMTUuMTUwNDM1IC0xNS4xNTI0NSwtMTUuMTUwNDM1IGwgMCwtNDUuNDU0Mjc2IC0zNi4zNjIy=
NzksMCAwLDQ1LjQ1NDI3NiBjIC03LjU3NjIyMywwIC0xNS4xNTI0NTEsNy41NzY1ODkgLTE1LjE=
1MjQ1MSwxNS4xNTA0MzUgbCAtNDUuNDUyMjE0LDAgeiIgaWQ9InBhdGgyMjk3IiBzdHlsZT0iZm=
9udC1zaXplOjEycHg7ZmlsbDojY2NjY2NjO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub=
2RkO3N0cm9rZS13aWR0aDoxcHQiLz4NCiAgPHBhdGggZD0ibSA4NC41MzU2OTIsNzEuNjgwNTAx=
IGMgMi42NjI2MzYsMi42NjI3OCAxLjk0MzExOSw3LjY5OTM2IC0xLjYwNzA2NCwxMS4yNDk2NTc=
gLTMuNTUwMTk1LDMuNTUwMjk4IC04LjU4NjY4NSw0LjI2OTc3NiAtMTEuMjQ5MzI0LDEuNjA3Mj=
I1IC0yLjY2MjYzNCwtMi42NjI1NTIgLTEuOTQzMTE4LC03LjY5OTM2IDEuNjA3MDY1LC0xMS4yN=
Dk2NTcgMy41NTAxOTQsLTMuNTUwMDY5IDguNTg2Njg3LC00LjI2OTc3NiAxMS4yNDkzMjMsLTEu=
NjA3MjI1IHoiIGlkPSJwYXRoMjMwMSIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk=
6MTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6bm9uZSIvPg0KICA8cGF0aCBkPSJtIDcxLjE0Mz=
QxMyw3OS43MTU0ODEgMS4wNzEyMzksLTEuMDcyMjQ1IDQuMjg1NjM4LDIuMTQyMjA0IC0yLjE0M=
jk1OSwtNC4yODUzMjMgMS4wNzE0NDUsLTEuMDcyMjQ1IDQuMjg1NDY5LDguNTcxMTAyIC04LjU3=
MDgzMiwtNC4yODU1NTEgeiIgaWQ9InBhdGgyMzAzIiBzdHlsZT0iZmlsbDojZDBkMGQwO2ZpbGw=
tb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTpub25lIi8+DQogIDxyZWN0IHdpZH=
RoPSIxLjUxNTE1MiIgaGVpZ2h0PSI5LjA5MDkxMjgiIHg9IjMuMDMxMjM1OSIgeT0iMTA2LjY3M=
zA1IiB0cmFuc2Zvcm09Im1hdHJpeCgwLjcwNzA5Njc5LC0wLjcwNzExNjc4LDAuNzA3MDk2Nzks=
MC43MDcxMTY3OCwwLDApIiBpZD0icmVjdDIzMDUiIHN0eWxlPSJmb250LXNpemU6MTJweDtmaWx=
sOiNkMGQwZDA7ZmlsbC1vcGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlLXdpZHRoOj=
FwdCIvPg0KICA8cGF0aCBkPSJtIDEzOS40MzE0Niw4NC41MzY5MjYgYyAtMi42NjI2MywyLjY2M=
jc4IC03LjY5OTEyLDEuOTQzMzAxIC0xMS4yNDkzMiwtMS42MDcyMjUgLTMuNTUwMTgsLTMuNTUw=
Mjk3IC00LjI2OTcsLTguNTg2ODc3IC0xLjYwNzA2LC0xMS4yNDk2NTcgMi42NjI2MywtMi42NjI=
3OCA3LjY5OTEyLC0xLjk0MzMwMSAxMS4yNDkzMiwxLjYwNzIyNCAzLjU1MDE4LDMuNTUwMjk4ID=
QuMjY5Nyw4LjU4Njg3OCAxLjYwNzA2LDExLjI0OTY1OCB6IiBpZD0icGF0aDIzMDkiIHN0eWxlP=
SJmaWxsOiM5Njg3N2Q7ZmlsbC1vcGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOm5v=
bmUiLz4NCiAgPHBhdGggZD0ibSAxMzEuMzk2MjIsNzEuMTQ0NjA3IDEuMDcxMjEsMS4wNzIyNDU=
gLTIuMTQyNzMsNC4yODU3OCA0LjI4NTQzLC0yLjE0MjIwNCAxLjA3MTQ0LDEuMDcyMjQ1IC04Lj=
U3MDgzLDQuMjg1NTUxIDQuMjg1NDcsLTguNTcxMTAyIHoiIGlkPSJwYXRoMjMxMSIgc3R5bGU9I=
mZpbGw6I2QwZDBkMDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6bm9u=
ZSIvPg0KICA8cmVjdCB3aWR0aD0iMS41MTUxNTIiIGhlaWdodD0iOS4wOTA5MTI4IiB4PSIxNTI=
uMzA5ODgiIHk9Ii00Mi42MDY0MTEiIHRyYW5zZm9ybT0ibWF0cml4KDAuNzA3MDk2NzksMC43MD=
cxMTY3OCwtMC43MDcwOTY3OSwwLjcwNzExNjc4LDAsMCkiIGlkPSJyZWN0MjMxMyIgc3R5bGU9I=
mZvbnQtc2l6ZToxMnB4O2ZpbGw6I2QwZDBkMDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bGU6ZXZl=
bm9kZDtzdHJva2Utd2lkdGg6MXB0Ii8+DQogIDxwYXRoIGQ9Im0gMTI2LjU3NDcsMTM5LjQzNDI=
3IGMgLTIuNjYyNjMsLTIuNjYyNzggLTEuOTQzMTIsLTcuNjk5MzYgMS42MDcwNywtMTEuMjQ5Nj=
UgMy41NTAxOCwtMy41NTAzIDguNTg2NjcsLTQuMjY5NzggMTEuMjQ5MzIsLTEuNjA3MjMgMi42N=
jI2MywyLjY2MjU1IDEuOTQzMTIsNy42OTkzNiAtMS42MDcwNywxMS4yNDk0MyAtMy41NTAxOSwz=
LjU1MDMgLTguNTg2NjgsNC4yNzAwMSAtMTEuMjQ5MzIsMS42MDcyMyB6IiBpZD0icGF0aDIzMTc=
iIHN0eWxlPSJmaWxsOiM5Njg3N2Q7ZmlsbC1vcGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3=
Ryb2tlOm5vbmUiLz4NCiAgPHBhdGggZD0ibSAxMzkuOTY3MDgsMTMxLjM5OTMgLTEuMDcxMjQsM=
S4wNzIyNCAtNC4yODU2NCwtMi4xNDIyIDIuMTQyOTYsNC4yODU1NSAtMS4wNzE0NCwxLjA3MjI0=
IC00LjI4NTQ2LC04LjU3MTEgOC41NzA4Myw0LjI4NTU1IHoiIGlkPSJwYXRoMjMxOSIgc3R5bGU=
9ImZpbGw6I2QwZDBkMDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6bm=
9uZSIvPg0KICA8cmVjdCB3aWR0aD0iMS41MTUxNTIiIGhlaWdodD0iOS4wOTA5MTI4IiB4PSIzL=
jAyOTcxOTgiIHk9Ii0xOTEuODg1MDYiIHRyYW5zZm9ybT0ibWF0cml4KC0wLjcwNzA5Njc5LDAu=
NzA3MTE2NzgsLTAuNzA3MDk2NzksLTAuNzA3MTE2NzgsMCwwKSIgaWQ9InJlY3QyMzIxIiBzdHl=
sZT0iZm9udC1zaXplOjEycHg7ZmlsbDojZDBkMGQwO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZT=
pldmVub2RkO3N0cm9rZS13aWR0aDoxcHQiLz4NCiAgPHBhdGggZD0ibSA3MS42Nzg5OTEsMTI2L=
jU3Nzg1IGMgMi42NjI2MzYsLTIuNjYyNTUgNy42OTkxMjksLTEuOTQzMyAxMS4yNDkzMjEsMS42=
MDcyMiAzLjU1MDE5MiwzLjU1MDMgNC4yNjk3MDEsOC41ODY4OCAxLjYwNzA2NSwxMS4yNDk0MyA=
tMi42NjI2MzYsMi42NjI3OCAtNy42OTkxMjksMS45NDMzIC0xMS4yNDkzMjIsLTEuNjA3MjIgLT=
MuNTUwMTkyLC0zLjU1MDMgLTQuMjY5NywtOC41ODY4OCAtMS42MDcwNjQsLTExLjI0OTY2IHoiI=
GlkPSJwYXRoMjMyNSIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1=
bGU6ZXZlbm9kZDtzdHJva2U6bm9uZSIvPg0KICA8cGF0aCBkPSJtIDc5LjcxNDI1NiwxMzkuOTc=
wMTcgLTEuMDcxMjM5LC0xLjA3MjI1IDIuMTQyNzMsLTQuMjg1NzggLTQuMjg1NDIxLDIuMTQyMj=
EgLTEuMDcxNDQ1LC0xLjA3MjI1IDguNTcwODMzLC00LjI4NTU1IC00LjI4NTQ2OSw4LjU3MTEge=
iIgaWQ9InBhdGgyMzI3IiBzdHlsZT0iZmlsbDojZDBkMGQwO2ZpbGwtb3BhY2l0eToxO2ZpbGwt=
cnVsZTpldmVub2RkO3N0cm9rZTpub25lIi8+DQogIDxyZWN0IHdpZHRoPSIxLjUxNTE1MiIgaGV=
pZ2h0PSI5LjA5MDkxMjgiIHg9Ii0xNDYuMjQ4OTIiIHk9Ii00Mi42MDQ4OTMiIHRyYW5zZm9ybT=
0ibWF0cml4KC0wLjcwNzA5Njc5LC0wLjcwNzExNjc4LDAuNzA3MDk2NzksLTAuNzA3MTE2NzgsM=
CwwKSIgaWQ9InJlY3QyMzI5IiBzdHlsZT0iZm9udC1zaXplOjEycHg7ZmlsbDojZDBkMGQwO2Zp=
bGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZS13aWR0aDoxcHQiLz4NCiAgPHB=
hdGggZD0ibSAxMzcuMzczMiwxMDUuNTU2ODIgYyAwLjAwNCwxNy41NzU2NyAtMTQuMjQyNDYsMz=
EuODI1NzkgLTMxLjgxNzc5LDMxLjgyNTc5IC0xNy41NzUzMzUsMCAtMzEuODIxODI2LC0xNC4yN=
TAxMiAtMzEuODE3Nzk4LC0zMS44MjU3OSAtMC4wMDQsLTE3LjU3NTY3OCAxNC4yNDI0NjMsLTMx=
LjgyNTc5MyAzMS44MTc3ODgsLTMxLjgyNTc5MyAxNy41NzUzNCwwIDMxLjgyMTgzLDE0LjI1MDE=
xNSAzMS44MTc4LDMxLjgyNTc5MyBsIDAsMCB6IiBpZD0icGF0aDIzMzEiIHN0eWxlPSJmaWxsOm=
5vbmU7c3Ryb2tlOiM5Njg3N2Q7c3Ryb2tlLXdpZHRoOjAuNTE0NDAyNjM7c3Ryb2tlLWxpbmVjY=
XA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0=
aCBkPSJtIDEyOS43OTcxMiwxMDUuNTU3MDUgYyAwLjAwMywxMy4zOTExNyAtMTAuODUxMzQsMjQ=
uMjQ4NTEgLTI0LjI0MjAxLDI0LjI0ODUxIC0xMy4zOTA2NzUsMCAtMjQuMjQ1MDk1LC0xMC44NT=
czNCAtMjQuMjQyMDI2LC0yNC4yNDg1MSAtMC4wMDMxLC0xMy4zOTA5NTIgMTAuODUxMzUxLC0yN=
C4yNDgyOTEgMjQuMjQyMDI2LC0yNC4yNDgyOTEgMTMuMzkwNjcsMCAyNC4yNDUwOCwxMC44NTcz=
MzkgMjQuMjQyMDEsMjQuMjQ4MjkxIGwgMCwwIHoiIGlkPSJwYXRoMjMzMyIgc3R5bGU9ImZpbGw=
6bm9uZTtzdHJva2U6Izk2ODc3ZDtzdHJva2Utd2lkdGg6MC41MTQ0MDI2MztzdHJva2UtbGluZW=
NhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxIi8+DQogIDxwY=
XRoIGQ9Im0gOTQuOTQ5MTU0LDEzMS4zMTQ3IGMgOC4xNGUtNCwwLjU0MTg0IC0wLjI4Nzc5Miwx=
LjA0MjUzIC0wLjc1NjkwNSwxLjMxNDU5IC0wLjQ2OTExMywwLjI3MjA2IC0xLjA0NzMyNSwwLjI=
3MjA2IC0xLjUxNjQzOCwwIC0wLjQ2OTExMywtMC4yNzIwNiAtMC43NTc3MjcsLTAuNzcyNzUgLT=
AuNzU2OTA0LC0xLjMxNDU5IC04LjFlLTQsLTAuNTQxODMgMC4yODc3OTEsLTEuMDQyNTIgMC43N=
TY5MDQsLTEuMzE0NTggMC40NjkxMTMsLTAuMjcyMDYgMS4wNDczMjUsLTAuMjcyMDYgMS41MTY0=
MzgsMCAwLjQ2OTExMywwLjI3MjA2IDAuNzU3NzA1LDAuNzcyNzUgMC43NTY5MDUsMS4zMTQ1OCB=
sIDAsMCB6IiBpZD0icGF0aDIzMzUiIHN0eWxlPSJmaWxsOiMwMDAwMDA7ZmlsbC1vcGFjaXR5Oj=
E7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOm5vbmUiLz4NCiAgPHBhdGggZD0ibSAxMTkuMTkxM=
jIsMTMxLjMxNDcgYyA4LjFlLTQsMC41NDE4NCAtMC4yODc4LDEuMDQyNTMgLTAuNzU2OTEsMS4z=
MTQ1OSAtMC40NjkxMSwwLjI3MjA2IC0xLjA0NzMyLDAuMjcyMDYgLTEuNTE2NDQsMCAtMC40Njk=
xMSwtMC4yNzIwNiAtMC43NTc3LC0wLjc3Mjc1IC0wLjc1NjksLTEuMzE0NTkgLThlLTQsLTAuNT=
QxODMgMC4yODc3OSwtMS4wNDI1MiAwLjc1NjksLTEuMzE0NTggMC40NjkxMiwtMC4yNzIwNiAxL=
jA0NzMzLC0wLjI3MjA2IDEuNTE2NDQsMCAwLjQ2OTExLDAuMjcyMDYgMC43NTc3MSwwLjc3Mjc1=
IDAuNzU2OTEsMS4zMTQ1OCBsIDAsMCB6IiBpZD0icGF0aDIzMzciIHN0eWxlPSJmaWxsOiMwMDA=
wMDA7ZmlsbC1vcGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOm5vbmUiLz4NCiAgPH=
BhdGggZD0ibSAxMDQuNTQ1MjksMTMxLjMxNDkzIDAsMS41Nzk3OSAtMi4wMjAyOCwwIGMgLTIuM=
DIwMjgsMCAtMi4wMjAyOCwxLjU3OTc5IDAsMS41Nzk3OSBsIDIuMDIwMjgsMCAwLDEuNTc5Nzkg=
YyAwLjAwNywxLjYzNjk1IDEuNzYzMTcsMS44MzU4NSAxLjg5MTcyLDAuMTM3MTggbCAwLjEyODI=
2LC0xLjcwNzgyIDIuMDIwMjgsMCBjIDIuMDE5OTgsMCAyLjAxOTk4LC0xLjU3OTc5IDAsLTEuNT=
c5NzkgbCAtMi4wMjAyOCwwIDAsLTEuNTc5NzkgYyAwLC0xLjU3OTc5IC0yLjAyLC0xLjU3OTc5I=
C0yLjAyLDAgeiIgaWQ9InBhdGgyMzM5IiBzdHlsZT0iZmlsbDojMDAwMDAwO2ZpbGwtb3BhY2l0=
eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTpub25lIi8+DQogIDxwYXRoIGQ9Im0gMTIyLjg=
1MDI2LDExMC4xODYzOCBjIDAuNTMxNjMsLTAuMTM0NTEgMS40MDkxNSwtMC4wMjU2IDEuNDA5MT=
UsLTAuMDI1NiAwLDAgMC4wNzY5LDAuMzY1MSAtMC4xNTM3MywwLjQ4NjggMC4yNTYyMSwwLjE0N=
zMyIDEuMTc4NTcsMC4xMDI0OCAxLjE3ODU3LDAuMTAyNDggMCwwIC0wLjM1ODcsMC4yNzU0MyAt=
MC41MzgwNCwwLjM4NDMxIDAuMzMzMDcsMC4wMzIgMC43NDMsMC40NjExOCAwLjc0MywwLjQ2MTE=
4IDAsMCAtMC43Njg2MiwwLjEyODEgLTEuMTAxNywtMC4wNTEyIDAuMjA0OTcsMC40MDk5MyAwLj=
E3OTM1LDAuNzY4NjMgMC4xNzkzNSwwLjc2ODYzIDAsMCAtMS4yNDI2MiwtMC4zMDc0NSAtMS42O=
TA5OCwtMS4xMjczMiIgaWQ9InBhdGg0OTQyIiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3Bh=
Y2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjI=
wMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2=
tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDEyMC43NzQ5NiwxMDkuNDk0NjEgYyAtMC4zM=
DEwNCwwLjc0MzAxIC0yLjUxMDg1LC0wLjY0MDUyIC0yLjUxMDg1LC0wLjY0MDUyIDAsMCAwLjk3=
MzYsMS41NDM2NiAyLjQzMzk5LDEuNzE2NiIgaWQ9InBhdGg0OTQ0IiBzdHlsZT0iZmlsbDojOTY=
4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm=
9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpva=
W46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDkzLjE4MTIxOSwxMjMu=
NjYyOTkgMjUuODc3MTQxLDAgMS45OTg0MywtMS41ODg1IC0zLjMzMDcyLC0xLjc5MzQ2IC01LjE=
yNDE4LC0xLjc0MjIzIC0yLjA0OTY4LC0xLjEyNzMyIC0zLjc5MTksMC4yMDQ5NyAtMy4xNzY5OS=
wxLjY5MDk4IC00LjM1NTU2MSwwLjUxMjQyIC0xLjAyNDgzNywxLjE3ODU2IC0zLjIyODIzOSwwL=
jI1NjIxIC01LjA3Mjk0MywtMC4xMDI0OCA4LjQ1NDkwNywxLjMzMjI5IC02Ljk2ODg5MiwtMC4z=
NTg3IDEuNzkzNDY0LDEuNTM3MjYgeiIgaWQ9InBhdGg0OTQ2IiBzdHlsZT0iZmlsbDojOTY4Nzd=
kO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS=
13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46b=
Wl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDEwNy4xMTkwMSwxMTYuMjMy=
OTIgYyAtMy4yNDEwNSwtMS43NDIyMyAtNC4xODkwMywyLjU0OTI4IC01LjU4NTM3LDMuNTg2OTM=
gMS44ODMxNCwwLjMyMDI2IDMuMzA1MSwtMS40NDc1OCA0LjkxOTIyLC0yLjMwNTg4IDEuMjI0MD=
QsMy4zMzI5NyAzLjE1MTM4LDEuMTI3MzIgMy4xNTEzOCwxLjEyNzMyIDAsMCAyLjAxMTI0LDMuM=
Tg5OCA0LjY4ODYzLDEuNzQyMjIgMC43MzAxOSwwLjU1MDg1IDEuNTM3MjUsMC4wNTEyIDEuNTM3=
MjUsMC4wNTEyIDAsMCAwLjk3MzYsMC4xNzkzNSAxLjE3ODU3LC0wLjI1NjIxIDAuNTEyNDEsMC4=
xNzkzNSAxLjA3NjA3LC0wLjQ2MTE3IDEuMDc2MDcsLTAuNDYxMTcgMCwwIDEuMTE0NTEsMC4wMT=
I4IDEuMzMyMjksLTAuNTYzNjYgMS42NTI1NSwwLjI5NDY0IDMuODQzMTQsLTMuMzgxOTcgMy44N=
DMxNCwtMy4zODE5NyBsIDAuNjY2MTUsLTEuMjgxMDQgMC45NzM1OSwtMC4yMDQ5NyBjIDAsMCAw=
LjA2NDEsLTAuNjQwNTIgLTAuNDYxMTgsLTAuNjE0OSAtMC4wMTI4LC0wLjM4NDMyIC0wLjM0NTg=
4LC0wLjU4OTI5IC0wLjgxOTg2LC0wLjUxMjQyIDAuMDg5NywtMC4yMzA1OSAtMC4yNTYyMSwtMC=
40MDk5NCAtMC4yNTYyMSwtMC40MDk5NCAtMC45MjIzNiwwLjIzMDU5IC0wLjk3MzYsMi41NjIxI=
C0wLjk3MzYsMi41NjIxIDAsMCAtMS42MTQxMiwxLjIyOTggLTIuMjAzNCwxLjUzNzI1IC0wLjAy=
NTYsLTEuMzMyMjkgLTIuMjU0NjQsLTMuMTM4NTYgLTEuNzkzNDYsLTMuOTk2ODYgMC40NjExNyw=
tMC44NTgzIDEuOTA4NzUsMS4zMTk0OCAzLjE3Njk5LDAuOTIyMzUgMS4yNjgyMywtMC4zOTcxMi=
AxLjg5MTM3LC0yLjA0NjggMS45NDcxOSwtMy4zMzA3MiAtMC4zNTg2OSwtMC44NzExMSAtMS4yM=
jk4LC0yLjMwNTg4IC0xLjIyOTgsLTIuMzA1ODggbCAtMC44MTk4NywtMC4wNTEyIC0wLjcxNzM5=
LC0xLjc0MjIyIGMgMCwwIC0xLjUxMTY0LDAuOTg2NDEgLTEuNDg2MDEsMS44NDQ3MSAwLjAyNTY=
sMC44NTgzIDEuNTg4NDksMS41ODg1IDEuNTg4NDksMS41ODg1IDAsMCAtMC45MDEyMSwwLjU2Mz=
I1IC0xLjc0MjIyLDAuMzA3NDUgLTAuMDc2OSwwLjg3MTExIDEuMDI0ODQsMC43MDQ1NyAxLjQzN=
Dc3LDAuNzE3MzggMC4yMDQ5NywwLjYyNzcxIDAuODE5ODcsMC45NzM2IDAuODE5ODcsMC45NzM2=
IDAsMCAwLjM4NDMyLDAuOTYwNzggLTAuNjE0OSwwLjg3MTExIC0wLjk5OTIyLC0wLjA4OTcgLTI=
uMTc4MDgsLTIuMzkxOTQgLTMuNTg2OTMsLTEuMzMyMjkgLTEuNDk4ODIsMS4xMjczMiAwLjY2Nj=
E0LDMuMTc3IDAuNjY2MTQsMy4xNzcgMCwwIC0xLjMxOTQ3LDAuNjkxNzYgLTIuMTAwOTEsMi40N=
Tk2MSAtMy4xODk4MSwtMi42OTAyIC01LjA2MDEzLC0xLjQzNDc4IC04LjYwODYzLC0wLjcxNzM5=
IHoiIGlkPSJwYXRoNDk0OCIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWx=
sLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3=
N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5O=
jEiLz4NCiAgPHBhdGggZD0ibSAxMDIuNDU2LDExMS42NzIzOSBjIDEuMzMyMjgsMS4yNTU0MyAw=
LjQwMzE2LDMuMzQyMjEgMC45MjIzNSwzLjc0MDY2IDAuNTUwODUsMC40MjI3NCAxLjMzMjI5LC0=
wLjIwNDk3IDEuMzMyMjksLTAuMjA0OTcgMS4zOTYzNCwwLjM3MTUxIDMuODk0MzgsLTAuNDA5OT=
MgMy44OTQzOCwtMC40MDk5MyAxLjA5OTM2LDAuNjE0NzMgMC42NjU0MSwtMC4yOTI0MSAxLjMzM=
jI5LC0wLjI1NjIxIDAuNTg5MjgsMS41MTE2MyAyLjU2MjA5LDEuMjI5OCAyLjU2MjA5LDEuMjI5=
OCAwLDAgLTEuODA2MjcsLTEuODQ0NyAtMi45MjA3OCwtMi4zNTcxMiAtMC44NTgzLDAuNTEyNDI=
gLTMuMzU2MzUsMC41ODkyOCAtMy43OTE5LDAuNTEyNDIgLTAuNDg1MzMsLTAuMDg1NyAtMC4xNz=
kzNSwtMC42Nzg5NiAtMC40MDk5NCwtMS4wMjQ4NCAwLjkxODQ5LC0wLjg5NDA2IDAuMTkyMTYsL=
TMuMTEyOTQgLTAuMzA3NDUsLTMuOTQ1NjIgLTIuMDM2MDMsLTEuMzU2MzIgLTQuNDY4NCwwLjk2=
Nzc3IC0yLjYxMzMzLDIuNzE1ODEgeiIgaWQ9InBhdGg0OTUwIiBzdHlsZT0iZmlsbDojOTY4Nzd=
kO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS=
13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46b=
Wl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDkzLjU5ODU0NSwxMDcuOTE1=
NzUgYyAtMS42NzU3OTgsMC40NTI5MSAtNC41ODM1MzQsLTIuMTY0OTUgLTUuOTQyMjksLTEuMTU=
5NDcgLTEuMzU4NzUzLDEuMDA1NDggLTAuNzI0NjY5LDMuNDc4NDEgMC4xODExNjgsNC43MTAzNS=
AwLjg4NDk5OSwxLjIwMzU5IC0xLjI5NTM0NiwxLjYzOTU2IC0xLjg4NDEzOSwyLjM1NTE3IC0wL=
jU1MzUzMywwLjY3Mjc2IDAuMTgxMTY2LDEuNDQ5MzQgMC4xODExNjYsMS40NDkzNCBsIDAuNjE1=
OTcsMC4zOTg1NyAtMC4xMDg3MDIsMC45MDU4MyAwLjMyNjEwMywxLjA4NzAxIGMgMCwwIDAuMjk=
4OTI1LDAuMjYyNjkgMC4zOTg1NjcsLTAuMDcyNSAwLjI4MDgxLDAuMjgwODEgMC4wMjk2NiwxLj=
A5MjgyIDAuNzI0NjcsMS4xOTU3MSAtMC4yNDg4NywtMC41MjAwMyAwLjE4MTE2OCwtMS45NTY2M=
SAwLjE4MTE2OCwtMS45NTY2MSAwLDAgMS4yMTM4MiwwLjA5MDYgMS41MjE4MDUsLTAuNDM0OCAw=
LjMwNzk4NSwtMC41MjUzOSAtMC4yODk4NjcsLTEuNjY2NzQgLTAuMjg5ODY3LC0xLjY2Njc0IDA=
sMCAwLjM2MjMzMywwIDAuMzYyMzMzLDAgLTAuNDA3NjI2LC0wLjI4MDgxIC0wLjU0MzUwMSwtMS=
4xMjMyNCAtMC41NDM1MDEsLTEuMTIzMjQgMCwwIDEuNjg0ODU2LC0wLjUzNDQ0IDEuNjY2NzQsL=
TEuODExNjcgLTAuMDE4MTIsLTEuMjc3MjMgLTIuNzM1NjI4LC0yLjYzNTk5IC0xLjczOTIwNywt=
My4yOTcyNSAxLjEwNTExOSwtMC43MzM3MyAzLjAyNTQ5NCwxLjkwMjI2IDQuNjc0MTE3LDAuNjg=
4NDQgMS42MzE0OTMsLTEuMjAxMjEgMC41Nzk3MzUsLTAuMDM2MiAwLjU3OTczNSwtMC4wMzYyID=
AsMCAwLjc0NTY5MiwtMS42NzgyOSAtMC45MDU4MzYsLTEuMjMxOTMgeiIgaWQ9InBhdGg0OTUyI=
iBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0=
cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV=
0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPS=
JtIDEwMi4yNTEwMyw4OS45NzE0NjcgYyAtMi4yNDE4MywtMC45MzUxNjQgLTYuODIxNTc0LC0wL=
jk5MjgxMiAtOS4zNzcyNjIsLTIuMjU0NjQyIC0xLjEyMDkxNSwwLjA3MDQ2IC0xLjYyMDUyNCww=
Ljk1NDM3OSAtMS42NjUzNjEsMS4zMDY2NjcgLTEuMTcyMTU3LC0wLjA1NzY1IC0xLjk2NjQwNiw=
xLjc4NzA2IC0xLjc5MzQ2NCwyLjE1MjE2IC0yLjEzMjk0MiwtMC44NjQ3MDkgLTMuMTI1NzU0LD=
IuNTEwODQ5IC0yLjQzMzk4OCwzLjIwMjYxNSAtMS44MTkwODcsMC4wNzY4NiAtMS41OTQ5MDMsM=
i40MDE5NjEgLTEuNzY3ODQ1LDMuMDQ4ODkxIC0wLjU4Mjg3NiwxLjQxNTU1NyAwLjEyOTgwMiwx=
Ljg5MTg2NiAxLjI4MTA0NiwxLjM4MzUzIDAuMTcyOTQyLDAuNjE0OTAzIC0wLjA2OTExLDAuOTU=
5MzQgLTAuNTg5MjgyLDEuMDc2MDc5IDMuMTU3NTI4LDMuNjEzMjYzIDQuOTQyMDc4LC0yLjIyMz=
Y1IDcuNzExOSwtMi4yMDM0IDMuNDU4MjYxLC0xLjAxMjQwNSA0LjgxNjczNiwtMi43MTU4MTggN=
C44MTY3MzYsLTIuNzE1ODE4IGwgMS4zNTc5MDksMC4xNzkzNDUgYyAwLDAgMi40NTk2MTEsLTUu=
MTc1NDI3IDIuNDU5NjExLC01LjE3NTQyNyB6IiBpZD0icGF0aDQ5NTQiIHN0eWxlPSJmaWxsOiM=
5Njg3N2Q7ZmlsbC1vcGFjaXR5OjE7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMwMDAwMDA7c3=
Ryb2tlLXdpZHRoOjAuMjAyOTA3NDFweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5la=
m9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxIi8+DQogIDxwYXRoIGQ9Im0gMTA4LjQ1MTI5LDg3=
LjM4Mzc0OCBjIDAsMS44MjUzNTcgLTEuNDc5NzQsMy4zMDUxIC0zLjMwNTEsMy4zMDUxIC0xLjg=
yNTM1LDAgLTMuMzA1MSwtMS40Nzk3NDMgLTMuMzA1MSwtMy4zMDUxIDAsLTEuODI1MzU2IDEuND=
c5NzUsLTMuMzA1MSAzLjMwNTEsLTMuMzA1MSAxLjgyNTM2LDAgMy4zMDUxLDEuNDc5NzQ0IDMuM=
zA1MSwzLjMwNTEgbCAwLDAgeiIgaWQ9InBhdGg0OTU2IiBzdHlsZT0iZmlsbDojOTY4NzdkO2Zp=
bGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpub256ZXJvO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR=
0aDowLjIwMjkwNzQxO3N0cm9rZS1saW5lY2FwOnJvdW5kO3N0cm9rZS1taXRlcmxpbWl0OjQ7c3=
Ryb2tlLW9wYWNpdHk6MTtzdHJva2UtZGFzaGFycmF5Om5vbmU7c3Ryb2tlLWRhc2hvZmZzZXQ6M=
CIvPg0KICA8cGF0aCBkPSJtIDk5LjMzMDI0MywxMTMuNDE0NjIgYyAtMi4wNDk2NzUsLTAuMzcx=
NTEgLTUuNDQ0NDQ4LC0yLjQ5ODA0IC01Ljc5MDMzLC01LjI3NzkxIDEuOTA4NzU4LC03LjQ5NDE=
zIDExLjc1NDkxNywtMy41ODA3MiAxMi42MDQ0MjcsLTkuMjE3MzIyIC0wLjIxNjM5LC0zLjcxOD=
cyMSAwLjQ0OTUxLC03LjM5OTkzNCAyLjUxMTkyLC0xMC41MTA3OTcgMC45NjA3OSwtMS4yMTY5O=
TQgMi4yMDM0LC0xLjUzNzI1NyAyLjIwMzQsLTEuNTM3MjU3IDAsMCAwLjIyMjU3LDAuNzkzNzIx=
IC0wLjEwMjQ4LDEuMzMyMjg4IDEuNjI2OTMsLTAuMTc5MzQ2IDMuODU1OTUsMC43MzAxOTcgNS4=
zODAzOSwwLjgxOTg3IDAuNDQ4MzcsMC45MDk1NDQgMC40MDk5NCwxLjI0MjYxNSAwLjMwNzQ1LD=
EuNzkzNDY2IC0wLjEwMjQ4LDAuNTUwODQ5IC0wLjcxNzM4LDAuNDA5OTM0IC0wLjcxNzM4LDAuN=
DA5OTM0IC0wLjM5NzY3LDAuMzc3MjI3IC0wLjg3NTY1LDAuNzYxMDUxIC0xLjk0NzE5LDAuNTYz=
NjYgLTAuODA3MDYsMC42MTQ5MDMgLTIuNTEwODUsMC43Njg2MyAtMi41MTA4NSwwLjc2ODYzIDA=
sMCAzLjU2MTMxLDMuNzUzNDY0IDIuOTcyMDIsNC45MTkyMTYgMC43NDMwMSwwLjM0NTg4MiAxLj=
g0NDcxLDEuOTk4NDMzIDEuODQ0NzEsMS45OTg0MzMgMCwwIDIuNDMzOTksLTEuMjgxMDQ2IDMuM=
jI4MjQsLTIuNDU5NjA5IDEuNDA5MTUsMCAzLjcxNTAzLDEuNDczMjAzIDQuODY3OTgsMS42Mzk3=
MzkgMS40MDkxNSwxLjE0MDEzMSAyLjgxODMsMi4zMDU4ODkgMi44MTgzLDIuMzA1ODg5IDAsMCA=
tMS42NzgxNywxLjEwMTcgLTIuNDA4MzcsLTAuMzU4NyAtMC44ODM5MiwwLjA3NjkgLTIuNzkyNj=
gsLTIuMDM2ODYyIC01LjQzMTY0LC0xLjM4MzUyOCAtMC4wNzY5LDIuMzQ0MzE4IC0yLjY2NDU3L=
DMuOTk2ODY4IC0yLjY2NDU3LDMuOTk2ODY4IDAsMCAyLjQxNTMsLTAuMzM4MDIgMy43NDA2NSww=
LjQ2MTE3IDEuMzcwNzIsMS4xNTI5NSAzLjM4MTk3LDIuNzE1ODIgMy4zODE5NywyLjcxNTgyIGw=
gMS43OTM0NiwzLjA3NDUxIGMgMCwwIC0xLjYzOTc0LDAuMjgxODMgLTIuMjU0NjQsLTEuODQ0Ny=
AtMC42MTQ5MSwxLjcxNjYgLTAuNjQwNTIsLTEuMDYzMjcgLTMuMDc0NTEsLTIuMzU3MTMgLTAuN=
zQzMDEsMC4wODk3IC0xLjExNDUxLDAuMTQwOTIgLTEuNzQyMjMsLTAuMzU4NjkgLTEuNzU1MDMs=
MC40NzM5OSAtMy44MzAzMiwxLjQ5ODgyIC02LjMwMjc1LDEuMjI5OCAtMS43NTUwMywwLjU1MDg=
1IC0zLjAzNjA4LDIuMDExMjUgLTQuODE2NzMsMi44MTgzMSAtMS43ODA2NiwwLjgwNzA2IC0yLj=
MwNTg4LDAuNDA5OTMgLTIuMzA1ODgsMC40MDk5MyBsIC0xLjQzNDc4LDAuMDUxMiBjIC0wLjIwN=
jk5LDAuODYzNzYgLTAuMDg5NywyLjE3Nzc4IC0wLjg3MTExLDIuNDA4MzcgMC40OTk2MSwwLjUz=
ODA0IC0wLjM1ODY5LDIuODMxMTEgLTEuMjI5OCwzLjIyODI0IDAuNDA5OTMsMS40NzMyIDEuNjE=
wODQsMS45MjQxNiAyLjg2OTU0LDIuNjY0NTcgMCwwIDEuMTE0NTEsLTAuNTEyNDEgMS44NDQ3MS=
wwLjE1MzczIDAuNzMwMTksMC42NjYxNCAxLjQ4NjAxLDIuNTYyMDkgMS40ODYwMSwyLjU2MjA5I=
DAsMCAtMS41MTk3MywwLjEwMjY4IC0xLjk5ODQzLC0wLjEwMjQ4IC0wLjQ3ODcxLC0wLjIwNTE2=
IC0wLjUyNTIzLC0wLjcwNDU4IC0xLjA3NjA4LC0wLjU2MzY2IC0zLjQ3MTY0LC0zLjA4NzMyIC0=
1LjMwMjQzNywtMS44NTkzMiAtNS42MzY2MDUsLTIuNTYyMDkgLTAuMzQyNTIsLTAuNzIwMzUgMC=
44MTk4NywtMi42MDA1MyAwLjQ2MTE3OCwtMy43OTE5IHoiIGlkPSJwYXRoNDk1OCIgc3R5bGU9I=
mZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzAw=
MDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2t=
lLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEiLz4NCiAgPHBhdGggZD0ibSA5MC45OD=
k3MzYsOTkuNjU0NTE3IGMgMC4xODExNjYsLTAuMjI2NDU5IDEuNDQ5MzM3LDAuMjUzNjM0IDEuN=
DQ5MzM3LDAuMjUzNjM0IGwgMi4zMTg5NDIsMS40NDkzMzkgNC43MTAzNTEsMy4wNDM2MSAxLjY2=
Njc0NCwyLjQyNzY0IC0zLjAwNzM4MSwtMC45NzgzIC00LjE2Njg1LC0zLjU4NzExIC0yLjI0NjQ=
3NSwtMS40NDkzNCBjIDAsMCAtMC45MDU4MzYsLTAuOTMzMDE0IC0wLjcyNDY2OCwtMS4xNTk0Nz=
MgeiIgaWQ9InBhdGg0OTYwIiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2Zpb=
GwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7=
c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk=
6MSIvPg0KICA8cGF0aCBkPSJtIDExOC44NTMzOSwxMDcuMzY4MDggYyAtMS42MjY5MywtMC40MD=
k5NCAtNS42MzY2LDQuNDU4MDQgLTUuNjM2Niw0LjQ1ODA0IGwgMy4wMjMyNywzLjI3OTQ4IGMgM=
CwwIDAuMDg5NywtNS41ODUzNiAyLjYxMzMzLC03LjczNzUyIHoiIGlkPSJwYXRoNDk2MiIgc3R5=
bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U=
6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3=
Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEiLz4NCiAgPHBhdGggZD0ibSA5O=
S4wMjI3OTIsOTMuNzg4OTg1IGMgLTAuODg3MjI3LDEuMTM2ODA3IC0wLjk2NjYxNSwzLjQyODY3=
OSAwLjE4NzU2NSw0LjM1MzA2NCAwLjEwODgwNywxLjM5MTA4MSAxLjI5MTUzMyw0LjE5NzA4MSA=
yLjIyMDgwMyw0LjQ2MDU0MSAxLjAxNTI3LDAuMjg3ODQgNS4wNzI5NCwxLjIyOTggNi42NjE0NC=
wwLjk3MzU5IC0wLjMwMzgxLDIuNTc0NTMgMS43MTY0Myw0LjY0MTAzIDMuNTg2OTMsNS45OTUzI=
C0wLjAxMzYsMC4yMzEwMyAtMC4wMTY4LDAuNTEzMDYgMC4xOTkyOCwwLjc5ODY0IDAuMjA5MzYs=
MC4yNzY2NCAxLjE5MjI2LDAuMzI3MzQgMS4yMzU0OSwwLjE3NDk1IDAuNDM1OTEsMC42MTI2IDI=
uNTQ3MzEsMC44ODE1NyAyLjcwMDI4LDAuNjA4NjkgMC4xNDg4NCwtMC4yNjU1MiAtMy4xMDU1OS=
wtMi41MzA3MyAtMy44Mjc2LC0zLjIyMjAyIC0wLjYxMzMsLTEuMTQ0MjIgLTEuNzc0OTEsLTMuN=
jkzODEgLTIuMDQ5NjcsLTUuNzM5MDkgLTEuNTk3MjksLTEuOTAwMzQgLTQuMzM5NDksLTEuODYy=
MjkgLTQuMzM5NDksLTEuODYyMjkgbCAwLjA4NjQsLTMuNzIzMDcyIDAuMTUzNzMsLTQuMjAxODM=
zIC0xLjQ4NjAxLC0wLjc2ODYyNyBjIDAsMCAwLjI5OTU2LC0wLjEzNjUyMSAwLjQ2MTE3LC0wLj=
MwNzQ1MiAwLjM2MDg5LDAuMTU1MTcgMS4wMzkwOSwtMC41Njk4NzcgMS4xMjczMiwtMC43NzQ4N=
DQgMC4zNDE4NywwLjEyMTEzMyAwLjY1MTM4LDAuMTE5NTE4IDAuNzExMTcsLTAuMDYzMTQgMC4w=
NTI4LC0wLjE2MTMxNiAwLjExMzk5LC0wLjg3OTQxNSAwLjIzODYzLC0xLjI1MDQ5NiAxLjEyMTA=
2LC0wLjk4NzA0OSAtMC4xNjM2NSwtMy4wNzk5NzQgLTEuODc3ODMsLTMuMTE0Mzg1IC0xLjY5Nj=
A3LC0wLjAzNDQxIC0yLjA3NjUsMi4wMjMxODcgLTIuMDQzOTksMi4xNzk1OTkgMC4xNTkzMiwwL=
jY0NTU2MiAwLjEyNDk5LDAuOTcxMDE5IDAsMS4xMjczMjEgLTAuMTI3NzcsMC4xNTk3NTcgLTAu=
NzE3MzksMC41MTI0MTggLTAuNzE3MzksMC41MTI0MTggMCwwIC0wLjk0Nzk3LC0wLjQ0ODM2NyA=
tMi4xMDA5MiwwIC0xLjE1MjkzOSwwLjQ0ODM2NiAtMi40NDY3OTcsMS4wNTA0NTggLTIuNTEwOD=
Q4LDEuNzkzNDY2IC0wLjUyNTIzLDAuMDc2ODYgLTEuMzgzNTMxLDAuNzU1ODE2IC0xLjUzNzI1N=
ywxLjMzMjI4OCAtMC40NjExNzcsLTAuMDg5NjcgLTEuMDYzMjY4LDAuMjk0NjQgLTIuMDQ5Njc0=
LDEuODk1OTQ5IC0xLjc2Nzg0NSwwLjc4MTQzNyAtMS44NzAzMjcsNC41NjA1MjQgLTEuODcwMzI=
3LDQuNTYwNTI0IDAsMCAtMC40NzcxOSwwLjY5NDk2NCAtMC40OTk2MDksMS4wNjMyNjQgLTAuMD=
IyNDIsMC4zNjgzIDAuMTY2NTM2LDAuNzA0NTggMC4zOTcxMjQsMC42NDA1MyAwLjAyNTYyLDAuM=
jQzMzkgMC4zNDU4ODIsMC40NjExNyAwLjQ4Njc5OCwwLjM4NDMxIDAuMDUxMjQsMC4yNDM0IDAu=
NDAyOTc2LDAuMzc5NTIgMC42MTQ5MDIsMC4zNDU4OCAwLjAxOTIyLDAuMTY2NTQgMC43MDEzNzQ=
sMC4xMjQ5MSAwLjc1NTgxOCwtMC4wMjU2IDAuMDYwMDgsLTAuMTY2MTEgLTAuMDY3NSwtMC45OT=
Y5MiAwLjAxMjgsLTEuMDYzMjcgMC4wNzM2NiwtMC4wNjA5IDAuNjQwNTI0LDAuMzcxNTEgMC43O=
TQyNDgsMC4yNTYyMSAwLjE1MzcyNywtMC4xMTUyOSAtMC4wMjkzNiwtMC40ODQ0OSAtMC4xMTUy=
OTQsLTAuNjI3NzEgLTAuMDc2ODYsLTAuMTI4MTEgLTAuNTYzNjYsLTAuMjY5MDIgLTAuNjc4OTU=
0LC0wLjg3MTEwOSAtMC4xMTUyOTQsLTAuNjAyMDkxIDAuMzA3NDUxLC0xLjQzNDc3MyAwLjMwNz=
Q1MSwtMS40MzQ3NzMgMCwwIDEuOTIxNTcsLTEuNTExNjM0IDIuMTM5MzQ4LC0yLjgwNTQ5MSAxL=
jQ0NzU4MiwwLjE0MDkxNSAyLjIxMzAwOCwtMS4xMjQxMTkgMi42MjYxNDYsLTEuNjAxMzA5IHoi=
IGlkPSJwYXRoNDk2NCIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ=
1bGU6ZXZlbm9kZDtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3N0cm=
9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEiL=
z4NCiAgPHBhdGggZD0ibSA5NS42NzkyNTksODguMzcwMTU4IGMgMC40Mzg3NTksLTEuMDcyODc1=
IDIuMDI0MDU0LC0wLjk3MzU5NCAyLjAyNDA1NCwtMC45NzM1OTQgMCwwIDAuNTY2ODY1LC0xLjQ=
5MjQyMSAyLjcwMzAwNywtMC42MDIwOTMgMC44MDM4NiwtMC42MjEzMDcgMi45MjA3OSwwLjI2OT=
AyIDIuOTIwNzksMC4yNjkwMiAwLDAgMC43OTI3LC0xLjA1NjIwMiAxLjgzMTksLTAuOTM1MTYzI=
DEuOTI0NzcsMC4yMjQxODIgMi4yNDUwMywxLjk4ODgyNSAyLjEyNjUzLDIuMjkzMDczIC0xLjA1=
MzY2LDAuMjY1ODE2IC0yLjg3OTAxLC0wLjg1NjI5MiAtNC4yNjU4OCwtMC41MzgwNCAtMC44MTA=
yNiwwLjQ1Nzk3NCAtMi4xMjMzNCwwLjk0MTU3IC0yLjYxMzM0LDEuNjAxMzA5IC0xLjI4NDI0OC=
wwLjEzNDUwOSAtMi42NTQ5NjYsLTEuMTgxNzY1IC00LjcyNzA2MSwtMS4xMTQ1MTIgeiIgaWQ9I=
nBhdGg0OTY2IiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpl=
dmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWx=
pbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KIC=
A8cGF0aCBkPSJtIDk5LjY4ODkzNSw5MC4xNTA4MTMgYyAwLjQ4MDM5NSwtMC4yOTQ2NCAxLjY1O=
DgzNSwtMC44MTI2MTYgMi40NTk2MTUsLTAuMTc5MzQ2IDAuODM5MDgsMC45MDMxMzcgMi4xMjY1=
MywxLjc0MjIyNCAyLjEyNjUzLDEuNzQyMjI0IGwgMS40NjA0LDAuNjE0OTAxIDAuNjY2MTQsMC4=
0MDk5MzYgLTAuNDM1NTYsNi42ODcwNjMgYyAtMS4zNTE3NSwtMS4zODMxMzEgLTIuNjE4NTksLT=
EuNjI1MjU2IC0zLjU4NjkyLC0zLjI1Mzg2IC0wLjUxODgzLC0wLjY5ODE3IC0wLjEyMTcsLTIuM=
zc2MzQgLTEuMDI0ODQsLTMuNDg0NDQ2IC0wLjkwMzE0LC0xLjEwODEwNSAtMS44NjM5MjYsLTEu=
ODU3NTE4IC0xLjY2NTM2NSwtMi41MzY0NzIgeiIgaWQ9InBhdGg0OTY4IiBzdHlsZT0iZmlsbDo=
jOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3=
N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZ=
WpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDEwMy4yMDA0MSw5=
Mi4wODE3MjIgYyAwLDAgMC43NjU0NCwtMC4xNDQ5MzQgMC45NzgzMSwwLjAzNjIzIDAuMjY3MjI=
sMC4wOTA1OCAwLjUyNTM4LDAuMTY3NTc5IDAuNTk3ODUsMC4zOTg1NjkgMC4yODk4NywwLjA4Nj=
A1IDAuNDg5MTUsMC4yMzU1MTYgMC40ODkxNSwwLjQ1MjkxNyAwLjI3MTc1LDAuMDcyNDcgMC4zO=
DA0NSwwLjU2MTYyIDAuMzgwNDUsMC41NjE2MiBsIC0wLjI1MzYzLDAuMzgwNDUxIGMgMCwwIC0w=
LjI4OTg3LC0wLjI3MTc1MiAtMC4zMjYxLC0wLjU2MTYxOSAtMC4xODM0LC0wLjA5MDMxIC0wLjU=
4ODgsLTAuMTg1Njk3IC0wLjY4ODQ0LC0wLjQ1MjkxOCAtMC4zMTcwNCwtMC4wMzE3IC0wLjUyMD=
g1LC0wLjE5NDc1NSAtMC41Nzk3MywtMC40NzEwMzUgLTAuMjk0NCwwLjA2Nzk0IC0wLjU5Nzg2L=
C0wLjM0NDIxOSAtMC41OTc4NiwtMC4zNDQyMTkgeiIgaWQ9InBhdGg0OTcwIiBzdHlsZT0iZmls=
bDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDA=
wO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbG=
luZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDEwOS42ODExL=
Dg3LjcxNjgyNSBjIC0wLjQzNTU2LC0wLjQ4Njc5NyAtMS4yMDQxOCwtMC4xMjgxMDQgLTEuMjA0=
MTgsLTAuMTI4MTA0IGwgLTIuMDQ5NjgsMy41MzU2ODggLTAuODk2NzMsMC43NDMwMDcgLTAuMDc=
2OSwyLjc2NzA2IDAuNzQzLDIuNTg3NzEzIC0wLjI1NjIxLDEuOTk4NDMzIGMgMCwwIDEuMDMyMj=
IsLTAuOTY4MzcgMS4xNTI5NSwtMS41MTE2MzYgMC4xMTUyOSwtMC41MTg4MjQgLTAuMzg0MzIsL=
TIuMjAzMzk4IC0wLjM4NDMyLC0yLjIwMzM5OCAwLDAgLTAuNjE0OSwtMS4wNTA0NTggMC4xMjgx=
MSwtMi45OTc2NDggMC43NDMsLTEuOTQ3MTkxIDIuNDMzOTgsLTMuNTYxMzEgMi44NDM5MiwtNC4=
3OTExMTUgeiIgaWQ9InBhdGg0OTcyIiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eT=
oxO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwN=
zQxcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9w=
YWNpdHk6MSIvPg0KICA8cGF0aCBkPSJtIDExNC43Mzg5LDkwLjg2ODIgYyAwLDAgLTMuMjAwMjg=
sNC41NzMzMzYgLTguNDM5NzYsNi4yMDAyNjQgLTEuNDQ3NTksMC4zNDU4ODIgLTAuOTIyMzYsLT=
MuMzgxOTYxIC0wLjkyMjM2LC0zLjM4MTk2MSBsIC0wLjM1ODY5LDAuMTAyNDgyIGMgMCwwIC0wL=
jgwNzA2LDMuNjUwOTgyIDEuMTI3MzIsMy42ODk0MTMgNS4yNjUxLC0xLjAzNzY0OCA5LjIxNTYx=
LC02LjU4MDYxNiA5LjIxNTYxLC02LjU4MDYxNiBMIDExNC43Mzg5LDkwLjg2ODIgeiIgaWQ9InB=
hdGg0OTc0IiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldm=
Vub2RkO3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpb=
mVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8=
cGF0aCBkPSJtIDExNi45MDYyLDExNy4xNTUyNyBjIDAsMCAtMC40ODY4LDAuMzU4NyAtMS4xMjc=
zMiwwIC0wLjMzMzA3LC0wLjc2ODYyIC0xLjIyOTgsLTAuODE5ODcgLTEuMjI5OCwtMC44MTk4Ny=
AwLDAgLTAuNTc3NTgsLTEuNjU5MjggLTEuNDg2MDIsLTEuMTc4NTYgLTAuMTQwOTEsLTAuODU4M=
yAtMS4xMjczMiwtMC40MDk5MyAtMS4xMjczMiwtMC40MDk5MyAwLDAgLTAuMDI1NiwtMS4yNDI2=
MiAtMS4xNzg1NiwtMS4wNzYwOCAwLjM4NDMxLC0xLjQyMTk3IC0xLjU4ODUsLTEuMzMyMjkgLTE=
uNTg4NSwtMS4zMzIyOSAwLDAgLTAuMDY0LC0xLjYwMTMxIC0yLjk3MjAzLC0xLjI4MTA1IDYuMj=
Y0MzIsLTIuODA1NDkgMTEuMjIxOTcsNC40MDY4IDExLjIyMTk3LDQuNDA2OCIgaWQ9InBhdGg0O=
Tc2IiBzdHlsZT0iZmlsbDojOTY4NzdkO2ZpbGwtb3BhY2l0eToxO2ZpbGwtcnVsZTpldmVub2Rk=
O3N0cm9rZTojMDAwMDAwO3N0cm9rZS13aWR0aDowLjIwMjkwNzQxcHg7c3Ryb2tlLWxpbmVjYXA=
6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MSIvPg0KICA8cGF0aC=
BkPSJtIDExOS44NzgyMywxMTcuNzcwMTggYyAwLDAgMS40NDc1OCwxLjYyNjkzIDIuMjAzNCwxL=
jYzOTc0IDAuNzU1ODIsMC4wMTI4IDAuODE5ODcsLTEuNTg4NSAwLjgxOTg3LC0xLjU4ODUgMCww=
IDAuMjQzNCwwLjY5MTc2IDAuNjE0OSwwLjUxMjQyIC0wLjAzODQsMC40ODY3OSAwLjQ2MTE4LDA=
uNjE0OSAwLjQ2MTE4LDAuNjE0OSAwLDAgLTEuMzA2NjcsMy4wMzYwOCAtNS4wMjE3LDAuMTUzNz=
IiIGlkPSJwYXRoNDk3OCIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsL=
XJ1bGU6ZXZlbm9kZDtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3N0=
cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjE=
iLz4NCiAgPHBhdGggZD0ibSAxMDguNTUzNzgsMTE4LjM4NTA4IC0wLjUxMjQyLDIuMTAwOTEgYy=
AwLDAgLTAuNjUzMzMsMC41ODkyOCAtMC40NjExOCwwLjcxNzM5IDAuMTkyMTYsMC4xMjgxIDEuM=
jI5ODEsLTAuMjA0OTcgMS4yMjk4MSwtMC4yMDQ5NyAwLDAgMS42MTQxMiwtMC4xOTIxNSAyLjEw=
MDkxLC0wLjY2NjE0IDAuMzMzMDgsMC43NTU4MiAxLjA3NjA4LDAuODE5ODcgMS4wNzYwOCwwLjg=
xOTg3IDAsMCAwLjA1MTIsLTAuMzIwMjYgLTAuMDUxMiwtMC41MTI0MiAwLjM1ODY5LDAuMDY0MS=
AwLjY2NjE1LC0wLjA1MTIgMC42NjYxNSwtMC4wNTEyIDAsMCAwLjIwNDk2LC0wLjU4OTI5IC0wL=
jI1NjIxLC0wLjgxOTg3IDAuMDUxMiwtMC40MzU1NiAwLjI2OTAxLC0wLjgxOTg3IC0wLjUxMjQy=
LC0wLjc2ODYzIC0wLjU3NjQ3LDAuNjE0OSAtMS45OTg0NCwxLjMxOTQ4IC0yLjM1NzEzLDEuMDc=
2MDggLTAuMzU4NjksLTAuMjQzNCAxLjQwOTE1LC0xLjAyNDg0IDAuOTIyMzYsLTIuMDQ5NjciIG=
lkPSJwYXRoNDk4MCIgc3R5bGU9ImZpbGw6Izk2ODc3ZDtmaWxsLW9wYWNpdHk6MTtmaWxsLXJ1b=
GU6ZXZlbm9kZDtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4yMDI5MDc0MXB4O3N0cm9r=
ZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEiLz4=
NCiAgPHBhdGggZD0ibSA3NS45NTM3NjgsMTEzLjQwMTQ2IDIuMDgzNjI0LC0wLjQ5NjY5IC0wLj=
IzMDE4MiwtMC45NjU1OCBjIC0wLjA1Mjc0LC0wLjIyMTU0IC0wLjE0MDI5NCwtMC4zNzIxMiAtM=
C4yNjI2MDcsLTAuNDUxNzYgLTAuMTIyMjcyLC0wLjA3OTYgLTAuMzMyMDgzLC0wLjEwMTkyIC0w=
LjYyOTQ0NiwtMC4wNjY5IGwgLTAuMDM0NTYsLTAuMTQ0NjIgMS43OTQzNDMsLTAuNDI3NzIgMC4=
wMzQ1NiwwLjE0NDYyIGMgLTAuMjA1MjgxLDAuMDUxNiAtMC4zNTAwNDUsMC4xMTQ0NSAtMC40Mz=
QzNzEsMC4xODgyMyAtMC4wODQzMSwwLjA3MzggLTAuMTM5ODU4LDAuMTYxNDEgLTAuMTY2NjM3L=
DAuMjYyODMgLTAuMDI2NzgsMC4xMDE0MSAtMC4wMTkwNCwwLjI0MDcyIDAuMDIzMTksMC40MTc5=
NCBsIDAuMjMwMTgzLDAuOTY1NTggMS42NjUzMzYsLTAuMzk2OTggYyAwLjI2ODQzOCwtMC4wNjQ=
gMC40NDE2MTYsLTAuMTIzMTcgMC41MTk1NSwtMC4xNzc1NCAwLjA1ODkzLC0wLjA0MTYgMC4xMD=
E5MTcsLTAuMTA5NjggMC4xMjg5NTIsLTAuMjA0MjYgMC4wMzUyMSwtMC4xMjk1OCAwLjAzNzksL=
TAuMjU2OTEgMC4wMDgxLC0wLjM4MjAyIGwgLTAuMDQ1NzIsLTAuMTkxNTIgMC4xNDQ2MTgsLTAu=
MDM0NiAwLjU0MjM1LDIuMjc1MTggLTAuMTQ0NjE4LDAuMDM0NiAtMC4wNDQ2NSwtMC4xODc2NyB=
jIC0wLjA1MjI4LC0wLjIxODg5IC0wLjE1MzkyNSwtMC4zNjI2OCAtMC4zMDUyNCwtMC40MzEyNy=
AtMC4wOTgzLC0wLjA0MjcgLTAuMzA2NDM3LC0wLjAyNjEgLTAuNjI0Mzg5LDAuMDQ5NyBsIC0zL=
jQyNDQ5MywwLjgxNjMyIGMgLTAuMjY4NDM1LDAuMDY0IC0wLjQ0MTYxMiwwLjEyMzE3IC0wLjUx=
OTU1LDAuMTc3NTMgLTAuMDU4OTMsMC4wNDE2IC0wLjEwMjIyNSwwLjEwODM4IC0wLjEyOTg5NSw=
wLjIwMDM1IC0wLjAzNTgyLDAuMTI2OTcgLTAuMDM4NTMsMC4yNTQzMSAtMC4wMDgxLDAuMzgyMD=
EgbCAwLjA0NDY1LDAuMTg3NjggLTAuMTQ0NjE5LDAuMDM0NiAtMC45NDAyNTcsLTMuOTQ0NDIgM=
S4xNTI4NDQsLTAuMzI4NTEgMC4wMzI2MSwwLjEzNjgzIGMgLTAuMjMxNDMxLDAuMTI2NzggLTAu=
Mzk0NDE1LDAuMjQ4OTYgLTAuNDg4OTY0LDAuMzY2NSAtMC4wOTQ1MywwLjExNzU2IC0wLjE1MjE=
3OSwwLjI0ODM3IC0wLjE3MjkzOCwwLjM5MjM5IC0wLjAyMDc1LDAuMTQ0MDMgMC4wMDE4LDAuMz=
U0MTggMC4wNjc2NiwwLjYzMDQzIGwgMC4yNzg2MjgsMS4xNjg4NiB6IG0gLTEuMzQyMTc0LC05L=
jQwMTk2IGMgMC4wMzk3OSwtMC43MDYxOCAwLjM0MjQzMywtMS4zMDI5NyAwLjkwNzkxOCwtMS43=
OTAzNSAwLjU2NTQ5MiwtMC40ODczOCAxLjI0OTQ3NiwtMC43MDg0NiAyLjA1MTk1NCwtMC42NjM=
yNiAwLjgyNjU1NywwLjA0NjYgMS40OTc5ODQsMC4zNDYwNCAyLjAxNDI4MSwwLjg5ODM5IDAuNT=
E2Mjk5LDAuNTUyMzYgMC43NTM1NzUsMS4xOTkwMiAwLjcxMTgyOSwxLjkzOTk4IC0wLjA0MjIsM=
C43NDg5OCAtMC4zNDM4MTIsMS4zNjMyNyAtMC45MDQ4MzcsMS44NDI4NSAtMC41NjEwMjMsMC40=
Nzk1OCAtMS4yNjQxNzUsMC42OTU1NiAtMi4xMDk0NTcsMC42NDc5NCAtMC44NjQwMDMsLTAuMDQ=
4NyAtMS41NTIyNzEsLTAuMzgyNjQgLTIuMDY0ODA2LC0xLjAwMTg3IC0wLjQ0NDY3MiwtMC41Mz=
c1OSAtMC42NDY5NjUsLTEuMTYyMTUgLTAuNjA2ODk4LC0xLjg3MzY4IGwgMCwwIHogbSAwLjI4O=
DYwOSwwLjA5MjcgYyAtMC4wMjc0MiwwLjQ4Njg0IDAuMTMxMTMsMC44ODc1NiAwLjQ3NTY2MSwx=
LjIwMjE0IDAuNDI4NzQ1LDAuMzkxNzkgMS4wNzY0NTYsMC42MTIxIDEuOTQzMTM0LDAuNjYwOTM=
gMC44ODgwODEsMC4wNSAxLjU4MjIzLC0wLjEwMTM3IDIuMDgyNDQ0LC0wLjQ1NDI0IDAuMzgwMj=
IzLC0wLjI3MTA2IDAuNTgzODE4LC0wLjY0NjAxIDAuNjEwNzk3LC0xLjEyNDgzIDAuMDI4NzgsL=
TAuNTEwOTEgLTAuMTQ2NzE1LC0wLjk0NDExIC0wLjUyNjUxOSwtMS4yOTk2IC0wLjM3OTgwMSwt=
MC4zNTU0OCAtMC45OTkwMjksLTAuNTU3NDEgLTEuODU3Njg3LC0wLjYwNTggLTAuOTMwODc2LC0=
wLjA1MjQgLTEuNjM1MzQ3LDAuMDkxNyAtMi4xMTM0MTMsMC40MzIzNyAtMC4zODAzNjQsMC4yNz=
M3NiAtMC41ODUxNjgsMC42NzAwOSAtMC42MTQ0MTMsMS4xODkwMyBsIDAsMCB6IG0gNy44OTM5N=
zcsLTkuOTUxMDg3IC0wLjUxNzU5NywxLjM1OTYwNCAtMy4wMzc0NzgsMC44MTc0MDQgYyAtMC4w=
NDM1OSwwLjEyOTYxNiAtMC4wODA2NiwwLjIzNDQ3NyAtMC4xMTExNzEsMC4zMTQ1OTUgLTAuMDE=
yNCwwLjAzMjU2IC0wLjAyNjM2LDAuMDY3MzggLTAuMDQxOTEsMC4xMDQ0NDUgLTAuMDE1NTUsMC=
4wMzcwOSAtMC4wMzIyMSwwLjA3NTE4IC0wLjA0OTk3LDAuMTE0MjgzIGwgMS40Nzk3OTIsMC41N=
jMzNTMgYyAwLjMyMDQ5NSwwLjEyMjAxNCAwLjUzMjg5OCwwLjE2Mjc0IDAuNjM3MjA4LDAuMTIy=
MTc5IDAuMTQ2NDEyLC0wLjA1MzE3IDAuMjU1ODEsLTAuMTc0OTU1IDAuMzI4MjU2LC0wLjM2NTI=
1IGwgMC4wNzU3NywtMC4xOTkwNTMgMC4xMzg5NiwwLjA1MjkgLTAuODMwNzI4LDIuMTgyMTI4IC=
0wLjEzODk2MSwtMC4wNTI5IDAuMDcyOTMsLTAuMTkxNTQ2IGMgMC4wODE5OCwtMC4yMTUzMjMgM=
C4wNzA0OCwtMC4zOTYwMDkgLTAuMDM0NDUsLTAuNTQyMDM3IC0wLjA1NzYxLC0wLjA4MjEzIC0w=
LjIzMTYzOSwtMC4xNzg0NzkgLTAuNTIyMDgsLTAuMjg5MDU3IGwgLTMuMjkwMDkzLC0xLjI1MjU=
yOSBjIC0wLjMyMDQ5MiwtMC4xMjIwMTEgLTAuNTMyODk1LC0wLjE2MjczNiAtMC42MzcyMDksLT=
AuMTIyMTgxIC0wLjE0NzM1OCwwLjA1NTY2IC0wLjI1NzcxMSwwLjE3OTk3NiAtMC4zMzExMTYsM=
C4zNzI3NjIgbCAtMC4wNzI5MywwLjE5MTU0NiAtMC4xMzg5NjEsLTAuMDUyOSAwLjcwNjMzNywt=
MS44NTUzNzMgYyAwLjIwNTg5OSwtMC41NDA4MzIgMC4zOTcxMzQsLTAuOTI0NTYyIDAuNTczNzA=
3LC0xLjE1MTE4NyAwLjE3NjU4MSwtMC4yMjY2MTkgMC40MDQ3MzYsLTAuMzg5MTY1IDAuNjg0ND=
Y2LC0wLjQ4NzY1MiAwLjI3OTcyOSwtMC4wOTg0OSAwLjU2NjA3NSwtMC4wOTE5NSAwLjg1OTAyO=
CwwLjAxOTU3IDAuMzEyOTg3LDAuMTE5MTU5IDAuNTQ1ODEzLDAuMzI0NjE1IDAuNjk4NDgsMC42=
MTYzNzEgMC4xNTI2NzIsMC4yOTE3NjggMC4xOTUwNzUsMC42Njk4NDMgMC4xMjcyMjQsMS4xMzQ=
yMjEgbCAxLjg2MTM2NSwtMC40OTU0MjEgYyAwLjQyNzAyNiwtMC4xMTI2NDEgMC43Mjg1MzMsLT=
AuMjM0MzEyIDAuOTA0NDU1LC0wLjM2NTIwOCAwLjE3NTk0MiwtMC4xMzA4MTYgMC4zMzE4NCwtM=
C4zMjk0NzkgMC40Njc2OTQsLTAuNTk1OTc1IGwgMC4xMzg5NiwwLjA1MjkgeiBtIC0zLjk5NDcy=
NiwyLjYyMDI1OCBjIDAuMDE4MTEsLTAuMDQ3NTggMC4wMzQ0NywtMC4wODg2NSAwLjA0OTA2LC0=
wLjEyMzIyMSAwLjAxNDYxLC0wLjAzNDU4IDAuMDI2MTgsLTAuMDYzMTMgMC4wMzQ3NywtMC4wOD=
U2NyAwLjE4NDkyNywtMC40ODU3NDkgMC4yMTkxNzMsLTAuODkxOTc2IDAuMTAyNzM4LC0xLjIxO=
DY4IC0wLjExNjQsLTAuMzI2NzEgLTAuMzM3NDAzLC0wLjU1MjAxIC0wLjY2MjkwNiwtMC42NzU5=
MzMgLTAuMzE3OTksLTAuMTIxMDUyIC0wLjYxNDQwNSwtMC4xMTk5NDMgLTAuODg5MjQ4LDAuMDA=
zMyAtMC4yNzQ4MzYsMC4xMjMyODIgLTAuNDc0Njg5LDAuMzQ4OTMyIC0wLjU5OTU2NSwwLjY3Nj=
kyOCAtMC4wNTUyOSwwLjE0NTIzMSAtMC4xMDYzMjQsMC4zNTA4MzggLTAuMTUzMTIyLDAuNjE2O=
DMxIGwgMi4xMTgyNzgsMC44MDY0MjMgeiBtIDExLjU5NjE5MSwtMTguMDUyNjk0IDEuMDUzMSwx=
LjM2NzIxOSAtMC4xMTgwNTksMC4wNzY0NiBjIC0wLjM1MjIxNiwtMC4yODI1OTkgLTAuNjgxNzU=
1LC0wLjQ1MzgwNSAtMC45ODg2MiwtMC41MTM2MTYgLTAuNDQyNSwtMC4wODY4NiAtMC44NzczNz=
ksMC4wMDgxIC0xLjMwNDY0MSwwLjI4NDc3NCAtMC41ODI0MTcsMC4zNzcyMzIgLTAuODc2MTMzL=
DAuODk0NjQxIC0wLjg4MTE0MSwxLjU1MjI0NSAtMC4wMDIxLDAuNTUzNjE2IDAuMTcwODMzLDEu=
MDk5MTQxIDAuNTE4OTM1LDEuNjM2NTc5IDAuMjgyNTQzLDAuNDM2MjU5IDAuNjI0NjcsMC43Nzk=
2NjQgMS4wMjYzNTcsMS4wMzAyMjYgMC40MDE2ODUsMC4yNTA1NjQgMC43OTMzOTEsMC4zNzExMy=
AxLjE3NTExNywwLjM2MTcwMiAwLjM4MTcyNSwtMC4wMDk0IDAuNzE2NTA2LC0wLjEwNzM1MSAxL=
jAwNDM0NiwtMC4yOTM3NzYgMC4xNjg2NDUsLTAuMTA5MjMxIDAuMzE3ODUsLTAuMjM2MTg5IDAu=
NDQ3NTkxLC0wLjM4MDg2OCAwLjEyOTczMywtMC4xNDQ2NzMgMC4yNDA3NDIsLTAuMzA1OTQ4IDA=
uMzMzMDI1LC0wLjQ4MzgyMyBsIC0wLjg1NjM5MSwtMS4zMjIyNTIgYyAtMC4xNDg1NjIsLTAuMj=
I5MzY0IC0wLjI2MzIwOCwtMC4zNjgxOCAtMC4zNDM5MzUsLTAuNDE2NDQ1IC0wLjA4MDc1LC0wL=
jA0ODI1IC0wLjE2OTY2MiwtMC4wNjcyNiAtMC4yNjY3NzEsLTAuMDU3MDQgLTAuMDk3MTEsMC4w=
MTAyMyAtMC4yMzc4NDksMC4wNzUxMyAtMC40MjIyNjgsMC4xOTQ0ODQgbCAtMC4wODMwMiwtMC4=
xMjgxNjggMS43NzA4NzIsLTEuMTQ2OTUzIDAuMDgzMDIsMC4xMjgxNjcgLTAuMDg0MzIsMC4wNT=
Q2MiBjIC0wLjE3NTQwNSwwLjExMzYwMSAtMC4yNTc4NCwwLjI1MDAwMiAtMC4yNDczMTcsMC40M=
DkxNjEgMC4wMDg5LDAuMTEyMzMyIDAuMDkyNzQsMC4yOTEwNiAwLjI1MTUsMC41MzYxNjYgbCAw=
LjkwNjY0MSwxLjM5OTgzMSBjIC0wLjE2ODMwOSwwLjMwNjkxNiAtMC4zNTcyNzEsMC41NzQ1NDE=
gLTAuNTY2ODg3LDAuODAyODczIC0wLjIwOTYyNCwwLjIyODMzNyAtMC40Njg0NzIsMC40NDIyNz=
MgLTAuNzc2NTQ1LDAuNjQxODAzIC0wLjg4Mzc1MSwwLjU3MjM4NSAtMS43Mzg1MDcsMC43MjM3O=
TkgLTIuNTY0MjczLDAuNDU0MjMyIC0wLjYxOTMyNCwtMC4yMDIxNzEgLTEuMTA4ODU4LC0wLjU4=
MDk3NSAtMS40Njg2MDIsLTEuMTM2NDEzIC0wLjI2MDY5NCwtMC40MDI1MjIgLTAuNDEzNzg4LC0=
wLjg1MDgwNSAtMC40NTkyNDEsLTEuMzQ0ODU4IC0wLjA1NDYzLC0wLjU4NzA1NyAwLjA0MTcyLC=
0xLjEyODI2OCAwLjI4OTA2NSwtMS42MjM2MzYgMC4yMDgzNDksLTAuNDEyNjQ1IDAuNTQwNzY5L=
C0wLjc2Njc5OCAwLjk5NzI2MiwtMS4wNjI0NjUgMC4xNjY0MDIsLTAuMTA3NzY0IDAuMzI2Mzcz=
LC0wLjE5MjIxNiAwLjQ3OTg5OCwtMC4yNTMzNTEgMC4xNTM1MTIsLTAuMDYxMiAwLjM4NDk2OCw=
tMC4xMjYzNyAwLjY5NDI3MywtMC4xOTU5MDQgMC4xNTY0NzQsLTAuMDM0NDEgMC4yNTYxMSwtMC=
4wNjU0IDAuMjk4ODc1LC0wLjA5Mjk3IDAuMDQyNjksLTAuMDI3NzYgMC4wNjY1MywtMC4wNzEgM=
C4wNzEzOCwtMC4xMzAwMjkgMC4wMDQ5LC0wLjA1OSAtMC4wMjY0NywtMC4xNDgwNDcgLTAuMDk0=
MDQsLTAuMjY3MDg5IGwgMC4xMjQ4MDEsLTAuMDgwODMgeiBtIDguODczNDY5LDAuNjE0NDIgLTI=
uMDM5LDAuNTQyMTk1IC0wLjEzNjMsMC45MjYxNDkgYyAtMC4wMzM2NCwwLjIyNzk2OSAtMC4wMz=
cwMywwLjM5MjQyMyAtMC4wMTAxOSwwLjQ5MzQwNCAwLjAyMTI2LDAuMDgwMjkgMC4wNzgyOSwwL=
jE0MDY2OCAwLjE3MDg1NywwLjE4MTIwMSAwLjA5MjU3LDAuMDQwNTMgMC4yNjgxMTgsMC4wMzYx=
MiAwLjUyNjY4NCwtMC4wMTMyMiBsIDAuMDM4MTcsMC4xNDM3MTUgLTEuNjU4Mzg4LDAuNDQwOTg=
xIC0wLjAzODE3LC0wLjE0MzcxNSBjIDAuMjA5NzU1LC0wLjA5NzM2IDAuMzM4NzMyLC0wLjE4NT=
cyMyAwLjM4Njk0MiwtMC4yNjUwNjYgMC4wOTksLTAuMTU5Mzk3IDAuMTc4MTYyLC0wLjQ1MDc0M=
yAwLjIzNzQ4NSwtMC44NzQwNDMgbCAwLjcwMDAxOSwtNC44MjY5NTQgMC4xMzU5MSwtMC4wMzYy=
IDIuOTk4MTA3LDMuODkzNDc1IGMgMC4yNDEyMiwwLjMxMjg5IDAuNDM1OTcsMC41MDU3NTYgMC4=
1ODQyNiwwLjU3ODYgMC4xNDgyNywwLjA3Mjg1IDAuMzMxNTksMC4wODcxOCAwLjU0OTk0LDAuMD=
QyOTcgbCAwLjAzODIsMC4xNDM3MTUgLTIuMDc3ODQ0LDAuNTUyNTE2IC0wLjAzODE3LC0wLjE0M=
zcxNSBjIDAuMjA2OTgsLTAuMDY2MDkgMC4zMzk0MywtMC4xMzg3ODEgMC4zOTczODQsLTAuMjE3=
OTYxIDAuMDU4LC0wLjA3OTE4IDAuMDc1NiwtMC4xNjE0ODggMC4wNTI5LC0wLjI0NjkyNiAtMC4=
wMzAzLC0wLjExMzkxNCAtMC4xMjk5MjksLTAuMjgwMTAzIC0wLjI5ODg5NiwtMC40OTg1NDIgbC=
AtMC41MTk4NjEsLTAuNjcyNjU3IHogbSAtMC4xODUxNjIsLTAuMjU4NDg2IC0xLjQ1OTIyNiwtM=
S44OTA3OTIgLTAuMzUwNjMsMi4zNzIwNTcgMS44MDk4NTUsLTAuNDgxMjY3IHogbSA5LjYyMDg4=
OCwtMC4wMjgyOCAwLjEzMTQzLDAuMDMzMjcgLTAuNTIzMzIsMS40NTk2NjggLTQuMjE2NTIsLTA=
uMTY0MDM1IDAuMDA2LC0wLjE0ODU4NCAwLjIwNDgxLDAuMDA4IGMgMC4yMzAyMywwLjAwOSAwLj=
M5Nzc5LC0wLjA1OTYgMC41MDI2OCwtMC4yMDU2NyAwLjA1OTYsLTAuMDgzNDkgMC4wOTU0LC0wL=
jI4MDQ5NCAwLjEwNzQ1LC0wLjU5MTA0OSBsIDAuMTM2NywtMy41MTM3NyBjIDAuMDEzMiwtMC4z=
Mzk5OTYgLTAuMDE2LC0wLjU1NDI4MiAtMC4wODc2LC0wLjY0Mjg3MyAtMC4wOTk4LC0wLjEyMTg=
2MiAtMC4yNTI4MSwtMC4xODY3OTMgLTAuNDU4OTUsLTAuMTk0ODEzIGwgLTAuMjA0ODEsLTAuMD=
A4IDAuMDA2LC0wLjE0ODU4NCAyLjQ2NTY3LDAuMDk1OTIgLTAuMDA2LDAuMTQ4NTg0IGMgLTAuM=
jg5MDMsLTAuMDEzOTIgLTAuNDkyODcsMC4wMDUgLTAuNjExNTEsMC4wNTY2NCAtMC4xMTg2NSww=
LjA1MTY5IC0wLjIwMTA1LDAuMTE5NTQ1IC0wLjI0NzIxLDAuMjAzNTQxIC0wLjA0NjIsMC4wODQ=
wMiAtMC4wNzU2LDAuMjg3OTc5IC0wLjA4ODIsMC42MTE5MDkgbCAtMC4xMzMxLDMuNDIxNDA4IG=
MgLTAuMDA5LDAuMjIyMjA1IDAuMDA3LDAuMzc1NjMzIDAuMDQ2NSwwLjQ2MDI5MSAwLjAyOTksM=
C4wNTc0OSAwLjA3NzgsMC4xMDA4ODYgMC4xNDM3NCwwLjEzMDI2MSAwLjA2NTksMC4wMjkzOCAw=
LjI3NDE4LDAuMDUwODggMC42MjQ4OSwwLjA2NDUzIGwgMC4zOTc1NiwwLjAxNTQ3IGMgMC40MTc=
2NCwwLjAxNjI2IDAuNzExOTgsLTAuMDAzMSAwLjg4MzA0LC0wLjA1ODE1IDAuMTcxMDksLTAuMD=
U0OTMgMC4zMjkyNCwtMC4xNTgxMDggMC40NzQ1NCwtMC4zMDkzMjIgMC4xNDUzLC0wLjE1MTE5M=
SAwLjI5NDEyLC0wLjM5Mjc1MSAwLjQ0NjQ2LC0wLjcyNDY1NyBsIDAsMCB6IG0gNy4yNTczMywx=
Ljk0MTk5NCAwLjExNzA3LDAuMDY4MzUgLTAuOTA2OTIsMS4yNTc3NjggLTQuMDA2MzUsLTEuMzI=
0ODE5IDAuMDQ2NywtMC4xNDExNzYgMC4xOTQ2LDAuMDY0MzYgYyAwLjIxODc1LDAuMDcyMzQgMC=
4zOTg3NCwwLjA1Mjg0IDAuNTM5OTcsLTAuMDU4NDcgMC4wODAzLC0wLjA2Mzc0IDAuMTY5MjksL=
TAuMjQzMTQyIDAuMjY2ODYsLTAuNTM4MjA4IGwgMS4xMDQwMiwtMy4zMzg2MjUgYyAwLjEwNjgy=
LC0wLjMyMzA0NiAwLjEzODA4LC0wLjUzNzA0NyAwLjA5MzgsLTAuNjQyMDA1IC0wLjA2MjIsLTA=
uMTQ0NzI2IC0wLjE5MTIzLC0wLjI0OTQ2OSAtMC4zODcwOSwtMC4zMTQyNDQgbCAtMC4xOTQ2LC=
0wLjA2NDM2IDAuMDQ2NywtMC4xNDExNzYgMi4zNDI3NiwwLjc3NDcwMyAtMC4wNDY3LDAuMTQxM=
Tc2IGMgLTAuMjczODgsLTAuMDkzMzkgLTAuNDc0OTgsLTAuMTMxNjY0IC0wLjYwMzI5LC0wLjEx=
NDg0IC0wLjEyODMxLDAuMDE2ODQgLTAuMjI2MjUsMC4wNTkzMSAtMC4yOTM5LDAuMTI3MTUgLTA=
uMDY3NiwwLjA2Nzk0IC0wLjE1MjMxLDAuMjU1ODE1IC0wLjI1NDA5LDAuNTYzNTk0IGwgLTEuMD=
c1LDMuMjUwODY3IGMgLTAuMDY5OCwwLjIxMTEyIC0wLjA5NzQsMC4zNjI4NDggLTAuMDgyOCwwL=
jQ1NTE2MiAwLjAxMjgsMC4wNjM1MiAwLjA0NjksMC4xMTg1MTUgMC4xMDIwNiwwLjE2NDk3MyAw=
LjA1NTIsMC4wNDY0NyAwLjI0OTM5LDAuMTI0NzkxIDAuNTgyNjEsMC4yMzQ5ODcgbCAwLjM3Nzc=
0LDAuMTI0OTEyIGMgMC4zOTY4MiwwLjEzMTIyIDAuNjg1MDMsMC4xOTQwNzMgMC44NjQ2MywwLj=
E4ODU2MiAwLjE3OTU5LC0wLjAwNTUgMC4zNjAxNCwtMC4wNjA4MSAwLjU0MTYzLC0wLjE2NTgzN=
iAwLjE4MTQ4LC0wLjEwNTA2NyAwLjM5MTM1LC0wLjI5NTk4OCAwLjYyOTYxLC0wLjU3Mjc1MyBs=
IDAsMCB6IG0gNS44NDg2NywzLjA5NzI1OCAtMS43MjIxMywtMS4yMTg5MTYgLTAuNzk4NjQsMC4=
0ODgzNzMgYyAtMC4xOTY2NCwwLjEyMDEyOCAtMC4zMjUxMywwLjIyMjg1MiAtMC4zODU0OSwwLj=
MwODEzMyAtMC4wNDgsMC4wNjc3OSAtMC4wNTc5LDAuMTUwMjEyIC0wLjAyOTgsMC4yNDcyNjMgM=
C4wMjgyLDAuMDk3MDQgMC4xNDM5NSwwLjIyOTA3MyAwLjM0NzQyLDAuMzk2MDcxIGwgLTAuMDg1=
OSwwLjEyMTM3OCAtMS40MDA2NywtMC45OTEzODUgMC4wODU5LC0wLjEyMTM3MSBjIDAuMjA5MSw=
wLjA5ODc1IDAuMzU5NTYsMC4xNDEyNTEgMC40NTEzOCwwLjEyNzQ2MiAwLjE4NTgyLC0wLjAyNj=
A0IDAuNDYwMjgsLTAuMTUxODE5IDAuODIzNDEsLTAuMzc3Mjg5IGwgNC4xNTU3NCwtMi41NTMyO=
DkgMC4xMTQ4MSwwLjA4MTI2IC0xLjA3MDY1LDQuNzk1OTg2IGMgLTAuMDg1OCwwLjM4NTYzMyAt=
MC4xMDkyOCwwLjY1ODcyMyAtMC4wNzAzLDAuODE5MjY2IDAuMDM5LDAuMTYwNTI3IDAuMTQ1Mzk=
sMC4zMTA1MDcgMC4zMTkxNSwwLjQ0OTkxOSBsIC0wLjA4NTksMC4xMjEzNzcgLTEuNzU0OTQsLT=
EuMjQyMTMzIDAuMDg1OSwtMC4xMjEzNzcgYyAwLjE4MzMxLDAuMTE2NjM0IDAuMzIzOTQsMC4xN=
zE4NDYgMC40MjE4NywwLjE2NTY2NCAwLjA5NzksLTAuMDA2MiAwLjE3MjQxLC0wLjA0NTM5IDAu=
MjIzNTEsLTAuMTE3NTIxIDAuMDY4MSwtMC4wOTYyMyAwLjEzMTkzLC0wLjI3OTE2MyAwLjE5MTU=
xLC0wLjU0ODgyNCBsIDAuMTgzNzYsLTAuODMwMDMyIHogbSAwLjA4LC0wLjMwNzc0NyAwLjUxNz=
g1LC0yLjMzMTU4IC0yLjA0NjQ1LDEuMjQ5NjQ3IDEuNTI4NiwxLjA4MTkzMyB6IG0gNi40NjI3M=
iwxLjE5MTAyNiAwLjg4MDY2LDEuMTg4MTEyIC0xLjI5OTU4LDUuMTEwMjYgMi41MjQ3NCwtMS44=
NzEzOTkgYyAwLjI2OTA0LC0wLjE5OTQxOSAwLjQxNDU5LC0wLjM1Mzk5MiAwLjQzNjY1LC0wLjQ=
2MzcyNCAwLjAzMTQsLTAuMTQ2NjMxIC0wLjAxNjgsLTAuMzA2MDY1IC0wLjE0NDM5LC0wLjQ3OD=
I1MyBsIC0wLjExMjQ2LC0wLjE1MTc0MiAwLjExOTQ2LC0wLjA4ODU0IDEuMTI5NTQsMS41MjM4O=
DQgLTAuMTE5NDYsMC4wODg1NCAtMC4xMTQ4NywtMC4xNTQ5NzIgYyAtMC4xMzcyMSwtMC4xODUx=
MDkgLTAuMjkwNDksLTAuMjc0OTIyIC0wLjQ1OTg1LC0wLjI2OTQ0NiAtMC4xMDM5OCwwLjAwMzc=
gLTAuMjc4NjgsMC4wOTY0IC0wLjUyNDAxLDAuMjc4Mzc0IGwgLTMuNjkwMjYsMi43MzUzMDYgLT=
AuMDg2MiwtMC4xMTYyMjMgMS4zODYxNywtNS40OTk1OTggLTIuNjk1ODYsMS45OTgyMzMgYyAtM=
C4yNjkwNSwwLjE5OTQyIC0wLjQxNTM5LDAuMzUyOTE2IC0wLjQzOTA0LDAuNDYwNDk1IC0wLjAy=
OTgsMC4xNDg3OSAwLjAxODMsMC4zMDgyMTUgMC4xNDQzOSwwLjQ3ODI1NCBsIDAuMTE0ODcsMC4=
xNTQ5NzIgLTAuMTE5NDYsMC4wODg1NCAtMS4xMjk1NCwtMS41MjM4ODUgMC4xMTk0NiwtMC4wOD=
g1NCAwLjExMjQ3LDAuMTUxNzQyIGMgMC4xMzg3OSwwLjE4NzI1OCAwLjI5Mjg3LDAuMjc4MTUgM=
C40NjIyMywwLjI3MjY3NCAwLjEwMzk3LC0wLjAwMzcgMC4yNzg2OCwtMC4wOTY0IDAuNTI0MDIs=
LTAuMjc4MzU0IGwgMy4wNDQ1NCwtMi4yNTY2ODkgYyAwLjA1NDQsLTAuMjM3MDY5IDAuMDgwOSw=
tMC40MDU5NzkgMC4wNzk2LC0wLjUwNjcyNyAtMC4wMDEsLTAuMTAwNzQ4IC0wLjAyODYsLTAuMj=
I5NzY3IC0wLjA4MTgsLTAuMzg3MDc0IC0wLjAyNjksLTAuMDc2NzcgLTAuMDg3NCwtMC4xNzg2N=
jYgLTAuMTgxNTQsLTAuMzA1NjQ5IGwgMC4xMTk0NiwtMC4wODg1NCB6IG0gNi44NzEwMiwxMi42=
NjI0MTkgLTEuMTg0NjgsMC40ODMwOTEgLTAuMDUwOCwtMC4xNDQwMDIgYyAwLjIwMjMzLC0wLjE=
wMjg1MiAwLjM0MDQ3LC0wLjE5NDM1NiAwLjQxNDQyLC0wLjI3NDUxMSAwLjExODc5LC0wLjEzMD=
EzNCAwLjE4OTksLTAuMjcyNTI4IDAuMjEzMzQsLTAuNDI3MTcxIDAuMDIzNCwtMC4xNTQ2NDkgL=
TAuMDAyLC0wLjMzODA2IC0wLjA3NzQsLTAuNTUwMjIyIGwgLTAuMjU2MSwtMC43MjM2MDcgLTMu=
OTI1MDIsMS4zODg3MTggYyAtMC4zMTU3NCwwLjExMTY0IC0wLjUwMDY2LDAuMjE1NDk4IC0wLjU=
1NDgzLDAuMzExMzk3IC0wLjA3MjEsMC4xMzM1MTIgLTAuMDcyOSwwLjMwMDAzMiAtMC4wMDIsMC=
40OTk1NjggbCAwLjA2MjksMC4xNzgwODUgLTAuMTQwMTgsMC4wNDk1NyAtMC43NzA3NiwtMi4xN=
zg0NiAwLjE0MDE5LC0wLjA0OTU3IDAuMDY0NCwwLjE4MTg0NCBjIDAuMDc2OSwwLjIxNzE5OSAw=
LjE5NzAzLDAuMzQ4MDUyIDAuMzYwNTQsMC4zOTI1MDggMC4xMDA0OCwwLjAyNjk3IDAuMjk0Nyw=
tMC4wMTA0NyAwLjU4MjYzLC0wLjExMjM2NSBsIDMuOTI1MDIsLTEuMzg4NzE3IC0wLjIxODQsLT=
AuNjE3NTc2IGMgLTAuMDg0OSwtMC4yMzk5MzMgLTAuMTYyOTEsLTAuNDA0MTc4IC0wLjIzNDAxL=
C0wLjQ5MjY5OCAtMC4wOTQ0LC0wLjExNDM1NiAtMC4yMjY0MywtMC4xOTQxMzYgLTAuMzk1ODcs=
LTAuMjM5MzM0IC0wLjE2OTQ2LC0wLjA0NTIgLTAuMzczNSwtMC4wMzU1NCAtMC42MTIxMiwwLjA=
yOSBsIC0wLjA1MDgsLTAuMTQ0MDAyIDEuMjI2MjMsLTAuMzY1NjM5IDEuNDgzODksNC4xOTQwMT=
EgeiBtIC00LjMxMzU2LDkuNjY1OTE5IC0wLjA3NTUsLTEuNDUyODQgMi40NDg3LC0xLjk3NDQxI=
GMgLTAuMDEyNSwtMC4xMzYxOCAtMC4wMjA5LC0wLjI0NzA3IC0wLjAyNTQsLTAuMzMyNjggLTAu=
MDAyLC0wLjAzNDggLTAuMDAzLC0wLjA3MjIgLTAuMDA0LC0wLjExMjQ3IC02LjdlLTQsLTAuMDQ=
wMiAtOS4xZS00LC0wLjA4MTggLTQuNWUtNCwtMC4xMjQ3NCBsIC0xLjU4MTI2LDAuMDgyMiBjIC=
0wLjM0MjQ3LDAuMDE3OCAtMC41NTMyMywwLjA2NjMgLTAuNjMyMjgsMC4xNDU1NSAtMC4xMTI0N=
SwwLjEwNzc5IC0wLjE2MzM3LDAuMjYzMzYgLTAuMTUyOCwwLjQ2NjcxIGwgMC4wMTExLDAuMjEy=
NzEgLTAuMTQ4NDksMC4wMDggLTAuMTIxMjIsLTIuMzMxNzYgMC4xNDg0OSwtMC4wMDggMC4wMTA=
2LDAuMjA0NjkgYyAwLjAxMiwwLjIzMDEgMC4wOTU0LDAuMzkwNzUgMC4yNTA0MiwwLjQ4MTk1ID=
AuMDg1OSwwLjA1MTkgMC4yODM5NywwLjA2OTcgMC41OTQzNCwwLjA1MzYgbCAzLjUxNTcsLTAuM=
TgyNzYgYyAwLjM0MjQ3LC0wLjAxNzggMC41NTMyMywtMC4wNjYzIDAuNjMyMjksLTAuMTQ1NTQg=
MC4xMTIyOCwtMC4xMTA0NyAwLjE2MzA5LC0wLjI2ODcxIDAuMTUyMzgsLTAuNDc0NzMgbCAtMC4=
wMTA2LC0wLjIwNDY3IDAuMTQ4NDksLTAuMDA4IDAuMTAzMDcsMS45ODI2IGMgMC4wMywwLjU3Nz=
kyIDAuMDEsMS4wMDYxOSAtMC4wNiwxLjI4NDgyIC0wLjA3LDAuMjc4NjMgLTAuMjEzMTEsMC41M=
Tk0NyAtMC40MjkyNCwwLjcyMjUzIC0wLjIxNjE1LDAuMjAzMDUgLTAuNDgwNzQsMC4zMTI3MiAt=
MC43OTM3OCwwLjMyODk5IC0wLjMzNDQ0LDAuMDE3NCAtMC42MzA0MSwtMC4wNzY1IC0wLjg4Nzk=
sLTAuMjgxODEgLTAuMjU3NDksLTAuMjA1MjYgLTAuNDQ4OTYsLTAuNTM0MDEgLTAuNTc0NDIsLT=
AuOTg2MjUgbCAtMS41MDI3NywxLjIwNDkgYyAtMC4zNDUxOCwwLjI3NTQ5IC0wLjU3MTgzLDAuN=
TA4NjEgLTAuNjc5OTUsMC42OTkzNCAtMC4xMDgxMiwwLjE5MDczIC0wLjE3MDUzLDAuNDM1NDMg=
LTAuMTg3MiwwLjczNDA5IGwgLTAuMTQ4NDksMC4wMDggeiBtIDIuNTk2MzksLTQuMDEwMjkgYyA=
wLjAwMywwLjA1MDggMC4wMDQsMC4wOTUgMC4wMDUsMC4xMzI1NCA2LjRlLTQsMC4wMzc1IDAuMD=
AyLDAuMDY4MyAwLjAwMywwLjA5MjQgMC4wMjcsMC41MTkwNiAwLjE1OTcsMC45MDQ1MiAwLjM5O=
DA2LDEuMTU2NDEgMC4yMzg0NSwwLjI1MTg2IDAuNTMxNTgsMC4zNjg3NSAwLjg3OTQxLDAuMzUw=
NjcgMC4zMzk3OSwtMC4wMTc3IDAuNjEwNTIsLTAuMTM4MzggMC44MTIxNywtMC4zNjIxNSAwLjI=
wMTY0LC0wLjIyMzc4IDAuMjkzMzYsLTAuNTEwOSAwLjI3NTE0LC0wLjg2MTQgLTAuMDA4LC0wLj=
E1NTE5IC0wLjA0NDQsLTAuMzYzOSAtMC4xMDkwMiwtMC42MjYxMyBsIC0yLjI2MzUzLDAuMTE3N=
jcgeiBtIDEuNDk0MTMsMTEuMjEwMDggLTAuNDgyMzksMS44Mzg2NSAtMC4xNDM4MiwtMC4wMzc3=
IDAuMDI2NSwtMC4xMDEwNiBjIDAuMDE3NywtMC4wNjc0IDAuMDEzNywtMC4xNzM2OCAtMC4wMTE=
5LC0wLjMxODg5IC0wLjAyNTYsLTAuMTQ1MjEgLTAuMDgwMywtMC4yODU1NSAtMC4xNjM3NiwtMC=
40MjEwNCAtMC4wODM2LC0wLjEzNTUgLTAuMjMwNjMsLTAuMzEzOTYgLTAuNDQxMiwtMC41MzUzO=
SBsIC0xLjY2ODQyLC0xLjc5NjM1IC0xLjMyMTY1LC0wLjM0Njc2IGMgLTAuMzIzOTQsLTAuMDg1=
IC0wLjUzNTU5LC0wLjEwMTc0IC0wLjYzNDk2LC0wLjA1MDMgLTAuMTM0NjgsMC4wNjk5IC0wLjI=
yOTksMC4yMTExMyAtMC4yODU2NSwwLjQyMzYzIGwgLTAuMDQ0OSwwLjE3MTA0IC0wLjE0MzgyLC=
0wLjAzNzcgMC41ODc0NCwtMi4yMzkwNCAwLjE0MzgyLDAuMDM3NyAtMC4wNDksMC4xODY2IGMgL=
TAuMDU4NSwwLjIyMjg1IC0wLjAzMjYsMC4zOTg2MiAwLjA3NzcsMC41MjcyNyAwLjA2OCwwLjA3=
ODggMC4yNDk2NywwLjE1NjkxIDAuNTQ1MDksMC4yMzQ0MiBsIDEuMjQ3OCwwLjMyNzM3IDIuNTg=
3MzMsLTAuODY2NzYgYyAwLjMwNDAxLC0wLjEwMzA1IDAuNDk2NDEsLTAuMTc2NTEgMC41NzcxNy=
wtMC4yMjA0MyAwLjA4MDcsLTAuMDQ0IDAuMTkxNjUsLTAuMTQ5ODMgMC4zMzI2NywtMC4zMTc4M=
iAwLjAzOTUsLTAuMDQ1IDAuMDcyMiwtMC4xMTY3NyAwLjA5OCwtMC4yMTUyNSBsIDAuMTQzODMs=
MC4wMzc4IC0wLjU5MTUyLDIuMjU0NTggLTAuMTQzODIsLTAuMDM3NyAwLjAzMDYsLTAuMTE2NjI=
gYyAwLjAzMTksLTAuMTIxODEgMC4wMzI4LC0wLjI0MTM2IDAuMDAzLC0wLjM1ODY4IC0wLjAzMD=
IsLTAuMTE3MzEgLTAuMTAyMjUsLTAuMTkwOTUgLTAuMjE2MjgsLTAuMjIwODYgLTAuMDkzMywtM=
C4wMjQ1IC0wLjI4MjQ4LDAuMDEwNCAtMC41Njc1NSwwLjEwNDU0IGwgLTEuOTg3MzYsMC42NTQz=
MSAxLjM1MzU3LDEuNDYwMzEgYyAwLjIwMjc5LDAuMjE5MzkgMC4zNjM4LDAuMzQ0NzMgMC40ODM=
wMSwwLjM3NjAxIDAuMDcyNiwwLjAxOSAwLjE0MjI3LDAuMDE3MiAwLjIwOTE1LC0wLjAwNSAwLj=
A2NjksLTAuMDIyNiAwLjEyNTY4LC0wLjA2NDcgMC4xNzY0MywtMC4xMjYxNCAwLjA1MDgsLTAuM=
DYxNSAwLjA5NDUsLTAuMTYyMTggMC4xMzEyLC0wLjMwMjEyIGwgMC4xNDM4MiwwLjAzNzcgeiIg=
aWQ9InRleHQxOTMwIiBzdHlsZT0iZm9udC1zaXplOjRweDtmb250LWZhbWlseTpUaW1lcyBOZXc=
gUm9tYW4iLz4NCjwvc3ZnPg=3D=3D"); }

.flag-list .pt a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCA3ND=
QuMTU2IDQ5Ni4xMjU0IiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGlua=
yI+DQo8ZGVmcz4NCjxsaW5lYXJHcmFkaWVudCBpZD0ibGluZWFyR3JhZGllbnQ1NjEiIHgxPSIw=
IiBncmFkaWVudFVuaXRzPSJvYmplY3RCb3VuZGluZ0JveCIgeDI9IjEiPg0KPHN0b3Agb2Zmc2V=
0PSIwIi8+DQo8c3RvcCBvZmZzZXQ9IjEiIHN0b3AtY29sb3I9IiNmZmYiLz4NCjwvbGluZWFyR3=
JhZGllbnQ+DQo8bGluZWFyR3JhZGllbnQgZ3JhZGllbnRUcmFuc2Zvcm09InNjYWxlKC43NzQ2N=
iAxLjI5MDg5KSIgaWQ9ImxpbmVhckdyYWRpZW50NTY0IiB4bGluazpocmVmPSIjbGluZWFyR3Jh=
ZGllbnQ1NjEiIHgxPSIzNTkuNTkzIiBncmFkaWVudFVuaXRzPSJ1c2VyU3BhY2VPblVzZSIgeDI=
9IjQyMDMuMzcxIi8+DQo8L2RlZnM+DQo8ZyBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT=
0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IC0yNy44ODA4MyA2NDkuMTU0MykiPg0KPHBhdGggZ=
mlsbD0iIzA5MCIgc3Ryb2tlPSJ1cmwoI2xpbmVhckdyYWRpZW50NTY0KSIgZD0ibTI3OS4xODgt=
NjQ5OS40OWgyOTc2LjM4MnY0OTYwLjYzaC0yOTc2LjM4MnoiLz4NCjxwYXRoIGZpbGw9IiNmMDA=
iIGZpbGwtcnVsZT0iZXZlbm9kZCIgZD0ibTMyNDkuMDEtNjQ5Mi45NGg0NDY0LjU3djQ5NjAuNj=
NoLTQ0NjQuNTd6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0a=
D0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLS4wMDUzNSAuMTA3NzcgLjA0NCAtLjAwNDM1IDI3=
Mi44NzkzMSAyNC43ODQxKSI+DQo8cGF0aCBkPSJtMTUyOC4yNSwzNzYuOTEzaDE3MS41NHYyODI=
0LjE1N2gtMTcxLjU0eiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ibTE1NDguMzMsNDA0Lj=
YwMWgxMzEuMzh2Mjc2OC43ODloLTEzMS4zOHoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlb=
m9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwNTM1IC4xMDc3=
NyAuMDQ0IC0uMDA0MzUgMjcyLjgyOTE1IDI1Ljc5NTQzKSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSw=
zNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPS=
JtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpb=
GwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgt=
LjAwNTM1IC4xMDc3NyAuMDQ0IC0uMDA0MzUgMjcxLjgyNjAxIDQ2LjAyMTk1KSI+DQo8cGF0aCB=
kPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPS=
IjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NC=
jwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zv=
cm09Im1hdHJpeCgtLjAwNTM1IC4xMDc3NyAuMDQ0IC0uMDA0MzUgMjkxLjY2MzUyIDgzLjgyNDM=
zKSI+DQo8cGF0aCBkPSJtMTUyOC4yNSwzNzYuOTEzaDE3MS41NHYyODI0LjE1N2gtMTcxLjU0ei=
IvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ibTE1NDguMzMsNDA0LjYwMWgxMzEuMzh2Mjc2O=
C43ODloLTEzMS4zOHoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdp=
ZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwNTM1IC4xMDc3NyAuMDQ0IC0uMDA0MzU=
gMjkxLjYxMzM2IDg0LjgzNTY1KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mj=
g1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuM=
jk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9k=
ZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwNTM1IC4xMDc3NyA=
uMDQ0IC0uMDA0MzUgMjkwLjYxMDIyIDEwNS4wNjIxNykiPg0KPHBhdGggZD0ibTE0ODIuNjUsMz=
U3Ljk1N2g1Ni4zdjI4NTIuNjkzaC01Ni4zeiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ib=
TE1MDIuODIsMzgzLjI5NGgxNS45NnYyODAyLjAxNmgtMTUuOTZ6Ii8+DQo8L2c+DQo8ZyBmaWxs=
LXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLS4=
wMDUzNSAuMTA3NzcgLjA0NCAtLjAwNDM1IDI4NC4xNDk4MiAxNTAuMzYxNzQpIj4NCjxwYXRoIG=
Q9Im0xNTI4LjI1LDM3Ni45MTNoMTcxLjU0djI4MjQuMTU3aC0xNzEuNTR6Ii8+DQo8cGF0aCBma=
WxsPSIjZWZlZjAwIiBkPSJtMTU0OC4zMyw0MDQuNjAxaDEzMS4zOHYyNzY4Ljc4OWgtMTMxLjM4=
eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHR=
yYW5zZm9ybT0ibWF0cml4KC0uMDA1MzUgLjEwNzc3IC4wNDQgLS4wMDQzNSAyODQuMDk5NjYgMT=
UxLjM3MzA2KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2L=
jN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4=
MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXd=
pZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwNTM1IC4xMDc3NyAuMDQ0IC0uMDA0Mz=
UgMjgzLjA5NjUyIDE3MS41OTk1OSkiPg0KPHBhdGggZD0ibTE0ODIuNjUsMzU3Ljk1N2g1Ni4zd=
jI4NTIuNjkzaC01Ni4zeiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ibTE1MDIuODIsMzgz=
LjI5NGgxNS45NnYyODAyLjAxNmgtMTUuOTZ6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5=
vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjAwNTM1IC4xMDc3Ny=
AtLjA0NCAtLjAwNDM1IDMxNS45MjIyNSAxNDUuNjc2MDEpIj4NCjxwYXRoIGQ9Im0xNTI4LjI1L=
DM3Ni45MTNoMTcxLjU0djI4MjQuMTU3aC0xNzEuNTR6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAw=
IiBkPSJtMTU0OC4zMyw0MDQuNjAxaDEzMS4zOHYyNzY4Ljc4OWgtMTMxLjM4eiIvPg0KPC9nPg0=
KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibW=
F0cml4KC4wMDUzNSAuMTA3NzcgLS4wNDQgLS4wMDQzNSAzMTUuOTcyNDEgMTQ2LjY4NzMzKSI+D=
Qo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0=
aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS4=
5NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1Ii=
B0cmFuc2Zvcm09Im1hdHJpeCguMDA1MzUgLjEwNzc3IC0uMDQ0IC0uMDA0MzUgMzE2Ljk3NTU1I=
DE2Ni45MTM4NikiPg0KPHBhdGggZD0ibTE0ODIuNjUsMzU3Ljk1N2g1Ni4zdjI4NTIuNjkzaC01=
Ni4zeiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ibTE1MDIuODIsMzgzLjI5NGgxNS45NnY=
yODAyLjAxNmgtMTUuOTZ6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS=
13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLS4wMzE4OCAuMDk3MTggLS4wNDY5MiAtL=
jAwNDk5IDM2NS4yNDE5MSAxMDguNjE4NjQpIj4NCjxwYXRoIGQ9Im0xNTI4LjI1LDM3Ni45MTNo=
MTcxLjU0djI4MjQuMTU3aC0xNzEuNTR6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTU=
0OC4zMyw0MDQuNjAxaDEzMS4zOHYyNzY4Ljc4OWgtMTMxLjM4eiIvPg0KPC9nPg0KPGcgZmlsbC=
1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC0uM=
DMxODggLjA5NzE4IC0uMDQ2OTIgLS4wMDQ5OSAzNjQuOTQyNzYgMTA5LjUzMDYpIj4NCjxwYXRo=
IGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3YyODUyLjY5M2gtNTYuM3oiLz4NCjxwYXRoIGZpbGw=
9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My4yOTRoMTUuOTZ2MjgwMi4wMTZoLTE1Ljk2eiIvPg=
0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZ=
m9ybT0ibWF0cml4KC0uMDMxODggLjA5NzE4IC0uMDQ2OTIgLS4wMDQ5OSAzNTguOTU5NzEgMTI3=
Ljc2OTczKSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN=
6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MD=
IuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZ=
HRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjA3ODU2IC4wODMxNCAtLjAzNDUxIC0uMDIz=
NTUgNDE1LjYyMTQxIDEzNC40MTc1KSI+DQo8cGF0aCBkPSJtMTUyOC4yNSwzNzYuOTEzaDE3MS4=
1NHYyODI0LjE1N2gtMTcxLjU0eiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0ibTE1NDguMz=
MsNDA0LjYwMWgxMzEuMzh2Mjc2OC43ODloLTEzMS4zOHoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZ=
T0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjA3ODU2=
IC4wODMxNCAtLjAzNDUxIC0uMDIzNTUgNDE0Ljg4NDE3IDEzNS4xOTc2NSkiPg0KPHBhdGggZD0=
ibTE0ODIuNjUsMzU3Ljk1N2g1Ni4zdjI4NTIuNjkzaC01Ni4zeiIvPg0KPHBhdGggZmlsbD0iI2=
VmZWYwMCIgZD0ibTE1MDIuODIsMzgzLjI5NGgxNS45NnYyODAyLjAxNmgtMTUuOTZ6Ii8+DQo8L=
2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3Jt=
PSJtYXRyaXgoLS4wNzg1NiAuMDgzMTQgLS4wMzQ1MSAtLjAyMzU1IDQwMC4xMzk0NCAxNTAuODA=
wNjUpIj4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3YyODUyLjY5M2gtNTYuM3oiLz=
4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My4yOTRoMTUuOTZ2MjgwMi4wM=
TZoLTE1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9=
IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IDQ3OC45NTU3OSAxNTE=
uOTM2NDQpIj4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGZpbGwtb3BhY2l0eT0iMSIgZD0ibS01Nz=
YuMDIzLTY4MC4wMzRjLjQ3Miw2MTcuNTgyOS01MDAuMzM3LDExMTguODExLTExMTcuOTE3LDExM=
TguODExLTYxNy41OCwuOTgxLTExMTkuMjMtNDk5LjQ0NS0xMTE5LjctMTExNy4wMjgtMS40OS02=
MTcuNTk5IDQ5OC41My0xMTE5LjYwOSAxMTE2LjE0LTExMjAuNTg5IDYxNy41OC0xLjk2IDExMTk=
uOTg1LDQ5Ny42NyAxMTIxLjQ1MSwxMTE1LjI0MiAuMDI2LDEuMjUzIC4wMjYsMi4zMSAuMDI2LD=
MuNTY0em0yNjIuNDQtLjAwMWMuNTgyLDc2Mi40NDg3LTYxNy43MDIsMTM4MS4yNDktMTM4MC4xN=
DcsMTM4MS4yNDktNzYyLjQ0LDEuMjExLTEzODEuNzYtNjE2LjU5ODktMTM4Mi4zNC0xMzc5LjA0=
OC0xLjg1LTc2Mi40NjYgNjE1LjQ3LTEzODIuMjM2IDEzNzcuOTQtMTM4My40NDYgNzYyLjQ0OC0=
yLjQyIDEzODIuNzA1LDYxNC40MSAxMzg0LjUxNSwxMzc2Ljg0NiAuMDMyLDEuNTQ3IC4wMzIsMi=
44NTIgLjAzMiw0LjM5OXoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKC0xNDkuODU2MiAxNjkwLjUzN=
SkiLz4NCjxwYXRoIGQ9Im0yOTYuNzQ2LDI2MjUuMTNjLjU4Miw3NjIuNDUtNjE3LjcwMiwxMzgx=
LjI1LTEzODAuMTQ2LDEzODEuMjUtNzYyLjQ1LDEuMjEtMTM4MS43Ni02MTYuNi0xMzgyLjM1LTE=
zNzkuMDUtMS44NC03NjIuNDYgNjE1LjQ4LTEzODIuMjMgMTM3Ny45NS0xMzgzLjQ0IDc2Mi40ND=
ctMi40MiAxMzgyLjcwNCw2MTQuNDEgMTM4NC41MTQsMTM3Ni44NCAuMDMyLDEuNTUgLjAzMiwyL=
jg2IC4wMzIsNC40em0tMjcuNjI0LDBjLjU3LDc0Ny4yLTYwNS4zNDgsMTM1My42My0xMzUyLjU0=
MiwxMzUzLjYzLTc0Ny4yLDEuMTgtMTM1NC4xMy02MDQuMjctMTM1NC43LTEzNTEuNDctMS44MS0=
3NDcuMjEgNjAzLjE2LTEzNTQuNTkgMTM1MC4zOS0xMzU1Ljc3IDc0Ny4xOTUtMi4zOCAxMzU1Lj=
A0Niw2MDIuMTEgMTM1Ni44MiwxMzQ5LjMgLjAzMiwxLjUyIC4wMzIsMi44IC4wMzIsNC4zMXoiI=
HRyYW5zZm9ybT0ibWF0cml4KC45OCAwIDAgLjk4IC03ODEuODc1MSAtMTU2Mi4xMzIpIi8+DQo8=
cGF0aCBkPSJtMjk2Ljc0NiwyNjI1LjEzYy41ODIsNzYyLjQ1LTYxNy43MDIsMTM4MS4yNS0xMzg=
wLjE0NiwxMzgxLjI1LTc2Mi40NSwxLjIxLTEzODEuNzYtNjE2LjYtMTM4Mi4zNS0xMzc5LjA1LT=
EuODQtNzYyLjQ2IDYxNS40OC0xMzgyLjIzIDEzNzcuOTUtMTM4My40NCA3NjIuNDQ3LTIuNDIgM=
TM4Mi43MDQsNjE0LjQxIDEzODQuNTE0LDEzNzYuODQgLjAzMiwxLjU1IC4wMzIsMi44NiAuMDMy=
LDQuNHptLTI3LjYyNCwwYy41Nyw3NDcuMi02MDUuMzQ4LDEzNTMuNjMtMTM1Mi41NDIsMTM1My4=
2My03NDcuMiwxLjE4LTEzNTQuMTMtNjA0LjI3LTEzNTQuNy0xMzUxLjQ3LTEuODEtNzQ3LjIxID=
YwMy4xNi0xMzU0LjU5IDEzNTAuMzktMTM1NS43NyA3NDcuMTk1LTIuMzggMTM1NS4wNDYsNjAyL=
jExIDEzNTYuODIsMTM0OS4zIC4wMzIsMS41MiAuMDMyLDIuOCAuMDMyLDQuMzF6IiB0cmFuc2Zv=
cm09Im1hdHJpeCguODUwMTYgMCAwIC44NTAxNiAtOTIyLjY4NzMgLTEyMjEuMjg1KSIvPg0KPC9=
nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT=
0ibWF0cml4KC4xMDAwOSAwIDAgLjA5ODIzIDEzNS4yMDQ4NCA3Ny41NTI2NykiPg0KPHBhdGggZ=
D0ibTE1MjguMjUsMzc2LjkxM2gxNzEuNTR2MjgyNC4xNTdoLTE3MS41NHoiLz4NCjxwYXRoIGZp=
bGw9IiNlZmVmMDAiIGQ9Im0xNTQ4LjMzLDQwNC42MDFoMTMxLjM4djI3NjguNzg5aC0xMzEuMzh=
6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdH=
JhbnNmb3JtPSJtYXRyaXgoLjEwMDA5IDAgMCAuMDk4MjMgMTM2LjE0NDA1IDc3LjU1MjY3KSI+D=
Qo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0=
aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS4=
5NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1Ii=
B0cmFuc2Zvcm09Im1hdHJpeCguMTAwMDkgMCAwIC4wOTgyMyAxNTQuOTI4MjggNzcuNTUyNjcpI=
j4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3YyODUyLjY5M2gtNTYuM3oiLz4NCjxw=
YXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My4yOTRoMTUuOTZ2MjgwMi4wMTZoLTE=
1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMj=
UiIHRyYW5zZm9ybT0ibWF0cml4KC4wMzcxNyAuMTAxMzMgLS4wNDMzMiAuMDA4ODggMjQ5LjIzM=
zIyIDExOC40MDY5OSkiPg0KPHBhdGggZD0ibTE1MjguMjUsMzc2LjkxM2gxNzEuNTR2MjgyNC4x=
NTdoLTE3MS41NHoiLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTQ4LjMzLDQwNC42MDF=
oMTMxLjM4djI3NjguNzg5aC0xMzEuMzh6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZG=
QiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjAzNzE3IC4xMDEzMyAtL=
jA0MzMyIC4wMDg4OCAyNDkuNTgyMDQgMTE5LjM1Nzg1KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwz=
NTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJ=
tMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbG=
wtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCguM=
DM3MTcgLjEwMTMzIC0uMDQzMzIgLjAwODg4IDI1Ni41NTg2IDEzOC4zNzUxKSI+DQo8cGF0aCBk=
PSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSI=
jZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCj=
wvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvc=
m09Im1hdHJpeCguMDA0ODIgLjEwMzM5IC0uMDQ1NDIgLjAwNDkyIDI5Mi45ODQ3OCA2NC45NzY4=
NikiPg0KPHBhdGggZD0ibTE1MjguMjUsMzc2LjkxM2gxNzEuNTR2MjgyNC4xNTdoLTE3MS41NHo=
iLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTQ4LjMzLDQwNC42MDFoMTMxLjM4djI3Nj=
guNzg5aC0xMzEuMzh6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13a=
WR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjAwNDgyIC4xMDMzOSAtLjA0NTQyIC4wMDQ5=
MiAyOTMuMDMwMDMgNjUuOTQ3MDcpIj4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3Y=
yODUyLjY5M2gtNTYuM3oiLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My=
4yOTRoMTUuOTZ2MjgwMi4wMTZoLTE1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub=
2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4wMDQ4MiAuMTAzMzkg=
LS4wNDU0MiAuMDA0OTIgMjkzLjkzNTAzIDg1LjM1MTE5KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSw=
zNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPS=
JtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpb=
GwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgt=
LjA2MTk3IC4wOTYwOSAtLjAzODI1IC0uMDE2ODUgMzk1LjUwODkzIDgwLjkyMDYzKSI+DQo8cGF=
0aCBkPSJtMTUyOC4yNSwzNzYuOTEzaDE3MS41NHYyODI0LjE1N2gtMTcxLjU0eiIvPg0KPHBhdG=
ggZmlsbD0iI2VmZWYwMCIgZD0ibTE1NDguMzMsNDA0LjYwMWgxMzEuMzh2Mjc2OC43ODloLTEzM=
S4zOHoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1=
IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjA2MTk3IC4wOTYwOSAtLjAzODI1IC0uMDE2ODUgMzk0Ljk=
yNzQzIDgxLjgyMjM2KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OT=
NoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1L=
jk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ry=
b2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjA2MTk3IC4wOTYwOSAtLjAzODI=
1IC0uMDE2ODUgMzgzLjI5NzU2IDk5Ljg1Njk0KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOT=
U3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwM=
i44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVs=
ZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwMTM=
0IC4xMDMzMyAtLjA0NTY0IC0uMDAyMjEgNDUzLjYxMjgxIDY5LjM2ODgzKSI+DQo8cGF0aCBkPS=
JtMTUyOC4yNSwzNzYuOTEzaDE3MS41NHYyODI0LjE1N2gtMTcxLjU0eiIvPg0KPHBhdGggZmlsb=
D0iI2VmZWYwMCIgZD0ibTE1NDguMzMsNDA0LjYwMWgxMzEuMzh2Mjc2OC43ODloLTEzMS4zOHoi=
Lz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmF=
uc2Zvcm09Im1hdHJpeCgtLjAwMTM0IC4xMDMzMyAtLjA0NTY0IC0uMDAyMjEgNDUzLjYwMDIzID=
cwLjMzODQ3KSI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2L=
jN6Ii8+DQo8cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4=
MDIuMDE2aC0xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXd=
pZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCgtLjAwMTM0IC4xMDMzMyAtLjA0NTY0IC0uMD=
AyMjEgNDUzLjM0ODUgODkuNzMxMjMpIj4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM=
3YyODUyLjY5M2gtNTYuM3oiLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4=
My4yOTRoMTUuOTZ2MjgwMi4wMTZoLTE1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmV=
ub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4wMjk0NCAuMDkyNT=
MgLS4wMzc2OSAtLjAwMTE5IDM4MC4zMzY5OSAzNC4zNTkzNikiPg0KPHBhdGggZD0ibTE1MjguM=
jUsMzc2LjkxM2gxNzEuNTR2MjgyNC4xNTdoLTE3MS41NHoiLz4NCjxwYXRoIGZpbGw9IiNlZmVm=
MDAiIGQ9Im0xNTQ4LjMzLDQwNC42MDFoMTMxLjM4djI3NjguNzg5aC0xMzEuMzh6Ii8+DQo8L2c=
+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPS=
JtYXRyaXgoLjAyOTQ0IC4wOTI1MyAtLjAzNzY5IC0uMDAxMTkgMzgwLjYxMzI3IDM1LjIyNzY4K=
SI+DQo8cGF0aCBkPSJtMTQ4Mi42NSwzNTcuOTU3aDU2LjN2Mjg1Mi42OTNoLTU2LjN6Ii8+DQo8=
cGF0aCBmaWxsPSIjZWZlZjAwIiBkPSJtMTUwMi44MiwzODMuMjk0aDE1Ljk2djI4MDIuMDE2aC0=
xNS45NnoiLz4NCjwvZz4NCjxnIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLj=
I1IiB0cmFuc2Zvcm09Im1hdHJpeCguMDI5NDQgLjA5MjUzIC0uMDM3NjkgLS4wMDExOSAzODYuM=
TM5MDMgNTIuNTk0MTMpIj4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3YyODUyLjY5=
M2gtNTYuM3oiLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My4yOTRoMTU=
uOTZ2MjgwMi4wMTZoLTE1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbC1ydWxlPSJldmVub2RkIiBzdH=
Jva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC0uMDQ0NjggLjA5NjAzIC0uMDQyM=
DEgLS4wMTUzMyA1MDkuNTc0NDEgMTU5Ljg0NzQxKSI+DQo8cGF0aCBkPSJtMTUyOC4yNSwzNzYu=
OTEzaDE3MS41NHYyODI0LjE1N2gtMTcxLjU0eiIvPg0KPHBhdGggZmlsbD0iI2VmZWYwMCIgZD0=
ibTE1NDguMzMsNDA0LjYwMWgxMzEuMzh2Mjc2OC43ODloLTEzMS4zOHoiLz4NCjwvZz4NCjxnIG=
ZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpe=
CgtLjA0NDY4IC4wOTYwMyAtLjA0MjAxIC0uMDE1MzMgNTA5LjE1NTExIDE2MC43NDg1NCkiPg0K=
PHBhdGggZD0ibTE0ODIuNjUsMzU3Ljk1N2g1Ni4zdjI4NTIuNjkzaC01Ni4zeiIvPg0KPHBhdGg=
gZmlsbD0iI2VmZWYwMCIgZD0ibTE1MDIuODIsMzgzLjI5NGgxNS45NnYyODAyLjAxNmgtMTUuOT=
Z6Ii8+DQo8L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgd=
HJhbnNmb3JtPSJtYXRyaXgoLS4wNDQ2OCAuMDk2MDMgLS4wNDIwMSAtLjAxNTMzIDUwMC43Njg5=
NSAxNzguNzcxMjMpIj4NCjxwYXRoIGQ9Im0xNDgyLjY1LDM1Ny45NTdoNTYuM3YyODUyLjY5M2g=
tNTYuM3oiLz4NCjxwYXRoIGZpbGw9IiNlZmVmMDAiIGQ9Im0xNTAyLjgyLDM4My4yOTRoMTUuOT=
Z2MjgwMi4wMTZoLTE1Ljk2eiIvPg0KPC9nPg0KPGcgZmlsbD0iI2Y2ZjZmYiI+DQo8ZyBmaWxsL=
XJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjEw=
MDA5IDAgMCAuMDk5ODcgMjk5LjQyNzY2IDg3NS41MjExMSkiPg0KPHBhdGggZD0ibS04NTAuODk=
0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMj=
g2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvc=
m09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8=
L2c+DQo8ZyBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3J=
tPSJtYXRyaXgoLjEwMDA5IDAgMCAuMDk5ODcgLTI5Ny40NzQxNSA1MjkuNjIwNjYpIj4NCjxwYX=
RoIGQ9Im01NDc4Ljc4LTMzNDAuNzJoODU5LjA5djYzMi4zOGgtODU5LjA5eiIvPg0KPGVsbGlwc=
2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3NDAuMjExIiByeT0iNjk2LjAxOSIg=
dHJhbnNmb3JtPSJtYXRyaXgoLjU4MDMgMCAwIC41NzQyOSA0MjQ3Ljg1MiAtNTA4OC41MDYpIi8=
+DQo8L2c+DQo8L2c+DQo8ZyBmaWxsPSIjZjAwIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS=
13aWR0aD0iMS4yNSI+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDk1MDggMCAwIC4wOTQ4NyAyO=
TkuMTUwMjEgODQ0LjUyMjE2KSI+DQo8cGF0aCBkPSJtLTg1MC44OTQtNzE0Ny4wNGgxNTkwLjkw=
MXYxMTcxLjA4aC0xNTkwLjkwMXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjc=
uMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KDEuMDc0Nj=
MgMCAwIDEuMDYzNDkgLTMxMzAuMzkzIC0xMDU0Ny4zNSkiLz4NCjwvZz4NCjxnIHRyYW5zZm9yb=
T0ibWF0cml4KC4wOTUwOCAwIDAgLjA5NDg3IC0yNjcuOTA2NTEgNTE1LjkxNjczKSI+DQo8cGF0=
aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHN=
lIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIH=
RyYW5zZm9ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvP=
g0KPC9nPg0KPC9nPg0KPGcgZmlsbD0iIzQwMCIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Ut=
d2lkdGg9IjEuMjUiPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjA1Njc1IDAgMCAuMDU2NjMgMjk=
3LjAyNDc1IDYwNy4wNzA2NCkiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MD=
F2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3L=
jMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYz=
IDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm0=
9Im1hdHJpeCguMDU2NzUgMCAwIC4wNTY2MyAtNDEuNDE4NTggNDEwLjk0NTA5KSI+DQo8cGF0aC=
BkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlI=
GN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRy=
YW5zZm9ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0=
KPC9nPg0KPC9nPg0KPGcgZmlsbD0iI2ZmZiIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2=
lkdGg9IjEuMjUiPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjA1MTIyIDAgMCAuMDUxMSAyOTYuN=
zE4MDggNTcyLjc5NjgyKSI+DQo8cGF0aCBkPSJtLTg1MC44OTQtNzE0Ny4wNGgxNTkwLjkwMXYx=
MTcxLjA4aC0xNTkwLjkwMXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA=
4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KDEuMDc0NjMgMC=
AwIDEuMDYzNDkgLTMxMzAuMzkzIC0xMDU0Ny4zNSkiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT0ib=
WF0cml4KC4wNTEyMiAwIDAgLjA1MTEgLTguNzI2NzMgMzk1Ljc5MzY4KSI+DQo8cGF0aCBkPSJt=
NTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSI=
yODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm=
9ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nP=
g0KPC9nPg0KPGcgZmlsbD0iIzNiM2JmZiIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lk=
dGg9IjEuMjUiPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNTAxIDAgMCAuMDE0OTggMjk1LjM=
yODU2IDM3OC41ODg5NykiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MT=
E3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwO=
CIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAg=
MCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1=
hdHJpeCguMDE1MDEgMCAwIC4wMTQ5OCAyMDUuNzkzMjkgMzI2LjcwMzkxKSI+DQo8cGF0aCBkPS=
JtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4P=
SIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5z=
Zm9ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9=
nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNDI2IDAgMCAuMDE0MjMgMjk1LjI4Njk1IDM3My=
45MzkxMykiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtM=
TU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0=
MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ=
5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMD=
E0MjYgMCAwIC4wMTQyMyAyMTAuMjI4NDQgMzI0LjY0ODMyKSI+DQo8cGF0aCBkPSJtNTQ3OC43O=
C0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQx=
MiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF=
0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdH=
JhbnNmb3JtPSJtYXRyaXgoLjAwODUxIDAgMCAuMDA4NDkgMjk0Ljk2ODEzIDMzOC4zMjE0KSI+D=
Qo8cGF0aCBkPSJtLTg1MC44OTQtNzE0Ny4wNGgxNTkwLjkwMXYxMTcxLjA4aC0xNTkwLjkwMXoi=
Lz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk=
9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KDEuMDc0NjMgMCAwIDEuMDYzNDkgLTMxMzAuMz=
kzIC0xMDU0Ny4zNSkiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4wMDg1MSAwIDAgL=
jAwODQ5IDI0NC4yMDE2MyAzMDguOTAyNTcpIj4NCjxwYXRoIGQ9Im01NDc4Ljc4LTMzNDAuNzJo=
ODU5LjA5djYzMi4zOGgtODU5LjA5eiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI=
2Ny4zMDgiIHJ4PSI3NDAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoLjU4MD=
MgMCAwIC41NzQyOSA0MjQ3Ljg1MiAtNTA4OC41MDYpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09I=
m1hdHJpeCguMDA3NjggMCAwIC4wMDc2NyAyOTQuOTIyMTMgMzMzLjE4MDMzKSI+DQo8cGF0aCBk=
PSJtLTg1MC44OTQtNzE0Ny4wNGgxNTkwLjkwMXYxMTcxLjA4aC0xNTkwLjkwMXoiLz4NCjxlbGx=
pcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMT=
kiIHRyYW5zZm9ybT0ibWF0cml4KDEuMDc0NjMgMCAwIDEuMDYzNDkgLTMxMzAuMzkzIC0xMDU0N=
y4zNSkiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4wMDc2OCAwIDAgLjAwNzY3IDI0=
OS4xMDU0MSAzMDYuNjI5ODYpIj4NCjxwYXRoIGQ9Im01NDc4Ljc4LTMzNDAuNzJoODU5LjA5djY=
zMi4zOGgtODU5LjA5eiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIH=
J4PSI3NDAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoLjU4MDMgMCAwIC41N=
zQyOSA0MjQ3Ljg1MiAtNTA4OC41MDYpIi8+DQo8L2c+DQo8L2c+DQo8ZyBmaWxsPSIjZmZmIiBm=
aWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXg=
oLjEwMDA5IDAgMCAuMDk5ODcgLTIuODU3ODMgNDYyLjQ5NDY5KSI+DQo8ZWxsaXBzZSBjeD0iMj=
kwMy4wMTciIGN5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9yb=
T0idHJhbnNsYXRlKC0zLjc4MTc0IC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTci=
IGN5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnN=
sYXRlKDEyOS45ODkxIC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSItMT=
g1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDYxL=
jkyMjA0IDY3LjU5NDU3KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5=
IiByeD0iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxLjQxNzg5IDE=
0MC4zODg1KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0iMz=
UuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMjguNTcxNiAxNDIuNzUyK=
SIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjEwMDA5IDAgMCAuMDk5ODcgMTM0LjI2=
NTYzIDcyLjI3ODk4KSI+DQo8cGF0aCBmaWxsPSIjZmYwIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN=
0cm9rZS13aWR0aD0iMS4yNSIgZD0ibS00MzMuOSw1NDUuMDQydjIyLjY4OWgzMDIuNTE5bC0wLT=
IyLjY4OWgtMzAyLjUxOXptMjYuMjQ5LTYyLjYwMXY2My4xNTJoMjU3LjE0M2wtMC02My4xNTJoL=
TI1Ny4xNDN6bS0yMi42ODgsMjA3LjYxOXYyMi42OTJoMzAyLjUxOXYtMjIuNjkyaC0zMDIuNTE5=
em04MS4wNjktNy4wMTdjLS4wMzEtNDEuMTkxIDMxLjYyMi03NC42MjEgNzAuNjU0LTc0LjYyMSA=
zOS4wMzMtLjA2NiA3MC43MzcsMzMuMzExIDcwLjc2OCw3NC41MDIgMCwuMzI3LS4wMDEsLjYwMi=
0uMDA0LC45MjhtLTE0OS4yNzUsMy4yOTJjLS4wMzQtNDUuNzY5IDM1LjEzNi04Mi45MTMgNzguN=
TA1LTgyLjkxMyA0My4zNy0uMDczIDc4LjU5NiwzNy4wMTIgNzguNjMsODIuNzggLjAwMSwuMzYz=
IDAsLjY2OS0uMDA0LDEuMDMxbS0yMDcuNjU0LTExNC4wODl2MTEzLjQ0NWgyNTcuMTQybDAtMTE=
zLjQ0NWgtMjU3LjE0MnptLTI2LjI1LTExMy4xNTN2MjEuNDZoMzAyLjUxOWwtMC0yMS40NmgtMz=
AyLjUxOXptLS4wMjctMzAuMjY4djMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0yNzkuM=
zYyLDB2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS0yMzIuOTAzLC42MTJ2MzAuNDg0=
aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bTE4NS4yMjItLjYxOHYzMC40ODRoMjMuMzA4di0zMC4=
0ODRoLTIzLjMwOHptLTEzOS45ODctMjguNzI1djMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMz=
A4em05Mi45MTctLjAwNnYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTQ1LjIzNi0uN=
jEydjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0tNDcuNzQ1LDMxLjMydjI5LjE0NGgx=
MTYuMTQ2di0yOS4xNDRoLTExNi4xNDZ6IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMjk2LjcyOSA=
1NjEuNDA5NykiLz4NCjwvZz4NCjxnIGZpbGw9IiNmMDAiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3=
Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCguMTAwMDkgMCAwIC4wOTk4NyAyN=
jQuNjE1NjQgMTI4LjQwMDgpIj4NCjxwYXRoIGQ9Im0tMzQ4Ljk1Nyw0NzcuNTk1aDIzLjMwOHYz=
MC40ODRoLTIzLjMwOHoiLz4NCjxwYXRoIGQ9Im0tMjQ0LjQyNiw0NzYuOTg0aDIzLjMwOXYzMC4=
0ODRoLTIzLjMwOXoiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDAgLj=
A5OTg3IDEzNC4yNjU2MyA3Mi4yNzg5OCkiPg0KPHBhdGggZmlsbD0iI2ZmMCIgZmlsbC1ydWxlP=
SJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIGQ9Im0tNDMzLjksNTQ1LjA0MnYyMi42ODlo=
MzAyLjUxOWwtMC0yMi42ODloLTMwMi41MTl6bTI2LjI0OS02Mi42MDF2NjMuMTUyaDI1Ny4xNDN=
sLTAtNjMuMTUyaC0yNTcuMTQzem0tMjIuNjg4LDIwNy42MTl2MjIuNjkyaDMwMi41MTl2LTIyLj=
Y5MmgtMzAyLjUxOXptODEuMDY5LTcuMDE3Yy0uMDMxLTQxLjE5MSAzMS42MjItNzQuNjIxIDcwL=
jY1NC03NC42MjEgMzkuMDMzLS4wNjYgNzAuNzM3LDMzLjMxMSA3MC43NjgsNzQuNTAyIDAsLjMy=
Ny0uMDAxLC42MDItLjAwNCwuOTI4bS0xNDkuMjc1LDMuMjkyYy0uMDM0LTQ1Ljc2OSAzNS4xMzY=
tODIuOTEzIDc4LjUwNS04Mi45MTMgNDMuMzctLjA3MyA3OC41OTYsMzcuMDEyIDc4LjYzLDgyLj=
c4IC4wMDEsLjM2MyAwLC42NjktLjAwNCwxLjAzMW0tMjA3LjY1NC0xMTQuMDg5djExMy40NDVoM=
jU3LjE0MmwwLTExMy40NDVoLTI1Ny4xNDJ6bS0yNi4yNS0xMTMuMTUzdjIxLjQ2aDMwMi41MTls=
LTAtMjEuNDZoLTMwMi41MTl6bS0uMDI3LTMwLjI2OHYzMC40ODRoMjMuMzA4di0zMC40ODRoLTI=
zLjMwOHptMjc5LjM2MiwwdjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0tMjMyLjkwMy=
wuNjEydjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0xODUuMjIyLS42MTh2MzAuNDg0a=
DIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS0xMzkuOTg3LTI4LjcyNXYzMC40ODRoMjMuMzA4di0z=
MC40ODRoLTIzLjMwOHptOTIuOTE3LS4wMDZ2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh=
6bS00NS4yMzYtLjYxMnYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTQ3Ljc0NSwzMS=
4zMnYyOS4xNDRoMTE2LjE0NnYtMjkuMTQ0aC0xMTYuMTQ2eiIgdHJhbnNmb3JtPSJ0cmFuc2xhd=
GUoMjQ1Ny45IDU2NS4wMzc2KSIvPg0KPC9nPg0KPGcgZmlsbD0iI2YwMCIgZmlsbC1ydWxlPSJl=
dmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDA=
gLjA5OTg3IDM4MC44MzQ5MiAxMjguNzYzMykiPg0KPHBhdGggZD0ibS0zNDguOTU3LDQ3Ny41OT=
VoMjMuMzA4djMwLjQ4NGgtMjMuMzA4eiIvPg0KPHBhdGggZD0ibS0yNDQuNDI2LDQ3Ni45ODRoM=
jMuMzA5djMwLjQ4NGgtMjMuMzA5eiIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjEw=
MDA5IDAgMCAuMDk5ODcgMTM0LjI2NTYzIDcyLjI3ODk4KSI+DQo8cGF0aCBmaWxsPSIjZmYwIiB=
maWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgZD0ibS00MzMuOSw1NDUuMD=
QydjIyLjY4OWgzMDIuNTE5bC0wLTIyLjY4OWgtMzAyLjUxOXptMjYuMjQ5LTYyLjYwMXY2My4xN=
TJoMjU3LjE0M2wtMC02My4xNTJoLTI1Ny4xNDN6bS0yMi42ODgsMjA3LjYxOXYyMi42OTJoMzAy=
LjUxOXYtMjIuNjkyaC0zMDIuNTE5em04MS4wNjktNy4wMTdjLS4wMzEtNDEuMTkxIDMxLjYyMi0=
3NC42MjEgNzAuNjU0LTc0LjYyMSAzOS4wMzMtLjA2NiA3MC43MzcsMzMuMzExIDcwLjc2OCw3NC=
41MDIgMCwuMzI3LS4wMDEsLjYwMi0uMDA0LC45MjhtLTE0OS4yNzUsMy4yOTJjLS4wMzQtNDUuN=
zY5IDM1LjEzNi04Mi45MTMgNzguNTA1LTgyLjkxMyA0My4zNy0uMDczIDc4LjU5NiwzNy4wMTIg=
NzguNjMsODIuNzggLjAwMSwuMzYzIDAsLjY2OS0uMDA0LDEuMDMxbS0yMDcuNjU0LTExNC4wODl=
2MTEzLjQ0NWgyNTcuMTQybDAtMTEzLjQ0NWgtMjU3LjE0MnptLTI2LjI1LTExMy4xNTN2MjEuND=
ZoMzAyLjUxOWwtMC0yMS40NmgtMzAyLjUxOXptLS4wMjctMzAuMjY4djMwLjQ4NGgyMy4zMDh2L=
TMwLjQ4NGgtMjMuMzA4em0yNzkuMzYyLDB2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6=
bS0yMzIuOTAzLC42MTJ2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bTE4NS4yMjItLjY=
xOHYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTEzOS45ODctMjguNzI1djMwLjQ4NG=
gyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em05Mi45MTctLjAwNnYzMC40ODRoMjMuMzA4di0zMC40O=
DRoLTIzLjMwOHptLTQ1LjIzNi0uNjEydjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0t=
NDcuNzQ1LDMxLjMydjI5LjE0NGgxMTYuMTQ2di0yOS4xNDRoLTExNi4xNDZ6IiB0cmFuc2Zvcm0=
9InRyYW5zbGF0ZSgxODg4LjIwMSA1NjUuMDM3NikiLz4NCjwvZz4NCjxnIGZpbGw9IiNmMDAiIG=
ZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpe=
CguMTAwMDkgMCAwIC4wOTk4NyAzMjMuODE0ODkgMTI4Ljc2MzMpIj4NCjxwYXRoIGQ9Im0tMzQ4=
Ljk1Nyw0NzcuNTk1aDIzLjMwOHYzMC40ODRoLTIzLjMwOHoiLz4NCjxwYXRoIGQ9Im0tMjQ0LjQ=
yNiw0NzYuOTg0aDIzLjMwOXYzMC40ODRoLTIzLjMwOXoiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT=
0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IDEzNC4yNjU2MyA3Mi4yNzg5OCkiPg0KPHBhdGggZ=
mlsbD0iI2ZmMCIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIGQ9Im0t=
NDMzLjksNTQ1LjA0MnYyMi42ODloMzAyLjUxOWwtMC0yMi42ODloLTMwMi41MTl6bTI2LjI0OS0=
2Mi42MDF2NjMuMTUyaDI1Ny4xNDNsLTAtNjMuMTUyaC0yNTcuMTQzem0tMjIuNjg4LDIwNy42MT=
l2MjIuNjkyaDMwMi41MTl2LTIyLjY5MmgtMzAyLjUxOXptODEuMDY5LTcuMDE3Yy0uMDMxLTQxL=
jE5MSAzMS42MjItNzQuNjIxIDcwLjY1NC03NC42MjEgMzkuMDMzLS4wNjYgNzAuNzM3LDMzLjMx=
MSA3MC43NjgsNzQuNTAyIDAsLjMyNy0uMDAxLC42MDItLjAwNCwuOTI4bS0xNDkuMjc1LDMuMjk=
yYy0uMDM0LTQ1Ljc2OSAzNS4xMzYtODIuOTEzIDc4LjUwNS04Mi45MTMgNDMuMzctLjA3MyA3OC=
41OTYsMzcuMDEyIDc4LjYzLDgyLjc4IC4wMDEsLjM2MyAwLC42NjktLjAwNCwxLjAzMW0tMjA3L=
jY1NC0xMTQuMDg5djExMy40NDVoMjU3LjE0MmwwLTExMy40NDVoLTI1Ny4xNDJ6bS0yNi4yNS0x=
MTMuMTUzdjIxLjQ2aDMwMi41MTlsLTAtMjEuNDZoLTMwMi41MTl6bS0uMDI3LTMwLjI2OHYzMC4=
0ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptMjc5LjM2MiwwdjMwLjQ4NGgyMy4zMDh2LTMwLj=
Q4NGgtMjMuMzA4em0tMjMyLjkwMywuNjEydjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4e=
m0xODUuMjIyLS42MTh2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS0xMzkuOTg3LTI4=
LjcyNXYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptOTIuOTE3LS4wMDZ2MzAuNDg0aDI=
zLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS00NS4yMzYtLjYxMnYzMC40ODRoMjMuMzA4di0zMC40OD=
RoLTIzLjMwOHptLTQ3Ljc0NSwzMS4zMnYyOS4xNDRoMTE2LjE0NnYtMjkuMTQ0aC0xMTYuMTQ2e=
iIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMTI3MS4zMjcgMTI3Mi42MjcpIi8+DQo8L2c+DQo8ZyBm=
aWxsPSIjZjAwIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnN=
mb3JtPSJtYXRyaXgoLjEwMDA5IDAgMCAuMDk5ODcgMjYyLjA3MzIxIDE5OS40MjkwMSkiPg0KPH=
BhdGggZD0ibS0zNDguOTU3LDQ3Ny41OTVoMjMuMzA4djMwLjQ4NGgtMjMuMzA4eiIvPg0KPHBhd=
GggZD0ibS0yNDQuNDI2LDQ3Ni45ODRoMjMuMzA5djMwLjQ4NGgtMjMuMzA5eiIvPg0KPC9nPg0K=
PGcgdHJhbnNmb3JtPSJtYXRyaXgoLjEwMDA5IDAgMCAuMDk5ODcgMTM0LjI2NTYzIDcyLjI3ODk=
4KSI+DQo8cGF0aCBmaWxsPSIjZmYwIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD=
0iMS4yNSIgZD0ibS00MzMuOSw1NDUuMDQydjIyLjY4OWgzMDIuNTE5bC0wLTIyLjY4OWgtMzAyL=
jUxOXptMjYuMjQ5LTYyLjYwMXY2My4xNTJoMjU3LjE0M2wtMC02My4xNTJoLTI1Ny4xNDN6bS0y=
Mi42ODgsMjA3LjYxOXYyMi42OTJoMzAyLjUxOXYtMjIuNjkyaC0zMDIuNTE5em04MS4wNjktNy4=
wMTdjLS4wMzEtNDEuMTkxIDMxLjYyMi03NC42MjEgNzAuNjU0LTc0LjYyMSAzOS4wMzMtLjA2Ni=
A3MC43MzcsMzMuMzExIDcwLjc2OCw3NC41MDIgMCwuMzI3LS4wMDEsLjYwMi0uMDA0LC45MjhtL=
TE0OS4yNzUsMy4yOTJjLS4wMzQtNDUuNzY5IDM1LjEzNi04Mi45MTMgNzguNTA1LTgyLjkxMyA0=
My4zNy0uMDczIDc4LjU5NiwzNy4wMTIgNzguNjMsODIuNzggLjAwMSwuMzYzIDAsLjY2OS0uMDA=
0LDEuMDMxbS0yMDcuNjU0LTExNC4wODl2MTEzLjQ0NWgyNTcuMTQybDAtMTEzLjQ0NWgtMjU3Lj=
E0MnptLTI2LjI1LTExMy4xNTN2MjEuNDZoMzAyLjUxOWwtMC0yMS40NmgtMzAyLjUxOXptLS4wM=
jctMzAuMjY4djMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0yNzkuMzYyLDB2MzAuNDg0=
aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS0yMzIuOTAzLC42MTJ2MzAuNDg0aDIzLjMwOHYtMzA=
uNDg0aC0yMy4zMDh6bTE4NS4yMjItLjYxOHYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOH=
ptLTEzOS45ODctMjguNzI1djMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em05Mi45MTctL=
jAwNnYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTQ1LjIzNi0uNjEydjMwLjQ4NGgy=
My4zMDh2LTMwLjQ4NGgtMjMuMzA4em0tNDcuNzQ1LDMxLjMydjI5LjE0NGgxMTYuMTQ2di0yOS4=
xNDRoLTExNi4xNDZ6IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgyNDc5LjY3MyAxMjY1LjM3KSIvPg=
0KPC9nPg0KPGcgZmlsbD0iI2YwMCIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9I=
jEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IDM4My4wMTQxNCAxOTgu=
NzA0MDYpIj4NCjxwYXRoIGQ9Im0tMzQ4Ljk1Nyw0NzcuNTk1aDIzLjMwOHYzMC40ODRoLTIzLjM=
wOHoiLz4NCjxwYXRoIGQ9Im0tMjQ0LjQyNiw0NzYuOTg0aDIzLjMwOXYzMC40ODRoLTIzLjMwOX=
oiLz4NCjwvZz4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IDEzNC4yN=
jU2MyA3Mi4yNzg5OCkiPg0KPHBhdGggZmlsbD0iI2ZmMCIgZmlsbC1ydWxlPSJldmVub2RkIiBz=
dHJva2Utd2lkdGg9IjEuMjUiIGQ9Im0tNDMzLjksNTQ1LjA0MnYyMi42ODloMzAyLjUxOWwtMC0=
yMi42ODloLTMwMi41MTl6bTI2LjI0OS02Mi42MDF2NjMuMTUyaDI1Ny4xNDNsLTAtNjMuMTUyaC=
0yNTcuMTQzem0tMjIuNjg4LDIwNy42MTl2MjIuNjkyaDMwMi41MTl2LTIyLjY5MmgtMzAyLjUxO=
XptODEuMDY5LTcuMDE3Yy0uMDMxLTQxLjE5MSAzMS42MjItNzQuNjIxIDcwLjY1NC03NC42MjEg=
MzkuMDMzLS4wNjYgNzAuNzM3LDMzLjMxMSA3MC43NjgsNzQuNTAyIDAsLjMyNy0uMDAxLC42MDI=
tLjAwNCwuOTI4bS0xNDkuMjc1LDMuMjkyYy0uMDM0LTQ1Ljc2OSAzNS4xMzYtODIuOTEzIDc4Lj=
UwNS04Mi45MTMgNDMuMzctLjA3MyA3OC41OTYsMzcuMDEyIDc4LjYzLDgyLjc4IC4wMDEsLjM2M=
yAwLC42NjktLjAwNCwxLjAzMW0tMjA3LjY1NC0xMTQuMDg5djExMy40NDVoMjU3LjE0MmwwLTEx=
My40NDVoLTI1Ny4xNDJ6bS0yNi4yNS0xMTMuMTUzdjIxLjQ2aDMwMi41MTlsLTAtMjEuNDZoLTM=
wMi41MTl6bS0uMDI3LTMwLjI2OHYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptMjc5Lj=
M2MiwwdjMwLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0tMjMyLjkwMywuNjEydjMwLjQ4N=
GgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0xODUuMjIyLS42MTh2MzAuNDg0aDIzLjMwOHYtMzAu=
NDg0aC0yMy4zMDh6bS0xMzkuOTg3LTI4LjcyNXYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjM=
wOHptOTIuOTE3LS4wMDZ2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS00NS4yMzYtLj=
YxMnYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTQ3Ljc0NSwzMS4zMnYyOS4xNDRoM=
TE2LjE0NnYtMjkuMTQ0aC0xMTYuMTQ2eiIgdHJhbnNmb3JtPSJtYXRyaXgoLjY1Mjc2IC0uNzU3=
NTcgLjc1NzU3IC42NTI3NiA5NjkuNTc0MSAxODE5LjMyMykiLz4NCjwvZz4NCjxnIGZpbGw9IiN=
mMDAiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im=
1hdHJpeCguMDY1MzMgLS4wNzU2NiAuMDc1ODIgLjA2NTE5IDIzMS43MTc3NCAyNTMuNTgxNTcpI=
j4NCjxwYXRoIGQ9Im0tMzQ4Ljk1Nyw0NzcuNTk1aDIzLjMwOHYzMC40ODRoLTIzLjMwOHoiLz4N=
CjxwYXRoIGQ9Im0tMjQ0LjQyNiw0NzYuOTg0aDIzLjMwOXYzMC40ODRoLTIzLjMwOXoiLz4NCjw=
vZz4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOSAwIDAgLjA5OTg3IDEzNC4yNjU2MyA3Mi=
4yNzg5OCkiPg0KPHBhdGggZmlsbD0iI2ZmMCIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd=
2lkdGg9IjEuMjUiIGQ9Im0tNDMzLjksNTQ1LjA0MnYyMi42ODloMzAyLjUxOWwtMC0yMi42ODlo=
LTMwMi41MTl6bTI2LjI0OS02Mi42MDF2NjMuMTUyaDI1Ny4xNDNsLTAtNjMuMTUyaC0yNTcuMTQ=
zem0tMjIuNjg4LDIwNy42MTl2MjIuNjkyaDMwMi41MTl2LTIyLjY5MmgtMzAyLjUxOXptODEuMD=
Y5LTcuMDE3Yy0uMDMxLTQxLjE5MSAzMS42MjItNzQuNjIxIDcwLjY1NC03NC42MjEgMzkuMDMzL=
S4wNjYgNzAuNzM3LDMzLjMxMSA3MC43NjgsNzQuNTAyIDAsLjMyNy0uMDAxLC42MDItLjAwNCwu=
OTI4bS0xNDkuMjc1LDMuMjkyYy0uMDM0LTQ1Ljc2OSAzNS4xMzYtODIuOTEzIDc4LjUwNS04Mi4=
5MTMgNDMuMzctLjA3MyA3OC41OTYsMzcuMDEyIDc4LjYzLDgyLjc4IC4wMDEsLjM2MyAwLC42Nj=
ktLjAwNCwxLjAzMW0tMjA3LjY1NC0xMTQuMDg5djExMy40NDVoMjU3LjE0MmwwLTExMy40NDVoL=
TI1Ny4xNDJ6bS0yNi4yNS0xMTMuMTUzdjIxLjQ2aDMwMi41MTlsLTAtMjEuNDZoLTMwMi41MTl6=
bS0uMDI3LTMwLjI2OHYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptMjc5LjM2MiwwdjM=
wLjQ4NGgyMy4zMDh2LTMwLjQ4NGgtMjMuMzA4em0tMjMyLjkwMywuNjEydjMwLjQ4NGgyMy4zMD=
h2LTMwLjQ4NGgtMjMuMzA4em0xODUuMjIyLS42MTh2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yM=
y4zMDh6bS0xMzkuOTg3LTI4LjcyNXYzMC40ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptOTIu=
OTE3LS4wMDZ2MzAuNDg0aDIzLjMwOHYtMzAuNDg0aC0yMy4zMDh6bS00NS4yMzYtLjYxMnYzMC4=
0ODRoMjMuMzA4di0zMC40ODRoLTIzLjMwOHptLTQ3Ljc0NSwzMS4zMnYyOS4xNDRoMTE2LjE0Nn=
YtMjkuMTQ0aC0xMTYuMTQ2eiIgdHJhbnNmb3JtPSJtYXRyaXgoLS42NTI3NiAtLjc1NzU3IC0uN=
zU3NTcgLjY1Mjc2IDIyMzEuMDI0IDE4MTUuNjk0KSIvPg0KPC9nPg0KPGcgZmlsbD0iI2YwMCIg=
ZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml=
4KC0uMDY1MzMgLS4wNzU2NiAtLjA3NTgyIC4wNjUxOSAzNTcuMTU1MiAyNTMuMjE5MjUpIj4NCj=
xwYXRoIGQ9Im0tMzQ4Ljk1Nyw0NzcuNTk1aDIzLjMwOHYzMC40ODRoLTIzLjMwOHoiLz4NCjxwY=
XRoIGQ9Im0tMjQ0LjQyNiw0NzYuOTg0aDIzLjMwOXYzMC40ODRoLTIzLjMwOXoiLz4NCjwvZz4N=
CjxnIGZpbGw9IiMzYjNiZmYiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI=
1Ij4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4wMTUwMSAwIDAgLjAxNDk4IDI5NC45NDk4NyAzMT=
YuMjc2MjIpIj4NCjxwYXRoIGQ9Im0tODUwLjg5NC03MTQ3LjA0aDE1OTAuOTAxdjExNzEuMDhoL=
TE1OTAuOTAxeiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3=
NDAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoMS4wNzQ2MyAwIDAgMS4wNjM=
0OSAtMzEzMC4zOTMgLTEwNTQ3LjM1KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLj=
AxNTAxIDAgMCAuMDE0OTggMjA1LjQxNDYgMjY0LjM5MTE1KSI+DQo8cGF0aCBkPSJtNTQ3OC43O=
C0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQx=
MiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF=
0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdH=
JhbnNmb3JtPSJtYXRyaXgoLjAxNDI2IDAgMCAuMDE0MjMgMjk0LjkwODI2IDMxMS42MjYzOCkiP=
g0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6=
Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ=
5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLj=
M5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDE0MjYgMCAwI=
C4wMTQyMyAyMDkuODQ5NzUgMjYyLjMzNTU2KSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcy=
aDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQ=
yNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41OD=
AzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtP=
SJtYXRyaXgoLjAwODUxIDAgMCAuMDA4NDkgMjk0LjU4OTQ0IDI3Ni4wMDg2NSkiPg0KPHBhdGgg=
ZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWx=
saXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMD=
E5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1N=
DcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA4NTEgMCAwIC4wMDg0OSAy=
NDMuODIyOTQgMjQ2LjU4OTgyKSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY=
2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4Ii=
ByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41ODAzIDAgMCAuN=
Tc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgo=
LjAwNzY4IDAgMCAuMDA3NjcgMjk0LjU0MzQ0IDI3MC44Njc1NykiPg0KPHBhdGggZD0ibS04NTA=
uODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD=
0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc=
2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+=
DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA3NjggMCAwIC4wMDc2NyAyNDguNzI2NzI=
gMjQ0LjMxNzEpIj4NCjxwYXRoIGQ9Im01NDc4Ljc4LTMzNDAuNzJoODU5LjA5djYzMi4zOGgtOD=
U5LjA5eiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3NDAuM=
jExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoLjU4MDMgMCAwIC41NzQyOSA0MjQ3=
Ljg1MiAtNTA4OC41MDYpIi8+DQo8L2c+DQo8L2c+DQo8ZyBmaWxsPSIjZmZmIiBmaWxsLXJ1bGU=
9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjEwMDA5ID=
AgMCAuMDk5ODcgLTMuMjM2NTIgNDAwLjE4MTkzKSI+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciI=
GN5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNs=
YXRlKC0zLjc4MTc0IC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSItMTg=
1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDEyOS=
45ODkxIC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSItMTg1NC45MDkiI=
HJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDYxLjkyMjA0IDY3=
LjU5NDU3KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0iMzU=
uNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxLjQxNzg5IDE0MC4zODg1KS=
IvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0iMzUuNjg4IiBye=
T0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMjguNTcxNiAxNDIuNzUyKSIvPg0KPC9n=
Pg0KPGcgZmlsbD0iIzNiM2JmZiIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjE=
uMjUiPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNTAxIDAgMCAuMDE0OTggMjk0Ljk0OTkgMz=
Q3LjI0MzcpIj4NCjxwYXRoIGQ9Im0tODUwLjg5NC03MTQ3LjA0aDE1OTAuOTAxdjExNzEuMDhoL=
TE1OTAuOTAxeiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3=
NDAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoMS4wNzQ2MyAwIDAgMS4wNjM=
0OSAtMzEzMC4zOTMgLTEwNTQ3LjM1KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLj=
AxNTAxIDAgMCAuMDE0OTggMjA1LjQxNDYzIDI5NS4zNTg2MykiPg0KPHBhdGggZD0ibTU0NzguN=
zgtMzM0MC43Mmg4NTkuMDl2NjMyLjM4aC04NTkuMDl6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40=
MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1=
hdHJpeCguNTgwMyAwIDAgLjU3NDI5IDQyNDcuODUyIC01MDg4LjUwNikiLz4NCjwvZz4NCjxnIH=
RyYW5zZm9ybT0ibWF0cml4KC4wMTQyNiAwIDAgLjAxNDIzIDI5NC45MDgyOSAzNDIuNTkzODYpI=
j4NCjxwYXRoIGQ9Im0tODUwLjg5NC03MTQ3LjA0aDE1OTAuOTAxdjExNzEuMDhoLTE1OTAuOTAx=
eiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3NDAuMjExIiB=
yeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoMS4wNzQ2MyAwIDAgMS4wNjM0OSAtMzEzMC=
4zOTMgLTEwNTQ3LjM1KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNDI2IDAgM=
CAuMDE0MjMgMjA5Ljg0OTc4IDI5My4zMDMwNSkiPg0KPHBhdGggZD0ibTU0NzguNzgtMzM0MC43=
Mmg4NTkuMDl2NjMyLjM4aC04NTkuMDl6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI=
0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCguNT=
gwMyAwIDAgLjU3NDI5IDQyNDcuODUyIC01MDg4LjUwNikiLz4NCjwvZz4NCjxnIHRyYW5zZm9yb=
T0ibWF0cml4KC4wMDg1MSAwIDAgLjAwODQ5IDI5NC41ODk0NyAzMDYuOTc2MTMpIj4NCjxwYXRo=
IGQ9Im0tODUwLjg5NC03MTQ3LjA0aDE1OTAuOTAxdjExNzEuMDhoLTE1OTAuOTAxeiIvPg0KPGV=
sbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3NDAuMjExIiByeT0iNjk2Lj=
AxOSIgdHJhbnNmb3JtPSJtYXRyaXgoMS4wNzQ2MyAwIDAgMS4wNjM0OSAtMzEzMC4zOTMgLTEwN=
TQ3LjM1KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAwODUxIDAgMCAuMDA4NDkg=
MjQzLjgyMjk3IDI3Ny41NTczKSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY=
2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4Ii=
ByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41ODAzIDAgMCAuN=
Tc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgo=
LjAwNzY4IDAgMCAuMDA3NjcgMjk0LjU0MzQ3IDMwMS44MzUwNikiPg0KPHBhdGggZD0ibS04NTA=
uODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD=
0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc=
2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+=
DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA3NjggMCAwIC4wMDc2NyAyNDguNzI2NzU=
gMjc1LjI4NDU5KSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLT=
g1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwL=
jIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0=
Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPC9nPg0KPGcgZmlsbD0iI2ZmZiIgZmlsbC1ydWx=
lPSJldmVub2RkIiBzdHJva2Utd2lkdGg9IjEuMjUiIHRyYW5zZm9ybT0ibWF0cml4KC4xMDAwOS=
AwIDAgLjA5OTg3IC0zLjIzNjQ5IDQzMS4xNDk0MSkiPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3I=
iBjeT0iLTE4NTQuOTA5IiByeD0iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5z=
bGF0ZSgtMy43ODE3NCAtNy41NjI5KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE=
4NTQuOTA5IiByeD0iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMj=
kuOTg5MSAtNy41NjI5KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5I=
iByeD0iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSg2MS45MjIwNCA2=
Ny41OTQ1NykiLz4NCjxlbGxpcHNlIGN4PSIyOTAzLjAxNyIgY3k9Ii0xODU0LjkwOSIgcng9IjM=
1LjY4OCIgcnk9IjM1LjY4OCIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMS40MTc4OSAxNDAuMzg4NS=
kiLz4NCjxlbGxpcHNlIGN4PSIyOTAzLjAxNyIgY3k9Ii0xODU0LjkwOSIgcng9IjM1LjY4OCIgc=
nk9IjM1LjY4OCIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMTI4LjU3MTYgMTQyLjc1MikiLz4NCjwv=
Zz4NCjxnIGZpbGw9IiMzYjNiZmYiIGZpbGwtcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSI=
xLjI1Ij4NCjxnIHRyYW5zZm9ybT0ibWF0cml4KC4wMTUwMSAwIDAgLjAxNDk4IDMyMS40NDM3OC=
AzNDcuMjQzNzEpIj4NCjxwYXRoIGQ9Im0tODUwLjg5NC03MTQ3LjA0aDE1OTAuOTAxdjExNzEuM=
DhoLTE1OTAuOTAxeiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4=
PSI3NDAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoMS4wNzQ2MyAwIDAgMS4=
wNjM0OSAtMzEzMC4zOTMgLTEwNTQ3LjM1KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRyaX=
goLjAxNTAxIDAgMCAuMDE0OTggMjMxLjkwODUgMjk1LjM1ODY0KSI+DQo8cGF0aCBkPSJtNTQ3O=
C43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYx=
LjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0=
ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPG=
cgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNDI2IDAgMCAuMDE0MjMgMzIxLjQwMjE2IDM0Mi41OTM4N=
ykiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45=
MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTE=
iIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMT=
MwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDE0MjYgM=
CAwIC4wMTQyMyAyMzYuMzQzNjUgMjkzLjMwMzA2KSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQw=
LjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k=
9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC=
41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb=
3JtPSJtYXRyaXgoLjAwODUxIDAgMCAuMDA4NDkgMzIxLjA4MzM0IDMwNi45NzYxNCkiPg0KPHBh=
dGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo=
8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OT=
YuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtM=
TA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA4NTEgMCAwIC4wMDg0=
OSAyNzAuMzE2ODQgMjc3LjU1NzMxKSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg1OS4=
wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNjcuMz=
A4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41ODAzIDAgM=
CAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJtYXRy=
aXgoLjAwNzY4IDAgMCAuMDA3NjcgMzIxLjAzNzM0IDMwMS44MzUwNykiPg0KPHBhdGggZD0ibS0=
4NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZS=
BjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0c=
mFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUp=
Ii8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA3NjggMCAwIC4wMDc2NyAyNzUuMjI=
wNjIgMjc1LjI4NDYpIj4NCjxwYXRoIGQ9Im01NDc4Ljc4LTMzNDAuNzJoODU5LjA5djYzMi4zOG=
gtODU5LjA5eiIvPg0KPGVsbGlwc2UgY3g9IjI4NjEuNDEyIiBjeT0iNDI2Ny4zMDgiIHJ4PSI3N=
DAuMjExIiByeT0iNjk2LjAxOSIgdHJhbnNmb3JtPSJtYXRyaXgoLjU4MDMgMCAwIC41NzQyOSA0=
MjQ3Ljg1MiAtNTA4OC41MDYpIi8+DQo8L2c+DQo8L2c+DQo8ZyBmaWxsPSIjZmZmIiBmaWxsLXJ=
1bGU9ImV2ZW5vZGQiIHN0cm9rZS13aWR0aD0iMS4yNSIgdHJhbnNmb3JtPSJtYXRyaXgoLjEwMD=
A5IDAgMCAuMDk5ODcgMjMuMjU3MzggNDMxLjE0OTQyKSI+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wM=
TciIGN5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJh=
bnNsYXRlKC0zLjc4MTc0IC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSI=
tMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKD=
EyOS45ODkxIC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSItMTg1NC45M=
DkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDYxLjkyMjA0=
IDY3LjU5NDU3KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0=
iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxLjQxNzg5IDE0MC4zOD=
g1KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0iMzUuNjg4I=
iByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMjguNTcxNiAxNDIuNzUyKSIvPg0K=
PC9nPg0KPGcgZmlsbD0iIzNiM2JmZiIgZmlsbC1ydWxlPSJldmVub2RkIiBzdHJva2Utd2lkdGg=
9IjEuMjUiPg0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNTAxIDAgMCAuMDE0OTggMjY4LjQ1Nj=
A2IDM0Ny4yNDM3MSkiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3M=
S4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIg=
cng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCA=
xLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdH=
JpeCguMDE1MDEgMCAwIC4wMTQ5OCAxNzguOTIwNzkgMjk1LjM1ODY0KSI+DQo8cGF0aCBkPSJtN=
TQ3OC43OC0zMzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIy=
ODYxLjQxMiIgY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9=
ybT0ibWF0cml4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg=
0KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjAxNDI2IDAgMCAuMDE0MjMgMjY4LjQxNDQ0IDM0Mi41O=
TM4NykiPg0KPHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5=
MC45MDF6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4=
yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC=
0zMTMwLjM5MyAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDE0M=
jYgMCAwIC4wMTQyMyAxODMuMzU1OTMgMjkzLjMwMzA2KSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0z=
MzQwLjcyaDg1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiI=
gY3k9IjQyNjcuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cm=
l4KC41ODAzIDAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhb=
nNmb3JtPSJtYXRyaXgoLjAwODUxIDAgMCAuMDA4NDkgMjY4LjA5NTYyIDMwNi45NzYxNCkiPg0K=
PHBhdGggZD0ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8=
+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PS=
I2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5M=
yAtMTA1NDcuMzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA4NTEgMCAwIC4w=
MDg0OSAyMTcuMzI5MTIgMjc3LjU1NzMxKSI+DQo8cGF0aCBkPSJtNTQ3OC43OC0zMzQwLjcyaDg=
1OS4wOXY2MzIuMzhoLTg1OS4wOXoiLz4NCjxlbGxpcHNlIGN4PSIyODYxLjQxMiIgY3k9IjQyNj=
cuMzA4IiByeD0iNzQwLjIxMSIgcnk9IjY5Ni4wMTkiIHRyYW5zZm9ybT0ibWF0cml4KC41ODAzI=
DAgMCAuNTc0MjkgNDI0Ny44NTIgLTUwODguNTA2KSIvPg0KPC9nPg0KPGcgdHJhbnNmb3JtPSJt=
YXRyaXgoLjAwNzY4IDAgMCAuMDA3NjcgMjY4LjA0OTYyIDMwMS44MzUwNykiPg0KPHBhdGggZD0=
ibS04NTAuODk0LTcxNDcuMDRoMTU5MC45MDF2MTE3MS4wOGgtMTU5MC45MDF6Ii8+DQo8ZWxsaX=
BzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9Ijc0MC4yMTEiIHJ5PSI2OTYuMDE5I=
iB0cmFuc2Zvcm09Im1hdHJpeCgxLjA3NDYzIDAgMCAxLjA2MzQ5IC0zMTMwLjM5MyAtMTA1NDcu=
MzUpIi8+DQo8L2c+DQo8ZyB0cmFuc2Zvcm09Im1hdHJpeCguMDA3NjggMCAwIC4wMDc2NyAyMjI=
uMjMyOSAyNzUuMjg0NikiPg0KPHBhdGggZD0ibTU0NzguNzgtMzM0MC43Mmg4NTkuMDl2NjMyLj=
M4aC04NTkuMDl6Ii8+DQo8ZWxsaXBzZSBjeD0iMjg2MS40MTIiIGN5PSI0MjY3LjMwOCIgcng9I=
jc0MC4yMTEiIHJ5PSI2OTYuMDE5IiB0cmFuc2Zvcm09Im1hdHJpeCguNTgwMyAwIDAgLjU3NDI5=
IDQyNDcuODUyIC01MDg4LjUwNikiLz4NCjwvZz4NCjwvZz4NCjxnIGZpbGw9IiNmZmYiIGZpbGw=
tcnVsZT0iZXZlbm9kZCIgc3Ryb2tlLXdpZHRoPSIxLjI1IiB0cmFuc2Zvcm09Im1hdHJpeCguMT=
AwMDkgMCAwIC4wOTk4NyAtMjkuNzMwMzQgNDMxLjE0OTQyKSI+DQo8ZWxsaXBzZSBjeD0iMjkwM=
y4wMTciIGN5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0i=
dHJhbnNsYXRlKC0zLjc4MTc0IC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN=
5PSItMTg1NC45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYX=
RlKDEyOS45ODkxIC03LjU2MjkpIi8+DQo8ZWxsaXBzZSBjeD0iMjkwMy4wMTciIGN5PSItMTg1N=
C45MDkiIHJ4PSIzNS42ODgiIHJ5PSIzNS42ODgiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDYxLjky=
MjA0IDY3LjU5NDU3KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiB=
yeD0iMzUuNjg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxLjQxNzg5IDE0MC=
4zODg1KSIvPg0KPGVsbGlwc2UgY3g9IjI5MDMuMDE3IiBjeT0iLTE4NTQuOTA5IiByeD0iMzUuN=
jg4IiByeT0iMzUuNjg4IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMjguNTcxNiAxNDIuNzUyKSIv=
Pg0KPC9nPg0KPC9zdmc+DQo=3D"); }

.flag-list .rs a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMz=
UwIDkwMCI+DQo8cGF0aCBmaWxsPSIjYzYzNjNjIiBkPSJtMCwwaDEzNTB2NDUwaC0xMzUweiIvP=
g0KPHBhdGggZmlsbD0iI2ZmZiIgZD0ibTAsNDUwaDEzNTB2NDUwaC0xMzUweiIvPg0KPHBhdGgg=
ZmlsbD0iIzBjNDA3NiIgZD0ibTAsMzAwaDEzNTB2MzAwaC0xMzUweiIvPg0KPC9zdmc+DQo=3D"=
); }

.flag-list .se a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxNj=
AwIDEwMDAiPg0KPHBhdGggZmlsbD0iIzBiNTA4OSIgZD0ibTAsMGgxNjAwdjEwMDBoLTE2MDB6I=
i8+DQo8ZyBmaWxsPSIjZmZjMTAwIj4NCjxwYXRoIGQ9Im01MDAsMGgyMDB2MTAwMGgtMjAweiIv=
Pg0KPHBhdGggZD0ibTAsNDAwaDE2MDB2MjAwaC0xNjAweiIvPg0KPC9nPg0KPC9zdmc+DQo=3D"=
); }

.flag-list .sk a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB3aWR0aD0iOTAwIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaW=
dodD0iNjAwIiB2aWV3Qm94PSIwIDAgNDUwIDMwMCI+DQo8cGF0aCBmaWxsPSIjZmZmIiBkPSJtM=
CwwaDQ1MHYzMDBoLTQ1MHoiLz4NCjxwYXRoIGZpbGw9IiMwMDM4YTgiIGQ9Im0wLDEwMGg0NTB2=
MjAwaC00NTB6Ii8+DQo8cGF0aCBmaWxsPSIjY2UxMTI2IiBkPSJtMCwyMDBoNDUwdjEwMGgtNDU=
weiIvPg0KPHBhdGggZmlsbD0iI2ZmZiIgZmlsbC1ydWxlPSJldmVub2RkIiBkPSJtNzcuODAyMS=
w3MC41MTk0Yy02LjA0NDQsLjQ1NzktNC4zMzksNy43ODc3LTUuMDg5MSwxMS45NDk5LTIuMTMyL=
DI4LjY4MS01LjA3NzEsNTguMjg3NiAzLjY4MjYsODYuMjIxNCA2LjkwOTcsMjIuNTQ0MiAyMy40=
MjMxLDQxLjE0ODggNDMuNDMzNSw1My4xNDc0IDQuOTI1MiwyLjczOTIgOS43MjI2LDYuMTc5NyA=
xNS4xNzA0LDcuNjYyIDUuNzAzMy0xLjU5OTEgMTAuNzQxNy01LjE4OTkgMTUuODg3NS04LjEwNj=
cgMTkuNjk1Ni0xMS45ODU0IDM1Ljg4NTgtMzAuNDM5NiA0Mi43MTY0LTUyLjcwMjcgOC44OTUtM=
jguNDAwOSA1LjcyNzctNTguNDg4NyAzLjU3Mi04Ny42MzQ0LS4zMTQtNC4wMTA0IC4yOTA3LTEw=
Ljk3MDctNS42MzM3LTEwLjUzNjgtMzcuOTEzMiwwLTc1LjgyNjQsMC0xMTMuNzM5NSwweiIvPg0=
KPGcgdHJhbnNmb3JtPSJtYXRyaXgoLjUgMCAwIC41IC0uMDAwMDUgMTUwLjAwMDIpIj4NCjxwYX=
RoIGZpbGw9IiNjZTExMjYiIGZpbGwtcnVsZT0iZXZlbm9kZCIgZD0ibTI3MC4wMDAxLTE1MC4wM=
DAzdjI5OS45ODE0Yy0xMzguNzI5LTY3LjIxMDEtMTIzLjU2LTE3OC41MzEtMTE0LjQwNjktMjk5=
Ljk4MTRoMTE0LjQwNjl6djI5OS45ODE0YzEzOC43MjktNjcuMjEwMSAxMjMuNTYtMTc4LjUzMSA=
xMTQuNDA2OS0yOTkuOTgxNGgtMTE0LjQwNjl6Ii8+DQo8L2c+DQo8ZyBmaWxsPSIjZmZmIiBmaW=
xsLXJ1bGU9ImV2ZW5vZGQiIHRyYW5zZm9ybT0ibWF0cml4KC41IDAgMCAuNSAtLjAwMDA1IDE1M=
C4wMDAyKSI+DQo8cGF0aCBkPSJtMjg2LjE5OTUtNjcuNzEzM2MxNC41OTk0LDAgMjkuNDc5NCwy=
LjY1OTIgNDMuNzk4Myw1LjQ5NDItNC4yMzgtMTMuOTA2LTQuMjM4LTIyLjQwMzMgMC0zNi4zMDk=
zLTE0LjMxODksMi44MzUtMjkuMTk4OSw1LjQ5NDItNDMuNzk4Myw1LjQ5NDJoLTMyLjM5ODdjLT=
E0LjU5OTQsMC0yOS40Nzk0LTIuNjU5Mi00My43OTgzLTUuNDk0MiA0LjIzOCwxMy45MDYgNC4yM=
zgsMjIuNDAzMyAwLDM2LjMwOTMgMTQuMzE4OS0yLjgzNSAyOS4xOTg5LTUuNDk0MiA0My43OTgz=
LTUuNDk0MmgzMi4zOTg3eiIvPg0KPHBhdGggZD0ibTI5OC43OTktMTMuMDgyMmMxNC41OTk0LDA=
gMjkuNDc5NCwyLjY1OTIgNDMuNzk4Myw1LjQ5NDItNC4yMzgtMTMuOTA2LTQuMjM4LTIyLjQwMz=
MgMC0zNi4zMDkzLTE0LjMxODksMi44MzUtMjkuMTk4OSw1LjQ5NDItNDMuNzk4Myw1LjQ5NDJoL=
TU3LjU5NzdjLTE0LjU5OTQsMC0yOS40Nzk0LTIuNjU5Mi00My43OTgzLTUuNDk0MiA0LjIzOCwx=
My45MDYgNC4yMzgsMjIuNDAzMyAwLDM2LjMwOTMgMTQuMzE4OS0yLjgzNSAyOS4xOTg4LTUuNDk=
0MiA0My43OTgzLTUuNDk0Mmg1Ny41OTc3eiIvPg0KPHBhdGggZD0ibTI1MS43NTYxLTEzOC41MD=
M4YzIuODQ4MiwxNC4yNTI1IDUuNTE5OCwyOS4wNjMzIDUuNTE5OCw0My41OTV2MTg1Ljc4NjRsM=
jUuNDM5LDB2LTE4NS43ODY0YzAtMTQuNTMxNyAyLjY3MTYtMjkuMzQyNiA1LjUxOTgtNDMuNTk1=
LTEzLjk3MDgsNC4yMTgzLTIyLjUwNzgsNC4yMTgzLTM2LjQ3ODYsMHoiLz4NCjwvZz4NCjxnIGZ=
pbGw9IiMwMDM4YTgiIGZpbGwtcnVsZT0iZXZlbm9kZCIgdHJhbnNmb3JtPSJtYXRyaXgoLjk1OT=
k2IDAgMCAuOTU1NTEgLTQ0Ljk5NTIyIC00MjIuNzE0MykiPg0KPHBhdGggZD0ibTE1Ny41LDYyM=
y4zNDM4Yy04LjU2NDYsMC0xNS41LDYuOTM1NC0xNS41LDE1LjUgMCwuNjUyOSAuMTA5MSwxLjI3=
NDQgLjE4NzUsMS45MDYyIDIuOTg1Myw0LjQyOTEgNi40NzczLDguNjc4MSAxMC41LDEyLjc4MTI=
gMS41MjU1LC41MDE4IDMuMTE5OCwuODQzOCA0LjgxMjUsLjg0MzggOC41NjQ2LDAgMTUuNTMxMi=
02Ljk2NjcgMTUuNTMxMi0xNS41MzEyIDAtOC41NjQ2LTYuOTY2Ny0xNS41LTE1LjUzMTItMTUuN=
XoiLz4NCjxwYXRoIGQ9Im0xODcuNSw2MTQuMTg3NWMtMTAuODg4MSwwLTE5LjcxODgsOC44NjE5=
LTE5LjcxODgsMTkuNzUgMCwxMC44ODgxIDguODMwNiwxOS43MTg3IDE5LjcxODgsMTkuNzE4OCA=
xMC44ODgxLDAgMTkuNzE4Ny04LjgzMDYgMTkuNzE4OC0xOS43MTg4IDAtMTAuODg4MS04LjgzMD=
YtMTkuNzUtMTkuNzE4OC0xOS43NXoiLz4NCjxwYXRoIGQ9Im0yMTcuNSw2MjMuMzQzOGMtOC41N=
jQ2LDAtMTUuNSw2LjkzNTQtMTUuNSwxNS41IDAsOC41NjQ2IDYuOTM1NCwxNS41MzEyIDE1LjUs=
MTUuNTMxMiAxLjY5MjcsMCAzLjI4Ny0uMzQxOSA0LjgxMjUtLjg0MzggNC4wMzM1LTQuMTE0MiA=
3LjU0MDUtOC4zNzA2IDEwLjUzMTItMTIuODEyNSAuMDc2LS42MjE5IC4xODc1LTEuMjMyNyAuMT=
g3NS0xLjg3NSAwLTguNTY0Ni02Ljk2NjctMTUuNS0xNS41MzEyLTE1LjV6Ii8+DQo8cGF0aCBkP=
SJtMTQ0LjYyNSw2NDQuMTI1YzkuNDc1LDEyLjcxODQgMjMuMDk5OCwyNC4xMjQ4IDQyLjg3NSwz=
My43NSAxOS43NzUyLTkuNjI1MiAzMy40LTIxLjAzMTYgNDIuODc1LTMzLjc1aC04NS43NXoiLz4=
NCjwvZz4NCjwvc3ZnPg0K"); }

.flag-list .ua a::before { background-image: url("data:image/svg+xml;base64=
,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgMCAxMj=
AwIDgwMCI+DQo8cGF0aCBmaWxsPSIjM2E3NWM0IiBkPSJtMCwwaDEyMDB2ODAwaC0xMjAweiIvP=
g0KPHBhdGggZmlsbD0iI2Y5ZGQxNiIgZD0ibTAsNDAwaDEyMDB2NDAwaC0xMjAweiIvPg0KPC9z=
dmc+DQo=3D"); }

.pat-form-field-name-value-list .pat-button-bar { --pat-button-bar-margin-t=
op-bottom: 0; }

:root { --form-field-range-size: 20px; --form-field-range-track-thickness: =
2px; }

.pat-form input[type=3D"range"] { appearance: none; padding: 0.2em 0px; bor=
der: none; outline: none; box-shadow: none; border-radius: 1em; position: r=
elative; top: 50%; transform: translateY(-50%); margin-top: calc(.5*var(--f=
orm-field-range-track-thickness)); background: rgba(0, 0, 0, 0) !important;=
 }

.pat-form input[type=3D"range"]:focus { outline: none; box-shadow: none; }

.pat-form input[type=3D"range"]::-webkit-slider-runnable-track { height: va=
r(--form-field-range-track-thickness); background: rgb(0, 0, 0); border: no=
ne; box-shadow: rgba(0, 0, 0, 0.2) 0px 0px 3px inset; border-radius: 1em; }

.pat-form input[type=3D"range"]::-webkit-slider-thumb { appearance: none; b=
order: none; height: var(--form-field-range-size); width: var(--form-field-=
range-size); border-radius: 50%; background: rgb(1, 104, 155); transform: t=
ranslateY(-50%); margin-top: calc(.5*var(--form-field-range-track-thickness=
)); }

.pswp { display: none; position: absolute; width: 100%; height: 100%; left:=
 0px; top: 0px; overflow: hidden; touch-action: none; z-index: 1500; text-s=
ize-adjust: 100%; backface-visibility: hidden; outline: none; }

.pswp * { box-sizing: border-box; }

.pswp img { max-width: none; }

.pswp--animate_opacity { opacity: 0.001; will-change: opacity; transition: =
opacity 333ms cubic-bezier(0.4, 0, 0.22, 1); }

.pswp--open { display: block; }

.pswp--zoom-allowed .pswp__img { cursor: zoom-in; }

.pswp--zoomed-in .pswp__img { cursor: grab; }

.pswp--dragging .pswp__img { cursor: grabbing; }

.pswp__bg { position: absolute; left: 0px; top: 0px; width: 100%; height: 1=
00%; background: rgb(0, 0, 0); opacity: 0; transform: translateZ(0px); back=
face-visibility: hidden; will-change: opacity; }

.pswp__scroll-wrap { position: absolute; left: 0px; top: 0px; width: 100%; =
height: 100%; overflow: hidden; }

.pswp__container, .pswp__zoom-wrap { touch-action: none; position: absolute=
; inset: 0px; }

.pswp__container, .pswp__img { user-select: none; -webkit-tap-highlight-col=
or: rgba(0, 0, 0, 0); }

.pswp__zoom-wrap { position: absolute; width: 100%; transform-origin: left =
top; transition: transform 333ms cubic-bezier(0.4, 0, 0.22, 1); }

.pswp__bg { will-change: opacity; transition: opacity 333ms cubic-bezier(0.=
4, 0, 0.22, 1); }

.pswp--animated-in .pswp__bg, .pswp--animated-in .pswp__zoom-wrap { transit=
ion: none; }

.pswp__container, .pswp__zoom-wrap { backface-visibility: hidden; }

.pswp__item { position: absolute; inset: 0px; overflow: hidden; }

.pswp__img { position: absolute; width: auto; height: auto; top: 0px; left:=
 0px; }

.pswp__img--placeholder { backface-visibility: hidden; }

.pswp__img--placeholder--blank { background: rgb(34, 34, 34); }

.pswp--ie .pswp__img { left: 0px; top: 0px; width: 100% !important; height:=
 auto !important; }

.pswp__error-msg { position: absolute; left: 0px; top: 50%; width: 100%; te=
xt-align: center; font-size: 14px; line-height: 16px; margin-top: -8px; col=
or: rgb(204, 204, 204); }

.pswp__error-msg a { color: rgb(204, 204, 204); text-decoration: underline;=
 }

.pswp__button { width: 44px; height: 44px; position: relative; background: =
none; cursor: pointer; overflow: visible; appearance: none; display: block;=
 border: 0px; padding: 0px; margin: 0px; float: right; opacity: 0.75; trans=
ition: opacity 0.2s; box-shadow: none; }

.pswp__button:focus, .pswp__button:hover { opacity: 1; }

.pswp__button:active { outline: none; opacity: 0.9; }

.pswp__ui--over-close .pswp__button--close { opacity: 1; }

.pswp__button, .pswp__button--arrow--left::before, .pswp__button--arrow--ri=
ght::before { background: url("photoswipe/default-skin.png") 0px 0px / 264p=
x 88px no-repeat; width: 44px; height: 44px; }

@media (-webkit-min-device-pixel-ratio: 1.1), (min-resolution: 105dpi), (mi=
n-resolution: 1.1dppx) {
  .pswp--svg .pswp__button, .pswp--svg .pswp__button--arrow--left::before, =
.pswp--svg .pswp__button--arrow--right::before { background-image: url("pho=
toswipe/default-skin.svg"); }
  .pswp--svg .pswp__button--arrow--left, .pswp--svg .pswp__button--arrow--r=
ight { background: none; }
}

.pswp__button--close { background-position: 0px -44px; }

.pswp__button--share { background-position: -44px -44px; }

.pswp__button--fs { display: none; }

.pswp--supports-fs .pswp__button--fs { display: block; }

.pswp--fs .pswp__button--fs { background-position: -44px 0px; }

.pswp__button--zoom { display: none; background-position: -88px 0px; }

.pswp--zoom-allowed .pswp__button--zoom { display: block; }

.pswp--zoomed-in .pswp__button--zoom { background-position: -132px 0px; }

.pswp--touch .pswp__button--arrow--left, .pswp--touch .pswp__button--arrow-=
-right { visibility: hidden; }

.pswp__button--arrow--left, .pswp__button--arrow--right { background: none;=
 top: 50%; margin-top: -50px; width: 70px; height: 100px; position: absolut=
e; }

.pswp__button--arrow--left { left: 0px; }

.pswp__button--arrow--right { right: 0px; }

.pswp__button--arrow--left::before, .pswp__button--arrow--right::before { c=
ontent: ""; top: 35px; background-color: rgba(0, 0, 0, 0.3); height: 30px; =
width: 32px; position: absolute; }

.pswp__button--arrow--left::before { left: 6px; background-position: -138px=
 -44px; }

.pswp__button--arrow--right::before { right: 6px; background-position: -94p=
x -44px; }

.pswp__counter, .pswp__share-modal { user-select: none; }

.pswp__share-modal { display: block; background: rgba(0, 0, 0, 0.5); width:=
 100%; height: 100%; top: 0px; left: 0px; padding: 10px; position: absolute=
; z-index: 1600; opacity: 0; transition: opacity 0.25s ease-out; backface-v=
isibility: hidden; will-change: opacity; }

.pswp__share-modal--hidden { display: none; }

.pswp__share-tooltip { z-index: 1620; position: absolute; background: rgb(2=
55, 255, 255); top: 56px; border-radius: 2px; display: block; width: auto; =
right: 44px; box-shadow: rgba(0, 0, 0, 0.25) 0px 2px 5px; transform: transl=
ateY(6px); transition: transform 0.25s; backface-visibility: hidden; will-c=
hange: transform; }

.pswp__share-tooltip a { display: block; padding: 8px 12px; color: rgb(0, 0=
, 0); text-decoration: none; font-size: 14px; line-height: 18px; }

.pswp__share-tooltip a:hover { text-decoration: none; color: rgb(0, 0, 0); =
}

.pswp__share-tooltip a:first-child { border-radius: 2px 2px 0px 0px; }

.pswp__share-tooltip a:last-child { border-radius: 0px 0px 2px 2px; }

.pswp__share-modal--fade-in { opacity: 1; }

.pswp__share-modal--fade-in .pswp__share-tooltip { transform: translateY(0p=
x); }

.pswp--touch .pswp__share-tooltip a { padding: 16px 12px; }

a.pswp__share--facebook::before { content: ""; display: block; width: 0px; =
height: 0px; position: absolute; top: -12px; right: 15px; border-width: 6px=
; border-style: solid; border-color: rgba(0, 0, 0, 0) rgba(0, 0, 0, 0) rgb(=
255, 255, 255); border-image: initial; pointer-events: none; }

a.pswp__share--facebook:hover { background: rgb(62, 92, 154); color: rgb(25=
5, 255, 255); }

a.pswp__share--facebook:hover::before { border-bottom-color: rgb(62, 92, 15=
4); }

a.pswp__share--twitter:hover { background: rgb(85, 172, 238); color: rgb(25=
5, 255, 255); }

a.pswp__share--pinterest:hover { background: rgb(204, 204, 204); color: rgb=
(206, 39, 45); }

a.pswp__share--download:hover { background: rgb(221, 221, 221); }

.pswp__counter { position: absolute; left: 0px; top: 0px; height: 44px; fon=
t-size: 13px; line-height: 44px; color: rgb(255, 255, 255); opacity: 0.75; =
padding: 0px 10px; }

.pswp__caption { position: absolute; left: 0px; bottom: 0px; width: 100%; m=
in-height: 44px; }

.pswp__caption small { font-size: 11px; color: rgb(187, 187, 187); }

.pswp__caption__center { text-align: left; max-width: 420px; margin: 0px au=
to; font-size: 13px; padding: 10px; line-height: 20px; color: rgb(204, 204,=
 204); }

body[dir=3D"rtl"] .pswp__caption__center { text-align: right; }

.pswp__caption--empty { display: none; }

.pswp__caption--fake { visibility: hidden; }

.pswp__preloader { width: 44px; height: 44px; position: absolute; top: 0px;=
 left: 50%; margin-left: -22px; opacity: 0; transition: opacity 0.25s ease-=
out; will-change: opacity; direction: ltr; }

.pswp__preloader__icn { width: 20px; height: 20px; margin: 12px; }

.pswp__preloader--active { opacity: 1; }

.pswp__preloader--active .pswp__preloader__icn { background: url("photoswip=
e/preloader.gif") 0px 0px no-repeat; }

.pswp--css_animation .pswp__preloader--active { opacity: 1; }

.pswp--css_animation .pswp__preloader--active .pswp__preloader__icn { anima=
tion: 500ms linear 0s infinite normal none running clockwise; }

.pswp--css_animation .pswp__preloader--active .pswp__preloader__donut { ani=
mation: 1000ms cubic-bezier(0.4, 0, 0.22, 1) 0s infinite normal none runnin=
g donut-rotate; }

.pswp--css_animation .pswp__preloader__icn { background: none; opacity: 0.7=
5; width: 14px; height: 14px; position: absolute; left: 15px; top: 15px; ma=
rgin: 0px; }

.pswp--css_animation .pswp__preloader__cut { position: relative; width: 7px=
; height: 14px; overflow: hidden; }

.pswp--css_animation .pswp__preloader__donut { box-sizing: border-box; widt=
h: 14px; height: 14px; border-width: 2px; border-style: solid; border-color=
: rgb(255, 255, 255) rgb(255, 255, 255) rgba(0, 0, 0, 0) rgba(0, 0, 0, 0); =
border-image: initial; border-radius: 50%; position: absolute; top: 0px; le=
ft: 0px; background: none; margin: 0px; }

@media screen and (max-width: 1024px) {
  .pswp__preloader { position: relative; left: auto; top: auto; margin: 0px=
; float: right; }
}

@keyframes clockwise {=20
  0% { transform: rotate(0deg); }
  100% { transform: rotate(360deg); }
}

@keyframes donut-rotate {=20
  0% { transform: rotate(0deg); }
  50% { transform: rotate(-140deg); }
  100% { transform: rotate(0deg); }
}

.pswp__ui { -webkit-font-smoothing: auto; visibility: visible; opacity: 1; =
z-index: 1550; }

.pswp__top-bar { position: absolute; left: 0px; top: 0px; height: 44px; wid=
th: 100%; }

.pswp__caption, .pswp__top-bar, .pswp--has_mouse .pswp__button--arrow--left=
, .pswp--has_mouse .pswp__button--arrow--right { backface-visibility: hidde=
n; will-change: opacity; transition: opacity 333ms cubic-bezier(0.4, 0, 0.2=
2, 1); }

.pswp--has_mouse .pswp__button--arrow--left, .pswp--has_mouse .pswp__button=
--arrow--right { visibility: visible; }

.pswp__top-bar, .pswp__caption { background-color: rgba(0, 0, 0, 0.5); }

.pswp__ui--fit .pswp__top-bar, .pswp__ui--fit .pswp__caption { background-c=
olor: rgba(0, 0, 0, 0.3); }

.pswp__ui--idle .pswp__top-bar { opacity: 0; }

.pswp__ui--idle .pswp__button--arrow--left, .pswp__ui--idle .pswp__button--=
arrow--right { opacity: 0; }

.pswp__ui--hidden .pswp__top-bar, .pswp__ui--hidden .pswp__caption, .pswp__=
ui--hidden .pswp__button--arrow--left, .pswp__ui--hidden .pswp__button--arr=
ow--right { opacity: 0.001; }

.pswp__ui--one-slide .pswp__button--arrow--left, .pswp__ui--one-slide .pswp=
__button--arrow--right, .pswp__ui--one-slide .pswp__counter { display: none=
; }

.pswp__element--disabled { display: none !important; }

.pswp--minimal--dark .pswp__top-bar { background: none; }

.pswp { z-index: 9999; }

.pswp img[src*=3D".svg"] { background: rgb(255, 255, 255); }

.pswp__button--arrow--left::before, .pswp__button--arrow--right::before { w=
idth: 40px; height: 40px; line-height: 40px; box-shadow: rgba(255, 255, 255=
, 0.7) 0px 0px 0px 2px; border-radius: 0px; color: rgb(255, 255, 255); text=
-align: center; font-size: 15px; font-family: fontello; background: rgba(0,=
 0, 0, 0.3) !important; }

.pswp__button--arrow--left::before { content: "=EE=A3=86"; }

.pswp__button--arrow--right::before { content: "=EE=A2=88"; }

.pswp__bg { background-color: rgba(255, 255, 255, 0.95); }

.backdropfilter .pswp__bg { background-color: rgba(255, 255, 255, 0.15); ba=
ckdrop-filter: blur(100px) saturate(4) brightness(1.2); }

.pswp__counter { color: rgb(0, 0, 0); }

.pswp__ui--fit .pswp__top-bar, .pswp__ui--fit .pswp__caption { background: =
none; }

.pswp__ui--fit .pswp__top-bar .pswp__caption__center, .pswp__ui--fit .pswp_=
_caption .pswp__caption__center { text-align: center; color: rgb(0, 0, 0); =
}

.row, .columns { box-sizing: border-box; }

.row { margin: 0px -15px; }

.row .row { width: auto; max-width: none; min-width: 0px; margin: 0px -15px=
; }

.row.collapse .column, .row.collapse .columns { padding: 0px; }

.row .row { width: auto; max-width: none; min-width: 0px; margin: 0px -15px=
; }

.row .row.collapse { margin: 0px; }

.column, .columns { float: left; min-height: 1px; padding: 0px 15px; positi=
on: relative; }

.column > .panel, .columns > .panel { height: 100%; box-sizing: border-box;=
 }

.column.centered, .columns.centered { float: none; margin: 0px auto; }

[class*=3D"column"] + [class*=3D"column"]:last-child { float: right; }

[class*=3D"column"] + [class*=3D"column"].end { float: left; }

.one, .row .one { width: 8.33333%; }

.two, .row .two { width: 16.6667%; }

.three, .row .three { width: 25%; }

.four, .row .four { width: 33.3333%; }

.five, .row .five { width: 41.6667%; }

.six, .row .six { width: 50%; }

.seven, .row .seven { width: 58.3333%; }

.eight, .row .eight { width: 66.6667%; }

.nine, .row .nine { width: 75%; }

.ten, .row .ten { width: 83.3333%; }

.eleven, .row .eleven { width: 91.6667%; }

.twelve { width: 100%; }

.row .twelve { width: 100%; }

.row .offset-by-one { margin-left: 8.33333%; }

.row .offset-by-two { margin-left: 16.6667%; }

.row .offset-by-three { margin-left: 25%; }

.row .offset-by-four { margin-left: 33.3333%; }

.row .offset-by-five { margin-left: 41.6667%; }

.row .offset-by-six { margin-left: 50%; }

.row .offset-by-seven { margin-left: 58.3333%; }

.row .offset-by-eight { margin-left: 66.6667%; }

.row .offset-by-nine { margin-left: 75%; }

.row .offset-by-ten { margin-left: 83.3333%; }

.push-two { left: 16.6667%; }

.pull-two { right: 16.6667%; }

.push-three { left: 25%; }

.pull-three { right: 25%; }

.push-four { left: 33.3333%; }

.pull-four { right: 33.3333%; }

.push-five { left: 41.6667%; }

.pull-five { right: 41.6667%; }

.push-six { left: 50%; }

.pull-six { right: 50%; }

.push-seven { left: 58.3333%; }

.pull-seven { right: 58.3333%; }

.push-eight { left: 66.6667%; }

.pull-eight { right: 66.6667%; }

.push-nine { left: 75%; }

.pull-nine { right: 75%; }

.push-ten { left: 83.3333%; }

.pull-ten { right: 83.3333%; }

.row { }

.row::before { content: " "; display: table; }

.row::after { content: " "; display: table; clear: both; }

@media only screen and (max-width: 767px) {
  body { text-size-adjust: none; min-width: 0px; margin-left: 0px; margin-r=
ight: 0px; }
  .row, .row .row { width: auto; margin: 0px; min-width: 0px; }
  .column, .columns { float: none; padding: 0px; width: auto !important; }
  .column:last-child, .columns:last-child, [class*=3D"column"] + [class*=3D=
"column"]:last-child { float: none; }
  .column::before, .columns::before, .column::after, .columns::after { cont=
ent: ""; display: table; }
  .column::after, .columns::after { clear: both; }
  .offset-by-one, .offset-by-two, .offset-by-three, .offset-by-four, .offse=
t-by-five, .offset-by-six, .offset-by-seven, .offset-by-eight, .offset-by-n=
ine, .offset-by-ten { margin-left: 0px !important; }
  .push-two, .push-three, .push-four, .push-five, .push-six, .push-seven, .=
push-eight, .push-nine, .push-ten { left: auto; }
  .pull-two, .pull-three, .pull-four, .pull-five, .pull-six, .pull-seven, .=
pull-eight, .pull-nine, .pull-ten { right: auto; }
}

.pat-grid-list { margin-bottom: 2em; margin-top: 0px; width: 100%; border-b=
ottom: 1px solid rgba(0, 0, 0, 0.15); }

.pat-grid-list.hd { font-size: 0.8em; }

.pat-grid-list.hd dt, .pat-grid-list.hd dd { padding-top: 0.1em; padding-bo=
ttom: 0.1em; }

@media only screen and (min-width: 770px) {
  .pat-grid-list { display: grid; column-gap: 0px; grid-template-columns: 3=
0% 70%; }
}

@media print {
  .pat-grid-list { display: grid; column-gap: 0px; grid-template-columns: 3=
0% 70%; }
}

.pat-grid-list dt { font-weight: bold; border-top: 1px solid rgba(0, 0, 0, =
0.15); padding-top: 0.5em; }

@media only screen and (min-width: 770px) {
  .pat-grid-list dt { padding-right: 2%; padding-bottom: 0.5em; }
}

@media only screen and (max-width: 769px) {
  .pat-grid-list dt { width: 100%; float: none; display: block; margin: 0px=
; overflow: hidden; clear: left; }
}

@media print {
  .pat-grid-list dt { display: block; width: 100%; border: none; }
}

.pat-grid-list dd { margin-bottom: 0px; padding-top: 0.5em; padding-bottom:=
 0.5em; margin-left: 0px; }

.pat-grid-list dd:has(.functions) { display: grid; grid-template-columns: a=
uto auto; grid-template-areas: "value functions"; grid-auto-rows: auto; gri=
d-auto-flow: dense; gap: 15px; }

@media print {
  .pat-grid-list dd { display: block; border: none; clear: both; width: 100=
%; }
}

.pat-grid-list dd > * { grid-area: value; }

.pat-grid-list dd > .functions { grid-area: functions; place-self: start en=
d; gap: 10px; display: flex; flex-wrap: nowrap; }

.pat-grid-list dd .item-info-card { display: block; box-sizing: border-box;=
 box-shadow: none; border-radius: 0px; background-color: var(--pat-form-pan=
el-background-colour); --pat-toolbar-margin-bottom: 15px; padding: 1rem; ma=
rgin-bottom: 0px; }

.pat-grid-list dd .item-info-card .well-title-group { position: relative; }

.pat-grid-list dd .item-info-card .well-title-group .buttons { position: ab=
solute; right: calc(var(--pat-form-panel-padding) + 31px + 15px); top: 50%;=
 transform: translateY(-50%); }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon { overfl=
ow: hidden; width: 31px; height: 31px; cursor: default; background-color: r=
gb(242, 242, 242); color: rgba(0, 0, 0, 0); position: relative; float: righ=
t; margin-left: 15px; border-radius: 0px; font-style: normal; font-weight: =
normal; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon::after {=
 font-family: fontello; font-size: 1em; z-index: 1; width: 31px; height: 31=
px; text-align: center; line-height: 31px; display: block; position: absolu=
te; color: rgb(1, 104, 154); top: 0px; left: 0px; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon:hover { =
background-color: rgb(237, 237, 237); }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon:hover::a=
fter { color: rgb(1, 104, 154); }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.tooltip-=
active-click { background-color: rgb(225, 112, 0); }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.tooltip-=
active-click::after { color: rgb(255, 255, 255); }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.help::af=
ter { content: "=EE=A2=82"; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.add::aft=
er { content: "=EE=A3=A4"; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.download=
::after { content: "=EE=A0=8F"; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.settings=
::after { content: "=EE=A3=98"; }

.pat-grid-list dd .item-info-card .well-title-group .buttons .icon.more::af=
ter { content: "=EE=A2=9E"; line-height: calc(34px); }

.pat-grid-list dd .item-info-card .well-header { margin-bottom: 40px; line-=
height: 1.3; font-size: 28px; font-weight: normal; color: rgb(0, 0, 0); }

.pat-grid-list dd .item-info-card .well-header .pat-avatar { float: left; w=
idth: 36px; height: 36px; margin-right: 10px; font-size: 0.7em; }

.pat-grid-list dd .item-info-card .well-separation-header { margin-bottom: =
1em; margin-top: 1.5em; font-size: 24px; font-weight: bold; }

.pat-grid-list dd .item-info-card .well-separation-header:first-child { mar=
gin-top: 0px; }

.pat-grid-list dd .item-info-card.pat-collapsible { transition: padding 0.4=
s; padding: 0px; }

.pat-grid-list dd .item-info-card.pat-collapsible .panel-content > :last-ch=
ild { margin-bottom: 0px; }

.pat-grid-list dd .item-info-card.pat-collapsible > .well-header, .pat-grid=
-list dd .item-info-card.pat-collapsible > .well-title-group > .well-header=
 { padding-right: 50px; padding-left: 40px; position: relative; margin: 0px=
; transition: padding 0.4s; }

.pat-grid-list dd .item-info-card.pat-collapsible > .well-header::after, .p=
at-grid-list dd .item-info-card.pat-collapsible > .well-title-group > .well=
-header::after { font-family: fontello; content: "=EE=A3=88"; font-size: 0.=
65em; background-color: rgb(242, 242, 242); color: rgb(1, 104, 154); positi=
on: absolute; right: var(--pat-form-panel-padding); top: 50%; transform: tr=
anslateY(-50%); z-index: 1; width: 31px; height: 31px; text-align: center; =
line-height: 31px; border-radius: 0px; display: inline-block; }

.pat-grid-list dd .item-info-card.pat-collapsible > .well-header:hover::aft=
er, .pat-grid-list dd .item-info-card.pat-collapsible > .well-title-group >=
 .well-header:hover::after { background-color: rgb(237, 237, 237); color: r=
gb(1, 104, 154); }

.pat-grid-list dd .item-info-card.pat-collapsible.open, .pat-grid-list dd .=
item-info-card.pat-collapsible.closed.in-progress { transition: box-shadow =
2s; }

.pat-grid-list dd .item-info-card.pat-collapsible.open > .well-header, .pat=
-grid-list dd .item-info-card.pat-collapsible.open > .well-title-group > .w=
ell-header, .pat-grid-list dd .item-info-card.pat-collapsible.closed.in-pro=
gress > .well-header, .pat-grid-list dd .item-info-card.pat-collapsible.clo=
sed.in-progress > .well-title-group > .well-header { padding-top: 40px; pad=
ding-bottom: 40px; }

.pat-grid-list dd .item-info-card.pat-collapsible.closed:hover { box-shadow=
: var(--pat-form-panel-box-shadow-hover); }

.pat-grid-list dd .item-info-card.pat-collapsible.closed > .well-header, .p=
at-grid-list dd .item-info-card.pat-collapsible.closed > .well-title-group =
> .well-header, .pat-grid-list dd .item-info-card.pat-collapsible.open.in-p=
rogress > .well-header, .pat-grid-list dd .item-info-card.pat-collapsible.o=
pen.in-progress > .well-title-group > .well-header { padding-top: 20px; pad=
ding-bottom: 20px; border-radius: 0px; }

.pat-grid-list dd .item-info-card.pat-collapsible.closed > .well-header::af=
ter, .pat-grid-list dd .item-info-card.pat-collapsible.closed > .well-title=
-group > .well-header::after, .pat-grid-list dd .item-info-card.pat-collaps=
ible.open.in-progress > .well-header::after, .pat-grid-list dd .item-info-c=
ard.pat-collapsible.open.in-progress > .well-title-group > .well-header::af=
ter { content: "=EE=A3=87"; }

.pat-grid-list dd .item-info-card.pat-collapsible > .panel-content { paddin=
g: 0px 40px 40px; box-sizing: border-box; }

.pat-grid-list dd .item-info-card form > fieldset:last-child, .pat-grid-lis=
t dd .item-info-card form > fieldset:last-child > .button-bar:last-child { =
margin-bottom: 0px; }

.pat-grid-list dd .item-info-card > :last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-grid-list dd .item-info-card { padding: 20px; }
}

.pat-grid-list dd .item-info-card.success { background-color: rgb(225, 237,=
 219); }

.pat-grid-list dd .item-info-card.success input { color: rgb(0, 0, 0); }

.pat-grid-list dd .item-info-card.notice { background-color: rgb(253, 246, =
187); }

.pat-grid-list dd .item-info-card.warning { background-color: rgb(251, 234,=
 217); }

.pat-grid-list dd .item-info-card.warning input { color: rgb(0, 0, 0); }

.pat-grid-list dd .item-info-card.info { background-color: rgb(217, 237, 24=
7); }

.pat-grid-list dd .item-info-card.success input, .pat-grid-list dd .item-in=
fo-card.success textarea, .pat-grid-list dd .item-info-card.success select,=
 .pat-grid-list dd .item-info-card.warning input, .pat-grid-list dd .item-i=
nfo-card.warning textarea, .pat-grid-list dd .item-info-card.warning select=
 { background-color: rgba(0, 0, 0, 0.3); outline: rgb(255, 255, 255) solid =
1px; }

.pat-grid-list dd .item-info-card.success select, .pat-grid-list dd .item-i=
nfo-card.warning select { background-image: url("data:image/svg+xml;base64,=
PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4NCjwhLS0gR2VuZXJhdG9yOiB=
BZG9iZSBJbGx1c3RyYXRvciAxNS4xLjAsIFNWRyBFeHBvcnQgUGx1Zy1JbiAgLS0+DQo8IURPQ1=
RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczL=
m9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmcxMS5kdGQiIFsNCgk8IUVOVElUWSBuc19mbG93=
cyAiaHR0cDovL25zLmFkb2JlLmNvbS9GbG93cy8xLjAvIj4NCl0+DQo8c3ZnIHZlcnNpb249IjE=
uMSINCgkgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaH=
R0cDovL3d3dy53My5vcmcvMTk5OS94bGluayIgeG1sbnM6YT0iaHR0cDovL25zLmFkb2JlLmNvb=
S9BZG9iZVNWR1ZpZXdlckV4dGVuc2lvbnMvMy4wLyINCgkgeD0iMHB4IiB5PSIwcHgiIHdpZHRo=
PSIxMnB4IiBoZWlnaHQ9IjEwcHgiIHZpZXdCb3g9IjAgLTEuNDk2IDEyIDEwIiBvdmVyZmxvdz0=
idmlzaWJsZSIgZW5hYmxlLWJhY2tncm91bmQ9Im5ldyAwIC0xLjQ5NiAxMiAxMCINCgkgeG1sOn=
NwYWNlPSJwcmVzZXJ2ZSI+DQo8ZGVmcz4NCjwvZGVmcz4NCjxwb2x5Z29uIGZpbGw9IiNGRkZGR=
kYiIHBvaW50cz0iMCwwIDQuMjA1LDcuMDA5IDguNDEsMCAiLz4NCjwvc3ZnPg0K"); }

.horizontal .pat-grid-list dd .item-info-card { --pat-form-panel-background=
-colour: white; }

.pat-grid-list dd .item-info-card .title { font-size: 1.2rem; margin-bottom=
: 5px; }

.pat-grid-list dd .item-info-card .tag-cloud { margin-top: 5px; }

.pat-grid-list dd .item-info-card > :last-child { margin-bottom: 0px; }

.pat-grid-list dd .item-info-card .meta { margin-top: 5px; font-weight: nor=
mal; color: rgb(83, 83, 83); width: 100%; }

.pat-grid-list dd .item-info-card .meta:last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-grid-list dd .item-info-card .meta { display: inline; }
}

@media only screen and (min-width: 770px) {
  .pat-grid-list dd .item-info-card .meta .meta-item { border-left: 1px sol=
id rgb(83, 83, 83); padding: 0px 0.2em; display: inline-block; }
  .pat-grid-list dd .item-info-card .meta .meta-item::before { content: " =
=C2=A0"; display: inline; }
  .pat-grid-list dd .item-info-card .meta .meta-item:first-child { padding-=
left: 0px; border-left: none; }
  .pat-grid-list dd .item-info-card .meta .meta-item:first-child::before { =
display: none; }
}

@media only screen and (max-width: 769px) {
  .pat-grid-list dd .item-info-card .meta .meta-item::after { content: ", "=
; }
}

.pat-grid-list dd > :last-child { margin-bottom: 0px; }

@media only screen and (min-width: 770px) {
  .pat-grid-list dd { border-top: 1px solid rgba(0, 0, 0, 0.15); }
}

@media only screen and (max-width: 769px) {
  .pat-grid-list dd { width: 100%; float: none; display: block; border: non=
e; overflow: hidden; }
  #user-data-view .pat-grid-list dd { padding-left: 30px; box-sizing: borde=
r-box; }
}

:root { --pat-checklist-label-padding-start: 1.5em; --pat-checklist-label-p=
adding-end: 0; --pat-checklist-item-separation: 0.2em; --pat-checklist-chec=
kbox-size: 18px; --pat-checklist-checkbox-background-colour: white; --pat-c=
hecklist-checkbox-box-shadow: inset 0 0 0 2px black; --pat-checklist-checkb=
ox-box-shadow-checked: none; --pat-checklist-checkbox-box-shadow-radio-chec=
ked: inset 0 0 0 2px var(--colour-accent), inset 0 0 0 5px white; --pat-che=
cklist-checkbox-background-colour-checked: var(--colour-accent); --pat-chec=
klist-checkbox-border-radius: calc(0.25 * var(--pat-checklist-checkbox-size=
)); --pat-checklist-line-height: 24px; --pat-checklist-checkbox-vertical-po=
sition: 12px; --pat-checklist-margin-bottom: 1rem; }

label.pat-checklist { display: grid; grid-template-columns: var(--pat-check=
list-label-padding-start) auto; grid-template-areas: "icon label" ". descri=
ption"; align-items: start; user-select: none; line-height: var(--pat-check=
list-line-height); padding-left: 1.1em; padding-right: 0.5em; }

body[dir=3D"rtl"] label.pat-checklist { padding-left: var(--pat-checklist-l=
abel-padding-end); }

label.pat-checklist > * { grid-area: label; }

label.pat-checklist:has(:focus)::before { outline: var(--pat-form-input-fie=
ld-outline-focus); outline-offset: var(--pat-form-input-field-outline-offse=
t); }

label.pat-checklist:has(input[type=3D"checkbox"])::before, label.pat-checkl=
ist:has(input[type=3D"radio"])::before { box-shadow: var(--pat-checklist-ch=
eckbox-box-shadow); content: ""; font-weight: normal; background-color: var=
(--pat-checklist-checkbox-background-colour); font-size: 0px; text-align: c=
enter; height: var(--pat-checklist-checkbox-size); width: var(--pat-checkli=
st-checkbox-size); line-height: var(--pat-checklist-checkbox-size); border-=
radius: var(--pat-checklist-checkbox-border-radius); justify-self: start; g=
rid-area: icon; position: relative; top: var(--pat-checklist-checkbox-verti=
cal-position); transform: translateY(-50%); transition: 0.2s ease-out; }

label.pat-checklist:has(input[type=3D"radio"])::before { border-radius: 50%=
; }

label.pat-checklist:has(input:checked)::before { background-color: var(--pa=
t-checklist-checkbox-background-colour-checked); box-shadow: var(--pat-chec=
klist-checkbox-box-shadow-checked); color: rgb(255, 255, 255); font-family:=
 fontello; content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-che=
ckbox-size)); }

label.pat-checklist:has([disabled]):has(input[type=3D"checkbox"])::before, =
label.pat-checklist:has([disabled]):has(input[type=3D"radio"])::before, lab=
el.pat-checklist:has([disabled]) .label-fragment-description:has(input[type=
=3D"checkbox"])::before, label.pat-checklist:has([disabled]) .label-fragmen=
t-description:has(input[type=3D"radio"])::before { background-color: rgba(0=
, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

label.pat-checklist .label-fragment-title { margin: 0px 0px 0px -30px; padd=
ing-left: 30px; }

label.pat-checklist .label-fragment-description { margin: 5px 0px 12px; col=
or: rgba(0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: desc=
ription; }

label.pat-checklist .label-fragment-description > * { color: rgb(0, 0, 0); =
}

label.pat-checklist input[type=3D"checkbox"], label.pat-checklist input[typ=
e=3D"radio"] { opacity: 0; position: absolute; left: 0px; width: 0px; margi=
n-top: 0.6px; }

.pat-checklist:not(.free-form) { line-height: 1.2em; min-height: 0.7em; mar=
gin-bottom: var(--pat-checklist-margin-bottom); }

form.vertical .pat-checklist:not(.free-form) > legend, form fieldset.vertic=
al .pat-checklist:not(.free-form) > legend, form.vertical .pat-checklist:no=
t(.free-form) > .legend, form fieldset.vertical .pat-checklist:not(.free-fo=
rm) > .legend { margin-bottom: calc(2*var(--pat-checklist-item-separation))=
; }

.pat-checklist:not(.free-form) .pat-checklist-sub { padding-left: 1em; padd=
ing-bottom: 1em; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label, .pat-checklist:n=
ot(.free-form) .pat-checklist-sub .label, .pat-checklist:not(.free-form) .p=
at-checklist-sub > li > label { position: relative; display: grid; grid-tem=
plate-columns: var(--pat-checklist-label-padding-start) auto; grid-template=
-areas: "icon label" ". description"; align-items: start; padding-right: va=
r(--pat-checklist-label-padding-end); user-select: none; line-height: var(-=
-pat-checklist-line-height); margin-top: var(--pat-checklist-item-separatio=
n); margin-bottom: var(--pat-checklist-item-separation); white-space: norma=
l; }

body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub > label=
, body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub .labe=
l, body[dir=3D"rtl"] .pat-checklist:not(.free-form) .pat-checklist-sub > li=
 > label { padding-left: var(--pat-checklist-label-padding-end); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label > *, .pat-checkli=
st:not(.free-form) .pat-checklist-sub .label > *, .pat-checklist:not(.free-=
form) .pat-checklist-sub > li > label > * { grid-area: label; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(:focus)::befo=
re, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(:focus)::b=
efore, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label:has(:=
focus)::before { outline: var(--pat-form-input-field-outline-focus); outlin=
e-offset: var(--pat-form-input-field-outline-offset); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input[type=3D=
"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub > l=
abel:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pa=
t-checklist-sub .label:has(input[type=3D"checkbox"])::before, .pat-checklis=
t:not(.free-form) .pat-checklist-sub .label:has(input[type=3D"radio"])::bef=
ore, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label:has(inp=
ut[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checkli=
st-sub > li > label:has(input[type=3D"radio"])::before { box-shadow: var(--=
pat-checklist-checkbox-box-shadow); content: ""; font-weight: normal; backg=
round-color: var(--pat-checklist-checkbox-background-colour); font-size: 0p=
x; text-align: center; height: var(--pat-checklist-checkbox-size); width: v=
ar(--pat-checklist-checkbox-size); line-height: var(--pat-checklist-checkbo=
x-size); border-radius: var(--pat-checklist-checkbox-border-radius); justif=
y-self: start; grid-area: icon; position: relative; top: var(--pat-checklis=
t-checkbox-vertical-position); transform: translateY(-50%); transition: 0.2=
s ease-out; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input[type=3D=
"radio"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label=
:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-ch=
ecklist-sub > li > label:has(input[type=3D"radio"])::before { border-radius=
: 50%; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has(input:checked=
)::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(inp=
ut:checked)::before, .pat-checklist:not(.free-form) .pat-checklist-sub > li=
 > label:has(input:checked)::before { background-color: var(--pat-checklist=
-checkbox-background-colour-checked); box-shadow: var(--pat-checklist-check=
box-box-shadow-checked); color: rgb(255, 255, 255); font-family: fontello; =
content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-size)=
); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label:has([disabled]):h=
as(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-c=
hecklist-sub > label:has([disabled]):has(input[type=3D"radio"])::before, .p=
at-checklist:not(.free-form) .pat-checklist-sub > label:has([disabled]) .la=
bel-fragment-description:has(input[type=3D"checkbox"])::before, .pat-checkl=
ist:not(.free-form) .pat-checklist-sub > label:has([disabled]) .label-fragm=
ent-description:has(input[type=3D"radio"])::before, .pat-checklist:not(.fre=
e-form) .pat-checklist-sub .label:has([disabled]):has(input[type=3D"checkbo=
x"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub .label:has(=
[disabled]):has(input[type=3D"radio"])::before, .pat-checklist:not(.free-fo=
rm) .pat-checklist-sub .label:has([disabled]) .label-fragment-description:h=
as(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-c=
hecklist-sub .label:has([disabled]) .label-fragment-description:has(input[t=
ype=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-checklist-sub =
> li > label:has([disabled]):has(input[type=3D"checkbox"])::before, .pat-ch=
ecklist:not(.free-form) .pat-checklist-sub > li > label:has([disabled]):has=
(input[type=3D"radio"])::before, .pat-checklist:not(.free-form) .pat-checkl=
ist-sub > li > label:has([disabled]) .label-fragment-description:has(input[=
type=3D"checkbox"])::before, .pat-checklist:not(.free-form) .pat-checklist-=
sub > li > label:has([disabled]) .label-fragment-description:has(input[type=
=3D"radio"])::before { background-color: rgba(0, 0, 0, 0.2); color: rgba(0,=
 0, 0, 0.3); box-shadow: none; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-t=
itle, .pat-checklist:not(.free-form) .pat-checklist-sub .label .label-fragm=
ent-title, .pat-checklist:not(.free-form) .pat-checklist-sub > li > label .=
label-fragment-title { margin: 0px 0px 0px -30px; padding-left: 30px; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-d=
escription, .pat-checklist:not(.free-form) .pat-checklist-sub .label .label=
-fragment-description, .pat-checklist:not(.free-form) .pat-checklist-sub > =
li > label .label-fragment-description { margin: 5px 0px 12px; color: rgba(=
0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: description; =
}

.pat-checklist:not(.free-form) .pat-checklist-sub > label .label-fragment-d=
escription > *, .pat-checklist:not(.free-form) .pat-checklist-sub .label .l=
abel-fragment-description > *, .pat-checklist:not(.free-form) .pat-checklis=
t-sub > li > label .label-fragment-description > * { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form) .pat-checklist-sub > label input[type=3D"che=
ckbox"], .pat-checklist:not(.free-form) .pat-checklist-sub > label input[ty=
pe=3D"radio"], .pat-checklist:not(.free-form) .pat-checklist-sub .label inp=
ut[type=3D"checkbox"], .pat-checklist:not(.free-form) .pat-checklist-sub .l=
abel input[type=3D"radio"], .pat-checklist:not(.free-form) .pat-checklist-s=
ub > li > label input[type=3D"checkbox"], .pat-checklist:not(.free-form) .p=
at-checklist-sub > li > label input[type=3D"radio"] { opacity: 0; position:=
 absolute; left: 0px; width: 0px; margin-top: 0.6px; }

.pat-checklist:not(.free-form) .pat-checklist-sub > label::after, .pat-chec=
klist:not(.free-form) .pat-checklist-sub .label::after, .pat-checklist:not(=
.free-form) .pat-checklist-sub > li > label::after { content: " "; display:=
 table; clear: both; }

.pat-checklist:not(.free-form) > br { display: none; }

.pat-checklist:not(.free-form):not(.free-form) > label, .pat-checklist:not(=
.free-form):not(.free-form) .label, .pat-checklist:not(.free-form):not(.fre=
e-form) li > label { position: relative; display: grid; grid-template-colum=
ns: var(--pat-checklist-label-padding-start) auto; grid-template-areas: "ic=
on label" ". description"; align-items: start; padding-right: var(--pat-che=
cklist-label-padding-end); user-select: none; line-height: var(--pat-checkl=
ist-line-height); margin-top: var(--pat-checklist-item-separation); margin-=
bottom: var(--pat-checklist-item-separation); white-space: normal; font-wei=
ght: normal; }

body[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) > label, b=
ody[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) .label, bod=
y[dir=3D"rtl"] .pat-checklist:not(.free-form):not(.free-form) li > label { =
padding-left: var(--pat-checklist-label-padding-end); }

.pat-checklist:not(.free-form):not(.free-form) > label > *, .pat-checklist:=
not(.free-form):not(.free-form) .label > *, .pat-checklist:not(.free-form):=
not(.free-form) li > label > * { grid-area: label; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(:focus)::before,=
 .pat-checklist:not(.free-form):not(.free-form) .label:has(:focus)::before,=
 .pat-checklist:not(.free-form):not(.free-form) li > label:has(:focus)::bef=
ore { outline: var(--pat-form-input-field-outline-focus); outline-offset: v=
ar(--pat-form-input-field-outline-offset); }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input[type=3D"ch=
eckbox"])::before, .pat-checklist:not(.free-form):not(.free-form) > label:h=
as(input[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free=
-form) .label:has(input[type=3D"checkbox"])::before, .pat-checklist:not(.fr=
ee-form):not(.free-form) .label:has(input[type=3D"radio"])::before, .pat-ch=
ecklist:not(.free-form):not(.free-form) li > label:has(input[type=3D"checkb=
ox"])::before, .pat-checklist:not(.free-form):not(.free-form) li > label:ha=
s(input[type=3D"radio"])::before { box-shadow: var(--pat-checklist-checkbox=
-box-shadow); content: ""; font-weight: normal; background-color: var(--pat=
-checklist-checkbox-background-colour); font-size: 0px; text-align: center;=
 height: var(--pat-checklist-checkbox-size); width: var(--pat-checklist-che=
ckbox-size); line-height: var(--pat-checklist-checkbox-size); border-radius=
: var(--pat-checklist-checkbox-border-radius); justify-self: start; grid-ar=
ea: icon; position: relative; top: var(--pat-checklist-checkbox-vertical-po=
sition); transform: translateY(-50%); transition: 0.2s ease-out; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input[type=3D"ra=
dio"])::before, .pat-checklist:not(.free-form):not(.free-form) .label:has(i=
nput[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free-for=
m) li > label:has(input[type=3D"radio"])::before { border-radius: 50%; }

.pat-checklist:not(.free-form):not(.free-form) > label:has(input:checked)::=
before, .pat-checklist:not(.free-form):not(.free-form) .label:has(input:che=
cked)::before, .pat-checklist:not(.free-form):not(.free-form) li > label:ha=
s(input:checked)::before { background-color: var(--pat-checklist-checkbox-b=
ackground-colour-checked); box-shadow: var(--pat-checklist-checkbox-box-sha=
dow-checked); color: rgb(255, 255, 255); font-family: fontello; content: "=
=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-size)); }

.pat-checklist:not(.free-form):not(.free-form) > label:has([disabled]):has(=
input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form):not(.free=
-form) > label:has([disabled]):has(input[type=3D"radio"])::before, .pat-che=
cklist:not(.free-form):not(.free-form) > label:has([disabled]) .label-fragm=
ent-description:has(input[type=3D"checkbox"])::before, .pat-checklist:not(.=
free-form):not(.free-form) > label:has([disabled]) .label-fragment-descript=
ion:has(input[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(=
.free-form) .label:has([disabled]):has(input[type=3D"checkbox"])::before, .=
pat-checklist:not(.free-form):not(.free-form) .label:has([disabled]):has(in=
put[type=3D"radio"])::before, .pat-checklist:not(.free-form):not(.free-form=
) .label:has([disabled]) .label-fragment-description:has(input[type=3D"chec=
kbox"])::before, .pat-checklist:not(.free-form):not(.free-form) .label:has(=
[disabled]) .label-fragment-description:has(input[type=3D"radio"])::before,=
 .pat-checklist:not(.free-form):not(.free-form) li > label:has([disabled]):=
has(input[type=3D"checkbox"])::before, .pat-checklist:not(.free-form):not(.=
free-form) li > label:has([disabled]):has(input[type=3D"radio"])::before, .=
pat-checklist:not(.free-form):not(.free-form) li > label:has([disabled]) .l=
abel-fragment-description:has(input[type=3D"checkbox"])::before, .pat-check=
list:not(.free-form):not(.free-form) li > label:has([disabled]) .label-frag=
ment-description:has(input[type=3D"radio"])::before { background-color: rgb=
a(0, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-titl=
e, .pat-checklist:not(.free-form):not(.free-form) .label .label-fragment-ti=
tle, .pat-checklist:not(.free-form):not(.free-form) li > label .label-fragm=
ent-title { margin: 0px 0px 0px -30px; padding-left: 30px; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-desc=
ription, .pat-checklist:not(.free-form):not(.free-form) .label .label-fragm=
ent-description, .pat-checklist:not(.free-form):not(.free-form) li > label =
.label-fragment-description { margin: 5px 0px 12px; color: rgba(0, 0, 0, 0.=
7); font-size: 0.9em; line-height: 1.4; grid-area: description; }

.pat-checklist:not(.free-form):not(.free-form) > label .label-fragment-desc=
ription > *, .pat-checklist:not(.free-form):not(.free-form) .label .label-f=
ragment-description > *, .pat-checklist:not(.free-form):not(.free-form) li =
> label .label-fragment-description > * { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form):not(.free-form) > label input[type=3D"checkb=
ox"], .pat-checklist:not(.free-form):not(.free-form) > label input[type=3D"=
radio"], .pat-checklist:not(.free-form):not(.free-form) .label input[type=
=3D"checkbox"], .pat-checklist:not(.free-form):not(.free-form) .label input=
[type=3D"radio"], .pat-checklist:not(.free-form):not(.free-form) li > label=
 input[type=3D"checkbox"], .pat-checklist:not(.free-form):not(.free-form) l=
i > label input[type=3D"radio"] { opacity: 0; position: absolute; left: 0px=
; width: 0px; margin-top: 0.6px; }

.pat-checklist:not(.free-form):not(.free-form) > label:first-of-type, .pat-=
checklist:not(.free-form):not(.free-form) .label:first-of-type, .pat-checkl=
ist:not(.free-form):not(.free-form) li > label:first-of-type { margin-top: =
0px; }

.pat-checklist:not(.free-form).cloud label { display: inline-grid; margin-r=
ight: 1em; }

.pat-checklist:not(.free-form):has(input[type=3D"radio"]) label:has(input:c=
hecked)::before, .pat-checklist:not(.free-form).radio-bars label:has(input:=
checked)::before { content: ""; box-shadow: var(--pat-checklist-checkbox-bo=
x-shadow-radio-checked); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form), .pat-checklist:n=
ot(.free-form).bars:not(.free-form) { --pat-checklist-label-padding-start: =
50px; border-radius: 0px; box-shadow: rgba(0, 0, 0, 0.15) 0px 1px 6px inset=
; padding: 5px 5px 0px; background: rgb(242, 242, 242); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label, .pat-che=
cklist:not(.free-form).bars:not(.free-form) > label { border-radius: 0px; p=
adding: 0.6em 0.6em 0.6em 0px; margin-bottom: 5px; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label .label-fr=
agment-description, .pat-checklist:not(.free-form).bars:not(.free-form) > l=
abel .label-fragment-description { margin-bottom: 0px; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label::before, =
.pat-checklist:not(.free-form).bars:not(.free-form) > label::before { align=
-self: center; justify-self: center !important; grid-row: 1 / last !importa=
nt; top: auto !important; transform: none !important; }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:hover, .p=
at-checklist:not(.free-form).bars:not(.free-form) > label:hover { backgroun=
d: rgba(0, 0, 0, 0.05); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked), .pat-checklist:not(.free-form).bars:not(.free-form) > label:has(=
input:checked) { background: rgb(225, 112, 0); color: rgb(255, 255, 255); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked) > *, .pat-checklist:not(.free-form).bars:not(.free-form) > label:=
has(input:checked) > * { color: rgb(255, 255, 255); }

.pat-checklist:not(.free-form).radio-bars:not(.free-form) > label:has(input=
:checked)::before, .pat-checklist:not(.free-form).bars:not(.free-form) > la=
bel:has(input:checked)::before { color: rgb(0, 0, 0); }

.pat-checklist:not(.free-form) fieldset.composed { padding-left: 0px; margi=
n-bottom: 0px; position: relative; }

.pat-checklist:not(.free-form) .additional-meta-data { position: relative; =
float: right; width: 70%; right: -100%; top: 0px; opacity: 0; transition: 1=
s; height: 0px; }

.sidebar-large .pat-checklist:not(.free-form) .additional-meta-data { right=
: 0%; opacity: 1; height: auto; }

.pat-checklist:not(.free-form) .meta-column { width: 0%; overflow: hidden; =
transition: width 1s; float: right; padding: 0px 0.5em; margin: 0px; box-si=
zing: border-box; }

.item-selector .pat-checklist:not(.free-form) .meta-column { padding: 1.2em=
 0.5em 1em; }

.pat-checklist:not(.free-form) .meta-column.tag-cloud { width: 40%; }

.sidebar-large .pat-checklist:not(.free-form) .meta-column { width: 30%; }

.sidebar-large .pat-checklist:not(.free-form) .meta-column.tag-cloud { widt=
h: 40%; }

.file-upload-button { position: relative; overflow: hidden; }

.file-upload-button:has(:focus) { outline: var(--pat-form-input-field-outli=
ne-focus); outline-offset: var(--pat-form-input-field-outline-offset); }

.file-upload-button input { position: absolute; inset: 0px; height: auto; w=
idth: auto; padding: 0px; margin: 0px; opacity: 0; }

@media only screen and (max-width: 769px) {
  .pat-form { --pat-form-panel-padding: var(--pat-form-panel-padding-small)=
; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .pat-form { --pat-form-panel-padding: var(--pat-form-panel-padding-medium=
); }
}

@media only screen and (min-width: 1280px) {
  .pat-form { --pat-form-panel-padding: var(--pat-form-panel-padding-large)=
; }
}

.pat-form section.help .panel-content { padding-bottom: 2em; }

.pat-form p.instruction .pat-message { margin: 1em 0px 0px; }

.pat-form .form-separation-title, .pat-form .form-separation-header, .pat-f=
orm .form-panel-title { margin: 2rem 0px 1rem; font-size: 28px; font-weight=
: normal; }

.pat-form .form-panel { padding: var(--pat-form-panel-padding); box-sizing:=
 border-box; box-shadow: none; border-radius: 0px; background-color: var(--=
pat-form-panel-background-colour); margin-bottom: 25px; }

.pat-form .form-panel .panel-content > :last-child { margin-bottom: 0px; }

.pat-form .form-panel .panel-content > .button-bar:last-child { margin-bott=
om: -10px; }

.pat-form .form-panel .form-separation-header, .pat-form .form-panel .form-=
panel-title { margin-top: 0px; transition: padding 0.4s; }

.pat-form .form-panel.pat-collapsible { transition: padding 0.4s; padding: =
0px; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group { position: r=
elative; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons { po=
sition: absolute; right: calc(var(--pat-form-panel-padding) + 31px + 15px);=
 top: 50%; transform: translateY(-50%); }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n { overflow: hidden; width: 31px; height: 31px; cursor: default; backgroun=
d-color: rgb(242, 242, 242); color: rgba(0, 0, 0, 0); position: relative; f=
loat: right; margin-left: 15px; border-radius: 0px; font-style: normal; fon=
t-weight: normal; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n::after { font-family: fontello; font-size: 1em; z-index: 1; width: 31px; =
height: 31px; text-align: center; line-height: 31px; display: block; positi=
on: absolute; color: rgb(1, 104, 154); top: 0px; left: 0px; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n:hover { background-color: rgb(237, 237, 237); }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n:hover::after { color: rgb(1, 104, 154); }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.tooltip-active-click { background-color: rgb(225, 112, 0); }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.tooltip-active-click::after { color: rgb(255, 255, 255); }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.help::after { content: "=EE=A2=82"; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.add::after { content: "=EE=A3=A4"; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.download::after { content: "=EE=A0=8F"; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.settings::after { content: "=EE=A3=98"; }

.pat-form .form-panel.pat-collapsible .form-panel-title-group .buttons .ico=
n.more::after { content: "=EE=A2=9E"; line-height: calc(34px); }

.pat-form .form-panel.pat-collapsible .form-separation-header, .pat-form .f=
orm-panel.pat-collapsible .form-panel-title { padding-right: 50px; padding-=
left: var(--pat-form-panel-padding); position: relative; margin: 0px; }

body[dir=3D"rtl"] .pat-form .form-panel.pat-collapsible .form-separation-he=
ader, body[dir=3D"rtl"] .pat-form .form-panel.pat-collapsible .form-panel-t=
itle { padding-left: 50px; padding-right: var(--pat-form-panel-padding); }

.pat-form .form-panel.pat-collapsible .form-separation-header::after, .pat-=
form .form-panel.pat-collapsible .form-panel-title::after { font-family: fo=
ntello; content: "=EE=A3=88"; font-size: 0.65em; background-color: rgb(242,=
 242, 242); color: rgb(1, 104, 154); position: absolute; right: var(--pat-f=
orm-panel-padding); top: 50%; transform: translateY(-50%); z-index: 1; widt=
h: 31px; height: 31px; text-align: center; line-height: 31px; border-radius=
: 0px; display: inline-block; }

.pat-form .form-panel.pat-collapsible .form-separation-header:hover::after,=
 .pat-form .form-panel.pat-collapsible .form-panel-title:hover::after { bac=
kground-color: rgb(237, 237, 237); color: rgb(1, 104, 154); }

.pat-form .form-panel.pat-collapsible.open, .pat-form .form-panel.pat-colla=
psible.closed.in-progress { transition: box-shadow 2s; }

.pat-form .form-panel.pat-collapsible.open .form-separation-header, .pat-fo=
rm .form-panel.pat-collapsible.open .form-panel-title, .pat-form .form-pane=
l.pat-collapsible.closed.in-progress .form-separation-header, .pat-form .fo=
rm-panel.pat-collapsible.closed.in-progress .form-panel-title { padding-top=
: var(--pat-form-panel-padding); padding-bottom: var(--pat-form-panel-paddi=
ng); }

.pat-form .form-panel.pat-collapsible.closed:hover { box-shadow: var(--pat-=
form-panel-box-shadow-hover); }

.pat-form .form-panel.pat-collapsible.closed .form-separation-header, .pat-=
form .form-panel.pat-collapsible.closed .form-panel-title, .pat-form .form-=
panel.pat-collapsible.open.in-progress .form-separation-header, .pat-form .=
form-panel.pat-collapsible.open.in-progress .form-panel-title { padding-top=
: 20px; padding-bottom: 20px; border-radius: 0px; }

.pat-form .form-panel.pat-collapsible.closed .form-separation-header::after=
, .pat-form .form-panel.pat-collapsible.closed .form-panel-title::after, .p=
at-form .form-panel.pat-collapsible.open.in-progress .form-separation-heade=
r::after, .pat-form .form-panel.pat-collapsible.open.in-progress .form-pane=
l-title::after { content: "=EE=A3=87"; }

.pat-form .form-panel.pat-collapsible .panel-content { padding: 0 var(--pat=
-form-panel-padding) var(--pat-form-panel-padding); box-sizing: border-box;=
 }

.pat-form .pat-message, .pat-form .message { color: rgb(0, 0, 0); padding: =
1.3rem; background-color: rgb(239, 239, 239); border-radius: 0px; line-heig=
ht: 1.3; font-family: "RO Sans"; box-shadow: rgb(255, 255, 255) 0px 0px 0px=
 2px; box-sizing: border-box; margin-bottom: 1em; display: block; clear: bo=
th; margin-top: 0.5em; font-style: normal; font-weight: normal; }

.pat-form .pat-message[class*=3D"icon-"], .pat-form .message[class*=3D"icon=
-"] { display: flex; align-items: center; padding-right: 40px; }

.pat-form .pat-message[class*=3D"icon-"]::before, .pat-form .message[class*=
=3D"icon-"]::before { font-family: fontello; width: 80px; font-size: 30px; =
margin-right: 0.4em; text-align: center; }

.pat-form .pat-message .pat-button, .pat-form .message .pat-button { text-d=
ecoration: none; }

.pat-form .pat-message > p, .pat-form .pat-message .message-title, .pat-for=
m .message > p, .pat-form .message .message-title { margin-bottom: 0.4rem; =
}

.pat-form .pat-message .message-title, .pat-form .message .message-title { =
font-size: 1.5rem; }

.pat-form .pat-message > :last-child, .pat-form .message > :last-child { ma=
rgin-bottom: 0px; }

.pat-form .pat-message.success, .pat-form .message.success { background-col=
or: rgb(225, 237, 219); }

.pat-form .pat-message.success::before, .pat-form .message.success::before =
{ color: rgb(225, 237, 219); }

.pat-form .pat-message.notice, .pat-form .message.notice { background-color=
: rgb(253, 246, 187); }

.pat-form .pat-message.notice::before, .pat-form .message.notice::before { =
color: rgb(132, 113, 10); }

.pat-form .pat-message.notice .pat-button, .pat-form .message.notice .pat-b=
utton { color: white; background-color: rgb(1, 104, 155); box-shadow: none;=
 }

.pat-form .pat-message.notice .pat-button:hover, .pat-form .message.notice =
.pat-button:hover { background-color: rgb(1, 70, 104); color: white; }

.pat-form .pat-message.info, .pat-form .message.info { background-color: rg=
b(217, 237, 247); }

.pat-form .pat-message.info .pat-button, .pat-form .message.info .pat-butto=
n { color: white; background-color: rgb(1, 104, 155); box-shadow: none; }

.pat-form .pat-message.info .pat-button:hover, .pat-form .message.info .pat=
-button:hover { background-color: rgb(1, 70, 104); color: white; }

.pat-form .pat-message.error, .pat-form .message.error { background-color: =
rgb(255, 200, 200); color: red; }

.pat-form .pat-message.warning, .pat-form .message.warning { background-col=
or: rgb(251, 234, 217); color: rgb(0, 0, 0); }

.pat-form .pat-message.warning::before, .pat-form .message.warning::before =
{ color: rgb(225, 112, 0); }

.pat-form .pat-message.warning .pat-button, .pat-form .message.warning .pat=
-button { color: white; background-color: rgb(1, 104, 155); box-shadow: non=
e; }

.pat-form .pat-message.warning .pat-button:hover, .pat-form .message.warnin=
g .pat-button:hover { background-color: rgb(1, 70, 104); color: white; }

.pat-form .pat-message:first-child, .pat-form .message:first-child { margin=
-top: 0px; }

.pat-form h2 { margin-bottom: 1em; }

.pat-form .form-section-header { margin-bottom: 1em; margin-top: 1.5em; fon=
t-size: 1.1em; }

body[dir=3D"rtl"] .pat-form .form-section-header { text-align: right; }

.pat-form .form-section-header:first-child { margin-top: 0px; }

.pat-form .field-cluster, .pat-form .field-list { margin: calc(-0.5*var(--p=
at-form-input-field-padding-top-bottom)) 0; max-width: 100%; line-height: i=
nherit; }

.pat-form input, .pat-form textarea, .pat-form .textarea.group, .pat-form s=
elect, .pat-form .select2-container .select2-choice, .pat-form .select2-con=
tainer .select2-choices, .pat-form .md-editor .md-render, .pat-form .pat-ri=
ch-editor, .pat-form .output-field { appearance: none; font-family: inherit=
; display: block; box-sizing: border-box; padding: var(--pat-form-input-fie=
ld-padding-top-bottom) var(--pat-form-input-field-padding-start-end); margi=
n: calc(-1*var(--pat-form-input-field-padding-top-bottom)) 0; border: var(-=
-pat-form-input-field-border); box-shadow: var(--pat-form-input-field-box-s=
hadow); outline: var(--pat-form-input-field-outline); outline-offset: var(-=
-pat-form-input-field-outline-offset); color: var(--pat-form-input-field-te=
xt-colour); font-size: var(--pat-form-input-field-font-size); max-width: 10=
0%; background-color: var(--pat-form-input-field-background-colour); border=
-radius: var(--pat-form-input-field-border-radius); line-height: var(--pat-=
form-input-field-line-height); }

.pat-form input:focus, .pat-form textarea:focus, .pat-form .textarea.group:=
focus, .pat-form select:focus, .pat-form .select2-container .select2-choice=
:focus, .pat-form .select2-container .select2-choices:focus, .pat-form .md-=
editor .md-render:focus, .pat-form .pat-rich-editor:focus, .pat-form .outpu=
t-field:focus { outline: var(--pat-form-input-field-outline-focus); border:=
 var(--pat-form-input-field-border-focus); box-shadow: var(--pat-form-input=
-field-box-shadow-focus); }

.pat-form input:disabled, .pat-form input.disabled, .pat-form textarea:disa=
bled, .pat-form textarea.disabled, .pat-form .textarea.group:disabled, .pat=
-form .textarea.group.disabled, .pat-form select:disabled, .pat-form select=
.disabled, .pat-form .select2-container .select2-choice:disabled, .pat-form=
 .select2-container .select2-choice.disabled, .pat-form .select2-container =
.select2-choices:disabled, .pat-form .select2-container .select2-choices.di=
sabled, .pat-form .md-editor .md-render:disabled, .pat-form .md-editor .md-=
render.disabled, .pat-form .pat-rich-editor:disabled, .pat-form .pat-rich-e=
ditor.disabled, .pat-form .output-field:disabled, .pat-form .output-field.d=
isabled { border: rgba(0, 0, 0, 0); outline: none; opacity: 1; padding-left=
: var(--pat-form-input-field-padding-left-right-disabled); padding-right: v=
ar(--pat-form-input-field-padding-left-right-disabled); padding-top: var(--=
pat-form-input-field-padding-top-bottom-disabled); padding-bottom: var(--pa=
t-form-input-field-padding-top-bottom-disabled); margin: calc(-1*var(--pat-=
form-input-field-padding-top-bottom-disabled)) 0; background: var(--pat-for=
m-input-field-background-colour-disabled); box-shadow: var(--pat-form-input=
-field-box-shadow-disabled); color: var(--pat-form-input-field-text-colour-=
disabled); }

@media print {
  .pat-form input, .pat-form textarea, .pat-form .textarea.group, .pat-form=
 select, .pat-form .select2-container .select2-choice, .pat-form .select2-c=
ontainer .select2-choices, .pat-form .md-editor .md-render, .pat-form .pat-=
rich-editor, .pat-form .output-field { border: rgba(0, 0, 0, 0); opacity: 1=
; padding: 0px; background-color: rgba(0, 0, 0, 0); }
}

.pat-form .horizontal .select2-container-active .select2-choice, .pat-form =
.horizontal .select2-container-active .select2-choices, .pat-form .horizont=
al .pat-rich-editor:has(.ProseMirror-focused), .pat-form .horizontal .pat-s=
elect.focus::before, .pat-form .horizontal select:focus, .pat-form .vertica=
l .select2-container-active .select2-choice, .pat-form .vertical .select2-c=
ontainer-active .select2-choices, .pat-form .vertical .pat-rich-editor:has(=
.ProseMirror-focused), .pat-form .vertical .pat-select.focus::before, .pat-=
form .vertical select:focus { outline: var(--pat-form-input-field-outline-f=
ocus); border: var(--pat-form-input-field-border-focus); box-shadow: var(--=
pat-form-input-field-box-shadow-focus); }

.pat-form .item-info-card { display: block; box-sizing: border-box; box-sha=
dow: none; border-radius: 0px; background-color: var(--pat-form-panel-backg=
round-colour); --pat-toolbar-margin-bottom: 15px; padding: 1rem; margin-bot=
tom: 0px; }

.pat-form .item-info-card .well-title-group { position: relative; }

.pat-form .item-info-card .well-title-group .buttons { position: absolute; =
right: calc(var(--pat-form-panel-padding) + 31px + 15px); top: 50%; transfo=
rm: translateY(-50%); }

.pat-form .item-info-card .well-title-group .buttons .icon { overflow: hidd=
en; width: 31px; height: 31px; cursor: default; background-color: rgb(242, =
242, 242); color: rgba(0, 0, 0, 0); position: relative; float: right; margi=
n-left: 15px; border-radius: 0px; font-style: normal; font-weight: normal; =
}

.pat-form .item-info-card .well-title-group .buttons .icon::after { font-fa=
mily: fontello; font-size: 1em; z-index: 1; width: 31px; height: 31px; text=
-align: center; line-height: 31px; display: block; position: absolute; colo=
r: rgb(1, 104, 154); top: 0px; left: 0px; }

.pat-form .item-info-card .well-title-group .buttons .icon:hover { backgrou=
nd-color: rgb(237, 237, 237); }

.pat-form .item-info-card .well-title-group .buttons .icon:hover::after { c=
olor: rgb(1, 104, 154); }

.pat-form .item-info-card .well-title-group .buttons .icon.tooltip-active-c=
lick { background-color: rgb(225, 112, 0); }

.pat-form .item-info-card .well-title-group .buttons .icon.tooltip-active-c=
lick::after { color: rgb(255, 255, 255); }

.pat-form .item-info-card .well-title-group .buttons .icon.help::after { co=
ntent: "=EE=A2=82"; }

.pat-form .item-info-card .well-title-group .buttons .icon.add::after { con=
tent: "=EE=A3=A4"; }

.pat-form .item-info-card .well-title-group .buttons .icon.download::after =
{ content: "=EE=A0=8F"; }

.pat-form .item-info-card .well-title-group .buttons .icon.settings::after =
{ content: "=EE=A3=98"; }

.pat-form .item-info-card .well-title-group .buttons .icon.more::after { co=
ntent: "=EE=A2=9E"; line-height: calc(34px); }

.pat-form .item-info-card .well-header { margin-bottom: 40px; line-height: =
1.3; font-size: 28px; font-weight: normal; color: rgb(0, 0, 0); }

.pat-form .item-info-card .well-header .pat-avatar { float: left; width: 36=
px; height: 36px; margin-right: 10px; font-size: 0.7em; }

.pat-form .item-info-card .well-separation-header { margin-bottom: 1em; mar=
gin-top: 1.5em; font-size: 24px; font-weight: bold; }

.pat-form .item-info-card .well-separation-header:first-child { margin-top:=
 0px; }

.pat-form .item-info-card.pat-collapsible { transition: padding 0.4s; paddi=
ng: 0px; }

.pat-form .item-info-card.pat-collapsible .panel-content > :last-child { ma=
rgin-bottom: 0px; }

.pat-form .item-info-card.pat-collapsible > .well-header, .pat-form .item-i=
nfo-card.pat-collapsible > .well-title-group > .well-header { padding-right=
: 50px; padding-left: 40px; position: relative; margin: 0px; transition: pa=
dding 0.4s; }

.pat-form .item-info-card.pat-collapsible > .well-header::after, .pat-form =
.item-info-card.pat-collapsible > .well-title-group > .well-header::after {=
 font-family: fontello; content: "=EE=A3=88"; font-size: 0.65em; background=
-color: rgb(242, 242, 242); color: rgb(1, 104, 154); position: absolute; ri=
ght: var(--pat-form-panel-padding); top: 50%; transform: translateY(-50%); =
z-index: 1; width: 31px; height: 31px; text-align: center; line-height: 31p=
x; border-radius: 0px; display: inline-block; }

.pat-form .item-info-card.pat-collapsible > .well-header:hover::after, .pat=
-form .item-info-card.pat-collapsible > .well-title-group > .well-header:ho=
ver::after { background-color: rgb(237, 237, 237); color: rgb(1, 104, 154);=
 }

.pat-form .item-info-card.pat-collapsible.open, .pat-form .item-info-card.p=
at-collapsible.closed.in-progress { transition: box-shadow 2s; }

.pat-form .item-info-card.pat-collapsible.open > .well-header, .pat-form .i=
tem-info-card.pat-collapsible.open > .well-title-group > .well-header, .pat=
-form .item-info-card.pat-collapsible.closed.in-progress > .well-header, .p=
at-form .item-info-card.pat-collapsible.closed.in-progress > .well-title-gr=
oup > .well-header { padding-top: 40px; padding-bottom: 40px; }

.pat-form .item-info-card.pat-collapsible.closed:hover { box-shadow: var(--=
pat-form-panel-box-shadow-hover); }

.pat-form .item-info-card.pat-collapsible.closed > .well-header, .pat-form =
.item-info-card.pat-collapsible.closed > .well-title-group > .well-header, =
.pat-form .item-info-card.pat-collapsible.open.in-progress > .well-header, =
.pat-form .item-info-card.pat-collapsible.open.in-progress > .well-title-gr=
oup > .well-header { padding-top: 20px; padding-bottom: 20px; border-radius=
: 0px; }

.pat-form .item-info-card.pat-collapsible.closed > .well-header::after, .pa=
t-form .item-info-card.pat-collapsible.closed > .well-title-group > .well-h=
eader::after, .pat-form .item-info-card.pat-collapsible.open.in-progress > =
.well-header::after, .pat-form .item-info-card.pat-collapsible.open.in-prog=
ress > .well-title-group > .well-header::after { content: "=EE=A3=87"; }

.pat-form .item-info-card.pat-collapsible > .panel-content { padding: 0px 4=
0px 40px; box-sizing: border-box; }

.pat-form .item-info-card form > fieldset:last-child, .pat-form .item-info-=
card form > fieldset:last-child > .button-bar:last-child { margin-bottom: 0=
px; }

.pat-form .item-info-card > :last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-form .item-info-card { padding: 20px; }
}

.pat-form .item-info-card.success { background-color: rgb(225, 237, 219); }

.pat-form .item-info-card.success input { color: rgb(0, 0, 0); }

.pat-form .item-info-card.notice { background-color: rgb(253, 246, 187); }

.pat-form .item-info-card.warning { background-color: rgb(251, 234, 217); }

.pat-form .item-info-card.warning input { color: rgb(0, 0, 0); }

.pat-form .item-info-card.info { background-color: rgb(217, 237, 247); }

.pat-form .item-info-card.success input, .pat-form .item-info-card.success =
textarea, .pat-form .item-info-card.success select, .pat-form .item-info-ca=
rd.warning input, .pat-form .item-info-card.warning textarea, .pat-form .it=
em-info-card.warning select { background-color: rgba(0, 0, 0, 0.3); outline=
: rgb(255, 255, 255) solid 1px; }

.pat-form .item-info-card.success select, .pat-form .item-info-card.warning=
 select { background-image: url("data:image/svg+xml;base64,PD94bWwgdmVyc2lv=
bj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4NCjwhLS0gR2VuZXJhdG9yOiBBZG9iZSBJbGx1c3R=
yYXRvciAxNS4xLjAsIFNWRyBFeHBvcnQgUGx1Zy1JbiAgLS0+DQo8IURPQ1RZUEUgc3ZnIFBVQk=
xJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljc=
y9TVkcvMS4xL0RURC9zdmcxMS5kdGQiIFsNCgk8IUVOVElUWSBuc19mbG93cyAiaHR0cDovL25z=
LmFkb2JlLmNvbS9GbG93cy8xLjAvIj4NCl0+DQo8c3ZnIHZlcnNpb249IjEuMSINCgkgeG1sbnM=
9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My=
5vcmcvMTk5OS94bGluayIgeG1sbnM6YT0iaHR0cDovL25zLmFkb2JlLmNvbS9BZG9iZVNWR1ZpZ=
XdlckV4dGVuc2lvbnMvMy4wLyINCgkgeD0iMHB4IiB5PSIwcHgiIHdpZHRoPSIxMnB4IiBoZWln=
aHQ9IjEwcHgiIHZpZXdCb3g9IjAgLTEuNDk2IDEyIDEwIiBvdmVyZmxvdz0idmlzaWJsZSIgZW5=
hYmxlLWJhY2tncm91bmQ9Im5ldyAwIC0xLjQ5NiAxMiAxMCINCgkgeG1sOnNwYWNlPSJwcmVzZX=
J2ZSI+DQo8ZGVmcz4NCjwvZGVmcz4NCjxwb2x5Z29uIGZpbGw9IiNGRkZGRkYiIHBvaW50cz0iM=
CwwIDQuMjA1LDcuMDA5IDguNDEsMCAiLz4NCjwvc3ZnPg0K"); }

.horizontal .pat-form .item-info-card { --pat-form-panel-background-colour:=
 white; }

.pat-form .item-info-card .title { font-size: 1.2rem; margin-bottom: 5px; }

.pat-form .item-info-card .description { font-size: 1rem; line-height: 1.3;=
 }

.pat-form .item-info-card .tag-cloud { font-size: 1rem; line-height: 1.3; m=
argin-top: 5px; }

.pat-form .item-info-card > :last-child { margin-bottom: 0px; }

.pat-form .item-info-card .meta { font-size: 1rem; line-height: 1.3; margin=
-top: 5px; font-weight: normal; color: rgb(83, 83, 83); width: 100%; }

.pat-form .item-info-card .meta:last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-form .item-info-card .meta { display: inline; }
}

@media only screen and (min-width: 770px) {
  .pat-form .item-info-card .meta .meta-item { border-left: 1px solid rgb(8=
3, 83, 83); padding: 0px 0.2em; display: inline-block; }
  .pat-form .item-info-card .meta .meta-item::before { content: " =C2=A0"; =
display: inline; }
  .pat-form .item-info-card .meta .meta-item:first-child { padding-left: 0p=
x; border-left: none; }
  .pat-form .item-info-card .meta .meta-item:first-child::before { display:=
 none; }
}

@media only screen and (max-width: 769px) {
  .pat-form .item-info-card .meta .meta-item::after { content: ", "; }
}

.pat-form .field-list > label { position: relative; color: rgba(0, 0, 0, 0)=
; display: block; margin-bottom: 24px; }

.pat-form .field-list > label:last-child { margin-bottom: 0px; }

.pat-form .field-list > label > input, .pat-form .field-list > label > .out=
put-field { position: absolute; top: 0px; left: 0px; right: 0px; }

.pat-form .field-cluster:not(.layout-inline) { display: grid; grid-template=
-columns: repeat(auto-fit, minmax(20px, 1fr)); column-gap: 10px; }

.pat-form .field-cluster:not(.layout-inline) label { position: relative; co=
lor: rgba(0, 0, 0, 0); display: grid; grid-template-areas: "field"; grid-au=
to-rows: 0px; grid-template-rows: auto 0px; }

.pat-form .field-cluster:not(.layout-inline) label input, .pat-form .field-=
cluster:not(.layout-inline) label .output-field, .pat-form .field-cluster:n=
ot(.layout-inline) label select, .pat-form .field-cluster:not(.layout-inlin=
e) label textarea { position: absolute; top: 0px; left: 0px; right: 0px; co=
lor: initial; grid-area: field; }

.pat-form .field-cluster:not(.layout-inline) label:has(textarea) { font-siz=
e: 0px; }

.pat-form .field-cluster:not(.layout-inline) label:has(textarea) textarea {=
 font-size: var(--pat-form-input-field-font-size); position: relative; widt=
h: 100%; min-height: 100%; max-height: 100%; height: 100%; grid-area: field=
; }

.pat-form .field-cluster:not(.layout-inline).layout-amount-per-timespan { g=
rid-template-columns: 100px 200px; justify-self: start; }

.pat-form .field-cluster:not(.layout-inline).layout-min-max { width: 260px;=
 max-width: 100%; grid-template-columns: 50% 50%; justify-self: start; }

.pat-form .field-cluster:not(.layout-inline).layout-min-max-decimal { width=
: 100%; max-width: 100%; grid-template-columns: auto 4px 54px 15px auto 4px=
 54px; justify-self: start; }

.pat-form .field-cluster:not(.layout-inline).layout-title-names { grid-temp=
late-columns: 50px auto auto; }

.pat-form .field-cluster:not(.layout-inline).layout-date-time { grid-templa=
te-columns: auto 100px; }

.pat-form .field-cluster:not(.layout-inline).layout-date { grid-template-co=
lumns: 100px 150px 100px; }

.pat-form .field-cluster:not(.layout-inline).layout-address-line-nl { grid-=
template-columns: auto 100px 60px; }

.pat-form .field-cluster:not(.layout-inline).layout-postal-code-place-line-=
nl { grid-template-columns: 100px auto; }

.pat-form .field-cluster:not(.layout-inline).layout-image-caption { grid-te=
mplate-columns: 35% auto; min-height: 87px; }

.pat-form .field-cluster:not(.layout-inline).layout-image-caption textarea =
{ height: 100%; resize: none; margin: 0px; }

.pat-form .field-cluster:not(.layout-inline).layout-image-caption img { max=
-width: 100%; width: 100%; object-fit: cover; border-radius: var(--pat-form=
-fields-border-radius); display: block; }

.pat-form .pat-rich-editor .ProseMirror { overflow: hidden; }

.pat-form .date-time-extended legend, .pat-form .date-time-extended .legend=
 { padding-bottom: 5px; font-size: 15px; font-weight: bold; }

.pat-form .date-time-extended .row { margin-bottom: 5px !important; }

.pat-form .date-time-extended .pat-checklist { padding-left: 0px; line-heig=
ht: var(--pat-form-input-field-line-height); }

.pat-form input[type=3D"color"], .pat-form input[type=3D"time"], .pat-form =
input[type=3D"date"], .pat-form input[type=3D"datetime"], .pat-form input[t=
ype=3D"datetime-local"] { height: calc(var(--pat-form-input-field-line-heig=
ht) + 2*var(--pat-form-input-field-padding-top-bottom)); }

.pat-form ::-webkit-datetime-edit-minute-field, .pat-form ::-webkit-datetim=
e-edit-hour-field, .pat-form ::-webkit-datetime-edit-text { padding-top: 0p=
x; padding-bottom: 0px; margin-top: 0px; margin-bottom: 0px; display: inlin=
e; }

.pat-form ::-webkit-input-placeholder { color: var(--pat-form-placeholder-c=
olour); }

.pat-form ::placeholder, .pat-form .select2-container .select2-choice.selec=
t2-default { color: var(--pat-form-placeholder-colour); }

.pat-form .output-field { position: relative; padding-right: 27px; }

.pat-form .output-field span.placeholder { color: var(--pat-form-placeholde=
r-colour); }

.pat-form .output-field::after { content: " "; display: inline-block; }

.pat-form .output-field .cancel-button, .pat-form .output-field .select2-se=
arch-choice-close { position: absolute; top: 50%; right: var(--pat-auto-sug=
gest-cancel-button-edge-distance); transform: translateY(-50%); }

.pat-form .output-field .cancel-button::before, .pat-form .output-field .se=
lect2-search-choice-close::before { font-family: fontello; text-align: cent=
er; display: block; content: "=EE=A2=83"; color: rgba(0, 0, 0, 0.5); }

.pat-form .output-field .cancel-button:hover::before, .pat-form .output-fie=
ld .select2-search-choice-close:hover::before { color: rgba(0, 0, 0, 0.7); =
}

.pat-form .file-upload-button, .pat-form fieldset.horizontal fieldset.group=
 .file-upload-button { justify-self: start; float: left; }

.pat-form .attachment-list + .file-upload-button { margin-top: 2px; }

.pat-form .schedules { overflow: hidden; }

.pat-form .group.layout-date label { display: inline-block; }

.pat-form .group.layout-date label.day { width: 80px; }

.pat-form .group.layout-date label.year { width: 83px; }

.pat-form .select2-container .select2-choices { padding-bottom: 0px; }

@media print {
  .pat-form textarea { display: block; height: auto; }
}

.pat-form input[type=3D"search"] { }

.pat-form input[type=3D"search"]::-webkit-search-decoration { display: none=
; }

.pat-form input[type=3D"file"] { align-items: center; column-gap: 15px; dis=
play: inline-flex; font-size: var(--pat-form-input-field-font-size); font-w=
eight: var(--pat-button-font-weight); }

.pat-form input[type=3D"file"]::file-selector-button { font-family: "RO San=
s"; margin: 0px 10px 0px 0px; border: none; cursor: default; border-radius:=
 0px; background-image: none; text-decoration: none; display: inline-block;=
 padding: var(--pat-button-paddings); vertical-align: text-bottom; box-shad=
ow: none; color: rgb(1, 104, 154); background-color: rgb(242, 242, 242); ma=
x-width: 100%; overflow: hidden; text-overflow: ellipsis; white-space: nowr=
ap; line-height: var(--pat-form-input-field-line-height); float: left; font=
-size: var(--pat-form-input-field-font-size); font-weight: var(--pat-button=
-font-weight); }

.pat-form input[type=3D"file"]::file-selector-button:focus { outline: var(-=
-pat-form-input-field-outline-focus); outline-offset: var(--pat-form-input-=
field-outline-offset); }

.pat-form input[type=3D"file"]::file-selector-button:hover { background-col=
or: rgb(237, 237, 237); text-decoration: none; color: rgb(1, 104, 154); }

@media print {
  .pat-form input[type=3D"file"]::file-selector-button { display: none; }
}

.pat-form .colour-chooser-launcher { margin: 0px; }

.pat-form .colour-chooser-launcher .pat-button { text-align: center; color:=
 rgb(255, 255, 255) !important; }

.pat-form .colour-chooser-launcher .pat-button#portal-header-colour-chooser=
-trigger { background-color: rgb(225, 112, 0); }

.pat-form .slider-labels { width: 100%; overflow: hidden; font-size: 0.8em;=
 }

.pat-form .slider-labels .label { float: left; width: 100%; text-align: cen=
ter; position: relative; white-space: nowrap; text-overflow: ellipsis; over=
flow: hidden; box-sizing: border-box; padding: 0.5em 0px 1.2em 0em; }

.pat-form .slider-labels .label .iconified { display: block; line-height: 1=
2px; clear: both; font-size: 10px; margin-top: 1px; width: auto; text-align=
: center; }

.pat-form .slider-labels .label .iconified::before { margin-right: 2px; }

.pat-form .slider-labels .label.disabled { opacity: 0.5; }

.pat-form .slider-labels .label:first-child { text-align: left; }

body[dir=3D"rtl"] .pat-form .slider-labels .label:first-child { text-align:=
 right; }

.pat-form .slider-labels .label:first-child .iconified { text-align: left; =
}

body[dir=3D"rtl"] .pat-form .slider-labels .label:first-child .iconified { =
text-align: right; }

.pat-form .slider-labels .label:last-child { text-align: right; }

.pat-form .slider-labels .label:last-child .iconified { text-align: right; =
}

.pat-form .slider-labels.two .label { width: 50%; }

.pat-form .slider-labels.three .label { width: 33.3333%; }

.pat-form .slider-labels.four .label { width: 33.3333%; }

.pat-form .slider-labels.four .label:first-child, .pat-form .slider-labels.=
four .label:last-child { width: 16.6667%; }

.pat-form .slider-labels.five .label { width: 24%; }

.pat-form .slider-labels.five .label:first-child, .pat-form .slider-labels.=
five .label:last-child { width: 14%; }

.pat-form .code-field { background-color: rgb(0, 0, 0); color: rgb(255, 255=
, 255); font-family: "Courier New", Courier, monospace; }

.pat-form .currency-field { display: inline-block; position: relative; }

.pat-form .currency-field::after { content: " "; display: block; height: 1p=
x; width: 1px; }

.pat-form .currency-field .currency { position: absolute; left: 0.45rem; to=
p: 50%; transform: translateY(-50%); z-index: 1; color: rgb(0, 0, 0); }

.pat-form .currency-field input, .pat-form .currency-field output { padding=
-left: 1.4rem; display: inline-block; }

.pat-form .percentage-field { display: inline-block; }

.pat-form .percentage-field input { display: inline-block; }

.pat-form .button-field { position: relative; }

.pat-form .button-field input, .pat-form .button-field select { border-top-=
right-radius: 0px; border-bottom-right-radius: 0px; width: calc(100% - 40px=
) !important; }

.pat-form .button-field > .follow { border-radius: 0px; width: 40px; overfl=
ow: hidden; position: absolute; top: 0px; right: 0px; bottom: 0px; border: =
0px; color: rgba(0, 0, 0, 0); background-color: var(--colour-accent); curso=
r: default; }

.pat-form .button-field > .follow[href]::before { opacity: 1; }

.pat-form .button-field > .follow[href]:hover { filter: brightness(1.1); }

.pat-form .button-field > .follow::before { opacity: 0.5; content: " "; fon=
t-family: fontello; width: 100%; top: 50%; left: 0px; right: 0px; transform=
: translateY(-50%); position: absolute; color: rgb(255, 255, 255); text-ali=
gn: center; }

.pat-form .button-field.type-url > .follow::before { content: "=EF=82=A9"; =
}

.pat-form select { text-indent: 0.01px; padding-right: var(--pat-select-arr=
ow-space); line-height: var(--pat-select-box-height); background-repeat: no=
-repeat; background-position: calc(100% - var(--pat-select-arrow-edge-dista=
nce)) center; background-image: url("data:image/svg+xml;base64,PD94bWwgdmVy=
c2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KPHN2ZyB2ZXJzaW9uPSIxLjEiIGlkPSJMYWF=
nXzEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dH=
A6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiIHg9IjBweCIgeT0iMHB4IgoJIHZpZXdCb3g9IjAgM=
CAxNC42IDguOCIgc3R5bGU9ImVuYWJsZS1iYWNrZ3JvdW5kOm5ldyAwIDAgMTQuNiA4Ljg7IiB4=
bWw6c3BhY2U9InByZXNlcnZlIj4KPHN0eWxlIHR5cGU9InRleHQvY3NzIj4KCS5zdDB7ZmlsbDp=
ub25lO3N0cm9rZTojMDM2ODlCO3N0cm9rZS13aWR0aDozO3N0cm9rZS1saW5lY2FwOnJvdW5kO3=
N0cm9rZS1saW5lam9pbjpyb3VuZDtzdHJva2UtbWl0ZXJsaW1pdDoxMDt9Cjwvc3R5bGU+Cjxwb=
2x5bGluZSBjbGFzcz0ic3QwIiBwb2ludHM9IjEuNSwxLjUgNy4zLDcuMyAxMy4xLDEuNSAiLz4K=
PC9zdmc+"); background-size: auto 10px; height: auto !important; }

body[dir=3D"rtl"] .pat-form select { background-position: var(--pat-select-=
arrow-edge-distance) center; }

.pat-form fieldset { border-style: none; padding: 0px; min-width: inherit; =
}

.pat-form fieldset.section { margin: 0px 0px 2em; }

.pat-form fieldset .help-icon { color: rgba(0, 0, 0, 0); content: "=EE=A2=
=82"; font-family: fontello; position: relative; margin: calc(-1*var(--pat-=
form-input-field-padding-top-bottom)) 0; line-height: var(--pat-form-input-=
field-line-height); height: var(--pat-form-help-button-height); width: var(=
--pat-form-help-button-width); font-size: 0px; }

.pat-form fieldset .help-icon:hover::before, .pat-form fieldset .help-icon.=
tooltip-active-click::before { background-color: rgb(1, 70, 104); }

.pat-form fieldset .help-icon:focus::before { outline: var(--pat-form-input=
-field-outline-focus); outline-offset: var(--pat-form-input-field-outline-o=
ffset); }

.pat-form fieldset .help-icon::before { content: "=EE=A2=82"; border-radius=
: var(--pat-form-help-button-icon-border-radius); background-color: rgb(1, =
104, 155); margin: 0px; font-family: fontello; color: rgb(255, 255, 255); p=
osition: absolute; top: 50%; right: 0px; transform: translateY(-50%); line-=
height: var(--pat-form-help-button-icon-height); height: var(--pat-form-hel=
p-button-icon-height); width: 100%; text-align: center; font-weight: normal=
; font-style: normal; font-size: 0.8rem; transition: opacity 0.8s 0.3s; ove=
rflow: hidden; }

@media only screen and (min-width: 770px) {
  .pat-form fieldset.horizontal, .pat-form fieldset.horizontal > .panel-con=
tent { --pat-select-box-height: var(--pat-form-input-field-line-height); --=
pat-button-height: var(--pat-form-input-field-line-height); --pat-auto-sugg=
est-pill-height: 28px; --pat-auto-suggest-padding-top-bottom: var(--pat-for=
m-input-field-padding-top-bottom); }
  .pat-form fieldset.horizontal .pat-button, .pat-form fieldset.horizontal =
> .panel-content .pat-button { display: inline-block; text-align: center; m=
argin-right: 0px; box-sizing: border-box; line-height: var(--pat-form-input=
-field-line-height); margin-top: calc(-1*var(--pat-form-input-field-padding=
-top-bottom)); margin-bottom: calc(-1*var(--pat-form-input-field-padding-to=
p-bottom)); padding-top: var(--pat-form-input-field-padding-top-bottom); pa=
dding-bottom: var(--pat-form-input-field-padding-top-bottom); float: left; =
height: calc(var(--pat-form-input-field-line-height) + 2*var(--pat-form-inp=
ut-field-padding-top-bottom)); font-size: var(--pat-form-input-field-font-s=
ize); font-weight: var(--pat-button-font-weight); }
  .pat-form fieldset.horizontal .pat-button#portal-header-colour-chooser-tr=
igger, .pat-form fieldset.horizontal > .panel-content .pat-button#portal-he=
ader-colour-chooser-trigger { background-color: rgb(225, 112, 0); }
  .pat-form fieldset.horizontal legend + .pat-button-bar, .pat-form fieldse=
t.horizontal .legend + .pat-button-bar, .pat-form fieldset.horizontal > .pa=
nel-content legend + .pat-button-bar, .pat-form fieldset.horizontal > .pane=
l-content .legend + .pat-button-bar { margin-top: 0px; }
  .pat-form fieldset.horizontal > br, .pat-form fieldset.horizontal > .pane=
l-content > br { display: none; }
  .pat-form fieldset.horizontal sup.required, .pat-form fieldset.horizontal=
 > .panel-content sup.required { float: none; position: static; vertical-al=
ign: baseline; filter: none; margin: 0px; }
  .pat-form fieldset.horizontal > label, .pat-form fieldset.horizontal > .p=
anel-content > label { position: relative; display: grid; grid-template-col=
umns: var(--pat-form-horizontal-label-width) auto 0 var(--pat-form-horizont=
al-extra-width); grid-template-areas: "label field . extra" "label message =
. extra"; grid-auto-rows: auto; align-items: flex-start; column-gap: var(--=
pat-form-horizontal-column-gap); clear: left; border-style: none; margin: 0=
 0 var(--pat-form-input-field-tail-white) 0; line-height: var(--pat-form-in=
put-field-line-height); }
  .pat-form fieldset.horizontal > label > *, .pat-form fieldset.horizontal =
> .panel-content > label > * { grid-area: field; min-width: 0px; }
  .pat-form fieldset.horizontal > label > [size], .pat-form fieldset.horizo=
ntal > .panel-content > label > [size] { overflow: hidden; }
  .pat-form fieldset.horizontal > label > .help-icon, .pat-form fieldset.ho=
rizontal > .panel-content > label > .help-icon { grid-area: 1 / extra / las=
t; }
  .pat-form fieldset.horizontal > label > .message, .pat-form fieldset.hori=
zontal > label > .pat-message, .pat-form fieldset.horizontal > .panel-conte=
nt > label > .message, .pat-form fieldset.horizontal > .panel-content > lab=
el > .pat-message { grid-area: message; }
  .pat-form fieldset.horizontal > label > .colour-chooser-launcher, .pat-fo=
rm fieldset.horizontal > .panel-content > label > .colour-chooser-launcher =
{ height: 0.6em; }
  .pat-form fieldset.horizontal label .iconified, .pat-form fieldset.horizo=
ntal > .panel-content label .iconified { float: none; position: static; lin=
e-height: 10px; margin-top: 0px; vertical-align: baseline; filter: none; }
  .pat-form fieldset.horizontal label textarea, .pat-form fieldset.horizont=
al > .panel-content label textarea { resize: vertical; }
  .pat-form fieldset.horizontal fieldset.group, .pat-form fieldset.horizont=
al div.group, .pat-form fieldset.horizontal > .pat-checklist, .pat-form fie=
ldset.horizontal > .panel-content fieldset.group, .pat-form fieldset.horizo=
ntal > .panel-content div.group, .pat-form fieldset.horizontal > .panel-con=
tent > .pat-checklist { margin: 0 0 var(--pat-form-input-field-tail-white) =
0; display: grid; grid-template-areas: "label field . extra"; grid-auto-flo=
w: column; column-gap: 25px; grid-auto-columns: var(--pat-form-horizontal-l=
abel-width) auto 0 var(--pat-form-horizontal-extra-width); }
  .pat-form fieldset.horizontal fieldset.group > :last-child, .pat-form fie=
ldset.horizontal div.group > :last-child, .pat-form fieldset.horizontal > .=
pat-checklist > :last-child, .pat-form fieldset.horizontal > .panel-content=
 fieldset.group > :last-child, .pat-form fieldset.horizontal > .panel-conte=
nt div.group > :last-child, .pat-form fieldset.horizontal > .panel-content =
> .pat-checklist > :last-child { margin-bottom: 0px; }
  .pat-form fieldset.horizontal fieldset.group:last-child, .pat-form fields=
et.horizontal div.group:last-child, .pat-form fieldset.horizontal > .pat-ch=
ecklist:last-child, .pat-form fieldset.horizontal > .panel-content fieldset=
.group:last-child, .pat-form fieldset.horizontal > .panel-content div.group=
:last-child, .pat-form fieldset.horizontal > .panel-content > .pat-checklis=
t:last-child { margin-bottom: 0px; }
  .pat-form fieldset.horizontal fieldset.group.image-selection, .pat-form f=
ieldset.horizontal fieldset.group.object-upload, .pat-form fieldset.horizon=
tal fieldset.group.image-upload, .pat-form fieldset.horizontal fieldset.gro=
up.video-upload, .pat-form fieldset.horizontal fieldset.group.pat-form-fiel=
d-image, .pat-form fieldset.horizontal fieldset.group.pat-form-field-video,=
 .pat-form fieldset.horizontal div.group.image-selection, .pat-form fieldse=
t.horizontal div.group.object-upload, .pat-form fieldset.horizontal div.gro=
up.image-upload, .pat-form fieldset.horizontal div.group.video-upload, .pat=
-form fieldset.horizontal div.group.pat-form-field-image, .pat-form fieldse=
t.horizontal div.group.pat-form-field-video, .pat-form fieldset.horizontal =
> .pat-checklist.image-selection, .pat-form fieldset.horizontal > .pat-chec=
klist.object-upload, .pat-form fieldset.horizontal > .pat-checklist.image-u=
pload, .pat-form fieldset.horizontal > .pat-checklist.video-upload, .pat-fo=
rm fieldset.horizontal > .pat-checklist.pat-form-field-image, .pat-form fie=
ldset.horizontal > .pat-checklist.pat-form-field-video, .pat-form fieldset.=
horizontal > .panel-content fieldset.group.image-selection, .pat-form field=
set.horizontal > .panel-content fieldset.group.object-upload, .pat-form fie=
ldset.horizontal > .panel-content fieldset.group.image-upload, .pat-form fi=
eldset.horizontal > .panel-content fieldset.group.video-upload, .pat-form f=
ieldset.horizontal > .panel-content fieldset.group.pat-form-field-image, .p=
at-form fieldset.horizontal > .panel-content fieldset.group.pat-form-field-=
video, .pat-form fieldset.horizontal > .panel-content div.group.image-selec=
tion, .pat-form fieldset.horizontal > .panel-content div.group.object-uploa=
d, .pat-form fieldset.horizontal > .panel-content div.group.image-upload, .=
pat-form fieldset.horizontal > .panel-content div.group.video-upload, .pat-=
form fieldset.horizontal > .panel-content div.group.pat-form-field-image, .=
pat-form fieldset.horizontal > .panel-content div.group.pat-form-field-vide=
o, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.image-se=
lection, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.ob=
ject-upload, .pat-form fieldset.horizontal > .panel-content > .pat-checklis=
t.image-upload, .pat-form fieldset.horizontal > .panel-content > .pat-check=
list.video-upload, .pat-form fieldset.horizontal > .panel-content > .pat-ch=
ecklist.pat-form-field-image, .pat-form fieldset.horizontal > .panel-conten=
t > .pat-checklist.pat-form-field-video { justify-items: start; }
  .pat-form fieldset.horizontal fieldset.group.image-selection input, .pat-=
form fieldset.horizontal fieldset.group.image-selection .pat-screenshot, .p=
at-form fieldset.horizontal fieldset.group.image-selection video, .pat-form=
 fieldset.horizontal fieldset.group.image-selection img, .pat-form fieldset=
.horizontal fieldset.group.image-selection .caption, .pat-form fieldset.hor=
izontal fieldset.group.object-upload input, .pat-form fieldset.horizontal f=
ieldset.group.object-upload .pat-screenshot, .pat-form fieldset.horizontal =
fieldset.group.object-upload video, .pat-form fieldset.horizontal fieldset.=
group.object-upload img, .pat-form fieldset.horizontal fieldset.group.objec=
t-upload .caption, .pat-form fieldset.horizontal fieldset.group.image-uploa=
d input, .pat-form fieldset.horizontal fieldset.group.image-upload .pat-scr=
eenshot, .pat-form fieldset.horizontal fieldset.group.image-upload video, .=
pat-form fieldset.horizontal fieldset.group.image-upload img, .pat-form fie=
ldset.horizontal fieldset.group.image-upload .caption, .pat-form fieldset.h=
orizontal fieldset.group.video-upload input, .pat-form fieldset.horizontal =
fieldset.group.video-upload .pat-screenshot, .pat-form fieldset.horizontal =
fieldset.group.video-upload video, .pat-form fieldset.horizontal fieldset.g=
roup.video-upload img, .pat-form fieldset.horizontal fieldset.group.video-u=
pload .caption, .pat-form fieldset.horizontal fieldset.group.pat-form-field=
-image input, .pat-form fieldset.horizontal fieldset.group.pat-form-field-i=
mage .pat-screenshot, .pat-form fieldset.horizontal fieldset.group.pat-form=
-field-image video, .pat-form fieldset.horizontal fieldset.group.pat-form-f=
ield-image img, .pat-form fieldset.horizontal fieldset.group.pat-form-field=
-image .caption, .pat-form fieldset.horizontal fieldset.group.pat-form-fiel=
d-video input, .pat-form fieldset.horizontal fieldset.group.pat-form-field-=
video .pat-screenshot, .pat-form fieldset.horizontal fieldset.group.pat-for=
m-field-video video, .pat-form fieldset.horizontal fieldset.group.pat-form-=
field-video img, .pat-form fieldset.horizontal fieldset.group.pat-form-fiel=
d-video .caption, .pat-form fieldset.horizontal div.group.image-selection i=
nput, .pat-form fieldset.horizontal div.group.image-selection .pat-screensh=
ot, .pat-form fieldset.horizontal div.group.image-selection video, .pat-for=
m fieldset.horizontal div.group.image-selection img, .pat-form fieldset.hor=
izontal div.group.image-selection .caption, .pat-form fieldset.horizontal d=
iv.group.object-upload input, .pat-form fieldset.horizontal div.group.objec=
t-upload .pat-screenshot, .pat-form fieldset.horizontal div.group.object-up=
load video, .pat-form fieldset.horizontal div.group.object-upload img, .pat=
-form fieldset.horizontal div.group.object-upload .caption, .pat-form field=
set.horizontal div.group.image-upload input, .pat-form fieldset.horizontal =
div.group.image-upload .pat-screenshot, .pat-form fieldset.horizontal div.g=
roup.image-upload video, .pat-form fieldset.horizontal div.group.image-uplo=
ad img, .pat-form fieldset.horizontal div.group.image-upload .caption, .pat=
-form fieldset.horizontal div.group.video-upload input, .pat-form fieldset.=
horizontal div.group.video-upload .pat-screenshot, .pat-form fieldset.horiz=
ontal div.group.video-upload video, .pat-form fieldset.horizontal div.group=
.video-upload img, .pat-form fieldset.horizontal div.group.video-upload .ca=
ption, .pat-form fieldset.horizontal div.group.pat-form-field-image input, =
.pat-form fieldset.horizontal div.group.pat-form-field-image .pat-screensho=
t, .pat-form fieldset.horizontal div.group.pat-form-field-image video, .pat=
-form fieldset.horizontal div.group.pat-form-field-image img, .pat-form fie=
ldset.horizontal div.group.pat-form-field-image .caption, .pat-form fieldse=
t.horizontal div.group.pat-form-field-video input, .pat-form fieldset.horiz=
ontal div.group.pat-form-field-video .pat-screenshot, .pat-form fieldset.ho=
rizontal div.group.pat-form-field-video video, .pat-form fieldset.horizonta=
l div.group.pat-form-field-video img, .pat-form fieldset.horizontal div.gro=
up.pat-form-field-video .caption, .pat-form fieldset.horizontal > .pat-chec=
klist.image-selection input, .pat-form fieldset.horizontal > .pat-checklist=
.image-selection .pat-screenshot, .pat-form fieldset.horizontal > .pat-chec=
klist.image-selection video, .pat-form fieldset.horizontal > .pat-checklist=
.image-selection img, .pat-form fieldset.horizontal > .pat-checklist.image-=
selection .caption, .pat-form fieldset.horizontal > .pat-checklist.object-u=
pload input, .pat-form fieldset.horizontal > .pat-checklist.object-upload .=
pat-screenshot, .pat-form fieldset.horizontal > .pat-checklist.object-uploa=
d video, .pat-form fieldset.horizontal > .pat-checklist.object-upload img, =
.pat-form fieldset.horizontal > .pat-checklist.object-upload .caption, .pat=
-form fieldset.horizontal > .pat-checklist.image-upload input, .pat-form fi=
eldset.horizontal > .pat-checklist.image-upload .pat-screenshot, .pat-form =
fieldset.horizontal > .pat-checklist.image-upload video, .pat-form fieldset=
.horizontal > .pat-checklist.image-upload img, .pat-form fieldset.horizonta=
l > .pat-checklist.image-upload .caption, .pat-form fieldset.horizontal > .=
pat-checklist.video-upload input, .pat-form fieldset.horizontal > .pat-chec=
klist.video-upload .pat-screenshot, .pat-form fieldset.horizontal > .pat-ch=
ecklist.video-upload video, .pat-form fieldset.horizontal > .pat-checklist.=
video-upload img, .pat-form fieldset.horizontal > .pat-checklist.video-uplo=
ad .caption, .pat-form fieldset.horizontal > .pat-checklist.pat-form-field-=
image input, .pat-form fieldset.horizontal > .pat-checklist.pat-form-field-=
image .pat-screenshot, .pat-form fieldset.horizontal > .pat-checklist.pat-f=
orm-field-image video, .pat-form fieldset.horizontal > .pat-checklist.pat-f=
orm-field-image img, .pat-form fieldset.horizontal > .pat-checklist.pat-for=
m-field-image .caption, .pat-form fieldset.horizontal > .pat-checklist.pat-=
form-field-video input, .pat-form fieldset.horizontal > .pat-checklist.pat-=
form-field-video .pat-screenshot, .pat-form fieldset.horizontal > .pat-chec=
klist.pat-form-field-video video, .pat-form fieldset.horizontal > .pat-chec=
klist.pat-form-field-video img, .pat-form fieldset.horizontal > .pat-checkl=
ist.pat-form-field-video .caption, .pat-form fieldset.horizontal > .panel-c=
ontent fieldset.group.image-selection input, .pat-form fieldset.horizontal =
> .panel-content fieldset.group.image-selection .pat-screenshot, .pat-form =
fieldset.horizontal > .panel-content fieldset.group.image-selection video, =
.pat-form fieldset.horizontal > .panel-content fieldset.group.image-selecti=
on img, .pat-form fieldset.horizontal > .panel-content fieldset.group.image=
-selection .caption, .pat-form fieldset.horizontal > .panel-content fieldse=
t.group.object-upload input, .pat-form fieldset.horizontal > .panel-content=
 fieldset.group.object-upload .pat-screenshot, .pat-form fieldset.horizonta=
l > .panel-content fieldset.group.object-upload video, .pat-form fieldset.h=
orizontal > .panel-content fieldset.group.object-upload img, .pat-form fiel=
dset.horizontal > .panel-content fieldset.group.object-upload .caption, .pa=
t-form fieldset.horizontal > .panel-content fieldset.group.image-upload inp=
ut, .pat-form fieldset.horizontal > .panel-content fieldset.group.image-upl=
oad .pat-screenshot, .pat-form fieldset.horizontal > .panel-content fieldse=
t.group.image-upload video, .pat-form fieldset.horizontal > .panel-content =
fieldset.group.image-upload img, .pat-form fieldset.horizontal > .panel-con=
tent fieldset.group.image-upload .caption, .pat-form fieldset.horizontal > =
.panel-content fieldset.group.video-upload input, .pat-form fieldset.horizo=
ntal > .panel-content fieldset.group.video-upload .pat-screenshot, .pat-for=
m fieldset.horizontal > .panel-content fieldset.group.video-upload video, .=
pat-form fieldset.horizontal > .panel-content fieldset.group.video-upload i=
mg, .pat-form fieldset.horizontal > .panel-content fieldset.group.video-upl=
oad .caption, .pat-form fieldset.horizontal > .panel-content fieldset.group=
.pat-form-field-image input, .pat-form fieldset.horizontal > .panel-content=
 fieldset.group.pat-form-field-image .pat-screenshot, .pat-form fieldset.ho=
rizontal > .panel-content fieldset.group.pat-form-field-image video, .pat-f=
orm fieldset.horizontal > .panel-content fieldset.group.pat-form-field-imag=
e img, .pat-form fieldset.horizontal > .panel-content fieldset.group.pat-fo=
rm-field-image .caption, .pat-form fieldset.horizontal > .panel-content fie=
ldset.group.pat-form-field-video input, .pat-form fieldset.horizontal > .pa=
nel-content fieldset.group.pat-form-field-video .pat-screenshot, .pat-form =
fieldset.horizontal > .panel-content fieldset.group.pat-form-field-video vi=
deo, .pat-form fieldset.horizontal > .panel-content fieldset.group.pat-form=
-field-video img, .pat-form fieldset.horizontal > .panel-content fieldset.g=
roup.pat-form-field-video .caption, .pat-form fieldset.horizontal > .panel-=
content div.group.image-selection input, .pat-form fieldset.horizontal > .p=
anel-content div.group.image-selection .pat-screenshot, .pat-form fieldset.=
horizontal > .panel-content div.group.image-selection video, .pat-form fiel=
dset.horizontal > .panel-content div.group.image-selection img, .pat-form f=
ieldset.horizontal > .panel-content div.group.image-selection .caption, .pa=
t-form fieldset.horizontal > .panel-content div.group.object-upload input, =
.pat-form fieldset.horizontal > .panel-content div.group.object-upload .pat=
-screenshot, .pat-form fieldset.horizontal > .panel-content div.group.objec=
t-upload video, .pat-form fieldset.horizontal > .panel-content div.group.ob=
ject-upload img, .pat-form fieldset.horizontal > .panel-content div.group.o=
bject-upload .caption, .pat-form fieldset.horizontal > .panel-content div.g=
roup.image-upload input, .pat-form fieldset.horizontal > .panel-content div=
.group.image-upload .pat-screenshot, .pat-form fieldset.horizontal > .panel=
-content div.group.image-upload video, .pat-form fieldset.horizontal > .pan=
el-content div.group.image-upload img, .pat-form fieldset.horizontal > .pan=
el-content div.group.image-upload .caption, .pat-form fieldset.horizontal >=
 .panel-content div.group.video-upload input, .pat-form fieldset.horizontal=
 > .panel-content div.group.video-upload .pat-screenshot, .pat-form fieldse=
t.horizontal > .panel-content div.group.video-upload video, .pat-form field=
set.horizontal > .panel-content div.group.video-upload img, .pat-form field=
set.horizontal > .panel-content div.group.video-upload .caption, .pat-form =
fieldset.horizontal > .panel-content div.group.pat-form-field-image input, =
.pat-form fieldset.horizontal > .panel-content div.group.pat-form-field-ima=
ge .pat-screenshot, .pat-form fieldset.horizontal > .panel-content div.grou=
p.pat-form-field-image video, .pat-form fieldset.horizontal > .panel-conten=
t div.group.pat-form-field-image img, .pat-form fieldset.horizontal > .pane=
l-content div.group.pat-form-field-image .caption, .pat-form fieldset.horiz=
ontal > .panel-content div.group.pat-form-field-video input, .pat-form fiel=
dset.horizontal > .panel-content div.group.pat-form-field-video .pat-screen=
shot, .pat-form fieldset.horizontal > .panel-content div.group.pat-form-fie=
ld-video video, .pat-form fieldset.horizontal > .panel-content div.group.pa=
t-form-field-video img, .pat-form fieldset.horizontal > .panel-content div.=
group.pat-form-field-video .caption, .pat-form fieldset.horizontal > .panel=
-content > .pat-checklist.image-selection input, .pat-form fieldset.horizon=
tal > .panel-content > .pat-checklist.image-selection .pat-screenshot, .pat=
-form fieldset.horizontal > .panel-content > .pat-checklist.image-selection=
 video, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.ima=
ge-selection img, .pat-form fieldset.horizontal > .panel-content > .pat-che=
cklist.image-selection .caption, .pat-form fieldset.horizontal > .panel-con=
tent > .pat-checklist.object-upload input, .pat-form fieldset.horizontal > =
.panel-content > .pat-checklist.object-upload .pat-screenshot, .pat-form fi=
eldset.horizontal > .panel-content > .pat-checklist.object-upload video, .p=
at-form fieldset.horizontal > .panel-content > .pat-checklist.object-upload=
 img, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.objec=
t-upload .caption, .pat-form fieldset.horizontal > .panel-content > .pat-ch=
ecklist.image-upload input, .pat-form fieldset.horizontal > .panel-content =
> .pat-checklist.image-upload .pat-screenshot, .pat-form fieldset.horizonta=
l > .panel-content > .pat-checklist.image-upload video, .pat-form fieldset.=
horizontal > .panel-content > .pat-checklist.image-upload img, .pat-form fi=
eldset.horizontal > .panel-content > .pat-checklist.image-upload .caption, =
.pat-form fieldset.horizontal > .panel-content > .pat-checklist.video-uploa=
d input, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.vi=
deo-upload .pat-screenshot, .pat-form fieldset.horizontal > .panel-content =
> .pat-checklist.video-upload video, .pat-form fieldset.horizontal > .panel=
-content > .pat-checklist.video-upload img, .pat-form fieldset.horizontal >=
 .panel-content > .pat-checklist.video-upload .caption, .pat-form fieldset.=
horizontal > .panel-content > .pat-checklist.pat-form-field-image input, .p=
at-form fieldset.horizontal > .panel-content > .pat-checklist.pat-form-fiel=
d-image .pat-screenshot, .pat-form fieldset.horizontal > .panel-content > .=
pat-checklist.pat-form-field-image video, .pat-form fieldset.horizontal > .=
panel-content > .pat-checklist.pat-form-field-image img, .pat-form fieldset=
.horizontal > .panel-content > .pat-checklist.pat-form-field-image .caption=
, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.pat-form-=
field-video input, .pat-form fieldset.horizontal > .panel-content > .pat-ch=
ecklist.pat-form-field-video .pat-screenshot, .pat-form fieldset.horizontal=
 > .panel-content > .pat-checklist.pat-form-field-video video, .pat-form fi=
eldset.horizontal > .panel-content > .pat-checklist.pat-form-field-video im=
g, .pat-form fieldset.horizontal > .panel-content > .pat-checklist.pat-form=
-field-video .caption { width: 100%; min-width: 100%; max-width: 100%; disp=
lay: block; border-radius: var(--pat-form-input-field-border-radius); }
  .pat-form fieldset.horizontal fieldset.group > *, .pat-form fieldset.hori=
zontal div.group > *, .pat-form fieldset.horizontal > .pat-checklist > *, .=
pat-form fieldset.horizontal > .panel-content fieldset.group > *, .pat-form=
 fieldset.horizontal > .panel-content div.group > *, .pat-form fieldset.hor=
izontal > .panel-content > .pat-checklist > * { grid-column-start: 2; }
  .pat-form fieldset.horizontal fieldset.group .help-icon, .pat-form fields=
et.horizontal div.group .help-icon, .pat-form fieldset.horizontal > .pat-ch=
ecklist .help-icon, .pat-form fieldset.horizontal > .panel-content fieldset=
.group .help-icon, .pat-form fieldset.horizontal > .panel-content div.group=
 .help-icon, .pat-form fieldset.horizontal > .panel-content > .pat-checklis=
t .help-icon { grid-area: 1 / extra / last; }
  .pat-form fieldset.horizontal fieldset.group > .legend, .pat-form fieldse=
t.horizontal fieldset.group legend, .pat-form fieldset.horizontal div.group=
 > .legend, .pat-form fieldset.horizontal div.group legend, .pat-form field=
set.horizontal > .pat-checklist > .legend, .pat-form fieldset.horizontal > =
.pat-checklist legend, .pat-form fieldset.horizontal > .panel-content field=
set.group > .legend, .pat-form fieldset.horizontal > .panel-content fieldse=
t.group legend, .pat-form fieldset.horizontal > .panel-content div.group > =
.legend, .pat-form fieldset.horizontal > .panel-content div.group legend, .=
pat-form fieldset.horizontal > .panel-content > .pat-checklist > .legend, .=
pat-form fieldset.horizontal > .panel-content > .pat-checklist legend { tex=
t-align: left; padding: 0px; box-sizing: border-box; position: relative; di=
splay: block; font-weight: normal; font-style: normal; text-transform: none=
; letter-spacing: 0px; grid-column-start: 1; grid-row: 1 / last; margin-bot=
tom: 0px; }
  body[dir=3D"rtl"] .pat-form fieldset.horizontal fieldset.group > .legend,=
 body[dir=3D"rtl"] .pat-form fieldset.horizontal fieldset.group legend, bod=
y[dir=3D"rtl"] .pat-form fieldset.horizontal div.group > .legend, body[dir=
=3D"rtl"] .pat-form fieldset.horizontal div.group legend, body[dir=3D"rtl"]=
 .pat-form fieldset.horizontal > .pat-checklist > .legend, body[dir=3D"rtl"=
] .pat-form fieldset.horizontal > .pat-checklist legend, body[dir=3D"rtl"] =
.pat-form fieldset.horizontal > .panel-content fieldset.group > .legend, bo=
dy[dir=3D"rtl"] .pat-form fieldset.horizontal > .panel-content fieldset.gro=
up legend, body[dir=3D"rtl"] .pat-form fieldset.horizontal > .panel-content=
 div.group > .legend, body[dir=3D"rtl"] .pat-form fieldset.horizontal > .pa=
nel-content div.group legend, body[dir=3D"rtl"] .pat-form fieldset.horizont=
al > .panel-content > .pat-checklist > .legend, body[dir=3D"rtl"] .pat-form=
 fieldset.horizontal > .panel-content > .pat-checklist legend { text-align:=
 right; }
  .pat-form fieldset.horizontal fieldset.group.button-bar, .pat-form fields=
et.horizontal div.group.button-bar, .pat-form fieldset.horizontal > .pat-ch=
ecklist.button-bar, .pat-form fieldset.horizontal > .panel-content fieldset=
.group.button-bar, .pat-form fieldset.horizontal > .panel-content div.group=
.button-bar, .pat-form fieldset.horizontal > .panel-content > .pat-checklis=
t.button-bar { display: flex; gap: 15px; padding-left: calc(var(--pat-form-=
horizontal-label-width) + var(--pat-form-horizontal-column-gap)); }
  .pat-form fieldset.horizontal fieldset.group.layout-inline label, .pat-fo=
rm fieldset.horizontal div.group.layout-inline label, .pat-form fieldset.ho=
rizontal > .pat-checklist.layout-inline label, .pat-form fieldset.horizonta=
l > .panel-content fieldset.group.layout-inline label, .pat-form fieldset.h=
orizontal > .panel-content div.group.layout-inline label, .pat-form fieldse=
t.horizontal > .panel-content > .pat-checklist.layout-inline label { displa=
y: inline-block; }
  .pat-form fieldset.horizontal fieldset.group > label:not(.pat-button):not=
(.file-upload-button), .pat-form fieldset.horizontal div.group > label:not(=
.pat-button):not(.file-upload-button), .pat-form fieldset.horizontal > .pat=
-checklist > label:not(.pat-button):not(.file-upload-button), .pat-form fie=
ldset.horizontal > .panel-content fieldset.group > label:not(.pat-button):n=
ot(.file-upload-button), .pat-form fieldset.horizontal > .panel-content div=
.group > label:not(.pat-button):not(.file-upload-button), .pat-form fieldse=
t.horizontal > .panel-content > .pat-checklist > label:not(.pat-button):not=
(.file-upload-button) { font-weight: normal; font-style: normal; position: =
relative; border-style: none; }
  .pat-form fieldset.horizontal fieldset.group > label:not(.pat-button):not=
(.file-upload-button) + .pat-checklist, .pat-form fieldset.horizontal div.g=
roup > label:not(.pat-button):not(.file-upload-button) + .pat-checklist, .p=
at-form fieldset.horizontal > .pat-checklist > label:not(.pat-button):not(.=
file-upload-button) + .pat-checklist, .pat-form fieldset.horizontal > .pane=
l-content fieldset.group > label:not(.pat-button):not(.file-upload-button) =
+ .pat-checklist, .pat-form fieldset.horizontal > .panel-content div.group =
> label:not(.pat-button):not(.file-upload-button) + .pat-checklist, .pat-fo=
rm fieldset.horizontal > .panel-content > .pat-checklist > label:not(.pat-b=
utton):not(.file-upload-button) + .pat-checklist { margin-top: 0.5em; displ=
ay: block; }
  .pat-form fieldset.horizontal dfn.help, .pat-form fieldset.horizontal > .=
panel-content dfn.help { box-sizing: border-box; margin: 0px; width: 80%; }
}

.pat-form fieldset .row { margin: 0px -5px 0.8em; }

.pat-form fieldset .row .column, .pat-form fieldset .row .columns { margin-=
bottom: 0px; padding: 0px 5px; }

.pat-form fieldset .row .column > *, .pat-form fieldset .row .columns > * {=
 margin-bottom: 0px; }

.pat-form fieldset .row:last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-form fieldset.horizontal > br, .pat-form fieldset.horizontal .group =
> br { display: none; }
  .pat-form fieldset.horizontal label { position: relative; display: block;=
 }
  .pat-form fieldset.horizontal label.columns, .pat-form fieldset.horizonta=
l label.column { display: inline-block; }
  .pat-form fieldset.horizontal label img { max-width: 100%; }
  .pat-form fieldset.horizontal .group.pat-checklist legend, .pat-form fiel=
dset.horizontal .group.pat-checklist .legend { margin-bottom: 0.2em; }
  .pat-form fieldset.horizontal label > input, .pat-form fieldset.horizonta=
l label > textarea, .pat-form fieldset.horizontal label > select, .pat-form=
 fieldset.horizontal label > .sortable-items-list, .pat-form fieldset.horiz=
ontal label > .pat-sortable-blocks, .pat-form fieldset.horizontal label > .=
select2-container, .pat-form fieldset.horizontal label > .button-field, .pa=
t-form fieldset.horizontal label > .group.textarea, .pat-form fieldset.hori=
zontal label > .field-value, .pat-form fieldset.horizontal label > .group.m=
d-editor, .pat-form fieldset.horizontal label > .colour-chooser-launcher, .=
pat-form fieldset.horizontal label > .read-only-field, .pat-form fieldset.h=
orizontal label > .pat-rich-editor, .pat-form fieldset.horizontal label > .=
pat-miller-columns, .pat-form fieldset.horizontal label > .output-field, .p=
at-form fieldset.horizontal label > .composed, .pat-form fieldset.horizonta=
l label > .field-cluster, .pat-form fieldset.horizontal label > .pat-checkl=
ist, .pat-form fieldset.horizontal .group > input, .pat-form fieldset.horiz=
ontal .group > textarea, .pat-form fieldset.horizontal .group > select, .pa=
t-form fieldset.horizontal .group > .sortable-items-list, .pat-form fieldse=
t.horizontal .group > .pat-sortable-blocks, .pat-form fieldset.horizontal .=
group > .select2-container, .pat-form fieldset.horizontal .group > .button-=
field, .pat-form fieldset.horizontal .group > .group.textarea, .pat-form fi=
eldset.horizontal .group > .field-value, .pat-form fieldset.horizontal .gro=
up > .group.md-editor, .pat-form fieldset.horizontal .group > .colour-choos=
er-launcher, .pat-form fieldset.horizontal .group > .read-only-field, .pat-=
form fieldset.horizontal .group > .pat-rich-editor, .pat-form fieldset.hori=
zontal .group > .pat-miller-columns, .pat-form fieldset.horizontal .group >=
 .output-field, .pat-form fieldset.horizontal .group > .composed, .pat-form=
 fieldset.horizontal .group > .field-cluster, .pat-form fieldset.horizontal=
 .group > .pat-checklist { display: block; margin-top: 0.2em; width: 100%; =
font-weight: normal; }
  .pat-form fieldset.horizontal .pat-checklist { margin-top: 8px; }
  .pat-form fieldset.horizontal label > .composed input, .pat-form fieldset=
.horizontal .group > .composed input { width: 100%; }
  .pat-form fieldset.horizontal textarea.pat-content-mirror, .pat-form fiel=
dset.horizontal .group.md-editor .md-render { margin-top: 0px; }
  .pat-form fieldset.horizontal .legend, .pat-form fieldset.horizontal > la=
bel:not(.pat-toggle-switch), .pat-form fieldset.horizontal .group:not(.pat-=
checklist):not(.pat-toggle-switch) > label { font-weight: normal; display: =
block; margin-bottom: 1em; }
  .pat-form fieldset.horizontal .group.pat-form-field-toggle { display: fle=
x; justify-content: space-between; }
  .pat-form fieldset.horizontal .group.pat-form-field-toggle .pat-toggle-sw=
itch { margin-bottom: 0em; margin-top: 8px; }
  .pat-form fieldset.horizontal .legend { margin-bottom: 0em; margin-top: 8=
px; }
}

.pat-form fieldset.vertical > br, .pat-form fieldset.vertical .group > br {=
 display: none; }

.pat-form fieldset.vertical label { position: relative; display: block; }

.pat-form fieldset.vertical label.columns, .pat-form fieldset.vertical labe=
l.column { display: inline-block; }

.pat-form fieldset.vertical label img { max-width: 100%; }

.pat-form fieldset.vertical .group.pat-checklist legend, .pat-form fieldset=
.vertical .group.pat-checklist .legend { margin-bottom: 0.2em; }

.pat-form fieldset.vertical label > input, .pat-form fieldset.vertical labe=
l > textarea, .pat-form fieldset.vertical label > select, .pat-form fieldse=
t.vertical label > .sortable-items-list, .pat-form fieldset.vertical label =
> .pat-sortable-blocks, .pat-form fieldset.vertical label > .select2-contai=
ner, .pat-form fieldset.vertical label > .button-field, .pat-form fieldset.=
vertical label > .group.textarea, .pat-form fieldset.vertical label > .fiel=
d-value, .pat-form fieldset.vertical label > .group.md-editor, .pat-form fi=
eldset.vertical label > .colour-chooser-launcher, .pat-form fieldset.vertic=
al label > .read-only-field, .pat-form fieldset.vertical label > .pat-rich-=
editor, .pat-form fieldset.vertical label > .pat-miller-columns, .pat-form =
fieldset.vertical label > .output-field, .pat-form fieldset.vertical label =
> .composed, .pat-form fieldset.vertical label > .field-cluster, .pat-form =
fieldset.vertical label > .pat-checklist, .pat-form fieldset.vertical .grou=
p > input, .pat-form fieldset.vertical .group > textarea, .pat-form fieldse=
t.vertical .group > select, .pat-form fieldset.vertical .group > .sortable-=
items-list, .pat-form fieldset.vertical .group > .pat-sortable-blocks, .pat=
-form fieldset.vertical .group > .select2-container, .pat-form fieldset.ver=
tical .group > .button-field, .pat-form fieldset.vertical .group > .group.t=
extarea, .pat-form fieldset.vertical .group > .field-value, .pat-form field=
set.vertical .group > .group.md-editor, .pat-form fieldset.vertical .group =
> .colour-chooser-launcher, .pat-form fieldset.vertical .group > .read-only=
-field, .pat-form fieldset.vertical .group > .pat-rich-editor, .pat-form fi=
eldset.vertical .group > .pat-miller-columns, .pat-form fieldset.vertical .=
group > .output-field, .pat-form fieldset.vertical .group > .composed, .pat=
-form fieldset.vertical .group > .field-cluster, .pat-form fieldset.vertica=
l .group > .pat-checklist { display: block; margin-top: 0.2em; width: 100%;=
 font-weight: normal; }

.pat-form fieldset.vertical .pat-checklist { margin-top: 8px; }

.pat-form fieldset.vertical label > .composed input, .pat-form fieldset.ver=
tical .group > .composed input { width: 100%; }

.pat-form fieldset.vertical textarea.pat-content-mirror, .pat-form fieldset=
.vertical .group.md-editor .md-render { margin-top: 0px; }

.pat-form fieldset.vertical .legend, .pat-form fieldset.vertical > label:no=
t(.pat-toggle-switch), .pat-form fieldset.vertical .group:not(.pat-checklis=
t):not(.pat-toggle-switch) > label { font-weight: normal; display: block; m=
argin-bottom: 1em; }

.pat-form fieldset.vertical .group.pat-form-field-toggle { display: flex; j=
ustify-content: space-between; }

.pat-form fieldset.vertical .group.pat-form-field-toggle .pat-toggle-switch=
 { margin-bottom: 0em; margin-top: 8px; }

.pat-form fieldset.vertical .legend { margin-bottom: 0em; margin-top: 8px; =
}

.zavat-chalav-ve-devach, .zavat-chalav-ve-devach input { opacity: 0; top: 0=
px; left: 0px; height: 0px; width: 0px; z-index: -1; speak: none; position:=
 absolute !important; }

.pat-icon { font-family: fontello; text-indent: -1000em; width: 44px; heigh=
t: 44px; position: relative; color: rgba(0, 0, 0, 0.6); cursor: default; li=
ne-height: 44px; border-radius: 0px; display: inline-block; text-align: lef=
t; }

body[dir=3D"rtl"] .pat-icon { text-align: right; }

.pat-icon::before { font-family: fontello; text-indent: 0px; line-height: 4=
5px; text-align: center; position: absolute; margin: 0px; top: 0px; left: 0=
px; width: 100%; height: 100%; display: inline-block; border-radius: 0px; b=
ox-sizing: border-box; }

.pat-icon:hover { color: rgb(0, 0, 0); text-decoration: none; }

.pat-icon.active { color: rgb(225, 112, 0); box-shadow: none; }

.pat-icon.active::before { color: rgb(225, 112, 0); }

.pat-inject[action].executing [type=3D"submit"], .pat-inject[formaction].ex=
ecuting [type=3D"submit"], .pat-inject.pat-subform.executing [type=3D"submi=
t"] { pointer-events: none; opacity: 0.5; }

.pat-inject[href].executing { pointer-events: none; opacity: 0.5; }

.pat-message { color: rgb(0, 0, 0); padding: 1.3rem; margin-bottom: 1rem; b=
ackground-color: rgb(239, 239, 239); border-radius: 0px; line-height: 1.3; =
font-family: "RO Sans"; box-shadow: rgb(255, 255, 255) 0px 0px 0px 2px; }

.pat-message[class*=3D"icon-"] { display: flex; align-items: center; paddin=
g-right: 40px; }

.pat-message[class*=3D"icon-"]::before { font-family: fontello; width: 80px=
; font-size: 30px; margin-right: 0.4em; text-align: center; }

.pat-message .pat-button { text-decoration: none; }

.pat-message > p, .pat-message .message-title { margin-bottom: 0.4rem; }

.pat-message .message-title { font-size: 1.5rem; }

.pat-message > :last-child { margin-bottom: 0px; }

.pat-message.success { background-color: rgb(225, 237, 219); }

.pat-message.success::before { color: rgb(225, 237, 219); }

.pat-message.notice { background-color: rgb(253, 246, 187); }

.pat-message.notice::before { color: rgb(132, 113, 10); }

.pat-message.notice .pat-button { color: white; background-color: rgb(1, 10=
4, 155); box-shadow: none; }

.pat-message.notice .pat-button:hover { background-color: rgb(1, 70, 104); =
color: white; }

.pat-message.info { background-color: rgb(217, 237, 247); }

.pat-message.info .pat-button { color: white; background-color: rgb(1, 104,=
 155); box-shadow: none; }

.pat-message.info .pat-button:hover { background-color: rgb(1, 70, 104); co=
lor: white; }

.pat-message.error { background-color: rgb(255, 200, 200); color: red; }

.pat-message.warning { background-color: rgb(251, 234, 217); color: rgb(0, =
0, 0); }

.pat-message.warning::before { color: rgb(225, 112, 0); }

.pat-message.warning .pat-button { color: white; background-color: rgb(1, 1=
04, 155); box-shadow: none; }

.pat-message.warning .pat-button:hover { background-color: rgb(1, 70, 104);=
 color: white; }

.pat-modal-panel { position: fixed; max-width: 95%; width: 840px; top: 50%;=
 left: 50%; transform: translate(-50%, -50%); animation: 0.2s ease 0s 1 nor=
mal none running fadeIn; padding: 0px; margin: 0px; z-index: 9998; border: =
none; }

.pat-modal-panel.small { width: 640px; }

.pat-modal-panel.small .modal-panel-body { width: 640px; }

.pat-modal-panel::after { position: fixed; inset: -2000px; content: " "; z-=
index: -1; background-color: rgba(0, 0, 0, 0.15); backdrop-filter: blur(3px=
) saturate(0.5); animation: 1s ease 0s 1 normal none running fadeIn; }

.pat-modal-panel .modal-panel-contents { position: relative; background-col=
or: rgb(255, 255, 255); border-radius: 0px; box-shadow: rgba(0, 0, 0, 0.7) =
0px 2px 50px; }

.pat-modal-panel .modal-panel-contents::after { content: " "; display: tabl=
e; clear: both; }

.pat-modal-panel .modal-panel-header { margin: 0px; padding: 20px 30px; }

.pat-modal-panel .modal-panel-header .modal-panel-title { font-weight: bold=
; text-overflow: ellipsis; overflow: hidden; text-align: center; font-size:=
 22px; }

.pat-modal-panel .pat-toolbar { margin-bottom: 10px; }

.pat-modal-panel .modal-panel-body { width: 840px; overflow: auto; max-heig=
ht: calc(-270px + 100vh); padding: 7px 30px 10px; box-sizing: border-box; }

.pat-modal-panel .modal-panel-body > .form-fields { padding-bottom: 20px; }

.pat-modal-panel .modal-panel-body > .modal-panel-main-button-bar { bottom:=
 0px; margin-bottom: 1px; background: rgb(255, 255, 255); padding-bottom: 3=
0px; padding-top: 25px; border-top: 1px solid rgb(255, 255, 255); z-index: =
10; position: sticky !important; }

.pat-modal-panel .modal-panel-body > .modal-panel-main-button-bar.bumped-bo=
ttom { border-top: 1px solid silver; }

.pat-modal-panel .sliding-sheets { width: 100%; overflow: scroll hidden; sc=
roll-snap-type: x mandatory; display: grid; grid-auto-flow: column; grid-au=
to-columns: 100%; scroll-behavior: smooth; margin-bottom: 77px; scrollbar-w=
idth: none; }

.pat-modal-panel .sliding-sheets::-webkit-scrollbar { display: none; }

.pat-modal-panel .sliding-sheets .modal-panel-footer { display: none; }

.pat-modal-panel .sliding-sheets .modal-panel-footer, .pat-modal-panel .sli=
ding-sheets + .modal-panel-footer { position: absolute; bottom: 0px; right:=
 30px; left: 30px; margin: 0px; padding-top: 20px; padding-bottom: 20px; bo=
rder-top: 1px solid silver; background-color: rgb(255, 255, 255); }

.pat-modal-panel .sliding-sheets .modal-panel-body { scroll-snap-align: cen=
ter; }

.pat-modal-panel .sliding-sheets .modal-panel-body:target .modal-panel-foot=
er, .pat-modal-panel .sliding-sheets .modal-panel-body:first-child .modal-p=
anel-footer { display: block; }

.pat-modal-panel.large { width: 1100px; }

.pat-modal-panel.large .modal-panel-body { width: 1100px; }

@media print {
  body.modal-active > :not(.pat-modal) { display: none; }
}

@keyframes show-sheet {=20
  0% { opacity: 0; transform: translate(-50%, 100%); }
  100% { opacity: 1; transform: translate(-50%, 0px); }
}

@media screen {
  div.pat-modal.sheet { position: absolute; left: 50%; max-width: 840px; wi=
dth: 90%; bottom: 0px; z-index: 10000; animation: 0.4s ease 0s 1 normal for=
wards running show-sheet; box-sizing: border-box; transform: translate(-50%=
, 0px); top: 80px !important; }
}

@media print {
  div.pat-modal.sheet { transform: translate(0px, 0px) !important; }
}

div.pat-modal.sheet .close-panel { position: absolute; top: 25px; right: 25=
px; z-index: 1; color: rgba(0, 0, 0, 0); }

div.pat-modal.sheet .close-panel:hover::before { background-color: rgba(0, =
0, 0, 0.4); }

div.pat-modal.sheet .close-panel::before { font-family: fontello; content: =
"=EE=A2=83"; color: rgb(255, 255, 255); border-radius: 50%; background-colo=
r: rgba(0, 0, 0, 0.3); width: 45px; height: 45px; line-height: 45px; text-a=
lign: center; display: block; font-size: 31px; }

@media print {
  div.pat-modal.sheet .close-panel { display: none !important; }
}

@media screen {
  div.pat-modal.sheet .panel-content { overflow: auto; padding: 80px; backg=
round-color: rgb(255, 255, 255); border-top-left-radius: 0px; border-top-ri=
ght-radius: 0px; position: absolute; inset: 0px; box-sizing: border-box; bo=
x-shadow: rgba(0, 0, 0, 0.5) 0px 0px 70px; }
}

@media print {
  div.pat-modal.sheet .panel-content { overflow: visible; }
}

@media screen {
  div.pat-modal.sheet::before { position: absolute; inset: -2000px; content=
: " "; z-index: -1; background-color: rgba(0, 0, 0, 0.15); backdrop-filter:=
 blur(3px); animation: 1s ease 0s 1 normal none running fadeIn; }
}

div.pat-modal.panel { position: fixed; z-index: 9998; max-width: 95%; trans=
form: translate(-50%, -50%); animation: 0.2s ease 0s 1 normal none running =
fadeIn; background-color: rgba(0, 0, 0, 0); border-radius: 0px; width: 550p=
x !important; height: auto !important; top: 50% !important; left: 50% !impo=
rtant; }

div.pat-modal.panel.carousel .panel-content .panel-body { overflow-y: visib=
le; padding-bottom: 0px; }

div.pat-modal.panel.carousel .panel-content .panel-body * { user-select: no=
ne; }

div.pat-modal.panel.carousel .panel-content .panel-body:has(.pat-button-bar=
) { padding-bottom: 20px; }

div.pat-modal.panel.carousel .panel-content .panel-body .pat-toolbar { marg=
in-bottom: 30px; margin-top: -10px; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel { margin: 0px -30px; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list { position: static; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list .slick-track { position: static; transform: none !impor=
tant; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list .slick-track .slick-slide { padding: 0px 30px; max-heig=
ht: calc(-390px + 100vh); overflow-y: auto; position: static; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list .slick-track .slick-slide .sheet-content:has(.pat-butto=
n-bar) { padding-bottom: 80px; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list .slick-track .slick-slide .sheet-content .modal-panel-m=
ain-button-bar { position: absolute; bottom: 0px; right: 30px; left: 30px; =
margin: 0px; padding-top: 20px; border-top: 1px solid silver; background-co=
lor: rgb(255, 255, 255); display: none; }

div.pat-modal.panel.carousel .panel-content .panel-body .panel-sheets.pat-c=
arousel .slick-list .slick-track .slick-slide.slick-current .sheet-content =
.modal-panel-main-button-bar { display: block; }

div.pat-modal.panel.carousel .panel-content .panel-body .container > .pat-b=
utton-bar:last-child, div.pat-modal.panel.carousel .panel-content .panel-bo=
dy .container .main.pat-button-bar { bottom: 0px; border-top: 1px solid sil=
ver; position: relative !important; }

div.pat-modal.panel.carousel .panel-content .panel-body .slick-slide:not(.s=
lick-active) .sheet-content > .pat-button-bar:last-child { opacity: 0; }

div.pat-modal.panel.small { animation: 0.5s ease 0s 1 normal none running b=
ounceInCentred; }

div.pat-modal.panel.medium { width: 900px !important; }

div.pat-modal.panel.large { width: 1200px !important; }

div.pat-modal.panel.large.object { box-sizing: border-box; height: calc(-80=
px + 100vh) !important; }

div.pat-modal.panel.large.object object { height: 100%; width: 100%; }

div.pat-modal.panel.large.object .panel-content { box-sizing: border-box; h=
eight: 100%; }

div.pat-modal.panel.full { width: 95% !important; }

div.pat-modal.panel > .header { position: absolute; top: 0px; left: 0px; ri=
ght: 0px; }

div.pat-modal.panel > .header h1 { text-align: center; font-size: 1em; font=
-weight: bold; margin: 0px; padding: 20px; text-overflow: ellipsis; overflo=
w: hidden; }

div.pat-modal.panel > .header .button-fullscreen, div.pat-modal.panel > .he=
ader .close-panel { display: none; position: absolute; top: 15px; height: 4=
0px; width: 40px; line-height: 40px; background-color: rgb(1, 104, 155); co=
lor: rgba(0, 0, 0, 0); }

div.pat-modal.panel > .header .button-fullscreen:hover, div.pat-modal.panel=
 > .header .close-panel:hover { background-color: rgb(1, 70, 104); }

div.pat-modal.panel > .header .button-fullscreen::before, div.pat-modal.pan=
el > .header .close-panel::before { font-family: fontello; content: "=EE=A2=
=83"; color: white; font-size: 24px; width: 100%; display: block; text-alig=
n: center; }

div.pat-modal.panel > .header .button-fullscreen { right: 65px; }

div.pat-modal.panel > .header .button-fullscreen::before { content: "=EE=A0=
=9B"; }

div.pat-modal.panel > .header .close-panel { right: 15px; }

div.pat-modal.panel > .header .close-panel::before { content: "=EE=A2=83"; =
}

div.pat-modal.panel.object > .header .close-panel, div.pat-modal.panel.obje=
ct > .header .button-fullscreen { display: block; }

div.pat-modal.panel.object:-webkit-full-screen { width: 100%; height: 100%;=
 background-color: rgb(0, 0, 0); position: absolute; inset: 0px; }

div.pat-modal.panel.object:fullscreen { width: 100%; height: 100%; backgrou=
nd-color: rgb(0, 0, 0); position: absolute; inset: 0px; }

div.pat-modal.panel .panel-content { background: rgb(255, 255, 255); box-sh=
adow: rgba(0, 0, 0, 0.7) 0px 2px 50px; border: 1px solid rgba(0, 0, 0, 0.15=
); padding-top: 68px; border-radius: 0px; }

div.pat-modal.panel .panel-content .panel-body { max-height: calc(-250px + =
100vh); overflow-y: auto; padding-top: 7px; }

div.pat-modal.panel .panel-content .panel-body > .pat-button-bar:last-child=
, div.pat-modal.panel .panel-content .panel-body .container > .pat-button-b=
ar:last-child, div.pat-modal.panel .panel-content .panel-body .container > =
form > .pat-button-bar:last-child, div.pat-modal.panel .panel-content .pane=
l-body .container > .panel-sheets > .sheet-content > form > .pat-button-bar=
:last-child { bottom: -21px; background: rgb(255, 255, 255); padding-bottom=
: 20px; padding-top: 20px; border-top: 1px solid rgb(255, 255, 255); z-inde=
x: 10; position: sticky !important; }

div.pat-modal.panel .panel-content .panel-body > .pat-button-bar:last-child=
.bumped, div.pat-modal.panel .panel-content .panel-body .container > .pat-b=
utton-bar:last-child.bumped, div.pat-modal.panel .panel-content .panel-body=
 .container > form > .pat-button-bar:last-child.bumped, div.pat-modal.panel=
 .panel-content .panel-body .container > .panel-sheets > .sheet-content > f=
orm > .pat-button-bar:last-child.bumped { border-top: 1px solid silver; }

div.pat-modal.panel .panel-content > .pat-button-bar, div.pat-modal.panel .=
panel-content .container > .pat-button-bar { margin: 0px; padding-bottom: 5=
px; }

div.pat-modal.panel::after { position: fixed; inset: -2000px; content: " ";=
 z-index: -1; background-color: rgba(0, 0, 0, 0.15); backdrop-filter: blur(=
3px) saturate(0.5); animation: 1s ease 0s 1 normal none running fadeIn; }

div.pat-modal.panel .panel-body { padding-bottom: 20px; }

div.pat-modal.panel .panel-footer { padding-bottom: 10px; }

div.pat-modal.panel .panel-footer .container::before { content: " "; height=
: 1px; display: block; margin-bottom: 20px; background: silver; }

div.pat-modal.panel .panel-footer .container .pat-button { margin: 0px 10px=
 10px 0px; }

div.pat-modal.panel .panel-footer .container .float-after { margin-right: 0=
px; float: right; }

div.pat-modal.panel .container { padding: 0px 30px; }

div.pat-modal:not(.panel):not(.sheet), div.pat-modal.document-content:not(.=
panel):not(.sheet) { background-color: rgba(255, 255, 255, 0.95); box-sizin=
g: border-box; position: fixed; z-index: 9998; width: 100% !important; heig=
ht: 100% !important; top: 0px !important; left: 0px !important; }

.backdropfilter div.pat-modal:not(.panel):not(.sheet), .backdropfilter div.=
pat-modal.document-content:not(.panel):not(.sheet) { background-color: rgba=
(255, 255, 255, 0.15); backdrop-filter: blur(100px) saturate(4) brightness(=
1.2); }

div.pat-modal:not(.panel):not(.sheet) .filter-bar, div.pat-modal.document-c=
ontent:not(.panel):not(.sheet) .filter-bar { margin-bottom: 2em; }

div.pat-modal:not(.panel):not(.sheet) .filter-bar input[type=3D"search"], d=
iv.pat-modal.document-content:not(.panel):not(.sheet) .filter-bar input[typ=
e=3D"search"] { float: right; width: 14em; }

div.pat-modal:not(.panel):not(.sheet) .header, div.pat-modal.document-conte=
nt:not(.panel):not(.sheet) .header { color: gray; padding: 0px; position: r=
elative; z-index: 2; background-color: rgba(0, 0, 0, 0); height: 0px; }

div.pat-modal:not(.panel):not(.sheet) .header *, div.pat-modal.document-con=
tent:not(.panel):not(.sheet) .header * { display: none; }

div.pat-modal:not(.panel):not(.sheet) .header .close-panel, div.pat-modal.d=
ocument-content:not(.panel):not(.sheet) .header .close-panel { position: ab=
solute; top: 1.5em; right: 1.5em; width: 3em; height: 3em; filter: none; bo=
rder: none; outline: none; display: block; overflow: visible; padding: 0px;=
 margin: 0px; opacity: 0.7; transition: transform 0.2s ease-out; z-index: 2=
; font-size: 20px; background: none; color: rgba(0, 0, 0, 0) !important; }

div.pat-modal:not(.panel):not(.sheet) .header .close-panel:active, div.pat-=
modal.document-content:not(.panel):not(.sheet) .header .close-panel:active =
{ transform: scale(0.6); box-shadow: none; }

div.pat-modal:not(.panel):not(.sheet) .header .close-panel:hover, div.pat-m=
odal.document-content:not(.panel):not(.sheet) .header .close-panel:hover { =
opacity: 1; }

div.pat-modal:not(.panel):not(.sheet) .header .close-panel::before, div.pat=
-modal.document-content:not(.panel):not(.sheet) .header .close-panel::befor=
e { font-family: fontello; content: "=EE=A2=83"; display: block; position: =
absolute; right: 0px; top: 0px; font-size: 2.5em; color: rgb(0, 0, 0); text=
-indent: 0px; }

div.pat-modal:not(.panel):not(.sheet).small .panel-content .container, div.=
pat-modal:not(.panel):not(.sheet) > .panel-content .panel-class-small .cont=
ainer, div.pat-modal.document-content:not(.panel):not(.sheet).small .panel-=
content .container, div.pat-modal.document-content:not(.panel):not(.sheet) =
> .panel-content .panel-class-small .container { max-width: 640px; }

div.pat-modal:not(.panel):not(.sheet).small > .panel-content > h1, div.pat-=
modal:not(.panel):not(.sheet) h1.panel-class-small, div.pat-modal.document-=
content:not(.panel):not(.sheet).small > .panel-content > h1, div.pat-modal.=
document-content:not(.panel):not(.sheet) h1.panel-class-small { max-width: =
530px; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  div.pat-modal:not(.panel):not(.sheet).small > .panel-content > h1, div.pa=
t-modal:not(.panel):not(.sheet) h1.panel-class-small, div.pat-modal.documen=
t-content:not(.panel):not(.sheet).small > .panel-content > h1, div.pat-moda=
l.document-content:not(.panel):not(.sheet) h1.panel-class-small { max-width=
: 580px; padding: 0px 2.25em; }
}

div.pat-modal:not(.panel):not(.sheet).medium .panel-content .container, div=
.pat-modal:not(.panel):not(.sheet) > .panel-content .panel-class-small .con=
tainer, div.pat-modal.document-content:not(.panel):not(.sheet).medium .pane=
l-content .container, div.pat-modal.document-content:not(.panel):not(.sheet=
) > .panel-content .panel-class-small .container { max-width: 840px; }

div.pat-modal:not(.panel):not(.sheet).medium > .panel-content > h1, div.pat=
-modal:not(.panel):not(.sheet) h1.panel-class-small, div.pat-modal.document=
-content:not(.panel):not(.sheet).medium > .panel-content > h1, div.pat-moda=
l.document-content:not(.panel):not(.sheet) h1.panel-class-small { max-width=
: 730px; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  div.pat-modal:not(.panel):not(.sheet).medium > .panel-content > h1, div.p=
at-modal:not(.panel):not(.sheet) h1.panel-class-small, div.pat-modal.docume=
nt-content:not(.panel):not(.sheet).medium > .panel-content > h1, div.pat-mo=
dal.document-content:not(.panel):not(.sheet) h1.panel-class-small { max-wid=
th: 780px; padding: 0px 2.25em; }
}

div.pat-modal:not(.panel):not(.sheet) > .panel-content, div.pat-modal.docum=
ent-content:not(.panel):not(.sheet) > .panel-content { background-color: rg=
ba(0, 0, 0, 0); position: absolute; z-index: 1; width: 100%; max-height: 10=
0%; display: block; margin: 0px auto; top: 50%; left: 50%; opacity: 0; padd=
ing: 5em 3em; box-sizing: border-box; transform: scale(1.5) translate(-50%,=
 -50%); transform-origin: 0px center; transition: 0.2s; overflow: auto; }

div.pat-modal:not(.panel):not(.sheet) > .panel-content > *, div.pat-modal.d=
ocument-content:not(.panel):not(.sheet) > .panel-content > * { max-width: 1=
280px; margin-left: auto; margin-right: auto; }

div.pat-modal:not(.panel):not(.sheet) > .panel-content > h1, div.pat-modal.=
document-content:not(.panel):not(.sheet) > .panel-content > h1 { max-width:=
 1280px; font-weight: 200; font-size: 2em; line-height: 1.3; margin-bottom:=
 0.7em; padding: 0px 3em; box-sizing: border-box; }

@media only screen and (max-width: 769px) {
  div.pat-modal:not(.panel):not(.sheet) > .panel-content > h1, div.pat-moda=
l.document-content:not(.panel):not(.sheet) > .panel-content > h1 { display:=
 none; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  div.pat-modal:not(.panel):not(.sheet) > .panel-content > h1, div.pat-moda=
l.document-content:not(.panel):not(.sheet) > .panel-content > h1 { padding:=
 0px 2.25em; }
}

@media only screen and (min-width: 1280px) {
  div.pat-modal:not(.panel):not(.sheet) > .panel-content > h1, div.pat-moda=
l.document-content:not(.panel):not(.sheet) > .panel-content > h1 { padding:=
 0px 6.7rem; }
}

@media only screen and (max-width: 769px) {
  div.pat-modal:not(.panel):not(.sheet) > .panel-content, div.pat-modal.doc=
ument-content:not(.panel):not(.sheet) > .panel-content { padding: 5em 1.5re=
m; }
}

.modal-active div.pat-modal:not(.panel):not(.sheet) > .panel-content, .moda=
l-active div.pat-modal.document-content:not(.panel):not(.sheet) > .panel-co=
ntent { transform: scale(1) translate(-50%, -50%); opacity: 1; }

div.pat-modal:not(.panel):not(.sheet).max-height > .panel-content, div.pat-=
modal.document-content:not(.panel):not(.sheet).max-height > .panel-content =
{ height: 100%; }

div.pat-modal:not(.panel):not(.sheet) img, div.pat-modal.document-content:n=
ot(.panel):not(.sheet) img { max-width: 100%; }

div.pat-modal:not(.panel):not(.sheet) .wizard-box, div.pat-modal.document-c=
ontent:not(.panel):not(.sheet) .wizard-box { padding: 0px; }

div.pat-modal:not(.panel):not(.sheet) .wizard-box .panel-body, div.pat-moda=
l.document-content:not(.panel):not(.sheet) .wizard-box .panel-body { paddin=
g: 0px 3em; margin-bottom: 0px; margin-top: 0px; }

@media only screen and (max-width: 769px) {
  div.pat-modal:not(.panel):not(.sheet) .wizard-box .panel-body, div.pat-mo=
dal.document-content:not(.panel):not(.sheet) .wizard-box .panel-body { padd=
ing: 5em 1em 0px; }
}

div.pat-modal:not(.panel):not(.sheet) .wizard-box .panel-footer, div.pat-mo=
dal.document-content:not(.panel):not(.sheet) .wizard-box .panel-footer { ma=
rgin: 0px; height: 1.6em; padding: 0.8em 3em; }

@media only screen and (max-width: 769px) {
  div.pat-modal:not(.panel):not(.sheet) .wizard-box .panel-footer, div.pat-=
modal.document-content:not(.panel):not(.sheet) .wizard-box .panel-footer { =
padding: 0.8em 1em; }
}

div.pat-modal:not(.panel):not(.sheet).max-height .wizard-box, div.pat-modal=
.document-content:not(.panel):not(.sheet).max-height .wizard-box { overflow=
: hidden; }

div.pat-modal:not(.panel):not(.sheet).max-height .wizard-box .panel-body, d=
iv.pat-modal.document-content:not(.panel):not(.sheet).max-height .wizard-bo=
x .panel-body { position: absolute; inset: 0px; padding: 5em 3em; overflow:=
 auto; }

div.pat-modal:not(.panel):not(.sheet).max-height .wizard-box .panel-footer,=
 div.pat-modal.document-content:not(.panel):not(.sheet).max-height .wizard-=
box .panel-footer { position: absolute; bottom: 0px; right: 0px; left: 0px;=
 border-top: 1px solid rgb(222, 222, 222); background: rgba(255, 255, 255, =
0.9); z-index: 10000; }

@media only screen and (max-width: 769px) {
  div.pat-modal:not(.panel):not(.sheet), div.pat-modal.document-content:not=
(.panel):not(.sheet) { width: 100% !important; height: 100% !important; pos=
ition: fixed !important; inset: 0px !important; max-width: inherit !importa=
nt; max-height: inherit !important; margin: 0px !important; border: none !i=
mportant; }
  div.pat-modal:not(.panel):not(.sheet) > .panel-content, div.pat-modal.doc=
ument-content:not(.panel):not(.sheet) > .panel-content { height: 100%; padd=
ing-top: 4em; box-sizing: border-box; }
  div.pat-modal:not(.panel):not(.sheet) .wizard-box, div.pat-modal.document=
-content:not(.panel):not(.sheet) .wizard-box { overflow: hidden; }
  div.pat-modal:not(.panel):not(.sheet) .header, div.pat-modal.document-con=
tent:not(.panel):not(.sheet) .header { position: absolute; top: 0px; left: =
0px; right: 0px; z-index: 2; }
  div.pat-modal:not(.panel):not(.sheet) .panel-body, div.pat-modal.document=
-content:not(.panel):not(.sheet) .panel-body { position: absolute; inset: 2=
em 0px 57px; }
  div.pat-modal:not(.panel):not(.sheet) .panel-footer, div.pat-modal.docume=
nt-content:not(.panel):not(.sheet) .panel-footer { position: absolute; bott=
om: 0px; right: 0px; left: 0px; }
}

.pat-notification-panel { width: 380px; box-sizing: border-box; overflow: h=
idden; position: relative; padding: 1rem; margin-bottom: 1em; box-shadow: r=
gba(0, 0, 0, 0.2) 0px 1px 10px; display: block; border-radius: 0px; backgro=
und-color: rgba(255, 255, 255, 0.5); color: rgba(0, 0, 0, 0.8); border: 1px=
 solid rgb(255, 255, 255); backdrop-filter: blur(3px) saturate(0.5); }

.pat-notification-panel button { font-family: "RO Sans"; margin: 0px; borde=
r: none; cursor: default; border-radius: 0px; background-image: none; text-=
decoration: none; display: inline-block; font-weight: var(--pat-button-font=
-weight); box-shadow: none; color: rgb(1, 104, 154); background-color: rgb(=
242, 242, 242); max-width: 100%; overflow: hidden; text-overflow: ellipsis;=
 white-space: nowrap; font-size: 18px; padding: 0px 0.8rem; line-height: 29=
px; vertical-align: baseline; }

.pat-notification-panel button::before { line-height: inherit; }

.pat-notification-panel button:focus { outline: var(--pat-form-input-field-=
outline-focus); outline-offset: var(--pat-form-input-field-outline-offset);=
 }

.pat-notification-panel button:hover { background-color: rgb(237, 237, 237)=
; text-decoration: none; color: rgb(1, 104, 154); }

.pat-notification-panel button.default { color: white; background-color: rg=
b(1, 104, 155); box-shadow: none; }

.pat-notification-panel button.default:hover { background-color: rgb(1, 70,=
 104); color: white; }

.pat-notification-panel button[disabled], .pat-notification-panel button.di=
sabled, .pat-notification-panel button:is(a):not([href]), .pat-notification=
-panel button.default[disabled], .pat-notification-panel button.default.dis=
abled, .pat-notification-panel button:is(a).default:not([href]) { color: rg=
ba(0, 0, 0, 0.3); background-color: rgb(242, 242, 242); }

.pat-notification-panel button[disabled]:hover, .pat-notification-panel but=
ton.disabled:hover, .pat-notification-panel button:is(a):not([href]):hover,=
 .pat-notification-panel button.default[disabled]:hover, .pat-notification-=
panel button.default.disabled:hover, .pat-notification-panel button:is(a).d=
efault:not([href]):hover { color: rgba(0, 0, 0, 0.3); background-color: rgb=
(242, 242, 242); }

@media print {
  .pat-notification-panel button { display: none; }
}

.pat-notification-panel button.small { font-size: 18px; padding: 0px 0.8rem=
; height: 29px; line-height: 29px; vertical-align: baseline; box-shadow: no=
ne; font-weight: normal; }

.pat-notification-panel button.small::before { font-size: 15px; }

.pat-notification-panel button.iconified { width: 30px; padding: 0px; }

.pat-notification-panel button.iconified::before { width: 100%; text-align:=
 center; line-height: 44px; }

.pat-notification-panel button.link { padding: 0px; display: inline; backgr=
ound: none; color: rgb(1, 104, 155); line-height: inherit; text-decoration:=
 underline; vertical-align: baseline; cursor: pointer; }

.pat-notification-panel button.link:hover { background: none; color: rgb(0,=
 2, 3); text-decoration: underline !important; }

.pat-notification-panel button.no-label { padding: 0px; aspect-ratio: 1 / 1=
; text-overflow: clip; height: var(--pat-button-height); min-width: var(--p=
at-button-height); }

.pat-notification-panel button.no-label::before { width: 100%; text-align: =
center; margin: 0px 1em 0px 0px; line-height: var(--pat-button-height); }

.pat-notification-panel button::before { font-weight: normal; margin-right:=
 5px; }

.pat-notification-panel button.add::before { font-family: fontello; content=
: "=EE=A3=A4"; }

@media only screen and (max-width: 769px) {
  .pat-notification-panel { width: 100%; box-sizing: border-box; }
}

.pat-notification-panel a { text-decoration: underline; }

.pat-notification-panel.notice { background-color: rgb(253, 246, 187); }

.pat-notification-panel.success { background-color: rgb(225, 237, 219); col=
or: rgb(0, 0, 0); }

.pat-notification-panel.success * { color: rgb(0, 0, 0) !important; }

.pat-notification-panel.warning { background-color: rgb(251, 234, 217); }

.pat-notification-panel.warning * { color: rgb(0, 0, 0) !important; }

.pat-notification-panel.error { background-color: rgb(255, 200, 200); }

.pat-notification-panel.error * { color: rgb(0, 0, 0) !important; }

.pat-notification-panel.info { background-color: rgb(217, 237, 247); color:=
 rgb(21, 73, 99); }

.pat-notification-panel p:last-of-type { margin-bottom: 0px; }

#pat-notification-banners { position: fixed; top: 0px; right: 0px; padding:=
 15px 0px; overflow: auto; z-index: 2147483647; }

@media only screen and (max-width: 769px) {
  #pat-notification-banners { left: 0px; }
}

#pat-notification-banners .pat-notification-panel { padding-right: 55px; po=
sition: relative; margin-left: 15px; margin-right: 15px; }

#pat-notification-banners .close-panel { position: absolute; top: 1.5em; ri=
ght: 1.5em; width: 3em; height: 3em; filter: none; border: none; background=
: none; outline: none; display: block; overflow: visible; padding: 0px; mar=
gin: 0px; opacity: 0.7; transition: transform 0.2s ease-out; z-index: 2; fo=
nt-size: 10px; color: rgba(0, 0, 0, 0) !important; }

#pat-notification-banners .close-panel:active { transform: scale(0.6); box-=
shadow: none; }

#pat-notification-banners .close-panel:hover { opacity: 1; }

#pat-notification-banners .close-panel::before { font-family: fontello; con=
tent: "=EE=A2=83"; display: block; position: absolute; right: 0px; top: 0px=
; font-size: 2.5em; color: rgb(0, 0, 0); text-indent: 0px; }

.pat-picture { position: relative; display: block; }

.pat-picture img { display: block; width: 100%; }

.pat-picture .copyright-mention { position: absolute; z-index: 10; bottom: =
0.5rem; left: 0.5rem; margin: 0px; color: rgb(255, 255, 255); text-shadow: =
rgba(0, 0, 0, 0.5) 0px 0px 1px, rgba(0, 0, 0, 0.5) -1px 0px 1px, rgba(0, 0,=
 0, 0.5) 1px 0px 1px, rgba(0, 0, 0, 0.5) 0px -1px 1px, rgba(0, 0, 0, 0.5) 0=
px 1px 1px, rgba(0, 0, 0, 0.5) 2px 2px 6px; font-size: 0.888889rem; line-he=
ight: 1.125; display: block; opacity: 0.7; }

.pat-picture .copyright-mention::before { font-family: fontello; }

.pat-picture .copyright-mention.type-copyright::before { content: "=EF=87=
=B9 "; }

.pat-picture .copyright-mention.type-creative-commons::before { content: "=
=EF=89=9E "; }

div.ProseMirror { outline: none !important; }

body div.ProseMirror { user-select: text; }

.pat-rich-editor { width: 100%; position: relative; }

.pat-form .pat-rich-editor:not(.toolbar-detached) { padding-top: calc(59px)=
; }

.pat-rich-editor .tiptap-menubar { display: none; }

.pat-rich-editor .canvas-toolbar.inline, .pat-rich-editor .pat-toolbar.inli=
ne { background-color: rgba(0, 0, 0, 0.06); position: absolute; top: 0px; r=
ight: 0px; left: 0px; border-bottom-left-radius: 0px; border-bottom-right-r=
adius: 0px; padding: 4px var(--pat-form-input-field-padding-start-end); fon=
t-size: 18px; }

.pat-rich-editor .canvas-toolbar.inline .canvas-toolbar-section.editor, .pa=
t-rich-editor .pat-toolbar.inline .canvas-toolbar-section.editor { font-siz=
e: 0.8em; }

.pat-rich-editor .canvas-toolbar.inline .pat-toolbar-section.editor, .pat-r=
ich-editor .pat-toolbar.inline .pat-toolbar-section.editor { font-size: 0.8=
em; }

.pat-screenshot { margin: -10px -10px 2em; overflow: hidden; position: rela=
tive; padding: 11px; }

.pat-screenshot::before { position: absolute; inset: 0px; content: " "; z-i=
ndex: 1; }

.pat-screenshot.allow-interaction::before { display: none; }

.pat-screenshot.allow-interaction object { user-select: auto; pointer-event=
s: auto; }

.pat-screenshot figcaption { position: relative; z-index: 2; }

.pat-screenshot figcaption .icon { height: 1em; margin-right: 0.2em; vertic=
al-align: middle; }

.pat-screenshot object { width: 1280px; height: 800px; user-select: none; p=
ointer-events: none; margin: 0px; background-color: rgb(255, 255, 255); }

.pat-screenshot .passe-partout { margin-top: 1px; width: 1280px; height: 80=
0px; overflow: hidden; box-shadow: rgba(0, 0, 0, 0.3) 0px 0px 1px 1px; back=
ground-color: rgb(242, 242, 242); }

.pat-screenshot .passe-partout.cutout object { transform: scale(2); }

.pat-screenshot .passe-partout.cut-tl object { transform-origin: left top; =
}

.pat-screenshot .passe-partout.cut-tr object { transform-origin: right top;=
 }

.pat-screenshot .passe-partout.cut-br object { transform-origin: right bott=
om; }

.pat-screenshot .passe-partout.cut-bl object { transform-origin: left botto=
m; }

.pat-screenshot.type-app-icon { margin-bottom: 0px; margin-top: 20px; }

.pat-screenshot.type-app-icon .auto-scale-wrapper { margin-bottom: -10px; }

.pat-screenshot.type-app-icon .passe-partout, .pat-screenshot.type-app-icon=
 object { height: 480px; box-shadow: none; }

.pat-screenshot.browser-window { background-color: rgb(255, 255, 255); bord=
er-radius: 8px; box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 16px; position: rela=
tive; overflow: hidden; border: 1px solid silver; padding: 0px; }

.pat-screenshot.browser-window .auto-scale-wrapper, .pat-screenshot.browser=
-window img { border-bottom-left-radius: 8px; border-bottom-right-radius: 8=
px; overflow: hidden; border-top: 35px solid rgba(192, 192, 192, 0.8); }

@media only screen and (max-width: 769px) {
  .pat-screenshot.browser-window .auto-scale-wrapper, .pat-screenshot.brows=
er-window img { border-top: 25px solid rgba(192, 192, 192, 0.8); }
}

.pat-screenshot.browser-window object { box-shadow: none; background-color:=
 rgb(255, 255, 255); }

.pat-screenshot.browser-window img { display: block; width: 100%; }

.pat-screenshot.browser-window::before, .pat-screenshot.browser-window::aft=
er { line-height: 24px; height: 24px; text-align: center; display: inline-b=
lock; position: absolute; top: 4px; border-radius: 6px; border: 1px solid r=
gba(0, 0, 0, 0.25); }

.pat-screenshot.browser-window::before { content: "=EE=A3=85"; font-family:=
 fontello; width: 48px; left: 14px; background-color: rgba(255, 255, 255, 0=
.5); color: rgba(0, 0, 0, 0.5); font-size: 29px; }

@media only screen and (max-width: 769px) {
  .pat-screenshot.browser-window::before { transform: scale(0.65); transfor=
m-origin: left top; }
}

.pat-screenshot.browser-window::after { content: attr(data-url); background=
-color: rgb(255, 255, 255); left: 120px; right: 120px; font-size: 15px; pad=
ding: 0px 25px; overflow: hidden; white-space: nowrap; }

.pat-sortable-blocks { counter-reset: count 0; user-select: none; display: =
none; }

.pat-sortable-blocks:has(.remove-clone) { margin-right: 36px; }

.horizontal .pat-sortable-blocks { margin-right: 0px; }

.horizontal .pat-sortable-blocks + .pat-button-bar { margin-top: 0px; }

.horizontal .pat-sortable-blocks + .pat-button-bar { margin-bottom: 0px; }

.pat-sortable-blocks .pat-button-bar { transition: padding-left 0.4s; }

.pat-sortable-blocks:has(.sortable-item) { display: block; margin-top: calc=
(-1*var(--pat-sortable-blocks-gap) + -1*var(--pat-form-input-field-padding-=
top-bottom)); margin-bottom: calc(-1*var(--pat-sortable-blocks-gap) + -1*va=
r(--pat-form-input-field-padding-top-bottom)); }

.pat-sortable-blocks:has(.sortable-item) + .pat-button-bar { margin-top: ca=
lc(2*var(--pat-sortable-blocks-gap) + var(--pat-form-input-field-padding-to=
p-bottom)); padding-left: var(--pat-sortable-blocks-padding-start); }

.pat-sortable-blocks .sortable-item { counter-increment: count 1; padding: =
var(--pat-sortable-blocks-gap) 0; position: relative; margin: 0 0 0 var(--p=
at-sortable-blocks-padding-start); }

.pat-sortable-blocks .sortable-item.dragged { opacity: 0.5; }

.pat-sortable-blocks .sortable-item:not(.dragged) { animation: 1s ease 0s 1=
 normal none running fadeIn; }

.pat-sortable-blocks .sortable-item::after { display: block; opacity: 0; he=
ight: 2px; content: " "; background: rgb(1, 104, 155); position: absolute; =
left: -15px; right: 15px; }

.pat-sortable-blocks .sortable-item.drop-target-above::after, .pat-sortable=
-blocks .sortable-item.drop-target-below::after { opacity: 1; }

.pat-sortable-blocks .sortable-item.drop-target-above .sortable-handle, .pa=
t-sortable-blocks .sortable-item.drop-target-below .sortable-handle { margi=
n-top: -24px; }

.pat-sortable-blocks .sortable-item.drop-target-above::after { top: -1px; }

.pat-sortable-blocks .sortable-item.drop-target-below::after { bottom: -1px=
; }

.pat-sortable-blocks .sortable-item::before, .pat-sortable-blocks .sortable=
-item .sortable-handle { content: counter(count); text-align: center; line-=
height: var(--pat-sortable-blocks-button-width); color: rgb(255, 255, 255);=
 display: block; position: absolute; left: calc(-1*var(--pat-sortable-block=
s-padding-start)); top: var(--pat-sortable-blocks-gap); bottom: var(--pat-s=
ortable-blocks-gap); width: var(--pat-sortable-blocks-button-width); backgr=
ound: var(--pat-sortable-blocks-handle-colour); border-radius: 0px; overflo=
w: hidden; margin: 0px; }

@media print {
  .pat-sortable-blocks .sortable-item::before, .pat-sortable-blocks .sortab=
le-item .sortable-handle { background: rgba(0, 0, 0, 0); width: 1em; text-a=
lign: left; color: rgb(0, 0, 0); }
}

.pat-sortable-blocks .sortable-item:has(.sortable-item-functions) { min-hei=
ght: 88px; }

.pat-sortable-blocks .sortable-item:has(.sortable-item-functions) .sortable=
-handle { height: var(--pat-sortable-blocks-button-width); }

.pat-sortable-blocks .sortable-item:has(.sortable-item-functions)::before {=
 height: var(--pat-sortable-blocks-button-width); }

.pat-sortable-blocks .sortable-item .sortable-item-functions { margin-top: =
calc(var(--pat-sortable-blocks-button-width) + 15px); position: absolute; t=
op: 0px; left: calc(var(--pat-sortable-blocks-padding-start)*-1); }

.pat-sortable-blocks .sortable-item .sortable-item-functions .pat-button { =
margin-bottom: 15px; width: var(--pat-sortable-blocks-button-width); }

.pat-sortable-blocks .sortable-item .sortable-item-functions .pat-button::b=
efore { font-family: fontello; display: block; font-weight: normal; }

.pat-sortable-blocks .sortable-item .sortable-item-functions .pat-button.ed=
it::before { content: "=EE=A0=B3"; }

.pat-sortable-blocks .sortable-item .sortable-item-functions .pat-button:la=
st-child { margin-bottom: 0px; }

.pat-sortable-blocks .sortable-item .sortable-handle { opacity: 0; text-ind=
ent: -10em; background: var(--pat-sortable-blocks-handle-colour); cursor: g=
rab; color: rgba(0, 0, 0, 0); }

.pat-sortable-blocks .sortable-item .sortable-handle:hover { }

.pat-sortable-blocks .sortable-item .sortable-handle:active, .pat-sortable-=
blocks .sortable-item .sortable-handle:focus { cursor: grabbing; }

.pat-sortable-blocks .sortable-item .sortable-handle::before { content: "=
=EE=A3=95"; display: block; font-family: fontello; text-indent: 0.1em; top:=
 0px; left: 0px; width: 100%; text-align: center; font-size: 0.8em; color: =
rgb(255, 255, 255); }

.pat-sortable-blocks .sortable-item:hover .sortable-handle { opacity: 1; }

.pat-sortable-blocks .sortable-item:hover .sortable-handle:hover { text-dec=
oration: none; }

.pat-sortable-blocks .sortable-item:active .sortable-handle, .pat-sortable-=
blocks .sortable-item:focus .sortable-handle { cursor: grabbing; }

.pat-sortable-blocks .sortable-item > .button-cluster { position: absolute;=
 pointer-events: none; opacity: 0; }

.pat-sortable-blocks .sortable-item .pat-well { margin-bottom: 0px; }

.pat-sortable-blocks .sortable-item .field-cluster { margin-top: 0px; margi=
n-bottom: 0px; min-height: calc(var(--pat-form-input-field-line-height) + v=
ar(--pat-form-input-field-padding-top-bottom)*2); }

.pat-sortable-blocks .sortable-item .field-cluster textarea, .pat-sortable-=
blocks .sortable-item .field-cluster input, .pat-sortable-blocks .sortable-=
item .field-cluster .output-field { margin: 0px; }

.pat-sortable-blocks .sortable-item .remove-clone { color: rgba(0, 0, 0, 0)=
; font-family: fontello; margin: 0px; line-height: var(--pat-form-input-fie=
ld-line-height); height: var(--pat-sortable-blocks-remove-button-height); w=
idth: var(--pat-sortable-blocks-remove-button-width); overflow: hidden; bac=
kground: rgba(0, 0, 0, 0); position: absolute; right: -31px; top: calc(var(=
--pat-form-input-field-padding-top-bottom) + 2px); }

.pat-sortable-blocks .sortable-item .remove-clone:hover::before, .pat-sorta=
ble-blocks .sortable-item .remove-clone.tooltip-active-click::before { back=
ground-color: rgb(1, 70, 104); }

.pat-sortable-blocks .sortable-item .remove-clone::before { content: "=EE=
=A3=92"; border-radius: var(--pat-sortable-blocks-remove-button-icon-border=
-radius); background-color: rgb(242, 242, 242); color: rgb(1, 104, 154); ma=
rgin: 0px; font-family: fontello; position: absolute; top: 50%; right: 0px;=
 transform: translateY(-50%); line-height: var(--pat-sortable-blocks-remove=
-button-icon-height); height: var(--pat-sortable-blocks-remove-button-icon-=
height); width: 100%; text-align: center; font-weight: normal; font-style: =
normal; font-size: 0.8em; transition: opacity 0.8s 0.3s; overflow: hidden; =
}

.pat-sortable-blocks .sortable-item .remove-clone:hover::before { backgroun=
d-color: rgb(237, 237, 237); color: rgb(1, 104, 154); }

.pat-sortable-blocks .sortable-item:not(.clone) .remove-clone { display: no=
ne; }

.data-table-top { font-size: 18px; line-height: 30px; margin-bottom: 0.3em;=
 overflow: hidden; }

.data-table-top::after { content: " "; display: table; clear: both; }

.data-table-top .dataTables_info { float: left; }

.data-table-top .dataTables_filter { float: right; color: rgba(0, 0, 0, 0);=
 }

.data-table-top .dataTables_filter input { background-color: rgba(0, 0, 0, =
0.09); padding: 0px 0.2em; font-size: 18px; border: none; outline: none; li=
ne-height: 30px; border-radius: 0px; margin-right: 0px; color: rgb(0, 0, 0)=
; }

.data-table-bottom { font-size: 20px; margin-top: 0.3em; margin-bottom: 1em=
; line-height: 44px; }

.data-table-bottom::after { content: " "; display: table; clear: both; }

.data-table-bottom .dataTables_paginate { float: left; }

.data-table-bottom .dataTables_paginate .paginate_button { display: inline-=
block; padding: 0px; cursor: pointer; width: 44px; height: 44px; text-align=
: center; line-height: 44px; border-radius: 0px; }

.data-table-bottom .dataTables_paginate .paginate_button:hover { background=
-color: rgba(0, 0, 0, 0.09); }

.data-table-bottom .dataTables_paginate .paginate_button.current { backgrou=
nd-color: rgb(225, 112, 0); color: rgb(255, 255, 255); }

.data-table-bottom .dataTables_length { float: right; }

.data-table-bottom .dataTables_length select { font-size: 18px; }

.pat-sortable-table thead th { cursor: default; }

.pat-sortable-table thead th.sorting, .pat-sortable-table thead th.sorting_=
asc, .pat-sortable-table thead th.sorting-asc, .pat-sortable-table thead th=
.sorting_desc, .pat-sortable-table thead th.sorting-desc { position: relati=
ve; padding-right: 30px; top: 0px; }

.pat-sortable-table thead th.sorting:focus, .pat-sortable-table thead th.so=
rting_asc:focus, .pat-sortable-table thead th.sorting-asc:focus, .pat-sorta=
ble-table thead th.sorting_desc:focus, .pat-sortable-table thead th.sorting=
-desc:focus { outline: none; cursor: default; }

.pat-sortable-table thead th.sorting::after, .pat-sortable-table thead th.s=
orting_asc::after, .pat-sortable-table thead th.sorting-asc::after, .pat-so=
rtable-table thead th.sorting_desc::after, .pat-sortable-table thead th.sor=
ting-desc::after { font-family: fontello; position: absolute; top: 50%; rig=
ht: 0.5em; display: block; width: 30px; height: 30px; line-height: 30px; te=
xt-align: right; transform: translateY(-50%); }

.pat-sortable-table thead th.sorting_asc::after, .pat-sortable-table thead =
th.sorting-asc::after { content: "=EE=A0=9D"; }

.pat-sortable-table thead th.sorting_desc::after, .pat-sortable-table thead=
 th.sorting-desc::after { content: "=EE=A0=9E"; }

pre.pat-syntax-highlight { background-color: rgba(0, 0, 0, 0.75); color: rg=
b(255, 255, 255); padding: 10px 15px; overflow: auto; font-size: 18px; bord=
er-radius: 0px; }

.pat-syntax-highlight { background-color: rgba(0, 0, 0, 0.75); user-select:=
 auto; }

.pat-syntax-highlight .str, .pat-syntax-highlight .str { color: rgb(101, 17=
6, 66); }

.pat-syntax-highlight .kwd, .pat-syntax-highlight .kwd { color: rgb(226, 13=
7, 100); }

.pat-syntax-highlight .com, .pat-syntax-highlight .com { color: rgb(173, 21=
6, 230); font-style: italic; }

.pat-syntax-highlight .typ, .pat-syntax-highlight .typ { color: rgb(137, 18=
9, 255); }

.pat-syntax-highlight .lit, .pat-syntax-highlight .lit { color: rgb(51, 135=
, 204); }

.pat-syntax-highlight .pun, .pat-syntax-highlight .pun { color: rgb(255, 25=
5, 255); }

.pat-syntax-highlight .pln, .pat-syntax-highlight .pln { color: rgb(255, 25=
5, 255); }

.pat-syntax-highlight .tag, .pat-syntax-highlight .tag { color: rgb(137, 18=
9, 255); }

.pat-syntax-highlight .atn, .pat-syntax-highlight .atn { color: rgb(189, 18=
3, 107); }

.pat-syntax-highlight .atv, .pat-syntax-highlight .atv { color: rgb(101, 17=
6, 66); }

.pat-syntax-highlight .dec, .pat-syntax-highlight .dec { color: rgb(51, 135=
, 204); }

.pat-syntax-highlight pre.prettyprint, .pat-syntax-highlight code.prettypri=
nt { background-color: rgba(0, 0, 0, 0.2); border-radius: 0.3em; }

.pat-syntax-highlight pre.prettyprint.light-bg, .pat-syntax-highlight code.=
prettyprint.light-bg { background-color: rgba(0, 0, 0, 0.9); }

.pat-syntax-highlight pre.prettyprint { display: block; margin: 0px 0px 2em=
; padding: 1em; white-space: pre-wrap; }

.pat-syntax-highlight ol.linenums { margin-top: 0px; margin-bottom: 0px; co=
lor: rgb(174, 174, 174); }

.pat-syntax-highlight li.L0, .pat-syntax-highlight li.L1, .pat-syntax-highl=
ight li.L2, .pat-syntax-highlight li.L3, .pat-syntax-highlight li.L5, .pat-=
syntax-highlight li.L6, .pat-syntax-highlight li.L7, .pat-syntax-highlight =
li.L8 { list-style-type: none; }

@media print {
  .pat-syntax-highlight .str, .pat-syntax-highlight .str { color: rgb(0, 10=
2, 0); }
  .pat-syntax-highlight .kwd, .pat-syntax-highlight .kwd { color: rgb(0, 0,=
 102); font-weight: bold; }
  .pat-syntax-highlight .com, .pat-syntax-highlight .com { color: rgb(102, =
0, 0); font-style: italic; }
  .pat-syntax-highlight .typ, .pat-syntax-highlight .typ { color: rgb(68, 0=
, 68); font-weight: bold; }
  .pat-syntax-highlight .lit, .pat-syntax-highlight .lit { color: rgb(0, 68=
, 68); }
  .pat-syntax-highlight .pun, .pat-syntax-highlight .pun { color: rgb(68, 6=
8, 0); }
  .pat-syntax-highlight .pln, .pat-syntax-highlight .pln { color: rgb(0, 0,=
 0); }
  .pat-syntax-highlight .tag, .pat-syntax-highlight .tag { color: rgb(0, 0,=
 102); font-weight: bold; }
  .pat-syntax-highlight .atn, .pat-syntax-highlight .atn { color: rgb(68, 0=
, 68); }
  .pat-syntax-highlight .atv, .pat-syntax-highlight .atv { color: rgb(0, 10=
2, 0); }
}

.js select.pat-select, .js label.pat-select select { display: inline-block;=
 height: var(--pat-select-box-height); line-height: var(--pat-select-box-he=
ight); padding-top: var(--pat-select-box-padding-top-bottom); padding-botto=
m: var(--pat-select-box-padding-top-bottom); padding-left: var(--pat-select=
-box-padding-start); padding-right: calc(var(--pat-select-box-arrow-width) =
+ var(--pat-select-box-padding-start)/2); position: relative; box-sizing: b=
order-box; border: var(--pat-form-input-field-border); border-radius: var(-=
-pat-form-input-field-border-radius); box-shadow: var(--pat-select-box-box-=
shadow); outline: var(--pat-form-input-field-outline); outline-offset: var(=
--pat-form-input-field-outline-offset); color: var(--pat-select-box-arrow-t=
ext-colour); font-size: var(--pat-select-box-font-size); max-width: 100%; b=
ackground-color: var(--pat-select-box-background-colour); overflow: hidden;=
 white-space: nowrap; text-overflow: ellipsis; cursor: default; font-weight=
: normal !important; }

.js select.pat-select:hover, .js label.pat-select select:hover { background=
-color: var(--pat-select-box-background-colour-hover); }

.js select.pat-select[data-value=3D"draft"], .js select.pat-select.state-dr=
aft, .js label.pat-select select[data-value=3D"draft"], .js label.pat-selec=
t select.state-draft { background-color: rgb(251, 234, 217); color: rgb(123=
, 61, 0); }

.js select.pat-select[data-value=3D"draft"]::after, .js select.pat-select.s=
tate-draft::after, .js label.pat-select select[data-value=3D"draft"]::after=
, .js label.pat-select select.state-draft::after { background-color: rgb(24=
6, 212, 178); }

.js select.pat-select[data-value=3D"draft"]::before, .js select.pat-select[=
data-value=3D"draft"]::after, .js select.pat-select.state-draft::before, .j=
s select.pat-select.state-draft::after, .js label.pat-select select[data-va=
lue=3D"draft"]::before, .js label.pat-select select[data-value=3D"draft"]::=
after, .js label.pat-select select.state-draft::before, .js label.pat-selec=
t select.state-draft::after { color: rgb(123, 61, 0); }

.js select.pat-select[data-value=3D"draft"]:hover, .js select.pat-select[da=
ta-value=3D"draft"].tooltip-active-click, .js select.pat-select.state-draft=
:hover, .js select.pat-select.state-draft.tooltip-active-click, .js label.p=
at-select select[data-value=3D"draft"]:hover, .js label.pat-select select[d=
ata-value=3D"draft"].tooltip-active-click, .js label.pat-select select.stat=
e-draft:hover, .js label.pat-select select.state-draft.tooltip-active-click=
 { background-color: rgb(249, 221, 194); }

.js select.pat-select[data-value=3D"draft"]:hover::after, .js select.pat-se=
lect[data-value=3D"draft"].tooltip-active-click::after, .js select.pat-sele=
ct.state-draft:hover::after, .js select.pat-select.state-draft.tooltip-acti=
ve-click::after, .js label.pat-select select[data-value=3D"draft"]:hover::a=
fter, .js label.pat-select select[data-value=3D"draft"].tooltip-active-clic=
k::after, .js label.pat-select select.state-draft:hover::after, .js label.p=
at-select select.state-draft.tooltip-active-click::after { background-color=
: rgb(243, 199, 155); }

.js select.pat-select[data-value=3D"for-review"], .js select.pat-select.sta=
te-for-review, .js label.pat-select select[data-value=3D"for-review"], .js =
label.pat-select select.state-for-review { background-color: rgb(242, 217, =
231); color: rgb(169, 0, 97); }

.js select.pat-select[data-value=3D"for-review"]::after, .js select.pat-sel=
ect.state-for-review::after, .js label.pat-select select[data-value=3D"for-=
review"]::after, .js label.pat-select select.state-for-review::after { back=
ground-color: rgb(229, 179, 208); }

.js select.pat-select[data-value=3D"for-review"]::before, .js select.pat-se=
lect[data-value=3D"for-review"]::after, .js select.pat-select.state-for-rev=
iew::before, .js select.pat-select.state-for-review::after, .js label.pat-s=
elect select[data-value=3D"for-review"]::before, .js label.pat-select selec=
t[data-value=3D"for-review"]::after, .js label.pat-select select.state-for-=
review::before, .js label.pat-select select.state-for-review::after { color=
: rgb(93, 0, 53); }

.js select.pat-select[data-value=3D"for-review"]:hover, .js select.pat-sele=
ct[data-value=3D"for-review"].tooltip-active-click, .js select.pat-select.s=
tate-for-review:hover, .js select.pat-select.state-for-review.tooltip-activ=
e-click, .js label.pat-select select[data-value=3D"for-review"]:hover, .js =
label.pat-select select[data-value=3D"for-review"].tooltip-active-click, .j=
s label.pat-select select.state-for-review:hover, .js label.pat-select sele=
ct.state-for-review.tooltip-active-click { background-color: rgb(236, 198, =
219); }

.js select.pat-select[data-value=3D"for-review"]:hover::after, .js select.p=
at-select[data-value=3D"for-review"].tooltip-active-click::after, .js selec=
t.pat-select.state-for-review:hover::after, .js select.pat-select.state-for=
-review.tooltip-active-click::after, .js label.pat-select select[data-value=
=3D"for-review"]:hover::after, .js label.pat-select select[data-value=3D"fo=
r-review"].tooltip-active-click::after, .js label.pat-select select.state-f=
or-review:hover::after, .js label.pat-select select.state-for-review.toolti=
p-active-click::after { background-color: rgb(223, 160, 196); }

.js select.pat-select[data-value=3D"approved"], .js select.pat-select.state=
-approved, .js label.pat-select select[data-value=3D"approved"], .js label.=
pat-select select.state-approved { background-color: rgb(225, 237, 219); co=
lor: rgb(43, 103, 9); }

.js select.pat-select[data-value=3D"approved"]::after, .js select.pat-selec=
t.state-approved::after, .js label.pat-select select[data-value=3D"approved=
"]::after, .js label.pat-select select.state-approved::after { background-c=
olor: rgb(196, 219, 182); }

.js select.pat-select[data-value=3D"approved"]::before, .js select.pat-sele=
ct[data-value=3D"approved"]::after, .js select.pat-select.state-approved::b=
efore, .js select.pat-select.state-approved::after, .js label.pat-select se=
lect[data-value=3D"approved"]::before, .js label.pat-select select[data-val=
ue=3D"approved"]::after, .js label.pat-select select.state-approved::before=
, .js label.pat-select select.state-approved::after { color: rgb(27, 65, 6)=
; }

.js select.pat-select[data-value=3D"approved"]:hover, .js select.pat-select=
[data-value=3D"approved"].tooltip-active-click, .js select.pat-select.state=
-approved:hover, .js select.pat-select.state-approved.tooltip-active-click,=
 .js label.pat-select select[data-value=3D"approved"]:hover, .js label.pat-=
select select[data-value=3D"approved"].tooltip-active-click, .js label.pat-=
select select.state-approved:hover, .js label.pat-select select.state-appro=
ved.tooltip-active-click { background-color: rgb(211, 229, 202); }

.js select.pat-select[data-value=3D"approved"]:hover::after, .js select.pat=
-select[data-value=3D"approved"].tooltip-active-click::after, .js select.pa=
t-select.state-approved:hover::after, .js select.pat-select.state-approved.=
tooltip-active-click::after, .js label.pat-select select[data-value=3D"appr=
oved"]:hover::after, .js label.pat-select select[data-value=3D"approved"].t=
ooltip-active-click::after, .js label.pat-select select.state-approved:hove=
r::after, .js label.pat-select select.state-approved.tooltip-active-click::=
after { background-color: rgb(182, 211, 165); }

.js select.pat-select[data-value=3D"published"], .js select.pat-select[data=
-value=3D"sent"], .js select.pat-select.state-published, .js select.pat-sel=
ect.state-sent, .js label.pat-select select[data-value=3D"published"], .js =
label.pat-select select[data-value=3D"sent"], .js label.pat-select select.s=
tate-published, .js label.pat-select select.state-sent { background-color: =
rgb(229, 240, 249); color: rgb(1, 53, 79); }

.js select.pat-select[data-value=3D"published"]::after, .js select.pat-sele=
ct[data-value=3D"sent"]::after, .js select.pat-select.state-published::afte=
r, .js select.pat-select.state-sent::after, .js label.pat-select select[dat=
a-value=3D"published"]::after, .js label.pat-select select[data-value=3D"se=
nt"]::after, .js label.pat-select select.state-published::after, .js label.=
pat-select select.state-sent::after { background-color: rgb(204, 224, 241);=
 }

.js select.pat-select[data-value=3D"published"]::before, .js select.pat-sel=
ect[data-value=3D"published"]::after, .js select.pat-select[data-value=3D"s=
ent"]::before, .js select.pat-select[data-value=3D"sent"]::after, .js selec=
t.pat-select.state-published::before, .js select.pat-select.state-published=
::after, .js select.pat-select.state-sent::before, .js select.pat-select.st=
ate-sent::after, .js label.pat-select select[data-value=3D"published"]::bef=
ore, .js label.pat-select select[data-value=3D"published"]::after, .js labe=
l.pat-select select[data-value=3D"sent"]::before, .js label.pat-select sele=
ct[data-value=3D"sent"]::after, .js label.pat-select select.state-published=
::before, .js label.pat-select select.state-published::after, .js label.pat=
-select select.state-sent::before, .js label.pat-select select.state-sent::=
after { color: rgb(1, 53, 79); }

.js select.pat-select[data-value=3D"published"]:hover, .js select.pat-selec=
t[data-value=3D"published"].tooltip-active-click, .js select.pat-select[dat=
a-value=3D"sent"]:hover, .js select.pat-select[data-value=3D"sent"].tooltip=
-active-click, .js select.pat-select.state-published:hover, .js select.pat-=
select.state-published.tooltip-active-click, .js select.pat-select.state-se=
nt:hover, .js select.pat-select.state-sent.tooltip-active-click, .js label.=
pat-select select[data-value=3D"published"]:hover, .js label.pat-select sel=
ect[data-value=3D"published"].tooltip-active-click, .js label.pat-select se=
lect[data-value=3D"sent"]:hover, .js label.pat-select select[data-value=3D"=
sent"].tooltip-active-click, .js label.pat-select select.state-published:ho=
ver, .js label.pat-select select.state-published.tooltip-active-click, .js =
label.pat-select select.state-sent:hover, .js label.pat-select select.state=
-sent.tooltip-active-click { background-color: rgb(208, 228, 244); }

.js select.pat-select[data-value=3D"published"]:hover::after, .js select.pa=
t-select[data-value=3D"published"].tooltip-active-click::after, .js select.=
pat-select[data-value=3D"sent"]:hover::after, .js select.pat-select[data-va=
lue=3D"sent"].tooltip-active-click::after, .js select.pat-select.state-publ=
ished:hover::after, .js select.pat-select.state-published.tooltip-active-cl=
ick::after, .js select.pat-select.state-sent:hover::after, .js select.pat-s=
elect.state-sent.tooltip-active-click::after, .js label.pat-select select[d=
ata-value=3D"published"]:hover::after, .js label.pat-select select[data-val=
ue=3D"published"].tooltip-active-click::after, .js label.pat-select select[=
data-value=3D"sent"]:hover::after, .js label.pat-select select[data-value=
=3D"sent"].tooltip-active-click::after, .js label.pat-select select.state-p=
ublished:hover::after, .js label.pat-select select.state-published.tooltip-=
active-click::after, .js label.pat-select select.state-sent:hover::after, .=
js label.pat-select select.state-sent.tooltip-active-click::after { backgro=
und-color: rgb(184, 212, 236); }

.js select.pat-select.locked::before, .js label.pat-select select.locked::b=
efore { font-family: fontello; content: "=EE=A0=AE"; display: inline-block;=
 margin-right: 5px; float: left; font-size: inherit; }

.js select.pat-select:not([class*=3D"icon-"])::before, .js label.pat-select=
 select:not([class*=3D"icon-"])::before { font-size: var(--pat-select-box-f=
ont-size); content: attr(data-option); white-space: nowrap; overflow: hidde=
n; text-overflow: ellipsis; display: block; }

.js select.pat-select[class*=3D"icon-"]::before, .js label.pat-select selec=
t[class*=3D"icon-"]::before { margin-left: -5px; margin-right: 8px; }

.js select.pat-select select, .js label.pat-select select select { position=
: absolute; inset: 0px; opacity: 0; margin: 0px; z-index: 1; height: 100% !=
important; width: 100% !important; }

.js select.pat-select select option, .js label.pat-select select select opt=
ion { font-size: initial; color: rgb(0, 0, 0); }

.js select.pat-select::after, .js label.pat-select select::after { font-fam=
ily: fontello; content: "=EE=A3=87"; width: var(--pat-select-box-arrow-widt=
h); background-color: var(--pat-select-box-arrow-background-colour); backgr=
ound-image: none; position: absolute; top: 0px; right: 0px; bottom: 0px; fo=
nt-size: var(--pat-select-box-arrow-size); border-top-right-radius: var(--p=
at-form-fields-border-radius); border-bottom-right-radius: var(--pat-form-f=
ields-border-radius); padding: 0px; display: flex; align-items: center; jus=
tify-content: center; }

.js select.pat-select option:disabled, .js label.pat-select select option:d=
isabled { color: silver; }

.js a.pat-select { display: inline-block; height: var(--pat-select-box-heig=
ht); line-height: var(--pat-select-box-height); padding-top: var(--pat-sele=
ct-box-padding-top-bottom); padding-bottom: var(--pat-select-box-padding-to=
p-bottom); padding-left: var(--pat-select-box-padding-start); padding-right=
: calc(var(--pat-select-box-arrow-width) + var(--pat-select-box-padding-sta=
rt)/2); position: relative; box-sizing: border-box; border: var(--pat-form-=
input-field-border); border-radius: var(--pat-form-input-field-border-radiu=
s); box-shadow: var(--pat-select-box-box-shadow); outline: var(--pat-form-i=
nput-field-outline); outline-offset: var(--pat-form-input-field-outline-off=
set); color: var(--pat-select-box-arrow-text-colour); font-size: var(--pat-=
select-box-font-size); max-width: 100%; background-color: var(--pat-select-=
box-background-colour); overflow: hidden; white-space: nowrap; text-overflo=
w: ellipsis; cursor: default; font-weight: normal !important; }

.js a.pat-select:hover { background-color: var(--pat-select-box-background-=
colour-hover); }

.js a.pat-select[data-value=3D"draft"], .js a.pat-select.state-draft { back=
ground-color: rgb(251, 234, 217); color: rgb(123, 61, 0); }

.js a.pat-select[data-value=3D"draft"]::after, .js a.pat-select.state-draft=
::after { background-color: rgb(246, 212, 178); }

.js a.pat-select[data-value=3D"draft"]::before, .js a.pat-select[data-value=
=3D"draft"]::after, .js a.pat-select.state-draft::before, .js a.pat-select.=
state-draft::after { color: rgb(123, 61, 0); }

.js a.pat-select[data-value=3D"draft"]:hover, .js a.pat-select[data-value=
=3D"draft"].tooltip-active-click, .js a.pat-select.state-draft:hover, .js a=
.pat-select.state-draft.tooltip-active-click { background-color: rgb(249, 2=
21, 194); }

.js a.pat-select[data-value=3D"draft"]:hover::after, .js a.pat-select[data-=
value=3D"draft"].tooltip-active-click::after, .js a.pat-select.state-draft:=
hover::after, .js a.pat-select.state-draft.tooltip-active-click::after { ba=
ckground-color: rgb(243, 199, 155); }

.js a.pat-select[data-value=3D"for-review"], .js a.pat-select.state-for-rev=
iew { background-color: rgb(242, 217, 231); color: rgb(169, 0, 97); }

.js a.pat-select[data-value=3D"for-review"]::after, .js a.pat-select.state-=
for-review::after { background-color: rgb(229, 179, 208); }

.js a.pat-select[data-value=3D"for-review"]::before, .js a.pat-select[data-=
value=3D"for-review"]::after, .js a.pat-select.state-for-review::before, .j=
s a.pat-select.state-for-review::after { color: rgb(93, 0, 53); }

.js a.pat-select[data-value=3D"for-review"]:hover, .js a.pat-select[data-va=
lue=3D"for-review"].tooltip-active-click, .js a.pat-select.state-for-review=
:hover, .js a.pat-select.state-for-review.tooltip-active-click { background=
-color: rgb(236, 198, 219); }

.js a.pat-select[data-value=3D"for-review"]:hover::after, .js a.pat-select[=
data-value=3D"for-review"].tooltip-active-click::after, .js a.pat-select.st=
ate-for-review:hover::after, .js a.pat-select.state-for-review.tooltip-acti=
ve-click::after { background-color: rgb(223, 160, 196); }

.js a.pat-select[data-value=3D"approved"], .js a.pat-select.state-approved =
{ background-color: rgb(225, 237, 219); color: rgb(43, 103, 9); }

.js a.pat-select[data-value=3D"approved"]::after, .js a.pat-select.state-ap=
proved::after { background-color: rgb(196, 219, 182); }

.js a.pat-select[data-value=3D"approved"]::before, .js a.pat-select[data-va=
lue=3D"approved"]::after, .js a.pat-select.state-approved::before, .js a.pa=
t-select.state-approved::after { color: rgb(27, 65, 6); }

.js a.pat-select[data-value=3D"approved"]:hover, .js a.pat-select[data-valu=
e=3D"approved"].tooltip-active-click, .js a.pat-select.state-approved:hover=
, .js a.pat-select.state-approved.tooltip-active-click { background-color: =
rgb(211, 229, 202); }

.js a.pat-select[data-value=3D"approved"]:hover::after, .js a.pat-select[da=
ta-value=3D"approved"].tooltip-active-click::after, .js a.pat-select.state-=
approved:hover::after, .js a.pat-select.state-approved.tooltip-active-click=
::after { background-color: rgb(182, 211, 165); }

.js a.pat-select[data-value=3D"published"], .js a.pat-select[data-value=3D"=
sent"], .js a.pat-select.state-published, .js a.pat-select.state-sent { bac=
kground-color: rgb(229, 240, 249); color: rgb(1, 53, 79); }

.js a.pat-select[data-value=3D"published"]::after, .js a.pat-select[data-va=
lue=3D"sent"]::after, .js a.pat-select.state-published::after, .js a.pat-se=
lect.state-sent::after { background-color: rgb(204, 224, 241); }

.js a.pat-select[data-value=3D"published"]::before, .js a.pat-select[data-v=
alue=3D"published"]::after, .js a.pat-select[data-value=3D"sent"]::before, =
.js a.pat-select[data-value=3D"sent"]::after, .js a.pat-select.state-publis=
hed::before, .js a.pat-select.state-published::after, .js a.pat-select.stat=
e-sent::before, .js a.pat-select.state-sent::after { color: rgb(1, 53, 79);=
 }

.js a.pat-select[data-value=3D"published"]:hover, .js a.pat-select[data-val=
ue=3D"published"].tooltip-active-click, .js a.pat-select[data-value=3D"sent=
"]:hover, .js a.pat-select[data-value=3D"sent"].tooltip-active-click, .js a=
.pat-select.state-published:hover, .js a.pat-select.state-published.tooltip=
-active-click, .js a.pat-select.state-sent:hover, .js a.pat-select.state-se=
nt.tooltip-active-click { background-color: rgb(208, 228, 244); }

.js a.pat-select[data-value=3D"published"]:hover::after, .js a.pat-select[d=
ata-value=3D"published"].tooltip-active-click::after, .js a.pat-select[data=
-value=3D"sent"]:hover::after, .js a.pat-select[data-value=3D"sent"].toolti=
p-active-click::after, .js a.pat-select.state-published:hover::after, .js a=
.pat-select.state-published.tooltip-active-click::after, .js a.pat-select.s=
tate-sent:hover::after, .js a.pat-select.state-sent.tooltip-active-click::a=
fter { background-color: rgb(184, 212, 236); }

.js a.pat-select.locked::before { font-family: fontello; content: "=EE=A0=
=AE"; display: inline-block; margin-right: 5px; float: left; font-size: inh=
erit; }

.js a.pat-select:not([class*=3D"icon-"])::before { font-size: var(--pat-sel=
ect-box-font-size); content: attr(data-option); white-space: nowrap; overfl=
ow: hidden; text-overflow: ellipsis; display: block; }

.js a.pat-select[class*=3D"icon-"]::before { margin-left: -5px; margin-righ=
t: 8px; }

.js a.pat-select select { position: absolute; inset: 0px; opacity: 0; margi=
n: 0px; z-index: 1; height: 100% !important; width: 100% !important; }

.js a.pat-select select option { font-size: initial; color: rgb(0, 0, 0); }

.js a.pat-select::after { font-family: fontello; content: "=EE=A3=87"; widt=
h: var(--pat-select-box-arrow-width); background-color: var(--pat-select-bo=
x-arrow-background-colour); background-image: none; position: absolute; top=
: 0px; right: 0px; bottom: 0px; font-size: var(--pat-select-box-arrow-size)=
; border-top-right-radius: var(--pat-form-fields-border-radius); border-bot=
tom-right-radius: var(--pat-form-fields-border-radius); padding: 0px; displ=
ay: flex; align-items: center; justify-content: center; }

.js a.pat-select option:disabled { color: silver; }

.js a.pat-select:hover { text-decoration: none; }

.js a.pat-select::after { font-family: fontello; content: "=EE=A3=87"; back=
ground-color: var(--pat-select-box-arrow-background-colour); background-ima=
ge: none; position: absolute; top: 0px; right: 0px; bottom: 0px; font-size:=
 var(--pat-select-box-arrow-size); border-top-right-radius: var(--pat-form-=
fields-border-radius); border-bottom-right-radius: var(--pat-form-fields-bo=
rder-radius); padding: 0px; display: flex; align-items: center; justify-con=
tent: center; width: 30px; }

.js label.pat-select.bare, .js a.pat-select.bare { --pat-select-arrow-edge-=
distance: 1px; --pat-select-arrow-space: 20px; position: relative; cursor: =
default; box-sizing: border-box; padding: 0 var(--pat-select-arrow-space) 0=
 0; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; max-wid=
th: 100%; border-radius: var(--pat-form-fields-border-radius); outline-offs=
et: var(--pat-form-input-field-outline-offset); }

.js label.pat-select.bare:hover, .js label.pat-select.bare.focus, .js a.pat=
-select.bare:hover, .js a.pat-select.bare.focus { text-decoration: none !im=
portant; }

@media print {
  .js label.pat-select.bare, .js a.pat-select.bare { background-image: none=
; padding-right: 0px; }
}

.js label.pat-select.bare::after, .js a.pat-select.bare::after { content: "=
 "; padding-right: var(--pat-select-arrow-space); position: absolute; top: =
2%; right: 0px; bottom: 0px; pointer-events: none; overflow: hidden; white-=
space: nowrap; text-overflow: ellipsis; background-repeat: no-repeat; backg=
round-position: calc(100% - var(--pat-select-arrow-edge-distance)) center; =
background-image: url("data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIi=
BlbmNvZGluZz0idXRmLTgiPz4KPHN2ZyB2ZXJzaW9uPSIxLjEiIGlkPSJMYWFnXzEiIHhtbG5zP=
SJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMu=
b3JnLzE5OTkveGxpbmsiIHg9IjBweCIgeT0iMHB4IgoJIHZpZXdCb3g9IjAgMCAxNC42IDguOCI=
gc3R5bGU9ImVuYWJsZS1iYWNrZ3JvdW5kOm5ldyAwIDAgMTQuNiA4Ljg7IiB4bWw6c3BhY2U9In=
ByZXNlcnZlIj4KPHN0eWxlIHR5cGU9InRleHQvY3NzIj4KCS5zdDB7ZmlsbDpub25lO3N0cm9rZ=
TojMDM2ODlCO3N0cm9rZS13aWR0aDozO3N0cm9rZS1saW5lY2FwOnJvdW5kO3N0cm9rZS1saW5l=
am9pbjpyb3VuZDtzdHJva2UtbWl0ZXJsaW1pdDoxMDt9Cjwvc3R5bGU+Cjxwb2x5bGluZSBjbGF=
zcz0ic3QwIiBwb2ludHM9IjEuNSwxLjUgNy4zLDcuMyAxMy4xLDEuNSAiLz4KPC9zdmc+"); ba=
ckground-size: auto 10px; box-shadow: none !important; }

.js label.pat-select.bare::before, .js a.pat-select.bare::before { display:=
 inline-block; content: attr(data-option); float: left; max-height: 100%; m=
ax-width: 100%; font-weight: normal; overflow: hidden; text-overflow: ellip=
sis; box-shadow: none !important; }

.js label.pat-select.bare:has(:focus), .js a.pat-select.bare:has(:focus) { =
outline: var(--pat-form-input-field-outline-focus); }

.js label.pat-select.bare select, .js a.pat-select.bare select { opacity: 0=
; line-height: 1.5em; font-size: 1em; position: absolute; top: 0px; right: =
0px; left: 0px; max-width: 100%; width: 100%; border-right: none; }

.scroll-table, .tableWrapper { overflow: auto visible; clear: both; }

.scroll-table.scroll-vertical, .tableWrapper.scroll-vertical { overflow: au=
to; max-height: calc(-130px + 100vh); }

.scroll-table.scroll-vertical thead.sticky, .scroll-table.scroll-vertical t=
foot.sticky, .tableWrapper.scroll-vertical thead.sticky, .tableWrapper.scro=
ll-vertical tfoot.sticky { position: sticky; top: 0px; z-index: 10; }

.pat-table { border-collapse: separate; border-spacing: 0px; vertical-align=
: top; width: 100%; }

@media only screen and (max-width: 769px) {
  .pat-table { background-color: rgba(0, 0, 0, 0); }
}

@media only screen and (min-width: 770px) {
  .pat-table { background-color: rgba(0, 0, 0, 0); border-bottom: none; pad=
ding: 5px 10px; }
}

.mode-select .pat-table { user-select: none; }

.pat-table .tableWrapper { display: none !important; }

.pat-table ins { background-color: rgb(152, 251, 152); text-decoration: non=
e; }

.pat-table del { background-color: pink; }

.pat-table abbr { text-decoration: none; }

.pat-table caption { padding-left: 0px; margin: 1em 0px; color: rgb(0, 0, 0=
); line-height: 1.5; text-align: left; font-weight: bold; }

.pat-table .status-marker { font-weight: normal; display: inline-block; bac=
kground: rgb(255, 255, 255); box-shadow: rgba(0, 0, 0, 0.4) 0px 0px 0px 1px=
 inset; border-radius: 20px; padding: 0px 0.8rem; margin-left: 0.2rem; font=
-style: normal; text-decoration: none; }

.pat-table .status-marker.warning { color: rgb(251, 234, 217); }

.pat-table tr { width: 100%; outline: none; overflow: hidden; }

.pat-table tr > :last-child { }

.pat-table tr > :first-child { }

@media only screen and (max-width: 769px) {
  .pat-table tr { padding: 15px; border-radius: 0px; margin-bottom: 20px; o=
verflow: hidden; box-shadow: none; background-color: rgb(255, 255, 255); bo=
x-sizing: border-box; align-items: flex-start; justify-content: space-betwe=
en; display: grid; grid-auto-rows: minmax(40px, auto); }
}

.pat-table tr.folder .item-name a { padding-left: 30px !important; position=
: relative; }

.mode-select .pat-table tr.folder .item-name a { pointer-events: none; }

.pat-table tr.folder .item-name a::before { position: absolute; left: 8px; =
display: inline-block; margin-right: 5px; font-family: fontello; content: "=
=EE=A0=B6"; }

.pat-table tr.state-draft th, .pat-table tr.state-draft th a { color: rgb(2=
25, 112, 0); }

.pat-table tr.state-archived th a { text-decoration: line-through; opacity:=
 0.5; }

.pat-table tr.mutated th, .pat-table tr.has-differences th { background: rg=
ba(255, 100, 0, 0.2); }

.pat-table tr.mutated td, .pat-table tr.has-differences td { background: rg=
ba(255, 100, 0, 0.1); }

.pat-table tr.has-mutations td:last-child { position: relative; padding-rig=
ht: 25px; }

.pat-table tr.has-mutations td:last-child::after { position: absolute; top:=
 50%; right: 15px; transform: translateY(-50%); content: " "; width: 10px; =
height: 10px; overflow: hidden; border: 2px solid rgb(255, 255, 255); paddi=
ng: 0px; border-radius: 50%; background: linear-gradient(rgb(143, 202, 231)=
 0%, rgb(0, 123, 199) 100%); display: inline-block; margin-top: 0px; color:=
 rgba(0, 0, 0, 0) !important; }

.pat-table tr td, .pat-table tr th { border-collapse: collapse; vertical-al=
ign: top; }

@media only screen and (min-width: 770px) {
  .pat-table tr td, .pat-table tr th { padding: 10px 15px; background-color=
: rgb(255, 255, 255); border-top: none; }
}

@media only screen and (max-width: 769px) {
  .pat-table tr td, .pat-table tr th { display: block; padding: 0px; margin=
-bottom: 0px; border: 0px; grid-column: 1 / 2; }
  .pat-table tr td:last-child, .pat-table tr th:last-child { margin-bottom:=
 0px; }
  .pat-table tr td::before, .pat-table tr th::before { content: attr(data-t=
itle); font-weight: bold; color: rgb(0, 0, 0); display: block; font-size: 0=
.8em; }
}

@media only screen and (min-width: 770px) {
  .pat-table tr td.item-name, .pat-table tr td.item-state, .pat-table tr th=
.item-name, .pat-table tr th.item-state { padding: 0px; }
}

.pat-table tr td.item-name a, .pat-table tr td.item-state a, .pat-table tr =
th.item-name a, .pat-table tr th.item-state a { display: flex; justify-cont=
ent: space-between; }

@media only screen and (min-width: 770px) {
  .pat-table tr td.item-name a, .pat-table tr td.item-state a, .pat-table t=
r th.item-name a, .pat-table tr th.item-state a { padding: 10px 15px; }
}

.pat-table tr td.item-name a .addition::before, .pat-table tr td.item-state=
 a .addition::before, .pat-table tr th.item-name a .addition::before, .pat-=
table tr th.item-state a .addition::before { content: ", "; }

.pat-table tr td.item-name a .byline, .pat-table tr td.item-state a .byline=
, .pat-table tr th.item-name a .byline, .pat-table tr th.item-state a .byli=
ne { color: rgba(0, 0, 0, 0.7); font-size: 0.8em; display: block; line-heig=
ht: 1.3; margin-top: 2px; margin-bottom: 3px; font-weight: normal; }

.pat-table tr td.item-name a[href]:hover, .pat-table tr td.item-state a[hre=
f]:hover, .pat-table tr th.item-name a[href]:hover, .pat-table tr th.item-s=
tate a[href]:hover { text-decoration: underline; }

.pat-table tr td.item-name a[href]:hover:has(.link-title), .pat-table tr td=
.item-state a[href]:hover:has(.link-title), .pat-table tr th.item-name a[hr=
ef]:hover:has(.link-title), .pat-table tr th.item-state a[href]:hover:has(.=
link-title) { text-decoration: none; }

.pat-table tr td.item-name a[href]:hover:has(.link-title) .link-title, .pat=
-table tr td.item-state a[href]:hover:has(.link-title) .link-title, .pat-ta=
ble tr th.item-name a[href]:hover:has(.link-title) .link-title, .pat-table =
tr th.item-state a[href]:hover:has(.link-title) .link-title { text-decorati=
on: underline; }

.pat-table tr td.item-name a[href]:hover:has(.link-title) .link-title:has(.=
byline), .pat-table tr td.item-state a[href]:hover:has(.link-title) .link-t=
itle:has(.byline), .pat-table tr th.item-name a[href]:hover:has(.link-title=
) .link-title:has(.byline), .pat-table tr th.item-state a[href]:hover:has(.=
link-title) .link-title:has(.byline) { text-decoration: none; }

.pat-table tr td.item-name a[href]:hover:has(.link-title) .link-title:has(.=
byline) .title, .pat-table tr td.item-state a[href]:hover:has(.link-title) =
.link-title:has(.byline) .title, .pat-table tr th.item-name a[href]:hover:h=
as(.link-title) .link-title:has(.byline) .title, .pat-table tr th.item-stat=
e a[href]:hover:has(.link-title) .link-title:has(.byline) .title { text-dec=
oration: underline; }

.pat-table tr td.item-name a .classification-tags, .pat-table tr td.item-st=
ate a .classification-tags, .pat-table tr th.item-name a .classification-ta=
gs, .pat-table tr th.item-state a .classification-tags { line-height: 19px;=
 }

.pat-table tr td.item-name::before, .pat-table tr th.item-name::before { di=
splay: none; }

@media only screen and (max-width: 769px) {
  .pat-table tr td.item-name, .pat-table tr th.item-name { grid-column: 1 /=
 1; font-size: 1.3em; padding-top: 8px; }
}

.pat-table tr td.select, .pat-table tr th.select { width: 0px; box-sizing: =
border-box; overflow: hidden; transition: width 1s, border 1s; border-left:=
 0px solid rgb(255, 255, 255); border-right: 0px solid rgb(255, 255, 255); =
position: relative; user-select: none; padding: 0px !important; }

.pat-table tr td.select:hover, .pat-table tr th.select:hover { background-c=
olor: rgb(219, 219, 219); }

.pat-table tr td.select label, .pat-table tr th.select label { width: 100%;=
 height: 100%; overflow: hidden; display: grid; grid-template-columns: var(=
--pat-checklist-label-padding-start) auto; grid-template-areas: "icon label=
" ". description"; align-items: start; padding-right: var(--pat-checklist-l=
abel-padding-end); user-select: none; line-height: var(--pat-checklist-line=
-height); position: absolute; inset: 0px; color: rgba(0, 0, 0, 0); box-sizi=
ng: border-box; }

body[dir=3D"rtl"] .pat-table tr td.select label, body[dir=3D"rtl"] .pat-tab=
le tr th.select label { padding-left: var(--pat-checklist-label-padding-end=
); }

.pat-table tr td.select label > *, .pat-table tr th.select label > * { grid=
-area: label; }

.pat-table tr td.select label:has(:focus)::before, .pat-table tr th.select =
label:has(:focus)::before { outline: var(--pat-form-input-field-outline-foc=
us); outline-offset: var(--pat-form-input-field-outline-offset); }

.pat-table tr td.select label:has(input[type=3D"checkbox"])::before, .pat-t=
able tr td.select label:has(input[type=3D"radio"])::before, .pat-table tr t=
h.select label:has(input[type=3D"checkbox"])::before, .pat-table tr th.sele=
ct label:has(input[type=3D"radio"])::before { box-shadow: var(--pat-checkli=
st-checkbox-box-shadow); content: ""; font-weight: normal; background-color=
: var(--pat-checklist-checkbox-background-colour); font-size: 0px; text-ali=
gn: center; height: var(--pat-checklist-checkbox-size); width: var(--pat-ch=
ecklist-checkbox-size); line-height: var(--pat-checklist-checkbox-size); bo=
rder-radius: var(--pat-checklist-checkbox-border-radius); justify-self: sta=
rt; grid-area: icon; position: relative; top: var(--pat-checklist-checkbox-=
vertical-position); transform: translateY(-50%); transition: 0.2s ease-out;=
 }

.pat-table tr td.select label:has(input[type=3D"radio"])::before, .pat-tabl=
e tr th.select label:has(input[type=3D"radio"])::before { border-radius: 50=
%; }

.pat-table tr td.select label:has(input:checked)::before, .pat-table tr th.=
select label:has(input:checked)::before { background-color: var(--pat-check=
list-checkbox-background-colour-checked); box-shadow: var(--pat-checklist-c=
heckbox-box-shadow-checked); color: rgb(255, 255, 255); font-family: fontel=
lo; content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-s=
ize)); }

.pat-table tr td.select label:has([disabled]):has(input[type=3D"checkbox"])=
::before, .pat-table tr td.select label:has([disabled]):has(input[type=3D"r=
adio"])::before, .pat-table tr td.select label:has([disabled]) .label-fragm=
ent-description:has(input[type=3D"checkbox"])::before, .pat-table tr td.sel=
ect label:has([disabled]) .label-fragment-description:has(input[type=3D"rad=
io"])::before, .pat-table tr th.select label:has([disabled]):has(input[type=
=3D"checkbox"])::before, .pat-table tr th.select label:has([disabled]):has(=
input[type=3D"radio"])::before, .pat-table tr th.select label:has([disabled=
]) .label-fragment-description:has(input[type=3D"checkbox"])::before, .pat-=
table tr th.select label:has([disabled]) .label-fragment-description:has(in=
put[type=3D"radio"])::before { background-color: rgba(0, 0, 0, 0.2); color:=
 rgba(0, 0, 0, 0.3); box-shadow: none; }

.pat-table tr td.select label .label-fragment-title, .pat-table tr th.selec=
t label .label-fragment-title { margin: 0px 0px 0px -30px; padding-left: 30=
px; }

.pat-table tr td.select label .label-fragment-description, .pat-table tr th=
.select label .label-fragment-description { margin: 5px 0px 12px; color: rg=
ba(0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: descriptio=
n; }

.pat-table tr td.select label .label-fragment-description > *, .pat-table t=
r th.select label .label-fragment-description > * { color: rgb(0, 0, 0); }

.pat-table tr td.select label input[type=3D"checkbox"], .pat-table tr td.se=
lect label input[type=3D"radio"], .pat-table tr th.select label input[type=
=3D"checkbox"], .pat-table tr th.select label input[type=3D"radio"] { opaci=
ty: 0; position: absolute; left: 0px; width: 0px; margin-top: 0.6px; }

.pat-table tr td.select label::before, .pat-table tr th.select label::befor=
e { position: absolute; color: rgb(0, 0, 0); top: 50% !important; left: 50%=
 !important; transform: translate(-50%, -50%) !important; font-size: 18px !=
important; }

#product-space.mode-select .pat-table tr td.select, #product-space.mode-sel=
ect .pat-table tr th.select { width: 32px; border-right: 2px solid rgb(255,=
 255, 255); }

.pat-table tr td a[href]:hover, .pat-table tr th a[href]:hover { text-decor=
ation: underline; }

.pat-table tr td.workflow-change, .pat-table tr th.workflow-change { width:=
 50px; max-width: 50px; font-size: 0px; background-color: rgb(217, 237, 247=
) !important; }

.pat-table tr td.workflow-change::before, .pat-table tr th.workflow-change:=
:before { display: none; }

.pat-table tr td.workflow-change .workflow-change-title, .pat-table tr th.w=
orkflow-change .workflow-change-title { position: absolute; top: -7px; left=
: -15px; transform: rotate(90deg); transform-origin: left bottom; font-size=
: 40px; width: calc(-140px + 100vh); text-align: left; line-height: 78px; h=
eight: 78px; color: rgba(0, 0, 0, 0.5); display: block; background: rgb(217=
, 237, 247); padding-left: 15px; font-weight: normal; overflow: hidden; tex=
t-overflow: ellipsis; white-space: nowrap; }

.pat-table tr td > :last-child, .pat-table tr th > :last-child { margin-bot=
tom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-table tr td, .pat-table tr th { hyphens: auto; padding: 5px 10px; }
}

.pat-table tr td.injecting > p, .pat-table tr th.injecting > p { opacity: 0=
.5; }

.pat-table tr td.injecting .suggested-content > *, .pat-table tr th.injecti=
ng .suggested-content > * { opacity: 0.5; }

.pat-table tr td.injecting .suggested-content::before, .pat-table tr th.inj=
ecting .suggested-content::before { position: absolute; top: 50%; left: 50%=
; content: "=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; margi=
n-left: -25px; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb(=
255, 255, 255) 0px 0px 2px; text-align: center; opacity: 0; animation: 2s l=
inear 0s infinite normal none running spin, 1s linear 1s 1 normal forwards =
running fadeIn; }

.pat-table tr td .suggested-content, .pat-table tr th .suggested-content { =
margin-bottom: 5px; margin-top: 10px; background-color: rgb(217, 237, 247);=
 position: relative; }

.pat-table tr td .suggested-content p.buttons, .pat-table tr th .suggested-=
content p.buttons { margin-top: 5px; }

.pat-table tr td .suggested-content p.buttons button, .pat-table tr th .sug=
gested-content p.buttons button { margin-right: 5px; }

.pat-table tr td .pat-button, .pat-table tr th .pat-button { padding: 0px 0=
.5em; line-height: 1.2em; }

.pat-table tr td.symbol, .pat-table tr th.symbol { text-align: center; }

.pat-table tr td.date-compact, .pat-table tr th.date-compact { width: 100px=
; }

.pat-table tr td.item-date, .pat-table tr td.date, .pat-table tr th.item-da=
te, .pat-table tr th.date { white-space: nowrap; }

.pat-table tr td.indicator-order, .pat-table tr td.indicator-number, .pat-t=
able tr th.indicator-order, .pat-table tr th.indicator-number { width: 50px=
; }

.pat-table tr td.icon, .pat-table tr th.icon { width: 1em; padding-left: 0.=
2em; padding-right: 0px; }

@media only screen and (max-width: 769px) {
  .pat-table tr td.icon, .pat-table tr th.icon { margin-bottom: 20px; }
}

.pat-table tr td.price, .pat-table tr th.price { white-space: nowrap; width=
: 5em; }

.pat-table tr td.cost, .pat-table tr th.cost { white-space: nowrap; width: =
2em; }

.pat-table tr th label { overflow: hidden; display: grid; grid-template-col=
umns: var(--pat-checklist-label-padding-start) auto; grid-template-areas: "=
icon label" ". description"; align-items: start; user-select: none; line-he=
ight: var(--pat-checklist-line-height); padding: 0px; color: rgba(0, 0, 0, =
0); box-sizing: border-box; transition: padding-left 1s; }

body[dir=3D"rtl"] .pat-table tr th label { padding-left: var(--pat-checklis=
t-label-padding-end); }

.pat-table tr th label > * { grid-area: label; }

.pat-table tr th label:has(:focus)::before { outline: var(--pat-form-input-=
field-outline-focus); outline-offset: var(--pat-form-input-field-outline-of=
fset); }

.pat-table tr th label:has(input[type=3D"checkbox"])::before, .pat-table tr=
 th label:has(input[type=3D"radio"])::before { box-shadow: var(--pat-checkl=
ist-checkbox-box-shadow); content: ""; font-weight: normal; background-colo=
r: var(--pat-checklist-checkbox-background-colour); font-size: 0px; text-al=
ign: center; height: var(--pat-checklist-checkbox-size); width: var(--pat-c=
hecklist-checkbox-size); line-height: var(--pat-checklist-checkbox-size); b=
order-radius: var(--pat-checklist-checkbox-border-radius); justify-self: st=
art; grid-area: icon; position: relative; top: var(--pat-checklist-checkbox=
-vertical-position); transform: translateY(-50%); transition: 0.2s ease-out=
; }

.pat-table tr th label:has(input[type=3D"radio"])::before { border-radius: =
50%; }

.pat-table tr th label:has(input:checked)::before { background-color: var(-=
-pat-checklist-checkbox-background-colour-checked); box-shadow: var(--pat-c=
hecklist-checkbox-box-shadow-checked); color: rgb(255, 255, 255); font-fami=
ly: fontello; content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-=
checkbox-size)); }

.pat-table tr th label:has([disabled]):has(input[type=3D"checkbox"])::befor=
e, .pat-table tr th label:has([disabled]):has(input[type=3D"radio"])::befor=
e, .pat-table tr th label:has([disabled]) .label-fragment-description:has(i=
nput[type=3D"checkbox"])::before, .pat-table tr th label:has([disabled]) .l=
abel-fragment-description:has(input[type=3D"radio"])::before { background-c=
olor: rgba(0, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

.pat-table tr th label .label-fragment-title { margin: 0px 0px 0px -30px; p=
adding-left: 30px; }

.pat-table tr th label .label-fragment-description { margin: 5px 0px 12px; =
color: rgba(0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: d=
escription; }

.pat-table tr th label .label-fragment-description > * { color: rgb(0, 0, 0=
); }

.pat-table tr th label input[type=3D"checkbox"], .pat-table tr th label inp=
ut[type=3D"radio"] { opacity: 0; position: absolute; left: 0px; width: 0px;=
 margin-top: 0.6px; }

.pat-table tr th label input { position: absolute; opacity: 0; }

.mode-select .pat-table tr th label { padding-left: 20px; }

.mode-select .pat-table tr th label:hover { background-color: rgb(219, 219,=
 219); }

.mode-select .pat-table tr th label a { pointer-events: none; }

.pat-table tr th label::before { position: absolute; color: rgb(0, 0, 0); o=
pacity: 0; transition: 1s; top: 50% !important; left: -5px !important; tran=
sform: translate(-50%, -50%) !important; font-size: 18px !important; }

.mode-select .pat-table tr th label::before { opacity: 1; left: 15px !impor=
tant; }

.pat-table tr td.no-width { width: auto; min-width: auto; max-width: none; =
}

.pat-table tr td.functions { white-space: nowrap; text-align: right; vertic=
al-align: middle !important; }

@media only screen and (max-width: 769px) {
  .pat-table tr td.functions { grid-row-start: 1; grid-column-start: 2; pad=
ding: 0px !important; }
}

@media only screen and (min-width: 770px) {
  .pat-table tr td.functions { padding: 0px 4px 0px 0px !important; }
}

.pat-table tr td.functions .icon { margin: 0px; padding: 0px; width: 48px; =
height: 48px; overflow: hidden; color: rgba(0, 0, 0, 0); cursor: default; t=
ext-decoration: none; display: inline-block; vertical-align: middle; border=
-radius: 0px; }

@media only screen and (max-width: 769px) {
  .pat-table tr td.functions .icon { display: inline-block; float: none; ve=
rtical-align: top; }
}

.pat-table tr td.functions .icon:hover { background-color: rgba(0, 0, 0, 0.=
05); }

.pat-table tr td.functions .icon:hover .pie-graph { --pie-graph-segment-col=
our: black; border-color: rgb(0, 0, 0); }

.pat-table tr td.functions .icon::before { font-family: fontello; display: =
block; line-height: 48px; width: 100%; text-align: center; color: gray; mar=
gin: 0px; }

.pat-table tr td.functions .icon.tooltip-active-click { background-color: r=
gb(225, 112, 0); }

.pat-table tr td.functions .icon.tooltip-active-click::before { color: rgb(=
255, 255, 255); }

.pat-table tr td.functions .icon.tooltip-active-click .pie-graph { border: =
2px solid rgb(255, 255, 255); --pie-graph-segment-colour: #e17000; }

.pat-table tr td.functions .icon:first-child { margin: 0px; }

.pat-table tr td.functions .icon.progress { display: inline-flex; align-ite=
ms: center; justify-content: center; }

.pat-table tr td.functions .icon.progress .pie-graph { --pie-graph-segment-=
colour: gray; }

.pat-table tr td.functions .icon.locked::before { content: "=EE=A0=AE"; }

.pat-table tr td.functions .icon.validated::before { content: "=EE=A0=AE"; =
color: rgb(225, 237, 219); }

.pat-table tr td.functions .icon.validated.tooltip-active-click { backgroun=
d-color: rgb(225, 237, 219); }

.pat-table tr td.functions .icon.validated.tooltip-active-click::before { c=
olor: rgb(225, 237, 219) !important; }

.pat-table tr td.functions .icon.under-review::before { color: rgb(225, 112=
, 0); }

.pat-table tr td.functions .icon.under-review.tooltip-active-click { backgr=
ound-color: rgb(251, 234, 217); }

.pat-table tr td.functions .icon.under-review.tooltip-active-click::before =
{ color: rgb(225, 112, 0) !important; }

.pat-table tr td.functions .icon.unlocked::before { content: "=EE=A0=AF"; }

.pat-table tr td.item-state { vertical-align: middle; white-space: nowrap; =
padding: 0px !important; }

.pat-table tr td.item-state a { background-color: rgb(242, 242, 242); color=
: rgb(0, 0, 0); cursor: default; }

.pat-table tr td.item-state a:hover { background-color: rgb(237, 237, 237);=
 text-decoration: none; }

.pat-table tr td.item-state a.state-draft { background-color: rgb(251, 234,=
 217); color: rgb(123, 61, 0); }

.pat-table tr td.item-state a.state-draft:hover, .pat-table tr td.item-stat=
e a.state-draft.tooltip-active-click { background-color: rgb(249, 221, 194)=
; }

.pat-table tr td.item-state a.state-for-review { background-color: rgb(227,=
 220, 231); color: rgb(66, 20, 95); }

.pat-table tr td.item-state a.state-for-review:hover, .pat-table tr td.item=
-state a.state-for-review.tooltip-active-click { background-color: rgb(215,=
 205, 221); }

.pat-table tr td.item-state a.state-sent, .pat-table tr td.item-state a.sta=
te-published { background-color: rgb(229, 240, 249); color: rgb(1, 70, 104)=
; }

.pat-table tr td.item-state a.state-sent:hover, .pat-table tr td.item-state=
 a.state-sent.tooltip-active-click, .pat-table tr td.item-state a.state-pub=
lished:hover, .pat-table tr td.item-state a.state-published.tooltip-active-=
click { background-color: rgb(208, 228, 244); }

.pat-table tr td.item-state a.state-approved { background-color: rgb(225, 2=
37, 219); color: rgb(43, 103, 9); }

.pat-table tr td.item-state a.state-approved:hover, .pat-table tr td.item-s=
tate a.state-approved.tooltip-active-click { background-color: rgb(211, 229=
, 202); }

@media only screen and (min-width: 770px) {
  .pat-table tbody td:not(.separation-cell), .pat-table tbody th:not(.separ=
ation-cell) { vertical-align: top; }
}

.pat-table tbody td:not(.separation-cell) .table-body-title, .pat-table tbo=
dy th:not(.separation-cell) .table-body-title { display: block; padding-top=
: 1.5em; font-weight: bold; font-size: 1.125em; line-height: 1.4444; }

@media only screen and (min-width: 770px) {
  .pat-table tbody th { width: 33%; position: sticky; left: 0px; z-index: 9=
; }
}

.pat-table tbody tr.header-row th, .pat-table tbody tr.header-row td { back=
ground: rgba(0, 0, 0, 0); }

.pat-table tbody tr.header-row th::after, .pat-table tbody tr.header-row td=
::after { display: none; }

.pat-table tbody tr.header-row th .table-body-title, .pat-table tbody tr.he=
ader-row td .table-body-title { padding-top: 1.5em; }

.pat-table tbody tr.header-row th .table-body-title a, .pat-table tbody tr.=
header-row td .table-body-title a { text-overflow: ellipsis; overflow: hidd=
en; }

.pat-table tbody tr.header-row:first-child .header-cell .table-body-title {=
 padding-top: 30px; }

.pat-table tbody .separation-cell { vertical-align: bottom; padding-top: 1.=
5em; background-color: rgba(0, 0, 0, 0); }

.pat-table tbody tr.header-row + .separation-row .separation-cell { padding=
-top: 0px; }

@media only screen and (max-width: 769px) {
  .pat-table thead { display: none; }
}

.pat-table thead tr { outline: none; }

.pat-table thead th { vertical-align: bottom; text-align: left; hyphens: no=
ne; position: relative; padding-bottom: 0px; padding-top: 0px; background-c=
olor: rgba(0, 0, 0, 0); }

.pat-table thead th .select-all-items { padding: 0px; z-index: 2; width: 31=
px; left: 0px; top: 0px; bottom: 0px; position: absolute !important; }

.pat-table thead th .select-all-items::before { top: 16px !important; }

.pat-table thead th.spacer-cell { position: sticky; left: 0px; z-index: 9; =
}

.pat-table thead th a.sorting, .pat-table thead th a.sorting_asc, .pat-tabl=
e thead th a.sorting-asc, .pat-table thead th a.sorting_desc, .pat-table th=
ead th a.sorting-desc { position: relative; padding-right: 30px; top: 0px; =
}

.pat-table thead th a.sorting:focus, .pat-table thead th a.sorting_asc:focu=
s, .pat-table thead th a.sorting-asc:focus, .pat-table thead th a.sorting_d=
esc:focus, .pat-table thead th a.sorting-desc:focus { outline: none; cursor=
: default; }

.pat-table thead th a.sorting::after, .pat-table thead th a.sorting_asc::af=
ter, .pat-table thead th a.sorting-asc::after, .pat-table thead th a.sortin=
g_desc::after, .pat-table thead th a.sorting-desc::after { font-family: fon=
tello; position: absolute; top: 50%; right: 0.5em; display: block; width: 3=
0px; height: 30px; line-height: 30px; text-align: right; transform: transla=
teY(-50%); }

.pat-table thead th a.sorting_asc::after, .pat-table thead th a.sorting-asc=
::after { content: "=EE=A0=9D"; }

.pat-table thead th a.sorting_desc::after, .pat-table thead th a.sorting-de=
sc::after { content: "=EE=A0=9E"; }

.pat-table thead th a.sorting { display: block; color: rgb(0, 0, 0); cursor=
: default; padding: 5px 20px 5px 10px; margin: -5px -10px; }

@media only screen and (min-width: 770px) {
  .pat-table { padding: 10px 15px; line-height: 1.5; }
}

@media only screen and (min-width: 770px) {
  .pat-table.hd { padding: 5px 10px; }
}

.pat-table.hd tbody, .pat-table.hd tfoot { font-size: 0.8em; }

@media only screen and (min-width: 770px) {
  .pat-table.hd tbody th:not(.item-name), .pat-table.hd tbody td:not(.item-=
state), .pat-table.hd tbody .item-name a, .pat-table.hd tbody .item-state >=
 a, .pat-table.hd tfoot th:not(.item-name), .pat-table.hd tfoot td:not(.ite=
m-state), .pat-table.hd tfoot .item-name a, .pat-table.hd tfoot .item-state=
 > a { padding: 8px; }
}

.pat-table.hd thead { font-size: 0.8em; }

.pat-table.hd thead th { padding: 0px 8px; }

.pat-table.hd tbody td.functions .icon { width: 34px; height: 34px; }

.pat-table.hd tbody td.functions .icon::before { line-height: 34px; }

:root { --pat-toolbar-button-height: 44px; --pat-toolbar-button-line-height=
: 44px; --pat-toolbar-font-size: 18px; --pat-toolbar-search-field-width-ope=
n: 350px; --pat-toolbar-element-separation: 15px; --pat-toolbar-bump-distan=
ce: 100px; --pat-toolbar-bump-distance-scroll-down: 100px; --pat-toolbar-pa=
dding: 10px; --pat-toolbar-margin-bottom: 40px; --pat-toolbar-top-distance:=
 -1px; --pat-toolbar-top-distance-scroll-down: -55px; --pat-toolbar-hiding-=
speed: 0.4s; --pat-toolbar-icon-background-colour: #f2f2f2; --pat-toolbar-i=
con-background-colour-hover: #ededed; }

@media only screen and (max-width: 769px) {
  :root { --pat-toolbar-auto-hide-offset: -15px; }
}

@media only screen and (min-width: 770px) {
  :root { --pat-toolbar-auto-hide-offset: -40px; }
}

.pat-toolbar { --pat-select-box-font-size: var(--pat-toolbar-font-size); --=
pat-select-box-background-colour: #f2f2f2; --pat-select-box-background-colo=
ur-hover: #ededed; --pat-select-box-padding-start: 18px; --pat-context-menu=
-panel-distance: 52px; position: relative; z-index: 11; padding: var(--pat-=
toolbar-padding); border-radius: 0px; font-size: 0px; user-select: none; }

@media only screen and (max-width: 769px) {
  .pat-toolbar { margin: calc(-1*var(--pat-toolbar-padding)) calc(-1*var(--=
pat-toolbar-padding)) 0; }
}

@media only screen and (min-width: 770px) {
  .pat-toolbar { height: var(--pat-toolbar-button-height); margin: 0 calc(-=
1*var(--pat-toolbar-padding)) var(--pat-toolbar-margin-bottom); }
}

.pat-toolbar::after { content: " "; display: table; clear: both; }

.pat-toolbar .toolbar-title { line-height: var(--pat-toolbar-button-line-he=
ight); margin: 0px; font-weight: normal; max-width: 100%; box-sizing: borde=
r-box; text-overflow: ellipsis; text-decoration: none; display: inline-bloc=
k; padding: 0px; color: rgb(0, 0, 0); font-size: calc(.7*var(--pat-toolbar-=
button-height)) !important; white-space: nowrap !important; }

.pat-toolbar .toolbar-title.auto-hide { opacity: 0; transition: 1s; }

.pat-toolbar .toolbar-title.select { overflow: hidden; color: rgba(0, 0, 0,=
 0.8); cursor: default; padding-right: 1.5em; background-repeat: no-repeat;=
 background-position: calc(100% - 10px) center; background-image: url("data=
:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgiPz4KP=
HN2ZyB2ZXJzaW9uPSIxLjEiIGlkPSJMYWFnXzEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8y=
MDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiIHg9IjB=
weCIgeT0iMHB4IgoJIHZpZXdCb3g9IjAgMCAxNC42IDguOCIgc3R5bGU9ImVuYWJsZS1iYWNrZ3=
JvdW5kOm5ldyAwIDAgMTQuNiA4Ljg7IiB4bWw6c3BhY2U9InByZXNlcnZlIj4KPHN0eWxlIHR5c=
GU9InRleHQvY3NzIj4KCS5zdDB7ZmlsbDpub25lO3N0cm9rZTojMDM2ODlCO3N0cm9rZS13aWR0=
aDozO3N0cm9rZS1saW5lY2FwOnJvdW5kO3N0cm9rZS1saW5lam9pbjpyb3VuZDtzdHJva2UtbWl=
0ZXJsaW1pdDoxMDt9Cjwvc3R5bGU+Cjxwb2x5bGluZSBjbGFzcz0ic3QwIiBwb2ludHM9IjEuNS=
wxLjUgNy4zLDcuMyAxMy4xLDEuNSAiLz4KPC9zdmc+"); background-size: auto 10px; }

@media print {
  .pat-toolbar .toolbar-title.select { background-image: none; }
}

.pat-toolbar .toolbar-title.select:hover { text-decoration: none; color: rg=
b(0, 0, 0); }

.pat-toolbar .toolbar-title .icon { height: calc(.6*var(--pat-toolbar-butto=
n-height)); width: auto; vertical-align: middle; }

.pat-toolbar .text-button { line-height: var(--pat-toolbar-button-line-heig=
ht); display: inline-block; cursor: default; border-radius: 0px; padding: 0=
px 1.26562rem; }

.pat-toolbar .text-button::before { margin-left: 0px; }

.pat-toolbar .text-button:hover { color: rgb(0, 0, 0); }

.pat-toolbar .text-button.tooltip-active-click { background-color: rgb(225,=
 112, 0); }

.pat-toolbar .text-button.tooltip-active-click::before { color: rgb(255, 25=
5, 255); }

.pat-toolbar:focus { outline: none; }

.pat-modal .pat-toolbar { margin-bottom: 15px; }

.pat-toolbar.inline { margin: 0px; padding: 0px; }

.pat-toolbar.pat-bumper { position: sticky; padding-top: var(--pat-toolbar-=
bump-distance); margin-top: calc(-1*var(--pat-toolbar-bump-distance)); top:=
 var(--pat-toolbar-top-distance); transition: top 0.4s; }

.scrolling-down .pat-toolbar.pat-bumper, .scroll-down .pat-toolbar.pat-bump=
er { top: var(--pat-toolbar-top-distance-scroll-down); padding-top: var(--p=
at-toolbar-bump-distance-scroll-down); }

.pat-toolbar.pat-bumper::before { position: absolute; left: calc(-0.5*var(-=
-pat-toolbar-padding)); right: calc(-0.5*var(--pat-toolbar-padding)); top: =
calc(var(--pat-toolbar-bump-distance) - 1.5*var(--pat-toolbar-padding)); bo=
ttom: calc(-0.5*var(--pat-toolbar-padding)); border-radius: 0px; transition=
: 1s; box-shadow: rgba(0, 0, 0, 0) 0px 0px 3px; content: " "; display: bloc=
k; background-color: rgba(255, 255, 255, 0.9); z-index: -1; }

.backdropfilter .pat-toolbar.pat-bumper::before { background-color: rgba(25=
5, 255, 255, 0.8); backdrop-filter: blur(10px) saturate(4) brightness(1.2);=
 }

.pat-toolbar.pat-bumper.bumped::before, .pat-toolbar.pat-bumper.tiptap-focu=
s::before { box-shadow: rgba(0, 0, 0, 0.15) 0px 0px 0px 1px; }

.pat-toolbar.pat-bumper.bumped .toolbar-title.auto-hide, .pat-toolbar.pat-b=
umper.tiptap-focus .toolbar-title.auto-hide { opacity: 1; }

.pat-toolbar.sticky { position: sticky; transition: 1s; top: var(--pat-tool=
bar-auto-hide-offset); }

.pat-toolbar.sticky.auto-hide { top: -150px; transition: 0.4s; }

.pat-toolbar.sticky.auto-hide.tiptap-focus { top: var(--pat-toolbar-auto-hi=
de-offset); }

@media screen and (min-height: 601px) {
  .scroll-up .pat-toolbar.sticky.auto-hide { top: var(--pat-toolbar-auto-hi=
de-offset); }
}

.pat-scroll-box:not(.scroll-position-top) .pat-toolbar.sticky, .pat-toolbar=
.sticky.tiptap-focus { box-shadow: rgba(0, 0, 0, 0.15) 0px 0px 0px 1px; bac=
kground-color: rgba(255, 255, 255, 0.8); backdrop-filter: blur(10px) satura=
te(4) brightness(1.2); }

.pat-toolbar .editor-toolbar { opacity: 0; transition: opacity 0.4s; pointe=
r-events: none; position: relative; z-index: 1; white-space: nowrap !import=
ant; }

.pat-toolbar .editor-toolbar.tiptap-focus { opacity: 1; pointer-events: ini=
tial; }

.pat-toolbar.tiptap-focus .editor-toolbar, .pat-toolbar.inline .editor-tool=
bar { opacity: 1; pointer-events: all; }

.pat-toolbar .toolbar-navigation-area, .pat-toolbar .toolbar-functions-area=
 { display: grid; grid-template-columns: 1fr 4fr 1fr; grid-template-areas: =
"left middle right"; gap: var(--pat-toolbar-element-separation); }

.pat-toolbar.type-document .toolbar-navigation-area, .pat-toolbar.type-docu=
ment .toolbar-functions-area { grid-template-columns: 1fr 0fr 4fr; grid-tem=
plate-areas: "left middle right"; }

@media only screen and (max-width: 769px) {
  .pat-toolbar .toolbar-functions-area { grid-template-columns: auto 0px au=
to; }
}

@media only screen and (min-width: 770px) {
  .pat-toolbar .toolbar-navigation-area { height: 0px; }
}

@media only screen and (max-width: 769px) {
  .pat-toolbar .toolbar-navigation-area { margin-bottom: 20px; grid-templat=
e-columns: 0px auto 0px; }
}

.pat-toolbar .toolbar-section { vertical-align: top; box-sizing: border-box=
; display: flex; justify-content: center; align-items: start; gap: var(--pa=
t-toolbar-element-separation); }

.pat-toolbar .toolbar-section:first-child { justify-content: flex-start; }

.pat-toolbar .toolbar-section:last-child { justify-content: flex-end; }

.pat-toolbar .toolbar-section > * { font-size: var(--pat-toolbar-font-size)=
; }

.pat-toolbar .toolbar-section * { white-space: normal; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls { box-shadow=
: none; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.view-=
month::before, .pat-toolbar .toolbar-section .pat-button-cluster.cal-contro=
ls button.view-week::before, .pat-toolbar .toolbar-section .pat-button-clus=
ter.cal-controls button.view-day::before, .pat-toolbar .toolbar-section .pa=
t-button-cluster.cal-controls button.view-listDay::before, .pat-toolbar .to=
olbar-section .pat-button-cluster.cal-controls button.view-listMonth::befor=
e { font-family: fontello; display: inline-block; margin-right: 5px; }

@media only screen and (max-width: 1279px) {
  .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.vie=
w-month, .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls but=
ton.view-week, .pat-toolbar .toolbar-section .pat-button-cluster.cal-contro=
ls button.view-day, .pat-toolbar .toolbar-section .pat-button-cluster.cal-c=
ontrols button.view-listDay, .pat-toolbar .toolbar-section .pat-button-clus=
ter.cal-controls button.view-listMonth { width: 40px; overflow: hidden; pad=
ding: 0px; color: rgba(0, 0, 0, 0); }
  .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.vie=
w-month::before, .pat-toolbar .toolbar-section .pat-button-cluster.cal-cont=
rols button.view-week::before, .pat-toolbar .toolbar-section .pat-button-cl=
uster.cal-controls button.view-day::before, .pat-toolbar .toolbar-section .=
pat-button-cluster.cal-controls button.view-listDay::before, .pat-toolbar .=
toolbar-section .pat-button-cluster.cal-controls button.view-listMonth::bef=
ore { width: 100%; text-align: center; }
}

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.view-=
month::before { content: ""; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.view-=
day::before { content: ""; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.view-=
week::before { content: ""; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.view-=
listDay::before, .pat-toolbar .toolbar-section .pat-button-cluster.cal-cont=
rols button.view-listMonth::before { content: ""; margin-right: 4px; }

@media only screen and (max-width: 769px) {
  .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jum=
p-today { width: 0.6em; color: rgba(0, 0, 0, 0); line-height: 1.4; }
  .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jum=
p-today::before { font-family: fontello; content: ""; text-align: center; c=
olor: rgb(0, 0, 0); font-size: 0.6em; }
}

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
prev, .pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button=
.jump-next { padding-left: 0px; padding-right: 0px; color: rgba(0, 0, 0, 0)=
; font-size: 0px; width: 32px; text-align: center; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
prev::before, .pat-toolbar .toolbar-section .pat-button-cluster.cal-control=
s button.jump-next::before { content: ""; font-family: fontello; font-size:=
 15px; display: block; margin: 0px; text-align: center; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
prev { text-align: left; }

body[dir=3D"rtl"] .pat-toolbar .toolbar-section .pat-button-cluster.cal-con=
trols button.jump-prev { text-align: right; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
prev::before { content: "=EE=A3=83"; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
next { text-align: right; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
next::before { content: "=EE=A3=84"; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
today { position: relative; width: 32px; padding-left: 0px; padding-right: =
0px; color: rgba(0, 0, 0, 0) !important; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
today::before { content: " "; display: block; border-radius: 50%; width: 8p=
x; height: 8px; background-color: rgb(0, 0, 0); position: absolute; top: 50=
%; left: 50%; transform: translate(-50%, -50%); }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
today::after { left: 0px; right: 0px; }

.pat-toolbar .toolbar-section .pat-button-cluster.cal-controls button.jump-=
today.active::before { background-color: rgb(255, 255, 255); }

.pat-toolbar .toolbar-section.view-options { grid-area: left; min-width: 0p=
x; }

@media only screen and (max-width: 769px) {
  .pat-toolbar .toolbar-section.view-options { float: left; width: auto; ma=
rgin-bottom: 15px; }
}

.pat-toolbar .toolbar-section.quick-functions { grid-area: right; }

.pat-toolbar .toolbar-section.quick-functions > .icon, .pat-toolbar .toolba=
r-section.quick-functions > .pat-subform .icon, .pat-toolbar .toolbar-secti=
on.quick-functions > .pat-button, .pat-toolbar .toolbar-section.quick-funct=
ions > .context-menu > .pat-button, .pat-toolbar .toolbar-section.quick-fun=
ctions > .pat-context-menu > .pat-button { margin: 0px; position: relative;=
 }

.pat-toolbar .toolbar-section.quick-functions .save-button { --pat-context-=
menu-panel-width: 450px; }

.pat-toolbar .toolbar-section.navigation { grid-area: middle; justify-conte=
nt: center; }

@media only screen and (max-width: 769px) {
  .pat-toolbar .toolbar-section.navigation .pat-tabs { z-index: 2; }
}

.pat-toolbar .toolbar-section.navigation .pat-select { margin: 0px; box-sha=
dow: rgba(0, 0, 0, 0.15) 0px 1px 6px inset; }

@media print {
  .pat-toolbar { display: none; }
}

.pat-toolbar .toolbar-section > label.pat-checklist { margin-left: 1em; }

.pat-toolbar .toolbar-section > label.pat-checklist::before { top: calc(.5*=
var(--pat-toolbar-button-height)); }

.pat-toolbar .toolbar-section > label.pat-checklist:hover { color: rgb(0, 0=
, 0); }

.pat-toolbar .pat-context-menu { display: inline-block; vertical-align: top=
; }

.pat-toolbar .pat-context-menu:hover.no-label::before { color: rgb(1, 104, =
155); text-decoration: none; background-color: rgb(237, 237, 237); }

.pat-toolbar .pat-context-menu .context-menu-label { height: var(--pat-tool=
bar-button-height); }

.pat-toolbar .pat-context-menu.open .label.default { color: rgb(255, 255, 2=
55); }

.pat-toolbar .pat-context-menu.no-label::before { background-color: rgb(242=
, 242, 242); color: rgb(1, 104, 155); border-radius: 0px; }

.pat-toolbar .pat-context-menu.no-label.open::before, .pat-toolbar .pat-con=
text-menu.no-label.closed.in-progress::before { background-color: var(--col=
our-accent); color: rgb(255, 255, 255); }

.pat-toolbar > .pat-select, .pat-toolbar .toolbar-section > .pat-select, .p=
at-toolbar .pat-context-menu:not(.no-label) > .context-menu-label, .pat-too=
lbar > input[type=3D"search"], .pat-toolbar .toolbar-section label.pat-chec=
klist { display: inline-block; vertical-align: top; height: var(--pat-toolb=
ar-button-height); line-height: var(--pat-toolbar-button-line-height); font=
-size: var(--pat-toolbar-font-size); }

.pat-toolbar > .pat-select.bare::before, .pat-toolbar .toolbar-section > .p=
at-select.bare::before, .pat-toolbar .pat-context-menu:not(.no-label) > .co=
ntext-menu-label.bare::before, .pat-toolbar > input[type=3D"search"].bare::=
before, .pat-toolbar .toolbar-section label.pat-checklist.bare::before { he=
ight: var(--pat-toolbar-button-height); line-height: var(--pat-toolbar-butt=
on-line-height); }

.pat-toolbar > .pat-select select, .pat-toolbar .toolbar-section > .pat-sel=
ect select, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-l=
abel select, .pat-toolbar > input[type=3D"search"] select, .pat-toolbar .to=
olbar-section label.pat-checklist select { line-height: var(--pat-toolbar-b=
utton-line-height); font-size: var(--pat-toolbar-font-size); height: var(--=
pat-toolbar-button-height); padding-top: 0px; padding-bottom: 0px; }

.pat-toolbar > .pat-select:not(.bare), .pat-toolbar .toolbar-section > .pat=
-select:not(.bare), .pat-toolbar .pat-context-menu:not(.no-label) > .contex=
t-menu-label, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.ba=
re) { --pat-select-box-padding-top-bottom: 0; --pat-select-box-box-shadow: =
none; --pat-select-box-background-color: #f2f2f2; --pat-select-box-arrow-te=
xt-colour: #01689b; --pat-select-box-height: var(--pat-toolbar-button-line-=
height); --pat-select-box-padding-right-left: 20px; display: inline-block; =
padding-top: var(--pat-select-box-padding-top-bottom); padding-bottom: var(=
--pat-select-box-padding-top-bottom); padding-left: var(--pat-select-box-pa=
dding-start); padding-right: calc(var(--pat-select-box-arrow-width) + var(-=
-pat-select-box-padding-start)/2); position: relative; box-sizing: border-b=
ox; border: var(--pat-form-input-field-border); border-radius: var(--pat-fo=
rm-input-field-border-radius); box-shadow: var(--pat-select-box-box-shadow)=
; outline: var(--pat-form-input-field-outline); outline-offset: var(--pat-f=
orm-input-field-outline-offset); color: var(--pat-select-box-arrow-text-col=
our); font-size: var(--pat-select-box-font-size); max-width: 100%; backgrou=
nd-color: var(--pat-select-box-background-colour); text-overflow: ellipsis;=
 cursor: default; line-height: var(--pat-toolbar-button-line-height); white=
-space: nowrap; overflow: hidden; height: var(--pat-toolbar-button-line-hei=
ght); font-weight: normal !important; text-decoration: none !important; }

.pat-toolbar > .pat-select:not(.bare):hover, .pat-toolbar .toolbar-section =
> .pat-select:not(.bare):hover, .pat-toolbar .pat-context-menu:not(.no-labe=
l) > .context-menu-label:hover, .pat-toolbar .toolbar-section > .extras > .=
pat-select:not(.bare):hover { background-color: var(--pat-select-box-backgr=
ound-colour-hover); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"], .pat-toolbar >=
 .pat-select:not(.bare).state-draft, .pat-toolbar .toolbar-section > .pat-s=
elect:not(.bare)[data-value=3D"draft"], .pat-toolbar .toolbar-section > .pa=
t-select:not(.bare).state-draft, .pat-toolbar .pat-context-menu:not(.no-lab=
el) > .context-menu-label[data-value=3D"draft"], .pat-toolbar .pat-context-=
menu:not(.no-label) > .context-menu-label.state-draft, .pat-toolbar .toolba=
r-section > .extras > .pat-select:not(.bare)[data-value=3D"draft"], .pat-to=
olbar .toolbar-section > .extras > .pat-select:not(.bare).state-draft { bac=
kground-color: rgb(251, 234, 217); color: rgb(123, 61, 0); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"]::after, .pat-to=
olbar > .pat-select:not(.bare).state-draft::after, .pat-toolbar .toolbar-se=
ction > .pat-select:not(.bare)[data-value=3D"draft"]::after, .pat-toolbar .=
toolbar-section > .pat-select:not(.bare).state-draft::after, .pat-toolbar .=
pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"draft"]=
::after, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-labe=
l.state-draft::after, .pat-toolbar .toolbar-section > .extras > .pat-select=
:not(.bare)[data-value=3D"draft"]::after, .pat-toolbar .toolbar-section > .=
extras > .pat-select:not(.bare).state-draft::after { background-color: rgb(=
246, 212, 178); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"]::before, .pat-t=
oolbar > .pat-select:not(.bare)[data-value=3D"draft"]::after, .pat-toolbar =
> .pat-select:not(.bare).state-draft::before, .pat-toolbar > .pat-select:no=
t(.bare).state-draft::after, .pat-toolbar .toolbar-section > .pat-select:no=
t(.bare)[data-value=3D"draft"]::before, .pat-toolbar .toolbar-section > .pa=
t-select:not(.bare)[data-value=3D"draft"]::after, .pat-toolbar .toolbar-sec=
tion > .pat-select:not(.bare).state-draft::before, .pat-toolbar .toolbar-se=
ction > .pat-select:not(.bare).state-draft::after, .pat-toolbar .pat-contex=
t-menu:not(.no-label) > .context-menu-label[data-value=3D"draft"]::before, =
.pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data-va=
lue=3D"draft"]::after, .pat-toolbar .pat-context-menu:not(.no-label) > .con=
text-menu-label.state-draft::before, .pat-toolbar .pat-context-menu:not(.no=
-label) > .context-menu-label.state-draft::after, .pat-toolbar .toolbar-sec=
tion > .extras > .pat-select:not(.bare)[data-value=3D"draft"]::before, .pat=
-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"=
draft"]::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.=
bare).state-draft::before, .pat-toolbar .toolbar-section > .extras > .pat-s=
elect:not(.bare).state-draft::after { color: rgb(123, 61, 0); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"]:hover, .pat-too=
lbar > .pat-select:not(.bare)[data-value=3D"draft"].tooltip-active-click, .=
pat-toolbar > .pat-select:not(.bare).state-draft:hover, .pat-toolbar > .pat=
-select:not(.bare).state-draft.tooltip-active-click, .pat-toolbar .toolbar-=
section > .pat-select:not(.bare)[data-value=3D"draft"]:hover, .pat-toolbar =
.toolbar-section > .pat-select:not(.bare)[data-value=3D"draft"].tooltip-act=
ive-click, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-dra=
ft:hover, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-draf=
t.tooltip-active-click, .pat-toolbar .pat-context-menu:not(.no-label) > .co=
ntext-menu-label[data-value=3D"draft"]:hover, .pat-toolbar .pat-context-men=
u:not(.no-label) > .context-menu-label[data-value=3D"draft"].tooltip-active=
-click, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label=
.state-draft:hover, .pat-toolbar .pat-context-menu:not(.no-label) > .contex=
t-menu-label.state-draft.tooltip-active-click, .pat-toolbar .toolbar-sectio=
n > .extras > .pat-select:not(.bare)[data-value=3D"draft"]:hover, .pat-tool=
bar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"draft=
"].tooltip-active-click, .pat-toolbar .toolbar-section > .extras > .pat-sel=
ect:not(.bare).state-draft:hover, .pat-toolbar .toolbar-section > .extras >=
 .pat-select:not(.bare).state-draft.tooltip-active-click { background-color=
: rgb(249, 221, 194); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"]:hover::after, .=
pat-toolbar > .pat-select:not(.bare)[data-value=3D"draft"].tooltip-active-c=
lick::after, .pat-toolbar > .pat-select:not(.bare).state-draft:hover::after=
, .pat-toolbar > .pat-select:not(.bare).state-draft.tooltip-active-click::a=
fter, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"=
draft"]:hover::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare=
)[data-value=3D"draft"].tooltip-active-click::after, .pat-toolbar .toolbar-=
section > .pat-select:not(.bare).state-draft:hover::after, .pat-toolbar .to=
olbar-section > .pat-select:not(.bare).state-draft.tooltip-active-click::af=
ter, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[da=
ta-value=3D"draft"]:hover::after, .pat-toolbar .pat-context-menu:not(.no-la=
bel) > .context-menu-label[data-value=3D"draft"].tooltip-active-click::afte=
r, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.stat=
e-draft:hover::after, .pat-toolbar .pat-context-menu:not(.no-label) > .cont=
ext-menu-label.state-draft.tooltip-active-click::after, .pat-toolbar .toolb=
ar-section > .extras > .pat-select:not(.bare)[data-value=3D"draft"]:hover::=
after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[dat=
a-value=3D"draft"].tooltip-active-click::after, .pat-toolbar .toolbar-secti=
on > .extras > .pat-select:not(.bare).state-draft:hover::after, .pat-toolba=
r .toolbar-section > .extras > .pat-select:not(.bare).state-draft.tooltip-a=
ctive-click::after { background-color: rgb(243, 199, 155); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"], .pat-tool=
bar > .pat-select:not(.bare).state-for-review, .pat-toolbar .toolbar-sectio=
n > .pat-select:not(.bare)[data-value=3D"for-review"], .pat-toolbar .toolba=
r-section > .pat-select:not(.bare).state-for-review, .pat-toolbar .pat-cont=
ext-menu:not(.no-label) > .context-menu-label[data-value=3D"for-review"], .=
pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state-fo=
r-review, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[=
data-value=3D"for-review"], .pat-toolbar .toolbar-section > .extras > .pat-=
select:not(.bare).state-for-review { background-color: rgb(242, 217, 231); =
color: rgb(169, 0, 97); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"]::after, .p=
at-toolbar > .pat-select:not(.bare).state-for-review::after, .pat-toolbar .=
toolbar-section > .pat-select:not(.bare)[data-value=3D"for-review"]::after,=
 .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-for-review::a=
fter, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[d=
ata-value=3D"for-review"]::after, .pat-toolbar .pat-context-menu:not(.no-la=
bel) > .context-menu-label.state-for-review::after, .pat-toolbar .toolbar-s=
ection > .extras > .pat-select:not(.bare)[data-value=3D"for-review"]::after=
, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare).state-fo=
r-review::after { background-color: rgb(229, 179, 208); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"]::before, .=
pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"]::after, .pa=
t-toolbar > .pat-select:not(.bare).state-for-review::before, .pat-toolbar >=
 .pat-select:not(.bare).state-for-review::after, .pat-toolbar .toolbar-sect=
ion > .pat-select:not(.bare)[data-value=3D"for-review"]::before, .pat-toolb=
ar .toolbar-section > .pat-select:not(.bare)[data-value=3D"for-review"]::af=
ter, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-for-revie=
w::before, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-for=
-review::after, .pat-toolbar .pat-context-menu:not(.no-label) > .context-me=
nu-label[data-value=3D"for-review"]::before, .pat-toolbar .pat-context-menu=
:not(.no-label) > .context-menu-label[data-value=3D"for-review"]::after, .p=
at-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state-for=
-review::before, .pat-toolbar .pat-context-menu:not(.no-label) > .context-m=
enu-label.state-for-review::after, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare)[data-value=3D"for-review"]::before, .pat-toolbar .=
toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"for-review=
"]::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)=
.state-for-review::before, .pat-toolbar .toolbar-section > .extras > .pat-s=
elect:not(.bare).state-for-review::after { color: rgb(93, 0, 53); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"]:hover, .pa=
t-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"].tooltip-activ=
e-click, .pat-toolbar > .pat-select:not(.bare).state-for-review:hover, .pat=
-toolbar > .pat-select:not(.bare).state-for-review.tooltip-active-click, .p=
at-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"for-revi=
ew"]:hover, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-val=
ue=3D"for-review"].tooltip-active-click, .pat-toolbar .toolbar-section > .p=
at-select:not(.bare).state-for-review:hover, .pat-toolbar .toolbar-section =
> .pat-select:not(.bare).state-for-review.tooltip-active-click, .pat-toolba=
r .pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"for-=
review"]:hover, .pat-toolbar .pat-context-menu:not(.no-label) > .context-me=
nu-label[data-value=3D"for-review"].tooltip-active-click, .pat-toolbar .pat=
-context-menu:not(.no-label) > .context-menu-label.state-for-review:hover, =
.pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state-f=
or-review.tooltip-active-click, .pat-toolbar .toolbar-section > .extras > .=
pat-select:not(.bare)[data-value=3D"for-review"]:hover, .pat-toolbar .toolb=
ar-section > .extras > .pat-select:not(.bare)[data-value=3D"for-review"].to=
oltip-active-click, .pat-toolbar .toolbar-section > .extras > .pat-select:n=
ot(.bare).state-for-review:hover, .pat-toolbar .toolbar-section > .extras >=
 .pat-select:not(.bare).state-for-review.tooltip-active-click { background-=
color: rgb(236, 198, 219); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"]:hover::aft=
er, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"for-review"].toolti=
p-active-click::after, .pat-toolbar > .pat-select:not(.bare).state-for-revi=
ew:hover::after, .pat-toolbar > .pat-select:not(.bare).state-for-review.too=
ltip-active-click::after, .pat-toolbar .toolbar-section > .pat-select:not(.=
bare)[data-value=3D"for-review"]:hover::after, .pat-toolbar .toolbar-sectio=
n > .pat-select:not(.bare)[data-value=3D"for-review"].tooltip-active-click:=
:after, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-for-re=
view:hover::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare).s=
tate-for-review.tooltip-active-click::after, .pat-toolbar .pat-context-menu=
:not(.no-label) > .context-menu-label[data-value=3D"for-review"]:hover::aft=
er, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[dat=
a-value=3D"for-review"].tooltip-active-click::after, .pat-toolbar .pat-cont=
ext-menu:not(.no-label) > .context-menu-label.state-for-review:hover::after=
, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state=
-for-review.tooltip-active-click::after, .pat-toolbar .toolbar-section > .e=
xtras > .pat-select:not(.bare)[data-value=3D"for-review"]:hover::after, .pa=
t-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D=
"for-review"].tooltip-active-click::after, .pat-toolbar .toolbar-section > =
.extras > .pat-select:not(.bare).state-for-review:hover::after, .pat-toolba=
r .toolbar-section > .extras > .pat-select:not(.bare).state-for-review.tool=
tip-active-click::after { background-color: rgb(223, 160, 196); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"], .pat-toolba=
r > .pat-select:not(.bare).state-approved, .pat-toolbar .toolbar-section > =
.pat-select:not(.bare)[data-value=3D"approved"], .pat-toolbar .toolbar-sect=
ion > .pat-select:not(.bare).state-approved, .pat-toolbar .pat-context-menu=
:not(.no-label) > .context-menu-label[data-value=3D"approved"], .pat-toolba=
r .pat-context-menu:not(.no-label) > .context-menu-label.state-approved, .p=
at-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=
=3D"approved"], .pat-toolbar .toolbar-section > .extras > .pat-select:not(.=
bare).state-approved { background-color: rgb(225, 237, 219); color: rgb(43,=
 103, 9); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat=
-toolbar > .pat-select:not(.bare).state-approved::after, .pat-toolbar .tool=
bar-section > .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat-=
toolbar .toolbar-section > .pat-select:not(.bare).state-approved::after, .p=
at-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data-valu=
e=3D"approved"]::after, .pat-toolbar .pat-context-menu:not(.no-label) > .co=
ntext-menu-label.state-approved::after, .pat-toolbar .toolbar-section > .ex=
tras > .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat-toolbar=
 .toolbar-section > .extras > .pat-select:not(.bare).state-approved::after =
{ background-color: rgb(196, 219, 182); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"]::before, .pa=
t-toolbar > .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat-to=
olbar > .pat-select:not(.bare).state-approved::before, .pat-toolbar > .pat-=
select:not(.bare).state-approved::after, .pat-toolbar .toolbar-section > .p=
at-select:not(.bare)[data-value=3D"approved"]::before, .pat-toolbar .toolba=
r-section > .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat-to=
olbar .toolbar-section > .pat-select:not(.bare).state-approved::before, .pa=
t-toolbar .toolbar-section > .pat-select:not(.bare).state-approved::after, =
.pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data-va=
lue=3D"approved"]::before, .pat-toolbar .pat-context-menu:not(.no-label) > =
.context-menu-label[data-value=3D"approved"]::after, .pat-toolbar .pat-cont=
ext-menu:not(.no-label) > .context-menu-label.state-approved::before, .pat-=
toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state-approv=
ed::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)=
[data-value=3D"approved"]::before, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare)[data-value=3D"approved"]::after, .pat-toolbar .too=
lbar-section > .extras > .pat-select:not(.bare).state-approved::before, .pa=
t-toolbar .toolbar-section > .extras > .pat-select:not(.bare).state-approve=
d::after { color: rgb(27, 65, 6); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"]:hover, .pat-=
toolbar > .pat-select:not(.bare)[data-value=3D"approved"].tooltip-active-cl=
ick, .pat-toolbar > .pat-select:not(.bare).state-approved:hover, .pat-toolb=
ar > .pat-select:not(.bare).state-approved.tooltip-active-click, .pat-toolb=
ar .toolbar-section > .pat-select:not(.bare)[data-value=3D"approved"]:hover=
, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"appr=
oved"].tooltip-active-click, .pat-toolbar .toolbar-section > .pat-select:no=
t(.bare).state-approved:hover, .pat-toolbar .toolbar-section > .pat-select:=
not(.bare).state-approved.tooltip-active-click, .pat-toolbar .pat-context-m=
enu:not(.no-label) > .context-menu-label[data-value=3D"approved"]:hover, .p=
at-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data-valu=
e=3D"approved"].tooltip-active-click, .pat-toolbar .pat-context-menu:not(.n=
o-label) > .context-menu-label.state-approved:hover, .pat-toolbar .pat-cont=
ext-menu:not(.no-label) > .context-menu-label.state-approved.tooltip-active=
-click, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[da=
ta-value=3D"approved"]:hover, .pat-toolbar .toolbar-section > .extras > .pa=
t-select:not(.bare)[data-value=3D"approved"].tooltip-active-click, .pat-too=
lbar .toolbar-section > .extras > .pat-select:not(.bare).state-approved:hov=
er, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare).state-=
approved.tooltip-active-click { background-color: rgb(211, 229, 202); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"]:hover::after=
, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"approved"].tooltip-ac=
tive-click::after, .pat-toolbar > .pat-select:not(.bare).state-approved:hov=
er::after, .pat-toolbar > .pat-select:not(.bare).state-approved.tooltip-act=
ive-click::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[da=
ta-value=3D"approved"]:hover::after, .pat-toolbar .toolbar-section > .pat-s=
elect:not(.bare)[data-value=3D"approved"].tooltip-active-click::after, .pat=
-toolbar .toolbar-section > .pat-select:not(.bare).state-approved:hover::af=
ter, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-approved.=
tooltip-active-click::after, .pat-toolbar .pat-context-menu:not(.no-label) =
> .context-menu-label[data-value=3D"approved"]:hover::after, .pat-toolbar .=
pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"approve=
d"].tooltip-active-click::after, .pat-toolbar .pat-context-menu:not(.no-lab=
el) > .context-menu-label.state-approved:hover::after, .pat-toolbar .pat-co=
ntext-menu:not(.no-label) > .context-menu-label.state-approved.tooltip-acti=
ve-click::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(=
.bare)[data-value=3D"approved"]:hover::after, .pat-toolbar .toolbar-section=
 > .extras > .pat-select:not(.bare)[data-value=3D"approved"].tooltip-active=
-click::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.b=
are).state-approved:hover::after, .pat-toolbar .toolbar-section > .extras >=
 .pat-select:not(.bare).state-approved.tooltip-active-click::after { backgr=
ound-color: rgb(182, 211, 165); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"], .pat-toolb=
ar > .pat-select:not(.bare)[data-value=3D"sent"], .pat-toolbar > .pat-selec=
t:not(.bare).state-published, .pat-toolbar > .pat-select:not(.bare).state-s=
ent, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"p=
ublished"], .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-val=
ue=3D"sent"], .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-=
published, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-sen=
t, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data=
-value=3D"published"], .pat-toolbar .pat-context-menu:not(.no-label) > .con=
text-menu-label[data-value=3D"sent"], .pat-toolbar .pat-context-menu:not(.n=
o-label) > .context-menu-label.state-published, .pat-toolbar .pat-context-m=
enu:not(.no-label) > .context-menu-label.state-sent, .pat-toolbar .toolbar-=
section > .extras > .pat-select:not(.bare)[data-value=3D"published"], .pat-=
toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"s=
ent"], .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare).sta=
te-published, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.ba=
re).state-sent { background-color: rgb(229, 240, 249); color: rgb(1, 53, 79=
); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"]::after, .pa=
t-toolbar > .pat-select:not(.bare)[data-value=3D"sent"]::after, .pat-toolba=
r > .pat-select:not(.bare).state-published::after, .pat-toolbar > .pat-sele=
ct:not(.bare).state-sent::after, .pat-toolbar .toolbar-section > .pat-selec=
t:not(.bare)[data-value=3D"published"]::after, .pat-toolbar .toolbar-sectio=
n > .pat-select:not(.bare)[data-value=3D"sent"]::after, .pat-toolbar .toolb=
ar-section > .pat-select:not(.bare).state-published::after, .pat-toolbar .t=
oolbar-section > .pat-select:not(.bare).state-sent::after, .pat-toolbar .pa=
t-context-menu:not(.no-label) > .context-menu-label[data-value=3D"published=
"]::after, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-la=
bel[data-value=3D"sent"]::after, .pat-toolbar .pat-context-menu:not(.no-lab=
el) > .context-menu-label.state-published::after, .pat-toolbar .pat-context=
-menu:not(.no-label) > .context-menu-label.state-sent::after, .pat-toolbar =
.toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"published=
"]::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)=
[data-value=3D"sent"]::after, .pat-toolbar .toolbar-section > .extras > .pa=
t-select:not(.bare).state-published::after, .pat-toolbar .toolbar-section >=
 .extras > .pat-select:not(.bare).state-sent::after { background-color: rgb=
(204, 224, 241); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"]::before, .p=
at-toolbar > .pat-select:not(.bare)[data-value=3D"published"]::after, .pat-=
toolbar > .pat-select:not(.bare)[data-value=3D"sent"]::before, .pat-toolbar=
 > .pat-select:not(.bare)[data-value=3D"sent"]::after, .pat-toolbar > .pat-=
select:not(.bare).state-published::before, .pat-toolbar > .pat-select:not(.=
bare).state-published::after, .pat-toolbar > .pat-select:not(.bare).state-s=
ent::before, .pat-toolbar > .pat-select:not(.bare).state-sent::after, .pat-=
toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"published"]=
::before, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=
=3D"published"]::after, .pat-toolbar .toolbar-section > .pat-select:not(.ba=
re)[data-value=3D"sent"]::before, .pat-toolbar .toolbar-section > .pat-sele=
ct:not(.bare)[data-value=3D"sent"]::after, .pat-toolbar .toolbar-section > =
.pat-select:not(.bare).state-published::before, .pat-toolbar .toolbar-secti=
on > .pat-select:not(.bare).state-published::after, .pat-toolbar .toolbar-s=
ection > .pat-select:not(.bare).state-sent::before, .pat-toolbar .toolbar-s=
ection > .pat-select:not(.bare).state-sent::after, .pat-toolbar .pat-contex=
t-menu:not(.no-label) > .context-menu-label[data-value=3D"published"]::befo=
re, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[dat=
a-value=3D"published"]::after, .pat-toolbar .pat-context-menu:not(.no-label=
) > .context-menu-label[data-value=3D"sent"]::before, .pat-toolbar .pat-con=
text-menu:not(.no-label) > .context-menu-label[data-value=3D"sent"]::after,=
 .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-label.state-=
published::before, .pat-toolbar .pat-context-menu:not(.no-label) > .context=
-menu-label.state-published::after, .pat-toolbar .pat-context-menu:not(.no-=
label) > .context-menu-label.state-sent::before, .pat-toolbar .pat-context-=
menu:not(.no-label) > .context-menu-label.state-sent::after, .pat-toolbar .=
toolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"published"=
]::before, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)=
[data-value=3D"published"]::after, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare)[data-value=3D"sent"]::before, .pat-toolbar .toolba=
r-section > .extras > .pat-select:not(.bare)[data-value=3D"sent"]::after, .=
pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare).state-publi=
shed::before, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.ba=
re).state-published::after, .pat-toolbar .toolbar-section > .extras > .pat-=
select:not(.bare).state-sent::before, .pat-toolbar .toolbar-section > .extr=
as > .pat-select:not(.bare).state-sent::after { color: rgb(1, 53, 79); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"]:hover, .pat=
-toolbar > .pat-select:not(.bare)[data-value=3D"published"].tooltip-active-=
click, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"sent"]:hover, .p=
at-toolbar > .pat-select:not(.bare)[data-value=3D"sent"].tooltip-active-cli=
ck, .pat-toolbar > .pat-select:not(.bare).state-published:hover, .pat-toolb=
ar > .pat-select:not(.bare).state-published.tooltip-active-click, .pat-tool=
bar > .pat-select:not(.bare).state-sent:hover, .pat-toolbar > .pat-select:n=
ot(.bare).state-sent.tooltip-active-click, .pat-toolbar .toolbar-section > =
.pat-select:not(.bare)[data-value=3D"published"]:hover, .pat-toolbar .toolb=
ar-section > .pat-select:not(.bare)[data-value=3D"published"].tooltip-activ=
e-click, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=
=3D"sent"]:hover, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[da=
ta-value=3D"sent"].tooltip-active-click, .pat-toolbar .toolbar-section > .p=
at-select:not(.bare).state-published:hover, .pat-toolbar .toolbar-section >=
 .pat-select:not(.bare).state-published.tooltip-active-click, .pat-toolbar =
.toolbar-section > .pat-select:not(.bare).state-sent:hover, .pat-toolbar .t=
oolbar-section > .pat-select:not(.bare).state-sent.tooltip-active-click, .p=
at-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[data-valu=
e=3D"published"]:hover, .pat-toolbar .pat-context-menu:not(.no-label) > .co=
ntext-menu-label[data-value=3D"published"].tooltip-active-click, .pat-toolb=
ar .pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"sen=
t"]:hover, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-la=
bel[data-value=3D"sent"].tooltip-active-click, .pat-toolbar .pat-context-me=
nu:not(.no-label) > .context-menu-label.state-published:hover, .pat-toolbar=
 .pat-context-menu:not(.no-label) > .context-menu-label.state-published.too=
ltip-active-click, .pat-toolbar .pat-context-menu:not(.no-label) > .context=
-menu-label.state-sent:hover, .pat-toolbar .pat-context-menu:not(.no-label)=
 > .context-menu-label.state-sent.tooltip-active-click, .pat-toolbar .toolb=
ar-section > .extras > .pat-select:not(.bare)[data-value=3D"published"]:hov=
er, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-v=
alue=3D"published"].tooltip-active-click, .pat-toolbar .toolbar-section > .=
extras > .pat-select:not(.bare)[data-value=3D"sent"]:hover, .pat-toolbar .t=
oolbar-section > .extras > .pat-select:not(.bare)[data-value=3D"sent"].tool=
tip-active-click, .pat-toolbar .toolbar-section > .extras > .pat-select:not=
(.bare).state-published:hover, .pat-toolbar .toolbar-section > .extras > .p=
at-select:not(.bare).state-published.tooltip-active-click, .pat-toolbar .to=
olbar-section > .extras > .pat-select:not(.bare).state-sent:hover, .pat-too=
lbar .toolbar-section > .extras > .pat-select:not(.bare).state-sent.tooltip=
-active-click { background-color: rgb(208, 228, 244); }

.pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"]:hover::afte=
r, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"published"].tooltip-=
active-click::after, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"se=
nt"]:hover::after, .pat-toolbar > .pat-select:not(.bare)[data-value=3D"sent=
"].tooltip-active-click::after, .pat-toolbar > .pat-select:not(.bare).state=
-published:hover::after, .pat-toolbar > .pat-select:not(.bare).state-publis=
hed.tooltip-active-click::after, .pat-toolbar > .pat-select:not(.bare).stat=
e-sent:hover::after, .pat-toolbar > .pat-select:not(.bare).state-sent.toolt=
ip-active-click::after, .pat-toolbar .toolbar-section > .pat-select:not(.ba=
re)[data-value=3D"published"]:hover::after, .pat-toolbar .toolbar-section >=
 .pat-select:not(.bare)[data-value=3D"published"].tooltip-active-click::aft=
er, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[data-value=3D"se=
nt"]:hover::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare)[d=
ata-value=3D"sent"].tooltip-active-click::after, .pat-toolbar .toolbar-sect=
ion > .pat-select:not(.bare).state-published:hover::after, .pat-toolbar .to=
olbar-section > .pat-select:not(.bare).state-published.tooltip-active-click=
::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-sent:=
hover::after, .pat-toolbar .toolbar-section > .pat-select:not(.bare).state-=
sent.tooltip-active-click::after, .pat-toolbar .pat-context-menu:not(.no-la=
bel) > .context-menu-label[data-value=3D"published"]:hover::after, .pat-too=
lbar .pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"p=
ublished"].tooltip-active-click::after, .pat-toolbar .pat-context-menu:not(=
.no-label) > .context-menu-label[data-value=3D"sent"]:hover::after, .pat-to=
olbar .pat-context-menu:not(.no-label) > .context-menu-label[data-value=3D"=
sent"].tooltip-active-click::after, .pat-toolbar .pat-context-menu:not(.no-=
label) > .context-menu-label.state-published:hover::after, .pat-toolbar .pa=
t-context-menu:not(.no-label) > .context-menu-label.state-published.tooltip=
-active-click::after, .pat-toolbar .pat-context-menu:not(.no-label) > .cont=
ext-menu-label.state-sent:hover::after, .pat-toolbar .pat-context-menu:not(=
.no-label) > .context-menu-label.state-sent.tooltip-active-click::after, .p=
at-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=
=3D"published"]:hover::after, .pat-toolbar .toolbar-section > .extras > .pa=
t-select:not(.bare)[data-value=3D"published"].tooltip-active-click::after, =
.pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare)[data-value=
=3D"sent"]:hover::after, .pat-toolbar .toolbar-section > .extras > .pat-sel=
ect:not(.bare)[data-value=3D"sent"].tooltip-active-click::after, .pat-toolb=
ar .toolbar-section > .extras > .pat-select:not(.bare).state-published:hove=
r::after, .pat-toolbar .toolbar-section > .extras > .pat-select:not(.bare).=
state-published.tooltip-active-click::after, .pat-toolbar .toolbar-section =
> .extras > .pat-select:not(.bare).state-sent:hover::after, .pat-toolbar .t=
oolbar-section > .extras > .pat-select:not(.bare).state-sent.tooltip-active=
-click::after { background-color: rgb(184, 212, 236); }

.pat-toolbar > .pat-select:not(.bare).locked::before, .pat-toolbar .toolbar=
-section > .pat-select:not(.bare).locked::before, .pat-toolbar .pat-context=
-menu:not(.no-label) > .context-menu-label.locked::before, .pat-toolbar .to=
olbar-section > .extras > .pat-select:not(.bare).locked::before { font-fami=
ly: fontello; content: "=EE=A0=AE"; display: inline-block; margin-right: 5p=
x; float: left; font-size: inherit; }

.pat-toolbar > .pat-select:not(.bare):not([class*=3D"icon-"])::before, .pat=
-toolbar .toolbar-section > .pat-select:not(.bare):not([class*=3D"icon-"]):=
:before, .pat-toolbar .pat-context-menu:not(.no-label) > .context-menu-labe=
l:not([class*=3D"icon-"])::before, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare):not([class*=3D"icon-"])::before { font-size: var(-=
-pat-select-box-font-size); content: attr(data-option); white-space: nowrap=
; overflow: hidden; text-overflow: ellipsis; display: block; }

.pat-toolbar > .pat-select:not(.bare)[class*=3D"icon-"]::before, .pat-toolb=
ar .toolbar-section > .pat-select:not(.bare)[class*=3D"icon-"]::before, .pa=
t-toolbar .pat-context-menu:not(.no-label) > .context-menu-label[class*=3D"=
icon-"]::before, .pat-toolbar .toolbar-section > .extras > .pat-select:not(=
.bare)[class*=3D"icon-"]::before { margin-left: -5px; margin-right: 8px; }

.pat-toolbar > .pat-select:not(.bare) select, .pat-toolbar .toolbar-section=
 > .pat-select:not(.bare) select, .pat-toolbar .pat-context-menu:not(.no-la=
bel) > .context-menu-label select, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare) select { position: absolute; inset: 0px; opacity: =
0; margin: 0px; z-index: 1; height: 100% !important; width: 100% !important=
; }

.pat-toolbar > .pat-select:not(.bare) select option, .pat-toolbar .toolbar-=
section > .pat-select:not(.bare) select option, .pat-toolbar .pat-context-m=
enu:not(.no-label) > .context-menu-label select option, .pat-toolbar .toolb=
ar-section > .extras > .pat-select:not(.bare) select option { font-size: in=
itial; color: rgb(0, 0, 0); }

.pat-toolbar > .pat-select:not(.bare)::after, .pat-toolbar .toolbar-section=
 > .pat-select:not(.bare)::after, .pat-toolbar .pat-context-menu:not(.no-la=
bel) > .context-menu-label::after, .pat-toolbar .toolbar-section > .extras =
> .pat-select:not(.bare)::after { font-family: fontello; content: "=EE=A3=
=87"; width: var(--pat-select-box-arrow-width); background-color: var(--pat=
-select-box-arrow-background-colour); background-image: none; position: abs=
olute; top: 0px; right: 0px; bottom: 0px; font-size: var(--pat-select-box-a=
rrow-size); border-top-right-radius: var(--pat-form-fields-border-radius); =
border-bottom-right-radius: var(--pat-form-fields-border-radius); padding: =
0px; display: flex; align-items: center; justify-content: center; }

.pat-toolbar > .pat-select:not(.bare) option:disabled, .pat-toolbar .toolba=
r-section > .pat-select:not(.bare) option:disabled, .pat-toolbar .pat-conte=
xt-menu:not(.no-label) > .context-menu-label option:disabled, .pat-toolbar =
.toolbar-section > .extras > .pat-select:not(.bare) option:disabled { color=
: silver; }

.pat-toolbar .pat-button, .pat-toolbar .icon { display: inline-block; verti=
cal-align: top; line-height: var(--pat-toolbar-button-line-height); border:=
 none; float: none; white-space: nowrap; font-size: var(--pat-toolbar-font-=
size); }

.pat-toolbar .pat-button.meta-data-toggle, .pat-toolbar .icon.meta-data-tog=
gle { transition: transform 0.3s; }

.more-metadata .pat-toolbar .pat-button.meta-data-toggle, .more-metadata .p=
at-toolbar .icon.meta-data-toggle { transform: scaleY(-1); }

@media only screen and (max-width: 769px) {
  .pat-toolbar .pat-button, .pat-toolbar .icon { margin: 0px; }
}

.pat-toolbar .pat-button:active, .pat-toolbar .icon:active { box-shadow: rg=
ba(0, 0, 0, 0.15) 0px 1px 3px inset; }

.pat-toolbar .pat-button:focus, .pat-toolbar .icon:focus { outline: var(--p=
at-form-input-field-outline-focus); outline-offset: var(--pat-form-input-fi=
eld-outline-offset); }

.pat-toolbar .pat-button:hover, .pat-toolbar .icon:hover { text-decoration:=
 none; }

.pat-toolbar .pat-button.locked { position: relative; padding-right: 3em; }

.pat-toolbar .pat-button.locked::after { display: block; font-family: fonte=
llo; content: "=EE=A0=AE"; position: absolute; right: 0px; top: 0px; bottom=
: 0px; height: 100%; width: 2em; text-align: center; background: rgb(225, 1=
12, 0); color: rgb(255, 255, 255); line-height: var(--pat-toolbar-button-he=
ight); }

.pat-toolbar .pat-button.locked.active::after { content: "=EE=A0=AF"; }

.pat-toolbar .pat-progress-bar { margin-top: 9px; width: 540px; float: left=
; }

.pat-toolbar .toolbar-section .icon { font-family: fontello; text-indent: -=
1000em; width: var(--pat-toolbar-button-height); height: var(--pat-toolbar-=
button-height); position: relative; cursor: default; line-height: var(--pat=
-toolbar-button-line-height); border-radius: 0px; display: inline-block; te=
xt-align: left; background-color: var(--pat-toolbar-icon-background-colour)=
; color: rgb(1, 104, 155); }

body[dir=3D"rtl"] .pat-toolbar .toolbar-section .icon { text-align: right; =
}

.pat-toolbar .toolbar-section .icon:not(.active):not(.current):not([disable=
d]):not(.default):hover { color: rgb(1, 104, 155); background-color: var(--=
pat-toolbar-icon-background-colour-hover); }

.pat-toolbar .toolbar-section .icon.progress .pie-graph { position: absolut=
e; top: 50%; left: 50%; transform: translate(-50%, -50%); }

.pat-toolbar .toolbar-section .icon.progress.pat-tooltip.tooltip-active-cli=
ck { background-color: var(--colour-accent); }

.pat-toolbar .toolbar-section .icon.progress.pat-tooltip.tooltip-active-cli=
ck .pie-graph { border-color: rgb(255, 255, 255); }

.pat-toolbar .toolbar-section .icon::before { font-family: fontello; text-i=
ndent: 0px; line-height: var(--pat-toolbar-button-line-height)1px; text-ali=
gn: center; position: absolute; margin: 0px; top: 0px; left: 0px; width: 10=
0%; height: 100%; display: inline-block; border-radius: 0px; box-sizing: bo=
rder-box; }

.pat-toolbar .toolbar-section .icon:not(.active):not(.icon):not([disabled])=
:not(.default):hover { color: rgb(1, 104, 155); text-decoration: none; back=
ground-color: rgb(237, 237, 237); }

.pat-toolbar .toolbar-section .icon:not(.active):not(.icon):not([disabled])=
:not(.default):hover::before { color: rgb(1, 104, 155); }

.pat-toolbar .toolbar-section .icon.active { color: var(--colour-accent); b=
ox-shadow: none; }

.pat-toolbar .toolbar-section .icon.active::before { color: var(--colour-ac=
cent); }

.pat-toolbar .toolbar-section .icon.warning { color: rgb(225, 112, 0); box-=
shadow: none; }

.pat-toolbar .toolbar-section .icon.warning::before { color: rgb(225, 112, =
0); }

.pat-toolbar .toolbar-section .icon.pat-tooltip.tooltip-active-click::befor=
e, .pat-toolbar .toolbar-section .icon.collapsible-open::before { backgroun=
d-color: var(--colour-accent); color: rgb(255, 255, 255); }

.pat-toolbar .toolbar-section .icon.create::before, .pat-toolbar .toolbar-s=
ection .icon.new::before { content: "=EE=A3=A4"; font-size: 1.3em; }

.pat-toolbar .toolbar-section .icon.settings::before { content: "=EE=A3=98"=
; }

.pat-toolbar .toolbar-section .icon.resize-full::before { content: "=EE=A0=
=9B"; }

.pat-toolbar .toolbar-section .icon.back::before { content: "=EE=A1=84"; }

.pat-toolbar .toolbar-section .icon.back + .toolbar-title { padding-left: 0=
px; }

.pat-toolbar .toolbar-section .icon.expand-all-sections::before, .pat-toolb=
ar .toolbar-section .icon.collapse-all-sections::before { font-family: font=
ello; content: "=EE=A2=84"; transform: rotate(90deg); }

.pat-toolbar .toolbar-section .icon.collapse-all-sections::before { transfo=
rm: rotate(-90deg); }

.pat-toolbar .toolbar-section .icon.level-up::before { font-family: fontell=
o; content: "=EF=85=88"; transform: scaleX(-1); }

.pat-toolbar .toolbar-section .icon.level-up + .toolbar-title { padding-lef=
t: 0px; }

.pat-toolbar .toolbar-section .icon.edit::before { content: "=EE=A0=B3"; }

.pat-toolbar .toolbar-section .icon.preview::before { content: "=EE=A3=97";=
 }

.pat-toolbar .toolbar-section .icon.settings::before { content: "=EE=A3=98"=
; }

.pat-toolbar .toolbar-section .icon.modify::before { content: "=EE=A0=98"; =
}

.pat-toolbar .toolbar-section .icon.more::before { content: "=EE=A2=9E"; }

.pat-toolbar .toolbar-section .icon.upload::before { content: "=EE=A0=88"; =
}

.pat-toolbar .toolbar-section .icon.download::before { content: "=EE=A0=8F"=
; }

.pat-toolbar .toolbar-section .icon.card-view::before { content: "=EE=A0=BD=
"; }

.pat-toolbar .toolbar-section .icon.list-view::before { content: "=EE=A0=BE=
"; }

.pat-toolbar .toolbar-section .icon.language::before { content: "=EE=A3=AA"=
; }

.pat-toolbar .toolbar-section .icon.menu::before { content: "=EE=A0=AA"; }

.pat-toolbar .toolbar-section .icon.search::before { content: "=EE=A0=BD"; =
}

.pat-toolbar .toolbar-section .icon.metadata::before { content: "=EE=A2=8C"=
; }

.pat-toolbar .toolbar-section .icon.select::before { content: "=EE=A4=92"; =
}

#product-space.mode-select .pat-toolbar .toolbar-section .icon.select { bac=
kground-color: rgb(225, 112, 0); }

#product-space.mode-select .pat-toolbar .toolbar-section .icon.select::befo=
re { color: rgb(255, 255, 255); }

.pat-toolbar .pat-toolbar-local-search-box { width: var(--pat-toolbar-butto=
n-height); margin: 0px; display: inline-block; padding: 0px; }

.pat-toolbar .pat-toolbar-local-search-box .spotlight-sentinel { overflow: =
hidden; width: var(--pat-toolbar-button-height); padding-top: calc(var(--pa=
t-toolbar-button-height) + 16px); padding-right: 10px; padding-bottom: 6px;=
 padding-left: 10px; float: right; margin: -52px -10px; transition: 0.5s; b=
ox-shadow: rgba(0, 0, 0, 0) 0px 0px 10px; }

.pat-toolbar .pat-toolbar-local-search-box .spotlight-sentinel .instance-co=
unter { margin-top: calc(-1*var(--pat-toolbar-button-height)); transition: =
0.5s; opacity: 0; }

.pat-toolbar .pat-toolbar-local-search-box .spotlight-sentinel .instance-co=
unter a:hover { text-decoration: underline; }

@media only screen and (min-width: 770px) {
  .pat-toolbar .pat-toolbar-local-search-box .spotlight-sentinel .instance-=
counter { width: 350px; }
}

@media only screen and (max-width: 769px) {
  .pat-toolbar .pat-toolbar-local-search-box .spotlight-sentinel .instance-=
counter { width: calc(-40px + 100vw); }
}

.pat-toolbar .pat-toolbar-local-search-box.focus .instance-counter, .pat-to=
olbar .pat-toolbar-local-search-box.has-value .instance-counter, .pat-toolb=
ar .pat-toolbar-local-search-box.fixed .instance-counter { margin-top: 0px;=
 opacity: 1; }

.pat-toolbar .pat-toolbar-local-search-box.focus .spotlight-sentinel, .pat-=
toolbar .pat-toolbar-local-search-box.has-value .spotlight-sentinel, .pat-t=
oolbar .pat-toolbar-local-search-box.fixed .spotlight-sentinel { background=
-color: rgb(255, 255, 255); box-shadow: rgba(0, 0, 0, 0.2) 0px 0px 10px; }

@media only screen and (min-width: 770px) {
  .pat-toolbar .pat-toolbar-local-search-box.focus .spotlight-sentinel, .pa=
t-toolbar .pat-toolbar-local-search-box.has-value .spotlight-sentinel, .pat=
-toolbar .pat-toolbar-local-search-box.fixed .spotlight-sentinel { width: 3=
50px; }
}

@media only screen and (max-width: 769px) {
  .pat-toolbar .pat-toolbar-local-search-box.focus .spotlight-sentinel, .pa=
t-toolbar .pat-toolbar-local-search-box.has-value .spotlight-sentinel, .pat=
-toolbar .pat-toolbar-local-search-box.fixed .spotlight-sentinel { width: c=
alc(-40px + 100vw); }
}

.pat-toolbar .pat-toolbar-search-field { width: var(--pat-toolbar-button-he=
ight); height: var(--pat-toolbar-button-height); position: relative; displa=
y: inline-block; z-index: 10; vertical-align: top; font-size: var(--pat-too=
lbar-font-size); background-color: rgb(242, 242, 242); border-radius: 0px; =
}

.pat-toolbar .pat-toolbar-search-field::after { position: absolute; top: 0p=
x; left: 0px; line-height: var(--pat-toolbar-button-line-height); width: va=
r(--pat-toolbar-button-height); text-align: center; font-family: fontello; =
content: "=EE=A2=B4"; font-size: var(--pat-toolbar-font-size); transition: =
left 0.5s, padding-left 0.5s, transform 1s; color: rgb(1, 104, 155); }

.pat-toolbar .pat-toolbar-search-field:hover { background-color: rgb(237, 2=
37, 237); }

.pat-toolbar .pat-toolbar-search-field:hover::after { color: rgb(1, 104, 15=
5); }

.pat-toolbar .pat-toolbar-search-field input { width: var(--pat-toolbar-but=
ton-height); height: var(--pat-toolbar-button-height); border-radius: 0px; =
background: rgb(255, 255, 255); border: 1px solid silver; max-width: 1000px=
; position: absolute; top: 0px; right: 0px; transition: 0.5s; opacity: 0; p=
adding-left: 34px; margin: 0px; }

.pat-toolbar .pat-toolbar-search-field input:focus { outline: none; box-sha=
dow: none; }

.pat-toolbar .pat-toolbar-search-field.focus input, .pat-toolbar .pat-toolb=
ar-search-field.has-value input, .pat-toolbar .pat-toolbar-search-field.fix=
ed input { opacity: 1; }

@media only screen and (min-width: 770px) {
  .pat-toolbar .pat-toolbar-search-field.focus input, .pat-toolbar .pat-too=
lbar-search-field.has-value input, .pat-toolbar .pat-toolbar-search-field.f=
ixed input { width: var(--pat-toolbar-search-field-width-open); }
}

@media only screen and (max-width: 769px) {
  .pat-toolbar .pat-toolbar-search-field.focus input, .pat-toolbar .pat-too=
lbar-search-field.has-value input, .pat-toolbar .pat-toolbar-search-field.f=
ixed input { width: calc(-40px + 100vw); }
}

.pat-toolbar .pat-toolbar-search-field.focus::after, .pat-toolbar .pat-tool=
bar-search-field.has-value::after, .pat-toolbar .pat-toolbar-search-field.f=
ixed::after { color: gray; }

@media only screen and (min-width: 770px) {
  .pat-toolbar .pat-toolbar-search-field.focus::after, .pat-toolbar .pat-to=
olbar-search-field.has-value::after, .pat-toolbar .pat-toolbar-search-field=
.fixed::after { left: calc(-1*var(--pat-toolbar-search-field-width-open)); =
padding-left: var(--pat-toolbar-button-height); }
}

@media only screen and (max-width: 769px) {
  .pat-toolbar .pat-toolbar-search-field.focus::after, .pat-toolbar .pat-to=
olbar-search-field.has-value::after, .pat-toolbar .pat-toolbar-search-field=
.fixed::after { left: calc(-1*(100vw - var(--pat-toolbar-button-height))); =
padding-left: var(--pat-toolbar-button-height); }
}

.pat-toolbar .pat-toolbar-search-field.fixed { width: 258px; }

.pat-toolbar .pat-toolbar-search-field.fixed::after { left: -123px; }

.pat-toggle-switch { display: inline-block; font-size: calc(.6*var(--pat-to=
ggle-height)); height: var(--pat-toggle-height); background-color: var(--pa=
t-toggle-background-colour-off); border-radius: var(--pat-toggle-switch-bor=
der-radius); transition: 0.3s; justify-self: start; position: relative; box=
-sizing: border-box; padding: 0 calc(var(--pat-toggle-height) - 1*var(--pat=
-toggle-toggle-distance) + .5*var(--pat-toggle-padding-start-end)) 0 var(--=
pat-toggle-padding-start-end); line-height: var(--pat-toggle-height); color=
: rgba(0, 0, 0, 0); box-shadow: var(--pat-toggle-box-shadow); user-select: =
none; }

.pat-toggle-switch:has(:focus) { outline: var(--pat-form-input-field-outlin=
e-focus); outline-offset: var(--pat-form-input-field-outline-offset); }

.pat-toggle-switch input { position: absolute; opacity: 0; }

.pat-toggle-switch::after { content: ""; display: inline-block; position: a=
bsolute; left: var(--pat-toggle-toggle-distance); width: calc(var(--pat-tog=
gle-height) - var(--pat-toggle-toggle-distance)*2); height: calc(var(--pat-=
toggle-height) - var(--pat-toggle-toggle-distance)*2); border-radius: var(-=
-pat-toggle-toggle-border-radius); transition: 0.2s; background-color: var(=
--pat-toggle-toggle-background-colour); top: 50%; transform: translateY(-50=
%); }

.pat-toggle-switch:has(input:checked) { background-color: var(--pat-toggle-=
background-colour-on); color: var(--pat-toggle-text-colour); box-shadow: va=
r(--pat-toggle-box-shadow-on); text-shadow: var(--pat-toggle-text-shadow-on=
); }

.pat-toggle-switch:has(input:checked)::after { left: calc(100% - (var(--pat=
-toggle-height) - var(--pat-toggle-toggle-distance))); background-color: va=
r(--pat-toggle-toggle-background-colour-on); }

textarea.pat-tiptap { opacity: 0; }

.ProseMirror-gapcursor { position: relative; display: block !important; }

.ProseMirror-gapcursor::after { content: " "; display: block; position: abs=
olute; top: -2px; width: 20px; border-top: 1px solid rgb(0, 0, 0); }

.tiptap-container { animation: 0.4s ease 0s 1 normal none running fadeIn; }

.tiptap-container .ProseMirror { outline: none; cursor: text; }

.tiptap-container .ProseMirror > p:first-child[data-placeholder]::before { =
content: attr(data-placeholder); color: rgba(0, 0, 0, 0.4); float: right; w=
idth: 100%; }

.tiptap-container .ProseMirror-separator + .ProseMirror-trailingBreak, .tip=
tap-container .ProseMirror-separator { display: none !important; }

.tiptap-container .collaboration-cursor__caret { border-left: 1px solid rgb=
(13, 13, 13); border-right: 1px solid rgb(13, 13, 13); margin-left: -1px; m=
argin-right: -1px; pointer-events: none; position: relative; word-break: no=
rmal; }

.tiptap-container .collaboration-cursor__label { border-radius: 3px 3px 3px=
 0px; color: rgb(13, 13, 13); font-size: 12px; font-style: normal; font-wei=
ght: 600; left: -1px; line-height: normal; padding: 0.1rem 0.3rem; position=
: absolute; top: -1.4em; user-select: none; white-space: nowrap; }

.tippy-box[data-animation=3D"fade"][data-state=3D"hidden"] { opacity: 0; }

[data-tippy-root] { max-width: calc(-10px + 100vw); }

.tippy-box { position: relative; background-color: rgb(51, 51, 51); color: =
rgb(255, 255, 255); border-radius: 4px; font-size: 14px; line-height: 1.4; =
outline: 0px; transition-property: transform, visibility, opacity; }

.tippy-box[data-placement^=3D"top"] > .tippy-arrow { bottom: 0px; }

.tippy-box[data-placement^=3D"top"] > .tippy-arrow::before { bottom: -7px; =
left: 0px; border-width: 8px 8px 0px; border-top-color: initial; transform-=
origin: center top; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-arrow { top: 0px; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-arrow::before { top: -7px; =
left: 0px; border-width: 0px 8px 8px; border-bottom-color: initial; transfo=
rm-origin: center bottom; }

.tippy-box[data-placement^=3D"left"] > .tippy-arrow { right: 0px; }

.tippy-box[data-placement^=3D"left"] > .tippy-arrow::before { border-width:=
 8px 0px 8px 8px; border-left-color: initial; right: -7px; transform-origin=
: left center; }

.tippy-box[data-placement^=3D"right"] > .tippy-arrow { left: 0px; }

.tippy-box[data-placement^=3D"right"] > .tippy-arrow::before { left: -7px; =
border-width: 8px 8px 8px 0px; border-right-color: initial; transform-origi=
n: right center; }

.tippy-box[data-inertia][data-state=3D"visible"] { transition-timing-functi=
on: cubic-bezier(0.54, 1.5, 0.38, 1.11); }

.tippy-arrow { width: 16px; height: 16px; color: rgb(51, 51, 51); }

.tippy-arrow::before { content: ""; position: absolute; border-color: rgba(=
0, 0, 0, 0); border-style: solid; }

.tippy-content { position: relative; padding: 5px 9px; z-index: 1; }

:root { --pat-tooltip-box-shadow: 0 4px 14px -2px $transparent-light; }

.tippy-box { background-color: rgb(255, 255, 255); background-clip: padding=
-box; border: 1px solid rgba(0, 8, 16, 0.15); box-shadow: var(--pat-tooltip=
-box-shadow); color: rgb(0, 0, 0); font-size: 1.26562rem; border-radius: 0p=
x; }

.tippy-box > .tippy-backdrop { background-color: rgb(255, 255, 255); }

.tippy-box > .tippy-arrow::after, .tippy-box > .tippy-svg-arrow::after { co=
ntent: ""; position: absolute; z-index: -1; }

.tippy-box .tippy-content { padding: 14px; max-height: calc(-100px + 100vh)=
; overflow: auto; }

.tippy-box .tippy-arrow { width: 22px; height: 22px; }

.tippy-box > .tippy-arrow::after { border-color: rgba(0, 0, 0, 0); border-s=
tyle: solid; }

.tippy-box[data-placement^=3D"top"] > .tippy-arrow::before { border-top-col=
or: rgb(255, 255, 255); }

.tippy-box[data-placement^=3D"top"] > .tippy-arrow::after { border-top-colo=
r: rgba(0, 8, 16, 0.2); border-width: 8px 8px 0px; top: 22px; left: 0px; }

.tippy-box[data-placement^=3D"top"] > .tippy-svg-arrow > svg { top: 8px; }

.tippy-box[data-placement^=3D"top"] > .tippy-svg-arrow::after { top: 9px; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-arrow::before { border-bott=
om-color: rgb(255, 255, 255); bottom: 22px; left: 3px; border-width: 0px 8p=
x 8px; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-arrow::after { border-botto=
m-color: rgba(0, 8, 16, 0.2); border-width: 0px 8px 8px; bottom: 23px; left=
: 3px; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-svg-arrow > svg { bottom: 2=
2px; }

.tippy-box[data-placement^=3D"bottom"] > .tippy-svg-arrow::after { bottom: =
23px; }

.tippy-box[data-placement^=3D"left"] > .tippy-arrow::before { border-left-c=
olor: rgb(255, 255, 255); }

.tippy-box[data-placement^=3D"left"] > .tippy-arrow::after { border-left-co=
lor: rgba(0, 8, 16, 0.2); border-width: 8px 0px 8px 8px; left: 22px; top: 0=
px; }

.tippy-box[data-placement^=3D"left"] > .tippy-svg-arrow > svg { left: 11px;=
 }

.tippy-box[data-placement^=3D"left"] > .tippy-svg-arrow::after { left: 12px=
; }

.tippy-box[data-placement^=3D"right"] > .tippy-arrow::before { border-right=
-color: rgb(255, 255, 255); right: 22px; top: 3px; }

.tippy-box[data-placement^=3D"right"] > .tippy-arrow::after { border-width:=
 8px 8px 8px 0px; right: 23px; top: 3px; border-right-color: rgba(0, 8, 16,=
 0.2); }

.tippy-box[data-placement^=3D"right"] > .tippy-svg-arrow > svg { right: 11p=
x; }

.tippy-box[data-placement^=3D"right"] > .tippy-svg-arrow::after { right: 12=
px; }

.tippy-box > .tippy-svg-arrow { fill: rgb(255, 255, 255); }

.tippy-box > .tippy-svg-arrow::after { background-image: url("data:image/sv=
g+xml;base64,PHN2ZyB3aWR0aD0iMTYiIGhlaWdodD0iNiIgeG1sbnM9Imh0dHA6Ly93d3cudz=
Mub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNMCA2czEuNzk2LS4wMTMgNC42Ny0zLjYxNUM1Ljg1M=
S45IDYuOTMuMDA2IDggMGMxLjA3LS4wMDYgMi4xNDguODg3IDMuMzQzIDIuMzg1QzE0LjIzMyA2=
LjAwNSAxNiA2IDE2IDZIMHoiIGZpbGw9InJnYmEoMCwgOCwgMTYsIDAuMikiIC8+PC9zdmc+");=
 background-size: 8px 6px; width: 8px; height: 6px; }

.tooltip-container { overflow: visible; font-size: 1rem; padding: 0px; user=
-select: none; }

@media print {
  .tooltip-container { display: none !important; }
}

.tooltip-container .tippy-content { min-width: 250px; border-radius: 0px; }

.tooltip-container .tippy-content > :last-child { margin-bottom: 0px; }

.tooltip-container ul.menu { margin: 0px 0px 1em; list-style-type: none; --=
pat-checklist-label-padding-start: var(--pat-menu-list-item-padding-start);=
 --pat-checklist-label-padding-end: 0.2em; --pat-checklist-item-separation:=
 0; --pat-checklist-checkbox-size: 16px; }

.tooltip-container ul.menu li { padding-left: 0px; --pat-checklist-margin-b=
ottom: 0; }

.tooltip-container ul.menu li > a, .tooltip-container ul.menu li > label, .=
tooltip-container ul.menu li > form > label, .tooltip-container ul.menu li =
> form > button, .tooltip-container ul.menu li > form > fieldset > label, .=
tooltip-container ul.menu li > fieldset.pat-checklist label, .tooltip-conta=
iner ul.menu li > button { padding: 0.3em 0px; color: rgb(0, 0, 0); line-he=
ight: 24px; cursor: default; overflow: hidden; border: none; width: 100%; b=
ackground: none; box-sizing: border-box; font-size: 1.26562rem; display: gr=
id; grid-template-columns: var(--pat-menu-list-item-padding-start) auto; bo=
rder-radius: var(--border-radii); user-select: none; }

.tooltip-container ul.menu li > a::before, .tooltip-container ul.menu li > =
label::before, .tooltip-container ul.menu li > form > label::before, .toolt=
ip-container ul.menu li > form > button::before, .tooltip-container ul.menu=
 li > form > fieldset > label::before, .tooltip-container ul.menu li > fiel=
dset.pat-checklist label::before, .tooltip-container ul.menu li > button::b=
efore { font-family: fontello; align-self: start; display: block; margin-ri=
ght: 0px; line-height: inherit; justify-self: center !important; }

.tooltip-container ul.menu li > a:has(input[type=3D"checkbox"])::before, .t=
ooltip-container ul.menu li > label:has(input[type=3D"checkbox"])::before, =
.tooltip-container ul.menu li > form > label:has(input[type=3D"checkbox"]):=
:before, .tooltip-container ul.menu li > form > button:has(input[type=3D"ch=
eckbox"])::before, .tooltip-container ul.menu li > form > fieldset > label:=
has(input[type=3D"checkbox"])::before, .tooltip-container ul.menu li > fiel=
dset.pat-checklist label:has(input[type=3D"checkbox"])::before, .tooltip-co=
ntainer ul.menu li > button:has(input[type=3D"checkbox"])::before { line-he=
ight: var(--pat-checklist-checkbox-size); }

.tooltip-container ul.menu li > a:has(input[type=3D"file"]), .tooltip-conta=
iner ul.menu li > label:has(input[type=3D"file"]), .tooltip-container ul.me=
nu li > form > label:has(input[type=3D"file"]), .tooltip-container ul.menu =
li > form > button:has(input[type=3D"file"]), .tooltip-container ul.menu li=
 > form > fieldset > label:has(input[type=3D"file"]), .tooltip-container ul=
.menu li > fieldset.pat-checklist label:has(input[type=3D"file"]), .tooltip=
-container ul.menu li > button:has(input[type=3D"file"]) { position: relati=
ve; }

.tooltip-container ul.menu li > a:hover, .tooltip-container ul.menu li > la=
bel:hover, .tooltip-container ul.menu li > form > label:hover, .tooltip-con=
tainer ul.menu li > form > button:hover, .tooltip-container ul.menu li > fo=
rm > fieldset > label:hover, .tooltip-container ul.menu li > fieldset.pat-c=
hecklist label:hover, .tooltip-container ul.menu li > button:hover { text-d=
ecoration: none; background: rgba(0, 0, 0, 0.05); color: rgb(0, 0, 0); }

.tooltip-container ul.menu li > a.tooltip-active-click, .tooltip-container =
ul.menu li > a:active, .tooltip-container ul.menu li > label.tooltip-active=
-click, .tooltip-container ul.menu li > label:active, .tooltip-container ul=
.menu li > form > label.tooltip-active-click, .tooltip-container ul.menu li=
 > form > label:active, .tooltip-container ul.menu li > form > button.toolt=
ip-active-click, .tooltip-container ul.menu li > form > button:active, .too=
ltip-container ul.menu li > form > fieldset > label.tooltip-active-click, .=
tooltip-container ul.menu li > form > fieldset > label:active, .tooltip-con=
tainer ul.menu li > fieldset.pat-checklist label.tooltip-active-click, .too=
ltip-container ul.menu li > fieldset.pat-checklist label:active, .tooltip-c=
ontainer ul.menu li > button.tooltip-active-click, .tooltip-container ul.me=
nu li > button:active { background-color: rgb(225, 112, 0); color: rgb(255,=
 255, 255); }

.tooltip-container ul.menu li > a .pat-message, .tooltip-container ul.menu =
li > label .pat-message, .tooltip-container ul.menu li > form > label .pat-=
message, .tooltip-container ul.menu li > form > button .pat-message, .toolt=
ip-container ul.menu li > form > fieldset > label .pat-message, .tooltip-co=
ntainer ul.menu li > fieldset.pat-checklist label .pat-message, .tooltip-co=
ntainer ul.menu li > button .pat-message { display: block; margin-top: 0.4e=
m; margin-bottom: 0.5em; padding: 0.3em 0.5em; }

.tooltip-container ul.menu li > a input[type=3D"file"], .tooltip-container =
ul.menu li > label input[type=3D"file"], .tooltip-container ul.menu li > fo=
rm > label input[type=3D"file"], .tooltip-container ul.menu li > form > but=
ton input[type=3D"file"], .tooltip-container ul.menu li > form > fieldset >=
 label input[type=3D"file"], .tooltip-container ul.menu li > fieldset.pat-c=
hecklist label input[type=3D"file"], .tooltip-container ul.menu li > button=
 input[type=3D"file"] { opacity: 0; position: absolute; left: 0px; top: 0px=
; height: 1.8em; width: 100%; }

.tooltip-container ul.menu li > a:not([class*=3D"icon-"]):not([class*=3D"ch=
ecked"])::before, .tooltip-container ul.menu li > label:not([class*=3D"icon=
-"]):not([class*=3D"checked"])::before, .tooltip-container ul.menu li > for=
m > label:not([class*=3D"icon-"]):not([class*=3D"checked"])::before, .toolt=
ip-container ul.menu li > form > button:not([class*=3D"icon-"]):not([class*=
=3D"checked"])::before, .tooltip-container ul.menu li > form > fieldset > l=
abel:not([class*=3D"icon-"]):not([class*=3D"checked"])::before, .tooltip-co=
ntainer ul.menu li > fieldset.pat-checklist label:not([class*=3D"icon-"]):n=
ot([class*=3D"checked"])::before, .tooltip-container ul.menu li > button:no=
t([class*=3D"icon-"]):not([class*=3D"checked"])::before { font-family: font=
ello; content: "=EE=A2=84"; }

.tooltip-container ul.menu li > a.current, .tooltip-container ul.menu li > =
label.current, .tooltip-container ul.menu li > form > label.current, .toolt=
ip-container ul.menu li > form > button.current, .tooltip-container ul.menu=
 li > form > fieldset > label.current, .tooltip-container ul.menu li > fiel=
dset.pat-checklist label.current, .tooltip-container ul.menu li > button.cu=
rrent { color: rgb(225, 112, 0); }

.tooltip-container ul.menu li > a.current a, .tooltip-container ul.menu li =
> label.current a, .tooltip-container ul.menu li > form > label.current a, =
.tooltip-container ul.menu li > form > button.current a, .tooltip-container=
 ul.menu li > form > fieldset > label.current a, .tooltip-container ul.menu=
 li > fieldset.pat-checklist label.current a, .tooltip-container ul.menu li=
 > button.current a { color: rgb(225, 112, 0); cursor: default; }

.tooltip-container.label .tippy-content { text-align: center; min-width: 0p=
x; padding: 6px 10px; }

.tooltip-container .tippy-content { background-color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"bottom"] .tippy-arrow { border-botto=
m-color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"bottom"] .tippy-arrow::before { bord=
er-bottom-color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"left"] .tippy-arrow { border-left-co=
lor: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"left"] .tippy-arrow::before { border=
-left-color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"right"] .tippy-arrow { border-right-=
color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"right"] .tippy-arrow::before { borde=
r-right-color: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"top"] .tippy-arrow { border-top-colo=
r: rgb(255, 255, 255); }

.tooltip-container [data-placement^=3D"top"] .tippy-arrow::before { border-=
top-color: rgb(255, 255, 255); }

.tooltip-container.info .tippy-content { background-color: rgb(253, 246, 18=
7); hyphens: auto; padding: 18px; }

.tooltip-container.info .tippy-content .pat-button.read-more { clear: both;=
 margin-top: 14px; margin-bottom: -5px; }

.tooltip-container.info [data-placement^=3D"bottom"] .tippy-arrow { border-=
bottom-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"bottom"] .tippy-arrow::before {=
 border-bottom-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"left"] .tippy-arrow { border-le=
ft-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"left"] .tippy-arrow::before { b=
order-left-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"right"] .tippy-arrow { border-r=
ight-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"right"] .tippy-arrow::before { =
border-right-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"top"] .tippy-arrow { border-top=
-color: rgb(253, 246, 187); }

.tooltip-container.info [data-placement^=3D"top"] .tippy-arrow::before { bo=
rder-top-color: rgb(253, 246, 187); }

.tooltip-container.rich { user-select: auto; }

.tooltip-container.rich .tippy-content::after { content: " "; display: tabl=
e; clear: both; }

.tooltip-container.rich .tippy-content h1, .tooltip-container.rich .tippy-c=
ontent h2, .tooltip-container.rich .tippy-content p, .tooltip-container.ric=
h .tippy-content ul, .tooltip-container.rich .tippy-content ol, .tooltip-co=
ntainer.rich .tippy-content table, .tooltip-container.rich .tippy-content d=
l, .tooltip-container.rich .tippy-content pre { margin-bottom: 1em; }

.tooltip-container.rich .tippy-content a { text-decoration: underline; }

.tooltip-container.rich .tippy-content ul, .tooltip-container.rich .tippy-c=
ontent ol { counter-reset: oli 0; }

.tooltip-container.rich .tippy-content ul li, .tooltip-container.rich .tipp=
y-content ol li { margin-left: 0px; padding-left: 1.5em; }

.tooltip-container.rich .tippy-content ul li::before, .tooltip-container.ri=
ch .tippy-content ol li::before { content: "=E2=80=A2"; float: left; margin=
-left: -1.4em; }

.tooltip-container.rich .tippy-content ul li[class^=3D"icon-"]::before, .to=
oltip-container.rich .tippy-content ul li[class*=3D" icon-"]::before, .tool=
tip-container.rich .tippy-content ol li[class^=3D"icon-"]::before, .tooltip=
-container.rich .tippy-content ol li[class*=3D" icon-"]::before { line-heig=
ht: inherit; margin-left: -1.5em; }

.tooltip-container.rich .tippy-content ol li { counter-increment: oli 1; }

.tooltip-container.rich .tippy-content ol li::before { content: counter(oli=
) "."; }

.tooltip-container.rich .tippy-content h1 { font-weight: 600; font-size: 2e=
m; line-height: 130%; margin-bottom: 0.7em; letter-spacing: 0.05em; }

.tooltip-container.rich .tippy-content h2 { font-size: 1.5em; line-height: =
130%; font-weight: 400; margin-bottom: 0.7em; letter-spacing: 0.05em; }

.tooltip-container.rich .tippy-content h3 { font-size: 1em; letter-spacing:=
 0.05em; font-weight: bold; margin-bottom: 1em; }

.tooltip-container.rich .tippy-content img, .tooltip-container.rich .tippy-=
content video { max-width: 100%; margin: 0px auto; display: block; }

.tooltip-container.rich .tippy-content img.float-before, .tooltip-container=
.rich .tippy-content video.float-before { margin-right: 1em; float: left; t=
op: 0.2em; position: relative; }

.tooltip-container.rich .tippy-content img.float-after, .tooltip-container.=
rich .tippy-content video.float-after { margin-left: 1em; float: right; top=
: 0.2em; position: relative; }

@media only screen and (min-width: 1280px) {
  .tooltip-container.rich .tippy-content img.medium, .tooltip-container.ric=
h .tippy-content video.medium { width: 33%; }
}

.tooltip-container.rich .tippy-content figure { margin-bottom: 2em; }

.tooltip-container.rich .tippy-content figure figcaption { font-style: ital=
ic; font-size: 0.7em; line-height: 1.3em; color: rgba(0, 0, 0, 0.3); border=
-bottom: 1px dotted rgba(0, 0, 0, 0.3); padding: 0.4em 0.7em; }

.tooltip-container.rich .tippy-content p, .tooltip-container.rich .tippy-co=
ntent h1, .tooltip-container.rich .tippy-content h2, .tooltip-container.ric=
h .tippy-content h3, .tooltip-container.rich .tippy-content ul, .tooltip-co=
ntainer.rich .tippy-content ol, .tooltip-container.rich .tippy-content tabl=
e { margin-bottom: 0.5em; }

.tooltip-container.rich .tippy-content > :not(.footer):last-child { margin-=
bottom: 0px; }

.tooltip-container .tooltip-separation-header { color: rgb(0, 0, 0); font-w=
eight: bold; font-size: 1em; margin: 10px 0px; }

.tooltip-container .tooltip-separation-header:first-child { margin-top: 0px=
; }

.tooltip-container .item-selector { position: static; }

.tooltip-container .button-bar.bottom { position: absolute; bottom: 0px; le=
ft: 0px; }

.pat-upload { margin: 0px; }

.pat-upload .row { margin-left: 0px; margin-right: 0px; }

.pat-upload h2.title, .pat-upload p.help, .pat-upload #fakeUploadFile, .pat=
-upload .btn.btn-primary.browse, .pat-upload .controls .progress { display:=
 none; }

.pat-upload.upload .accessibility-options { position: absolute; opacity: 0;=
 pointer-events: none; }

.pat-upload .upload-area .dz-message p { display: block; padding: 3em 1em; =
border: 0.2em dashed rgba(0, 0, 0, 0.2); border-radius: 0px; text-align: ce=
nter; color: gray; cursor: default; margin-bottom: 1em !important; }

.pat-upload .upload-area .dz-message p::before { content: ""; font-family: =
fontello; display: inline-block; margin-right: 0.3em; }

.pat-upload .upload-area .dz-message p:active { background-color: rgb(242, =
242, 242); }

.pat-upload .upload-area.dz-drag-hover .dz-message p { background-color: rg=
b(242, 242, 242); }

.pat-upload .upload-area .upload-queue .previews { margin-bottom: 1em; }

.pat-upload .upload-area .upload-queue .previews .dz-filename { font-weight=
: bold; overflow: hidden; text-overflow: ellipsis; white-space: nowrap; dis=
play: block; }

.pat-upload .upload-area .upload-queue .previews .row { overflow: hidden; c=
olor: rgb(163, 30, 57); user-select: none; padding: 0.5em 2em 0.5em 3.6em; =
margin: 0px 0px 10px; position: relative; border-radius: 0px; box-shadow: r=
gba(0, 0, 0, 0.15) 0px 0px 5px inset; }

.pat-upload .upload-area .upload-queue .previews .row .info::before { conte=
nt: "=EE=A0=91"; font-family: fontello; font-size: 1.4em; position: absolut=
e; left: 0.8em; top: 50%; margin-top: -0.5em; font-weight: normal; transiti=
on: left 0.4s; }

.pat-upload .upload-area .upload-queue .previews .row .info .dz-size { font=
-style: italic; }

.pat-upload .upload-area .upload-queue .previews .row .info .dz-size strong=
 { font-weight: normal; }

.pat-upload .upload-area .upload-queue .previews .row .info img { height: 3=
em; max-width: 3em; position: absolute; left: 0.3em; top: 50%; margin-top: =
-1.5em; background-color: rgb(255, 255, 255); }

.pat-upload .upload-area .upload-queue .previews .row .btn { border: none; =
background: none; position: absolute; padding: 0px 0.35em; top: 50%; border=
-radius: 50%; transform: translateY(-50%); color: rgb(0, 0, 0); right: 0px;=
 z-index: 1; }

.pat-upload .upload-area .upload-queue .previews .row .btn:active { box-sha=
dow: none; }

.pat-upload .upload-area .upload-queue .previews .row .btn:active::before {=
 color: rgb(0, 0, 0); }

.pat-upload .upload-area .upload-queue .previews .row .btn::before { font-f=
amily: fontello; content: "=EE=A0=83"; }

.pat-upload .upload-area .upload-queue .previews .row .dz-progress { height=
: 3em; position: absolute; inset: 0px; opacity: 0.3; }

.pat-upload .upload-area .upload-queue .previews .row .dz-progress .dz-uplo=
ad { background: rgb(225, 237, 219); display: block; height: 4em; }

.pat-upload .upload-area .upload-queue .previews .row.dz-error .dz-progress=
 .dz-upload { background-color: red; }

.pat-upload .upload-area .upload-queue .previews .row .dz-success-mark, .pa=
t-upload .upload-area .upload-queue .previews .row .dz-error-mark { float: =
right; top: 50%; margin-top: -0.5em; right: 0.6em; position: absolute; disp=
lay: none; }

.pat-upload .upload-area .upload-queue .previews .row.dz-success .dz-succes=
s-mark, .pat-upload .upload-area .upload-queue .previews .row.dz-error .dz-=
error-mark { display: inline-block; }

.pat-upload .upload-area .upload-queue .previews .row .dz-error-mark { colo=
r: red; }

form .pat-verification-code, form.pat-form .pat-verification-code { width: =
352px; height: 80px; background: url("code-digits-6.svg") 0px 0px / 352px 1=
00% no-repeat; position: relative; margin: 40px 0px; display: block; paddin=
g: 0px; clip-path: inset(0px); font-size: 0px; color: rgba(0, 0, 0, 0); }

form .pat-verification-code input.code, form.pat-form .pat-verification-cod=
e input.code { background-color: rgba(0, 0, 0, 0); font-family: Courier, mo=
nospace; padding: 0px; text-indent: 12px; font-size: 50px; text-align: just=
ify; letter-spacing: 30px; line-height: 60px; font-weight: bold; height: 10=
0%; width: 140%; max-width: 140%; box-sizing: border-box; color: rgb(0, 0, =
0); margin: 0px; display: inline-block; resize: none; white-space: nowrap; =
overflow: hidden; caret-shape: underscore; border: none !important; outline=
: none !important; box-shadow: none !important; }

@media only screen and (max-width: 769px) {
  form .pat-verification-code input.code, form.pat-form .pat-verification-c=
ode input.code { caret-color: rgb(0, 0, 0); }
}

form .pat-verification-code input.code::selection, form.pat-form .pat-verif=
ication-code input.code::selection { background: rgba(0, 0, 0, 0); }

.pat-well { display: block; padding: 40px; box-sizing: border-box; box-shad=
ow: none; border-radius: 0px; background-color: var(--pat-form-panel-backgr=
ound-colour); margin-bottom: 25px; --pat-toolbar-margin-bottom: 15px; }

.pat-well .well-title-group { position: relative; }

.pat-well .well-title-group .buttons { position: absolute; right: calc(var(=
--pat-form-panel-padding) + 31px + 15px); top: 50%; transform: translateY(-=
50%); }

.pat-well .well-title-group .buttons .icon { overflow: hidden; width: 31px;=
 height: 31px; cursor: default; background-color: rgb(242, 242, 242); color=
: rgba(0, 0, 0, 0); position: relative; float: right; margin-left: 15px; bo=
rder-radius: 0px; font-style: normal; font-weight: normal; }

.pat-well .well-title-group .buttons .icon::after { font-family: fontello; =
font-size: 1em; z-index: 1; width: 31px; height: 31px; text-align: center; =
line-height: 31px; display: block; position: absolute; color: rgb(1, 104, 1=
54); top: 0px; left: 0px; }

.pat-well .well-title-group .buttons .icon:hover { background-color: rgb(23=
7, 237, 237); }

.pat-well .well-title-group .buttons .icon:hover::after { color: rgb(1, 104=
, 154); }

.pat-well .well-title-group .buttons .icon.tooltip-active-click { backgroun=
d-color: rgb(225, 112, 0); }

.pat-well .well-title-group .buttons .icon.tooltip-active-click::after { co=
lor: rgb(255, 255, 255); }

.pat-well .well-title-group .buttons .icon.help::after { content: "=EE=A2=
=82"; }

.pat-well .well-title-group .buttons .icon.add::after { content: "=EE=A3=A4=
"; }

.pat-well .well-title-group .buttons .icon.download::after { content: "=EE=
=A0=8F"; }

.pat-well .well-title-group .buttons .icon.settings::after { content: "=EE=
=A3=98"; }

.pat-well .well-title-group .buttons .icon.more::after { content: "=EE=A2=
=9E"; line-height: calc(34px); }

.pat-well .well-header { margin-bottom: 40px; line-height: 1.3; font-size: =
28px; font-weight: normal; color: rgb(0, 0, 0); }

.pat-well .well-header .pat-avatar { float: left; width: 36px; height: 36px=
; margin-right: 10px; font-size: 0.7em; }

.pat-well .well-separation-header { margin-bottom: 1em; margin-top: 1.5em; =
font-size: 24px; font-weight: bold; }

.pat-well .well-separation-header:first-child { margin-top: 0px; }

.pat-well.pat-collapsible { transition: padding 0.4s; padding: 0px; }

.pat-well.pat-collapsible .panel-content > :last-child { margin-bottom: 0px=
; }

.pat-well.pat-collapsible > .well-header, .pat-well.pat-collapsible > .well=
-title-group > .well-header { padding-right: 50px; padding-left: 40px; posi=
tion: relative; margin: 0px; transition: padding 0.4s; }

.pat-well.pat-collapsible > .well-header::after, .pat-well.pat-collapsible =
> .well-title-group > .well-header::after { font-family: fontello; content:=
 "=EE=A3=88"; font-size: 0.65em; background-color: rgb(242, 242, 242); colo=
r: rgb(1, 104, 154); position: absolute; right: var(--pat-form-panel-paddin=
g); top: 50%; transform: translateY(-50%); z-index: 1; width: 31px; height:=
 31px; text-align: center; line-height: 31px; border-radius: 0px; display: =
inline-block; }

.pat-well.pat-collapsible > .well-header:hover::after, .pat-well.pat-collap=
sible > .well-title-group > .well-header:hover::after { background-color: r=
gb(237, 237, 237); color: rgb(1, 104, 154); }

.pat-well.pat-collapsible.open, .pat-well.pat-collapsible.closed.in-progres=
s { transition: box-shadow 2s; }

.pat-well.pat-collapsible.open > .well-header, .pat-well.pat-collapsible.op=
en > .well-title-group > .well-header, .pat-well.pat-collapsible.closed.in-=
progress > .well-header, .pat-well.pat-collapsible.closed.in-progress > .we=
ll-title-group > .well-header { padding-top: 40px; padding-bottom: 40px; }

.pat-well.pat-collapsible.closed:hover { box-shadow: var(--pat-form-panel-b=
ox-shadow-hover); }

.pat-well.pat-collapsible.closed > .well-header, .pat-well.pat-collapsible.=
closed > .well-title-group > .well-header, .pat-well.pat-collapsible.open.i=
n-progress > .well-header, .pat-well.pat-collapsible.open.in-progress > .we=
ll-title-group > .well-header { padding-top: 20px; padding-bottom: 20px; bo=
rder-radius: 0px; }

.pat-well.pat-collapsible.closed > .well-header::after, .pat-well.pat-colla=
psible.closed > .well-title-group > .well-header::after, .pat-well.pat-coll=
apsible.open.in-progress > .well-header::after, .pat-well.pat-collapsible.o=
pen.in-progress > .well-title-group > .well-header::after { content: "=EE=
=A3=87"; }

.pat-well.pat-collapsible > .panel-content { padding: 0px 40px 40px; box-si=
zing: border-box; }

.pat-well form > fieldset:last-child, .pat-well form > fieldset:last-child =
> .button-bar:last-child { margin-bottom: 0px; }

.pat-well > :last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .pat-well { padding: 20px; }
}

.pat-well.success { background-color: rgb(225, 237, 219); }

.pat-well.success input { color: rgb(0, 0, 0); }

.pat-well.notice { background-color: rgb(253, 246, 187); }

.pat-well.warning { background-color: rgb(251, 234, 217); }

.pat-well.warning input { color: rgb(0, 0, 0); }

.pat-well.info { background-color: rgb(217, 237, 247); }

.pat-well.success input, .pat-well.success textarea, .pat-well.success sele=
ct, .pat-well.warning input, .pat-well.warning textarea, .pat-well.warning =
select { background-color: rgba(0, 0, 0, 0.3); outline: rgb(255, 255, 255) =
solid 1px; }

.pat-well.success select, .pat-well.warning select { background-image: url(=
"data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0idXRmLTgi=
Pz4NCjwhLS0gR2VuZXJhdG9yOiBBZG9iZSBJbGx1c3RyYXRvciAxNS4xLjAsIFNWRyBFeHBvcnQ=
gUGx1Zy1JbiAgLS0+DQo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS=
8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmcxMS5kdGQiI=
FsNCgk8IUVOVElUWSBuc19mbG93cyAiaHR0cDovL25zLmFkb2JlLmNvbS9GbG93cy8xLjAvIj4N=
Cl0+DQo8c3ZnIHZlcnNpb249IjEuMSINCgkgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDA=
vc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayIgeG1sbnM6YT=
0iaHR0cDovL25zLmFkb2JlLmNvbS9BZG9iZVNWR1ZpZXdlckV4dGVuc2lvbnMvMy4wLyINCgkge=
D0iMHB4IiB5PSIwcHgiIHdpZHRoPSIxMnB4IiBoZWlnaHQ9IjEwcHgiIHZpZXdCb3g9IjAgLTEu=
NDk2IDEyIDEwIiBvdmVyZmxvdz0idmlzaWJsZSIgZW5hYmxlLWJhY2tncm91bmQ9Im5ldyAwIC0=
xLjQ5NiAxMiAxMCINCgkgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+DQo8ZGVmcz4NCjwvZGVmcz4NCj=
xwb2x5Z29uIGZpbGw9IiNGRkZGRkYiIHBvaW50cz0iMCwwIDQuMjA1LDcuMDA5IDguNDEsMCAiL=
z4NCjwvc3ZnPg0K"); }

:root { --pat-button-font-size: 1.125rem; --pat-button-font-weight: normal;=
 --pat-checklist-label-padding-start: 32px; --pat-checklist-checkbox-size: =
18px; --pat-checklist-checkbox-vertical-position: 10.5px; --pat-checklist-c=
heckbox-background-colour: white; --pat-checklist-checkbox-box-shadow: inse=
t 0 0 0 2px black; --pat-checklist-checkbox-box-shadow-checked: none; --pat=
-checklist-checkbox-box-shadow-radio-checked: inset 0 0 0 2px #01689b, inse=
t 0 0 0 5px white; --pat-checklist-checkbox-background-colour-checked: #016=
89b; --pat-checklist-checkbox-border-radius: 0; --pat-menu-list-item-paddin=
g-start: 32px; --pat-form-input-field-padding-top-bottom: 4px; --pat-form-i=
nput-field-padding-start-end: 8px; --pat-form-input-field-line-height: 28px=
; --pat-form-input-field-border: none; --pat-form-input-field-outline-offse=
t: 2px; --pat-form-input-field-outline-focus: 2px dotted black; --pat-form-=
input-field-box-shadow: 0 0 0 1px dimgray; --pat-form-input-field-box-shado=
w-disabled: 0 0 0 1px #efefef; --pat-form-input-field-box-shadow-focus: 0 0=
 1px 1px dimgray; --pat-form-panel-background-colour: rgba(0, 0, 0, 0.045);=
 --pat-form-proportion-ceiling: 260%; --pat-form-proportion-name: 30%; --pa=
t-form-proportion-value: 80%; --pat-form-proportion-value-small: 100%; --pa=
t-form-input-field-tail-white: 26px; --pat-form-input-field-padding-top-bot=
tom-disabled: 2px; --pat-form-input-field-padding-left-right-disabled: 5px;=
 --pat-form-input-field-background-colour: white; --pat-form-input-field-ba=
ckground-colour-disabled: #efefef; --pat-form-placeholder-colour: rgba(0, 0=
, 0, 0.35); --pat-form-input-field-text-colour-disabled: rgba(0,0,0,0.5); -=
-pat-form-panel-colour: $colour-grey-1; --pat-form-panel-padding-large: 20p=
x; --pat-form-panel-padding-medium: 20px; --pat-form-panel-padding-small: 2=
0px; --pat-select-box-padding-top-bottom: 4px; --pat-select-box-padding-sta=
rt-end: 8px; --pat-select-box-font-size: {#$base-font-size}; --pat-toggle-b=
ackground-colour-on: #39870c; --pat-toggle-background-colour-off: white; --=
pat-toggle-toggle-background-colour: #01689b; --pat-toggle-toggle-backgroun=
d-colour-on: white; --pat-toggle-toggle-distance: 4px; --pat-toggle-box-sha=
dow: inset 0 0 0 2px black; --pat-toggle-box-shadow-on: inset 0 0 0 2px rgb=
a(0, 0, 0, 0); --pat-sortable-blocks-handle-colour: #39870c; --border-radii=
: 0; --pat-auto-suggest-pills-colour: #01689b; }

.advanced-search { overflow: hidden visible; }

.advanced-search .search-rule { margin-bottom: 0.5em; transition: 0.4s; cle=
ar: both; }

.advanced-search .search-rule.row-1 { height: 2em; }

.view-compact .advanced-search .search-rule { height: 4em; }

.view-compact .advanced-search .search-rule:not(.row-1) { display: none; }

.advanced-search .search-rule select, .advanced-search .search-rule input {=
 box-sizing: border-box; margin: 0px; height: 2em; line-height: 2em; paddin=
g: 0px 0.5em; width: 100%; float: left; color: rgb(0, 0, 0); font-weight: n=
ormal; }

.header.home .advanced-search .search-rule select, .header.home .advanced-s=
earch .search-rule input { background-color: rgba(255, 255, 255, 0.5); }

.header.home .advanced-search .search-rule .and-or.pat-select::after { back=
ground-image: url("data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbm=
NvZGluZz0idXRmLTgiPz4NCjwhLS0gR2VuZXJhdG9yOiBBZG9iZSBJbGx1c3RyYXRvciAxNS4xL=
jAsIFNWRyBFeHBvcnQgUGx1Zy1JbiAgLS0+DQo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzND=
Ly9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0R=
URC9zdmcxMS5kdGQiIFsNCgk8IUVOVElUWSBuc19mbG93cyAiaHR0cDovL25zLmFkb2JlLmNvbS=
9GbG93cy8xLjAvIj4NCl0+DQo8c3ZnIHZlcnNpb249IjEuMSINCgkgeG1sbnM9Imh0dHA6Ly93d=
3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94=
bGluayIgeG1sbnM6YT0iaHR0cDovL25zLmFkb2JlLmNvbS9BZG9iZVNWR1ZpZXdlckV4dGVuc2l=
vbnMvMy4wLyINCgkgeD0iMHB4IiB5PSIwcHgiIHdpZHRoPSIxMnB4IiBoZWlnaHQ9IjEwcHgiIH=
ZpZXdCb3g9IjAgLTEuNDk2IDEyIDEwIiBvdmVyZmxvdz0idmlzaWJsZSIgZW5hYmxlLWJhY2tnc=
m91bmQ9Im5ldyAwIC0xLjQ5NiAxMiAxMCINCgkgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+DQo8ZGVm=
cz4NCjwvZGVmcz4NCjxwb2x5Z29uIGZpbGw9IiNGRkZGRkYiIHBvaW50cz0iMCwwIDQuMjA1LDc=
uMDA5IDguNDEsMCAiLz4NCjwvc3ZnPg0K"); color: rgb(255, 255, 255); }

.advanced-search .search-rule [data-option=3D"Bevat niet"] select { backgro=
und-image: url("data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZ=
GluZz0idXRmLTgiPz4NCjwhLS0gR2VuZXJhdG9yOiBBZG9iZSBJbGx1c3RyYXRvciAxNS4xLjAs=
IFNWRyBFeHBvcnQgUGx1Zy1JbiAgLS0+DQo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9=
EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC=
9zdmcxMS5kdGQiIFsNCgk8IUVOVElUWSBuc19mbG93cyAiaHR0cDovL25zLmFkb2JlLmNvbS9Gb=
G93cy8xLjAvIj4NCl0+DQo8c3ZnIHZlcnNpb249IjEuMSINCgkgeG1sbnM9Imh0dHA6Ly93d3cu=
dzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGl=
uayIgeG1sbnM6YT0iaHR0cDovL25zLmFkb2JlLmNvbS9BZG9iZVNWR1ZpZXdlckV4dGVuc2lvbn=
MvMy4wLyINCgkgeD0iMHB4IiB5PSIwcHgiIHdpZHRoPSIxMnB4IiBoZWlnaHQ9IjEwcHgiIHZpZ=
XdCb3g9IjAgLTEuNDk2IDEyIDEwIiBvdmVyZmxvdz0idmlzaWJsZSIgZW5hYmxlLWJhY2tncm91=
bmQ9Im5ldyAwIC0xLjQ5NiAxMiAxMCINCgkgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+DQo8ZGVmcz4=
NCjwvZGVmcz4NCjxwb2x5Z29uIGZpbGw9IiNGRkZGRkYiIHBvaW50cz0iMCwwIDQuMjA1LDcuMD=
A5IDguNDEsMCAiLz4NCjwvc3ZnPg0K"); color: rgb(255, 255, 255); }

.advanced-search .search-rule .section-choice { width: 35%; overflow: hidde=
n; transition: 0.4s; }

.view-compact .advanced-search .search-rule .section-choice { margin-left: =
-100%; opacity: 0; width: 0px !important; }

.advanced-search .search-rule .and-or.pat-select.bare { width: 100%; margin=
: 0.5em auto 1.2em; display: inline-block; padding: 0px 15px; color: rgb(0,=
 0, 0); }

.header.home .advanced-search .search-rule .and-or.pat-select.bare { color:=
 rgb(255, 255, 255); }

.header.home .advanced-search .search-rule .and-or.pat-select.bare::after {=
 color: rgb(255, 255, 255); }

.advanced-search .search-rule .and-or.pat-select.bare select { width: auto;=
 right: inherit; color: rgb(0, 0, 0); }

.header.home .advanced-search .search-rule .and-or.pat-select.bare select {=
 color: rgb(255, 255, 255); }

.advanced-search .search-rule .lemma { width: 65%; transition: width 0.4s; =
}

.view-compact .advanced-search .search-rule .lemma { width: 100% !important=
; font-size: 1.93em; }

.advanced-search .search-rule .lemma [data-option=3D"Bevat"] select { backg=
round-color: rgb(214, 215, 178); }

.advanced-search .search-rule .lemma [data-option=3D"Bevat niet"] select { =
background-color: rgb(225, 112, 0); }

.advanced-search .search-rule .lemma > [data-option] { float: left; width: =
30%; margin: 0px; transition: 0.4s; }

.view-compact .advanced-search .search-rule .lemma > [data-option] { margin=
-left: -100%; opacity: 0; }

.advanced-search .search-rule .lemma input { width: calc(70% - 3em); float:=
 left; padding: 0px 0.8em; margin: 0px; border: none; z-index: 4; box-shado=
w: none; color: rgb(1, 104, 155); transition: 0.4s; position: absolute; top=
: 0px; left: calc(30% + 6px); }

.header.home .advanced-search .search-rule .lemma input { background: rgb(2=
55, 255, 255); }

.view-compact .advanced-search .search-rule .lemma input { width: calc(100%=
 - 18rem); height: 62px; font-size: 0.95em; left: 15px; }

.view-compact .advanced-search .search-rule .lemma input.lemma-field { opac=
ity: 0; pointer-events: none; }

.advanced-search .search-rule .lemma .remove-clone { border: none; backgrou=
nd: none; width: 1.5em; height: 2em; overflow: hidden; margin: 0px; padding=
: 0px; color: rgba(0, 0, 0, 0); position: absolute; right: 15px; text-inden=
t: -1000px; }

.advanced-search .search-rule .lemma .remove-clone:active { box-shadow: non=
e !important; }

.advanced-search .search-rule .lemma .remove-clone::before { font-family: f=
ontello; content: "=EE=A0=88"; color: rgb(1, 104, 155); position: absolute;=
 right: 0px; text-indent: -1em; }

.header.home .advanced-search .search-rule .lemma .remove-clone::before { c=
olor: rgb(255, 255, 255); }

.advanced-search .button-bar { overflow: hidden; transition: 0.4s; height: =
2em; margin: 0px; }

.header.home .view-extended .advanced-search .button-bar { margin-bottom: 2=
em; }

.view-compact .advanced-search .button-bar { height: 0px; margin-bottom: 0p=
x; opacity: 0; }

.advanced-search .button-bar .pat-button.icon-search { background: linear-g=
radient(rgb(225, 112, 0) 0%, rgb(175, 96, 0) 100%); color: rgb(255, 255, 25=
5); }

.applied-filters { background: rgb(132, 113, 10); padding: 1em; }

.applied-filters::after { content: " "; display: table; clear: both; }

.applied-filters a { text-decoration: underline; }

.applied-filters button { margin: -0.5em -0.5em -0.5em 1em; float: right; c=
olor: rgb(255, 255, 255); }

.search-box { user-select: none; }

.search-box.closed #close-trigger, .search-box.open #open-trigger { display=
: none; }

.search-box::after { content: " "; display: table; clear: both; }

.search-box fieldset.horizontal { margin: 0px; }

.search-box .main-filter-toggle { display: none !important; }

.search-box.filters-closed #close-trigger, .search-box.filters-open #open-t=
rigger { display: none; }

.search-box .filter-header { border-bottom: 1px solid rgb(118, 118, 118); }

.search-box .filter-header::after { content: " "; display: table; clear: bo=
th; }

.search-box .filter-header .filter-tags .tag { float: left; line-height: 32=
px; background-color: rgb(242, 242, 242); color: rgb(0, 0, 0); padding: 0px=
 30px 0px 0.5rem; margin: 0px 10px 6px 0px; border-radius: 3px; font-size: =
0.875rem; overflow: hidden; box-sizing: border-box; animation: 1s ease 0s 1=
 normal none running fadeIn; white-space: nowrap; position: relative; }

.search-box .filter-header .filter-tags .tag.collapsed { opacity: 0; width:=
 0px; margin: 0px 0px 6px; }

.search-box .filter-header .filter-tags .tag::after { font-family: fontello=
; content: "=EE=A2=83"; right: 10px; top: 0px; font-size: 16px; position: a=
bsolute; }

.search-box .filter-header .filter-tags .tag:hover { text-decoration: line-=
through; background-color: rgb(237, 237, 237); color: rgb(0, 0, 0); }

.search-box .filter-header .filter-tags .tag:hover::after { }

.search-box .filter-header .buttons .filter-toggle { background-color: rgba=
(0, 0, 0, 0); white-space: nowrap; color: rgb(0, 0, 0); font-size: 1rem; pa=
dding: 0px 30px 0px 0.5rem; margin: 0px 0px 17px; border-radius: 3px; float=
: right; line-height: 32px; position: relative; cursor: default; }

.search-box .filter-header .buttons .filter-toggle::after { font-family: fo=
ntello; content: "=EE=A3=87"; right: 10px; top: 0px; position: absolute; fo=
nt-size: 22px; transition: transform 0.2ms; }

.search-box .filter-header .buttons .filter-toggle.filter-close-trigger::af=
ter { content: "=EE=A3=88"; }

.search-box .filter-header .buttons .filter-toggle:hover { background-color=
: rgb(237, 237, 237); color: rgb(0, 0, 0); }

.search-box .filters.panel-content { padding-top: 0px; padding-bottom: 0px;=
 overflow: hidden; margin: 0px; }

.search-box .filters.panel-content::after { content: " "; display: table; c=
lear: both; }

.search-box .filters .filter-toggle { display: none; }

@media only screen and (max-width: 769px) {
  .search-box .filters .form-panel { padding-left: 20px; padding-right: 20p=
x; }
}

.search-box .filters .form-panel .panel-content { padding: 0px 0px 1.5em; }

.search-box .sorting { margin: 1rem 0rem 2rem; clear: both; }

.search-box .sorting a { color: rgb(0, 0, 0); text-decoration: underline; }

#app-space { background-color: rgb(255, 255, 255); }

#app-space.injecting > * { opacity: 0.19; }

#app-space.injecting.injecting-after *, #app-space.injecting.injecting-cont=
ent-after * { opacity: inherit; }

#app-space.injecting::before { position: absolute; top: 50%; left: 50%; con=
tent: "=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; margin-lef=
t: -25px; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb(255, =
255, 255) 0px 0px 2px; text-align: center; opacity: 0; animation: 2s linear=
 0s infinite normal none running spin, 1s linear 1s 1 normal forwards runni=
ng fadeIn; }

#app-space.state-paused { display: none; }

#app-space .pane.injecting > * { opacity: 0.19; }

#app-space .pane.injecting.injecting-after *, #app-space .pane.injecting.in=
jecting-content-after * { opacity: inherit; }

#app-space .pane.injecting::before { position: absolute; top: 50%; left: 50=
%; content: "=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; marg=
in-left: -25px; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb=
(255, 255, 255) 0px 0px 2px; text-align: center; opacity: 0; animation: 2s =
linear 0s infinite normal none running spin, 1s linear 1s 1 normal forwards=
 running fadeIn; }

#app-space .pane.state-inactive { display: none; }

#app-space .pane.state-active { display: block; }

#app-space .pane.app-launchpad { padding-top: 60px; }

#app-space .pane .coming-soon { position: fixed; top: 50%; left: 0px; right=
: 0px; text-align: center; margin-top: -30px; font-size: 60px; font-style: =
italic; animation: 0.4s ease 0.4s 1 normal none running pulse; }

#app-space .pane .app-loader { position: fixed; top: 50%; left: 50%; transf=
orm: translate(-50%, -50%); display: block; text-align: center; color: rgba=
(0, 0, 0, 0.6); box-sizing: border-box; clear: both; cursor: default; point=
er-events: none; padding-top: 100px; text-decoration: none !important; }

#app-space .pane .app-loader::before { opacity: 1; position: absolute; top:=
 50%; left: 50%; content: "=EF=84=A6"; width: 50px; height: 50px; margin-to=
p: -25px; margin-left: -25px; z-index: 1000; font: 50px / 50px fontello; te=
xt-shadow: rgb(255, 255, 255) 0px 0px 2px; text-align: center; animation: 2=
s linear 0s infinite normal none running spin; color: rgba(0, 0, 0, 0.5); }

@media only screen and (min-width: 770px) {
  .app-body { padding-top: 60px; padding-bottom: 70px; }
}

@media only screen and (max-width: 769px) {
  .app-body { padding-top: 20px; padding-bottom: 20px; }
}

.app-tiles { display: grid; margin: 40px; gap: 40px 0px; user-select: none;=
 }

@media only screen and (max-width: 769px) {
  .app-tiles { grid-template-columns: 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .app-tiles { grid-template-columns: 1fr 1fr 1fr 1fr; }
}

@media only screen and (min-width: 1280px) {
  .app-tiles { grid-template-columns: 1fr 1fr 1fr 1fr 1fr; }
}

.app-tiles .app-tile { display: inline-block; text-align: center; font-weig=
ht: bold; margin: 0px; color: rgb(0, 0, 0); font-size: 20px; }

.app-tiles .app-tile .app-icon { display: block; margin: 0px auto 10px; wid=
th: calc(100% - 70px); }

.app-tiles .app-tile:hover img { filter: brightness(1.2); }

.app-icon { aspect-ratio: 1 / 1; background-color: rgb(239, 239, 239); }

.app-icon.app-settings { background-color: rgb(68, 68, 68); }

.app-icon.app-image-bank { background-color: rgb(202, 0, 93); }

.app-icon.app-contacts { background-color: rgb(132, 113, 10); }

.app-icon.app-organisations { background-color: rgb(66, 20, 95); }

.app-icon.app-user-management { background-color: rgb(68, 68, 68); }

.app-icon.app-documents { background-color: rgb(0, 123, 199); }

.app-icon.app-cost { background-color: rgb(0, 123, 199); }

.app-icon.app-help-desk { background-color: rgb(225, 112, 0); }

.app-icon.app-medicines { background-color: rgb(118, 210, 182); }

.app-icon.app-indicators { background-color: rgb(0, 123, 199); }

.app-icon.app-public-data { background-color: rgb(43, 103, 9); }

.app-icon.app-help { background-color: rgb(68, 68, 68); }

.app-icon.app-tags { background-color: rgb(202, 0, 93); }

.app-icon.app-demo { background-color: rgb(194, 230, 8); }

html { line-height: 1.15; }

@media only screen and (max-width: 769px) {
  html { font-size: 80%; }
  html :root { font-size: 80%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  html { font-size: 90%; }
  html :root { font-size: 90%; }
}

@media only screen and (min-width: 1280px) {
  html { font-size: 100%; }
  html :root { font-size: 100%; }
}

body { font-family: "RO Sans"; font-weight: normal; line-height: 1.38272; f=
ont-size: 1.26562rem; transition: padding 0.4s; }

body.page-type-prozin-component { padding: 20px; margin: 0px; }

@media screen {
  body { background-color: rgb(255, 255, 255); }
}

body ::before { -webkit-font-smoothing: antialiased; text-rendering: optimi=
zelegibility; }

body > section.content-block, body > p.directory-more, body > .result-item,=
 body > .pagination { display: none; }

@media only screen and (min-width: 770px) {
  body { padding-top: 125px; }
}

@media (display-mode: standalone) {
  body { padding-top: 70px; }
}

body:has(#global-nav.app), body:has(nav.app-icons), body:has(#global-nav.lo=
gged-in) { padding-top: 0px !important; }

body[data-error-message]::after { content: "De pagina die u probeert te ope=
nen is op dit moment niet beschikbaar. Probeert u het later nog eens of nee=
m contact op met Het Zorginstituut via de link naar het contactformulier on=
deraan elke pagina. \a \a Klik of raak aan om dit bericht te sluiten."; tex=
t-align: center; white-space: pre-wrap; font-size: 1.5em; line-height: 1.5;=
 display: block; color: rgb(0, 0, 0); position: fixed; top: 50%; left: 50%;=
 padding: 6%; opacity: 0; animation: 1s ease 0.5s 1 normal forwards running=
 fadeIn; z-index: 10001; transform: translate(-50%, -50%); box-sizing: bord=
er-box; width: 100%; max-width: 1000px; pointer-events: none; }

body[data-error-message]::before { position: fixed; inset: 0px; background-=
color: rgb(255, 255, 255); z-index: 10000; width: 100%; height: 100%; conte=
nt: " "; animation: 1.5s ease 0s 1 normal none running fadeIn; pointer-even=
ts: none; }

body[data-error-message] #site-header { z-index: 10000; display: block; bac=
kground-color: rgba(0, 0, 0, 0); position: fixed; top: 0px; left: 0px; righ=
t: 0px; }

body[data-error-message] #site-header .homepage::after { position: fixed; i=
nset: 0px; z-index: 10002; width: 100%; height: 100%; content: " "; display=
: block; }

body.injecting > * { opacity: 0.19; }

body.injecting.injecting-after *, body.injecting.injecting-content-after * =
{ opacity: inherit; }

body.injecting::before { position: absolute; top: 50%; left: 50%; content: =
"=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; margin-left: -25=
px; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb(255, 255, 2=
55) 0px 0px 2px; text-align: center; opacity: 0; animation: 2s linear 0s in=
finite normal none running spin, 1s linear 1s 1 normal forwards running fad=
eIn; }

body.injecting:not(.discrete-injection) { background-color: rgb(255, 255, 2=
55); }

body.injecting:not(.discrete-injection) #global-nav, body.injecting:not(.di=
screte-injection) #site-header, body.injecting:not(.discrete-injection) #fo=
oter { opacity: 1; }

body.injecting:not(.discrete-injection) #main { filter: blur(100px) saturat=
e(250%); opacity: 0; }

body.injecting:not(.discrete-injection)::before { position: fixed; }

@media print {
  body { font-size: 14px; line-height: 22px; }
  body * { font-family: arial !important; }
  body #main { padding: 0px 8% !important; }
}

body a { text-decoration: none; color: rgb(1, 104, 155); text-underline-off=
set: 0.1em; }

body .float-after { float: right; }

body .float-before { float: left; }

body [hidden] { display: none; }

body .assistive { overflow: hidden; clip: rect(0px, 0px, 0px, 0px); margin:=
 -1px; padding: 0px; width: 1px; height: 1px; border: 0px; position: absolu=
te !important; display: inline-block !important; }

body .ui-helper-hidden-accessible, body .select2-hidden-accessible { positi=
on: absolute; left: -9999px; opacity: 0; pointer-events: none; }

.bar-graph { width: 100%; overflow: hidden; }

.bar-graph::after { content: " "; display: table; clear: both; }

.bar-graph .segment { float: left; overflow: hidden; color: rgba(0, 0, 0, 0=
); height: 1em; background-color: rgb(57, 135, 12); cursor: default; }

.bar-graph .segment:nth-child(2n) { background-color: rgb(246, 212, 178); }

fieldset.pat-bar-toggles .legend, fieldset.pat-checklist.pat-bar-toggles:no=
t(.free-form) .legend, div.pat-bar-toggles .legend, div.pat-checklist.pat-b=
ar-toggles:not(.free-form) .legend { margin-bottom: 0.5em; font-weight: bol=
d; }

fieldset.pat-bar-toggles.multi-line label, fieldset.pat-checklist.pat-bar-t=
oggles:not(.free-form).multi-line label, div.pat-bar-toggles.multi-line lab=
el, div.pat-checklist.pat-bar-toggles:not(.free-form).multi-line label { wh=
ite-space: inherit; padding-top: 0.2em; padding-bottom: 0.2em; }

fieldset.pat-bar-toggles.multi-line label.hidden, fieldset.pat-checklist.pa=
t-bar-toggles:not(.free-form).multi-line label.hidden, div.pat-bar-toggles.=
multi-line label.hidden, div.pat-checklist.pat-bar-toggles:not(.free-form).=
multi-line label.hidden { padding-top: 0px; padding-bottom: 0px; }

fieldset.pat-bar-toggles.multi-line label::before, fieldset.pat-checklist.p=
at-bar-toggles:not(.free-form).multi-line label::before, div.pat-bar-toggle=
s.multi-line label::before, div.pat-checklist.pat-bar-toggles:not(.free-for=
m).multi-line label::before { top: 50%; transform: translateY(-50%); }

fieldset.pat-bar-toggles:not(.radio) label.checked, fieldset.pat-checklist.=
pat-bar-toggles:not(.free-form):not(.radio) label.checked, div.pat-bar-togg=
les:not(.radio) label.checked, div.pat-checklist.pat-bar-toggles:not(.free-=
form):not(.radio) label.checked { padding-right: 2em; }

fieldset.pat-bar-toggles:not(.radio) label.checked::after, fieldset.pat-che=
cklist.pat-bar-toggles:not(.free-form):not(.radio) label.checked::after, di=
v.pat-bar-toggles:not(.radio) label.checked::after, div.pat-checklist.pat-b=
ar-toggles:not(.free-form):not(.radio) label.checked::after { position: abs=
olute; right: 0.2em; top: 0.2em; content: "=E2=9E=96"; font-family: fontell=
o; font-size: 1em; width: 1.2em; height: 1.2em; text-align: center; line-he=
ight: 1.25em; opacity: 0.8; }

fieldset.pat-bar-toggles label, fieldset.pat-checklist.pat-bar-toggles:not(=
.free-form) label, div.pat-bar-toggles label, div.pat-checklist.pat-bar-tog=
gles:not(.free-form) label { padding: 0px 0.5em 0px 1.7em; border-left: non=
e; border-right: none; margin-bottom: 0px; display: block; text-overflow: e=
llipsis; overflow: hidden; white-space: nowrap; user-select: none; position=
: relative; background: rgb(255, 255, 255); }

fieldset.pat-bar-toggles label:first-of-type, fieldset.pat-checklist.pat-ba=
r-toggles:not(.free-form) label:first-of-type, div.pat-bar-toggles label:fi=
rst-of-type, div.pat-checklist.pat-bar-toggles:not(.free-form) label:first-=
of-type { border-top: none; }

fieldset.pat-bar-toggles label:last-child, fieldset.pat-checklist.pat-bar-t=
oggles:not(.free-form) label:last-child, div.pat-bar-toggles label:last-chi=
ld, div.pat-checklist.pat-bar-toggles:not(.free-form) label:last-child { bo=
rder-bottom: none; }

fieldset.pat-bar-toggles label::before, fieldset.pat-checklist.pat-bar-togg=
les:not(.free-form) label::before, div.pat-bar-toggles label::before, div.p=
at-checklist.pat-bar-toggles:not(.free-form) label::before { position: abso=
lute; left: 0px; }

fieldset.pat-bar-toggles label input, fieldset.pat-checklist.pat-bar-toggle=
s:not(.free-form) label input, div.pat-bar-toggles label input, div.pat-che=
cklist.pat-bar-toggles:not(.free-form) label input { position: absolute; op=
acity: 0; }

.js fieldset.pat-bar-toggles label input, .js fieldset.pat-checklist.pat-ba=
r-toggles:not(.free-form) label input, .js div.pat-bar-toggles label input,=
 .js div.pat-checklist.pat-bar-toggles:not(.free-form) label input { opacit=
y: 0; }

.no-js fieldset.pat-bar-toggles label input, .no-js fieldset.pat-checklist.=
pat-bar-toggles:not(.free-form) label input, .no-js div.pat-bar-toggles lab=
el input, .no-js div.pat-checklist.pat-bar-toggles:not(.free-form) label in=
put { opacity: 1; }

fieldset.pat-bar-toggles label::before, fieldset.pat-checklist.pat-bar-togg=
les:not(.free-form) label::before, div.pat-bar-toggles label::before, div.p=
at-checklist.pat-bar-toggles:not(.free-form) label::before { padding-left: =
0.5em; font-family: fontello; display: none; }

fieldset.pat-bar-toggles label::after, fieldset.pat-checklist.pat-bar-toggl=
es:not(.free-form) label::after, div.pat-bar-toggles label::after, div.pat-=
checklist.pat-bar-toggles:not(.free-form) label::after { display: none; }

fieldset.pat-bar-toggles label:hover, fieldset.pat-checklist.pat-bar-toggle=
s:not(.free-form) label:hover, div.pat-bar-toggles label:hover, div.pat-che=
cklist.pat-bar-toggles:not(.free-form) label:hover { background: rgb(255, 2=
55, 255); }

.js fieldset.pat-bar-toggles label:hover::before, .js fieldset.pat-checklis=
t.pat-bar-toggles:not(.free-form) label:hover::before, .js div.pat-bar-togg=
les label:hover::before, .js div.pat-checklist.pat-bar-toggles:not(.free-fo=
rm) label:hover::before { display: inline-block; opacity: 0.1; content: "=
=EE=A4=8E"; }

fieldset.pat-bar-toggles label:hover.checked::after, fieldset.pat-checklist=
.pat-bar-toggles:not(.free-form) label:hover.checked::after, div.pat-bar-to=
ggles label:hover.checked::after, div.pat-checklist.pat-bar-toggles:not(.fr=
ee-form) label:hover.checked::after { opacity: 1; }

fieldset.pat-bar-toggles label.checked, fieldset.pat-checklist.pat-bar-togg=
les:not(.free-form) label.checked, div.pat-bar-toggles label.checked, div.p=
at-checklist.pat-bar-toggles:not(.free-form) label.checked { background-col=
or: rgb(39, 89, 55); color: rgb(255, 255, 255); }

fieldset.pat-bar-toggles label.checked::before, fieldset.pat-checklist.pat-=
bar-toggles:not(.free-form) label.checked::before, div.pat-bar-toggles labe=
l.checked::before, div.pat-checklist.pat-bar-toggles:not(.free-form) label.=
checked::before { display: inline-block; content: "=EE=A4=8E"; opacity: 1; =
}

.js fieldset.pat-bar-toggles label.checked::before, .js fieldset.pat-checkl=
ist.pat-bar-toggles:not(.free-form) label.checked::before, .js div.pat-bar-=
toggles label.checked::before, .js div.pat-checklist.pat-bar-toggles:not(.f=
ree-form) label.checked::before { opacity: 1; }

.bar-buttons { margin: 5em auto; display: grid; grid-template-columns: 1fr;=
 gap: 15px; }

.bar-buttons .item { font-family: "RO Sans"; border: none; border-radius: 0=
px; background-image: none; line-height: var(--pat-button-height); vertical=
-align: text-bottom; font-weight: var(--pat-button-font-weight); box-shadow=
: none; color: rgb(1, 104, 154); background-color: rgb(242, 242, 242); max-=
width: 100%; overflow: hidden; text-overflow: ellipsis; padding: 15px 10px;=
 text-align: center; text-decoration: none; font-size: 1.2em; width: 100%; =
display: block; cursor: pointer; white-space: nowrap; margin: 0px; box-sizi=
ng: border-box; }

.bar-buttons .item::before { line-height: inherit; }

.bar-buttons .item:focus { outline: var(--pat-form-input-field-outline-focu=
s); outline-offset: var(--pat-form-input-field-outline-offset); }

.bar-buttons .item:hover { background-color: rgb(237, 237, 237); text-decor=
ation: none; color: rgb(1, 104, 154); }

.bar-buttons .item.default { color: white; background-color: rgb(1, 104, 15=
5); box-shadow: none; }

.bar-buttons .item.default:hover { background-color: rgb(1, 70, 104); color=
: white; }

.bar-buttons .item[disabled], .bar-buttons .item.disabled, .bar-buttons .it=
em:is(a):not([href]), .bar-buttons .item.default[disabled], .bar-buttons .i=
tem.default.disabled, .bar-buttons .item:is(a).default:not([href]) { color:=
 rgba(0, 0, 0, 0.3); background-color: rgb(242, 242, 242); }

.bar-buttons .item[disabled]:hover, .bar-buttons .item.disabled:hover, .bar=
-buttons .item:is(a):not([href]):hover, .bar-buttons .item.default[disabled=
]:hover, .bar-buttons .item.default.disabled:hover, .bar-buttons .item:is(a=
).default:not([href]):hover { color: rgba(0, 0, 0, 0.3); background-color: =
rgb(242, 242, 242); }

@media print {
  .bar-buttons .item { display: none; }
}

.bar-buttons .item.small { font-size: 18px; padding: 0px 0.8rem; height: 29=
px; line-height: 29px; vertical-align: baseline; box-shadow: none; font-wei=
ght: normal; }

.bar-buttons .item.small::before { font-size: 15px; }

.bar-buttons .item.iconified { width: 30px; padding: 0px; }

.bar-buttons .item.iconified::before { width: 100%; text-align: center; lin=
e-height: 44px; }

.bar-buttons .item.link { padding: 0px; display: inline; background: none; =
color: rgb(1, 104, 155); line-height: inherit; text-decoration: underline; =
vertical-align: baseline; cursor: pointer; }

.bar-buttons .item.link:hover { background: none; color: rgb(0, 2, 3); text=
-decoration: underline !important; }

.bar-buttons .item.no-label { padding: 0px; aspect-ratio: 1 / 1; text-overf=
low: clip; height: var(--pat-button-height); min-width: var(--pat-button-he=
ight); }

.bar-buttons .item.no-label::before { width: 100%; text-align: center; marg=
in: 0px 1em 0px 0px; line-height: var(--pat-button-height); }

.bar-buttons .item::before { font-weight: normal; margin-right: 5px; }

.bar-buttons .item.add::before { font-family: fontello; content: "=EE=A3=A4=
"; }

.bar-buttons.col-1 { max-width: 550px; }

.bar-buttons.col-2 { grid-template-columns: 1fr 1fr; }

.form-panel .button-bar:last-child .pat-button { margin-bottom: 0px; }

.form-panel .pat-button:not(.default), .pat-well .pat-button:not(.default) =
{ box-shadow: rgb(1, 104, 155) 0px 0px 0px 1px inset; }

.pat-button, #document-alert-bar .context-menu, .status-inactive .content-m=
irror .placeholder { display: inline-block; }

@keyframes make-ok {=20
  0% { content: "=EE=A2=9B"; transform: scale(1); }
  50% { transform: scale(1.5); content: "=EE=A2=9B"; }
  100% { content: "=EE=A4=8E"; transform: scale(1); color: green; }
}

.pat-button.validate:active::before, #document-alert-bar .context-menu.vali=
date:active::before, .status-inactive .content-mirror .placeholder.validate=
:active::before { animation: 0.5s ease 0s 1 normal forwards running make-ok=
; }

.pat-button.link, #document-alert-bar .context-menu.link, .status-inactive =
.content-mirror .placeholder.link { padding: 0px; display: inline; backgrou=
nd: none; color: rgb(1, 104, 155); line-height: inherit; text-decoration: u=
nderline; }

.pat-button.link:hover, #document-alert-bar .context-menu.link:hover, .stat=
us-inactive .content-mirror .placeholder.link:hover { text-decoration: unde=
rline; }

.pat-button:hover, #document-alert-bar .context-menu:hover, .status-inactiv=
e .content-mirror .placeholder:hover { text-decoration: none; }

.pat-button.warning, #document-alert-bar .context-menu.warning, .status-ina=
ctive .content-mirror .placeholder.warning { background: rgb(225, 112, 0); =
}

.pat-button.warning:hover, #document-alert-bar .context-menu.warning:hover,=
 .status-inactive .content-mirror .placeholder.warning:hover { background: =
rgb(174, 87, 0); }

.pat-button::before, #document-alert-bar .context-menu::before, .status-ina=
ctive .content-mirror .placeholder::before { margin-left: 0px; }

.button-bar { display: flex; justify-content: start; gap: 1rem; margin: var=
(--pat-button-bar-margin-top-bottom) 0; }

.button-bar .pat-button { margin: 0px; }

.button-bar .pat-button.float-after { margin-left: auto; }

.button-bar#button-bar-organise-sections { margin: 40px 0px; }

#browse-bar { background-color: rgb(242, 242, 242); position: relative; pad=
ding-top: 70px; margin-top: -70px; font-size: 1.125rem; }

#browse-bar::after { content: " "; display: table; clear: both; }

#browse-bar .collapse-expand-toggle { position: absolute; left: 50%; bottom=
: 0px; height: 30px; width: 30px; border-radius: 50%; background-color: rgb=
(242, 242, 242); margin: 0px 0px -15px -15px; color: rgba(0, 0, 0, 0); tran=
sform: rotate(-90deg); transition: 0.5s; }

#browse-bar .collapse-expand-toggle:focus { outline: none; box-shadow: rgb(=
173, 216, 230) 0px 0px 5px 5px; }

#browse-bar .collapse-expand-toggle::before { font-family: fontello; conten=
t: "=EE=A2=84"; color: rgb(0, 0, 0); font-size: 20px; width: 100%; height: =
100%; text-align: center; line-height: 30px; display: block; }

#browse-bar .container { padding-top: 50px; padding-bottom: 150px; position=
: relative; transition: 1s; }

#browse-bar .container .button-bar { position: absolute; left: 0px; right: =
15px; bottom: 50px; justify-content: flex-end; }

#browse-bar .button-bar { margin-top: 1em; margin-bottom: 0px; opacity: 1; =
transition: 0.5s; }

#browse-bar .button-bar .pat-button:not(.default) { box-shadow: rgb(1, 104,=
 155) 0px 0px 0px 1px inset; }

#browse-bar .pat-bar-toggles label { overflow: hidden; box-sizing: border-b=
ox; height: 38px; line-height: 32px; transition: height 1s, padding 1s; bor=
der-left: 1px solid dimgray; border-right: 1px solid dimgray; }

#browse-bar .pat-bar-toggles label:first-of-type { border-top: 1px solid di=
mgray; margin-top: -4px; }

#browse-bar .pat-bar-toggles label:last-of-type { border-bottom: 1px solid =
dimgray; }

#browse-bar .pat-bar-toggles label.pat-depends { height: 0px; display: bloc=
k !important; }

#browse-bar .pat-bar-toggles label.visible { height: 38px; }

#browse-bar .select2-container { margin-top: 1px; }

#browse-bar.state-collapsed .collapse-expand-toggle { transform: rotate(90d=
eg); }

#browse-bar.state-collapsed .container { padding-top: 20px; padding-bottom:=
 20px; }

#browse-bar.state-collapsed .container .button-bar { margin-top: 1em; margi=
n-bottom: 0px; opacity: 0; pointer-events: none; }

#browse-bar.state-collapsed .container .pat-bar-toggles .unchecked { height=
: 0px; padding-top: 0px; padding-bottom: 0px; }

#global-nav.bumped ~ #main .canvas-toolbar.sticky { box-shadow: rgba(0, 0, =
0, 0.3) 0px 1px 10px; }

.canvas-toolbar { line-height: 44px; color: rgb(1, 104, 154); z-index: 1; p=
osition: relative; user-select: none; margin-bottom: 26px; padding-bottom: =
26px; }

.canvas-toolbar::after { content: " "; display: table; clear: both; }

.canvas-toolbar .pat-select:not(.bare) { --select-box-padding-top-bottom: 0=
; --select-box-box-shadow: none; --select-box-background-color: #f2f2f2; --=
select-box-arrow-text-colour: #01689b; display: inline-block; height: var(-=
-pat-select-box-height); line-height: var(--pat-select-box-height); padding=
-left: var(--pat-select-box-padding-start); padding-right: calc(var(--pat-s=
elect-box-arrow-width) + var(--pat-select-box-padding-start)/2); position: =
relative; box-sizing: border-box; border: var(--pat-form-input-field-border=
); border-radius: var(--pat-form-input-field-border-radius); box-shadow: va=
r(--pat-select-box-box-shadow); outline: var(--pat-form-input-field-outline=
); outline-offset: var(--pat-form-input-field-outline-offset); color: var(-=
-pat-select-box-arrow-text-colour); font-size: var(--pat-select-box-font-si=
ze); max-width: 100%; background-color: var(--pat-select-box-background-col=
our); white-space: nowrap; text-overflow: ellipsis; cursor: default; paddin=
g-top: 0px; padding-bottom: 0px; overflow: hidden; font-weight: normal !imp=
ortant; }

.canvas-toolbar .pat-select:not(.bare):hover { background-color: var(--pat-=
select-box-background-colour-hover); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"], .canvas-toolb=
ar .pat-select:not(.bare).state-draft { background-color: rgb(251, 234, 217=
); color: rgb(123, 61, 0); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"]::after, .canva=
s-toolbar .pat-select:not(.bare).state-draft::after { background-color: rgb=
(246, 212, 178); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"]::before, .canv=
as-toolbar .pat-select:not(.bare)[data-value=3D"draft"]::after, .canvas-too=
lbar .pat-select:not(.bare).state-draft::before, .canvas-toolbar .pat-selec=
t:not(.bare).state-draft::after { color: rgb(123, 61, 0); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"]:hover, .canvas=
-toolbar .pat-select:not(.bare)[data-value=3D"draft"].tooltip-active-click,=
 .canvas-toolbar .pat-select:not(.bare).state-draft:hover, .canvas-toolbar =
.pat-select:not(.bare).state-draft.tooltip-active-click { background-color:=
 rgb(249, 221, 194); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"]:hover::after, =
.canvas-toolbar .pat-select:not(.bare)[data-value=3D"draft"].tooltip-active=
-click::after, .canvas-toolbar .pat-select:not(.bare).state-draft:hover::af=
ter, .canvas-toolbar .pat-select:not(.bare).state-draft.tooltip-active-clic=
k::after { background-color: rgb(243, 199, 155); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"], .canvas-=
toolbar .pat-select:not(.bare).state-for-review { background-color: rgb(242=
, 217, 231); color: rgb(169, 0, 97); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"]::after, .=
canvas-toolbar .pat-select:not(.bare).state-for-review::after { background-=
color: rgb(229, 179, 208); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"]::before, =
.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"]::after, .=
canvas-toolbar .pat-select:not(.bare).state-for-review::before, .canvas-too=
lbar .pat-select:not(.bare).state-for-review::after { color: rgb(93, 0, 53)=
; }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"]:hover, .c=
anvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"].tooltip-act=
ive-click, .canvas-toolbar .pat-select:not(.bare).state-for-review:hover, .=
canvas-toolbar .pat-select:not(.bare).state-for-review.tooltip-active-click=
 { background-color: rgb(236, 198, 219); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"]:hover::af=
ter, .canvas-toolbar .pat-select:not(.bare)[data-value=3D"for-review"].tool=
tip-active-click::after, .canvas-toolbar .pat-select:not(.bare).state-for-r=
eview:hover::after, .canvas-toolbar .pat-select:not(.bare).state-for-review=
.tooltip-active-click::after { background-color: rgb(223, 160, 196); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"], .canvas-to=
olbar .pat-select:not(.bare).state-approved { background-color: rgb(225, 23=
7, 219); color: rgb(43, 103, 9); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"]::after, .ca=
nvas-toolbar .pat-select:not(.bare).state-approved::after { background-colo=
r: rgb(196, 219, 182); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"]::before, .c=
anvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"]::after, .canv=
as-toolbar .pat-select:not(.bare).state-approved::before, .canvas-toolbar .=
pat-select:not(.bare).state-approved::after { color: rgb(27, 65, 6); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"]:hover, .can=
vas-toolbar .pat-select:not(.bare)[data-value=3D"approved"].tooltip-active-=
click, .canvas-toolbar .pat-select:not(.bare).state-approved:hover, .canvas=
-toolbar .pat-select:not(.bare).state-approved.tooltip-active-click { backg=
round-color: rgb(211, 229, 202); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"]:hover::afte=
r, .canvas-toolbar .pat-select:not(.bare)[data-value=3D"approved"].tooltip-=
active-click::after, .canvas-toolbar .pat-select:not(.bare).state-approved:=
hover::after, .canvas-toolbar .pat-select:not(.bare).state-approved.tooltip=
-active-click::after { background-color: rgb(182, 211, 165); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"], .canvas-t=
oolbar .pat-select:not(.bare)[data-value=3D"sent"], .canvas-toolbar .pat-se=
lect:not(.bare).state-published, .canvas-toolbar .pat-select:not(.bare).sta=
te-sent { background-color: rgb(229, 240, 249); color: rgb(1, 53, 79); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"]::after, .c=
anvas-toolbar .pat-select:not(.bare)[data-value=3D"sent"]::after, .canvas-t=
oolbar .pat-select:not(.bare).state-published::after, .canvas-toolbar .pat-=
select:not(.bare).state-sent::after { background-color: rgb(204, 224, 241);=
 }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"]::before, .=
canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"]::after, .ca=
nvas-toolbar .pat-select:not(.bare)[data-value=3D"sent"]::before, .canvas-t=
oolbar .pat-select:not(.bare)[data-value=3D"sent"]::after, .canvas-toolbar =
.pat-select:not(.bare).state-published::before, .canvas-toolbar .pat-select=
:not(.bare).state-published::after, .canvas-toolbar .pat-select:not(.bare).=
state-sent::before, .canvas-toolbar .pat-select:not(.bare).state-sent::afte=
r { color: rgb(1, 53, 79); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"]:hover, .ca=
nvas-toolbar .pat-select:not(.bare)[data-value=3D"published"].tooltip-activ=
e-click, .canvas-toolbar .pat-select:not(.bare)[data-value=3D"sent"]:hover,=
 .canvas-toolbar .pat-select:not(.bare)[data-value=3D"sent"].tooltip-active=
-click, .canvas-toolbar .pat-select:not(.bare).state-published:hover, .canv=
as-toolbar .pat-select:not(.bare).state-published.tooltip-active-click, .ca=
nvas-toolbar .pat-select:not(.bare).state-sent:hover, .canvas-toolbar .pat-=
select:not(.bare).state-sent.tooltip-active-click { background-color: rgb(2=
08, 228, 244); }

.canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"]:hover::aft=
er, .canvas-toolbar .pat-select:not(.bare)[data-value=3D"published"].toolti=
p-active-click::after, .canvas-toolbar .pat-select:not(.bare)[data-value=3D=
"sent"]:hover::after, .canvas-toolbar .pat-select:not(.bare)[data-value=3D"=
sent"].tooltip-active-click::after, .canvas-toolbar .pat-select:not(.bare).=
state-published:hover::after, .canvas-toolbar .pat-select:not(.bare).state-=
published.tooltip-active-click::after, .canvas-toolbar .pat-select:not(.bar=
e).state-sent:hover::after, .canvas-toolbar .pat-select:not(.bare).state-se=
nt.tooltip-active-click::after { background-color: rgb(184, 212, 236); }

.canvas-toolbar .pat-select:not(.bare).locked::before { font-family: fontel=
lo; content: "=EE=A0=AE"; display: inline-block; margin-right: 5px; float: =
left; font-size: inherit; }

.canvas-toolbar .pat-select:not(.bare):not([class*=3D"icon-"])::before { fo=
nt-size: var(--pat-select-box-font-size); content: attr(data-option); white=
-space: nowrap; overflow: hidden; text-overflow: ellipsis; display: block; =
}

.canvas-toolbar .pat-select:not(.bare)[class*=3D"icon-"]::before { margin-l=
eft: -5px; margin-right: 8px; }

.canvas-toolbar .pat-select:not(.bare) select { position: absolute; inset: =
0px; opacity: 0; margin: 0px; z-index: 1; height: 100% !important; width: 1=
00% !important; }

.canvas-toolbar .pat-select:not(.bare) select option { font-size: initial; =
color: rgb(0, 0, 0); }

.canvas-toolbar .pat-select:not(.bare)::after { font-family: fontello; cont=
ent: "=EE=A3=87"; width: var(--pat-select-box-arrow-width); background-colo=
r: var(--pat-select-box-arrow-background-colour); background-image: none; p=
osition: absolute; top: 0px; right: 0px; bottom: 0px; font-size: var(--pat-=
select-box-arrow-size); border-top-right-radius: var(--pat-form-fields-bord=
er-radius); border-bottom-right-radius: var(--pat-form-fields-border-radius=
); padding: 0px; display: flex; align-items: center; justify-content: cente=
r; }

.canvas-toolbar .pat-select:not(.bare) option:disabled { color: silver; }

.canvas-toolbar .pat-select:not(.bare)::before { max-width: 350px; }

.canvas-toolbar.sticky { background-color: rgba(255, 255, 255, 0.95); box-s=
hadow: rgba(0, 0, 0, 0) 0px 1px 5px; transition: box-shadow 1s; padding: 15=
px; position: sticky; top: 85px; border-radius: 10px; margin-top: -15px; ma=
rgin-right: -15px; margin-left: -15px; z-index: 10; }

.backdropfilter .canvas-toolbar.sticky { background-color: rgba(255, 255, 2=
55, 0.12); backdrop-filter: blur(50px) saturate(4) brightness(1.2); }

.canvas-toolbar.inline { margin: 0px; padding: 0px; }

.no-js .canvas-toolbar#toolbar-medicine, .no-js .canvas-toolbar#toolbar-ind=
ication, .no-js .canvas-toolbar#toolbar-medicine-group { display: none; }

@media only screen and (max-width: 769px) {
  .canvas-toolbar#toolbar-news-overview { display: none; }
}

.canvas-toolbar + .pat-rich > .pat-message { margin-top: -27px; }

@media only screen and (min-width: 770px) {
  .canvas-toolbar { height: 44px; }
}

@media only screen and (max-width: 769px) {
  .canvas-toolbar { padding: 0px; }
}

.canvas-toolbar .control-group { float: left; animation: 0.6s ease 0s 1 nor=
mal none running fadeIn; }

.mode-select .canvas-toolbar .control-group.view-options { display: none; }

.mode-follow .canvas-toolbar .control-group.batch-operations { display: non=
e; }

@media only screen and (min-width: 1280px) {
  .canvas-toolbar.indented { padding-left: 28%; }
}

@media only screen and (min-width: 1280px) {
  .canvas-toolbar.indented { padding-left: 28%; }
}

.canvas-toolbar .float-after { margin-left: 2em; padding-right: 0px; }

.canvas-toolbar #dynamic-options { margin: 0px; }

.no-js .canvas-toolbar #dynamic-options { display: none; }

.canvas-toolbar #dynamic-options .pat-select, .canvas-toolbar #dynamic-opti=
ons input[type=3D"search"] { opacity: 0; animation: 1s ease 1s 1 normal for=
wards running fadeIn; float: left; }

.canvas-toolbar #dynamic-options #trigger-advanced-search.collapsible-open =
{ background-color: rgb(225, 112, 0); color: rgb(255, 255, 255); }

@media print {
  .canvas-toolbar { display: none; }
}

.canvas-toolbar .bar-title { margin: 0px 1em 0px 0px; float: left; }

.canvas-toolbar label.pat-checklist:hover { color: rgb(1, 104, 154); }

@media only screen and (max-width: 769px) {
  .canvas-toolbar#dashboard-toolbar { display: none; }
}

.canvas-toolbar .pat-select:not(.bare) select { background-color: rgb(231, =
231, 231); border-radius: 0px; padding: 0px 25px; display: inline-block; cu=
rsor: default; color: rgb(1, 104, 154); white-space: nowrap; font-size: 18p=
x; height: 35px; }

.canvas-toolbar .pat-select:not(.bare) select:hover { color: rgb(1, 104, 15=
4); }

.canvas-toolbar .pat-select, .canvas-toolbar .pat-select.bare, .canvas-tool=
bar .context-menu { display: inline-block; float: none; width: auto; vertic=
al-align: top; color: rgb(0, 0, 0); }

.canvas-toolbar .pat-select:hover, .canvas-toolbar .pat-select.bare:hover, =
.canvas-toolbar .context-menu:hover { text-decoration: none; }

@media only screen and (min-width: 770px) {
  .canvas-toolbar .pat-select, .canvas-toolbar .pat-select.bare, .canvas-to=
olbar .context-menu { margin-right: 18px; }
}

@media only screen and (max-width: 769px) {
  .canvas-toolbar .pat-select, .canvas-toolbar .pat-select.bare, .canvas-to=
olbar .context-menu { margin-right: 0.6em; margin-bottom: 0.5em; }
}

.canvas-toolbar input[type=3D"search"] { float: right; border-radius: 1em; =
background: rgb(255, 255, 255); }

@media only screen and (max-width: 769px) {
  .canvas-toolbar input[type=3D"search"] { width: 100%; margin-bottom: 1.5e=
m; margin-top: 0.5em; }
}

.canvas-toolbar .icons, .canvas-toolbar .functions { float: right; }

@media only screen and (max-width: 769px) {
  .canvas-toolbar .icons, .canvas-toolbar .functions { display: none; }
}

.canvas-toolbar .button { font-family: "RO Sans"; margin: 0px; border: none=
; cursor: default; border-radius: 0px; background-image: none; text-decorat=
ion: none; line-height: var(--pat-button-height); display: inline-block; pa=
dding: var(--pat-button-paddings); font-size: 1.26562rem; vertical-align: t=
ext-bottom; font-weight: var(--pat-button-font-weight); box-shadow: none; c=
olor: rgb(1, 104, 154); background-color: rgb(242, 242, 242); max-width: 10=
0%; overflow: hidden; text-overflow: ellipsis; white-space: nowrap; height:=
 44px; }

.canvas-toolbar .button::before { line-height: inherit; }

.canvas-toolbar .button:focus { outline: var(--pat-form-input-field-outline=
-focus); outline-offset: var(--pat-form-input-field-outline-offset); }

.canvas-toolbar .button:hover { background-color: rgb(237, 237, 237); text-=
decoration: none; color: rgb(1, 104, 154); }

.canvas-toolbar .button.default { color: white; background-color: rgb(1, 10=
4, 155); box-shadow: none; }

.canvas-toolbar .button.default:hover { background-color: rgb(1, 70, 104); =
color: white; }

.canvas-toolbar .button[disabled], .canvas-toolbar .button.disabled, .canva=
s-toolbar .button:is(a):not([href]), .canvas-toolbar .button.default[disabl=
ed], .canvas-toolbar .button.default.disabled, .canvas-toolbar .button:is(a=
).default:not([href]) { color: rgba(0, 0, 0, 0.3); background-color: rgb(24=
2, 242, 242); }

.canvas-toolbar .button[disabled]:hover, .canvas-toolbar .button.disabled:h=
over, .canvas-toolbar .button:is(a):not([href]):hover, .canvas-toolbar .but=
ton.default[disabled]:hover, .canvas-toolbar .button.default.disabled:hover=
, .canvas-toolbar .button:is(a).default:not([href]):hover { color: rgba(0, =
0, 0, 0.3); background-color: rgb(242, 242, 242); }

@media print {
  .canvas-toolbar .button { display: none; }
}

.canvas-toolbar .button.small { font-size: 18px; padding: 0px 0.8rem; heigh=
t: 29px; line-height: 29px; vertical-align: baseline; box-shadow: none; fon=
t-weight: normal; }

.canvas-toolbar .button.small::before { font-size: 15px; }

.canvas-toolbar .button.iconified { width: 30px; padding: 0px; }

.canvas-toolbar .button.iconified::before { width: 100%; text-align: center=
; line-height: 44px; }

.canvas-toolbar .button.link { padding: 0px; display: inline; background: n=
one; color: rgb(1, 104, 155); line-height: inherit; text-decoration: underl=
ine; vertical-align: baseline; cursor: pointer; }

.canvas-toolbar .button.link:hover { background: none; color: rgb(0, 2, 3);=
 text-decoration: underline !important; }

.canvas-toolbar .button.no-label { padding: 0px; aspect-ratio: 1 / 1; text-=
overflow: clip; height: var(--pat-button-height); min-width: var(--pat-butt=
on-height); }

.canvas-toolbar .button.no-label::before { width: 100%; text-align: center;=
 margin: 0px 1em 0px 0px; line-height: var(--pat-button-height); }

.canvas-toolbar .button::before { font-weight: normal; margin-right: 5px; }

.canvas-toolbar .button.add::before { font-family: fontello; content: "=EE=
=A3=A4"; }

.canvas-toolbar .button.no-label { width: 44px; }

.canvas-toolbar .button.context-menu { overflow: visible; }

.canvas-toolbar .button.context-menu .panel-content { color: rgb(0, 0, 0); =
}

.canvas-toolbar .button:hover { text-decoration: none; }

.canvas-toolbar .button .counter { display: inline-block; margin: 1.1em 0em=
 0.5em 0.5em; background-color: rgb(213, 43, 30); color: rgb(255, 255, 255)=
; border-radius: 1em; border: 1px solid rgb(255, 255, 255); height: 1.8em; =
min-width: 1.8em; box-sizing: border-box; padding: 0px 0.5em; transition: o=
pacity 0.5s; animation: 0.6s ease 0s 1 normal none running zoomIn; float: r=
ight; vertical-align: baseline; line-height: 1.7em; font-size: 0.6em; text-=
align: center; font-weight: normal; }

.canvas-toolbar .button .counter.disabled { opacity: 0.2; animation: auto e=
ase 0s 1 normal none running none; background-color: gray; }

.canvas-toolbar .button .counter.injecting { opacity: 0; }

.canvas-toolbar .button .counter.injecting::before { display: none; }

.canvas-toolbar .button.checked, .canvas-toolbar .button.current { backgrou=
nd: rgb(1, 104, 155); color: rgb(255, 255, 255); }

.canvas-toolbar .button.checked .counter, .canvas-toolbar .button.current .=
counter { background: rgb(213, 43, 30); }

.mode-select .canvas-toolbar .button.selection-mode-toggle { background: rg=
b(225, 112, 0) !important; color: rgb(255, 255, 255) !important; border-col=
or: rgba(0, 0, 0, 0) !important; }

.canvas-toolbar .button:not([disabled]):not(.current):hover, .canvas-toolba=
r .button[href]:not(.current):hover { color: rgb(1, 104, 154); background-c=
olor: rgb(237, 237, 237); }

.canvas-toolbar .button:not([disabled]):not(.current):active, .canvas-toolb=
ar .button[href]:not(.current):active { box-shadow: none; }

.canvas-toolbar .button.icon-envelope-open::before { transform: scale(0.8);=
 }

.canvas-toolbar .button.icon-plus::before { transform: scale(1.4); }

.canvas-toolbar .button.locked { position: relative; padding-right: 3em; co=
lor: rgb(225, 112, 0); }

.canvas-toolbar .button.locked::after { display: block; font-family: fontel=
lo; content: "=EE=A0=AE"; position: absolute; right: 0px; top: 0px; bottom:=
 0px; height: 100%; width: 2em; text-align: center; background: rgb(225, 11=
2, 0); color: rgb(255, 255, 255); line-height: 44px; }

.canvas-toolbar .button.locked.active::after { content: "=EE=A0=AF"; }

.canvas-toolbar a.button:not([href]) { opacity: 0.4; }

.canvas-toolbar .button-cluster { display: inline-block; margin: 0px 1em 1e=
m 0px; vertical-align: top; border-radius: 0px; background-color: rgb(242, =
242, 242); overflow: hidden; height: 44px; max-width: 769px; }

.canvas-toolbar .button-cluster.align-centre { position: relative; left: 50=
%; transform: translateX(-50%); transition: 0.5s 0.5s; }

.canvas-toolbar .button-cluster .button { border-radius: 0px; margin: 0px; =
background-color: rgba(0, 0, 0, 0); }

.canvas-toolbar .button-cluster .button input { position: absolute; opacity=
: 0; }

.canvas-toolbar .button-cluster .button[disabled] { opacity: 0.5; color: gr=
ay; }

.canvas-toolbar .button-cluster .button.current, .canvas-toolbar .button-cl=
uster .button.current:hover, .canvas-toolbar .button-cluster .button.checke=
d, .canvas-toolbar .button-cluster .button.checked:hover { background-color=
: rgb(1, 104, 155); color: rgb(255, 255, 255); }

.canvas-toolbar .button-cluster .button:first-child { border-top-left-radiu=
s: 0px; border-bottom-left-radius: 0px; }

.canvas-toolbar .button-cluster .button:last-child { border-top-right-radiu=
s: 0px; border-bottom-right-radius: 0px; }

.canvas-toolbar .button, .canvas-toolbar .icon { margin: 0px 1em 1em 0px; d=
isplay: inline-block; vertical-align: top; line-height: 44px; border: none;=
 background-color: rgb(242, 242, 242); }

.canvas-toolbar .button:active, .canvas-toolbar .icon:active { box-shadow: =
rgba(0, 0, 0, 0.15) 0px 1px 3px inset; }

.canvas-toolbar .functions { margin-left: 18px; }

.canvas-toolbar .functions .button, .canvas-toolbar .functions .icon { marg=
in: 0px 0px 0px 1em; }

.canvas-toolbar .icon { font-family: fontello; text-indent: -1000em; width:=
 44px; height: 44px; position: relative; color: rgb(102, 102, 102); cursor:=
 default; margin: 0px 0px 1em 1em; line-height: 44px; }

.canvas-toolbar .icon.level-up { float: left; margin-left: 0px; transform: =
scale(-1, 1); overflow: hidden; }

.canvas-toolbar .icon.level-up::before { content: "=EF=85=88"; }

.canvas-toolbar .icon::before { font-family: fontello; text-indent: 0px; li=
ne-height: 44px; text-align: center; position: absolute; margin: 0px; top: =
0px; left: 0px; width: 100%; height: 100%; display: inline-block; backgroun=
d: rgb(242, 242, 242); border-radius: 0px; color: rgb(1, 104, 154); box-siz=
ing: border-box; }

.canvas-toolbar .icon:hover { color: rgb(1, 104, 154); }

.canvas-toolbar .icon:hover::before { background-color: rgb(237, 237, 237);=
 }

.canvas-toolbar .icon.tooltip-active-click::before { background-color: rgb(=
225, 112, 0); color: rgb(255, 255, 255); }

.canvas-toolbar .icon.open-all-sections::before { content: "=EE=A1=8D"; tra=
nsform: rotate(90deg); font-size: 21px; line-height: 44px; }

.canvas-toolbar .icon.create::before, .canvas-toolbar .icon.new::before { c=
ontent: "=EE=A2=87"; }

.canvas-toolbar .icon.edit::before { content: "=EE=A0=92"; }

.canvas-toolbar .icon.download::before { content: "=EE=A0=8F"; }

.canvas-toolbar .icon.more::before { content: "=EE=A2=9E"; }

.canvas-toolbar .canvas-toolbar-search-field { width: 44px; height: 44px; p=
osition: relative; display: inline-block; z-index: 1; margin-left: 18px; co=
lor: rgb(1, 104, 154); background-color: rgb(242, 242, 242); }

.canvas-toolbar .canvas-toolbar-search-field:not([disabled]):not(.focus):no=
t(.has-value):hover { color: rgb(1, 104, 154); background-color: rgb(237, 2=
37, 237); }

.canvas-toolbar .canvas-toolbar-search-field::after { position: absolute; t=
op: 0px; left: 0px; line-height: 44px; width: 44px; text-align: center; fon=
t-family: fontello; content: "=EE=A2=B4"; font-size: 22px; transition: left=
 0.5s, padding-left 0.5s, transform 1s; }

.canvas-toolbar .canvas-toolbar-search-field:hover { color: rgb(0, 0, 0); }

.canvas-toolbar .canvas-toolbar-search-field input { width: 44px; height: 4=
4px; border-radius: 0px; background: rgb(255, 255, 255); border: 1px solid =
silver; max-width: 1000px; position: absolute; top: 0px; right: 0px; transi=
tion: 0.5s; opacity: 0; padding-left: 34px; margin: 0px; }

.canvas-toolbar .canvas-toolbar-search-field input:focus { outline: none; b=
ox-shadow: none; }

.canvas-toolbar .canvas-toolbar-search-field.focus input, .canvas-toolbar .=
canvas-toolbar-search-field.has-value input { width: 270px; opacity: 1; }

@media only screen and (min-width: 770px) {
  .canvas-toolbar .canvas-toolbar-search-field.focus input, .canvas-toolbar=
 .canvas-toolbar-search-field.has-value input { width: 350px; }
}

.canvas-toolbar .canvas-toolbar-search-field.focus::after, .canvas-toolbar =
.canvas-toolbar-search-field.has-value::after { color: gray; left: -270px; =
}

@media only screen and (min-width: 770px) {
  .canvas-toolbar .canvas-toolbar-search-field.focus::after, .canvas-toolba=
r .canvas-toolbar-search-field.has-value::after { left: -350px; padding-lef=
t: 40px; }
}

.classification-tag { border-radius: 20px; font-size: 10px; height: 12px; l=
ine-height: 12px; padding: 0px 6px; vertical-align: middle; display: inline=
; background: silver; color: rgb(0, 0, 0); margin-top: -2px; margin-left: 3=
px; text-decoration: none; }

.classification-tag:hover { text-decoration: none !important; }

.classification-tag.language.active { background: rgb(0, 123, 199); color: =
rgb(255, 255, 255) !important; }

.classification-tag.mutated { width: 10px; height: 10px; overflow: hidden; =
border: 2px solid rgb(255, 255, 255); padding: 0px; border-radius: 50%; bac=
kground: linear-gradient(rgb(143, 202, 231) 0%, rgb(0, 123, 199) 100%); dis=
play: inline-block; margin-top: 0px; color: rgba(0, 0, 0, 0) !important; }

.classification-tag.wegiz { background: rgb(213, 43, 30); color: rgb(255, 2=
55, 255) !important; }

.classification-tag.biosimilar { background: rgb(214, 215, 178); color: rgb=
(57, 135, 12) !important; }

.classification-tag.generic { background: rgb(102, 102, 102); color: rgb(23=
9, 239, 239) !important; }

.classification-tag.sluice { background: rgb(251, 234, 217); color: rgb(225=
, 112, 0) !important; }

.classification-tag.indication { background: rgb(198, 184, 207); color: rgb=
(66, 20, 95) !important; }

.classification-tag.meerjarenagenda { background: rgb(225, 112, 0); color: =
rgb(255, 255, 255) !important; }

.classification-tag.has-mutations { background: rgb(225, 112, 0); text-tran=
sform: uppercase; color: rgb(255, 255, 255) !important; }

.classification-tag.new { background: rgb(57, 135, 12); text-transform: upp=
ercase; color: rgb(255, 255, 255) !important; }

.cms-page-module { border: 2px solid rgba(0, 0, 0, 0); padding: 0px 15px; m=
argin: 0px -15px; transition: margin 0.3s, box-shadow 0.3s; }

.cms-page-module::after { content: " "; display: table; clear: both; }

.cms-page-module .panel-content > .pat-rich { padding: 0px 20px; }

.cms-page-module .panel-content > .pat-rich .ProseMirror > :first-child { m=
argin-top: 0px; }

.cms-page-module .panel-content > .pat-rich + .form-panel { margin-top: 40p=
x; }

.cms-page-module .section-destroyer { position: absolute; opacity: 0; z-ind=
ex: -1; }

.cms-page-module .section-destroyer.checked ~ .page-module-title { box-shad=
ow: rgb(255, 255, 255) 0px 0px 0px 5px; background: rgb(255, 255, 255) !imp=
ortant; }

.cms-page-module .section-destroyer.checked ~ .page-module-title .title-seg=
ment { text-decoration: line-through; }

.cms-page-module .section-destroyer.checked ~ .page-module-title .buttons-s=
egment { display: none; }

.cms-page-module .section-destroyer.checked ~ .page-module-title::before { =
content: "=EE=A0=96" !important; }

.cms-page-module .section-destroyer.checked ~ .panel-content { display: non=
e !important; }

.cms-page-module .page-module-title { margin: 0px 0px 20px; font-size: 22px=
; line-height: 1.625; padding-top: 10px; }

.cms-page-module .page-module-title.assistive { position: absolute !importa=
nt; }

.cms-page-module .form-panel.horizontal { width: auto; }

.cms-page-module .form-panel:first-child { margin-top: -29px; }

.cms-page-module .form-panel:last-child { margin-bottom: -30px; }

.cms-page-module .form-panel + .pat-rich { margin-top: 50px; }

.cms-page-module.type-downloads.pat-collapsible .panel-content, .cms-page-m=
odule.type-reports.pat-collapsible .panel-content { padding: 15px; }

.cms-page-module.type-downloads.pat-collapsible .panel-content .item-info, =
.cms-page-module.type-reports.pat-collapsible .panel-content .item-info { b=
ackground-color: rgb(242, 242, 242); }

.cms-page-module.type-object .pat-screenshot { margin-bottom: -2px; }

.cms-page-module .grid-editor .link-list { margin-bottom: 0px; }

.cms-page-module .grid-editor .link-list li:last-child { margin-bottom: 15p=
x; }

.cms-page-module .grid-editor .pat-button-bar { margin-top: 0px; }

.cms-page-module .grid-editor:has(.link-list li) .pat-button-bar { margin-t=
op: 15px; }

.cms-page-module.type-data-exchange .ProseMirror { min-height: 80px; paddin=
g-bottom: 40px; }

.cms-page-module.type-data-exchange .sortable-blocks { margin: 0px; }

.cms-page-module.type-data-exchange .sortable-blocks li:last-child { margin=
-bottom: 15px; }

.cms-page-module.type-definition .input-list { margin-bottom: 0px; }

.cms-page-module.type-definition .input-list li:last-child { margin-bottom:=
 15px; }

.cms-page-module.type-metadata { margin-bottom: 60px; }

.cms-page-module.type-metadata.pat-collapsible .page-module-title { backgro=
und-color: rgb(229, 240, 249); }

.cms-page-module.type-object figcaption .enlarge-link { color: gray; text-d=
ecoration: none; float: right; cursor: pointer; }

.cms-page-module.type-object figcaption .icon-right-dir::before { transform=
: scale(1.4); }

.cms-page-module.type-object .enlarge-button { position: absolute; inset: 0=
px 10px; z-index: 1; color: rgba(0, 0, 0, 0); overflow: hidden; }

.cms-page-module.type-object .enlarge-button::before { position: absolute; =
font-family: fontello; content: "=EE=A0=BB"; top: 50%; left: 50%; transform=
: translate(-50%, -50%); color: rgb(255, 255, 255); width: 60px; height: 60=
px; line-height: 60px; background-color: rgba(0, 0, 0, 0.4); font-size: 50p=
x; display: block; text-align: center; padding: 0px; margin: -10px 0px 0px;=
 }

.cms-page-module.has-differences .page-module-title { background: rgba(255,=
 100, 0, 0.1); }

.cms-page-module.has-mutations .page-module-title { position: relative; pad=
ding-right: 25px; }

.cms-page-module.has-mutations .page-module-title::after { position: absolu=
te; top: 50%; right: 10px; transform: translateY(-50%); content: " "; width=
: 10px; height: 10px; overflow: hidden; border: 2px solid rgb(255, 255, 255=
); padding: 0px; border-radius: 50%; background: linear-gradient(rgb(143, 2=
02, 231) 0%, rgb(0, 123, 199) 100%); display: inline-block; margin-top: 0px=
; color: rgba(0, 0, 0, 0) !important; }

.cms-page-module.pat-collapsible + .page-module.pat-collapsible { margin-to=
p: -130px; }

.cms-page-module.pat-collapsible .page-module-title { min-height: 60px; fon=
t-weight: 600; color: rgb(1, 104, 155); background-color: rgb(255, 255, 255=
); padding: 10px 15px 10px 39px; margin: 0px -15px; position: relative; use=
r-select: none; cursor: default; box-sizing: border-box; display: flex; ali=
gn-items: stretch; justify-content: space-between; }

.cms-page-module.pat-collapsible .page-module-title .title-segment { paddin=
g: 12px 20px 12px 39px; margin: -10px 0px -10px -39px; width: 100%; display=
: flex; justify-content: flex-start; font-size: 30px; line-height: 35px; }

.cms-page-module.pat-collapsible .page-module-title .title-segment::after {=
 font-family: fontello; font-size: 16px; display: inline-block; margin-left=
: 15px; margin-top: 0px; color: rgb(66, 20, 95); transition: 0.2s; }

.cms-page-module.pat-collapsible .page-module-title .title-segment .fractio=
n-id { border-radius: 4px; font-size: 16px; line-height: 33px; position: re=
lative; top: 5px; height: 32px; margin-right: 10px; background: rgb(229, 24=
0, 249); filter: brightness(0.92); font-weight: normal; font-family: monosp=
ace; color: rgba(0, 0, 0, 0.6); padding: 0px 15px; display: inline-block; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment { whit=
e-space: nowrap; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect { --select-box-height: 39px; vertical-align: middle; display: inline-=
block; height: var(--pat-select-box-height); line-height: var(--pat-select-=
box-height); padding-top: var(--pat-select-box-padding-top-bottom); padding=
-bottom: var(--pat-select-box-padding-top-bottom); padding-left: var(--pat-=
select-box-padding-start); padding-right: calc(var(--pat-select-box-arrow-w=
idth) + var(--pat-select-box-padding-start)/2); position: relative; box-siz=
ing: border-box; border: var(--pat-form-input-field-border); border-radius:=
 var(--pat-form-input-field-border-radius); box-shadow: var(--pat-select-bo=
x-box-shadow); outline: var(--pat-form-input-field-outline); outline-offset=
: var(--pat-form-input-field-outline-offset); color: var(--pat-select-box-a=
rrow-text-colour); font-size: var(--pat-select-box-font-size); max-width: 1=
00%; background-color: var(--pat-select-box-background-colour); overflow: h=
idden; white-space: nowrap; text-overflow: ellipsis; cursor: default; font-=
weight: normal !important; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect:hover { background-color: var(--pat-select-box-background-colour-hove=
r); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"draft"], .cms-page-module.pat-collapsible .page-module-=
title .buttons-segment .pat-select.state-draft { background-color: rgb(251,=
 234, 217); color: rgb(123, 61, 0); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"draft"]::after, .cms-page-module.pat-collapsible .page-=
module-title .buttons-segment .pat-select.state-draft::after { background-c=
olor: rgb(246, 212, 178); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"draft"]::before, .cms-page-module.pat-collapsible .page=
-module-title .buttons-segment .pat-select[data-value=3D"draft"]::after, .c=
ms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-sel=
ect.state-draft::before, .cms-page-module.pat-collapsible .page-module-titl=
e .buttons-segment .pat-select.state-draft::after { color: rgb(123, 61, 0);=
 }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"draft"]:hover, .cms-page-module.pat-collapsible .page-m=
odule-title .buttons-segment .pat-select[data-value=3D"draft"].tooltip-acti=
ve-click, .cms-page-module.pat-collapsible .page-module-title .buttons-segm=
ent .pat-select.state-draft:hover, .cms-page-module.pat-collapsible .page-m=
odule-title .buttons-segment .pat-select.state-draft.tooltip-active-click {=
 background-color: rgb(249, 221, 194); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"draft"]:hover::after, .cms-page-module.pat-collapsible =
.page-module-title .buttons-segment .pat-select[data-value=3D"draft"].toolt=
ip-active-click::after, .cms-page-module.pat-collapsible .page-module-title=
 .buttons-segment .pat-select.state-draft:hover::after, .cms-page-module.pa=
t-collapsible .page-module-title .buttons-segment .pat-select.state-draft.t=
ooltip-active-click::after { background-color: rgb(243, 199, 155); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"for-review"], .cms-page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select.state-for-review { background-color=
: rgb(242, 217, 231); color: rgb(169, 0, 97); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"for-review"]::after, .cms-page-module.pat-collapsible .=
page-module-title .buttons-segment .pat-select.state-for-review::after { ba=
ckground-color: rgb(229, 179, 208); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"for-review"]::before, .cms-page-module.pat-collapsible =
.page-module-title .buttons-segment .pat-select[data-value=3D"for-review"]:=
:after, .cms-page-module.pat-collapsible .page-module-title .buttons-segmen=
t .pat-select.state-for-review::before, .cms-page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select.state-for-review::after { col=
or: rgb(93, 0, 53); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"for-review"]:hover, .cms-page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select[data-value=3D"for-review"].to=
oltip-active-click, .cms-page-module.pat-collapsible .page-module-title .bu=
ttons-segment .pat-select.state-for-review:hover, .cms-page-module.pat-coll=
apsible .page-module-title .buttons-segment .pat-select.state-for-review.to=
oltip-active-click { background-color: rgb(236, 198, 219); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"for-review"]:hover::after, .cms-page-module.pat-collaps=
ible .page-module-title .buttons-segment .pat-select[data-value=3D"for-revi=
ew"].tooltip-active-click::after, .cms-page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select.state-for-review:hover::after, .cms=
-page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t.state-for-review.tooltip-active-click::after { background-color: rgb(223,=
 160, 196); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"approved"], .cms-page-module.pat-collapsible .page-modu=
le-title .buttons-segment .pat-select.state-approved { background-color: rg=
b(225, 237, 219); color: rgb(43, 103, 9); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"approved"]::after, .cms-page-module.pat-collapsible .pa=
ge-module-title .buttons-segment .pat-select.state-approved::after { backgr=
ound-color: rgb(196, 219, 182); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"approved"]::before, .cms-page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select[data-value=3D"approved"]::aft=
er, .cms-page-module.pat-collapsible .page-module-title .buttons-segment .p=
at-select.state-approved::before, .cms-page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select.state-approved::after { color: rgb(=
27, 65, 6); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"approved"]:hover, .cms-page-module.pat-collapsible .pag=
e-module-title .buttons-segment .pat-select[data-value=3D"approved"].toolti=
p-active-click, .cms-page-module.pat-collapsible .page-module-title .button=
s-segment .pat-select.state-approved:hover, .cms-page-module.pat-collapsibl=
e .page-module-title .buttons-segment .pat-select.state-approved.tooltip-ac=
tive-click { background-color: rgb(211, 229, 202); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"approved"]:hover::after, .cms-page-module.pat-collapsib=
le .page-module-title .buttons-segment .pat-select[data-value=3D"approved"]=
.tooltip-active-click::after, .cms-page-module.pat-collapsible .page-module=
-title .buttons-segment .pat-select.state-approved:hover::after, .cms-page-=
module.pat-collapsible .page-module-title .buttons-segment .pat-select.stat=
e-approved.tooltip-active-click::after { background-color: rgb(182, 211, 16=
5); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"published"], .cms-page-module.pat-collapsible .page-mod=
ule-title .buttons-segment .pat-select[data-value=3D"sent"], .cms-page-modu=
le.pat-collapsible .page-module-title .buttons-segment .pat-select.state-pu=
blished, .cms-page-module.pat-collapsible .page-module-title .buttons-segme=
nt .pat-select.state-sent { background-color: rgb(229, 240, 249); color: rg=
b(1, 53, 79); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"published"]::after, .cms-page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select[data-value=3D"sent"]::after, =
.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect.state-published::after, .cms-page-module.pat-collapsible .page-module=
-title .buttons-segment .pat-select.state-sent::after { background-color: r=
gb(204, 224, 241); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"published"]::before, .cms-page-module.pat-collapsible .=
page-module-title .buttons-segment .pat-select[data-value=3D"published"]::a=
fter, .cms-page-module.pat-collapsible .page-module-title .buttons-segment =
.pat-select[data-value=3D"sent"]::before, .cms-page-module.pat-collapsible =
.page-module-title .buttons-segment .pat-select[data-value=3D"sent"]::after=
, .cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat=
-select.state-published::before, .cms-page-module.pat-collapsible .page-mod=
ule-title .buttons-segment .pat-select.state-published::after, .cms-page-mo=
dule.pat-collapsible .page-module-title .buttons-segment .pat-select.state-=
sent::before, .cms-page-module.pat-collapsible .page-module-title .buttons-=
segment .pat-select.state-sent::after { color: rgb(1, 53, 79); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"published"]:hover, .cms-page-module.pat-collapsible .pa=
ge-module-title .buttons-segment .pat-select[data-value=3D"published"].tool=
tip-active-click, .cms-page-module.pat-collapsible .page-module-title .butt=
ons-segment .pat-select[data-value=3D"sent"]:hover, .cms-page-module.pat-co=
llapsible .page-module-title .buttons-segment .pat-select[data-value=3D"sen=
t"].tooltip-active-click, .cms-page-module.pat-collapsible .page-module-tit=
le .buttons-segment .pat-select.state-published:hover, .cms-page-module.pat=
-collapsible .page-module-title .buttons-segment .pat-select.state-publishe=
d.tooltip-active-click, .cms-page-module.pat-collapsible .page-module-title=
 .buttons-segment .pat-select.state-sent:hover, .cms-page-module.pat-collap=
sible .page-module-title .buttons-segment .pat-select.state-sent.tooltip-ac=
tive-click { background-color: rgb(208, 228, 244); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-value=3D"published"]:hover::after, .cms-page-module.pat-collapsi=
ble .page-module-title .buttons-segment .pat-select[data-value=3D"published=
"].tooltip-active-click::after, .cms-page-module.pat-collapsible .page-modu=
le-title .buttons-segment .pat-select[data-value=3D"sent"]:hover::after, .c=
ms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-sel=
ect[data-value=3D"sent"].tooltip-active-click::after, .cms-page-module.pat-=
collapsible .page-module-title .buttons-segment .pat-select.state-published=
:hover::after, .cms-page-module.pat-collapsible .page-module-title .buttons=
-segment .pat-select.state-published.tooltip-active-click::after, .cms-page=
-module.pat-collapsible .page-module-title .buttons-segment .pat-select.sta=
te-sent:hover::after, .cms-page-module.pat-collapsible .page-module-title .=
buttons-segment .pat-select.state-sent.tooltip-active-click::after { backgr=
ound-color: rgb(184, 212, 236); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect.locked::before { font-family: fontello; content: "=EE=A0=AE"; display=
: inline-block; margin-right: 5px; float: left; font-size: inherit; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect:not([class*=3D"icon-"])::before { font-size: var(--pat-select-box-fon=
t-size); content: attr(data-option); white-space: nowrap; overflow: hidden;=
 text-overflow: ellipsis; display: block; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[class*=3D"icon-"]::before { margin-left: -5px; margin-right: 8px; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect select { position: absolute; inset: 0px; opacity: 0; margin: 0px; z-i=
ndex: 1; height: 100% !important; width: 100% !important; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect select option { font-size: initial; color: rgb(0, 0, 0); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect::after { font-family: fontello; content: "=EE=A3=87"; width: var(--pa=
t-select-box-arrow-width); background-color: var(--pat-select-box-arrow-bac=
kground-colour); background-image: none; position: absolute; top: 0px; righ=
t: 0px; bottom: 0px; font-size: var(--pat-select-box-arrow-size); border-to=
p-right-radius: var(--pat-form-fields-border-radius); border-bottom-right-r=
adius: var(--pat-form-fields-border-radius); padding: 0px; display: flex; a=
lign-items: center; justify-content: center; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect option:disabled { color: silver; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect.injecting { opacity: 0.3; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"draft"] { background-color: rgb(225, 112, 0); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"draft"]::before { color: rgb(255, 255, 255); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"for-review"] { background-color: rgb(169, 0, 97)=
; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"for-review"]::before { color: rgb(255, 255, 255)=
; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"published"] { background-color: rgb(214, 215, 17=
8); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .pat-s=
elect[data-option-value=3D"published"]::before { color: rgb(57, 135, 12); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon =
{ color: rgba(0, 0, 0, 0); width: 39px; height: 39px; line-height: 39px; po=
sition: relative; background: rgba(0, 0, 0, 0); display: inline-block; marg=
in-left: 5px; cursor: default; vertical-align: middle; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon:=
hover { text-decoration: none; background: rgb(237, 237, 237); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon.=
tooltip-active-click { background: rgb(225, 112, 0); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon.=
tooltip-active-click::before { color: rgb(255, 255, 255); }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon:=
:before { font-family: fontello; position: absolute; inset: 0px; text-align=
: center; color: rgb(1, 104, 155); line-height: 39px; font-size: 20px; widt=
h: 100%; margin: 0px; font-style: normal; font-weight: normal; }

.cms-page-module.pat-collapsible .page-module-title .buttons-segment .icon.=
help-icon::before { content: "=EE=A2=82"; font-size: 0.8em; }

.cms-page-module.pat-collapsible .page-module-title:focus { border-bottom: =
1px solid rgba(255, 255, 255, 0); outline: rgb(0, 123, 199) solid 2px; z-in=
dex: 2; }

.cms-page-module.pat-collapsible .page-module-title::before { position: abs=
olute; left: 0px; top: 50%; transform: translateY(-50%); font-family: fonte=
llo; content: "=EE=A3=87"; display: inline-block; width: 40px; text-align: =
center; font-weight: normal; font-size: 20px; pointer-events: none; }

.cms-page-module.pat-collapsible.closed:hover, .cms-page-module.pat-collaps=
ible.closed.in-progress:hover { border: 2px dotted rgb(143, 202, 231); }

.cms-page-module.pat-collapsible.closed, .cms-page-module.pat-collapsible.o=
pen.in-progress { margin-top: 0px; margin-bottom: 0px; }

.cms-page-module.pat-collapsible.open, .cms-page-module.pat-collapsible.clo=
sed.in-progress { box-shadow: rgb(255, 255, 255) 0px 0px 0px 6px, silver 0p=
x 0px 0px 7px; margin-top: 50px; margin-bottom: 50px; }

.cms-page-module.pat-collapsible.open .page-module-title, .cms-page-module.=
pat-collapsible.closed.in-progress .page-module-title { background: rgb(229=
, 240, 249); }

.cms-page-module.pat-collapsible.open .page-module-title .title-segment::af=
ter, .cms-page-module.pat-collapsible.closed.in-progress .page-module-title=
 .title-segment::after { opacity: 1; }

.cms-page-module.pat-collapsible.open .page-module-title .buttons-segment .=
icon, .cms-page-module.pat-collapsible.closed.in-progress .page-module-titl=
e .buttons-segment .icon { background-color: rgb(1, 104, 155); }

.cms-page-module.pat-collapsible.open .page-module-title .buttons-segment .=
icon::before, .cms-page-module.pat-collapsible.closed.in-progress .page-mod=
ule-title .buttons-segment .icon::before { color: rgb(255, 255, 255); }

.cms-page-module.pat-collapsible.open .page-module-title .buttons-segment .=
icon:hover, .cms-page-module.pat-collapsible.closed.in-progress .page-modul=
e-title .buttons-segment .icon:hover { background-color: rgb(1, 70, 104); }

.cms-page-module.pat-collapsible.open .page-module-title .buttons-segment .=
icon.tooltip-active-click, .cms-page-module.pat-collapsible.closed.in-progr=
ess .page-module-title .buttons-segment .icon.tooltip-active-click { backgr=
ound-color: rgb(225, 112, 0); }

.cms-page-module.pat-collapsible.open .page-module-title::before { content:=
 "=EE=A3=88"; }

.cms-page-module.pat-collapsible.has-differences .page-module-title { backg=
round: rgba(255, 100, 0, 0.1); }

.cms-page-module.pat-collapsible.has-differences .page-module-title.collaps=
ible-open, .cms-page-module.pat-collapsible.has-differences .page-module-ti=
tle.collapsible-closed.collapsible-in-progress { background: rgba(255, 100,=
 0, 0.2); }

.cms-page-module.pat-collapsible > .panel-content { padding: 30px 0px; marg=
in: 0px -15px; }

.cms-page-module h2, .cms-page-module .page-module-title { transition: back=
ground-color 0.2s; }

.cms-page-module h2 a, .cms-page-module .page-module-title a { text-decorat=
ion: none; color: rgb(0, 0, 0); }

.cms-page-module h2 a[href]:not(.follow):not(.icon)::after, .cms-page-modul=
e .page-module-title a[href]:not(.follow):not(.icon)::after { font-family: =
fontello; content: "=EE=A1=9A"; margin-left: 0.5em; font-size: 1em; positio=
n: absolute; text-decoration: none !important; }

.cms-page-module h2 a[href]:hover, .cms-page-module .page-module-title a[hr=
ef]:hover { text-decoration: underline; }

.cms-page-module h2 a[href]:hover::after, .cms-page-module .page-module-tit=
le a[href]:hover::after { text-decoration: none !important; }

.cms-page-module h2 a.follow, .cms-page-module .page-module-title a.follow =
{ font-size: 1.7rem; color: rgb(1, 104, 155); text-decoration: underline; o=
pacity: 0.6; }

.cms-page-module h2 a.follow:hover, .cms-page-module .page-module-title a.f=
ollow:hover { opacity: 1; }

.cms-page-module h2 a.follow::before, .cms-page-module .page-module-title a=
.follow::before { content: "("; }

.cms-page-module h2 a.follow::after, .cms-page-module .page-module-title a.=
follow::after { content: ")"; }

.cms-page-module.frame { padding: 8px 20px; margin-top: 0px; background: rg=
b(229, 240, 249); }

.cms-page-module.type-links h3 + .link-list { margin-bottom: 20px; }

.no-js .cms-page-module#section-group-information .link-list { display: non=
e; }

.no-js .cms-page-module[id$=3D"compare"] { display: none; }

.cms-page-module#section-cost table.cost-table { clear: none; animation: 1s=
 ease 0s 1 normal forwards running fadeIn; }

.cms-page-module#section-cost #cost-overview .pat-inject { position: relati=
ve; display: block; opacity: 1; }

.js .cms-page-module#section-cost #cost-overview .pat-inject { color: rgb(0=
, 0, 0); text-decoration: none; padding-left: 1.9em; }

.js .cms-page-module#section-cost #cost-overview .pat-inject::before { opac=
ity: 1; position: absolute; top: 50%; content: "=EF=84=A6"; width: 50px; he=
ight: 50px; margin-top: -25px; margin-left: -25px; z-index: 1000; font: 27p=
x / 50px fontello; text-shadow: rgb(255, 255, 255) 0px 0px 2px; text-align:=
 center; animation: 2s linear 0s infinite normal none running spin; left: 0=
.5em; color: rgba(0, 0, 0, 0.6); }

.cms-page-module .stacks-toggle a { display: inline-block; }

.cms-page-module .stacks-toggle a.current { display: none; }

.comments { background-color: rgba(0, 0, 0, 0); margin: 0px; position: rela=
tive; }

table .comments { margin: -210px -15px -10px; padding: 210px 15px 2px; poin=
ter-events: none; }

table .comments textarea { min-height: 33px; }

table .comments > * { pointer-events: auto; }

table .comments:not(.no-comments) { margin-bottom: 0px; }

.comments .comment-trail { font-size: 0.9em; }

.comments .comment-trail.injecting.injecting-element > * { opacity: 1; }

.comments .comment-trail.injecting.injecting-element::before { display: non=
e; }

.pat-grid-list dd .comments { margin: -0.4em 0px; }

.pat-grid-list dd .comments .comment-trail { padding: 0.4em 0px; }

.comments .comment:first-child { padding-top: 0px; }

.comments .comment:first-child .pat-avatar { top: 0.35em; }

.comments .comment:last-child { margin-bottom: 1em; }

.comments .older-comments { position: relative; padding: 0px 0px 0.8em; mar=
gin: 0px; }

.comments .older-comments a { color: gray; font-size: 0.9em; }

.comments .older-comments a:hover { text-decoration: underline; }

.comments .older-comments a::before { content: "=EE=A0=9D "; font-family: f=
ontello; }

.comments .older-comments .counter { float: right; opacity: 0.5; }

.comments .comment { position: relative; padding: 0.5em 1em 0.5em 42px; min=
-height: 2em; }

.comments .comment .pat-avatar { position: absolute; left: 0px; top: 0.8em;=
 }

.comments .comment .comment-content, .comments .comment .comment-header { f=
ont-size: 0.9em; line-height: 1.4em; }

.comments .comment .comment-content p, .comments .comment .comment-content =
ul, .comments .comment .comment-content ol, .comments .comment .comment-con=
tent table, .comments .comment .comment-content dl, .comments .comment .com=
ment-header p, .comments .comment .comment-header ul, .comments .comment .c=
omment-header ol, .comments .comment .comment-header table, .comments .comm=
ent .comment-header dl { margin-bottom: 1em; }

.comments .comment .comment-content p { white-space: pre-line; margin-botto=
m: 0px; }

.comments .comment .date { font-style: italic; color: gray; }

.comments .comment .preview img { max-width: 100%; margin: 0px auto; displa=
y: block; }

.comments .comment .edited-toggle { transition: opacity 1s; opacity: 1; cur=
sor: pointer; }

.comments .comment .edited-toggle:hover { text-decoration: underline; }

.comments .comment .edited-toggle.collapsible-open { opacity: 0; cursor: de=
fault; pointer-events: none; }

.comments .comment .original-text { opacity: 0.5; font-size: 0.8em; }

.comments .comment .comment-header .name { padding-right: 0.15em; color: rg=
b(1, 104, 155); display: inline-block; }

.comments .comment .comment-header .name::after { content: " =E2=80=94"; di=
splay: inline-block; color: rgba(0, 0, 0, 0.5); padding-left: 5px; }

.comments .comment .comment-header a { color: rgba(0, 0, 0, 0.5); text-deco=
ration: none; }

.comments .comment .comment-header a[href]:hover { text-decoration: none; }

.comments .comment .comment-header a[href]:hover .name { text-decoration: u=
nderline; }

.comments .comment .comment-header .icon-cog { position: absolute; color: r=
gba(0, 0, 0, 0.3); font-size: 0.9em; right: 0em; top: 0.8em; }

.comments .comment .comment-header .icon-cog:hover, .comments .comment .com=
ment-header .icon-cog.active { color: rgb(0, 0, 0); }

.comments .comment-trail.has-comments + .message-box { margin-left: 42px !i=
mportant; margin-top: 20px !important; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) { clear: both; float: right; width: 100%; =
display: block; }

.no-js .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.=
page-module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.=
pat-context-menu):not(.place-on-homescreen):not(.search-box):not(.help):not=
(.pat-message):not(.filters):not(.help) { position: relative; }

.no-touchevents .pat-collapsible:not(.content):not(.form-panel):not(.pat-we=
ll):not(.page-module):not(.free-form):not(.cms-page-module):not(.context-me=
nu):not(.pat-context-menu):not(.place-on-homescreen):not(.search-box):not(.=
help):not(.pat-message):not(.filters):not(.help):not(.borderless) .collapsi=
ble-closed:hover { background-color: rgba(0, 0, 0, 0.03); }

@media screen {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help).borderless .collapsible-closed, .pat-col=
lapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-module):no=
t(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-context-men=
u):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):=
not(.filters):not(.help).borderless .collapsible-open { padding: 0px 0px 0p=
x 1.8rem; }
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help).borderless .collapsible-closed::before, =
.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help).borderless .collapsible-open::before { lef=
t: 0px; }
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help).borderless .panel-content { padding-left=
: 1.8rem; }
}

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help).warning { color: rgb(225, 112, 0); }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help).warning .collapsible-closed, .pat-collapsi=
ble:not(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.fr=
ee-form):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):no=
t(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.=
filters):not(.help).warning .collapsible-open { color: rgb(225, 112, 0); }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help).explanation { color: rgb(1, 104, 155); }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help).explanation .collapsible-closed, .pat-coll=
apsible:not(.content):not(.form-panel):not(.pat-well):not(.page-module):not=
(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-context-menu=
):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):n=
ot(.filters):not(.help).explanation .collapsible-open { color: rgb(1, 104, =
155); }

.no-js .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.=
page-module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.=
pat-context-menu):not(.place-on-homescreen):not(.search-box):not(.help):not=
(.pat-message):not(.filters):not(.help) .collapsible-loading-message { padd=
ing: 0px; position: absolute; bottom: 1px; left: 0px; right: 0px; height: 6=
7px; }

.no-js .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.=
page-module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.=
pat-context-menu):not(.place-on-homescreen):not(.search-box):not(.help):not=
(.pat-message):not(.filters):not(.help) .collapsible-loading-message a { di=
splay: block; height: 100%; width: 100%; color: rgba(0, 0, 0, 0) !important=
; }

.no-js .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.=
page-module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.=
pat-context-menu):not(.place-on-homescreen):not(.search-box):not(.help):not=
(.pat-message):not(.filters):not(.help) .collapsible-loading-message a:hove=
r { background-color: rgba(0, 0, 0, 0.03); }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .panel-content .summary { margin: -8px 0px=
 15px; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .panel-content .collapsible-loading-messag=
e { height: 40px; text-align: center; position: relative; opacity: 0; anima=
tion: 1s ease 0.4s 1 normal forwards running fadeIn; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .panel-content .collapsible-loading-messag=
e a { opacity: 0; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .panel-content .collapsible-loading-messag=
e::before { opacity: 1; position: absolute; top: 50%; left: 50%; content: "=
=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; margin-left: -25p=
x; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb(255, 255, 25=
5) 0px 0px 2px; text-align: center; animation: 2s linear 0s infinite normal=
 none running spin; color: gray; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .collapsible-closed, .pat-collapsible:not(=
.content):not(.form-panel):not(.pat-well):not(.page-module):not(.free-form)=
:not(.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.place=
-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.filters)=
:not(.help) .collapsible-open, .pat-collapsible:not(.content):not(.form-pan=
el):not(.pat-well):not(.page-module):not(.free-form):not(.cms-page-module):=
not(.context-menu):not(.pat-context-menu):not(.place-on-homescreen):not(.se=
arch-box):not(.help):not(.pat-message):not(.filters):not(.help) .block-titl=
e { font-weight: bold; color: rgb(1, 104, 155); position: relative; cursor:=
 pointer; display: block; user-select: none; margin: 0px; text-decoration: =
none; }

@media screen {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed, .pat-collapsible:no=
t(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.free-for=
m):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.pla=
ce-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.filter=
s):not(.help) .collapsible-open, .pat-collapsible:not(.content):not(.form-p=
anel):not(.pat-well):not(.page-module):not(.free-form):not(.cms-page-module=
):not(.context-menu):not(.pat-context-menu):not(.place-on-homescreen):not(.=
search-box):not(.help):not(.pat-message):not(.filters):not(.help) .block-ti=
tle { padding: 0.8em 0px 0.8em 2.8rem; }
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed.borderless, .pat-col=
lapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-module):no=
t(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-context-men=
u):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):=
not(.filters):not(.help) .collapsible-open.borderless, .pat-collapsible:not=
(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.free-form=
):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.plac=
e-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.filters=
):not(.help) .block-title.borderless { padding: 0px; }
}

@media screen and (min-width: 0\0 ) {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed, .pat-collapsible:no=
t(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.free-for=
m):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.pla=
ce-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.filter=
s):not(.help) .collapsible-open, .pat-collapsible:not(.content):not(.form-p=
anel):not(.pat-well):not(.page-module):not(.free-form):not(.cms-page-module=
):not(.context-menu):not(.pat-context-menu):not(.place-on-homescreen):not(.=
search-box):not(.help):not(.pat-message):not(.filters):not(.help) .block-ti=
tle { text-decoration: none !important; }
}

@media print {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed, .pat-collapsible:no=
t(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.free-for=
m):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.pla=
ce-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.filter=
s):not(.help) .collapsible-open, .pat-collapsible:not(.content):not(.form-p=
anel):not(.pat-well):not(.page-module):not(.free-form):not(.cms-page-module=
):not(.context-menu):not(.pat-context-menu):not(.place-on-homescreen):not(.=
search-box):not(.help):not(.pat-message):not(.filters):not(.help) .block-ti=
tle { color: rgb(0, 0, 0); font-weight: bold; text-decoration: none; }
}

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .collapsible-closed::before, .pat-collapsi=
ble:not(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.fr=
ee-form):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):no=
t(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.=
filters):not(.help) .collapsible-open::before, .pat-collapsible:not(.conten=
t):not(.form-panel):not(.pat-well):not(.page-module):not(.free-form):not(.c=
ms-page-module):not(.context-menu):not(.pat-context-menu):not(.place-on-hom=
escreen):not(.search-box):not(.help):not(.pat-message):not(.filters):not(.h=
elp) .block-title::before { font-family: fontello; content: "=EE=A2=83"; te=
xt-indent: 0px; font-size: 1em; width: 1em; height: 1em; line-height: 1.1em=
; transition: transform 0.4s; text-decoration: none; display: inline-block;=
 white-space: pre-wrap; border-radius: 2em; text-align: center; position: a=
bsolute; top: 50%; left: 0.9rem; transform: translateY(-50%) rotate(-45deg)=
; margin-top: -0.04em; font-weight: normal; }

@media print {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed::before, .pat-collap=
sible:not(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.=
free-form):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):=
not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):not=
(.filters):not(.help) .collapsible-open::before, .pat-collapsible:not(.cont=
ent):not(.form-panel):not(.pat-well):not(.page-module):not(.free-form):not(=
.cms-page-module):not(.context-menu):not(.pat-context-menu):not(.place-on-h=
omescreen):not(.search-box):not(.help):not(.pat-message):not(.filters):not(=
.help) .block-title::before { display: none; }
}

@media screen {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-closed { text-decoration: n=
one; }
}

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .collapsible-closed:hover { text-decoratio=
n: underline; }

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .collapsible-open { text-decoration: none;=
 }

@media screen {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .collapsible-open::before, .pat-collapsi=
ble:not(.content):not(.form-panel):not(.pat-well):not(.page-module):not(.fr=
ee-form):not(.cms-page-module):not(.context-menu):not(.pat-context-menu):no=
t(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):not(.=
filters):not(.help) .collapsible-closed.collapsible-in-progress::before { t=
ransform: translateY(-50%) rotate(0deg); }
}

.pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-mo=
dule):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-con=
text-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-m=
essage):not(.filters):not(.help) .panel-content { padding: 0px 0px 2em; }

@media screen {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .panel-content { padding-left: 2.8rem; }
}

@media print {
  .pat-collapsible:not(.content):not(.form-panel):not(.pat-well):not(.page-=
module):not(.free-form):not(.cms-page-module):not(.context-menu):not(.pat-c=
ontext-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat=
-message):not(.filters):not(.help) .panel-content { display: block !importa=
nt; }
}

.container { display: block; padding: 0px 15px; margin: 0px auto; box-sizin=
g: border-box; }

.container::before { display: table; content: " "; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .container { max-width: 960px; }
}

@media only screen and (min-width: 1280px) {
  .container { max-width: 1200px; }
  .pat-modal.medium .container { max-width: 960px; }
  .pat-modal.small .container { max-width: 640px; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .container { padding: 0px 15px; }
}

.container::after { content: " "; display: table; clear: both; }

#product-space, #search-content { min-height: calc(-70px + 100vh); box-sizi=
ng: border-box; }

@media only screen and (min-width: 770px) {
  #product-space, #search-content { padding-top: 60px; padding-bottom: 70px=
; }
}

#product-space:has(.swimlane), #search-content:has(.swimlane) { padding-top=
: 0px; }

@media only screen and (max-width: 769px) {
  #product-space, #search-content { padding-top: 20px; padding-bottom: 20px=
; }
}

#product-space:has(.swim-lane), #search-content:has(.swim-lane) { padding-t=
op: 0px; padding-bottom: 0px; }

#product-space:has(#browse-bar), #search-content:has(#browse-bar) { padding=
-top: 0px; padding-bottom: 0px; }

#product-space:has(#browse-bar) #content, #search-content:has(#browse-bar) =
#content { padding: 40px 0px; }

#product-space.grid-on, #search-content.grid-on { background-image: -webkit=
-linear-gradient(top, rgba(0, 0, 0, 0) 95%, rgba(0, 0, 0, 0.3) 100%); backg=
round-size: 100% 26px; }

body:has(#app-space.state-on) #product-space, body:has(#app-space.state-on)=
 #search-content { display: none; }

.variation-compare ~ #main #product-space:not(.compare-count-0), .variation=
-compare ~ #main #search-content:not(.compare-count-0), .variation-medicine=
-compare ~ #main #product-space:not(.compare-count-0), .variation-medicine-=
compare ~ #main #search-content:not(.compare-count-0), .variation-indicatio=
n-compare ~ #main #product-space:not(.compare-count-0), .variation-indicati=
on-compare ~ #main #search-content:not(.compare-count-0), .variation-medici=
ne-group-compare ~ #main #product-space .variation-medicine-group-compare ~=
 #main #search-content:not(.compare-count-0) { background: rgb(255, 255, 25=
5); padding-top: 0px; }

.variation-compare ~ #main #product-space:not(.compare-count-0) > .containe=
r, .variation-compare ~ #main #search-content:not(.compare-count-0) > .cont=
ainer, .variation-medicine-compare ~ #main #product-space:not(.compare-coun=
t-0) > .container, .variation-medicine-compare ~ #main #search-content:not(=
.compare-count-0) > .container, .variation-indication-compare ~ #main #prod=
uct-space:not(.compare-count-0) > .container, .variation-indication-compare=
 ~ #main #search-content:not(.compare-count-0) > .container, .variation-med=
icine-group-compare ~ #main #product-space .variation-medicine-group-compar=
e ~ #main #search-content:not(.compare-count-0) > .container { max-width: i=
nherit; }

@media only screen and (max-width: 769px) {
  .variation-compare ~ #main #product-space:not(.compare-count-0) > .contai=
ner, .variation-compare ~ #main #search-content:not(.compare-count-0) > .co=
ntainer, .variation-medicine-compare ~ #main #product-space:not(.compare-co=
unt-0) > .container, .variation-medicine-compare ~ #main #search-content:no=
t(.compare-count-0) > .container, .variation-indication-compare ~ #main #pr=
oduct-space:not(.compare-count-0) > .container, .variation-indication-compa=
re ~ #main #search-content:not(.compare-count-0) > .container, .variation-m=
edicine-group-compare ~ #main #product-space .variation-medicine-group-comp=
are ~ #main #search-content:not(.compare-count-0) > .container { padding: 0=
px; }
}

:root { --pat-tooltip-box-shadow: 0 4px 14px -2px $transparent-light; }

body:has(#app-dashboard .app-body.mode-select) .pat-toggle.select { color: =
rgb(225, 112, 0); }

body:has(#app-dashboard .app-body.mode-select) li:has(a) { opacity: 0.4; po=
inter-events: none; }

.context-menu.pat-collapsible, .pat-context-menu { position: relative; }

.context-menu.pat-collapsible.save-button .close-menu, .pat-context-menu.sa=
ve-button .close-menu { color: rgba(0, 0, 0, 0); text-align: right; cursor:=
 default; }

.context-menu.pat-collapsible.save-button .close-menu::after, .pat-context-=
menu.save-button .close-menu::after { font-family: fontello; content: "=EE=
=A2=83"; color: gray; font-size: 1.2em; }

.context-menu.pat-collapsible.save-button .close-menu:hover::after, .pat-co=
ntext-menu.save-button .close-menu:hover::after { color: rgb(0, 0, 0); }

.context-menu.pat-collapsible .panel-content, .pat-context-menu .panel-cont=
ent { position: absolute; left: 0px; display: none; background-color: rgb(2=
55, 255, 255); padding: 1em; width: 350px; z-index: 10; top: 53px; border: =
1px solid silver; box-shadow: var(--pat-tooltip-box-shadow); }

.context-menu.pat-collapsible .panel-content :last-child, .pat-context-menu=
 .panel-content :last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .context-menu.pat-collapsible .panel-content, .pat-context-menu .panel-co=
ntent { position: fixed; top: 50%; left: 50%; width: 90%; box-sizing: borde=
r-box; max-height: 80%; transform: translate(-50%, -50%); z-index: 1000; }
}

.context-menu.pat-collapsible .panel-content li button, .context-menu.pat-c=
ollapsible .panel-content li .button, .pat-context-menu .panel-content li b=
utton, .pat-context-menu .panel-content li .button { margin: 0px; }

@media only screen and (min-width: 770px) {
  .context-menu.pat-collapsible.align-right .panel-content, .pat-context-me=
nu.align-right .panel-content { right: 0px; left: inherit; }
}

.cookiewarning { display: none; padding: 2% 6%; position: fixed; right: 0px=
; bottom: 0px; left: 0px; background-color: rgba(255, 255, 255, 0.9); font-=
size: 1em; border-top: 1px solid rgb(203, 203, 203); backdrop-filter: blur(=
5px); z-index: 1000; }

.cookiewarning .cookiewarning_yes { padding: 0px; }

.cookiewarning .close-button { position: absolute; filter: none; border: no=
ne; outline: none; display: block; overflow: visible; padding: 0px; margin:=
 0px; transition: transform 0.2s ease-out; z-index: 2; font-size: 10px; rig=
ht: 2%; top: 50%; transform: translateY(-50%); background: rgb(1, 104, 155)=
; opacity: 1; width: 50px; height: 50px; color: rgba(0, 0, 0, 0) !important=
; }

.cookiewarning .close-button:active { transform: scale(0.6); box-shadow: no=
ne; }

.cookiewarning .close-button:hover { opacity: 1; }

.cookiewarning .close-button::before { font-family: fontello; content: "=EE=
=A2=83"; display: block; position: absolute; right: 0px; top: 0px; font-siz=
e: 2.5em; color: rgb(0, 0, 0); text-indent: 0px; }

@media only screen and (max-width: 769px) {
  .cookiewarning .close-button { top: auto; bottom: 30px; left: 50%; transf=
orm: translateX(-50%); font-size: 0.6em; }
}

.cookiewarning .close-button::before { color: rgb(255, 255, 255); font-size=
: 30px; text-align: center; display: block; width: 50px; line-height: 50px;=
 }

.cookiewarning .close-button:hover::before { color: rgb(255, 255, 255); bac=
kground: rgb(1, 70, 104); }

.cookie-ok .cookiewarning { display: none; }

.pat-checklist label .label-fragment-title { font-weight: bold; }

.pat-checklist label .label-fragment-description { opacity: 0.8; display: b=
lock; font-size: 0.9em; padding-bottom: 0.5em; }

#dashboard { position: relative; overflow: hidden; margin: 0px -15px; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  #dashboard { margin: 0px -10.5px; }
}

.pat-message + #dashboard { margin-top: 30px; }

#dashboard .js::before { opacity: 1; top: 50%; left: 50%; content: "=EF=84=
=A6"; width: 50px; height: 50px; margin-top: -25px; margin-left: -25px; z-i=
ndex: 1000; font: 50px / 50px fontello; text-shadow: rgb(255, 255, 255) 0px=
 0px 2px; text-align: center; animation: 2s linear 0s infinite normal none =
running spin; position: fixed !important; }

@media only screen and (max-width: 769px) {
  #dashboard { margin: 0px; }
}

#dashboard.masonry-ready::before { display: none; }

@media only screen and (max-width: 769px) {
  #dashboard .grid-sizer { width: 100%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  #dashboard .grid-sizer { width: 50%; }
}

@media only screen and (min-width: 1280px) {
  #dashboard .grid-sizer { width: 33.3333%; }
}

#dashboard .portlet { box-sizing: border-box; padding: 0px 15px; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  #dashboard .portlet { padding: 0px 10.5px; }
}

@media only screen and (max-width: 769px) {
  #dashboard .portlet { padding: 0px; }
}

.js #dashboard .portlet { opacity: 0; transition: opacity 0.5s; }

@media only screen and (min-width: 1280px) {
  .js #dashboard .portlet.span-1 { width: 33.3333%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .js #dashboard .portlet.span-1 { width: 50%; }
}

@media only screen and (min-width: 1280px) {
  .js #dashboard .portlet.span-2 { width: 66.6667%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .js #dashboard .portlet.span-2 { width: 50%; }
}

.js #dashboard .portlet.span-3, .js #dashboard .portlet.span-full { width: =
100%; }

@media only screen and (max-width: 769px) {
  .js #dashboard .portlet.stamp { position: static !important; }
}

@media only screen and (min-width: 770px) {
  .js #dashboard .portlet.stamp { position: absolute; top: 0px; }
  .js #dashboard .portlet.stamp.right { right: 0px; }
  .js #dashboard .portlet.stamp.left { left: 0px; }
}

.js #dashboard.masonry-ready .portlet { opacity: 1; }

.directory.injecting::before { position: absolute; }

.directory h2 { text-transform: uppercase; margin: 0px 0px 20px; font-size:=
 1.625rem; padding-top: 10px; }

.directory .link-list { margin-bottom: 20px; }

.directory .block { padding-top: 95px; pointer-events: none; margin-top: -9=
6px !important; margin-bottom: 0px !important; border-top: none !important;=
 }

.directory .block > * { pointer-events: auto; }

.directory .block .block-title { border-top: 1px solid rgb(223, 223, 223); =
}

.no-js .directory .block .block-title { padding: 1em 0px 1em 1rem; }

.directory .loading { color: gray; display: block; padding-top: 6.5em; text=
-align: center; cursor: default; opacity: 1 !important; }

.directory .loading:hover { text-decoration: none; }

.editorial-list { gap: 32px; }

@media only screen and (min-width: 770px) {
  .editorial-list { display: grid; }
}

@media only screen and (min-width: 1280px) {
  .editorial-list.col-2 { grid-template-columns: 1fr 1fr; }
  .editorial-list.col-3 { grid-template-columns: 1fr 1fr 1fr; }
  .editorial-list.col-4 { grid-template-columns: 1fr 1fr 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .editorial-list.col-2 { grid-template-columns: 1fr 1fr; }
  .editorial-list.col-3 { grid-template-columns: 1fr 1fr 1fr; }
  .editorial-list.col-4 { grid-template-columns: 1fr 1fr 1fr; }
}

.editorial-list li.state-draft a { color: rgb(225, 112, 0); }

.editorial-list li a:hover { text-decoration: none; }

.editorial-list li a:hover .item-title { text-decoration: underline; }

@media only screen and (max-width: 769px) {
  .editorial-list li a { padding: 15px 40px 15px 20px; display: block; back=
ground-color: rgb(243, 243, 243); position: relative; margin-bottom: 2px; }
  .editorial-list li a::after { position: absolute; top: 50%; height: auto;=
 transform: translateY(-50%); right: 20px; font-family: fontello; content: =
"=EE=A2=84"; font-size: 25px; color: gray; }
}

.editorial-list li a .item-title { font-size: 1.60181rem; line-height: 1.24=
859; font-weight: normal; margin-top: 0px; margin-bottom: 0.5rem; text-unde=
rline-offset: 0.18em; }

@media only screen and (max-width: 769px) {
  .editorial-list li a .item-title { font-size: 1.3125em; font-weight: bold=
; line-height: 1.2381; margin: 0px; }
}

.editorial-list li a .byline { color: rgb(0, 0, 0); line-height: 1.375em; h=
yphens: auto; display: -webkit-box; -webkit-box-orient: vertical; -webkit-l=
ine-clamp: 3; overflow: hidden; }

@media only screen and (max-width: 769px) {
  .editorial-list li a .byline { padding-top: 2px; font-size: 16px; display=
: none; }
}

.file-download { display: block; box-sizing: border-box; box-shadow: none; =
border-radius: 0px; --pat-toolbar-margin-bottom: 15px; padding: 1rem; backg=
round-color: rgb(243, 243, 243); margin-bottom: 0.5rem; }

.file-download .well-title-group { position: relative; }

.file-download .well-title-group .buttons { position: absolute; right: calc=
(var(--pat-form-panel-padding) + 31px + 15px); top: 50%; transform: transla=
teY(-50%); }

.file-download .well-title-group .buttons .icon { overflow: hidden; width: =
31px; height: 31px; cursor: default; background-color: rgb(242, 242, 242); =
color: rgba(0, 0, 0, 0); position: relative; float: right; margin-left: 15p=
x; border-radius: 0px; font-style: normal; font-weight: normal; }

.file-download .well-title-group .buttons .icon::after { font-family: fonte=
llo; font-size: 1em; z-index: 1; width: 31px; height: 31px; text-align: cen=
ter; line-height: 31px; display: block; position: absolute; color: rgb(1, 1=
04, 154); top: 0px; left: 0px; }

.file-download .well-title-group .buttons .icon:hover { background-color: r=
gb(237, 237, 237); }

.file-download .well-title-group .buttons .icon:hover::after { color: rgb(1=
, 104, 154); }

.file-download .well-title-group .buttons .icon.tooltip-active-click { back=
ground-color: rgb(225, 112, 0); }

.file-download .well-title-group .buttons .icon.tooltip-active-click::after=
 { color: rgb(255, 255, 255); }

.file-download .well-title-group .buttons .icon.help::after { content: "=EE=
=A2=82"; }

.file-download .well-title-group .buttons .icon.add::after { content: "=EE=
=A3=A4"; }

.file-download .well-title-group .buttons .icon.download::after { content: =
"=EE=A0=8F"; }

.file-download .well-title-group .buttons .icon.settings::after { content: =
"=EE=A3=98"; }

.file-download .well-title-group .buttons .icon.more::after { content: "=EE=
=A2=9E"; line-height: calc(34px); }

.file-download .well-header { margin-bottom: 40px; line-height: 1.3; font-s=
ize: 28px; font-weight: normal; color: rgb(0, 0, 0); }

.file-download .well-header .pat-avatar { float: left; width: 36px; height:=
 36px; margin-right: 10px; font-size: 0.7em; }

.file-download .well-separation-header { margin-bottom: 1em; margin-top: 1.=
5em; font-size: 24px; font-weight: bold; }

.file-download .well-separation-header:first-child { margin-top: 0px; }

.file-download.pat-collapsible { transition: padding 0.4s; padding: 0px; }

.file-download.pat-collapsible .panel-content > :last-child { margin-bottom=
: 0px; }

.file-download.pat-collapsible > .well-header, .file-download.pat-collapsib=
le > .well-title-group > .well-header { padding-right: 50px; padding-left: =
40px; position: relative; margin: 0px; transition: padding 0.4s; }

.file-download.pat-collapsible > .well-header::after, .file-download.pat-co=
llapsible > .well-title-group > .well-header::after { font-family: fontello=
; content: "=EE=A3=88"; font-size: 0.65em; background-color: rgb(242, 242, =
242); color: rgb(1, 104, 154); position: absolute; right: var(--pat-form-pa=
nel-padding); top: 50%; transform: translateY(-50%); z-index: 1; width: 31p=
x; height: 31px; text-align: center; line-height: 31px; border-radius: 0px;=
 display: inline-block; }

.file-download.pat-collapsible > .well-header:hover::after, .file-download.=
pat-collapsible > .well-title-group > .well-header:hover::after { backgroun=
d-color: rgb(237, 237, 237); color: rgb(1, 104, 154); }

.file-download.pat-collapsible.open, .file-download.pat-collapsible.closed.=
in-progress { transition: box-shadow 2s; }

.file-download.pat-collapsible.open > .well-header, .file-download.pat-coll=
apsible.open > .well-title-group > .well-header, .file-download.pat-collaps=
ible.closed.in-progress > .well-header, .file-download.pat-collapsible.clos=
ed.in-progress > .well-title-group > .well-header { padding-top: 40px; padd=
ing-bottom: 40px; }

.file-download.pat-collapsible.closed:hover { box-shadow: var(--pat-form-pa=
nel-box-shadow-hover); }

.file-download.pat-collapsible.closed > .well-header, .file-download.pat-co=
llapsible.closed > .well-title-group > .well-header, .file-download.pat-col=
lapsible.open.in-progress > .well-header, .file-download.pat-collapsible.op=
en.in-progress > .well-title-group > .well-header { padding-top: 20px; padd=
ing-bottom: 20px; border-radius: 0px; }

.file-download.pat-collapsible.closed > .well-header::after, .file-download=
.pat-collapsible.closed > .well-title-group > .well-header::after, .file-do=
wnload.pat-collapsible.open.in-progress > .well-header::after, .file-downlo=
ad.pat-collapsible.open.in-progress > .well-title-group > .well-header::aft=
er { content: "=EE=A3=87"; }

.file-download.pat-collapsible > .panel-content { padding: 0px 40px 40px; b=
ox-sizing: border-box; }

.file-download form > fieldset:last-child, .file-download form > fieldset:l=
ast-child > .button-bar:last-child { margin-bottom: 0px; }

.file-download > :last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .file-download { padding: 20px; }
}

.file-download.success { background-color: rgb(225, 237, 219); }

.file-download.success input { color: rgb(0, 0, 0); }

.file-download.notice { background-color: rgb(253, 246, 187); }

.file-download.warning { background-color: rgb(251, 234, 217); }

.file-download.warning input { color: rgb(0, 0, 0); }

.file-download.info { background-color: rgb(217, 237, 247); }

.file-download.success input, .file-download.success textarea, .file-downlo=
ad.success select, .file-download.warning input, .file-download.warning tex=
tarea, .file-download.warning select { background-color: rgba(0, 0, 0, 0.3)=
; outline: rgb(255, 255, 255) solid 1px; }

.file-download.success select, .file-download.warning select { background-i=
mage: url("data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz=
0idXRmLTgiPz4NCjwhLS0gR2VuZXJhdG9yOiBBZG9iZSBJbGx1c3RyYXRvciAxNS4xLjAsIFNWR=
yBFeHBvcnQgUGx1Zy1JbiAgLS0+DQo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQg=
U1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmc=
xMS5kdGQiIFsNCgk8IUVOVElUWSBuc19mbG93cyAiaHR0cDovL25zLmFkb2JlLmNvbS9GbG93cy=
8xLjAvIj4NCl0+DQo8c3ZnIHZlcnNpb249IjEuMSINCgkgeG1sbnM9Imh0dHA6Ly93d3cudzMub=
3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayIg=
eG1sbnM6YT0iaHR0cDovL25zLmFkb2JlLmNvbS9BZG9iZVNWR1ZpZXdlckV4dGVuc2lvbnMvMy4=
wLyINCgkgeD0iMHB4IiB5PSIwcHgiIHdpZHRoPSIxMnB4IiBoZWlnaHQ9IjEwcHgiIHZpZXdCb3=
g9IjAgLTEuNDk2IDEyIDEwIiBvdmVyZmxvdz0idmlzaWJsZSIgZW5hYmxlLWJhY2tncm91bmQ9I=
m5ldyAwIC0xLjQ5NiAxMiAxMCINCgkgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+DQo8ZGVmcz4NCjwv=
ZGVmcz4NCjxwb2x5Z29uIGZpbGw9IiNGRkZGRkYiIHBvaW50cz0iMCwwIDQuMjA1LDcuMDA5IDg=
uNDEsMCAiLz4NCjwvc3ZnPg0K"); }

.file-download .meta { margin-top: 5px; font-weight: normal; color: rgb(83,=
 83, 83); width: 100%; }

.file-download .meta:last-child { margin-bottom: 0px; }

@media only screen and (max-width: 769px) {
  .file-download .meta { display: inline; }
}

@media only screen and (min-width: 770px) {
  .file-download .meta .meta-item { border-left: 1px solid rgb(83, 83, 83);=
 padding: 0px 0.2em; display: inline-block; }
  .file-download .meta .meta-item::before { content: " =C2=A0"; display: in=
line; }
  .file-download .meta .meta-item:first-child { padding-left: 0px; border-l=
eft: none; }
  .file-download .meta .meta-item:first-child::before { display: none; }
}

@media only screen and (max-width: 769px) {
  .file-download .meta .meta-item::after { content: ", "; }
}

#footer { background: rgb(57, 135, 12); position: relative; clear: both; fo=
nt-size: 1.125rem; }

body:has(#app-space.state-on) #footer { display: none; }

@media print {
  #footer { display: none; }
}

@media (display-mode: standalone) {
  #footer { display: none; }
}

#footer .container { padding: 50px 0px; }

@media only screen and (max-width: 769px) {
  #footer .container { padding-top: 30px; padding-bottom: 30px; }
}

#footer .payoff, #footer .column { float: left; padding: 0px 15px; box-sizi=
ng: border-box; }

@media only screen and (min-width: 1280px) {
  #footer .column { width: 16.6667%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  #footer .column { width: 25%; }
}

@media only screen and (max-width: 769px) {
  #footer .column { width: 50% !important; font-size: 16px; }
}

#footer .payoff { font-family: "RO Serif"; color: rgb(255, 255, 255); posit=
ion: relative; font-size: 2.02729rem; line-height: 0.98654; font-style: ita=
lic; }

@media only screen and (min-width: 1280px) {
  #footer .payoff { width: 58.3333%; padding-right: 8%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  #footer .payoff { width: 50%; padding-right: 8%; }
}

@media only screen and (max-width: 769px) {
  #footer .payoff { font-size: 1.5em; padding-bottom: 25px; width: 100% !im=
portant; }
  #footer .payoff br { display: none; }
}

#footer li { list-style: none; margin: 0px; }

#footer li a { text-decoration: none; color: rgb(255, 255, 255); padding: 1=
0px 0px 2px; display: block; line-height: 24px; hyphens: auto; }

@media only screen and (max-width: 769px) {
  #footer li a { padding: 0px; }
}

#footer li a:hover { text-decoration: underline; }

#footer h2 { font-family: "RO Sans", sans-serif; font-size: 1.5em; margin: =
8px 0px 5px; padding-top: 0px; color: rgb(255, 255, 255); font-weight: norm=
al; border: 0px; }

.pat-form { counter-reset: form-panel 0; }

.pat-form.two-factor-authentication .form-panel { padding-left: 0px; }

.pat-form.two-factor-authentication .form-panel .pat-verification-code { ma=
rgin: 70px auto 10px; }

.pat-form.two-factor-authentication .form-panel .pat-button-bar, .pat-form.=
two-factor-authentication .form-panel .pat-checklist { width: 352px; paddin=
g: 0px; margin: 0px auto; }

.pat-form.two-factor-authentication .form-panel .pat-checklist { margin-bot=
tom: 50px; }

.pat-form#search-form { padding-top: 80px; margin-top: -80px; }

.pat-form .e-form-text .meta { text-align: right; font-size: 0.8125em; line=
-height: 1.5; color: rgb(102, 102, 102); }

.pat-form h2 { font-size: 1.536em; font-weight: normal; line-height: 1.1429=
; }

.pat-form h2.req { margin: 0.67em 0px 0px; }

.pat-form label.slider.type-euro { padding-bottom: 1.5em; }

.pat-form label.slider.type-euro::after { content: attr(data-value); }

.pat-form label.slider.type-euro input { position: absolute; }

.pat-form .has-changes { position: absolute; inset: -13px 0px -12px -20px; =
background: rgba(255, 100, 0, 0.1); border-left: 8px solid rgba(255, 100, 0=
, 0.2); z-index: 0; color: rgba(0, 0, 0, 0); display: block; animation: 1s =
ease 0s 1 normal none running fadeIn; grid-area: label !important; }

.pat-form input, .pat-form textarea, .pat-form .textarea.group, .pat-form s=
elect, .pat-form .select2-container .select2-choice, .pat-form .select2-con=
tainer .select2-choices, .pat-form .md-editor .md-render, .pat-form .pat-ri=
ch-editor, .pat-form .output-field { font-family: "RO Sans"; }

.pat-form input[size=3D"4"], .pat-form textarea[size=3D"4"], .pat-form .tex=
tarea.group[size=3D"4"], .pat-form select[size=3D"4"], .pat-form .select2-c=
ontainer .select2-choice[size=3D"4"], .pat-form .select2-container .select2=
-choices[size=3D"4"], .pat-form .md-editor .md-render[size=3D"4"], .pat-for=
m .pat-rich-editor[size=3D"4"], .pat-form .output-field[size=3D"4"] { width=
: 6em; }

.pat-form input:invalid, .pat-form textarea:invalid, .pat-form .textarea.gr=
oup:invalid, .pat-form select:invalid, .pat-form .select2-container .select=
2-choice:invalid, .pat-form .select2-container .select2-choices:invalid, .p=
at-form .md-editor .md-render:invalid, .pat-form .pat-rich-editor:invalid, =
.pat-form .output-field:invalid { border-color: rgb(225, 112, 0); }

.pat-form input:required:valid, .pat-form textarea:required:valid, .pat-for=
m .textarea.group:required:valid, .pat-form select:required:valid, .pat-for=
m .select2-container .select2-choice:required:valid, .pat-form .select2-con=
tainer .select2-choices:required:valid, .pat-form .md-editor .md-render:req=
uired:valid, .pat-form .pat-rich-editor:required:valid, .pat-form .output-f=
ield:required:valid { transition-delay: 0s; border-color: rgb(1, 104, 155);=
 }

.pat-form .form-callout { margin: 0px 0px 15px; padding: 15px; outline: sil=
ver solid 1px; background-color: rgba(0, 0, 0, 0.02); }

.pat-form .form-callout .legend { float: left; font-weight: bold; }

.pat-form .form-callout .functions { padding-right: 5px; text-align: right;=
 }

.pat-form .form-callout .functions .icon { display: inline-block; width: 30=
px; line-height: 30px; height: 30px; margin: 0px 0px 0px 10px; overflow: hi=
dden; color: rgba(0, 0, 0, 0); }

.pat-form .form-callout .functions .icon::before { display: block; color: r=
gb(1, 104, 155); line-height: 30px; width: 30px; text-align: center; }

.pat-form .form-callout .functions .icon:hover::before { color: rgb(0, 0, 0=
); }

.pat-form fieldset.form-panel, .pat-form div.form-panel { background: rgb(2=
43, 243, 243); box-sizing: border-box; }

.pat-form fieldset.form-panel .form-separation-header, .pat-form div.form-p=
anel .form-separation-header { margin-top: 0px; }

.pat-form fieldset.form-panel .form-separation-header::before, .pat-form di=
v.form-panel .form-separation-header::before { display: inline-block; margi=
n-right: 8px; font-family: fontello; }

.pat-form fieldset.form-panel#settings-panel-language .form-separation-head=
er::before, .pat-form div.form-panel#settings-panel-language .form-separati=
on-header::before { content: "=EE=A3=AA"; }

.pat-form fieldset.form-panel#settings-panel-homepage .form-separation-head=
er::before, .pat-form div.form-panel#settings-panel-homepage .form-separati=
on-header::before { content: "=EE=A0=AB"; }

.pat-form fieldset.form-panel#settings-panel-content-updates .horizontal, .=
pat-form div.form-panel#settings-panel-content-updates .horizontal { displa=
y: grid; }

@media only screen and (min-width: 770px) {
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal,=
 .pat-form div.form-panel#settings-panel-content-updates .horizontal { grid=
-template-columns: 1fr 1fr 1fr; gap: 15px; }
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal =
.pat-well, .pat-form div.form-panel#settings-panel-content-updates .horizon=
tal .pat-well { display: grid; grid-template-columns: 100%; align-content: =
space-between; grid-template-rows: min-content 1fr min-content; overflow: h=
idden; }
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal =
.pat-well .well-separation-header, .pat-form div.form-panel#settings-panel-=
content-updates .horizontal .pat-well .well-separation-header { margin-bott=
om: 10px; font-size: 22px; align-self: start; }
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal =
.pat-well .description, .pat-form div.form-panel#settings-panel-content-upd=
ates .horizontal .pat-well .description { align-self: stretch; }
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal =
.pat-well .button-bar, .pat-form div.form-panel#settings-panel-content-upda=
tes .horizontal .pat-well .button-bar { align-self: end; }
  .pat-form fieldset.form-panel#settings-panel-content-updates .horizontal =
.pat-well .pat-message, .pat-form div.form-panel#settings-panel-content-upd=
ates .horizontal .pat-well .pat-message { animation: 0.8s ease 0s 1 normal =
none running bounceInUp; }
}

.pat-form fieldset.form-panel#settings-panel-content-updates .form-separati=
on-header::before, .pat-form div.form-panel#settings-panel-content-updates =
.form-separation-header::before { content: "=EE=A2=9D"; }

.pat-form fieldset.form-panel#settings-panel-footer .form-separation-header=
::before, .pat-form div.form-panel#settings-panel-footer .form-separation-h=
eader::before { content: "=EE=A3=B4"; }

div.pat-modal .pat-form fieldset.form-panel, div.pat-modal .pat-form div.fo=
rm-panel { padding: 0px; background-color: rgba(0, 0, 0, 0); }

.page-type-login .pat-form fieldset.form-panel, .page-type-login .pat-form =
div.form-panel { margin-bottom: 35px; }

.pat-form fieldset.form-panel::after, .pat-form div.form-panel::after { con=
tent: " "; display: table; clear: both; }

.pat-form fieldset.form-panel > .button-bar, .pat-form div.form-panel > .bu=
tton-bar { width: 100%; margin: 0px !important; }

.pat-form fieldset.form-panel > .button-bar .filter-toggle, .pat-form div.f=
orm-panel > .button-bar .filter-toggle { background: rgba(0, 0, 0, 0); colo=
r: rgb(1, 104, 155); cursor: pointer; vertical-align: text-bottom; line-hei=
ght: 1.6; float: left; font-size: 1em; text-decoration: underline !importan=
t; }

.pat-form fieldset.form-panel > .button-bar .filter-toggle:active, .pat-for=
m div.form-panel > .button-bar .filter-toggle:active { box-shadow: none; }

.pat-form fieldset.horizontal .help { padding: 0px; margin-top: 1px; margin=
-bottom: -3px; clear: both; }

.pat-form fieldset.horizontal .help .help-content { padding: 20px 0px; disp=
lay: block; line-height: 1.3; }

.pat-form fieldset.horizontal .help .help-label, .pat-form fieldset.horizon=
tal .help .help-label.collapsible-open.collapsible-in-progress { position: =
absolute; top: -33px; right: -25%; z-index: 2; width: 26px; height: 35px; o=
verflow: hidden; background-color: rgb(1, 104, 155); color: rgba(0, 0, 0, 0=
); padding: 0px; content: "=EE=A2=82"; font-family: fontello; transition: t=
ranslate 0.25s; transform: translateY(0%); }

.pat-form fieldset.horizontal .help .help-label:hover, .pat-form fieldset.h=
orizontal .help .help-label.collapsible-open.collapsible-in-progress:hover =
{ color: rgba(0, 0, 0, 0); }

.pat-form fieldset.horizontal .help .help-label.collapsible-open.collapsibl=
e-in-progress, .pat-form fieldset.horizontal .help .help-label.collapsible-=
open.collapsible-in-progress.collapsible-open.collapsible-in-progress { tra=
nsform: translateY(0%); }

.pat-form fieldset.horizontal .help .help-label.collapsible-open, .pat-form=
 fieldset.horizontal .help .help-label.collapsible-closed.collapsible-in-pr=
ogress, .pat-form fieldset.horizontal .help .help-label.collapsible-open.co=
llapsible-in-progress.collapsible-open, .pat-form fieldset.horizontal .help=
 .help-label.collapsible-open.collapsible-in-progress.collapsible-closed.co=
llapsible-in-progress { transform: translateY(100%); }

.pat-form fieldset.horizontal .help .help-label.collapsible-open::before, .=
pat-form fieldset.horizontal .help .help-label.collapsible-closed.collapsib=
le-in-progress::before, .pat-form fieldset.horizontal .help .help-label.col=
lapsible-open.collapsible-in-progress.collapsible-open::before, .pat-form f=
ieldset.horizontal .help .help-label.collapsible-open.collapsible-in-progre=
ss.collapsible-closed.collapsible-in-progress::before { opacity: 0; }

.pat-form fieldset.horizontal .help .help-label.collapsible-open::after, .p=
at-form fieldset.horizontal .help .help-label.collapsible-closed.collapsibl=
e-in-progress::after, .pat-form fieldset.horizontal .help .help-label.colla=
psible-open.collapsible-in-progress.collapsible-open::after, .pat-form fiel=
dset.horizontal .help .help-label.collapsible-open.collapsible-in-progress.=
collapsible-closed.collapsible-in-progress::after { opacity: 1; }

.pat-form fieldset.horizontal .help .help-label::before, .pat-form fieldset=
.horizontal .help .help-label.collapsible-open.collapsible-in-progress::bef=
ore { content: "=EE=A2=82"; background-color: rgba(0, 0, 0, 0); transform: =
none; margin: 0px; font-family: fontello; color: rgb(255, 255, 255); positi=
on: absolute; top: 0px; right: 0px; width: 100%; height: 100%; line-height:=
 35px; text-align: center; font-weight: normal; font-style: normal; font-si=
ze: 0.8em; transition: opacity 0.8s 0.3s; }

.pat-form fieldset.horizontal .help .help-label::after, .pat-form fieldset.=
horizontal .help .help-label.collapsible-open.collapsible-in-progress::afte=
r { content: "=EE=A2=83"; font-size: 0.8em; font-family: fontello; color: r=
gb(255, 255, 255); width: 100%; position: absolute; top: 0px; left: 0px; fo=
nt-weight: normal; font-style: normal; line-height: 35px; text-align: cente=
r; background: rgb(1, 104, 155); z-index: 1; opacity: 0; transition: opacit=
y 0.8s 0.3s; }

.pat-form fieldset.horizontal .pat-collapsible > .panel-content { box-sizin=
g: border-box; }

.pat-form fieldset.horizontal > label { clear: both; z-index: 1; }

.pat-form fieldset.horizontal fieldset.group, .pat-form fieldset.horizontal=
 div.group, .pat-form fieldset.horizontal .help, .pat-form fieldset.horizon=
tal .instruction { position: relative; }

#global-nav { border: none; background-color: rgb(57, 135, 12); clear: both=
; user-select: none; z-index: 12; transition: top 0.4s; position: sticky !i=
mportant; top: -0.05px !important; }

@keyframes red-alert {=20
  0% { background-color: rgb(57, 135, 12); }
  50% { background-color: rgb(213, 43, 30); }
  100% { background-color: rgb(57, 135, 12); }
}

#global-nav.impersonation { animation: 0.9s ease 0s infinite normal none ru=
nning red-alert; }

#global-nav .icons { position: absolute; right: 70px; }

@media only screen and (min-width: 770px) {
  #global-nav .icons { top: 11px; }
}

@media only screen and (max-width: 769px) {
  #global-nav .icons { top: 12px; }
}

#global-nav .icons .icon { width: 48px; height: 48px; padding: 0px; border:=
 0px; color: rgba(0, 0, 0, 0); font-size: 18px; position: relative; float: =
left; margin: 0px 0px 0px 7px; cursor: default; background-color: rgba(0, 0=
, 0, 0); }

#global-nav .icons .icon:hover { background-color: rgba(0, 0, 0, 0.2); }

#global-nav .icons .icon.tooltip-active-click, #global-nav .icons .icon.cur=
rent { background-color: rgb(0, 0, 0); }

#global-nav .icons .icon::before { position: absolute; top: 0px; right: 0px=
; left: 0px; width: 100%; color: rgb(255, 255, 255); font-family: fontello;=
 text-align: center; line-height: 48px; font-size: 22px; }

#global-nav .icons .icon#dashboard-trigger::before { content: "=EE=A3=A5"; =
font-size: 20px; }

body:has(#app-space.state-on #app-dashboard.state-active) #global-nav .icon=
s .icon#dashboard-trigger::before { background-color: rgb(0, 0, 0); }

#global-nav .icons .icon#apps-trigger::before { content: "=EE=A7=8F"; font-=
size: 38px; line-height: 52px; }

body:has(#app-space.state-on #app-launchpad.state-active) #global-nav .icon=
s .icon#apps-trigger::before { background-color: rgb(0, 0, 0); }

#global-nav .icons .icon#user-menu-trigger { overflow: hidden; }

#global-nav .icons .icon#user-menu-trigger::before { content: "=EE=A0=A6"; =
}

#global-nav .icons .icon#user-menu-trigger:has(img)::before, #global-nav .i=
cons .icon#user-menu-trigger.has-image::before { display: none; }

#global-nav .icons .icon#user-menu-trigger img { position: absolute; left: =
50%; border-radius: 50%; width: 28px; object-fit: cover; height: 28px; back=
ground: rgb(255, 255, 255); top: 50%; transform: translate(-50%, -50%); bor=
der: 2px solid rgb(255, 255, 255); box-sizing: border-box; }

@keyframes background-glow {=20
  0%, 100% { background-color: rgb(57, 135, 12); }
  50% { background-color: rgb(255, 20, 147); }
}

.css-extern #global-nav { animation: 2s ease 1s 3 normal none running backg=
round-glow; }

@media only screen and (min-width: 770px) {
  #global-nav { min-height: 70px; }
}

@media only screen and (max-width: 769px) {
  #global-nav { min-height: 70px; margin-top: 70px; }
}

@media (display-mode: standalone) {
  #global-nav { margin-top: 0px; position: fixed; top: 0px; right: 0px; lef=
t: 0px; }
}

@media print {
  #global-nav { display: none; }
}

.scrolling-down #global-nav, .scroll-down #global-nav { top: -70px !importa=
nt; }

#global-nav .container { position: relative; padding: 0px calc(235px) 0px 1=
5px; }

body:has(#app-space.state-on) #global-nav .container #breadcrumbs { display=
: none; }

#global-nav .container #breadcrumbs, #global-nav .container #dashboard-brea=
dcrumbs { font-size: 1.25rem; letter-spacing: 0.03rem; float: left; line-he=
ight: 70px; display: flex; width: calc(100% - 20px); }

@media only screen and (max-width: 769px) {
  #global-nav .container #breadcrumbs, #global-nav .container #dashboard-br=
eadcrumbs { padding-top: 0px; padding-bottom: 0px; width: 100%; }
}

#global-nav .container #breadcrumbs > a:not(.app-label), #global-nav .conta=
iner #dashboard-breadcrumbs > a:not(.app-label) { color: rgb(255, 255, 255)=
; text-decoration: none; font-weight: bold; overflow: hidden; text-overflow=
: ellipsis; box-sizing: border-box; max-width: 100%; white-space: nowrap; h=
eight: 70px; float: left; display: inline-block; position: relative; paddin=
g-right: 37px; }

#global-nav .container #breadcrumbs > a:not(.app-label).homepage, #global-n=
av .container #dashboard-breadcrumbs > a:not(.app-label).homepage { font-we=
ight: normal; min-width: min-content; }

#global-nav .container #breadcrumbs > a:not(.app-label):last-child, #global=
-nav .container #dashboard-breadcrumbs > a:not(.app-label):last-child { min=
-width: fit-content; }

@media only screen and (min-width: 770px) {
  #global-nav .container #breadcrumbs > a:not(.app-label), #global-nav .con=
tainer #dashboard-breadcrumbs > a:not(.app-label) { font-size: 1.625rem; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #breadcrumbs > a:not(.app-label), #global-nav .con=
tainer #dashboard-breadcrumbs > a:not(.app-label) { display: none; padding:=
 0px 0.2em; }
  #global-nav .container #breadcrumbs > a:not(.app-label)[href]:last-of-typ=
e, #global-nav .container #dashboard-breadcrumbs > a:not(.app-label)[href]:=
last-of-type { display: inline-block; }
}

#global-nav .container #breadcrumbs > a:not(.app-label)[href], #global-nav =
.container #dashboard-breadcrumbs > a:not(.app-label)[href] { font-weight: =
normal; }

.no-touchevents #global-nav .container #breadcrumbs > a:not(.app-label)[hre=
f]:hover, .no-touchevents #global-nav .container #dashboard-breadcrumbs > a=
:not(.app-label)[href]:hover { text-decoration: underline; }

@media only screen and (min-width: 770px) {
  #global-nav .container #breadcrumbs > a:not(.app-label)[href]::after, #gl=
obal-nav .container #dashboard-breadcrumbs > a:not(.app-label)[href]::after=
 { content: "=EF=80=86"; font-weight: normal; font-family: fontello; vertic=
al-align: middle; speak: none; -webkit-font-smoothing: antialiased; padding=
: 0px 6px 0px 10px; display: inline-block; font-size: 22px; line-height: 1e=
m; margin: -3px 0px 0px; text-decoration: none; width: 21px; text-align: ce=
nter; position: absolute; right: 0px; top: 27px; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #breadcrumbs > a:not(.app-label)[href].homepage, #=
global-nav .container #dashboard-breadcrumbs > a:not(.app-label)[href].home=
page { width: 30px; overflow: hidden; height: 70px; }
  #global-nav .container #breadcrumbs > a:not(.app-label)[href]::before, #g=
lobal-nav .container #dashboard-breadcrumbs > a:not(.app-label)[href]::befo=
re { font-family: fontello; content: "=EE=A2=A7"; display: inline-block; pa=
dding-right: 0.3em; font-size: 46px; float: left; }
  #global-nav .container #breadcrumbs > a:not(.app-label)[href]::after, #gl=
obal-nav .container #dashboard-breadcrumbs > a:not(.app-label)[href]::after=
 { display: none; }
}

#global-nav .container #quick-search-form { position: absolute; right: 15px=
; top: 0px; }

#global-nav .container #quick-search-form.injecting { opacity: 1; }

#global-nav .container #quick-search-form.injecting::before { display: none=
; }

@media only screen and (min-width: 770px) {
  #global-nav .container #quick-search-form { padding-top: 11px; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form { clear: both; font-size: 1.25e=
m; padding-bottom: 12px; padding-top: 12px; overflow: hidden; }
}

#global-nav .container #quick-search-form label { position: absolute; top: =
0px; right: -11px; height: 70px; width: 60px; color: rgba(0, 0, 0, 0); over=
flow: hidden; }

#global-nav .container #quick-search-form label::before { content: " "; dis=
play: block; position: absolute; top: 11px; right: 11px; height: 48px; widt=
h: 48px; background-color: rgb(0, 0, 0); opacity: 0; }

.no-touchevents #global-nav .container #quick-search-form:hover label::befo=
re { opacity: 0.2; }

#global-nav .container #quick-search-form .clear-field { position: absolute=
; width: 22px; line-height: 16px; top: 28px; right: 57px; color: rgba(0, 0,=
 0, 0); overflow: hidden; transition: opacity 1s; z-index: 10; opacity: 0; =
cursor: default; pointer-events: none; }

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form .clear-field { top: 29px; }
}

#global-nav .container #quick-search-form .clear-field::before { font-famil=
y: fontello; content: "=EE=A2=83"; width: 100%; height: 100%; position: abs=
olute; color: rgb(0, 0, 0); }

#global-nav .container #quick-search-form .has-value ~ .clear-field { opaci=
ty: 1; cursor: pointer; pointer-events: auto; }

#global-nav .container #quick-search-form input, #global-nav .container #qu=
ick-search-form input:focus { float: right; background-color: rgb(255, 255,=
 255); border: 0px; outline: 0px; height: 48px; margin: 0px; padding: 0px 8=
0px 0px 10px; text-align: left; max-width: 1000px; transition: 0.4s; positi=
on: absolute; right: 0px; z-index: 1; box-shadow: none; box-sizing: border-=
box; }

@media only screen and (min-width: 770px) {
  #global-nav .container #quick-search-form input, #global-nav .container #=
quick-search-form input:focus { position: absolute; width: 390px; font-size=
: 1.025em; top: 11px; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form input, #global-nav .container #=
quick-search-form input:focus { position: relative; width: 100%; font-size:=
 16px; top: 0px; }
}

#global-nav .container #quick-search-form button { width: 48px; height: 48p=
x; position: absolute; top: 0px; right: 0px; padding: 0px; border: 0px; mar=
gin: 0px; background: rgb(0, 0, 0); border-radius: 0px; color: rgba(0, 0, 0=
, 0); transition: 0.3s; z-index: 2; font-size: 18px; }

@media only screen and (min-width: 770px) {
  #global-nav .container #quick-search-form button { top: 11px; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form button { top: 12px; }
}

#global-nav .container #quick-search-form button::before { position: absolu=
te; top: 0px; right: 0px; width: 97%; color: rgb(255, 255, 255); content: "=
=EE=A2=B4"; font-family: fontello; text-align: center; line-height: 47px; f=
ont-size: 27px; }

#global-nav.variation-compare, #global-nav.variation-medicine-compare, #glo=
bal-nav.variation-medicine-group-compare, #global-nav.variation-indication-=
compare, #global-nav.variation-medicine-compare-versions, #global-nav.varia=
tion-indicator-set-compare-locations { z-index: 12; position: fixed !import=
ant; left: 0px !important; right: 0px !important; top: 0px !important; }

.no-csspositionsticky #global-nav.variation-compare, .no-csspositionsticky =
#global-nav.variation-medicine-compare, .no-csspositionsticky #global-nav.v=
ariation-medicine-group-compare, .no-csspositionsticky #global-nav.variatio=
n-indication-compare, .no-csspositionsticky #global-nav.variation-medicine-=
compare-versions, .no-csspositionsticky #global-nav.variation-indicator-set=
-compare-locations { top: 122px !important; }

#global-nav.variation-compare ~ #site-header, #global-nav.variation-medicin=
e-compare ~ #site-header, #global-nav.variation-medicine-group-compare ~ #s=
ite-header, #global-nav.variation-indication-compare ~ #site-header, #globa=
l-nav.variation-medicine-compare-versions ~ #site-header, #global-nav.varia=
tion-indicator-set-compare-locations ~ #site-header { display: none; }

#global-nav.variation-compare ~ #footer, #global-nav.variation-medicine-com=
pare ~ #footer, #global-nav.variation-medicine-group-compare ~ #footer, #gl=
obal-nav.variation-indication-compare ~ #footer, #global-nav.variation-medi=
cine-compare-versions ~ #footer, #global-nav.variation-indicator-set-compar=
e-locations ~ #footer { display: none; }

#global-nav.variation-homepage .container #breadcrumbs a.homepage, #global-=
nav.variation-search-results .container #breadcrumbs a.homepage, #global-na=
v.variation-news-overview .container #breadcrumbs a.homepage, #global-nav.v=
ariation-landing-tiles .container #breadcrumbs a.homepage, #global-nav.vari=
ation-landing .container #breadcrumbs a.homepage { display: inline-block; }

#global-nav:not(.variation-homepage):not(.variation-search-results) .contai=
ner #quick-search-form input, .logged-in #global-nav .container #quick-sear=
ch-form input, #global-nav.logged-in .container #quick-search-form input { =
width: 48px; padding-left: 0px; padding-right: 0px; opacity: 0; cursor: def=
ault; pointer-events: auto; }

#global-nav:not(.variation-homepage):not(.variation-search-results) .contai=
ner #quick-search-form input:focus, #global-nav:not(.variation-homepage):no=
t(.variation-search-results) .container #quick-search-form input.has-value,=
 .logged-in #global-nav .container #quick-search-form input:focus, .logged-=
in #global-nav .container #quick-search-form input.has-value, #global-nav.l=
ogged-in .container #quick-search-form input:focus, #global-nav.logged-in .=
container #quick-search-form input.has-value { opacity: 1; padding: 0px 80p=
x 0px 10px; cursor: text; }

@media only screen and (min-width: 770px) {
  #global-nav:not(.variation-homepage):not(.variation-search-results) .cont=
ainer #quick-search-form input:focus, #global-nav:not(.variation-homepage):=
not(.variation-search-results) .container #quick-search-form input.has-valu=
e, .logged-in #global-nav .container #quick-search-form input:focus, .logge=
d-in #global-nav .container #quick-search-form input.has-value, #global-nav=
.logged-in .container #quick-search-form input:focus, #global-nav.logged-in=
 .container #quick-search-form input.has-value { width: 390px; }
}

@media only screen and (max-width: 769px) {
  #global-nav:not(.variation-homepage):not(.variation-search-results) .cont=
ainer #quick-search-form input:focus, #global-nav:not(.variation-homepage):=
not(.variation-search-results) .container #quick-search-form input.has-valu=
e, .logged-in #global-nav .container #quick-search-form input:focus, .logge=
d-in #global-nav .container #quick-search-form input.has-value, #global-nav=
.logged-in .container #quick-search-form input:focus, #global-nav.logged-in=
 .container #quick-search-form input.has-value { width: 100%; }
}

#global-nav:not(.variation-homepage):not(.variation-search-results) .contai=
ner #quick-search-form button, .logged-in #global-nav .container #quick-sea=
rch-form button, #global-nav.logged-in .container #quick-search-form button=
 { background-color: rgba(0, 0, 0, 0); z-index: 0; }

#global-nav:not(.variation-homepage):not(.variation-search-results) .contai=
ner #quick-search-form input:focus + button, #global-nav:not(.variation-hom=
epage):not(.variation-search-results) .container #quick-search-form input.h=
as-value + button, .logged-in #global-nav .container #quick-search-form inp=
ut:focus + button, .logged-in #global-nav .container #quick-search-form inp=
ut.has-value + button, #global-nav.logged-in .container #quick-search-form =
input:focus + button, #global-nav.logged-in .container #quick-search-form i=
nput.has-value + button { background-color: rgb(0, 0, 0); z-index: 2; point=
er-events: all; }

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form { float: right; left: 15px; pos=
ition: absolute; pointer-events: none; }
  #global-nav .container #quick-search-form input { width: 48px; padding-le=
ft: 0px; padding-right: 0px; opacity: 0; cursor: default; pointer-events: a=
uto; }
  #global-nav .container #quick-search-form input:focus, #global-nav .conta=
iner #quick-search-form input.has-value { opacity: 1; padding: 0px 80px 0px=
 10px; cursor: text; }
}

@media only screen and (max-width: 769px) and (min-width: 770px) {
  #global-nav .container #quick-search-form input:focus, #global-nav .conta=
iner #quick-search-form input.has-value { width: 390px; }
}

@media only screen and (max-width: 769px) and (max-width: 769px) {
  #global-nav .container #quick-search-form input:focus, #global-nav .conta=
iner #quick-search-form input.has-value { width: 100%; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form button { background-color: rgba=
(0, 0, 0, 0); z-index: 0; }
}

@media only screen and (max-width: 769px) {
  #global-nav .container #quick-search-form input:focus + button, #global-n=
av .container #quick-search-form input.has-value + button { background-colo=
r: rgb(0, 0, 0); z-index: 2; pointer-events: all; }
}

.glossary { font-size: 1.125rem; margin-top: 80px; }

.glossary .glossary-section { display: grid; column-gap: 10px; grid-templat=
e-columns: 30% 70%; margin-bottom: 20px; padding-top: 180px; margin-top: -1=
80px; }

.glossary .glossary-section .glossary-section-title { background-color: rgb=
(196, 219, 182); text-align: center; padding: 20px 30px; font-weight: 100; =
font-size: 210px; line-height: 245px; color: rgb(255, 255, 255); }

.glossary .glossary-section .terms-list { padding: 0px 30px; margin: 0px; }

.glossary .glossary-section .terms-list dt, .glossary .glossary-section .te=
rms-list dd { padding: 0px; }

.glossary .glossary-section .terms-list dt { font-weight: bold; float: left=
; clear: both; margin-top: 0px; }

.glossary .glossary-section .terms-list dt::after { content: "=E2=80=A2"; d=
isplay: inline-block; padding: 0px 7px; }

.glossary .glossary-section .terms-list dd { padding: 180px 0px 20px; margi=
n-left: 0px; margin-top: -180px; pointer-events: none; }

.glossary .glossary-section .terms-list dd > * { pointer-events: auto; }

.glossary .glossary-section .terms-list dd a { text-decoration: underline; =
}

.glossary .glossary-section .terms-list dd a:hover { color: rgb(1, 70, 104)=
; }

.glossary .glossary-section .terms-list dd:last-child { padding-bottom: 0px=
; }

.pat-grid-list::after { content: " "; display: table; clear: both; }

.pat-grid-list .medicine-active-substance, .pat-grid-list .medicine-method,=
 .pat-grid-list .medicine-strength, .pat-grid-list .medicine-manufacturer {=
 text-transform: lowercase; }

.pat-grid-list .medicine-active-substance::first-letter, .pat-grid-list .me=
dicine-method::first-letter, .pat-grid-list .medicine-strength::first-lette=
r, .pat-grid-list .medicine-manufacturer::first-letter { text-transform: ca=
pitalize; }

.pat-grid-list dd p { margin-bottom: 0.3em; }

.pat-grid-list dd p:last-child { margin-bottom: 0px; }

.pat-grid-list dd .info-button { float: right; margin: 0px 0px 0px 15px; }

.pat-grid-list dd > :last-child { margin-bottom: 0px; }

.pat-grid-list dt.mutated, .pat-grid-list dd.mutated { background: rgba(255=
, 100, 0, 0.1); }

.pat-grid-list dt .pat-select, .pat-grid-list dd .pat-select { color: rgb(1=
, 104, 155); float: left; }

.pat-grid-list dt > div :last-child, .pat-grid-list dd > div :last-child { =
margin-bottom: 0px !important; }

.pat-grid-list dt .link-list, .pat-grid-list dd .link-list { line-height: i=
nherit; }

.pat-grid-list dt .link-list.alternatives li a .facets, .pat-grid-list dt .=
link-list.variants li a .facets, .pat-grid-list dd .link-list.alternatives =
li a .facets, .pat-grid-list dd .link-list.variants li a .facets { text-tra=
nsform: lowercase; }

.pat-grid-list dt .link-list.alternatives li a .facets .facet:first-child::=
before, .pat-grid-list dt .link-list.variants li a .facets .facet:first-chi=
ld::before, .pat-grid-list dd .link-list.alternatives li a .facets .facet:f=
irst-child::before, .pat-grid-list dd .link-list.variants li a .facets .fac=
et:first-child::before { content: "("; color: rgb(0, 0, 0); }

.pat-grid-list dt .link-list.alternatives li a .facets .facet.reimbursed, .=
pat-grid-list dt .link-list.variants li a .facets .facet.reimbursed, .pat-g=
rid-list dd .link-list.alternatives li a .facets .facet.reimbursed, .pat-gr=
id-list dd .link-list.variants li a .facets .facet.reimbursed { }

.pat-grid-list dt .link-list.alternatives li a .facets .facet.not-reimburse=
d, .pat-grid-list dt .link-list.variants li a .facets .facet.not-reimbursed=
, .pat-grid-list dd .link-list.alternatives li a .facets .facet.not-reimbur=
sed, .pat-grid-list dd .link-list.variants li a .facets .facet.not-reimburs=
ed { color: red; }

.pat-grid-list dt .link-list.alternatives li a .facets .facet:last-child::a=
fter, .pat-grid-list dt .link-list.variants li a .facets .facet:last-child:=
:after, .pat-grid-list dd .link-list.alternatives li a .facets .facet:last-=
child::after, .pat-grid-list dd .link-list.variants li a .facets .facet:las=
t-child::after { content: ")"; color: rgb(0, 0, 0); }

.pat-grid-list dt .link-list.alternatives li a .facets .facet:not(:last-chi=
ld)::after, .pat-grid-list dt .link-list.variants li a .facets .facet:not(:=
last-child)::after, .pat-grid-list dd .link-list.alternatives li a .facets =
.facet:not(:last-child)::after, .pat-grid-list dd .link-list.variants li a =
.facets .facet:not(:last-child)::after { content: ", "; }

.pat-grid-list dt .link-list li, .pat-grid-list dd .link-list li { line-hei=
ght: inherit; }

.pat-grid-list dt .link-list li:last-child, .pat-grid-list dd .link-list li=
:last-child { border: none; }

.pat-grid-list dt .link-list li a, .pat-grid-list dd .link-list li a { line=
-height: inherit; font-weight: normal; }

.pat-grid-list dt .link-list li a::before, .pat-grid-list dd .link-list li =
a::before { line-height: inherit; }

.pat-grid-list dt.mutated { border-left: 8px solid rgba(255, 100, 0, 0.2); =
padding-left: 0.5em; }

.pat-grid-list dt .pat-select { color: rgb(1, 104, 155); float: left; }

.pat-grid-list dt .pat-select::before { font-weight: bold !important; }

#hero { margin-top: -60px; width: 100%; margin-bottom: 40px; height: 250px;=
 overflow: hidden; position: relative; }

#hero img { width: 100%; position: absolute; top: 50%; transform: translate=
Y(-50%); }

html { font-size: 100%; text-size-adjust: 100%; -webkit-tap-highlight-color=
: rgba(0, 0, 0, 0); scroll-behavior: smooth; }

.iconified { overflow: hidden; text-decoration: none; position: relative; d=
isplay: inline-block; white-space: nowrap; line-height: 10px; border-style:=
 none; background-image: none; width: 0.9em; height: 0.9em; filter: none !i=
mportant; outline: none !important; }

.iconified:active { box-shadow: none; }

.iconified:hover { text-decoration: none; }

.iconified::before { text-indent: 0px; display: inline-block; margin: 0px 1=
0px 0px 0px; }

.icon-tile-navigation { display: grid; gap: 30px; }

@media only screen and (min-width: 1280px) {
  .icon-tile-navigation.col-3 { grid-template-columns: repeat(3, 1fr); gap:=
 20px; }
  .icon-tile-navigation.col-3 .icon-tile-navigation-follow { padding: 6% 7%=
 6% 90px; }
  .icon-tile-navigation.col-3 .icon-tile-navigation-follow .title { font-si=
ze: 1.5em; line-height: 1.2; margin-bottom: 5px; }
  .icon-tile-navigation.col-3 .icon-tile-navigation-follow .byline { margin=
-bottom: 0px; }
  .icon-tile-navigation.col-3 .icon-tile-navigation-follow::before { width:=
 90px; background-size: auto 60% !important; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .icon-tile-navigation.col-3 { grid-template-columns: 1fr 1fr; }
}

@media only screen and (min-width: 770px) {
  .icon-tile-navigation.col-1, .icon-tile-navigation.col-2 { grid-template-=
columns: 1fr 1fr; }
}

@media only screen and (max-width: 1279px) {
  .icon-tile-navigation { grid-template-columns: 1fr; }
}

.icon-tile-navigation .icon-tile-navigation-follow { background: rgb(243, 2=
43, 243); display: block; padding: 7% 10%; position: relative; hyphens: aut=
o; }

@media only screen and (min-width: 1280px) {
  .icon-tile-navigation .icon-tile-navigation-follow { padding-left: 170px;=
 }
}

.icon-tile-navigation .icon-tile-navigation-follow::before { padding: 0px; =
margin: 0px; font-size: 80px; width: 170px; text-align: center; position: a=
bsolute; top: 50%; left: 0px; transform: translateY(-50%); transition: tran=
sform 0.2s; color: rgb(57, 135, 12); }

@media only screen and (max-width: 1279px) {
  .icon-tile-navigation .icon-tile-navigation-follow::before { display: non=
e; }
}

.icon-tile-navigation .icon-tile-navigation-follow.icon-quality-thumb::befo=
re, .icon-tile-navigation .icon-tile-navigation-follow.icon-privacy-ok::bef=
ore, .icon-tile-navigation .icon-tile-navigation-follow.icon-analytics::bef=
ore { color: rgba(0, 0, 0, 0); background-repeat: no-repeat; background-pos=
ition: center center; background-size: auto 100%; }

.icon-tile-navigation .icon-tile-navigation-follow.icon-quality-thumb::befo=
re { background-image: url("icon-kwaliteitsinstrumenten.svg"); }

.icon-tile-navigation .icon-tile-navigation-follow.icon-privacy-ok::before =
{ background-image: url("icon-kwaliteitsregistraties.svg"); }

.icon-tile-navigation .icon-tile-navigation-follow.icon-analytics::before {=
 background-image: url("icon-openbare-data.svg"); }

.icon-tile-navigation .icon-tile-navigation-follow.icon-swiss-army-knife::b=
efore { font-size: 100px; }

.icon-tile-navigation .icon-tile-navigation-follow:hover { text-decoration:=
 none; }

.no-touchevents .icon-tile-navigation .icon-tile-navigation-follow:hover .t=
itle { text-decoration: underline; }

.no-touchevents .icon-tile-navigation .icon-tile-navigation-follow:hover::b=
efore { transform: scale(1.1) translateY(-50%); }

.icon-tile-navigation .icon-tile-navigation-follow .title { margin-top: 0px=
; padding-top: 0px; margin-bottom: 13px; font-weight: normal; font-size: 1.=
8em; line-height: 1.4444; color: rgb(1, 104, 155); text-underline-offset: 0=
.18em; }

.icon-tile-navigation .icon-tile-navigation-follow .byline { margin-bottom:=
 10px; color: rgb(0, 0, 0); }

.image-selector { --image-selector-gap: 15px; display: grid; grid-template-=
columns: repeat(var(--image-selector-columns), 1fr); grid-template-rows: au=
to; gap: var(--image-selector-gap); }

.image-selector .photo-skimmer { overflow: hidden; display: grid; grid-auto=
-columns: minmax(0px, 1fr); grid-auto-flow: column; position: relative; z-i=
ndex: 1; }

.image-selector .photo-skimmer .image { width: 100%; }

.image-selector .photo-skimmer .image img { height: 100%; width: 100%; obje=
ct-fit: cover; float: left; border-radius: 0px; opacity: 0; position: absol=
ute; z-index: -1; left: 0px; right: 0px; }

.image-selector .photo-skimmer .image:hover img { opacity: 1; }

.image-selector .photo-skimmer .image:first-child img { opacity: 1; }

@media only screen and (min-width: 1280px) {
  .image-selector { --image-selector-columns: 4; }
  .image-selector .infinite-scrolling-trigger { grid-column: span 4; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .image-selector { --image-selector-columns: 3; }
  .image-selector .infinite-scrolling-trigger { grid-column: span 3; }
}

@media only screen and (max-width: 769px) {
  .image-selector { --image-selector-columns: 2; }
  .image-selector .infinite-scrolling-trigger { grid-column: span 2; }
}

@media only screen and (min-width: 1280px) {
  .image-selector.col-6 { --image-selector-columns: 6; }
  .image-selector.col-6 .infinite-scrolling-trigger { grid-column: span 6; =
}
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .image-selector.col-6 { --image-selector-columns: 4; }
  .image-selector.col-6 .infinite-scrolling-trigger { grid-column: span 4; =
}
}

@media only screen and (max-width: 769px) {
  .image-selector.col-6 { --image-selector-columns: 2; }
  .image-selector.col-6 .infinite-scrolling-trigger { grid-column: span 2; =
}
}

.image-selector.cropping-cover .item.image img { object-fit: cover; }

.image-selector.cropping-contain .item { padding: 5px; }

.image-selector .item { display: inline-block; width: 100%; aspect-ratio: 1=
 / 1; position: relative; padding: 0px; box-sizing: border-box; perspective=
: 100px; perspective-origin: center bottom; }

.image-selector .item.no-image::before { font-family: fontello; content: "=
=EE=A3=93"; display: block; position: absolute; top: 50%; height: 50px; lin=
e-height: 50px; font-size: 50px; margin-top: -25px; width: 100%; text-align=
: center; text-indent: 2%; color: gray; }

.image-selector .item[href] { cursor: pointer; }

.image-selector .item[data-title]::after, .image-selector .item figcaption =
{ position: absolute; padding: 4px 10px; text-align: center; font-size: 14p=
x; line-height: 18px; display: block; overflow: hidden; text-overflow: elli=
psis; white-space: nowrap; height: 20px; transition: 0.4s; }

.image-selector .item.collection.empty figure::before { content: ""; font-f=
amily: fontello; font-size: 50px; color: rgba(0, 0, 0, 0.4); width: 100%; p=
osition: absolute; top: 50%; left: 0px; right: 0px; text-align: center; tra=
nsform: translateY(-50%); }

.image-selector .item.collection figure { border-radius: 0px; background-co=
lor: rgba(0, 0, 0, 0.1); border: 4px solid rgba(0, 0, 0, 0.1); box-shadow: =
rgba(0, 0, 0, 0.1) 0px 0px 15px inset; position: absolute; inset: 29px; }

.image-selector .item.collection figure .photo-skimmer { width: 100%; heigh=
t: 100%; border-radius: 0px; }

.image-selector .item.collection figure figcaption { color: rgb(0, 0, 0); l=
eft: -39px; right: -39px; bottom: -33px; }

.image-selector .item:hover figure { background-color: rgba(0, 0, 0, 0.05);=
 }

.image-selector .item[data-title]::after { background-color: rgba(0, 0, 0, =
0.4); backdrop-filter: blur(2px); content: attr(data-title); text-shadow: r=
gb(0, 0, 0) 0px 0px 4px; color: rgb(255, 255, 255); opacity: 0; transform: =
translateY(100%); transform-origin: center bottom; transition: 0.2s; left: =
0px; right: 0px; bottom: 0px; }

.image-selector .item input { display: none; }

.image-selector .item.image { box-shadow: none; background-color: rgb(242, =
242, 242); overflow: hidden; }

.image-selector .item.image img { display: block; width: 100%; aspect-ratio=
: 1 / 1; object-fit: contain; transition: object-fit 0.4s; }

.image-selector .item.image.state-draft::after, .image-selector .item.image=
.state-archived::after { position: absolute; z-index: 1; font-family: fonte=
llo; display: block; bottom: 0px; right: 0px; font-size: 20px; width: 35px;=
 height: 35px; line-height: 35px; text-align: center; color: rgb(255, 255, =
255); border-left: 3px solid rgb(255, 255, 255); border-top: 3px solid rgb(=
255, 255, 255); padding: 5px 0px 0px 5px; }

.image-selector .item.image.state-draft { border: 6px solid rgb(225, 112, 0=
); }

.image-selector .item.image.state-draft img { filter: sepia(100%) hue-rotat=
e(-30deg) saturate(300%) contrast(150%); border: 3px solid rgb(255, 255, 25=
5); box-sizing: border-box; }

.image-selector .item.image.state-draft::after { content: "=EE=A0=B3"; back=
ground-color: rgb(225, 112, 0); }

.image-selector .item.image.state-archived { border: 6px solid rgb(0, 0, 0)=
; }

.image-selector .item.image.state-archived img { filter: grayscale(100%); b=
order: 3px solid rgb(255, 255, 255); box-sizing: border-box; }

.image-selector .item.image.state-archived::after { content: "=EE=A0=B7"; b=
ackground: rgb(0, 0, 0); }

.image-selector .item.image.checked, .image-selector .item.image:active { b=
ox-shadow: inset 0 0 0 5px var(--colour-accent); }

.image-selector .item.image.checked[data-title]::after { background-color: =
var(--colour-accent); text-shadow: none; }

.image-selector .item::before { display: none; }

.image-selector .item.image:hover::after, .image-selector .item.checked::af=
ter { opacity: 1; transform: rotate3d(1, 0, 0, 0deg); }

.image-selector.titles-visible .item.image::after { opacity: 1; transform: =
translateY(0px); }

.image-uploader { position: relative; overflow: hidden; aspect-ratio: 1 / 1=
; display: block; background-color: rgb(232, 232, 232); }

.image-uploader::before { top: 0.2em; bottom: 0px; display: block; content:=
 " "; background-color: rgb(242, 242, 242); position: absolute; z-index: 0;=
 }

.image-uploader::after { position: absolute; top: 50%; left: 50%; margin: -=
1em 0px 0px -1em; width: 2em; height: 2em; text-align: center; line-height:=
 2em; display: block; content: "=EE=A1=82"; font-family: fontello; z-index:=
 0; font-size: 2em; color: rgba(0, 0, 0, 0.5); }

.image-uploader.columns::before { left: 15px; right: 15px; }

.image-uploader .image-upload-remove-button { position: absolute; top: 10px=
; right: 10px; width: 30px; height: 30px; overflow: hidden; color: rgba(0, =
0, 0, 0); z-index: 2; background: none; }

.image-uploader .image-upload-remove-button::before { width: 30px; height: =
30px; text-align: center; line-height: 30px; border-radius: 50%; color: rgb=
(255, 255, 255); margin: 0px; font-size: 18px; }

.image-uploader .image-upload-remove-button:hover::before { background-colo=
r: rgba(0, 0, 0, 0.5); }

.image-uploader .upload-button { position: absolute; z-index: 3; left: 13%;=
 right: 13%; bottom: 20px; text-align: center; text-overflow: ellipsis; ove=
rflow: hidden; line-height: 1.5; font-size: 0.9em; height: auto; margin: 0p=
x; }

.image-uploader .upload-button:hover { background: rgb(1, 70, 104) !importa=
nt; color: rgb(255, 255, 255) !important; }

.image-uploader input[type=3D"file"] { width: 100%; height: 100%; position:=
 absolute; inset: 0px; opacity: 0; z-index: 1; }

.image-uploader img { width: 100%; display: block; position: relative; z-in=
dex: 1; aspect-ratio: 1 / 1; object-fit: cover; }

.image-uploader img + .upload-button { color: rgb(255, 255, 255); backgroun=
d: rgba(0, 0, 0, 0.4); backdrop-filter: blur(2px); border: none; padding: 0=
px; border-radius: 20px; bottom: 15px; }

.image-uploader img + .upload-button:hover { background: rgba(0, 0, 0, 0.5)=
; }

.infinite-scrolling-trigger { display: block; text-align: center; position:=
 relative; color: rgba(0, 0, 0, 0.6); padding-top: 585px; margin-top: -450p=
x; height: 675px; box-sizing: border-box; clear: both; cursor: default; poi=
nter-events: none; text-decoration: none !important; }

.infinite-scrolling-trigger::before { opacity: 1; position: absolute; left:=
 50%; content: "=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; m=
argin-left: -25px; z-index: 1000; font: 50px / 50px fontello; text-shadow: =
rgb(255, 255, 255) 0px 0px 2px; text-align: center; animation: 2s linear 0s=
 infinite normal none running spin; top: 550px; color: rgba(0, 0, 0, 0.5); =
}

.iconed-list li { padding: 0px 0px 0px 22px; }

.iconed-list li.icon-ok-circle::before { color: rgb(57, 135, 12); }

.iconed-list li::before { grid-area: label; font-family: fontello; margin-l=
eft: -22px; font-weight: normal; float: left; text-decoration: none; width:=
 22px; text-align: left; speak: none; display: inline-block; line-height: i=
nherit; position: absolute; }

#sub-nav .iconed-list li::before { margin-left: -30px; }

.icon-selector, .pat-checklist.icon-selector { overflow: hidden; user-selec=
t: none; }

.icon-selector label, .pat-checklist.icon-selector label { float: left; mar=
gin: 0px; height: 1.8em; overflow: hidden; border-radius: 0px; position: re=
lative; line-height: 1.9em; padding: 0px; color: rgba(0, 0, 0, 0); width: 1=
.8em !important; border: 2px solid rgba(0, 0, 0, 0) !important; }

.icon-selector label:hover, .pat-checklist.icon-selector label:hover { back=
ground-color: rgba(0, 0, 0, 0.1); }

.icon-selector label:hover::before, .pat-checklist.icon-selector label:hove=
r::before { color: rgb(0, 0, 0); }

.icon-selector label.checked, .pat-checklist.icon-selector label.checked { =
background-color: rgb(225, 112, 0); }

.icon-selector label.checked::before, .pat-checklist.icon-selector label.ch=
ecked::before { color: rgb(255, 255, 255); }

.icon-selector label::before, .pat-checklist.icon-selector label::before { =
float: left; margin: 0px; text-align: center; width: 100%; line-height: 1.9=
em; color: rgba(0, 0, 0, 0.6); position: absolute; top: 0px; left: 0px; hei=
ght: 100%; }

.icon-selector label input, .pat-checklist.icon-selector label input { posi=
tion: absolute; opacity: 0; }

.info-button { cursor: pointer; font-style: normal; font-weight: normal; di=
splay: inline-block; height: 29px; width: 29px; }

.info-button::before { content: "=EE=A1=AC"; font-family: fontello; text-tr=
ansform: none; line-height: 29px; font-size: 30px; height: 100%; width: 100=
%; color: rgb(1, 104, 155); }

.info-button:hover::before { color: rgb(1, 70, 104); }

.input-list { line-height: 1.625rem; margin-bottom: 1em; }

.input-list:empty { display: none; }

.input-list li { margin: 0px; padding: 0px; list-style: none; display: flex=
; }

.input-list li.deleted { display: none; }

.input-list li input[type=3D"text"] { width: 100%; margin: 0px; padding-top=
: 0px; padding-bottom: 0px; box-sizing: border-box; height: 29px; }

.input-list li .functions { grid-area: functions; text-align: right; }

.input-list li .functions .button { font-family: "RO Sans"; border: none; c=
ursor: default; border-radius: 0px; background-image: none; text-decoration=
: none; display: inline-block; box-shadow: none; color: rgb(1, 104, 154); b=
ackground-color: rgb(242, 242, 242); max-width: 100%; overflow: hidden; tex=
t-overflow: ellipsis; white-space: nowrap; font-size: 18px; padding: 0px 0.=
8rem; height: 29px; line-height: 29px; vertical-align: baseline; font-weigh=
t: normal; margin: 0px 0px -4px 5px; }

.input-list li .functions .button::before { line-height: inherit; }

.input-list li .functions .button:focus { outline: var(--pat-form-input-fie=
ld-outline-focus); outline-offset: var(--pat-form-input-field-outline-offse=
t); }

.input-list li .functions .button:hover { background-color: rgb(237, 237, 2=
37); text-decoration: none; color: rgb(1, 104, 154); }

.input-list li .functions .button.default { color: white; background-color:=
 rgb(1, 104, 155); box-shadow: none; }

.input-list li .functions .button.default:hover { background-color: rgb(1, =
70, 104); color: white; }

.input-list li .functions .button[disabled], .input-list li .functions .but=
ton.disabled, .input-list li .functions .button:is(a):not([href]), .input-l=
ist li .functions .button.default[disabled], .input-list li .functions .but=
ton.default.disabled, .input-list li .functions .button:is(a).default:not([=
href]) { color: rgba(0, 0, 0, 0.3); background-color: rgb(242, 242, 242); }

.input-list li .functions .button[disabled]:hover, .input-list li .function=
s .button.disabled:hover, .input-list li .functions .button:is(a):not([href=
]):hover, .input-list li .functions .button.default[disabled]:hover, .input=
-list li .functions .button.default.disabled:hover, .input-list li .functio=
ns .button:is(a).default:not([href]):hover { color: rgba(0, 0, 0, 0.3); bac=
kground-color: rgb(242, 242, 242); }

@media print {
  .input-list li .functions .button { display: none; }
}

.input-list li .functions .button.small { font-size: 18px; padding: 0px 0.8=
rem; height: 29px; line-height: 29px; vertical-align: baseline; box-shadow:=
 none; font-weight: normal; }

.input-list li .functions .button.small::before { font-size: 15px; }

.input-list li .functions .button.iconified { width: 30px; padding: 0px; }

.input-list li .functions .button.iconified::before { width: 100%; text-ali=
gn: center; line-height: 44px; }

.input-list li .functions .button.link { padding: 0px; display: inline; bac=
kground: none; color: rgb(1, 104, 155); line-height: inherit; text-decorati=
on: underline; vertical-align: baseline; cursor: pointer; }

.input-list li .functions .button.link:hover { background: none; color: rgb=
(0, 2, 3); text-decoration: underline !important; }

.input-list li .functions .button.no-label { padding: 0px; aspect-ratio: 1 =
/ 1; text-overflow: clip; height: var(--pat-button-height); min-width: var(=
--pat-button-height); }

.input-list li .functions .button.no-label::before { width: 100%; text-alig=
n: center; margin: 0px 1em 0px 0px; line-height: var(--pat-button-height); =
}

.input-list li .functions .button::before { font-weight: normal; margin-rig=
ht: 5px; }

.input-list li .functions .button.add::before { font-family: fontello; cont=
ent: "=EE=A3=A4"; }

.input-list li .functions .button input { position: absolute; opacity: 0; }

#language-switch { padding: 35px 15px; position: relative; z-index: 10; bac=
kground: rgb(255, 255, 255); clear: both; }

body:has(#app-space.state-on) #language-switch { display: none; }

#language-switch .languages-list { text-align: center; }

#language-switch .languages-list li { display: inline-block; float: none; w=
idth: auto; }

#language-switch .languages-list li.active { display: none; }

#language-switch .languages-list li a { padding: 0px 10px; background: none=
; border: 1px solid rgb(178, 215, 238); color: rgb(0, 123, 199); margin: 0p=
x 10px; font-size: 17px; text-decoration: none; display: inline-block; heig=
ht: 38px; line-height: 39px; }

.link-list { line-height: 1.625rem; margin-bottom: 1em; }

.link-list.col-2, .link-list.col-3, .link-list.col-4, .link-list.col-full {=
 font-size: 1.125rem; }

.link-list .facets { text-transform: lowercase; }

.link-list .facets .facet { color: rgb(0, 0, 0); }

.link-list .facets .facet:first-child::before { content: "("; color: rgb(0,=
 0, 0); }

.link-list .facets .facet.reimbursed { color: rgb(57, 135, 12); }

.link-list .facets .facet.partially-reimbursed { color: rgb(225, 112, 0); }

.link-list .facets .facet.not-reimbursed { color: rgb(213, 43, 30); }

.link-list .facets .facet:last-child::after { content: ")"; color: rgb(0, 0=
, 0); }

.link-list .facets .facet:not(:last-child)::after { content: ", "; }

@media only screen and (min-width: 1280px) {
  .link-list.col-2 { column-count: 2; overflow: hidden; }
  .link-list.col-3 { column-count: 3; overflow: hidden; }
  .link-list.col-4 { column-count: 4; overflow: hidden; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .link-list.col-2 { column-count: 2; overflow: hidden; }
  .link-list.col-3 { column-count: 3; overflow: hidden; }
  .portlet.span-2 .link-list.col-3 { column-count: 2; }
  .link-list.col-4 { column-count: 3; overflow: hidden; }
}

.aside-block .link-list { margin-bottom: 1em; margin-left: 25px; }

@media only screen and (min-width: 770px) {
  .aside-block .link-list { font-size: 0.8em; }
}

.link-list.compact li { margin: 0px; padding-bottom: 0.4em; }

.link-list.compact li ul { padding: 0px 0px 5px; }

.link-list.expanded > li { padding-bottom: 0.4em; }

.page-module-group-title + .link-list { margin-top: 20px; }

.link-list.no-spread li { overflow: hidden; }

.link-list li { margin: 0px; border-bottom: 0.3em solid rgba(0, 0, 0, 0); p=
adding: 0px 0px 0px 22px; list-style: none; display: grid; grid-template-ar=
eas: "label functions" "children children"; break-inside: avoid; }

.link-list li .functions { grid-area: functions; text-align: right; }

.link-list li .functions .button { font-family: "RO Sans"; border: none; cu=
rsor: default; border-radius: 0px; background-image: none; text-decoration:=
 none; display: inline-block; box-shadow: none; color: rgb(1, 104, 154); ba=
ckground-color: rgb(242, 242, 242); max-width: 100%; overflow: hidden; text=
-overflow: ellipsis; white-space: nowrap; font-size: 18px; padding: 0px 0.8=
rem; height: 29px; line-height: 29px; vertical-align: baseline; font-weight=
: normal; margin: -2px 0px -4px 5px; }

.link-list li .functions .button::before { line-height: inherit; }

.link-list li .functions .button:focus { outline: var(--pat-form-input-fiel=
d-outline-focus); outline-offset: var(--pat-form-input-field-outline-offset=
); }

.link-list li .functions .button:hover { background-color: rgb(237, 237, 23=
7); text-decoration: none; color: rgb(1, 104, 154); }

.link-list li .functions .button.default { color: white; background-color: =
rgb(1, 104, 155); box-shadow: none; }

.link-list li .functions .button.default:hover { background-color: rgb(1, 7=
0, 104); color: white; }

.link-list li .functions .button[disabled], .link-list li .functions .butto=
n.disabled, .link-list li .functions .button:is(a):not([href]), .link-list =
li .functions .button.default[disabled], .link-list li .functions .button.d=
efault.disabled, .link-list li .functions .button:is(a).default:not([href])=
 { color: rgba(0, 0, 0, 0.3); background-color: rgb(242, 242, 242); }

.link-list li .functions .button[disabled]:hover, .link-list li .functions =
.button.disabled:hover, .link-list li .functions .button:is(a):not([href]):=
hover, .link-list li .functions .button.default[disabled]:hover, .link-list=
 li .functions .button.default.disabled:hover, .link-list li .functions .bu=
tton:is(a).default:not([href]):hover { color: rgba(0, 0, 0, 0.3); backgroun=
d-color: rgb(242, 242, 242); }

@media print {
  .link-list li .functions .button { display: none; }
}

.link-list li .functions .button.small { font-size: 18px; padding: 0px 0.8r=
em; height: 29px; line-height: 29px; vertical-align: baseline; box-shadow: =
none; font-weight: normal; }

.link-list li .functions .button.small::before { font-size: 15px; }

.link-list li .functions .button.iconified { width: 30px; padding: 0px; }

.link-list li .functions .button.iconified::before { width: 100%; text-alig=
n: center; line-height: 44px; }

.link-list li .functions .button.link { padding: 0px; display: inline; back=
ground: none; color: rgb(1, 104, 155); line-height: inherit; text-decoratio=
n: underline; vertical-align: baseline; cursor: pointer; }

.link-list li .functions .button.link:hover { background: none; color: rgb(=
0, 2, 3); text-decoration: underline !important; }

.link-list li .functions .button.no-label { padding: 0px; aspect-ratio: 1 /=
 1; text-overflow: clip; height: var(--pat-button-height); min-width: var(-=
-pat-button-height); }

.link-list li .functions .button.no-label::before { width: 100%; text-align=
: center; margin: 0px 1em 0px 0px; line-height: var(--pat-button-height); }

.link-list li .functions .button::before { font-weight: normal; margin-righ=
t: 5px; }

.link-list li .functions .button.add::before { font-family: fontello; conte=
nt: "=EE=A3=A4"; }

.form-panel .link-list li .functions .button { box-shadow: rgb(1, 104, 155)=
 0px 0px 0px 1px; }

.link-list li .functions .button input { position: absolute; opacity: 0; }

.link-list li .classification-tags { line-height: 15px; height: 20px; displ=
ay: inline-block; vertical-align: middle; }

.link-list li.deleted { display: none; }

.pat-rich .link-list li { list-style: none; }

#sub-nav .link-list li { padding-left: 30px; }

.link-list li > * { pointer-events: auto; }

.link-list li.state-archived .link-title { text-decoration: line-through; o=
pacity: 0.5; }

.link-list li.state-draft a[href], .link-list li.state-new a[href] { color:=
 rgb(225, 112, 0); }

.link-list li.state-draft a[href]:hover, .link-list li.state-new a[href]:ho=
ver { color: rgb(174, 87, 0); }

.link-list li.processed a { text-decoration: line-through; }

.link-list li.warning a:not([class*=3D"icon-"])::before { font-family: font=
ello; content: "=EE=A0=95"; color: rgb(225, 112, 0); font-size: 0.7em; }

.link-list li.type-reference { display: list-item; }

.link-list li.type-reference a::before { display: none !important; }

.link-list li.type-reference .reference-badge { float: left; margin-left: -=
22px; font-size: 0.7em; margin-top: 2px; position: relative; line-height: 1=
9px; }

.link-list li.type-reference .reference-badge::before { position: absolute;=
 inset: 0px; background: rgb(1, 104, 155); color: rgb(255, 255, 255); font-=
family: fontello; content: "=EE=A3=88"; display: none; width: 100%; text-al=
ign: center; margin: 0px; border-radius: 0.8em; }

.link-list li.type-reference .reference-badge:hover::before { display: bloc=
k !important; }

.link-list li > a, .link-list li > .group-title, .link-list li > .link-titl=
e { display: block; font-weight: normal; margin-left: 0px; position: relati=
ve; grid-area: label; font-size: 1em; line-height: 24px; padding: 0px !impo=
rtant; }

.link-list li > a .link-title, .link-list li > .group-title .link-title, .l=
ink-list li > .link-title .link-title { font-weight: normal; font-size: inh=
erit; line-height: inherit; }

.link-list li > a .link-byline, .link-list li > .group-title .link-byline, =
.link-list li > .link-title .link-byline { font-size: 0.888889rem; line-hei=
ght: 1.6875; font-weight: normal; color: rgb(83, 83, 83); margin: 0px; text=
-decoration: none !important; }

.-ms- .link-list li > a, .-ms- .link-list li > .group-title, .-ms- .link-li=
st li > .link-title { text-decoration: none; }

.link-list li > a::before, .link-list li > .group-title::before, .link-list=
 li > .link-title::before { grid-area: label; font-family: fontello; margin=
-left: -22px; font-weight: normal; float: left; text-decoration: none; widt=
h: 22px; text-align: left; speak: none; display: inline-block; line-height:=
 inherit; position: absolute; }

#sub-nav .link-list li > a::before, #sub-nav .link-list li > .group-title::=
before, #sub-nav .link-list li > .link-title::before { margin-left: -30px; =
}

.link-list li > a:not([class*=3D"icon-"])::before, .link-list li > .group-t=
itle:not([class*=3D"icon-"])::before, .link-list li > .link-title:not([clas=
s*=3D"icon-"])::before { content: "=EE=A2=84"; }

.link-list li > a.type-link-external::before, .link-list li > .group-title.=
type-link-external::before, .link-list li > .link-title.type-link-external:=
:before { content: "=EE=A3=8F"; font-size: 0.595rem; }

.link-list li > a.type-link-internal::before, .link-list li > .group-title.=
type-link-internal::before, .link-list li > .link-title.type-link-internal:=
:before { content: "=EE=A1=9A"; }

.link-list li > a.type-tag::before, .link-list li > .group-title.type-tag::=
before, .link-list li > .link-title.type-tag::before { content: "=EE=A0=8C"=
; font-size: 0.9em; }

.link-list li > a.medicine::before, .link-list li > a.type-medicine::before=
, .link-list li > .group-title.medicine::before, .link-list li > .group-tit=
le.type-medicine::before, .link-list li > .link-title.medicine::before, .li=
nk-list li > .link-title.type-medicine::before { content: "=EE=A1=8B"; }

.link-list li > a.medicine-group::before, .link-list li > a.type-medicine-g=
roup::before, .link-list li > .group-title.medicine-group::before, .link-li=
st li > .group-title.type-medicine-group::before, .link-list li > .link-tit=
le.medicine-group::before, .link-list li > .link-title.type-medicine-group:=
:before { content: "=EE=A1=89"; }

.link-list li > a.indication::before, .link-list li > a.super-indication::b=
efore, .link-list li > a.type-indication::before, .link-list li > a.type-su=
per-indication::before, .link-list li > .group-title.indication::before, .l=
ink-list li > .group-title.super-indication::before, .link-list li > .group=
-title.type-indication::before, .link-list li > .group-title.type-super-ind=
ication::before, .link-list li > .link-title.indication::before, .link-list=
 li > .link-title.super-indication::before, .link-list li > .link-title.typ=
e-indication::before, .link-list li > .link-title.type-super-indication::be=
fore { content: "=EF=83=B0"; }

.link-list li > a.type-is::before, .link-list li > .group-title.type-is::be=
fore, .link-list li > .link-title.type-is::before { content: "=EE=A2=B0"; f=
ont-size: 0.8em; }

.link-list li > a.type-rs::before, .link-list li > .group-title.type-rs::be=
fore, .link-list li > .link-title.type-rs::before { content: "=EE=A2=B1"; f=
ont-size: 0.8em; }

.link-list li > a.type-qs::before, .link-list li > .group-title.type-qs::be=
fore, .link-list li > .link-title.type-qs::before { content: "=EE=A2=AA"; }

.link-list li > a.type-mi::before, .link-list li > .group-title.type-mi::be=
fore, .link-list li > .link-title.type-mi::before { content: "=EE=A2=AC"; m=
argin-top: 0.15em; font-size: 0.8em; }

.link-list li.medicine a::before { content: "=EE=A1=8B"; }

.link-list li .group-title { color: rgb(0, 0, 0); }

.link-list li a { color: rgb(0, 0, 0); }

.link-list li a[href] { color: rgb(1, 104, 155); }

.link-list li a[href]:hover { text-decoration: underline; color: rgb(1, 70,=
 104); }

.link-list li a[href]:hover .classification-tags .classification-tag { text=
-decoration: none; }

.link-list li a[href]:hover:has(.link-title) { text-decoration: none; }

.link-list li a[href]:hover .link-byline { text-decoration: none !important=
; }

.link-list li a[href]:hover:hover .link-title { text-decoration: underline;=
 }

.link-list li ul { font-size: 0.8em; margin: 0.5em 0px 0px; line-height: 1.=
2; grid-area: children; }

.link-list li ul li { margin: 0px; padding: 0px; border-bottom: none; left:=
 0px; }

.link-list li ul li a { white-space: nowrap; overflow: hidden; text-overflo=
w: ellipsis; transform: translateZ(0px); padding: 0px 0px 0px 17px !importa=
nt; }

.link-list li ul li a .classification-tags { position: absolute; right: 0px=
; top: 0px; background: rgb(255, 255, 255); box-shadow: rgb(255, 255, 255) =
0px 0px 10px 10px; }

.portlet .link-list li ul li a .classification-tags { background: rgb(243, =
243, 243); box-shadow: rgb(243, 243, 243) 0px 0px 10px 10px; }

.editors-well .link-list li ul li a .classification-tags, #portlet-drafts .=
link-list li ul li a .classification-tags { background: rgb(251, 234, 217);=
 box-shadow: rgb(251, 234, 217) 0px 0px 10px 10px; }

.link-list li ul li a::before { margin-left: -17px; margin-top: 0px; font-w=
eight: normal; float: left; content: "=EE=A2=84"; font-family: fontello; li=
ne-height: inherit; }

.link-list li::before { display: none; }

.link-tiles-photos .link-tiles-photos-follow { margin-bottom: 25px; display=
: block; background-color: rgb(242, 242, 242); }

.link-tiles-photos .link-tiles-photos-follow:hover { background-color: rgb(=
237, 237, 237); }

.link-tiles-photos .link-tiles-photos-follow:hover figcaption .link-tiles-p=
hotos-tile-title { color: rgb(1, 104, 154); }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile { disp=
lay: grid; grid-template-columns: 30% 70%; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e { position: relative; width: 100%; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e img { position: absolute; width: 100%; height: 100%; object-fit: cover; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e .link-tiles-photos-copyright { position: absolute; z-index: 10; bottom: 0=
.5rem; left: 0.5rem; margin: 0px; color: rgb(255, 255, 255); text-shadow: r=
gba(0, 0, 0, 0.5) 0px 0px 1px, rgba(0, 0, 0, 0.5) -1px 0px 1px, rgba(0, 0, =
0, 0.5) 1px 0px 1px, rgba(0, 0, 0, 0.5) 0px -1px 1px, rgba(0, 0, 0, 0.5) 0p=
x 1px 1px, rgba(0, 0, 0, 0.5) 2px 2px 6px; line-height: 1.125; display: blo=
ck; opacity: 0.7; font-size: 0.5em; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e .link-tiles-photos-copyright::before { font-family: fontello; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e .link-tiles-photos-copyright.type-copyright::before { content: "=EF=87=B9=
 "; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile pictur=
e .link-tiles-photos-copyright.type-creative-commons::before { content: "=
=EF=89=9E "; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile figcap=
tion { padding: 10px 20px; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile figcap=
tion .link-tiles-photos-tile-title { font-size: 1.42383rem; line-height: 1.=
40466; font-weight: bold; display: block; color: rgb(1, 104, 154); margin: =
0px; }

.link-tiles-photos .link-tiles-photos-follow .link-tiles-photos-tile figcap=
tion .link-tiles-photos-tile-byline { font-size: 1rem; line-height: 1.6875;=
 font-weight: normal; color: rgb(83, 83, 83); margin: 0px; text-decoration:=
 none !important; }

.logo-cloud { padding: 0px; text-align: center; }

.logo-cloud::after { content: " "; display: table; clear: both; }

.logo-cloud .logo { width: 19%; padding: 0px 1em; margin: 0px; display: inl=
ine-block; vertical-align: middle; box-sizing: border-box; text-align: cent=
er; }

.logo-cloud .logo::after { content: " "; display: table; clear: both; }

@media only screen and (max-width: 769px) {
  .logo-cloud .logo { width: 46%; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .logo-cloud .logo { width: 32%; }
}

.logo-cloud .logo img { max-width: 100%; position: relative; top: 50%; disp=
lay: inline-block; }

.message-box { position: relative; transition: 1s; margin: 0px !important; =
}

table .message-box { margin-bottom: 0px; line-height: 1.5; }

.message-box .content-mirror { content: attr(data-value); -webkit-text-fill=
-color: rgba(0, 0, 0, 0); padding-bottom: 26px; padding-right: 10px; color:=
 rgb(0, 0, 0); font-family: inherit; cursor: default; text-align: start; wh=
ite-space: pre-wrap; vertical-align: text-bottom; overflow: visible; width:=
 100%; box-sizing: border-box; transition: 0.5s; background-color: rgb(255,=
 255, 255); }

.message-box .content-mirror .placeholder { display: none; }

.message-box .placeholder { color: rgb(1, 104, 155); -webkit-text-fill-colo=
r: rgb(1, 104, 155); text-decoration: underline; font-weight: normal; }

.message-box.status-active .button-bar { height: 1.8em; padding-top: 2em; p=
adding-bottom: 0.7em; }

@media print {
  .message-box { display: none; }
}

.message-box textarea { min-height: 36px; }

.message-box textarea, .message-box .content-mirror { padding-right: 2em; p=
adding-left: 0.5em; font-size: 1em; font-family: "RO Sans"; float: left; bo=
rder: none; overflow: hidden; resize: none; width: 100%; }

.message-box textarea { padding-right: 10px; position: absolute; inset: 0px=
; z-index: 1; height: 100%; }

.message-box.status-inactive .button-bar { opacity: 0; }

.message-box .button-bar { height: 0px; padding: 0px 0.5em; overflow: hidde=
n; margin: 0px; transition: 0.4s; z-index: 2; position: relative; }

.message-box .button-bar .pat-button { margin-right: 8px; line-height: 19px=
; float: left; padding: 0.4em 10px; }

.message-box .button-bar br { display: none; }

ul.menu, .menu-list { margin: 0px 0px 1em; list-style-type: none; --pat-che=
cklist-label-padding-start: var(--pat-menu-list-item-padding-start); --pat-=
checklist-label-padding-end: 0.2em; --pat-checklist-item-separation: 0; --p=
at-checklist-checkbox-size: 16px; }

ul.menu li, .menu-list li { padding-left: 0px; --pat-checklist-margin-botto=
m: 0; }

ul.menu li > a, ul.menu li > label, ul.menu li > form > label, ul.menu li >=
 form > button, ul.menu li > form > fieldset > label, ul.menu li > fieldset=
.pat-checklist label, ul.menu li > button, .menu-list li > a, .menu-list li=
 > label, .menu-list li > form > label, .menu-list li > form > button, .men=
u-list li > form > fieldset > label, .menu-list li > fieldset.pat-checklist=
 label, .menu-list li > button { padding: 0.3em 0px; color: rgb(0, 0, 0); l=
ine-height: 24px; cursor: default; overflow: hidden; border: none; width: 1=
00%; background: none; box-sizing: border-box; font-size: 1.26562rem; displ=
ay: grid; grid-template-columns: var(--pat-menu-list-item-padding-start) au=
to; border-radius: var(--border-radii); user-select: none; }

ul.menu li > a::before, ul.menu li > label::before, ul.menu li > form > lab=
el::before, ul.menu li > form > button::before, ul.menu li > form > fieldse=
t > label::before, ul.menu li > fieldset.pat-checklist label::before, ul.me=
nu li > button::before, .menu-list li > a::before, .menu-list li > label::b=
efore, .menu-list li > form > label::before, .menu-list li > form > button:=
:before, .menu-list li > form > fieldset > label::before, .menu-list li > f=
ieldset.pat-checklist label::before, .menu-list li > button::before { font-=
family: fontello; align-self: start; display: block; margin-right: 0px; lin=
e-height: inherit; justify-self: center !important; }

ul.menu li > a:has(input[type=3D"checkbox"])::before, ul.menu li > label:ha=
s(input[type=3D"checkbox"])::before, ul.menu li > form > label:has(input[ty=
pe=3D"checkbox"])::before, ul.menu li > form > button:has(input[type=3D"che=
ckbox"])::before, ul.menu li > form > fieldset > label:has(input[type=3D"ch=
eckbox"])::before, ul.menu li > fieldset.pat-checklist label:has(input[type=
=3D"checkbox"])::before, ul.menu li > button:has(input[type=3D"checkbox"]):=
:before, .menu-list li > a:has(input[type=3D"checkbox"])::before, .menu-lis=
t li > label:has(input[type=3D"checkbox"])::before, .menu-list li > form > =
label:has(input[type=3D"checkbox"])::before, .menu-list li > form > button:=
has(input[type=3D"checkbox"])::before, .menu-list li > form > fieldset > la=
bel:has(input[type=3D"checkbox"])::before, .menu-list li > fieldset.pat-che=
cklist label:has(input[type=3D"checkbox"])::before, .menu-list li > button:=
has(input[type=3D"checkbox"])::before { line-height: var(--pat-checklist-ch=
eckbox-size); }

ul.menu li > a:has(input[type=3D"file"]), ul.menu li > label:has(input[type=
=3D"file"]), ul.menu li > form > label:has(input[type=3D"file"]), ul.menu l=
i > form > button:has(input[type=3D"file"]), ul.menu li > form > fieldset >=
 label:has(input[type=3D"file"]), ul.menu li > fieldset.pat-checklist label=
:has(input[type=3D"file"]), ul.menu li > button:has(input[type=3D"file"]), =
.menu-list li > a:has(input[type=3D"file"]), .menu-list li > label:has(inpu=
t[type=3D"file"]), .menu-list li > form > label:has(input[type=3D"file"]), =
.menu-list li > form > button:has(input[type=3D"file"]), .menu-list li > fo=
rm > fieldset > label:has(input[type=3D"file"]), .menu-list li > fieldset.p=
at-checklist label:has(input[type=3D"file"]), .menu-list li > button:has(in=
put[type=3D"file"]) { position: relative; }

ul.menu li > a:hover, ul.menu li > label:hover, ul.menu li > form > label:h=
over, ul.menu li > form > button:hover, ul.menu li > form > fieldset > labe=
l:hover, ul.menu li > fieldset.pat-checklist label:hover, ul.menu li > butt=
on:hover, .menu-list li > a:hover, .menu-list li > label:hover, .menu-list =
li > form > label:hover, .menu-list li > form > button:hover, .menu-list li=
 > form > fieldset > label:hover, .menu-list li > fieldset.pat-checklist la=
bel:hover, .menu-list li > button:hover { text-decoration: none; background=
: rgba(0, 0, 0, 0.05); color: rgb(0, 0, 0); }

ul.menu li > a.tooltip-active-click, ul.menu li > a:active, ul.menu li > la=
bel.tooltip-active-click, ul.menu li > label:active, ul.menu li > form > la=
bel.tooltip-active-click, ul.menu li > form > label:active, ul.menu li > fo=
rm > button.tooltip-active-click, ul.menu li > form > button:active, ul.men=
u li > form > fieldset > label.tooltip-active-click, ul.menu li > form > fi=
eldset > label:active, ul.menu li > fieldset.pat-checklist label.tooltip-ac=
tive-click, ul.menu li > fieldset.pat-checklist label:active, ul.menu li > =
button.tooltip-active-click, ul.menu li > button:active, .menu-list li > a.=
tooltip-active-click, .menu-list li > a:active, .menu-list li > label.toolt=
ip-active-click, .menu-list li > label:active, .menu-list li > form > label=
.tooltip-active-click, .menu-list li > form > label:active, .menu-list li >=
 form > button.tooltip-active-click, .menu-list li > form > button:active, =
.menu-list li > form > fieldset > label.tooltip-active-click, .menu-list li=
 > form > fieldset > label:active, .menu-list li > fieldset.pat-checklist l=
abel.tooltip-active-click, .menu-list li > fieldset.pat-checklist label:act=
ive, .menu-list li > button.tooltip-active-click, .menu-list li > button:ac=
tive { background-color: rgb(225, 112, 0); color: rgb(255, 255, 255); }

ul.menu li > a .pat-message, ul.menu li > label .pat-message, ul.menu li > =
form > label .pat-message, ul.menu li > form > button .pat-message, ul.menu=
 li > form > fieldset > label .pat-message, ul.menu li > fieldset.pat-check=
list label .pat-message, ul.menu li > button .pat-message, .menu-list li > =
a .pat-message, .menu-list li > label .pat-message, .menu-list li > form > =
label .pat-message, .menu-list li > form > button .pat-message, .menu-list =
li > form > fieldset > label .pat-message, .menu-list li > fieldset.pat-che=
cklist label .pat-message, .menu-list li > button .pat-message { display: b=
lock; margin-top: 0.4em; margin-bottom: 0.5em; padding: 0.3em 0.5em; }

ul.menu li > a input[type=3D"file"], ul.menu li > label input[type=3D"file"=
], ul.menu li > form > label input[type=3D"file"], ul.menu li > form > butt=
on input[type=3D"file"], ul.menu li > form > fieldset > label input[type=3D=
"file"], ul.menu li > fieldset.pat-checklist label input[type=3D"file"], ul=
.menu li > button input[type=3D"file"], .menu-list li > a input[type=3D"fil=
e"], .menu-list li > label input[type=3D"file"], .menu-list li > form > lab=
el input[type=3D"file"], .menu-list li > form > button input[type=3D"file"]=
, .menu-list li > form > fieldset > label input[type=3D"file"], .menu-list =
li > fieldset.pat-checklist label input[type=3D"file"], .menu-list li > but=
ton input[type=3D"file"] { opacity: 0; position: absolute; left: 0px; top: =
0px; height: 1.8em; width: 100%; }

ul.menu li > a:not([class*=3D"icon-"]):not([class*=3D"checked"])::before, u=
l.menu li > label:not([class*=3D"icon-"]):not([class*=3D"checked"])::before=
, ul.menu li > form > label:not([class*=3D"icon-"]):not([class*=3D"checked"=
])::before, ul.menu li > form > button:not([class*=3D"icon-"]):not([class*=
=3D"checked"])::before, ul.menu li > form > fieldset > label:not([class*=3D=
"icon-"]):not([class*=3D"checked"])::before, ul.menu li > fieldset.pat-chec=
klist label:not([class*=3D"icon-"]):not([class*=3D"checked"])::before, ul.m=
enu li > button:not([class*=3D"icon-"]):not([class*=3D"checked"])::before, =
.menu-list li > a:not([class*=3D"icon-"]):not([class*=3D"checked"])::before=
, .menu-list li > label:not([class*=3D"icon-"]):not([class*=3D"checked"])::=
before, .menu-list li > form > label:not([class*=3D"icon-"]):not([class*=3D=
"checked"])::before, .menu-list li > form > button:not([class*=3D"icon-"]):=
not([class*=3D"checked"])::before, .menu-list li > form > fieldset > label:=
not([class*=3D"icon-"]):not([class*=3D"checked"])::before, .menu-list li > =
fieldset.pat-checklist label:not([class*=3D"icon-"]):not([class*=3D"checked=
"])::before, .menu-list li > button:not([class*=3D"icon-"]):not([class*=3D"=
checked"])::before { font-family: fontello; content: "=EE=A2=84"; }

ul.menu li > a.current, ul.menu li > label.current, ul.menu li > form > lab=
el.current, ul.menu li > form > button.current, ul.menu li > form > fieldse=
t > label.current, ul.menu li > fieldset.pat-checklist label.current, ul.me=
nu li > button.current, .menu-list li > a.current, .menu-list li > label.cu=
rrent, .menu-list li > form > label.current, .menu-list li > form > button.=
current, .menu-list li > form > fieldset > label.current, .menu-list li > f=
ieldset.pat-checklist label.current, .menu-list li > button.current { color=
: rgb(225, 112, 0); }

ul.menu li > a.current a, ul.menu li > label.current a, ul.menu li > form >=
 label.current a, ul.menu li > form > button.current a, ul.menu li > form >=
 fieldset > label.current a, ul.menu li > fieldset.pat-checklist label.curr=
ent a, ul.menu li > button.current a, .menu-list li > a.current a, .menu-li=
st li > label.current a, .menu-list li > form > label.current a, .menu-list=
 li > form > button.current a, .menu-list li > form > fieldset > label.curr=
ent a, .menu-list li > fieldset.pat-checklist label.current a, .menu-list l=
i > button.current a { color: rgb(225, 112, 0); cursor: default; }

#main { background: rgb(255, 255, 255); transition: 0.5s; padding-top: 70px=
; margin-top: -70px; }

.page-type-homepage #main.injecting * { opacity: 1; }

.page-type-homepage #main.injecting::before { display: none; }

.page-type-homepage #main.injecting .search-button-main, .page-type-homepag=
e #main.injecting .search-field button { transition: none; text-indent: -10=
00px; }

.page-type-homepage #main.injecting .search-button-main::before, .page-type=
-homepage #main.injecting .search-field button::before { opacity: 1; positi=
on: absolute; top: 50%; left: 50%; content: "=EF=84=A6"; width: 50px; heigh=
t: 50px; margin-top: -25px; margin-left: -25px; z-index: 1000; font-style: =
normal; font-variant: normal; font-size-adjust: none; font-language-overrid=
e: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-sett=
ings: normal; font-variation-settings: normal; font-weight: normal; font-st=
retch: normal; line-height: 50px; font-family: fontello; text-shadow: rgb(2=
55, 255, 255) 0px 0px 2px; text-align: center; animation: 2s linear 0s infi=
nite normal none running spin; text-indent: 0px; font-size: 1.3em !importan=
t; }

.variation-medicine-compare-versions ~ #main { padding-top: 125px; margin-t=
op: -125px; }

.variation-medicine-compare-versions ~ #main #product-space { padding-top: =
0px; }

.variation-compare ~ #main, .variation-medicine-compare ~ #main, .variation=
-indication-compare ~ #main, .variation-medicine-group-compare ~ #main { po=
sition: relative; z-index: 11; min-width: 100%; }

.no-csspositionsticky .variation-compare ~ #main, .no-csspositionsticky .va=
riation-medicine-compare ~ #main, .no-csspositionsticky .variation-indicati=
on-compare ~ #main, .no-csspositionsticky .variation-medicine-group-compare=
 ~ #main { margin-top: -5px; }

@keyframes intro-shake {=20
  0%, 15%, 50% { left: 50%; }
  20%, 30%, 40% { left: 45%; }
  25%, 35%, 45% { left: 55%; }
  5%, 80% { opacity: 1; }
  0%, 100% { opacity: 0; }
}

@media only screen and (max-width: 769px) {
  .variation-compare ~ #main, .variation-medicine-compare ~ #main, .variati=
on-indication-compare ~ #main, .variation-medicine-group-compare ~ #main { =
margin-top: 138px; }
  .variation-compare ~ #main::before, .variation-medicine-compare ~ #main::=
before, .variation-indication-compare ~ #main::before, .variation-medicine-=
group-compare ~ #main::before { position: fixed; display: block; text-align=
: center; left: 50%; top: 50%; width: 80%; transform: translate(-50%, -50%)=
; content: "Schuif de pagina van rechts naar links om te vergelijken"; padd=
ing: 2rem 1rem; z-index: 100; font-size: 1.3em; line-height: 1.3; color: rg=
b(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: bold; opacit=
y: 0; animation: 5s ease 2s 1 normal none running intro-shake; pointer-even=
ts: none; box-shadow: rgba(0, 0, 0, 0.5) 0px 0px 20px; }
}

@media (display-mode: standalone) {
  .variation-compare ~ #main, .variation-medicine-compare ~ #main, .variati=
on-indication-compare ~ #main, .variation-medicine-group-compare ~ #main { =
margin-top: 0px; border-top: none; }
}

#main-content:not(.content-group), .main-content { max-width: 768px; margin=
: 0px auto; counter-reset: tab 0 fig 0; box-sizing: border-box; }

.variation-landing-toc ~ #main #main-content:not(.content-group):has(.link-=
list li:nth-child(12)), .variation-landing-toc ~ #main .main-content:has(.l=
ink-list li:nth-child(12)) { margin: 0px; padding: 0px; max-width: 100%; }

@media only screen and (min-width: 1280px) {
  .variation-landing-toc ~ #main #main-content:not(.content-group):has(.lin=
k-list li:nth-child(12)) .link-list, .variation-landing-toc ~ #main .main-c=
ontent:has(.link-list li:nth-child(12)) .link-list { column-count: 4; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .variation-landing-toc ~ #main #main-content:not(.content-group):has(.lin=
k-list li:nth-child(12)) .link-list, .variation-landing-toc ~ #main .main-c=
ontent:has(.link-list li:nth-child(12)) .link-list { column-count: 3; }
}

@media only screen and (max-width: 769px) {
  .variation-landing-toc ~ #main #main-content:not(.content-group):has(.lin=
k-list li:nth-child(12)) .link-list, .variation-landing-toc ~ #main .main-c=
ontent:has(.link-list li:nth-child(12)) .link-list { column-count: 1; }
}

.variation-report ~ #main #main-content:not(.content-group), .variation-rep=
ort ~ #main .main-content { width: 100%; max-width: 100%; margin: 0px; }

@media only screen and (min-width: 1280px) {
  .variation-report ~ #main #main-content:not(.content-group):has(.sidebar)=
, .variation-report ~ #main .main-content:has(.sidebar) { display: grid; gr=
id-template-columns: auto 300px; grid-template-areas: "main sidebar"; gap: =
30px; }
}

.variation-report ~ #main #main-content:not(.content-group) .table-data, .v=
ariation-report ~ #main .main-content .table-data { grid-area: main; overfl=
ow: auto; }

.variation-report ~ #main #main-content:not(.content-group) .sidebar, .vari=
ation-report ~ #main .main-content .sidebar { grid-area: sidebar; }

.variation-report ~ #main #main-content:not(.content-group) .pat-message + =
.pat-rich, .variation-report ~ #main .main-content .pat-message + .pat-rich=
 { margin-top: 3rem; }

@media only screen and (min-width: 1280px) {
  .variation-landing-tiles ~ #main #main-content:not(.content-group) .tile-=
navigation.col-3, .variation-landing-tiles ~ #main .main-content .tile-navi=
gation.col-3 { grid-template-columns: repeat(2, 1fr); gap: 20px; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .variation-landing-tiles ~ #main #main-content:not(.content-group) .tile-=
navigation.col-3, .variation-landing-tiles ~ #main .main-content .tile-navi=
gation.col-3 { grid-template-columns: 1fr; }
}

.variation-landing-tiles ~ #main #main-content:not(.content-group):has(.til=
e-navigation .tile-navigation-follow:nth-child(5)), .variation-landing-tile=
s ~ #main .main-content:has(.tile-navigation .tile-navigation-follow:nth-ch=
ild(5)) { margin: 0px; padding: 0px; max-width: 100%; }

@media only screen and (min-width: 1280px) {
  .variation-landing-tiles ~ #main #main-content:not(.content-group):has(.t=
ile-navigation .tile-navigation-follow:nth-child(5)) .tile-navigation.col-3=
, .variation-landing-tiles ~ #main .main-content:has(.tile-navigation .tile=
-navigation-follow:nth-child(5)) .tile-navigation.col-3 { grid-template-col=
umns: repeat(3, 1fr); gap: 20px; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .variation-landing-tiles ~ #main #main-content:not(.content-group):has(.t=
ile-navigation .tile-navigation-follow:nth-child(5)) .tile-navigation.col-3=
, .variation-landing-tiles ~ #main .main-content:has(.tile-navigation .tile=
-navigation-follow:nth-child(5)) .tile-navigation.col-3 { grid-template-col=
umns: 1fr 1fr; }
}

#main-content:not(.content-group).cms-edit-form .body-text .ProseMirror, .m=
ain-content.cms-edit-form .body-text .ProseMirror { min-height: 0px; margin=
: -15px; padding: 15px 15px 100px; }

#main-content:not(.content-group)::before, .main-content::before { backgrou=
nd: rgb(0, 0, 0); position: fixed; inset: 0px; z-index: 2; content: " "; di=
splay: block; opacity: 0; pointer-events: none; }

.spotlight-on #main-content:not(.content-group)::before, .spotlight-on .mai=
n-content::before { opacity: 0.5; }

#main-content:not(.content-group)::after, .main-content::after { position: =
fixed; inset: 0px; z-index: 3; content: " "; display: none; }

.spotlight-on #main-content:not(.content-group)::after, .spotlight-on .main=
-content::after { display: block; }

@media only screen and (min-width: 770px) {
  .variation-medicine-compare-versions ~ #main #main-content:not(.content-g=
roup), .variation-medicine-compare-versions ~ #main .main-content { margin:=
 0px; padding: 0px; }
}

.variation-overview ~ #main #main-content:not(.content-group), .variation-l=
anding ~ #main #main-content:not(.content-group), .variation-themes ~ #main=
 #main-content:not(.content-group), .variation-landing-indicator-sets ~ #ma=
in #main-content:not(.content-group), .variation-landing-topics ~ #main #ma=
in-content:not(.content-group), .variation-overview ~ #main .main-content, =
.variation-landing ~ #main .main-content, .variation-themes ~ #main .main-c=
ontent, .variation-landing-indicator-sets ~ #main .main-content, .variation=
-landing-topics ~ #main .main-content { margin-left: 0px; padding: 0px; }

#main-content:not(.content-group).page-type-landing, #main-content:not(.con=
tent-group).page-type-landing-topics, #main-content:not(.content-group).pag=
e-type-overview, #main-content:not(.content-group).page-type-themes, .main-=
content.page-type-landing, .main-content.page-type-landing-topics, .main-co=
ntent.page-type-overview, .main-content.page-type-themes { margin-left: 0px=
; padding: 0px; }

@media only screen and (max-width: 769px) {
  #main-content:not(.content-group), .main-content { width: 100%; margin: 0=
px; }
}

.pat-message.processing { padding: 30px 30px 30px 140px; position: relative=
; }

.pat-message.processing::before { opacity: 1; content: "=EF=84=A6"; width: =
50px; height: 50px; margin-top: -25px; margin-left: -25px; font: 50px / 50p=
x fontello; text-shadow: rgb(255, 255, 255) 0px 0px 2px; text-align: center=
; animation: 2s linear 0s infinite normal none running spin; position: abso=
lute; top: 50%; left: 70px; z-index: 1; }

@media only screen and (max-width: 769px) {
  .pat-message.processing { padding: 140px 30px 30px; }
  .pat-message.processing::before { left: 50%; top: 80px; }
}

.pat-message.info { background-color: rgb(229, 240, 249); }

.pat-message.error, .pat-message.warning { padding-top: 30px; position: rel=
ative; }

.pat-message.error::before, .pat-message.warning::before { position: absolu=
te; top: 0px; left: 1.3rem; width: 22px; height: 22px; color: rgb(255, 255,=
 255); content: "!"; font-weight: bold; line-height: 22px; text-align: cent=
er; display: block; }

.pat-message.error::before, .pat-message.error .panel-content::before { bac=
kground-color: rgb(202, 0, 93); }

.pat-message.warning::before, .pat-message.warning .panel-content::before {=
 background-color: rgb(225, 112, 0); color: rgb(251, 234, 217) !important; =
}

.pat-message.error { background-color: rgb(247, 210, 221); color: rgb(0, 0,=
 0); position: relative; }

.pat-message.pat-collapsible { padding: 0px; }

.pat-message.pat-collapsible.closed { margin: 0px !important; }

.pat-message.pat-collapsible::before { display: none; }

.pat-message.pat-collapsible .panel-content { padding: 10px 15px; }

.pat-message.pat-collapsible.error .panel-content, .pat-message.pat-collaps=
ible.warning .panel-content { padding-top: 30px; }

.pat-message.pat-collapsible.error .panel-content::before, .pat-message.pat=
-collapsible.warning .panel-content::before { position: absolute; top: 0px;=
 left: 1.3rem; width: 22px; height: 22px; color: rgb(255, 255, 255); conten=
t: "!"; font-weight: bold; line-height: 22px; text-align: center; display: =
block; }

.nav-tiles { display: grid; gap: 10px 30px; margin-bottom: 1rem; }

.nav-tiles:has(.byline) { margin-bottom: 0px; }

@media only screen and (min-width: 1280px) {
  .nav-tiles { grid-template-columns: 1fr 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .nav-tiles { grid-template-columns: 1fr 1fr; }
}

@media only screen and (max-width: 769px) {
  .nav-tiles { grid-template-columns: 1fr; margin: 0px; }
}

.nav-tiles.count-1 { grid-template-columns: 100%; }

@media only screen and (min-width: 1280px) {
  .nav-tiles.count-2, .nav-tiles.count-4 { grid-template-columns: 50% 50%; =
}
}

.nav-tiles .item a { padding-left: 40px; padding-bottom: 1rem; display: blo=
ck; position: relative; height: 100%; text-decoration: none; box-sizing: bo=
rder-box; }

.no-touchevents .nav-tiles .item a:hover .item-title { text-decoration: und=
erline; }

.nav-tiles .item a::before { position: absolute; left: 0px; top: 2px; width=
: 25px; height: 100%; font-size: 25px; color: rgb(57, 135, 12); font-family=
: fontello; line-height: 1em; text-align: center; }

@media only screen and (max-width: 769px) {
  .nav-tiles .item a::before { left: 15px; top: 23px; height: auto; margin:=
 0px; }
}

.nav-tiles .item a:not([class*=3D"icon-"])::before { content: "=EE=A1=85"; =
font-size: 18px; line-height: 28px; text-indent: 12px; }

@media only screen and (max-width: 769px) {
  .nav-tiles .item a { padding: 20px 40px 20px 49px; }
  .nav-tiles .item a::after { position: absolute; top: 50%; height: auto; t=
ransform: translateY(-50%); right: 20px; font-family: fontello; content: "=
=EE=A2=84"; font-size: 25px; }
}

.nav-tiles .item a .item-title { hyphens: auto; overflow: hidden; text-over=
flow: ellipsis; color: rgb(1, 104, 155); font-weight: normal; }

@media only screen and (min-width: 770px) {
  .nav-tiles .item a .item-title { font-size: 1.60181rem; line-height: 1.24=
859; margin: 0rem 0rem 0px; }
}

@media only screen and (max-width: 769px) {
  .nav-tiles .item a .item-title { font-size: 1.3125em; line-height: 1.2381=
; }
}

.nav-tiles .item a .byline { font-size: 1.125rem; line-height: 1.33333; col=
or: rgb(0, 0, 0); margin-bottom: 20px; }

@media only screen and (min-width: 770px) {
  .nav-tiles .item a .byline { margin-top: 0.5rem; }
}

@media only screen and (max-width: 769px) {
  .nav-tiles .item a .byline { padding-top: 2px; font-size: 16px; }
}

.news-feed { margin: 0px -15px 26px; display: flex; flex-wrap: wrap; }

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .news-feed { grid-template-columns: 1fr 1fr; }
}

@media only screen and (max-width: 769px) {
  .news-feed { grid-template-columns: 1fr; }
}

.news-feed .item.pinned a .item-title { margin-top: 0px; padding-top: 0px; =
padding-left: 28px; position: relative; overflow: hidden; }

.news-feed .item.pinned a .item-title::before { content: "=EE=A0=8B"; font-=
family: fontello; color: rgb(255, 255, 255); background-color: rgb(1, 104, =
155); position: absolute; width: 20px; text-align: center; top: 50%; left: =
0px; height: 500px; line-height: 500px; transform: translateY(-50%); font-s=
ize: 15px; }

@media only screen and (min-width: 770px) {
  .news-feed.image-flow .item { width: 50%; }
}

.news-feed.image-flow .item .illustration { display: none; }

@media only screen and (min-width: 770px) {
  .news-feed.image-flow .item:nth-child(1) { width: 50%; }
  .news-feed.image-flow .item:nth-child(1) .illustration { display: block; =
}
}

@media only screen and (max-width: 769px) {
  .news-feed.image-flow .item:nth-child(1) .illustration { display: block; =
}
}

@media only screen and (min-width: 770px) {
  .news-feed.image-flow .item:nth-child(2) { width: 50%; }
  .news-feed.image-flow .item:nth-child(2) .illustration { display: block; =
}
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .news-feed.image-flow .item:nth-child(3) { width: 50%; margin-bottom: 30p=
x; }
  .news-feed.image-flow .item:nth-child(3) .illustration { display: block; =
}
}

@media only screen and (min-width: 1280px) {
  .news-feed.image-flow .item:nth-child(3) { width: 33.3332%; margin-bottom=
: 30px; }
  .news-feed.image-flow .item:nth-child(3) .illustration { display: block; =
}
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .news-feed.image-flow .item:nth-child(4) { width: 50%; margin-bottom: 30p=
x; }
  .news-feed.image-flow .item:nth-child(4) .illustration { display: block; =
}
}

@media only screen and (min-width: 1280px) {
  .news-feed.image-flow .item:nth-child(4) { width: 33.3332%; margin-bottom=
: 30px; }
  .news-feed.image-flow .item:nth-child(4) .illustration { display: block; =
}
}

@media only screen and (min-width: 1280px) {
  .news-feed.image-flow .item:nth-child(5) { width: 33.3332%; margin-bottom=
: 30px; }
  .news-feed.image-flow .item:nth-child(5) .illustration { display: block; =
}
}

@media only screen and (min-width: 770px) {
  .news-feed.image-flow .item:nth-child(1).pinned a .item-title, .news-feed=
.image-flow .item:nth-child(2).pinned a .item-title, .news-feed.image-flow =
.item:nth-child(3).pinned a .item-title, .news-feed.image-flow .item:nth-ch=
ild(4).pinned a .item-title, .news-feed.has-images .item:nth-child(1).pinne=
d a .item-title, .news-feed.has-images .item:nth-child(2).pinned a .item-ti=
tle, .news-feed.has-images .item:nth-child(3).pinned a .item-title, .news-f=
eed.has-images .item:nth-child(4).pinned a .item-title { padding-left: 0px;=
 }
  .news-feed.image-flow .item:nth-child(1).pinned a .item-title::before, .n=
ews-feed.image-flow .item:nth-child(2).pinned a .item-title::before, .news-=
feed.image-flow .item:nth-child(3).pinned a .item-title::before, .news-feed=
.image-flow .item:nth-child(4).pinned a .item-title::before, .news-feed.has=
-images .item:nth-child(1).pinned a .item-title::before, .news-feed.has-ima=
ges .item:nth-child(2).pinned a .item-title::before, .news-feed.has-images =
.item:nth-child(3).pinned a .item-title::before, .news-feed.has-images .ite=
m:nth-child(4).pinned a .item-title::before { display: none; }
  .news-feed.image-flow .item:nth-child(1).pinned a::after, .news-feed.imag=
e-flow .item:nth-child(2).pinned a::after, .news-feed.image-flow .item:nth-=
child(3).pinned a::after, .news-feed.image-flow .item:nth-child(4).pinned a=
::after, .news-feed.has-images .item:nth-child(1).pinned a::after, .news-fe=
ed.has-images .item:nth-child(2).pinned a::after, .news-feed.has-images .it=
em:nth-child(3).pinned a::after, .news-feed.has-images .item:nth-child(4).p=
inned a::after { z-index: 1; content: "=EE=A0=8B"; font-family: fontello; p=
osition: absolute; top: 0px; right: 0px; left: auto; color: rgb(255, 255, 2=
55); display: block; width: 29px; line-height: 33px; text-align: center; }
  .news-feed.image-flow .item:nth-child(1).pinned a::before, .news-feed.ima=
ge-flow .item:nth-child(2).pinned a::before, .news-feed.image-flow .item:nt=
h-child(3).pinned a::before, .news-feed.image-flow .item:nth-child(4).pinne=
d a::before, .news-feed.has-images .item:nth-child(1).pinned a::before, .ne=
ws-feed.has-images .item:nth-child(2).pinned a::before, .news-feed.has-imag=
es .item:nth-child(3).pinned a::before, .news-feed.has-images .item:nth-chi=
ld(4).pinned a::before { z-index: 1; position: absolute; top: 0px; right: 1=
5px; left: auto; display: block; content: " "; width: 0px; height: 0px; bor=
der-top: 35px solid rgba(0, 0, 0, 0); border-bottom: 35px solid rgba(0, 0, =
0, 0); border-left: 35px solid rgb(1, 104, 155); transform-origin: 0px 0px;=
 transform: rotate(-45deg); outline: rgb(255, 255, 255) solid 1px; }
}

@media only screen and (min-width: 1280px) {
  .news-feed.image-flow .item:nth-child(5).pinned a .item-title, .news-feed=
.has-images .item:nth-child(5).pinned a .item-title { padding-left: 0px; }
  .news-feed.image-flow .item:nth-child(5).pinned a .item-title::before, .n=
ews-feed.has-images .item:nth-child(5).pinned a .item-title::before { displ=
ay: none; }
  .news-feed.image-flow .item:nth-child(5).pinned a::after, .news-feed.has-=
images .item:nth-child(5).pinned a::after { z-index: 1; content: "=EE=A0=8B=
"; font-family: fontello; position: absolute; top: 0px; right: 0px; left: a=
uto; color: rgb(255, 255, 255); display: block; width: 29px; line-height: 3=
3px; text-align: center; }
  .news-feed.image-flow .item:nth-child(5).pinned a::before, .news-feed.has=
-images .item:nth-child(5).pinned a::before { z-index: 1; position: absolut=
e; top: 0px; right: 15px; left: auto; display: block; content: " "; width: =
0px; height: 0px; border-top: 35px solid rgba(0, 0, 0, 0); border-bottom: 3=
5px solid rgba(0, 0, 0, 0); border-left: 35px solid rgb(1, 104, 155); trans=
form-origin: 0px 0px; transform: rotate(-45deg); outline: rgb(255, 255, 255=
) solid 1px; }
}

.news-feed .item { padding-left: 15px; padding-right: 15px; width: 33.3333%=
; float: left; box-sizing: border-box; }

.portlet .news-feed .item { width: 100%; padding-bottom: 25px; }

@media only screen and (min-width: 770px) {
  .news-feed .item { padding-bottom: 52px; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .news-feed .item { width: 50%; }
  .portlet .news-feed .item { width: 100%; }
}

@media only screen and (max-width: 769px) {
  .news-feed .item { width: 100%; padding-bottom: 26px; }
}

.news-feed .item.warning .item-title { color: rgb(225, 112, 0); }

.news-feed .item a { text-decoration: none; color: rgb(0, 0, 0); display: b=
lock; position: relative; }

.news-feed .item a:hover .item-title { text-decoration: underline; }

.news-feed .item a::before { position: absolute; left: 0px; top: 2px; width=
: 25px; height: 100%; font-size: 25px; }

.news-feed .item a .illustration { margin-bottom: 10px; }

.news-feed .item a .illustration .picture { margin-bottom: 14px; aspect-rat=
io: 16 / 9; background-color: rgb(242, 242, 242); }

.news-feed .item a .illustration img { width: 100%; border: none; backgroun=
d-size: cover; background-position: center center; background-color: rgb(24=
2, 242, 242); display: block; object-fit: cover; aspect-ratio: 16 / 9; }

.news-feed .item a .item-title { font-size: 1.5102rem; line-height: 1.15879=
; margin-bottom: 0.5rem; font-weight: normal; color: rgb(1, 104, 155); widt=
h: auto; text-underline-offset: 0.18em; hyphens: auto; }

.news-feed .item a p { font-size: 1.125rem; line-height: 1.33333; margin-bo=
ttom: 0.5em; hyphens: auto; display: -webkit-box; -webkit-box-orient: verti=
cal; -webkit-line-clamp: 3; overflow: hidden; }

.news-feed .item a .byline { color: rgb(0, 0, 0); font-size: 0px; margin: 0=
px; display: flex; }

.news-feed .item a .byline .byline-item { border-left: 1px solid rgb(83, 83=
, 83); padding: 0px 0.5em; display: inline; font-size: 1.125rem; margin-bot=
tom: 7px; }

.news-feed .item a .byline .byline-item:first-child { padding-left: 0px; bo=
rder-left: none; }

.news-feed .item a .byline .byline-item.tags .tag { hyphens: auto; }

.news-feed .item a .byline .byline-item.tags .tag::after { content: ", "; }

.news-feed .item a .byline .byline-item.tags .tag:last-child::after { displ=
ay: none; }

.news-feed .item a .byline time { font-weight: bold; white-space: nowrap; }

.news-feed .item a p.source { font-size: 1em; font-style: italic; color: rg=
ba(0, 0, 0, 0.5); margin: 0.5rem 0px 0px; }

.object-history { position: relative; margin-bottom: 40px; }

.object-history::before { content: " "; display: block; position: absolute;=
 width: 15px; top: 2em; bottom: 2em; left: 19px; background: rgb(57, 135, 1=
2); z-index: 1; }

.object-history .object { margin-bottom: 1em; padding-left: 4.2em; position=
: relative; }

.object-history .object::after { content: " "; display: table; clear: both;=
 }

.object-history .object:last-child { height: 4em; }

.object-history .object form a, .object-history .object form button { font-=
size: 16px; text-decoration: underline; }

.object-history .object form a:hover, .object-history .object form button:h=
over { background: none; color: rgb(0, 2, 3); text-decoration: underline !i=
mportant; }

.object-history .object:last-child form { padding-bottom: 40px; }

.object-history .object .meta[href]:hover .user-name { text-decoration: und=
erline; }

.object-history .object .user-name { padding-top: 0.15em; display: block; }

.object-history .object.user-inactive .meta { color: gray; }

.object-history .object.user-inactive .meta .pat-avatar { filter: grayscale=
(100%) brightness(200%) contrast(40%); }

.object-history .object .byline { padding-bottom: 6px; margin-bottom: 0px; =
font-size: 1.125rem; }

.object-history .object .byline a { text-decoration: underline; }

.object-history .object .byline * { font-style: normal; }

.object-history .object .save-message { font-style: normal; background-colo=
r: rgb(253, 246, 187); padding: 12px 14px; margin: 6px 0px; font-size: 16px=
; line-height: 1.4; color: rgb(0, 0, 0); }

.object-history .object .save-message p.generated-message { margin-bottom: =
0.5em; }

.object-history .object .pat-avatar { position: absolute; left: 0px; top: 7=
px; border: 0.2em solid rgb(0, 0, 0); width: 2.2em; height: 2.2em; z-index:=
 1; background-color: rgb(239, 239, 239); background-size: cover; }

.object-history.action-centric::before { display: none; }

.object-history.action-centric .object { background-color: rgba(0, 0, 0, 0.=
08); margin-bottom: 0.25em; padding-left: 3.2em; padding-right: 1em; }

.object-history.action-centric .object .title::before { font-family: fontel=
lo; content: ""; display: block; margin: 0px; position: absolute; left: 0.9=
6em; top: 0.96em; color: rgba(0, 0, 0, 0.5); line-height: 1.9em; width: 1.6=
em; height: 1.85em; font-size: 1em; z-index: 1; text-align: center; }

.object-history.action-centric .object .title.action-edited::before { conte=
nt: "=E2=9C=8E"; }

.object-history.action-centric .object .title.action-deleted::before { cont=
ent: "=EE=9C=A9"; }

.object-history.action-centric .object .title.action-created::before { cont=
ent: "=EE=A0=B1"; line-height: 2em; }

.object-history.action-centric .object .title.action-state::before { conten=
t: "=EE=A1=92"; }

.page-module { display: block; margin-top: -100px; padding-top: 100px; poin=
ter-events: none; }

.page-module::after { content: " "; display: table; clear: both; }

.page-module > * { pointer-events: auto; }

.page-module .page-module-title { margin: 0rem 0rem 1rem; font-size: 1.8020=
3rem; line-height: 1.38732; margin-block: 1.75rem 0.75rem; }

.page-module .page-module-title .counter { line-height: 24px; font-size: 16=
px; border-radius: 12px; padding: 0px 6px; height: 24px; min-width: 24px; b=
ox-sizing: border-box; display: inline-block; background-color: rgb(227, 22=
0, 231); color: rgb(66, 20, 95); text-align: center; font-weight: normal; }

.page-module .page-module-title.assistive { position: absolute !important; =
}

.page-module .page-module-group-title { font-size: 1.42383rem; line-height:=
 1.40466; display: block; font-weight: bold; margin: 0rem 0rem 0.5rem; }

.page-module .page-module-footer a { font-weight: bold; }

.page-module .page-module-footer a:hover { text-decoration: underline; }

.page-module .page-module-footer a::before { display: inline-block; width: =
1em; font-family: fontello; content: "=EE=A2=84"; }

.page-module.type-downloads h3 { font-size: 1.42383rem; line-height: 1.4046=
6; display: block; font-weight: bold; margin: 0rem 0rem 0.5rem; }

.page-module.type-message { padding-bottom: 2rem; }

.page-module.type-composition .compare-to-other { margin-top: 60px; clear: =
both; }

.page-module.type-cost .cost-table { margin-bottom: 20px; }

.page-module.type-icon-tile-navigation { padding-bottom: 1rem; }

.page-module.type-object figcaption .enlarge-link { color: gray; text-decor=
ation: none; float: right; cursor: pointer; }

.page-module.type-object figcaption .icon-right-dir::before { transform: sc=
ale(1.4); }

.page-module.type-object .enlarge-button { position: absolute; inset: 0px 1=
0px; z-index: 1; color: rgba(0, 0, 0, 0); overflow: hidden; }

.page-module.type-object .enlarge-button::before { position: absolute; font=
-family: fontello; content: "=EE=A0=BB"; top: 50%; left: 50%; transform: tr=
anslate(-50%, -50%); color: rgb(255, 255, 255); width: 60px; height: 60px; =
line-height: 60px; background-color: rgba(0, 0, 0, 0.4); font-size: 50px; d=
isplay: block; text-align: center; padding: 0px; margin: -10px 0px 0px; }

.page-module.pat-rich { overflow-x: hidden; }

.page-module.pat-rich .pat-collapsible .panel-content > :last-child { margi=
n-bottom: 0px; }

.no-js .page-module.pat-rich .pat-collapsible .panel-content #close-excipie=
nts-warning { display: none; }

.page-module.has-differences .page-module-title { background: rgba(255, 100=
, 0, 0.1); }

.page-module.has-mutations .page-module-title { position: relative; padding=
-right: 25px; }

.page-module.has-mutations .page-module-title::after { position: absolute; =
top: 50%; right: 10px; transform: translateY(-50%); content: " "; width: 10=
px; height: 10px; overflow: hidden; border: 2px solid rgb(255, 255, 255); p=
adding: 0px; border-radius: 50%; background: linear-gradient(rgb(143, 202, =
231) 0%, rgb(0, 123, 199) 100%); display: inline-block; margin-top: 0px; co=
lor: rgba(0, 0, 0, 0) !important; }

.page-module.pat-collapsible + .page-module.pat-collapsible { margin-top: -=
100px; }

.page-module.pat-collapsible .page-module-title { min-height: 60px; font-we=
ight: normal; color: rgb(1, 104, 155); padding: 10px 40px 10px 39px; margin=
: -1px 0px 0px; position: relative; user-select: none; cursor: default; box=
-sizing: border-box; display: flex; align-items: stretch; justify-content: =
space-between; border-top: 1px solid rgb(204, 224, 241); border-bottom: 1px=
 solid rgb(204, 224, 241); }

.page-module.pat-collapsible .page-module-title:hover { background-color: r=
gb(229, 240, 249); color: rgb(1, 104, 155); }

.product-fk .page-module.pat-collapsible .page-module-title { border-top: 1=
px solid rgb(196, 219, 182); border-bottom: 1px solid rgb(196, 219, 182); }

.product-fk .page-module.pat-collapsible .page-module-title:hover { backgro=
und-color: rgb(225, 237, 219); color: rgb(39, 89, 55); }

.page-module.pat-collapsible .page-module-title .title-segment { padding: 1=
0px 20px 10px 39px; margin: -10px 0px -10px -39px; width: 100%; display: fl=
ex; justify-content: flex-start; font-size: 26px; line-height: 34px; }

.page-module.pat-collapsible .page-module-title .title-segment .fraction-na=
me { padding: 4px 0px; }

.page-module.pat-collapsible .page-module-title .title-segment .fraction-id=
 { border-radius: 4px; font-size: 16px; line-height: 33px; position: relati=
ve; top: 5px; height: 32px; margin-right: 10px; background: rgb(229, 240, 2=
49); filter: brightness(0.92); font-weight: normal; font-family: monospace;=
 color: rgba(0, 0, 0, 0.6); padding: 0px 15px; display: inline-block; }

.page-module.pat-collapsible .page-module-title .buttons-segment { white-sp=
ace: nowrap; --pat-form-input-field-border: none; --pat-select-box-box-shad=
ow: 0 0 0 1px white; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t { --select-box-height: 39px; --select-box-padding-top-bottom: 0; --select=
-box-box-shadow: none; --pat-select-box-font-size: 20px; display: inline-bl=
ock; padding-top: var(--pat-select-box-padding-top-bottom); padding-bottom:=
 var(--pat-select-box-padding-top-bottom); padding-left: var(--pat-select-b=
ox-padding-start); padding-right: calc(var(--pat-select-box-arrow-width) + =
var(--pat-select-box-padding-start)/2); position: relative; box-sizing: bor=
der-box; border: var(--pat-form-input-field-border); border-radius: var(--p=
at-form-input-field-border-radius); box-shadow: var(--pat-select-box-box-sh=
adow); outline: var(--pat-form-input-field-outline); outline-offset: var(--=
pat-form-input-field-outline-offset); color: var(--pat-select-box-arrow-tex=
t-colour); font-size: var(--pat-select-box-font-size); max-width: 100%; bac=
kground-color: var(--pat-select-box-background-colour); overflow: hidden; w=
hite-space: nowrap; text-overflow: ellipsis; cursor: default; height: 39px;=
 line-height: 32px; vertical-align: middle; font-weight: normal !important;=
 }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t:hover { background-color: var(--pat-select-box-background-colour-hover); =
}

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"draft"], .page-module.pat-collapsible .page-module-title .b=
uttons-segment .pat-select.state-draft { background-color: rgb(251, 234, 21=
7); color: rgb(123, 61, 0); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"draft"]::after, .page-module.pat-collapsible .page-module-t=
itle .buttons-segment .pat-select.state-draft::after { background-color: rg=
b(246, 212, 178); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"draft"]::before, .page-module.pat-collapsible .page-module-=
title .buttons-segment .pat-select[data-value=3D"draft"]::after, .page-modu=
le.pat-collapsible .page-module-title .buttons-segment .pat-select.state-dr=
aft::before, .page-module.pat-collapsible .page-module-title .buttons-segme=
nt .pat-select.state-draft::after { color: rgb(123, 61, 0); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"draft"]:hover, .page-module.pat-collapsible .page-module-ti=
tle .buttons-segment .pat-select[data-value=3D"draft"].tooltip-active-click=
, .page-module.pat-collapsible .page-module-title .buttons-segment .pat-sel=
ect.state-draft:hover, .page-module.pat-collapsible .page-module-title .but=
tons-segment .pat-select.state-draft.tooltip-active-click { background-colo=
r: rgb(249, 221, 194); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"draft"]:hover::after, .page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select[data-value=3D"draft"].tooltip-activ=
e-click::after, .page-module.pat-collapsible .page-module-title .buttons-se=
gment .pat-select.state-draft:hover::after, .page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select.state-draft.tooltip-active-cl=
ick::after { background-color: rgb(243, 199, 155); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"for-review"], .page-module.pat-collapsible .page-module-tit=
le .buttons-segment .pat-select.state-for-review { background-color: rgb(24=
2, 217, 231); color: rgb(169, 0, 97); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"for-review"]::after, .page-module.pat-collapsible .page-mod=
ule-title .buttons-segment .pat-select.state-for-review::after { background=
-color: rgb(229, 179, 208); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"for-review"]::before, .page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select[data-value=3D"for-review"]::after, =
.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t.state-for-review::before, .page-module.pat-collapsible .page-module-title=
 .buttons-segment .pat-select.state-for-review::after { color: rgb(93, 0, 5=
3); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"for-review"]:hover, .page-module.pat-collapsible .page-modu=
le-title .buttons-segment .pat-select[data-value=3D"for-review"].tooltip-ac=
tive-click, .page-module.pat-collapsible .page-module-title .buttons-segmen=
t .pat-select.state-for-review:hover, .page-module.pat-collapsible .page-mo=
dule-title .buttons-segment .pat-select.state-for-review.tooltip-active-cli=
ck { background-color: rgb(236, 198, 219); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"for-review"]:hover::after, .page-module.pat-collapsible .pa=
ge-module-title .buttons-segment .pat-select[data-value=3D"for-review"].too=
ltip-active-click::after, .page-module.pat-collapsible .page-module-title .=
buttons-segment .pat-select.state-for-review:hover::after, .page-module.pat=
-collapsible .page-module-title .buttons-segment .pat-select.state-for-revi=
ew.tooltip-active-click::after { background-color: rgb(223, 160, 196); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"approved"], .page-module.pat-collapsible .page-module-title=
 .buttons-segment .pat-select.state-approved { background-color: rgb(225, 2=
37, 219); color: rgb(43, 103, 9); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"approved"]::after, .page-module.pat-collapsible .page-modul=
e-title .buttons-segment .pat-select.state-approved::after { background-col=
or: rgb(196, 219, 182); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"approved"]::before, .page-module.pat-collapsible .page-modu=
le-title .buttons-segment .pat-select[data-value=3D"approved"]::after, .pag=
e-module.pat-collapsible .page-module-title .buttons-segment .pat-select.st=
ate-approved::before, .page-module.pat-collapsible .page-module-title .butt=
ons-segment .pat-select.state-approved::after { color: rgb(27, 65, 6); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"approved"]:hover, .page-module.pat-collapsible .page-module=
-title .buttons-segment .pat-select[data-value=3D"approved"].tooltip-active=
-click, .page-module.pat-collapsible .page-module-title .buttons-segment .p=
at-select.state-approved:hover, .page-module.pat-collapsible .page-module-t=
itle .buttons-segment .pat-select.state-approved.tooltip-active-click { bac=
kground-color: rgb(211, 229, 202); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"approved"]:hover::after, .page-module.pat-collapsible .page=
-module-title .buttons-segment .pat-select[data-value=3D"approved"].tooltip=
-active-click::after, .page-module.pat-collapsible .page-module-title .butt=
ons-segment .pat-select.state-approved:hover::after, .page-module.pat-colla=
psible .page-module-title .buttons-segment .pat-select.state-approved.toolt=
ip-active-click::after { background-color: rgb(182, 211, 165); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"published"], .page-module.pat-collapsible .page-module-titl=
e .buttons-segment .pat-select[data-value=3D"sent"], .page-module.pat-colla=
psible .page-module-title .buttons-segment .pat-select.state-published, .pa=
ge-module.pat-collapsible .page-module-title .buttons-segment .pat-select.s=
tate-sent { background-color: rgb(229, 240, 249); color: rgb(1, 53, 79); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"published"]::after, .page-module.pat-collapsible .page-modu=
le-title .buttons-segment .pat-select[data-value=3D"sent"]::after, .page-mo=
dule.pat-collapsible .page-module-title .buttons-segment .pat-select.state-=
published::after, .page-module.pat-collapsible .page-module-title .buttons-=
segment .pat-select.state-sent::after { background-color: rgb(204, 224, 241=
); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"published"]::before, .page-module.pat-collapsible .page-mod=
ule-title .buttons-segment .pat-select[data-value=3D"published"]::after, .p=
age-module.pat-collapsible .page-module-title .buttons-segment .pat-select[=
data-value=3D"sent"]::before, .page-module.pat-collapsible .page-module-tit=
le .buttons-segment .pat-select[data-value=3D"sent"]::after, .page-module.p=
at-collapsible .page-module-title .buttons-segment .pat-select.state-publis=
hed::before, .page-module.pat-collapsible .page-module-title .buttons-segme=
nt .pat-select.state-published::after, .page-module.pat-collapsible .page-m=
odule-title .buttons-segment .pat-select.state-sent::before, .page-module.p=
at-collapsible .page-module-title .buttons-segment .pat-select.state-sent::=
after { color: rgb(1, 53, 79); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"published"]:hover, .page-module.pat-collapsible .page-modul=
e-title .buttons-segment .pat-select[data-value=3D"published"].tooltip-acti=
ve-click, .page-module.pat-collapsible .page-module-title .buttons-segment =
.pat-select[data-value=3D"sent"]:hover, .page-module.pat-collapsible .page-=
module-title .buttons-segment .pat-select[data-value=3D"sent"].tooltip-acti=
ve-click, .page-module.pat-collapsible .page-module-title .buttons-segment =
.pat-select.state-published:hover, .page-module.pat-collapsible .page-modul=
e-title .buttons-segment .pat-select.state-published.tooltip-active-click, =
.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t.state-sent:hover, .page-module.pat-collapsible .page-module-title .button=
s-segment .pat-select.state-sent.tooltip-active-click { background-color: r=
gb(208, 228, 244); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[data-value=3D"published"]:hover::after, .page-module.pat-collapsible .pag=
e-module-title .buttons-segment .pat-select[data-value=3D"published"].toolt=
ip-active-click::after, .page-module.pat-collapsible .page-module-title .bu=
ttons-segment .pat-select[data-value=3D"sent"]:hover::after, .page-module.p=
at-collapsible .page-module-title .buttons-segment .pat-select[data-value=
=3D"sent"].tooltip-active-click::after, .page-module.pat-collapsible .page-=
module-title .buttons-segment .pat-select.state-published:hover::after, .pa=
ge-module.pat-collapsible .page-module-title .buttons-segment .pat-select.s=
tate-published.tooltip-active-click::after, .page-module.pat-collapsible .p=
age-module-title .buttons-segment .pat-select.state-sent:hover::after, .pag=
e-module.pat-collapsible .page-module-title .buttons-segment .pat-select.st=
ate-sent.tooltip-active-click::after { background-color: rgb(184, 212, 236)=
; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t.locked::before { font-family: fontello; content: "=EE=A0=AE"; display: in=
line-block; margin-right: 5px; float: left; font-size: inherit; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t:not([class*=3D"icon-"])::before { font-size: var(--pat-select-box-font-si=
ze); content: attr(data-option); white-space: nowrap; overflow: hidden; tex=
t-overflow: ellipsis; display: block; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t[class*=3D"icon-"]::before { margin-left: -5px; margin-right: 8px; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t select { position: absolute; inset: 0px; opacity: 0; margin: 0px; z-index=
: 1; height: 100% !important; width: 100% !important; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t select option { font-size: initial; color: rgb(0, 0, 0); }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t::after { font-family: fontello; content: "=EE=A3=87"; width: var(--pat-se=
lect-box-arrow-width); background-color: var(--pat-select-box-arrow-backgro=
und-colour); background-image: none; position: absolute; top: 0px; right: 0=
px; bottom: 0px; font-size: var(--pat-select-box-arrow-size); border-top-ri=
ght-radius: var(--pat-form-fields-border-radius); border-bottom-right-radiu=
s: var(--pat-form-fields-border-radius); padding: 0px; display: flex; align=
-items: center; justify-content: center; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t option:disabled { color: silver; }

.page-module.pat-collapsible .page-module-title .buttons-segment .pat-selec=
t.injecting { opacity: 0.3; }

.page-module.pat-collapsible .page-module-title .buttons-segment .icon { co=
lor: rgba(0, 0, 0, 0); width: 39px; height: 39px; line-height: 39px; positi=
on: relative; background: rgb(1, 104, 155); display: inline-block; margin-l=
eft: 5px; cursor: default; vertical-align: middle; }

.page-module.pat-collapsible .page-module-title .buttons-segment .icon:hove=
r { text-decoration: none; background: rgb(1, 70, 104); }

.page-module.pat-collapsible .page-module-title .buttons-segment .icon::bef=
ore { position: absolute; inset: 0px; text-align: center; color: rgb(255, 2=
55, 255); line-height: 39px; font-size: 20px; width: 100%; margin: 0px; }

.product-fk .page-module.pat-collapsible .page-module-title { color: rgb(57=
, 135, 12); background: rgb(255, 255, 255); font-weight: normal; }

.page-module.pat-collapsible .page-module-title:focus { border-bottom: 1px =
solid rgba(255, 255, 255, 0); outline: rgb(0, 123, 199) solid 2px; z-index:=
 2; }

.page-module.pat-collapsible .page-module-title::before { position: absolut=
e; left: 0px; top: 50%; transform: translateY(-50%); font-family: fontello;=
 content: "=EE=A3=87"; display: inline-block; width: 40px; text-align: cent=
er; font-weight: normal; font-size: 20px; pointer-events: none; }

.page-module.pat-collapsible .page-module-title.collapsible-open, .page-mod=
ule.pat-collapsible .page-module-title.collapsible-closed.collapsible-in-pr=
ogress { border-bottom: none; background-color: rgb(229, 240, 249); }

.product-fk .page-module.pat-collapsible .page-module-title.collapsible-ope=
n, .product-fk .page-module.pat-collapsible .page-module-title.collapsible-=
closed.collapsible-in-progress { background: rgb(225, 237, 219); color: rgb=
(39, 89, 55); }

.page-module.pat-collapsible .page-module-title.collapsible-open::before, .=
page-module.pat-collapsible .page-module-title.collapsible-closed.collapsib=
le-in-progress::before { content: "=EE=A3=88"; }

.page-module.pat-collapsible.open .page-module-title::before { content: "=
=EE=A3=88"; }

.page-module.pat-collapsible.has-differences .page-module-title { backgroun=
d: rgba(255, 100, 0, 0.1); }

.page-module.pat-collapsible.has-differences .page-module-title.collapsible=
-open, .page-module.pat-collapsible.has-differences .page-module-title.coll=
apsible-closed.collapsible-in-progress { background: rgba(255, 100, 0, 0.2)=
; }

.page-module.pat-collapsible > .panel-content { padding: 20px 15px 40px; }

.page-module h4 { margin-bottom: 0px; font-weight: bold; font-size: 1em; }

.page-module h2 a, .page-module .page-module-title a, .page-module h3 a { t=
ext-decoration: none; color: rgb(0, 0, 0); }

.page-module h2 a[href]:not(.follow):not(.icon)::after, .page-module .page-=
module-title a[href]:not(.follow):not(.icon)::after, .page-module h3 a[href=
]:not(.follow):not(.icon)::after { font-family: fontello; content: "=EE=A1=
=9A"; margin-left: 0.5em; font-size: 1em; position: absolute; text-decorati=
on: none !important; }

.page-module h2 a[href]:hover, .page-module .page-module-title a[href]:hove=
r, .page-module h3 a[href]:hover { text-decoration: underline; }

.page-module h2 a[href]:hover::after, .page-module .page-module-title a[hre=
f]:hover::after, .page-module h3 a[href]:hover::after { text-decoration: no=
ne !important; }

.page-module h2 a.follow, .page-module .page-module-title a.follow, .page-m=
odule h3 a.follow { font-size: 1.7rem; color: rgb(1, 104, 155); text-decora=
tion: underline; opacity: 0.6; }

.page-module h2 a.follow:hover, .page-module .page-module-title a.follow:ho=
ver, .page-module h3 a.follow:hover { opacity: 1; }

.page-module h2 a.follow::before, .page-module .page-module-title a.follow:=
:before, .page-module h3 a.follow::before { content: "("; }

.page-module h2 a.follow::after, .page-module .page-module-title a.follow::=
after, .page-module h3 a.follow::after { content: ")"; }

.page-module.frame { padding: 8px 20px; margin-top: 0px; background: rgb(22=
9, 240, 249); }

.page-module.type-news .page-module-title { margin-bottom: 1.5rem; padding-=
top: 0.5rem; border-top: 1px solid rgb(225, 225, 225); }

.page-module.type-involved-parties .link-list, .page-module.type-organisati=
ons .link-list { font-size: 1.26562rem; line-height: 1.38272; }

.page-module.type-listing .page-module-title { margin-bottom: 1.5rem; paddi=
ng-top: 0.5rem; border-top: 1px solid rgb(225, 225, 225); }

.page-module.type-listing .page-module-title + .link-list, .page-module.typ=
e-listing .page-module-summary + .link-list { margin-top: 20px; }

.page-module.type-wegiz .page-module-title, .page-module.type-wegiz-sector =
.page-module-title { margin-bottom: 1.5rem; padding-top: 0.5rem; border-top=
: 1px solid rgb(225, 225, 225); }

.page-module.type-wegiz .page-module-title + .link-list, .page-module.type-=
wegiz .page-module-summary + .link-list, .page-module.type-wegiz-sector .pa=
ge-module-title + .link-list, .page-module.type-wegiz-sector .page-module-s=
ummary + .link-list { margin-top: 20px; }

.page-module.type-table .page-module-title + table, .page-module.type-table=
 .page-module-summary + table { margin-top: 20px; }

.page-module.type-table table { margin-bottom: 30px; }

.page-module.type-treatment-plan .pat-collapsible { margin: 0px; clear: bot=
h; float: none !important; }

.page-module.type-treatment-plan .pat-collapsible .title { font-size: 1em; =
}

.page-module.pat-collapsible + .page-module.type-links .page-module-title, =
.page-module.pat-collapsible + .page-module.type-attributions .page-module-=
title { padding-top: 0.5rem; border-top: none; margin-top: 80px; }

.page-module.pat-collapsible + .page-module.type-attributions + .page-modul=
e.type-links .page-module-title { border-top: none; }

.page-module.type-applicability .pat-collapsible { margin-bottom: 30px; }

.page-module.type-topics .page-module-title { margin-bottom: 1.5rem; paddin=
g-top: 0.5rem; border-top: 1px solid rgb(225, 225, 225); }

.page-module.type-topics .page-module-title + .link-list, .page-module.type=
-topics .page-module-summary + .link-list { margin-top: 20px; }

.page-module.type-topics .page-module-summary { margin-top: -5px; margin-bo=
ttom: 25px; }

.page-module.type-links .page-module-title, .page-module.type-attributions =
.page-module-title { margin-bottom: 1.5rem; padding-top: 0.5rem; border-top=
: 1px solid rgb(225, 225, 225); }

.page-module.type-links h3 + .link-list, .page-module.type-attributions h3 =
+ .link-list { margin-bottom: 20px; }

.page-module.type-links h2 + .link-list, .page-module.type-attributions h2 =
+ .link-list { margin-top: 30px; font-size: 1.27rem; }

.page-module.type-links h2 + .link-list li, .page-module.type-attributions =
h2 + .link-list li { margin-bottom: 8px; }

.page-module.type-attributions .link-list li { pointer-events: none; paddin=
g-top: 180px; margin-top: -180px; }

.page-module.type-attributions .link-list li > * { pointer-events: all; }

.page-module.type-sample-card { margin-bottom: 20px; }

.page-module.type-sample-card:focus { outline: rgb(0, 123, 199) solid 2px; =
outline-offset: 15px; }

.page-module.type-body-text-segment.pat-collapsible { margin-top: calc(-100=
px + 3rem); }

.page-module.type-body-text-segment.pat-collapsible:first-child { margin-to=
p: -100px; }

.page-module.type-body-text-segment .section-introduction { font-weight: bo=
ld; }

.page-module.type-body-text-segment > * { pointer-events: all; }

@media only screen and (min-width: 770px) {
  .page-module.type-body-text .main-illustration { float: left; width: 50%;=
 margin: 5px 34px 10px 0px; }
  .page-module.type-body-text .main-illustration .picture, .page-module.typ=
e-body-text .main-illustration img { float: left; }
  .page-module.type-body-text .main-illustration .picture img, .page-module=
.type-body-text .main-illustration img img { float: none; height: 275px; ob=
ject-fit: cover; cursor: zoom-in; }
}

@media only screen and (max-width: 769px) {
  .page-module.type-body-text .main-illustration { width: 100%; margin-bott=
om: 20px; }
}

.page-module.type-body-text .pat-rich h2:first-child { margin-top: 0px; }

.no-js .page-module#section-group-information .link-list { display: none; }

.no-js .page-module[id$=3D"compare"] { display: none; }

.page-module#section-cost table.cost-table { clear: none; animation: 1s eas=
e 0s 1 normal forwards running fadeIn; }

.page-module#section-cost #cost-overview .pat-inject { position: relative; =
display: block; opacity: 1; }

.js .page-module#section-cost #cost-overview .pat-inject { color: rgb(0, 0,=
 0); text-decoration: none; padding-left: 1.9em; }

.js .page-module#section-cost #cost-overview .pat-inject::before { opacity:=
 1; position: absolute; top: 50%; content: "=EF=84=A6"; width: 50px; height=
: 50px; margin-top: -25px; margin-left: -25px; z-index: 1000; font: 27px / =
50px fontello; text-shadow: rgb(255, 255, 255) 0px 0px 2px; text-align: cen=
ter; animation: 2s linear 0s infinite normal none running spin; left: 0.5em=
; color: rgba(0, 0, 0, 0.6); }

.page-module .stacks-toggle a { display: inline-block; }

.page-module .stacks-toggle a.current { display: none; }

.page-module-separation-title { font-size: 1.80203rem; line-height: 1.38732=
; margin-block: 3rem 0.75rem; margin: 40px 0px; }

.photo-tiles { display: grid; gap: 30px; }

@media only screen and (min-width: 1280px) {
  .photo-tiles { grid-template-columns: 1fr 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .photo-tiles { grid-template-columns: 1fr 1fr; }
}

@media only screen and (max-width: 769px) {
  .photo-tiles { grid-template-columns: 1fr; }
}

.photo-tiles .photo-tiles-tile img { width: 100%; aspect-ratio: 21 / 9; obj=
ect-fit: cover; display: block; }

.photo-tiles .photo-tiles-tile picture { position: relative; display: block=
; }

.photo-tiles .photo-tiles-tile .photo-tiles-copyright { position: absolute;=
 z-index: 10; bottom: 0.5rem; left: 0.5rem; margin: 0px; color: rgb(255, 25=
5, 255); text-shadow: rgba(0, 0, 0, 0.5) 0px 0px 1px, rgba(0, 0, 0, 0.5) -1=
px 0px 1px, rgba(0, 0, 0, 0.5) 1px 0px 1px, rgba(0, 0, 0, 0.5) 0px -1px 1px=
, rgba(0, 0, 0, 0.5) 0px 1px 1px, rgba(0, 0, 0, 0.5) 2px 2px 6px; font-size=
: 0.888889rem; line-height: 1.125; display: block; opacity: 0.7; }

.photo-tiles .photo-tiles-tile .photo-tiles-copyright::before { font-family=
: fontello; }

.photo-tiles .photo-tiles-tile .photo-tiles-copyright.type-copyright::befor=
e { content: "=EF=87=B9 "; }

.photo-tiles .photo-tiles-tile .photo-tiles-copyright.type-creative-commons=
::before { content: "=EF=89=9E "; }

.photo-tiles .photo-tiles-tile figcaption { font-size: 1.5102rem; line-heig=
ht: 1.15879; margin: 0.5rem 0rem 1rem; font-weight: normal; }

.picture { position: relative; display: block; }

.picture .copyright-mention { position: absolute; z-index: 10; bottom: 0.5r=
em; left: 0.5rem; margin: 0px; color: rgb(255, 255, 255); text-shadow: rgba=
(0, 0, 0, 0.5) 0px 0px 1px, rgba(0, 0, 0, 0.5) -1px 0px 1px, rgba(0, 0, 0, =
0.5) 1px 0px 1px, rgba(0, 0, 0, 0.5) 0px -1px 1px, rgba(0, 0, 0, 0.5) 0px 1=
px 1px, rgba(0, 0, 0, 0.5) 2px 2px 6px; font-size: 0.888889rem; line-height=
: 1.125; display: block; opacity: 0.7; }

.picture .copyright-mention::before { font-family: fontello; }

.picture .copyright-mention.type-copyright::before { content: "=EF=87=B9 ";=
 }

.picture .copyright-mention.type-creative-commons::before { content: "=EF=
=89=9E "; }

.portlet { font-size: 1.125rem; margin-bottom: 2rem; }

@media only screen and (min-width: 1280px) {
  .portlet.height-full { min-height: 100%; }
}

.portlet.span-2 .link-list { column-count: 3; }

.portlet.span-full .link-list, .portlet.span-3 .link-list { column-count: 5=
; }

.portlet .pat-rich { font-size: 1em; line-height: 1.3; }

.portlet .content { position: relative; background: rgb(243, 243, 243); }

.portlet .content.pat-collapsible.closed .portlet-intro { padding: 25px; }

.portlet .content .portlet-intro { display: flex; transition: padding 0.3s;=
 padding: 25px 25px 12.5px; }

.portlet .content .portlet-intro .portlet-title-group { display: flex; widt=
h: 100%; justify-content: space-between; }

.portlet .content .portlet-intro .portlet-title-group .buttons .button { fl=
oat: right; margin-left: 15px; color: rgba(0, 0, 0, 0); background: rgba(0,=
 0, 0, 0.1); width: 32px; height: 32px; line-height: 32px; overflow: hidden=
; }

.portlet .content .portlet-intro .portlet-title-group .buttons .button:hove=
r { background: rgba(0, 0, 0, 0.15); }

.portlet .content .portlet-intro .portlet-title-group .buttons .button::bef=
ore { font-family: fontello; width: 100%; line-height: 32px; display: block=
; color: rgb(0, 0, 0); font-size: 22px; text-align: center; }

.portlet .content .portlet-intro .portlet-title-group .buttons .button.info=
-button::before { content: "=EE=A3=AD"; background-color: rgb(1, 104, 155);=
 color: rgb(255, 255, 255); font-size: 18px; }

.portlet .content .portlet-intro .portlet-title-group .buttons .button.info=
-button:hover::before { background-color: rgb(1, 70, 104); }

.portlet .content .portlet-intro .portlet-title-group .buttons .button.coll=
apse-button::before { content: "=EE=A3=87"; transition: transform 0.2s; }

.portlet .content .portlet-intro .portlet-title-group .buttons .button.coll=
apse-button.collapsible-open::before { transform: scaleY(-1); }

.portlet .content .portlet-intro .portlet-title-group h1 { margin-bottom: 0=
px; }

.portlet .content .portlet-intro .portlet-title-group .byline { margin-top:=
 -30px; margin-bottom: 30px; }

.portlet .content .portlet-body { padding: 0px 25px 25px; overflow: auto; }

.portlet .content .portlet-body > :last-child { margin-bottom: 0px; }

.portlet .content .portlet-body .message-no-content { margin-bottom: 1.5rem=
; font-size: 1em; }

.portlet .content .portlet-body .portlet-separation-title { font-size: 1em;=
 margin: 0.5em 0px; }

.portlet .content .portlet-body .portlet-separation-title a { text-decorati=
on: none; color: rgb(0, 0, 0); }

.portlet .content .portlet-body .portlet-separation-title a[href]:not(.foll=
ow)::after { font-family: fontello; content: "=EE=A1=9A"; margin-left: 0.5e=
m; font-size: 1em; position: absolute; text-decoration: none !important; }

.portlet .content .portlet-body .portlet-separation-title a[href]:hover { t=
ext-decoration: underline; }

.portlet .content .portlet-body .portlet-separation-title a[href]:hover::af=
ter { text-decoration: none !important; }

.portlet .content .portlet-body .portlet-separation-title a[href]:hover::be=
fore { text-decoration: none !important; }

.portlet .content .portlet-body .portlet-toolbar { margin-bottom: 1em; }

.portlet .content .portlet-body .portlet-toolbar::after { content: " "; dis=
play: table; clear: both; }

.portlet .content .portlet-body .portlet-toolbar .pat-select { float: left;=
 }

.portlet .content .portlet-body .training { padding-top: 1em; }

.portlet .content .portlet-body .training .auto-scale-wrapper { overflow: h=
idden; }

.portlet .content .portlet-body .training .training-title { margin-bottom: =
0.5em; }

.portlet .content .portlet-body .training .certificate { margin-bottom: 1em=
; float: left; }

.portlet .content .portlet-body .certificates .auto-scale-wrapper { overflo=
w: hidden; margin-bottom: 1em; }

.portlet .content .portlet-body .certificates a.certificate { float: left; =
}

@media only screen and (max-width: 769px) {
  .portlet .content { padding: 0px; border: none; background-color: rgba(0,=
 0, 0, 0); }
}

@media only screen and (max-width: 769px) {
  .portlet { width: 100%; }
}

.portlet .portlet-title { margin: 0px; padding-right: 20px; font-size: 28px=
; line-height: 1.2; font-weight: normal; }

.portlet .portlet-title::before, .portlet .portlet-title a::before { font-f=
amily: fontello; font-size: 22px; line-height: 28px; display: inline-block;=
 margin-right: 5px; color: rgb(57, 135, 12); font-weight: normal; position:=
 relative; top: -2px; }

.portlet .portlet-title a { text-decoration: none; color: rgb(0, 0, 0); }

.portlet .portlet-title a[href]:not(.follow)::after { font-family: fontello=
; content: "=EE=A1=9A"; margin-left: 0.5em; font-size: 1em; position: absol=
ute; text-decoration: none !important; }

.portlet .portlet-title a[href]:hover { text-decoration: underline; }

.portlet .portlet-title a[href]:hover::after { text-decoration: none !impor=
tant; }

.portlet .portlet-title a[href]:hover::before { text-decoration: none !impo=
rtant; }

.portlet .portlet-title sup { font-size: 0.6em; color: gray; }

.portlet#portlet-drafts .content, .portlet.state-draft .content { backgroun=
d-color: rgb(251, 234, 217); }

.portlet#portlet-portfolio .content, .portlet.type-portfolio .content { bac=
kground-color: rgb(255, 255, 255); border: 1px solid rgb(227, 227, 227); }

.portlet#portlet-portfolio .content h3, .portlet.type-portfolio .content h3=
 { font-size: 1em; margin: 1em 0px; }

.portlet.type-ready .content, .portlet.type-workflow .content { background-=
color: rgb(242, 217, 231); }

.portlet.type-ready .content .link-list a, .portlet.type-workflow .content =
.link-list a { color: rgb(169, 0, 97); }

.portlet.state-approved .content { background-color: rgb(225, 237, 219); }

.portlet.state-approved .content .link-list a { color: rgb(57, 135, 12); }

.portlet .link:hover { text-decoration: none; }

.portlet .portlet-footer a { font-weight: bold; }

.portlet .portlet-footer a:hover { text-decoration: underline; }

.portlet .portlet-footer a::before { display: inline-block; width: 22px; fo=
nt-family: fontello; content: "=EE=A2=84"; }

.portlet .title { margin: 0px; font-size: 1em; font-weight: normal; }

.portlet .byline { color: rgb(102, 102, 102); font-size: 0.8em; line-height=
: 1.3em; font-style: italic; margin: 0px; }

.portlet table td.date-finished { width: 20%; }

.portlet .pat-rich table a { text-decoration: none; }

.portlet .pat-rich table a:hover { text-decoration: underline; }

.process-diagram .process-diagram-title { margin-bottom: 40px; font-size: 5=
0px; }

.process-diagram .process-diagram-graph { margin-bottom: 30px; margin-top: =
0px; }

.process-diagram .process-diagram-graph .process-diagram-steps { display: f=
lex; margin: 0px -20px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s { margin: 0px -10px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s .step { margin: 0px 10px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s .step a { padding: 24px 20px 0px; font-size: 16px; height: 178px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s .step a .step-title { line-height: 22px; height: 48px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s .step a::before { font-size: 60px; margin: 5px 0px; line-height: 80px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s .step a::after { right: -20px; width: 40px; height: 40px; margin-top: -20=
px; }

.process-diagram .process-diagram-graph .process-diagram-steps .step { colo=
r: rgb(57, 135, 12); text-align: center; display: block; flex-grow: 1; box-=
sizing: border-box; position: relative; width: 25%; margin: 0px 20px; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(1) { z-index: 10; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(2) { z-index: 9; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(3) { z-index: 8; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(4) { z-index: 7; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(5) { z-index: 6; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:nth-ch=
ild(6) { z-index: 5; }

.process-diagram .process-diagram-graph .process-diagram-steps .step:last-c=
hild a::after { display: none; }

.process-diagram .process-diagram-graph .process-diagram-steps .step.curren=
t + .step::before { background: rgb(1, 104, 155); }

.process-diagram .process-diagram-graph .process-diagram-steps .step.size-2=
 { flex-grow: 2; }

.process-diagram .process-diagram-graph .process-diagram-steps .step a { di=
splay: block; font-size: 25px; padding: 50px 40px 30px; box-sizing: border-=
box; height: 100%; z-index: 1; color: rgb(57, 135, 12); background: rgb(242=
, 242, 242); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a .ste=
p-title { hyphens: auto; display: -webkit-box; -webkit-box-orient: vertical=
; -webkit-line-clamp: 2; overflow: hidden; height: 60px; line-height: 30px;=
 color: rgb(0, 0, 0); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a::aft=
er { width: 80px; height: 80px; transform: rotate(45deg); content: " "; bac=
kground: rgb(242, 242, 242); position: absolute; right: -40px; top: 50%; ma=
rgin-top: -40px; box-shadow: rgb(255, 255, 255) 0px 0px 0px 3px; z-index: -=
1; }

.process-diagram .process-diagram-graph .process-diagram-steps .step a:hove=
r { background: rgb(237, 237, 237); text-decoration: none; color: rgb(43, 1=
03, 9); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a:hove=
r::after { background: rgb(237, 237, 237); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a.curr=
ent { background: rgb(1, 104, 155); cursor: default; color: rgb(255, 255, 2=
55); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a.curr=
ent .step-title { color: rgb(255, 255, 255); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a.curr=
ent::after { background: rgb(1, 104, 155); }

.process-diagram .process-diagram-graph .process-diagram-steps .step a::bef=
ore { width: 100%; font-size: 80px; line-height: 100px; display: block; mar=
gin: 0px 0px 20px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s:has(.step:nth-child(6)) .step a { padding: 10px 20px 30px; height: 160px;=
 }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s:has(.step:nth-child(6)) .step a::before { font-size: 35px; }

#main-content .process-diagram .process-diagram-graph .process-diagram-step=
s:has(.step:nth-child(6)) .step a .step-title { height: 50px; font-size: 14=
px; line-height: 16px; }

.process-diagram .process-diagram-explanations .explanation { font-size: 30=
px; line-height: 1.4; margin-bottom: 20px; float: left; width: 100%; margin=
-left: -100%; opacity: 0; pointer-events: none; display: block !important; =
}

.process-diagram .process-diagram-explanations .explanation .step-title { f=
ont-size: 1em; }

.process-diagram .process-diagram-explanations .explanation.visible { margi=
n-left: 0px; animation: 0.5s ease 0s 1 normal forwards running fadeInUp; po=
inter-events: initial; }

.rating[class*=3D"stars"] { position: relative; color: rgba(0, 0, 0, 0); he=
ight: 1em; line-height: 1em; font-size: 1.5em; top: 0.2em; letter-spacing: =
6px; display: inline-block; overflow: hidden; }

.rating[class*=3D"stars"]::before, .rating[class*=3D"stars"]::after { font-=
family: fontello; display: block; position: absolute; top: 0px; bottom: 0px=
; left: 0px; width: 30px; overflow: hidden; }

.rating[class*=3D"stars"]::before { content: "=EE=A0=83=EE=A0=83=EE=A0=83=
=EE=A0=83=EE=A0=83"; color: rgb(225, 112, 0); z-index: 1; width: 0px; }

.rating[class*=3D"stars"]::after { content: "=EE=A0=84=EE=A0=84=EE=A0=84=EE=
=A0=84=EE=A0=84"; color: gray; width: 100%; }

.rating[class*=3D"stars"].stars-3 { width: 90px; }

.rating[class*=3D"stars"].stars-5 { width: 150px; }

.rating[class*=3D"stars"].score-1::before { width: 30px; }

.rating[class*=3D"stars"].score-2::before { width: 60px; }

.rating[class*=3D"stars"].score-3::before { width: 90px; }

.rating[class*=3D"stars"].score-4::before { width: 120px; }

.rating[class*=3D"stars"].score-5::before { width: 150px; }

.reference-badge { height: 19px; line-height: 19px; min-width: 19px; text-a=
lign: center; box-sizing: border-box; padding: 0px 0.1em; border-radius: 0.=
8em; background: rgb(204, 224, 241); display: inline-block; font-size: 18px=
; color: rgb(1, 104, 155) !important; text-decoration: none !important; }

.reference-badge::before { line-height: 19px; }

.reference-badge.active, .reference-badge.tooltip-active-hover { box-shadow=
: rgb(1, 104, 155) 0px 0px 1px 1px; }

.reference-badge.tooltip-active-hover { background: rgb(1, 70, 104); color:=
 rgb(255, 255, 255) !important; }

.pat-rich { font-size: 1.26562rem; line-height: 1.38272; overflow-wrap: bre=
ak-word; }

.pat-rich#page-head { max-width: 768px; margin-bottom: 45px; }

.pat-rich blockquote { display: block; font-style: italic; clear: both; wid=
th: 100%; margin: 2rem 0px; padding: 1rem; color: rgb(0, 0, 0); border-left=
: 0.5rem solid dimgray; background: rgb(243, 243, 243); box-sizing: border-=
box; }

.pat-rich blockquote::before { display: block; margin-top: 0.75rem; margin-=
bottom: 0rem; content: "=E2=80=9C"; color: dimgray; font-size: 6rem; line-h=
eight: 0.1em; }

.pat-rich .inline-reference { padding: 200px 0px 0px; margin: calc(-200px) =
0px 0px; pointer-events: none; transition: 1s; }

.pat-rich .inline-reference:target { text-shadow: rgb(255, 255, 0) 0px 0px =
12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255=
, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px=
 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rg=
b(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0=
) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12p=
x, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 2=
55, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0p=
x 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(2=
55, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0px 0px 12px, rgb(255, 255, 0) 0=
px 0px 12px, rgb(255, 255, 0) 0px 0px 12px; }

.pat-rich .inline-reference:target .reference-badge { box-shadow: rgb(255, =
255, 0) 0px 0px 0px 4px; text-shadow: none; }

.pat-rich .inline-reference > * { pointer-events: auto; }

.pat-rich :not(img):not(br):not(a):empty:not(textarea):not(td):not(th) { di=
splay: none; }

.pat-rich .message-no-info { margin: 0.5em 0px; color: rgb(102, 102, 102); =
}

@media only screen and (max-width: 769px) {
  .pat-rich { hyphens: auto; }
}

.group-3 .pat-rich #extended-view-toggle { display: none; }

.pat-rich .attention { color: rgb(225, 112, 0); }

.pat-rich.group-1 { display: none; animation: 1s ease 0s 1 normal none runn=
ing fadeIn; }

.group-1 .pat-rich.group-1 { display: block; }

.pat-rich .table-group .scroll-table { margin-bottom: 26px; }

.pat-rich .table-group .scroll-table:last-child { margin-bottom: 0px; }

.pat-rich table + .button-bar, .pat-rich figure + .button-bar, .pat-rich .s=
croll-table + .button-bar, .pat-rich .table-group + .button-bar { font-size=
: 80%; text-align: right; }

.pat-rich table + .button-bar a, .pat-rich figure + .button-bar a, .pat-ric=
h .scroll-table + .button-bar a, .pat-rich .table-group + .button-bar a { t=
ext-decoration: none; color: gray; }

.pat-rich table + .button-bar a:hover, .pat-rich figure + .button-bar a:hov=
er, .pat-rich .scroll-table + .button-bar a:hover, .pat-rich .table-group +=
 .button-bar a:hover { text-decoration: underline; color: rgb(0, 0, 0); }

.pat-rich table + .button-bar a:hover::before, .pat-rich figure + .button-b=
ar a:hover::before, .pat-rich .scroll-table + .button-bar a:hover::before, =
.pat-rich .table-group + .button-bar a:hover::before { text-decoration: non=
e; }

.pat-rich.group-2 { display: none; animation: 1s ease 0s 1 normal none runn=
ing fadeIn; }

.group-2 .pat-rich.group-2 { display: block; }

.pat-rich.group-3 { display: none; animation: 1s ease 0s 1 normal none runn=
ing fadeIn; }

.group-3 .pat-rich.group-3 { display: block; }

.pat-rich .section-introduction { font-weight: bold; }

.pat-rich section { box-sizing: border-box; }

@media only screen and (max-width: 769px) {
  .pat-rich section { margin: 0px; }
}

@media only screen and (min-width: 770px) {
  .pat-rich section { margin: 0px 0px 26px; }
}

@media screen {
  .pat-rich section::after { content: " "; display: table; clear: both; }
}

.pat-rich section.content-block { margin-top: -96px; pointer-events: none; =
}

.pat-rich section.content-block > * { pointer-events: auto; }

.pat-rich section.content-block section:not(.pat-collapsible):not(.action-p=
lan):not(.pat-well):not(.recipe):not(.discrete) { margin-bottom: 0px; }

.pat-rich section.content-block .pat-collapsible { margin-bottom: 26px; }

.pat-rich section.content-block .pat-collapsible .panel-content > :last-chi=
ld { margin-bottom: 0px; }

.no-js .pat-rich section.content-block .pat-collapsible .panel-content #clo=
se-excipients-warning { display: none; }

.pat-rich section.content-block .pat-well.collapsibles .pat-collapsible { m=
argin-bottom: 0px; }

.pat-rich section.content-block .pat-well.collapsibles .pat-collapsible .pa=
nel-content > :last-child { margin-bottom: 26px; }

.pat-rich section.theme { padding-bottom: 30px; margin-left: 0px; margin-ri=
ght: 0px; border-bottom: 2px solid rgb(243, 243, 243); }

.pat-rich section.block { margin-bottom: 20px; }

.pat-rich section.block h2 { padding: 0.4333em 0px 0px; font-size: 1.125em;=
 line-height: 1.4444; }

.pat-rich section.block h2::before { border-top: 1px solid rgb(1, 104, 155)=
; display: block; content: " "; height: 0.4333em; }

.pat-rich .summary h1 { font-weight: bold; font-size: 2.02729rem; line-heig=
ht: 1.23318; }

.pat-rich .summary h2 { margin: 0px 0px 30px; color: rgb(118, 118, 118); fo=
nt-size: 1.3125em; font-weight: normal; line-height: 1.5238; vertical-align=
: baseline; }

@media only screen and (max-width: 769px) {
  .pat-rich .summary h2 { padding-top: 0px; }
}

@media only screen and (max-width: 1279px) {
  .variation-search-results ~ #main .pat-rich .summary h2 { margin-top: -80=
px; }
}

.pat-rich .summary h2 strong { font-size: 1.3333em; line-height: 1.1429em; =
font-weight: normal; color: rgb(0, 0, 0); display: inline-block; vertical-a=
lign: baseline; }

.pat-rich .introduction#page-intro { font-size: 1.60181rem; --pat-form-inpu=
t-field-font-size: 1.60181rem; line-height: 1.40466; --pat-form-input-field=
-line-height: 1.40466; hyphens: auto; color: rgb(0, 0, 0); --pat-form-input=
-field-text-colour: black; margin-top: 2rem; margin-bottom: 1.5rem; }

.pat-rich .introduction#page-intro:has(.pat-content-mirror) #document-summa=
ry { white-space: pre-wrap; }

@media only screen and (max-width: 769px) {
  .pat-rich .introduction#page-intro { --pat-form-input-field-line-height: =
"1.3 * 26px"; }
}

.pat-rich .subject > .introduction { color: rgb(57, 135, 12); margin: 0px; =
}

.pat-rich h1 .brand-name, .pat-rich h1 .adm-r, .pat-rich h1 .adm-m, .pat-ri=
ch h2 .brand-name, .pat-rich h2 .adm-r, .pat-rich h2 .adm-m, .pat-rich h3 .=
brand-name, .pat-rich h3 .adm-r, .pat-rich h3 .adm-m, .pat-rich h4 .brand-n=
ame, .pat-rich h4 .adm-r, .pat-rich h4 .adm-m, .pat-rich h5 .brand-name, .p=
at-rich h5 .adm-r, .pat-rich h5 .adm-m, .pat-rich h6 .brand-name, .pat-rich=
 h6 .adm-r, .pat-rich h6 .adm-m { text-transform: lowercase; }

.pat-rich h1 a, .pat-rich h2 a, .pat-rich h3 a, .pat-rich h4 a, .pat-rich h=
5 a, .pat-rich h6 a { text-decoration: none; }

.pat-rich h1 a.follow, .pat-rich h2 a.follow, .pat-rich h3 a.follow, .pat-r=
ich h4 a.follow, .pat-rich h5 a.follow, .pat-rich h6 a.follow { font-size: =
1.7rem; color: rgb(1, 104, 155); text-decoration: underline; opacity: 0.6; =
}

.pat-rich h1 a.follow:hover, .pat-rich h2 a.follow:hover, .pat-rich h3 a.fo=
llow:hover, .pat-rich h4 a.follow:hover, .pat-rich h5 a.follow:hover, .pat-=
rich h6 a.follow:hover { opacity: 1; }

.pat-rich h1 a.follow::before, .pat-rich h2 a.follow::before, .pat-rich h3 =
a.follow::before, .pat-rich h4 a.follow::before, .pat-rich h5 a.follow::bef=
ore, .pat-rich h6 a.follow::before { content: "("; }

.pat-rich h1 a.follow::after, .pat-rich h2 a.follow::after, .pat-rich h3 a.=
follow::after, .pat-rich h4 a.follow::after, .pat-rich h5 a.follow::after, =
.pat-rich h6 a.follow::after { content: ")"; }

.pat-rich h2 a[href], .pat-rich h3 a[href], .pat-rich h4 a[href], .pat-rich=
 h5 a[href], .pat-rich h6 a[href] { text-decoration: none; }

.pat-rich h2 a[href]:not(.follow)::after, .pat-rich h3 a[href]:not(.follow)=
::after, .pat-rich h4 a[href]:not(.follow)::after, .pat-rich h5 a[href]:not=
(.follow)::after, .pat-rich h6 a[href]:not(.follow)::after { font-family: f=
ontello; content: "=EE=A1=9A"; margin-left: 0.5em; font-size: 1em; position=
: absolute; text-decoration: none !important; }

.pat-rich h2 a[href]:hover, .pat-rich h3 a[href]:hover, .pat-rich h4 a[href=
]:hover, .pat-rich h5 a[href]:hover, .pat-rich h6 a[href]:hover { text-deco=
ration: underline; }

.pat-rich h2 a[href]:hover::after, .pat-rich h3 a[href]:hover::after, .pat-=
rich h4 a[href]:hover::after, .pat-rich h5 a[href]:hover::after, .pat-rich =
h6 a[href]:hover::after { text-decoration: none !important; }

.pat-rich h1 { margin-bottom: 32px; }

.pat-rich h1 .logo { float: right; height: 55px; margin-top: -8px; margin-l=
eft: 15px; }

@media only screen and (max-width: 769px) {
  .pat-rich h1 { margin-bottom: 0.7692em; padding-bottom: 1px; font-weight:=
 bold; font-size: 1.625em; line-height: 1.1538em; }
}

.pat-rich h1 + .byline { margin-bottom: 1.8em; color: rgb(83, 83, 83); font=
-style: normal; line-height: 1.3; font-size: 0.9em; }

.pat-rich h1 + .byline .byline-item { border-left: 1px solid rgb(83, 83, 83=
); padding: 0px 0.5em; display: inline-block; }

.pat-rich h1 + .byline .byline-item:first-child { padding-left: 0px; border=
-left: none; }

@media only screen and (min-width: 770px) {
  .pat-rich h1 + .byline { margin: -28px 0px 32px; }
}

@media only screen and (max-width: 769px) {
  .pat-rich h1 + .byline { margin: -12px 0px 20px; }
}

.pat-rich h1[class^=3D"icon-"] { padding-left: 1.6em; position: relative; }

.pat-rich h1[class^=3D"icon-"]::before { position: absolute; left: 0px; top=
: 50%; margin-top: -1px; transform: translateY(-50%); }

.pat-rich h1, .pat-rich #title-block .pat-content-mirror { font-weight: bol=
d; font-size: 2.02729rem; line-height: 1.23318; color: rgb(0, 0, 0); box-sh=
adow: none; }

.pat-rich #title-block .pat-content-mirror { margin: 0px; }

.pat-rich .introduction + h2 { margin-top: 3rem; }

.pat-rich h2 { margin: 0rem 0rem 1rem; font-size: 1.80203rem; line-height: =
1.38732; margin-block: 3rem 0.75rem; color: rgb(0, 0, 0); }

.pat-rich h2 a { color: rgb(0, 0, 0); }

.pat-rich#main-content h2 { margin: 3rem 0px calc(-200px + 0.75rem); paddin=
g-top: 120px; position: relative; top: -120px; pointer-events: none; }

.pat-rich .main-illustration + h2 { margin-top: 0px; }

.pat-rich h3 { font-size: 1.42383rem; line-height: 1.40466; display: block;=
 font-weight: bold; margin: 0rem 0rem 0.5rem; }

.pat-rich h3::before { width: 1.25em; text-align: left; padding: 0px; margi=
n: 0px; }

.pat-rich h3 .pat-button { font-size: 0.7em; float: right; line-height: 1.3=
em; border: none; background: rgb(204, 224, 241); color: rgb(1, 104, 155); =
cursor: pointer; padding: 0.3em 0.5em; }

.pat-rich h3 .pat-button:hover { background: rgb(229, 240, 249); }

.pat-rich h3 .pat-button::after { display: none; }

.pat-rich h4 { font-size: 1em; font-weight: bold; margin: 0px; }

.pat-rich h4 + ul, .pat-rich h4 + ol { margin-top: 10px; }

.pat-rich h5 { font-size: 1em; font-weight: bold; margin: 0px; }

.pat-rich h6 { font-size: 1em; font-weight: bold; margin: 0px; }

.pat-rich em { font-style: italic; }

.pat-rich i { font-style: italic; }

.pat-rich strong { font-weight: bold; }

.pat-rich strong.warning { color: rgb(213, 43, 30); font-weight: normal; }

.pat-rich .page-title { position: relative; }

.six.columns .pat-rich .page-title { padding-top: 18px; padding-bottom: 9px=
; }

.pat-rich .page-title h1 { font-size: 2.02729rem; line-height: 1.23318; }

.pat-rich .page-title .icons { position: absolute; top: 0.9em; right: 0px; =
}

@media only screen and (max-device-width: 667px) and (orientation: portrait=
) {
  .pat-rich .page-title .icons { right: 0px; }
}

.pat-rich .page-title .icons .icon-close-thin, .pat-rich .page-title .icons=
 .icon-close, .pat-rich .page-title .icons .icon-3909-kruis { width: 1em; h=
eight: 1em; font-size: 30px; color: rgba(0, 0, 0, 0); cursor: default; }

.pat-rich .page-title .icons .icon-close-thin:hover::before, .pat-rich .pag=
e-title .icons .icon-close:hover::before, .pat-rich .page-title .icons .ico=
n-3909-kruis:hover::before { color: rgb(0, 0, 0); }

.pat-rich .page-title .icons .icon-close-thin::before, .pat-rich .page-titl=
e .icons .icon-close::before, .pat-rich .page-title .icons .icon-3909-kruis=
::before { color: rgba(0, 0, 0, 0.6); text-decoration: none; }

.pat-rich .page-title::before { font-family: fontello; float: left; positio=
n: absolute; left: 0px; top: 50%; margin-top: -20px; font-size: 1.6em; colo=
r: rgb(1, 104, 155); }

@media only screen and (max-device-width: 667px) and (orientation: portrait=
) {
  .pat-rich .page-title::before { left: 0px; margin-left: -15px; margin-top=
: 5px; }
}

.pat-rich .page-title.medicine::before { content: "=EE=A1=8B"; }

.pat-rich .page-title.medicine-group::before { content: "=EE=A1=89"; }

.pat-rich .page-title.indication::before { content: "=EF=83=B0"; }

.pat-rich .page-title h1 { font-size: 2.02729rem; color: rgb(57, 135, 12); =
line-height: 1.2; margin: 0px 0px 0.3em; padding-left: 1.45em; padding-righ=
t: 1.45em; }

.pat-rich .page-title h1::first-letter { text-transform: capitalize; }

@media only screen and (max-device-width: 667px) and (orientation: portrait=
) {
  .pat-rich .page-title h1 { font-size: 1.6em; }
}

.pat-rich .page-title h1 + .byline { margin-bottom: 0.7em; padding-left: 2.=
6rem; padding-right: 2.6rem; }

@media only screen and (min-width: 770px) {
  .pat-rich .page-title h1 + .byline { margin-top: -0.5em; }
}

@media only screen and (max-width: 769px) {
  .pat-rich .page-title h1 + .byline { margin-top: 0px; }
}

@media only screen and (max-device-width: 667px) and (orientation: portrait=
) {
  .pat-rich .page-title h1 + .byline { margin-bottom: 0px; }
}

.pat-rich .discrete { color: rgba(0, 0, 0, 0.7); font-size: 0.8em; padding-=
left: 1.2em; border-left: 3px solid rgba(0, 0, 0, 0.2); }

.pat-rich .discrete p, .pat-rich .discrete ul, .pat-rich .discrete ol, .pat=
-rich .discrete h3 { margin: 0px 0px 1.25rem; }

.pat-rich .discrete :last-child { margin-bottom: 0px; }

.pat-rich .captioned { color: rgba(0, 0, 0, 0.8); font-size: 0.8em; padding=
: 1.5em; background: rgb(229, 240, 249); }

.pat-rich .captioned p, .pat-rich .captioned ul, .pat-rich .captioned ol, .=
pat-rich .captioned table, .pat-rich .captioned h3 { margin: 0px 0px 1.25re=
m; }

.pat-rich .captioned :last-child { margin-bottom: 0px; }

.pat-rich .logo-cloud img { margin: 1.5em 5%; display: inline-block; }

.pat-rich img, .pat-rich iframe { cursor: default; }

.pat-rich img:focus, .pat-rich img.ProseMirror-selectednode, .pat-rich ifra=
me:focus, .pat-rich iframe.ProseMirror-selectednode { outline: rgb(225, 112=
, 0) solid 3px; outline-offset: 4px; }

.pat-rich figure { width: 100%; margin-bottom: 26px; }

.pat-rich figure.banner img, .pat-rich figure.banner svg { width: auto; max=
-width: 100%; }

.pat-rich figure img, .pat-rich figure svg { width: 100%; overflow: hidden;=
 margin: 0px auto; }

.pat-rich figure img *, .pat-rich figure svg * { font-family: "RO Sans" !im=
portant; }

.pat-rich figure table { margin-bottom: 0px; }

@media (-ms-high-contrast: none) {
  .pat-rich figure svg { height: 350px; }
}

.pat-rich figure a img { border: none; }

.pat-rich figure figcaption { color: rgba(0, 0, 0, 0.5); font-size: 0.8em; =
padding: 10px 0px 0px; }

.pat-rich figure figcaption .icon-zoom-in { color: rgb(1, 104, 155); text-d=
ecoration: none; float: right; cursor: pointer; }

.no-js .pat-rich figure figcaption .icon-zoom-in { display: none; }

@media only screen and (max-width: 769px) {
  .pat-rich figure figcaption .icon-zoom-in { display: none; }
}

.pat-rich figure figcaption .icon-zoom-in:hover { color: rgb(0, 0, 0); text=
-decoration: underline; }

.pat-rich figure figcaption .icon-zoom-in::before { text-decoration: none; =
}

.pat-rich figure svg + figcaption::before, .pat-rich figure img + figcaptio=
n::before, .pat-rich figure a + figcaption::before, .pat-rich figure .illus=
tration-group + figcaption::before { content: "Fig. " counter(fig) ": "; co=
unter-increment: fig 1; }

.pat-rich figure table + figcaption::before, .pat-rich figure .scroll-table=
 + figcaption::before, .pat-rich figure .table-group + figcaption::before, =
.pat-rich figure .tables + figcaption::before { content: "Tabel " counter(t=
ab) ": "; counter-increment: tab 1; }

.pat-rich table { padding: 0px; margin: 2rem auto; overflow: hidden; width:=
 100%; max-width: 100%; }

.pat-rich table tbody tr th { position: static; }

.pat-rich img { max-width: 100%; margin: 2rem auto; display: block; }

.pat-rich p, .pat-rich ul, .pat-rich ol, .pat-rich dl { margin-block: 0px 1=
.25rem; }

.pat-rich p:not(:last-child):not(.byline), .pat-rich ul:not(:last-child):no=
t(.byline), .pat-rich ol:not(:last-child):not(.byline), .pat-rich dl:not(:l=
ast-child):not(.byline) { margin-bottom: 1rem; }

.no-js .pat-rich p.compare-to-other, .no-js .pat-rich ul.compare-to-other, =
.no-js .pat-rich ol.compare-to-other, .no-js .pat-rich dl.compare-to-other =
{ display: none; }

@media print {
  .pat-rich p.compare-to-other, .pat-rich ul.compare-to-other, .pat-rich ol=
.compare-to-other, .pat-rich dl.compare-to-other { display: none; }
}

@media screen and (min-width: 0\0 ) {
  .pat-rich a[class^=3D"icon-"] { text-decoration: none; }
  .pat-rich a[class^=3D"icon-"]:hover { text-decoration: none; }
  .pat-rich a[class^=3D"icon-"]:hover .link-label { text-decoration: underl=
ine; }
}

.pat-rich a[href] { text-decoration: underline; }

.pat-rich a[href]:hover { color: rgb(1, 70, 104); }

.pat-rich a[href][href$=3D".pdf"]::after { content: " (pdf)"; }

body.product-fk .pat-rich a:not([href~=3D".farmacotherapeutischkompas.nl"])=
:not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"]):not([href^=
=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"reference-badg=
e"]) { position: relative; padding-left: 1rem; }

body.product-fk .pat-rich a:not([href~=3D".farmacotherapeutischkompas.nl"])=
:not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"]):not([href^=
=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"reference-badg=
e"])::before { display: inline-flex; content: "=EE=A3=8F"; font-family: fon=
tello; font-size: 0.7rem; font-weight: normal; line-height: inherit; -webki=
t-font-smoothing: antialiased; left: 1px; top: -2px; align-items: center; h=
eight: 28px; position: absolute; text-decoration: none !important; }

body.product-hor .pat-rich a:not([href~=3D".horizonscan.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"]) { positio=
n: relative; padding-left: 1rem; }

body.product-hor .pat-rich a:not([href~=3D".horizonscan.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"])::before {=
 display: inline-flex; content: "=EE=A3=8F"; font-family: fontello; font-si=
ze: 0.7rem; font-weight: normal; line-height: inherit; -webkit-font-smoothi=
ng: antialiased; left: 1px; top: -2px; align-items: center; height: 28px; p=
osition: absolute; text-decoration: none !important; }

body.product-ziz .pat-rich a:not([href~=3D".zorginzicht.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"]) { positio=
n: relative; padding-left: 1rem; }

body.product-ziz .pat-rich a:not([href~=3D".zorginzicht.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"])::before {=
 display: inline-flex; content: "=EE=A3=8F"; font-family: fontello; font-si=
ze: 0.7rem; font-weight: normal; line-height: inherit; -webkit-font-smoothi=
ng: antialiased; left: 1px; top: -2px; align-items: center; height: 28px; p=
osition: absolute; text-decoration: none !important; }

body.product-gip .pat-rich a:not([href~=3D".gipdatabank.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"]) { positio=
n: relative; padding-left: 1rem; }

body.product-gip .pat-rich a:not([href~=3D".gipdatabank.nl"]):not([href^=3D=
"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):not([=
class~=3D"type-link-external"]):not([class~=3D"reference-badge"])::before {=
 display: inline-flex; content: "=EE=A3=8F"; font-family: fontello; font-si=
ze: 0.7rem; font-weight: normal; line-height: inherit; -webkit-font-smoothi=
ng: antialiased; left: 1px; top: -2px; align-items: center; height: 28px; p=
osition: absolute; text-decoration: none !important; }

body.product-med .pat-rich a:not([href~=3D".medicijnkosten.nl"]):not([href^=
=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):no=
t([class~=3D"type-link-external"]):not([class~=3D"reference-badge"]) { posi=
tion: relative; padding-left: 1rem; }

body.product-med .pat-rich a:not([href~=3D".medicijnkosten.nl"]):not([href^=
=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"#"]):no=
t([class~=3D"type-link-external"]):not([class~=3D"reference-badge"])::befor=
e { display: inline-flex; content: "=EE=A3=8F"; font-family: fontello; font=
-size: 0.7rem; font-weight: normal; line-height: inherit; -webkit-font-smoo=
thing: antialiased; left: 1px; top: -2px; align-items: center; height: 28px=
; position: absolute; text-decoration: none !important; }

body.product-zor .pat-rich a:not([href~=3D".zorgcijfersdatabank.nl"]):not([=
href^=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"=
]):not([href^=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"r=
eference-badge"]) { position: relative; padding-left: 1rem; }

body.product-zor .pat-rich a:not([href~=3D".zorgcijfersdatabank.nl"]):not([=
href^=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"=
]):not([href^=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"r=
eference-badge"])::before { display: inline-flex; content: "=EE=A3=8F"; fon=
t-family: fontello; font-size: 0.7rem; font-weight: normal; line-height: in=
herit; -webkit-font-smoothing: antialiased; left: 1px; top: -2px; align-ite=
ms: center; height: 28px; position: absolute; text-decoration: none !import=
ant; }

body.product-ist .pat-rich a:not([href~=3D".istandaarden.nl"]):not([href^=
=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"]):no=
t([href^=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"refere=
nce-badge"]) { position: relative; padding-left: 1rem; }

body.product-ist .pat-rich a:not([href~=3D".istandaarden.nl"]):not([href^=
=3D"/"]):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([href^=3D"/"]):no=
t([href^=3D"#"]):not([class~=3D"type-link-external"]):not([class~=3D"refere=
nce-badge"])::before { display: inline-flex; content: "=EE=A3=8F"; font-fam=
ily: fontello; font-size: 0.7rem; font-weight: normal; line-height: inherit=
; -webkit-font-smoothing: antialiased; left: 1px; top: -2px; align-items: c=
enter; height: 28px; position: absolute; text-decoration: none !important; =
}

body.environment-prototype .pat-rich a:not([href^=3D"/"]):not([href^=3D"#"]=
):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([class~=3D"type-link-ext=
ernal"]):not([class~=3D"reference-badge"]) { position: relative; padding-le=
ft: 1rem; }

body.environment-prototype .pat-rich a:not([href^=3D"/"]):not([href^=3D"#"]=
):not([href^=3D"tel"]):not([href^=3D"mailto"]):not([class~=3D"type-link-ext=
ernal"]):not([class~=3D"reference-badge"])::before { display: inline-flex; =
content: "=EE=A3=8F"; font-family: fontello; font-size: 0.7rem; font-weight=
: normal; line-height: inherit; -webkit-font-smoothing: antialiased; left: =
1px; top: -2px; align-items: center; height: 28px; position: absolute; text=
-decoration: none !important; }

.pat-rich a:not([href]) { text-decoration: none; color: inherit; }

.pat-rich a.reference:not([href])::after { content: " (" attr(title) ")"; t=
ext-decoration: none; color: rgba(0, 0, 0, 0.6); font-style: italic; }

.pat-rich ul { margin-left: 0px; padding: 0px; }

.pat-rich ul li { list-style-type: square; list-style-position: outside; po=
sition: relative; left: 22px; padding-right: 22px; display: list-item; }

.pat-rich ul, .pat-rich ol { margin-block: 0px 1.25rem; }

.pat-rich ul.footnotes .footnote::before, .pat-rich ol.footnotes .footnote:=
:before { vertical-align: super; font-size: 0.6em; color: rgb(102, 102, 102=
); text-align: right; padding-right: 0.5em; box-sizing: border-box; top: -0=
.4em; position: relative; }

.pat-rich ul li, .pat-rich ol li { margin: 0px 0px 0.5rem; padding-inline-s=
tart: 0.25rem; list-style-position: outside; display: list-item; position: =
relative; left: 22px; padding-right: 22px; }

.pat-rich ul li > :last-child, .pat-rich ol li > :last-child { margin-botto=
m: 0px; }

.pat-rich ol { list-style-type: decimal; margin-block: 0px 1.25rem; padding=
-inline-start: 1.5rem; }

.pat-rich ol > li { list-style: decimal; }

.pat-rich ol p:last-child { margin-bottom: 0px; }

.pat-rich ol.roman { list-style: upper-roman; }

.pat-rich ul.link-list li a[href] { text-decoration: none; }

.pat-rich ul.link-list li a[href]:hover { text-decoration: underline; }

.pat-rich ul.link-list.medicines li a { display: inline-block; padding: 0px=
; }

.pat-rich ul.link-list.medicines li a.icon-medicine { max-width: calc(100% =
- 100px); }

.pat-rich ul.link-list.medicines li::before { font-family: fontello; conten=
t: "=EE=A1=8B"; }

.pat-rich ul.link-list.medicines .button-compare { border: none; background=
-color: rgb(246, 212, 178); font-size: 0.9em; color: rgb(255, 255, 255); fl=
oat: right; margin: 0px 0px 0px 0.2em; line-height: 1.5em; text-decoration:=
 none; cursor: default; padding: 0px 1em !important; }

@media print {
  .pat-rich ul.link-list.medicines .button-compare { display: none; }
}

.pat-rich ul.link-list.medicines .button-compare[href] { background-color: =
rgb(225, 112, 0); cursor: pointer; }

.pat-rich ul.link-list.medicines .button-compare[href]:hover { opacity: 0.8=
; }

.pat-rich ol { counter-reset: list 0; }

.pat-rich ol li > :last-child { margin-bottom: 0px; }

.pat-rich ol.link-list li a[href] { text-decoration: none; }

.pat-rich ol.link-list li a[href]:hover { text-decoration: underline; }

.pat-rich.indented { font-size: 1em; line-height: 1.4; }

.pat-rich.indented .content-block#extra-info .link-list { padding-left: 22p=
x; }

.pat-rich.indented .content-block#extra-info .link-list li { position: stat=
ic; }

.pat-rich.indented .content-block#extra-info .link-list li .reference-badge=
 { top: 0px; }

.pat-rich.indented .metro-line { padding-left: 0px; }

.pat-rich.indented .metro-line li { margin-bottom: 0px; margin-left: 0px; }

@media only screen and (min-width: 1280px) {
  .pat-rich.indented { padding-left: 28%; }
  .pat-rich.indented h2 { width: 36%; float: left; margin-left: -39%; margi=
n-top: -0.3em; color: rgb(66, 20, 95); background-color: rgb(227, 220, 231)=
; padding: 0.3em 0.8em; font-size: 1em; position: sticky; top: 90px; box-si=
zing: border-box; transition: 0.4s; }
  body.scroll-down .pat-rich.indented h2 { top: 20px; }
  .pat-rich.indented h2 + .pat-message { margin-top: -5.5px; }
  .pat-rich.indented h2 + .pat-message + .recipe { margin-top: 22px; transi=
tion: margin 0.5s; }
  .pat-rich.indented h2 + .pat-message.closed + .recipe { margin-top: 0px; =
}
}

@media print {
  .pat-rich.indented h2 { position: static !important; width: auto !importa=
nt; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .pat-rich.indented h2 { position: static !important; }
}

@media only screen and (max-width: 769px) {
  .pat-rich.indented h2 { position: static !important; }
}

.pat-select.versions:not([data-option-value*=3D"versie"])::after { color: r=
gb(225, 112, 0); font-weight: bold; }

.pat-select.versions time { display: inline-block; padding: 0px 12px; line-=
height: 27px; margin-left: 14px; background-color: rgb(204, 224, 241); colo=
r: rgb(1, 104, 155); border-radius: 15px; font-size: 0.8em; }

.pat-select.versions:hover time, .pat-select.versions.tooltip-active-click =
time { background-color: rgb(184, 212, 236); }

#site-header { line-height: 16px; border: none; background-color: rgb(255, =
255, 255); position: absolute; top: 0px; width: 100%; transition: 0.4s; }

@media only screen and (max-width: 769px) {
  #site-header { height: 72px; }
}

@media only screen and (min-width: 770px) {
  #site-header { height: 125px; }
}

body:has(#app-space.state-on) #site-header, body:has(nav.app-icons) #site-h=
eader, body:has(#global-nav.logged-in) #site-header { height: 0px !importan=
t; opacity: 0; }

@media (display-mode: standalone) {
  #site-header { display: none; }
}

#site-header #global-functions { position: absolute; top: 13px; }

@media only screen and (min-width: 770px) {
  #site-header #global-functions { right: 15px; }
}

@media only screen and (max-width: 769px) {
  #site-header #global-functions { left: 15px; max-width: calc(50% - 40px);=
 font-size: 14px; }
}

#site-header #global-functions a { color: rgb(102, 102, 102); display: inli=
ne-block; }

@media only screen and (min-width: 770px) {
  #site-header #global-functions a { margin-left: 15px; padding-left: 15px;=
 border-left: 1px solid silver; float: left; }
  #site-header #global-functions a:first-child { border-left: none; }
}

@media only screen and (max-width: 769px) {
  #site-header #global-functions a { display: block; margin-bottom: 10px; }
}

#site-header #global-functions a.active { color: rgb(0, 0, 0); text-decorat=
ion: none; cursor: default; }

#site-header > #login { position: absolute; top: 13px; color: rgb(102, 102,=
 102); }

@media only screen and (min-width: 770px) {
  #site-header > #login { right: 15px; }
}

@media only screen and (max-width: 769px) {
  #site-header > #login { left: 15px; max-width: calc(50% - 40px); font-siz=
e: 14px; }
}

#site-header > #login.active { color: rgb(0, 0, 0); text-decoration: none; =
cursor: default; }

#site-header .date-modified { font-size: 12px; position: absolute; top: 12p=
x; left: 18px; color: silver; cursor: default; max-width: 40%; }

@media only screen and (max-width: 769px) {
  #site-header .date-modified { display: none; }
}

#site-header a.homepage { width: 50px; display: block; margin: 0px auto; te=
xt-decoration: none; }

@media only screen and (max-width: 769px) {
  #site-header a.homepage { width: 40px; }
}

#site-header a.homepage .logo { display: none; }

@keyframes beaker {=20
  0%, 64%, 66% { transform: rotate(0deg); opacity: 1; }
  4%, 15%, 28%, 47% { transform: rotate(-20deg); opacity: 1; }
  9%, 22%, 37% { transform: rotate(20deg); opacity: 1; }
  100% { opacity: 0; }
}

.css-externN #site-header a.homepage::after { text-align: center; height: 5=
0px; width: 50px; border-radius: 50%; font-family: fontello; line-height: 5=
0px; background-color: rgb(21, 66, 115); display: block; position: absolute=
; top: 27px; left: 50%; margin-left: -25px; content: "=EF=83=83"; color: rg=
b(255, 255, 255); font-size: 1.6em; animation: 4s ease 2s 1 normal forwards=
 running beaker; }

#site-header a.homepage::before { display: inline-block; background-color: =
rgb(21, 66, 115); color: rgb(255, 255, 255); font-family: fontello; content=
: "=EE=A1=8F"; text-align: center; }

@media only screen and (min-width: 770px) {
  #site-header a.homepage::before { width: 50px; height: 100px; line-height=
: 135px; font-size: 36px; }
}

@media only screen and (max-width: 769px) {
  #site-header a.homepage::before { width: 40px; height: 60px; line-height:=
 67px; font-size: 30px; }
}

@media print {
  #site-header a.homepage::before { content: "=EE=A1=9D"; background-color:=
 rgb(255, 255, 255); color: rgb(21, 66, 115); font-size: 74px; line-height:=
 74px; }
}

@media only screen and (max-width: 769px) {
  #site-header a.homepage::after { position: absolute; top: 90px; right: 10=
px; content: "=EE=A2=B4"; line-height: 2em; text-align: center; font-family=
: fontello; display: block; color: rgb(255, 255, 255); width: 2em; height: =
2em; z-index: 2; }
  .page-type-homepage #site-header a.homepage::after { display: none; }
}

#site-header .dept { font-size: 15px; position: absolute; top: 51px; margin=
-left: 12px; color: rgb(0, 0, 0); }

@media only screen and (max-width: 769px) {
  #site-header .dept { display: none; }
}

@media print {
  #site-header .dept { font-family: "Times New Roman", Georgia, serif !impo=
rtant; }
}

@media (max-width: 767px) {
  #site-header .header .dept { width: 50px; top: 20px; }
}

@media only screen and (max-device-width: 667px) and (orientation: portrait=
) {
  .page-type-medicine-compare #site-header::before, .page-type-medicine-gro=
up-compare #site-header::before, .page-type-indication-compare #site-header=
::before { position: absolute; display: block; text-align: center; min-heig=
ht: 92px; left: 0px; right: 0px; top: 13rem; content: "Schuif de pagina van=
 rechts naar links om te vergelijken"; padding: 2rem calc(100% + 2rem) 1rem=
 2rem; z-index: 1; font-size: 1.3em; line-height: 1.2; color: rgb(225, 112,=
 0); background-color: rgb(225, 237, 219); font-weight: bold; animation: 3s=
 ease 4s 3 normal none running shake; pointer-events: none; }
}

.show-more-snippet { display: inline; letter-spacing: -1em; }

.show-more-snippet.collapsed { cursor: pointer; overflow: hidden; color: rg=
ba(0, 0, 0, 0); }

.show-more-snippet.collapsed::before { content: "=E2=80=A6"; letter-spacing=
: 0px; color: rgb(0, 0, 0); display: inline; }

.show-more-snippet.collapsed::after { color: rgb(1, 104, 155); content: att=
r(title); letter-spacing: 0px; display: block; clear: both; }

.show-more-snippet.collapsed:hover::after { text-decoration: underline; }

.show-more-snippet.expanded { font-size: inherit; color: inherit; letter-sp=
acing: 0px; }

.search-box { user-select: none; }

.search-box.closed #close-trigger, .search-box.open #open-trigger { display=
: none; }

.search-box::after { content: " "; display: table; clear: both; }

.search-box fieldset.horizontal { margin: 0px; }

.search-box .main-filter-toggle { display: none !important; }

.search-box.filters-closed #close-trigger, .search-box.filters-open #open-t=
rigger { display: none; }

.search-box .filter-header { border-bottom: 1px solid rgb(118, 118, 118); }

.search-box .filter-header::after { content: " "; display: table; clear: bo=
th; }

.search-box .filter-header .filter-tags .tag { float: left; line-height: 32=
px; background-color: rgb(242, 242, 242); color: rgb(0, 0, 0); padding: 0px=
 30px 0px 0.5rem; margin: 0px 10px 6px 0px; border-radius: 3px; font-size: =
0.875rem; overflow: hidden; box-sizing: border-box; animation: 1s ease 0s 1=
 normal none running fadeIn; white-space: nowrap; position: relative; }

.search-box .filter-header .filter-tags .tag.collapsed { opacity: 0; width:=
 0px; margin: 0px 0px 6px; }

.search-box .filter-header .filter-tags .tag::after { font-family: fontello=
; content: "=EE=A2=83"; right: 10px; top: 0px; font-size: 16px; position: a=
bsolute; }

.search-box .filter-header .filter-tags .tag:hover { text-decoration: line-=
through; background-color: rgb(237, 237, 237); color: rgb(0, 0, 0); }

.search-box .filter-header .filter-tags .tag:hover::after { }

.search-box .filter-header .buttons .filter-toggle { background-color: rgba=
(0, 0, 0, 0); white-space: nowrap; color: rgb(0, 0, 0); font-size: 1rem; pa=
dding: 0px 30px 0px 0.5rem; margin: 0px 0px 17px; border-radius: 3px; float=
: right; line-height: 32px; position: relative; cursor: default; }

.search-box .filter-header .buttons .filter-toggle::after { font-family: fo=
ntello; content: "=EE=A3=87"; right: 10px; top: 0px; position: absolute; fo=
nt-size: 22px; transition: transform 0.2ms; }

.search-box .filter-header .buttons .filter-toggle.filter-close-trigger::af=
ter { content: "=EE=A3=88"; }

.search-box .filter-header .buttons .filter-toggle:hover { background-color=
: rgb(237, 237, 237); color: rgb(0, 0, 0); }

.search-box .filters.panel-content { padding-top: 0px; padding-bottom: 0px;=
 overflow: hidden; margin: 0px; }

.search-box .filters.panel-content::after { content: " "; display: table; c=
lear: both; }

.search-box .filters .filter-toggle { display: none; }

@media only screen and (max-width: 769px) {
  .search-box .filters .form-panel { padding-left: 20px; padding-right: 20p=
x; }
}

.search-box .filters .form-panel .panel-content { padding: 0px 0px 1.5em; }

.search-box .sorting { margin: 1rem 0rem 2rem; clear: both; }

.search-box .sorting a { color: rgb(0, 0, 0); text-decoration: underline; }

.search-results { line-height: 1.3; position: relative; clear: both; }

.search-results.injecting::before { top: 1em; }

@media only screen and (min-width: 1280px) {
  .search-results { font-size: 1.1em; }
}

.search-results .result-item { position: relative; display: block; padding-=
left: 20px; font-weight: normal; color: rgb(0, 0, 0); font-size: 1.125rem; =
line-height: 1.625rem; margin-bottom: 29px; animation: 1s ease 0s 1 normal =
none running fadeIn; text-decoration: none; }

.search-results .result-item:hover .result-title { text-decoration: underli=
ne; }

.search-results .result-item:hover .result-description, .search-results .re=
sult-item:hover .meta .facet { text-decoration: none; }

.search-results .result-item .result-description { font-size: 1.125rem; lin=
e-height: 1.33333; font-weight: normal; }

.search-results .result-item .result-description .facet { display: inline-b=
lock; }

.search-results .result-item .result-description .facet::after { content: "=
, "; }

.search-results .result-item .result-description .facet:last-child::after {=
 content: "."; }

.search-results .result-item.medicine .result-title { text-transform: lower=
case; }

.search-results .result-item.medicine .result-title::first-letter { text-tr=
ansform: uppercase; }

.search-results .result-item.medicine .description { text-transform: lowerc=
ase; }

.search-results .result-item.medicine .description .facet::first-letter { t=
ext-transform: uppercase; }

.search-results .result-item.state-draft::before { color: rgb(225, 112, 0);=
 }

.search-results .result-item.state-draft .result-title, .search-results .re=
sult-item.state-draft .meta { color: rgb(225, 112, 0); }

.search-results .result-item .result-title { line-height: 28px; font-size: =
1.42383rem; margin: 0rem 0rem 0.5rem; font-style: normal; font-weight: norm=
al; color: rgb(1, 104, 155); }

.search-results .result-item .meta { display: block; font-size: 0.888889rem=
; line-height: 1.6875; font-weight: normal; color: rgb(83, 83, 83); margin:=
 0.5rem 0px 0px; }

.search-results .result-item .meta .byline-item { padding-right: 7px; margi=
n-right: 7px; border-right: 1px solid silver; }

.search-results .result-item .meta .byline-item:last-child { border-right: =
none; }

.search-results .result-item .meta .byline-item.price { border-right: none;=
 padding-right: 0px; margin-right: 0px; }

.search-results .result-item .meta .byline-item.price::before { font-family=
: fontello; display: inline-block; margin-right: 5px; }

.search-results .result-item .meta .byline-item.price.not-reimbursed { colo=
r: rgb(213, 43, 30); }

.search-results .result-item .meta .byline-item.price.reimbursed { color: r=
gb(57, 135, 12); }

.search-results .result-item .meta .byline-item.price.possibly-reimbursed {=
 color: rgb(225, 112, 0); }

.search-results .result-item .meta .byline-item.price.partially-reimbursed =
{ color: rgb(225, 112, 0); }

.search-results .result-item .meta .byline-item.reimbursement::before { con=
tent: "("; }

.search-results .result-item .meta .byline-item.reimbursement::after { cont=
ent: ")"; }

.search-results .result-item .meta .byline-item.reimbursement.not-reimburse=
d { color: rgb(213, 43, 30); }

.search-results .result-item .meta .byline-item.reimbursement.reimbursed { =
color: rgb(57, 135, 12); }

.search-results .result-item .meta .byline-item.reimbursement.possibly-reim=
bursed { color: rgb(225, 112, 0); }

.search-results .result-item .meta .byline-item.reimbursement.partially-rei=
mbursed { color: rgb(225, 112, 0); }

.search-results .result-item::before { font-family: fontello; position: abs=
olute; top: 0px; font-size: 1rem; left: 0px; display: inline-block; color: =
rgb(1, 104, 155); font-style: normal; }

.search-results .result-item.generic::before { content: "=EE=A1=85"; font-s=
ize: 1rem; }

.search-results .result-item.news-item::before { content: "=EE=A1=A7"; }

.search-results .result-item.medicine::before { content: "=EE=A1=8B"; }

.search-results .result-item.group::before { content: "=EE=A1=89"; }

.search-results .result-item.indication::before { content: "=EF=83=B0"; }

.search-results .result-item.info::before { content: "=EE=A3=AD"; }

.search-results .result-item.type-qs::before { content: "=EE=A2=AA"; }

.search-results .result-item.type-is::before { content: "=EE=A2=B0"; }

.search-results .result-item.type-mi::before { content: "=EE=A2=AC"; font-s=
ize: 0.8em; }

.search-results .result-item.type-dt::before { content: "=EE=A0=9A"; font-s=
ize: 0.8em; }

.search-results .result-more { display: block; margin-bottom: 15px; }

.search-results .result-more::before { content: "=EF=81=95"; display: inlin=
e-block; font-family: FontAwesome; font-size: 16px; margin-right: 7px; colo=
r: rgb(51, 122, 183); position: relative; top: 2px; }

.spotlight { transition: box-shadow 0.5s, background 0.5s, padding 0.5s, ma=
rgin 0.5s, border-radius 0.5s; padding: 0px 0.35em; margin: 0px -0.35em; bo=
rder-radius: 8px; position: relative; z-index: 9; }

.spotlight-on .spotlight { box-shadow: rgb(255, 255, 255) 0px 0px 0px 0.15e=
m, rgb(0, 0, 0) 0px 0px 10px; background: rgb(255, 255, 255); }

#sub-nav { background: rgb(243, 243, 243); margin: 0px; animation: 0.4s eas=
e 0s 1 normal none running fadeIn; }

#sub-nav #hero { margin: 0px; }

#sub-nav .container { padding: 40px 15px 28px; }

#sub-nav .container .link-list { margin-bottom: -12px; }

@media only screen and (min-width: 770px) {
  #sub-nav .container .link-list { column-count: 3; }
  #sub-nav .container .link-list li { padding-bottom: 12px; margin-bottom: =
0px; border-bottom: none; font-size: 20px; line-height: 28px; }
  #sub-nav .container .link-list li a:hover { text-decoration: underline; }
}

#page-intro { position: relative; }

#page-intro .validation.message { font-size: 1rem; }

#page-intro .placeholder { font-style: normal; color: silver; }

#page-intro:hover textarea { outline: rgb(143, 202, 231) dotted 2px; outlin=
e-offset: 13px; }

#page-intro textarea:focus { outline: rgb(0, 0, 0) dotted 2px; outline-offs=
et: 13px; }

#page-intro .pat-content-mirror { position: absolute; inset: 0px; padding: =
0px; margin: 0px; resize: none; width: 100%; height: 100%; background: rgba=
(0, 0, 0, 0); box-shadow: none; }

#page-intro .pat-content-mirror.has-value { -webkit-text-fill-color: rgba(0=
, 0, 0, 0); background-color: rgba(0, 0, 0, 0); }

.swim-lane { background: rgb(255, 255, 255); font-size: 1.125rem; }

.swim-lane .container { padding-top: 50px; padding-bottom: 50px; }

@media only screen and (max-width: 769px) {
  .swim-lane .container { padding-top: 30px; padding-bottom: 30px; }
}

.swim-lane .lane-title { margin: 0px 0px 20px; font-size: 1.80203rem; }

@media only screen and (min-width: 770px) {
  .swim-lane .lane-title { padding-top: 10px; border-top: 1px solid rgb(225=
, 225, 225); }
}

.swim-lane .lane-footer { clear: both; font-size: 1.26562rem; }

.swim-lane .lane-footer a { font-weight: bold; }

.swim-lane .lane-footer a:hover { text-decoration: underline; }

.swim-lane .lane-footer a::before { display: inline-block; width: 1em; font=
-family: fontello; content: "=EE=A2=84"; }

.swim-lane#swim-lane-sectors + #swim-lane-browser-warning .container, .swim=
-lane#swim-lane-sectors + #partners .container, .swim-lane#swim-lane-sector=
s + #news .container, .swim-lane#swim-lane-sectors + #swim-lane-reports .co=
ntainer, .swim-lane#swim-lane-sectors + #site-summary .container, .swim-lan=
e#swim-lane-sectors + #swim-lane-quote .container, .swim-lane#swim-lane-sec=
tors + #swim-lane-secondary-tasks .container, .swim-lane#swim-lane-sectors =
+ #swim-lane-sectors .container, .swim-lane#swim-lane-sectors + #swim-lane-=
social .container { padding-top: 0px; }

.swim-lane#swim-lane-sectors .lane-title { margin-top: 0px; border-top: non=
e; }

.swim-lane#swim-lane-reports + #swim-lane-browser-warning .container, .swim=
-lane#swim-lane-reports + #partners .container, .swim-lane#swim-lane-report=
s + #news .container, .swim-lane#swim-lane-reports + #swim-lane-reports .co=
ntainer, .swim-lane#swim-lane-reports + #site-summary .container, .swim-lan=
e#swim-lane-reports + #swim-lane-quote .container, .swim-lane#swim-lane-rep=
orts + #swim-lane-secondary-tasks .container, .swim-lane#swim-lane-reports =
+ #swim-lane-sectors .container, .swim-lane#swim-lane-reports + #swim-lane-=
social .container { padding-top: 0px; }

.swim-lane#swim-lane-reports .lane-title { margin-top: 0px; border-top: non=
e; }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-reports .task-list { display: grid; grid-template-co=
lumns: 1fr 1fr; }
}

.swim-lane#swim-lane-secondary-tasks .intro { font-size: 1.60181rem; line-h=
eight: 1.5; font-weight: normal; margin: 0px 0px 40px; }

.swim-lane#swim-lane-secondary-tasks + #swim-lane-browser-warning .containe=
r, .swim-lane#swim-lane-secondary-tasks + #partners .container, .swim-lane#=
swim-lane-secondary-tasks + #news .container, .swim-lane#swim-lane-secondar=
y-tasks + #swim-lane-reports .container, .swim-lane#swim-lane-secondary-tas=
ks + #site-summary .container, .swim-lane#swim-lane-secondary-tasks + #swim=
-lane-quote .container, .swim-lane#swim-lane-secondary-tasks + #swim-lane-s=
econdary-tasks .container, .swim-lane#swim-lane-secondary-tasks + #swim-lan=
e-sectors .container, .swim-lane#swim-lane-secondary-tasks + #swim-lane-soc=
ial .container { padding-top: 0px; }

.swim-lane#swim-lane-site-navigation-illustrated + #swim-lane-secondary-tas=
ks .lane-title { margin-top: 0px; border-top: none; }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated { background: rgb(242, 2=
42, 242); }
}

.swim-lane#swim-lane-site-navigation-illustrated .container { padding-top: =
4rem; padding-bottom: 3.5rem; margin: 0px auto; }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated { display: grid; grid-auto-flow: column; gap: 0px; }
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated.count-2 { grid-template-columns: 1fr 1fr; padding: 0px 8%; }
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated.count-3 { grid-template-columns: 1fr 1fr 1fr; }
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated.count-3 li a { padding: 0px 5%; }
}

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a { display: block; position: relative; height: 100%; text-decor=
ation: none; text-align: center; box-sizing: border-box; color: rgb(0, 0, 0=
); padding: 0px 10%; }

.no-touchevents .swim-lane#swim-lane-site-navigation-illustrated .container=
 .nav-tiles-illustrated li a:hover .item-title { text-decoration: underline=
; }

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a::before { display: block; text-align: center; width: 100%; box=
-sizing: border-box; padding: 0px; margin: 0px; transition: transform 0.2s;=
 color: rgb(57, 135, 12); }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a::before { height: 200px; line-height: 200px; margin-bottom: =
30px; font-size: 120px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a::before { height: 130px; line-height: 130px; font-size: 90px=
; }
}

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a.icon-quality-thumb, .swim-lane#swim-lane-site-navigation-illus=
trated .container .nav-tiles-illustrated li a.icon-privacy-ok, .swim-lane#s=
wim-lane-site-navigation-illustrated .container .nav-tiles-illustrated li a=
.icon-analytics { position: relative; }

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a.icon-quality-thumb::before, .swim-lane#swim-lane-site-navigati=
on-illustrated .container .nav-tiles-illustrated li a.icon-privacy-ok::befo=
re, .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-=
illustrated li a.icon-analytics::before { color: rgba(0, 0, 0, 0); backgrou=
nd-repeat: no-repeat; background-position: center center; background-size: =
auto 70%; }

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a.icon-quality-thumb::after, .swim-lane#swim-lane-site-navigatio=
n-illustrated .container .nav-tiles-illustrated li a.icon-privacy-ok::after=
, .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-analytics::after { position: absolute; content: " "; }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-quality-thumb::before { background-image: url("icon-kwa=
liteitsinstrumenten-bg.svg"); }
}

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-quality-thumb::before { background-image: url("icon-kwa=
liteitsinstrumenten.svg"); }
}

@keyframes thumb {=20
  0% { transform: rotate(8deg) scale(1); }
  20% { transform: rotate(-8deg) scale(1); }
  40% { transform: rotate(8deg) scale(1); }
  60% { transform: rotate(-8deg) scale(0.8) translate(9%); }
  80% { transform: rotate(8deg) scale(1.4) translate(-13%); }
  100% { transform: rotate(0deg) scale(1) translate(0%); }
}

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-quality-thumb::after { background-image: url("icon-kwal=
iteitsinstrumenten-fg.svg"); width: 110px; height: 110px; background-size: =
contain; margin-left: -55px; top: 44px; left: 50%; }
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-quality-thumb:hover::after { animation: 0.8s ease 0s 1 =
normal forwards running thumb; transform-origin: 0px 50%; }
}

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a.icon-privacy-ok::before { background-image: url("icon-kwalitei=
tsregistraties.svg"); }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-analytics::before { background-image: url("icon-openbar=
e-data-bg.svg"); background-size: 150px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-analytics::before { background-image: url("icon-openbar=
e-data.svg"); }
}

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-analytics::after { background-image: url("icon-openbare=
-data-fg.svg"); top: 10px; left: 15%; right: 15%; height: 100px; background=
-size: 150px; background-repeat: no-repeat; background-position: calc(50% -=
 0.2px) center; transform-origin: center 79px; }
  @keyframes bars {=20
  0% { transform: scaleY(1); }
  40% { transform: scaleY(1.1); }
  60% { transform: scaleY(0.2); }
  80% { transform: scaleY(1.4); }
  100% { transform: scaleY(1); }
}
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a.icon-analytics:hover::after { animation: 0.8s ease 0s 1 norm=
al forwards running bars; }
}

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a.icon-swiss-army-knife::before { font-size: 100px; }

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a .item-title { hyphens: auto; overflow: hidden; text-overflow: =
ellipsis; text-align: center; text-underline-offset: 0.18em; color: rgb(1, =
104, 155); }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a .item-title { font-size: 1.45em; line-height: 1.2em; margin-=
bottom: 15px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-il=
lustrated li a .item-title { font-size: 1.3125em; font-weight: bold; line-h=
eight: 1.2381; margin-bottom: 15px; }
}

.swim-lane#swim-lane-site-navigation-illustrated .container .nav-tiles-illu=
strated li a .byline { line-height: 1.375em; text-align: center; color: rgb=
(0, 0, 0); }

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-site-navigation-illustrated .container { padding: 0p=
x; }
}

.swim-lane#swim-lane-browser-warning { color: rgb(225, 112, 0); font-size: =
26px; margin: 2px 0px; line-height: 44px; }

.swim-lane#swim-lane-browser-warning + #swim-lane-browser-warning .containe=
r, .swim-lane#swim-lane-browser-warning + #partners .container, .swim-lane#=
swim-lane-browser-warning + #news .container, .swim-lane#swim-lane-browser-=
warning + #swim-lane-reports .container, .swim-lane#swim-lane-browser-warni=
ng + #site-summary .container, .swim-lane#swim-lane-browser-warning + #swim=
-lane-quote .container, .swim-lane#swim-lane-browser-warning + #swim-lane-s=
econdary-tasks .container, .swim-lane#swim-lane-browser-warning + #swim-lan=
e-sectors .container, .swim-lane#swim-lane-browser-warning + #swim-lane-soc=
ial .container { padding-top: 0px; }

.swim-lane#swim-lane-browser-warning .message { margin-bottom: 25px; }

.no-js .swim-lane#swim-lane-browser-warning .message.with-js { display: non=
e; }

.js .swim-lane#swim-lane-browser-warning .message.without-js { display: non=
e; }

.swim-lane#swim-lane-browser-warning .browser-options a { color: rgb(255, 2=
55, 255); display: inline-block; margin-right: 20px; text-decoration: none;=
 padding: 0px 20px 0px 15px; background-color: rgb(1, 104, 155); line-heigh=
t: 50px; }

.swim-lane#swim-lane-browser-warning .browser-options a:hover { filter: bri=
ghtness(1.1); }

.swim-lane#swim-lane-browser-warning .browser-options a::before { text-deco=
ration: none; font-weight: normal; }

.swim-lane#site-navigation { background: rgb(242, 242, 242); }

.swim-lane#site-navigation .container { padding-top: 4rem; padding-bottom: =
2rem; }

.swim-lane#site-navigation .container .intro { font-size: 1.60181rem; line-=
height: 1.5; font-weight: normal; margin: 0px 0px 40px; }

@media only screen and (max-width: 769px) {
  .swim-lane#site-navigation .container { padding: 0px; }
  .swim-lane#site-navigation .container .intro { margin-bottom: 20px; margi=
n-top: 20px; padding: 0px 15px; }
}

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-editorial { background-color: rgb(243, 243, 243); }
}

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-editorial .container { padding: 0px; }
}

.swim-lane#swim-lane-social .container > * { max-width: 370px; }

.swim-lane#swim-lane-search { will-change: transform; position: relative; z=
-index: 1; }

@media screen {
  .swim-lane#swim-lane-search { background-color: rgb(225, 237, 219); }
}

.swim-lane#swim-lane-search .container { position: relative; }

.swim-lane#swim-lane-search .medicine-group::first-letter { text-transform:=
 capitalize; }

.swim-lane#swim-lane-search .medicine-group :not([href]) { text-decoration:=
 none; color: inherit; }

@media screen and (min-width: 950px) {
  .swim-lane#swim-lane-search { background-image: url("pills-5.jpg"); backg=
round-size: 100%; background-position: center center; background-repeat: no=
-repeat; }
}

.swim-lane#swim-lane-search.warning { color: rgb(225, 112, 0); border-botto=
m: 5px solid rgb(225, 112, 0); }

.swim-lane#swim-lane-search.warning h1 { color: rgb(225, 112, 0); }

.swim-lane#swim-lane-search.warning h1::before { content: "=EE=A0=95"; marg=
in-top: 0.5em; }

.swim-lane#swim-lane-search .tabs { clear: left; margin: 0px; padding: 0px;=
 position: relative; display: block; float: left; width: 100%; }

.swim-lane#swim-lane-search .tabs::after { content: " "; display: table; cl=
ear: both; }

.swim-lane#swim-lane-search .tabs.injecting::before { display: none; }

.swim-lane#swim-lane-search .tabs.injecting > * { opacity: 1; }

.swim-lane#swim-lane-search .tabs.injecting > * .counter { opacity: 0; }

.swim-lane#swim-lane-search .tabs a, .swim-lane#swim-lane-search .tabs labe=
l { border-top: 0px; font-weight: normal; cursor: pointer; text-decoration:=
 none; font-size: 1em; margin: 0px; color: rgb(1, 104, 155); float: left; p=
adding: 0.5em 1em; transition: padding 0.4s; }

.swim-lane#swim-lane-search .tabs a:first-child, .swim-lane#swim-lane-searc=
h .tabs label:first-child { padding-left: 2.2em; }

.swim-lane#swim-lane-search .tabs a input, .swim-lane#swim-lane-search .tab=
s a::before, .swim-lane#swim-lane-search .tabs label input, .swim-lane#swim=
-lane-search .tabs label::before { display: none; }

.swim-lane#swim-lane-search .tabs a:hover, .swim-lane#swim-lane-search .tab=
s label:hover { text-decoration: underline; }

.swim-lane#swim-lane-search .tabs a.active, .swim-lane#swim-lane-search .ta=
bs a.current, .swim-lane#swim-lane-search .tabs a.checked, .swim-lane#swim-=
lane-search .tabs label.active, .swim-lane#swim-lane-search .tabs label.cur=
rent, .swim-lane#swim-lane-search .tabs label.checked { text-decoration: no=
ne; background: rgb(1, 104, 155); cursor: default; color: rgb(255, 255, 255=
); padding: 0.5em 2.2em; }

.swim-lane#swim-lane-search .tabs a .counter, .swim-lane#swim-lane-search .=
tabs label .counter { display: inline-block; margin: 0px -0.3em 0px 0.5em; =
background-color: rgb(1, 104, 155); color: rgb(255, 255, 255); border-radiu=
s: 1em; height: 1.7em; min-width: 1.7em; box-sizing: border-box; padding: 0=
px 0.5em; transition: opacity 0.5s; animation: 0.6s ease 0s 1 normal none r=
unning zoomIn; vertical-align: baseline; line-height: 1.8em; font-size: 0.6=
em; text-align: center; top: -0.8em; }

.swim-lane#swim-lane-search .tabs a .counter.disabled, .swim-lane#swim-lane=
-search .tabs label .counter.disabled { background-color: rgb(196, 219, 182=
); animation: auto ease 0s 1 normal none running none; }

.swim-lane#swim-lane-search .tabs a .counter.injecting, .swim-lane#swim-lan=
e-search .tabs label .counter.injecting { opacity: 0; }

.swim-lane#swim-lane-search .tabs a .counter.injecting::before, .swim-lane#=
swim-lane-search .tabs label .counter.injecting::before { display: none; }

.touch .swim-lane#swim-lane-search .tabs { overflow: auto hidden; margin: 0=
px -15px; width: calc(100% + 30px); white-space: nowrap; }

.touch .swim-lane#swim-lane-search .tabs .extra-tabs { padding-right: 15px;=
 display: inline-block; }

.touch .swim-lane#swim-lane-search .tabs a, .touch .swim-lane#swim-lane-sea=
rch .tabs label { float: none; display: inline-block; margin: 0px; }

.no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs { border: 2px s=
olid rgba(0, 0, 0, 0); padding-top: 2.3em; display: inline-block; height: 0=
px; width: 2.4em; overflow: hidden; position: absolute; top: -6px; z-index:=
 1; transition: 0.3s; }

@media only screen and (max-width: 769px) {
  .no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs { right: 0px;=
 }
}

.no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs::before { font-=
family: fontello; content: "=EE=A1=8D"; background: rgb(57, 135, 12); line-=
height: 1.8em; text-align: center; position: absolute; right: 0.3em; top: 0=
.3em; height: 1.8em; width: 1.8em; color: rgb(225, 237, 219); border-radius=
: 50%; transition: 0.5s; }

.no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs:hover { border:=
 2px solid rgb(255, 255, 255); padding-bottom: 0.5em; margin-left: -17em; b=
ackground-color: rgb(225, 237, 219); height: auto; width: 22em; }

@media only screen and (max-width: 769px) {
  .no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs:hover { width=
: 100%; }
}

.no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs:hover::before {=
 color: rgb(0, 0, 0); background-color: rgb(196, 219, 182); transform: rota=
te(90deg); }

.no-touch .swim-lane#swim-lane-search .tabs span.extra-tabs a, .no-touch .s=
wim-lane#swim-lane-search .tabs span.extra-tabs label { display: block; flo=
at: none; padding: 0.3em 0.7em; margin: 0px; text-align: left; color: rgb(0=
, 0, 0); line-height: 1.6; overflow: hidden; text-overflow: ellipsis; white=
-space: nowrap; }

.swim-lane#swim-lane-search .options { float: right; position: absolute; ri=
ght: 15px; bottom: 0px; color: rgb(1, 104, 155); text-shadow: rgb(225, 237,=
 219) 0px 0px 10px, rgb(225, 237, 219) 0px 0px 10px, rgb(225, 237, 219) 0px=
 0px 10px, rgb(225, 237, 219) 0px 0px 10px, rgb(225, 237, 219) 0px 0px 10px=
, rgb(225, 237, 219) 0px 0px 10px, rgb(225, 237, 219) 0px 0px 10px; }

.swim-lane#swim-lane-search #breadcrumb { margin-bottom: 0.3384em; font-siz=
e: 0.8125em; padding-top: 10px; margin-top: 0px; }

@media only screen and (max-width: 769px) {
  .swim-lane#swim-lane-search #breadcrumb { display: none; }
}

.swim-lane#site-summary { background-color: rgb(255, 255, 255); }

.swim-lane#site-summary + #swim-lane-browser-warning .container, .swim-lane=
#site-summary + #partners .container, .swim-lane#site-summary + #news .cont=
ainer, .swim-lane#site-summary + #swim-lane-reports .container, .swim-lane#=
site-summary + #site-summary .container, .swim-lane#site-summary + #swim-la=
ne-quote .container, .swim-lane#site-summary + #swim-lane-secondary-tasks .=
container, .swim-lane#site-summary + #swim-lane-sectors .container, .swim-l=
ane#site-summary + #swim-lane-social .container { padding-top: 0px; }

@media only screen and (min-width: 1280px) {
  .swim-lane#site-summary .container .summary { width: 770px; }
}

.swim-lane#site-summary .container .summary p { font-size: 1.3125em; line-h=
eight: 1.5238; }

.swim-lane#site-summary .container .video-player { margin-top: 40px; }

@media only screen and (min-width: 1280px) {
  .swim-lane#site-summary .container .video-player { width: 770px; }
}

.swim-lane#swim-lane-quote { background-color: rgb(255, 255, 255); }

.swim-lane#swim-lane-quote + #swim-lane-browser-warning .container, .swim-l=
ane#swim-lane-quote + #partners .container, .swim-lane#swim-lane-quote + #n=
ews .container, .swim-lane#swim-lane-quote + #swim-lane-reports .container,=
 .swim-lane#swim-lane-quote + #site-summary .container, .swim-lane#swim-lan=
e-quote + #swim-lane-quote .container, .swim-lane#swim-lane-quote + #swim-l=
ane-secondary-tasks .container, .swim-lane#swim-lane-quote + #swim-lane-sec=
tors .container, .swim-lane#swim-lane-quote + #swim-lane-social .container =
{ padding-top: 0px; }

.swim-lane#swim-lane-quote .container .quote { font-size: 40px; line-height=
: 1.4; overflow-wrap: break-word; margin: 1.5em 0px; position: relative; bo=
rder: none; color: rgba(0, 0, 0, 0.5); font-family: "Palatino Linotype", "B=
ook Antiqua", Palatino, serif; font-style: italic; }

.swim-lane#swim-lane-quote .container .quote :last-child { margin: 0px; }

@media only screen and (min-width: 770px) {
  .swim-lane#swim-lane-quote .container .quote { padding: 0px 2.5em; }
  .swim-lane#swim-lane-quote .container .quote::before { content: "=E2=80=
=9C"; font-size: 4em; font-weight: bold; font-style: normal; position: abso=
lute; top: 0px; left: 0px; line-height: 0.85em; color: rgba(0, 0, 0, 0.2); =
}
}

.swim-lane#swim-lane-quote .container .quote .author { color: rgb(0, 0, 0);=
 margin-top: 0.7em; font-size: 0.7em; font-style: normal; }

.swim-lane#editorial-navigation { background: rgb(1, 104, 155); }

.swim-lane#editorial-navigation * { color: rgb(255, 255, 255); }

.swim-lane#editorial-navigation .container { padding-top: 50px; padding-bot=
tom: 15px; }

.swim-lane#partners + #swim-lane-browser-warning .container, .swim-lane#par=
tners + #partners .container, .swim-lane#partners + #news .container, .swim=
-lane#partners + #swim-lane-reports .container, .swim-lane#partners + #site=
-summary .container, .swim-lane#partners + #swim-lane-quote .container, .sw=
im-lane#partners + #swim-lane-secondary-tasks .container, .swim-lane#partne=
rs + #swim-lane-sectors .container, .swim-lane#partners + #swim-lane-social=
 .container { padding-top: 0px; }

.swim-lane#news + #swim-lane-browser-warning .container, .swim-lane#news + =
#partners .container, .swim-lane#news + #news .container, .swim-lane#news +=
 #swim-lane-reports .container, .swim-lane#news + #site-summary .container,=
 .swim-lane#news + #swim-lane-quote .container, .swim-lane#news + #swim-lan=
e-secondary-tasks .container, .swim-lane#news + #swim-lane-sectors .contain=
er, .swim-lane#news + #swim-lane-social .container { padding-top: 0px; }

.swim-lane#news .container .news-feed { margin-bottom: -30px; }

@keyframes bounce-memo {=20
  0% { background-position: right 0px; }
  50% { background-position: right 20px; }
  0% { background-position: right 0px; }
}

.swim-lane#home-hero { background-color: rgb(225, 237, 219); background-ima=
ge: url("drugs-money-3-cropped.jpg"); background-size: cover; background-po=
sition: center center; background-repeat: no-repeat; position: relative; }

.swim-lane#home-hero::before { content: ""; position: absolute; z-index: 10=
; bottom: 0.5rem; left: 0.5rem; margin: 0px; color: rgb(255, 255, 255); tex=
t-shadow: rgba(0, 0, 0, 0.5) 0px 0px 1px, rgba(0, 0, 0, 0.5) -1px 0px 1px, =
rgba(0, 0, 0, 0.5) 1px 0px 1px, rgba(0, 0, 0, 0.5) 0px -1px 1px, rgba(0, 0,=
 0, 0.5) 0px 1px 1px, rgba(0, 0, 0, 0.5) 2px 2px 6px; font-size: 0.888889re=
m; line-height: 1.125; display: block; opacity: 0.7; }

@media only screen and (max-width: 769px) {
  .swim-lane#home-hero { min-height: 2px; }
}

.swim-lane#home-hero .promo-block { font-size: 32px; opacity: 0; padding: 2=
5px 20% 25px 25px; animation: 0.2s ease 0.5s 1 normal forwards running fade=
InDown; overflow: hidden; background: rgb(255, 255, 255); grid-area: promo;=
 }

@media only screen and (min-width: 770px) {
  .swim-lane#home-hero .promo-block { background: url("checklist.jpg") righ=
t center / 33% no-repeat rgb(255, 255, 255); padding: 25px 20% 25px 25px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#home-hero .promo-block { padding: 25px; }
}

.swim-lane#home-hero .promo-block .button-bar { margin-bottom: 0px; margin-=
top: 30px; }

.swim-lane#home-hero .promo-block .button-bar .pat-button { margin: 0px; fl=
oat: left; padding: 5px 30px; }

.swim-lane#home-hero.has-top-promo:not(.has-top-task-push) .button-bar { ma=
rgin-top: 15px; }

.swim-lane#home-hero .container::before { display: none !important; }

.swim-lane#home-hero.has-top-task-push .container::after, .swim-lane#home-h=
ero.has-promo .container::after { display: none !important; }

.swim-lane#home-hero.has-top-tasks.has-top-task-push .promo-block { backgro=
und: rgb(255, 255, 255); padding-right: 25px; font-size: 24px; }

.swim-lane#home-hero.has-top-tasks.has-top-task-push .promo-block .button-b=
ar .pat-button { padding: 0px 25px; }

.swim-lane#home-hero .container { padding-top: 25px; position: relative; }

@media only screen and (min-width: 770px) {
  .swim-lane#home-hero .container { display: grid; justify-content: space-b=
etween; grid-template-areas: "top-tasks promo breaking-news"; opacity: 0; a=
lign-items: start; animation: 1s ease 0.5s 1 normal forwards running fadeIn=
; min-height: 200px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#home-hero .container { padding: 20px 15px 25px; }
}

.swim-lane#home-hero .container::after { display: none; }

.swim-lane#home-hero .nav-tiles * { color: rgb(255, 255, 255); }

.swim-lane#home-hero .top-task-push { padding: 25px; grid-area: breaking-ne=
ws; background-color: rgb(39, 89, 55); box-sizing: border-box; color: rgb(2=
55, 255, 255); }

.swim-lane#home-hero .top-task-push h2 { margin-top: 0px; color: rgb(255, 2=
55, 255); line-height: 1.2; }

.swim-lane#home-hero .top-task-push .button-bar { margin: 0px; }

.swim-lane#home-hero .top-task-push .button-bar .pat-button { text-decorati=
on: none; }

@media only screen and (min-width: 770px) {
  .swim-lane#home-hero .top-task-push { width: 390px; min-width: 390px; flo=
at: right; opacity: 0; animation: 0.2s ease 1s 1 normal forwards running fa=
deInDown; margin-left: 25px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#home-hero .top-task-push { margin-top: 1px; margin-bottom: 15p=
x; }
}

.swim-lane#home-hero .top-task-push .pat-rich a { color: rgb(255, 255, 255)=
; }

.swim-lane#home-hero .top-task-navigation { background: rgb(255, 255, 255);=
 padding: 25px; margin-bottom: 0px; grid-area: top-tasks; box-sizing: borde=
r-box; }

@media only screen and (min-width: 770px) {
  .swim-lane#home-hero .top-task-navigation { margin-left: -25px; width: 39=
0px; opacity: 0; animation: 0.2s ease 1.5s 1 normal forwards running fadeIn=
Down; margin-right: 25px; }
}

@media only screen and (max-width: 769px) {
  .swim-lane#home-hero .top-task-navigation { margin-bottom: 15px; }
}

.swim-lane#home-hero .top-task-navigation h2 { margin-bottom: 0.755em; line=
-height: 1.55rem; font-size: 1.625rem; font-weight: normal; }

.swim-lane#home-hero .top-task-navigation .link-list { margin: 0px; }

.swim-lane#home-hero .top-task-navigation .link-list li { margin-bottom: 5p=
x; }

.swim-lane#home-hero .top-task-navigation .link-list li a { font-weight: no=
rmal; font-size: 1.125rem; line-height: 1.625rem; overflow-wrap: break-word=
; text-decoration: none; }

.swim-lane#home-hero .top-task-navigation .link-list li a:hover { text-deco=
ration: underline; }

.social-list { font-size: 1.26562rem; line-height: 28px; }

.social-list li { margin-bottom: 1rem; }

.social-list li a { display: block; position: relative; padding-left: 33px;=
 }

.social-list li a:hover { text-decoration: underline; }

.social-list li a:hover::before { text-decoration: none; }

.social-list li a::before { position: absolute; display: block; font-family=
: fontello; font-weight: normal; -webkit-font-smoothing: antialiased; color=
: rgb(0, 0, 0); text-align: left; font-size: 30px; line-height: 26px; top: =
-1px; left: 0px; width: 26px; height: 26px; border-radius: 5px; overflow: h=
idden; }

.social-list li a.facebook::before { color: rgb(60, 81, 147); content: "=EF=
=8C=88"; }

.social-list li a.linkedin::before { color: rgb(0, 123, 182); content: "=EF=
=8C=8C"; }

.social-list li a.x::before { color: rgb(0, 0, 0); content: "=EE=A6=B8"; fo=
nt-size: 26px; }

.sortable-list { counter-reset: count 0; user-select: none; }

.sortable-list .sortable-item { counter-increment: count 1; padding: 4px 0p=
x; position: relative; margin: 0px 0px 0px 30px; }

.sortable-list .sortable-item:has(.field-cluster) { padding: 11px 0px; marg=
in-left: 40px; }

.sortable-list .sortable-item:has(.field-cluster) + .button-bar { margin-to=
p: 15px; }

.sortable-list .sortable-item:has(.field-cluster)::before, .sortable-list .=
sortable-item:has(.field-cluster) .sortable-handle { left: -40px; }

.sortable-list .sortable-item.dragged { opacity: 0.5; }

.sortable-list .sortable-item:not(.dragged) { animation: 1s ease 0s 1 norma=
l none running fadeIn; }

.sortable-list .sortable-item::after { display: block; opacity: 0; height: =
2px; content: " "; background: rgb(1, 104, 155); position: absolute; left: =
-15px; right: 15px; }

.sortable-list .sortable-item.drop-target-above::after, .sortable-list .sor=
table-item.drop-target-below::after { opacity: 1; }

.sortable-list .sortable-item.drop-target-above .sortable-handle, .sortable=
-list .sortable-item.drop-target-below .sortable-handle { margin-top: -24px=
; }

.sortable-list .sortable-item.drop-target-above::after { top: -1px; }

.sortable-list .sortable-item.drop-target-below::after { bottom: -1px; }

.sortable-list .sortable-item::before, .sortable-list .sortable-item .sorta=
ble-handle { content: counter(count); line-height: 1.7em; text-align: cente=
r; color: rgb(255, 255, 255); display: block; position: absolute; left: -30=
px; top: 4px; width: 1.8em; height: 1.6765em; background: rgb(225, 112, 0);=
 border-top-left-radius: 0px; border-bottom-left-radius: 0px; overflow: hid=
den; }

@media print {
  .sortable-list .sortable-item::before, .sortable-list .sortable-item .sor=
table-handle { background: rgba(0, 0, 0, 0); width: 1em; text-align: left; =
color: rgb(0, 0, 0); }
}

.sortable-list .sortable-item .button-cluster { display: none; }

.sortable-list .sortable-item .sortable-handle { opacity: 0; line-height: 1=
.9em; text-indent: -10em; background: rgb(225, 112, 0); cursor: grab; }

.sortable-list .sortable-item .sortable-handle:hover { background: rgb(174,=
 87, 0); }

.sortable-list .sortable-item .sortable-handle:active, .sortable-list .sort=
able-item .sortable-handle:focus { cursor: grabbing; }

.sortable-list .sortable-item .sortable-handle::before { content: "=EE=A3=
=95"; display: block; font-family: fontello; text-indent: 0.1em; top: 0px; =
left: 0px; width: 100%; line-height: 2.28em; text-align: center; font-size:=
 0.8em; }

.sortable-list .sortable-item:hover .sortable-handle { opacity: 1; }

.sortable-list .sortable-item:hover .sortable-handle:hover { text-decoratio=
n: none; }

.sortable-list .sortable-item:active .sortable-handle, .sortable-list .sort=
able-item:focus .sortable-handle { cursor: grabbing; }

:root { --table-avatar-height: 34px; }

.scroll-table, .tableWrapper { overflow: auto visible; clear: both; }

.scroll-table.scroll-vertical, .tableWrapper.scroll-vertical { overflow: au=
to; max-height: calc(-130px + 100vh); }

.scroll-table.scroll-vertical thead.sticky, .scroll-table.scroll-vertical t=
foot.sticky, .tableWrapper.scroll-vertical thead.sticky, .tableWrapper.scro=
ll-vertical tfoot.sticky { position: sticky; top: 0px; z-index: 10; }

table { border-bottom: 2px solid rgb(255, 255, 255); border-top: 2px solid =
rgb(255, 255, 255); border-left: 2px solid rgb(255, 255, 255); padding: 5px=
 10px; border-collapse: collapse; vertical-align: top; width: 100%; font-si=
ze: 1.125rem; hyphens: auto; }

.mode-select table { user-select: none; }

table .tableWrapper { display: none !important; }

table ins { background-color: rgb(152, 251, 152); text-decoration: none; }

table del { background-color: pink; }

table abbr { text-decoration: none; }

table caption { padding-left: 0px; margin: 1em 0px; color: rgb(0, 0, 0); li=
ne-height: 1.5; text-align: left; font-weight: bold; }

table .status-marker { font-weight: normal; display: inline-block; backgrou=
nd: rgb(255, 255, 255); box-shadow: rgba(0, 0, 0, 0.4) 0px 0px 0px 1px inse=
t; border-radius: 20px; padding: 0px 0.8rem; margin-left: 0.2rem; font-styl=
e: normal; text-decoration: none; }

table .status-marker.warning { color: rgb(251, 234, 217); }

table.data-table { width: auto; table-layout: fixed; }

.variation-medicine-compare-versions ~ #main table.data-table { width: auto=
; }

table.data-table th, table.data-table td { border: none; position: relative=
; animation: 1s ease 0s 1 normal none running fadeIn; padding-bottom: 12px;=
 }

table.data-table th a[href]:hover, table.data-table td a[href]:hover { text=
-decoration: underline; }

table.data-table th a[href]:hover::before, table.data-table td a[href]:hove=
r::before { text-decoration: none; }

table.data-table th.injecting::before, table.data-table td.injecting::befor=
e { z-index: 1; }

table.data-table th:not(:last-child)::after, table.data-table td:not(:last-=
child)::after { display: block; content: " "; width: 2px; height: 100%; bac=
kground: rgb(255, 255, 255); position: absolute; top: 0px; right: 0px; bott=
om: 0px; }

table.data-table th::before, table.data-table td::before { display: block; =
content: " "; height: 2px; width: 100%; background: rgb(255, 255, 255); pos=
ition: absolute; left: 0px; bottom: 0px; }

table.data-table tr#title-header th { background: rgb(255, 255, 255); left:=
 15px; position: sticky; height: 100px; padding-left: 0px; z-index: 10; }

table.data-table tr#title-header td { background: rgba(0, 0, 0, 0); }

table.data-table thead.sticky, table.data-table tfoot.sticky { position: st=
icky; top: 0px; z-index: 10; }

table.data-table tfoot.sticky { bottom: -1px; margin-bottom: 0px; border-bo=
ttom: 0px; }

table.data-table tr#version-headers th { background: rgba(255, 255, 255, 0.=
7); backdrop-filter: blur(6px) saturate(3); position: sticky; top: 70px; te=
xt-align: center; }

table.data-table tr#version-headers th.version-header { z-index: 9; }

table.data-table tr#version-headers th.fieldname-header { color: rgba(0, 0,=
 0, 0); background: rgb(255, 255, 255); left: 0px; z-index: 10; min-width: =
280px; }

table.data-table tr#version-headers th .version-details { min-width: 360px;=
 padding-left: 56px; position: relative; }

table.data-table tr#version-headers th .version-details .pat-avatar { posit=
ion: absolute; left: 0px; top: 3px; aspect-ratio: 1 / 1; height: 45px; z-in=
dex: 1; background-color: rgb(239, 239, 239); background-size: cover; }

table.data-table tr#version-headers th .version-details .meta[href]:hover .=
user-name { text-decoration: underline; }

table.data-table tr#version-headers th .version-details .save-message { fon=
t-size: 16px; color: gray; line-height: 1.4; font-weight: normal; margin-bo=
ttom: 5px; }

table.data-table tr#version-headers th .version-details .user-name { paddin=
g-top: 0px; display: block; }

table.data-table tr#version-headers th .version-details.user-inactive .meta=
 { color: gray; }

table.data-table tr#version-headers th .version-details.user-inactive .meta=
 .pat-avatar { filter: grayscale(100%) brightness(200%) contrast(40%); }

table.data-table tr#version-headers th .version-details .byline { padding-b=
ottom: 6px; margin-bottom: 0px; font-weight: normal; }

table.data-table tr#version-headers th .version-details .byline a.date { co=
lor: rgb(0, 0, 0) !important; text-decoration: none !important; cursor: def=
ault !important; }

table.data-table tr#version-headers th .version-details .byline .byline-ite=
m { display: inline-block; font-size: 16px; line-height: 20px; font-weight:=
 normal; border-left: 1px solid rgb(83, 83, 83); padding: 0px 0.5em; }

table.data-table tr#version-headers th .version-details .byline .byline-ite=
m:first-child { padding-left: 0px; border-left: none; }

table.data-table tr#version-headers th .version-details .byline a, table.da=
ta-table tr#version-headers th .version-details .byline button.link { curso=
r: pointer; text-decoration: none; }

table.data-table tr#version-headers th .version-details .byline a[href]:hov=
er, table.data-table tr#version-headers th .version-details .byline button.=
link[href]:hover { text-decoration: underline; color: rgb(1, 104, 155); }

table.data-table tr#version-headers th .version-details .byline * { font-st=
yle: normal; }

table.data-table tr#location-headers th { background: rgba(255, 255, 255, 0=
.7); backdrop-filter: blur(6px) saturate(3); position: sticky; top: 70px; t=
ext-align: center; z-index: 10; }

table.data-table tr#location-headers th.version-header { z-index: 9; }

table.data-table tr#location-headers th.fieldname-header { color: rgba(0, 0=
, 0, 0); background: rgb(255, 255, 255); left: 0px; z-index: 10; min-width:=
 280px; }

table.data-table tr#location-headers th .location-details { min-width: 360p=
x; padding-left: 0px; position: relative; font-size: 25px; font-weight: nor=
mal; }

table.data-table tr#location-headers th .load-extra-column-trigger { positi=
on: absolute; opacity: 0; z-index: -1000; }

table.data-table tfoot th { position: sticky; left: 0px; z-index: 9; }

table.data-table tbody th { width: 310px; position: sticky; left: 0px; z-in=
dex: 9; background: rgb(230, 230, 230); }

table tr { width: 100%; }

table tr.content-type-prozin-landing-toc .item-name a, table tr.folder .ite=
m-name a { padding-left: 30px !important; position: relative; }

.mode-select table tr.content-type-prozin-landing-toc .item-name a, .mode-s=
elect table tr.folder .item-name a { pointer-events: none; }

table tr.content-type-prozin-landing-toc .item-name a::before, table tr.fol=
der .item-name a::before { position: absolute; left: 8px; display: inline-b=
lock; margin-right: 5px; font-family: fontello; content: "=EE=A0=B6"; }

table tr.state-draft th, table tr.state-draft th a { color: rgb(225, 112, 0=
); }

table tr.state-archived th a, table tr.state-inactive th a { opacity: 0.5; =
filter: grayscale(1); }

table tr.mutated th, table tr.has-differences th { background: rgba(255, 10=
0, 0, 0.2); }

table tr.mutated td, table tr.has-differences td { background: rgba(255, 10=
0, 0, 0.1); }

table tr.has-mutations td:last-child { position: relative; padding-right: 2=
5px; }

table tr.has-mutations td:last-child::after { position: absolute; top: 50%;=
 right: 15px; transform: translateY(-50%); content: " "; width: 10px; heigh=
t: 10px; overflow: hidden; border: 2px solid rgb(255, 255, 255); padding: 0=
px; border-radius: 50%; background: linear-gradient(rgb(143, 202, 231) 0%, =
rgb(0, 123, 199) 100%); display: inline-block; margin-top: 0px; color: rgba=
(0, 0, 0, 0) !important; }

table tr td, table tr th { padding: 10px 15px; border-collapse: collapse; v=
ertical-align: top; border-right: 2px solid rgb(255, 255, 255); border-bott=
om: 2px solid rgb(255, 255, 255); background-color: rgba(0, 0, 0, 0.05); }

table tr td.item-name, table tr td.item-state, table tr th.item-name, table=
 tr th.item-state { padding: 0px; overflow: hidden; }

table tr td.item-name a, table tr td.item-state a, table tr th.item-name a,=
 table tr th.item-state a { padding: 10px 15px; display: flex; justify-cont=
ent: space-between; }

table tr td.item-name a:has(.avatar), table tr td.item-state a:has(.avatar)=
, table tr th.item-name a:has(.avatar), table tr th.item-state a:has(.avata=
r) { display: grid; grid-template-columns: calc(var(--table-avatar-height) =
+ 6px) auto auto; grid-template-areas: "avatar label markers"; align-items:=
 center; justify-content: initial; }

table tr td.item-name a:has(.avatar) .avatar, table tr td.item-state a:has(=
.avatar) .avatar, table tr th.item-name a:has(.avatar) .avatar, table tr th=
.item-state a:has(.avatar) .avatar { grid-area: avatar; margin: -6px 20% -6=
px 0px; justify-self: end; height: var(--table-avatar-height); width: auto;=
 object-fit: cover; }

table tr td.item-name a:has(.avatar) .label, table tr td.item-state a:has(.=
avatar) .label, table tr th.item-name a:has(.avatar) .label, table tr th.it=
em-state a:has(.avatar) .label { grid-area: label; justify-self: start; }

table tr td.item-name a:has(.avatar) .markers, table tr td.item-state a:has=
(.avatar) .markers, table tr th.item-name a:has(.avatar) .markers, table tr=
 th.item-state a:has(.avatar) .markers { justify-self: end; grid-area: mark=
ers; }

table tr td.item-name a:has(.node), table tr td.item-state a:has(.node), ta=
ble tr th.item-name a:has(.node), table tr th.item-state a:has(.node) { dis=
play: flex; }

table tr td.item-name a:has(.node):hover, table tr td.item-state a:has(.nod=
e):hover, table tr th.item-name a:has(.node):hover, table tr th.item-state =
a:has(.node):hover { text-decoration: none; }

table tr td.item-name a:has(.node):hover .node, table tr td.item-state a:ha=
s(.node):hover .node, table tr th.item-name a:has(.node):hover .node, table=
 tr th.item-state a:has(.node):hover .node { text-decoration: underline; }

table tr td.item-name a .node, table tr td.item-state a .node, table tr th.=
item-name a .node, table tr th.item-state a .node { display: inline; vertic=
al-align: middle; }

table tr td.item-name a .node.folder, table tr td.item-state a .node.folder=
, table tr th.item-name a .node.folder, table tr th.item-state a .node.fold=
er { padding-left: 20px; overflow: hidden; text-overflow: ellipsis; positio=
n: relative; display: inline-block; float: left; max-width: 100%; }

table tr td.item-name a .node.folder:not(:last-of-type)::after, table tr td=
.item-state a .node.folder:not(:last-of-type)::after, table tr th.item-name=
 a .node.folder:not(:last-of-type)::after, table tr th.item-state a .node.f=
older:not(:last-of-type)::after { content: "=EF=80=86"; display: inline-blo=
ck; width: 20px; font-family: fontello; text-align: center; font-size: 0.8r=
em; font-weight: normal; }

table tr td.item-name a .node.folder::before, table tr td.item-state a .nod=
e.folder::before, table tr th.item-name a .node.folder::before, table tr th=
.item-state a .node.folder::before { position: absolute; left: 0px; display=
: inline-block; font-family: fontello; content: "=EE=A0=B6"; font-weight: n=
ormal; }

table tr td.item-name a .addition::before, table tr td.item-state a .additi=
on::before, table tr th.item-name a .addition::before, table tr th.item-sta=
te a .addition::before { content: ", "; }

table tr td.item-name a .byline, table tr td.item-state a .byline, table tr=
 th.item-name a .byline, table tr th.item-state a .byline { color: rgba(0, =
0, 0, 0.7); font-size: 0.8em; display: block; line-height: 1.3; margin-top:=
 2px; margin-bottom: 3px; font-weight: normal; }

table tr td.item-name a[href]:hover, table tr td.item-state a[href]:hover, =
table tr th.item-name a[href]:hover, table tr th.item-state a[href]:hover {=
 text-decoration: underline; }

table tr td.item-name a[href]:hover:has(.link-title), table tr td.item-stat=
e a[href]:hover:has(.link-title), table tr th.item-name a[href]:hover:has(.=
link-title), table tr th.item-state a[href]:hover:has(.link-title) { text-d=
ecoration: none; }

table tr td.item-name a[href]:hover:has(.link-title) .link-title, table tr =
td.item-state a[href]:hover:has(.link-title) .link-title, table tr th.item-=
name a[href]:hover:has(.link-title) .link-title, table tr th.item-state a[h=
ref]:hover:has(.link-title) .link-title { text-decoration: underline; }

table tr td.item-name a[href]:hover:has(.link-title) .link-title:has(.bylin=
e), table tr td.item-state a[href]:hover:has(.link-title) .link-title:has(.=
byline), table tr th.item-name a[href]:hover:has(.link-title) .link-title:h=
as(.byline), table tr th.item-state a[href]:hover:has(.link-title) .link-ti=
tle:has(.byline) { text-decoration: none; }

table tr td.item-name a[href]:hover:has(.link-title) .link-title:has(.bylin=
e) .title, table tr td.item-state a[href]:hover:has(.link-title) .link-titl=
e:has(.byline) .title, table tr th.item-name a[href]:hover:has(.link-title)=
 .link-title:has(.byline) .title, table tr th.item-state a[href]:hover:has(=
.link-title) .link-title:has(.byline) .title { text-decoration: underline; =
}

table tr td.item-name a .classification-tags, table tr td.item-state a .cla=
ssification-tags, table tr th.item-name a .classification-tags, table tr th=
.item-state a .classification-tags { line-height: 19px; }

table tr td.select, table tr th.select { width: 0px; box-sizing: border-box=
; overflow: hidden; transition: width 1s, border 1s; border-left: 0px solid=
 rgb(255, 255, 255); border-right: 0px solid rgb(255, 255, 255); position: =
relative; user-select: none; padding: 0px !important; }

table tr td.select:hover, table tr th.select:hover { background-color: rgb(=
219, 219, 219); }

table tr td.select label, table tr th.select label { width: 100%; height: 1=
00%; overflow: hidden; display: grid; grid-template-columns: var(--pat-chec=
klist-label-padding-start) auto; grid-template-areas: "icon label" ". descr=
iption"; align-items: start; padding-right: var(--pat-checklist-label-paddi=
ng-end); user-select: none; line-height: var(--pat-checklist-line-height); =
position: absolute; inset: 0px; color: rgba(0, 0, 0, 0); box-sizing: border=
-box; }

body[dir=3D"rtl"] table tr td.select label, body[dir=3D"rtl"] table tr th.s=
elect label { padding-left: var(--pat-checklist-label-padding-end); }

table tr td.select label > *, table tr th.select label > * { grid-area: lab=
el; }

table tr td.select label:has(:focus)::before, table tr th.select label:has(=
:focus)::before { outline: var(--pat-form-input-field-outline-focus); outli=
ne-offset: var(--pat-form-input-field-outline-offset); }

table tr td.select label:has(input[type=3D"checkbox"])::before, table tr td=
.select label:has(input[type=3D"radio"])::before, table tr th.select label:=
has(input[type=3D"checkbox"])::before, table tr th.select label:has(input[t=
ype=3D"radio"])::before { box-shadow: var(--pat-checklist-checkbox-box-shad=
ow); content: ""; font-weight: normal; background-color: var(--pat-checklis=
t-checkbox-background-colour); font-size: 0px; text-align: center; height: =
var(--pat-checklist-checkbox-size); width: var(--pat-checklist-checkbox-siz=
e); line-height: var(--pat-checklist-checkbox-size); border-radius: var(--p=
at-checklist-checkbox-border-radius); justify-self: start; grid-area: icon;=
 position: relative; top: var(--pat-checklist-checkbox-vertical-position); =
transform: translateY(-50%); transition: 0.2s ease-out; }

table tr td.select label:has(input[type=3D"radio"])::before, table tr th.se=
lect label:has(input[type=3D"radio"])::before { border-radius: 50%; }

table tr td.select label:has(input:checked)::before, table tr th.select lab=
el:has(input:checked)::before { background-color: var(--pat-checklist-check=
box-background-colour-checked); box-shadow: var(--pat-checklist-checkbox-bo=
x-shadow-checked); color: rgb(255, 255, 255); font-family: fontello; conten=
t: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-checkbox-size)); }

table tr td.select label:has([disabled]):has(input[type=3D"checkbox"])::bef=
ore, table tr td.select label:has([disabled]):has(input[type=3D"radio"])::b=
efore, table tr td.select label:has([disabled]) .label-fragment-description=
:has(input[type=3D"checkbox"])::before, table tr td.select label:has([disab=
led]) .label-fragment-description:has(input[type=3D"radio"])::before, table=
 tr th.select label:has([disabled]):has(input[type=3D"checkbox"])::before, =
table tr th.select label:has([disabled]):has(input[type=3D"radio"])::before=
, table tr th.select label:has([disabled]) .label-fragment-description:has(=
input[type=3D"checkbox"])::before, table tr th.select label:has([disabled])=
 .label-fragment-description:has(input[type=3D"radio"])::before { backgroun=
d-color: rgba(0, 0, 0, 0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

table tr td.select label .label-fragment-title, table tr th.select label .l=
abel-fragment-title { margin: 0px 0px 0px -30px; padding-left: 30px; }

table tr td.select label .label-fragment-description, table tr th.select la=
bel .label-fragment-description { margin: 5px 0px 12px; color: rgba(0, 0, 0=
, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: description; }

table tr td.select label .label-fragment-description > *, table tr th.selec=
t label .label-fragment-description > * { color: rgb(0, 0, 0); }

table tr td.select label input[type=3D"checkbox"], table tr td.select label=
 input[type=3D"radio"], table tr th.select label input[type=3D"checkbox"], =
table tr th.select label input[type=3D"radio"] { opacity: 0; position: abso=
lute; left: 0px; width: 0px; margin-top: 0.6px; }

table tr td.select label::before, table tr th.select label::before { positi=
on: absolute; color: rgb(0, 0, 0); top: 50% !important; left: 50% !importan=
t; transform: translate(-50%, -50%) !important; }

#product-space.mode-select table tr td.select, #product-space.mode-select t=
able tr th.select { width: 32px; border-right: 2px solid rgb(255, 255, 255)=
; }

table tr td a[href]:hover, table tr th a[href]:hover { text-decoration: und=
erline; }

table tr td.workflow-change, table tr th.workflow-change { width: 50px; max=
-width: 50px; font-size: 0px; background-color: rgb(217, 237, 247) !importa=
nt; }

table tr td.workflow-change::before, table tr th.workflow-change::before { =
display: none; }

table tr td.workflow-change .workflow-change-title, table tr th.workflow-ch=
ange .workflow-change-title { position: absolute; top: -7px; left: -15px; t=
ransform: rotate(90deg); transform-origin: left bottom; font-size: 40px; wi=
dth: calc(-140px + 100vh); text-align: left; line-height: 78px; height: 78p=
x; color: rgba(0, 0, 0, 0.5); display: block; background: rgb(217, 237, 247=
); padding-left: 15px; font-weight: normal; overflow: hidden; text-overflow=
: ellipsis; white-space: nowrap; }

table tr td > :last-child, table tr th > :last-child { margin-bottom: 0px; =
}

@media only screen and (max-width: 769px) {
  table tr td, table tr th { hyphens: auto; padding: 5px 10px; }
}

table tr td.injecting > p, table tr th.injecting > p { opacity: 0.5; }

table tr td.injecting .suggested-content > *, table tr th.injecting .sugges=
ted-content > * { opacity: 0.5; }

table tr td.injecting .suggested-content::before, table tr th.injecting .su=
ggested-content::before { position: absolute; top: 50%; left: 50%; content:=
 "=EF=84=A6"; width: 50px; height: 50px; margin-top: -25px; margin-left: -2=
5px; z-index: 1000; font: 50px / 50px fontello; text-shadow: rgb(255, 255, =
255) 0px 0px 2px; text-align: center; opacity: 0; animation: 2s linear 0s i=
nfinite normal none running spin, 1s linear 1s 1 normal forwards running fa=
deIn; }

table tr td .suggested-content, table tr th .suggested-content { margin-bot=
tom: 5px; margin-top: 10px; background-color: rgb(217, 237, 247); position:=
 relative; }

table tr td .suggested-content p.buttons, table tr th .suggested-content p.=
buttons { margin-top: 5px; }

table tr td .suggested-content p.buttons button, table tr th .suggested-con=
tent p.buttons button { margin-right: 5px; }

table tr td p.contribution, table tr th p.contribution { font-size: 0.8em; =
line-height: 1.4; color: rgb(225, 112, 0); font-weight: bold; margin-bottom=
: 0px; }

table tr td .pat-button, table tr th .pat-button { padding: 0px 0.5em; line=
-height: 1.2em; }

table tr td.symbol, table tr th.symbol { text-align: center; }

table tr td.indicator-inid, table tr th.indicator-inid { width: 90px; }

table tr td.date-compact, table tr th.date-compact { width: 100px; }

table tr td.item-date, table tr td.date, table tr th.item-date, table tr th=
.date { white-space: nowrap; }

table tr td.indicator-order, table tr td.indicator-number, table tr th.indi=
cator-order, table tr th.indicator-number { width: 50px; }

table tr td.dataSpiegel, table tr th.dataSpiegel { color: red; }

table tr td.totaal, table tr th.totaal { font-weight: bold; background-colo=
r: rgb(229, 240, 249); }

table tr td.l, table tr th.l { text-align: left; }

table tr td.r, table tr th.r { text-align: right; }

table tr td .tekstBold, table tr th .tekstBold { font-weight: bold; }

table tr td.kop, table tr th.kop { font-weight: bold; background-color: rgb=
(230, 230, 230); }

table tr td.large, table tr th.large { width: 6em; min-width: 6em; max-widt=
h: 6em; }

table tr td.medium, table tr th.medium { width: 5.5em; min-width: 5.5em; ma=
x-width: 5.5em; }

table tr td.small, table tr th.small { width: 4em; min-width: 4em; max-widt=
h: 4em; }

table tr td.remarks, table tr th.remarks { background-color: rgba(0, 0, 0, =
0); padding-bottom: 13px; font-size: 0.9em; }

table tr td.remarks::after, table tr th.remarks::after { display: none; }

table tr td.active-substance, table tr td.active-ingredient, table tr th.ac=
tive-substance, table tr th.active-ingredient { width: 25%; }

table tr td.medicine, table tr th.medicine { width: 25%; }

table tr td.medicine-group, table tr th.medicine-group { width: 25%; }

table tr td.application, table tr th.application { width: 25%; }

table tr td.strength, table tr th.strength { width: 25%; }

table tr td.icon, table tr th.icon { width: 1em; padding-left: 0.2em; paddi=
ng-right: 0px; }

table tr td.icon .iconified.pat-tooltip, table tr th.icon .iconified.pat-to=
oltip { color: rgb(1, 104, 155); cursor: pointer; margin-bottom: -2px; }

table tr td.price, table tr th.price { white-space: nowrap; width: 5em; }

table tr td.cost, table tr th.cost { white-space: nowrap; width: 2em; }

table tr td.k-label, table tr th.k-label { font-weight: bold; width: 25%; }

table tr th label { display: grid; grid-template-areas: "icon label" ". des=
cription"; align-items: start; user-select: none; line-height: var(--pat-ch=
ecklist-line-height); padding: 0px; color: rgba(0, 0, 0, 0); box-sizing: bo=
rder-box; transition: grid 0.2s; overflow: hidden; grid-template-columns: 0=
px auto; }

body[dir=3D"rtl"] table tr th label { padding-left: var(--pat-checklist-lab=
el-padding-end); }

table tr th label > * { grid-area: label; }

table tr th label:has(:focus)::before { outline: var(--pat-form-input-field=
-outline-focus); outline-offset: var(--pat-form-input-field-outline-offset)=
; }

table tr th label:has(input[type=3D"checkbox"])::before, table tr th label:=
has(input[type=3D"radio"])::before { box-shadow: var(--pat-checklist-checkb=
ox-box-shadow); content: ""; font-weight: normal; background-color: var(--p=
at-checklist-checkbox-background-colour); font-size: 0px; text-align: cente=
r; height: var(--pat-checklist-checkbox-size); width: var(--pat-checklist-c=
heckbox-size); line-height: var(--pat-checklist-checkbox-size); border-radi=
us: var(--pat-checklist-checkbox-border-radius); justify-self: start; grid-=
area: icon; position: relative; top: var(--pat-checklist-checkbox-vertical-=
position); transform: translateY(-50%); transition: 0.2s ease-out; }

table tr th label:has(input[type=3D"radio"])::before { border-radius: 50%; =
}

table tr th label:has(input:checked)::before { background-color: var(--pat-=
checklist-checkbox-background-colour-checked); box-shadow: var(--pat-checkl=
ist-checkbox-box-shadow-checked); color: rgb(255, 255, 255); font-family: f=
ontello; content: "=EE=A4=8E"; font-size: calc(.7*var(--pat-checklist-check=
box-size)); }

table tr th label:has([disabled]):has(input[type=3D"checkbox"])::before, ta=
ble tr th label:has([disabled]):has(input[type=3D"radio"])::before, table t=
r th label:has([disabled]) .label-fragment-description:has(input[type=3D"ch=
eckbox"])::before, table tr th label:has([disabled]) .label-fragment-descri=
ption:has(input[type=3D"radio"])::before { background-color: rgba(0, 0, 0, =
0.2); color: rgba(0, 0, 0, 0.3); box-shadow: none; }

table tr th label .label-fragment-title { margin: 0px 0px 0px -30px; paddin=
g-left: 30px; }

table tr th label .label-fragment-description { margin: 5px 0px 12px; color=
: rgba(0, 0, 0, 0.7); font-size: 0.9em; line-height: 1.4; grid-area: descri=
ption; }

table tr th label .label-fragment-description > * { color: rgb(0, 0, 0); }

table tr th label input[type=3D"checkbox"], table tr th label input[type=3D=
"radio"] { opacity: 0; position: absolute; left: 0px; width: 0px; margin-to=
p: 0.6px; }

table tr th label input { position: absolute; opacity: 0; }

.mode-select table tr th label { grid-template-columns: 20px auto; }

.mode-select table tr th label:hover { background-color: rgb(219, 219, 219)=
; }

.mode-select table tr th label a { pointer-events: none; }

table tr th label::before { position: absolute; --pat-checklist-checkbox-ve=
rtical-position: 15px; color: rgb(0, 0, 0); opacity: 0; transition: 1s; lef=
t: -5px !important; transform: translate(-50%, -50%) !important; margin-top=
: 0px !important; }

.mode-select table tr th label::before { opacity: 1; left: 15px !important;=
 }

table tr td.no-width { width: auto; min-width: auto; max-width: none; }

table tr td.functions { width: 1px; vertical-align: middle; white-space: no=
wrap; padding: 0px !important; }

table tr td.functions a { padding: 10px 15px; margin: 0px; display: inline-=
block; }

table tr td.functions a.icon { margin: 0px; padding: 0px; float: left; widt=
h: 47px; height: 47px; overflow: hidden; color: rgba(0, 0, 0, 0); cursor: d=
efault; text-decoration: none; }

table tr td.functions a.icon:hover { background-color: rgb(237, 237, 237); =
}

table tr td.functions a.icon::before { display: block; line-height: 47px; w=
idth: 100%; text-align: center; color: rgb(1, 104, 155); margin: 0px; }

table tr td.functions a.icon.tooltip-active-click { background-color: rgb(2=
25, 112, 0); border-radius: 0px; }

table tr td.functions a.icon.tooltip-active-click::before { color: rgb(255,=
 255, 255); }

table tr td.functions a.icon:first-child { margin: 0px; }

table tr td.item-state { vertical-align: middle; white-space: nowrap; paddi=
ng: 0px !important; }

table tr td.item-state a { color: rgb(0, 0, 0); text-decoration: none; }

table tr td.item-state a:hover { text-decoration: none; }

table tr td.item-state a.pat-select { background-color: rgb(242, 242, 242);=
 color: rgb(0, 0, 0); cursor: default; display: block; padding-right: 35px;=
 height: auto; line-height: inherit; font-size: inherit; --pat-select-box-b=
ox-shadow: none; --pat-select-box-height: inherit; --pat-select-box-arrow-b=
ackground-colour: transparent; }

table tr td.item-state a.pat-select:hover { background-color: rgb(237, 237,=
 237); text-decoration: none; }

table tr td.item-state a.pat-select.state-draft { background-color: rgb(251=
, 234, 217); color: rgb(123, 61, 0); }

table tr td.item-state a.pat-select.state-draft:hover, table tr td.item-sta=
te a.pat-select.state-draft.tooltip-active-click { background-color: rgb(24=
9, 221, 194); }

table tr td.item-state a.pat-select.state-for-review { background-color: rg=
b(227, 220, 231); color: rgb(66, 20, 95); }

table tr td.item-state a.pat-select.state-for-review:hover, table tr td.ite=
m-state a.pat-select.state-for-review.tooltip-active-click { background-col=
or: rgb(215, 205, 221); }

table tr td.item-state a.pat-select.state-sent, table tr td.item-state a.pa=
t-select.state-published { background-color: rgb(229, 240, 249); color: rgb=
(1, 70, 104); }

table tr td.item-state a.pat-select.state-sent:hover, table tr td.item-stat=
e a.pat-select.state-sent.tooltip-active-click, table tr td.item-state a.pa=
t-select.state-published:hover, table tr td.item-state a.pat-select.state-p=
ublished.tooltip-active-click { background-color: rgb(208, 228, 244); }

table tr td.item-state a.pat-select.state-approved { background-color: rgb(=
225, 237, 219); color: rgb(43, 103, 9); }

table tr td.item-state a.pat-select.state-approved:hover, table tr td.item-=
state a.pat-select.state-approved.tooltip-active-click { background-color: =
rgb(211, 229, 202); }

@media only screen and (min-width: 770px) {
  table tbody td:not(.separation-cell), table tbody th:not(.separation-cell=
) { vertical-align: top; }
}

table tbody td:not(.separation-cell) .table-body-title, table tbody th:not(=
.separation-cell) .table-body-title { display: block; padding-top: 1.5em; f=
ont-weight: bold; font-size: 1.125em; line-height: 1.4444; }

table tbody th { width: 33%; position: sticky; left: 0px; z-index: 9; backg=
round: rgba(0, 0, 0, 0.09); }

table tbody th.section-header { background: linear-gradient(to right, rgb(2=
55, 255, 255) 0%, rgba(255, 255, 255, 0) 500%); text-shadow: rgb(255, 255, =
255) 0px 0px 20px; padding-left: 0px; left: 15px; z-index: 8; }

table tbody th.section-header h2 { margin: 20px 0px 0px; }

table tbody th.section-header .byline { font-weight: normal; }

table tbody tr.header-row th, table tbody tr.header-row td { background: rg=
ba(0, 0, 0, 0); }

table tbody tr.header-row th::after, table tbody tr.header-row td::after { =
display: none; }

table tbody tr.header-row th .table-body-title, table tbody tr.header-row t=
d .table-body-title { padding-top: 1.5em; }

table tbody tr.header-row th .table-body-title a, table tbody tr.header-row=
 td .table-body-title a { text-overflow: ellipsis; overflow: hidden; }

table tbody tr.header-row:first-child .header-cell .table-body-title { padd=
ing-top: 13px; }

table tbody .separation-cell { vertical-align: bottom; padding-top: 1.5em; =
background-color: rgba(0, 0, 0, 0); }

table tbody tr.header-row + .separation-row .separation-cell { padding-top:=
 0px; }

table thead th { vertical-align: bottom; text-align: center; hyphens: none;=
 position: relative; }

table thead th .select-all-items { padding: 0px; z-index: 2; width: 31px; p=
osition: absolute; left: 0px; top: 0px; bottom: 0px; }

table thead th .select-all-items::before { top: 16px !important; }

table thead th.spacer-cell { position: sticky; left: 0px; z-index: 9; }

table thead th a.sorting, table thead th a.sorting_asc, table thead th a.so=
rting-asc, table thead th a.sorting_desc, table thead th a.sorting-desc { p=
osition: relative; padding-right: 30px; top: 0px; }

table thead th a.sorting:focus, table thead th a.sorting_asc:focus, table t=
head th a.sorting-asc:focus, table thead th a.sorting_desc:focus, table the=
ad th a.sorting-desc:focus { outline: none; cursor: default; }

table thead th a.sorting::after, table thead th a.sorting_asc::after, table=
 thead th a.sorting-asc::after, table thead th a.sorting_desc::after, table=
 thead th a.sorting-desc::after { font-family: fontello; position: absolute=
; top: 50%; right: 0.5em; display: block; width: 30px; height: 30px; line-h=
eight: 30px; text-align: right; transform: translateY(-50%); }

table thead th a.sorting_asc::after, table thead th a.sorting-asc::after { =
content: "=EE=A0=9D"; }

table thead th a.sorting_desc::after, table thead th a.sorting-desc::after =
{ content: "=EE=A0=9E"; }

table thead th a.sorting { display: block; color: rgb(0, 0, 0); cursor: def=
ault; padding: 5px 20px 5px 10px; margin: -5px -10px; }

@media only screen and (min-width: 770px) {
  table { padding: 10px 15px; line-height: 1.5; --pat-checklist-line-height=
: 1.5; }
}

table.table, table.scroll-table { overflow: auto visible; display: block; p=
adding: 0px; }

table.side-effects-table th::first-letter, table.side-effects-table td::fir=
st-letter, table.side-effects-table .table-body-title::first-letter { text-=
transform: capitalize; }

table.side-effects-table tbody:first-of-type tr.header-row:first-child .hea=
der-cell .table-body-title { padding-top: 0px; }

table.side-effects-table tbody tr.separation-row th.separation-cell { paddi=
ng: 20px 0px 0px; font-weight: bold; }

#bijwerkingen table.side-effects-table tbody tr.frequency-0 td, #bijwerking=
en table.side-effects-table tbody tr.frequency-0 th { background: rgba(0, 0=
, 0, 0); }

#bijwerkingen table.side-effects-table tbody tr.frequency-0 th.side-effect-=
name { padding: 0px 0px 0px 22px; }

#bijwerkingen table.side-effects-table tbody tr.frequency-0 th.side-effect-=
name::before { content: "=E2=80=A2"; margin-left: -22px; font-size: 1em; wi=
dth: 22px; float: left; }

table.side-effects-table .side-effect-name { font-style: normal; font-weigh=
t: normal; }

table.side-effects-table .frequency { text-align: center; vertical-align: m=
iddle; width: 100px; }

table.side-effects-table .frequency-2 .frequency { background-color: rgb(22=
8, 194, 191); }

table.side-effects-table .frequency-3 .frequency { background-color: rgb(22=
2, 138, 131); }

table.side-effects-table .frequency-4 .frequency { background-color: rgb(21=
7, 82, 71); color: rgb(255, 255, 255); }

table.side-effects-table .frequency-5 .frequency { background-color: rgb(21=
3, 43, 30); color: rgb(255, 255, 255); }

table.side-effects-table .bars .frequency { background-color: rgb(243, 243,=
 243); color: rgba(0, 0, 0, 0); width: 95px; }

table.side-effects-table .bars .frequency .frequency-indicator { width: 100=
%; height: 12px; margin-top: 8px; display: block; background: linear-gradie=
nt(to right, rgb(249, 225, 30) 0%, rgb(213, 43, 30) 100%); position: relati=
ve; }

table.side-effects-table .bars .frequency .frequency-indicator::before { co=
ntent: " "; display: block; width: 19px; height: 19px; position: absolute; =
top: 0px; left: 0px; margin: -6px 0px 0px -2px; border: 2px solid rgb(255, =
255, 255); background-color: rgb(249, 225, 30); box-shadow: rgba(0, 0, 0, 0=
.6) 0px 0px 4px; }

table.side-effects-table .bars.frequency-2 .frequency-indicator::before { l=
eft: 20%; background-color: rgb(243, 198, 30); }

table.side-effects-table .bars.frequency-3 .frequency-indicator::before { l=
eft: 40%; background-color: rgb(236, 157, 30); }

table.side-effects-table .bars.frequency-4 .frequency-indicator::before { l=
eft: 60%; background-color: rgb(226, 112, 30); }

table.side-effects-table .bars.frequency-5 .frequency-indicator::before { l=
eft: 80%; background-color: rgb(213, 43, 30); }

table.cost-table { clear: both; }

@media only screen and (max-width: 769px) {
  table.cost-table { display: block; padding: 0px; }
  table.cost-table td { background-color: rgba(0, 0, 0, 0); }
}

table.cost-table .injecting::before { display: none; }

table.cost-table caption { padding: 0px; margin: 0px; display: block; text-=
transform: lowercase; }

.pat-modal table.cost-table caption { margin-top: 1em; margin-bottom: 13px;=
 font-size: 1.5em; padding: 0px; font-weight: bold; line-height: 26px; colo=
r: rgb(225, 112, 0); }

.pat-modal table.cost-table caption label.pat-select.bare { color: rgb(225,=
 112, 0); }

@media only screen and (max-width: 769px) {
  table.cost-table caption { font-size: 1.4em; line-height: 33.8px; display=
: block; }
}

table.cost-table caption label.pat-select.bare { text-transform: none; colo=
r: rgb(0, 0, 0); float: left; }

table.cost-table caption a { color: rgb(225, 112, 0); }

table.cost-table caption::first-letter { text-transform: capitalize; }

table.cost-table .table-body-title { text-transform: lowercase; font-size: =
1.2em; }

table.cost-table .table-body-title::first-letter { text-transform: capitali=
ze; }

@media only screen and (max-width: 769px) {
  table.cost-table thead tr, table.cost-table tbody tr { display: block; }
}

@media only screen and (max-width: 769px) {
  table.cost-table thead tr.separation-row, table.cost-table tbody tr.separ=
ation-row { text-align: center; border-bottom: 1px solid silver; margin-bot=
tom: 1.5em; }
}

table.cost-table thead tr.separation-row th, table.cost-table tbody tr.sepa=
ration-row th { background: rgba(0, 0, 0, 0); }

@media only screen and (max-width: 769px) {
  table.cost-table thead tr.separation-row th, table.cost-table tbody tr.se=
paration-row th { display: none; }
  table.cost-table thead tr.separation-row th.price, table.cost-table tbody=
 tr.separation-row th.price { display: inline-block; background: rgb(255, 2=
55, 255); width: auto; padding: 0px 0.8em; margin-bottom: -1.03em; font-siz=
e: 0.8em; color: gray; }
}

table.cost-table thead tr.separation-row .separation-cell, table.cost-table=
 tbody tr.separation-row .separation-cell { padding-top: 1em; }

table.cost-table thead tr.separation-row:first-child .separation-cell, tabl=
e.cost-table tbody tr.separation-row:first-child .separation-cell { padding=
-top: 0px; }

table.cost-table thead th, table.cost-table thead td, table.cost-table tbod=
y th, table.cost-table tbody td { border-right: none; }

table.cost-table thead th.header-cell, table.cost-table thead td.header-cel=
l, table.cost-table tbody th.header-cell, table.cost-table tbody td.header-=
cell { padding: 0px; }

@media only screen and (min-width: 770px) {
  .product-fk .content-block table.cost-table thead th, .product-fk .conten=
t-block table.cost-table thead td, .product-fk .content-block table.cost-ta=
ble tbody th, .product-fk .content-block table.cost-table tbody td { font-s=
ize: 0.8em; line-height: 19.5px; }
}

@media only screen and (max-width: 769px) {
  table.cost-table thead th, table.cost-table thead td, table.cost-table tb=
ody th, table.cost-table tbody td { display: block; padding: 0px; }
  table.cost-table thead th::after, table.cost-table thead td::after, table=
.cost-table tbody th::after, table.cost-table tbody td::after { display: no=
ne; }
}

@media only screen and (max-width: 769px) {
  table.cost-table tbody { border: 1px solid silver; background: rgb(255, 2=
55, 255); padding: 0.8em; display: block; }
}

table.cost-table .active-ingredient { text-transform: lowercase; width: aut=
o; }

table.cost-table caption strong { text-transform: lowercase; }

table.cost-table p.variations { display: inline; }

table.cost-table p.variations .strengths .strength { text-transform: lowerc=
ase; display: inline-block; }

table.cost-table p.variations .strengths .strength::before { content: " =E2=
=80=A2 "; }

table.cost-table p.variations .strengths .strength:first-child::before { co=
ntent: "("; }

table.cost-table p.variations .strengths .strength:last-child::after { cont=
ent: ")"; }

table.cost-table th { width: auto; }

table.cost-table td.description { width: 60%; }

table.cost-table td.description .unit { text-transform: lowercase; display:=
 inline-block; margin-right: 0.2em; }

table.cost-table td.description .article-code { text-transform: lowercase; =
display: inline-block; background-color: rgba(0, 0, 0, 0.1); padding: 0px 0=
.5em; border-radius: 0.2em; color: gray; }

table.cost-table td.brand-name { text-transform: lowercase; width: auto; }

table.cost-table td.brand-name strong { display: inline-block; }

table.cost-table td.brand-name strong::first-letter { text-transform: upper=
case; }

table.cost-table td.brand-name .strength { font-style: normal; }

table.cost-table td.brand-name .strength::before { content: "("; }

table.cost-table td.brand-name .strength::after { content: ")"; }

@media only screen and (max-width: 769px) {
  table.cost-table td.brand-name { display: inline; }
}

table.cost-table td.unit, table.cost-table th.unit { width: auto; text-tran=
sform: lowercase; }

table.cost-table td.unit .volume .entity, table.cost-table th.unit .volume =
.entity { font-style: normal; }

table.cost-table td.unit::first-letter, table.cost-table th.unit::first-let=
ter { text-transform: uppercase; }

@media only screen and (min-width: 770px) {
  table.cost-table td.ddd { white-space: nowrap; width: 100px; }
  #kosten table.cost-table td.ddd { width: 60px; }
}

@media only screen and (max-width: 769px) {
  table.cost-table td.ddd { display: inline; }
  table.cost-table td.ddd::before { content: "DDD: "; }
}

@media only screen and (min-width: 770px) {
  table.cost-table td.price { width: 3em; }
}

@media only screen and (max-width: 769px) {
  table.cost-table td.price { float: right; font-weight: bold; padding: 0px=
; width: auto; }
}

table.cost-table th.price { width: auto; }

table.cost-table td.variations, table.cost-table th.variations { width: aut=
o; }

table.cost-table td.graph { font-size: 1em; line-height: 26px; padding-top:=
 0.2em; padding-bottom: 0.2em; }

@media only screen and (min-width: 770px) {
  table.cost-table td.graph { width: 180px; }
  .pat-modal table.cost-table td.graph { width: 420px; }
}

@media only screen and (max-width: 769px) {
  table.cost-table td.graph { padding: 0.5em 0px; clear: both; }
}

table.cost-table td.graph .graph-cluster { position: relative; margin-top: =
0.25em; margin-bottom: 0.25em; min-height: 1em; transition: 0.4s; width: 10=
0%; box-sizing: border-box; cursor: default; }

@media only screen and (min-width: 770px) {
  table.cost-table td.graph .graph-cluster { padding: 0px; }
}

@media only screen and (max-width: 769px) {
  table.cost-table td.graph .graph-cluster { padding: 0px 1.5em; }
  table.cost-table td.graph .graph-cluster::after { content: " "; display: =
block; position: absolute; inset: 0px; box-shadow: rgba(0, 0, 0, 0.4) 0px 0=
px 10px inset; }
}

table.cost-table td.graph .graph-cluster.pat-toggle::before { font-family: =
fontello; content: "=EE=A1=94"; background-color: rgb(229, 240, 249); posit=
ion: absolute; top: 0px; left: 0px; border-radius: 50%; width: 1em; height:=
 1em; line-height: 1.111em; text-align: center; padding: 0px; font-size: 1e=
m; color: rgb(1, 104, 155); transition: 0.4s; z-index: 1; cursor: pointer; =
}

.-moz- table.cost-table td.graph .graph-cluster.pat-toggle::before { conten=
t: ""; background-image: url("icon-close-circled-blue.svg"); background-siz=
e: 100% 100%; }

table.cost-table td.graph .graph-cluster:hover::before { color: rgb(0, 0, 0=
); }

table.cost-table td.graph .graph-cluster > .bar-graph { position: absolute;=
 top: 0px; bottom: 0px; left: 0px; margin: 0px; }

@media only screen and (min-width: 770px) {
  table.cost-table td.graph .graph-cluster > .bar-graph { right: 2px; }
}

table.cost-table td.graph .graph-cluster > .bar-graph > .segment { height: =
100%; }

table.cost-table td.graph .graph-cluster.collapsed .detail { margin: 0px 0p=
x -1em; opacity: 0; z-index: -1; }

table.cost-table td.graph .graph-cluster.expanded { overflow: hidden; paddi=
ng: 0.2em 0px 0.2em 1.5em; margin-top: 0px; margin-bottom: 0.1em; }

@media only screen and (max-width: 769px) {
  table.cost-table td.graph .graph-cluster.expanded { padding: 0.2em 1.5em;=
 }
}

table.cost-table td.graph .graph-cluster.expanded::before { transform: rota=
te(45deg); top: 0.25em; }

table.cost-table td.graph .graph-cluster.expanded > .bar-graph { top: -0.1e=
m; bottom: -0.1em; }

table.cost-table td.graph .graph-cluster.expanded > .bar-graph .segment { b=
ackground-color: rgba(0, 0, 0, 0.07); box-sizing: border-box; transition: 2=
s; }

table.cost-table td.graph .graph-cluster.expanded > .bar-graph .segment:las=
t-child { border-right: 2px dotted rgb(225, 112, 0); margin-right: -2px; }

table.cost-table td.graph .graph-cluster .detail { position: relative; marg=
in: 0.05em 0px; float: left; width: 100%; clear: both; transition: 0.8s; z-=
index: 1; cursor: pointer; }

table.cost-table td.graph .graph-cluster .detail .bar-graph { margin: 0px; =
height: 1em; transition: 0.5s; }

table.cost-table td.graph .graph-cluster .detail .bar-graph .segment { tran=
sition: 0.4s; cursor: pointer; }

table.cost-table td.graph .graph-cluster:hover > .detail-label .label { dis=
play: block; }

table.cost-table td.graph .graph-cluster .detail-label { position: absolute=
; top: 0px; right: 0px; left: 0.4em; display: block; z-index: 1; color: rgb=
(255, 255, 255); text-shadow: rgb(57, 135, 12) 0px 0px 2px, rgb(57, 135, 12=
) 0px 0px 2px, rgb(57, 135, 12) 0px 0px 2px, rgb(57, 135, 12) 0px 0px 2px, =
rgb(57, 135, 12) 0px 0px 2px; font-size: 0.6em; line-height: 1.8em; }

table.cost-table td.graph .graph-cluster .detail-label .quantity { text-tra=
nsform: lowercase; font-style: normal; background-color: rgba(0, 0, 0, 0); =
}

table.cost-table td.graph .graph-cluster .detail-label .label { display: no=
ne; font-style: normal; background-color: rgba(0, 0, 0, 0); }

table.cost-table td.graph .graph-cluster .detail-label:hover .quantity { di=
splay: none; }

table.cost-table td.graph .graph-cluster .detail-label:hover .label { displ=
ay: block; overflow: hidden; text-overflow: ellipsis; white-space: nowrap; =
}

table.hd { --table-avatar-height: 23px; }

table.hd thead, table.hd tbody, table.hd tfoot { font-size: 0.8em; }

table.hd thead th:not(.item-name), table.hd thead td:not(.item-state), tabl=
e.hd thead .item-name a, table.hd thead .item-state > a, table.hd tbody th:=
not(.item-name), table.hd tbody td:not(.item-state), table.hd tbody .item-n=
ame a, table.hd tbody .item-state > a, table.hd tfoot th:not(.item-name), t=
able.hd tfoot td:not(.item-state), table.hd tfoot .item-name a, table.hd tf=
oot .item-state > a { padding: 5px 10px; }

table.hd tbody td.functions a { width: 31px; height: 31px; }

table.hd tbody td.functions a::before { line-height: 32px; }

table.diagonal-headers { overflow-x: visible; }

table.diagonal-headers thead th { height: 120px; position: relative; backgr=
ound: rgba(0, 0, 0, 0); }

table.diagonal-headers thead th > :first-child { transform: rotate(-45deg);=
 transform-origin: 0px 0px; white-space: nowrap; overflow: hidden; text-ove=
rflow: ellipsis; position: absolute; bottom: 0px; width: 160px; cursor: def=
ault; transition: width 1s; }

table.diagonal-headers thead th:last-child { min-width: 120px; }

table.diagonal-headers thead:hover th > :first-child { width: auto; }

@media only screen and (max-width: 769px) {
  table { font-size: 0.9em; }
}

body:has(#global-nav.environment-product) #tabs, body:has(#app-space.state-=
paused) #tabs { display: none; }

#tabs .breadcrumbs { display: none; }

body:has(#app-dashboard.state-active) #tabs .breadcrumbs { display: flex; }

body:has(#app-dashboard.state-inactive) #tabs .breadcrumbs { display: none;=
 }

#tabs .tabs { display: flex; }

#tabs .tabs span.extra-tabs { font-size: 1.26562rem; padding-top: 54px; dis=
play: inline-block; float: right; height: 0px; width: 64px; overflow: hidde=
n; position: absolute; top: 0px; right: 0px; z-index: 1; box-sizing: border=
-box; transition: 0.1s; background: rgba(0, 0, 0, 0) !important; box-shadow=
: none !important; }

body[dir=3D"rtl"] #tabs .tabs span.extra-tabs { right: auto; left: 0px; flo=
at: left; }

#tabs .tabs span.extra-tabs::before { font-family: fontello; content: "=EE=
=A1=8D"; display: block; height: 44px; width: 64px; text-align: center; pos=
ition: absolute; top: 0px; right: 0px; border-top-right-radius: 0px; border=
-bottom-right-radius: 0px; }

body[dir=3D"rtl"] #tabs .tabs span.extra-tabs::before { content: ""; right:=
 auto; left: 0px; }

#tabs .tabs span.extra-tabs::after { content: " "; display: block; position=
: absolute; inset: 54px 0px 0px; border: 1px solid rgba(0, 0, 0, 0); box-sh=
adow: rgba(0, 0, 0, 0.2) 0px 2px 15px; border-radius: 0px; background: rgb(=
255, 255, 255); transition: border 0.2s; }

body[dir=3D"rtl"] #tabs .tabs span.extra-tabs::after { right: auto; left: 0=
px; }

#tabs .tabs span.extra-tabs:hover::before { color: rgb(0, 0, 0); }

#tabs .tabs span.extra-tabs a, #tabs .tabs span.extra-tabs label { display:=
 block; float: none; padding: 0.4em 0.7em; line-height: 1.5; text-align: le=
ft; color: rgb(0, 0, 0); position: relative; z-index: 1; opacity: 0; height=
: auto; border: none !important; border-radius: 0px !important; }

body[dir=3D"rtl"] #tabs .tabs span.extra-tabs a, body[dir=3D"rtl"] #tabs .t=
abs span.extra-tabs label { text-align: right; }

#tabs .tabs span.extra-tabs a::after, #tabs .tabs span.extra-tabs label::af=
ter { left: 0px; right: 0px; }

#tabs .tabs span.extra-tabs a:hover, #tabs .tabs span.extra-tabs label:hove=
r { background-color: rgba(0, 0, 0, 0.05); text-decoration: none; }

#tabs .tabs span.extra-tabs a.current, #tabs .tabs span.extra-tabs label.cu=
rrent { background: var(--colour-accent); color: rgb(255, 255, 255); }

#tabs .tabs.open span.extra-tabs { overflow: visible; height: auto; width: =
300px; padding-bottom: 15px; padding-top: 69px; }

#tabs .tabs.open span.extra-tabs::before { color: rgb(0, 0, 0); background-=
color: rgba(255, 255, 255, 0.4); }

#tabs .tabs.open span.extra-tabs::after { border-color: silver; }

#tabs .tabs.open span.extra-tabs a, #tabs .tabs.open span.extra-tabs label =
{ animation: 0.5s ease 0.2s 1 normal forwards running fadeIn; }

body:has(#app-dashboard.state-active) #tabs .tabs { display: none; }

#tabs .tabs .tab { background-color: rgba(0, 0, 0, 0.2); margin: 10px 10px =
0px 0px; box-sizing: border-box; height: 48px; line-height: 48px; grid-temp=
late-columns: 48px auto 44px; align-items: center; color: rgb(255, 255, 255=
); font-size: 22px; float: left; display: none; cursor: default; animation:=
 0.4s ease 0s 1 normal none running bounceIn; position: relative; }

#tabs .tabs .tab .label { overflow: hidden; text-overflow: ellipsis; white-=
space: nowrap; }

#tabs .tabs .tab.state-on, #tabs .tabs .tab.state-dormant { display: inline=
-grid; }

#tabs .tabs .tab.state-dormant:hover { background-color: rgba(0, 0, 0, 0.3)=
; }

#tabs .tabs .tab.state-dormant::before, #tabs .tabs .tab.state-dormant .app=
-icon { background-color: rgba(0, 0, 0, 0) !important; }

#tabs .tabs .tab.state-dormant .label::before { content: " "; display: inli=
ne-block; background-color: rgba(0, 0, 0, 0); width: 48px; height: 48px; po=
sition: absolute; left: 0px; }

#tabs .tabs .tab.state-on { box-shadow: rgb(255, 255, 255) 0px 0px 0px 2px =
inset; }

#tabs .tabs .tab .app-menu-trigger { height: 48px; display: inline-block; c=
ursor: default; }

#tabs .tabs .tab .app-menu-trigger:hover .app-icon { filter: brightness(1.2=
); }

#tabs .tabs .tab .app-icon { width: 38px; height: 38px; margin: 5px 0px 5px=
 5px; }

#tabs .tabs .tab .close-button { font-size: 0px; overflow: hidden; white-sp=
ace: nowrap; position: relative; cursor: default; height: 100%; background-=
color: rgba(0, 0, 0, 0); }

#tabs .tabs .tab .close-button:hover::before { background-color: rgba(0, 0,=
 0, 0.4); color: rgb(255, 255, 255); }

#tabs .tabs .tab .close-button::before { display: block; font-family: fonte=
llo; content: "=EE=A2=83"; background-color: rgba(0, 0, 0, 0.2); color: rgb=
a(255, 255, 255, 0.8); border-radius: 50%; font-size: 10px; width: 18px; he=
ight: 18px; line-height: 18px; text-align: center; position: absolute; top:=
 50%; right: 10px; transform: translateY(-50%); }

.task-list { gap: 32px; margin-bottom: 1em; }

@media only screen and (min-width: 770px) {
  .task-list { display: grid; }
}

@media only screen and (min-width: 1280px) {
  .task-list.count-2 { grid-template-columns: 1fr 1fr; }
  .task-list.count-3 { grid-template-columns: 1fr 1fr 1fr; }
  .task-list.count-4 { grid-template-columns: 1fr 1fr 1fr 1fr; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .task-list.count-2 { grid-template-columns: 1fr 1fr; }
  .task-list.count-3 { grid-template-columns: 1fr 1fr 1fr; }
  .task-list.count-4 { grid-template-columns: 1fr 1fr 1fr; }
}

.task-list li.state-draft a { color: rgb(225, 112, 0); }

.task-list li a:hover { text-decoration: none; }

.task-list li a:hover .item-title { text-decoration: underline; }

@media only screen and (max-width: 769px) {
  .task-list li a { padding: 15px 40px 15px 20px; display: block; backgroun=
d-color: rgb(243, 243, 243); position: relative; margin-bottom: 2px; }
  .task-list li a::after { position: absolute; top: 50%; height: auto; tran=
sform: translateY(-50%); right: 20px; font-family: fontello; content: "=EE=
=A2=84"; font-size: 25px; color: gray; }
}

.task-list li a .item-title { font-size: 1.60181rem; line-height: 1.24859; =
font-weight: normal; margin-top: 0px; margin-bottom: 0.5rem; text-underline=
-offset: 0.18em; }

@media only screen and (max-width: 769px) {
  .task-list li a .item-title { font-size: 1.3125em; font-weight: bold; lin=
e-height: 1.2381; margin: 0px; }
}

.task-list li a .byline { color: rgb(0, 0, 0); line-height: 1.375em; hyphen=
s: auto; display: -webkit-box; -webkit-box-orient: vertical; -webkit-line-c=
lamp: 3; overflow: hidden; }

@media only screen and (max-width: 769px) {
  .task-list li a .byline { padding-top: 2px; font-size: 16px; display: non=
e; }
}

.tile-navigation { display: grid; gap: 30px; grid-auto-rows: 1fr; font-size=
: 1.125rem; }

@media only screen and (min-width: 1280px) {
  .tile-navigation.col-3 { grid-template-columns: repeat(3, 1fr); gap: 20px=
; }
}

@media only screen and (min-width: 770px) and (max-width: 1279px) {
  .tile-navigation.col-3 { grid-template-columns: 1fr 1fr; }
}

@media only screen and (min-width: 770px) {
  .tile-navigation.col-1, .tile-navigation.col-2 { grid-template-columns: 1=
fr 1fr; }
}

@media only screen and (max-width: 1279px) {
  .tile-navigation { grid-template-columns: 1fr; }
}

.tile-navigation .tile-navigation-follow { background: rgb(243, 243, 243); =
display: block; padding: 7% 10%; position: relative; hyphens: auto; }

.tile-navigation .tile-navigation-follow:hover { text-decoration: none; }

.no-touchevents .tile-navigation .tile-navigation-follow:hover .title { tex=
t-decoration: underline; }

.no-touchevents .tile-navigation .tile-navigation-follow:hover::before { tr=
ansform: scale(1.1) translateY(-50%); }

.tile-navigation .tile-navigation-follow .title { font-size: 1.60181rem; li=
ne-height: 1.24859; font-weight: normal; margin-top: 0px; margin-bottom: 0.=
5rem; text-underline-offset: 0.18em; }

@media only screen and (max-width: 769px) {
  .tile-navigation .tile-navigation-follow .title { font-size: 1.3125em; fo=
nt-weight: bold; line-height: 1.2381; margin: 0px; }
}

.tile-navigation .tile-navigation-follow .byline { color: rgb(0, 0, 0); lin=
e-height: 1.375em; hyphens: auto; display: -webkit-box; -webkit-box-orient:=
 vertical; -webkit-line-clamp: 3; overflow: hidden; }

#title-block { position: relative; }

#title-block .validation.message { font-size: 1rem; }

#title-block .placeholder { font-style: normal; color: silver; }

#title-block:hover textarea { outline: rgb(143, 202, 231) dotted 2px; outli=
ne-offset: 13px; }

#title-block textarea:focus { outline: rgb(0, 0, 0) dotted 2px; outline-off=
set: 13px; }

#title-block #document-title { white-space: pre-wrap; }

#title-block .pat-content-mirror { position: absolute; inset: 0px; padding:=
 0px; margin: 0px; resize: none; width: 100%; height: 100%; background: rgb=
a(0, 0, 0, 0); white-space: pre-wrap; }

#title-block .pat-content-mirror.has-value { -webkit-text-fill-color: rgba(=
0, 0, 0, 0); background-color: rgba(0, 0, 0, 0); }

.pat-toolbar { pointer-events: none; }

.pat-toolbar > * { pointer-events: all; }

.pat-modal .pat-toolbar { margin-top: -7px; margin-bottom: 10px; padding-to=
p: 0px; }

.pat-toolbar .pat-context-menu .panel-content { font-size: 18px; }

.pat-toolbar .pat-context-menu .panel-content .menu-list li button, .pat-to=
olbar .pat-context-menu .panel-content .menu-list li a { font-size: 18px; }

.pat-toolbar#dashboard-toolbar > * { grid-template-columns: 1fr 0px 1fr; }

.pat-toolbar#medicine-landing-toolbar > * { grid-template-columns: 4fr 0px =
1fr; }

.pat-toolbar#report-toolbar > * { grid-template-columns: 100% 0px 0px; }

.pat-toolbar#report-toolbar > * .toolbar-section.view-options { justify-con=
tent: flex-start; }

.pat-toolbar#cms-section-toolbar .toolbar-navigation-area, .pat-toolbar#fol=
der-toolbar .toolbar-navigation-area { transition: opacity 1s; }

.app-body.mode-select .pat-toolbar#cms-section-toolbar .toolbar-navigation-=
area, .app-body.mode-select .pat-toolbar#folder-toolbar .toolbar-navigation=
-area { opacity: 0; pointer-events: none; }

.app-body.mode-select .pat-toolbar#cms-section-toolbar .toolbar-functions-a=
rea, .app-body.mode-select .pat-toolbar#folder-toolbar .toolbar-functions-a=
rea { grid-template-columns: auto 0px auto; }

.app-body.mode-select .pat-toolbar#cms-section-toolbar .pat-toolbar-search-=
field, .app-body.mode-select .pat-toolbar#cms-section-toolbar .icon.new, .a=
pp-body.mode-select .pat-toolbar#folder-toolbar .pat-toolbar-search-field, =
.app-body.mode-select .pat-toolbar#folder-toolbar .icon.new { opacity: 0.5;=
 pointer-events: none; }

.app-body.mode-select .pat-toolbar#cms-section-toolbar .filter-menu, .app-b=
ody.mode-select .pat-toolbar#cms-section-toolbar .toolbar-title, .app-body.=
mode-select .pat-toolbar#cms-section-toolbar .icon.level-up, .app-body.mode=
-select .pat-toolbar#cms-section-toolbar .pat-button.edit, .app-body.mode-s=
elect .pat-toolbar#cms-section-toolbar .icon.language, .app-body.mode-selec=
t .pat-toolbar#cms-section-toolbar .icon.preview, .app-body.mode-select .pa=
t-toolbar#folder-toolbar .filter-menu, .app-body.mode-select .pat-toolbar#f=
older-toolbar .toolbar-title, .app-body.mode-select .pat-toolbar#folder-too=
lbar .icon.level-up, .app-body.mode-select .pat-toolbar#folder-toolbar .pat=
-button.edit, .app-body.mode-select .pat-toolbar#folder-toolbar .icon.langu=
age, .app-body.mode-select .pat-toolbar#folder-toolbar .icon.preview { disp=
lay: none; }

.pat-toolbar#cms-section-toolbar .batch-operation, .pat-toolbar#folder-tool=
bar .batch-operation { display: none; animation: 1s ease 0s 1 normal none r=
unning fadeIn; }

.app-body.mode-select .pat-toolbar#cms-section-toolbar .batch-operation, .a=
pp-body.mode-select .pat-toolbar#folder-toolbar .batch-operation { display:=
 inline-block; }

.pat-toolbar#landing-browse-toolbar > * { grid-template-columns: 1fr 0px 1f=
r; }

.pat-toolbar#landing-browse-toolbar .toolbar-section.view-options { grid-ar=
ea: right; text-align: right; }

.pat-toolbar#landing-browse-toolbar .toolbar-section.view-options > * { mar=
gin-right: 0px; }

.pat-toolbar#landing-browse-toolbar .toolbar-section.navigation { grid-area=
: left; text-align: left; }

@media only screen and (max-width: 769px) {
  .pat-toolbar#landing-browse-toolbar #grouping-options { display: none; }
}

.pat-toolbar#organisations-toolbar > * { grid-template-columns: auto 0px 25=
0px; }

.pat-toolbar#organisations-toolbar .toolbar-section.navigation { grid-area:=
 left; text-align: left; }

.pat-toolbar#glossary-toolbar > * { grid-template-columns: auto 0px 130px; =
}

.pat-toolbar#glossary-toolbar .toolbar-section.navigation { grid-area: left=
; text-align: left; }

.pat-toolbar#cms-page-toolbar .toolbar-functions-area, .pat-toolbar#cms-pag=
e-toolbar .toolbar-navigation-area { grid-template-columns: 4fr 1fr; }

.pat-toolbar#user-management-toolbar .toolbar-functions-area, .pat-toolbar#=
user-management-toolbar .toolbar-navigation-area { grid-template-columns: 1=
fr 1fr 1fr; }

.pat-toolbar#cms-settings-toolbar .toolbar-functions-area, .pat-toolbar#cms=
-settings-toolbar .toolbar-navigation-area { grid-template-columns: 1fr 1fr=
 1fr; }

.pat-toolbar#folder-toolbar .toolbar-functions-area, .pat-toolbar#folder-to=
olbar .toolbar-navigation-area { grid-template-columns: 1fr 1fr 1fr; }

.pat-toolbar#cms-page-toolbar-edit .context-menu { display: inline-block; }

.pat-toolbar#cms-page-toolbar-edit .toolbar-functions-area { grid-template-=
columns: auto 0px auto; }

.pat-toolbar#image-bank-toolbar .toolbar-functions-area, .pat-toolbar#image=
-bank-toolbar .toolbar-navigation-area { grid-template-columns: 4fr 1fr; }

.pat-toolbar#transparency-calendar-toolbar .toolbar-functions-area, .pat-to=
olbar#transparency-calendar-toolbar .toolbar-navigation-area { grid-templat=
e-columns: 4fr 1fr; }

.pat-toolbar#image-edit-toolbar .toolbar-functions-area, .pat-toolbar#image=
-edit-toolbar .toolbar-navigation-area { grid-template-columns: 1fr 4fr; }

.tooltip-container.medicine-cost-details { width: 450px; }

.tooltip-container.versioning-menu .tippy-content { padding: 25px; }

.tooltip-container.versioning-menu .tippy-box { width: 700px; max-width: 10=
0% !important; }

.tooltip-container.versioning-menu .tippy-box .pat-grid-list { font-size: 0=
.8em; margin-bottom: 20px; grid-template-columns: 25% auto; }

.tooltip-container.versioning-menu .tippy-box .pat-grid-list a { text-decor=
ation: none; }

.tooltip-container.versioning-menu .tippy-box .pat-grid-list a:hover { text=
-decoration: underline; }

.tooltip-container.versioning-menu .tippy-box .pat-grid-list .pat-message {=
 margin-top: 8px; margin-bottom: 5px; box-shadow: rgba(0, 0, 0, 0.1) 0px 0p=
x 0px 1px inset; padding: 9px; font-size: 0.9em; }

.tooltip-container.versioning-menu .tippy-box .pat-well { padding: 15px 18p=
x 18px; margin: -18px -18px 15px; }

.tooltip-container.versioning-menu .tippy-box .pat-well:last-child { margin=
: -18px; }

.tooltip-container.versioning-menu .tippy-box .link-list { columns: 4; }

.tooltip-container > div > section.pat-rich:last-child > :last-child { marg=
in-bottom: 0px; }

.tooltip-container > div .label { display: inline-block; border-radius: 0.3=
em; background-color: gray; color: rgb(255, 255, 255); padding: 0px 0.6em; =
}

.tooltip-container > div .label.reimbursed { background-color: rgb(57, 135,=
 12); }

.tooltip-container > div .label.contribution { background-color: rgb(196, 2=
19, 182); color: rgb(57, 135, 12); }

.tooltip-container .content-type-switch { display: block; padding: 5px 0px;=
 font-size: 1em; margin-bottom: 0px; text-align: left; }

.tooltip-container .content-type-switch a { margin: 0px; padding: 10px 0px;=
 text-align: center; }

.tooltip-container .content-type-switch::before { display: none; }

.tooltip-container .content-type-switch .counter { display: inline-block; m=
argin: 0.8em 0em 0.5em 0.5em; background-color: rgb(213, 43, 30); color: rg=
b(255, 255, 255); border-radius: 1em; border: 1px solid rgb(255, 255, 255);=
 height: 1.8em; min-width: 1.8em; box-sizing: border-box; padding: 0px 0.5e=
m; transition: opacity 0.5s; animation: 0.6s ease 0s 1 normal none running =
zoomIn; vertical-align: baseline; line-height: 1.7em; font-size: 0.6em; tex=
t-align: center; font-weight: normal; position: relative; top: -0.2em; }

.tooltip-container .content-type-switch .counter.disabled { opacity: 0.2; a=
nimation: auto ease 0s 1 normal none running none; background-color: gray; =
}

.tooltip-container .content-type-switch .counter.injecting { opacity: 0; }

.tooltip-container .content-type-switch .counter.injecting::before { displa=
y: none; }

.tooltip-container.medicine-cost-details { width: 450px; }

.tooltip-container > div > section.pat-rich:last-child > :last-child { marg=
in-bottom: 0px; }

.tooltip-container > div .label { display: inline-block; border-radius: 0.3=
em; background-color: gray; color: rgb(255, 255, 255); padding: 0px 0.6em; =
}

.tooltip-container > div .label.reimbursed { background-color: rgb(57, 135,=
 12); }

.tooltip-container > div .label.contribution { background-color: rgb(196, 2=
19, 182); color: rgb(57, 135, 12); }

.topic-list { margin: 3rem auto 1.5rem; }

.topic-list .topic-list-section .topic-list-section-title { margin-bottom: =
1.5rem; font-size: 1.60181rem; line-height: 1.24859; font-weight: bold; }

.topic-list .topic-list-section + .topic-list-section .topic-list-section-t=
itle { padding-top: 2rem; border-top: 1px solid rgb(225, 225, 225); }

.topic-list .topic-list-section .link-list { margin-bottom: 2rem; }

.user-info .user-image { width: 100%; }

.video-player video { width: 100%; display: block; margin: 0px 0px 2px; }

.video-player .video-player-extras .video-player-extra { background: rgb(24=
3, 243, 243); margin-bottom: 1px; }

.video-player .video-player-extras .video-player-extra .panel-content { pad=
ding-bottom: 20px; }

.no-js .video-player .video-player-extras .video-player-extra .video-player=
-extra-title { padding: 0px 0px 12px; display: block; }

.js .video-player .video-player-extras .video-player-extra .video-player-ex=
tra-title { padding: 0.75rem 40px 0.75rem 0.75rem; color: rgb(1, 104, 155);=
 cursor: pointer; font-size: 1rem; line-height: 1; font-weight: normal; pos=
ition: relative; display: block; }

.js .video-player .video-player-extras .video-player-extra .video-player-ex=
tra-title::after { content: "=EE=A3=87"; font-family: fontello; position: a=
bsolute; right: 1rem; top: 50%; transform: translateY(-50%); transition: 0.=
4s; }

.js .video-player .video-player-extras .video-player-extra .video-player-ex=
tra-title.collapsible-open::after { transform: translateY(-50%) scaleY(-1);=
 }

.video-player .video-player-extras .video-player-extra .pat-rich { padding:=
 1rem; }

.video-player .video-player-extras .video-player-extra .file-download { pad=
ding: 0.5rem 1rem; text-decoration: none; margin: 0px; font-size: 1.26562re=
m; line-height: 1.58025; }

.video-player .video-player-extras .video-player-extra .file-download .titl=
e { font-size: 1.26562rem; line-height: 1.58025; font-weight: normal; margi=
n: 0px; }

.video-player .video-player-extras .video-player-extra .file-download:hover=
 { text-decoration: none; background: rgb(230, 230, 230); }

.video-player .video-player-extras .video-player-extra .file-download:hover=
 .title { text-decoration: none; }

.video-player .video-player-extras .video-player-extra .file-download::befo=
re, .video-player .video-player-extras .video-player-extra .file-download::=
after { left: 0px; margin: 0px; }

.pat-well { text-decoration: none; padding: 20px; margin-bottom: 26px; }

.pat-well.applied-filters .button-cancel { float: right; margin-top: -7px; =
margin-right: 0px; margin-left: 1em; }

@media print {
  .pat-well { background: rgb(255, 255, 255); border: 3px solid rgb(229, 24=
0, 249); }
}

.content-block h2 + .pat-well { margin-top: -0.3em; }

.pat-well.tickets { background: rgba(0, 0, 0, 0); overflow: hidden; padding=
: 0px; }

.pat-well.tickets .intro-bar { margin-bottom: 1em; }

.pat-well.tickets .intro-bar::after { content: " "; display: table; clear: =
both; }

@media only screen and (min-width: 770px) {
  .pat-well.tickets .intro-bar .intro-bar-functions { float: right; margin-=
bottom: 0px; }
  .pat-well.tickets .intro-bar .intro-bar-functions a { text-decoration: no=
ne; color: rgb(1, 104, 155); }
  .pat-well.tickets .intro-bar .intro-bar-functions a:hover { text-decorati=
on: underline; color: rgb(0, 0, 0); }
  .pat-well.tickets .intro-bar .intro-bar-functions a:hover::before { text-=
decoration: none; }
}

.pat-well.tickets * { color: rgb(0, 0, 0); }

.pat-well.collapsibles { background: rgba(0, 0, 0, 0); overflow: hidden; pa=
dding: 0px; }

.pat-well.collapsibles .pat-collapsible:not(.page-module):not(.context-menu=
):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):n=
ot(.place-on-homescreen):not(.borderless) { margin-bottom: 2px; background-=
color: rgb(243, 243, 243); border: none; margin-top: 0px !important; }

.no-js .pat-well.collapsibles .pat-collapsible:not(.page-module):not(.conte=
xt-menu):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-mes=
sage):not(.place-on-homescreen):not(.borderless) { padding: 1em; box-sizing=
: border-box; }

.pat-well.collapsibles .pat-collapsible:not(.page-module):not(.context-menu=
):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):n=
ot(.place-on-homescreen):not(.borderless):last-child { margin-bottom: 0px; =
}

.pat-well.collapsibles .pat-collapsible:not(.page-module):not(.context-menu=
):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):n=
ot(.place-on-homescreen):not(.borderless) .panel-content { box-sizing: bord=
er-box; padding-right: 1em; }

.pat-well.collapsibles .pat-collapsible:not(.page-module):not(.context-menu=
):not(.place-on-homescreen):not(.search-box):not(.help):not(.pat-message):n=
ot(.place-on-homescreen):not(.borderless) .panel-content > :last-child { ma=
rgin-bottom: 0px; }

.pat-well.collapsibles .pat-collapsible > h3 { font-weight: bold; }

.pat-well.collapsibles .pat-collapsible > h3.collapsible-closed, .pat-well.=
collapsibles .pat-collapsible > h3.collapsible-open { padding-right: 1em; }

.pat-well h2, .pat-well h3, .pat-well h4 { color: rgb(0, 0, 0); }

.pat-well > .title { margin: 0px; font-size: 1em; line-height: 1.4; }

.pat-well > .title.warning::before { font-family: fontello; content: "=EE=
=A0=95"; }

.pat-well .publication-date { font-size: 0.8em; font-style: italic; }

.pat-well .read-more { margin: 0px; padding: 0px; text-decoration: underlin=
e; font-weight: bold; }

.pat-well p { margin-bottom: 26px; }

.pat-well > p:last-child { margin-bottom: 0px; }

.pat-well .buttons::after { content: " "; display: table; clear: both; }

.pat-well.editors-well { padding: 10px 20px 20px; background-color: rgb(251=
, 234, 217); }

.pat-well.editors-well h2 { border: none; }

.pat-well.editors-well h2::before { display: none; }

.pat-well.editors-well h2 a { color: rgb(103, 51, 39); }

.pat-well.editors-well ul { margin-bottom: 10px; }

.pat-well .function-header { height: 2.2em; margin-top: -26px; margin-right=
: -26px; margin-left: -26px; overflow: hidden; transition: 0.4s; background=
: rgba(0, 0, 0, 0.05); display: none; }

@media print {
  .pat-well .function-header { display: none; }
}

.pat-well .function-header a.pat-switch { text-decoration: none; cursor: po=
inter; }

.pat-well .function-header .function { padding: 0.35em 1em; }

.pat-well .function-header #dose-close-all::before { transform: rotate(45de=
g); }

.pat-well div.no-title { padding: 13px 0px; margin-bottom: 26px; clear: bot=
h; }

@media screen {
  .pat-well div.no-title { border-top: 2px dotted rgba(0, 0, 0, 0.2); borde=
r-bottom: 2px dotted rgba(0, 0, 0, 0.2); }
}

.pat-well div.no-title > :last-child { margin-bottom: 0px; }

.pat-well.all-open .dose-open-all { display: none; }

.pat-well.all-closed .dose-close-all { display: none; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: cid:css-6cc66aba-3c49-4ab9-aa19-14b345540fa3@mhtml.blink

@charset "utf-8";

@font-face { font-family: FigtreeVF; src: url("chrome-extension://majdfhpai=
honcoakbjgbdhglocklcgno/fonts/FigtreeVF.woff2") format("woff2-variations");=
 font-weight: 100 1000; font-display: swap; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: cid:css-e30718dc-8993-479a-9861-d8463642433f@mhtml.blink

@charset "utf-8";

@font-face { font-family: "Inter var"; font-weight: 100 900; font-display: =
swap; font-style: normal; src: url("chrome-extension://infppggnoaenmfagbfkn=
fkancpbljcca/Inter-roman-latin.var.woff2") format("woff2"); }

.automa-element-selector { direction: ltr; }

[automa-isdragging] { user-select: none; }

[automa-el-list] { outline: rgb(99, 102, 241) dashed 2px; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz----
Content-Type: text/css
Content-Transfer-Encoding: quoted-printable
Content-Location: cid:css-06842c42-6ff6-42d3-ad3a-feac74438445@mhtml.blink

@charset "utf-8";

body { transition: opacity 0.2s ease-in; }

body[unresolved] { opacity: 0; display: block; overflow: hidden; position: =
relative; }
------MultipartBoundary--ufALSudqSCtYFPz4wm6OWEZxU1CPlksO02xykp1nMz------
